Gene	"Gene synonym"	Ensembl	"Gene description"	Uniprot	Chromosome	Position	"Protein class"	"Biological process"	"Molecular function"	"Disease involvement"	Evidence	"HPA evidence"	"UniProt evidence"	"NeXtProt evidence"	"MS evidence"	"RNA tissue specificity"	"RNA tissue distribution"	"RNA tissue specificity score"	"RNA tissue specific NX"	"RNA cell line specificity"	"RNA cell line distribution"	"RNA cell line specificity score"	"RNA cell line specific NX"	"RNA cancer specificity"	"RNA cancer distribution"	"RNA cancer specificity score"	"RNA cancer specific FPKM"	"RNA brain regional specificity"	"RNA brain regional distribution"	"RNA brain regional specificity score"	"RNA brain regional specific NX"	"RNA blood cell specificity"	"RNA blood cell distribution"	"RNA blood cell specificity score"	"RNA blood cell specific NX"	"RNA blood lineage specificity"	"RNA blood lineage distribution"	"RNA blood lineage specificity score"	"RNA blood lineage specific NX"	"RNA mouse brain regional specificity"	"RNA mouse brain regional distribution"	"RNA mouse brain regional specificity score"	"RNA mouse brain regional specific pTPM"	"RNA pig brain regional specificity"	"RNA pig brain regional distribution"	"RNA pig brain regional specificity score"	"RNA pig brain regional specific pTPM"	Antibody	"Reliability (IH)"	"Reliability (Mouse Brain)"	"Reliability (IF)"	"Subcellular location"	"Secretome location"	"Blood concentration - Conc. blood IM [pg/L]"	"Blood concentration - Conc. blood MS [pg/L]"	"Subcellular main location"	"Subcellular additional location"	"Antibody RRID"	"Pathology prognostics - Breast cancer"	"Pathology prognostics - Cervical cancer"	"Pathology prognostics - Colorectal cancer"	"Pathology prognostics - Endometrial cancer"	"Pathology prognostics - Glioma"	"Pathology prognostics - Head and neck cancer"	"Pathology prognostics - Liver cancer"	"Pathology prognostics - Lung cancer"	"Pathology prognostics - Melanoma"	"Pathology prognostics - Ovarian cancer"	"Pathology prognostics - Pancreatic cancer"	"Pathology prognostics - Prostate cancer"	"Pathology prognostics - Renal cancer"	"Pathology prognostics - Stomach cancer"	"Pathology prognostics - Testis cancer"	"Pathology prognostics - Thyroid cancer"	"Pathology prognostics - Urothelial cancer"	"Tissue RNA - adipose tissue [NX]"	"Tissue RNA - adrenal gland [NX]"	"Tissue RNA - amygdala [NX]"	"Tissue RNA - appendix [NX]"	"Tissue RNA - basal ganglia [NX]"	"Tissue RNA - bone marrow [NX]"	"Tissue RNA - breast [NX]"	"Tissue RNA - cerebellum [NX]"	"Tissue RNA - cerebral cortex [NX]"	"Tissue RNA - cervix, uterine [NX]"	"Tissue RNA - colon [NX]"	"Tissue RNA - corpus callosum [NX]"	"Tissue RNA - ductus deferens [NX]"	"Tissue RNA - duodenum [NX]"	"Tissue RNA - endometrium 1 [NX]"	"Tissue RNA - epididymis [NX]"	"Tissue RNA - esophagus [NX]"	"Tissue RNA - fallopian tube [NX]"	"Tissue RNA - gallbladder [NX]"	"Tissue RNA - heart muscle [NX]"	"Tissue RNA - hippocampal formation [NX]"	"Tissue RNA - hypothalamus [NX]"	"Tissue RNA - kidney [NX]"	"Tissue RNA - liver [NX]"	"Tissue RNA - lung [NX]"	"Tissue RNA - lymph node [NX]"	"Tissue RNA - midbrain [NX]"	"Tissue RNA - olfactory region [NX]"	"Tissue RNA - ovary [NX]"	"Tissue RNA - pancreas [NX]"	"Tissue RNA - parathyroid gland [NX]"	"Tissue RNA - pituitary gland [NX]"	"Tissue RNA - placenta [NX]"	"Tissue RNA - pons and medulla [NX]"	"Tissue RNA - prostate [NX]"	"Tissue RNA - rectum [NX]"	"Tissue RNA - retina [NX]"	"Tissue RNA - salivary gland [NX]"	"Tissue RNA - seminal vesicle [NX]"	"Tissue RNA - skeletal muscle [NX]"	"Tissue RNA - skin 1 [NX]"	"Tissue RNA - small intestine [NX]"	"Tissue RNA - smooth muscle [NX]"	"Tissue RNA - spinal cord [NX]"	"Tissue RNA - spleen [NX]"	"Tissue RNA - stomach 1 [NX]"	"Tissue RNA - testis [NX]"	"Tissue RNA - thalamus [NX]"	"Tissue RNA - thymus [NX]"	"Tissue RNA - thyroid gland [NX]"	"Tissue RNA - tongue [NX]"	"Tissue RNA - tonsil [NX]"	"Tissue RNA - urinary bladder [NX]"	"Tissue RNA - vagina [NX]"	"Tissue RNA - B-cells [NX]"	"Tissue RNA - dendritic cells [NX]"	"Tissue RNA - granulocytes [NX]"	"Tissue RNA - monocytes [NX]"	"Tissue RNA - NK-cells [NX]"	"Tissue RNA - T-cells [NX]"	"Tissue RNA - total PBMC [NX]"	"Cell RNA - A-431 [NX]"	"Cell RNA - A549 [NX]"	"Cell RNA - AF22 [NX]"	"Cell RNA - AN3-CA [NX]"	"Cell RNA - ASC diff [NX]"	"Cell RNA - ASC TERT1 [NX]"	"Cell RNA - BEWO [NX]"	"Cell RNA - BJ [NX]"	"Cell RNA - BJ hTERT+ [NX]"	"Cell RNA - BJ hTERT+ SV40 Large T+ [NX]"	"Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [NX]"	"Cell RNA - CACO-2 [NX]"	"Cell RNA - CAPAN-2 [NX]"	"Cell RNA - Daudi [NX]"	"Cell RNA - EFO-21 [NX]"	"Cell RNA - fHDF/TERT166 [NX]"	"Cell RNA - HaCaT [NX]"	"Cell RNA - HAP1 [NX]"	"Cell RNA - HBEC3-KT [NX]"	"Cell RNA - HBF TERT88 [NX]"	"Cell RNA - HDLM-2 [NX]"	"Cell RNA - HEK 293 [NX]"	"Cell RNA - HEL [NX]"	"Cell RNA - HeLa [NX]"	"Cell RNA - Hep G2 [NX]"	"Cell RNA - HHSteC [NX]"	"Cell RNA - HL-60 [NX]"	"Cell RNA - HMC-1 [NX]"	"Cell RNA - HSkMC [NX]"	"Cell RNA - hTCEpi [NX]"	"Cell RNA - hTEC/SVTERT24-B [NX]"	"Cell RNA - hTERT-HME1 [NX]"	"Cell RNA - HUVEC TERT2 [NX]"	"Cell RNA - K-562 [NX]"	"Cell RNA - Karpas-707 [NX]"	"Cell RNA - LHCN-M2 [NX]"	"Cell RNA - MCF7 [NX]"	"Cell RNA - MOLT-4 [NX]"	"Cell RNA - NB-4 [NX]"	"Cell RNA - NTERA-2 [NX]"	"Cell RNA - PC-3 [NX]"	"Cell RNA - REH [NX]"	"Cell RNA - RH-30 [NX]"	"Cell RNA - RPMI-8226 [NX]"	"Cell RNA - RPTEC TERT1 [NX]"	"Cell RNA - RT4 [NX]"	"Cell RNA - SCLC-21H [NX]"	"Cell RNA - SH-SY5Y [NX]"	"Cell RNA - SiHa [NX]"	"Cell RNA - SK-BR-3 [NX]"	"Cell RNA - SK-MEL-30 [NX]"	"Cell RNA - T-47d [NX]"	"Cell RNA - THP-1 [NX]"	"Cell RNA - TIME [NX]"	"Cell RNA - U-138 MG [NX]"	"Cell RNA - U-2 OS [NX]"	"Cell RNA - U-2197 [NX]"	"Cell RNA - U-251 MG [NX]"	"Cell RNA - U-266/70 [NX]"	"Cell RNA - U-266/84 [NX]"	"Cell RNA - U-698 [NX]"	"Cell RNA - U-87 MG [NX]"	"Cell RNA - U-937 [NX]"	"Cell RNA - WM-115 [NX]"	"Blood RNA - basophil [NX]"	"Blood RNA - classical monocyte [NX]"	"Blood RNA - eosinophil [NX]"	"Blood RNA - gdT-cell [NX]"	"Blood RNA - intermediate monocyte [NX]"	"Blood RNA - MAIT T-cell [NX]"	"Blood RNA - memory B-cell [NX]"	"Blood RNA - memory CD4 T-cell [NX]"	"Blood RNA - memory CD8 T-cell [NX]"	"Blood RNA - myeloid DC [NX]"	"Blood RNA - naive B-cell [NX]"	"Blood RNA - naive CD4 T-cell [NX]"	"Blood RNA - naive CD8 T-cell [NX]"	"Blood RNA - neutrophil [NX]"	"Blood RNA - NK-cell [NX]"	"Blood RNA - non-classical monocyte [NX]"	"Blood RNA - plasmacytoid DC [NX]"	"Blood RNA - T-reg [NX]"	"Blood RNA - total PBMC [NX]"	"Brain RNA - amygdala [NX]"	"Brain RNA - basal ganglia [NX]"	"Brain RNA - cerebellum [NX]"	"Brain RNA - cerebral cortex [NX]"	"Brain RNA - hippocampal formation [NX]"	"Brain RNA - hypothalamus [NX]"	"Brain RNA - midbrain [NX]"	"Brain RNA - olfactory region [NX]"	"Brain RNA - pons and medulla [NX]"	"Brain RNA - thalamus [NX]"
AADAT	"KAT2, KATII, KYAT2"	ENSG00000109576	"Aminoadipate aminotransferase"	Q8N5Z0	4	170060222-170091699	"Enzymes, Predicted intracellular proteins"		"Aminotransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"liver: 56.5"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA037502	Enhanced		Approved	"Vesicles,Plasma membrane"				"Plasma membrane"	Vesicles	"HPA037502: AB_10671759"	"unprognostic (1.90e-1)"	"unprognostic (1.82e-2)"	"prognostic favourable (5.59e-4)"	"unprognostic (4.21e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.06e-1)"	"unprognostic (7.41e-2)"	"unprognostic (1.03e-2)"	"unprognostic (2.97e-2)"	"unprognostic (3.38e-2)"	"unprognostic (1.23e-2)"	"unprognostic (3.55e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.23e-2)"	"unprognostic (1.39e-1)"	"unprognostic (7.28e-3)"	"unprognostic (1.17e-2)"	3.0	3.1	9.2	2.2	9.0	0.9	4.7	0.8	10.8	8.3	4.7	10.3	2.9	1.9	9.7	5.8	2.8	5.7	3.9	2.8	7.2	6.4	6.3	56.5	4.7	1.1	8.2	8.0	4.7	4.6	7.6	8.9	2.2	6.0	13.3	5.0	6.6	1.7	5.4	3.6	1.8	2.0	7.0	7.0	2.0	3.2	7.2	9.2	0.9	7.0	1.2	1.3	5.5	4.9	0.4	0.4	0.0	0.7	0.0	0.7	0.0	2.1	5.4	16.4	0.0	3.2	12.8	5.9	5.6	2.7	3.2	3.3	5.2	0.6	0.0	0.9	6.2	1.9	7.3	2.6	2.3	0.0	6.3	0.0	6.1	8.8	2.6	0.0	2.4	5.2	1.6	2.6	3.4	3.0	0.9	0.1	12.3	5.5	2.6	0.1	12.4	4.9	0.0	5.1	0.0	2.9	9.8	13.2	15.5	4.4	1.1	5.4	0.0	1.0	2.0	8.3	8.9	9.3	8.7	0.0	0.0	0.0	8.3	0.0	9.7	0.0	0.7	0.0	0.0	0.1	0.2	0.0	0.3	0.3	0.4	0.4	0.3	0.0	0.0	0.0	0.2	0.0	0.7	0.0	9.2	9.0	0.8	10.8	7.2	6.4	8.2	8.0	6.0	9.2
ABCA12	"DKFZP434G232, ICR2B, LI2"	ENSG00000144452	"ATP binding cassette subfamily A member 12"	Q86UK0	2	214931542-215138428	"Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters"	Transport		"Disease mutation, Ichthyosis"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"skin 1: 23.1;tongue: 29.3"	"Cell line enhanced"	"Detected in some"		"hTCEpi: 28.0;SK-BR-3: 13.1;T-47d: 6.8"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	9	"cerebral cortex: 1.6;hippocampal formation: 1.8"	HPA078239			Approved	"Nucleoli,Vesicles,Plasma membrane,Cytosol"				"Vesicles, Plasma membrane"	"Nucleoli, Cytosol"	"HPA078239: "	"unprognostic (6.12e-2)"	"unprognostic (4.33e-2)"	"unprognostic (1.43e-1)"	"unprognostic (2.03e-1)"	"unprognostic (2.49e-1)"	"unprognostic (2.13e-1)"	"unprognostic (2.09e-4)"	"unprognostic (6.52e-3)"	"unprognostic (3.75e-2)"	"unprognostic (1.11e-1)"	"unprognostic (6.35e-4)"	"unprognostic (2.50e-2)"	"unprognostic (7.69e-2)"	"unprognostic (5.92e-2)"	"unprognostic (2.64e-2)"	"unprognostic (2.36e-1)"	"unprognostic (5.08e-2)"	0.1	0.0	0.1	0.1	0.1	0.0	6.9	0.1	0.1	6.2	0.3	0.0	1.4	0.0	0.0	4.4	8.4	0.1	0.0	0.0	0.6	0.1	0.2	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	6.1	4.9	0.0	0.1	0.4	0.0	0.3	0.0	0.1	23.1	0.0	0.0	0.1	0.0	0.1	0.7	0.0	0.1	0.0	29.3	6.1	0.1	3.7	0.0	0.2	0.8	0.0	0.0	0.1	0.0	0.0	1.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.7	0.0	0.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	28.0	0.0	2.0	0.0	0.0	0.1	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.4	0.0	2.0	0.0	13.1	0.0	6.8	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.1	0.1	0.1	0.1	0.6	0.1	0.1	0.0	0.0	0.0
ABCC4	"EST170205, MOAT-B, MOATB, MRP4"	ENSG00000125257	"ATP binding cassette subfamily C member 4"	O15439	13	95019829-95301475	"Plasma proteins, Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"prostate: 35.0"	"Group enriched"	"Detected in many"	4	"HEL: 60.4;HMC-1: 66.1;RPTEC TERT1: 17.8"	"Cancer enriched"	"Detected in all"	8	"prostate cancer: 90.8"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA002476	Enhanced		Approved	"Nucleoli,Golgi apparatus,Plasma membrane"				"Nucleoli, Plasma membrane"	"Golgi apparatus"	"HPA002476: AB_1844434"	"unprognostic (8.77e-2)"	"unprognostic (1.94e-2)"	"unprognostic (1.48e-1)"	"prognostic unfavourable (9.89e-4)"	"unprognostic (2.83e-2)"	"unprognostic (1.23e-1)"	"unprognostic (7.45e-3)"	"unprognostic (2.40e-2)"	"unprognostic (9.96e-2)"	"unprognostic (2.60e-2)"	"unprognostic (1.28e-1)"	"unprognostic (2.55e-2)"	"prognostic favourable (2.25e-10)"	"unprognostic (7.44e-3)"	"unprognostic (1.67e-1)"	"unprognostic (5.55e-2)"	"unprognostic (2.35e-2)"	3.2	1.7	3.8	11.8	4.7	2.9	6.2	1.0	4.6	4.4	11.6	10.3	3.9	4.1	5.8	16.4	3.0	8.6	10.3	3.5	5.7	3.9	19.6	1.9	13.8	7.4	6.6	2.2	7.2	3.5	7.0	2.8	1.8	7.4	35.0	7.3	6.0	3.3	5.2	7.6	4.5	7.4	11.1	6.5	3.8	8.2	3.8	7.0	3.4	6.6	3.1	5.8	25.6	13.4	3.6	4.1	1.0	4.8	4.1	3.6	3.4	4.4	7.8	1.3	2.3	2.4	3.2	0.3	3.6	3.6	3.2	2.8	10.8	3.3	2.5	2.3	4.8	6.0	2.0	1.7	4.0	7.3	3.0	60.4	2.4	2.1	5.0	6.9	66.1	2.4	0.8	2.3	4.7	4.1	6.2	0.1	4.3	1.4	1.2	1.1	1.5	1.9	1.8	3.6	6.5	17.8	10.0	3.2	2.3	1.2	0.2	2.5	0.0	3.7	6.7	3.4	2.2	2.8	4.2	0.0	0.0	1.0	6.5	3.9	1.6	0.6	1.2	0.4	3.2	1.2	2.7	3.6	2.6	3.6	4.1	2.7	1.6	3.5	1.0	4.1	4.8	0.7	3.3	3.4	3.8	4.7	1.0	4.6	5.7	3.9	6.6	2.2	7.4	7.0
ABCC5	"EST277145, MOAT-C, MRP5, SMRP"	ENSG00000114770	"ATP binding cassette subfamily C member 5"	O15440	3	183919934-184018015	"Cancer-related genes, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport		"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"RT4: 47.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044067, HPA052295"	Uncertain		Approved	"Nucleoplasm,Plasma membrane,Cell Junctions"				"Plasma membrane, Cell Junctions"	Nucleoplasm	"HPA044067: , HPA052295: "	"unprognostic (9.39e-2)"	"unprognostic (6.23e-3)"	"unprognostic (3.83e-2)"	"unprognostic (1.10e-3)"	"unprognostic (2.28e-2)"	"unprognostic (2.07e-1)"	"prognostic unfavourable (6.78e-8)"	"unprognostic (4.46e-2)"	"unprognostic (6.07e-3)"	"unprognostic (1.02e-1)"	"unprognostic (5.91e-3)"	"prognostic unfavourable (3.40e-4)"	"unprognostic (1.10e-1)"	"unprognostic (9.05e-3)"	"unprognostic (1.64e-1)"	"unprognostic (3.33e-2)"	"unprognostic (1.24e-2)"	7.9	11.2	24.7	9.6	26.2	12.0	6.7	42.8	28.6	7.7	11.4	12.0	13.4	6.8	14.1	7.0	17.1	6.1	11.6	16.0	19.1	13.7	12.8	3.6	9.4	7.3	20.5	18.5	11.8	4.9	22.4	20.5	10.8	21.7	10.6	14.4	31.1	7.4	9.3	41.0	14.5	8.5	10.5	12.9	16.3	48.5	9.4	20.9	9.3	5.5	7.3	7.4	18.1	12.7	4.2	3.5	15.8	4.5	5.0	7.0	4.5	7.3	4.0	9.3	11.1	9.3	10.6	14.4	5.9	4.7	5.3	5.8	6.3	5.6	7.9	14.0	5.6	29.5	11.4	6.5	7.0	8.6	11.1	16.7	10.1	5.7	3.8	5.1	13.1	16.9	6.6	5.7	3.8	6.2	15.5	11.0	9.1	19.3	13.9	5.8	9.6	7.8	9.7	3.1	4.7	19.4	47.5	17.0	10.1	6.1	33.6	10.0	20.2	1.6	7.1	6.2	6.1	7.9	8.1	4.2	8.2	7.3	4.6	10.2	6.3	10.7	4.5	7.7	7.0	2.1	4.5	3.2	4.0	3.1	3.5	4.2	4.6	6.3	15.8	5.0	3.5	1.3	5.0	4.5	24.7	26.2	42.8	28.6	19.1	13.7	20.5	18.5	21.7	20.9
ABHD3	LABH3	ENSG00000158201	"Abhydrolase domain containing 3"	Q8WU67	18	21650897-21704805	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Lipid metabolism, Phospholipid metabolism"	"Hydrolase, Serine esterase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"REH: 54.1;RPMI-8226: 60.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA010729	Approved		Approved	"Nucleoplasm,Vesicles,Plasma membrane"				"Nucleoplasm, Vesicles"	"Plasma membrane"	"HPA010729: AB_1844449"	"unprognostic (1.46e-1)"	"unprognostic (4.61e-2)"	"unprognostic (2.37e-2)"	"unprognostic (3.52e-1)"	"unprognostic (8.46e-2)"	"unprognostic (3.14e-3)"	"unprognostic (3.54e-3)"	"unprognostic (1.52e-1)"	"prognostic unfavourable (8.52e-4)"	"unprognostic (6.21e-2)"	"unprognostic (1.98e-1)"	"unprognostic (6.37e-2)"	"unprognostic (1.73e-1)"	"unprognostic (2.15e-2)"	"unprognostic (1.00e-1)"	"unprognostic (3.98e-2)"	"unprognostic (4.58e-2)"	9.2	5.4	12.0	14.2	10.7	8.6	20.7	19.5	11.1	6.4	34.2	4.8	5.1	23.8	6.0	5.4	12.7	7.8	13.5	7.1	8.8	8.5	8.7	21.7	12.8	21.3	11.5	5.0	9.4	8.8	10.7	11.8	10.8	16.6	6.9	37.1	14.7	10.3	4.1	10.1	3.8	45.3	5.5	12.3	17.9	19.0	4.4	10.8	20.9	12.9	6.7	13.7	9.2	25.5	7.1	6.1	33.0	23.3	7.1	17.6	9.1	7.4	5.4	5.3	3.4	3.4	2.2	0.0	4.9	2.0	3.5	4.8	5.6	7.7	21.4	9.0	1.6	24.8	8.6	4.0	4.9	13.4	6.0	2.3	9.1	9.6	5.2	10.1	7.8	2.0	4.8	5.2	2.4	2.3	5.9	12.8	3.1	3.0	9.7	11.3	2.6	12.8	54.1	4.0	60.2	9.7	7.2	4.5	2.0	11.2	10.0	2.8	3.1	17.9	1.8	3.4	4.9	6.0	7.5	14.4	9.3	22.1	4.4	13.3	7.8	29.1	10.2	11.4	11.1	17.9	8.5	7.1	10.0	10.6	6.1	5.1	8.2	10.3	33.0	7.1	23.3	4.2	17.6	9.1	12.0	10.7	19.5	11.1	8.8	8.5	11.5	5.0	16.6	10.8
ABLIM3	KIAA0843	ENSG00000173210	"Actin binding LIM protein family member 3"	O94929	5	149141483-149260542	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 58.4"	"Cell line enhanced"	"Detected in many"		"ASC TERT1: 25.2;HHSteC: 25.8;HSkMC: 29.7;hTERT-HME1: 29.7;TIME: 32.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"neutrophil: 2.2"	"Lineage enhanced"	"Detected in single"		"granulocytes: 2.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003245	Approved		Approved	"Nucleoplasm,Plasma membrane,Cell Junctions"				"Plasma membrane"	"Nucleoplasm, Cell Junctions"	"HPA003245: AB_1078083"	"unprognostic (1.07e-1)"	"unprognostic (1.31e-1)"	"unprognostic (9.87e-2)"	"unprognostic (1.75e-1)"	"unprognostic (8.74e-2)"	"unprognostic (4.19e-2)"	"unprognostic (9.48e-3)"	"unprognostic (4.37e-3)"	"unprognostic (1.05e-1)"	"unprognostic (1.09e-2)"	"unprognostic (4.17e-3)"	"unprognostic (2.42e-1)"	"prognostic unfavourable (1.28e-4)"	"unprognostic (3.12e-2)"	"unprognostic (8.10e-2)"	"unprognostic (2.45e-3)"	"unprognostic (1.20e-1)"	45.9	6.0	7.9	3.5	9.8	1.2	35.0	29.7	12.5	9.1	4.7	11.6	7.0	2.9	4.9	8.9	15.6	5.8	6.1	58.4	8.5	10.2	17.0	48.1	9.1	4.8	9.9	5.9	2.6	2.4	39.3	3.1	26.1	14.3	6.5	4.7	7.7	3.0	9.9	24.3	3.5	3.7	8.7	14.0	5.0	2.7	2.3	3.3	0.1	4.2	8.9	4.5	8.8	14.6	0.0	0.6	2.2	0.3	0.0	0.0	6.8	7.3	1.5	0.0	0.0	13.1	25.2	0.0	5.1	14.3	2.9	5.2	0.0	5.1	0.0	0.8	6.4	0.1	0.0	6.0	5.8	0.0	0.0	0.0	0.3	0.1	25.8	0.0	0.0	29.7	1.6	10.5	29.7	13.1	0.0	2.3	17.1	2.8	0.0	0.0	0.0	20.2	0.0	0.0	0.0	16.4	5.0	2.0	0.0	1.0	0.3	2.8	0.4	0.0	32.9	6.2	1.4	6.4	8.6	0.0	0.0	0.0	10.8	0.0	17.6	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.6	0.0	6.8	7.9	9.8	29.7	12.5	8.5	10.2	9.9	5.9	14.3	3.3
AC004691.2		ENSG00000250424			7	30852273-30923812	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"				"Low tissue specificity"	"Detected in some"			"Cell line enhanced"	"Detected in some"		"A549: 1.3;ASC diff: 1.1;SH-SY5Y: 1.9;SK-BR-3: 1.2"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA019206, HPA030130"	Approved		Approved	"Plasma membrane"				"Plasma membrane"		"HPA019206: AB_1844965, HPA030130: AB_10601565"	"unprognostic (2.15e-1)"	"unprognostic (3.12e-1)"			"unprognostic (1.83e-1)"	"unprognostic (1.66e-1)"		"unprognostic (2.72e-4)"		"unprognostic (5.13e-2)"	"unprognostic (3.44e-2)"	"unprognostic (2.15e-1)"	"unprognostic (2.88e-2)"	"unprognostic (3.76e-1)"		"unprognostic (2.49e-1)"	"unprognostic (3.71e-2)"	0.8	0.2	0.0	0.0	0.4	0.2	0.6	0.0	0.3	1.1	1.3			1.4	1.4	1.5	0.7	2.4	3.1	0.8	0.0	0.1	0.5	0.0	1.1	0.0	0.0		0.6	2.2	0.0	0.3	0.0		0.7	0.2		0.7	1.2	0.4	0.3	0.4	2.3	0.0	0.0	0.9	0.1			0.7		0.0	1.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	1.3	0.0	0.4	1.1	0.0	0.0	0.0	0.0	0.0	0.4	0.6	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.2	0.7	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	1.2	0.0	0.3	0.0	0.0	0.0	0.0	0.3	0.0	0.5	0.6	0.0	0.3	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2										
AC005324.3		ENSG00000251537			17	15571491-15651653	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"				"Tissue enhanced"	"Detected in many"		"esophagus: 23.3;tongue: 21.1;vagina: 17.9"	"Cell line enhanced"	"Detected in some"		"A549: 3.5;CAPAN-2: 3.1;HaCaT: 6.5;HeLa: 3.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA023623, HPA066431"	Uncertain		Approved	"Plasma membrane,Cytosol"				Cytosol	"Plasma membrane"	"HPA023623: AB_1858273, HPA066431: "	"unprognostic (3.45e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.93e-1)"	"unprognostic (2.48e-1)"	"unprognostic (1.24e-2)"	"unprognostic (3.52e-2)"	"unprognostic (2.87e-3)"	"unprognostic (1.93e-1)"	"unprognostic (2.98e-2)"	"unprognostic (4.39e-2)"	"unprognostic (4.81e-3)"	"unprognostic (6.35e-3)"	"unprognostic (1.80e-11)"	"unprognostic (1.95e-1)"	"unprognostic (1.36e-1)"	"unprognostic (5.30e-2)"	"unprognostic (3.09e-1)"	7.5	2.8	0.9	1.5	1.0	1.0	7.7	0.9	1.0	5.3	2.2	1.3	0.0	2.1	0.7	1.5	23.3	0.8	4.0	2.6	0.8	0.9	0.9	1.0	2.1	1.6	3.7	0.0	0.7	1.0	0.8	0.7	12.4	2.7	1.4	0.9	0.2	2.4	1.1	2.9	4.4	1.6	2.1	1.5	1.0	2.8	1.8	1.0	1.6	1.8	21.1	17.5	3.2	17.9	0.6	0.6	0.0	0.1	0.0	0.5	0.0	0.6	3.5	0.1	0.1	0.0	0.3	0.0	0.2	0.3	0.0	0.1	0.1	3.1	0.1	0.1	1.0	6.5	0.0	0.0	0.1	1.0	0.2	0.0	3.0	0.0	0.0	0.1	0.0	0.0	0.7	0.2	0.1	0.0	0.0	0.2	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.9	0.0	0.0	0.6	0.4	0.1	0.0	0.0	0.4	0.0	0.1	0.0	0.1	0.3	0.9	0.0	0.2	0.0	0.6	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.5	0.0	0.6	0.6	0.1	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.9	1.0	0.9	1.0	0.8	0.9	3.7	0.0	2.7	1.0
AC005726.1		ENSG00000258472			17	28455752-28614197	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"				"Tissue enriched"	"Detected in many"	5	"brain: 16.8"	"Cell line enhanced"	"Detected in some"		"A549: 6.4;Karpas-707: 3.4;PC-3: 3.2;THP-1: 3.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA046590	Uncertain		Approved	"Nucleoplasm,Vesicles,Plasma membrane"				"Vesicles, Plasma membrane"	Nucleoplasm	"HPA046590: "	"unprognostic (1.26e-2)"	"unprognostic (1.82e-1)"	"unprognostic (6.04e-3)"	"unprognostic (1.19e-1)"	"unprognostic (1.14e-1)"	"unprognostic (2.23e-3)"	"unprognostic (2.76e-3)"	"unprognostic (7.25e-2)"	"unprognostic (5.96e-2)"	"unprognostic (4.58e-2)"	"unprognostic (9.22e-3)"	"unprognostic (3.17e-3)"	"unprognostic (1.49e-4)"	"unprognostic (1.25e-1)"	"unprognostic (2.65e-1)"	"unprognostic (7.50e-2)"	"unprognostic (3.79e-4)"	0.5	0.6	6.3	0.4	16.4	1.6	0.5	3.5	16.8	2.8	0.9	0.0	0.0	1.6	1.3	0.6	1.4	2.3	2.4	1.0	5.1	3.6	0.9	1.5	3.6	0.5	1.6	6.6	0.8	3.6	0.2	3.1	0.4	6.9	1.0	0.2	3.6	0.5	0.2	0.6	0.5	0.5	0.8	1.1	0.5	1.0	0.6	2.1	0.0	2.6	0.0	1.3	3.5	0.5	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	6.4	0.2	0.8	0.0	0.0	0.2	0.3	0.0	0.2	0.0	2.0	0.0	0.0	0.1	0.0	0.7	0.0	0.0	0.2	0.0	0.0	0.0	0.8	0.0	1.3	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.5	3.4	0.0	0.5	0.0	0.9	0.0	3.2	0.3	0.0	0.0	0.2	1.3	0.0	0.4	0.3	0.9	0.0	0.6	3.4	0.0	0.8	0.0	0.0	0.1	0.5	0.1	0.0	0.0	0.3	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.1	0.0	6.3	16.4	3.5	16.8	5.1	3.6	1.6	6.6	6.9	2.1
AC138696.1		ENSG00000264668			8	143247110-143276403	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"ASC diff: 4.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"MAIT T-cell: 2.1"	"Low lineage specificity"	"Detected in single"											"HPA047232, HPA056268"	Uncertain		Approved	"Nucleoplasm,Nucleoli,Plasma membrane"				Nucleoli	"Nucleoplasm, Plasma membrane"	"HPA047232: , HPA056268: "	"unprognostic (2.24e-2)"	"unprognostic (2.10e-1)"	"unprognostic (3.56e-3)"		"unprognostic (1.87e-1)"	"unprognostic (8.68e-3)"	"unprognostic (1.14e-1)"	"unprognostic (1.51e-1)"	"unprognostic (9.80e-2)"	"unprognostic (4.20e-1)"	"unprognostic (3.27e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.03e-2)"	"unprognostic (2.20e-2)"	"unprognostic (3.99e-1)"	"unprognostic (2.59e-2)"	"unprognostic (4.06e-1)"	3.6	4.8	6.2	2.5	4.4	1.5	2.5	5.8	7.3	3.3	3.8	4.7	2.5	2.6	5.7	2.7	2.8	7.8	2.0	2.7	6.2	4.8	2.6	1.9	2.7	2.5	4.8	3.0	5.8	6.8	4.6	4.5	2.2	4.2	3.0	2.2	3.8	3.6	3.9	4.7	1.8	3.1	3.2	3.7	2.7	2.7	3.5	3.6	1.5	2.7	1.5	2.6	3.6	4.4	0.6	0.6	0.0	0.2	0.9	2.1	0.1	1.3	0.0	0.0	0.8	4.7	0.3	0.5	1.3	3.0	1.5	0.6	0.0	1.8	0.2	0.8	0.3	0.7	0.0	0.6	0.5	0.0	1.4	0.3	0.0	0.0	0.0	0.3	0.6	2.8	1.2	0.0	1.0	0.9	0.0	0.1	0.0	0.0	3.2	0.0	3.0	0.9	1.6	2.8	0.1	0.0	0.0	0.0	2.1	0.0	0.0	0.7	0.9	0.9	0.0	0.0	0.7	2.9	0.1	2.2	0.7	1.6	1.1	0.3	0.4	0.0	0.0	0.0	0.1	0.0	2.1	0.2	0.0	0.1	0.0	0.6	0.3	0.0	0.0	0.9	0.2	0.6	0.3	0.1	6.2	4.4	5.8	7.3	6.2	4.8	4.8	3.0	4.2	3.6
ACOT9	"ACATE2, CGI-16, MT-ACT48"	ENSG00000123130	"Acyl-CoA thioesterase 9"	Q9Y305	X	23702253-23766475	"Predicted intracellular proteins"		"Hydrolase, Serine esterase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA035533	Supported		Approved	"Nucleoplasm,Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"	Nucleoplasm	"HPA035533: AB_10696506"	"unprognostic (5.69e-2)"	"unprognostic (6.34e-2)"	"unprognostic (1.59e-1)"	"unprognostic (2.09e-1)"	"unprognostic (1.53e-2)"	"unprognostic (1.27e-2)"	"prognostic unfavourable (3.23e-4)"	"unprognostic (1.12e-1)"	"unprognostic (1.89e-1)"	"unprognostic (2.50e-1)"	"unprognostic (9.75e-3)"	"unprognostic (3.49e-2)"	"unprognostic (2.15e-3)"	"unprognostic (6.53e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.14e-1)"	19.1	15.9	6.3	14.1	7.7	10.5	29.2	6.5	13.6	15.4	16.3	5.4	17.6	11.5	21.2	16.1	12.0	14.5	15.5	35.7	5.7	7.7	12.8	15.5	23.6	36.0	7.3	8.6	13.4	16.6	9.1	7.8	13.3	12.7	12.8	12.7	13.9	16.3	23.0	28.8	10.4	12.5	35.7	13.8	15.8	15.0	7.1	4.5	3.8	15.1	11.4	9.7	15.9	14.4	5.5	16.4	11.1	26.5	6.0	10.0	8.4	26.4	18.1	7.9	17.4	13.0	14.8	4.0	21.0	18.3	20.9	20.3	16.0	24.0	1.3	13.5	23.4	16.2	9.9	26.8	29.1	6.2	15.1	9.0	19.0	11.6	17.5	3.5	11.4	13.1	18.3	24.4	27.8	30.4	5.7	9.1	22.5	9.2	4.8	8.5	11.5	22.1	5.1	30.1	11.2	24.7	9.9	1.5	7.6	22.8	9.6	13.5	10.8	4.6	28.2	17.4	11.6	25.2	11.4	2.2	5.2	0.1	12.9	3.5	14.7	9.1	16.1	11.1	5.6	22.2	7.6	5.5	7.0	6.3	16.4	4.6	2.3	5.3	8.4	6.0	26.5	2.8	10.0	8.4	6.3	7.7	6.5	13.6	5.7	7.7	7.3	8.6	12.7	4.5
ACTN1		ENSG00000072110	"Actinin alpha 1"	P12814	14	68874143-68979440	"Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"		Actin-binding	"Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 71.8"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004303, HPA006035"	Approved		Approved	"Plasma membrane,Actin filaments,Focal adhesion sites"			780000000	"Plasma membrane, Actin filaments, Focal adhesion sites"		"CAB004303: AB_626633, HPA006035: AB_1078095"	"unprognostic (4.40e-2)"	"unprognostic (1.03e-3)"	"unprognostic (2.49e-2)"	"unprognostic (1.96e-1)"	"unprognostic (1.19e-1)"	"prognostic unfavourable (2.49e-4)"	"unprognostic (6.19e-3)"	"prognostic unfavourable (7.63e-5)"	"unprognostic (3.62e-1)"	"unprognostic (3.23e-2)"	"unprognostic (3.16e-2)"	"unprognostic (1.71e-1)"	"prognostic unfavourable (9.08e-10)"	"unprognostic (2.87e-2)"	"unprognostic (2.00e-1)"	"unprognostic (6.05e-3)"	"prognostic unfavourable (8.00e-4)"	27.6	10.8	18.7	33.1	28.4	31.0	38.8	4.1	20.0	30.5	101.8	3.1	43.7	11.6	80.3	24.6	48.3	38.7	53.3	31.2	9.9	6.2	11.2	20.3	23.9	23.1	4.7	15.0	27.8	12.4	2.3	7.9	22.0	8.7	43.2	26.4	11.1	30.1	72.7	7.1	14.6	25.9	135.4	10.3	19.4	52.3	9.5	9.6	7.0	9.3	9.9	11.3	81.1	53.1	0.0	8.8	71.8	12.5	0.7	22.0	14.9	83.8	25.9	16.0	12.1	28.4	18.8	60.0	74.2	71.1	78.1	58.4	20.7	19.6	0.0	26.1	73.2	36.6	12.6	78.3	98.8	0.4	3.8	11.4	13.6	17.3	51.2	8.2	1.4	23.9	15.4	48.5	55.2	42.8	5.4	0.1	61.2	23.9	0.9	17.4	12.5	19.8	5.7	29.7	3.1	29.7	22.2	5.7	6.9	64.4	9.7	17.9	14.6	16.6	53.9	111.0	44.2	12.8	64.5	11.5	4.4	0.3	32.1	11.3	58.3	11.2	12.5	25.6	1.1	5.7	1.4	0.0	4.6	2.5	8.8	0.0	22.0	18.7	71.8	0.7	1.6	0.4	1.8	14.9	18.7	28.4	4.1	20.0	9.9	6.2	4.7	15.0	8.7	9.6
ACTR6	"ARP6, FLJ13433"	ENSG00000075089	"ARP6 actin related protein 6 homolog"	Q9GZN1	12	100199122-100241865	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038587, HPA038588"	Uncertain		Approved	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		"HPA038587: AB_10670781, HPA038588: AB_10672719"	"unprognostic (1.24e-2)"	"unprognostic (8.43e-3)"	"unprognostic (1.81e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.70e-1)"	"unprognostic (1.24e-2)"	"prognostic unfavourable (7.70e-9)"	"unprognostic (4.11e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.05e-1)"	"unprognostic (6.98e-2)"	"unprognostic (3.99e-1)"	"unprognostic (5.32e-2)"	"unprognostic (4.30e-2)"	"unprognostic (3.22e-1)"	"unprognostic (6.67e-3)"	"unprognostic (3.40e-2)"	7.6	8.0	12.6	6.6	13.8	5.6	20.5	14.8	20.2	10.3	9.9	10.2	6.9	7.5	8.6	7.2	10.4	9.6	5.9	8.1	15.2	15.7	12.3	12.5	8.2	11.6	13.8	15.4	9.9	5.9	15.8	14.0	11.6	21.2	11.0	10.6	6.7	7.7	12.2	8.3	6.8	9.2	8.3	12.8	9.6	7.3	13.9	14.6	13.4	9.6	5.8	11.9	11.6	8.6	6.1	6.1	4.6	5.8	7.9	10.9	6.6	17.8	7.0	9.0	10.9	8.9	11.0	18.3	5.0	8.8	8.4	5.8	5.0	5.3	9.4	7.0	7.9	5.8	13.0	8.2	15.3	8.9	11.8	5.8	7.2	5.4	9.7	8.8	5.9	6.5	10.0	7.1	9.2	11.4	10.0	3.8	11.6	3.9	11.7	9.9	8.7	8.8	7.3	8.7	11.0	11.3	10.3	7.8	13.7	9.2	19.6	9.0	12.8	8.5	5.7	5.1	3.8	6.8	5.4	6.3	16.1	12.1	3.6	5.8	7.5	3.8	2.8	4.6	8.0	5.8	9.9	6.0	8.8	7.5	4.1	6.1	10.9	10.0	2.1	7.9	4.5	6.1	7.7	6.6	12.6	13.8	14.8	20.2	15.2	15.7	13.8	15.4	21.2	14.6
ADAMTS1	"C3-C5, KIAA1346, METH1"	ENSG00000154734	"ADAM metallopeptidase with thrombospondin type 1 motif 1"	Q9UHI8	21	26835747-26845409	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters"		"Heparin-binding, Hydrolase, Metalloprotease, Protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ovary: 112.8"	"Cell line enhanced"	"Detected in many"		"ASC diff: 60.9;BJ: 71.0;hTEC/SVTERT24-B: 49.0;hTERT-HME1: 44.6;RPTEC TERT1: 41.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"gdT-cell: 8.0;NK-cell: 9.0"	"Group enriched"	"Detected in many"	85	"NK-cells: 9.0;T-cells: 8.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"CAB016394, HPA031498"	Uncertain		Approved	"Plasma membrane"	"Secreted to extracellular matrix"		1900000	"Plasma membrane"		"CAB016394: AB_626637, HPA031498: "	"unprognostic (6.82e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.64e-1)"	"unprognostic (1.18e-2)"	"prognostic unfavourable (5.13e-4)"	"unprognostic (1.03e-1)"	"unprognostic (3.28e-1)"	"unprognostic (2.37e-2)"	"unprognostic (5.39e-2)"	"unprognostic (1.75e-1)"	"unprognostic (4.55e-2)"	"unprognostic (9.70e-3)"	"unprognostic (8.27e-3)"	"unprognostic (1.12e-1)"	"unprognostic (6.76e-2)"	"unprognostic (1.57e-1)"	70.6	13.4	8.2	18.7	14.0	0.7	29.0	6.3	9.2	22.0	18.2	9.5	4.8	3.3	27.7	25.8	30.0	45.8	62.3	40.9	7.6	4.8	15.4	22.8	25.0	10.9	12.7	3.7	112.8	9.3	6.3	7.6	56.8	13.2	23.3	16.5	7.8	5.8	8.1	25.7	6.1	16.2	46.4	10.2	7.2	16.8	12.8	11.4	0.0	14.3	18.1	2.7	32.7	45.3	0.0	0.0	0.0	0.0	9.0	8.0	1.4	0.0	0.0	1.1	0.0	60.9	15.1	3.7	71.0	24.8	12.3	8.1	0.0	0.0	0.0	4.9	22.5	1.3	0.8	3.6	21.7	0.0	22.6	0.0	7.4	0.0	11.7	2.8	0.0	16.9	0.0	49.0	44.6	5.0	1.2	0.0	36.4	0.0	0.3	0.0	4.0	2.8	0.0	28.1	0.2	41.6	4.0	0.0	5.5	3.3	0.0	0.3	0.1	0.7	5.1	17.5	0.9	27.2	10.5	0.1	0.0	0.0	14.4	0.0	5.3	0.0	0.0	0.0	8.0	0.0	0.8	0.0	0.3	0.6	0.0	0.0	0.0	1.5	0.0	9.0	0.0	0.0	0.0	1.4	8.2	14.0	6.3	9.2	7.6	4.8	12.7	3.7	13.2	11.4
ADAMTS2	"ADAM-TS2, ADAMTS-3, hPCPNI, NPI, PCINP"	ENSG00000087116	"ADAM metallopeptidase with thrombospondin type 1 motif 2"	O95450	5	179110851-179345430	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins"	"Collagen degradation"	"Hydrolase, Metalloprotease, Protease"	"Ehlers-Danlos syndrome"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"ASC diff: 13.7;ASC TERT1: 13.7;BJ: 12.1;fHDF/TERT166: 14.2;HHSteC: 44.5;HSkMC: 35.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"HPA028363, HPA028444"	Uncertain		Approved	"Vesicles,Plasma membrane"	"Secreted to extracellular matrix"			"Plasma membrane"	Vesicles	"HPA028363: , HPA028444: AB_10601964"	"unprognostic (6.78e-2)"	"unprognostic (7.83e-2)"	"unprognostic (1.13e-1)"	"unprognostic (5.50e-2)"	"unprognostic (8.85e-3)"	"unprognostic (4.80e-2)"	"unprognostic (1.09e-1)"	"unprognostic (2.22e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.91e-2)"	"unprognostic (2.08e-1)"	"unprognostic (2.45e-1)"	"prognostic unfavourable (1.71e-8)"	"unprognostic (1.32e-3)"	"unprognostic (1.03e-2)"	"unprognostic (7.16e-3)"	"unprognostic (1.48e-2)"	24.2	4.3	0.9	5.8	0.7	0.7	29.1	0.9	2.3	16.3	10.1	0.4	3.9	2.7	12.0	9.5	6.0	7.2	9.5	10.1	0.7	1.2	4.2	7.4	13.1	25.9	1.0	1.3	6.3	2.7	1.0	8.7	15.1	2.4	6.0	2.6	3.8	2.5	3.8	3.8	4.6	4.6	13.8	0.7	16.5	4.2	4.3	0.5	0.8	3.2	5.9	1.2	8.8	14.7	1.4	1.3	2.1	0.3	0.8	0.6	0.1	0.0	0.0	0.0	0.3	13.7	13.7	0.0	12.1	2.0	4.6	4.9	0.0	0.0	0.0	0.1	14.2	0.0	0.7	0.0	2.0	0.0	0.6	0.0	0.0	0.9	44.5	0.0	0.0	35.5	0.0	1.2	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.4	0.3	0.0	0.0	0.0	0.1	0.0	0.0	2.8	0.5	0.0	0.0	0.1	0.0	3.9	0.0	7.7	1.2	10.1	0.0	0.1	0.0	0.0	0.3	0.1	0.0	1.5	0.3	0.4	0.6	0.2	0.3	0.6	0.5	0.4	1.3	1.4	0.5	0.5	2.1	0.8	0.1	0.8	0.5	0.1	0.9	0.7	0.9	2.3	0.7	1.2	1.0	1.3	2.4	0.5
ADAMTSL4	"DKFZP434K1772, TSRC1"	ENSG00000143382	"ADAMTS like 4"	Q6UY14	1	150549369-150560937	"Disease related genes, Predicted secreted proteins"	Apoptosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"placenta: 157.1"	"Cell line enhanced"	"Detected in many"		"ASC TERT1: 29.5;BEWO: 62.2;HSkMC: 13.9;K-562: 19.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	4	"classical monocyte: 1.6;intermediate monocyte: 1.8;neutrophil: 2.3;non-classical monocyte: 3.5"	"Group enriched"	"Detected in many"	5	"granulocytes: 2.3;monocytes: 3.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			HPA006279	Approved		Approved	"Plasma membrane,Cytosol"	"Secreted to extracellular matrix"		47000000	"Plasma membrane, Cytosol"		"HPA006279: AB_1078102"	"unprognostic (2.00e-2)"	"unprognostic (1.24e-2)"	"prognostic unfavourable (1.86e-4)"	"unprognostic (8.09e-4)"	"prognostic unfavourable (2.43e-4)"	"unprognostic (1.09e-1)"	"unprognostic (1.65e-1)"	"unprognostic (7.52e-2)"	"unprognostic (3.56e-2)"	"unprognostic (1.68e-2)"	"unprognostic (1.28e-2)"	"unprognostic (1.51e-1)"	"prognostic unfavourable (4.35e-7)"	"unprognostic (1.90e-1)"	"unprognostic (5.23e-2)"	"unprognostic (1.44e-2)"	"unprognostic (7.40e-3)"	14.4	2.4	0.8	8.9	1.4	2.2	13.2	0.7	1.1	11.0	8.2	1.5	3.9	2.2	9.7	8.1	19.7	11.1	6.6	10.7	1.0	0.2	3.4	14.9	13.3	2.3	1.4	0.4	14.5	1.8	0.2	1.3	157.1	3.4	9.4	2.4	19.1	5.7	2.3	21.1	5.4	6.0	17.4	2.2	3.9	8.9	3.3	1.1	0.8	3.8	15.5	4.8	19.1	15.9	0.0	0.5	2.3	3.5	0.0	0.1	0.6	6.5	0.1	0.1	1.2	6.0	29.5	62.2	6.3	5.6	3.8	2.2	0.5	2.5	0.0	1.3	4.3	3.3	0.2	0.9	1.5	0.5	0.1	1.8	0.7	2.6	4.8	0.0	0.9	13.9	0.2	0.9	2.1	0.0	19.9	0.1	0.6	0.1	0.0	0.3	1.1	0.2	0.0	0.0	0.0	0.6	0.2	0.0	0.2	2.0	4.9	0.0	1.4	3.4	1.1	0.2	1.8	2.6	0.1	0.5	0.1	1.4	0.2	1.2	0.1	0.0	1.6	0.0	0.0	1.8	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	2.3	0.0	3.5	0.0	0.0	0.6	0.8	1.4	0.7	1.1	1.0	0.2	1.4	0.4	3.4	1.1
ADAP1	"CENTA1, GCS1L"	ENSG00000105963	"ArfGAP with dual PH domains 1"	O75689	7	897901-955407	"Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 41.8;intestine: 30.8"	"Cell line enhanced"	"Detected in many"		"A-431: 35.6;CAPAN-2: 25.7;HaCaT: 16.3;HMC-1: 24.6;THP-1: 41.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007033, HPA012049"	Enhanced		Supported	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		"HPA007033: AB_1846529, HPA012049: AB_1846527"	"unprognostic (2.45e-1)"	"unprognostic (7.15e-2)"	"prognostic unfavourable (5.25e-4)"	"unprognostic (4.41e-2)"	"unprognostic (1.97e-1)"	"prognostic unfavourable (9.13e-4)"	"unprognostic (3.06e-1)"	"unprognostic (9.10e-3)"	"unprognostic (1.70e-2)"	"unprognostic (1.38e-1)"	"unprognostic (5.74e-2)"	"unprognostic (1.69e-1)"	"prognostic favourable (4.13e-5)"	"unprognostic (5.88e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.79e-2)"	3.0	2.1	32.9	8.9	25.9	8.1	1.2	13.8	41.8	3.6	30.8	30.3	1.7	16.7	2.6	1.3	4.5	4.2	6.2	3.9	36.1	17.7	6.5	1.6	5.8	3.3	28.0	20.1	0.7	5.4	3.7	1.3	3.0	19.3	1.9	20.6	0.9	3.0	3.1	0.8	2.0	22.8	7.7	36.1	7.4	16.3	1.1	19.3	0.0	4.8	0.4	2.3	5.1	1.0	1.3	5.5	3.4	11.7	1.6	6.8	3.7	35.6	1.3	0.0	1.2	0.5	0.0	0.4	1.1	0.0	0.3	0.1	14.2	25.7	0.0	3.5	0.2	16.3	1.9	2.7	0.1	0.2	1.5	0.0	2.2	8.0	0.6	0.2	24.6	0.6	7.6	0.0	0.0	0.0	0.1	0.0	0.0	11.4	0.0	9.6	1.1	0.0	4.8	0.0	0.1	1.9	8.6	1.1	0.3	1.1	0.4	0.1	9.2	41.9	0.2	0.2	1.0	0.0	0.1	0.0	0.0	0.0	0.0	7.5	1.3	1.1	7.6	3.4	6.8	8.1	3.3	1.3	2.0	6.1	5.5	1.1	0.6	3.1	3.4	1.6	11.7	0.4	0.9	3.7	32.9	25.9	13.8	33.4	36.1	17.7	28.0	20.1	19.3	19.3
ADCK5	FLJ35454	ENSG00000173137	"AarF domain containing kinase 5"	Q3MIX3	8	144373101-144393242	"Enzymes, Predicted membrane proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA025692, HPA028679"	Approved		Approved	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		"HPA025692: AB_10599486, HPA028679: AB_10600226"	"unprognostic (6.76e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.68e-2)"	"unprognostic (8.96e-2)"	"unprognostic (1.68e-2)"	"unprognostic (1.00e-1)"	"unprognostic (2.31e-3)"	"unprognostic (6.45e-2)"	"unprognostic (2.70e-1)"	"unprognostic (4.25e-2)"	"unprognostic (6.60e-2)"	"unprognostic (2.03e-2)"	"unprognostic (1.33e-3)"	"unprognostic (1.39e-2)"	"unprognostic (1.20e-1)"	"unprognostic (3.47e-1)"	"unprognostic (2.90e-2)"	4.1	10.0	4.8	8.9	4.5	4.5	4.3	11.5	9.1	4.6	18.3	2.8	7.6	19.1	5.8	4.2	7.2	4.2	6.3	3.8	3.9	4.1	4.8	6.9	3.7	5.0	3.4	8.4	5.5	5.6	4.7	4.1	3.7	4.5	4.7	4.0	4.6	7.4	4.7	5.6	8.3	17.0	2.7	2.4	6.7	5.6	7.7	3.8	6.8	4.1	4.9	6.1	5.1	5.0	4.7	6.3	2.5	5.4	1.8	4.1	2.8	3.8	4.8	1.0	3.3	0.9	0.8	5.7	3.3	1.8	2.6	0.9	5.2	4.2	1.7	2.3	0.7	5.1	0.2	3.5	0.2	4.3	1.6	4.4	3.6	5.8	2.6	1.0	3.4	1.3	2.1	0.9	0.8	1.8	2.9	3.0	1.5	10.1	3.2	4.4	0.6	3.6	4.2	1.6	3.0	1.7	3.6	0.7	1.8	4.8	3.9	2.7	3.3	3.0	1.2	1.4	5.1	3.5	2.2	1.4	0.4	1.5	3.2	3.8	2.0	1.8	4.2	2.5	2.3	5.4	3.0	1.8	2.8	1.8	6.3	4.7	2.9	1.5	0.7	1.8	5.0	4.0	4.1	2.8	4.8	4.5	11.5	9.1	3.9	4.1	3.4	8.4	4.5	3.8
ADGRL2	"KIAA0786, LEC1, LPHH1, LPHN2"	ENSG00000117114	"Adhesion G protein-coupled receptor L2"	O95490	1	81306160-81992436	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"AF22: 62.8;hTEC/SVTERT24-B: 31.2;NTERA-2: 26.3;SH-SY5Y: 42.1;U-2197: 28.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043447			Approved	"Plasma membrane,Cell Junctions"			280000	"Plasma membrane, Cell Junctions"		"HPA043447: AB_2678486"	"unprognostic (2.54e-2)"	"unprognostic (6.29e-3)"	"unprognostic (2.57e-1)"	"prognostic unfavourable (1.33e-4)"	"unprognostic (3.22e-1)"	"unprognostic (1.61e-1)"	"prognostic unfavourable (9.92e-4)"	"unprognostic (3.55e-2)"	"unprognostic (9.84e-2)"	"unprognostic (2.42e-1)"	"unprognostic (7.81e-2)"	"unprognostic (8.01e-2)"	"unprognostic (1.61e-1)"	"prognostic unfavourable (3.00e-4)"	"unprognostic (2.76e-1)"	"unprognostic (3.38e-3)"	"unprognostic (1.41e-2)"	8.9	10.5	21.1	3.6	20.9	0.0	8.8	1.5	45.8	7.5	7.0	1.4	1.2	2.7	6.1	8.6	12.0	12.0	11.5	17.6	12.2	6.6	10.9	18.7	32.7	3.5	3.5	22.8	18.8	4.9	20.3	11.8	24.4	6.2	15.6	5.4	9.4	19.1	10.1	2.0	6.3	6.1	6.0	3.2	10.0	7.6	2.0	3.3	0.6	22.4	15.0	5.0	6.5	11.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.3	2.3	62.8	0.0	7.8	8.9	0.8	1.5	3.5	0.6	0.7	0.0	0.0	0.0	17.2	8.0	2.5	5.0	6.6	0.5	0.1	10.2	0.0	1.8	4.4	2.9	0.0	0.1	7.6	0.4	31.2	3.1	10.3	0.0	0.0	0.8	0.0	0.0	0.0	26.3	1.8	0.0	8.6	0.0	14.3	0.9	3.1	42.1	0.0	1.7	0.0	0.1	18.5	6.7	6.4	7.3	28.7	2.2	0.0	0.0	0.0	3.6	0.0	4.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	21.1	20.9	1.5	45.8	12.2	6.6	3.5	22.8	6.2	3.3
ADH1A	ADH1	ENSG00000187758	"Alcohol dehydrogenase 1A (class I), alpha polypeptide"	P07327	4	99276367-99291028	"Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	322	"liver: 250.3"	"Cell line enriched"	"Detected in some"	5	"ASC diff: 10.9"	"Cancer enriched"	"Detected in some"	251	"liver cancer: 165.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"CAB009562, HPA047814, HPA060902"	Enhanced		Approved	"Plasma membrane,Cytosol"			12000000	"Plasma membrane, Cytosol"		"CAB009562: AB_2257984, HPA047814: , HPA060902: "	"unprognostic (5.89e-2)"	"unprognostic (6.16e-2)"		"unprognostic (1.20e-1)"	"unprognostic (2.07e-1)"	"unprognostic (4.40e-1)"	"prognostic favourable (2.38e-4)"	"unprognostic (2.78e-3)"		"unprognostic (4.25e-1)"	"unprognostic (4.79e-3)"	"unprognostic (6.21e-2)"	"unprognostic (9.36e-2)"	"unprognostic (3.25e-2)"	"unprognostic (1.40e-1)"		"unprognostic (2.86e-2)"	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.7	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	250.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	10.9	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.1	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.7	0.0	0.0	0.0	0.1	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.9	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0
ADH1B	ADH2	ENSG00000196616	"Alcohol dehydrogenase 1B (class I), beta polypeptide"	P00325	4	99304964-99352760	"Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"adipose tissue: 253.5;liver: 466.3"	"Cell line enriched"	"Detected in some"	7	"ASC diff: 385.0"	"Cancer enriched"	"Detected in many"	31	"liver cancer: 223.1"	"Group enriched"	"Detected in some"	5	"midbrain: 2.3;pons and medulla: 1.6"	"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"											"HPA047814, HPA060902"	Supported		Approved	"Plasma membrane,Cytosol"			16000000	"Plasma membrane, Cytosol"		"HPA047814: , HPA060902: "	"unprognostic (5.13e-2)"	"unprognostic (9.80e-3)"	"unprognostic (6.59e-2)"	"unprognostic (5.56e-2)"	"unprognostic (9.49e-2)"	"unprognostic (5.53e-2)"	"unprognostic (1.54e-3)"	"unprognostic (1.04e-2)"	"unprognostic (6.51e-2)"	"unprognostic (2.73e-2)"	"unprognostic (7.47e-3)"	"unprognostic (7.79e-2)"	"prognostic unfavourable (7.87e-4)"	"unprognostic (4.60e-3)"	"unprognostic (2.33e-1)"	"unprognostic (2.58e-1)"	"unprognostic (1.60e-2)"	253.5	12.3	0.2	21.8	0.0	0.4	78.7	0.2	0.4	18.3	60.0	0.4	5.7	3.5	12.8	14.4	33.5	22.3	31.9	24.2	0.3	0.0	9.2	466.3	43.8	17.5	2.3	0.1	18.0	8.7	0.8	5.3	0.9	1.6	30.7	10.1	2.3	11.2	3.9	20.5	11.9	25.4	30.8	2.4	5.9	10.9	18.0	0.2	0.2	16.1	9.7	2.0	42.3	76.0	0.6	0.2	1.2	0.3	0.8	0.4	0.0	0.0	0.0	0.0	0.0	385.0	56.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.1	0.0	12.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.3	0.3	0.2	0.1	0.1	0.2	0.4	0.1	0.0	0.6	0.3	0.4	1.2	0.8	0.1	0.2	0.1	0.0	0.2	0.0	0.2	0.0	0.3	0.0	2.3	0.1	1.6	0.2
ADH7	ADH-4	ENSG00000196344	"Alcohol dehydrogenase 7 (class IV), mu or sigma polypeptide"	P40394	4	99412261-99435737	"Enzymes, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"esophagus: 75.0;lymphoid tissue: 30.7;tongue: 68.7"	"Group enriched"	"Detected in some"	7	"ASC TERT1: 3.9;HaCaT: 4.4"	"Group enriched"	"Detected in some"	17	"cervical cancer: 18.4;head and neck cancer: 18.9;lung cancer: 22.4;urothelial cancer: 5.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							HPA039695	Enhanced		Supported	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		"HPA039695: AB_10795681"		"unprognostic (1.02e-2)"			"unprognostic (8.64e-2)"	"unprognostic (4.86e-2)"	"unprognostic (5.66e-3)"	"unprognostic (4.50e-2)"	"unprognostic (1.66e-1)"					"unprognostic (2.02e-1)"			"unprognostic (1.88e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	75.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.7	0.0	0.0	0.2	0.0	0.1	0.0	0.0	9.4	0.0	0.0	0.1	0.0	68.7	30.7	0.1	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	3.9	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	4.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ADRM1	"ARM1, GP110, Rpn13"	ENSG00000130706	"Adhesion regulating molecule 1"	Q16186	20	62302093-62308862	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA042266	Supported		Supported	"Nucleoplasm,Plasma membrane,Cytosol"				"Nucleoplasm, Cytosol"	"Plasma membrane"	"HPA042266: AB_10794044"	"unprognostic (5.49e-2)"	"unprognostic (5.14e-3)"	"unprognostic (7.34e-2)"	"unprognostic (6.16e-2)"	"unprognostic (2.06e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.77e-3)"	"unprognostic (2.14e-2)"	"unprognostic (3.56e-2)"	"unprognostic (2.13e-3)"	"unprognostic (8.98e-2)"	"unprognostic (3.50e-1)"	"prognostic unfavourable (9.02e-6)"	"unprognostic (4.15e-2)"	"unprognostic (1.09e-1)"	"unprognostic (3.22e-1)"	"unprognostic (8.47e-2)"	22.9	22.9	14.8	23.4	16.8	30.5	17.0	24.1	29.3	14.7	16.9	18.8	12.4	24.0	19.9	15.3	23.9	14.0	20.4	24.6	14.6	15.1	21.7	54.5	15.7	22.1	15.5	13.4	17.2	34.9	9.5	13.4	27.6	21.4	14.8	7.9	14.8	21.0	18.3	86.6	26.4	19.5	17.3	15.4	23.5	20.1	30.0	10.1	23.8	16.4	29.1	29.4	17.3	14.6	79.2	67.2	69.4	78.0	51.7	77.6	70.9	33.7	37.8	10.6	22.6	10.2	7.5	28.9	22.3	15.2	41.9	16.8	112.7	35.8	18.2	40.8	12.7	38.2	13.4	32.8	12.9	21.2	27.3	44.1	27.4	59.4	17.2	22.7	42.1	9.4	20.2	27.3	10.9	16.2	32.2	19.9	9.6	45.4	28.5	44.6	36.0	56.5	23.0	18.7	28.8	11.2	25.4	19.0	23.7	24.1	38.3	26.8	26.6	25.1	23.7	41.9	44.4	40.8	44.7	42.5	33.4	24.3	44.1	22.9	30.3	48.3	66.3	69.4	66.0	78.0	58.9	79.2	59.8	62.7	67.2	75.5	45.1	51.4	62.2	51.7	65.0	62.7	77.6	70.9	14.8	16.8	24.1	29.3	14.6	15.1	15.5	13.4	21.4	10.1
ADSS		ENSG00000035687	"Adenylosuccinate synthase"	P30520	1	244408494-244452134	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Purine biosynthesis"	Ligase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA024400	Supported		Supported	"Plasma membrane,Cytosol"			620000	Cytosol	"Plasma membrane"	"HPA024400: AB_1844623"	"unprognostic (4.24e-3)"	"unprognostic (2.63e-1)"	"unprognostic (3.95e-2)"	"unprognostic (8.68e-2)"	"unprognostic (6.91e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.62e-2)"	"unprognostic (2.58e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.01e-2)"	"unprognostic (1.44e-2)"	"unprognostic (3.10e-1)"	"unprognostic (1.35e-1)"	"unprognostic (7.62e-2)"	"unprognostic (1.86e-1)"	"unprognostic (2.04e-1)"	"unprognostic (1.18e-2)"	19.4	17.8	23.2	23.8	31.2	29.2	26.3	18.3	26.3	20.9	20.9	35.9	27.1	21.1	18.9	23.3	27.7	18.3	15.8	9.8	24.9	23.4	25.1	19.3	19.2	21.2	42.5	16.6	20.9	21.2	26.6	17.7	21.0	34.9	19.8	22.7	13.1	25.0	21.7	11.0	26.5	23.2	22.9	29.3	24.9	24.7	48.9	36.7	26.7	26.3	17.9	24.8	26.5	21.8	10.9	13.6	24.6	21.3	15.5	16.0	11.9	25.4	14.1	12.3	10.8	14.4	20.7	22.7	25.8	21.7	18.5	14.1	18.5	24.7	22.8	17.1	19.8	19.3	13.4	16.8	20.8	16.9	23.7	15.2	14.1	14.0	17.4	35.8	19.6	14.1	20.4	17.2	17.5	66.0	26.3	17.0	18.4	6.1	23.0	24.1	32.7	15.6	21.3	11.7	24.6	30.7	15.9	16.7	14.7	21.9	20.4	25.7	14.1	19.1	28.8	17.2	9.4	19.8	26.7	20.6	27.0	17.2	14.2	42.1	25.3	24.6	15.8	13.0	15.0	20.5	16.0	10.9	13.7	12.8	13.6	8.6	11.8	13.3	11.9	15.5	21.3	5.5	14.7	11.9	23.2	31.2	18.3	26.3	24.9	23.4	42.5	16.6	34.9	36.7
AFG1L	"AFG1, LACE1"	ENSG00000135537	"AFG1 like ATPase"	Q8WV93	6	108294894-108526796	"Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030154, HPA030155, HPA030659"	Approved		Approved	"Plasma membrane,Cytosol"	"Intracellular and membrane"			"Plasma membrane, Cytosol"		"HPA030154: AB_10600769, HPA030155: AB_10601232, HPA030659: AB_10602415"	"unprognostic (9.76e-5)"	"unprognostic (1.72e-1)"	"unprognostic (1.68e-1)"	"unprognostic (3.76e-2)"	"unprognostic (1.62e-1)"	"unprognostic (7.04e-2)"	"unprognostic (2.57e-1)"	"unprognostic (5.53e-2)"	"unprognostic (2.35e-3)"	"unprognostic (1.48e-1)"	"unprognostic (2.73e-2)"	"unprognostic (9.61e-2)"	"unprognostic (8.40e-8)"	"unprognostic (2.03e-2)"	"unprognostic (2.03e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.23e-1)"	4.9	7.3	7.6	6.5	6.6	4.3	5.7	6.2	7.3	4.1	5.7	7.3	6.9	8.9	3.7	4.9	5.5	5.1	4.8	9.4	6.3	4.9	11.0	7.6	9.1	4.8	7.3	7.4	4.1	5.2	11.6	6.9	4.7	6.1	3.9	7.0	5.5	4.7	5.4	9.0	4.2	6.3	4.0	5.6	4.4	6.0	25.4	6.5	5.6	6.6	4.1	4.5	4.8	4.3	5.7	3.0	5.1	7.2	4.2	4.4	1.7	3.4	1.8	4.6	8.1	4.8	7.0	4.5	3.9	5.9	6.5	6.4	7.3	4.3	6.2	5.2	6.0	1.9	5.8	5.8	7.3	3.6	3.5	7.4	2.3	8.4	4.7	6.5	3.6	6.5	4.8	4.8	7.8	3.4	7.4	2.9	6.0	3.2	1.2	6.1	3.0	3.6	4.3	6.2	3.6	8.1	3.8	5.0	4.4	3.2	4.6	8.6	3.8	12.8	4.3	4.0	1.0	3.4	4.4	2.1	3.2	4.8	4.9	7.8	6.0	0.0	3.1	5.1	2.0	2.2	2.6	4.8	3.2	3.8	2.7	5.7	4.4	2.9	0.8	4.2	7.2	3.0	4.1	1.7	7.6	6.6	6.2	7.3	6.3	4.9	7.3	7.4	6.1	6.5
AIFM2	"AMID, FLJ14497, PRG3"	ENSG00000042286	"Apoptosis inducing factor, mitochondria associated 2"	Q9BRQ8	10	70098223-70132934	"Predicted intracellular proteins"	Apoptosis	"DNA-binding, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"breast: 41.9"	"Cell line enhanced"	"Detected in many"		"Hep G2: 56.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028961, HPA042309, HPA075576"	Approved		Supported	"Vesicles,Plasma membrane,Cytosol"				Vesicles	"Plasma membrane, Cytosol"	"HPA028961: , HPA042309: AB_10796575, HPA075576: "	"unprognostic (6.62e-2)"	"unprognostic (2.73e-1)"	"unprognostic (4.29e-1)"	"prognostic favourable (2.80e-4)"	"unprognostic (7.26e-3)"	"unprognostic (2.57e-2)"	"unprognostic (7.95e-3)"	"unprognostic (2.80e-1)"	"unprognostic (5.31e-2)"	"unprognostic (8.90e-2)"	"unprognostic (2.23e-1)"	"unprognostic (1.53e-1)"	"unprognostic (4.49e-1)"	"unprognostic (4.59e-3)"	"unprognostic (2.17e-1)"	"unprognostic (1.11e-1)"	"prognostic favourable (2.92e-4)"	32.9	7.8	3.1	6.6	5.9	1.3	41.9	5.0	3.7	3.5	9.0	2.1	22.1	7.6	4.5	9.6	9.1	4.0	7.6	19.7	2.8	4.1	10.2	18.2	8.1	4.0	2.9	2.4	7.5	3.6	3.9	3.1	5.2	3.5	6.4	5.9	9.2	5.8	15.2	9.1	2.8	9.9	7.8	3.7	5.9	6.5	3.1	2.1	1.0	10.8	6.4	7.3	11.8	15.7	3.4	0.7	1.5	1.0	7.8	3.5	1.2	8.6	15.1	0.4	3.9	9.1	3.4	0.1	3.5	8.6	7.2	8.1	11.6	16.8	1.2	8.9	4.8	9.4	4.3	1.2	2.0	16.9	0.7	0.0	8.9	56.6	19.6	0.0	2.2	4.6	2.8	11.5	2.4	3.2	6.6	7.5	3.7	11.0	0.3	0.4	1.5	4.9	0.2	1.4	4.1	3.8	6.4	1.3	0.3	6.4	5.6	9.8	0.2	2.4	3.9	0.1	8.9	5.3	10.1	5.6	10.4	2.4	4.8	0.3	4.7	1.5	0.9	1.0	3.5	0.8	3.1	3.4	1.2	3.0	0.7	2.9	1.7	2.7	1.0	7.8	1.0	0.5	2.4	1.2	3.1	5.9	5.0	3.7	2.8	4.1	2.9	2.4	3.5	2.1
AKAP10	"D-AKAP2, MGC9414, PRKA10"	ENSG00000108599	"A-kinase anchoring protein 10"	O43572	17	19904302-19978343	"Disease related genes, Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028901	Approved		Supported	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		"HPA028901: AB_10602227"	"unprognostic (2.17e-2)"	"unprognostic (3.48e-2)"	"unprognostic (5.33e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.50e-1)"	"unprognostic (5.51e-2)"	"unprognostic (1.59e-3)"	"unprognostic (3.88e-1)"	"unprognostic (7.69e-3)"	"unprognostic (1.89e-1)"	"unprognostic (3.59e-2)"	"unprognostic (3.21e-2)"	"unprognostic (3.21e-2)"	"unprognostic (2.49e-2)"	"unprognostic (7.15e-2)"	"unprognostic (2.16e-2)"	"unprognostic (5.20e-2)"	20.5	24.2	22.5	19.4	25.5	16.1	21.2	22.8	27.9	21.2	19.4	17.4	13.4	16.1	22.3	15.9	18.5	19.2	18.4	14.4	20.1	17.9	22.7	14.9	18.5	24.3	22.4	23.2	24.3	16.2	28.0	20.3	20.3	19.2	19.5	20.3	16.1	17.8	21.3	13.7	17.5	18.5	22.9	19.0	28.6	20.2	22.9	24.2	25.9	26.0	9.1	20.5	22.2	22.7	7.3	6.1	24.4	10.3	5.1	7.9	3.0	11.0	13.3	8.9	6.2	11.8	14.9	16.4	12.9	13.9	14.4	17.4	14.4	6.7	9.5	8.8	10.2	11.8	11.4	10.8	19.7	7.8	9.8	8.1	13.0	6.9	11.2	5.9	13.4	12.5	13.6	13.1	16.3	11.6	5.2	4.8	15.0	8.0	10.9	8.8	5.8	4.6	7.3	29.2	4.9	12.0	7.0	3.0	9.1	14.9	7.0	12.3	17.0	6.6	10.1	11.2	9.3	9.5	11.9	6.0	6.4	11.6	14.8	7.1	10.7	3.6	7.3	8.8	6.7	10.3	6.1	6.0	6.5	7.2	6.1	7.3	7.9	7.0	24.4	5.1	9.3	4.6	4.9	3.0	22.5	25.5	22.8	27.9	20.1	17.9	22.4	23.2	19.2	24.2
AL132780.3		ENSG00000259132			14	22946270-22982258	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"				"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"Hep G2: 27.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"											HPA029803	Approved		Approved	"Plasma membrane,Focal adhesion sites"				"Plasma membrane, Focal adhesion sites"		"HPA029803: AB_10601428"																		4.8	6.2	4.5	4.7	5.5	6.6	5.3	3.5	2.4	16.1	7.1	2.3	7.1	5.5	12.4	9.2	16.2	6.6	11.2	6.0	4.6	3.8	20.4	24.5	10.5	7.9	5.3	1.9	11.8	13.8	0.0	3.5	18.1	3.8	13.1	6.1	10.4	5.7	16.0	6.2	8.8	4.5	3.5	4.5	11.3	4.5	6.0	1.9	10.3	22.1	7.7	9.6	5.0	7.9	3.3	5.7	10.2	5.9	1.1	4.1	2.8	4.0	8.7	6.1	2.0	6.0	7.1	3.9	0.7	5.7	3.6	3.8	2.9	3.1	0.0	2.4	6.7	1.5	2.8	3.1	2.6	0.0	0.7	1.3	6.7	27.6	3.9	3.2	2.6	3.1	8.1	2.8	6.8	5.0	0.0	6.0	3.9	16.5	6.9	11.8	3.0	1.9	3.3	4.3	3.8	10.1	8.2	3.4	2.0	2.7	3.6	1.7	5.4	6.9	1.0	4.6	3.4	1.9	3.4	5.9	7.2	6.2	1.5	3.2	2.8	0.5	5.9	2.1	2.5	4.2	1.2	2.7	1.8	2.1	5.7	3.3	3.4	1.7	10.2	1.1	2.9	2.6	4.1	2.8	4.5	5.5	3.5	2.4	4.6	3.8	5.3	1.9	3.8	1.9
AL358113.1		ENSG00000285130			9	69035750-69255187	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"				"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"HaCaT: 2.8;HUVEC TERT2: 2.1;REH: 9.6;U-2 OS: 2.2"									"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	11	"dendritic cells: 1.3;monocytes: 2.8;T-cells: 2.6"									"HPA001813, HPA068304, HPA070714"	Uncertain		Approved	"Nucleoplasm,Plasma membrane,Cell Junctions"				"Nucleoplasm, Plasma membrane, Cell Junctions"		"HPA001813: AB_1080764, HPA068304: , HPA070714: "																		1.6	4.3	2.5	1.9	2.1	2.6	2.8	3.6	2.5	1.6	2.8	3.0	2.7	1.6	2.2	1.6	1.6	3.4	1.6	5.8	1.3		2.1	8.8	2.1	3.2	2.8	1.7	3.7	9.4	1.6	1.7	1.6	2.4	4.0	1.6	2.9	2.8	3.2	7.5	1.6	3.0	4.5	1.6	3.1	3.1	3.4	2.1	0.0	2.6	2.0	2.1	2.4	1.3	0.1	1.3	0.1	2.8	0.0	2.6	0.4	0.4	0.0	0.9	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.1	1.7	0.3	2.8	0.2	1.3	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.5	0.9	0.0	0.0	0.0	2.1	0.1	0.0	0.2	0.0	1.2	0.2	0.8	0.0	9.6	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.1	0.0	0.0	0.1	0.0	2.2	0.0	0.4	0.0	0.3	0.6	0.0	0.0	0.0	0.0	1.0	0.0	0.2	2.6	0.2	0.1	1.3	0.1	1.0	0.1	0.6	0.3	0.1	0.0	2.8	1.3	2.6	0.4										
ALDH3A1	ALDH3	ENSG00000108602	"Aldehyde dehydrogenase 3 family member A1"	P30838	17	19737984-19748943	"Enzymes, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 88.2;lymphoid tissue: 70.3;stomach 1: 49.9;tongue: 106.6"	"Cell line enriched"	"Detected in some"	20	"A549: 321.7"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in single"		"pons and medulla: 1.8"	"Cell type enhanced"	"Detected in some"		"NK-cell: 2.4"	"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB045957, HPA051150, HPA063783"	Enhanced		Supported	"Nucleoplasm,Vesicles,Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"	"Nucleoplasm, Vesicles"	"CAB045957: AB_11127164, HPA051150: , HPA063783: "	"unprognostic (3.11e-5)"	"unprognostic (1.20e-2)"	"unprognostic (1.08e-1)"	"unprognostic (7.04e-3)"	"unprognostic (4.36e-3)"	"prognostic favourable (7.55e-5)"	"unprognostic (3.12e-1)"	"unprognostic (3.84e-1)"	"unprognostic (2.10e-1)"	"unprognostic (1.67e-1)"	"unprognostic (2.69e-3)"	"unprognostic (5.54e-2)"	"unprognostic (1.72e-1)"	"unprognostic (3.84e-2)"	"unprognostic (1.83e-1)"	"unprognostic (2.88e-2)"	"unprognostic (7.23e-2)"	0.7	0.1	0.2	0.8	0.4	0.0	0.5	0.2	0.3	1.3	0.9	0.8	0.3	1.3	0.2	0.4	88.2	1.2	3.8	0.2	0.4	0.0	0.4	0.4	26.0	0.2	0.2	0.3	0.6	0.2	0.0	0.3	0.2	1.8	0.5	0.6	0.5	26.7	0.3	0.4	16.2	0.6	0.3	0.3	0.3	49.9	0.3	0.2	0.2	0.2	106.6	70.3	1.6	3.9	1.1	0.3	0.0	0.0	2.4	0.7	0.1	0.0	321.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	16.1	0.0	0.1	0.0	1.9	0.0	0.8	0.0	0.0	0.0	0.0	8.1	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	5.7	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.1	0.0	0.0	0.3	1.1	0.0	0.7	0.0	2.4	0.0	0.0	0.0	0.1	0.2	0.4	0.2	0.3	0.4	0.0	0.2	0.3	1.8	0.2
ALOXE3	"E-LOX, eLOX3"	ENSG00000179148	"Arachidonate lipoxygenase 3"	Q9BYJ1	17	8095900-8119047	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	"Dioxygenase, Isomerase, Lyase, Oxidoreductase"	"Disease mutation, Ichthyosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	11	"skin 1: 30.2"	"Cell line enhanced"	"Detected in some"		"A-431: 6.5;HBEC3-KT: 10.6;hTCEpi: 7.8;hTERT-HME1: 14.8;T-47d: 4.7"	"Cancer enhanced"	"Detected in some"		"head and neck cancer: 3.9"	"Group enriched"	"Detected in many"	8	"basal ganglia: 1.1;cerebellum: 1.4;cerebral cortex: 2.3;pons and medulla: 1.1"	"Group enriched"	"Detected in some"	5	"gdT-cell: 1.0;naive CD4 T-cell: 2.7"	"Lineage enriched"	"Detected in single"	28	"T-cells: 2.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA023120, HPA078597"	Enhanced		Approved	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		"HPA023120: AB_10959300, HPA078597: "	"unprognostic (2.40e-1)"	"unprognostic (3.01e-2)"	"unprognostic (1.87e-3)"	"unprognostic (2.09e-4)"	"unprognostic (1.07e-2)"	"unprognostic (4.06e-2)"		"unprognostic (3.56e-4)"	"unprognostic (3.60e-1)"	"unprognostic (4.65e-2)"	"unprognostic (3.82e-2)"	"unprognostic (3.72e-1)"	"unprognostic (3.66e-5)"	"unprognostic (9.81e-2)"	"unprognostic (2.55e-1)"	"unprognostic (1.08e-2)"	"unprognostic (2.88e-2)"	0.1	0.0	0.1	0.1	1.1	0.0	1.6	1.4	2.3	1.2	0.1	0.1	0.1	0.0	0.1	0.1	0.3	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	1.1	0.1	0.0	0.1	0.1	0.1	0.1	30.2	0.1	0.1	0.1	0.1	0.0	0.4	0.1	0.1	0.1	0.1	1.0	0.1	0.8	0.0	0.0	0.0	0.0	0.0	2.7	0.2	6.5	0.8	0.0	0.0	0.0	0.0	0.0	0.5	0.5	0.1	0.4	0.1	0.5	0.2	0.2	0.1	0.4	0.9	10.6	0.1	0.0	0.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	7.8	0.1	14.8	0.0	0.0	0.1	0.0	2.3	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.1	0.3	0.0	0.1	0.0	0.7	0.0	4.7	0.0	0.1	0.0	2.3	0.0	0.3	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	2.7	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.1	1.1	1.4	2.3	0.1	0.1	0.1	0.1	1.1	0.1
ALPI		ENSG00000163295	"Alkaline phosphatase, intestinal"	P09923	2	232456123-232460032	"Enzymes, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	406	"intestine: 133.2"	"Cell line enriched"	"Detected in some"	12	"CACO-2: 12.4"	"Cancer enhanced"	"Detected in many"		"liver cancer: 4.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA038764, HPA038765, HPA051699"	Supported		Approved	"Plasma membrane"	"Intracellular and membrane"			"Plasma membrane"		"HPA038764: , HPA038765: , HPA051699: "			"unprognostic (1.01e-1)"	"unprognostic (7.71e-2)"			"unprognostic (4.14e-2)"			"unprognostic (1.47e-1)"	"unprognostic (9.57e-4)"		"unprognostic (8.07e-2)"	"unprognostic (1.71e-1)"	"unprognostic (9.99e-2)"			0.1	0.1	0.1	0.2	0.1	0.0	0.1	0.1	0.1	0.1	63.0	0.0	0.0	57.3	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.3	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.1	1.3	0.0	0.1	0.0	0.1	0.1	133.2	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	12.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.2	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0
ALPP		ENSG00000163283	"Alkaline phosphatase, placental"	P05187	2	232378534-232382889	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"		Hydrolase	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	17	"placenta: 240.2"	"Group enriched"	"Detected in some"	6	"HaCaT: 86.1;SiHa: 23.7"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 15.3"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"											"CAB026327, HPA038764, HPA038765, HPA051699"	Enhanced		Approved	"Plasma membrane"	"Intracellular and membrane"			"Plasma membrane"		"CAB026327: , HPA038764: , HPA038765: , HPA051699: "		"unprognostic (4.86e-2)"	"unprognostic (5.19e-3)"	"unprognostic (6.67e-3)"		"unprognostic (2.60e-1)"		"unprognostic (2.44e-3)"		"unprognostic (1.26e-2)"	"prognostic unfavourable (4.33e-4)"	"unprognostic (1.44e-1)"		"unprognostic (4.09e-1)"	"unprognostic (2.12e-1)"		"unprognostic (1.27e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	14.5	0.1	0.0	0.0	0.0	0.1	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	9.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	240.2	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	1.0	0.5	1.6	0.5	1.1	0.5	0.3	0.4	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.1	9.7	0.0	0.0	0.0	86.1	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	23.7	8.4	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.4	0.7	0.5	0.2	0.5	0.3	0.3	0.3	0.1	1.0	0.4	0.4	1.6	1.1	0.5	0.5	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ALPPL2		ENSG00000163286	"Alkaline phosphatase, placental like 2"	P10696	2	232406843-232410714	"Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"		Hydrolase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"fallopian tube: 4.2;lung: 9.4"	"Group enriched"	"Detected in some"	4	"CAPAN-2: 24.5;HaCaT: 18.0"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 49.1;testis cancer: 64.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"CAB020698, HPA038764, HPA038765, HPA051699"	Supported		Approved	"Plasma membrane"	"Intracellular and membrane"			"Plasma membrane"		"CAB020698: , HPA038764: , HPA038765: , HPA051699: "		"unprognostic (1.39e-1)"	"unprognostic (6.63e-3)"	"unprognostic (1.27e-2)"		"unprognostic (2.89e-1)"		"unprognostic (1.46e-1)"		"unprognostic (1.26e-1)"	"unprognostic (1.69e-3)"			"unprognostic (1.65e-1)"	"unprognostic (2.67e-1)"		"unprognostic (6.72e-3)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	1.0	0.0	0.0	0.2	1.5	0.0	0.0	4.2	0.0	0.0	0.0	0.0	0.0	0.0	9.4	0.0	0.0	0.0	1.5	0.0	0.0	0.0	1.9	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	1.6	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.9	0.0	0.0	0.0	0.0	0.5	24.5	0.0	0.0	0.0	18.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ALS2CR12		ENSG00000155749	"Amyotrophic lateral sclerosis 2 chromosome region 12"	Q96Q35	2	201288271-201357398	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"brain: 14.3;epididymis: 14.4;testis: 29.9"	"Cell line enhanced"	"Detected in many"		"SK-MEL-30: 6.9;U-2197: 9.4"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in many"		"pons and medulla: 14.3"	"Cell type enhanced"	"Detected in many"		"neutrophil: 7.3"	"Low lineage specificity"	"Detected in many"							"Low region specificity"	"Detected in many"			HPA035793			Approved	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		"HPA035793: AB_10602429"	"unprognostic (1.45e-1)"	"unprognostic (1.91e-1)"	"unprognostic (9.72e-2)"	"unprognostic (2.95e-2)"	"unprognostic (1.53e-1)"	"unprognostic (8.33e-2)"	"unprognostic (1.32e-1)"	"unprognostic (8.40e-3)"	"unprognostic (1.40e-5)"	"unprognostic (1.37e-1)"	"unprognostic (3.62e-2)"	"unprognostic (1.14e-1)"	"unprognostic (6.23e-2)"	"unprognostic (1.13e-1)"	"unprognostic (2.73e-2)"	"unprognostic (2.23e-1)"	"unprognostic (8.25e-2)"	0.8	0.9	1.5	0.7	3.6	4.3	0.5	0.7	1.1	0.9	0.6	7.6	0.4	0.3	0.7	14.4	1.1	9.9	0.9	4.7	2.1	2.6	1.3	0.7	3.7	1.4	1.0	1.3	5.3	0.7	1.2	1.3	0.9	14.3	0.4	0.9	0.5	0.7	0.7	1.4	1.1	0.9	0.9	0.9	0.8	0.5	29.9	1.3	0.4	1.7	0.4	0.5	0.6	0.4	1.8	0.5	7.3	1.1	2.8	1.5	0.4	0.3	0.4	2.0	1.4	5.6	2.2	0.1	1.5	0.5	1.2	0.8	0.0	0.4	0.7	1.2	2.1	2.0	0.7	0.2	0.6	1.2	0.2	0.3	2.5	0.7	1.1	2.1	1.8	1.0	0.5	1.3	0.3	0.2	1.0	2.9	1.2	0.0	1.1	1.8	0.6	1.2	0.5	1.0	1.3	0.7	0.5	0.5	1.3	1.6	0.0	6.9	1.5	2.4	1.5	2.8	1.7	9.4	1.0	1.6	3.0	1.0	2.7	1.0	1.3	5.4	1.1	1.0	1.5	0.5	0.7	0.6	1.0	0.9	0.5	1.8	1.2	1.4	7.3	2.8	0.6	0.4	0.6	0.4	1.5	3.6	0.7	1.0	2.1	2.6	1.0	1.3	14.3	1.3
AMACR	"P504S, RACE"	ENSG00000242110	"Alpha-methylacyl-CoA racemase"	Q9UHK6	5	33986178-34008108	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		Isomerase	"Disease mutation, Intrahepatic cholestasis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 68.0;liver: 63.6"	"Cell line enhanced"	"Detected in many"		"U-266/70: 58.5;U-266/84: 30.5"	"Cancer enhanced"	"Detected in all"		"prostate cancer: 34.5"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB001809, HPA019527, HPA020912"	Enhanced		Supported	"Vesicles,Plasma membrane"			65000	"Vesicles, Plasma membrane"		"CAB001809: AB_2305454, HPA019527: AB_10669651, HPA020912: AB_10670034"	"unprognostic (8.96e-2)"	"unprognostic (5.20e-3)"	"prognostic favourable (7.11e-4)"	"unprognostic (9.55e-2)"	"unprognostic (1.39e-1)"	"unprognostic (9.12e-3)"	"unprognostic (1.68e-1)"	"unprognostic (5.41e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.60e-1)"	"unprognostic (5.59e-5)"	"unprognostic (1.95e-2)"	"unprognostic (5.52e-3)"	"unprognostic (6.32e-2)"	"unprognostic (3.41e-1)"	"unprognostic (2.18e-1)"	"unprognostic (1.50e-1)"	2.8	8.3	5.2	2.7	8.2	0.9	2.8	4.7	7.8	4.4	14.1	4.3	6.5	6.2	4.0	3.6	8.2	2.3	11.0	3.5	4.5	6.8	68.0	63.6	3.3	2.0	4.5	4.5	2.9	5.1	5.4	4.3	3.2	7.0	13.9	15.5	5.5	25.4	5.4	6.0	2.6	7.4	3.7	3.8	2.9	15.9	2.1	2.1	3.8	3.3	3.4	3.3	5.7	4.5	7.8	10.2	11.2	14.2	9.9	10.0	6.8	4.0	6.5	3.7	4.7	2.6	4.0	6.3	5.4	4.0	2.5	1.9	21.1	4.9	1.3	2.9	7.6	1.9	0.9	3.9	2.6	4.0	3.4	3.1	4.7	6.1	1.8	1.9	1.0	6.1	1.9	3.2	1.2	2.8	1.1	4.8	7.3	2.9	1.5	2.4	3.3	10.6	1.9	6.1	2.0	11.1	20.3	2.0	2.8	8.9	6.4	5.4	4.9	1.9	5.0	8.3	1.8	2.0	4.3	58.5	30.5	2.3	2.3	3.9	6.1	0.3	7.1	10.2	10.0	8.8	8.4	7.8	8.7	7.8	10.2	7.0	8.1	6.1	11.2	9.9	14.2	5.3	8.9	6.8	5.2	8.2	4.7	7.8	4.5	6.8	4.5	4.5	7.0	2.1
AMDHD1	MGC35366	ENSG00000139344	"Amidohydrolase domain containing 1"	Q96NU7	12	95943293-95968716	"Enzymes, Predicted intracellular proteins"	"Histidine metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	9	"liver: 99.0"	"Cell line enhanced"	"Detected in many"		"A-431: 19.1;HMC-1: 21.1;Karpas-707: 26.1;SiHa: 17.5;SK-BR-3: 19.6;U-266/70: 21.1;U-266/84: 24.7"	"Cancer enriched"	"Detected in many"	14	"liver cancer: 23.4"	"Low region specificity"	"Detected in single"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA039720, HPA040149"	Uncertain		Approved	"Nucleoplasm,Plasma membrane,Cytosol"			410000	Cytosol	"Nucleoplasm, Plasma membrane"	"HPA039720: AB_10672967, HPA040149: "	"unprognostic (4.81e-2)"	"unprognostic (2.91e-1)"	"unprognostic (1.53e-1)"	"unprognostic (2.09e-2)"	"unprognostic (1.80e-2)"	"unprognostic (2.88e-2)"	"unprognostic (2.33e-2)"	"unprognostic (6.62e-3)"	"unprognostic (1.06e-1)"	"unprognostic (7.01e-2)"	"unprognostic (3.35e-3)"	"unprognostic (1.17e-1)"	"unprognostic (4.63e-3)"	"unprognostic (3.98e-2)"	"unprognostic (1.70e-1)"	"unprognostic (4.08e-3)"	"unprognostic (2.61e-1)"	1.1	5.7	0.5	2.4	0.8	2.0	0.9	0.5	1.3	0.7	0.7	0.6	0.4	1.9	0.9	0.5	0.8	0.5	0.7	1.1	0.6	0.5	4.4	99.0	1.3	1.4	0.5	0.4	0.7	1.1	0.0	1.2	0.6	1.0	0.7	0.0	0.8	1.3	0.7	11.3	2.2	1.9	0.6	0.6	2.9	1.9	6.2	0.5	0.7	0.6	0.7	0.7	0.8	0.9	1.5	1.2	3.7	3.8	5.7	1.6	1.4	19.1	4.2	0.3	2.8	0.1	0.0	4.3	0.6	0.2	0.3	0.6	1.9	2.5	1.7	1.9	0.0	3.6	0.1	0.0	0.1	6.6	0.7	1.8	2.9	3.7	0.0	2.5	21.1	0.0	0.1	0.3	0.0	0.1	1.3	26.1	0.0	2.9	1.6	4.7	2.0	1.0	3.5	0.1	2.1	0.0	1.8	2.2	3.1	17.5	19.6	2.2	2.0	3.6	0.0	2.7	9.5	3.4	2.4	21.1	24.7	2.6	1.9	5.1	3.1	0.3	1.6	3.7	1.2	1.4	1.1	1.5	0.6	1.6	1.2	1.0	1.0	1.1	1.2	5.7	3.8	0.6	0.3	1.4	0.5	0.8	0.5	0.6	0.6	0.5	0.5	0.4	1.0	0.5
AMIGO2	"ALI1, DEGA"	ENSG00000139211	"Adhesion molecule with Ig like domain 2"	Q86SJ2	12	47075707-47079951	"Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"ovary: 43.4"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 43.9;fHDF/TERT166: 42.2;LHCN-M2: 42.2;RT4: 57.8;U-2 OS: 35.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA054004, HPA059601"	Uncertain		Approved	"Golgi apparatus,Plasma membrane,Cytosol"			160000	"Golgi apparatus, Plasma membrane"	Cytosol	"HPA054004: AB_2682339, HPA059601: "	"unprognostic (2.63e-1)"	"unprognostic (6.00e-3)"	"unprognostic (1.10e-2)"	"unprognostic (3.91e-2)"	"unprognostic (3.86e-1)"	"unprognostic (1.07e-2)"	"unprognostic (3.65e-2)"	"unprognostic (1.67e-1)"	"unprognostic (3.17e-1)"	"unprognostic (3.30e-1)"	"prognostic unfavourable (1.80e-4)"	"unprognostic (2.98e-2)"	"unprognostic (4.87e-2)"	"unprognostic (1.16e-2)"	"unprognostic (2.95e-1)"	"unprognostic (7.47e-2)"	"unprognostic (2.29e-3)"	5.6	11.9	5.4	4.0	8.8	1.4	14.5	1.6	6.5	18.3	20.3	3.5	1.9	1.6	19.7	12.4	3.1	21.2	12.4	3.4	2.7	7.5	4.3	2.9	11.9	6.7	2.9	5.1	43.4	2.3	2.0	9.5	7.6	16.2	12.8	5.6	6.7	3.1	7.1	1.5	2.3	7.1	21.0	3.0	9.8	3.5	13.1	3.6	1.6	2.5	4.1	4.5	16.6	15.1	2.8	7.4	0.1	0.2	6.6	14.2	4.3	9.7	24.1	1.5	0.0	0.6	0.0	3.9	3.3	9.1	1.1	0.9	0.0	43.9	0.0	11.0	42.2	14.6	0.0	27.0	1.3	1.9	0.1	0.0	2.4	0.0	0.9	0.2	0.4	0.2	4.8	28.9	14.3	3.5	1.8	0.0	42.2	0.4	0.7	0.0	1.0	6.1	0.0	10.9	0.0	12.5	57.8	4.4	0.0	17.4	2.1	0.1	2.6	0.2	0.9	0.6	35.0	0.4	26.9	0.4	0.0	0.0	2.3	0.7	0.6	0.0	0.1	0.0	4.0	0.2	5.4	2.8	6.2	6.2	0.6	1.3	14.2	11.1	0.1	6.6	0.0	7.4	3.6	4.3	5.4	8.8	1.6	6.5	2.7	7.5	2.9	5.1	16.2	3.6
AMPH		ENSG00000078053	Amphiphysin	P49418	7	38383704-38631567	"Cancer-related genes, Predicted intracellular proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"brain: 57.2"	"Cell line enhanced"	"Detected in some"		"ASC diff: 31.8;ASC TERT1: 18.8;BJ hTERT+ SV40 Large T+: 12.3;BJ hTERT+ SV40 Large T+ RasG12V: 14.6;HBF TERT88: 11.3;HSkMC: 11.0;U-138 MG: 12.1;WM-115: 10.8"	"Cancer enhanced"	"Detected in many"		"glioma: 3.8"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB008559, HPA019828, HPA019829"	Enhanced		Supported	"Plasma membrane,Cytosol"				Cytosol	"Plasma membrane"	"CAB008559: AB_1611845, HPA019828: AB_1844801, HPA019829: AB_1844802"	"unprognostic (1.76e-2)"	"unprognostic (1.59e-1)"	"unprognostic (5.94e-2)"	"unprognostic (7.36e-2)"	"unprognostic (3.24e-3)"	"unprognostic (2.92e-1)"	"unprognostic (4.90e-2)"	"unprognostic (2.55e-2)"	"unprognostic (4.37e-1)"	"unprognostic (1.08e-1)"	"prognostic favourable (9.96e-4)"	"unprognostic (5.06e-2)"	"unprognostic (5.81e-5)"	"unprognostic (1.23e-2)"	"unprognostic (5.63e-2)"	"unprognostic (8.03e-2)"	"unprognostic (1.68e-3)"	3.8	2.4	17.4	2.5	17.7	1.0	2.8	29.7	57.2	7.7	2.2	1.8	0.0	1.4	5.1	4.7	4.5	5.7	4.2	6.5	13.5	16.0	3.7	1.4	1.6	1.3	10.4	20.4	1.7	2.9	1.2	12.6	1.0	26.5	2.4	2.5	4.8	1.5	4.2	2.9	1.3	1.9	5.0	4.9	1.9	2.0	3.5	1.5	0.0	1.2	0.2	1.1	2.9	1.7	0.2	1.6	0.0	0.8	0.7	2.9	0.2	0.0	0.0	8.0	0.0	31.8	18.8	0.0	1.1	0.0	12.3	14.6	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	11.3	0.0	0.9	0.1	0.0	0.0	0.0	0.1	0.0	11.0	0.0	0.0	0.0	0.9	0.0	0.2	0.0	0.1	0.0	0.1	4.0	0.0	0.0	0.0	0.9	0.0	0.0	2.3	0.0	0.0	0.0	0.3	0.0	0.0	0.0	12.1	8.5	4.2	4.5	0.0	0.1	0.0	8.2	0.1	10.8	0.0	0.8	0.0	2.9	0.2	1.7	0.0	1.0	1.5	0.2	0.2	0.4	2.0	0.0	0.7	0.2	1.6	0.2	0.2	17.4	17.7	29.7	32.9	13.5	16.0	10.4	20.4	26.5	1.5
ANKEF1	"ANKRD5, dJ839B4.6, FLJ21669"	ENSG00000132623	"Ankyrin repeat and EF-hand domain containing 1"	Q9NU02	20	9986126-10058303	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pancreas: 25.0;testis: 22.7"	"Cell line enhanced"	"Detected in many"		"U-266/84: 17.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			HPA041151	Approved		Approved	"Nucleoli fibrillar center,Plasma membrane,Cytosol"				"Nucleoli fibrillar center, Plasma membrane, Cytosol"		"HPA041151: AB_10796569"	"unprognostic (4.72e-2)"	"unprognostic (9.86e-2)"	"unprognostic (2.31e-2)"	"unprognostic (2.09e-1)"	"unprognostic (5.38e-4)"	"unprognostic (2.54e-1)"	"unprognostic (1.83e-3)"	"prognostic unfavourable (1.81e-4)"	"unprognostic (3.21e-2)"	"unprognostic (1.12e-1)"	"unprognostic (3.28e-1)"	"unprognostic (6.73e-2)"	"prognostic favourable (4.44e-4)"	"unprognostic (3.90e-2)"	"unprognostic (1.65e-1)"	"prognostic unfavourable (1.58e-4)"	"unprognostic (3.11e-1)"	5.6	2.9	1.4	2.3	2.4	0.5	3.7	5.7	2.0	2.7	3.1	0.8	11.3	2.9	1.9	4.2	4.7	4.9	4.0	3.2	2.3	2.5	5.7	6.7	2.3	1.3	1.5	1.1	3.6	25.0	5.3	13.6	1.7	4.1	3.4	3.0	3.0	4.2	13.0	1.7	2.9	3.6	1.0	1.2	1.8	5.1	22.7	1.0	3.2	8.6	2.5	3.9	2.1	2.6	2.5	1.6	0.7	0.1	1.5	5.4	1.3	10.1	10.3	1.4	2.5	2.1	1.2	5.9	1.9	0.1	1.8	0.9	6.0	9.2	0.0	3.2	0.4	8.8	1.8	12.1	2.2	0.0	1.6	1.3	2.0	5.5	1.4	1.1	0.2	3.7	8.6	1.6	1.7	1.5	3.8	9.0	0.4	3.2	1.6	0.0	4.3	2.4	0.0	0.0	6.9	4.4	6.5	7.8	3.9	4.7	10.3	0.0	9.0	0.9	1.1	1.3	1.5	0.1	2.0	9.3	17.9	1.6	2.6	0.3	1.7	0.0	0.0	0.0	2.8	0.1	5.4	2.5	3.3	2.6	0.2	2.3	4.1	3.0	0.7	1.5	0.0	1.6	3.8	1.3	1.4	2.4	5.7	2.0	2.3	2.5	1.5	1.1	4.1	1.0
ANKFN1	FLJ38335	ENSG00000153930	"Ankyrin repeat and fibronectin type III domain containing 1"	Q8N957	17	55882301-56511659	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"brain: 11.8;cervix, uterine: 19.9;fallopian tube: 10.9"	"Cell line enhanced"	"Detected in some"		"HeLa: 7.9;MOLT-4: 16.4;T-47d: 5.7;U-2197: 5.5"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Low region specificity"	"Detected in many"			"HPA021566, HPA022538, HPA048953"	Uncertain		Approved	"Nucleoplasm,Plasma membrane"				Nucleoplasm	"Plasma membrane"	"HPA021566: AB_1844828, HPA022538: AB_1844829, HPA048953: "	"unprognostic (6.64e-2)"	"unprognostic (1.29e-1)"	"unprognostic (3.52e-2)"	"unprognostic (9.38e-5)"	"unprognostic (2.39e-1)"	"unprognostic (2.31e-3)"	"unprognostic (3.84e-2)"	"unprognostic (1.68e-1)"	"unprognostic (3.31e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.24e-2)"	"unprognostic (6.81e-3)"	"unprognostic (3.44e-8)"	"unprognostic (1.24e-1)"	"unprognostic (1.69e-1)"	"unprognostic (4.93e-2)"	"unprognostic (9.51e-2)"	3.9	1.0	5.5	0.5	10.2	0.5	1.2	2.6	4.7	19.9	0.7	11.4	0.5	0.7	0.8	3.4	0.7	10.9	0.9	0.5	6.8	4.6	0.7	0.6	2.0	0.6	6.3	3.7	0.5	0.5	0.5	1.0	2.1	11.8	0.9	0.8	0.0	0.7	0.8	0.6	5.2	0.8	0.5	7.5	0.6	1.1	3.6	10.0	0.0	0.6	0.0	0.5	3.2	5.3	0.2	0.5	0.1	0.1	0.3	0.4	0.0	0.0	0.0	0.1	0.0	1.3	0.2	0.3	0.0	2.8	0.2	0.3	0.0	0.1	0.3	0.2	0.7	0.1	0.0	0.0	0.2	0.0	0.0	0.1	7.9	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	2.1	0.1	0.4	16.4	0.0	0.0	0.7	0.1	0.0	0.0	0.0	0.1	1.5	0.0	1.7	0.0	0.3	5.7	0.0	0.0	0.0	0.4	5.5	0.1	1.5	0.3	0.0	0.8	0.0	0.4	0.0	0.1	0.0	0.2	0.0	0.2	0.0	0.0	0.4	0.0	0.2	0.0	0.3	0.1	0.3	0.1	0.5	0.0	0.0	5.5	10.2	2.6	4.7	6.8	4.6	6.3	3.7	11.8	10.0
ANKLE2	"KIAA0692, Lem4, LEMD7"	ENSG00000176915	"Ankyrin repeat and LEM domain containing 2"	Q86XL3	12	132725503-132761888	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Cell cycle, Cell division, Mitosis"		"Disease mutation, Primary microcephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003602, HPA074838"	Uncertain		Supported	"Endoplasmic reticulum,Plasma membrane"				"Endoplasmic reticulum, Plasma membrane"		"HPA003602: AB_1858349, HPA074838: "	"unprognostic (4.43e-2)"	"unprognostic (6.92e-2)"	"unprognostic (7.97e-2)"	"unprognostic (9.84e-3)"	"unprognostic (1.97e-2)"	"unprognostic (5.81e-2)"	"prognostic unfavourable (3.97e-6)"	"unprognostic (3.19e-2)"	"unprognostic (1.11e-2)"	"unprognostic (2.49e-1)"	"unprognostic (4.76e-2)"	"unprognostic (6.10e-2)"	"prognostic unfavourable (1.90e-8)"	"unprognostic (1.42e-1)"	"unprognostic (1.42e-1)"	"unprognostic (6.92e-3)"	"unprognostic (2.09e-1)"	20.1	26.4	14.9	21.3	17.6	27.2	21.8	23.3	20.4	15.6	15.4	19.6	15.1	14.6	18.9	16.8	23.7	18.6	17.0	16.5	12.4	10.7	16.3	16.3	21.6	24.1	16.0	11.3	20.7	18.1	17.2	22.3	18.3	15.2	17.2	13.9	16.7	19.1	15.7	19.9	27.3	22.8	18.5	13.4	27.4	16.8	43.7	14.1	31.4	17.4	15.8	27.9	16.4	28.6	4.8	3.3	7.7	2.2	4.7	5.5	1.4	20.8	19.5	20.5	12.6	11.9	18.8	25.7	25.5	19.1	25.6	19.7	22.2	14.3	16.4	13.4	22.4	25.2	17.8	23.2	24.6	7.0	22.1	20.8	32.7	10.4	13.3	22.4	14.7	17.4	23.8	24.3	18.1	18.2	18.7	6.5	26.1	15.0	20.8	37.0	17.3	18.8	24.0	13.4	6.9	18.4	27.3	25.1	15.5	32.9	13.9	11.2	24.4	16.3	26.0	30.9	22.3	16.4	28.4	12.1	11.9	20.1	23.9	14.9	17.3	1.4	2.2	7.7	3.6	2.1	4.8	4.8	5.3	5.5	3.3	4.3	5.0	4.1	1.3	4.7	2.2	3.2	4.7	1.4	14.9	17.6	23.3	20.4	12.4	10.7	16.0	11.3	15.2	14.1
ANKRD11	"LZ16, T13"	ENSG00000167522	"Ankyrin repeat domain 11"	Q6UB99	16	89267619-89490561	"Disease related genes, Predicted intracellular proteins"			"Disease mutation, Dwarfism, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB019288, HPA049470"	Approved		Enhanced	"Nucleoplasm,Plasma membrane,Cytosol"				Nucleoplasm	"Plasma membrane, Cytosol"	"CAB019288: , HPA049470: "	"unprognostic (7.31e-2)"	"unprognostic (6.35e-2)"	"unprognostic (1.85e-1)"	"unprognostic (3.53e-3)"	"unprognostic (1.82e-1)"	"unprognostic (1.69e-1)"	"prognostic unfavourable (6.39e-4)"	"unprognostic (1.81e-1)"	"unprognostic (1.83e-2)"	"unprognostic (1.78e-1)"	"unprognostic (4.81e-2)"	"prognostic unfavourable (7.67e-4)"	"unprognostic (1.56e-3)"	"unprognostic (1.79e-1)"	"unprognostic (7.93e-2)"	"unprognostic (5.78e-3)"	"unprognostic (2.16e-1)"	24.2	23.3	22.8	25.6	23.1	48.7	41.4	32.3	31.7	22.0	24.1	22.9	22.0	22.4	26.9	18.9	25.0	23.4	23.4	22.2	24.6	20.0	17.8	15.1	32.3	33.8	20.8	21.0	32.6	27.9	33.7	31.5	18.8	19.3	20.5	14.9	23.3	21.4	25.8	27.0	35.8	24.1	26.7	20.3	26.1	22.6	21.3	22.1	26.1	21.6	19.3	19.6	23.4	34.4	4.2	7.2	11.7	5.9	9.8	4.5	1.8	22.0	27.6	27.8	21.3	17.2	17.8	26.9	25.2	16.9	15.3	10.8	32.2	23.7	20.5	17.5	18.3	22.4	19.0	23.2	17.3	10.1	22.7	16.1	19.1	25.7	26.0	11.8	18.4	19.7	23.6	20.0	25.9	18.3	34.6	16.4	19.1	20.9	19.6	29.9	24.4	25.5	40.6	32.1	17.1	15.8	18.5	16.4	20.1	36.4	7.6	26.1	17.9	18.7	33.8	32.2	30.1	17.8	27.7	29.9	10.5	25.5	25.9	19.7	17.3	7.5	3.9	3.7	3.8	4.0	4.3	3.1	4.3	4.5	2.1	4.2	3.8	3.5	11.7	9.8	5.9	7.2	4.2	1.8	22.8	23.1	32.3	31.7	24.6	20.0	20.8	21.0	19.3	22.1
ANKRD35	FLJ25124	ENSG00000198483	"Ankyrin repeat domain 35"	Q8N283	1	145866560-145885866	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skin 1: 42.4"	"Cell line enhanced"	"Detected in some"		"ASC TERT1: 10.8;THP-1: 7.2;TIME: 9.2;U-87 MG: 9.2;U-937: 8.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"classical monocyte: 5.5"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA035453	Enhanced		Approved	"Nucleoplasm,Plasma membrane"				"Plasma membrane"	Nucleoplasm	"HPA035453: AB_10672864"	"prognostic favourable (9.35e-4)"	"prognostic favourable (2.90e-4)"	"unprognostic (2.07e-1)"	"unprognostic (7.39e-3)"	"unprognostic (1.77e-2)"	"unprognostic (1.02e-2)"	"unprognostic (3.27e-1)"	"unprognostic (3.58e-2)"	"unprognostic (3.03e-1)"	"unprognostic (1.79e-1)"	"unprognostic (2.98e-1)"	"unprognostic (5.86e-2)"	"unprognostic (9.29e-10)"	"unprognostic (8.80e-3)"	"unprognostic (2.18e-1)"	"unprognostic (5.92e-2)"	"unprognostic (8.69e-3)"	2.1	1.2	3.3	1.0	3.7	0.4	3.6	12.1	7.4	16.1	1.7	0.8	0.3	0.5	2.1	1.3	11.4	2.5	1.1	0.8	3.4	3.6	0.4	1.4	0.8	0.5	3.7	3.4	2.8	0.5	0.2	0.3	0.3	8.0	2.5	0.8	0.3	4.2	2.3	5.2	42.4	0.7	1.8	2.0	0.4	1.2	0.8	0.3	0.7	0.3	14.9	13.6	2.3	7.7	0.0	1.3	0.3	5.5	1.5	2.9	1.9	0.1	0.0	0.0	0.0	2.5	10.8	0.3	1.5	3.9	0.5	1.3	0.4	0.0	0.0	0.3	1.2	0.2	0.0	0.0	0.2	0.0	0.0	3.1	0.0	0.0	1.2	3.0	0.1	3.7	0.5	0.3	0.1	0.4	0.0	0.0	2.3	0.0	0.0	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	1.1	0.0	0.0	0.0	0.0	0.0	7.2	9.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	9.2	8.1	0.0	0.0	5.5	0.0	2.0	2.0	0.3	0.0	0.8	2.9	0.7	0.0	0.6	1.9	0.3	1.5	0.4	1.3	1.5	1.9	3.3	3.7	12.1	7.4	3.4	3.6	3.7	3.4	8.0	0.3
ANKRD42	"FLJ37874, PPP1R79, SARP"	ENSG00000137494	"Ankyrin repeat domain 42"	Q8N9B4	11	83193739-83260694	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 41.8"	"Cell line enhanced"	"Detected in all"		"U-2197: 26.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039917	Approved		Approved	"Nucleoplasm,Plasma membrane,Cytosol"				"Nucleoplasm, Cytosol"	"Plasma membrane"	"HPA039917: AB_10672894"	"unprognostic (6.59e-2)"	"unprognostic (9.00e-2)"	"unprognostic (1.00e-1)"	"unprognostic (1.31e-3)"	"unprognostic (9.12e-2)"	"unprognostic (3.78e-1)"	"unprognostic (1.67e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.11e-1)"	"unprognostic (2.11e-1)"	"unprognostic (2.99e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.09e-2)"	"unprognostic (3.10e-3)"	"unprognostic (1.79e-1)"	"unprognostic (4.25e-1)"	"unprognostic (1.90e-1)"	5.6	14.5	13.9	5.4	22.1	8.3	7.1	4.8	15.1	8.2	5.4	3.0	11.6	5.8	6.9	22.2	5.6	17.2	8.7	5.4	18.1	13.4	12.3	5.2	7.4	4.5	8.2	12.4	9.9	8.6	16.8	17.9	4.5	13.1	8.4	4.8	6.5	6.7	10.3	6.1	6.2	5.3	6.7	8.7	4.8	6.4	41.8	5.3	1.0	13.0	1.5	4.5	6.8	16.1	7.1	4.8	7.9	11.1	5.8	4.3	2.1	3.9	6.8	3.2	6.7	10.6	11.1	3.0	8.0	6.2	4.7	2.9	4.1	4.7	1.6	10.3	7.1	8.4	3.4	5.4	3.9	2.1	2.7	2.7	9.2	2.7	7.2	7.7	6.5	6.5	6.5	11.9	6.4	4.9	8.0	1.5	6.8	5.7	1.1	8.5	2.8	4.3	1.8	4.9	2.0	15.8	4.7	2.6	3.5	10.3	6.5	2.0	9.8	4.3	7.0	7.4	5.1	26.8	3.7	2.0	4.6	3.3	5.8	4.8	3.1	7.9	3.6	4.3	4.1	4.1	2.8	7.1	3.7	4.3	4.8	5.2	1.9	3.0	3.0	5.8	11.1	2.0	1.4	2.1	13.9	22.1	4.8	15.1	18.1	13.4	8.2	12.4	13.1	5.3
ANKRD45	"CT117, FLJ45235"	ENSG00000183831	"Ankyrin repeat domain 45"	Q5TZF3	1	173609561-173669862	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 14.6;fallopian tube: 24.8;parathyroid gland: 16.8;pituitary gland: 7.9;testis: 20.8"	"Cell line enhanced"	"Detected in some"		"AF22: 11.8;BJ hTERT+: 4.2;BJ hTERT+ SV40 Large T+: 3.8;BJ hTERT+ SV40 Large T+ RasG12V: 6.4;HBF TERT88: 4.2;SH-SY5Y: 10.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031655, HPA031656, HPA031657"	Enhanced		Approved	"Plasma membrane,Centrosome,Cytosol"				Cytosol	"Plasma membrane, Centrosome"	"HPA031655: AB_10610975, HPA031656: AB_10600331, HPA031657: AB_10602196"	"unprognostic (1.93e-1)"	"unprognostic (1.22e-1)"	"unprognostic (2.21e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.29e-3)"	"unprognostic (4.02e-1)"	"unprognostic (3.57e-2)"	"unprognostic (2.69e-3)"	"unprognostic (4.15e-2)"	"unprognostic (6.93e-2)"	"unprognostic (2.45e-1)"	"unprognostic (3.05e-2)"	"unprognostic (4.49e-2)"	"unprognostic (8.80e-3)"	"unprognostic (2.91e-2)"	"unprognostic (5.15e-2)"	"unprognostic (1.61e-1)"	0.5	1.3	5.9	0.4	14.6	0.5	0.6	1.1	7.0	2.8	0.7	9.0	1.3	0.4	3.3	2.5	0.5	24.8	1.0	0.9	7.7	4.7	2.7	0.5	2.8	0.4	2.4	5.3	2.4	1.0	16.8	7.9	0.4	9.2	1.9	0.5	1.8	0.4	1.2	0.4	0.4	0.5	2.4	2.7	1.3	0.5	20.8	4.2	0.0	1.3	0.0	0.4	0.6	0.3	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.4	11.8	0.0	0.0	0.9	2.0	0.1	4.2	3.8	6.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	4.2	0.0	0.0	0.3	0.0	0.0	0.3	0.0	0.0	0.5	0.0	2.3	0.0	0.1	0.2	0.2	0.5	0.0	0.0	0.0	0.4	0.1	0.1	0.0	0.3	0.4	0.0	1.6	10.7	0.0	0.0	0.2	0.0	0.6	0.0	0.0	0.0	0.0	0.4	0.1	0.9	0.0	2.2	0.1	1.8	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	5.9	14.6	1.1	7.0	7.7	4.7	2.4	5.3	9.2	4.2
ANKS1B	"AIDA-1, ANKS2, cajalin-2, EB-1"	ENSG00000185046	"Ankyrin repeat and sterile alpha motif domain containing 1B"	Q7Z6G8	12	98726457-99984654	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 66.2;skeletal muscle: 28.2"	"Cell line enhanced"	"Detected in some"		"AF22: 11.8;ASC TERT1: 7.0;SCLC-21H: 12.9"	"Cancer enhanced"	"Detected in some"		"glioma: 1.6"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"HPA044628, HPA078230"	Enhanced		Supported	"Vesicles,Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"	Vesicles	"HPA044628: , HPA078230: "	"unprognostic (5.50e-2)"	"unprognostic (3.26e-2)"	"unprognostic (1.01e-2)"	"unprognostic (6.87e-3)"	"unprognostic (1.18e-1)"	"unprognostic (1.14e-4)"	"unprognostic (7.94e-2)"	"unprognostic (2.47e-1)"	"unprognostic (1.84e-2)"	"unprognostic (3.03e-2)"	"unprognostic (4.97e-4)"	"unprognostic (2.81e-1)"	"unprognostic (1.14e-3)"	"unprognostic (1.64e-2)"	"unprognostic (1.15e-2)"	"unprognostic (1.09e-2)"	"unprognostic (3.75e-3)"	2.3	4.5	21.4	1.7	41.2	1.2	3.7	21.0	66.2	3.3	2.3	27.5	0.0	1.5	3.3	2.4	3.9	4.4	2.2	2.2	28.3	17.3	5.4	1.8	2.0	1.6	20.3	24.8	9.7	2.1	1.9	4.4	2.7	16.0	4.1	2.1	0.1	3.8	3.7	28.2	1.9	1.6	3.3	25.8	2.0	1.8	7.6	23.0	0.0	6.3	0.0	1.3	2.1	0.8	2.1	2.4	5.3	3.1	3.1	8.3	1.3	0.3	2.5	11.8	2.8	4.8	7.0	0.7	0.0	1.2	0.9	0.9	0.2	0.9	1.0	0.5	1.7	0.5	0.1	0.1	0.2	1.4	0.8	0.1	0.8	0.0	0.0	0.1	0.6	0.2	0.0	0.0	0.0	0.3	0.3	0.9	0.2	0.7	0.5	0.5	3.4	2.2	0.8	0.0	0.3	0.1	0.0	12.9	1.4	1.1	3.8	1.5	4.4	0.1	0.1	1.0	1.1	0.7	0.7	0.1	0.7	0.6	1.1	0.3	1.1	5.3	1.4	2.1	1.7	2.1	2.5	1.9	2.9	1.6	1.3	2.1	2.4	2.3	3.9	3.1	3.1	2.4	8.3	1.3	21.4	41.2	21.0	27.9	28.3	17.3	20.3	24.8	16.0	23.0
ANXA2	"ANX2, ANX2L4, CAL1H, LIP2, LPC2D"	ENSG00000182718	"Annexin A2"	P07355	15	60347134-60402883	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins, Transporters"	"Host-virus interaction"	RNA-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB004311, HPA046964, HPA061798"	Enhanced		Approved	"Plasma membrane,Cytosol"	"Secreted to blood"		16000000	"Plasma membrane"	Cytosol	"CAB004311: AB_626677, HPA046964: AB_2732537, HPA061798: AB_2732671"	"unprognostic (1.61e-1)"	"unprognostic (1.31e-3)"	"unprognostic (1.84e-1)"	"prognostic favourable (6.88e-5)"	"unprognostic (4.06e-3)"	"unprognostic (5.42e-3)"	"prognostic unfavourable (2.54e-5)"	"prognostic unfavourable (7.51e-4)"	"unprognostic (2.94e-1)"	"unprognostic (4.10e-3)"	"prognostic unfavourable (8.47e-6)"	"unprognostic (5.16e-2)"	"prognostic unfavourable (2.11e-6)"	"unprognostic (7.74e-2)"	"unprognostic (2.55e-1)"	"unprognostic (7.41e-2)"	"prognostic unfavourable (6.59e-5)"	91.7	29.8	4.9	23.5	7.1	6.6	50.1	4.5	5.6	65.1	39.1	8.6	38.2	26.4	38.3	40.3	158.8	26.2	54.9	29.9	4.7	5.5	36.7	28.5	62.0	46.6	10.8	5.7	23.3	94.3	29.7	12.8	84.1	25.7	29.5	35.2	31.7	74.7	27.9	22.7	77.3	71.9	37.1	15.1	32.6	25.6	18.7	7.1	14.6	31.0	122.7	81.4	34.0	87.4	35.5	209.6	183.3	138.0	15.2	83.9	150.8	142.1	158.7	8.4	3.7	114.7	184.1	36.5	169.9	109.6	108.0	94.8	75.2	68.6	0.3	139.9	219.8	152.1	37.3	319.1	118.4	30.3	3.9	2.8	76.4	29.2	69.2	0.1	2.1	89.8	87.1	76.7	165.4	201.2	11.3	16.6	230.6	16.5	0.6	8.4	18.2	123.6	1.6	46.1	7.9	191.4	86.7	11.0	6.2	67.2	15.3	66.7	32.8	5.9	229.5	92.1	125.5	308.8	166.8	6.2	20.3	2.7	86.8	1.6	183.2	183.3	138.0	17.7	33.4	122.6	36.5	35.5	38.5	38.5	209.6	16.9	4.5	18.1	3.9	15.2	129.1	32.0	83.9	150.8	4.9	7.1	4.5	5.6	4.7	5.5	10.8	5.7	25.7	7.1
APMAP	"BSCv, C20orf3"	ENSG00000101474	"Adipocyte plasma membrane associated protein"	Q9HDC9	20	24962925-24992979	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 93.8;liver: 100.5"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"granulocytes: 93.8;NK-cells: 43.2;T-cells: 53.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA012863, HPA064700"	Uncertain		Approved	"Plasma membrane"			80000000	"Plasma membrane"		"HPA012863: AB_1845683, HPA064700: "	"unprognostic (4.07e-3)"	"unprognostic (2.50e-2)"	"unprognostic (1.20e-1)"	"unprognostic (8.16e-2)"	"unprognostic (6.79e-2)"	"unprognostic (2.14e-2)"	"unprognostic (1.10e-2)"	"unprognostic (4.09e-2)"	"unprognostic (3.10e-2)"	"unprognostic (1.19e-2)"	"unprognostic (6.46e-2)"	"unprognostic (1.54e-1)"	"unprognostic (7.99e-3)"	"unprognostic (8.26e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.23e-1)"	"unprognostic (3.51e-2)"	43.5	13.0	14.8	12.4	16.1	44.5	23.1	47.3	22.7	11.7	12.3	15.7	17.9	8.9	14.8	31.8	7.5	13.0	13.4	10.2	18.2	20.9	12.9	100.5	14.4	15.9	15.4	17.2	12.3	12.2	18.9	20.2	28.3	17.0	12.5	12.4	11.6	10.6	18.7	9.8	14.0	9.3	13.8	13.7	16.9	10.2	19.9	15.4	10.6	57.9	5.7	9.2	13.0	10.6	5.2	13.9	93.8	13.9	43.2	53.4	40.1	23.0	40.0	20.6	30.8	40.0	21.9	20.9	30.1	33.0	29.1	30.2	23.6	40.9	9.5	35.2	36.2	42.5	18.8	35.0	34.2	12.7	14.7	10.5	14.4	47.9	31.5	20.6	25.4	29.6	49.6	34.1	24.5	41.4	12.4	43.0	28.2	34.6	14.1	23.2	12.9	36.4	11.8	68.3	19.9	31.0	21.1	33.7	13.0	31.0	53.7	33.3	19.0	17.3	36.2	35.0	31.4	29.6	44.8	24.5	27.1	10.6	18.4	31.3	33.2	7.4	13.9	26.1	53.4	13.4	33.0	5.1	15.1	38.8	13.9	5.2	11.9	30.9	93.8	43.2	9.0	6.8	9.9	40.1	14.8	16.1	47.3	22.7	18.2	20.9	15.4	17.2	17.0	15.4
APOD		ENSG00000189058	"Apolipoprotein D"	P05090	3	195568702-195584205	"Cancer-related genes, Candidate cardiovascular disease genes, Plasma proteins, Predicted secreted proteins"	Transport		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	6	"breast: 840.7"	"Group enriched"	"Detected in some"	7	"ASC diff: 233.9;ASC TERT1: 126.0"	"Cancer enhanced"	"Detected in all"		"melanoma: 925.2"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	10	"memory B-cell: 6.7"	"Lineage enriched"	"Detected in single"	10	"B-cells: 6.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040520	Enhanced		Approved	"Plasma membrane"	"Secreted to blood"	27730000	220000000000	"Plasma membrane"		"HPA040520: "	"prognostic favourable (5.51e-4)"	"unprognostic (7.62e-3)"	"unprognostic (7.85e-3)"	"unprognostic (3.34e-3)"	"unprognostic (2.20e-1)"	"unprognostic (1.02e-2)"	"unprognostic (3.09e-2)"	"unprognostic (2.06e-3)"	"unprognostic (1.26e-1)"	"unprognostic (3.45e-1)"	"unprognostic (3.38e-1)"	"unprognostic (3.19e-1)"	"unprognostic (6.90e-3)"	"prognostic unfavourable (6.02e-4)"	"unprognostic (1.38e-1)"	"prognostic unfavourable (4.12e-4)"	"unprognostic (1.71e-3)"	134.4	15.2	39.7	5.7	39.9	3.4	840.7	14.7	66.1	75.0	16.4	79.7	10.9	12.9	36.6	30.0	46.1	42.9	36.4	124.7	45.5	29.2	8.5	3.5	11.8	6.5	96.9	28.2	19.4	28.3	9.0	14.3	59.6	50.9	39.7	13.1	99.1	152.5	35.1	110.4	66.0	7.2	30.4	81.6	3.6	28.7	32.0	56.5	0.0	87.7	42.2	6.6	62.1	95.7	6.7	0.1	0.4	0.6	0.0	0.1	0.1	0.0	0.1	0.0	0.0	233.9	126.0	0.3	2.0	0.5	0.0	0.0	12.9	0.0	0.0	0.0	0.1	0.0	0.0	0.7	0.0	0.0	0.1	0.0	0.0	0.0	0.9	0.0	0.0	6.4	1.4	0.0	1.1	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	2.3	2.0	4.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	25.3	0.4	0.1	0.0	0.1	0.1	0.0	6.7	0.0	0.0	0.0	0.6	0.0	0.0	0.3	0.0	0.6	0.1	0.0	0.1	39.7	39.9	14.7	39.5	45.5	29.2	96.9	28.2	50.9	56.5
AQP10		ENSG00000143595	"Aquaporin 10"	Q96PS8	1	154321090-154325325	"Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	8	"intestine: 59.9"	"Cell line enhanced"	"Detected in some"		"HEL: 15.6;HMC-1: 6.5;K-562: 17.9;SH-SY5Y: 4.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Low region specificity"	"Detected in many"			"HPA062621, HPA065947"	Enhanced		Approved	"Nuclear bodies,Vesicles,Plasma membrane"				"Nuclear bodies, Vesicles, Plasma membrane"		"HPA062621: , HPA065947: "	"unprognostic (6.84e-2)"	"unprognostic (4.97e-2)"		"unprognostic (4.19e-2)"	"unprognostic (1.87e-1)"	"unprognostic (1.09e-1)"	"unprognostic (8.45e-4)"	"unprognostic (1.63e-1)"	"unprognostic (3.07e-1)"	"unprognostic (4.08e-2)"	"unprognostic (3.99e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.68e-1)"		"unprognostic (7.64e-3)"	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	36.0	0.0	0.0	37.2	0.2	0.3	0.1	4.3	0.5	0.7	0.4	0.0	0.0	0.1	2.2	0.4	0.1	0.0	0.4	0.1	0.0	0.0	0.2	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.3	59.9	0.0	0.0	2.7	0.3	1.3	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.9	0.1	0.0	0.0	7.6	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	15.6	0.0	0.0	0.0	0.0	6.5	0.0	0.1	0.0	0.0	0.0	17.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.1	4.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	7.6	0.0	0.2	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0
AQP4	MIWC	ENSG00000171885	"Aquaporin 4"	P55087	18	26852038-26865818	"Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 185.1;lung: 53.5"	"Cell line enhanced"	"Detected in some"		"AF22: 6.7;Karpas-707: 2.0;RPTEC TERT1: 3.8;U-87 MG: 1.7"	"Cancer enriched"	"Detected in some"	22	"glioma: 223.7"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005079, HPA014784, CAB058689"	Enhanced	Supported	Approved	"Plasma membrane,Cell Junctions"				"Plasma membrane"	"Cell Junctions"	"CAB005079: AB_2274338, CAB058689: , HPA014784: AB_1844967"	"unprognostic (7.23e-5)"	"unprognostic (1.55e-1)"		"unprognostic (3.19e-8)"	"unprognostic (3.68e-1)"	"unprognostic (1.96e-1)"	"unprognostic (2.69e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.34e-1)"	"unprognostic (5.38e-3)"	"unprognostic (1.64e-3)"	"unprognostic (8.98e-2)"	"unprognostic (1.22e-1)"	"unprognostic (4.14e-2)"	"unprognostic (1.35e-1)"	"unprognostic (4.10e-2)"		1.7	1.7	60.7	1.6	57.1	1.6	1.8	21.8	185.1	1.9	1.6	41.3	0.0	1.6	1.6	2.0	1.9	2.1	1.6	2.7	64.3	27.1	2.7	2.0	53.5	1.7	39.8	36.4	2.8	1.7	2.9	0.8	1.6	39.1	1.8	1.6	0.0	1.8	1.7	25.4	1.6	1.6	1.6	67.2	1.8	6.1	1.7	42.2	0.0	8.4	0.1	1.6	1.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.5	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.5	0.2	0.9	0.0	0.0	0.0	0.0	3.8	0.0	1.3	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	1.7	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	60.7	57.1	21.8	31.7	64.3	27.1	39.8	36.4	39.1	42.2
AQP5		ENSG00000161798	"Aquaporin 5"	P55064	12	49961870-49965681	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	Transport		"Disease mutation, Palmoplantar keratoderma"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"salivary gland: 217.9;testis: 76.2"	"Group enriched"	"Detected in some"	9	"CAPAN-2: 11.2;REH: 12.8"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 87.5"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			HPA065008	Enhanced		Approved	"Plasma membrane"				"Plasma membrane"		"HPA065008: "	"unprognostic (4.67e-3)"	"unprognostic (5.00e-2)"	"unprognostic (3.30e-1)"	"unprognostic (6.00e-3)"	"unprognostic (1.92e-3)"	"prognostic favourable (1.75e-5)"	"unprognostic (4.13e-3)"	"unprognostic (1.02e-2)"	"unprognostic (9.39e-2)"	"unprognostic (3.70e-3)"	"unprognostic (2.88e-3)"	"unprognostic (2.46e-3)"	"unprognostic (1.69e-4)"	"unprognostic (2.53e-1)"	"unprognostic (5.28e-2)"	"unprognostic (2.51e-3)"	"unprognostic (9.11e-3)"	0.2	0.1	0.4	0.2	1.1	0.0	3.8	0.4	0.3	3.0	0.3	0.4	0.3	3.2	0.6	0.8	3.8	0.1	15.6	1.0	0.3	0.3	0.2	0.2	2.3	0.2	0.7	0.2	0.2	0.8	0.1	0.4	0.2	0.3	0.5	0.0	0.4	217.9	0.6	0.9	23.5	0.3	0.6	0.2	0.2	12.0	76.2	0.3	0.2	0.3	2.8	11.5	0.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	11.2	0.0	1.3	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.5	0.9	0.0	12.8	0.0	0.0	0.4	0.0	0.3	0.1	1.0	0.1	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	1.1	0.4	0.3	0.3	0.3	0.7	0.2	0.3	0.3
ARAP1	CENTD2	ENSG00000186635	"ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 1"	Q96P48	11	72685069-72793599	"Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB020703, HPA070383"	Approved		Approved	"Nucleoplasm,Vesicles,Plasma membrane,Cytosol"			39000	"Nucleoplasm, Plasma membrane"	"Vesicles, Cytosol"	"CAB020703: , HPA070383: "	"unprognostic (3.60e-2)"	"unprognostic (7.68e-2)"	"unprognostic (6.19e-2)"	"unprognostic (5.98e-2)"	"unprognostic (5.76e-2)"	"unprognostic (1.64e-2)"	"prognostic unfavourable (6.45e-4)"	"unprognostic (4.01e-2)"	"unprognostic (4.07e-1)"	"unprognostic (5.95e-2)"	"prognostic favourable (2.04e-5)"	"unprognostic (1.84e-1)"	"unprognostic (1.05e-3)"	"unprognostic (6.93e-2)"	"unprognostic (2.57e-2)"	"prognostic favourable (6.41e-4)"	"unprognostic (7.56e-3)"	19.2	29.6	28.8	32.9	29.1	51.1	17.9	34.0	37.5	19.6	16.8	26.6	20.0	17.4	23.7	20.0	21.1	30.3	26.1	20.3	27.7	14.4	20.9	16.6	35.5	27.8	27.5	17.8	28.8	18.9	14.3	31.0	20.9	23.0	21.3	11.2	18.1	19.9	19.0	12.9	27.5	23.6	17.1	25.6	53.8	16.2	23.5	32.3	18.8	24.7	14.0	18.6	28.4	19.6	3.3	7.4	24.0	22.5	6.1	4.4	6.4	7.1	15.1	5.8	7.0	24.8	16.8	8.7	9.8	17.7	11.2	11.1	20.7	19.0	15.8	19.8	16.5	24.1	8.8	23.4	4.8	18.6	10.3	13.4	14.3	28.5	17.2	9.1	37.7	17.9	24.9	18.3	8.8	11.8	11.2	6.4	5.2	14.7	13.8	31.8	3.6	9.8	13.5	8.8	7.7	10.4	22.8	6.0	12.3	7.1	10.6	31.6	9.3	20.8	14.0	15.9	11.0	16.1	6.0	10.3	5.0	8.3	8.4	13.7	8.4	7.5	11.0	13.3	4.4	18.7	2.6	3.3	2.9	3.3	7.4	2.6	2.3	2.7	24.0	6.1	22.5	2.5	3.1	6.4	28.8	29.1	34.0	37.5	27.7	14.4	27.5	17.8	23.0	32.3
ARF1		ENSG00000143761	"ADP ribosylation factor 1"	P84077	1	228082660-228099212	"Predicted intracellular proteins"	"ER-Golgi transport, Protein transport, Transport"		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											CAB007742	Uncertain		Approved	"Plasma membrane,Cytosol"				Cytosol	"Plasma membrane"	"CAB007742: AB_562043"	"unprognostic (9.54e-2)"	"unprognostic (1.35e-2)"	"unprognostic (2.30e-2)"	"unprognostic (2.50e-3)"	"unprognostic (2.33e-1)"	"prognostic unfavourable (1.55e-4)"	"unprognostic (4.65e-2)"	"unprognostic (1.78e-1)"	"unprognostic (3.73e-1)"	"unprognostic (8.95e-3)"	"unprognostic (6.74e-2)"	"unprognostic (2.96e-2)"	"unprognostic (5.85e-2)"	"unprognostic (2.69e-2)"	"unprognostic (1.56e-1)"	"unprognostic (8.57e-2)"	"unprognostic (1.94e-1)"	72.0	70.1	64.8	51.0	82.5	111.1	59.3	50.0	116.9	76.0	76.7	53.5	63.6	73.6	71.1	63.3	81.1	66.8	58.5	101.1	70.3	65.9	81.7	135.9	77.4	55.6	52.7	56.5	73.5	109.2	64.9	79.7	129.6	61.4	70.1	55.7	67.8	106.7	68.6	96.5	57.5	91.6	54.7	45.9	81.5	66.0	73.0	33.8	75.6	102.9	60.5	76.5	72.6	57.6	37.4	73.3	111.7	70.0	41.5	64.7	110.7	65.5	45.4	37.3	37.0	43.1	54.6	62.0	58.1	62.3	64.7	56.8	53.6	63.1	33.4	62.5	61.9	42.5	45.6	56.9	32.5	49.1	72.9	32.5	31.9	53.3	83.5	46.9	48.5	52.1	69.5	59.5	62.8	63.7	62.2	76.7	62.2	47.2	47.6	69.4	47.8	92.9	38.6	33.0	104.0	45.7	34.0	52.7	46.6	37.5	113.8	64.8	78.2	95.4	57.0	47.6	37.8	69.2	87.1	72.5	40.4	45.9	65.4	40.0	95.9	104.5	70.0	77.2	53.1	66.5	64.7	37.4	45.7	49.1	54.5	34.9	36.2	39.4	111.7	41.5	63.0	73.3	51.8	110.7	64.8	82.5	50.0	116.9	70.3	65.9	52.7	56.5	61.4	33.8
ARHGAP18	"bA307O14.2, MacGAP"	ENSG00000146376	"Rho GTPase activating protein 18"	Q8N392	6	129576132-129710225	"Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HMC-1: 91.0;LHCN-M2: 25.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA031595	Approved		Approved	"Nuclear speckles,Plasma membrane,Cytosol"			840000	"Plasma membrane, Cytosol"	"Nuclear speckles"	"HPA031595: AB_10959905"	"unprognostic (6.39e-2)"	"unprognostic (1.60e-1)"	"unprognostic (5.45e-2)"	"unprognostic (5.49e-2)"	"unprognostic (3.05e-1)"	"unprognostic (3.17e-1)"	"unprognostic (9.32e-3)"	"unprognostic (1.25e-2)"	"unprognostic (2.98e-2)"	"unprognostic (3.12e-2)"	"prognostic unfavourable (2.54e-4)"	"unprognostic (4.08e-1)"	"unprognostic (2.29e-3)"	"unprognostic (2.22e-1)"	"unprognostic (3.05e-2)"	"unprognostic (5.52e-2)"	"unprognostic (1.08e-1)"	23.8	32.2	4.1	14.1	4.0	1.7	19.7	2.5	2.4	9.6	19.5	2.9	12.0	13.3	7.8	25.8	5.8	15.7	11.8	16.9	4.4	6.8	33.2	4.5	38.8	15.5	4.1	1.4	8.0	38.2	10.6	22.0	16.7	12.2	9.6	8.2	10.4	16.7	24.2	12.1	5.4	40.6	6.5	9.0	15.8	15.1	10.9	3.8	5.1	12.7	12.1	6.4	10.3	5.8	2.9	11.8	13.0	5.9	2.5	5.8	6.0	1.8	4.2	0.4	0.5	4.1	5.9	3.4	14.3	11.0	6.3	4.3	2.2	3.1	1.5	7.0	9.6	2.4	3.0	4.7	11.9	1.5	1.3	10.2	3.3	12.5	5.9	1.5	91.0	3.7	0.7	11.5	10.3	18.0	5.4	3.9	25.6	0.5	0.0	1.4	0.4	1.0	0.0	1.9	2.9	19.3	1.0	0.0	0.0	1.1	2.0	7.0	2.2	1.8	13.7	6.6	0.9	0.5	11.4	1.8	1.3	1.0	2.2	2.8	9.2	8.9	5.2	13.0	5.3	5.9	3.3	2.9	2.8	5.8	4.8	1.7	0.5	2.9	4.0	2.5	3.1	11.8	2.7	6.0	4.1	4.0	2.5	2.4	4.4	6.8	4.1	1.4	12.2	3.8
ARHGAP23	KIAA1501	ENSG00000275832	"Rho GTPase activating protein 23"	Q9P227	17	38419280-38512392	"Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 52.4"	"Cell line enhanced"	"Detected in many"		"HaCaT: 75.4;RT4: 29.3"	"Low cancer specificity"	"Detected in all"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019818, HPA047291"	Approved		Approved	"Nucleoplasm,Plasma membrane,Cytosol"				"Nucleoplasm, Plasma membrane"	Cytosol	"HPA019818: AB_1844993, HPA047291: "	"unprognostic (3.35e-1)"	"unprognostic (5.11e-2)"	"unprognostic (6.43e-2)"	"prognostic unfavourable (6.87e-5)"	"unprognostic (9.53e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.99e-1)"	"unprognostic (5.56e-2)"	"unprognostic (1.50e-3)"	"prognostic unfavourable (3.24e-4)"	"unprognostic (3.67e-2)"	"prognostic unfavourable (5.38e-5)"	"unprognostic (8.36e-2)"	"unprognostic (5.83e-2)"	"unprognostic (4.57e-2)"	"unprognostic (2.25e-1)"	4.3	2.7	11.7	3.5	32.1	4.2	1.7	3.6	20.1	4.4	1.4	52.4	0.0	1.0	5.1	1.5	13.3	4.0	3.6	7.8	12.6		1.6	0.5	5.7	1.3	42.3	12.6	6.1	0.8	1.5	0.0	9.5	20.2	3.7	0.9	0.9	0.7	6.6	2.1	16.3	1.1	5.5	16.3	10.5	0.5	5.2	39.0	1.4	0.9	0.5	5.0	11.6	2.3	0.0	0.8	0.0	0.1	0.0	0.1	0.1	8.1	4.3	3.9	1.3	2.5	8.3	4.9	11.1	12.5	9.8	5.7	14.3	14.2	0.1	9.2	25.7	75.4	0.4	15.7	7.0	0.8	0.8	0.0	13.8	0.1	12.5	0.8	0.0	4.8	3.0	7.1	4.5	10.0	0.1	2.1	5.5	0.0	2.4	1.5	2.3	1.6	4.2	8.5	2.6	4.1	29.3	0.9	2.2	6.7	0.0	0.0	1.7	1.9	14.5	16.5	5.8	3.3	2.9	1.7	1.7	0.4	4.1	2.0	14.6	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1										
ARHGAP24	"DKFZP564B1162, FilGAP, FLJ33877"	ENSG00000138639	"Rho GTPase activating protein 24"	Q8N264	4	85475114-86002670	"Predicted intracellular proteins"	"Angiogenesis, Differentiation"	"Developmental protein, GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"kidney: 62.5"	"Cell line enhanced"	"Detected in many"		"ASC diff: 35.7;ASC TERT1: 21.6;HHSteC: 20.8;HUVEC TERT2: 38.4;RPTEC TERT1: 21.5;TIME: 27.1;U-138 MG: 19.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"classical monocyte: 8.0;memory B-cell: 23.1;naive B-cell: 18.4;plasmacytoid DC: 6.5"	"Group enriched"	"Detected in many"	4	"B-cells: 23.1;dendritic cells: 6.5;monocytes: 8.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA014288	Approved		Approved	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		"HPA014288: AB_1844994"	"unprognostic (2.19e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.14e-1)"	"unprognostic (2.95e-2)"	"unprognostic (2.81e-1)"	"unprognostic (9.22e-2)"	"unprognostic (5.75e-3)"	"unprognostic (4.28e-3)"	"unprognostic (3.66e-1)"	"unprognostic (1.33e-1)"	"unprognostic (5.91e-2)"	"unprognostic (6.45e-2)"	"prognostic favourable (1.67e-11)"	"unprognostic (1.75e-2)"	"unprognostic (6.86e-2)"	"unprognostic (2.50e-2)"	"unprognostic (8.75e-4)"	21.3	1.9	5.3	16.4	7.9	10.7	17.6	1.8	9.4	5.8	6.2	8.4	2.4	4.8	9.2	7.3	7.7	3.9	7.1	16.8	6.3	7.3	62.5	6.0	9.9	23.8	11.0	3.3	4.1	21.5	6.9	8.2	13.9	9.0	6.7	4.3	8.7	9.0	5.8	7.6	6.2	8.7	13.2	19.8	33.6	15.9	2.8	6.7	2.1	17.8	6.5	24.2	13.0	5.2	23.1	6.5	2.8	8.0	0.0	0.0	1.4	0.9	1.9	1.4	0.0	35.7	21.6	1.5	6.7	9.0	1.6	2.7	0.0	0.0	0.8	2.4	15.1	0.0	0.0	2.8	3.5	0.0	0.3	1.1	0.2	0.0	20.8	0.1	0.0	15.8	0.3	3.3	1.5	38.4	1.9	0.1	14.6	0.0	0.0	0.0	0.1	3.5	0.1	7.1	3.6	21.5	0.0	0.7	0.7	0.7	1.1	2.4	0.1	0.0	27.1	19.3	0.4	1.4	0.1	0.1	0.0	1.1	3.3	0.7	6.2	0.0	8.0	0.0	0.0	1.5	0.0	23.1	0.0	0.0	1.9	18.4	0.0	0.0	2.8	0.0	1.1	6.5	0.0	1.4	5.3	7.9	1.8	9.4	6.3	7.3	11.0	3.3	9.0	6.7
ARHGAP29	PARG1	ENSG00000137962	"Rho GTPase activating protein 29"	Q52LW3	1	94148988-94275068	"Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"A-431: 47.6;hTERT-HME1: 43.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	27	"classical monocyte: 1.6;intermediate monocyte: 2.6;non-classical monocyte: 3.7"	"Lineage enriched"	"Detected in single"	38	"monocytes: 3.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026534	Approved		Approved	"Nucleoplasm,Plasma membrane,Centrosome,Cytosol"				"Nucleoplasm, Centrosome"	"Plasma membrane, Cytosol"	"HPA026534: AB_1844998"	"unprognostic (2.49e-1)"	"unprognostic (1.52e-3)"	"unprognostic (3.16e-2)"	"prognostic unfavourable (6.26e-5)"	"unprognostic (8.53e-2)"	"unprognostic (2.94e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.11e-1)"	"unprognostic (8.02e-2)"	"unprognostic (2.89e-2)"	"prognostic unfavourable (9.63e-4)"	"unprognostic (4.42e-1)"	"unprognostic (2.36e-2)"	"unprognostic (3.81e-3)"	"unprognostic (1.94e-1)"	"unprognostic (1.13e-1)"	"unprognostic (4.61e-3)"	28.1	3.2	7.2	6.8	10.6	0.3	24.4	34.9	11.5	11.9	7.4	2.3	9.0	2.8	10.3	8.1	6.9	8.2	9.1	15.9	7.8	5.2	27.7	21.1	23.0	8.2	6.7	3.6	11.5	6.5	12.8	7.4	22.9	10.0	12.2	4.7	11.7	20.7	10.4	10.3	13.5	5.4	8.0	6.4	26.0	8.8	7.7	7.0	2.2	22.7	8.9	3.8	10.6	14.8	0.0	0.0	0.0	3.7	0.0	0.0	0.3	47.6	2.0	2.9	0.0	10.4	24.7	10.6	16.0	26.1	13.6	19.8	5.7	2.4	0.0	36.1	32.1	10.2	0.1	10.9	28.0	0.0	1.5	0.2	2.7	2.5	1.0	0.0	0.0	4.8	2.0	10.3	43.0	36.5	0.0	0.0	13.4	1.6	0.9	0.0	3.9	32.9	0.6	2.4	0.0	28.6	4.2	0.0	0.6	9.8	7.7	0.7	2.3	0.1	32.8	8.2	11.3	12.6	12.3	0.0	0.0	0.0	1.6	0.0	0.4	0.0	1.6	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.7	0.0	0.0	0.3	7.2	10.6	34.9	11.5	7.8	5.2	6.7	3.6	10.0	7.0
ARHGAP33	"FLJ39019, SNX26, TCGAP"	ENSG00000004777	"Rho GTPase activating protein 33"	O14559	19	35774532-35788822	"Predicted intracellular proteins"	"Protein transport, Transport"	"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HMC-1: 33.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA030117, HPA030118"	Supported		Approved	"Plasma membrane,Actin filaments,Cytosol"				"Plasma membrane"	"Actin filaments, Cytosol"	"HPA030117: AB_10599306, HPA030118: AB_10601238"	"unprognostic (1.44e-3)"	"unprognostic (3.40e-2)"	"unprognostic (1.07e-1)"	"unprognostic (3.33e-2)"	"unprognostic (2.66e-1)"	"unprognostic (2.82e-3)"	"unprognostic (3.61e-3)"	"unprognostic (4.80e-2)"	"unprognostic (1.45e-1)"	"unprognostic (2.99e-2)"	"unprognostic (2.97e-3)"	"unprognostic (2.40e-2)"	"prognostic unfavourable (3.09e-8)"	"unprognostic (5.70e-2)"	"unprognostic (2.66e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.19e-2)"	4.8	7.6	17.2	6.6	21.9	27.8	4.0	18.1	27.1	6.0	3.8	22.0	2.8	6.8	8.4	2.9	3.6	6.1	4.9	4.5	14.9	11.7	3.8	2.0	4.7	8.7	18.4	13.8	11.8	7.3	6.2	13.2	3.3	12.7	5.8	2.9	6.8	8.9	6.2	4.7	12.9	6.0	4.0	15.4	7.8	7.2	18.2	17.9	12.2	6.8	2.3	4.2	3.1	5.3	0.1	0.0	0.7	0.0	0.0	0.4	0.0	4.8	3.1	8.8	6.6	0.3	0.9	0.7	4.0	0.5	1.5	1.1	1.2	3.7	2.8	1.5	1.1	1.3	1.1	1.1	0.5	8.9	2.0	4.1	4.1	1.1	0.4	1.5	33.2	1.3	0.2	1.2	0.4	0.9	2.0	12.5	1.3	3.7	10.1	4.0	2.0	1.4	13.9	1.4	1.3	0.7	0.8	8.8	5.4	1.8	3.2	0.6	4.7	4.1	1.7	6.3	6.3	3.3	4.6	11.1	2.1	2.8	2.3	4.9	4.0	0.0	0.0	0.3	0.4	0.0	0.2	0.0	0.0	0.2	0.0	0.1	0.0	0.1	0.7	0.0	0.0	0.0	0.0	0.0	17.2	21.9	18.1	27.1	14.9	11.7	18.4	13.8	12.7	17.9
ARHGAP36	FLJ30058	ENSG00000147256	"Rho GTPase activating protein 36"	Q6ZRI8	X	131058242-131089883	"Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"adrenal gland: 58.4;brain: 25.5;pituitary gland: 50.3"	"Cell line enriched"	"Detected in single"	164	"SH-SY5Y: 62.9"	"Cancer enriched"	"Detected in some"	21	"thyroid cancer: 62.5"	"Region enriched"	"Detected in many"	5	"hypothalamus: 25.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in many"		"hypothalamus: 104.3"	"Group enriched"	"Detected in many"	5	"basal ganglia: 19.8;hypothalamus: 57.8;midbrain: 27.1;pons and medulla: 20.1"	"HPA002064, HPA076209"	Enhanced		Approved	"Nucleoplasm,Vesicles,Plasma membrane"				Nucleoplasm	"Vesicles, Plasma membrane"	"HPA002064: AB_1078891, HPA076209: "	"unprognostic (2.92e-2)"			"unprognostic (7.71e-9)"	"unprognostic (2.19e-1)"	"unprognostic (8.15e-2)"				"unprognostic (1.67e-1)"	"unprognostic (1.78e-1)"	"unprognostic (2.73e-1)"		"unprognostic (1.40e-2)"	"unprognostic (1.34e-2)"	"unprognostic (2.31e-1)"		6.9	58.4	1.4	0.2	3.6	0.1	1.0	0.0	2.7	0.5	0.2	0.0	0.0	0.1	0.1	2.0	0.3	0.2	0.2	0.1	1.0	25.5	0.1	0.1	0.1	0.1	0.5	0.0	0.1	0.1	0.1	50.3	0.3	5.4	0.3	0.2	0.6	0.2	0.2	13.7	0.1	0.1	0.1	0.8	0.1	0.2	0.6	0.0	0.5	0.5	4.0	0.5	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	62.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	3.6	0.0	0.4	1.0	25.5	0.5	0.0	5.4	0.0
ARHGEF12	"KIAA0382, LARG"	ENSG00000196914	"Rho guanine nucleotide exchange factor 12"	Q9NZN5	11	120336914-120489936	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"		"GTPase activation, Guanine-nucleotide releasing factor"	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"basophil: 2.2"	"Group enriched"	"Detected in many"	5	"granulocytes: 2.2;NK-cells: 1.5;T-cells: 1.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018911, CAB025581"	Approved		Approved	"Nucleoplasm,Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"	Nucleoplasm	"CAB025581: , HPA018911: AB_1845003"	"unprognostic (1.55e-1)"	"unprognostic (1.29e-1)"	"unprognostic (6.91e-3)"	"unprognostic (1.28e-1)"	"unprognostic (7.28e-2)"	"unprognostic (5.39e-2)"	"unprognostic (1.56e-1)"	"unprognostic (5.55e-2)"	"unprognostic (4.79e-2)"	"unprognostic (7.77e-2)"	"unprognostic (4.34e-3)"	"unprognostic (4.78e-2)"	"prognostic favourable (5.43e-6)"	"unprognostic (1.29e-1)"	"unprognostic (4.38e-2)"	"unprognostic (2.13e-1)"	"unprognostic (1.48e-1)"	17.6	19.2	27.6	8.3	32.5	5.9	19.6	40.4	41.5	21.7	16.4	12.4	15.7	14.9	17.5	15.9	17.8	18.6	17.3	23.4	21.8	17.7	41.2	38.8	24.1	6.5	15.8	26.3	16.3	16.9	55.8	17.2	25.4	21.1	16.8	17.8	20.7	16.7	20.0	24.1	29.0	14.8	18.6	10.8	12.4	19.0	6.7	13.0	3.0	31.3	15.0	10.9	19.4	22.9	0.3	0.3	2.2	0.1	1.5	1.0	0.4	12.9	10.9	14.7	14.0	19.9	19.9	6.1	15.3	17.3	9.3	11.9	12.7	9.5	1.1	18.8	27.3	9.8	18.8	19.4	18.2	10.7	9.2	21.1	11.7	9.8	17.8	0.0	15.7	18.9	14.1	20.4	22.7	28.2	17.8	43.3	23.5	9.0	0.0	0.0	4.0	9.4	4.6	16.8	4.1	22.9	22.6	10.8	13.3	21.4	18.0	5.6	15.3	1.7	27.8	20.7	8.9	13.4	11.1	12.7	5.1	7.2	8.5	2.7	15.6	2.2	0.0	0.0	1.0	0.1	0.2	0.3	0.6	0.6	0.0	0.3	0.0	0.5	0.0	1.5	0.1	0.3	0.7	0.4	27.6	32.5	40.4	41.5	21.8	17.7	15.8	26.3	21.1	13.0
ARHGEF28	"p190RhoGEF, RGNEF, RIP2"	ENSG00000214944	"Rho guanine nucleotide exchange factor 28"	Q8N1W1	5	73626158-73941993	"Predicted intracellular proteins"	Differentiation	"Guanine-nucleotide releasing factor, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 43.0"	"Cell line enhanced"	"Detected in many"		"hTERT-HME1: 37.8;LHCN-M2: 34.8;TIME: 22.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"gdT-cell: 1.2;memory CD8 T-cell: 1.1"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA037602	Enhanced		Approved	"Plasma membrane,Microtubules,Cytosol"				"Microtubules, Cytosol"	"Plasma membrane"	"HPA037602: AB_10672282"	"unprognostic (1.97e-1)"	"prognostic favourable (5.31e-4)"	"unprognostic (7.66e-2)"	"unprognostic (1.53e-1)"	"unprognostic (3.33e-3)"	"unprognostic (3.18e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.05e-1)"	"unprognostic (5.37e-1)"	"unprognostic (3.63e-1)"	"unprognostic (2.62e-1)"	"unprognostic (3.04e-1)"	"prognostic favourable (1.91e-6)"	"unprognostic (1.07e-1)"	"unprognostic (1.55e-2)"	"unprognostic (1.62e-2)"	"prognostic favourable (8.98e-4)"	3.4	17.7	3.0	2.7	1.4	0.0	7.7	2.3	2.3	9.7	6.7	1.1	8.6	2.3	11.9	9.7	7.1	7.5	12.0	1.5	1.4	1.9	43.0	5.5	5.5	0.3	1.7	3.2	14.5	19.2	0.2	7.0	1.1	2.5	5.1	2.8	4.3	20.0	9.5	0.9	11.1	3.9	2.7	3.3	2.0	14.8	2.0	1.0	4.1	10.5	6.0	6.0	3.4	6.2	0.0	0.0	0.0	0.0	0.6	1.2	0.1	10.9	7.8	0.0	1.0	1.0	1.4	0.0	4.0	8.1	5.1	5.1	2.3	4.8	0.0	8.6	1.4	3.7	0.5	6.5	7.8	0.0	1.1	0.2	1.2	9.9	8.2	0.0	0.0	1.3	2.6	8.0	37.8	16.7	0.0	0.0	34.8	1.0	0.0	0.0	0.1	3.2	0.0	2.1	1.3	14.0	6.7	0.7	1.5	1.9	0.3	0.2	1.7	0.0	22.3	2.5	3.5	0.2	3.8	0.4	0.0	0.0	3.9	0.5	1.5	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.3	1.1	0.0	0.0	0.0	0.9	0.0	0.6	0.0	0.0	0.0	0.1	3.0	1.4	2.3	2.3	1.4	1.9	1.7	3.2	2.5	1.0
ARID2	"BAF200, DKFZp686G052, FLJ30619, KIAA1557"	ENSG00000189079	"AT-rich interaction domain 2"	Q68CP9	12	45729665-45908040	"Cancer-related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Chromatin regulator, DNA-binding"	"Cancer-related genes, Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA063044			Supported	"Nucleoplasm,Plasma membrane"				Nucleoplasm	"Plasma membrane"	"HPA063044: "	"unprognostic (8.41e-2)"	"unprognostic (1.03e-1)"	"unprognostic (4.02e-2)"	"unprognostic (3.94e-2)"	"unprognostic (4.15e-2)"	"prognostic favourable (5.75e-4)"	"unprognostic (1.26e-2)"	"unprognostic (9.71e-2)"	"unprognostic (9.04e-2)"	"unprognostic (5.57e-2)"	"unprognostic (1.34e-1)"	"unprognostic (2.47e-1)"	"unprognostic (1.12e-2)"	"unprognostic (9.21e-2)"	"unprognostic (3.02e-1)"	"unprognostic (2.00e-1)"	"unprognostic (6.53e-2)"	9.0	7.9	7.1	14.6	7.2	14.0	11.8	15.7	8.8	10.2	11.4	8.2	17.9	6.4	12.2	10.7	11.5	8.8	10.6	8.2	7.4	5.8	8.7	6.9	10.2	13.0	9.6	3.8	12.2	10.7	18.4	15.1	10.3	7.5	9.9	8.1	10.1	9.7	20.6	8.6	13.5	12.6	12.5	7.3	10.2	9.0	30.9	11.0	33.3	11.5	8.2	11.2	10.0	10.0	2.1	5.3	10.5	4.9	3.1	4.4	1.3	5.4	7.8	14.0	6.1	6.0	4.2	7.6	3.8	5.4	5.3	5.0	11.1	5.6	10.5	7.0	5.2	6.6	11.3	6.4	7.7	4.6	5.4	13.9	8.6	5.4	4.1	10.9	6.4	3.4	4.9	6.7	10.7	5.4	11.7	10.9	4.7	7.1	15.6	7.8	8.3	4.2	12.1	10.0	10.1	5.1	9.0	7.6	9.7	6.2	7.2	6.0	10.9	21.9	6.4	5.7	6.9	3.8	4.9	7.3	6.0	29.3	4.4	28.7	4.0	10.5	1.7	4.2	4.1	2.2	4.3	1.7	3.7	4.4	2.4	2.1	3.6	3.3	2.4	3.1	4.9	5.3	3.1	1.3	7.1	7.2	15.7	8.8	7.4	5.8	9.6	3.8	7.5	11.0
ARID4A	"RBBP1, RBP-1, RBP1"	ENSG00000032219	"AT-rich interaction domain 4A"	P29374	14	58298385-58373887	"Predicted intracellular proteins, Transcription factors"	"Differentiation, Spermatogenesis, Transcription, Transcription regulation"	"Chromatin regulator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048899			Supported	"Nucleoplasm,Plasma membrane,Cytosol"				Nucleoplasm	"Plasma membrane, Cytosol"	"HPA048899: "	"unprognostic (1.57e-1)"	"unprognostic (9.39e-2)"	"unprognostic (5.17e-2)"	"unprognostic (2.69e-1)"	"unprognostic (3.70e-2)"	"prognostic favourable (1.91e-4)"	"unprognostic (2.71e-1)"	"prognostic favourable (7.82e-4)"	"unprognostic (2.08e-2)"	"unprognostic (6.92e-2)"	"unprognostic (3.27e-1)"	"unprognostic (3.72e-2)"	"unprognostic (9.32e-2)"	"unprognostic (2.32e-1)"	"unprognostic (2.64e-1)"	"unprognostic (4.11e-2)"	"unprognostic (3.52e-2)"	15.1	8.5	17.3	15.1	22.2	34.5	13.4	45.9	27.0	12.8	12.0	7.9	12.7	10.2	11.6	9.7	10.1	10.7	10.7	10.0	13.3	11.5	11.3	21.7	12.0	15.8	9.6	18.7	15.3	11.4	17.2	22.9	11.3	17.3	10.8	10.6	6.4	10.8	13.5	10.6	13.2	12.3	12.5	11.0	15.3	10.2	7.9	15.0	15.0	12.6	4.5	12.8	13.8	11.9	15.1	7.5	42.7	14.1	10.7	11.1	3.6	6.6	5.6	15.7	7.7	7.8	9.5	7.9	7.9	6.8	5.4	8.6	6.5	10.5	16.0	8.5	6.6	7.7	6.9	3.8	8.0	11.2	4.4	7.2	6.3	6.3	4.7	15.2	10.5	7.1	4.2	5.2	5.4	8.5	8.2	13.2	5.7	8.9	11.0	13.7	3.1	6.8	11.3	13.5	4.7	5.8	11.8	13.5	11.7	13.4	6.8	9.4	11.6	14.0	12.1	9.2	7.2	7.4	3.6	4.3	3.2	14.7	5.5	9.7	4.6	19.3	7.6	21.7	8.5	7.8	9.5	11.6	10.3	8.8	5.6	15.1	11.1	10.8	42.7	10.7	14.1	7.5	7.2	3.6	17.3	22.2	45.9	27.0	13.3	11.5	9.6	18.7	17.3	15.0
ARID5B	"FLJ21150, MRF2"	ENSG00000150347	"AT-rich interaction domain 5B"	Q14865	10	61901300-62096944	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 88.6"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 44.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA015037	Uncertain		Approved	"Nucleoplasm,Endoplasmic reticulum,Plasma membrane,Cytosol"				"Endoplasmic reticulum"	"Nucleoplasm, Plasma membrane, Cytosol"	"HPA015037: AB_1845015"	"unprognostic (3.31e-1)"	"unprognostic (1.99e-2)"	"unprognostic (2.94e-2)"	"unprognostic (1.86e-1)"	"unprognostic (1.17e-1)"	"unprognostic (5.60e-2)"	"unprognostic (1.50e-2)"	"unprognostic (4.90e-2)"	"unprognostic (3.90e-1)"	"unprognostic (6.03e-2)"	"unprognostic (1.97e-1)"	"unprognostic (5.75e-1)"	"unprognostic (1.20e-2)"	"unprognostic (1.15e-1)"	"unprognostic (2.58e-1)"	"unprognostic (1.94e-1)"	"unprognostic (3.93e-2)"	43.3	5.6	7.8	13.8	9.9	4.2	22.6	3.3	11.5	27.5	14.0	9.5	4.4	6.8	29.4	10.4	14.0	15.6	27.2	16.0	5.9	5.1	14.6	5.7	14.6	14.4	11.8	6.5	18.6	4.3	14.7	11.4	22.4	9.4	16.6	8.2	6.9	14.5	7.3	88.6	15.0	12.1	29.4	10.4	12.7	9.4	7.7	10.5	8.6	7.5	11.7	18.0	22.5	17.1	21.2	1.0	4.3	3.6	5.7	14.7	2.6	0.8	0.3	2.3	5.7	5.1	13.7	0.4	16.6	44.8	11.8	9.3	20.1	0.9	1.4	4.0	15.9	5.5	8.0	2.5	14.3	5.2	2.4	0.7	4.1	5.0	9.5	0.2	9.9	17.3	1.3	7.0	8.0	1.4	0.7	2.2	3.8	2.8	5.4	0.4	0.4	5.2	6.6	3.8	0.4	7.8	9.0	1.3	1.7	7.4	4.1	4.8	3.4	0.2	1.2	6.6	8.9	9.9	4.2	0.1	0.0	4.3	5.7	0.3	2.1	4.3	0.6	0.4	7.3	1.4	0.9	19.0	10.5	6.3	1.0	21.2	6.9	4.5	1.2	5.7	3.6	0.5	14.7	2.6	7.8	9.9	3.3	11.5	5.9	5.1	11.8	6.5	9.4	10.5
ARL15	"ARFRP2, FLJ20051"	ENSG00000185305	"ADP ribosylation factor like GTPase 15"	Q9NXU5	5	53883945-54310582	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044604, HPA063820"	Uncertain		Approved	"Golgi apparatus,Plasma membrane,Cell Junctions"				"Golgi apparatus"	"Plasma membrane, Cell Junctions"	"HPA044604: AB_10960542, HPA063820: "	"unprognostic (2.18e-1)"	"unprognostic (4.32e-2)"	"unprognostic (1.82e-2)"	"unprognostic (2.41e-2)"	"unprognostic (1.08e-1)"	"unprognostic (3.70e-1)"	"unprognostic (8.52e-3)"	"unprognostic (1.16e-2)"	"unprognostic (3.05e-2)"	"unprognostic (6.56e-2)"	"unprognostic (4.26e-3)"	"unprognostic (3.86e-1)"	"unprognostic (2.48e-3)"	"unprognostic (1.35e-1)"	"unprognostic (9.15e-2)"	"unprognostic (5.60e-2)"	"unprognostic (1.08e-1)"	22.0	19.9	13.4	13.1	10.5	2.2	20.1	15.7	22.4	29.9	15.6	5.9	8.7	13.9	32.2	9.9	13.2	12.7	20.5	20.1	19.7	13.2	23.9	12.8	14.4	13.9	11.3	11.2	9.8	7.8	3.5	28.0	31.4	12.3	14.3	15.4	15.3	19.6	12.1	5.2	16.9	12.7	26.7	15.1	15.2	11.1	14.2	10.5	17.4	13.4	13.9	10.8	19.1	13.6	2.0	5.0	7.4	3.5	1.4	4.8	2.3	1.9	3.8	5.9	9.9	5.9	5.2	7.4	6.2	9.4	6.2	13.3	14.6	4.8	17.1	10.2	6.0	4.7	8.9	10.2	8.7	2.2	9.2	23.6	5.5	1.2	1.4	2.2	27.7	7.4	7.0	10.2	7.1	15.0	21.2	2.7	4.1	4.1	4.3	2.2	2.0	2.5	3.9	6.3	0.4	8.7	20.7	7.5	3.9	7.9	4.4	5.0	4.7	2.9	7.6	3.9	6.0	2.9	4.5	1.1	1.1	19.6	5.9	6.3	6.3	2.7	3.5	4.6	2.9	3.2	1.7	2.0	2.0	2.1	5.0	1.6	2.1	1.7	7.4	1.4	2.3	0.7	4.8	2.3	13.4	10.5	15.7	22.4	19.7	13.2	11.3	11.2	12.3	10.5
ARMC12	"C6orf81, FLJ25390"	ENSG00000157343	"Armadillo repeat containing 12"	Q5T9G4	6	35737032-35749079	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	10	"testis: 60.2"	"Cell line enhanced"	"Detected in some"		"ASC diff: 7.2;HSkMC: 9.5;MOLT-4: 6.5;U-698: 7.1"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in single"			"Cell type enhanced"	"Detected in some"		"naive CD8 T-cell: 3.2;plasmacytoid DC: 2.9"	"Group enriched"	"Detected in many"	11	"dendritic cells: 2.9;monocytes: 1.0;T-cells: 3.2"	"Not detected"	"Not detected"							"HPA030895, HPA075457, HPA075777"	Enhanced		Approved	"Nucleoplasm,Plasma membrane"				"Nucleoplasm, Plasma membrane"		"HPA030895: AB_10602114, HPA075457: , HPA075777: "	"unprognostic (1.94e-4)"	"unprognostic (2.21e-1)"	"unprognostic (3.24e-1)"	"unprognostic (1.32e-2)"	"unprognostic (2.34e-1)"	"unprognostic (1.19e-1)"	"unprognostic (2.52e-1)"	"unprognostic (2.12e-1)"	"unprognostic (4.48e-1)"	"unprognostic (3.52e-2)"	"unprognostic (6.36e-4)"	"unprognostic (8.99e-2)"	"unprognostic (1.17e-12)"	"unprognostic (6.53e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.49e-1)"	"unprognostic (2.09e-1)"	0.5	0.4	0.9	0.5	1.2	0.7	0.7	0.5	0.9	0.6	0.5	0.5	0.5	0.0	0.5	5.8	0.5	0.6	0.8	0.5	0.7	0.9	0.5	1.4	0.5	1.1	0.7	0.5	1.0	0.5	0.1	4.8	0.5	0.5	1.1	0.3	0.6	0.5	1.0	0.5	0.5	0.5	0.6	0.5	0.8	0.1	60.2	0.5	0.5	0.7	0.5	0.6	0.5	0.5	0.1	2.9	0.0	1.0	0.2	3.2	0.4	0.0	0.5	3.1	3.8	7.2	3.4	0.0	0.1	0.2	0.3	0.4	0.1	0.2	0.7	0.1	0.1	0.1	1.1	0.2	0.2	1.6	0.9	0.4	0.1	0.1	3.7	0.0	0.0	9.5	2.3	0.1	1.3	0.7	0.1	4.4	1.1	0.4	6.5	0.8	0.5	0.2	3.0	0.0	0.0	0.8	0.0	0.9	3.1	0.0	0.0	0.5	2.0	0.3	0.0	0.6	0.3	0.1	0.0	1.0	0.3	7.1	0.3	3.9	0.3	0.0	1.0	0.0	0.1	0.0	1.2	0.0	1.2	0.5	0.7	0.1	0.7	3.2	0.0	0.2	0.1	2.9	0.0	0.4	0.9	1.2	0.5	0.6	0.7	0.9	0.7	0.5	0.5	0.5
ARMCX5	"FLJ12969, GASP5"	ENSG00000125962	"Armadillo repeat containing, X-linked 5"	Q6P1M9	X	102599168-102604159	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"RH-30: 42.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000996	Approved		Approved	"Nuclear speckles,Plasma membrane,Cytosol"				"Nuclear speckles, Cytosol"	"Plasma membrane"	"HPA000996: AB_1078212"	"unprognostic (7.71e-2)"	"unprognostic (2.43e-2)"	"unprognostic (1.20e-1)"	"unprognostic (3.50e-2)"	"unprognostic (1.54e-1)"	"unprognostic (5.05e-2)"	"unprognostic (4.07e-2)"	"prognostic favourable (6.58e-5)"	"unprognostic (1.12e-1)"	"unprognostic (2.76e-2)"	"unprognostic (2.83e-1)"	"unprognostic (3.28e-3)"	"unprognostic (1.17e-1)"	"unprognostic (2.40e-1)"	"unprognostic (1.17e-2)"	"unprognostic (2.83e-1)"	"unprognostic (5.24e-2)"	8.6	13.2	11.4	7.0	17.3	6.4	13.8	24.3	19.8	11.2	9.5	8.7	13.1	7.9	13.3	12.5	10.1	11.9	7.5	7.8	11.1	6.3	10.0	15.5	8.3	6.9	8.1	12.9	16.5	25.3	14.5	26.4	6.1	12.8	16.6	11.9	9.2	13.4	11.0	6.1	9.9	10.4	10.8	7.0	10.2	11.7	6.1	8.4	9.5	15.3	7.0	9.6	10.4	9.8	9.7	9.3	2.5	9.8	7.1	15.9	8.5	8.0	7.3	17.2	9.1	7.7	8.7	9.7	7.9	6.1	9.3	16.6	8.6	10.0	0.0	9.7	7.9	7.0	15.3	7.5	10.6	0.0	6.1	8.1	9.2	7.1	10.0	14.7	9.5	10.8	9.8	8.0	9.7	9.4	7.8	0.0	12.3	7.1	10.4	1.7	7.7	13.8	10.3	42.2	0.0	6.9	11.2	8.2	7.3	14.2	7.4	11.3	5.1	7.1	9.5	6.9	6.2	7.8	5.6	0.0	5.7	0.0	5.4	15.1	17.7	0.0	9.5	2.5	12.0	9.8	11.5	9.7	11.3	9.4	9.3	6.0	15.9	12.3	0.8	7.1	6.0	8.1	7.7	8.5	11.4	17.3	24.3	19.8	11.1	6.3	8.1	12.9	12.8	8.4
ARPC5	"ARC16, dJ127C7.3, p16-Arc"	ENSG00000162704	"Actin related protein 2/3 complex subunit 5"	O15511	1	183620846-183635757	"Plasma proteins, Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 154.0"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA022013, HPA031972"	Approved		Approved	"Vesicles,Plasma membrane,Cell Junctions,Cytosol"			15000000	"Vesicles, Plasma membrane, Cell Junctions, Cytosol"		"HPA022013: AB_1845045, HPA031972: "	"unprognostic (3.82e-1)"	"unprognostic (8.78e-2)"	"unprognostic (1.43e-1)"	"unprognostic (2.36e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.85e-2)"	"prognostic unfavourable (3.63e-4)"	"unprognostic (5.90e-3)"	"unprognostic (3.84e-2)"	"unprognostic (3.17e-3)"	"unprognostic (1.14e-1)"	"unprognostic (1.29e-1)"	"prognostic unfavourable (1.21e-10)"	"unprognostic (3.03e-2)"	"unprognostic (4.66e-2)"	"unprognostic (1.49e-2)"	"unprognostic (2.48e-1)"	46.6	25.1	24.9	57.5	24.3	25.2	28.9	13.8	24.8	26.6	42.3	26.5	18.6	40.8	39.0	26.7	44.5	29.3	24.6	36.8	28.2	22.3	28.8	29.7	52.3	58.3	28.4	18.7	27.3	21.5	12.4	18.2	84.8	20.0	23.2	29.2	17.0	25.4	16.5	16.4	25.2	47.3	32.8	46.0	79.9	35.6	21.7	23.5	61.2	27.5	22.7	52.8	30.6	30.8	27.4	68.9	154.0	96.6	30.7	40.7	124.3	50.8	28.2	24.3	16.7	20.1	28.7	58.2	69.9	53.9	30.5	24.9	25.5	36.1	46.8	79.6	40.2	35.4	17.1	23.8	16.1	67.4	15.3	28.3	38.4	22.0	32.7	41.0	55.2	34.7	25.4	36.9	29.4	35.7	21.5	38.8	39.5	20.9	38.2	11.0	23.2	10.8	35.6	21.6	45.2	17.1	26.4	10.5	28.3	72.9	31.5	27.0	31.6	36.7	79.5	44.6	23.2	49.8	67.3	46.3	51.1	32.0	35.1	29.6	34.2	79.3	80.0	124.1	34.8	89.8	27.7	27.4	34.2	35.5	68.9	24.4	37.1	37.6	154.0	30.7	96.6	32.5	40.7	124.3	24.9	24.3	13.8	21.1	28.2	22.3	28.4	18.7	20.0	23.5
ASAP1	"CENTB4, DDEF1, KIAA1249, PAP, ZG14P"	ENSG00000153317	"ArfGAP with SH3 domain, ankyrin repeat and PH domain 1"	Q9ULH1	8	130052104-130443660	"Predicted intracellular proteins"	"Cilium biogenesis/degradation"	"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"TIME: 61.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 13.0"	"Group enriched"	"Detected in many"	5	"dendritic cells: 4.1;granulocytes: 13.0;monocytes: 6.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA011136, CAB037292, HPA048565"	Approved		Approved	"Plasma membrane,Centrosome,Cytosol"			25000	"Plasma membrane, Centrosome, Cytosol"		"CAB037292: AB_476723, HPA011136: , HPA048565: "	"unprognostic (1.20e-2)"	"unprognostic (1.15e-2)"	"unprognostic (7.68e-2)"	"prognostic unfavourable (5.81e-5)"	"unprognostic (1.77e-1)"	"unprognostic (3.33e-2)"	"prognostic unfavourable (5.63e-8)"	"prognostic unfavourable (3.56e-5)"	"unprognostic (3.34e-1)"	"unprognostic (5.27e-2)"	"unprognostic (8.56e-3)"	"unprognostic (1.10e-1)"	"prognostic unfavourable (1.50e-7)"	"unprognostic (3.79e-2)"	"unprognostic (1.19e-1)"	"unprognostic (7.38e-2)"	"unprognostic (1.22e-3)"	34.1	17.2	10.5	9.5	12.5	29.7	19.8	6.4	21.8	19.3	8.9	9.1	6.6	4.4	15.6	18.9	10.5	11.8	14.5	17.5	10.0	11.0	7.9	7.6	26.2	12.9	11.3	8.0	15.2	6.8	21.7	8.2	27.3	15.2	9.9	7.2	13.9	6.2	13.9	13.0	12.1	8.4	16.6	11.9	26.1	8.0	21.7	9.7	5.6	12.3	10.6	14.5	12.9	21.2	1.5	4.1	13.0	6.6	0.7	1.6	1.1	15.3	11.5	16.8	9.5	14.6	21.7	13.5	16.4	28.7	20.1	21.5	5.8	5.8	3.5	11.7	23.8	3.9	8.6	14.4	28.1	5.5	5.2	6.1	6.7	7.4	37.6	2.6	1.9	20.4	4.8	10.6	17.7	21.0	3.1	14.1	17.5	4.6	3.5	2.7	4.2	10.5	4.9	3.0	2.4	5.1	8.3	4.8	15.7	12.1	7.4	8.7	6.2	6.0	61.6	16.1	7.8	6.3	24.1	13.0	3.0	2.5	11.9	3.8	17.9	0.0	2.4	1.6	0.7	2.4	0.4	1.5	1.2	1.0	4.1	1.3	1.6	1.0	13.0	0.7	6.6	0.4	0.8	1.1	10.5	12.5	6.4	14.6	10.0	11.0	11.3	8.0	15.2	9.7
ASB5		ENSG00000164122	"Ankyrin repeat and SOCS box containing 5"	Q8WWX0	4	176213673-176277571	"Predicted intracellular proteins, Predicted membrane proteins"	"Ubl conjugation pathway"			"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in many"	4	"skeletal muscle: 133.4"	"Cell line enriched"	"Detected in some"	16	"LHCN-M2: 161.1"	"Cancer enhanced"	"Detected in some"		"prostate cancer: 1.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA028870			Approved	"Plasma membrane"				"Plasma membrane"		"HPA028870: AB_10611679"					"unprognostic (1.76e-1)"	"prognostic unfavourable (5.67e-4)"		"unprognostic (1.90e-1)"			"unprognostic (7.38e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.06e-2)"	"unprognostic (4.28e-2)"	"unprognostic (1.65e-1)"		"unprognostic (6.80e-3)"	2.3	0.0	0.3	0.3	0.2	0.0	0.0	0.2	0.2	0.3	3.5	0.0	0.0	0.1	0.2	6.3	7.9	0.0	0.4	1.3	0.2	0.2	0.3	0.0	0.1	0.0	0.5	0.0	0.0	0.0	0.1	0.2	0.0	0.0	9.6	1.3	0.0	8.0	0.1	133.4	0.0	0.5	23.5	1.0	0.0	2.0	2.2	0.0	0.0	2.3	31.4	2.2	15.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	3.9	0.0	3.5	7.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	161.1	0.0	0.0	0.0	0.0	0.0	0.0	10.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.2	0.2	0.2	0.2	0.5	0.0	0.0	0.0
ASIC4	"ACCN4, BNAC4"	ENSG00000072182	"Acid sensing ion channel subunit family member 4"	Q96FT7	2	219514170-219538772	"Predicted membrane proteins"	"Ion transport, Sodium transport, Transport"	"Ion channel, Sodium channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"brain: 17.7;pituitary gland: 20.6"	"Group enriched"	"Detected in some"	30	"HEL: 18.7;HMC-1: 5.6;K-562: 10.7;SH-SY5Y: 5.1"	"Cancer enriched"	"Detected in single"	38	"glioma: 8.7"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in many"		"basal ganglia: 65.5"	"Low region specificity"	"Detected in many"			"HPA036042, HPA057078"			Approved	"Nucleoplasm,Golgi apparatus,Plasma membrane,Centriolar satellite"				"Golgi apparatus, Centriolar satellite"	"Nucleoplasm, Plasma membrane"	"HPA036042: AB_10672998, HPA057078: "	"unprognostic (3.48e-1)"	"unprognostic (1.44e-1)"	"unprognostic (2.55e-1)"	"unprognostic (1.61e-2)"	"unprognostic (2.62e-1)"	"unprognostic (8.74e-2)"	"unprognostic (3.04e-2)"	"unprognostic (2.54e-1)"	"unprognostic (6.53e-2)"	"unprognostic (1.90e-2)"	"unprognostic (9.46e-3)"	"unprognostic (1.88e-1)"	"unprognostic (7.80e-8)"	"unprognostic (3.82e-2)"	"unprognostic (2.30e-1)"	"unprognostic (5.51e-1)"	"unprognostic (2.48e-2)"	0.8	3.3	4.9	0.6	4.7	0.5	0.6	6.9	17.7	1.0	0.5	1.6	0.0	0.5	0.8	0.6	0.5	0.6	0.6	0.6	3.9	4.5	0.5	0.6	0.9	0.6	4.8	2.9	0.5	0.5	0.5	20.6	0.6	3.0	0.6	0.5	4.9	0.6	0.8	0.5	0.6	0.5	0.7	1.9	0.6	0.7	1.6	3.1	0.0	0.5	0.0	0.6	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.7	0.0	0.0	0.0	0.0	5.6	0.0	0.0	0.0	0.0	0.0	10.7	0.1	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.9	4.7	6.9	4.9	3.9	4.5	4.8	2.9	3.0	3.1
ASPM	"ASP, Calmbp1, FLJ10517, FLJ10549, MCPH5"	ENSG00000066279	"Abnormal spindle microtubule assembly"	Q8IZT6	1	197084128-197146694	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	Calmodulin-binding	"Cancer-related genes, Disease mutation, Mental retardation, Primary microcephaly"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"lymphoid tissue: 62.8"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"plasmacytoid DC: 1.5;T-reg: 2.4"	"Group enriched"	"Detected in many"	5	"dendritic cells: 1.5;T-cells: 2.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			CAB017816			Approved	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		"CAB017816: "	"unprognostic (3.24e-1)"	"unprognostic (1.56e-1)"	"unprognostic (2.81e-2)"	"prognostic unfavourable (1.97e-4)"	"unprognostic (3.67e-1)"	"unprognostic (3.47e-2)"	"prognostic unfavourable (1.25e-4)"	"prognostic unfavourable (2.41e-4)"	"unprognostic (4.67e-3)"	"unprognostic (9.29e-2)"	"prognostic unfavourable (2.40e-4)"	"unprognostic (1.03e-1)"	"unprognostic (0.00e+0)"	"unprognostic (7.31e-3)"	"unprognostic (1.23e-1)"	"unprognostic (4.94e-2)"	"unprognostic (3.66e-2)"	0.7	0.7	0.2	12.4	0.4	13.8	1.5	0.2	0.4	1.2	2.8	0.2	0.2	2.8	0.3	1.5	8.7	0.2	0.4	0.6	0.2	0.2	0.5	1.3	1.9	7.0	0.3	0.2	0.5	0.3	0.0	0.2	1.8	0.5	0.4	2.8	0.3	1.5	0.2	0.5	4.6	3.1	0.8	0.5	4.3	1.7	6.3	0.2	62.8	0.3	5.0	6.9	1.2	2.3	0.0	1.5	0.0	0.0	0.3	2.4	0.0	19.8	11.1	18.1	11.0	1.0	2.5	6.8	15.9	11.2	15.8	12.5	7.7	15.5	20.3	5.7	12.4	20.1	15.5	6.3	19.7	18.2	11.8	14.2	26.2	7.4	0.2	21.2	10.1	0.2	0.6	12.7	8.9	16.6	17.8	24.1	16.2	7.8	17.0	9.9	8.2	3.0	13.0	24.8	14.9	5.7	5.5	9.5	13.5	22.6	11.7	5.1	13.0	8.8	12.6	9.8	9.5	16.8	28.9	6.9	9.4	11.7	7.7	5.8	19.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	1.5	2.4	0.0	0.2	0.4	0.2	0.4	0.2	0.2	0.3	0.2	0.5	0.2
ATG13	KIAA0652	ENSG00000175224	"Autophagy related 13"	O75143	11	46617527-46674818	"Cancer-related genes, Predicted intracellular proteins, Transporters"	Autophagy		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039350			Approved	"Nucleoplasm,Plasma membrane,Cytosol"				Cytosol	"Nucleoplasm, Plasma membrane"	"HPA039350: AB_10673142"	"unprognostic (3.66e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.65e-1)"	"unprognostic (5.36e-2)"	"unprognostic (2.31e-1)"	"prognostic unfavourable (8.59e-5)"	"unprognostic (1.05e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.35e-1)"	"unprognostic (7.57e-2)"	"unprognostic (2.44e-2)"	"unprognostic (2.41e-1)"	"unprognostic (2.14e-1)"	"unprognostic (7.68e-2)"	"unprognostic (3.47e-1)"	13.8	15.8	20.2	11.9	27.3	25.8	12.5	32.8	37.0	13.2	12.6	39.5	9.2	14.3	12.9	16.8	14.9	16.6	14.5	17.8	19.5	16.3	14.3	21.1	11.5	13.6	31.8	18.2	15.6	19.7	24.4	23.1	13.5	27.2	12.8	12.0	21.3	17.0	13.5	20.9	16.3	12.4	12.3	15.7	16.2	16.5	60.6	34.9	14.8	18.6	8.8	15.8	12.5	13.0	15.8	20.0	38.9	24.0	17.0	24.7	20.3	13.7	25.2	19.4	11.4	27.1	31.8	19.6	16.0	28.4	19.8	25.4	17.2	13.7	12.9	11.4	24.1	16.8	18.6	21.7	20.1	24.4	35.5	13.8	17.6	30.0	30.4	18.4	24.1	38.2	25.9	13.6	30.2	19.5	24.1	29.5	17.7	20.6	18.3	27.3	24.2	21.9	17.5	25.1	22.5	13.3	15.1	18.5	18.6	22.1	17.8	23.6	25.4	38.1	19.1	24.4	15.0	22.5	17.5	26.9	29.8	16.3	30.3	16.7	17.9	21.2	20.7	26.9	21.3	24.0	17.2	15.8	19.2	16.8	20.0	12.7	16.6	18.3	38.9	17.0	18.7	14.9	24.7	20.3	20.2	27.3	32.8	37.0	19.5	16.3	31.8	18.2	27.2	34.9
ATG7	"APG7L, DKFZp434N0735, GSA7"	ENSG00000197548	"Autophagy related 7"	O95352	3	11272309-11557665	"Predicted intracellular proteins, Transporters"	"Autophagy, Biological rhythms, Protein transport, Transport, Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"basophil: 13.1;classical monocyte: 39.7;eosinophil: 24.5;intermediate monocyte: 22.9;myeloid DC: 23.8;neutrophil: 31.3;non-classical monocyte: 16.3"	"Group enriched"	"Detected in all"	5	"dendritic cells: 23.8;granulocytes: 31.3;monocytes: 39.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007639, CAB018771"	Supported		Supported	"Nucleoplasm,Plasma membrane,Cytosol"			13000	Cytosol	"Nucleoplasm, Plasma membrane"	"CAB018771: AB_2062165, HPA007639: AB_1845162"	"unprognostic (3.97e-2)"	"unprognostic (2.83e-2)"	"prognostic favourable (9.66e-4)"	"unprognostic (1.18e-2)"	"unprognostic (2.79e-1)"	"unprognostic (5.19e-2)"	"prognostic unfavourable (1.41e-4)"	"unprognostic (1.82e-1)"	"unprognostic (2.40e-1)"	"unprognostic (1.80e-3)"	"unprognostic (2.30e-2)"	"unprognostic (2.67e-1)"	"prognostic favourable (9.55e-4)"	"unprognostic (1.61e-1)"	"unprognostic (3.65e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.50e-1)"	27.0	18.6	14.8	21.1	21.9	37.5	16.6	14.1	29.2	16.4	15.2	26.2	13.4	11.6	28.9	15.9	18.9	17.4	15.1	12.3	14.0	13.1	13.1	11.8	18.4	18.8	14.8	17.1	15.5	13.1	18.7	23.0	18.7	21.6	12.9	17.8	19.3	16.6	11.6	15.8	22.2	16.9	18.3	16.6	19.7	13.1	19.7	13.9	17.7	12.7	12.2	21.6	16.5	15.2	4.0	23.8	31.3	39.7	5.9	4.8	14.2	18.2	14.4	6.5	3.4	11.3	15.0	32.0	17.2	22.4	17.2	20.1	6.1	16.6	8.4	10.4	15.2	5.6	7.2	24.1	29.6	7.4	9.0	6.0	13.9	7.3	15.0	17.4	20.1	15.4	11.2	33.3	21.0	23.7	8.9	6.9	23.8	11.9	4.9	8.2	5.0	18.7	6.2	7.7	7.4	13.0	13.2	5.7	5.7	12.2	10.4	6.6	11.3	17.0	16.1	14.2	10.3	9.2	24.0	4.4	11.5	14.1	22.9	16.4	19.0	13.1	39.7	24.5	4.8	22.9	3.7	4.0	4.0	4.5	23.8	3.7	3.5	4.2	31.3	5.9	16.3	4.2	3.4	14.2	14.8	21.9	14.1	29.2	14.0	13.1	14.8	17.1	21.6	13.9
ATOX1	HAH1	ENSG00000177556	"Antioxidant 1 copper chaperone"	O00244	5	151742316-151772532	"Predicted intracellular proteins"	"Copper transport, Ion transport, Transport"	Chaperone		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA055036			Approved	"Nucleoplasm,Plasma membrane"			27000	Nucleoplasm	"Plasma membrane"	"HPA055036: "	"unprognostic (5.55e-2)"	"unprognostic (1.60e-1)"	"unprognostic (3.84e-1)"	"unprognostic (1.82e-1)"	"unprognostic (8.11e-2)"	"unprognostic (3.34e-2)"	"unprognostic (2.33e-1)"	"unprognostic (8.60e-2)"	"unprognostic (3.58e-2)"	"unprognostic (2.53e-2)"	"prognostic favourable (9.57e-4)"	"unprognostic (2.72e-1)"	"unprognostic (7.15e-2)"	"unprognostic (8.18e-2)"	"unprognostic (2.57e-2)"	"unprognostic (1.87e-1)"	"unprognostic (2.22e-1)"	27.0	37.2	43.1	25.6	40.4	23.4	39.1	22.8	38.5	29.0	23.9	29.7	32.3	30.2	21.4	37.6	28.4	24.5	33.4	27.7	37.5	45.7	50.5	96.1	21.3	48.9	54.3	37.0	16.2	29.0	31.5	23.0	25.6	35.2	25.7	24.4	25.0	34.7	29.8	12.8	26.3	31.6	28.1	46.5	34.1	21.0	28.7	33.8	24.5	36.3	29.7	44.8	27.2	22.1	22.5	49.9	43.3	54.8	20.1	22.8	24.2	13.9	23.0	13.5	9.3	36.1	29.6	17.9	25.2	28.6	25.4	34.7	31.1	30.2	28.1	30.8	43.2	13.1	16.4	63.3	20.9	18.0	28.0	12.3	15.0	31.6	33.7	17.0	14.1	38.3	13.3	31.9	21.1	37.2	10.1	83.2	38.5	34.2	12.5	37.7	7.7	48.3	7.7	15.6	43.5	24.4	12.2	17.7	10.4	21.6	61.8	94.2	30.2	20.8	41.6	26.4	21.1	32.2	43.8	68.7	60.4	16.8	35.8	11.5	108.8	27.5	48.7	43.3	18.3	54.8	16.7	22.5	16.6	15.8	39.1	16.2	13.2	14.3	36.4	20.1	37.4	49.9	22.8	24.2	43.1	40.4	22.8	38.5	37.5	45.7	54.3	37.0	35.2	33.8
ATP13A3	AFURS1	ENSG00000133657	"ATPase 13A3"	Q9H7F0	3	194402672-194498364	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029471	Approved		Approved	"Nucleoli,Plasma membrane,Cytosol"				Nucleoli	"Plasma membrane, Cytosol"	"HPA029471: AB_10600784"	"unprognostic (5.07e-2)"	"unprognostic (3.53e-2)"	"unprognostic (2.94e-1)"	"unprognostic (5.31e-2)"	"unprognostic (3.20e-2)"	"unprognostic (3.55e-1)"	"unprognostic (1.57e-1)"	"unprognostic (9.87e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.51e-1)"	"prognostic unfavourable (1.60e-4)"	"unprognostic (2.70e-2)"	"prognostic unfavourable (1.63e-4)"	"unprognostic (1.22e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.34e-2)"	"unprognostic (3.77e-1)"	27.1	14.4	9.0	20.8	12.7	17.5	22.8	15.3	13.8	12.1	13.4	10.8	17.2	11.4	16.2	13.2	12.4	11.3	17.1	37.8	9.6	8.1	29.7	56.9	22.1	11.6	10.1	8.3	13.2	11.4	37.6	10.6	28.9	10.6	11.8	12.6	12.9	16.7	15.9	11.8	7.7	15.0	12.1	9.0	17.1	16.3	8.8	8.4	18.9	37.1	12.0	12.7	17.8	16.1	1.9	2.4	2.3	2.3	2.2	4.7	1.0	49.9	5.7	10.2	9.7	11.6	18.1	24.8	17.2	18.7	18.7	34.0	31.3	12.2	19.7	51.1	24.7	17.0	9.7	17.1	43.5	65.7	8.5	10.9	7.6	6.7	20.1	35.4	28.6	8.3	7.7	38.8	25.3	9.7	12.5	39.9	22.7	8.5	14.2	7.1	9.7	9.9	13.0	21.9	11.8	15.8	16.0	15.6	8.3	18.2	19.0	12.8	36.3	24.8	12.6	22.8	19.0	45.3	32.0	26.4	47.5	35.1	45.4	21.0	15.8	1.8	1.7	2.3	1.8	2.3	2.2	1.9	1.7	2.8	2.4	1.1	2.5	2.5	0.3	2.2	0.9	1.6	4.7	1.0	9.0	12.7	15.3	13.8	9.6	8.1	10.1	8.3	10.6	8.4
ATP2C2	"KIAA0703, SPCA2"	ENSG00000064270	"ATPase secretory pathway Ca2+ transporting 2"	O75185	16	84368527-84464187	"Enzymes, Predicted membrane proteins, Transporters"	"Calcium transport, Ion transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 23.0;salivary gland: 35.8"	"Cell line enhanced"	"Detected in some"		"HaCaT: 6.3;MCF7: 16.3;RT4: 12.9;SK-BR-3: 22.7;T-47d: 7.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	24	"neutrophil: 2.7"	"Lineage enriched"	"Detected in single"	24	"granulocytes: 2.7"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in single"			"HPA052262, HPA075812"	Approved		Approved	"Plasma membrane,Focal adhesion sites"				"Plasma membrane, Focal adhesion sites"		"HPA052262: , HPA075812: "	"unprognostic (2.28e-2)"	"unprognostic (6.13e-2)"	"unprognostic (3.34e-2)"	"prognostic favourable (6.20e-6)"	"unprognostic (2.04e-1)"	"unprognostic (2.41e-2)"	"unprognostic (8.36e-2)"	"unprognostic (1.72e-1)"	"unprognostic (9.92e-2)"	"unprognostic (1.89e-2)"	"unprognostic (5.08e-2)"	"unprognostic (2.16e-1)"	"unprognostic (8.37e-3)"	"unprognostic (1.17e-1)"	"unprognostic (1.02e-1)"	"unprognostic (4.32e-4)"	"unprognostic (1.39e-1)"	0.3	0.0	2.1	8.0	1.5	6.1	2.5	0.2	2.0	3.5	23.0	0.5	1.9	16.3	1.8	1.9	2.7	4.0	18.8	0.4	1.8	1.9	2.6	0.2	21.9	0.2	1.3	0.7	1.3	0.5	0.0	2.9	4.8	0.7	7.9	21.9	1.0	35.8	0.2	0.9	15.2	14.5	0.5	0.6	0.2	3.4	0.4	0.4	0.3	8.2	2.2	8.1	4.8	7.8	0.0	0.0	2.7	0.0	0.0	0.1	0.0	4.1	0.3	0.5	0.0	0.0	0.0	4.4	0.1	0.0	0.0	0.0	3.9	3.6	0.0	0.0	0.0	6.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	16.3	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	12.9	3.3	0.0	0.0	22.7	0.2	7.6	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	2.1	1.5	0.2	2.0	1.8	1.9	1.3	0.7	0.7	0.4
ATP6AP1	"16A, Ac45, ATP6IP1, ATP6S1, CF2, ORF, VATPS1, XAP-3, XAP3"	ENSG00000071553	"ATPase H+ transporting accessory protein 1"	Q15904	X	154428632-154436516	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Hydrogen ion transport, Ion transport, Transport"		"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB015218	Uncertain		Approved	"Plasma membrane,Microtubules,Cytosol"			160000	"Plasma membrane, Microtubules, Cytosol"		"CAB015218: "	"prognostic unfavourable (2.40e-4)"	"unprognostic (1.95e-2)"	"unprognostic (2.06e-3)"	"unprognostic (2.20e-1)"	"prognostic unfavourable (8.94e-4)"	"unprognostic (1.84e-3)"	"unprognostic (4.99e-3)"	"unprognostic (2.57e-1)"	"unprognostic (1.10e-2)"	"unprognostic (1.84e-1)"	"prognostic favourable (7.83e-4)"	"unprognostic (1.07e-1)"	"prognostic favourable (5.26e-8)"	"unprognostic (2.45e-1)"	"unprognostic (4.66e-2)"	"unprognostic (3.39e-1)"	"unprognostic (1.62e-1)"	29.8	37.8	36.6	20.0	50.3	27.5	22.1	59.2	82.7	28.4	26.5	39.4	27.4	24.0	20.6	43.2	29.1	29.6	23.0	35.1	40.8	47.5	42.4	26.9	37.9	21.8	36.5	40.5	24.4	42.6	67.1	41.5	66.1	60.1	41.6	24.7	29.8	35.9	29.4	18.4	30.2	24.2	22.9	39.4	36.4	27.6	21.2	24.2	22.1	39.7	20.9	21.4	27.3	21.1	20.1	68.4	64.0	56.6	23.7	28.9	33.8	22.4	21.4	18.3	31.1	29.7	16.4	34.4	16.6	23.6	25.9	37.8	20.2	28.1	13.3	70.4	35.6	24.1	26.9	15.4	14.3	12.1	27.8	7.6	27.5	20.0	37.4	12.3	56.5	21.8	26.4	24.3	14.0	35.9	9.1	37.6	16.9	32.9	8.9	18.6	6.8	21.9	13.8	12.2	34.5	27.4	18.8	18.3	19.0	14.5	59.3	31.1	26.1	30.4	27.7	18.9	17.1	32.2	27.0	54.3	58.3	15.7	22.6	26.7	19.0	37.4	53.9	64.0	28.6	56.6	28.9	17.5	23.7	24.7	68.4	20.1	21.4	23.5	60.0	23.7	43.4	39.0	26.9	33.8	36.6	50.3	59.2	82.7	40.8	47.5	36.5	40.5	60.1	24.2
ATP6V0A2	"a2, ATP6a2, ATP6N1D, J6B7, Stv1, TJ6, TJ6M, TJ6s, Vph1"	ENSG00000185344	"ATPase H+ transporting V0 subunit a2"	Q9Y487	12	123712318-123761755	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Hydrogen ion transport, Ion transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HMC-1: 37.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"eosinophil: 13.1"	"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044279	Approved		Approved	"Plasma membrane,Cytosol"				Cytosol	"Plasma membrane"	"HPA044279: AB_10961274"	"unprognostic (2.60e-1)"	"unprognostic (8.79e-3)"	"unprognostic (3.60e-2)"	"unprognostic (1.50e-1)"	"unprognostic (2.70e-1)"	"unprognostic (2.29e-2)"	"unprognostic (2.06e-4)"	"unprognostic (1.40e-1)"	"unprognostic (3.77e-2)"	"unprognostic (1.75e-1)"	"unprognostic (8.85e-3)"	"unprognostic (1.63e-1)"	"unprognostic (1.26e-1)"	"unprognostic (7.48e-2)"	"unprognostic (1.12e-1)"	"unprognostic (3.47e-1)"	"unprognostic (1.58e-1)"	13.5	9.4	7.2	13.0	9.9	15.5	11.5	16.2	9.8	8.9	13.1	13.0	9.0	16.0	13.4	8.8	9.1	10.4	10.4	13.6	8.0	7.9	8.9	13.7	13.1	16.6	12.8	6.9	9.7	18.1	8.1	10.4	10.2	9.1	9.8	12.0	9.8	24.5	10.0	13.0	20.5	15.8	12.3	9.4	13.1	15.9	15.9	10.8	24.0	10.3	8.6	17.5	11.0	10.3	2.3	3.4	13.1	1.5	2.1	2.7	0.9	3.2	8.3	8.6	11.6	5.1	4.9	5.3	3.9	4.6	5.1	5.6	6.1	2.6	12.5	2.8	5.3	7.0	11.2	4.1	3.8	8.5	6.3	18.0	6.6	3.5	8.1	11.4	37.1	4.4	3.6	6.0	6.5	4.4	10.9	2.3	5.6	9.0	10.8	14.1	9.0	5.5	10.4	7.5	4.0	4.9	8.1	5.2	8.8	6.6	4.6	5.8	4.8	8.4	6.4	6.5	2.5	7.9	6.5	7.5	8.2	11.7	5.4	6.9	5.5	6.4	0.9	13.1	2.1	0.9	1.5	1.3	2.1	1.8	1.1	2.3	1.9	2.7	2.4	2.1	1.5	3.4	1.4	0.9	7.2	9.9	16.2	9.8	8.0	7.9	12.8	6.9	9.1	10.8
ATXN10	"E46L, FLJ37990, SCA10"	ENSG00000130638	"Ataxin 10"	Q9UBB4	22	45671798-45845307	"Disease related genes, Predicted intracellular proteins"			"Ciliopathy, Neurodegeneration, Spinocerebellar ataxia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049531	Approved		Supported	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		"HPA049531: "	"unprognostic (5.73e-2)"	"unprognostic (1.97e-1)"	"unprognostic (1.27e-2)"	"unprognostic (5.76e-2)"	"unprognostic (3.01e-2)"	"unprognostic (7.50e-2)"	"unprognostic (1.19e-3)"	"unprognostic (3.18e-1)"	"unprognostic (2.15e-2)"	"unprognostic (5.07e-2)"	"unprognostic (8.38e-2)"	"unprognostic (3.51e-1)"	"unprognostic (1.23e-2)"	"unprognostic (1.18e-1)"	"unprognostic (6.22e-2)"	"unprognostic (7.48e-2)"	"unprognostic (6.98e-2)"	18.1	33.3	40.2	20.6	40.5	20.9	38.5	31.7	75.3	28.5	20.6	20.9	22.0	13.8	28.8	23.9	27.5	33.6	23.3	42.3	44.5	42.4	32.0	37.0	30.5	38.8	35.6	41.2	35.4	33.5	39.7	32.6	28.1	38.1	28.3	21.8	18.0	22.6	30.1	47.5	18.3	13.6	29.7	38.3	18.3	18.5	31.5	22.3	34.0	37.2	21.8	28.7	26.8	21.8	23.3	52.2	28.1	40.4	25.2	31.0	33.3	40.8	21.2	41.2	24.9	18.9	28.5	22.2	46.8	50.0	33.5	36.8	10.6	27.5	42.2	19.3	46.8	24.5	29.7	31.2	36.2	7.7	30.6	19.8	40.8	20.3	27.3	52.8	14.8	29.3	21.7	17.4	27.4	24.4	14.4	23.5	50.7	17.4	28.7	23.8	27.2	16.4	41.5	15.8	34.2	42.6	39.1	22.8	35.8	29.1	17.5	31.6	26.4	28.3	22.2	33.9	12.6	12.1	15.3	23.1	13.9	34.0	21.1	22.2	35.9	19.0	31.7	28.1	23.4	37.6	31.0	23.3	23.3	28.3	52.2	22.6	25.7	24.8	1.5	25.2	40.4	18.5	21.9	33.3	40.2	40.5	31.7	75.3	44.5	42.4	35.6	41.2	38.1	22.3
ATXN3	"ATX3, JOS, MJD, SCA3"	ENSG00000066427	"Ataxin 3"	P54252	14	92044496-92106625	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Transcription, Transcription regulation, Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"	"Neurodegeneration, Spinocerebellar ataxia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"CAB021976, HPA024123, HPA069338"	Uncertain		Approved	"Nucleoplasm,Nucleoli,Plasma membrane"				"Nucleoplasm, Nucleoli"	"Plasma membrane"	"CAB021976: , HPA024123: AB_1845133, HPA069338: "	"unprognostic (1.06e-2)"	"unprognostic (2.93e-1)"	"unprognostic (1.22e-1)"	"unprognostic (3.67e-2)"	"unprognostic (5.76e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.42e-1)"	"unprognostic (9.85e-3)"	"unprognostic (1.69e-1)"	"unprognostic (6.75e-2)"	"unprognostic (1.04e-2)"	"unprognostic (3.06e-2)"	"unprognostic (2.03e-2)"	"unprognostic (8.94e-3)"	"unprognostic (4.22e-1)"	"unprognostic (1.64e-1)"	"unprognostic (1.11e-1)"	17.8	10.3	10.2	9.1	11.6	14.3	12.8	18.7	12.1	16.0	11.8	12.2	11.9	6.4	17.9	12.4	17.7	9.5	11.2	10.4	9.0	9.9	9.9	16.0	12.3	11.6	16.3	9.5	14.0	10.3	11.9	17.2	11.7	13.8	15.8	11.7	8.6	11.4	10.2	6.1	21.0	8.7	20.6	16.5	12.6	9.0	14.8	14.3	16.2	11.5	12.0	15.6	15.4	13.6	9.8	14.5	11.4	18.8	7.0	8.5	5.3	5.6	11.1	10.0	9.3	14.6	14.3	19.6	6.4	10.4	8.2	11.4	8.0	15.7	11.5	12.8	10.5	9.8	7.7	14.0	18.1	13.1	2.3	4.9	5.4	11.7	12.1	8.6	8.8	11.6	12.5	14.3	15.0	12.6	6.5	8.6	12.4	21.9	9.0	7.8	7.1	9.2	7.2	18.5	6.5	10.5	12.8	3.4	6.0	15.5	6.6	8.8	12.3	6.0	6.7	8.1	11.9	5.2	3.4	7.5	12.5	10.6	6.0	8.5	4.7	11.4	13.4	9.4	5.9	14.5	7.0	7.1	6.9	6.5	14.5	9.8	7.6	8.5	11.3	7.0	18.8	8.4	6.8	5.3	10.2	11.6	18.7	12.1	9.0	9.9	16.3	9.5	13.8	14.3
ATXN7L3	DKFZp761G2113	ENSG00000087152	"Ataxin 7 like 3"	Q14CW9	17	44191805-44200113	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, Chromatin regulator"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA064316	Supported		Approved	"Nuclear speckles,Plasma membrane"				"Nuclear speckles"	"Plasma membrane"	"HPA064316: "	"unprognostic (2.37e-2)"	"unprognostic (8.87e-3)"	"unprognostic (1.10e-1)"	"unprognostic (3.74e-2)"	"unprognostic (3.75e-2)"	"unprognostic (1.23e-1)"	"prognostic unfavourable (4.03e-4)"	"unprognostic (2.86e-3)"	"unprognostic (6.74e-3)"	"unprognostic (1.09e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.00e-1)"	"prognostic unfavourable (2.87e-4)"	"unprognostic (1.21e-3)"	"unprognostic (9.05e-2)"	"unprognostic (3.75e-2)"	"unprognostic (1.40e-1)"	14.0	12.9	36.7	18.9	25.1	23.8	11.9	23.0	53.1	13.2	16.1	11.3	16.7	19.1	14.3	16.9	22.3	14.2	14.9	12.4	30.7	24.8	12.4	12.6	14.3	20.8	22.7	32.1	13.2	13.7	16.3	17.1	18.8	23.6	13.0	15.3	7.9	16.9	18.5	11.3	19.0	16.5	16.1	15.1	17.6	15.5	17.0	14.1	13.9	14.3	11.3	21.3	16.7	22.4	5.1	4.4	6.7	3.2	1.3	4.8	2.6	17.5	29.8	32.9	21.3	23.0	22.9	17.9	21.6	24.2	27.7	26.3	22.7	20.0	30.9	17.4	24.3	19.4	25.6	20.3	23.3	36.0	25.4	20.9	24.5	25.1	22.7	32.6	42.6	25.8	31.0	23.2	24.6	26.7	27.9	19.4	18.2	13.2	39.1	24.9	24.7	23.4	27.0	31.9	23.1	22.3	25.3	21.0	26.6	12.8	11.3	22.1	27.7	29.1	22.9	28.0	29.4	14.5	20.1	23.5	30.5	37.4	18.4	14.2	16.3	1.4	3.2	3.7	4.8	2.2	2.9	3.6	3.8	3.0	2.7	5.1	2.9	3.6	6.7	1.3	2.3	4.4	2.0	2.6	36.7	25.1	23.0	53.1	30.7	24.8	22.7	32.1	23.6	14.1
AVEN	PDCD12	ENSG00000169857	"Apoptosis and caspase activation inhibitor"	Q9NQS1	15	33866227-34039176	"Predicted intracellular proteins"	Apoptosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 6.1"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							HPA020863	Approved		Approved	"Plasma membrane,Actin filaments,Centrosome"				"Plasma membrane, Actin filaments"	Centrosome	"HPA020863: AB_1845219"	"unprognostic (1.54e-3)"	"unprognostic (1.99e-1)"	"unprognostic (8.93e-2)"	"unprognostic (5.77e-2)"	"unprognostic (5.57e-2)"	"unprognostic (2.05e-1)"	"unprognostic (1.18e-1)"	"unprognostic (6.32e-3)"	"unprognostic (1.70e-1)"	"unprognostic (1.40e-1)"	"unprognostic (4.14e-3)"	"unprognostic (1.79e-1)"	"prognostic unfavourable (5.29e-10)"	"unprognostic (7.66e-3)"	"unprognostic (2.40e-1)"	"unprognostic (1.63e-1)"	"unprognostic (2.84e-3)"	11.0	11.1	7.1	8.7	7.7	5.2	16.1	14.4	8.8	9.6	12.4	6.8	8.6	9.0	13.4	9.5	11.5	8.9	10.6	35.0	6.9	8.7	5.8	16.7	8.0	6.0	8.6	6.8	10.3	41.0	3.6	9.0	15.0	8.3	10.6	12.2	5.4	9.8	11.8	25.7	9.3	9.9	15.3	8.1	7.3	10.9	14.1	6.1	9.9	5.4	11.6	9.4	11.6	15.0	1.2	6.1	0.2	1.7	1.2	2.3	0.3	8.3	13.6	14.1	4.6	11.5	13.1	8.4	21.3	19.1	17.1	11.0	3.7	5.9	7.8	13.2	17.9	5.7	6.4	13.9	14.1	7.6	4.2	13.5	8.9	10.4	17.2	13.5	9.9	10.9	27.5	10.0	24.4	18.3	13.3	11.5	23.7	8.9	5.3	23.3	6.6	4.7	8.1	7.9	16.7	13.9	11.0	7.5	9.1	11.8	6.2	5.8	6.7	15.0	12.9	15.1	5.2	6.4	17.6	11.3	8.9	16.5	7.2	15.9	8.0	0.0	0.8	0.0	1.6	1.7	2.0	1.2	1.7	0.6	0.6	0.6	0.8	1.1	0.2	1.2	0.7	6.1	2.3	0.3	7.1	7.7	14.4	8.8	6.9	8.7	8.6	6.8	8.3	6.1
AVPI1	"PP5395, VIP32, VIT32"	ENSG00000119986	"Arginine vasopressin induced 1"	Q5T686	10	97677424-97687323	"Predicted intracellular proteins"	"Cell cycle"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HeLa: 28.4;HHSteC: 29.3;hTCEpi: 55.3;SK-MEL-30: 44.6;U-2197: 32.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA037649	Approved		Approved	"Nucleoplasm,Plasma membrane"				"Nucleoplasm, Plasma membrane"		"HPA037649: AB_10671879"	"unprognostic (4.57e-2)"	"unprognostic (3.28e-2)"	"unprognostic (3.04e-2)"	"unprognostic (4.79e-2)"	"unprognostic (2.73e-1)"	"unprognostic (1.25e-1)"	"unprognostic (4.37e-3)"	"unprognostic (4.60e-2)"	"unprognostic (7.34e-3)"	"unprognostic (8.56e-3)"	"unprognostic (2.29e-3)"	"unprognostic (1.23e-1)"	"unprognostic (3.91e-3)"	"unprognostic (4.04e-1)"	"unprognostic (2.03e-1)"	"unprognostic (8.66e-2)"	"unprognostic (3.83e-3)"	21.5	27.4	5.1	4.7	8.5	3.3	11.0	6.3	17.7	13.0	18.6	3.6	4.8	10.7	5.8	8.2	16.3	6.5	19.9	8.5	5.5	5.8	5.6	29.9	17.1	1.7	7.3	5.6	43.3	10.8	4.1	7.2	19.3	8.0	15.3	15.0	13.6	10.7	13.8	8.3	35.5	15.3	8.5	12.6	11.9	12.7	8.4	2.5	1.3	8.2	9.7	7.6	22.0	16.6	3.5	12.4	2.3	7.1	2.0	5.0	3.0	8.9	23.4	0.1	3.4	4.9	2.2	4.8	4.4	23.9	6.0	9.1	4.3	11.2	0.2	3.1	2.4	9.4	1.8	7.6	2.2	0.2	2.1	0.6	28.4	12.0	29.3	0.5	0.7	3.6	55.3	4.5	11.9	0.8	1.3	0.4	3.3	7.6	0.4	0.7	0.8	2.2	0.3	2.7	0.3	5.8	4.8	0.4	0.9	15.1	5.4	44.6	4.1	0.7	1.3	1.4	2.8	32.3	1.0	1.0	0.7	0.1	5.4	1.8	0.9	0.0	7.1	2.3	5.0	6.1	2.3	3.5	3.3	3.7	12.4	2.2	3.6	4.4	0.7	2.0	0.5	2.4	2.9	3.0	5.1	8.5	6.3	17.7	5.5	5.8	7.3	5.6	8.0	2.5
B3GALT2	beta3Gal-T2	ENSG00000162630	"Beta-1,3-galactosyltransferase 2"	O43825	1	193179045-193186654	"Enzymes, Predicted membrane proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"brain: 32.9;gallbladder: 19.0;heart muscle: 25.1"	"Group enriched"	"Detected in some"	4	"AF22: 16.0;ASC TERT1: 7.3;LHCN-M2: 10.9;WM-115: 19.0"	"Cancer enhanced"	"Detected in some"		"glioma: 2.4"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	4	"MAIT T-cell: 11.9"	"Lineage enriched"	"Detected in single"	57	"T-cells: 11.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA078659			Approved	"Plasma membrane,Microtubules"				"Plasma membrane, Microtubules"		"HPA078659: "	"unprognostic (1.83e-2)"	"unprognostic (3.81e-2)"	"unprognostic (1.91e-2)"	"unprognostic (1.17e-1)"	"unprognostic (3.67e-1)"	"unprognostic (1.58e-3)"	"unprognostic (2.34e-3)"	"unprognostic (2.43e-3)"	"unprognostic (1.63e-1)"	"unprognostic (2.44e-1)"	"unprognostic (6.14e-4)"	"unprognostic (4.41e-2)"	"unprognostic (8.10e-3)"	"unprognostic (2.72e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.89e-1)"	"unprognostic (4.56e-3)"	0.7	2.0	11.3	1.3	8.9	0.7	0.9	1.4	32.9	0.8	1.7	1.2	0.9	1.6	0.6	1.8	1.2	0.7	19.0	25.1	10.1	7.9	1.7	0.8	2.6	0.7	5.7	19.1	13.8	0.8	0.4	0.9	0.9	5.0	6.5	2.0	0.3	0.5	7.1	0.6	0.7	4.1	0.8	6.5	1.4	2.1	1.4	4.7	0.0	1.8	0.0	1.6	2.0	0.7	0.0	0.2	0.1	0.0	0.0	11.9	0.3	0.0	0.0	16.0	0.0	0.4	7.3	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	10.9	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	1.4	0.9	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.0	0.0	0.0	0.0	0.2	0.0	11.9	0.0	2.7	1.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	2.3	0.3	11.3	8.9	1.4	32.9	10.1	7.9	5.7	19.1	5.0	4.7
BANK1	"BANK, FLJ20706"	ENSG00000153064	"B cell scaffold protein with ankyrin repeats 1"	Q8NDB2	4	101411286-102074812	"Disease related genes, Predicted intracellular proteins"	"B-cell activation"		"Systemic lupus erythematosus"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"blood: 61.4;intestine: 18.0;lymphoid tissue: 67.0"	"Cell line enhanced"	"Detected in some"		"Daudi: 10.2;HEL: 8.0;HL-60: 7.1;U-266/70: 24.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Group enriched"	"Detected in many"	15	"memory B-cell: 61.4;naive B-cell: 46.2"	"Lineage enriched"	"Detected in many"	17	"B-cells: 61.4"	"Low region specificity"	"Detected in many"							HPA037002	Enhanced		Approved	"Nucleoplasm,Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"	Nucleoplasm	"HPA037002: AB_10672383"	"unprognostic (1.59e-2)"	"unprognostic (2.08e-2)"	"unprognostic (6.43e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.28e-3)"	"unprognostic (1.73e-2)"	"unprognostic (4.89e-2)"	"unprognostic (1.62e-2)"	"unprognostic (1.01e-1)"	"unprognostic (9.97e-2)"	"unprognostic (4.25e-2)"	"unprognostic (7.89e-2)"	"unprognostic (2.80e-1)"	"unprognostic (2.18e-1)"	"unprognostic (2.75e-2)"	"unprognostic (6.09e-3)"	"unprognostic (1.75e-1)"	3.3	2.9	0.7	45.4	0.9	2.0	1.9	2.1	0.7	0.7	1.3	0.7	1.4	0.7	0.4	1.2	6.0	1.0	1.6	0.9	0.8	0.7	2.0	0.5	4.9	30.3	0.7	0.2	0.9	0.6	0.0	3.7	0.5	0.6	2.2	1.1	0.5	7.7	1.8	0.4	0.6	18.0	0.3	0.8	67.0	2.5	1.3	0.7	4.8	5.5	0.4	42.3	6.5	1.1	61.4	2.0	3.6	0.3	0.2	0.0	2.1	0.0	2.2	0.0	0.0	2.7	1.1	0.0	0.1	0.0	0.3	0.5	0.0	3.5	10.2	1.0	0.0	0.1	0.1	1.1	0.3	0.0	0.0	8.0	2.1	0.0	0.1	7.1	0.0	0.5	0.3	0.0	0.0	0.1	0.0	3.1	0.4	0.4	0.0	0.4	0.0	4.3	0.1	0.4	0.0	0.3	4.7	2.0	0.0	0.2	0.1	0.0	0.4	1.8	1.0	0.0	0.4	0.0	0.0	24.5	0.0	1.6	0.1	4.1	0.0	1.5	0.3	3.6	0.0	0.1	0.0	61.4	0.0	0.0	2.0	46.2	0.0	0.0	0.1	0.2	0.0	1.0	0.0	2.1	0.7	0.9	2.1	0.7	0.8	0.7	0.7	0.2	0.6	0.7
BBOF1	"C14orf45, CCDC176"	ENSG00000119636	"Basal body orientation factor 1"	Q8ND07	14	74019353-74082863	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 37.7"	"Cell line enhanced"	"Detected in many"		"U-87 MG: 15.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA003090, HPA003136, HPA075108"	Approved		Approved	"Nucleoplasm,Plasma membrane,Centriolar satellite"				"Nucleoplasm, Plasma membrane"	"Centriolar satellite"	"HPA003090: AB_1845571, HPA003136: AB_1078330, HPA075108: "	"unprognostic (1.84e-2)"	"unprognostic (1.31e-1)"	"unprognostic (5.71e-2)"	"prognostic favourable (6.34e-4)"	"unprognostic (1.11e-2)"	"unprognostic (1.29e-2)"	"unprognostic (1.28e-2)"	"unprognostic (2.08e-1)"	"unprognostic (1.85e-1)"	"unprognostic (4.62e-2)"	"unprognostic (1.01e-1)"	"unprognostic (3.89e-1)"	"unprognostic (1.40e-3)"	"unprognostic (6.14e-2)"	"unprognostic (2.57e-1)"	"unprognostic (7.93e-2)"	"unprognostic (6.04e-3)"	5.3	3.5	9.4	4.1	12.5	6.0	8.4	4.3	12.5	7.7	6.5	4.4	8.5	2.5	8.2	16.4	6.1	24.1	6.6	4.8	11.5	8.2	10.6	2.8	7.6	2.2	7.3	9.2	5.8	3.2	6.1	17.4	3.0	22.3	6.4	4.2	5.8	4.4	8.9	5.3	3.7	2.7	7.7	13.8	1.8	3.9	37.7	6.7	2.5	14.5	2.6	2.6	7.0	3.4	1.5	5.0	2.4	0.1	2.1	4.2	3.0	4.8	2.8	1.2	8.0	5.4	12.0	1.0	4.2	6.0	4.3	4.1	1.0	3.3	4.7	1.2	5.1	1.2	1.6	0.7	4.9	0.7	0.9	0.5	2.7	1.0	4.6	2.3	0.3	5.7	4.0	9.6	1.2	1.5	2.5	0.9	3.1	3.8	7.4	1.2	0.4	2.0	2.7	3.1	0.8	7.4	1.2	4.9	3.1	8.2	3.3	2.2	8.5	0.2	3.5	5.3	3.8	7.1	1.2	1.8	4.2	2.9	15.7	0.3	1.5	2.4	0.1	0.2	3.4	0.0	4.0	1.3	3.2	2.2	0.2	1.5	4.2	3.4	2.4	2.1	0.0	5.0	0.6	3.0	9.4	12.5	4.3	12.5	11.5	8.2	7.3	9.2	22.3	6.7
BCAR1	"CAS, CASS1, Crkas, P130Cas"	ENSG00000050820	"BCAR1, Cas family scaffolding protein"	P56945	16	75228187-75268053	"Plasma proteins, Predicted intracellular proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000443, HPA042282"	Approved	Approved	Approved	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		"CAB000443: , HPA042282: "	"unprognostic (5.44e-2)"	"unprognostic (2.96e-1)"	"unprognostic (1.61e-2)"	"unprognostic (1.67e-2)"	"unprognostic (2.17e-1)"	"unprognostic (5.43e-3)"	"prognostic unfavourable (9.11e-5)"	"prognostic unfavourable (1.24e-4)"	"unprognostic (2.15e-1)"	"unprognostic (3.49e-2)"	"unprognostic (5.18e-2)"	"unprognostic (1.77e-2)"	"prognostic favourable (4.55e-8)"	"unprognostic (3.38e-1)"	"unprognostic (3.60e-2)"	"unprognostic (8.20e-2)"	"unprognostic (2.20e-1)"	16.6	12.3	14.3	8.4	19.5	1.8	11.5	29.1	26.7	16.7	22.7	31.5	9.1	28.6	17.5	11.0	9.6	10.8	20.4	17.8	14.2	9.4	21.3	17.3	15.9	4.9	18.9	13.5	11.3	31.0	9.2	13.2	28.1	13.9	10.9	7.9	14.6	25.7	12.5	37.4	7.2	25.7	8.6	10.4	28.9	28.7	17.3	20.1	0.2	11.8	9.7	6.3	13.3	11.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.1	16.2	7.9	2.6	3.0	2.8	15.2	12.8	7.4	9.4	7.4	20.7	13.9	0.8	17.0	14.2	7.9	2.6	14.6	2.7	0.0	9.1	0.0	9.8	17.2	7.7	0.0	6.6	8.6	7.3	11.1	5.5	25.4	8.2	0.4	5.5	22.0	0.0	0.5	10.4	10.8	0.3	3.5	3.3	8.6	12.0	9.7	13.9	12.2	2.8	4.9	6.6	2.2	22.8	15.8	13.7	3.9	18.8	3.5	1.9	0.2	9.9	0.0	10.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.3	19.5	29.1	26.7	14.2	9.4	18.9	13.5	13.9	20.1
BCAR3	"AND-34, NSP2, SH2D3B"	ENSG00000137936	"BCAR3, NSP family adaptor protein"	O75815	1	93561786-93847150	"Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 59.5"	"Cell line enhanced"	"Detected in many"		"hTERT-HME1: 45.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"basophil: 4.4;memory B-cell: 4.5"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA014858	Approved		Approved	"Plasma membrane,Centrosome,Cytosol"				"Plasma membrane, Cytosol"	Centrosome	"HPA014858: AB_1845302"	"unprognostic (9.16e-2)"	"unprognostic (2.06e-2)"	"unprognostic (2.79e-2)"	"unprognostic (1.09e-1)"	"unprognostic (9.60e-3)"	"prognostic unfavourable (8.41e-4)"	"prognostic unfavourable (5.42e-4)"	"prognostic unfavourable (8.92e-7)"	"unprognostic (2.44e-1)"	"unprognostic (3.66e-1)"	"prognostic unfavourable (4.38e-4)"	"unprognostic (1.51e-2)"	"prognostic favourable (3.08e-7)"	"unprognostic (2.13e-1)"	"unprognostic (1.14e-1)"	"unprognostic (7.05e-2)"	"unprognostic (1.87e-1)"	26.0	10.4	10.1	11.6	14.2	0.9	23.1	8.6	8.1	10.2	14.1	10.0	6.2	12.4	5.7	5.9	8.9	9.4	15.5	10.6	10.6	8.0	15.5	11.0	12.8	11.8	11.7	5.6	11.2	4.1	4.5	4.6	59.5	10.6	11.2	15.7	10.1	20.5	14.5	19.5	13.3	14.8	10.6	9.7	5.4	15.2	7.3	8.0	2.6	10.0	6.6	11.7	12.7	17.7	4.5	1.7	4.4	1.1	0.0	0.3	0.1	15.1	6.5	12.2	0.9	5.3	4.2	10.5	15.6	27.3	12.9	8.0	1.1	11.3	2.4	5.4	24.1	9.4	0.3	20.2	11.3	1.0	0.3	0.0	4.7	2.8	9.5	0.1	0.0	4.9	22.4	13.3	45.4	14.2	0.4	0.0	34.9	2.3	0.2	0.0	3.8	22.5	1.0	17.6	0.3	33.8	19.2	0.4	1.0	7.6	8.1	9.7	9.1	0.6	16.7	19.2	5.0	8.2	20.6	1.3	0.5	0.3	2.8	0.0	7.0	4.4	0.0	0.1	0.0	1.1	0.0	4.5	0.1	0.0	0.8	2.5	0.0	0.3	0.0	0.0	0.0	1.7	0.3	0.1	10.1	14.2	8.6	8.1	10.6	8.0	11.7	5.6	10.6	8.0
BCL2L12		ENSG00000126453	"BCL2 like 12"	Q9HB09	19	49665142-49673916	"Predicted intracellular proteins"	Apoptosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA020856	Approved		Approved	"Vesicles,Plasma membrane"				Vesicles	"Plasma membrane"	"HPA020856: AB_1845320"	"unprognostic (2.59e-1)"	"unprognostic (3.96e-2)"	"unprognostic (2.24e-1)"	"unprognostic (5.72e-2)"	"unprognostic (3.64e-1)"	"unprognostic (3.68e-2)"	"unprognostic (6.80e-3)"	"unprognostic (3.87e-3)"	"unprognostic (6.12e-2)"	"unprognostic (8.90e-2)"	"unprognostic (1.60e-2)"	"unprognostic (2.33e-2)"	"prognostic unfavourable (8.75e-5)"	"unprognostic (8.67e-2)"	"unprognostic (3.62e-2)"	"unprognostic (2.37e-1)"	"unprognostic (2.56e-1)"	6.7	6.5	2.8	15.3	3.3	12.6	7.9	1.2	3.2	8.8	11.8	2.9	9.3	8.3	8.2	9.1	14.0	7.2	11.3	9.5	3.3	1.8	8.1	15.3	12.0	15.5	3.7	2.2	9.2	18.0	3.2	2.6	21.5	3.8	9.0	5.8	6.3	10.6	9.4	12.5	6.5	9.0	8.1	3.4	14.8	8.9	10.0	3.8	29.8	6.6	18.1	15.1	8.4	7.0	13.9	22.4	13.4	9.8	12.0	13.6	5.6	32.9	20.0	16.2	30.4	4.2	4.1	19.0	18.7	7.6	18.8	20.1	27.8	18.0	18.6	9.0	6.3	16.4	14.7	12.3	10.3	23.2	32.3	17.1	13.6	19.3	3.7	17.6	20.9	4.9	6.0	21.0	6.0	12.5	43.7	24.0	9.9	18.7	21.1	30.5	20.8	26.0	27.4	17.3	20.1	8.2	16.2	0.3	9.5	19.1	25.9	13.3	10.8	22.6	7.5	21.3	25.3	14.9	30.7	20.2	31.2	35.4	9.1	25.0	21.1	9.6	6.8	13.4	11.4	9.8	13.6	13.9	12.3	11.0	6.0	11.6	11.9	11.6	9.2	12.0	7.1	22.4	12.4	5.6	2.8	3.3	1.2	3.2	3.3	1.8	3.7	2.2	3.8	3.8
BEND6	"bA203B9.1, C6orf65, FLJ30162"	ENSG00000151917	"BEN domain containing 6"	Q5SZJ8	6	56955126-57027342	"Predicted intracellular proteins"	"Neurogenesis, Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"brain: 33.0"	"Cell line enhanced"	"Detected in many"		"ASC TERT1: 20.0;fHDF/TERT166: 18.2"	"Cancer enriched"	"Detected in many"	6	"glioma: 4.1"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	5	"plasmacytoid DC: 11.1"	"Lineage enriched"	"Detected in many"	5	"dendritic cells: 11.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031605, HPA052973"	Enhanced		Approved	"Nucleoplasm,Plasma membrane"				"Nucleoplasm, Plasma membrane"		"HPA031605: AB_10602395, HPA052973: "	"unprognostic (4.27e-1)"	"unprognostic (7.05e-2)"	"unprognostic (4.42e-2)"	"unprognostic (1.18e-6)"	"unprognostic (2.44e-1)"	"unprognostic (2.10e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.77e-2)"	"unprognostic (9.41e-3)"	"unprognostic (1.57e-1)"	"unprognostic (8.82e-2)"	"unprognostic (1.94e-2)"	"unprognostic (9.84e-6)"	"unprognostic (9.27e-3)"	"unprognostic (1.51e-1)"	"unprognostic (4.79e-2)"	"unprognostic (2.98e-3)"	1.5	3.1	12.0	2.0	10.7	1.0	1.1	29.2	29.7	5.8	1.7	2.5	0.6	0.8	3.2	1.3	1.8	1.1	5.2	3.1	11.2	10.0	1.0	0.5	1.0	1.2	11.3	8.6	2.9	0.8	2.8	1.1	2.7	33.0	3.4	2.2	0.2	1.0	3.4	4.3	1.5	1.2	4.8	7.2	1.2	1.3	1.5	4.1	0.0	1.3	0.0	1.3	3.9	1.6	0.0	11.1	0.0	0.0	2.1	0.0	0.1	3.3	1.4	0.8	0.4	12.0	20.0	3.2	10.2	10.0	4.6	5.3	0.1	1.6	0.0	3.3	18.2	0.4	1.1	0.5	5.8	1.5	0.6	2.2	4.9	0.2	3.2	6.2	0.1	8.6	2.9	6.4	2.9	3.0	2.8	5.9	9.3	3.4	3.7	1.6	2.9	0.8	0.0	0.1	1.6	1.7	3.4	4.0	4.0	6.8	0.8	0.8	0.2	3.8	3.9	14.0	0.4	9.4	2.2	8.2	9.0	2.6	8.2	4.3	12.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	2.1	0.0	11.1	0.0	0.1	12.0	10.7	29.2	20.8	11.2	10.0	11.3	8.6	33.0	4.1
BIN2	BRAP-1	ENSG00000110934	"Bridging integrator 2"		12	51281038-51324668	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"				"Group enriched"	"Detected in many"	6	"blood: 85.3;bone marrow: 38.0;lymphoid tissue: 24.8"	"Cell line enhanced"	"Detected in some"		"HEL: 23.3;HMC-1: 39.7;Karpas-707: 17.3;NB-4: 39.5;RPMI-8226: 15.5;THP-1: 33.5;U-937: 21.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA038666, HPA038667"	Enhanced		Approved	"Plasma membrane"				"Plasma membrane"		"HPA038666: AB_2676139, HPA038667: AB_2676140"	"unprognostic (8.44e-3)"	"prognostic favourable (1.33e-4)"	"unprognostic (2.48e-1)"	"prognostic favourable (6.34e-4)"	"unprognostic (4.63e-1)"	"unprognostic (2.00e-3)"	"unprognostic (1.21e-1)"	"unprognostic (3.59e-2)"	"unprognostic (3.72e-2)"	"unprognostic (7.47e-2)"	"unprognostic (5.71e-2)"	"unprognostic (3.29e-1)"	"unprognostic (1.65e-3)"	"unprognostic (4.03e-1)"	"unprognostic (3.96e-2)"	"unprognostic (1.24e-1)"	"unprognostic (2.22e-1)"	4.6	1.8	3.5	12.3	4.7	38.0	1.7	1.8	2.0	2.3	3.3	3.6	0.7	2.2	1.4	2.8	2.2	1.4	3.6	2.2	3.1	2.1	2.5	3.1	7.7	23.9	4.4	0.9	1.8	2.3	0.0	1.7	8.4	3.2	1.8	3.6	1.5	4.7	0.6	1.9	2.0	3.3	2.3	4.1	18.3	2.6	3.5	3.9	24.8	1.9	0.7	17.5	4.4	1.9	10.5	17.1	85.3	59.9	35.8	47.7	61.4	0.0	0.0	0.0	0.0	0.0	0.0	11.8	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	10.8	0.0	23.3	0.0	0.0	0.0	9.7	39.7	0.0	0.0	0.0	0.0	0.0	0.0	17.3	0.0	0.1	6.7	39.5	0.0	0.0	0.0	0.0	15.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	33.5	0.0	0.0	0.0	0.0	0.0	9.3	0.0	2.3	0.0	21.9	0.0	85.3	30.9	37.4	47.7	49.0	38.5	8.1	32.4	39.8	17.1	10.5	25.3	33.5	61.0	35.8	59.9	6.3	40.9	61.4	3.5	4.7	1.8	2.0	3.1	2.1	4.4	0.9	3.2	3.9
BRPF1	BR140	ENSG00000156983	"Bromodomain and PHD finger containing 1"	P55201	3	9731729-9748018	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, Chromatin regulator, DNA-binding"	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"BEWO: 42.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003359	Enhanced		Approved	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		"HPA003359: AB_1078217"	"unprognostic (4.18e-2)"	"unprognostic (2.21e-2)"	"unprognostic (6.47e-2)"	"unprognostic (9.10e-2)"	"unprognostic (3.42e-1)"	"unprognostic (2.33e-2)"	"prognostic unfavourable (3.20e-5)"	"unprognostic (3.00e-1)"	"unprognostic (3.72e-1)"	"unprognostic (3.26e-3)"	"unprognostic (4.27e-2)"	"prognostic unfavourable (5.28e-4)"	"unprognostic (1.51e-3)"	"unprognostic (4.86e-2)"	"unprognostic (3.55e-1)"	"unprognostic (6.87e-2)"	"unprognostic (9.67e-3)"	10.5	7.7	6.2	10.4	8.1	29.2	10.7	16.5	13.1	10.7	9.5	10.4	5.0	6.8	14.4	8.9	10.7	12.9	10.7	7.0	5.4	4.2	8.2	5.3	10.7	12.3	8.3	7.0	12.5	9.2	11.3	9.5	9.9	7.5	9.0	6.3	9.6	12.1	8.5	11.1	14.2	10.5	8.3	5.1	12.2	9.2	23.7	11.4	24.3	12.0	7.8	11.4	11.5	9.4	1.2	3.5	2.3	1.8	9.3	4.2	1.3	5.3	8.3	8.3	4.0	5.2	4.4	42.4	6.6	4.4	7.8	5.8	7.4	4.6	9.2	3.1	6.6	4.5	8.4	6.7	5.6	9.7	8.9	11.9	16.6	4.9	6.1	16.9	11.1	5.6	5.6	11.5	6.9	6.0	12.6	9.3	4.9	12.9	10.5	13.9	10.5	7.8	14.2	5.8	6.4	4.1	8.5	4.9	7.6	7.1	5.2	6.0	5.2	16.4	7.6	9.2	7.8	7.9	12.1	7.5	8.4	17.1	7.2	13.9	7.9	2.2	1.8	2.3	2.7	1.6	4.2	1.1	2.1	2.5	1.5	1.2	2.5	2.9	1.3	9.3	1.5	3.5	1.3	1.3	6.2	8.1	16.5	13.1	5.4	4.2	8.3	7.0	7.5	11.4
BSDC1	"FLJ10276, RP4-811H24.7"	ENSG00000160058	"BSD domain containing 1"	Q9NW68	1	32365103-32394731	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"basophil: 36.4"	"Lineage enriched"	"Detected in all"	4	"granulocytes: 36.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031358, HPA031360"	Approved		Supported	"Golgi apparatus,Plasma membrane"				"Golgi apparatus"	"Plasma membrane"	"HPA031358: AB_2673841, HPA031360: AB_10601120"	"unprognostic (1.42e-1)"	"unprognostic (8.97e-2)"	"unprognostic (2.91e-2)"	"unprognostic (3.86e-2)"	"unprognostic (2.48e-1)"	"prognostic favourable (8.82e-5)"	"unprognostic (3.40e-1)"	"unprognostic (2.06e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.04e-1)"	"unprognostic (9.56e-3)"	"unprognostic (5.92e-2)"	"unprognostic (1.95e-3)"	"unprognostic (1.92e-3)"	"unprognostic (2.68e-1)"	"unprognostic (2.37e-1)"	"unprognostic (2.07e-1)"	21.9	34.7	30.5	16.8	33.9	45.6	22.8	44.0	41.2	20.7	20.5	34.4	30.8	20.7	25.9	36.8	19.9	22.5	23.4	19.6	27.7	27.1	20.1	41.4	19.6	16.6	27.8	27.2	32.0	37.1	44.5	26.4	28.1	32.5	24.8	24.3	22.2	30.4	21.2	19.0	25.1	23.9	22.8	28.9	20.1	21.4	40.4	27.3	16.2	23.9	16.1	20.3	19.5	19.8	8.4	6.8	36.4	5.8	5.2	6.8	5.4	17.8	9.6	19.9	18.5	28.4	23.8	16.1	20.4	27.8	26.0	26.2	14.1	16.4	12.9	23.4	29.5	16.4	15.7	15.3	20.8	24.5	19.8	10.4	18.1	16.1	26.5	13.0	17.9	24.0	34.3	23.6	16.4	22.4	27.8	22.2	18.7	9.3	15.1	11.7	17.4	15.6	12.5	15.1	17.3	18.9	13.8	29.1	16.1	19.1	19.9	19.5	16.0	11.5	22.2	16.3	13.8	22.7	17.1	25.2	29.9	9.4	21.0	14.2	12.2	36.4	4.9	17.2	6.5	5.8	6.8	5.9	5.8	5.4	4.6	8.4	6.8	5.9	8.1	5.2	5.1	6.8	6.1	5.4	30.5	33.9	44.0	41.2	27.7	27.1	27.8	27.2	32.5	27.3
BTN2A1	"BT2.1, BTF1, BTN2.1"	ENSG00000112763	"Butyrophilin subfamily 2 member A1"	Q7KYR7	6	26457904-26476621	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											HPA019208	Approved		Approved	"Plasma membrane"				"Plasma membrane"		"HPA019208: AB_1845492"	"unprognostic (1.86e-1)"	"unprognostic (3.48e-1)"	"unprognostic (1.20e-1)"	"unprognostic (2.87e-1)"	"unprognostic (2.29e-1)"	"unprognostic (6.17e-2)"	"unprognostic (5.74e-3)"	"unprognostic (1.22e-2)"	"unprognostic (1.03e-1)"	"unprognostic (3.26e-2)"	"unprognostic (6.90e-3)"	"unprognostic (5.14e-2)"	"prognostic unfavourable (5.90e-5)"	"unprognostic (1.97e-1)"	"unprognostic (4.89e-2)"	"unprognostic (7.92e-2)"	"prognostic favourable (4.52e-5)"	15.3	16.7	10.8	16.3	13.7	18.5	17.2	42.2	16.2	14.8	15.8	13.2	17.4	12.2	18.8	15.0	11.5	14.9	12.7	15.6	11.2	14.6	13.1	8.5	17.2	16.3	14.4	10.2	15.8	8.9	7.7	16.9	23.2	16.1	16.5	14.6	12.0	11.1	19.3	12.1	9.5	13.9	21.1	15.6	23.5	12.4	13.0	15.0	11.3	10.8	7.3	14.4	21.4	13.4	4.8	4.7	28.8	4.8	4.8	8.1	3.4	7.5	6.9	13.7	8.4	6.2	5.0	0.6	16.7	14.1	20.5	18.8	6.1	5.1	6.2	23.0	11.8	3.4	10.8	4.3	19.6	9.0	10.6	3.7	7.4	7.5	9.6	5.3	10.0	6.9	4.1	22.8	7.4	7.4	6.0	9.9	17.5	3.2	9.4	8.9	4.7	5.7	7.8	13.5	6.5	7.6	3.8	14.3	7.8	5.3	6.8	11.9	2.2	4.7	9.7	15.4	8.2	13.3	18.7	8.0	18.6	5.2	6.1	10.6	24.3	16.7	4.8	15.5	6.5	2.7	5.9	4.8	5.4	7.1	4.3	3.9	5.0	6.4	28.8	4.8	4.1	4.7	8.1	3.4	10.8	13.7	42.2	16.2	11.2	14.6	14.4	10.2	16.1	15.0
BTRC	"beta-TrCP1, betaTrCP, bTrCP, bTrCP1, FBXW1A, Fwd1"	ENSG00000166167	"Beta-transducin repeat containing E3 ubiquitin protein ligase"	Q9Y297	10	101354033-101557321	"Predicted intracellular proteins"	"Biological rhythms, Host-virus interaction, Ubl conjugation pathway, Wnt signaling pathway"	Ligase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031156, CAB032986"	Approved		Approved	"Nucleoplasm,Plasma membrane,Cytosol"				Nucleoplasm	"Plasma membrane, Cytosol"	"CAB032986: AB_2243598, HPA031156: "	"unprognostic (1.43e-1)"	"unprognostic (2.35e-2)"	"unprognostic (8.88e-2)"	"unprognostic (2.09e-1)"	"unprognostic (3.55e-1)"	"unprognostic (2.73e-1)"	"unprognostic (2.41e-2)"	"unprognostic (9.25e-2)"	"unprognostic (3.22e-1)"	"unprognostic (1.59e-2)"	"unprognostic (8.80e-3)"	"unprognostic (5.05e-1)"	"unprognostic (2.81e-3)"	"unprognostic (1.33e-1)"	"unprognostic (2.95e-2)"	"unprognostic (3.07e-2)"	"unprognostic (2.23e-1)"	6.6	11.2	16.0	7.3	23.1	3.6	11.8	16.2	28.0	10.2	6.6	10.7	13.7	5.4	8.8	14.5	11.5	10.8	8.1	18.6	15.7	18.3	11.6	7.1	6.8	5.3	14.3	15.3	15.5	8.6	21.5	17.3	10.4	13.5	12.2	7.0	11.9	9.0	8.7	14.1	9.0	5.4	9.7	10.2	7.5	6.4	17.9	9.0	6.3	11.4	7.1	7.5	7.3	9.8	5.2	4.8	3.9	3.7	5.1	8.1	3.4	6.5	10.1	14.2	16.3	13.9	12.1	5.1	9.5	15.3	9.9	8.3	7.0	5.2	10.7	9.6	8.0	10.2	11.6	10.3	10.8	7.0	9.2	7.8	6.3	9.1	7.4	11.3	4.2	7.4	12.0	8.5	15.2	12.2	8.4	3.6	9.5	5.6	7.6	5.7	6.6	7.9	9.6	19.9	2.2	9.1	4.3	10.5	9.0	6.2	2.8	8.8	7.7	4.0	10.3	5.2	8.3	6.8	6.6	6.0	13.0	6.8	5.2	5.7	3.5	3.8	3.7	3.9	6.1	3.1	6.1	5.2	6.5	5.5	4.8	4.4	8.1	6.5	2.4	5.1	3.1	2.4	5.6	3.4	16.0	23.1	16.2	23.3	15.7	18.3	14.3	15.3	13.5	9.0
BZW2	"HSPC028, MST017, MSTP017"	ENSG00000136261	"Basic leucine zipper and W2 domains 2"	Q9Y6E2	7	16646131-16706523	"Predicted intracellular proteins"	"Differentiation, Neurogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"placenta: 104.4;skeletal muscle: 89.7"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA022813, HPA026709"	Approved		Approved	"Plasma membrane,Actin filaments,Cytosol"				"Plasma membrane, Actin filaments, Cytosol"		"HPA022813: AB_1845511, HPA026709: AB_10600752"	"unprognostic (2.27e-3)"	"unprognostic (1.77e-3)"	"unprognostic (5.91e-2)"	"unprognostic (4.79e-3)"	"unprognostic (2.80e-2)"	"unprognostic (7.08e-3)"	"prognostic unfavourable (7.86e-8)"	"unprognostic (9.13e-3)"	"unprognostic (8.49e-3)"	"unprognostic (2.81e-2)"	"unprognostic (1.83e-3)"	"unprognostic (3.37e-2)"	"prognostic unfavourable (6.01e-4)"	"unprognostic (1.00e-1)"	"unprognostic (1.66e-1)"	"unprognostic (6.77e-2)"	"unprognostic (1.25e-1)"	10.6	7.2	4.2	7.8	8.5	10.1	13.5	3.4	8.9	7.9	13.6	3.4	22.0	7.7	7.6	7.6	17.9	7.1	6.1	70.8	4.4	2.8	8.4	10.2	8.1	11.4	3.5	5.8	6.4	12.3	1.8	5.7	104.4	2.5	9.8	16.2	13.2	10.1	25.3	89.7	16.8	8.0	16.6	2.8	8.4	15.6	3.5	3.4	14.5	13.6	41.1	11.1	16.8	10.3	17.2	37.3	1.7	20.3	20.1	23.6	16.3	16.8	16.4	27.9	40.2	13.6	24.2	25.0	24.1	31.7	23.9	25.4	39.7	25.7	39.4	28.7	18.7	35.2	32.8	27.5	31.6	5.2	18.9	24.5	18.5	22.3	14.2	33.5	15.4	18.5	14.9	20.8	38.5	34.0	46.9	8.5	19.3	19.8	17.0	38.9	28.4	33.9	20.4	18.2	41.4	22.5	30.8	35.7	21.0	9.5	85.1	12.6	37.5	29.1	19.3	18.9	23.9	27.7	26.5	16.4	17.1	55.5	9.2	42.2	67.6	0.9	17.4	1.7	11.0	20.3	17.9	17.2	16.1	14.9	37.3	15.8	23.6	19.5	0.7	20.1	14.5	14.4	11.9	16.3	4.2	8.5	3.4	8.9	4.4	2.8	3.5	5.8	2.5	3.4
C10orf90	"bA422P15.2, FATS, FLJ32938"	ENSG00000154493	"Chromosome 10 open reading frame 90"	Q96M02	10	126424997-126670446	"Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase	"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"brain: 30.9;breast: 9.2;salivary gland: 18.6;testis: 12.3"	"Cell line enhanced"	"Detected in some"		"SK-MEL-30: 48.4;U-2197: 14.8;U-266/84: 10.4;U-87 MG: 15.4;WM-115: 12.1"	"Cancer enriched"	"Detected in some"	5	"melanoma: 4.7"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	7	"MAIT T-cell: 2.7"	"Lineage enriched"	"Detected in single"	28	"T-cells: 2.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA038648, HPA075229"	Approved		Supported	"Nucleoplasm,Plasma membrane,Cytosol"				"Nucleoplasm, Plasma membrane, Cytosol"		"HPA038648: AB_10672721, HPA075229: "	"unprognostic (1.21e-2)"	"unprognostic (3.34e-1)"	"unprognostic (7.50e-2)"	"unprognostic (2.05e-2)"	"unprognostic (1.66e-1)"	"unprognostic (9.30e-2)"	"unprognostic (1.98e-3)"	"unprognostic (5.06e-2)"	"unprognostic (9.34e-3)"	"unprognostic (3.73e-2)"	"unprognostic (9.52e-2)"	"unprognostic (1.22e-1)"	"unprognostic (5.06e-11)"	"unprognostic (2.69e-3)"	"unprognostic (9.91e-3)"	"unprognostic (1.26e-1)"	"unprognostic (2.88e-1)"	1.9	0.8	7.5	1.0	21.5	0.8	9.2	1.4	18.7	0.9	0.9	30.9	0.0	0.7	0.8	0.8	0.9	0.7	1.1	0.8	10.8	5.9	0.9	0.8	0.8	0.7	26.0	5.9	0.9	1.1	0.7	0.5	1.3	14.4	0.9	1.0	1.7	18.6	0.7	0.9	1.9	0.8	0.8	17.2	0.8	0.7	12.3	28.0	0.0	1.3	0.0	2.0	0.8	0.2	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.1	0.0	0.0	0.0	0.3	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.9	0.0	0.6	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	48.4	0.0	0.1	0.0	1.9	0.0	14.8	0.2	0.0	10.4	0.0	15.4	0.0	12.1	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.5	21.5	1.4	11.3	10.8	5.9	26.0	5.9	14.4	28.0
C12orf73	"DKFZp547P055, FLJ13975"	ENSG00000204954	"Chromosome 12 open reading frame 73"	Q69YU5	12	103950202-103965708	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 43.8"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA038883	Uncertain		Approved	"Plasma membrane,Centrosome,Mitochondria"	"Secreted - unknown location"			"Centrosome, Mitochondria"	"Plasma membrane"	"HPA038883: AB_10794735"	"unprognostic (9.24e-2)"	"unprognostic (3.26e-3)"	"unprognostic (3.66e-3)"	"unprognostic (7.20e-2)"	"unprognostic (3.28e-1)"	"unprognostic (1.77e-1)"	"prognostic unfavourable (6.98e-4)"	"unprognostic (8.96e-2)"	"unprognostic (1.86e-2)"	"unprognostic (3.79e-2)"	"unprognostic (3.03e-3)"	"unprognostic (2.07e-1)"	"unprognostic (1.33e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.40e-2)"	"unprognostic (6.27e-2)"	"prognostic favourable (1.61e-4)"	6.7	11.4	14.3	8.3	14.5	4.4	9.7	15.5	17.5	7.2	7.4	11.4	7.2	7.7	9.5	13.2	7.0	8.9	5.5	11.1	13.0	14.6	9.4	8.3	5.8	10.0	13.3	13.3	11.5	9.7	9.4	21.0	7.3	13.6	10.7	9.5	8.3	8.3	11.1	43.8	9.0	7.7	7.9	14.1	7.0	9.9	10.1	13.8	11.4	11.5	12.9	10.2	6.6	6.9	11.7	11.3	8.6	5.1	12.0	14.5	3.9	5.9	11.2	16.9	10.4	4.9	6.5	11.0	6.5	3.9	7.2	5.9	11.9	5.2	7.1	8.6	3.9	9.6	10.1	8.2	5.5	10.1	20.4	10.7	16.3	14.9	7.2	15.7	9.8	5.7	9.5	3.6	6.4	6.6	13.7	4.9	6.6	6.8	17.4	23.7	8.2	19.1	10.1	6.3	7.0	9.5	8.1	27.8	9.5	6.5	11.4	15.0	19.4	8.5	3.4	8.9	5.0	6.6	6.6	13.2	20.2	14.8	10.1	8.9	7.7	7.3	5.1	8.6	10.5	4.2	10.4	11.7	9.8	10.0	7.2	10.7	14.5	13.5	1.4	12.0	3.8	11.3	13.8	3.9	14.3	14.5	15.5	17.5	13.0	14.6	13.3	13.3	13.6	13.8
C12orf76	FLJ40142	ENSG00000174456	"Chromosome 12 open reading frame 76"	Q8N812	12	110027028-110073686	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in all"		"brain: 47.6"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"HPA039713, HPA042013"	Uncertain		Approved	"Plasma membrane,Actin filaments"				"Actin filaments"	"Plasma membrane"	"HPA039713: AB_2676640, HPA042013: "	"unprognostic (9.20e-2)"	"unprognostic (3.31e-2)"	"unprognostic (2.35e-3)"	"unprognostic (9.54e-2)"	"unprognostic (3.50e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.75e-2)"	"prognostic favourable (6.44e-5)"	"unprognostic (1.39e-1)"	"unprognostic (1.47e-1)"	"unprognostic (8.86e-3)"	"unprognostic (1.75e-1)"	"prognostic unfavourable (5.74e-5)"	"unprognostic (2.09e-1)"	"unprognostic (7.85e-2)"	"unprognostic (4.12e-2)"	"unprognostic (1.26e-1)"	5.7	8.8	34.6	8.4	26.1	11.6	9.4	19.7	47.6	6.6	6.1	32.6	2.5	7.6	8.1	14.0	5.9	12.0	6.7	5.3	36.1	33.5	8.5	7.9	9.7	11.4	36.2	21.2	11.9	8.4	5.1	7.5	9.4	26.1	7.5	6.4	5.9	7.7	7.9	8.3	14.6	7.4	5.3	38.7	11.1	9.2	9.8	27.4	4.8	11.1	1.8	7.9	6.3	5.0	14.0	12.8	31.3	9.4	14.3	16.3	11.1	6.4	9.5	11.6	10.4	8.3	17.1	12.7	5.7	3.2	5.5	4.1	7.8	6.3	7.9	6.8	2.5	12.8	4.7	4.7	4.1	11.7	10.1	7.9	14.5	15.7	7.8	12.8	15.4	13.7	15.6	4.8	8.8	8.5	11.7	20.7	5.6	6.9	6.5	21.1	9.0	8.7	12.4	7.1	12.8	9.9	6.2	23.2	12.6	7.1	5.3	12.7	11.5	6.7	10.9	8.4	6.1	6.3	3.3	9.5	10.9	6.5	9.3	7.4	4.8	31.3	9.4	11.2	8.3	6.2	9.2	14.0	13.1	9.3	8.8	11.8	16.3	10.6	12.8	14.3	6.1	12.8	12.6	11.1	34.6	26.1	19.7	35.1	36.1	33.5	36.2	21.2	26.1	27.4
C14orf37	UT2	ENSG00000139971	"Chromosome 14 open reading frame 37"	Q86TY3	14	57999735-58298139	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 21.5"	"Cell line enhanced"	"Detected in many"		"AF22: 11.0;AN3-CA: 6.9;fHDF/TERT166: 12.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001580, HPA001789"	Enhanced		Approved	"Plasma membrane"			270000	"Plasma membrane"		"HPA001580: , HPA001789: AB_1078328"	"unprognostic (2.56e-2)"	"unprognostic (2.04e-2)"	"unprognostic (1.20e-3)"	"unprognostic (8.56e-2)"	"unprognostic (1.15e-1)"	"unprognostic (6.97e-3)"	"unprognostic (1.94e-1)"	"unprognostic (7.84e-3)"	"unprognostic (2.66e-1)"	"unprognostic (2.32e-1)"	"unprognostic (2.42e-1)"	"unprognostic (1.01e-1)"	"unprognostic (3.87e-8)"	"unprognostic (5.22e-6)"	"unprognostic (4.93e-2)"	"unprognostic (8.74e-4)"	"unprognostic (3.01e-4)"	2.8	5.3	11.4	1.5	11.7	1.8	2.4	10.1	14.0	4.1	2.3	3.9	1.1	1.6	6.7	4.0	1.9	4.7	3.9	6.3	8.6	4.6	16.5	2.2	1.8	1.1	5.1	7.8	9.3	2.4	9.2	5.8	1.4	21.5	4.0	2.7	3.9	2.0	3.3	1.2	2.5	1.8	5.0	3.3	1.3	3.0	5.1	5.0	0.0	3.4	0.3	0.9	2.6	3.0	0.3	0.6	0.5	0.3	0.1	0.0	0.0	0.0	0.0	11.0	6.9	5.4	2.3	0.0	2.1	1.7	0.4	0.3	0.5	0.1	0.0	0.7	12.0	0.1	3.4	0.0	0.4	0.1	1.1	0.0	0.0	0.5	0.2	0.0	5.5	2.3	0.2	0.2	0.2	0.5	0.1	0.3	1.4	0.3	0.0	0.0	5.1	2.3	1.6	0.3	2.7	4.4	0.5	1.3	0.1	0.1	0.0	0.3	0.3	0.2	0.1	1.6	4.1	0.6	2.9	0.3	0.3	0.0	3.4	0.3	1.2	0.5	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.0	0.0	0.4	0.1	0.0	0.6	0.0	0.0	11.4	11.7	10.1	14.0	8.6	4.6	5.1	7.8	21.5	5.0
C14orf93	"FLJ12154, RTFC"	ENSG00000100802	"Chromosome 14 open reading frame 93"	Q9H972	14	22985908-23010166	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002569	Approved		Approved	"Nucleoplasm,Plasma membrane"	"Secreted - unknown location"			"Nucleoplasm, Plasma membrane"		"HPA002569: AB_1078334"	"prognostic favourable (5.05e-4)"	"unprognostic (1.31e-2)"	"unprognostic (2.97e-2)"	"unprognostic (2.23e-3)"	"unprognostic (2.30e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.24e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.88e-1)"	"unprognostic (1.29e-1)"	"unprognostic (4.86e-3)"	"unprognostic (7.45e-2)"	"unprognostic (2.01e-3)"	"unprognostic (1.10e-1)"	"unprognostic (2.49e-1)"	"unprognostic (2.14e-1)"	"unprognostic (7.11e-2)"	10.4	6.1	10.2	11.8	7.3	12.4	9.8	14.3	7.9	12.0	12.2	8.3	16.7	8.1	10.8	13.5	10.3	11.1	10.3	7.2	9.6	4.6	10.3	9.7	8.7	10.3	6.8	5.9	12.2	15.9	12.9	18.9	5.4	7.4	11.0	10.9	9.1	9.8	10.2	7.3	20.3	9.4	8.4	11.0	12.9	9.5	5.8	9.0	22.7	16.3	7.8	14.6	11.6	9.5	9.7	8.8	21.3	11.3	8.8	12.4	6.6	3.8	7.3	6.2	8.7	10.1	22.5	8.7	4.6	7.1	3.7	4.8	4.5	11.5	10.9	4.4	4.2	8.3	3.8	11.5	3.5	4.2	2.6	6.9	8.8	10.4	8.8	5.0	5.9	16.3	9.0	5.4	6.9	6.7	7.4	2.4	3.7	11.0	6.3	9.3	2.1	5.1	10.3	6.0	6.6	4.8	6.0	22.7	9.9	6.1	5.9	6.2	9.1	8.8	3.8	6.9	9.2	3.1	4.5	8.5	2.3	7.5	4.8	6.2	7.0	11.7	7.5	21.3	8.3	6.9	7.3	9.7	6.8	8.6	8.8	9.4	10.2	9.8	10.7	8.8	11.3	6.2	12.4	6.6	10.2	7.3	14.3	7.9	9.6	4.6	6.8	5.9	7.4	9.0
C16orf74	MGC17624	ENSG00000154102	"Chromosome 16 open reading frame 74"	Q96GX8	16	85690084-85751129	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 44.6"	"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 33.7;hTCEpi: 28.8;T-47d: 30.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"naive B-cell: 26.3"	"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA049367	Uncertain		Approved	"Plasma membrane,Centrosome"				"Plasma membrane"	Centrosome	"HPA049367: "	"unprognostic (1.16e-1)"	"unprognostic (2.21e-2)"	"unprognostic (6.74e-3)"	"unprognostic (2.15e-3)"	"unprognostic (3.65e-2)"	"prognostic unfavourable (1.71e-4)"	"unprognostic (1.08e-3)"	"unprognostic (4.22e-3)"	"prognostic unfavourable (4.08e-4)"	"unprognostic (5.06e-2)"	"prognostic unfavourable (1.54e-5)"	"unprognostic (3.40e-1)"	"unprognostic (1.76e-3)"	"unprognostic (2.51e-1)"	"unprognostic (3.55e-1)"	"unprognostic (2.15e-2)"	"unprognostic (9.07e-3)"	2.7	0.7	6.3	5.6	3.9	9.3	6.8	0.6	3.3	4.7	3.0	1.4	10.8	1.5	2.1	3.7	6.8	1.5	2.4	1.8	9.2	1.7	2.0	0.8	2.0	11.7	2.0	2.1	0.9	2.1	3.9	1.0	44.6	1.6	7.1	1.3	18.8	4.5	9.5	1.5	6.3	4.2	3.9	1.5	12.9	3.0	1.4	1.5	0.4	4.7	6.2	10.3	18.9	10.0	26.3	8.8	10.3	8.2	3.3	8.3	5.4	12.0	4.0	0.1	1.6	1.8	2.0	5.0	1.5	1.9	4.7	1.3	3.1	11.3	0.1	17.1	1.1	17.4	0.7	33.7	2.7	0.0	2.7	0.0	1.8	0.3	5.1	0.3	0.0	4.5	28.8	4.5	19.8	15.3	0.0	0.0	0.1	10.1	0.0	18.4	1.1	11.6	0.5	0.0	1.0	0.0	13.7	3.8	1.0	6.1	3.1	3.1	30.0	5.1	15.6	3.0	7.9	1.3	4.3	4.2	3.0	13.2	0.0	4.3	0.6	0.0	8.2	10.3	0.6	2.7	2.2	20.4	4.5	3.6	8.8	26.3	7.6	4.7	3.2	3.3	0.8	0.1	8.3	5.4	6.3	3.9	0.6	3.3	9.2	1.7	2.0	2.1	1.6	1.5
C17orf58		ENSG00000186665	"Chromosome 17 open reading frame 58"	Q2M2W7	17	67991101-67996431	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"SK-BR-3: 30.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Region enriched"	"Detected in all"	4	"cerebellum: 110.1"	HPA023036	Uncertain		Approved	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		"HPA023036: AB_10601144"	"unprognostic (1.41e-1)"	"unprognostic (1.22e-1)"	"unprognostic (6.66e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.00e-1)"	"unprognostic (7.65e-3)"	"prognostic unfavourable (8.99e-4)"	"unprognostic (7.45e-2)"	"unprognostic (2.20e-1)"	"unprognostic (2.27e-2)"	"unprognostic (6.22e-2)"	"unprognostic (6.69e-2)"	"prognostic unfavourable (1.31e-10)"	"unprognostic (1.16e-2)"	"unprognostic (1.04e-1)"	"unprognostic (5.00e-2)"	"unprognostic (1.01e-1)"	11.1	6.8	10.7	6.2	9.3	3.5	17.3	8.8	11.5	29.0	8.3	5.7	8.3	4.1	15.4	8.1	6.5	8.1	6.6	8.9	7.7	6.3	6.3	9.1	6.2	3.1	7.4	5.0	6.3	10.4	5.2	3.6	33.3	5.2	7.8	7.5	5.7	5.3	4.0	6.9	3.7	6.1	11.8	5.5	5.1	6.6	4.8	4.4	1.1	6.9	4.5	6.8	11.0	11.7	3.6	5.2	9.5	6.3	3.2	3.0	2.2	5.2	5.2	5.2	6.4	3.8	9.6	4.1	2.2	6.2	3.9	6.3	3.0	6.9	7.0	5.0	1.8	2.7	11.8	4.7	9.4	12.6	11.9	4.5	1.9	9.6	6.0	3.8	8.4	5.2	5.7	3.7	8.7	18.1	9.6	10.9	3.7	7.0	0.7	5.1	5.9	5.5	1.7	5.7	9.3	4.9	3.5	3.9	7.0	3.3	30.9	11.3	8.8	4.5	3.3	3.3	3.4	2.3	4.6	21.9	16.0	6.2	8.4	6.8	5.8	9.5	3.8	6.3	3.0	3.6	1.0	3.6	1.1	2.4	5.2	0.8	0.5	1.2	1.5	3.2	6.3	0.2	0.5	2.2	10.7	9.3	8.8	11.5	7.7	6.3	7.4	5.0	5.2	4.4
C17orf62	"FLJ90469, MGC4368"	ENSG00000178927	"Chromosome 17 open reading frame 62"	Q9BQA9	17	82442589-82450829	"Predicted intracellular proteins, Predicted membrane proteins"	"Immunity, Innate immunity"	Chaperone		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045696	Uncertain		Approved	"Plasma membrane,Cell Junctions"				"Plasma membrane"	"Cell Junctions"	"HPA045696: "	"unprognostic (1.87e-2)"	"unprognostic (6.92e-3)"	"unprognostic (2.25e-1)"	"unprognostic (2.15e-3)"	"unprognostic (5.75e-2)"	"unprognostic (2.05e-3)"	"unprognostic (3.81e-3)"	"unprognostic (4.86e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.44e-1)"	"unprognostic (3.49e-3)"	"unprognostic (7.99e-2)"	"prognostic unfavourable (6.83e-11)"	"unprognostic (1.47e-1)"	"unprognostic (5.51e-2)"	"unprognostic (7.78e-2)"	"unprognostic (9.14e-3)"	19.9	17.3	16.8	35.8	25.2	16.4	20.0	8.6	20.4	16.2	16.2	20.8	10.5	12.1	16.5	13.1	17.1	16.0	22.9	12.1	15.2	12.1	17.5	29.1	20.2	48.3	26.8	12.4	17.6	21.3	12.9	15.7	14.9	20.6	19.5	13.6	12.2	14.7	12.7	6.5	13.9	21.1	20.2	19.0	53.7	16.4	8.3	20.9	26.0	13.8	8.2	42.3	29.2	13.3	30.6	33.0	74.9	44.2	24.2	25.9	34.6	14.0	20.5	11.3	18.6	17.9	18.8	11.0	12.7	15.4	18.7	22.3	7.6	14.3	35.7	11.7	17.9	14.2	7.7	9.5	12.9	25.4	6.3	9.7	6.7	8.9	18.6	10.9	28.7	21.7	13.8	16.0	9.0	24.2	8.1	26.8	15.7	15.6	45.2	9.2	8.6	11.0	34.6	6.8	27.4	13.8	17.9	9.7	18.4	22.9	26.8	16.3	27.5	43.9	8.3	14.6	14.3	23.9	13.4	49.0	16.3	26.3	19.0	17.8	12.8	43.8	34.1	44.0	25.9	44.2	20.0	30.2	23.9	25.0	31.4	30.6	20.2	19.6	74.9	24.2	39.6	33.0	24.8	34.6	16.8	25.2	8.6	20.4	15.2	12.1	26.8	12.4	20.6	20.9
C18orf21	"HsT3108, PNAS-124, PNAS-131"	ENSG00000141428	"Chromosome 18 open reading frame 21"	Q32NC0	18	35972083-35979286	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA065505, HPA067322"	Uncertain		Approved	"Nucleoli,Plasma membrane"				"Nucleoli, Plasma membrane"		"HPA065505: , HPA067322: "	"unprognostic (7.31e-2)"	"unprognostic (2.14e-3)"	"unprognostic (9.88e-2)"	"unprognostic (8.66e-3)"	"unprognostic (2.04e-1)"	"unprognostic (1.77e-1)"	"prognostic unfavourable (1.38e-6)"	"unprognostic (2.53e-3)"	"unprognostic (1.83e-2)"	"prognostic favourable (1.81e-6)"	"unprognostic (2.88e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.21e-2)"	"unprognostic (5.15e-3)"	"unprognostic (2.35e-3)"	"unprognostic (5.97e-2)"	14.1	16.1	13.4	16.7	12.5	53.0	18.4	23.1	25.8	13.0	12.8	7.9	17.6	15.2	15.0	17.7	15.0	12.9	11.7	15.2	12.4	12.5	14.0	14.5	11.3	17.1	11.7	14.7	16.4	22.0	12.9	16.9	14.8	13.0	13.4	12.3	8.1	16.5	17.8	28.7	13.6	14.1	15.8	10.6	17.2	16.7	28.7	11.7	22.9	14.8	21.4	15.7	17.8	14.8	18.5	15.1	40.6	16.5	16.5	21.7	10.6	13.3	9.0	19.7	13.6	12.7	19.2	13.3	18.3	17.4	22.0	22.4	7.7	9.1	10.7	19.6	13.4	13.6	13.7	14.1	24.4	16.1	14.0	11.1	10.8	17.2	18.3	33.8	13.9	18.6	22.9	19.4	19.7	17.9	18.0	17.3	14.4	14.8	22.3	23.4	16.5	9.9	15.1	16.8	20.7	14.9	14.6	12.6	18.9	12.2	9.8	29.2	14.3	15.3	12.7	21.7	10.4	8.0	16.1	24.3	21.5	23.4	11.1	17.6	11.4	40.6	16.5	18.3	14.6	16.5	14.6	18.5	15.9	13.7	15.1	16.1	12.3	16.0	14.9	16.5	15.3	14.6	21.7	10.6	13.4	12.5	23.1	25.8	12.4	12.5	11.7	14.7	13.0	11.7
C19orf33	"H2RSP, IMUP, IMUP-1, IMUP-2"	ENSG00000167644	"Chromosome 19 open reading frame 33"	Q9GZP8	19	38304161-38305009	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 88.4;intestine: 105.8;tongue: 78.5"	"Cell line enhanced"	"Detected in some"		"A-431: 69.7;A549: 107.5;CAPAN-2: 66.4;HBEC3-KT: 64.5;hTCEpi: 67.5;PC-3: 61.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Cell type enriched"	"Detected in some"	11	"myeloid DC: 15.1"	"Lineage enriched"	"Detected in many"	11	"dendritic cells: 15.1"									"HPA054406, HPA059696"	Uncertain		Supported	"Nucleoplasm,Plasma membrane,Cytosol"				"Nucleoplasm, Cytosol"	"Plasma membrane"	"HPA054406: , HPA059696: "	"unprognostic (9.31e-2)"	"unprognostic (2.06e-1)"	"unprognostic (4.34e-2)"	"unprognostic (1.44e-2)"	"unprognostic (3.92e-3)"	"unprognostic (2.37e-2)"	"unprognostic (9.49e-2)"	"prognostic unfavourable (5.42e-4)"	"unprognostic (2.09e-1)"	"unprognostic (1.74e-2)"	"prognostic unfavourable (5.05e-4)"	"unprognostic (6.92e-2)"	"unprognostic (5.50e-2)"	"unprognostic (4.82e-2)"	"unprognostic (1.61e-1)"	"unprognostic (3.63e-2)"	"unprognostic (6.01e-2)"	6.9	0.6	0.5	16.4	0.7	0.3	5.0	0.5	0.8	14.5	58.8	0.6	3.5	34.6	3.9	4.3	88.4	18.2	45.2	9.9	0.8	0.3	5.8	1.0	34.8	0.6	0.7	1.4	4.9	0.8	0.0	2.0	10.0	1.7	10.3	18.2	1.2	21.5	6.8	2.8	53.3	105.8	2.9	3.1	1.9	28.7	1.5	0.5	1.5	4.4	78.5	39.2	16.2	35.1	0.1	15.1	1.4	0.6	0.3	0.4	14.6	69.7	107.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.4	66.4	0.0	39.9	0.0	26.2	0.0	64.5	0.0	0.0	0.0	0.0	22.6	1.8	0.5	0.0	0.0	0.0	67.5	0.0	43.3	1.1	0.0	0.0	0.0	18.0	0.0	0.1	0.1	61.5	0.0	0.0	0.0	40.8	20.7	0.1	0.0	40.7	29.5	0.0	9.2	0.2	14.6	0.0	20.3	0.0	0.3	0.0	0.1	0.2	0.0	0.0	0.0	1.1	0.6	1.4	0.3	0.0	0.3	0.1	0.2	0.1	15.1	0.1	0.4	0.3	0.9	0.3	0.0	0.9	0.0	14.6	0.5	0.7	0.5	0.8	0.8	0.3	0.7	1.4	1.7	0.5
C19orf48	"BC006151, MGC13170"	ENSG00000167747	"Chromosome 19 open reading frame 48"	Q6RUI8	19	50797704-50804929	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"											HPA042000	Uncertain		Approved	"Plasma membrane"				"Plasma membrane"		"HPA042000: AB_10797377"	"unprognostic (2.25e-1)"	"unprognostic (2.82e-2)"	"unprognostic (5.39e-2)"	"unprognostic (7.92e-2)"	"unprognostic (2.86e-1)"	"unprognostic (1.69e-1)"	"prognostic unfavourable (8.80e-5)"	"unprognostic (6.59e-3)"	"unprognostic (1.84e-3)"	"unprognostic (2.84e-1)"	"unprognostic (1.14e-2)"	"unprognostic (2.97e-1)"	"unprognostic (6.84e-3)"	"unprognostic (1.29e-1)"	"unprognostic (3.67e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.16e-1)"	5.0	9.7	6.5	11.0	6.2	20.7	9.6	7.0	8.9	7.2	9.3	7.0	4.1	6.8	7.8	6.9	13.2	13.5	9.5	4.1	4.0	3.4	7.4	12.0	8.0	22.2	6.8	8.7	13.0	40.7	3.2	4.0	7.5	5.2	32.1	5.8	6.9	8.3	5.6	6.4	15.9	6.4	6.7	5.1	8.8	7.0	19.8	5.0	23.6	17.9	9.1	12.5	5.1	7.3	29.0	20.8	2.8	8.7	12.4	21.6	9.9	21.4	34.2	16.1	10.1	3.1	9.6	14.9	19.4	13.3	28.7	28.7	41.1	20.0	36.8	9.0	7.5	15.3	26.8	27.3	9.9	11.5	64.8	24.5	14.5	23.9	8.7	25.6	12.4	15.7	28.4	29.9	32.6	15.3	26.8	18.4	13.3	18.5	34.3	31.1	12.9	43.7	25.8	26.3	34.9	9.3	35.9	26.6	12.8	19.5	25.3	26.4	14.9	25.2	7.2	13.3	24.6	8.1	26.3	10.8	12.2	30.3	8.1	23.3	17.8	1.0	6.0	2.8	9.9	8.7	14.0	29.0	14.1	11.2	11.8	27.3	21.6	16.1	0.4	12.4	6.3	20.8	14.5	9.9	6.5	6.2	7.0	8.9	4.0	3.4	6.8	8.7	5.2	5.0
C19orf71	LOC100128569	ENSG00000183397	"Chromosome 19 open reading frame 71"	A6NCJ1	19	3539154-3544030	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	9	"testis: 88.8"	"Group enriched"	"Detected in many"	4	"HeLa: 26.7;SK-MEL-30: 16.3;WM-115: 58.2"	"Cancer enriched"	"Detected in all"	5	"melanoma: 23.7"	"Region enriched"	"Detected in all"	4	"cerebellum: 9.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA048654	Uncertain		Approved	"Endoplasmic reticulum,Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"	"Endoplasmic reticulum"	"HPA048654: "	"unprognostic (1.06e-1)"	"unprognostic (1.21e-1)"	"unprognostic (7.04e-3)"	"unprognostic (7.37e-2)"	"unprognostic (4.74e-2)"	"prognostic favourable (2.35e-4)"	"unprognostic (4.21e-1)"	"unprognostic (2.00e-1)"	"unprognostic (7.23e-2)"	"unprognostic (3.13e-2)"	"prognostic favourable (2.03e-5)"	"unprognostic (6.19e-2)"	"prognostic favourable (2.02e-5)"	"unprognostic (5.52e-3)"	"unprognostic (1.02e-1)"	"unprognostic (3.84e-2)"	"unprognostic (1.97e-3)"	1.6	2.3	1.6	4.1	2.2	5.1	1.6	9.8	2.2	1.7	1.6	2.0	1.6	4.7	2.5	1.9	1.6	2.6	1.6	1.6	1.6	1.3	3.5	1.6	2.1	4.9	1.8	1.9	2.8	4.2	0.0	4.5	1.6	1.7	2.2	0.0	1.6	7.6	1.6	1.6	7.4	3.9	1.6	1.6	5.2	3.2	88.8	1.8	1.6	6.3	1.6	1.6	1.7	1.6	0.3	0.5	0.0	0.2	0.0	0.7	0.1	5.2	4.3	1.4	1.9	0.0	0.0	2.9	3.3	0.0	0.0	0.0	2.7	1.6	0.9	2.5	0.0	4.7	0.0	0.2	0.0	5.3	2.5	0.7	26.7	0.8	0.0	0.7	3.3	0.0	0.0	0.1	0.0	0.0	3.6	4.8	0.0	3.7	1.1	1.7	1.2	1.3	1.7	2.1	4.9	0.0	2.1	3.4	3.1	5.8	2.9	16.3	3.3	1.7	4.4	2.6	3.5	8.0	3.0	3.8	1.0	1.3	7.9	3.1	58.2	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.1	0.0	0.6	0.7	0.0	0.0	0.2	0.5	0.0	0.1	1.6	2.2	9.8	2.2	1.6	1.3	1.8	1.9	1.7	1.8
C1orf35	"MGC4174, MMTAG2"	ENSG00000143793	"Chromosome 1 open reading frame 35"	Q9BU76	1	228100726-228105411	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046175	Approved		Approved	"Nuclear speckles,Plasma membrane,Cytosol"				"Nuclear speckles, Plasma membrane"	Cytosol	"HPA046175: AB_10959459"	"unprognostic (1.12e-1)"	"unprognostic (2.91e-1)"	"prognostic unfavourable (7.71e-4)"	"unprognostic (6.41e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.64e-2)"	"unprognostic (5.44e-3)"	"unprognostic (1.81e-1)"	"unprognostic (1.39e-1)"	"prognostic favourable (7.38e-4)"	"unprognostic (6.12e-2)"	"unprognostic (1.39e-1)"	"prognostic unfavourable (1.79e-6)"	"unprognostic (2.70e-1)"	"unprognostic (8.58e-2)"	"unprognostic (5.56e-2)"	"unprognostic (3.70e-2)"	10.1	12.7	14.3	15.6	17.0	12.7	12.0	23.9	15.7	12.5	11.2	11.6	16.1	12.5	13.7	10.6	17.3	14.9	8.1	8.0	13.8	10.0	10.6	10.2	11.0	12.5	17.7	13.6	19.0	21.0	12.5	10.0	12.4	15.0	13.2	6.4	10.4	19.1	16.1	14.0	24.1	11.3	13.3	9.2	12.6	13.2	8.8	13.2	14.6	12.4	6.9	12.0	12.8	13.9	20.2	26.7	21.9	18.4	17.6	21.5	10.3	9.5	10.7	6.8	4.1	3.7	3.8	16.0	7.4	3.4	6.6	4.8	9.6	9.1	9.3	16.0	2.5	10.7	6.4	7.1	2.4	10.6	34.1	5.8	7.4	9.4	6.2	12.9	7.3	3.3	8.5	6.3	6.1	7.2	14.7	5.2	4.9	11.3	17.2	16.5	13.4	24.8	12.2	10.8	15.4	5.7	7.2	12.0	11.3	6.9	11.1	9.5	13.2	12.1	6.3	5.2	7.7	13.7	15.6	9.6	4.9	8.7	6.3	7.6	8.1	6.3	16.3	21.9	16.2	18.4	20.9	20.2	18.1	17.7	20.4	16.7	21.5	18.1	2.2	17.6	17.5	26.7	18.0	10.3	14.3	17.0	23.9	15.7	13.8	10.0	17.7	13.6	15.0	13.2
C1orf54	FLJ23221	ENSG00000118292	"Chromosome 1 open reading frame 54"	Q8WWF1	1	150268200-150280916	"Predicted secreted proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"AF22: 20.5;AN3-CA: 30.9;ASC diff: 22.0;ASC TERT1: 36.7;HSkMC: 29.7;HUVEC TERT2: 28.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	5	"myeloid DC: 36.2"	"Lineage enriched"	"Detected in many"	5	"dendritic cells: 36.2"	"Low region specificity"	"Detected in all"							"HPA026518, HPA043874"	Approved		Approved	"Plasma membrane"	"Secreted to blood"			"Plasma membrane"		"HPA026518: AB_1845647, HPA043874: "	"unprognostic (4.64e-3)"	"unprognostic (6.81e-3)"	"unprognostic (4.01e-3)"	"unprognostic (5.69e-3)"	"unprognostic (2.22e-1)"	"unprognostic (1.72e-1)"	"unprognostic (1.51e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.33e-1)"	"unprognostic (3.45e-1)"	"unprognostic (3.21e-1)"	"prognostic unfavourable (2.43e-4)"	"unprognostic (3.16e-2)"	"unprognostic (8.06e-2)"	"unprognostic (1.33e-2)"	"unprognostic (4.48e-2)"	16.0	8.8	16.4	19.0	19.3	4.5	13.8	5.8	10.5	11.9	14.0	4.5	19.1	5.8	19.8	21.1	11.0	17.1	21.6	13.8	13.7	13.7	12.7	12.0	11.8	21.5	21.8	8.3	8.3	6.8	2.0	6.7	24.4	14.0	15.3	11.1	10.9	9.8	30.4	13.4	4.5	8.1	24.1	20.4	27.3	8.3	5.7	14.8	4.9	8.3	17.1	11.2	22.0	14.3	0.3	36.2	0.4	7.7	0.2	1.5	2.2	0.5	0.1	20.5	30.9	22.0	36.7	0.6	3.3	4.9	0.9	3.0	0.2	0.6	0.1	1.1	2.9	0.8	0.0	0.1	1.1	0.3	3.6	0.5	0.5	0.3	4.5	1.1	0.8	29.7	1.5	6.1	0.4	28.5	0.4	4.0	3.1	1.1	0.2	7.1	1.7	1.1	5.1	0.5	0.4	0.3	1.6	0.4	0.4	0.4	0.2	2.2	0.4	15.5	0.2	7.3	0.6	0.2	0.3	1.7	1.4	0.3	16.2	0.9	0.2	0.0	7.7	0.3	0.2	6.8	0.9	0.3	1.5	0.6	36.2	0.3	1.5	0.8	0.4	0.2	1.9	0.7	0.6	2.2	16.4	19.3	5.8	10.5	13.7	13.7	21.8	8.3	14.0	14.8
C1orf74	"FLJ25078, URLC4"	ENSG00000162757	"Chromosome 1 open reading frame 74"	Q96LT6	1	209779208-209784559	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028496	Uncertain		Approved	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		"HPA028496: AB_10602698"	"unprognostic (3.25e-1)"	"prognostic unfavourable (8.52e-6)"	"unprognostic (8.41e-3)"	"unprognostic (9.96e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.75e-2)"	"unprognostic (9.98e-2)"	"unprognostic (3.82e-2)"	"unprognostic (1.39e-2)"	"unprognostic (4.95e-1)"	"unprognostic (2.81e-1)"	"unprognostic (6.31e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.67e-2)"	"unprognostic (1.07e-1)"	"unprognostic (5.40e-2)"	2.5	3.9	5.7	5.5	8.5	2.3	5.8	10.4	8.9	2.7	3.8	5.8	4.0	3.3	2.3	5.2	10.4	2.8	2.3	4.1	3.7	2.9	4.9	4.1	2.2	9.8	5.1	4.6	2.5	4.5	4.5	6.5	3.4	4.8	4.6	5.2	3.9	5.1	2.7	2.3	15.0	4.1	2.4	4.9	4.9	3.9	3.9	5.0	4.9	3.2	0.0	5.7	3.9	4.7	6.3	5.5	5.9	1.9	2.8	2.9	1.9	5.6	3.0	1.9	1.1	2.6	2.9	4.4	3.2	4.2	3.9	4.1	5.9	4.4	5.9	1.9	2.1	11.4	1.2	9.3	4.6	5.9	3.8	3.9	2.2	0.5	3.6	5.5	1.8	1.7	8.3	4.8	8.0	2.3	7.7	4.3	3.4	2.8	4.6	5.7	7.9	5.1	4.9	9.0	8.3	3.3	4.9	7.6	8.2	4.4	3.4	4.8	5.3	2.9	2.1	3.4	3.9	3.4	5.1	4.0	4.0	6.6	3.0	4.6	4.7	5.9	1.6	1.4	2.9	1.9	2.1	3.8	1.4	2.3	3.2	6.3	2.4	2.8	1.1	2.8	1.0	5.5	1.2	1.9	5.7	8.5	10.4	8.9	3.7	2.9	5.1	4.6	4.8	5.0
C1QBP	"gC1Q-R, gC1qR, HABP1, p32, SF2p32"	ENSG00000108561	"Complement C1q binding protein"	Q07021	17	5432777-5448830	"Cancer-related genes, Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"Adaptive immunity, Apoptosis, Complement pathway, Host-virus interaction, Immunity, Innate immunity, mRNA processing, mRNA splicing, Ribosome biogenesis, Transcription, Transcription regulation"		"Cancer-related genes, Disease mutation, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA026483	Supported		Approved	"Plasma membrane,Mitochondria"	"Intracellular and membrane"		930000	"Plasma membrane"	Mitochondria	"HPA026483: AB_1847108"	"unprognostic (2.18e-1)"	"unprognostic (1.74e-1)"	"unprognostic (3.80e-2)"	"unprognostic (6.40e-2)"	"unprognostic (2.60e-1)"	"unprognostic (6.76e-2)"	"unprognostic (7.47e-2)"	"unprognostic (4.62e-2)"	"unprognostic (2.40e-3)"	"unprognostic (6.03e-2)"	"unprognostic (4.60e-3)"	"unprognostic (3.08e-2)"	"unprognostic (7.80e-3)"	"unprognostic (1.20e-1)"	"unprognostic (3.13e-1)"	"unprognostic (3.28e-1)"	"unprognostic (3.97e-1)"	24.1	51.6	34.0	51.0	31.4	36.3	42.3	25.8	46.2	22.0	48.8	21.1	22.5	33.9	25.8	25.7	51.1	27.1	33.0	47.1	34.8	35.4	48.4	69.0	26.6	81.1	35.4	25.1	25.2	51.9	32.7	31.2	26.7	36.6	23.8	52.2	24.9	25.1	28.0	55.0	27.3	30.0	29.2	27.8	43.8	26.4	21.3	17.2	55.4	28.1	71.9	46.0	25.5	25.4	59.5	68.1	9.9	35.8	39.0	55.6	65.7	48.8	76.0	26.9	43.4	20.1	24.8	36.4	37.5	30.7	87.4	53.8	72.7	16.4	105.0	37.1	28.3	43.8	86.4	50.9	80.9	24.0	148.7	48.3	39.5	84.5	32.1	58.9	38.5	27.4	46.8	48.0	69.5	44.5	57.4	26.9	33.9	34.1	83.6	42.6	60.6	45.5	66.7	38.1	57.3	50.4	37.0	21.6	40.5	30.8	39.6	52.2	25.0	29.8	26.1	28.1	25.6	31.9	81.4	14.1	21.5	46.2	26.8	56.7	43.0	9.9	34.7	8.3	40.1	35.8	52.5	59.5	45.0	39.9	68.1	49.4	55.6	46.3	2.8	39.0	26.9	56.9	34.3	65.7	34.0	31.4	25.8	46.2	34.8	35.4	35.4	25.1	36.6	17.2
C2orf72	LOC257407	ENSG00000204128	"Chromosome 2 open reading frame 72"	A6NCS6	2	231037490-231049719	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 22.5;placenta: 23.9"	"Cell line enhanced"	"Detected in some"		"BEWO: 13.1;CACO-2: 3.0;EFO-21: 4.9;SH-SY5Y: 2.2"	"Cancer enhanced"	"Detected in many"		"liver cancer: 40.4"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044962	Approved		Approved	"Nucleoplasm,Plasma membrane"				"Nucleoplasm, Plasma membrane"		"HPA044962: AB_10960863"	"unprognostic (4.90e-2)"	"unprognostic (7.03e-2)"	"unprognostic (2.15e-1)"	"unprognostic (7.44e-3)"	"unprognostic (2.88e-2)"	"unprognostic (6.41e-2)"	"unprognostic (3.38e-1)"	"unprognostic (6.51e-2)"	"unprognostic (6.25e-3)"	"unprognostic (1.84e-1)"	"prognostic favourable (5.27e-4)"	"unprognostic (2.65e-1)"	"prognostic unfavourable (4.74e-4)"	"unprognostic (2.78e-1)"	"unprognostic (7.23e-3)"	"unprognostic (2.70e-2)"	"unprognostic (5.19e-2)"	1.0	0.9	6.5	0.9	8.4	0.8	1.6	1.7	10.1	0.8	7.8	9.9	0.0	2.3	0.8	1.1	0.9	0.9	1.8	0.8	7.7	4.7	1.4	22.5	1.2	0.8	5.1	7.9	0.8	6.1	1.7	1.7	23.9	8.2	2.0	2.5	0.8	1.0	0.9	0.8	0.8	2.6	1.0	2.2	0.8	4.2	0.9	5.9	0.0	0.8	0.0	0.8	0.8	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.6	0.0	0.0	0.0	13.1	0.0	0.0	0.1	0.0	3.0	0.0	0.0	4.9	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.0	0.1	0.0	0.0	0.3	0.0	0.0	0.1	2.2	0.1	1.5	0.8	0.9	0.0	0.0	0.0	0.8	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.5	8.4	1.7	10.1	7.7	4.7	5.1	7.9	8.2	5.9
C3orf14	HT021	ENSG00000114405	"Chromosome 3 open reading frame 14"	Q9HBI5	3	62318973-62336213	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"MCF7: 105.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"non-classical monocyte: 21.0"	"Low lineage specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			HPA048286	Approved		Approved	"Plasma membrane,Cytosol"				"Plasma membrane"	Cytosol	"HPA048286: "	"unprognostic (8.00e-2)"	"unprognostic (1.32e-1)"	"unprognostic (7.81e-2)"	"unprognostic (3.69e-3)"	"unprognostic (6.91e-2)"	"unprognostic (9.19e-2)"	"unprognostic (5.76e-5)"	"unprognostic (1.57e-3)"	"unprognostic (2.67e-1)"	"unprognostic (9.61e-2)"	"unprognostic (1.08e-1)"	"unprognostic (3.67e-1)"	"prognostic favourable (4.33e-5)"	"unprognostic (8.19e-2)"	"unprognostic (1.73e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.59e-1)"	3.8	14.7	28.2	5.6	23.6	1.0	35.0	16.4	31.2	5.0	3.9	7.7	2.5	3.3	5.5	6.8	11.0	4.1	6.8	4.6	20.9	22.0	9.6	2.9	6.4	5.0	19.9	20.5	8.2	6.3	2.3	19.0	4.8	25.9	17.8	4.1	4.1	5.0	5.6	1.0	12.0	2.7	6.8	15.2	3.0	6.1	20.9	8.1	1.2	9.2	3.8	8.2	13.5	3.4	3.7	6.7	5.2	21.0	0.7	6.1	2.1	0.0	5.7	6.9	0.0	5.0	7.3	5.3	9.3	5.6	11.8	11.7	0.0	8.4	0.0	0.0	6.3	1.5	0.0	5.9	9.1	0.0	3.9	5.1	0.0	0.0	3.4	0.0	11.0	3.3	8.0	13.3	10.9	5.7	0.6	0.0	11.6	105.2	0.0	0.0	8.7	11.8	0.0	0.0	2.8	9.6	16.0	12.1	10.2	6.2	22.3	8.6	9.0	5.7	0.1	5.8	0.0	26.9	9.3	5.7	0.0	0.0	5.6	0.0	20.2	5.2	4.3	0.4	0.2	14.3	0.1	3.7	3.6	2.8	4.6	1.1	1.0	0.7	0.3	0.7	21.0	6.7	6.1	2.1	28.2	23.6	16.4	31.2	20.9	22.0	19.9	20.5	25.9	8.1
C3orf38	MGC26717	ENSG00000179021	"Chromosome 3 open reading frame 38"	Q5JPI3	3	88149743-88168729	"Predicted intracellular proteins"	Apoptosis			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-2197: 58.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034736, HPA034737"	Approved		Approved	"Nucleoplasm,Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"	Nucleoplasm	"HPA034736: , HPA034737: AB_10671505"	"unprognostic (1.93e-1)"	"unprognostic (1.40e-1)"	"unprognostic (3.75e-3)"	"unprognostic (1.48e-2)"	"unprognostic (1.74e-2)"	"unprognostic (2.41e-2)"	"unprognostic (2.26e-3)"	"unprognostic (1.54e-1)"	"unprognostic (1.80e-2)"	"prognostic favourable (3.55e-4)"	"unprognostic (9.28e-3)"	"prognostic unfavourable (4.12e-4)"	"unprognostic (1.95e-2)"	"unprognostic (2.88e-3)"	"unprognostic (1.63e-1)"	"unprognostic (4.57e-2)"	"unprognostic (3.67e-2)"	12.2	11.7	13.7	12.8	16.1	35.2	12.3	12.9	12.8	11.6	11.9	13.6	8.4	9.5	11.5	10.7	14.6	10.7	9.4	9.7	11.3	11.1	10.2	13.5	10.6	19.2	15.1	9.4	12.1	9.3	7.1	15.8	12.5	11.4	11.2	11.2	9.0	10.6	10.2	9.7	11.6	11.4	10.9	11.3	17.0	10.1	33.2	13.5	29.5	11.6	9.0	17.1	12.4	11.6	20.0	17.7	25.8	24.2	17.1	17.4	15.3	6.3	6.6	12.9	6.9	8.6	7.8	5.9	10.3	12.3	15.3	20.8	7.5	8.7	8.5	9.2	9.4	4.6	9.3	7.5	13.2	15.2	4.4	10.4	5.1	6.4	12.3	14.2	9.0	11.2	7.6	10.3	8.8	8.8	6.6	9.7	16.6	7.3	14.3	6.0	15.6	7.4	9.0	4.5	8.0	10.1	8.6	3.9	5.7	9.4	5.1	15.4	9.9	10.8	8.0	9.6	10.4	58.0	11.3	9.0	13.3	12.6	7.4	11.3	8.9	25.8	16.8	17.5	13.5	24.2	17.4	20.0	12.6	13.8	17.7	15.9	12.6	12.8	7.5	17.1	19.7	12.3	15.1	15.3	13.7	16.1	12.9	12.8	11.3	11.1	15.1	9.4	11.4	13.5
C4orf22		ENSG00000197826	"Chromosome 4 open reading frame 22"	Q6V702	4	80335720-80963756	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 22.0;fallopian tube: 19.8;testis: 34.8"	"Cell line enhanced"	"Detected in some"		"A-431: 3.5;ASC TERT1: 2.1;BJ: 4.5;LHCN-M2: 2.7;SCLC-21H: 3.0;U-251 MG: 2.9;U-87 MG: 2.1"	"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	5	"basal ganglia: 8.4;pons and medulla: 22.0"	"Cell type enhanced"	"Detected in some"		"memory B-cell: 1.2;naive B-cell: 2.1"	"Lineage enhanced"	"Detected in single"		"B-cells: 2.1"	"Low region specificity"	"Detected in many"							HPA043383	Approved		Approved	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		"HPA043383: AB_10797140"	"unprognostic (4.77e-4)"	"unprognostic (1.52e-1)"		"unprognostic (4.06e-2)"	"unprognostic (1.45e-2)"			"unprognostic (7.24e-2)"		"unprognostic (3.27e-1)"	"unprognostic (6.93e-2)"	"unprognostic (5.90e-2)"	"unprognostic (2.67e-3)"	"unprognostic (1.47e-1)"	"unprognostic (2.79e-1)"	"unprognostic (1.79e-2)"	"unprognostic (4.61e-2)"	0.1	0.1	1.4	0.1	8.4	0.1	0.3	0.6	0.2	0.9	0.1	5.1	0.1	0.3	0.4	7.8	0.2	19.8	0.3	0.1	2.8	2.5	0.4	0.1	5.9	0.3	0.1	0.1	3.5	0.1	0.1	1.2	0.1	22.0	0.2	0.1	0.3	0.2	0.2	0.1	0.2	0.1	0.2	0.4	0.1	0.1	34.8	2.4	2.9	0.7	0.0	0.2	0.1	0.0	2.1	0.5	0.1	0.0	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.3	2.1	0.0	4.5	0.8	0.1	0.2	0.0	0.0	1.3	0.0	1.5	0.0	0.0	0.2	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	2.9	0.0	0.0	1.2	2.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	2.1	0.0	0.0	0.1	0.0	0.0	0.5	0.0	0.0	1.4	8.4	0.6	0.2	2.8	2.5	0.1	0.1	22.0	2.4
C7orf43	FLJ10925	ENSG00000146826	"Chromosome 7 open reading frame 43"	Q8WVR3	7	100154420-100158715	"Predicted intracellular proteins"			"Disease mutation, Primary microcephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019359, HPA029463, HPA029464"	Approved		Enhanced	"Vesicles,Plasma membrane,Centriolar satellite"				Vesicles	"Plasma membrane, Centriolar satellite"	"HPA019359: AB_1848677, HPA029463: AB_10600001, HPA029464: AB_10600205"	"unprognostic (1.57e-2)"	"unprognostic (1.24e-1)"	"unprognostic (6.19e-3)"	"unprognostic (2.59e-1)"	"unprognostic (5.23e-2)"	"unprognostic (1.06e-1)"	"unprognostic (9.36e-3)"	"unprognostic (5.68e-3)"	"unprognostic (6.97e-3)"	"unprognostic (1.25e-1)"	"prognostic favourable (6.19e-5)"	"unprognostic (2.42e-2)"	"unprognostic (1.85e-2)"	"unprognostic (4.26e-2)"	"unprognostic (2.81e-1)"	"unprognostic (3.26e-1)"	"unprognostic (6.54e-3)"	7.0	10.4	10.6	23.0	11.3	12.2	12.2	24.8	23.2	6.7	14.0	9.4	13.6	16.2	9.6	10.8	12.1	8.4	10.5	6.4	12.8	13.9	12.3	12.9	19.0	21.4	10.8	10.6	5.7	11.6	18.7	14.5	21.6	14.6	10.2	13.5	8.8	13.5	10.8	10.1	28.1	16.4	6.9	6.0	25.8	14.9	26.8	6.9	17.6	12.2	7.4	14.0	8.5	7.8	2.1	0.7	5.2	1.7	0.5	2.6	1.0	4.8	6.2	7.3	12.3	4.6	2.5	8.2	9.0	7.1	6.2	4.6	4.8	5.7	6.1	8.3	6.8	9.3	3.5	7.1	2.4	11.4	6.7	4.5	7.8	4.2	5.5	5.7	21.4	5.1	4.9	6.1	4.7	5.4	9.9	11.1	8.1	14.9	12.8	12.2	8.2	9.0	7.7	3.3	6.8	5.4	5.5	9.3	9.9	8.0	23.5	4.8	4.8	6.9	7.5	12.4	10.6	16.5	6.9	16.6	15.6	6.1	7.0	7.8	13.2	1.7	1.0	3.5	2.0	1.6	1.4	0.9	2.6	1.8	0.7	2.1	1.5	2.2	5.2	0.5	1.7	0.6	0.2	1.0	10.6	11.3	24.8	23.2	12.8	13.9	10.8	10.6	14.6	6.9
C8orf37	"BBS21, CORD16, FLJ30600, RP64"	ENSG00000156172	"Chromosome 8 open reading frame 37"	Q96NL8	8	95244919-95269201	"Disease related genes, Predicted intracellular proteins"			"Bardet-Biedl syndrome, Ciliopathy, Cone-rod dystrophy, Disease mutation, Obesity, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA024198	Approved		Approved	"Plasma membrane,Cell Junctions,Cytosol"				Cytosol	"Plasma membrane, Cell Junctions"	"HPA024198: AB_1845775"	"unprognostic (7.90e-2)"	"unprognostic (1.98e-2)"	"unprognostic (5.68e-2)"	"prognostic unfavourable (4.63e-4)"	"unprognostic (2.72e-3)"	"unprognostic (4.20e-3)"	"unprognostic (2.04e-2)"	"unprognostic (8.94e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.76e-1)"	"unprognostic (6.11e-3)"	"unprognostic (2.32e-1)"	"unprognostic (1.09e-1)"	"unprognostic (6.72e-3)"	"unprognostic (2.02e-1)"	"unprognostic (1.33e-2)"	"unprognostic (3.29e-1)"	4.8	5.6	7.9	5.8	9.9	2.4	6.4	9.8	8.0	6.7	3.1	10.5	2.9	2.6	6.5	8.6	3.3	10.5	4.0	7.0	8.7	7.1	6.6	4.9	4.3	5.6	7.4	6.9	13.0	3.8	10.1	9.9	4.9	7.9	5.6	2.8	4.6	4.3	7.1	2.9	4.2	3.3	6.2	9.2	4.4	3.2	4.5	9.5	3.8	6.7	1.6	5.1	4.0	4.4	3.9	1.9	2.3	1.4	2.7	2.3	0.8	4.1	6.7	5.6	2.9	2.0	5.2	1.6	1.8	4.1	2.4	3.1	1.0	9.1	8.3	4.4	3.0	3.4	2.3	4.6	5.2	2.6	2.1	6.5	4.1	3.0	2.2	1.4	3.6	5.2	2.2	2.8	7.8	3.5	3.3	4.9	3.0	3.2	6.9	1.6	1.8	4.6	3.6	3.0	2.1	5.2	1.8	5.4	5.3	3.7	0.8	3.1	6.5	1.3	3.0	2.9	3.8	2.5	1.8	4.5	4.3	5.6	5.6	3.1	3.6	1.3	1.4	0.6	1.2	0.9	2.1	1.9	1.4	1.3	1.9	3.9	1.4	2.3	2.3	2.7	0.7	0.9	0.5	0.8	7.9	9.9	9.8	8.0	8.7	7.1	7.4	6.9	7.9	9.5
CA14		ENSG00000118298	"Carbonic anhydrase 14"	Q9ULX7	1	150257159-150265078	"Enzymes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins"		Lyase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 20.9;retina: 29.4;seminal vesicle: 16.5;skeletal muscle: 24.1"	"Group enriched"	"Detected in some"	18	"AF22: 28.0;AN3-CA: 16.6;NTERA-2: 21.8;SK-MEL-30: 55.8"	"Group enriched"	"Detected in many"	7	"glioma: 4.9;melanoma: 23.2"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA008482	Approved		Approved	"Plasma membrane"				"Plasma membrane"		"HPA008482: AB_1078395"	"unprognostic (3.06e-2)"	"unprognostic (1.67e-1)"	"unprognostic (2.10e-2)"	"unprognostic (3.25e-2)"	"prognostic favourable (8.47e-4)"	"unprognostic (7.28e-2)"	"unprognostic (4.48e-2)"	"unprognostic (1.49e-1)"	"unprognostic (2.10e-1)"	"unprognostic (2.47e-1)"	"unprognostic (5.46e-2)"	"unprognostic (1.73e-1)"	"unprognostic (5.89e-3)"	"unprognostic (1.91e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.22e-1)"	"unprognostic (5.80e-2)"	0.1	0.3	4.6	0.2	5.2	0.9	0.3	1.4	6.8	0.1	1.7	10.8	0.1	0.3	0.1	0.5	1.6	1.3	0.7	4.4	6.4	4.1	0.3	6.3	0.2	0.2	11.3	3.2	1.4	0.3	0.8	0.1	0.3	4.4	3.2	0.7	29.4	0.6	16.5	24.1	3.7	0.6	0.5	20.9	0.3	0.8	0.5	2.7	0.1	0.9	0.1	0.1	0.2	0.1	2.8	2.2	2.1	2.0	0.2	1.6	0.2	0.2	0.0	28.0	16.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.1	0.1	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	21.8	0.2	0.0	0.0	0.0	0.0	0.0	0.7	0.4	0.0	0.1	55.8	0.2	0.1	0.0	0.0	0.0	0.0	0.1	0.2	1.2	0.1	0.1	0.1	0.0	0.0	0.9	1.3	1.6	2.0	0.6	2.0	1.0	1.2	0.2	2.8	1.2	1.3	2.1	0.2	0.5	2.2	0.0	0.2	4.6	5.2	1.4	4.7	6.4	4.1	11.3	3.2	4.4	2.7
CACNA1E	"BII, CACH6, CACNL1A6, Cav2.3"	ENSG00000198216	"Calcium voltage-gated channel subunit alpha1 E"	Q15878	1	181317690-181808084	"FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Voltage-gated ion channels"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Ion channel, Voltage-gated channel"	"Disease mutation, Epilepsy, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"brain: 30.8"	"Cell line enhanced"	"Detected in some"		"CACO-2: 4.0;NB-4: 2.5;NTERA-2: 2.9;SCLC-21H: 2.3;U-266/70: 7.0"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	8	"neutrophil: 1.8"	"Lineage enriched"	"Detected in single"	8	"granulocytes: 1.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042515, CAB079032"		Approved	Approved	"Plasma membrane,Actin filaments,Cytosol"				"Plasma membrane"	"Actin filaments, Cytosol"	"CAB079032: , HPA042515: "	"unprognostic (3.96e-3)"	"unprognostic (1.89e-1)"	"unprognostic (1.05e-2)"	"unprognostic (1.54e-5)"	"unprognostic (6.56e-2)"	"unprognostic (3.16e-2)"	"unprognostic (4.30e-3)"	"unprognostic (1.18e-1)"	"unprognostic (2.40e-1)"	"unprognostic (9.48e-3)"	"unprognostic (1.04e-1)"	"unprognostic (2.06e-1)"	"unprognostic (9.85e-7)"	"unprognostic (1.74e-2)"	"unprognostic (2.07e-2)"	"unprognostic (1.16e-1)"	"unprognostic (3.75e-2)"	0.6	3.0	17.9	2.1	19.7	3.1	0.5	3.9	22.5	0.6	0.8	1.3	0.0	0.6	0.6	4.4	1.1	2.3	0.6	0.6	30.8	5.8	3.8	0.6	0.6	1.4	2.4	10.6	0.5	0.6	0.5	0.2	0.8	4.2	0.5	0.8	0.5	0.5	0.5	0.6	0.5	1.1	1.0	5.2	0.9	0.8	2.8	2.4	0.0	0.6	0.0	1.0	0.6	0.1	0.2	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.0	0.0	1.4	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	2.9	0.0	0.0	0.0	1.0	1.3	0.0	2.3	0.1	0.0	0.0	0.0	0.0	0.8	0.0	0.1	0.1	0.0	0.0	7.0	0.0	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	17.9	19.7	3.9	22.5	30.8	5.8	2.4	10.6	4.2	2.4
CALML5	CLSP	ENSG00000178372	"Calmodulin like 5"	Q9NZT1	10	5498697-5499555	"Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	9	"salivary gland: 129.5;skin 1: 212.5"	"Cell line enriched"	"Detected in some"	21	"A-431: 92.9"	"Group enriched"	"Detected in many"	6	"breast cancer: 97.6;cervical cancer: 189.1;head and neck cancer: 206.0;melanoma: 222.1;urothelial cancer: 82.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			HPA040725	Enhanced		Approved	"Plasma membrane,Cytosol"			75000000	"Plasma membrane, Cytosol"		"HPA040725: AB_10793863"	"unprognostic (7.68e-3)"	"unprognostic (5.06e-3)"		"unprognostic (5.64e-2)"		"prognostic favourable (2.59e-5)"		"unprognostic (4.82e-2)"	"unprognostic (2.67e-1)"	"unprognostic (1.37e-1)"	"unprognostic (8.27e-2)"	"unprognostic (1.14e-1)"		"unprognostic (2.79e-1)"	"unprognostic (1.71e-1)"		"unprognostic (4.99e-2)"	0.2	0.0	0.2	0.2	0.2	0.0	8.0	0.3	0.2	6.7	0.2	0.2	0.2	0.0	1.0	0.2	4.8	0.0	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2	0.0	0.2	129.5	0.2	1.8	212.5	0.2	0.2	0.2	0.2	0.0	0.2	0.2	3.1	0.2	10.9	8.2	0.2	19.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	92.9	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.3	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.3	0.2	0.2	0.0	0.2	0.2	0.2	0.2
CAMK2A	"CAMKA, CaMKIINalpha, KIAA0968"	ENSG00000070808	"Calcium/calmodulin dependent protein kinase II alpha"	Q9UQM7	5	150219491-150290291	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Calmodulin-binding, Kinase, Serine/threonine-protein kinase, Transferase"	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	21	"brain: 105.7;skeletal muscle: 50.1"	"Cell line enhanced"	"Detected in some"		"HaCaT: 2.6;SCLC-21H: 9.5;U-87 MG: 8.0"	"Cancer enriched"	"Detected in single"	13	"glioma: 6.0"	"Group enriched"	"Detected in all"	6	"amygdala: 60.7;basal ganglia: 50.6;cerebral cortex: 99.6;hippocampal formation: 74.6;olfactory region: 39.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in all"	4	"amygdala: 1311.6;basal ganglia: 698.1;cerebral cortex: 1576.4;hippocampal formation: 1569.1"	"Low region specificity"	"Detected in all"			"CAB004330, HPA051783, HPA051785, HPA053973"	Supported		Approved	"Plasma membrane,Cell Junctions,Cytosol"			21000	"Plasma membrane"	"Cell Junctions, Cytosol"	"CAB004330: AB_626788, HPA051783: , HPA051785: , HPA053973: "	"unprognostic (7.20e-3)"	"unprognostic (6.47e-3)"	"unprognostic (6.16e-3)"	"unprognostic (4.85e-2)"	"unprognostic (4.25e-2)"	"unprognostic (1.06e-3)"	"unprognostic (1.13e-1)"	"unprognostic (6.19e-3)"	"unprognostic (3.07e-1)"	"unprognostic (1.05e-1)"	"unprognostic (4.49e-2)"	"unprognostic (1.41e-2)"	"unprognostic (2.00e-8)"	"unprognostic (2.71e-4)"	"unprognostic (1.68e-1)"	"unprognostic (1.70e-2)"	"unprognostic (1.36e-3)"	1.3	1.7	60.7	1.3	50.6	1.3	1.1	1.4	105.7	1.8	1.3	3.7	0.0	1.2	2.1	1.4	1.9	1.7	1.3	3.7	74.6	10.5	1.6	1.2	1.5	1.2	5.1	39.8	1.3	1.1	1.1	0.4	1.3	2.4	1.6	1.3	0.0	1.2	1.4	50.1	1.6	1.3	2.5	1.7	1.2	1.3	1.2	2.3	0.0	1.2	0.0	1.1	1.4	0.1	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.6	0.5	0.0	0.0	0.6	0.0	0.5	1.3	0.8	0.7	0.0	0.1	0.0	0.2	0.6	2.6	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.4	0.1	0.0	0.2	0.5	0.2	1.7	0.0	0.0	0.0	0.7	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.5	0.2	0.0	0.0	9.5	0.0	0.1	0.2	0.2	0.0	0.1	0.0	0.0	0.3	0.0	0.1	0.2	0.1	0.0	8.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	60.7	50.6	1.4	99.6	74.6	10.5	5.1	39.8	2.4	2.3
CAMK2D	CAMKD	ENSG00000145349	"Calcium/calmodulin dependent protein kinase II delta"	Q13557	4	113451032-113761927	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Calmodulin-binding, Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 66.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026281, HPA051783, HPA051785, HPA053973"	Approved		Approved	"Plasma membrane,Cell Junctions,Cytosol"			140000	"Plasma membrane"	"Cell Junctions, Cytosol"	"HPA026281: AB_1845944, HPA051783: , HPA051785: , HPA053973: "	"unprognostic (2.14e-2)"	"unprognostic (3.17e-1)"	"unprognostic (2.13e-1)"	"unprognostic (7.49e-2)"	"unprognostic (2.19e-1)"	"unprognostic (5.09e-1)"	"unprognostic (4.26e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.26e-1)"	"unprognostic (2.62e-1)"	"unprognostic (7.81e-2)"	"unprognostic (7.91e-3)"	"unprognostic (2.62e-2)"	"unprognostic (1.46e-1)"	"unprognostic (9.68e-2)"	"unprognostic (1.87e-1)"	"unprognostic (1.90e-2)"	22.8	12.9	47.7	18.3	13.0	2.8	23.5	50.2	30.6	11.0	18.2	7.4	28.6	13.6	11.6	9.4	15.6	9.6	14.8	77.1	17.9	21.4	9.6	17.6	14.7	17.5	14.0	23.8	12.9	7.4	33.7	7.0	9.3	12.5	16.3	19.0	9.9	9.4	48.3	48.5	10.8	19.2	26.2	16.0	8.4	17.6	9.4	8.5	11.2	11.6	9.8	14.5	21.5	22.6	18.5	11.2	0.6	8.8	6.4	9.7	5.2	1.0	14.3	15.8	5.3	34.6	66.2	5.6	33.5	22.4	13.2	11.4	9.6	4.0	20.5	4.9	23.3	0.5	9.8	5.2	13.5	7.8	2.5	0.0	5.2	11.0	17.5	0.0	0.0	42.3	7.2	10.2	25.3	11.7	0.8	9.2	24.8	3.8	2.0	0.8	2.2	5.3	4.0	18.5	0.1	13.5	9.7	4.3	4.3	4.5	6.8	4.5	0.1	5.5	7.0	34.9	8.2	14.8	6.6	7.1	3.6	17.6	18.0	1.2	16.4	0.0	8.8	0.0	5.1	5.1	9.7	8.0	5.0	5.6	11.2	18.5	5.8	4.9	0.6	6.4	1.7	0.0	9.3	5.2	47.7	13.0	50.2	25.6	17.9	21.4	14.0	23.8	12.5	8.5
CAMK2G	CAMKG	ENSG00000148660	"Calcium/calmodulin dependent protein kinase II gamma"	Q13555	10	73812501-73874591	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Differentiation, Neurogenesis"	"Calmodulin-binding, Developmental protein, Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 73.0"	"Cell line enhanced"	"Detected in all"		"PC-3: 45.4;SK-BR-3: 57.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Lineage enriched"	"Detected in all"	4	"granulocytes: 39.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040656, HPA051783, HPA051785, HPA053973"	Approved		Approved	"Plasma membrane,Cell Junctions,Cytosol"			170000	"Plasma membrane"	"Cell Junctions, Cytosol"	"HPA040656: , HPA051783: , HPA051785: , HPA053973: "	"unprognostic (8.63e-3)"	"unprognostic (2.01e-1)"	"unprognostic (1.05e-1)"	"unprognostic (3.46e-3)"	"unprognostic (4.27e-2)"	"unprognostic (1.82e-2)"	"unprognostic (2.19e-2)"	"unprognostic (2.36e-1)"	"unprognostic (2.48e-1)"	"unprognostic (6.25e-2)"	"unprognostic (2.92e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.73e-2)"	"unprognostic (2.48e-1)"	"unprognostic (8.28e-2)"	"unprognostic (9.64e-2)"	"unprognostic (4.62e-2)"	9.1	8.8	27.4	9.4	20.7	17.4	6.8	22.2	53.8	9.0	37.3	13.3	9.7	19.7	20.1	9.1	20.6	13.2	10.6	6.7	22.8	24.4	11.6	5.9	10.7	8.9	26.8	31.2	6.4	5.7	8.0	6.0	15.8	38.6	18.5	15.5	8.5	12.4	29.8	73.0	9.1	18.1	29.6	29.8	11.0	14.2	3.8	13.4	4.4	6.4	7.6	8.7	26.5	10.8	4.2	7.1	39.8	5.6	9.8	9.2	5.0	10.9	7.9	7.1	13.6	5.2	8.6	8.4	7.5	12.9	10.4	8.5	12.2	11.8	8.1	7.9	9.7	17.0	5.6	6.4	8.3	7.3	6.7	5.5	6.1	5.5	2.6	7.5	9.3	4.5	5.8	10.3	7.2	8.8	6.0	12.1	5.7	7.6	12.5	11.2	5.2	45.4	11.4	7.5	4.3	5.4	15.9	3.7	8.6	4.3	57.2	3.7	10.7	4.7	10.8	7.7	12.4	4.2	10.1	3.7	4.4	7.5	8.3	21.5	2.7	8.5	5.6	39.8	7.5	2.3	9.2	4.2	8.4	8.0	7.1	3.9	8.1	7.9	36.4	9.8	4.0	2.4	8.1	5.0	27.4	20.7	22.2	53.8	22.8	24.4	26.8	31.2	38.6	13.4
CAP2		ENSG00000112186	"Cyclase associated actin cytoskeleton regulatory protein 2"	P40123	6	17393216-17557792	"Cancer-related genes, Predicted intracellular proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"skeletal muscle: 165.7"	"Cell line enhanced"	"Detected in many"		"LHCN-M2: 33.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	4	"MAIT T-cell: 2.9"	"Lineage enriched"	"Detected in single"	29	"T-cells: 2.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA050530, HPA054147"	Enhanced		Approved	"Nucleoplasm,Plasma membrane,Cytosol"				"Nucleoplasm, Cytosol"	"Plasma membrane"	"HPA050530: AB_2681159, HPA054147: AB_2682400"	"unprognostic (7.27e-2)"	"unprognostic (5.71e-3)"	"unprognostic (1.63e-2)"	"unprognostic (1.55e-1)"	"unprognostic (4.86e-1)"	"unprognostic (2.23e-2)"	"unprognostic (9.94e-2)"	"unprognostic (3.58e-2)"	"unprognostic (7.72e-2)"	"unprognostic (1.65e-1)"	"unprognostic (6.43e-2)"	"unprognostic (2.30e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.06e-2)"	"unprognostic (1.47e-1)"	"unprognostic (8.05e-2)"	"unprognostic (1.75e-3)"	5.8	4.1	13.8	3.0	20.1	0.7	3.9	7.5	26.4	5.6	7.7	1.9	2.0	1.9	9.2	5.9	7.0	5.8	3.8	31.2	19.9	8.7	3.3	2.0	2.1	1.1	5.3	17.3	2.1	1.6	3.2	1.7	6.2	8.6	8.4	3.6	2.9	2.5	10.1	165.7	0.9	2.6	13.1	2.0	1.6	3.3	1.1	1.3	0.0	2.3	14.5	1.3	4.6	6.4	0.0	0.0	0.0	0.0	0.0	2.9	0.1	5.4	8.4	16.3	19.6	0.1	0.0	3.5	19.3	14.1	15.9	14.5	2.8	2.4	0.0	18.2	20.7	2.8	7.2	7.2	23.0	0.0	2.7	0.0	5.4	9.2	1.5	0.0	0.0	1.2	3.5	8.0	3.5	0.7	0.0	0.0	33.5	8.7	0.0	0.0	6.2	4.8	1.8	21.7	0.3	8.3	2.2	2.1	4.1	6.5	21.0	11.4	23.2	3.9	0.0	12.9	12.3	0.3	16.9	0.0	0.0	0.0	4.2	0.0	17.5	0.0	0.0	0.0	0.1	0.0	2.9	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	13.8	20.1	7.5	26.4	19.9	8.7	5.3	17.3	8.6	1.3
CAPS	"CAPS1, MGC126562"	ENSG00000105519	Calcyphosine		19	5911707-5915877	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"				"Tissue enhanced"	"Detected in many"		"brain: 71.4;fallopian tube: 116.0"	"Cell line enhanced"	"Detected in many"		"SK-BR-3: 36.0;U-266/70: 10.0"	"Cancer enriched"	"Detected in all"	5	"endometrial cancer: 171.3"	"Region enhanced"	"Detected in all"		"pons and medulla: 71.4"	"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in many"			HPA043520	Enhanced		Approved	"Nucleoplasm,Plasma membrane,Cytosol"				"Plasma membrane"	"Nucleoplasm, Cytosol"	"HPA043520: AB_10964138"	"unprognostic (2.06e-1)"	"unprognostic (1.13e-2)"	"unprognostic (7.94e-3)"	"prognostic favourable (7.63e-5)"	"unprognostic (5.18e-1)"	"prognostic favourable (8.60e-4)"	"unprognostic (7.07e-2)"	"unprognostic (2.46e-3)"	"unprognostic (1.51e-1)"	"unprognostic (1.82e-1)"	"unprognostic (4.70e-2)"	"unprognostic (9.99e-2)"	"unprognostic (4.01e-2)"	"unprognostic (8.47e-2)"	"unprognostic (3.25e-1)"	"unprognostic (6.86e-3)"	"unprognostic (5.96e-3)"	2.6	4.1	8.0	4.3	14.7	4.3	2.8	1.4	3.3	12.4	3.3	34.4	15.6	3.1	9.1	49.4	2.8	116.0	13.6	2.0	13.4	6.6	8.9	5.0	25.4	4.4	8.0	7.8	26.7	6.5	2.5	7.5	17.7	71.4	9.4	2.0	3.3	7.7	12.7	2.0	5.7	5.0	2.9	7.5	7.6	9.4	2.1	17.9	0.4	7.8	0.9	2.5	8.8	11.3	4.9	4.0	5.2	2.2	5.3	4.8	2.4	1.0	1.1	0.7	3.4	1.3	1.8	2.1	0.5	0.4	0.2	0.3	0.8	7.4	0.8	2.2	0.9	1.3	0.3	0.3	0.1	2.4	1.0	0.6	2.2	2.0	1.2	0.6	1.8	2.2	2.1	0.2	0.5	0.5	0.5	2.9	0.4	2.1	1.4	2.0	0.6	5.6	1.7	0.3	2.3	1.0	3.1	0.7	2.5	0.5	36.0	3.6	2.2	2.3	1.0	0.6	0.4	2.6	9.5	10.0	3.4	0.6	4.2	1.0	1.4	3.3	2.2	1.6	4.8	1.8	2.6	3.1	3.0	3.6	2.1	4.9	2.4	2.0	5.2	5.3	1.6	4.0	3.2	2.4	8.0	14.7	1.4	3.3	13.4	6.6	8.0	7.8	71.4	17.9
CASP4	"ICE(rel)II, ICH-2, TX"	ENSG00000196954	"Caspase 4"	P49662	11	104942866-104969436	"Cancer-related genes, Enzymes, Predicted intracellular proteins"	"Immunity, Inflammatory response, Innate immunity, Necrosis"	"Hydrolase, Protease, Thiol protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"blood: 82.8"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"HPA027588, CAB037167"	Approved		Approved	"Plasma membrane,Cytosol"	"Intracellular and membrane"			Cytosol	"Plasma membrane"	"CAB037167: AB_258864, HPA027588: AB_10603781"	"unprognostic (1.19e-2)"	"unprognostic (3.73e-1)"	"unprognostic (3.44e-1)"	"unprognostic (1.99e-2)"	"unprognostic (7.19e-3)"	"unprognostic (2.63e-2)"	"unprognostic (1.26e-2)"	"unprognostic (1.56e-2)"	"unprognostic (5.31e-2)"	"unprognostic (2.71e-1)"	"unprognostic (2.38e-3)"	"unprognostic (8.39e-3)"	"prognostic unfavourable (3.27e-11)"	"unprognostic (6.75e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.79e-2)"	"unprognostic (4.08e-3)"	10.6	6.3	0.5	9.7	0.5	6.1	9.4	0.0	0.0	4.7	3.5			8.9	3.5	5.9	14.1	5.8	7.3	4.9	0.5	0.5	6.7	16.5	14.0	10.5	1.0		7.5	16.8	0.0	3.0	10.7		5.8	4.0		11.2	1.9	1.6	10.4	8.8	4.3	2.0	19.0	8.2	0.2			4.2		11.3	8.2	8.0	20.5	29.3	82.8	43.2	29.6	35.7	46.8	6.3	2.1	0.0	2.8	13.7	31.2	5.3	11.0	21.5	17.7	24.8	5.3	29.0	3.3	23.7	14.2	10.6	0.0	19.0	16.9	3.7	0.1	8.6	1.6	13.8	33.6	8.6	4.2	28.3	28.5	21.1	29.5	30.7	0.2	0.0	13.5	0.6	5.0	10.2	0.0	6.3	3.8	4.1	2.9	14.8	10.1	0.1	0.0	10.1	7.2	10.0	2.9	12.6	15.9	18.7	6.5	16.4	7.7	0.0	0.0	0.0	9.5	19.7	13.0	14.9	39.1	7.0	31.5	43.2	34.6	20.5	24.2	30.1	29.3	20.0	14.8	22.0	82.8	29.6	33.5	4.9	35.7	46.8										
CAV3	"LGMD1C, LQT9, VIP-21, VIP21"	ENSG00000182533	"Caveolin 3"	P56539	3	8733800-8841808	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"			"Cardiomyopathy, Disease mutation, Limb-girdle muscular dystrophy, Long QT syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"skeletal muscle: 65.8;tongue: 44.6"	"Cell line enriched"	"Detected in some"	4	"RH-30: 45.1"	"Cancer enhanced"	"Detected in single"		"head and neck cancer: 0.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"CAB017518, CAB018557, HPA054488"	Enhanced		Approved	"Vesicles,Plasma membrane"				"Plasma membrane"	Vesicles	"CAB017518: AB_628860, CAB018557: AB_626814, HPA054488: "	"unprognostic (1.79e-1)"				"unprognostic (1.43e-1)"	"unprognostic (1.40e-2)"		"unprognostic (6.43e-2)"		"unprognostic (8.79e-2)"	"unprognostic (3.05e-3)"	"unprognostic (8.38e-3)"		"unprognostic (9.79e-2)"	"unprognostic (1.36e-1)"			1.3	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.1	6.3	2.3	0.0	0.3	10.0	0.0	0.0	0.0	0.0	0.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.8	0.0	0.7	1.3	0.1	65.8	0.1	0.0	0.1	0.0	0.1	0.0	0.2	0.0	0.0	0.1	44.6	1.5	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	10.8	0.0	0.0	0.0	0.0	0.0	0.0	45.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.2	0.0
CAVIN3	"cavin-3, HSRBC, MGC20400, PRKCDBP, SRBC"	ENSG00000170955	"Caveolae associated protein 3"	Q969G5	11	6318946-6320647	"Predicted intracellular proteins"	"Biological rhythms"		"Tumor suppressor"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 73.7"	"Cell line enhanced"	"Detected in many"		"A-431: 29.6;BJ: 28.5;HaCaT: 22.9;TIME: 33.9;U-87 MG: 32.1;WM-115: 34.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"classical monocyte: 8.1;myeloid DC: 22.4"	"Group enriched"	"Detected in many"	5	"dendritic cells: 22.4;monocytes: 8.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA055136, HPA073327"	Approved		Approved	"Plasma membrane"				"Plasma membrane"		"HPA055136: AB_2682711, HPA073327: "	"unprognostic (7.92e-2)"	"prognostic unfavourable (3.75e-5)"	"unprognostic (3.12e-2)"	"unprognostic (2.30e-1)"	"unprognostic (4.69e-2)"	"unprognostic (2.69e-1)"	"unprognostic (2.24e-2)"	"unprognostic (1.19e-3)"	"unprognostic (2.49e-2)"	"unprognostic (6.03e-3)"	"unprognostic (3.37e-1)"	"unprognostic (6.66e-2)"	"prognostic unfavourable (5.21e-6)"	"unprognostic (3.85e-2)"	"unprognostic (1.70e-1)"	"unprognostic (1.62e-1)"	"unprognostic (1.96e-2)"	30.2	5.1	0.9	14.2	1.6	0.8	12.6	0.8	2.9	38.3	16.1	1.8	14.2	5.8	31.6	32.2	20.3	13.4	15.3	16.8	0.9	1.0	8.6	2.6	9.8	6.8	2.2	3.5	14.0	5.6	1.0	1.7	22.0	2.8	20.9	2.3	11.1	5.0	11.0	12.1	6.8	7.9	34.7	1.3	9.8	11.3	73.7	0.4	0.7	5.5	14.5	4.3	26.5	16.5	0.0	22.4	0.1	8.1	0.1	3.1	2.7	29.6	2.8	0.0	0.1	1.1	5.1	0.0	28.5	8.8	3.9	4.1	0.0	0.0	0.0	9.5	4.0	22.9	0.0	1.7	0.5	7.5	0.0	0.0	2.9	0.0	3.0	0.0	0.1	3.3	2.4	1.4	1.2	6.9	0.0	0.2	2.4	0.0	0.0	0.0	19.0	0.5	0.0	0.0	0.0	3.4	0.0	0.0	0.0	10.2	0.0	6.2	0.0	0.1	33.9	0.0	0.1	11.1	0.1	0.0	0.2	0.0	32.1	0.0	34.0	0.0	8.1	0.0	0.0	0.5	0.0	0.0	0.4	0.0	22.4	0.0	0.0	0.0	0.1	0.1	0.0	0.0	3.1	2.7	0.9	1.6	0.8	2.9	0.9	1.0	2.2	3.5	2.8	0.4
CBWD1		ENSG00000172785	"COBW domain containing 1"	Q9BRT8	9	121038-179147	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"NB-4: 53.7"	"Low cancer specificity"	"Detected in many"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"HPA042759, HPA042813"	Approved		Approved	"Plasma membrane"				"Plasma membrane"		"HPA042759: , HPA042813: "	"unprognostic (3.75e-2)"	"unprognostic (3.47e-2)"	"unprognostic (5.23e-2)"	"unprognostic (4.15e-2)"	"unprognostic (1.39e-1)"	"unprognostic (2.67e-2)"	"unprognostic (3.91e-2)"	"unprognostic (3.72e-1)"	"unprognostic (4.15e-2)"	"unprognostic (2.07e-3)"	"unprognostic (1.82e-1)"	"unprognostic (4.68e-2)"	"unprognostic (5.80e-7)"	"unprognostic (7.19e-2)"	"unprognostic (1.04e-1)"	"unprognostic (8.94e-2)"	"unprognostic (4.98e-3)"	6.3	14.1	5.5	5.3	6.7	3.8	7.2	5.5	4.5	4.9	5.5			4.6	4.5	8.3	10.4	5.0	3.5	7.0	4.9	6.9	16.3	10.1	5.7	4.1	5.9		5.5	10.5	7.5	7.6	8.3		7.2	5.7		8.6	4.5	7.5	7.1	4.1	4.2	4.8	5.6	6.1	6.3			10.0		7.3	6.9	5.1	8.2	28.0	7.0	28.2	4.5	7.6	15.6	12.5	4.7	6.9	3.6	9.0	8.2	15.3	6.6	4.4	9.2	7.0	6.9	4.8	11.5	8.6	2.4	2.2	3.3	6.3	10.0	19.7	11.6	0.1	11.2	21.1	9.8	33.1	5.2	7.3	3.0	2.2	18.1	9.8	3.8	25.4	7.5	15.1	7.1	53.7	6.9	10.3	13.8	10.5	21.9	11.9	35.7	12.4	7.5	13.6	5.1	5.1	10.7	31.8	10.2	4.9	6.9	6.3	5.7	3.0	4.1	13.2	12.1	17.8	5.7	1.2	25.3	7.0	4.2	28.2	6.8	8.2	7.6	6.7	28.0	5.6	6.7	7.3	3.8	4.5	21.3	7.4	6.6	15.6										
CBWD2		ENSG00000136682	"COBW domain containing 2"	Q8IUF1	2	113437691-113496189	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 27.4"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"HPA042759, HPA042813"	Approved		Approved	"Plasma membrane"				"Plasma membrane"		"HPA042759: , HPA042813: "	"unprognostic (4.67e-2)"	"unprognostic (2.17e-1)"	"unprognostic (4.14e-1)"	"prognostic unfavourable (3.22e-5)"	"unprognostic (7.69e-2)"	"unprognostic (2.17e-1)"	"unprognostic (2.16e-3)"	"unprognostic (1.31e-3)"	"unprognostic (3.69e-2)"	"unprognostic (1.72e-2)"	"unprognostic (5.85e-2)"	"unprognostic (1.39e-1)"	"unprognostic (8.50e-2)"	"unprognostic (1.90e-1)"	"unprognostic (4.90e-2)"	"unprognostic (3.21e-1)"	"unprognostic (7.57e-3)"	2.0	5.7	3.2	2.6	6.0	0.3	4.3	7.0	4.1	5.6	3.6			0.9	4.1	4.9	5.9	2.1	2.5	9.1	3.1	4.5	8.9	6.6	1.8	1.3	3.2		3.0	3.6	7.7	5.3	3.4		4.1	3.6		4.3	5.0	15.0	1.7	2.2	5.0	1.6	2.3	3.3	1.2			6.2		2.5	4.2	2.5	7.8	26.5	13.8	27.4	7.5	10.4	17.5	8.2	5.0	5.5	6.2	14.4	6.7	10.3	6.4	4.1	5.1	6.7	8.4	5.2	10.9	19.8	6.8	6.9	5.8	7.1	6.9	3.7	15.3	9.0	8.9	15.7	4.8	3.8	4.3	6.2	4.4	7.4	4.4	9.2	5.1	11.9	7.4	8.8	12.0	12.8	6.6	11.0	5.7	14.4	28.5	13.5	13.4	15.2	4.5	16.7	2.4	2.7	7.9	11.1	10.9	4.3	6.1	2.6	6.2	4.6	19.2	5.8	7.1	23.6	10.2	4.2	27.4	13.8	5.2	27.1	5.6	7.3	7.9	6.1	26.5	7.8	6.8	6.2	7.5	7.5	21.2	6.5	10.4	17.5										
CBWD3	bA561O23.1	ENSG00000196873	"COBW domain containing 3"	Q5JTY5	9	68232003-68300015	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in all"		"blood: 34.4"	"Low cell line specificity"	"Detected in all"			"Not detected"	"Not detected"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"HPA042759, HPA042813"	Uncertain		Approved	"Plasma membrane"				"Plasma membrane"		"HPA042759: , HPA042813: "	"unprognostic (1.72e-2)"	"unprognostic (2.15e-1)"	"unprognostic (1.95e-1)"	"unprognostic (9.71e-3)"	"unprognostic (9.99e-2)"	"unprognostic (6.38e-2)"	"unprognostic (3.44e-2)"	"unprognostic (1.79e-2)"	"unprognostic (3.54e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.05e-2)"	"unprognostic (2.05e-2)"	"unprognostic (1.05e-3)"	"unprognostic (3.77e-2)"	"unprognostic (1.67e-1)"	"unprognostic (4.43e-3)"	"unprognostic (5.16e-4)"	3.8	6.0	4.4	6.6	4.9	4.0	6.5	5.7	5.1	2.7	4.7			4.2	2.9	2.1	5.4	3.0	1.8	2.9	4.8	4.4	7.7	11.1	2.9	5.7	4.5		3.6	10.7	4.2	5.0	5.5		4.1	3.2		3.7	3.6	5.2	4.9	7.6	2.8	3.9	5.0	6.3	3.2			5.1		4.3	4.5	3.5	20.3	24.4	34.4	33.9	5.7	14.0	19.9	21.1	15.7	7.7	12.0	5.8	1.9	10.2	10.6	4.2	4.5	5.3	4.4	20.8	24.6	10.3	7.7	26.0	14.1	20.9	12.3	37.7	9.1	9.4	35.9	20.9	7.3	17.7	11.8	4.8	6.5	8.2	10.7	10.4	17.2	20.0	6.6	13.6	20.7	23.7	11.4	26.5	9.5	24.1	26.6	5.1	9.2	12.0	7.7	17.4	10.5	13.0	7.6	20.7	4.9	7.0	17.7	11.4	20.4	11.9	47.0	30.0	20.8	26.3	12.5	9.1	33.9	24.8	11.6	27.2	10.0	20.3	10.8	11.9	24.4	18.4	11.7	10.9	34.4	5.7	19.0	18.3	14.0	19.9										
CBWD5		ENSG00000147996	"COBW domain containing 5"	Q5RIA9	9	65668805-65734041	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in some"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"HPA042759, HPA042813"	Approved		Approved	"Plasma membrane"				"Plasma membrane"		"HPA042759: , HPA042813: "	"unprognostic (1.34e-1)"	"unprognostic (3.62e-2)"	"unprognostic (8.18e-2)"	"unprognostic (4.23e-3)"	"unprognostic (5.25e-3)"	"unprognostic (1.02e-3)"	"unprognostic (5.32e-3)"	"unprognostic (9.24e-2)"	"unprognostic (2.07e-1)"	"unprognostic (1.54e-2)"	"unprognostic (1.11e-2)"	"unprognostic (6.46e-3)"	"unprognostic (1.03e-1)"	"unprognostic (4.61e-3)"	"unprognostic (1.17e-1)"	"unprognostic (5.68e-2)"	"unprognostic (3.87e-1)"	4.1	6.0	5.2	3.7	6.8	2.5	9.2	8.2	3.7	2.8	3.3			5.4	1.7	4.8	3.3	1.7	2.2	2.4	6.2	6.0	7.6	17.9	1.9	2.6	4.8		2.1	6.6	2.9	4.0	2.9		4.3	5.5		2.2	3.8	2.1	2.8	4.4	2.5	2.6	5.7	2.2	2.1			5.1		4.4	5.4	1.5	5.5	11.7	7.7	14.0	2.5	5.5	9.3	14.9	16.2	5.7	7.3	8.9	4.1	7.0	10.6	7.2	8.4	8.7	2.1	13.9	20.4	6.8	6.1	11.1	26.2	8.5	16.0	3.3	6.3	5.7	26.1	36.3	6.7	12.8	3.7	7.2	9.9	7.7	6.3	15.2	8.0	15.3	8.6	18.1	6.4	13.6	7.1	17.4	11.2	8.0	20.4	13.4	9.8	7.7	7.8	8.6	6.8	3.1	31.7	8.6	4.3	3.8	14.1	11.7	12.2	5.0	13.4	4.8	16.0	14.8	14.4	1.6	11.6	7.7	3.4	14.0	3.7	5.5	5.5	4.7	11.7	2.9	5.1	4.1	7.1	2.5	8.5	4.9	4.1	9.3										
CBWD6	CBWD7	ENSG00000215126	"COBW domain containing 6"	Q4V339	9	41131306-41199261	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Tissue enhanced"	"Detected in many"		"blood: 9.3;liver: 6.1"	"Cell line enhanced"	"Detected in many"		"PC-3: 19.1"	"Not detected"	"Not detected"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"											"HPA042759, HPA042813"	Approved		Approved	"Plasma membrane"				"Plasma membrane"		"HPA042759: , HPA042813: "	"unprognostic (9.48e-2)"	"unprognostic (6.02e-2)"	"unprognostic (1.62e-2)"	"unprognostic (1.91e-2)"	"unprognostic (1.30e-2)"	"unprognostic (6.28e-2)"	"unprognostic (5.92e-2)"	"unprognostic (3.71e-2)"	"unprognostic (2.07e-2)"	"unprognostic (1.12e-1)"	"unprognostic (4.24e-2)"	"unprognostic (1.09e-1)"	"unprognostic (2.28e-4)"	"unprognostic (5.65e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.01e-2)"	"unprognostic (9.94e-4)"	0.1	5.2	2.2	0.4	2.4	2.0	2.8	1.0	2.0	0.2	0.3			1.2	0.1	0.0	0.2	0.0	1.6	1.3	2.8	1.5	2.1	6.1	0.1	0.0	1.2		0.2	1.3	0.0	0.5	0.0		0.6	0.0		2.8	2.5	4.3	0.4	0.9	0.0	1.2	0.3	0.2	0.1			0.3		0.2	0.2	0.1	4.8	4.0	2.5	9.3	0.6	4.3	2.8	1.4	0.3	0.6	0.3	0.7	1.8	1.2	7.8	8.7	9.0	0.0	2.9	0.9	1.8	0.4	6.3	1.2	11.4	0.2	0.3	1.8	7.3	0.5	4.1	2.1	0.0	2.2	0.7	0.2	1.1	6.0	7.5	6.9	1.0	1.1	12.3	1.2	3.4	0.6	1.9	19.1	0.8	7.6	2.6	8.0	0.5	0.9	1.0	1.9	0.7	0.9	0.6	1.2	11.5	0.1	0.8	0.3	0.8	3.4	0.6	10.1	1.2	0.8	0.9	1.6	5.9	2.5	0.8	6.8	1.4	4.8	4.3	3.5	3.3	1.8	3.0	3.4	0.9	0.6	9.3	4.0	1.8	2.8										
CC2D1A	"FLJ20241, MRT3"	ENSG00000132024	"Coiled-coil and C2 domain containing 1A"	Q6P1N0	19	13906201-13930879	"Disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"	"Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA005436, CAB015220"	Supported		Supported	"Nucleoli fibrillar center,Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"	"Nucleoli fibrillar center"	"CAB015220: , HPA005436: AB_1078884"	"unprognostic (8.66e-2)"	"unprognostic (1.31e-2)"	"unprognostic (2.55e-1)"	"unprognostic (2.34e-1)"	"unprognostic (1.07e-1)"	"prognostic favourable (7.02e-4)"	"unprognostic (7.00e-2)"	"unprognostic (1.59e-3)"	"unprognostic (1.17e-1)"	"unprognostic (2.82e-2)"	"unprognostic (2.61e-3)"	"unprognostic (4.07e-2)"	"unprognostic (1.23e-3)"	"unprognostic (6.67e-3)"	"unprognostic (1.97e-1)"	"unprognostic (9.22e-2)"	"unprognostic (1.71e-2)"	11.2	9.5	19.1	14.5	18.7	9.1	12.0	30.5	22.2	11.4	28.7	13.6	15.3	43.2	10.1	10.0	18.2	16.9	16.6	10.4	17.8	21.3	12.6	16.2	11.9	9.5	15.8	20.1	11.5	30.0	17.3	18.7	12.2	16.1	14.2	14.7	13.3	32.7	16.9	18.7	28.6	35.3	11.1	12.6	11.3	21.0	10.1	13.7	10.6	12.0	13.6	13.7	13.1	14.1	2.4	3.0	4.1	5.2	1.6	4.8	2.0	22.0	9.3	3.1	12.8	6.3	5.2	9.9	7.7	9.5	12.5	12.0	12.8	6.7	11.6	12.6	7.7	16.2	5.8	11.7	4.3	16.9	32.0	5.7	11.4	8.0	10.5	4.7	16.9	6.3	14.3	7.7	5.1	8.4	5.9	9.5	4.0	23.4	11.1	12.9	7.0	16.7	11.5	6.9	9.2	8.5	16.8	11.5	6.7	10.2	15.5	11.6	11.4	9.0	7.9	9.6	4.8	21.2	9.3	16.2	7.2	6.0	12.2	15.9	8.7	3.9	3.2	4.1	4.8	5.2	1.9	2.4	2.3	2.1	3.0	1.3	1.2	2.7	2.8	1.6	4.8	2.5	1.9	2.0	19.1	18.7	30.5	22.2	17.8	21.3	15.8	20.1	16.1	13.7
CCDC107	MGC31967	ENSG00000159884	"Coiled-coil domain containing 107"	Q8WV48	9	35658290-35661511	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016857, HPA050442"			Approved	"Nucleoplasm,Plasma membrane,Cell Junctions"				"Plasma membrane, Cell Junctions"	Nucleoplasm	"HPA016857: AB_10669751, HPA050442: "	"unprognostic (3.70e-3)"	"unprognostic (7.07e-3)"	"unprognostic (3.60e-2)"	"unprognostic (2.63e-2)"	"unprognostic (7.77e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.86e-1)"	"unprognostic (4.09e-2)"	"unprognostic (4.13e-1)"	"unprognostic (1.72e-2)"	"unprognostic (1.32e-2)"	"unprognostic (1.26e-1)"	"unprognostic (8.33e-2)"	"unprognostic (1.89e-1)"	"unprognostic (5.15e-1)"	"unprognostic (1.96e-1)"	"unprognostic (5.75e-2)"	42.1	23.4	11.1	15.4	10.3	5.4	50.3	17.2	12.9	17.5	35.2	8.5	18.1	15.0	24.9	28.6	22.4	18.2	31.5	31.3	10.2	11.0	13.0	15.0	14.0	14.1	9.7	7.9	15.3	80.2	7.6	10.5	10.8	8.4	22.8	13.7	11.5	14.6	24.5	29.3	9.6	16.0	44.8	9.7	13.5	24.2	9.2	8.8	19.3	14.0	8.8	10.9	38.9	24.1	20.7	32.5	7.6	11.0	16.4	46.9	18.3	7.9	7.2	6.0	7.5	30.3	19.5	3.5	13.5	12.2	8.7	8.1	3.3	2.4	5.2	6.0	17.7	2.7	4.4	6.5	6.4	15.3	7.1	2.4	11.0	8.1	7.2	3.8	9.5	11.5	7.8	9.2	7.2	6.0	3.2	10.1	10.8	5.1	4.2	5.6	4.4	22.3	6.1	1.4	4.1	28.7	4.3	3.9	6.6	7.0	9.8	6.6	5.1	4.7	7.5	13.9	7.7	10.0	12.3	4.5	6.7	10.4	25.7	6.1	12.1	7.6	10.6	5.1	36.1	11.0	46.9	20.7	31.7	31.4	11.8	20.1	15.5	21.3	2.1	16.4	6.4	32.5	35.2	18.3	11.1	10.3	17.2	12.9	10.2	11.0	9.7	7.9	8.4	8.8
CCDC144NL	MGC87631	ENSG00000205212	"Coiled-coil domain containing 144 family, N-terminal like"	Q6NUI1	17	20836447-20896140	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Group enriched"	"Detected in some"	7	"brain: 13.1;testis: 10.6"	"Cell line enriched"	"Detected in some"	5	"U-2 OS: 26.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in single"		"memory CD4 T-cell: 1.2"	"Lineage enriched"	"Detected in single"	5	"T-cells: 1.2"									HPA023457	Uncertain		Approved	"Nucleoplasm,Plasma membrane"				"Plasma membrane"	Nucleoplasm	"HPA023457: AB_2671217"	"unprognostic (1.29e-1)"				"unprognostic (6.71e-2)"	"unprognostic (1.21e-1)"		"unprognostic (3.53e-1)"		"unprognostic (7.53e-2)"	"unprognostic (5.17e-2)"	"unprognostic (6.33e-2)"		"unprognostic (1.08e-1)"	"unprognostic (1.22e-1)"		"unprognostic (2.28e-1)"	0.3	0.9	0.9	0.2	13.1	0.5	1.0	2.4	6.6	0.3	0.4	1.4	0.0	0.5	1.5	0.3	0.3	0.9	0.2	0.5	1.2	1.1	0.3	0.6	0.5	0.5	1.7	1.4	1.3	0.4	0.2	1.2	0.8	4.5	1.6	0.5	0.6	0.3	1.8	0.8	0.3	0.2	1.2	4.5	0.4	0.5	10.6	0.0	0.4	0.4	0.0	0.7	0.9	0.2	0.0	0.1	0.0	0.2	0.0	1.2	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	5.0	0.0	0.0	0.0	0.0	0.0	0.4	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.4	0.0	0.0	2.3	0.0	0.0	26.1	0.0	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.2	0.0	1.2	0.3	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.9	13.1	2.4	6.6	1.2	1.1	1.7	1.4	4.5	0.0
CCDC15	FLJ13215	ENSG00000149548	"Coiled-coil domain containing 15"	Q0P6D6	11	124954121-125041489	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 16.2;testis: 19.4"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA040450, HPA041738"	Uncertain		Approved	"Plasma membrane,Cytosol"				"Plasma membrane"	Cytosol	"HPA040450: AB_10794031, HPA041738: AB_10794675"	"unprognostic (2.38e-1)"	"unprognostic (3.93e-2)"	"unprognostic (8.81e-2)"	"unprognostic (1.85e-1)"	"unprognostic (2.50e-1)"	"unprognostic (4.59e-4)"	"unprognostic (2.12e-3)"	"unprognostic (1.43e-1)"	"unprognostic (1.46e-2)"	"unprognostic (2.04e-2)"	"unprognostic (9.05e-3)"	"unprognostic (3.25e-2)"	"unprognostic (9.38e-3)"	"unprognostic (1.33e-2)"	"unprognostic (3.14e-1)"	"unprognostic (5.04e-2)"	"unprognostic (1.66e-1)"	1.9	1.3	2.2	2.5	3.9	3.2	5.2	1.2	2.4	1.6	2.2	2.2	0.3	1.3	2.2	2.9	2.4	2.1	1.5	0.9	1.9	1.2	1.2	2.4	2.6	2.0	1.6	0.8	1.7	2.3	1.7	3.8	1.6	1.6	3.0	1.6	1.5	7.7	2.2	0.8	3.7	1.8	1.2	3.3	2.5	1.5	19.4	2.3	16.2	1.3	2.6	2.9	2.6	2.2	1.5	1.1	6.7	1.7	2.3	3.9	1.3	4.7	0.9	6.4	0.0	0.5	1.8	0.0	5.2	6.4	4.9	6.1	0.1	4.0	5.6	4.6	1.8	3.8	2.7	3.5	8.9	4.7	1.1	6.9	0.8	1.5	0.2	2.0	4.0	0.4	2.5	10.2	5.1	3.7	4.6	5.8	10.3	1.0	4.2	2.3	1.5	5.9	5.3	11.7	1.8	0.7	2.0	3.6	3.2	3.0	0.3	1.3	7.3	1.8	2.6	10.1	2.3	4.4	6.4	1.4	1.5	4.9	1.4	11.3	6.7	6.7	1.3	1.7	2.4	1.7	2.5	0.8	2.2	3.9	0.4	1.5	3.1	3.4	0.8	2.3	1.7	1.1	3.7	1.3	2.2	3.9	1.2	2.4	1.9	1.2	1.6	0.8	1.6	2.3
CCDC154	"C16orf29, LOC645811"	ENSG00000197599	"Coiled-coil domain containing 154"	A6NI56	16	1434383-1444556	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"testis: 10.8"	"Cell line enhanced"	"Detected in some"		"A-431: 7.3;SCLC-21H: 26.0;U-266/70: 4.7"	"Low cancer specificity"	"Detected in many"							"Cell type enhanced"	"Detected in single"		"memory CD8 T-cell: 1.1"	"Low lineage specificity"	"Detected in single"			"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	6	"cerebellum: 5.4"	"HPA041158, HPA043535, HPA048237"	Uncertain		Approved	"Golgi apparatus,Plasma membrane"				"Plasma membrane"	"Golgi apparatus"	"HPA041158: , HPA043535: , HPA048237: "	"unprognostic (2.40e-1)"	"unprognostic (1.42e-2)"	"unprognostic (5.97e-4)"	"unprognostic (3.28e-2)"	"unprognostic (1.97e-1)"	"unprognostic (5.76e-3)"	"unprognostic (7.96e-2)"	"unprognostic (3.01e-3)"	"unprognostic (1.67e-1)"	"unprognostic (5.34e-2)"	"unprognostic (4.19e-5)"	"unprognostic (2.35e-2)"	"unprognostic (8.02e-6)"	"unprognostic (9.33e-2)"	"unprognostic (1.43e-1)"	"unprognostic (2.33e-1)"	"unprognostic (9.35e-5)"	0.6	1.5	0.6	1.5	1.1	1.6	0.5	4.5	1.4	1.0	0.7			2.6	1.3	0.4	0.0	1.5	0.7	0.2	0.7	0.9	1.2	0.4	0.4	2.5	0.5		1.3	1.1	0.0	3.9	0.6		2.9	0.0		1.2	0.8	1.2	2.9	1.2	0.2	0.7	3.4	3.7	10.8			2.8		0.6	0.2	0.6	0.7	0.0	0.8	0.1	0.0	1.1	0.0	7.3	0.3	0.2	0.5	0.3	0.1	0.3	0.0	0.0	0.0	0.0	0.2	0.6	0.1	0.2	0.0	0.1	0.0	0.0	0.0	0.3	0.1	0.0	0.2	0.3	0.3	0.1	0.4	0.0	0.2	0.1	0.0	0.0	0.9	0.4	0.0	0.5	0.0	3.7	0.2	0.1	2.1	0.1	0.1	0.0	0.1	26.0	0.4	0.1	0.1	1.1	0.8	1.9	0.0	0.4	0.1	0.3	0.0	4.7	1.2	0.0	0.0	3.7	0.1	0.0	0.1	0.0	0.3	0.0	0.0	0.1	0.0	1.1	0.0	0.7	0.2	0.1	0.8	0.0	0.0	0.0	0.0	0.0										
CCDC24	MGC45441	ENSG00000159214	"Coiled-coil domain containing 24"	Q8N4L8	1	43991359-43996528	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 14.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"memory B-cell: 6.8"	"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA035424, HPA061710"	Uncertain		Approved	"Nucleoli,Plasma membrane,Cytosol"				"Plasma membrane"	"Nucleoli, Cytosol"	"HPA035424: AB_2674619, HPA061710: "	"prognostic favourable (3.06e-5)"	"unprognostic (1.47e-1)"	"unprognostic (1.13e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.65e-2)"	"prognostic favourable (3.18e-4)"	"prognostic unfavourable (1.70e-4)"	"unprognostic (1.92e-2)"	"unprognostic (6.38e-2)"	"unprognostic (2.81e-1)"	"unprognostic (7.00e-3)"	"unprognostic (3.00e-1)"	"unprognostic (1.74e-2)"	"unprognostic (6.91e-2)"	"unprognostic (1.51e-1)"	"unprognostic (7.84e-2)"	"unprognostic (2.15e-3)"	1.8	5.5	9.3	2.6	9.8	1.1	5.1	3.0	9.8	7.2	5.0	3.2	18.9	3.7	4.9	6.6	2.6	20.3	13.1	1.5	6.4	8.0	8.9	3.0	3.2	2.6	5.5	9.6	3.4	6.0	9.6	14.5	2.4	5.2	7.2	4.1	6.5	8.4	14.7	1.5	0.9	3.3	3.4	3.3	3.0	4.9	15.4	1.7	0.6	8.8	1.0	2.5	4.7	2.1	6.8	0.8	1.4	4.0	0.5	0.6	0.5	5.1	3.0	1.4	1.5	1.4	0.9	3.1	0.2	2.1	1.6	2.8	2.0	14.8	4.1	5.8	0.6	5.2	0.8	7.3	1.5	4.3	1.8	2.1	1.8	0.6	1.6	0.7	3.6	0.3	0.7	5.2	0.5	1.3	0.9	1.5	2.2	4.4	0.2	1.5	3.1	2.6	1.3	0.0	0.8	6.1	2.0	3.4	3.0	4.5	2.6	2.8	7.6	0.1	0.4	2.4	6.9	1.7	0.7	0.6	1.9	0.9	6.2	0.6	1.9	0.0	0.7	1.4	0.6	4.0	0.3	6.8	0.2	0.2	0.8	3.0	0.0	0.0	0.6	0.5	3.1	0.6	0.0	0.5	9.3	9.8	3.0	9.8	6.4	8.0	5.5	9.6	5.2	1.7
CCDC28A	"C6orf80, CCRL1AP, DKFZp586D0623"	ENSG00000024862	"Coiled-coil domain containing 28A"	Q8IWP9	6	138773509-138793319	"Disease related genes, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA055125	Approved		Approved	"Nucleoplasm,Plasma membrane"				"Plasma membrane"	Nucleoplasm	"HPA055125: "	"unprognostic (1.51e-1)"	"unprognostic (6.88e-3)"	"unprognostic (2.70e-1)"	"unprognostic (6.67e-2)"	"unprognostic (7.96e-2)"	"unprognostic (9.66e-3)"	"unprognostic (1.16e-1)"	"unprognostic (2.58e-3)"	"unprognostic (3.80e-1)"	"unprognostic (8.34e-3)"	"unprognostic (4.29e-3)"	"unprognostic (1.02e-1)"	"prognostic favourable (1.11e-5)"	"unprognostic (1.63e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.28e-2)"	"unprognostic (2.37e-2)"	12.9	30.8	25.4	19.8	28.7	20.9	17.9	22.6	27.9	15.6	17.4	13.3	18.7	18.5	11.5	24.8	12.4	22.6	16.8	11.0	31.4	32.2	36.5	40.5	17.4	19.2	22.2	21.7	14.2	22.2	25.5	19.2	19.3	28.3	16.1	15.4	16.4	31.6	20.8	17.4	11.0	21.3	13.9	16.1	18.3	16.5	15.0	13.4	18.2	33.9	9.3	19.8	19.3	12.5	30.0	29.3	73.5	27.3	30.6	44.5	24.5	3.3	6.2	4.7	8.5	8.9	12.4	9.6	5.7	10.0	7.4	12.3	5.3	6.8	14.7	11.0	5.6	6.0	7.6	7.9	12.2	16.9	17.1	11.9	7.6	10.5	14.0	20.6	12.6	8.0	10.0	5.4	16.0	12.2	12.0	20.7	8.4	7.5	16.8	27.2	4.3	6.4	10.2	4.7	13.6	8.9	5.1	5.8	9.0	7.5	6.8	16.3	3.3	22.8	9.3	5.9	6.8	10.9	8.5	27.7	24.5	10.8	6.3	12.8	5.2	33.2	27.3	33.7	26.0	27.0	23.2	30.0	27.6	28.3	29.3	29.7	32.1	29.5	73.5	30.6	22.9	25.8	44.5	24.5	25.4	28.7	22.6	27.9	31.4	32.2	22.2	21.7	28.3	13.4
CCDC59	"BR22, HSPC128, TAP26"	ENSG00000133773	"Coiled-coil domain containing 59"	Q9P031	12	82223681-82358805	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038555	Approved		Approved	"Nucleoplasm,Nucleoli,Plasma membrane"				Nucleoli	"Nucleoplasm, Plasma membrane"	"HPA038555: AB_10669543"	"unprognostic (1.61e-1)"	"unprognostic (6.28e-3)"	"unprognostic (1.27e-1)"	"unprognostic (2.11e-2)"	"unprognostic (1.13e-1)"	"unprognostic (6.73e-2)"	"unprognostic (1.42e-3)"	"unprognostic (1.50e-2)"	"unprognostic (1.86e-2)"	"unprognostic (1.22e-2)"	"unprognostic (2.62e-1)"	"unprognostic (5.56e-2)"	"prognostic unfavourable (1.39e-6)"	"unprognostic (5.73e-2)"	"unprognostic (2.01e-1)"	"unprognostic (8.86e-2)"	"unprognostic (1.02e-2)"	17.9	10.2	11.3	14.2	16.3	54.9	18.9	14.9	14.7	17.6	16.9	8.9	7.7	7.5	14.8	17.4	17.0	17.2	11.2	14.5	11.5	12.5	16.0	15.4	12.6	13.7	14.8	12.4	18.8	12.5	2.6	18.2	18.7	13.5	18.7	12.5	6.5	12.7	13.3	23.5	12.7	18.9	14.5	16.5	17.3	12.1	18.4	14.9	15.3	19.9	17.9	18.1	21.4	20.9	18.9	18.6	17.9	14.0	13.1	23.6	6.7	11.4	10.8	9.0	6.4	10.0	8.7	14.0	10.4	12.0	18.3	15.0	21.8	6.5	13.4	5.3	10.3	7.3	40.9	19.8	15.6	14.1	21.8	13.2	6.4	14.4	29.5	17.4	7.6	15.1	16.8	19.3	24.4	15.0	24.9	6.9	11.2	20.7	16.0	23.8	14.2	25.2	12.1	13.4	10.9	9.7	11.4	15.3	7.4	11.9	6.4	15.1	13.8	23.1	7.0	9.1	7.0	6.5	19.0	11.0	12.3	25.7	6.5	13.9	12.3	12.7	9.3	16.8	11.6	9.6	19.8	15.2	18.6	16.9	9.6	18.9	22.1	17.6	17.9	13.1	14.0	18.6	23.6	6.7	11.3	16.3	14.9	14.7	11.5	12.5	14.8	12.4	13.5	14.9
CCDC62	"CT109, ERAP75, FLJ40344, TSP-NY"	ENSG00000130783	"Coiled-coil domain containing 62"	Q6P9F0	12	122774327-122827528	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	18	"testis: 44.3"	"Cell line enhanced"	"Detected in some"		"U-2 OS: 7.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			"HPA039021, HPA058741"	Approved		Approved	"Nucleoplasm,Plasma membrane"				"Nucleoplasm, Plasma membrane"		"HPA039021: AB_10673604, HPA058741: "	"unprognostic (3.39e-2)"	"unprognostic (4.16e-2)"	"unprognostic (1.46e-2)"	"unprognostic (7.48e-2)"	"unprognostic (1.58e-2)"	"unprognostic (9.37e-2)"	"unprognostic (1.65e-1)"	"unprognostic (7.09e-2)"	"unprognostic (1.97e-1)"	"unprognostic (1.48e-1)"	"unprognostic (2.21e-4)"	"unprognostic (5.23e-1)"	"unprognostic (6.39e-6)"	"unprognostic (2.78e-2)"	"unprognostic (6.18e-2)"	"unprognostic (7.27e-2)"	"unprognostic (3.25e-4)"	0.2	0.2	0.3	0.1	0.3	0.1	0.1	0.3	0.7	0.2	0.1	0.1	0.1	0.0	0.1	0.8	0.1	0.0	0.1	0.1	0.7	0.2	0.1	0.3	0.1	0.6	0.1	0.2	0.1	0.1	0.1	0.4	0.1	0.2	0.1	0.0	0.1	0.1	0.5	0.3	0.2	0.1	0.1	0.2	0.3	0.0	44.3	0.1	0.1	0.1	0.1	0.1	0.1	0.1	1.0	1.1	2.4	0.6	0.8	1.9	0.4	0.4	0.5	0.3	0.9	0.1	0.7	0.9	0.2	0.3	0.8	0.3	0.3	0.7	1.6	0.2	0.0	0.3	0.5	0.2	0.4	0.7	0.7	2.6	0.3	0.2	0.0	1.7	2.1	0.3	1.0	1.1	0.4	0.1	0.9	0.8	1.1	0.3	0.2	3.3	0.4	1.9	2.0	0.8	0.3	0.5	0.3	1.5	0.0	0.3	0.9	1.2	0.1	1.6	0.4	0.9	7.6	0.4	0.4	1.0	0.7	0.7	0.0	0.7	0.5	1.5	0.6	0.4	0.5	0.3	0.9	0.3	0.3	0.4	0.2	1.0	0.8	0.7	2.4	0.8	0.3	1.1	1.9	0.4	0.3	0.3	0.3	0.7	0.7	0.2	0.1	0.2	0.2	0.1
CCDC69	"DKFZP434C171, FLJ13705"	ENSG00000198624	"Coiled-coil domain containing 69"	A6NI79	5	151181052-151224145	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"breast: 99.8"	"Cell line enhanced"	"Detected in many"		"ASC diff: 34.2;Daudi: 52.8;U-266/70: 33.8;U-698: 34.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA043648, HPA052896"	Uncertain		Approved	"Golgi apparatus,Plasma membrane,Actin filaments"				"Plasma membrane"	"Golgi apparatus, Actin filaments"	"HPA043648: AB_10795877, HPA052896: "	"prognostic favourable (3.21e-4)"	"unprognostic (2.60e-2)"	"unprognostic (1.28e-1)"	"unprognostic (2.78e-2)"	"unprognostic (5.62e-2)"	"unprognostic (8.63e-3)"	"unprognostic (3.07e-2)"	"unprognostic (6.48e-2)"	"unprognostic (2.00e-1)"	"unprognostic (9.29e-2)"	"unprognostic (3.85e-2)"	"unprognostic (1.55e-2)"	"unprognostic (3.67e-1)"	"unprognostic (4.31e-2)"	"unprognostic (3.69e-1)"	"unprognostic (2.93e-1)"	"unprognostic (2.01e-1)"	31.6	33.7	2.1	33.4	3.2	10.9	99.8	1.7	4.7	7.3	43.4	2.5	6.6	5.7	12.2	7.3	28.1	12.7	14.0	57.6	2.2	2.5	3.8	12.6	23.7	23.2	4.3	0.9	11.4	15.3	5.3	6.1	21.4	8.4	17.2	5.8	9.0	5.5	8.7	87.1	4.5	14.9	53.0	5.1	21.7	15.6	6.7	2.2	13.3	5.1	18.8	17.7	37.2	58.4	11.4	20.4	18.0	10.7	11.9	11.7	8.3	2.1	0.2	0.1	1.8	34.2	3.6	1.2	0.3	3.3	0.6	0.5	0.4	0.2	52.8	1.9	0.1	0.1	0.8	0.6	0.2	0.0	0.7	6.7	0.0	3.2	5.6	2.4	9.7	8.7	0.0	0.2	0.0	3.3	6.3	11.9	0.0	0.0	11.2	6.2	2.0	4.3	9.6	0.2	3.2	0.1	1.4	0.0	0.2	0.6	0.9	0.4	0.5	6.2	8.2	0.2	1.7	0.1	0.4	33.8	15.7	34.1	0.4	5.9	0.0	18.0	10.7	12.3	11.7	8.6	10.2	5.9	9.1	11.0	9.3	11.4	7.3	6.7	9.2	11.9	8.2	20.4	6.6	8.3	2.1	3.2	1.7	4.7	2.2	2.5	4.3	0.9	8.4	2.2
CCDC8	"3M3, DKFZp564K0322, PPP1R20"	ENSG00000169515	"Coiled-coil domain containing 8"	Q9H0W5	19	46410372-46413584	"Disease related genes, Predicted intracellular proteins"			Dwarfism	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ovary: 39.4"	"Cell line enhanced"	"Detected in many"		"AF22: 11.9;AN3-CA: 14.2;HSkMC: 13.0;K-562: 12.4;RH-30: 16.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	9	"neutrophil: 3.6"	"Lineage enriched"	"Detected in single"	9	"granulocytes: 3.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA041993	Uncertain		Approved	"Nucleoplasm,Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"	Nucleoplasm	"HPA041993: AB_10795388"	"unprognostic (3.05e-3)"	"unprognostic (2.16e-1)"	"unprognostic (2.28e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.39e-3)"	"unprognostic (3.69e-1)"	"unprognostic (6.64e-2)"	"unprognostic (5.16e-2)"	"unprognostic (7.77e-2)"	"unprognostic (1.62e-1)"	"unprognostic (1.15e-1)"	"unprognostic (5.72e-2)"	"prognostic favourable (1.72e-5)"	"unprognostic (5.43e-3)"	"unprognostic (5.77e-2)"	"unprognostic (4.09e-2)"	"unprognostic (4.18e-3)"	2.7	13.3	3.0	2.1	3.8	0.6	7.6	0.9	2.3	18.9	2.4	5.1	6.2	0.8	15.5	17.3	2.9	19.0	9.7	18.9	3.1	2.3	7.9	0.7	7.1	0.9	2.4	2.9	39.4	19.2	8.5	9.9	5.6	4.6	12.1	1.1	10.0	8.7	7.5	3.0	2.2	1.6	6.7	2.0	1.8	1.7	9.0	2.6	4.2	11.8	2.6	1.4	4.8	5.8	0.4	0.3	3.6	0.4	0.2	0.2	0.1	1.1	0.1	11.9	14.2	3.2	4.0	5.8	6.1	0.0	1.4	0.6	0.0	0.1	0.1	8.1	4.8	0.1	0.1	9.5	0.6	0.0	6.0	0.0	0.1	0.6	10.6	0.0	0.1	13.0	0.0	3.3	9.9	0.0	12.4	0.0	4.3	0.0	0.0	0.8	8.6	0.0	0.4	16.1	0.0	10.4	0.0	1.9	0.1	0.0	0.0	0.0	0.1	2.9	1.1	0.8	3.2	0.2	0.2	0.0	0.1	0.0	0.1	0.1	0.0	0.3	0.4	0.2	0.2	0.2	0.2	0.4	0.1	0.1	0.1	0.4	0.2	0.2	3.6	0.2	0.3	0.3	0.1	0.1	3.0	3.8	0.9	2.3	3.1	2.3	2.4	2.9	4.6	2.6
CCDC97	"FLJ40267, MGC20255"	ENSG00000142039	"Coiled-coil domain containing 97"	Q96F63	19	41310189-41324883	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043320, HPA043572"	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Cytosol"				Nucleoplasm	"Plasma membrane, Cytosol"	"HPA043320: AB_10964344, HPA043572: AB_10962488"	"unprognostic (9.25e-3)"	"unprognostic (7.26e-2)"	"unprognostic (1.68e-1)"	"unprognostic (5.10e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.51e-2)"	"prognostic unfavourable (1.09e-4)"	"unprognostic (8.40e-2)"	"unprognostic (1.91e-2)"	"unprognostic (2.44e-1)"	"unprognostic (5.93e-3)"	"unprognostic (4.51e-2)"	"unprognostic (2.16e-1)"	"unprognostic (2.96e-1)"	"unprognostic (4.08e-1)"	"unprognostic (7.92e-2)"	"unprognostic (1.65e-2)"	20.4	15.3	15.5	20.7	18.8	21.5	16.8	16.1	24.7	21.3	16.7	26.7	17.8	15.1	21.3	26.6	22.9	24.5	15.8	16.4	14.6	14.1	16.5	13.3	15.4	23.2	16.0	16.2	27.4	20.6	20.8	21.9	22.9	18.6	19.0	12.6	20.9	21.1	17.2	28.8	21.5	18.4	15.6	21.0	24.2	17.3	39.9	16.8	27.7	17.9	20.4	27.2	17.7	19.7	13.6	7.6	14.6	13.3	11.5	16.8	8.3	12.9	28.4	15.1	17.5	19.9	15.9	10.9	8.7	7.1	13.9	11.9	16.8	12.5	12.3	9.4	7.2	8.8	20.6	17.4	10.6	22.6	20.0	11.3	12.8	11.0	15.2	18.7	24.5	15.4	22.4	16.1	13.5	9.5	14.4	23.7	13.2	9.4	17.0	4.5	7.0	10.3	19.3	12.0	9.0	12.7	24.7	13.5	12.0	19.5	21.5	8.5	14.7	14.3	11.3	12.0	12.1	6.2	14.4	24.4	20.8	11.9	11.4	13.8	15.9	9.0	8.3	9.7	15.3	9.2	16.8	11.3	10.3	10.9	6.8	13.6	11.4	10.0	14.6	11.5	13.3	7.6	8.5	8.3	15.5	18.8	16.1	24.7	14.6	14.1	16.0	16.2	18.6	16.8
CCNT2		ENSG00000082258	"Cyclin T2"	O60583	2	134918235-134959342	"Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Host-virus interaction, Transcription, Transcription regulation"	Cyclin		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA005559	Supported		Approved	"Nucleoplasm,Plasma membrane,Cytosol"				"Nucleoplasm, Plasma membrane, Cytosol"		"HPA005559: AB_1078608"	"unprognostic (2.49e-2)"	"unprognostic (1.19e-1)"	"unprognostic (9.57e-2)"	"unprognostic (1.25e-1)"	"unprognostic (4.92e-2)"	"unprognostic (2.65e-3)"	"unprognostic (1.85e-2)"	"unprognostic (1.00e-2)"	"unprognostic (1.61e-2)"	"unprognostic (1.21e-2)"	"unprognostic (2.79e-1)"	"prognostic unfavourable (2.44e-4)"	"prognostic unfavourable (1.25e-5)"	"unprognostic (2.33e-1)"	"unprognostic (8.51e-2)"	"unprognostic (9.94e-2)"	"prognostic favourable (3.28e-4)"	15.8	14.1	21.0	15.2	19.9	32.5	21.1	30.5	22.2	16.4	14.2	16.9	17.8	17.6	22.6	20.9	15.4	16.1	12.9	14.2	16.1	14.3	12.9	20.8	17.5	18.9	18.6	16.2	22.8	24.0	25.1	29.6	17.9	20.0	18.0	16.7	11.5	16.9	19.4	14.5	20.3	17.2	18.0	17.1	19.8	18.9	15.8	19.1	23.0	18.7	9.4	18.2	18.9	19.5	3.8	4.9	6.9	4.5	6.2	8.4	3.4	6.8	3.4	22.3	8.3	11.1	11.3	17.0	9.4	7.8	8.9	11.2	9.1	7.9	11.2	7.1	7.7	8.9	13.3	7.1	13.1	6.0	9.0	12.0	8.7	12.9	10.8	10.8	10.7	10.3	14.1	8.8	10.9	13.1	10.0	11.5	10.3	4.6	11.9	16.2	18.1	7.1	11.6	8.0	8.9	13.9	18.9	15.3	12.6	6.9	8.1	10.7	8.5	13.2	11.9	11.6	12.8	4.9	6.9	8.1	5.0	11.7	7.2	8.6	9.8	6.9	3.7	4.5	4.3	4.5	5.3	3.8	4.8	5.1	4.9	3.1	8.4	6.4	4.8	6.2	2.3	4.5	5.9	3.4	21.0	19.9	30.5	22.2	16.1	14.3	18.6	16.2	20.0	19.1
CCNYL1	FLJ40432	ENSG00000163249	"Cyclin Y like 1"	Q8N7R7	2	207711540-207761839	"Predicted intracellular proteins"		Cyclin		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"BEWO: 41.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											HPA046825	Approved		Approved	"Plasma membrane"				"Plasma membrane"		"HPA046825: AB_10963934"	"unprognostic (2.59e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.03e-2)"	"unprognostic (1.20e-3)"	"unprognostic (1.78e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.31e-3)"	"unprognostic (5.48e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.41e-2)"	"unprognostic (7.12e-3)"	"unprognostic (7.99e-2)"	"unprognostic (3.92e-2)"	"unprognostic (8.08e-2)"	"unprognostic (7.91e-2)"	"unprognostic (2.37e-2)"	"unprognostic (1.96e-3)"	17.5	8.0	9.8	12.2	10.7	10.6	14.5	4.8	12.8	12.6	18.1	11.2	11.5	13.3	8.8	8.2	24.6	8.0	10.0	11.7	8.0	7.2	15.9	18.4	14.5	11.9	9.1	10.1	6.3	21.6	6.9	8.3	16.8	9.3	7.9	16.4	7.9	12.1	10.0	10.1	5.8	16.3	10.8	11.7	12.1	14.8	18.3	8.1	10.9	14.4	6.6	13.9	10.8	13.9	4.1	1.8	4.6	3.8	1.9	2.7	0.9	11.7	5.1	6.9	9.8	9.3	10.6	41.7	7.2	12.3	7.6	8.3	22.9	11.2	4.5	7.0	13.2	8.3	8.2	13.5	7.4	1.6	6.2	6.0	5.9	19.2	8.8	5.6	7.2	5.0	5.5	9.2	10.6	24.4	2.9	4.7	9.9	6.0	4.9	4.9	13.7	5.6	4.2	6.8	3.6	8.1	8.9	1.6	5.4	9.0	3.8	11.0	3.5	14.2	13.0	8.5	8.7	10.7	4.9	2.7	3.7	6.9	9.6	6.4	7.3	1.7	3.8	1.5	1.1	1.9	1.4	1.2	1.9	1.9	1.8	4.1	1.5	2.7	4.6	1.9	1.7	1.7	1.3	0.9	9.8	10.7	4.8	12.8	8.0	7.2	9.1	10.1	9.3	8.1
CD163	"M130, MM130, SCARI1"	ENSG00000177575	"CD163 molecule"	Q86VB7	12	7470813-7503893	"CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	"Acute phase, Inflammatory response"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 113.6"	"Cell line enhanced"	"Detected in some"		"ASC diff: 2.1;CACO-2: 1.9;HSkMC: 5.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	10	"classical monocyte: 28.2;myeloid DC: 25.3"	"Group enriched"	"Detected in many"	40	"dendritic cells: 25.3;monocytes: 28.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"CAB002432, HPA046404, HPA051974"	Enhanced		Approved	"Plasma membrane"	"Secreted to blood"	903333333	1600000000	"Plasma membrane"		"CAB002432: AB_563510, HPA046404: AB_2679655, HPA051974: AB_2681678"	"unprognostic (1.13e-1)"	"unprognostic (2.13e-1)"	"unprognostic (5.02e-3)"	"unprognostic (2.72e-1)"	"unprognostic (6.17e-3)"	"unprognostic (2.09e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.21e-1)"	"unprognostic (2.78e-1)"	"prognostic unfavourable (7.27e-4)"	"unprognostic (1.04e-1)"	"unprognostic (6.50e-2)"	"unprognostic (1.84e-2)"	"unprognostic (8.77e-2)"	"unprognostic (4.95e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.20e-2)"	66.7	23.8	2.1	44.6	7.2	4.1	23.2	2.8	4.9	11.3	25.3	1.6	1.4	3.5	7.2	16.8	11.3	20.1	13.2	15.7	2.8	1.8	43.9	38.9	81.0	99.8	6.9	0.5	10.3	6.7	3.1	11.7	31.9	9.9	6.8	6.5	9.8	8.6	2.2	15.2	4.0	12.5	37.2	5.7	113.6	10.2	19.6	4.3	3.4	15.5	2.9	3.5	20.1	8.3	0.0	25.3	0.6	28.2	0.0	0.0	6.3	0.0	0.0	0.0	0.0	2.1	1.1	0.4	0.0	0.1	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.6	0.0	0.6	0.3	5.9	0.0	0.4	0.6	0.0	0.0	0.0	0.2	0.0	0.1	0.6	0.6	0.0	0.1	1.0	0.1	0.0	0.0	0.3	0.6	0.1	0.2	0.0	0.0	0.3	0.0	1.1	0.3	0.2	0.0	0.3	0.0	0.0	0.3	0.0	0.1	0.5	28.2	0.1	0.0	2.5	0.0	0.0	0.0	0.0	25.3	0.0	0.0	0.0	0.6	0.0	0.0	0.3	0.0	6.3	2.1	7.2	2.8	2.4	2.8	1.8	6.9	0.5	9.9	4.3
CD164L2		ENSG00000174950	"CD164 molecule like 2"	Q6UWJ8	1	27379176-27383380	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"fallopian tube: 26.8"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 7.5;HaCaT: 3.5;HBEC3-KT: 3.9;hTCEpi: 5.3;SK-BR-3: 4.8;T-47d: 2.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA062915	Enhanced		Approved	"Plasma membrane,Cytosol"				Cytosol	"Plasma membrane"	"HPA062915: "	"unprognostic (8.97e-3)"	"unprognostic (2.15e-2)"	"unprognostic (3.56e-2)"	"unprognostic (1.36e-2)"	"unprognostic (1.04e-1)"	"prognostic favourable (1.64e-5)"		"unprognostic (7.81e-3)"	"unprognostic (4.47e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.65e-2)"	"unprognostic (4.07e-2)"	"unprognostic (5.91e-6)"	"unprognostic (1.33e-2)"	"unprognostic (6.42e-2)"	"unprognostic (1.34e-2)"	"unprognostic (2.71e-2)"	0.1	0.1	0.2	0.1	0.5	0.0	2.3	0.1	0.4	3.2	0.4	0.7	1.2	0.0	0.4	12.6	13.4	26.8	0.1	0.1	0.4	0.4	0.4	0.3	7.4	0.1	0.1	0.6	3.3	0.3	0.4	5.8	0.1	1.1	2.4	0.2	1.0	12.9	0.3	0.1	8.1	0.1	0.1	0.1	0.1	0.2	1.0	0.4	0.1	0.9	5.9	6.0	0.1	5.5	0.0	0.0	0.0	0.0	0.0	0.5	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.5	0.0	0.0	0.0	3.5	0.0	3.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	5.3	0.0	0.6	0.0	0.1	0.0	0.0	0.7	0.0	0.0	0.7	0.1	0.0	0.0	0.1	1.0	0.0	0.9	0.0	0.0	4.8	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.5	0.1	0.4	0.4	0.4	0.1	0.6	1.1	0.4
CD248	"CD164L1, TEM1"	ENSG00000174807	"CD248 molecule"	Q9HCU0	11	66314487-66317044	"CD markers, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 71.0"	"Cell line enhanced"	"Detected in some"		"ASC diff: 66.6;ASC TERT1: 65.7;BJ hTERT+: 43.3;fHDF/TERT166: 58.0;HSkMC: 70.0;U-2197: 104.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in some"	6	"naive CD8 T-cell: 17.8"	"Lineage enriched"	"Detected in single"	122	"T-cells: 17.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA051856	Enhanced		Approved	"Nucleoplasm,Plasma membrane"			27000000	"Plasma membrane"	Nucleoplasm	"HPA051856: "	"unprognostic (2.26e-1)"	"unprognostic (1.72e-1)"	"unprognostic (8.95e-2)"	"unprognostic (2.77e-2)"	"unprognostic (1.14e-2)"	"unprognostic (2.61e-1)"	"unprognostic (7.21e-3)"	"unprognostic (1.36e-2)"	"unprognostic (1.01e-1)"	"unprognostic (2.82e-2)"	"unprognostic (6.31e-2)"	"unprognostic (4.77e-2)"	"prognostic unfavourable (2.69e-7)"	"unprognostic (1.90e-2)"	"unprognostic (2.92e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.30e-2)"	59.2	3.5	0.8	14.4	2.5	0.0	55.2	0.6	2.2	21.2	7.6	1.9	6.3	2.7	14.1	22.9	14.8	17.7	12.3	18.2	1.2	0.5	5.3	1.7	9.3	16.2	1.3	1.6	15.6	4.9	1.4	2.3	71.0	2.1	10.6	2.7	11.5	4.6	8.0	6.7	13.3	7.5	27.6	1.2	1.9	7.5	8.0	0.7	4.1	9.4	6.6	4.5	19.5	17.6	0.1	0.0	0.0	0.0	0.0	17.8	1.9	0.0	0.0	0.6	0.0	66.6	65.7	0.0	28.8	43.3	2.1	2.0	0.0	0.0	0.0	0.7	58.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.4	13.2	0.0	0.0	70.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.4	0.3	0.1	1.2	0.0	0.0	0.0	0.0	0.3	1.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	104.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.8	0.0	0.0	2.3	0.0	0.1	2.8	17.8	0.0	0.0	0.0	0.0	0.0	1.9	0.8	2.5	0.6	2.2	1.2	0.5	1.3	1.6	2.1	0.7
CD34		ENSG00000174059	"CD34 molecule"	P28906	1	207880972-207911402	"CD markers, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"HUVEC TERT2: 31.8;MOLT-4: 31.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000018, HPA036722, HPA036723"	Enhanced		Approved	"Nucleoplasm,Plasma membrane,Cell Junctions"			69000000	"Plasma membrane, Cell Junctions"	Nucleoplasm	"CAB000018: AB_2063006, HPA036722: , HPA036723: "	"unprognostic (3.82e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.04e-1)"	"unprognostic (3.09e-1)"	"unprognostic (1.24e-1)"	"prognostic favourable (5.93e-5)"	"unprognostic (1.25e-2)"	"unprognostic (7.74e-2)"	"unprognostic (7.65e-2)"	"unprognostic (3.53e-1)"	"unprognostic (1.37e-3)"	"unprognostic (6.95e-2)"	"prognostic unfavourable (8.47e-4)"	"unprognostic (1.51e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.01e-2)"	61.9	8.8	4.6	12.8	7.6	1.9	37.5	3.1	6.7	38.3	15.9	5.2	20.5	5.0	41.4	40.3	33.8	22.3	20.6	51.2	5.4	4.9	18.8	2.2	25.0	11.9	8.1	6.7	20.7	8.6	7.8	3.6	78.9	6.3	21.0	7.4	12.8	12.4	20.5	39.7	21.2	12.1	42.3	4.7	9.2	11.3	23.1	4.7	3.5	25.8	35.9	11.0	33.6	33.1	0.6	1.7	1.6	0.3	0.6	0.5	1.5	0.0	0.0	0.0	0.0	1.6	0.1	0.1	0.2	1.1	0.3	0.9	0.0	0.0	0.0	3.1	0.3	0.0	0.0	0.0	0.3	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	31.8	0.0	0.0	0.8	0.0	31.4	0.1	0.2	0.0	0.0	1.8	0.0	0.1	0.0	0.0	0.1	0.0	0.3	0.0	1.1	0.0	4.8	0.1	1.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	1.6	0.2	0.3	0.5	0.2	0.5	0.3	0.3	0.2	0.2	0.6	0.3	0.3	1.1	0.6	0.3	1.7	0.2	1.5	4.6	7.6	3.1	6.7	5.4	4.9	8.1	6.7	6.3	4.7
CD93	"C1qR(P), C1QR1, C1qRP, CDw93, dJ737E23.1, ECSM3, MXRA4"	ENSG00000125810	"CD93 molecule"	Q9NPY3	20	23079349-23086340	"CD markers, Plasma proteins, Predicted membrane proteins"	"Cell adhesion, Host-virus interaction"	Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"HUVEC TERT2: 57.0;TIME: 72.2;U-937: 96.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"classical monocyte: 14.4;neutrophil: 17.4"	"Group enriched"	"Detected in many"	40	"dendritic cells: 5.5;granulocytes: 17.4;monocytes: 14.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA009300, HPA012368"	Enhanced		Approved	"Vesicles,Plasma membrane"			440000000	"Vesicles, Plasma membrane"		"HPA009300: AB_1846342, HPA012368: AB_1846341"	"unprognostic (2.05e-1)"	"unprognostic (2.85e-1)"	"unprognostic (1.07e-1)"	"unprognostic (4.83e-2)"	"unprognostic (2.31e-1)"	"unprognostic (2.66e-2)"	"unprognostic (6.45e-2)"	"unprognostic (2.77e-1)"	"unprognostic (4.51e-1)"	"unprognostic (3.74e-2)"	"unprognostic (2.61e-1)"	"unprognostic (1.81e-1)"	"prognostic unfavourable (2.74e-4)"	"unprognostic (8.81e-3)"	"unprognostic (6.13e-2)"	"unprognostic (4.49e-2)"	"unprognostic (3.11e-2)"	50.5	6.1	2.4	15.0	3.4	4.7	31.4	1.0	3.0	13.6	8.1	1.7	3.9	3.2	14.3	12.5	10.0	13.6	14.2	33.3	2.4	2.2	10.8	10.9	34.8	25.3	4.1	1.2	11.6	5.9	5.1	4.3	48.9	5.3	9.7	4.3	4.9	5.9	3.9	16.2	6.8	7.7	15.4	4.3	17.5	7.5	6.9	3.3	6.9	12.3	9.3	4.5	15.6	12.2	0.0	5.5	17.4	14.4	0.0	0.3	4.7	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	57.0	0.1	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.1	0.0	4.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.0	72.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	96.6	0.0	0.0	14.4	0.2	0.2	10.3	0.0	0.0	0.1	0.0	5.5	0.0	0.0	0.0	17.4	0.0	4.2	0.7	0.3	4.7	2.4	3.4	1.0	3.0	2.4	2.2	4.1	1.2	5.3	3.3
CDC42EP1	"Borg5, CEP1, MSE55"	ENSG00000128283	"CDC42 effector protein 1"	Q00587	22	37560447-37569405	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	8	"classical monocyte: 9.4;intermediate monocyte: 2.9;myeloid DC: 3.5"	"Group enriched"	"Detected in many"	10	"dendritic cells: 3.5;monocytes: 9.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006379	Approved		Supported	"Plasma membrane,Actin filaments"				"Plasma membrane, Actin filaments"		"HPA006379: AB_1078486"	"unprognostic (1.32e-1)"	"unprognostic (1.81e-1)"	"unprognostic (2.44e-1)"	"unprognostic (3.79e-3)"	"unprognostic (5.82e-2)"	"unprognostic (4.06e-2)"	"unprognostic (4.38e-2)"	"unprognostic (5.57e-2)"	"unprognostic (9.45e-2)"	"unprognostic (1.63e-1)"	"unprognostic (2.06e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.86e-2)"	"unprognostic (2.85e-2)"	"unprognostic (3.85e-2)"	"unprognostic (3.81e-2)"	"unprognostic (1.09e-3)"	19.1	26.2	12.1	10.6	29.4	1.9	21.9	2.9	27.3	17.2	13.0	68.7	7.2	19.7	21.0	6.2	25.0	20.4	31.9	12.2	18.3	10.1	14.6	57.4	18.6	6.9	41.4	13.1	31.7	80.8	7.4	5.7	24.9	28.7	11.5	9.9	12.0	36.5	16.9	7.2	22.4	13.8	13.2	34.5	9.7	69.5	8.8	34.2	0.4	9.7	14.2	14.2	10.3	19.2	0.6	3.5	0.4	9.4	0.6	0.3	3.5	30.2	8.8	3.8	17.1	6.1	10.5	18.6	17.4	10.3	20.1	13.9	21.5	3.9	0.0	6.1	20.1	23.6	4.5	8.7	6.7	3.7	15.2	0.1	8.5	12.9	43.8	0.0	0.1	19.5	13.2	16.5	15.8	14.9	18.9	0.1	8.2	10.3	0.0	0.1	3.4	19.9	0.1	6.9	0.6	7.0	0.4	0.1	0.7	12.7	28.4	27.2	12.6	2.7	22.7	42.2	25.2	20.2	24.0	0.0	0.1	0.0	16.7	0.1	33.9	0.4	9.4	0.0	0.2	2.9	0.2	0.0	0.1	0.1	3.5	0.6	0.1	0.3	0.3	0.6	0.2	0.4	0.0	3.5	12.1	29.4	2.9	27.3	18.3	10.1	41.4	13.1	28.7	34.2
CDH8		ENSG00000150394	"Cadherin 8"	P55286	16	61647242-62037035	"Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 29.6;seminal vesicle: 9.5"	"Group enriched"	"Detected in some"	4	"AF22: 6.8;fHDF/TERT166: 6.0;HaCaT: 13.6;LHCN-M2: 16.4"	"Cancer enhanced"	"Detected in single"		"testis cancer: 0.6"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in single"		"basophil: 1.0"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA014908, HPA076441"	Approved		Approved	"Plasma membrane"				"Plasma membrane"		"HPA014908: AB_1845908, HPA076441: "	"unprognostic (1.91e-1)"	"unprognostic (2.41e-1)"	"unprognostic (4.02e-2)"	"unprognostic (7.70e-2)"	"unprognostic (1.96e-1)"	"unprognostic (3.26e-2)"	"unprognostic (1.83e-1)"	"unprognostic (8.71e-2)"	"unprognostic (3.66e-2)"	"unprognostic (5.41e-2)"	"unprognostic (2.85e-1)"	"unprognostic (6.59e-2)"	"unprognostic (2.91e-4)"	"unprognostic (6.02e-2)"	"unprognostic (4.06e-1)"	"unprognostic (2.26e-1)"	"unprognostic (1.06e-1)"	0.9	0.9	13.0	0.7	20.4	0.7	1.2	0.5	29.6	1.4	0.8	5.5	0.0	1.2	0.9	1.1	1.0	0.7	1.1	1.1	10.4	7.7	0.8	0.7	0.9	0.7	9.3	12.2	3.7	0.7	0.8	0.9	1.3	12.8	1.4	0.9	0.0	1.4	9.5	1.4	0.9	1.0	1.4	7.7	0.8	0.8	1.2	5.6	0.0	1.0	0.0	0.8	1.7	0.3	0.0	0.0	1.0	0.2	0.1	0.1	0.0	0.0	0.0	6.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	6.0	13.6	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.3	0.0	16.4	0.0	0.0	0.0	1.2	1.2	0.0	0.0	1.0	0.0	1.8	0.1	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.2	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.1	0.1	0.0	0.1	0.0	13.0	20.4	0.5	17.8	10.4	7.7	9.3	12.2	12.8	5.6
CDIPT	"PIS, PIS1"	ENSG00000103502	"CDP-diacylglycerol--inositol 3-phosphatidyltransferase"	O14735	16	29858357-29863736	"Enzymes, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA056597	Approved		Approved	"Nucleoplasm,Nuclear membrane,Plasma membrane"				"Nucleoplasm, Nuclear membrane, Plasma membrane"		"HPA056597: "	"unprognostic (7.81e-2)"	"prognostic favourable (9.40e-4)"	"unprognostic (1.93e-3)"	"unprognostic (8.08e-3)"	"unprognostic (1.50e-2)"	"unprognostic (2.84e-2)"	"unprognostic (7.60e-2)"	"unprognostic (1.09e-2)"	"unprognostic (7.03e-2)"	"unprognostic (8.75e-2)"	"unprognostic (5.56e-3)"	"unprognostic (1.61e-1)"	"unprognostic (6.17e-2)"	"unprognostic (3.36e-2)"	"unprognostic (6.95e-2)"	"unprognostic (1.56e-1)"	"unprognostic (2.48e-1)"	40.4	40.8	24.3	20.2	28.1	15.3	42.9	50.7	39.5	37.1	37.2	21.5	33.9	24.8	33.4	23.0	39.4	30.1	34.5	44.4	23.1	27.9	34.8	66.3	27.1	22.4	24.1	26.4	52.7	40.0	47.1	24.9	43.7	21.8	36.8	16.1	29.3	42.2	38.8	21.0	29.6	32.6	31.8	21.0	25.6	29.5	20.2	16.4	30.4	47.1	19.9	17.3	41.8	42.8	4.8	6.1	20.6	6.5	8.2	8.4	2.7	12.3	26.8	7.5	15.1	41.3	28.6	22.4	21.7	24.3	15.4	15.4	15.6	23.8	8.3	41.1	25.0	19.5	12.2	14.0	7.1	20.7	24.5	5.9	20.0	22.8	28.8	8.8	15.4	48.3	24.8	20.7	9.5	19.3	8.8	21.5	13.9	39.4	11.9	17.4	18.0	20.0	23.3	9.4	24.1	20.3	11.9	31.2	17.5	11.5	24.5	17.1	18.3	23.9	16.7	22.9	7.2	18.6	11.1	16.0	18.1	5.9	25.0	14.2	13.8	7.5	6.5	20.6	6.9	4.6	4.6	4.7	6.4	7.3	3.0	4.8	6.3	5.9	16.4	8.2	5.7	6.1	8.4	2.7	24.3	28.1	50.7	39.5	23.1	27.9	24.1	26.4	21.8	16.4
CDRT15		ENSG00000223510	"CMT1A duplicated region transcript 15"	Q96T59	17	14235673-14236862	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"skin 1: 5.1;testis: 19.0"	"Cell line enhanced"	"Detected in many"		"HEK 293: 6.9"	"Not detected"	"Not detected"							"Cell type enhanced"	"Detected in single"		"T-reg: 2.0"	"Low lineage specificity"	"Detected in single"											HPA055952	Uncertain		Approved	"Plasma membrane"				"Plasma membrane"		"HPA055952: "	"unprognostic (3.27e-2)"	"unprognostic (1.77e-2)"	"unprognostic (8.61e-2)"	"unprognostic (9.33e-2)"	"unprognostic (5.15e-3)"	"unprognostic (2.90e-1)"	"unprognostic (6.16e-3)"	"unprognostic (1.98e-1)"	"unprognostic (1.15e-3)"	"unprognostic (2.66e-1)"	"unprognostic (2.55e-1)"	"unprognostic (1.99e-1)"	"unprognostic (5.30e-7)"	"unprognostic (1.55e-1)"	"unprognostic (1.52e-1)"	"unprognostic (6.81e-2)"	"unprognostic (2.38e-2)"	0.1	0.3	0.0	1.5	0.0	0.5	0.1	0.3	0.1	0.2	0.2			0.9	0.1	0.0	0.4	0.2	0.4	0.2	0.1	0.1	0.1	0.5	0.2	3.8	0.1		0.4	0.2	0.0	0.1	0.0		0.2	0.0		0.9	0.0	0.1	5.1	1.0	0.0	0.3	1.1	0.4	19.0			0.5		0.0	0.2	0.2	0.2	0.3	0.5	0.1	0.0	2.0	0.0	1.3	2.3	1.6	3.7	0.0	0.0	0.9	1.4	0.0	0.0	0.1	4.4	0.6	3.7	0.9	0.0	1.7	0.0	0.0	0.0	3.7	6.9	2.1	3.8	3.1	0.0	1.7	2.7	0.0	0.0	0.0	0.0	0.0	1.7	0.8	0.0	0.9	1.8	2.7	1.5	2.3	1.4	0.7	1.5	0.0	1.9	1.8	3.3	0.4	1.0	0.6	0.8	0.9	2.0	6.0	0.9	1.4	1.6	1.2	1.4	1.7	0.9	2.8	4.3	0.0	0.1	0.5	0.4	0.0	0.0	0.2	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.0	0.0										
CEP55	"C10orf3, CT111, FLJ10540"	ENSG00000138180	"Centrosomal protein 55"	Q53EZ4	10	93496632-93529092	"Disease related genes, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	"Developmental protein"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 52.9;testis: 19.3"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	9	"T-reg: 4.4"	"Lineage enriched"	"Detected in single"	24	"T-cells: 4.4"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			HPA023430	Approved		Supported	"Plasma membrane,Midbody,Centriolar satellite"				"Plasma membrane, Centriolar satellite"	Midbody	"HPA023430: AB_10960212"	"unprognostic (9.85e-2)"	"unprognostic (1.12e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.29e-1)"	"unprognostic (5.15e-2)"	"unprognostic (4.26e-2)"	"prognostic unfavourable (3.20e-9)"	"prognostic unfavourable (1.45e-4)"	"unprognostic (1.50e-1)"	"unprognostic (1.05e-1)"	"prognostic unfavourable (2.66e-5)"	"unprognostic (3.99e-2)"	"prognostic unfavourable (0.00e+0)"	"prognostic favourable (3.15e-4)"	"unprognostic (7.86e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.63e-1)"	3.2	1.4	0.5	12.1	0.4	3.1	3.6	0.3	0.6	2.0	5.2	0.3	0.2	4.6	0.8	1.5	11.6	0.6	2.5	0.7	0.4	0.5	1.5	0.7	4.4	10.1	0.6	0.2	0.8	0.6	0.0	0.7	3.8	0.5	0.8	6.5	0.4	2.3	0.2	0.7	3.0	5.2	3.5	1.1	4.8	3.2	19.3	0.3	52.9	0.7	10.8	11.0	2.7	3.3	0.1	0.1	0.0	0.0	0.0	4.4	0.0	51.0	20.4	13.6	17.2	1.5	3.1	7.6	28.1	19.9	26.7	27.7	21.6	27.5	13.6	12.4	18.2	29.2	16.4	13.8	32.1	41.0	8.5	5.1	12.6	7.3	0.1	8.8	11.9	0.7	1.0	28.4	34.7	24.6	4.6	25.9	30.1	11.8	23.2	13.4	5.3	14.9	10.1	22.2	7.5	12.0	6.3	5.6	7.9	21.6	6.7	17.0	17.5	9.0	15.3	16.9	23.7	23.2	46.1	11.6	15.7	16.7	13.2	33.4	15.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.5	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	4.4	0.0	0.5	0.4	0.3	0.6	0.4	0.5	0.6	0.2	0.5	0.3
CEP57L1	"bA487F23.2, C6orf182, MGC21731"	ENSG00000183137	"Centrosomal protein 57 like 1"	Q8IYX8	6	109095110-109163932	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040378	Approved		Approved	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		"HPA040378: AB_10794028"	"unprognostic (5.93e-3)"	"unprognostic (4.95e-2)"	"unprognostic (1.40e-2)"	"unprognostic (2.13e-2)"	"unprognostic (1.11e-1)"	"unprognostic (3.41e-2)"	"unprognostic (4.69e-3)"	"unprognostic (3.63e-2)"	"unprognostic (7.25e-2)"	"unprognostic (1.27e-1)"	"unprognostic (2.33e-1)"	"unprognostic (9.97e-2)"	"unprognostic (2.42e-5)"	"unprognostic (2.37e-1)"	"unprognostic (2.00e-1)"	"unprognostic (8.48e-2)"	"unprognostic (1.72e-1)"	11.9	9.3	10.6	7.3	13.5	8.9	11.4	13.9	16.1	11.3	8.8	8.1	8.6	8.4	9.6	10.9	8.0	7.1	9.3	10.4	8.9	6.9	8.1	11.8	8.4	8.1	10.2	10.5	9.3	7.5	18.5	13.5	9.7	13.5	7.1	11.1	7.0	7.4	7.3	7.8	6.8	7.6	10.7	12.8	7.2	7.8	24.6	11.8	6.3	8.7	6.1	6.9	7.6	9.1	7.4	6.9	14.6	10.3	13.4	8.2	5.2	8.3	3.6	11.0	11.2	10.6	17.5	8.9	19.4	10.6	17.2	19.7	5.5	7.3	7.4	8.9	9.9	4.4	7.7	7.1	27.2	9.5	7.5	16.0	8.8	5.8	9.7	13.1	7.1	10.0	5.5	14.7	14.6	15.0	28.9	25.9	15.7	5.6	14.5	11.4	3.6	7.1	12.0	8.4	7.5	8.2	3.5	8.6	7.0	9.4	7.1	6.3	9.0	20.9	7.2	11.4	6.8	12.0	20.2	7.6	8.6	11.8	10.8	20.2	9.1	14.6	6.3	7.4	6.1	7.1	6.2	4.0	6.0	8.2	6.7	7.4	5.8	8.2	3.6	13.4	10.3	6.9	8.0	5.2	10.6	13.5	13.9	16.1	8.9	6.9	10.2	10.5	13.5	11.8
CEP89	"CCDC123, FLJ14640"	ENSG00000121289	"Centrosomal protein 89"	Q96ST8	19	32875925-32971991	"Disease related genes, Predicted intracellular proteins"	"Cilium biogenesis/degradation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039382, HPA040056"			Supported	"Plasma membrane,Cytosol"	"Intracellular and membrane"			Cytosol	"Plasma membrane"	"HPA039382: , HPA040056: AB_10671048"	"unprognostic (4.23e-2)"	"unprognostic (7.50e-3)"	"unprognostic (1.97e-1)"	"unprognostic (1.53e-3)"	"unprognostic (1.30e-1)"	"unprognostic (1.08e-1)"	"prognostic unfavourable (8.78e-5)"	"unprognostic (1.12e-1)"	"unprognostic (4.55e-2)"	"unprognostic (3.04e-2)"	"unprognostic (1.80e-2)"	"unprognostic (4.00e-2)"	"unprognostic (1.74e-1)"	"unprognostic (4.48e-2)"	"unprognostic (6.53e-2)"	"unprognostic (3.03e-1)"	"unprognostic (2.47e-2)"	10.1	9.5	8.5	8.3	12.1	6.8	11.6	16.4	14.4	12.9	10.5	12.5	9.7	6.4	17.0	11.3	10.1	14.8	8.3	8.8	8.1	6.4	9.8	5.6	9.4	8.9	7.9	8.4	17.1	9.0	11.3	20.2	8.8	9.1	15.0	7.4	10.2	10.3	10.2	10.5	10.7	7.4	11.4	6.6	7.7	8.1	8.4	8.4	10.1	11.8	5.0	7.6	10.2	11.4	7.7	5.1	12.7	6.1	2.8	6.9	2.1	13.1	18.1	12.6	10.8	6.8	8.0	7.3	10.7	7.1	18.9	14.5	6.5	8.2	5.4	5.8	10.8	7.6	12.3	8.6	13.1	14.2	7.5	4.2	12.6	6.2	5.4	5.8	4.2	9.6	12.0	17.8	11.7	14.1	6.4	8.1	8.7	10.0	6.6	4.5	5.4	5.8	7.3	6.8	4.7	8.6	7.4	17.8	13.1	10.9	7.6	6.1	5.7	4.8	9.0	13.7	12.2	11.7	10.8	4.0	6.2	4.9	11.8	5.5	10.2	12.7	4.4	2.1	4.0	6.1	6.9	4.7	4.2	3.4	2.4	7.7	4.1	4.7	5.3	2.8	3.0	5.1	4.4	2.1	8.5	12.1	16.4	14.4	8.1	6.4	7.9	8.4	9.1	8.4
CFAP58	"bA554P13.1, C10orf80, CCDC147, FLJ35908"	ENSG00000120051	"Cilia and flagella associated protein 58"	Q5T655	10	104353764-104455090	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"fallopian tube: 10.9;testis: 17.5"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 5.1;U-2 OS: 10.7"	"Low cancer specificity"	"Detected in some"			"Region enhanced"	"Detected in many"		"pons and medulla: 6.8"	"Cell type enriched"	"Detected in single"	6	"neutrophil: 5.5"	"Lineage enriched"	"Detected in single"	55	"granulocytes: 5.5"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"HPA036555, HPA071938"	Uncertain		Approved	"Vesicles,Plasma membrane,Cytosol"				Vesicles	"Plasma membrane, Cytosol"	"HPA036555: AB_10673622, HPA071938: "	"unprognostic (5.32e-1)"	"unprognostic (2.59e-1)"	"unprognostic (6.26e-2)"	"unprognostic (1.57e-3)"	"unprognostic (5.41e-3)"	"unprognostic (1.01e-1)"	"unprognostic (9.62e-2)"	"unprognostic (5.64e-2)"	"unprognostic (3.11e-1)"	"unprognostic (2.18e-1)"	"unprognostic (8.93e-2)"	"unprognostic (3.15e-1)"	"unprognostic (1.65e-1)"	"unprognostic (3.97e-2)"	"unprognostic (6.81e-2)"	"unprognostic (4.19e-2)"	"unprognostic (1.59e-1)"	0.3	0.5	0.8	0.6	2.0	0.4	0.3	0.7	1.0	3.0	0.3	2.9	0.3	0.1	2.3	0.3	0.3	10.9	0.3	3.0	1.4	1.5	0.3	0.3	2.1	0.3	0.3	0.3	2.0	0.3	1.5	1.9	0.4	6.8	0.4	0.0	0.6	0.3	0.4	1.4	0.2	0.3	0.8	0.3	0.3	0.1	17.5	0.7	0.3	0.8	0.3	0.4	0.3	0.7	0.0	0.0	5.5	0.0	0.0	0.0	0.0	0.1	0.0	1.2	0.1	0.2	0.6	0.2	1.7	5.1	1.0	2.8	0.0	0.0	3.9	0.4	0.6	0.3	0.0	0.3	3.1	0.4	0.2	0.9	1.2	0.0	0.6	0.5	0.7	0.6	2.2	0.8	2.7	1.6	1.0	1.2	1.3	0.0	0.0	1.1	0.3	0.0	0.4	0.3	0.5	0.6	0.0	0.6	0.4	0.0	0.2	0.9	0.3	0.6	3.3	1.1	10.7	0.6	3.0	0.3	0.1	0.2	1.2	1.3	3.4	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.5	0.0	0.0	0.0	0.0	0.0	0.8	2.0	0.7	1.0	1.4	1.5	0.3	0.3	6.8	0.7
CFL2	NEM7	ENSG00000165410	"Cofilin 2"	Q9Y281	14	34706769-34714823	"Disease related genes, Plasma proteins, Predicted intracellular proteins"		Actin-binding	"Disease mutation, Nemaline myopathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 88.5;skeletal muscle: 185.9"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB037078, HPA045599"	Enhanced		Approved	"Nucleoplasm,Plasma membrane,Cytosol"			90000000	"Nucleoplasm, Cytosol"	"Plasma membrane"	"CAB037078: AB_259128, HPA045599: "	"unprognostic (1.05e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.29e-2)"	"unprognostic (1.59e-1)"	"unprognostic (3.02e-2)"	"unprognostic (2.80e-3)"	"unprognostic (3.82e-1)"	"unprognostic (2.02e-1)"	"unprognostic (3.02e-1)"	"unprognostic (2.92e-2)"	"unprognostic (2.48e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.65e-2)"	"unprognostic (3.13e-3)"	"unprognostic (9.59e-2)"	"unprognostic (1.89e-2)"	"prognostic unfavourable (2.16e-5)"	14.0	16.5	15.9	8.8	17.7	5.0	6.7	13.6	16.6	13.7	23.2	25.8	9.2	4.7	21.3	10.2	20.7	11.2	7.2	88.5	19.0	14.5	8.7	33.0	7.8	3.7	22.7	10.6	12.9	3.0	9.3	4.5	10.3	28.9	22.4	8.6	7.8	5.4	31.8	185.9	2.6	6.7	38.1	24.6	4.2	11.9	6.9	20.1	0.5	9.0	30.8	3.4	34.7	9.3	8.5	2.9	3.6	1.8	3.2	5.8	1.6	17.6	15.9	10.2	6.6	10.4	39.0	5.8	30.8	35.5	29.5	31.5	11.9	7.6	6.3	12.6	49.1	3.5	21.8	6.5	52.0	0.8	9.0	1.3	18.8	28.2	17.0	1.6	1.0	29.5	2.3	25.1	13.9	29.2	1.9	5.0	36.2	5.0	1.2	0.8	3.3	24.4	1.1	32.5	0.9	10.7	3.6	2.1	8.8	20.1	4.3	10.4	9.6	1.5	25.6	29.4	19.6	13.8	14.7	7.0	4.5	2.4	10.8	2.3	6.9	3.6	1.8	2.1	3.7	1.8	5.8	8.5	4.3	4.0	2.9	5.0	3.4	3.5	0.7	3.2	0.8	2.8	3.6	1.6	15.9	17.7	13.6	16.6	19.0	14.5	22.7	10.6	28.9	20.1
CHD8	"DUPLIN, HELSNF1, KIAA1564"	ENSG00000100888	"Chromodomain helicase DNA binding protein 8"	Q9HCK8	14	21385194-21456126	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Transcription, Transcription regulation, Wnt signaling pathway"	"Activator, Chromatin regulator, DNA-binding, Helicase, Hydrolase, Repressor"	"Autism, Autism spectrum disorder, Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA052186, HPA076133"			Enhanced	"Nucleoplasm,Plasma membrane"				Nucleoplasm	"Plasma membrane"	"HPA052186: , HPA076133: "	"unprognostic (3.45e-1)"	"unprognostic (9.71e-2)"	"unprognostic (3.31e-1)"	"unprognostic (2.67e-1)"	"unprognostic (1.14e-1)"	"unprognostic (3.43e-1)"	"prognostic unfavourable (4.94e-4)"	"unprognostic (7.31e-2)"	"unprognostic (9.22e-2)"	"prognostic favourable (8.35e-4)"	"unprognostic (1.64e-1)"	"unprognostic (2.63e-2)"	"unprognostic (2.54e-3)"	"unprognostic (2.88e-1)"	"unprognostic (9.24e-2)"	"unprognostic (2.51e-1)"	"unprognostic (8.07e-3)"	13.9	14.5	13.0	14.8	21.5	34.8	17.0	28.9	25.7	15.8	14.4	26.6	14.1	11.1	18.3	13.4	17.4	15.9	11.7	12.3	13.5	13.3	14.0	11.2	15.5	18.5	15.4	15.2	20.7	19.0	34.7	25.3	15.2	20.3	16.3	14.6	19.3	15.7	14.9	16.9	24.5	16.4	17.2	13.1	19.2	16.1	15.2	18.1	29.9	17.4	10.4	24.8	16.6	14.5	12.3	7.8	12.8	7.4	8.7	8.6	3.0	16.2	21.3	23.6	11.0	15.1	13.1	13.4	12.9	14.9	19.7	19.7	18.5	14.1	26.9	8.2	17.3	20.0	28.9	18.2	25.0	20.6	13.2	23.6	14.3	22.4	14.0	32.6	22.5	17.6	14.8	22.1	15.9	17.5	16.4	14.4	14.9	17.5	23.4	13.3	18.0	18.1	22.0	17.9	9.1	14.6	30.1	17.3	16.6	20.3	15.8	11.2	11.1	15.8	20.5	16.4	12.6	9.6	15.3	16.4	19.5	26.9	6.6	12.1	16.3	12.8	4.8	12.1	7.7	5.0	8.6	5.8	6.8	7.5	3.3	12.3	7.4	6.4	11.0	8.7	7.4	7.8	5.7	3.0	13.0	21.5	28.9	25.7	13.5	13.3	15.4	15.2	20.3	18.1
CHD9	"BC022889, FLJ12178, KIAA0308"	ENSG00000177200	"Chromodomain helicase DNA binding protein 9"	Q3L8U1	16	53055033-53329150	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator, DNA-binding, Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"plasmacytoid DC: 42.9"	"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042053, HPA049420"	Approved		Approved	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		"HPA042053: , HPA049420: "	"unprognostic (3.57e-2)"	"unprognostic (3.73e-2)"	"unprognostic (3.44e-3)"	"unprognostic (2.42e-1)"	"unprognostic (4.34e-2)"	"unprognostic (4.35e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.68e-1)"	"unprognostic (7.75e-3)"	"unprognostic (2.87e-2)"	"unprognostic (3.39e-1)"	"unprognostic (2.35e-2)"	"prognostic favourable (1.84e-4)"	"unprognostic (4.96e-2)"	"unprognostic (1.74e-1)"	"unprognostic (5.09e-2)"	"unprognostic (2.87e-1)"	18.0	12.6	14.5	12.5	17.3	30.3	15.7	49.3	19.6	18.5	13.8	6.6	17.4	8.0	14.2	15.0	14.4	13.5	11.6	12.2	15.9	8.2	16.8	12.3	12.3	9.2	16.0	12.3	18.8	12.9	28.1	39.9	12.3	15.1	13.7	11.5	8.9	17.8	15.3	17.1	14.4	11.1	11.6	20.1	11.6	13.4	7.0	18.7	15.6	17.7	11.2	9.4	13.9	15.1	16.4	42.9	23.7	12.7	12.1	8.8	1.7	5.7	6.7	15.0	12.2	11.2	16.4	2.6	10.6	7.8	5.6	2.5	3.7	5.2	7.7	6.9	8.7	7.0	7.8	5.5	7.9	2.7	5.8	10.9	6.4	2.3	7.8	15.1	9.1	11.3	5.6	8.2	10.4	8.3	12.7	2.6	7.0	2.2	7.5	3.4	5.4	5.1	26.5	18.0	3.3	3.4	5.4	6.4	7.1	9.4	3.1	7.8	3.4	7.0	16.0	10.6	5.4	3.9	7.1	8.0	5.5	13.5	7.5	6.5	10.4	23.7	9.2	8.9	5.7	7.6	8.8	12.5	3.9	6.2	5.4	16.4	3.1	4.4	3.0	12.1	12.7	42.9	1.9	1.7	14.5	17.3	49.3	19.6	15.9	8.2	16.0	12.3	15.1	18.7
CHMP2A	"BC-2, CHMP2, VPS2, VPS2A"	ENSG00000130724	"Charged multivesicular body protein 2A"	O43633	19	58551566-58555124	"Predicted intracellular proteins"	"Host-virus interaction, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HEK 293: 104.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041153, HPA042031"	Enhanced		Approved	"Nucleoplasm,Plasma membrane,Cytosol"			49000	Cytosol	"Nucleoplasm, Plasma membrane"	"HPA041153: AB_10964358, HPA042031: AB_10961727"	"unprognostic (1.80e-1)"	"unprognostic (4.70e-2)"	"unprognostic (7.29e-2)"	"unprognostic (1.44e-3)"	"unprognostic (6.60e-2)"	"unprognostic (2.54e-1)"	"unprognostic (3.86e-2)"	"unprognostic (2.60e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.45e-2)"	"unprognostic (2.69e-1)"	"unprognostic (1.45e-1)"	"unprognostic (2.98e-1)"	"unprognostic (2.21e-1)"	"unprognostic (3.09e-2)"	"unprognostic (4.23e-2)"	"unprognostic (2.71e-2)"	40.7	59.6	52.5	37.3	56.7	55.1	41.2	36.3	44.8	39.0	53.2	37.8	50.4	43.5	36.9	61.7	57.4	41.9	60.4	80.6	45.0	40.1	64.8	66.5	36.4	55.8	48.2	38.7	36.9	59.8	46.9	39.1	79.2	38.5	35.2	49.2	33.0	62.4	64.8	75.7	54.9	72.0	42.4	48.5	43.4	45.2	29.4	35.1	34.0	49.8	53.9	44.4	42.5	34.0	17.5	30.5	117.2	34.7	17.0	29.4	24.9	17.7	48.1	15.5	14.2	24.0	30.1	19.1	16.5	34.2	8.8	9.6	14.1	26.6	4.7	24.4	27.6	14.6	12.8	31.5	7.5	15.9	104.7	11.6	35.2	21.7	46.5	19.3	18.3	34.9	44.7	13.8	44.2	25.5	13.8	22.8	26.5	30.1	24.4	17.9	6.5	36.9	10.6	13.4	35.7	38.4	40.5	18.3	31.0	26.9	35.9	19.7	27.6	19.8	28.7	45.1	6.5	13.1	19.1	58.2	63.6	15.5	31.7	22.9	29.5	33.5	34.7	46.6	20.2	31.7	17.0	17.5	22.3	22.7	30.5	15.8	15.7	17.7	117.2	17.0	31.6	27.8	29.4	24.9	52.5	56.7	36.3	44.8	45.0	40.1	48.2	38.7	38.5	35.1
CLCA4	CaCC2	ENSG00000016602	"Chloride channel accessory 4"	Q14CN2	1	86547078-86580754	"Predicted membrane proteins"	Transport	"Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"esophagus: 182.1;intestine: 64.2"	"Cell line enriched"	"Detected in single"	964	"RT4: 96.4"	"Cancer enhanced"	"Detected in many"		"cervical cancer: 21.4"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA017045, HPA064770"	Uncertain		Approved	"Nucleoplasm,Plasma membrane,Aggresome"	"Intracellular and membrane"		210000	"Plasma membrane"	"Nucleoplasm, Aggresome"	"HPA017045: AB_2291679, HPA064770: "	"unprognostic (1.38e-4)"	"unprognostic (1.52e-1)"	"prognostic favourable (7.47e-4)"	"unprognostic (2.73e-2)"	"unprognostic (7.03e-2)"	"prognostic favourable (8.63e-4)"		"unprognostic (7.59e-2)"	"unprognostic (3.35e-1)"	"unprognostic (1.26e-1)"	"unprognostic (6.01e-2)"	"unprognostic (1.20e-1)"		"unprognostic (2.57e-2)"	"unprognostic (2.29e-1)"	"unprognostic (5.69e-2)"	"unprognostic (3.43e-2)"	0.2	0.1	2.2	8.8	3.0	0.1	0.6	0.0	2.0	12.3	64.2	2.0	0.0	0.1	0.3	0.1	182.1	0.1	0.1	0.1	2.2	0.6	0.1	0.1	0.1	0.1	3.2	1.6	0.1	0.0	0.1	0.0	0.1	3.0	1.8	38.4	0.0	5.9	0.1	0.1	4.5	6.1	0.8	2.4	0.1	0.1	0.1	5.0	0.0	0.1	8.6	21.5	9.0	13.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	96.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	3.0	0.0	2.0	2.2	0.6	3.2	1.6	3.0	5.0
CLCN6	"CLC-6, KIAA0046"	ENSG00000011021	"Chloride voltage-gated channel 6"	P51797	1	11806096-11843144	"Plasma proteins, Predicted membrane proteins"	"Antiport, Ion transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA032097	Approved		Approved	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		"HPA032097: AB_10670827"	"unprognostic (3.14e-2)"	"unprognostic (1.14e-1)"	"unprognostic (2.46e-1)"	"unprognostic (8.83e-2)"	"unprognostic (2.08e-1)"	"unprognostic (3.84e-3)"	"unprognostic (1.51e-3)"	"unprognostic (6.49e-2)"	"unprognostic (7.76e-2)"	"unprognostic (6.61e-3)"	"unprognostic (1.71e-3)"	"unprognostic (3.44e-1)"	"unprognostic (2.13e-2)"	"unprognostic (6.91e-2)"	"unprognostic (1.45e-1)"	"unprognostic (1.69e-1)"	"unprognostic (3.65e-2)"	11.2	14.6	18.9	11.5	18.7	12.2	8.6	18.0	27.9	9.2	8.7	22.4	8.6	9.6	12.8	14.2	6.3	10.7	8.1	15.7	15.0	20.6	10.0	9.1	10.6	11.1	16.4	17.8	21.4	6.6	8.4	14.8	9.6	32.4	11.3	7.8	13.1	6.7	8.7	11.2	10.0	9.1	10.8	15.9	10.6	8.5	16.1	14.5	4.3	10.7	5.0	9.5	7.7	8.2	10.1	3.2	4.2	4.6	2.0	3.2	1.1	5.7	5.3	12.1	10.1	13.0	13.5	3.8	4.8	9.2	6.6	10.4	8.2	13.9	8.1	4.0	4.4	8.5	7.9	8.9	5.9	3.6	4.3	8.4	10.6	10.8	16.8	4.7	7.9	9.2	5.3	12.5	7.0	5.9	10.7	11.8	6.7	3.1	4.9	12.8	8.1	4.2	6.1	6.6	7.4	8.8	4.7	5.3	8.4	3.2	5.1	11.1	4.5	8.5	7.2	6.2	7.0	10.6	3.3	7.1	4.3	21.0	7.7	9.5	4.5	4.2	4.6	1.5	2.6	3.7	1.5	8.0	2.1	3.2	2.7	10.1	2.3	2.1	3.9	2.0	4.6	3.2	1.4	1.1	18.9	18.7	18.0	27.9	15.0	20.6	16.4	17.8	32.4	14.5
CLTB	Lcb	ENSG00000175416	"Clathrin light chain B"	P09497	5	176392455-176416569	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HBEC3-KT: 103.7;MCF7: 92.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB003692, HPA036458"	Approved		Supported	"Vesicles,Plasma membrane,Cytosol"			350000	Vesicles	"Plasma membrane, Cytosol"	"CAB003692: AB_425372, HPA036458: AB_2675136"	"unprognostic (1.09e-1)"	"unprognostic (1.73e-1)"	"unprognostic (4.51e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.34e-2)"	"unprognostic (1.60e-1)"	"unprognostic (3.54e-3)"	"unprognostic (1.83e-2)"	"unprognostic (1.74e-2)"	"unprognostic (1.93e-1)"	"unprognostic (7.42e-3)"	"unprognostic (1.25e-1)"	"prognostic unfavourable (7.89e-5)"	"unprognostic (3.55e-1)"	"unprognostic (7.50e-2)"	"unprognostic (8.59e-2)"	"unprognostic (1.60e-2)"	20.4	24.1	29.7	18.7	26.7	13.5	16.0	27.5	47.9	27.7	34.7	14.2	11.4	35.4	15.0	15.7	94.2	12.7	28.4	65.7	26.4	26.9	20.3	15.0	15.6	12.2	25.9	22.7	24.3	19.7	17.9	19.8	61.2	28.7	16.8	18.1	19.4	22.2	19.3	93.7	81.8	41.1	27.1	15.4	14.2	39.6	9.9	10.1	14.3	17.2	55.4	31.2	26.1	45.3	4.3	9.9	28.0	9.9	7.4	11.6	3.6	32.8	15.8	4.5	19.1	10.1	7.6	36.8	42.4	16.5	26.9	19.3	20.3	15.4	7.2	25.0	19.0	31.4	7.6	103.7	10.5	49.2	14.1	4.8	23.4	12.5	15.9	7.6	12.9	8.0	36.1	14.7	17.4	12.6	9.2	18.5	14.8	92.2	12.0	11.6	3.6	23.5	13.1	7.9	23.6	14.2	13.4	19.3	6.6	20.1	22.2	14.4	9.0	14.8	27.2	9.7	14.5	17.6	23.9	14.7	10.1	9.7	7.8	16.3	11.0	2.8	9.9	28.0	7.2	7.5	3.7	3.1	6.4	7.0	9.9	4.3	5.2	5.5	18.7	7.4	9.7	8.0	11.6	3.6	29.7	26.7	27.5	47.9	26.4	26.9	25.9	22.7	28.7	10.1
CLUL1		ENSG00000079101	"Clusterin like 1"	Q15846	18	596988-650334	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"retina: 45.2"	"Cell line enhanced"	"Detected in many"		"Hep G2: 24.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"							"Not detected"	"Not detected"			"CAB025264, HPA075240"	Enhanced		Approved	"Endoplasmic reticulum,Plasma membrane"	"Secreted in other tissues"			"Endoplasmic reticulum"	"Plasma membrane"	"CAB025264: , HPA075240: "	"unprognostic (1.75e-2)"	"unprognostic (9.15e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.51e-1)"	"unprognostic (7.81e-3)"	"unprognostic (3.00e-3)"	"unprognostic (1.96e-1)"	"unprognostic (2.97e-3)"	"unprognostic (8.38e-3)"	"unprognostic (3.76e-2)"	"unprognostic (4.85e-3)"	"unprognostic (4.96e-3)"	"unprognostic (6.36e-4)"	"unprognostic (1.32e-1)"	"unprognostic (7.89e-2)"	"unprognostic (1.29e-3)"	"unprognostic (2.37e-2)"	0.5	1.4	5.0	0.5	3.8	4.3	3.1	4.5	6.6	2.1	1.0	1.4	1.0	0.6	1.9	0.7	1.6	2.4	2.5	0.4	5.9	6.4	7.5	0.7	1.8	0.8	4.9	2.0	7.4	1.6	2.5	6.1	0.7	5.1	12.0	0.0	45.2	3.1	1.6	0.1	0.8	1.7	0.4	5.3	0.1	3.9	3.4	2.8	0.3	9.4	0.1	0.4	2.1	0.3	1.0	1.3	2.1	0.3	0.1	2.0	0.5	2.5	3.9	7.4	5.0	0.0	0.0	4.4	2.8	0.2	0.0	0.0	3.0	1.5	3.1	0.7	0.0	1.1	0.0	0.4	0.0	2.5	6.8	5.2	2.1	24.3	0.0	1.7	1.0	0.2	0.0	0.0	0.0	0.3	7.2	9.0	0.0	0.8	3.0	5.5	0.5	1.7	6.2	3.5	10.8	0.8	0.7	6.5	4.5	2.9	1.8	2.2	2.4	0.7	0.6	3.0	4.3	2.1	1.4	5.1	8.9	6.4	2.4	3.3	2.5	0.9	0.3	0.2	0.2	0.0	0.1	1.0	0.4	0.2	0.5	0.1	0.1	0.8	2.1	0.1	0.0	1.3	2.0	0.5	5.0	3.8	4.5	5.7	5.9	6.4	4.9	2.0	5.1	2.8
CMTM4	CKLFSF4	ENSG00000183723	"CKLF like MARVEL transmembrane domain containing 4"	Q8IZR5	16	66614750-66696707	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"thyroid gland: 39.3"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA014704, HPA023890"	Enhanced		Approved	"Golgi apparatus,Vesicles,Plasma membrane"				"Golgi apparatus, Vesicles, Plasma membrane"		"HPA014704: AB_1847005, HPA023890: AB_1847007"	"unprognostic (2.65e-3)"	"unprognostic (1.16e-1)"	"unprognostic (6.17e-3)"	"unprognostic (3.43e-1)"	"unprognostic (5.13e-1)"	"unprognostic (8.30e-2)"	"unprognostic (2.88e-2)"	"unprognostic (2.65e-1)"	"unprognostic (3.35e-3)"	"unprognostic (6.06e-3)"	"unprognostic (2.07e-2)"	"unprognostic (3.08e-1)"	"prognostic favourable (4.72e-9)"	"unprognostic (1.41e-1)"	"unprognostic (2.31e-1)"	"unprognostic (4.94e-2)"	"unprognostic (1.00e-1)"	2.7	4.8	18.9	3.3	18.2	2.9	6.6	8.3	22.1	4.8	16.1	13.5	8.7	12.6	3.2	21.8	4.5	11.5	4.8	3.3	20.0	16.2	18.3	2.5	6.5	1.3	17.0	13.0	2.5	15.1	31.7	9.4	4.3	12.5	6.8	13.4	5.2	10.7	6.9	2.7	7.2	15.8	4.2	13.3	1.8	18.5	6.3	10.3	0.0	39.3	0.5	2.1	4.3	2.6	0.2	1.3	0.1	1.2	0.2	0.9	0.2	9.7	8.3	4.9	12.0	1.6	2.5	20.4	4.1	3.6	2.2	3.6	14.7	11.1	0.4	7.1	2.4	12.4	11.9	4.6	3.3	0.8	10.9	0.9	3.0	8.9	3.5	0.8	1.9	4.0	8.3	2.6	5.2	1.2	4.9	2.7	3.2	10.7	0.1	1.9	5.7	5.5	2.1	6.4	3.0	9.6	8.8	11.6	4.5	16.8	9.2	5.8	9.9	2.0	2.5	4.1	4.7	1.1	4.2	0.9	2.0	0.5	5.0	2.0	4.9	0.0	1.2	0.0	0.3	0.3	0.0	0.0	0.1	0.9	1.3	0.2	0.1	0.2	0.1	0.2	0.7	1.3	0.7	0.2	18.9	18.2	8.3	22.1	20.0	16.2	17.0	13.0	12.5	10.3
CMTM7	"CKLFSF7, FLJ30992"	ENSG00000153551	"CKLF like MARVEL transmembrane domain containing 7"	Q96FZ5	3	32391671-32483067	"Predicted membrane proteins, Transporters"	Chemotaxis	Cytokine		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 41.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA077409			Approved	"Plasma membrane"				"Plasma membrane"		"HPA077409: "	"unprognostic (2.27e-3)"	"unprognostic (3.16e-2)"	"unprognostic (3.98e-2)"	"unprognostic (1.15e-1)"	"unprognostic (5.42e-2)"	"unprognostic (3.16e-2)"	"prognostic unfavourable (3.21e-4)"	"unprognostic (3.03e-2)"	"unprognostic (3.92e-2)"	"unprognostic (2.60e-1)"	"unprognostic (6.55e-3)"	"unprognostic (1.64e-1)"	"prognostic unfavourable (1.00e-6)"	"unprognostic (5.86e-2)"	"unprognostic (2.51e-1)"	"unprognostic (3.79e-1)"	"unprognostic (3.12e-2)"	14.5	6.5	3.3	18.9	5.7	23.8	43.1	4.5	2.2	10.0	6.2	4.3	11.0	3.1	7.7	12.3	4.8	24.5	14.6	8.3	2.8	2.8	14.8	5.9	25.1	47.5	5.9	1.0	9.3	27.6	0.9	2.8	11.4	4.7	12.8	5.9	6.1	8.7	17.6	4.0	6.4	10.9	7.0	10.3	32.4	8.2	5.8	4.6	45.9	24.5	3.3	23.1	16.5	12.4	10.0	24.8	24.4	47.0	4.9	36.2	22.1	0.1	4.7	10.1	12.3	9.5	9.4	28.9	4.6	5.5	8.3	7.7	5.2	41.1	0.0	14.2	5.5	5.2	12.5	21.2	7.3	0.0	9.9	5.4	0.0	12.0	38.8	1.4	8.8	9.9	2.8	8.5	13.5	18.5	4.5	12.3	6.1	0.1	0.0	12.7	12.2	21.6	26.4	3.8	25.1	11.6	9.1	0.5	10.5	0.6	0.7	23.5	6.4	14.3	10.7	7.8	7.9	8.6	15.9	3.5	1.3	0.0	2.8	17.2	16.4	5.5	47.0	24.4	5.3	44.1	3.2	10.0	17.9	10.9	24.8	7.0	19.5	13.5	18.0	4.9	37.2	10.5	36.2	22.1	3.3	5.7	4.5	2.2	2.8	2.8	5.9	1.0	4.7	4.6
CNGA1	"CNCG, CNCG1, CNG1, RCNC1, RCNCa, RP49"	ENSG00000198515	"Cyclic nucleotide gated channel alpha 1"	P29973	4	47935977-48016672	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Sensory transduction, Transport, Vision"	"Ion channel, Ligand-gated ion channel"	"Disease mutation, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 23.7"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 13.1;RT4: 10.5;U-2 OS: 4.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA076168			Approved	"Nucleoplasm,Vesicles,Plasma membrane"				"Vesicles, Plasma membrane"	Nucleoplasm	"HPA076168: "	"unprognostic (2.68e-2)"	"unprognostic (4.90e-2)"	"unprognostic (1.33e-1)"	"unprognostic (8.59e-2)"	"unprognostic (2.07e-1)"	"unprognostic (1.11e-2)"	"unprognostic (1.76e-2)"	"unprognostic (3.85e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.98e-2)"	"unprognostic (3.18e-1)"	"unprognostic (2.91e-1)"	"unprognostic (5.48e-6)"	"unprognostic (1.86e-1)"	"unprognostic (1.04e-1)"	"unprognostic (4.66e-2)"	"unprognostic (8.23e-2)"	4.9	1.1	0.6	2.7	1.0	0.1	2.9	0.3	0.5	5.7	6.1	0.2	1.6	2.1	0.6	12.1	13.7	3.9	1.5	1.0	0.6	0.6	4.9	23.7	0.5	0.0	1.3	0.0	1.6	2.1	5.2	4.2	21.3	0.4	6.2	2.3	14.7	4.9	1.7	4.2	5.3	12.7	0.5	0.9	8.2	2.5	1.4	0.2	0.1	2.2	3.6	2.7	8.2	8.8	0.7	2.7	1.2	0.4	1.9	1.6	0.1	3.2	1.1	0.0	0.1	0.0	0.0	0.3	0.0	0.2	0.0	0.2	2.9	13.1	0.1	0.7	0.0	2.0	0.3	0.4	0.1	0.0	0.8	0.0	0.3	1.0	0.0	0.1	0.3	0.1	0.6	0.0	0.1	0.0	0.8	0.7	0.2	1.3	0.1	0.2	0.6	3.0	0.1	0.0	0.1	0.6	10.5	0.3	0.1	0.2	0.6	0.2	1.1	0.0	0.6	0.3	4.1	0.1	0.1	0.9	1.0	0.1	0.1	0.1	2.3	0.2	0.4	0.0	0.5	0.4	0.1	0.3	0.2	1.6	0.3	0.7	0.3	0.6	1.2	1.9	0.2	2.7	0.1	0.1	0.6	1.0	0.3	0.5	0.6	0.6	1.3	0.0	0.4	0.2
CNKSR2	"CNK2, KIAA0902, KSR2"	ENSG00000149970	"Connector enhancer of kinase suppressor of Ras 2"	Q8WXI2	X	21372801-21654695	"Predicted intracellular proteins"			"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"brain: 38.4"	"Cell line enhanced"	"Detected in some"		"A549: 6.7;AF22: 4.7;NTERA-2: 10.8;PC-3: 5.5;RH-30: 10.1;U-251 MG: 6.7"	"Cancer enhanced"	"Detected in some"		"glioma: 2.1"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"naive B-cell: 2.9;naive CD4 T-cell: 3.0"	"Group enriched"	"Detected in many"	5	"B-cells: 2.9;T-cells: 3.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA001502			Approved	"Golgi apparatus,Plasma membrane"				"Golgi apparatus, Plasma membrane"		"HPA001502: AB_1078542"	"unprognostic (1.33e-2)"	"unprognostic (1.00e-3)"	"unprognostic (5.35e-2)"	"unprognostic (4.90e-4)"	"unprognostic (1.26e-1)"	"unprognostic (5.40e-2)"	"unprognostic (4.35e-3)"	"unprognostic (2.58e-2)"	"unprognostic (3.47e-1)"	"unprognostic (7.16e-2)"	"unprognostic (1.35e-2)"	"unprognostic (2.01e-1)"	"unprognostic (1.78e-2)"	"unprognostic (2.72e-2)"	"unprognostic (3.93e-2)"	"unprognostic (2.27e-2)"	"unprognostic (4.13e-2)"	2.0	5.2	23.5	1.4	29.6	1.3	2.1	31.3	38.4	1.4	1.2	1.7	0.0	1.1	1.4	1.8	1.1	2.3	1.2	1.7	26.4	4.4	1.0	2.0	2.8	2.4	3.1	20.8	1.9	4.9	1.0	1.0	1.1	1.8	2.2	1.1	3.5	1.7	1.2	7.4	1.1	1.2	1.2	1.7	1.8	1.3	1.8	5.0	0.6	1.2	0.0	2.6	1.3	0.7	2.9	0.1	0.6	0.0	0.0	3.0	0.3	0.0	6.7	4.7	0.0	0.5	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.7	0.0	0.0	1.4	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.0	0.1	10.8	5.5	0.0	10.1	0.0	0.0	0.0	4.6	1.8	0.0	0.1	0.2	0.0	0.6	0.0	0.1	2.1	0.0	6.7	3.5	0.0	3.5	0.9	0.0	2.6	0.1	0.0	0.6	0.1	0.0	0.4	1.1	0.6	0.0	0.0	2.9	3.0	1.0	0.0	0.0	0.0	0.1	0.8	0.3	23.5	29.6	31.3	24.4	26.4	4.4	3.1	20.8	1.8	5.0
COBL	KIAA0633	ENSG00000106078	"Cordon-bleu WH2 repeat protein"	O75128	7	51016212-51316818	"Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 68.7"	"Cell line enhanced"	"Detected in many"		"BEWO: 15.9;HeLa: 28.3;RPMI-8226: 21.8;SK-BR-3: 12.7;U-266/84: 16.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	46	"plasmacytoid DC: 4.6"	"Lineage enriched"	"Detected in single"	46	"dendritic cells: 4.6"	"Low region specificity"	"Detected in many"							"HPA019033, HPA019167"	Enhanced		Approved	"Plasma membrane,Cell Junctions"				"Plasma membrane, Cell Junctions"		"HPA019033: AB_2083648, HPA019167: AB_1847070"	"unprognostic (8.09e-2)"	"unprognostic (1.08e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.62e-3)"	"unprognostic (3.13e-1)"	"unprognostic (5.33e-3)"	"unprognostic (2.90e-1)"	"unprognostic (5.29e-2)"	"unprognostic (1.70e-1)"	"unprognostic (1.17e-1)"	"unprognostic (3.51e-2)"	"unprognostic (3.92e-2)"	"prognostic favourable (5.21e-12)"	"unprognostic (7.64e-2)"	"unprognostic (1.79e-1)"	"unprognostic (2.08e-1)"	"unprognostic (5.41e-3)"	1.8	1.3	27.5	1.8	26.1	0.7	9.5	12.5	23.8	3.9	11.6	27.9	2.2	11.6	2.0	4.4	9.5	12.7	5.8	32.8	27.7	14.5	8.3	12.3	8.8	0.7	23.8	13.8	2.6	11.4	24.7	5.2	3.4	10.8	9.4	7.3	2.8	26.9	3.7	68.7	10.7	20.7	2.2	25.0	0.8	7.4	2.5	16.8	0.0	5.5	12.2	3.1	1.0	2.3	0.0	4.6	0.0	0.0	0.0	0.0	0.0	5.8	4.3	0.0	0.1	0.0	0.0	15.9	0.0	0.0	0.0	0.0	10.4	9.4	0.0	0.4	0.0	10.9	6.0	0.0	0.0	0.0	4.6	0.0	28.3	2.2	0.0	0.0	0.0	0.8	1.4	0.0	0.0	0.0	3.0	0.1	0.0	3.6	0.0	0.0	4.2	3.6	0.0	0.2	21.8	8.5	0.0	5.7	0.1	2.0	12.7	1.8	9.1	0.0	0.0	0.0	5.2	0.1	0.4	0.0	16.1	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.6	0.0	0.0	27.5	26.1	12.5	19.0	27.7	14.5	23.8	13.8	10.8	16.8
COL16A1		ENSG00000084636	"Collagen type XVI alpha 1 chain"	Q07092	1	31652247-31704319	"Predicted intracellular proteins, Predicted secreted proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC diff: 38.1;ASC TERT1: 29.5;BJ hTERT+: 32.3;fHDF/TERT166: 29.4;HSkMC: 27.8;U-2197: 27.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA027235, HPA027237"			Approved	"Golgi apparatus,Plasma membrane,Cytosol"	"Secreted to extracellular matrix"		530000	"Golgi apparatus, Plasma membrane, Cytosol"		"HPA027235: AB_1847101, HPA027237: AB_10600699"	"unprognostic (2.25e-2)"	"unprognostic (9.88e-2)"	"unprognostic (5.64e-2)"	"unprognostic (8.43e-2)"	"prognostic unfavourable (8.08e-4)"	"unprognostic (1.00e-1)"	"unprognostic (3.99e-2)"	"unprognostic (2.04e-1)"	"unprognostic (4.48e-3)"	"unprognostic (1.66e-3)"	"unprognostic (1.44e-1)"	"unprognostic (2.43e-1)"	"prognostic unfavourable (4.00e-9)"	"unprognostic (9.62e-2)"	"unprognostic (6.13e-2)"	"unprognostic (4.60e-2)"	"unprognostic (2.15e-2)"	18.0	7.3	7.0	12.7	9.0	0.2	10.8	2.8	8.2	63.1	17.3	10.2	12.5	6.1	31.0	15.2	9.3	8.3	15.9	9.1	9.6	6.2	3.4	1.0	7.2	3.1	9.9	10.2	62.6	2.6	1.3	7.3	8.2	8.8	29.3	4.6	12.5	15.3	38.1	4.2	26.9	8.6	45.2	15.7	3.9	10.5	10.0	10.3	1.5	11.8	7.9	5.0	26.1	28.3	0.2	0.0	0.7	0.1	0.1	0.4	0.0	0.0	0.5	0.0	0.0	38.1	29.5	4.0	17.5	32.3	4.2	4.5	0.1	3.0	0.0	0.5	29.4	13.6	0.0	18.0	1.0	0.0	0.0	0.0	2.0	5.9	12.7	0.0	0.1	27.8	12.4	12.1	6.6	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.1	0.0	0.1	0.4	0.7	2.1	0.3	2.6	0.3	0.0	0.0	15.7	15.7	27.0	0.3	0.0	0.0	0.0	10.7	0.0	1.0	0.3	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.1	0.7	0.1	0.1	0.0	0.0	0.0	7.0	9.0	2.8	7.1	9.6	6.2	9.9	10.2	8.8	10.3
COL6A2		ENSG00000142173	"Collagen type VI alpha 2 chain"	P12110	21	46098097-46132849	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Cell adhesion"		"Congenital muscular dystrophy, Disease mutation, Limb-girdle muscular dystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC diff: 93.7;ASC TERT1: 173.4;BJ: 83.4;BJ hTERT+: 77.6;HHSteC: 92.0;HSkMC: 123.8;U-138 MG: 90.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"gdT-cell: 7.6;MAIT T-cell: 5.1;memory CD8 T-cell: 3.8;naive CD8 T-cell: 2.1"	"Lineage enriched"	"Detected in single"	14	"T-cells: 7.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"HPA007029, HPA030920, HPA038799"	Enhanced		Approved	"Plasma membrane,Cytosol"	"Secreted to extracellular matrix"		8900000	Cytosol	"Plasma membrane"	"HPA007029: AB_1078549, HPA030920: AB_2673659, HPA038799: AB_2676214"	"unprognostic (3.53e-1)"	"unprognostic (3.76e-2)"	"unprognostic (3.20e-2)"	"unprognostic (4.87e-2)"	"unprognostic (2.92e-2)"	"unprognostic (1.38e-1)"	"unprognostic (2.39e-1)"	"unprognostic (5.28e-3)"	"unprognostic (2.11e-2)"	"unprognostic (1.68e-2)"	"unprognostic (1.56e-1)"	"unprognostic (2.01e-1)"	"prognostic unfavourable (8.72e-14)"	"unprognostic (2.13e-2)"	"unprognostic (7.61e-2)"	"unprognostic (2.31e-2)"	"unprognostic (2.22e-3)"	81.2	8.7	1.5	65.0	2.7	0.2	116.7	1.8	2.7	103.5	112.6	4.7	75.0	15.3	127.2	160.3	55.5	66.5	179.8	90.6	2.1	1.3	9.6	9.1	38.7	38.3	3.2	3.8	76.1	14.8	2.7	11.8	52.6	8.8	81.0	9.8	23.5	33.4	81.4	30.6	37.8	38.1	231.3	5.8	23.6	49.0	33.2	1.8	9.8	19.9	58.5	17.2	107.2	76.1	0.0	0.0	0.0	0.0	0.5	7.6	0.7	0.7	0.9	2.7	2.4	93.7	173.4	0.7	83.4	77.6	21.1	9.7	0.1	3.3	0.0	6.3	59.8	0.0	0.6	0.0	1.7	0.0	0.9	0.0	0.0	0.0	92.0	0.0	0.3	123.8	0.0	39.9	0.8	0.0	0.0	0.0	8.5	0.3	0.0	0.1	1.5	10.2	0.0	5.3	0.1	0.0	0.0	0.0	4.3	3.2	0.0	0.0	0.0	0.5	0.0	90.5	10.6	33.3	20.6	0.0	0.0	0.0	46.3	0.0	12.8	0.0	0.0	0.0	7.6	0.0	5.1	0.0	0.7	3.8	0.0	0.0	0.8	2.1	0.0	0.5	0.0	0.0	0.1	0.7	1.5	2.7	1.8	2.7	2.1	1.3	3.2	3.8	8.8	1.8
COLQ	EAD	ENSG00000206561	"Collagen like tail subunit of asymmetric acetylcholinesterase"	Q9Y215	3	15450133-15521751	"Disease related genes, Predicted intracellular proteins, Predicted secreted proteins"	"Neurotransmitter degradation"		"Congenital myasthenic syndrome, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"blood: 31.8;lymphoid tissue: 19.6"	"Group enriched"	"Detected in some"	5	"BEWO: 16.9;HDLM-2: 5.5;U-937: 8.5"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in many"	5	"cerebellum: 11.4"	"Cell type enriched"	"Detected in some"	6	"MAIT T-cell: 31.8"	"Lineage enriched"	"Detected in single"	35	"T-cells: 31.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA045876			Approved	"Plasma membrane,Cell Junctions"	"Secreted to blood"			"Plasma membrane"	"Cell Junctions"	"HPA045876: "	"unprognostic (4.08e-3)"	"unprognostic (2.61e-2)"	"unprognostic (2.13e-3)"	"unprognostic (2.37e-1)"	"unprognostic (2.11e-1)"	"unprognostic (4.62e-2)"	"unprognostic (1.27e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.99e-1)"	"unprognostic (1.28e-3)"	"unprognostic (4.68e-1)"	"unprognostic (7.00e-5)"	"unprognostic (6.58e-2)"	"unprognostic (1.97e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.30e-4)"	2.7	0.7	0.9	0.7	1.1	1.3	0.9	11.4	2.1	2.4	2.3	0.4	0.2	0.8	3.2	2.7	1.3	8.8	1.8	15.9	1.5	1.2	0.5	0.9	2.1	19.6	0.9	1.1	2.3	0.6	10.0	1.1	0.5	2.1	2.0	0.5	2.0	1.1	1.4	14.3	0.9	1.4	1.1	1.5	3.8	1.5	2.0	0.4	3.8	1.0	0.6	3.3	1.3	1.4	0.0	0.2	0.0	0.4	0.9	31.8	1.7	0.1	0.5	2.0	1.1	1.4	1.0	16.9	0.3	0.5	0.4	0.6	0.0	0.3	0.1	0.7	0.2	0.2	0.3	0.4	0.5	5.5	1.2	0.6	0.7	0.1	0.2	0.4	1.1	0.8	0.4	0.8	0.3	0.3	0.0	0.5	0.8	0.3	0.6	1.8	0.2	0.6	0.8	0.2	0.4	0.4	0.4	0.6	1.7	0.2	0.1	0.4	1.2	0.8	0.1	0.1	1.0	1.8	0.6	1.6	1.5	0.1	0.1	8.5	0.1	0.0	0.4	0.0	5.5	0.0	31.8	0.0	2.7	3.9	0.0	0.0	0.3	0.3	0.0	0.9	0.0	0.2	0.1	1.7	0.9	1.1	11.4	2.1	1.5	1.2	0.9	1.1	2.1	0.4
COMMD4	FLJ20452	ENSG00000140365	"COMM domain containing 4"	Q9H0A8	15	75335891-75343224	"Predicted intracellular proteins"	"Transcription, Transcription regulation, Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA066957	Uncertain		Supported	"Nucleoplasm,Plasma membrane"				Nucleoplasm	"Plasma membrane"	"HPA066957: "	"unprognostic (7.77e-2)"	"unprognostic (3.07e-3)"	"unprognostic (1.03e-1)"	"unprognostic (6.57e-3)"	"unprognostic (1.32e-1)"	"unprognostic (1.89e-1)"	"unprognostic (1.49e-1)"	"unprognostic (2.60e-1)"	"unprognostic (9.11e-2)"	"unprognostic (1.78e-3)"	"unprognostic (2.01e-1)"	"unprognostic (2.65e-1)"	"unprognostic (1.39e-3)"	"unprognostic (2.51e-1)"	"unprognostic (2.27e-1)"	"unprognostic (1.96e-1)"	"unprognostic (5.07e-2)"	15.9	35.2	16.1	20.7	17.5	20.4	16.2	12.6	23.1	14.4	19.5	21.7	22.2	21.9	20.7	26.2	17.7	15.7	30.1	16.6	13.9	12.9	25.1	28.1	24.3	17.4	15.6	15.4	13.7	15.2	14.9	16.2	23.7	14.1	15.2	15.9	20.9	30.8	16.6	13.2	15.2	20.1	16.7	16.6	19.3	18.3	32.7	14.7	30.4	20.3	27.4	17.3	16.4	14.5	17.3	26.0	14.6	22.3	26.9	33.4	13.8	33.1	51.5	23.7	30.7	10.4	15.0	23.3	25.7	24.0	44.3	44.9	29.7	44.4	21.2	24.3	19.4	34.9	45.1	26.9	22.3	15.5	57.7	25.2	41.4	32.7	18.4	19.6	24.7	16.7	14.3	28.7	5.5	22.0	25.9	30.9	34.1	39.4	16.9	21.8	33.3	30.3	29.9	38.4	27.9	22.6	29.4	19.1	28.0	33.4	25.2	39.3	38.9	35.0	20.3	31.4	29.9	31.6	45.1	22.1	50.5	24.3	34.6	40.6	30.2	10.8	17.3	14.6	33.4	22.3	20.8	17.3	20.9	24.6	19.0	15.8	12.6	19.7	3.6	26.9	18.7	26.0	30.9	13.8	16.1	17.5	12.6	23.1	13.9	12.9	15.6	15.4	14.1	14.7
COMTD1	FLJ23841	ENSG00000165644	"Catechol-O-methyltransferase domain containing 1"	Q86VU5	10	75233969-75236030	"Predicted intracellular proteins"		"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 57.2"	"Cell line enhanced"	"Detected in many"		"HEK 293: 22.5;PC-3: 31.2;RPMI-8226: 17.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042165	Approved		Approved	"Golgi apparatus,Plasma membrane,Cytosol"				"Golgi apparatus"	"Plasma membrane, Cytosol"	"HPA042165: AB_10794042"	"unprognostic (2.53e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.49e-1)"	"unprognostic (9.07e-2)"	"unprognostic (2.44e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.90e-1)"	"unprognostic (3.23e-2)"	"unprognostic (8.08e-3)"	"unprognostic (9.35e-2)"	"unprognostic (6.74e-2)"	"prognostic favourable (1.88e-4)"	"unprognostic (1.33e-1)"	"unprognostic (1.73e-1)"	"unprognostic (1.12e-1)"	"unprognostic (2.35e-1)"	2.5	5.2	1.3	5.8	1.4	2.9	5.7	3.6	2.2	4.8	14.1	0.5	9.7	17.9	2.0	5.9	20.0	1.6	6.4	8.0	1.2	1.6	12.6	14.9	4.4	4.1	1.9	1.7	2.2	57.2	3.2	5.3	7.8	2.2	3.1	2.1	3.2	21.2	9.1	19.6	7.3	22.9	1.9	1.0	3.4	16.1	1.5	0.6	2.7	7.0	14.4	6.0	2.4	7.5	6.6	15.7	3.8	9.3	7.3	12.5	7.1	4.8	0.9	0.2	0.9	0.1	0.4	14.6	1.4	0.4	0.1	0.3	1.2	4.3	13.7	2.8	0.3	6.9	0.4	1.2	0.0	2.1	22.5	0.5	1.3	2.3	0.7	2.6	2.3	0.3	1.9	0.0	1.1	0.0	5.5	2.7	0.0	3.2	3.8	8.1	0.7	31.2	7.1	0.7	17.5	1.0	0.2	5.3	1.3	1.5	11.3	3.0	6.6	0.3	1.2	0.3	4.3	0.4	1.6	15.0	3.1	6.6	0.3	2.3	0.3	0.0	8.9	3.8	12.1	9.3	12.5	6.6	11.7	12.2	10.1	4.7	3.8	6.7	1.8	7.3	8.9	15.7	9.0	7.1	1.3	1.4	3.6	1.7	1.2	1.6	1.9	1.7	2.2	0.6
COQ7	"CAT5, CLK-1"	ENSG00000167186	"Coenzyme Q7, hydroxylase"	Q99807	16	19067599-19080095	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Ubiquinone biosynthesis"	"Monooxygenase, Oxidoreductase"	"Disease mutation, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in all"	4	"neutrophil: 45.2"	"Lineage enriched"	"Detected in all"	8	"granulocytes: 45.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA067252, HPA071922"	Approved		Approved	"Nucleoplasm,Plasma membrane"				"Plasma membrane"	Nucleoplasm	"HPA067252: , HPA071922: "	"unprognostic (1.37e-1)"	"unprognostic (6.89e-3)"	"unprognostic (1.59e-2)"	"unprognostic (6.08e-2)"	"unprognostic (2.44e-2)"	"unprognostic (9.03e-2)"	"unprognostic (1.31e-1)"	"unprognostic (4.42e-2)"	"unprognostic (1.15e-1)"	"unprognostic (7.27e-3)"	"unprognostic (2.15e-1)"	"unprognostic (8.32e-2)"	"prognostic favourable (8.23e-12)"	"unprognostic (2.19e-1)"	"unprognostic (2.76e-1)"	"unprognostic (3.14e-2)"	"unprognostic (5.27e-2)"	9.1	14.2	13.5	7.8	12.9	4.0	12.6	11.3	18.5	11.2	12.8	12.8	15.2	11.4	14.7	17.4	11.9	15.0	13.9	21.1	12.1	13.0	13.5	11.4	14.6	11.1	12.2	12.0	19.4	12.2	23.7	15.1	9.4	12.9	17.1	12.5	16.5	11.3	14.7	37.3	7.5	12.1	11.1	12.4	8.7	11.8	34.7	10.7	9.4	15.3	24.7	7.6	12.1	10.0	5.1	5.3	45.2	4.0	4.1	4.4	1.8	12.4	13.4	11.6	6.8	6.6	7.0	9.8	7.3	6.0	10.0	10.4	8.5	10.4	9.5	35.6	5.6	13.2	16.2	9.1	7.2	8.0	16.3	5.0	12.3	26.0	8.1	12.0	11.2	5.8	8.1	9.3	6.8	8.1	13.8	8.9	7.0	22.4	12.5	9.7	8.8	7.2	15.3	12.9	12.1	8.7	8.4	16.9	9.7	6.8	15.1	8.5	13.8	16.4	8.8	10.7	6.2	7.7	10.5	8.3	13.4	10.4	11.4	7.0	6.8	10.8	4.0	5.8	3.5	3.5	3.3	5.1	3.2	3.1	4.3	5.0	4.4	3.9	45.2	4.1	3.9	5.3	2.0	1.8	13.5	12.9	11.3	18.5	12.1	13.0	12.2	12.0	12.9	10.7
CORIN	"ATC2, CRN, Lrp4, PRSC, TMPRSS10"	ENSG00000145244	"Corin, serine peptidase"	Q9Y5Q5	4	47593998-47838106	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"epididymis: 11.6;heart muscle: 39.5"	"Cell line enriched"	"Detected in some"	4	"ASC TERT1: 31.8"	"Low cancer specificity"	"Detected in some"			"Region enriched"	"Detected in single"	5	"pons and medulla: 1.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in some"		"basal ganglia: 2.7"	"Low region specificity"	"Detected in single"			HPA070941			Approved	"Nuclear bodies,Plasma membrane,Actin filaments"	"Intracellular and membrane"			"Plasma membrane"	"Nuclear bodies, Actin filaments"	"HPA070941: "	"unprognostic (1.05e-1)"	"unprognostic (2.52e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.93e-1)"	"unprognostic (2.10e-1)"	"unprognostic (3.18e-1)"	"unprognostic (3.58e-4)"	"unprognostic (3.19e-1)"	"unprognostic (3.67e-2)"	"unprognostic (8.22e-2)"	"unprognostic (9.78e-2)"	"unprognostic (6.53e-2)"	"unprognostic (1.18e-1)"	"unprognostic (2.86e-2)"	"unprognostic (5.18e-2)"	"unprognostic (7.22e-2)"	"unprognostic (1.33e-2)"	0.3	0.1	0.3	0.0	0.1	0.0	0.8	0.1	0.1	3.1	0.1	0.1	2.6	0.0	3.4	11.6	0.7	1.2	4.5	39.5	0.0	0.2	2.0	0.0	1.3	0.0	0.2	0.0	0.6	0.1	0.0	1.5	0.6	1.6	1.7	0.0	0.4	0.3	4.6	0.2	5.3	0.4	0.5	0.0	3.5	0.3	3.7	0.0	0.2	0.1	1.7	0.4	0.8	3.2	0.2	0.0	0.5	0.5	0.0	0.3	0.0	0.0	0.0	0.0	0.2	7.3	31.8	0.0	1.3	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	1.5	0.1	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.6	1.0	0.0	0.2	0.1	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.5	0.3	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.3	0.1	0.1	0.1	0.0	0.2	0.2	0.0	1.6	0.0
CORO2A	"IR10, WDR2"	ENSG00000106789	"Coronin 2A"	Q92828	9	98120975-98192640	"Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 27.7;intestine: 36.1"	"Cell line enhanced"	"Detected in many"		"BEWO: 33.9;SK-BR-3: 22.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	6	"granulocytes: 10.9;monocytes: 7.0;T-cells: 11.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041161, HPA041302"	Enhanced		Approved	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		"HPA041161: AB_10795537, HPA041302: AB_10794195"	"unprognostic (4.49e-3)"	"unprognostic (3.44e-2)"	"unprognostic (3.14e-1)"	"unprognostic (1.78e-1)"	"unprognostic (3.39e-3)"	"unprognostic (1.64e-1)"	"unprognostic (3.73e-2)"	"unprognostic (5.73e-2)"	"unprognostic (2.79e-1)"	"unprognostic (1.52e-1)"	"unprognostic (4.50e-3)"	"unprognostic (2.85e-1)"	"prognostic unfavourable (6.56e-4)"	"unprognostic (4.16e-2)"	"unprognostic (1.40e-2)"	"unprognostic (1.87e-2)"	"unprognostic (6.40e-3)"	1.6	0.8	1.2	6.9	1.8	8.1	2.9	9.3	2.4	3.9	22.0	0.7	1.3	20.8	2.0	2.2	13.6	2.7	27.7	1.5	1.3	3.0	1.4	2.9	7.5	1.6	2.6	1.3	1.5	1.4	2.8	5.2	3.5	3.3	9.0	7.9	1.2	5.4	1.9	0.9	6.3	36.1	1.9	0.6	3.8	6.6	11.4	0.6	5.6	1.1	3.6	6.6	7.7	6.2	0.6	0.7	10.9	7.0	1.5	11.1	1.4	4.1	1.4	0.3	1.0	0.6	0.7	33.9	0.3	0.3	1.0	1.6	9.4	0.7	0.0	4.8	0.6	11.5	3.8	6.3	0.7	3.3	0.9	0.1	5.8	8.3	1.4	3.8	0.3	0.2	7.8	0.5	9.5	0.3	3.2	1.9	0.1	3.1	0.7	3.8	4.3	1.1	2.9	0.0	0.1	0.7	11.6	0.8	1.2	2.1	22.8	0.8	2.7	6.3	0.3	0.1	5.0	0.1	1.2	0.3	1.9	0.3	0.2	1.2	1.4	7.7	1.5	10.9	2.4	3.0	5.5	0.6	4.1	3.8	0.5	0.6	2.7	3.5	1.1	1.5	7.0	0.7	11.1	1.4	1.2	1.8	9.3	2.4	1.3	3.0	2.6	1.3	3.3	0.6
CORO2B	"ClipinC, KIAA0925"	ENSG00000103647	"Coronin 2B"	Q9UQ03	15	68578969-68727806	"Plasma proteins, Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 53.5;fallopian tube: 27.4"	"Cell line enhanced"	"Detected in many"		"ASC diff: 12.7;ASC TERT1: 27.4;HSkMC: 19.7;hTEC/SVTERT24-B: 16.0;U-87 MG: 27.3"	"Group enriched"	"Detected in many"	8	"glioma: 34.7;melanoma: 21.5"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	13	"memory B-cell: 1.2;naive B-cell: 4.5"	"Lineage enriched"	"Detected in single"	21	"B-cells: 4.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017960	Enhanced		Approved	"Plasma membrane,Focal adhesion sites"				"Plasma membrane, Focal adhesion sites"		"HPA017960: AB_1847167"	"unprognostic (1.35e-1)"	"unprognostic (2.63e-2)"	"unprognostic (2.81e-3)"	"unprognostic (4.71e-3)"	"unprognostic (3.28e-1)"	"unprognostic (8.11e-5)"	"unprognostic (4.77e-2)"	"unprognostic (1.24e-1)"	"unprognostic (3.68e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.33e-3)"	"unprognostic (4.12e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.10e-2)"	"unprognostic (5.83e-2)"	"unprognostic (3.59e-2)"	"unprognostic (1.87e-2)"	10.9	4.4	15.7	3.2	30.1	1.9	4.8	33.7	53.5	6.5	3.4	27.3	0.8	2.4	7.5	3.9	2.7	27.4	6.3	7.2	23.0	15.1	5.5	2.0	5.8	3.5	20.9	18.8	18.4	2.9	1.6	1.5	4.7	23.6	3.2	2.9	11.8	3.4	6.9	3.8	5.6	3.3	8.4	35.0	3.6	2.0	2.2	17.5	0.0	4.6	0.6	1.9	3.0	1.6	4.5	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.3	12.1	1.0	12.7	27.4	0.0	6.1	6.8	1.0	1.5	0.1	1.3	1.4	0.7	1.0	0.0	0.4	0.1	4.4	0.0	0.5	0.0	0.0	0.6	4.6	0.0	0.1	19.7	0.1	16.0	0.9	0.4	0.0	0.0	11.2	0.0	0.0	0.0	2.9	0.0	0.9	0.0	0.5	1.7	0.0	7.0	0.1	0.1	0.0	3.6	0.0	1.4	0.1	3.6	4.1	0.7	8.1	0.0	0.0	1.4	27.3	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.2	4.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.7	30.1	33.7	29.3	23.0	15.1	20.9	18.8	23.6	17.5
COX6B2	"COXVIB2, CT59, FLJ32865"	ENSG00000160471	"Cytochrome c oxidase subunit 6B2"	Q6YFQ2	19	55349306-55354814	"Predicted intracellular proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	12	"testis: 66.5"	"Group enriched"	"Detected in some"	6	"CAPAN-2: 22.1;SCLC-21H: 9.5"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in many"		"neutrophil: 5.7"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			HPA035014			Approved	"Nucleoplasm,Plasma membrane,Cytosol"				"Nucleoplasm, Plasma membrane, Cytosol"		"HPA035014: AB_10601261"	"unprognostic (7.43e-3)"	"unprognostic (8.72e-2)"	"unprognostic (1.42e-1)"	"unprognostic (5.75e-2)"	"unprognostic (2.59e-2)"	"unprognostic (9.23e-3)"	"unprognostic (1.88e-2)"	"unprognostic (6.45e-3)"	"unprognostic (1.02e-1)"	"unprognostic (6.82e-2)"	"prognostic unfavourable (9.70e-5)"	"unprognostic (8.11e-2)"	"unprognostic (1.81e-6)"	"unprognostic (9.91e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.02e-2)"	"unprognostic (2.02e-1)"	0.3	0.0	0.4	0.6	0.6	0.7	0.5	0.3	0.6	0.2	3.3	0.2	0.2	0.0	0.2	0.8	0.5	0.4	0.2	0.2	0.2	0.5	0.5	0.2	0.2	0.6	0.4	0.2	0.4	0.2	0.0	0.4	0.2	0.6	0.2	3.5	0.7	0.6	0.2	0.2	1.8	0.2	0.2	0.7	0.2	0.0	66.5	0.3	0.2	0.2	0.2	1.2	0.2	0.4	1.3	1.4	5.7	1.0	1.6	0.9	0.8	2.7	0.4	0.1	0.1	0.0	0.0	0.2	0.4	0.1	0.3	0.5	0.1	22.1	0.1	0.2	0.2	1.7	0.7	0.2	0.2	0.8	0.6	0.0	1.7	0.1	0.3	0.1	1.7	0.2	2.4	0.4	0.5	0.0	0.4	0.2	0.0	0.4	0.1	0.2	0.6	0.5	0.1	0.0	0.2	0.0	0.4	9.5	0.3	0.3	0.1	0.0	0.4	0.0	0.3	0.3	0.5	0.1	0.2	1.5	1.2	0.1	0.1	0.3	0.2	1.9	1.0	1.0	0.8	0.5	0.5	0.7	0.7	0.6	0.3	1.3	0.7	0.9	5.7	1.6	0.7	1.4	0.6	0.8	0.4	0.6	0.3	0.6	0.2	0.5	0.4	0.2	0.6	0.3
CPZ		ENSG00000109625	"Carboxypeptidase Z"	Q66K79	4	8592660-8619759	"Enzymes, Predicted intracellular proteins, Predicted secreted proteins"	"Wnt signaling pathway"	"Carboxypeptidase, Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ovary: 63.2"	"Cell line enhanced"	"Detected in some"		"BEWO: 29.2;BJ: 16.8;BJ hTERT+: 22.6;RH-30: 24.8;U-2197: 18.1"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA078608			Approved	"Plasma membrane"	"Secreted to extracellular matrix"			"Plasma membrane"		"HPA078608: "	"unprognostic (2.58e-1)"	"unprognostic (7.16e-2)"	"unprognostic (4.83e-2)"	"unprognostic (1.42e-1)"	"unprognostic (7.77e-2)"	"unprognostic (2.20e-2)"	"unprognostic (2.98e-1)"	"unprognostic (7.77e-2)"	"unprognostic (2.30e-1)"	"unprognostic (1.95e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.59e-1)"	"unprognostic (7.23e-8)"	"unprognostic (4.30e-3)"	"unprognostic (3.58e-2)"	"unprognostic (6.13e-4)"	"unprognostic (5.51e-2)"	4.3	0.9	0.3	2.8	1.1	0.0	5.4	1.1	1.6	15.7	1.8	1.5	27.1	0.1	7.9	24.1	3.0	7.4	12.9	2.4	0.4	0.3	1.5	0.8	2.9	0.7	1.5	0.4	63.2	1.1	0.3	2.3	18.9	2.3	4.1	0.5	4.4	0.8	20.6	0.3	5.5	1.2	10.3	1.3	0.7	1.7	4.4	0.1	1.6	3.5	0.1	2.2	9.8	11.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.3	0.1	0.0	0.7	2.2	0.2	29.2	16.8	22.6	6.3	2.5	0.7	0.3	0.0	1.6	9.2	0.0	0.0	0.0	2.4	0.0	1.2	0.0	0.1	0.3	2.0	0.0	0.0	4.1	0.0	0.0	0.0	0.0	0.4	0.0	0.4	2.5	0.0	0.0	3.9	9.2	0.0	24.8	0.0	0.0	0.5	0.0	0.0	0.6	0.2	0.0	0.1	0.0	0.0	0.9	1.2	18.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	1.1	1.1	1.6	0.4	0.3	1.5	0.4	2.3	0.1
CREB5	"CRE-BPA, H_GS165L15.1"	ENSG00000146592	"CAMP responsive element binding protein 5"	Q02930	7	28299321-28825894	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 53.3;brain: 38.0"	"Cell line enhanced"	"Detected in many"		"HL-60: 31.6;Karpas-707: 13.2;U-2 OS: 13.9;U-2197: 15.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	7	"neutrophil: 53.3"	"Lineage enriched"	"Detected in many"	7	"granulocytes: 53.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA050020, HPA061622"			Approved	"Nucleoplasm,Vesicles,Plasma membrane"				"Nucleoplasm, Plasma membrane"	Vesicles	"HPA050020: , HPA061622: "	"unprognostic (3.59e-2)"	"unprognostic (3.80e-1)"	"unprognostic (1.06e-1)"	"unprognostic (6.46e-2)"	"unprognostic (1.01e-1)"	"unprognostic (4.90e-3)"	"unprognostic (2.01e-3)"	"unprognostic (2.87e-1)"	"unprognostic (3.31e-1)"	"unprognostic (1.04e-1)"	"unprognostic (3.49e-1)"	"unprognostic (2.67e-1)"	"unprognostic (4.91e-3)"	"unprognostic (6.61e-2)"	"unprognostic (3.95e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.52e-3)"	20.0	3.6	12.1	15.4	19.5	11.5	9.0	10.4	17.8	4.6	5.6	38.0	0.9	2.8	16.3	6.9	7.7	4.7	23.1	10.4	16.7	8.7	6.6	4.6	9.5	6.1	17.9	12.1	2.4	7.0	1.5	2.8	19.5	18.3	3.1	4.3	1.1	6.5	3.0	6.2	5.5	4.2	9.8	14.6	12.6	3.2	2.3	22.7	0.0	3.8	7.0	2.5	5.5	5.0	0.3	4.8	53.3	7.8	0.0	0.0	1.5	0.0	0.3	3.9	0.2	0.2	5.6	0.1	0.3	0.8	2.3	3.5	2.2	1.4	9.7	0.7	0.9	0.4	0.1	3.3	7.4	0.0	2.6	10.5	2.0	0.2	0.2	31.6	0.4	0.7	0.7	10.0	10.8	1.5	1.2	13.2	0.8	0.0	0.0	0.0	4.8	3.9	0.2	3.6	0.2	4.8	1.0	0.4	2.8	0.1	0.2	1.1	0.1	0.7	0.4	4.6	13.9	15.2	4.4	0.8	2.2	0.1	5.1	0.2	7.8	0.0	7.8	0.0	0.0	2.7	0.0	0.3	0.0	0.0	4.8	0.0	0.0	0.0	53.3	0.0	0.8	0.0	0.0	1.5	12.1	19.5	10.4	15.6	16.7	8.7	17.9	12.1	18.3	22.7
CRIP1	CRIP	ENSG00000213145	"Cysteine rich protein 1"	P50238	14	105486317-105488947	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"A549: 129.0;CAPAN-2: 71.9;HaCaT: 77.9;HDLM-2: 55.1;HeLa: 63.2;T-47d: 101.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA042462	Approved		Approved	"Nuclear speckles,Plasma membrane,Centrosome,Cytosol"				"Nuclear speckles, Cytosol"	"Plasma membrane, Centrosome"	"HPA042462: AB_10794277"	"unprognostic (2.97e-3)"	"unprognostic (1.27e-3)"	"unprognostic (1.34e-2)"	"unprognostic (1.17e-2)"	"unprognostic (2.39e-1)"	"unprognostic (2.93e-3)"	"unprognostic (4.33e-1)"	"unprognostic (3.33e-1)"	"unprognostic (3.20e-2)"	"unprognostic (2.60e-2)"	"unprognostic (2.87e-1)"	"unprognostic (9.16e-2)"	"unprognostic (3.26e-3)"	"unprognostic (5.10e-2)"	"unprognostic (2.66e-1)"	"unprognostic (7.51e-3)"	"unprognostic (2.14e-1)"	44.3	3.3	3.8	37.5	4.9	5.5	97.2	3.2	4.0	37.7	44.0	4.5	65.3	25.7	20.0	83.0	28.4	23.7	33.8	45.5	4.5	4.7	20.4	2.6	56.7	53.0	4.7	4.5	11.2	4.2	1.1	7.3	38.5	4.8	11.7	13.2	9.9	21.8	71.0	12.9	48.8	106.3	25.9	5.1	16.6	20.3	7.5	1.9	24.2	32.0	83.4	58.3	18.4	18.9	111.4	79.3	56.3	49.4	56.9	121.1	75.8	0.0	129.0	0.8	0.1	2.3	1.6	12.0	0.2	0.0	1.7	0.0	4.0	71.9	38.9	0.7	34.4	77.9	0.0	0.0	0.1	55.1	0.0	3.0	63.2	21.7	0.4	0.0	0.0	0.7	0.0	4.2	0.0	0.1	0.1	0.1	0.0	1.0	1.9	0.3	1.2	6.7	30.5	0.0	8.1	0.0	0.0	3.4	0.2	0.4	0.2	0.0	101.1	18.5	0.2	0.0	0.1	0.9	0.0	0.0	0.0	3.2	0.0	0.0	0.1	19.4	43.3	56.3	47.7	38.5	32.7	111.4	92.1	51.4	79.3	43.6	21.9	25.7	2.9	56.9	49.4	62.1	121.1	75.8	3.8	4.9	3.2	4.0	4.5	4.7	4.7	4.5	4.8	1.9
CRIP2	"CRP2, ESP1"	ENSG00000182809	"Cysteine rich protein 2"	P52943	14	105472962-105480170	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"heart muscle: 180.3"	"Cell line enhanced"	"Detected in many"		"A549: 37.7;EFO-21: 38.6;HUVEC TERT2: 36.1;MCF7: 55.4;SK-BR-3: 43.4;T-47d: 37.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"memory CD4 T-cell: 24.0;T-reg: 29.2"	"Group enriched"	"Detected in many"	19	"B-cells: 17.9;T-cells: 29.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042664	Approved		Approved	"Nucleoplasm,Nucleoli,Plasma membrane"			490000	Nucleoli	"Nucleoplasm, Plasma membrane"	"HPA042664: AB_10797017"	"unprognostic (2.68e-1)"	"unprognostic (6.53e-3)"	"unprognostic (2.11e-3)"	"unprognostic (2.19e-1)"	"unprognostic (2.39e-1)"	"unprognostic (2.14e-1)"	"unprognostic (1.63e-2)"	"unprognostic (2.56e-1)"	"unprognostic (3.20e-3)"	"unprognostic (9.68e-2)"	"unprognostic (6.96e-2)"	"unprognostic (1.14e-1)"	"unprognostic (2.04e-2)"	"unprognostic (6.25e-2)"	"unprognostic (2.35e-2)"	"unprognostic (2.39e-2)"	"unprognostic (8.26e-3)"	22.8	11.5	27.5	9.1	24.6	1.6	16.9	3.6	30.3	20.2	10.1	9.4	33.7	7.9	15.3	30.6	25.6	29.5	24.5	180.3	22.6	18.7	20.0	6.9	28.5	9.3	13.5	16.9	12.5	12.6	4.3	20.4	29.1	10.4	14.6	3.8	8.8	18.4	28.0	10.7	28.4	9.1	24.9	10.3	13.0	11.3	10.9	7.8	1.0	17.8	23.8	13.3	23.8	17.5	17.9	0.9	0.2	0.5	1.2	29.2	3.4	0.4	37.7	5.5	15.0	0.9	3.9	1.6	1.7	0.4	0.5	0.1	1.1	7.0	0.0	38.6	12.3	21.6	0.7	9.2	0.0	0.2	0.2	0.0	23.7	14.3	4.0	0.0	3.2	1.9	0.8	0.9	5.1	36.1	0.0	0.3	5.4	55.4	0.1	0.1	1.5	22.7	0.0	0.7	1.6	25.4	0.1	8.4	20.9	2.4	43.4	0.3	37.2	0.0	14.0	12.5	5.9	0.3	7.0	0.1	0.1	0.1	3.6	0.0	25.2	0.0	0.5	0.0	2.4	0.2	2.3	14.4	24.0	5.3	0.9	17.9	5.9	1.6	0.2	1.2	0.1	0.1	29.2	3.4	27.5	24.6	3.6	30.3	22.6	18.7	13.5	16.9	10.4	7.8
CRK		ENSG00000167193	"CRK proto-oncogene, adaptor protein"	P46108	17	1420689-1463162	"Predicted intracellular proteins"			Proto-oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010485, HPA068087"	Approved		Approved	"Plasma membrane"			390000	"Plasma membrane"		"CAB010485: AB_2085043, HPA068087: "	"unprognostic (6.82e-3)"	"unprognostic (1.94e-1)"	"unprognostic (8.70e-3)"	"unprognostic (5.34e-2)"	"unprognostic (2.43e-1)"	"unprognostic (3.32e-2)"	"unprognostic (2.48e-1)"	"unprognostic (1.67e-2)"	"unprognostic (6.65e-2)"	"unprognostic (1.88e-1)"	"unprognostic (2.65e-1)"	"unprognostic (5.35e-2)"	"unprognostic (1.96e-1)"	"unprognostic (1.67e-1)"	"unprognostic (3.77e-1)"	"unprognostic (1.56e-1)"	"unprognostic (3.93e-2)"	37.1	22.1	23.3	15.9	23.7	4.2	40.0	25.1	23.4	23.3	27.2	21.2	31.5	21.4	26.0	27.5	25.9	19.0	27.5	22.0	23.0	21.6	26.0	40.5	25.6	14.6	25.3	18.4	21.4	22.1	22.6	11.8	33.6	24.2	22.4	28.6	18.0	21.2	27.3	27.8	18.1	26.9	29.3	24.0	17.6	21.6	17.9	26.4	13.6	32.5	20.2	15.8	28.8	40.7	5.5	4.7	16.3	4.6	3.0	4.2	1.7	14.8	23.2	17.3	18.4	29.4	24.8	16.2	25.8	21.8	20.4	19.1	29.9	8.8	7.2	12.9	29.6	23.1	23.0	18.6	30.1	3.6	15.7	8.0	15.2	16.4	27.3	3.4	7.1	23.9	22.1	21.1	26.7	25.0	13.5	6.9	28.4	15.1	3.7	4.0	15.7	11.6	7.9	8.7	6.5	26.8	16.1	6.4	16.9	24.6	15.3	17.6	15.0	5.8	26.6	20.6	11.8	21.7	25.3	3.3	5.0	4.5	17.4	6.8	22.4	5.4	4.4	5.4	3.6	4.6	3.6	4.1	3.8	3.1	4.7	5.5	2.9	4.2	16.3	3.0	4.6	4.4	2.6	1.7	23.3	23.7	25.1	22.3	23.0	21.6	25.3	18.4	24.2	26.4
CROCC	"ROLT, rootletin"	ENSG00000058453	"Ciliary rootlet coiled-coil, rootletin"	Q5TZA2	1	16740273-16972979	"Predicted intracellular proteins"	"Cell cycle, Cilium biogenesis/degradation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"salivary gland: 135.2"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							"HPA021191, HPA021762"	Enhanced		Supported	"Plasma membrane,Centrosome"				"Plasma membrane, Centrosome"		"HPA021191: AB_1856395, HPA021762: AB_1856396"	"unprognostic (9.07e-3)"	"unprognostic (9.03e-2)"	"unprognostic (6.04e-2)"	"prognostic favourable (8.34e-5)"	"unprognostic (3.27e-1)"	"unprognostic (1.25e-3)"	"unprognostic (1.42e-3)"	"prognostic favourable (7.92e-4)"	"unprognostic (2.05e-1)"	"unprognostic (7.75e-2)"	"unprognostic (3.36e-3)"	"unprognostic (5.75e-2)"	"prognostic unfavourable (7.97e-4)"	"unprognostic (1.58e-1)"	"unprognostic (9.83e-2)"	"unprognostic (6.05e-2)"	"unprognostic (1.76e-3)"	5.0	3.8	3.2	3.2	7.0	2.1	2.5	12.9	3.0	3.9	2.8	5.4	2.2	2.4	5.1	2.4	3.2	9.9	2.3	2.1	4.6	3.5	2.4	1.8	3.9	3.2	2.1	2.5	5.0	4.2	3.0	3.6	2.2	11.3	3.3	0.6	30.6	135.2	2.9	8.2	14.4	3.1	1.8	2.3	6.4	3.5	1.9	4.3	2.1	2.5	2.3	1.8	2.9	3.8	1.1	0.6	1.7	0.8	1.3	2.8	0.6	4.1	1.7	3.2	3.2	2.3	2.1	1.3	3.0	1.0	1.0	1.1	0.2	1.9	10.9	2.8	1.2	4.9	0.8	2.2	0.1	0.9	5.8	5.0	5.3	0.8	3.9	0.3	5.1	1.8	5.2	0.9	0.9	1.6	0.7	2.8	0.3	3.5	3.3	1.2	11.6	2.7	3.1	4.2	3.7	0.7	1.1	9.8	10.6	3.2	2.1	9.7	4.2	1.4	4.3	2.8	3.7	7.0	2.3	5.0	3.6	2.2	2.7	0.7	3.3	0.0	0.4	1.7	1.6	0.8	2.8	0.7	1.3	1.3	0.2	1.1	1.1	0.9	0.1	1.3	0.3	0.6	1.3	0.6	3.2	7.0	12.9	3.0	4.6	3.5	2.1	2.5	11.3	4.3
CRTC1	"FLJ14027, KIAA0616, MECT1, TORC1"	ENSG00000105662	"CREB regulated transcription coactivator 1"	Q6UUV9	19	18683677-18782333	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"Biological rhythms, Host-virus interaction, Transcription, Transcription regulation"	Activator	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 40.7"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA022035	Enhanced		Supported	"Nucleoplasm,Nuclear bodies,Plasma membrane,Cytosol"				"Nucleoplasm, Nuclear bodies"	"Plasma membrane, Cytosol"	"HPA022035: AB_1847255"	"unprognostic (5.95e-3)"	"unprognostic (2.57e-1)"	"unprognostic (9.94e-2)"	"unprognostic (8.62e-3)"	"unprognostic (9.07e-2)"	"unprognostic (1.57e-2)"	"unprognostic (1.04e-1)"	"unprognostic (5.57e-2)"	"unprognostic (2.27e-1)"	"unprognostic (6.68e-2)"	"prognostic favourable (1.80e-5)"	"unprognostic (3.37e-2)"	"prognostic favourable (3.83e-5)"	"unprognostic (6.83e-3)"	"unprognostic (1.02e-1)"	"unprognostic (2.51e-2)"	"unprognostic (2.03e-2)"	8.6	7.7	26.0	7.4	38.8	3.2	3.8	40.7	30.1	5.0	4.4	6.5	4.3	6.5	6.8	5.6	3.1	10.5	5.5	5.6	17.7	7.8	6.6	4.5	5.7	6.3	6.4	18.1	6.7	10.0	8.4	11.3	6.4	6.0	7.0	2.6	5.1	8.8	9.4	12.4	5.5	6.2	4.3	4.8	8.1	8.0	7.5	10.2	1.9	7.4	1.1	3.7	4.6	3.5	4.1	3.8	1.8	3.4	1.1	3.0	1.3	4.3	8.0	5.8	9.3	5.4	4.6	16.5	4.8	3.2	4.6	4.5	5.4	5.7	6.1	10.2	4.6	4.7	1.7	3.0	1.1	2.7	13.9	5.1	7.1	8.8	5.2	7.0	14.5	7.4	2.9	4.0	1.2	2.6	4.0	5.6	2.6	16.0	4.5	8.1	7.5	11.8	7.2	2.5	6.7	2.9	7.8	10.7	9.6	5.4	5.2	5.8	5.8	4.3	4.6	5.3	8.1	9.6	5.5	3.8	3.0	4.0	6.1	7.6	4.0	1.5	3.4	1.8	1.7	1.3	1.8	2.3	2.7	3.0	3.0	4.1	2.3	1.8	1.7	1.1	1.9	3.8	1.8	1.3	26.0	38.8	40.7	30.1	17.7	7.8	6.4	18.1	6.0	10.2
CRYGD	CRYG4	ENSG00000118231	"Crystallin gamma D"	P07320	2	208121607-208124501	"Disease related genes, Predicted intracellular proteins"	"Sensory transduction, Vision"	"Eye lens protein"	"Cataract, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"ovary: 17.7"	"Cell line enriched"	"Detected in single"	19	"HEL: 15.0"	"Cancer enhanced"	"Detected in some"		"testis cancer: 3.5"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"HPA041269, HPA043386"	Supported		Approved	"Plasma membrane,Intermediate filaments,Cytokinetic bridge"				"Plasma membrane, Intermediate filaments"	"Cytokinetic bridge"	"HPA041269: , HPA043386: "					"unprognostic (4.49e-2)"						"unprognostic (2.64e-1)"				"unprognostic (3.62e-1)"			0.2	0.2	4.2	0.2	2.0	2.3	0.2	0.0	2.5	0.2	0.2	0.3	0.0	0.4	0.2	0.2	0.3	0.3	0.2	0.6	2.1	4.3	0.2	0.2	0.2	0.2	4.0	1.6	17.7	0.2	0.2	0.4	0.5	1.9	2.0	0.2	2.1	0.2	0.2	0.2	0.2	0.4	0.2	0.4	0.2	0.5	1.4	0.5	0.0	0.2	0.0	0.2	0.3	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	15.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	4.2	2.0	0.0	2.5	2.1	4.3	4.0	1.6	1.9	0.5
CRYL1	"GDH, lambda-CRY, MGC149525, MGC149526"	ENSG00000165475	"Crystallin lambda 1"	Q9Y2S2	13	20403666-20525873	"Enzymes, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"kidney: 104.0;liver: 80.8"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040403	Enhanced		Approved	"Nucleoplasm,Nucleoli,Golgi apparatus,Plasma membrane"			210000	"Nucleoplasm, Nucleoli"	"Golgi apparatus, Plasma membrane"	"HPA040403: AB_10795632"	"unprognostic (1.84e-1)"	"unprognostic (1.25e-1)"	"unprognostic (3.25e-2)"	"prognostic favourable (1.76e-5)"	"unprognostic (3.10e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.09e-3)"	"unprognostic (4.75e-3)"	"unprognostic (1.19e-1)"	"unprognostic (4.09e-2)"	"unprognostic (2.12e-2)"	"unprognostic (8.80e-2)"	"prognostic favourable (2.30e-9)"	"unprognostic (9.00e-2)"	"unprognostic (1.30e-1)"	"unprognostic (2.39e-2)"	"unprognostic (3.11e-1)"	9.8	8.9	21.5	8.8	22.9	3.5	7.0	10.4	17.4	11.8	35.1	26.7	18.9	61.0	9.2	18.0	7.4	9.3	16.1	9.3	18.8	19.8	104.0	80.8	6.8	5.9	24.5	12.3	7.3	15.4	5.3	10.4	5.6	16.8	11.2	16.5	17.2	13.1	20.1	5.4	4.1	45.7	8.0	32.0	6.5	12.0	2.7	16.4	3.2	11.9	5.6	5.5	8.6	5.9	9.3	25.7	1.8	24.3	6.0	15.6	17.5	3.4	3.0	2.6	19.0	14.5	16.8	2.6	4.9	8.8	2.1	1.7	1.1	3.2	0.0	9.3	6.7	0.8	2.5	4.4	2.2	8.3	2.1	6.1	0.3	23.7	8.3	1.9	5.5	9.9	2.8	1.6	10.0	23.0	0.4	2.4	5.6	12.5	5.2	3.1	0.1	4.6	2.7	1.7	0.4	18.3	7.4	1.8	2.2	2.9	1.4	21.8	9.4	7.8	22.0	2.7	1.2	6.5	3.0	3.4	0.7	0.0	5.1	3.4	10.9	1.8	21.8	1.4	10.5	24.3	8.5	9.3	14.0	10.0	25.7	9.1	11.0	10.2	0.7	6.0	20.1	2.8	15.6	17.5	21.5	22.9	10.4	17.4	18.8	19.8	24.5	12.3	16.8	16.4
CST6		ENSG00000175315	"Cystatin E/M"	Q15828	11	66011841-66013505	"Cancer-related genes, Plasma proteins, Predicted secreted proteins"		"Protease inhibitor, Thiol protease inhibitor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"skin 1: 124.5"	"Group enriched"	"Detected in some"	6	"A-431: 26.2;CAPAN-2: 73.1"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 171.0"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"classical monocyte: 1.6"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"CAB019316, HPA044963"	Enhanced		Approved	"Plasma membrane,Cytosol"	"Secreted in other tissues"		110000000	"Plasma membrane"	Cytosol	"CAB019316: , HPA044963: "	"unprognostic (3.01e-2)"	"unprognostic (5.10e-2)"	"unprognostic (1.14e-1)"	"unprognostic (3.59e-2)"	"unprognostic (5.00e-2)"	"unprognostic (2.60e-1)"	"unprognostic (1.65e-1)"	"unprognostic (8.38e-2)"	"unprognostic (5.02e-1)"	"unprognostic (8.89e-3)"	"unprognostic (1.29e-3)"	"unprognostic (1.46e-1)"	"unprognostic (1.74e-3)"	"unprognostic (5.89e-3)"	"unprognostic (1.83e-1)"	"unprognostic (1.64e-2)"	"unprognostic (2.59e-2)"	0.6	0.2	0.1	1.5	0.1	0.2	8.7	0.4	0.2	5.5	0.2	0.0	1.4	0.1	0.3	0.8	11.3	4.3	0.7	2.4	0.1	0.2	1.0	0.1	27.2	1.2	0.1	0.0	1.3	0.2	0.5	0.4	26.5	0.2	0.9	0.1	1.1	1.3	26.5	0.7	124.5	0.2	0.2	0.2	0.2	0.2	1.0	0.0	2.8	14.6	13.6	4.4	0.5	3.7	0.4	0.9	0.0	1.6	0.0	0.2	0.7	26.2	0.0	0.0	0.1	0.0	0.0	7.8	0.2	0.0	0.0	0.0	0.1	73.1	0.0	0.4	0.9	0.9	0.0	6.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.1	0.0	0.0	7.3	0.1	0.1	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.9	0.4	0.0	0.2	0.0	0.0	0.6	0.0	0.0	0.7	0.1	0.1	0.4	0.1	0.1	0.2	0.1	0.0	0.2	0.0
CTNNBIP1	"ICAT, MGC15093"	ENSG00000178585	"Catenin beta interacting protein 1"	Q9NSA3	1	9848276-9910336	"Predicted intracellular proteins"	"Wnt signaling pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skin 1: 116.5"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042617, HPA067089"	Enhanced		Approved	"Plasma membrane,Cell Junctions,Mitochondria"				"Plasma membrane, Cell Junctions, Mitochondria"		"HPA042617: , HPA067089: "	"unprognostic (2.71e-1)"	"unprognostic (4.46e-2)"	"unprognostic (1.94e-1)"	"prognostic favourable (5.68e-6)"	"unprognostic (3.08e-1)"	"unprognostic (2.63e-2)"	"unprognostic (2.22e-2)"	"unprognostic (1.19e-1)"	"unprognostic (2.23e-2)"	"unprognostic (2.62e-1)"	"unprognostic (2.17e-2)"	"unprognostic (1.77e-1)"	"unprognostic (1.24e-3)"	"unprognostic (3.62e-2)"	"unprognostic (3.22e-2)"	"unprognostic (8.63e-2)"	"unprognostic (4.37e-2)"	12.6	4.0	10.1	4.3	8.1	7.7	18.3	21.4	14.8	16.6	5.8	10.1	10.9	7.4	4.8	31.3	49.0	5.2	4.8	13.7	10.1	9.5	5.6	4.8	15.2	4.0	8.4	11.3	5.5	14.1	4.0	6.6	11.0	13.7	9.9	4.2	13.3	15.5	16.5	13.1	116.5	5.8	4.5	9.2	3.3	8.8	11.8	6.5	4.8	7.9	33.9	13.5	5.6	21.7	1.9	6.8	12.9	5.4	8.8	2.9	2.3	25.8	3.8	23.8	18.1	3.6	6.0	7.6	5.1	9.0	7.6	4.9	1.8	33.0	8.0	14.9	6.6	13.2	2.7	30.5	3.5	20.1	4.2	5.2	1.2	24.1	7.5	3.8	3.0	6.7	30.2	9.6	9.9	20.4	9.1	3.8	4.6	15.8	8.6	14.4	12.6	6.7	9.8	7.0	5.1	3.9	8.9	26.2	16.5	11.7	10.6	15.5	13.0	9.5	13.3	4.9	6.0	7.4	11.2	8.3	10.8	9.3	1.8	19.8	19.5	2.7	5.4	12.9	2.9	1.9	1.7	1.9	1.5	2.4	6.8	1.6	1.4	1.4	4.0	8.8	1.2	2.1	1.2	2.3	10.1	8.1	21.4	14.8	10.1	9.5	8.4	11.3	13.7	6.5
CTSF	"CATSF, CLN13"	ENSG00000174080	"Cathepsin F"	Q9UBX1	11	66563463-66568841	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Hydrolase, Protease, Thiol protease"	"Disease mutation, Neurodegeneration, Neuronal ceroid lipofuscinosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HSkMC: 28.2;SK-MEL-30: 52.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"NK-cells: 7.5;T-cells: 9.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002141, HPA031431, HPA055610"	Approved		Approved	"Vesicles,Plasma membrane,Cytosol"	"Intracellular and membrane"		3600000	Cytosol	"Vesicles, Plasma membrane"	"CAB002141: AB_563471, HPA031431: , HPA055610: "	"unprognostic (1.52e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.03e-1)"	"unprognostic (7.22e-3)"	"unprognostic (2.25e-2)"	"unprognostic (6.72e-2)"	"unprognostic (2.67e-2)"	"unprognostic (2.76e-2)"	"unprognostic (3.69e-1)"	"unprognostic (4.14e-1)"	"unprognostic (1.69e-2)"	"unprognostic (9.12e-2)"	"prognostic favourable (8.92e-7)"	"unprognostic (1.36e-2)"	"unprognostic (1.28e-1)"	"unprognostic (3.89e-1)"	"unprognostic (2.42e-1)"	28.1	29.4	24.7	8.0	29.0	1.8	31.1	38.4	47.1	37.3	23.8	32.6	25.2	5.8	38.1	29.8	12.9	34.3	37.3	34.5	25.3	20.5	29.8	45.4	17.3	8.5	28.0	26.0	68.2	23.1	42.6	15.9	20.2	25.4	32.3	8.1	35.0	35.5	37.8	35.8	19.7	9.4	34.6	22.4	10.4	17.8	37.1	30.1	0.8	18.6	14.2	6.3	22.2	21.5	2.1	1.1	0.5	0.7	7.5	9.7	2.4	0.1	9.2	5.0	12.9	21.3	8.6	3.6	6.5	16.5	6.8	4.8	0.0	8.2	0.0	11.0	14.2	0.9	8.5	2.8	3.6	2.2	0.0	0.3	3.8	0.0	11.9	0.1	5.0	28.2	9.6	1.5	1.1	4.3	2.8	1.5	8.5	1.9	0.1	1.1	0.6	3.4	0.0	1.9	1.6	6.1	0.2	6.0	6.4	17.4	2.0	52.3	13.2	0.8	2.8	2.7	2.7	3.2	0.6	8.8	0.1	0.0	6.5	0.1	4.1	0.0	0.7	0.4	6.5	0.7	7.0	2.0	5.6	7.3	0.8	2.1	9.7	5.5	0.5	7.5	0.3	1.1	1.7	2.4	24.7	29.0	38.4	47.1	25.3	20.5	28.0	26.0	25.4	30.1
CTSV	"CTSL2, CTSU"	ENSG00000136943	"Cathepsin V"	O60911	9	97029679-97039643	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"lymphoid tissue: 154.7"	"Cell line enriched"	"Detected in many"	8	"BEWO: 113.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	6	"NK-cell: 4.2;plasmacytoid DC: 15.7"	"Group enriched"	"Detected in many"	42	"dendritic cells: 15.7;NK-cells: 4.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB017112	Uncertain		Approved	"Nucleoplasm,Nucleoli fibrillar center,Plasma membrane,Cytosol"	"Intracellular and membrane"		260000	"Nucleoli fibrillar center, Cytosol"	"Nucleoplasm, Plasma membrane"	"CAB017112: "	"unprognostic (2.40e-1)"	"unprognostic (2.74e-2)"	"unprognostic (1.50e-1)"	"prognostic favourable (8.41e-4)"	"unprognostic (7.29e-2)"	"unprognostic (5.59e-2)"	"prognostic unfavourable (2.83e-5)"	"unprognostic (7.04e-3)"	"unprognostic (6.06e-2)"	"unprognostic (1.39e-2)"	"prognostic unfavourable (2.87e-4)"	"unprognostic (1.86e-2)"	"unprognostic (1.78e-1)"	"unprognostic (2.41e-2)"	"unprognostic (1.33e-1)"	"unprognostic (3.04e-3)"	"prognostic unfavourable (2.39e-4)"	0.7	0.0	0.4	0.6	0.7	0.0	3.5	0.4	1.0	23.0	1.4	2.0	0.4	0.5	1.5	1.5	9.8	0.6	0.5	0.2	0.8	0.6	9.7	0.4	0.6	0.2	1.5	0.7	0.4	1.1	1.1	0.9	8.7	1.6	0.5	1.6	4.3	5.0	0.6	0.5	25.0	0.6	0.2	3.0	0.2	1.1	32.4	1.0	154.7	0.7	6.3	2.7	0.2	9.9	0.2	15.7	0.2	0.0	4.2	0.0	0.1	7.3	2.2	2.5	6.5	0.1	0.0	113.4	0.0	0.0	1.6	1.3	14.9	7.3	0.1	0.6	0.1	14.0	12.1	8.9	2.3	0.0	1.6	0.3	0.7	2.3	0.0	0.0	1.0	0.0	3.0	0.4	0.3	0.5	0.2	0.0	2.9	2.7	0.2	0.1	15.0	2.1	0.0	5.4	0.1	2.2	0.9	0.6	1.1	7.4	2.6	2.6	4.6	0.8	0.0	0.4	7.4	0.1	0.8	1.5	4.0	0.1	0.4	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.2	0.0	0.0	0.2	4.2	0.0	15.7	0.0	0.1	0.4	0.7	0.4	1.0	0.8	0.6	1.5	0.7	1.6	1.0
CTXN1	FLJ25968	ENSG00000178531	"Cortexin 1"	P60606	19	7924485-7926166	"Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"		"Tissue enriched"	"Detected in many"	5	"brain: 91.1"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 33.2;HEK 293: 23.1;NTERA-2: 25.2;REH: 19.1;SCLC-21H: 19.6;SH-SY5Y: 32.9"	"Cancer enhanced"	"Detected in all"		"ovarian cancer: 138.6"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA016669	Uncertain		Approved	"Nucleoplasm,Plasma membrane,Cell Junctions"				Nucleoplasm	"Plasma membrane, Cell Junctions"	"HPA016669: AB_1847330"	"unprognostic (1.49e-2)"	"unprognostic (3.52e-2)"	"unprognostic (1.79e-2)"	"unprognostic (2.47e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.82e-2)"	"unprognostic (5.42e-2)"	"unprognostic (2.17e-1)"	"unprognostic (2.58e-1)"	"unprognostic (2.28e-2)"	"unprognostic (1.69e-3)"	"unprognostic (3.31e-2)"	"unprognostic (1.56e-3)"	"unprognostic (4.84e-2)"	"unprognostic (3.09e-2)"	"unprognostic (3.76e-2)"	"unprognostic (9.41e-2)"	2.1	4.8	47.7	2.5	91.1	1.6	2.1	0.0	74.2	5.2	6.1	5.0	3.6	2.6	17.5	5.1	2.4	16.4	1.8	1.6	49.4	16.8	3.1	1.5	3.0	1.6	15.7	20.1	2.7	2.1	2.3	6.5	2.0	4.0	5.5	2.1	0.0	2.1	16.5	1.6	2.8	2.1	7.1	1.5	2.0	2.2	6.1	8.3	0.0	1.8	0.0	1.6	2.9	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.0	2.7	7.1	33.2	0.0	0.1	1.6	2.9	0.8	1.4	0.8	0.8	1.7	0.0	5.6	0.7	12.1	1.6	0.3	0.0	1.0	23.1	0.2	1.9	0.5	0.3	0.5	0.6	0.0	0.9	0.5	0.3	1.8	7.0	0.1	0.1	13.4	6.1	4.5	25.2	11.7	19.1	0.0	2.1	5.1	0.5	19.6	32.9	1.7	0.9	3.0	7.3	0.2	2.8	0.7	11.7	1.3	1.6	0.2	0.3	1.5	2.8	1.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	47.7	91.1	0.0	63.8	49.4	16.8	15.7	20.1	4.0	8.3
CUEDC1		ENSG00000180891	"CUE domain containing 1"	Q9NWM3	17	57861243-57955323	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"T-47d: 36.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	10	"plasmacytoid DC: 17.6"	"Lineage enriched"	"Detected in many"	10	"dendritic cells: 17.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023050, HPA024836"	Approved		Approved	"Plasma membrane,Centrosome,Cytosol"				"Plasma membrane, Cytosol"	Centrosome	"HPA023050: AB_1847332, HPA024836: AB_1847333"	"unprognostic (4.46e-1)"	"unprognostic (3.76e-3)"	"unprognostic (4.77e-2)"	"unprognostic (4.87e-3)"	"unprognostic (4.04e-1)"	"unprognostic (3.56e-2)"	"prognostic unfavourable (2.65e-5)"	"unprognostic (6.69e-2)"	"unprognostic (1.53e-2)"	"unprognostic (6.65e-2)"	"unprognostic (1.28e-3)"	"unprognostic (1.37e-1)"	"prognostic favourable (8.46e-4)"	"unprognostic (1.96e-1)"	"unprognostic (2.69e-2)"	"unprognostic (2.52e-2)"	"unprognostic (2.65e-2)"	9.8	10.6	11.7	8.6	19.3	5.2	9.3	8.5	16.6	22.3	18.5	39.1	11.8	5.0	13.4	13.9	21.2	21.6	12.9	24.2	12.6	12.1	12.0	3.7	13.7	4.4	30.0	8.0	6.4	11.6	7.1	11.5	7.8	18.5	13.0	7.2	19.3	19.1	18.4	48.9	5.5	7.3	19.2	18.7	6.6	12.2	2.9	28.3	2.5	11.2	15.8	4.7	15.4	10.4	0.0	17.6	1.8	1.3	0.1	0.0	0.1	8.2	25.4	26.6	4.7	4.3	8.0	0.9	5.8	11.8	12.2	8.9	4.6	31.6	0.1	23.7	11.2	6.6	2.9	12.5	4.4	16.0	4.9	0.2	16.5	3.8	10.5	0.1	2.0	8.1	7.6	7.1	6.0	5.9	0.3	0.1	11.2	4.6	0.4	0.2	0.9	7.0	0.8	6.9	1.2	8.3	5.4	11.0	6.0	2.4	2.6	10.0	36.8	0.9	7.4	32.7	20.7	8.9	12.9	0.0	0.1	0.1	14.2	1.1	26.1	0.6	0.4	1.8	0.0	0.7	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.7	0.1	1.3	17.6	0.0	0.1	11.7	19.3	8.5	15.4	12.6	12.1	30.0	8.0	18.5	28.3
CUTA	"ACHAP, C6orf82"	ENSG00000112514	"CutA divalent cation tolerance homolog"	O60888	6	33416442-33418317	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB016787, HPA064369"	Uncertain		Approved	"Plasma membrane,Focal adhesion sites"	"Secreted to blood"		35000000	"Plasma membrane, Focal adhesion sites"		"CAB016787: , HPA064369: "	"unprognostic (7.03e-2)"	"unprognostic (5.44e-2)"	"unprognostic (4.56e-2)"	"unprognostic (8.91e-2)"	"unprognostic (1.86e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.98e-2)"	"prognostic favourable (8.50e-4)"	"unprognostic (1.87e-1)"	"unprognostic (2.78e-2)"	"unprognostic (1.27e-3)"	"unprognostic (1.91e-1)"	"unprognostic (5.55e-2)"	"unprognostic (9.90e-2)"	"unprognostic (1.54e-1)"	"unprognostic (7.94e-2)"	"unprognostic (2.74e-1)"	26.6	65.6	47.9	28.3	60.1	33.5	47.6	37.7	73.7	47.7	37.9	36.8	53.9	42.1	40.1	78.5	30.5	46.0	48.8	49.6	45.2	44.9	46.3	61.6	39.0	77.4	46.5	37.8	57.7	66.6	43.8	86.1	45.7	39.8	38.8	28.9	34.2	74.3	69.7	34.6	32.7	37.2	32.4	47.0	36.0	38.7	27.3	31.6	52.2	69.7	30.3	31.3	42.6	28.9	56.5	31.4	27.1	32.0	49.9	69.8	60.8	43.2	25.9	41.5	52.6	31.3	30.8	20.1	39.6	74.0	76.5	81.6	25.8	27.0	30.6	30.7	45.3	26.5	27.0	40.3	43.2	25.9	59.7	31.9	43.0	67.6	40.7	24.8	24.3	40.8	34.0	36.7	31.1	20.5	39.1	62.2	55.9	33.6	37.5	52.8	37.2	34.3	41.2	24.8	80.8	52.6	18.8	81.3	41.4	23.7	41.2	71.8	30.3	52.1	22.6	41.4	35.2	29.4	41.2	61.2	60.8	33.4	35.8	54.9	33.6	27.1	32.0	16.5	45.7	22.9	63.2	56.5	67.6	52.7	31.4	44.2	68.5	53.2	4.6	49.9	16.8	27.1	69.8	60.8	47.9	60.1	37.7	73.7	45.2	44.9	46.5	37.8	39.8	31.6
DAAM1	KIAA0666	ENSG00000100592	"Dishevelled associated activator of morphogenesis 1"	Q9Y4D1	14	59188646-59371405	"Plasma proteins, Predicted intracellular proteins"	"Wnt signaling pathway"	Actin-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HaCaT: 26.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"plasmacytoid DC: 18.3"	"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026605, HPA064789"	Uncertain		Approved	"Plasma membrane,Cytosol"			450000	"Plasma membrane, Cytosol"		"HPA026605: AB_1847464, HPA064789: "	"unprognostic (2.81e-1)"	"unprognostic (9.70e-2)"	"unprognostic (3.85e-2)"	"unprognostic (2.74e-1)"	"unprognostic (2.32e-1)"	"unprognostic (1.84e-1)"	"unprognostic (1.76e-2)"	"unprognostic (2.48e-1)"	"unprognostic (2.02e-1)"	"unprognostic (6.40e-2)"	"unprognostic (1.98e-1)"	"unprognostic (4.64e-2)"	"prognostic favourable (3.77e-4)"	"unprognostic (5.01e-2)"	"unprognostic (3.29e-1)"	"unprognostic (1.39e-1)"	"unprognostic (3.15e-2)"	13.8	8.0	13.8	9.4	9.3	3.7	9.3	17.3	13.3	14.6	11.4	6.3	7.4	4.5	16.9	7.0	19.2	8.4	6.0	17.3	10.2	6.7	6.0	10.7	9.7	8.8	5.6	13.6	8.6	8.2	25.6	9.6	12.4	8.7	10.9	7.8	16.9	12.0	10.5	6.0	25.6	7.7	19.5	10.0	10.2	9.1	5.8	7.2	4.1	7.1	14.1	13.8	15.3	13.1	10.7	18.3	4.9	3.1	6.9	3.8	1.9	12.8	1.3	8.8	2.3	5.8	4.1	11.6	1.6	1.6	3.4	3.6	6.6	10.7	13.3	3.4	4.0	26.5	8.3	6.4	2.8	5.8	2.9	5.0	3.3	7.9	3.6	5.6	2.6	2.7	6.5	2.9	2.9	7.5	8.1	6.6	2.1	11.0	4.7	2.7	4.8	3.8	4.4	7.5	1.3	4.4	10.1	13.8	3.1	11.2	16.4	10.0	21.8	1.2	7.5	2.6	5.1	5.9	1.5	1.4	1.6	15.6	3.6	1.0	6.3	4.9	2.1	2.5	2.6	2.4	3.1	10.7	3.3	2.4	2.4	4.7	2.7	2.7	2.6	6.9	3.1	18.3	3.8	1.9	13.8	9.3	17.3	13.3	10.2	6.7	5.6	13.6	8.7	7.2
DAW1	"FLJ25955, ODA16, WDR69"	ENSG00000123977	"Dynein assembly factor with WD repeats 1"	Q8N136	2	227871054-227924344	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	9	"brain: 14.9;fallopian tube: 24.4;testis: 49.9"	"Group enriched"	"Detected in some"	6	"HUVEC TERT2: 14.9;U-2197: 28.1"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"midbrain: 25.4"	HPA046118	Approved		Approved	"Nucleoplasm,Nuclear bodies,Plasma membrane"				Nucleoplasm	"Nuclear bodies, Plasma membrane"	"HPA046118: AB_10961428"		"unprognostic (1.23e-1)"	"unprognostic (1.42e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.66e-1)"	"unprognostic (4.37e-1)"		"unprognostic (1.23e-1)"	"unprognostic (5.63e-3)"	"unprognostic (2.90e-2)"	"unprognostic (9.92e-3)"		"unprognostic (1.54e-5)"	"unprognostic (1.52e-1)"	"unprognostic (6.83e-3)"	"unprognostic (1.70e-1)"	"unprognostic (3.08e-1)"	0.4	0.1	2.5	0.3	14.9	0.4	0.5	0.0	1.8	0.7	0.3	3.1	0.0	0.1	0.3	3.1	0.6	24.4	0.4	0.4	3.9	3.0	0.3	0.5	2.4	0.3	0.3	2.7	1.3	0.1	0.7	0.2	0.8	14.3	0.2	0.2	0.0	0.3	0.2	2.6	0.3	0.2	0.2	0.3	0.3	0.2	49.9	1.1	0.0	0.2	0.0	0.3	0.3	0.0	0.5	0.5	1.2	0.5	0.2	0.8	0.0	0.6	0.0	0.1	0.0	0.2	0.9	0.4	0.5	0.3	0.6	0.4	3.6	0.3	0.2	0.0	0.1	0.1	0.0	0.1	1.8	0.0	0.0	0.0	0.3	0.0	0.8	0.0	0.1	1.3	0.0	0.7	0.5	14.9	0.0	0.2	0.2	0.0	0.0	0.4	0.3	0.1	0.0	0.1	0.2	0.0	0.1	0.2	0.1	0.5	0.0	0.0	0.1	0.3	1.5	0.1	1.4	28.1	0.0	0.0	0.1	0.2	2.7	0.0	0.2	1.2	0.0	0.2	0.2	0.5	0.8	0.3	0.4	0.4	0.0	0.5	0.6	0.3	0.0	0.2	0.5	0.5	0.6	0.0	2.5	14.9	0.0	1.8	3.9	3.0	0.3	2.7	14.3	1.1
DBN1	D0S117E	ENSG00000113758	"Drebrin 1"	Q16643	5	177456608-177474401	"Plasma proteins, Predicted intracellular proteins"	"Differentiation, Neurogenesis"	"Actin-binding, Developmental protein"	"Alzheimer disease, Amyloidosis, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"MAIT T-cell: 12.7"	"Group enriched"	"Detected in many"	8	"dendritic cells: 5.1;granulocytes: 6.0;T-cells: 12.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA051452, HPA056940"	Enhanced	Supported	Supported	"Plasma membrane,Actin filaments"			17000000	"Plasma membrane, Actin filaments"		"HPA051452: AB_2681489, HPA056940: AB_2683279"	"unprognostic (3.81e-2)"	"unprognostic (6.60e-3)"	"unprognostic (2.88e-2)"	"unprognostic (7.57e-3)"	"unprognostic (9.32e-2)"	"unprognostic (5.68e-2)"	"unprognostic (2.01e-3)"	"unprognostic (4.29e-2)"	"unprognostic (1.73e-2)"	"unprognostic (7.92e-2)"	"unprognostic (2.94e-2)"	"unprognostic (3.64e-1)"	"prognostic favourable (8.28e-4)"	"unprognostic (1.53e-1)"	"unprognostic (4.56e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.76e-3)"	21.4	9.0	21.7	15.0	42.4	5.4	13.5	12.0	46.0	25.7	21.7	8.8	8.7	8.6	37.4	15.0	19.2	16.2	21.5	13.9	24.2	20.9	15.1	2.7	12.1	7.3	11.9	22.1	20.2	13.2	9.1	17.1	6.7	20.3	14.9	5.8	9.3	24.8	23.0	21.3	12.7	10.0	29.5	8.6	7.8	17.0	14.4	9.4	19.8	20.0	11.0	4.4	20.6	12.0	0.2	5.1	6.0	0.9	0.1	12.7	1.5	2.9	10.1	33.8	58.9	8.0	12.7	10.5	36.1	9.3	21.2	17.8	34.9	10.6	0.0	25.8	28.0	4.7	14.9	26.2	10.0	0.8	12.9	19.6	13.2	14.5	28.5	7.3	3.6	16.6	6.9	23.7	7.1	34.9	9.0	4.7	15.4	4.2	20.1	11.2	48.9	22.7	60.2	36.6	5.9	15.8	4.2	39.8	54.1	11.8	5.2	20.0	14.4	7.6	53.9	23.7	32.2	5.2	16.7	1.1	0.5	31.6	9.9	6.9	14.5	6.0	0.9	0.7	9.2	0.5	12.7	0.1	0.2	6.6	1.4	0.2	0.3	4.5	2.5	0.1	0.4	5.1	0.0	1.5	21.7	42.4	12.0	40.8	24.2	20.9	11.9	22.1	20.3	9.4
DCAF16	"C4orf30, FLJ20280"	ENSG00000163257	"DDB1 and CUL4 associated factor 16"	Q9NXF7	4	17800655-17810758	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA042487	Uncertain		Approved	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		"HPA042487: AB_10795505"	"unprognostic (2.23e-3)"	"unprognostic (1.05e-1)"	"unprognostic (1.19e-1)"	"unprognostic (3.97e-1)"	"unprognostic (8.02e-2)"	"unprognostic (2.14e-1)"	"prognostic unfavourable (6.40e-4)"	"prognostic favourable (5.78e-4)"	"unprognostic (5.31e-2)"	"unprognostic (3.30e-1)"	"unprognostic (1.45e-2)"	"unprognostic (3.19e-2)"	"unprognostic (1.78e-1)"	"unprognostic (8.72e-2)"	"unprognostic (1.68e-1)"	"unprognostic (2.23e-3)"	"prognostic favourable (7.67e-4)"	13.0	13.1	12.7	12.1	20.5	23.3	19.8	19.4	19.7	18.5	13.1	22.5	9.9	12.0	26.9	16.5	11.5	16.1	11.3	11.8	13.9	15.7	11.3	6.8	12.6	16.7	14.4	16.2	29.6	16.0	17.8	25.8	14.8	19.0	16.9	14.8	17.1	15.2	13.0	16.2	22.4	14.0	17.2	16.0	13.3	13.6	19.2	16.3	30.6	15.7	7.0	18.3	16.3	14.6	4.8	3.0	9.7	2.8	3.6	6.3	2.2	12.1	2.6	14.2	14.8	4.1	7.2	7.8	8.0	9.4	9.5	11.3	7.4	9.9	13.7	6.4	7.3	6.2	8.3	8.4	14.2	4.6	7.6	19.2	8.7	12.1	9.8	16.8	7.9	9.3	7.0	12.0	12.0	6.5	20.6	22.9	5.5	4.5	18.5	16.2	11.7	7.7	19.6	16.2	8.8	4.1	9.6	21.2	17.0	8.4	2.3	9.1	8.3	4.6	8.2	11.1	8.7	12.2	10.0	10.2	4.0	17.2	9.1	11.7	7.4	9.7	2.4	3.4	4.5	2.8	5.9	3.7	5.0	4.9	1.5	4.8	6.3	5.9	1.8	3.6	1.9	3.0	3.4	2.2	12.7	20.5	19.4	19.7	13.9	15.7	14.4	16.2	19.0	16.3
DCBLD2	"CLCP1, ESDN"	ENSG00000057019	"Discoidin, CUB and LCCL domain containing 2"	Q96PD2	3	98795941-98901689	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"hTERT-HME1: 61.3;LHCN-M2: 102.3;RPTEC TERT1: 64.1;U-87 MG: 78.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA016909	Approved		Approved	"Golgi apparatus,Plasma membrane,Cytosol"			1800000	"Plasma membrane, Cytosol"	"Golgi apparatus"	"HPA016909: AB_1847510"	"unprognostic (1.66e-1)"	"unprognostic (1.45e-1)"	"unprognostic (4.46e-2)"	"unprognostic (2.64e-1)"	"unprognostic (5.97e-3)"	"unprognostic (9.29e-3)"	"unprognostic (8.31e-3)"	"unprognostic (1.06e-3)"	"unprognostic (1.42e-1)"	"unprognostic (1.63e-1)"	"prognostic unfavourable (1.52e-4)"	"unprognostic (2.43e-1)"	"prognostic unfavourable (3.32e-5)"	"prognostic unfavourable (2.87e-4)"	"unprognostic (7.76e-2)"	"unprognostic (3.93e-2)"	"unprognostic (1.59e-3)"	13.1	14.6	4.5	6.4	7.2	1.1	19.3	9.7	9.6	12.0	13.1	5.1	8.1	2.7	16.8	9.2	8.8	13.9	11.7	24.2	4.5	6.2	11.3	9.2	13.1	3.2	6.7	3.5	19.0	6.4	17.6	12.7	9.9	6.5	11.2	6.8	19.3	11.1	14.7	6.6	7.7	5.2	16.7	7.1	2.1	8.6	33.8	7.3	8.1	18.7	6.3	3.6	15.1	6.8	0.6	1.2	1.7	0.5	0.1	1.1	0.2	7.0	51.5	6.9	5.4	9.2	22.0	3.0	15.9	7.6	10.8	12.4	4.3	22.5	0.0	50.1	27.3	6.5	3.1	25.9	25.1	0.1	1.1	2.4	1.6	6.5	5.6	1.1	1.1	8.7	4.0	31.2	61.3	7.1	0.5	0.6	102.3	1.8	0.9	0.7	4.8	17.8	1.0	13.0	0.6	64.1	1.8	1.8	3.2	4.3	0.9	18.6	3.4	0.9	11.7	28.0	22.5	7.1	55.7	0.8	1.2	0.9	78.2	0.4	12.2	1.2	0.5	1.7	0.0	0.1	0.0	0.6	0.1	0.1	0.5	0.2	1.1	0.1	0.9	0.1	0.3	1.2	0.0	0.2	4.5	7.2	9.7	9.6	4.5	6.2	6.7	3.5	6.5	7.3
DCHS1	"CDH25, CDHR6, FIB1, FLJ11790, KIAA1773, PCDH16"	ENSG00000166341	"Dachsous cadherin-related 1"	Q96JQ0	11	6621323-6655854	"Disease related genes, Plasma proteins, Predicted membrane proteins"	"Cell adhesion"		"Deafness, Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"AF22: 18.8;HUVEC TERT2: 26.1;REH: 12.6;SH-SY5Y: 18.2;TIME: 11.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"plasmacytoid DC: 1.4"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA017970, HPA050246"	Approved		Approved	"Plasma membrane"			75000	"Plasma membrane"		"HPA017970: , HPA050246: "	"unprognostic (2.42e-1)"	"unprognostic (1.13e-1)"	"unprognostic (8.93e-2)"	"unprognostic (3.52e-2)"	"unprognostic (1.83e-1)"	"unprognostic (1.38e-3)"	"unprognostic (2.52e-2)"	"unprognostic (4.55e-3)"	"unprognostic (2.63e-2)"	"unprognostic (2.93e-2)"	"unprognostic (5.96e-2)"	"unprognostic (6.87e-2)"	"prognostic unfavourable (9.32e-4)"	"unprognostic (5.62e-2)"	"unprognostic (2.28e-1)"	"unprognostic (1.60e-2)"	"unprognostic (1.24e-3)"	9.0	2.0	4.1	7.7	4.7	0.5	6.8	5.2	4.4	26.1	12.9	4.4	9.0	3.8	23.9	4.7	5.0	10.4	9.1	8.0	4.0	4.5	3.4	5.6	7.7	3.9	2.5	3.4	13.7	3.3	1.6	2.7	9.7	3.3	12.0	3.4	9.7	3.3	12.0	3.5	3.4	6.0	16.0	1.6	10.2	6.8	2.6	2.5	5.8	3.3	2.6	2.6	10.9	11.9	0.0	1.4	0.1	0.0	0.0	0.9	0.4	0.0	0.0	18.8	0.1	0.0	0.0	0.1	0.6	4.8	3.0	3.4	0.1	0.0	0.1	2.9	5.4	0.0	1.5	0.0	2.1	0.0	0.5	0.3	0.0	0.0	0.2	0.1	0.0	0.6	0.1	1.4	0.0	26.1	0.1	0.0	1.1	0.0	0.6	0.3	2.8	0.0	12.6	0.0	0.0	0.0	0.0	1.4	18.2	0.0	0.1	0.1	0.0	0.7	11.1	0.0	5.8	0.0	0.0	0.0	0.0	0.1	0.1	0.4	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.6	0.6	0.0	0.0	0.8	0.9	0.1	0.0	0.0	1.4	0.0	0.4	4.1	4.7	5.2	4.4	4.0	4.5	2.5	3.4	3.3	2.5
DCHS2	"CDH27, CDHJ, CDHR7, FLJ20047, PCDH23, PCDHJ"	ENSG00000197410	"Dachsous cadherin-related 2"		4	154231742-154495570	"Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in many"		"endometrium 1: 8.6"	"Cell line enriched"	"Detected in some"	6	"U-2 OS: 7.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Low region specificity"	"Detected in many"			HPA064159	Uncertain		Approved	"Vesicles,Plasma membrane"				"Vesicles, Plasma membrane"		"HPA064159: "	"unprognostic (1.38e-2)"	"unprognostic (1.51e-1)"	"unprognostic (5.74e-3)"	"unprognostic (5.93e-2)"	"unprognostic (7.43e-3)"	"unprognostic (1.29e-1)"	"unprognostic (2.27e-4)"	"unprognostic (1.18e-1)"	"unprognostic (4.00e-1)"	"unprognostic (1.61e-1)"	"unprognostic (2.53e-3)"	"unprognostic (1.62e-1)"	"unprognostic (1.06e-3)"	"unprognostic (3.13e-1)"	"unprognostic (2.62e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.68e-3)"	0.9	1.6	3.4	1.3	7.0	1.1	1.0	0.6	4.8	2.6	4.0	1.9	1.1	1.3	8.6	1.5	1.0	2.0	1.6	0.8	3.5	2.6	0.9	0.7	1.1	0.8	3.0	2.3	1.9	0.6	1.1	1.7	0.8	4.6	1.6	1.5	2.7	0.8	3.6	1.0	2.1	1.0	3.0	7.0	0.8	4.9	2.6	2.9	0.0	1.0	0.0	0.9	2.3	1.2	0.3	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.3	0.2	0.0	0.0	0.0	0.0	1.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	7.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.4	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	3.4	7.0	0.6	4.8	3.5	2.6	3.0	2.3	4.6	2.9
DCUN1D2	"C13orf17, FLJ10704, FLJ20092"	ENSG00000150401	"Defective in cullin neddylation 1 domain containing 2"	Q6PH85	13	113455819-113490952	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	5	"brain: 24.0;heart muscle: 59.1;skeletal muscle: 65.6"	"Cell line enhanced"	"Detected in all"		"SCLC-21H: 31.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039349	Uncertain		Approved	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		"HPA039349: AB_10673240"	"unprognostic (3.09e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.78e-1)"	"unprognostic (4.69e-2)"	"unprognostic (7.43e-2)"	"unprognostic (7.68e-2)"	"unprognostic (4.33e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.40e-1)"	"unprognostic (2.02e-2)"	"prognostic favourable (5.65e-5)"	"unprognostic (1.21e-2)"	"unprognostic (7.20e-2)"	"unprognostic (3.57e-2)"	"unprognostic (1.28e-1)"	"unprognostic (3.69e-2)"	"unprognostic (1.25e-2)"	4.9	4.5	6.2	6.0	7.0	7.8	4.6	24.0	13.3	4.1	4.3	6.5	3.4	3.1	6.2	6.6	4.7	4.0	4.9	59.1	5.9	7.2	4.3	4.0	3.8	4.6	7.2	5.9	5.5	4.5	3.5	7.1	5.2	9.7	3.9	4.5	6.2	4.5	4.5	65.6	9.1	5.4	5.2	8.5	4.9	4.3	5.6	6.1	5.3	3.3	7.5	4.9	3.8	3.7	3.5	2.7	10.9	2.2	2.8	4.1	1.8	6.7	4.2	7.1	5.4	5.2	4.6	5.5	5.3	6.5	5.0	5.7	15.0	4.1	4.9	1.7	6.1	9.8	7.6	4.0	7.2	3.2	12.8	8.3	19.2	4.1	2.7	12.6	6.2	6.8	6.7	5.6	4.5	4.2	4.6	4.7	4.8	4.8	8.6	20.8	4.5	6.6	9.0	11.7	6.5	3.7	4.5	31.6	7.0	4.1	14.2	3.9	8.1	5.9	7.0	6.6	9.0	5.0	7.6	14.0	5.9	9.8	15.0	5.6	4.4	10.9	1.9	3.6	3.1	1.7	4.1	3.5	2.8	1.9	2.7	1.9	3.0	1.6	1.5	2.8	2.2	0.3	2.9	1.8	6.2	7.0	24.0	13.3	5.9	7.2	7.2	5.9	9.7	6.1
DDAH1	DDAH	ENSG00000153904	"Dimethylarginine dimethylaminohydrolase 1"	O94760	1	85318481-85578363	"Enzymes, Plasma proteins, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 61.6"	"Cell line enhanced"	"Detected in many"		"SH-SY5Y: 36.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"memory B-cell: 1.3;naive B-cell: 1.0"	"Lineage enhanced"	"Detected in single"		"B-cells: 1.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006308	Enhanced		Approved	"Nucleoli,Plasma membrane,Cytosol"			140000	"Plasma membrane, Cytosol"	Nucleoli	"HPA006308: AB_1847532"	"unprognostic (1.44e-2)"	"unprognostic (2.43e-1)"	"prognostic favourable (5.99e-4)"	"unprognostic (6.82e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.62e-2)"	"unprognostic (2.55e-1)"	"unprognostic (3.85e-2)"	"unprognostic (2.57e-1)"	"unprognostic (1.02e-2)"	"unprognostic (3.62e-2)"	"unprognostic (1.56e-1)"	"prognostic favourable (5.21e-6)"	"unprognostic (5.37e-2)"	"unprognostic (9.06e-2)"	"unprognostic (5.81e-2)"	"unprognostic (1.56e-2)"	4.3	14.3	43.9	5.8	44.9	0.7	6.6	14.4	37.2	7.7	22.1	20.7	4.3	21.1	6.0	33.8	4.9	18.4	12.2	6.4	29.5	24.1	61.6	39.9	11.8	1.1	24.9	37.0	3.4	13.8	13.0	7.2	3.1	13.8	13.1	21.4	4.1	8.5	6.2	13.8	2.8	19.9	7.4	8.1	4.1	15.6	9.3	11.0	0.0	14.1	1.0	1.2	6.0	3.0	1.3	0.4	0.0	0.0	0.0	0.0	0.0	18.7	2.3	6.6	1.2	11.1	9.4	0.8	22.1	13.4	7.9	8.4	26.6	5.0	0.0	9.2	25.0	5.4	23.9	4.6	10.1	0.0	9.2	0.0	6.3	9.2	4.0	17.0	1.0	7.8	0.4	6.6	4.2	12.5	0.0	1.9	20.2	1.5	0.9	0.0	7.9	6.9	0.0	15.5	0.2	33.7	14.0	18.7	36.3	2.9	16.8	2.7	9.1	1.3	24.4	6.9	5.6	1.7	15.4	0.0	0.0	0.0	0.3	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	43.9	44.9	14.4	37.2	29.5	24.1	24.9	37.0	13.8	11.0
DDIAS	"C11orf82, FLJ25416, FLJ38838, noxin"	ENSG00000165490	"DNA damage induced apoptosis suppressor"	Q8IXT1	11	82899975-82958277	"Predicted intracellular proteins"	"Apoptosis, Cell cycle, Growth arrest"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 17.6;testis: 16.3"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			"HPA038540, HPA038541"	Approved		Approved	"Plasma membrane,Cytosol"	"Intracellular and membrane"			"Plasma membrane, Cytosol"		"HPA038540: AB_10672648, HPA038541: "	"unprognostic (2.53e-1)"	"unprognostic (2.27e-1)"	"unprognostic (5.04e-3)"	"unprognostic (1.25e-2)"	"unprognostic (1.20e-1)"	"unprognostic (5.32e-2)"	"unprognostic (3.86e-6)"	"unprognostic (4.65e-3)"	"unprognostic (1.01e-3)"	"unprognostic (8.24e-3)"	"unprognostic (2.04e-4)"	"unprognostic (4.72e-2)"	"unprognostic (1.11e-16)"	"unprognostic (7.17e-3)"	"unprognostic (9.59e-2)"	"unprognostic (1.89e-1)"	"unprognostic (9.13e-2)"	1.3	1.0	0.8	6.1	0.8	7.0	1.7	0.8	1.2	1.9	2.3	1.2	0.2	1.3	1.5	2.6	5.5	1.0	0.4	2.6	0.9	0.7	1.0	2.3	3.1	5.0	0.8	0.6	1.3	0.9	0.0	0.5	2.5	1.0	0.9	2.0	0.2	2.1	0.2	10.1	2.3	1.9	1.5	0.9	5.5	1.1	16.3	0.9	17.6	0.8	9.5	5.9	1.8	1.8	2.0	4.5	5.8	10.7	1.9	0.7	3.2	6.0	9.5	9.8	7.1	1.0	1.5	7.2	11.4	4.8	12.6	14.7	9.3	7.5	7.3	17.1	2.6	11.5	16.6	7.2	17.5	13.2	8.9	10.4	4.9	4.1	0.1	12.7	9.2	0.3	0.7	15.9	7.3	5.9	10.4	12.7	11.1	8.7	12.0	10.4	11.7	10.9	8.9	19.0	9.4	2.7	10.0	7.4	9.9	7.0	7.1	2.7	7.7	5.3	2.8	12.7	17.2	33.3	13.8	7.2	18.9	25.5	4.0	9.2	12.0	0.6	10.7	3.9	0.5	8.3	0.3	1.1	0.3	0.7	4.5	2.0	0.7	0.4	5.8	1.9	7.8	1.4	0.5	3.2	0.8	0.8	0.8	1.2	0.9	0.7	0.8	0.6	1.0	0.9
DDX58	"DKFZp434J1111, FLJ13599, RIG-I"	ENSG00000107201	"DExD/H-box helicase 58"	O95786	9	32455705-32526324	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Antiviral defense, Host-virus interaction, Immunity, Innate immunity"	"Helicase, Hydrolase, RNA-binding"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"BJ hTERT+ SV40 Large T+: 44.8;BJ hTERT+ SV40 Large T+ RasG12V: 46.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB012643, HPA047193"	Uncertain		Approved	"Plasma membrane,Cytosol"				"Plasma membrane"	Cytosol	"CAB012643: , HPA047193: "	"unprognostic (1.10e-1)"	"unprognostic (4.65e-2)"	"unprognostic (6.56e-2)"	"prognostic unfavourable (5.46e-4)"	"unprognostic (2.45e-1)"	"unprognostic (2.37e-1)"	"unprognostic (8.15e-2)"	"unprognostic (4.57e-2)"	"unprognostic (2.82e-1)"	"unprognostic (6.48e-3)"	"unprognostic (1.00e-2)"	"unprognostic (3.35e-1)"	"prognostic unfavourable (4.66e-4)"	"unprognostic (2.22e-2)"	"unprognostic (3.68e-2)"	"unprognostic (1.05e-2)"	"unprognostic (1.26e-1)"	27.7	8.2	5.7	14.5	7.9	5.6	11.3	4.2	5.7	9.9	9.5	5.2	9.1	7.2	12.7	11.7	10.8	7.6	10.3	7.1	6.0	5.1	14.7	8.5	13.7	14.3	6.3	4.5	9.2	7.7	6.6	10.2	14.8	7.5	12.1	8.1	5.5	12.4	5.8	8.3	10.7	16.1	10.8	7.7	13.8	8.0	4.5	6.4	35.4	13.0	7.4	9.7	9.9	9.4	4.9	2.0	24.8	5.7	6.1	6.5	3.0	2.9	1.1	1.6	0.9	3.8	4.0	2.5	1.8	8.8	44.8	46.8	1.2	2.6	0.8	3.2	1.6	2.4	1.7	1.9	6.3	7.2	0.6	2.8	2.5	2.0	3.1	1.8	2.2	2.8	0.7	5.2	1.5	8.1	0.6	0.6	5.9	0.4	2.5	4.6	1.3	1.2	2.4	1.2	0.3	6.8	1.6	1.2	0.7	2.6	1.1	4.9	1.9	1.5	9.3	1.3	1.3	1.1	0.9	0.1	0.5	0.5	2.0	0.8	0.9	8.5	3.8	10.3	6.2	5.7	5.5	4.8	5.6	5.6	2.0	4.9	5.1	5.6	24.8	6.1	3.9	0.1	6.5	3.0	5.7	7.9	4.2	5.7	6.0	5.1	6.3	4.5	7.5	6.4
DDX60L	FLJ31033	ENSG00000181381	"DExD/H-box 60 like"	Q5H9U9	4	168356735-168537786	"Enzymes, Predicted intracellular proteins"		"Helicase, Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+: 23.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 22.5"	"Group enriched"	"Detected in all"	4	"granulocytes: 22.5;monocytes: 7.8"									"HPA043211, HPA055501"	Approved		Approved	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		"HPA043211: AB_10794390, HPA055501: "	"unprognostic (8.86e-2)"	"unprognostic (2.77e-1)"	"unprognostic (1.16e-1)"	"unprognostic (2.45e-1)"	"unprognostic (2.38e-1)"	"unprognostic (3.20e-2)"	"unprognostic (1.05e-1)"	"unprognostic (7.94e-2)"	"unprognostic (1.78e-1)"	"unprognostic (4.19e-2)"	"prognostic unfavourable (3.04e-5)"	"unprognostic (1.70e-1)"	"prognostic unfavourable (2.94e-4)"	"unprognostic (1.13e-1)"	"unprognostic (8.80e-2)"	"unprognostic (8.93e-2)"	"unprognostic (1.69e-1)"	12.7	5.0	2.8	13.1	3.1	33.0	9.9	1.4	3.2	7.2	8.4	3.2	2.7	6.0	9.2	7.9	3.8	6.9	6.7	6.0	2.4	2.4	4.5	6.0	25.8	17.7	3.8	1.4	7.3	5.1	4.4	5.2	32.6	3.4	5.0	6.5	6.8	7.0	5.7	3.3	4.3	14.0	5.3	4.2	11.9	9.5	2.7	3.1	25.3	5.8	3.5	8.1	4.9	6.8	1.6	2.4	22.5	7.8	1.7	3.7	1.6	6.0	3.6	1.4	0.6	3.7	10.7	7.0	6.1	13.0	23.1	16.1	0.0	14.4	0.1	0.3	6.2	2.4	0.6	3.7	6.7	3.5	0.5	13.4	4.0	0.3	4.5	5.5	3.4	3.0	1.1	8.3	0.7	16.2	0.2	0.1	14.8	0.1	4.9	3.5	0.3	3.0	2.7	3.1	0.0	2.2	3.6	0.2	1.9	10.9	1.3	6.1	1.0	7.7	17.3	1.2	8.2	2.9	2.1	5.9	0.9	0.0	4.1	16.3	1.7	1.6	4.0	3.5	2.7	6.3	3.7	0.9	2.7	2.7	2.4	1.6	2.2	2.3	22.5	1.7	7.8	0.0	3.6	1.6	2.8	3.1	1.4	3.2	2.4	2.4	3.8	1.4	3.4	3.1
DFFA	"DFF-45, DFF1, DFF45, ICAD"	ENSG00000160049	"DNA fragmentation factor subunit alpha"	O00273	1	10456522-10472526	"Plasma proteins, Predicted intracellular proteins"	Apoptosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002679, HPA018859, HPA019938, HPA025230"	Supported		Supported	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		"CAB002679: , HPA018859: AB_1847622, HPA019938: AB_1847625, HPA025230: AB_1847623"	"unprognostic (1.23e-1)"	"unprognostic (2.63e-1)"	"unprognostic (1.06e-1)"	"unprognostic (3.59e-2)"	"unprognostic (1.57e-2)"	"unprognostic (1.81e-1)"	"prognostic unfavourable (9.46e-4)"	"unprognostic (1.55e-1)"	"unprognostic (9.24e-3)"	"unprognostic (3.57e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.91e-1)"	"prognostic favourable (1.57e-9)"	"unprognostic (1.21e-2)"	"unprognostic (3.46e-2)"	"unprognostic (3.89e-2)"	"unprognostic (1.88e-1)"	17.8	19.9	22.9	15.6	23.0	7.9	20.9	20.4	20.7	16.6	15.1	22.5	19.1	16.5	18.4	14.4	24.2	18.6	15.3	17.2	20.7	19.9	23.7	18.9	15.5	15.6	26.4	18.9	22.5	19.8	25.7	17.2	27.2	26.1	17.0	17.3	15.0	16.3	18.4	16.8	14.8	14.7	22.4	24.1	14.8	16.8	13.4	21.9	16.7	18.0	13.0	21.4	18.7	26.1	14.1	10.7	7.2	9.9	14.1	14.4	8.9	14.3	14.4	12.4	14.1	10.5	10.0	6.0	20.6	13.3	21.5	16.0	34.3	19.1	30.8	13.3	17.3	11.9	23.9	24.4	21.8	12.2	16.5	15.3	14.9	13.7	17.2	18.7	10.2	12.5	12.3	33.8	27.3	16.3	27.4	7.0	15.2	18.3	18.4	8.5	10.9	16.8	15.9	14.8	15.5	19.3	11.1	14.7	14.3	19.1	16.8	22.6	10.7	6.5	17.0	10.1	13.8	18.5	13.5	8.7	12.1	44.9	10.7	17.8	15.2	1.3	9.9	7.2	14.4	8.0	10.9	14.1	9.7	12.4	9.2	13.7	10.2	12.3	1.5	14.1	9.7	10.7	13.5	8.9	22.9	23.0	20.4	20.7	20.7	19.9	26.4	18.9	26.1	21.9
DGKG	DAGK3	ENSG00000058866	"Diacylglycerol kinase gamma"	P49619	3	186105668-186362237	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 53.4"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 19.8;HL-60: 6.3;U-266/84: 7.5;U-87 MG: 12.5;U-937: 5.9"	"Cancer enhanced"	"Detected in some"		"glioma: 2.8"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"classical monocyte: 4.2;eosinophil: 2.4;intermediate monocyte: 2.4;myeloid DC: 2.9;neutrophil: 5.3;non-classical monocyte: 2.8"	"Group enriched"	"Detected in many"	6	"dendritic cells: 2.9;granulocytes: 5.3;monocytes: 4.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036577	Approved		Approved	"Vesicles,Plasma membrane"				"Vesicles, Plasma membrane"		"HPA036577: AB_10672358"	"unprognostic (2.23e-1)"	"unprognostic (1.97e-1)"	"unprognostic (1.56e-2)"	"unprognostic (3.24e-5)"	"unprognostic (2.70e-1)"	"unprognostic (6.09e-4)"	"unprognostic (1.21e-3)"	"unprognostic (3.80e-2)"	"unprognostic (5.88e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.94e-1)"	"unprognostic (5.09e-2)"	"unprognostic (8.05e-7)"	"unprognostic (3.47e-3)"	"unprognostic (7.19e-2)"	"unprognostic (1.41e-1)"	"unprognostic (9.16e-3)"	3.1	6.9	13.4	3.1	7.1	14.5	1.9	53.4	23.1	2.7	3.5	6.2	1.1	3.0	1.9	14.6	8.5	7.7	2.2	15.0	15.3	7.4	3.1	2.1	4.3	2.1	7.4	11.3	2.0	1.6	4.7	7.5	13.5	25.2	3.1	2.1	7.8	1.9	4.0	2.4	1.4	2.7	5.3	5.6	2.0	3.3	1.2	7.1	0.0	2.5	0.0	2.1	4.8	2.4	0.6	2.9	5.3	4.2	0.0	0.0	1.3	2.6	4.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	2.3	0.0	0.2	0.0	0.0	0.0	19.8	0.0	2.6	0.0	2.9	0.0	6.3	0.3	0.0	0.0	1.2	0.0	0.0	0.0	0.3	0.3	0.1	0.1	2.2	0.4	1.2	1.4	0.0	2.2	0.0	0.0	0.5	0.0	0.8	0.0	1.6	0.1	4.1	0.0	0.0	0.7	2.0	2.4	0.0	7.5	0.0	12.5	5.9	2.3	0.0	4.2	2.4	0.0	2.4	0.0	0.6	0.0	0.0	2.9	0.3	0.0	0.0	5.3	0.0	2.8	0.5	0.0	1.3	13.4	7.1	53.4	14.7	15.3	7.4	7.4	11.3	25.2	7.1
DHPS	MIG13	ENSG00000095059	"Deoxyhypusine synthase"	P49366	19	12675717-12681902	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Hypusine biosynthesis"	Transferase	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA014461, HPA029413"	Approved		Approved	"Nucleoplasm,Plasma membrane,Cytosol"				Nucleoplasm	"Plasma membrane, Cytosol"	"HPA014461: AB_1847651, HPA029413: AB_10602217"	"unprognostic (4.17e-2)"	"unprognostic (2.55e-2)"	"unprognostic (2.05e-2)"	"unprognostic (2.61e-1)"	"unprognostic (3.10e-1)"	"unprognostic (1.01e-2)"	"unprognostic (3.06e-1)"	"unprognostic (2.42e-1)"	"unprognostic (1.85e-1)"	"unprognostic (3.59e-2)"	"unprognostic (1.20e-2)"	"unprognostic (4.85e-2)"	"unprognostic (3.05e-2)"	"unprognostic (2.46e-3)"	"unprognostic (1.32e-1)"	"unprognostic (1.56e-1)"	"unprognostic (8.83e-2)"	16.4	30.3	26.9	18.6	31.2	17.0	24.8	43.3	38.8	20.7	25.7	27.5	25.3	23.1	20.9	16.9	21.3	32.3	18.2	26.0	26.3	28.0	23.4	30.3	18.9	24.2	27.5	28.0	34.8	32.0	28.8	32.6	23.2	22.4	24.1	24.5	20.2	24.8	24.6	65.1	25.6	21.5	24.5	29.1	19.5	24.2	13.3	26.3	31.9	24.9	22.9	26.9	23.5	19.2	39.6	29.5	35.8	30.5	27.8	38.1	29.7	20.7	15.3	24.9	13.2	11.2	18.5	5.8	13.3	19.6	25.5	25.7	10.9	10.1	21.5	15.1	14.5	12.6	17.0	18.9	17.6	18.8	12.0	14.3	16.7	14.3	13.8	17.1	22.9	14.9	23.3	15.4	26.6	17.8	13.0	15.3	18.6	41.2	30.5	24.8	19.5	26.1	20.3	9.3	31.0	19.6	11.2	32.4	44.0	13.4	19.5	22.6	18.1	28.7	8.9	30.0	12.2	29.3	20.2	48.9	52.7	14.6	18.4	21.1	28.3	14.5	27.0	35.8	24.7	24.2	25.9	39.6	28.9	25.6	29.0	36.9	38.1	28.1	9.7	27.8	30.5	29.5	34.3	29.7	26.9	31.2	43.3	38.8	26.3	28.0	27.5	28.0	22.4	26.3
DHRS7B	"CGI-93, DKFZp566O084, MGC8916, SDR32C1"	ENSG00000109016	"Dehydrogenase/reductase 7B"	Q6IAN0	17	21123364-21193265	"Predicted intracellular proteins, Predicted membrane proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA012132, HPA016873"	Uncertain		Approved	"Plasma membrane,Cell Junctions,Cytosol"				"Plasma membrane, Cell Junctions, Cytosol"		"HPA012132: AB_1847658, HPA016873: AB_1847657"	"unprognostic (1.90e-1)"	"unprognostic (3.16e-2)"	"unprognostic (2.71e-1)"	"prognostic favourable (1.98e-8)"	"unprognostic (9.83e-2)"	"unprognostic (1.18e-1)"	"unprognostic (3.46e-1)"	"unprognostic (1.45e-1)"	"unprognostic (5.02e-3)"	"unprognostic (2.76e-1)"	"unprognostic (1.70e-1)"	"unprognostic (2.81e-1)"	"prognostic favourable (3.95e-5)"	"unprognostic (1.20e-2)"	"unprognostic (6.26e-2)"	"unprognostic (9.20e-2)"	"unprognostic (3.97e-1)"	15.9	17.8	14.0	10.3	14.5	2.5	16.2	11.1	15.2	17.6	14.2	11.9	16.7	14.4	13.5	25.3	12.8	15.4	16.3	17.9	11.8	13.2	23.1	18.4	13.9	14.0	14.5	14.8	11.8	18.9	31.2	11.4	14.2	12.9	14.8	15.2	16.5	17.5	10.5	23.7	15.7	18.3	12.7	11.1	11.5	14.7	30.5	9.1	8.0	19.7	15.8	10.9	10.7	12.8	4.2	11.7	15.0	20.4	4.1	5.7	7.5	10.0	11.9	4.4	9.5	11.6	8.0	7.6	9.6	5.4	7.0	12.9	15.0	10.6	4.2	14.7	8.2	14.3	6.4	15.7	10.0	8.1	20.6	5.8	8.8	12.8	6.4	3.2	4.3	6.2	10.5	9.0	13.7	6.8	3.5	5.3	8.2	20.7	3.5	12.7	6.0	5.1	5.9	11.5	7.4	23.4	12.2	2.4	5.1	11.9	10.6	10.3	7.1	6.7	3.4	5.9	4.1	17.6	10.8	2.9	4.5	7.9	9.2	12.0	8.7	9.7	18.9	15.0	3.8	17.9	3.4	4.2	3.8	2.5	11.7	3.6	4.1	3.6	13.5	4.1	20.4	5.0	5.7	7.5	14.0	14.5	11.1	15.2	11.8	13.2	14.5	14.8	12.9	9.1
DIAPH1	"DFNA1, hDIA1, LFHL1"	ENSG00000131504	"Diaphanous related formin 1"	O60610	5	141515016-141619055	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	Hearing	Actin-binding	"Cancer-related genes, Deafness, Disease mutation, Epilepsy, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 79.8"	"Cell line enhanced"	"Detected in all"		"HMC-1: 105.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA004916, HPA076913"	Approved		Approved	"Plasma membrane"			10000000	"Plasma membrane"		"HPA004916: AB_1847668, HPA076913: "	"unprognostic (6.79e-2)"	"unprognostic (2.99e-1)"	"unprognostic (2.12e-3)"	"unprognostic (3.73e-2)"	"unprognostic (4.18e-2)"	"unprognostic (1.54e-1)"	"unprognostic (2.08e-1)"	"unprognostic (4.54e-3)"	"unprognostic (2.03e-1)"	"unprognostic (1.27e-2)"	"prognostic unfavourable (7.81e-5)"	"unprognostic (2.88e-3)"	"prognostic favourable (1.29e-5)"	"unprognostic (1.64e-2)"	"unprognostic (1.84e-2)"	"unprognostic (7.00e-2)"	"unprognostic (1.65e-1)"	14.5	10.0	5.2	22.3	10.4	27.9	10.6	8.8	7.8	11.6	17.1	3.9	11.4	14.2	9.9	16.8	26.5	9.1	15.7	21.3	5.1	6.3	30.1	48.7	22.4	21.7	3.8	4.3	9.7	20.2	17.6	22.1	28.2	7.2	7.8	11.0	8.8	18.0	13.8	79.8	19.1	24.1	9.6	3.4	20.2	15.5	12.1	2.9	44.2	14.9	23.8	34.1	12.3	13.3	5.9	8.6	19.2	9.3	8.2	22.7	9.3	25.5	16.6	9.6	12.6	7.7	10.4	13.3	10.5	11.2	12.3	12.9	56.6	24.5	28.6	16.1	15.4	28.5	21.4	35.8	15.6	15.4	11.9	49.3	21.9	18.4	7.3	34.3	105.8	6.6	19.0	17.7	17.9	16.1	17.3	20.2	12.1	24.9	38.1	44.8	9.5	11.0	42.8	15.8	15.8	23.6	28.2	12.8	6.8	26.0	34.7	10.4	14.5	16.6	9.3	17.3	9.2	9.5	21.4	10.1	16.0	19.8	9.4	27.5	10.7	12.7	8.6	19.2	22.7	9.2	15.2	5.9	14.4	17.6	8.6	5.0	10.5	17.3	9.4	8.2	9.3	6.6	11.9	9.3	5.2	10.4	8.8	7.8	5.1	6.3	3.8	4.3	7.2	2.9
DIS3L	"DIS3L1, FLJ38088, KIAA1955, MGC4562"	ENSG00000166938	"DIS3 like exosome 3'-5' exoribonuclease"	Q8TF46	15	66293217-66333898	"Predicted intracellular proteins"		"Exonuclease, Hydrolase, Nuclease, RNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041805	Approved		Approved	"Plasma membrane,Centrosome,Cytosol"				"Plasma membrane, Cytosol"	Centrosome	"HPA041805: AB_10796783"	"unprognostic (2.57e-1)"	"unprognostic (5.37e-2)"	"unprognostic (1.12e-1)"	"unprognostic (3.99e-2)"	"unprognostic (3.16e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.68e-1)"	"unprognostic (2.94e-2)"	"unprognostic (2.27e-2)"	"unprognostic (1.28e-2)"	"unprognostic (1.59e-3)"	"unprognostic (1.86e-1)"	"unprognostic (3.42e-3)"	"unprognostic (2.66e-1)"	"unprognostic (6.18e-2)"	"unprognostic (9.58e-2)"	"unprognostic (3.40e-1)"	13.7	15.4	18.7	14.7	16.6	11.8	14.5	15.7	16.4	13.7	11.8	20.7	19.1	9.0	14.7	15.5	10.6	15.5	10.0	20.1	17.3	17.0	14.2	15.2	10.8	14.0	19.4	10.8	16.2	24.4	24.9	18.9	9.0	17.7	14.7	10.3	15.4	14.4	16.3	29.4	9.4	9.0	15.2	19.6	11.1	10.5	15.4	14.0	19.3	18.0	9.4	12.8	12.5	9.7	9.1	10.5	7.8	13.1	14.1	13.2	8.0	8.4	19.2	5.8	7.7	7.3	9.9	8.2	6.3	6.9	9.3	7.8	9.4	5.7	30.0	6.9	7.5	14.4	14.3	5.0	6.9	7.9	13.2	17.6	12.5	10.7	5.5	17.1	6.2	4.0	5.7	2.5	8.3	7.2	10.2	7.3	8.3	6.2	7.6	10.0	9.2	10.6	11.5	25.0	17.5	3.1	9.6	9.9	9.7	12.8	4.2	7.0	6.3	11.4	9.3	10.8	10.2	4.5	10.8	6.4	19.9	14.5	3.7	22.6	4.3	7.8	5.9	5.1	9.9	7.1	12.8	8.5	9.5	13.2	10.5	9.1	11.6	9.6	0.7	14.1	13.1	7.5	8.8	8.0	18.7	16.6	15.7	16.4	17.3	17.0	19.4	10.8	17.7	14.0
DLG2	"chapsyn-110, PPP1R58, PSD-93, PSD93"	ENSG00000150672	"Discs large MAGUK scaffold protein 2"	Q15700	11	83455012-85627922	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 44.7"	"Cell line enhanced"	"Detected in some"		"BEWO: 7.5;CACO-2: 4.6;NTERA-2: 5.1;SCLC-21H: 5.2;SH-SY5Y: 7.8;SK-BR-3: 4.6;T-47d: 19.2"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"naive B-cell: 1.3"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021307, HPA023896, CAB072341"	Enhanced		Approved	"Vesicles,Plasma membrane"				"Plasma membrane"	Vesicles	"CAB072341: , HPA021307: AB_1846625, HPA023896: "	"unprognostic (2.61e-3)"	"unprognostic (2.81e-2)"	"unprognostic (4.05e-2)"	"unprognostic (9.03e-2)"	"unprognostic (3.25e-1)"	"unprognostic (1.09e-1)"	"unprognostic (9.44e-3)"	"unprognostic (7.78e-2)"	"unprognostic (4.32e-1)"	"unprognostic (4.61e-2)"	"unprognostic (9.28e-3)"	"unprognostic (4.84e-1)"	"unprognostic (7.66e-6)"	"unprognostic (2.92e-2)"	"unprognostic (2.41e-1)"	"unprognostic (6.52e-2)"	"unprognostic (8.89e-2)"	1.4	11.0	20.0	1.4	30.7	0.7	2.5	9.3	44.7	2.4	1.7	39.5	0.6	1.5	3.3	4.4	7.8	6.0	2.3	2.8	19.9	9.9	3.7	2.8	1.9	1.3	28.7	21.2	6.2	3.3	14.6	7.9	2.7	25.7	4.3	1.5	2.9	3.1	5.4	1.2	19.5	1.5	2.6	19.7	2.6	1.5	6.6	37.3	0.0	15.6	0.0	2.9	1.5	2.1	1.3	0.5	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.5	0.0	0.0	0.1	7.5	0.0	0.0	0.0	0.0	4.6	0.1	0.0	0.1	0.0	0.2	1.4	0.0	0.0	0.0	0.1	0.0	4.1	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.4	0.0	0.1	5.1	0.0	0.0	0.7	0.4	0.0	0.0	5.2	7.8	0.0	4.6	0.0	19.2	0.0	0.0	0.3	0.9	0.2	0.0	0.0	0.0	3.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.2	0.3	0.0	0.0	0.0	0.5	0.0	0.2	20.0	30.7	9.3	34.9	19.9	9.9	28.7	21.2	25.7	37.3
DLL3	SCDO1	ENSG00000090932	"Delta like canonical Notch ligand 3"	Q9NYJ7	19	39498895-39508481	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Differentiation, Notch signaling pathway"	"Developmental protein"	"Disease mutation, Dwarfism"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"brain: 38.5"	"Cell line enriched"	"Detected in some"	5	"SK-MEL-30: 41.1"	"Group enriched"	"Detected in many"	11	"glioma: 29.2;melanoma: 15.5;testis cancer: 8.0"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"memory B-cell: 5.4;naive CD8 T-cell: 3.3"	"Group enriched"	"Detected in many"	13	"B-cells: 5.4;T-cells: 3.3"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			HPA056533			Approved	"Nucleoplasm,Plasma membrane"				"Nucleoplasm, Plasma membrane"		"HPA056533: "	"unprognostic (2.52e-1)"	"unprognostic (3.81e-1)"	"unprognostic (3.13e-2)"	"prognostic unfavourable (2.94e-4)"	"unprognostic (9.85e-2)"	"unprognostic (1.41e-2)"	"unprognostic (1.65e-3)"	"unprognostic (1.85e-1)"	"unprognostic (4.82e-2)"	"unprognostic (6.58e-2)"	"unprognostic (1.06e-2)"	"unprognostic (4.20e-2)"	"unprognostic (3.82e-4)"	"unprognostic (4.94e-2)"	"unprognostic (5.13e-2)"	"unprognostic (4.15e-2)"	"unprognostic (2.97e-1)"	0.6	0.6	8.9	0.7	10.1	0.6	0.6	1.4	38.5	0.5	0.6	10.3	0.0	0.5	0.6	0.5	0.5	0.5	0.5	0.6	6.5	6.8	0.5	0.6	0.6	0.7	4.5	1.9	0.6	0.5	0.6	3.2	0.5	4.3	0.6	0.5	0.0	0.6	0.5	0.5	0.6	0.6	0.5	3.6	0.6	0.6	1.2	2.3	0.0	0.7	0.0	0.6	0.6	0.0	5.4	0.3	0.0	0.0	0.0	3.3	0.4	0.0	1.9	0.4	1.0	0.0	0.0	0.3	0.5	0.0	0.3	0.1	0.3	0.4	0.0	1.9	0.0	0.0	1.2	0.5	0.1	0.5	3.0	0.1	0.0	0.1	0.1	0.5	2.4	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.2	0.0	0.1	0.0	0.4	3.1	0.3	0.1	0.1	0.1	0.1	7.3	7.4	1.4	0.0	41.1	0.0	0.1	0.0	0.0	1.3	0.1	0.5	0.7	0.0	0.4	0.0	0.2	1.2	0.0	0.0	0.0	0.9	0.0	0.4	5.4	0.2	1.3	0.3	1.2	0.2	3.3	0.0	0.0	0.0	0.0	0.0	0.4	8.9	10.1	1.4	4.8	6.5	6.8	4.5	1.9	4.3	2.3
DMWD	"D19S593E, DMR-N9, gene59"	ENSG00000185800	"DM1 locus, WD repeat containing"	Q09019	19	45782947-45792802	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA068172, HPA069843"	Approved		Approved	"Plasma membrane,Actin filaments"				"Plasma membrane, Actin filaments"		"HPA068172: , HPA069843: "	"unprognostic (6.49e-2)"	"unprognostic (3.35e-1)"	"unprognostic (1.03e-2)"	"unprognostic (1.65e-3)"	"unprognostic (3.10e-2)"	"unprognostic (2.39e-1)"	"prognostic unfavourable (1.47e-4)"	"unprognostic (5.11e-3)"	"unprognostic (7.61e-2)"	"unprognostic (7.26e-3)"	"unprognostic (1.31e-2)"	"unprognostic (2.16e-1)"	"unprognostic (1.81e-1)"	"unprognostic (1.85e-1)"	"unprognostic (1.97e-1)"	"unprognostic (1.18e-2)"	"unprognostic (4.59e-2)"	20.1	15.5	24.2	12.9	29.4	7.3	11.0	17.1	34.2	12.1	17.7	19.2	6.6	10.8	21.7	9.0	13.2	14.5	16.6	29.0	20.2	16.2	9.6	5.8	13.6	11.5	17.8	19.1	17.0	13.4	13.7	20.3	16.7	18.8	14.7	8.7	14.8	13.6	14.9	31.8	13.1	10.4	16.9	9.9	15.0	13.1	17.8	16.7	11.2	11.8	6.7	8.5	14.6	11.8	4.3	0.7	1.8	1.9	4.8	3.8	0.9	16.9	19.0	17.2	11.9	10.5	13.4	13.2	14.9	10.5	13.3	12.1	11.2	9.5	7.2	8.8	16.7	12.9	9.0	7.4	7.0	21.0	16.7	6.1	18.8	9.7	13.1	0.7	10.0	12.5	9.2	12.4	17.7	11.4	15.0	16.2	10.5	13.9	8.5	4.8	7.8	12.4	8.8	6.2	7.9	8.2	16.3	17.2	19.2	16.0	12.5	10.7	10.8	4.2	23.9	15.4	15.3	10.2	22.1	23.4	14.4	8.2	16.0	1.1	17.9	1.3	0.7	0.5	3.8	1.6	3.0	1.7	3.2	3.0	0.7	4.3	1.2	2.4	1.8	4.8	1.9	0.6	1.9	0.9	24.2	29.4	17.1	34.2	20.2	16.2	17.8	19.1	18.8	16.7
DNAAF1	"CILD13, FLJ25330, LRRC50, ODA7, swt"	ENSG00000154099	"Dynein axonemal assembly factor 1"	Q8NEP3	16	84145287-84178767	"Disease related genes, Predicted intracellular proteins"			"Ciliopathy, Disease mutation, Kartagener syndrome, Primary ciliary dyskinesia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"fallopian tube: 21.3;testis: 49.6"	"Cell line enhanced"	"Detected in some"		"Hep G2: 3.4;Karpas-707: 8.6;PC-3: 2.6;SK-BR-3: 2.4;U-266/70: 7.2;U-266/84: 4.7"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 3.1"	"Group enriched"	"Detected in many"	5	"amygdala: 3.5;basal ganglia: 9.4;hippocampal formation: 4.6;hypothalamus: 6.5;pons and medulla: 11.1"	"Cell type enhanced"	"Detected in some"		"neutrophil: 5.5"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"HPA041166, HPA074239"	Enhanced		Approved	"Nuclear speckles,Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"	"Nuclear speckles"	"HPA041166: AB_10794190, HPA074239: "	"unprognostic (5.25e-3)"	"unprognostic (2.40e-2)"	"unprognostic (2.77e-2)"	"prognostic favourable (2.14e-4)"	"unprognostic (1.42e-1)"	"unprognostic (9.99e-2)"	"unprognostic (1.25e-1)"	"unprognostic (4.48e-2)"	"unprognostic (7.71e-2)"	"unprognostic (1.58e-1)"	"unprognostic (3.31e-5)"	"unprognostic (2.70e-2)"	"unprognostic (4.61e-3)"	"unprognostic (1.77e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.27e-4)"	"unprognostic (7.51e-4)"	0.8	1.2	3.5	0.6	9.4	1.5	0.5	0.1	1.5	2.1	0.6	5.3	1.5	0.4	1.0	13.3	0.9	21.3	0.5	0.4	4.6	6.5	0.7	2.0	3.7	0.9	0.5	1.5	4.2	0.4	0.7	6.1	1.5	11.1	0.4	0.4	0.9	0.5	0.6	0.6	0.5	0.6	0.4	1.0	7.2	0.5	49.6	1.2	0.0	1.2	0.0	0.4	0.8	0.0	0.5	1.0	5.5	0.8	0.9	2.1	0.9	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.7	3.4	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.6	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.3	0.0	0.1	1.3	0.2	0.0	0.0	2.4	0.1	0.9	0.0	0.0	0.4	0.0	0.0	0.0	7.2	4.7	0.7	0.2	0.4	0.0	3.6	0.8	0.4	0.4	0.6	0.1	0.0	0.2	0.1	0.4	0.5	0.8	0.8	5.5	0.9	0.4	1.0	2.1	0.9	3.5	9.4	0.1	1.5	4.6	6.5	0.5	1.5	11.1	1.2
DNAH17	"DNAHL1, DNEL2, FLJ40457"	ENSG00000187775	"Dynein axonemal heavy chain 17"	Q9UFH2	17	78423697-78577394	"Predicted intracellular proteins"		"Motor protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	45	"testis: 39.4"	"Group enriched"	"Detected in some"	5	"HeLa: 9.8;MOLT-4: 4.6"	"Cancer enhanced"	"Detected in some"		"head and neck cancer: 2.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"HPA024354, HPA076261"	Enhanced		Approved	"Nucleoplasm,Plasma membrane,Cytosol"				"Nucleoplasm, Plasma membrane"	Cytosol	"HPA024354: AB_1847911, HPA076261: "	"unprognostic (4.98e-4)"	"unprognostic (2.26e-1)"	"unprognostic (2.30e-3)"	"unprognostic (8.70e-3)"	"unprognostic (6.66e-2)"	"unprognostic (9.23e-2)"	"unprognostic (3.72e-3)"	"unprognostic (8.41e-2)"	"unprognostic (2.66e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.20e-3)"	"unprognostic (8.35e-3)"	"unprognostic (1.58e-10)"	"unprognostic (5.25e-2)"	"unprognostic (1.54e-1)"	"unprognostic (5.12e-1)"	"unprognostic (6.04e-3)"	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.1	0.0	0.3	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.8	0.1	0.0	39.4	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	1.0	0.0	9.8	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	4.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.1	0.8	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.3	0.0	0.0	0.0
DNAJA4	PRO1472	ENSG00000140403	"DnaJ heat shock protein family (Hsp40) member A4"	Q8WW22	15	78264086-78282196	"Predicted intracellular proteins"		Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 63.2;skeletal muscle: 69.0"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 17.4;HeLa: 18.2;RT4: 33.9;SCLC-21H: 21.8;SiHa: 17.0;THP-1: 15.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004646, HPA041790"	Uncertain		Approved	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		"CAB004646: AB_426011, HPA041790: "	"unprognostic (8.41e-2)"	"unprognostic (2.48e-1)"	"unprognostic (3.00e-2)"	"unprognostic (8.20e-3)"	"unprognostic (1.14e-3)"	"unprognostic (1.99e-1)"	"unprognostic (2.28e-2)"	"unprognostic (2.46e-1)"	"unprognostic (5.86e-2)"	"unprognostic (7.78e-2)"	"unprognostic (2.31e-2)"	"unprognostic (1.28e-1)"	"prognostic favourable (1.08e-7)"	"unprognostic (1.89e-1)"	"unprognostic (2.84e-1)"	"unprognostic (9.01e-2)"	"unprognostic (2.93e-2)"	7.3	10.1	29.6	7.6	33.7	28.6	7.6	20.1	25.8	8.6	8.7	10.5	10.4	7.8	5.1	25.3	9.1	21.7	6.6	63.2	22.3	33.8	7.7	1.9	7.0	6.0	26.0	28.1	3.6	3.2	9.5	11.9	5.5	29.2	15.4	10.6	7.2	6.8	9.6	69.0	15.5	9.0	10.7	16.0	5.1	10.8	26.8	14.9	2.0	6.3	15.2	6.9	12.6	62.3	1.9	1.1	2.7	1.0	0.4	4.7	1.6	13.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.4	0.2	0.0	17.4	0.0	0.1	1.2	12.5	0.0	0.0	0.0	0.0	0.0	7.8	18.2	0.0	3.9	0.0	8.4	1.5	1.7	1.0	0.0	2.6	0.0	0.0	0.1	13.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	33.9	21.8	0.0	17.0	3.4	1.5	13.1	15.7	0.2	0.0	3.6	1.6	0.1	0.2	0.9	0.0	0.0	1.6	0.0	0.0	0.8	2.7	1.8	0.9	2.6	1.9	2.5	2.5	1.1	0.4	4.7	3.9	0.0	0.4	1.0	0.6	1.4	1.6	29.6	33.7	20.1	25.8	22.3	33.8	26.0	28.1	29.2	14.9
DNAJB13	"RSPH16A, TSARG6"	ENSG00000187726	"DnaJ heat shock protein family (Hsp40) member B13"	P59910	11	73950319-73970366	"Disease related genes, Predicted intracellular proteins"	"Cilium biogenesis/degradation"	Chaperone	"Ciliopathy, Disease mutation, Primary ciliary dyskinesia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"fallopian tube: 30.4;testis: 10.8"	"Cell line enhanced"	"Detected in many"		"RPTEC TERT1: 8.1"	"Cancer enhanced"	"Detected in some"		"ovarian cancer: 2.9"					"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"HPA052465, HPA061330"	Enhanced		Approved	"Plasma membrane"				"Plasma membrane"		"HPA052465: AB_2681842, HPA061330: "	"unprognostic (1.07e-1)"	"unprognostic (3.23e-2)"	"unprognostic (3.27e-3)"	"unprognostic (1.56e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.20e-4)"	"unprognostic (1.30e-2)"	"unprognostic (1.72e-4)"	"unprognostic (5.00e-2)"	"unprognostic (4.73e-2)"	"unprognostic (6.30e-2)"	"unprognostic (1.22e-1)"	"prognostic unfavourable (2.10e-6)"	"unprognostic (3.32e-2)"	"unprognostic (1.41e-1)"	"unprognostic (9.44e-2)"	"unprognostic (2.40e-2)"	0.0	0.0	1.2	0.4	1.4	2.1	0.0	0.0	0.1	4.7	0.0			0.1	1.0	3.2	0.0	30.4	1.1	0.0	1.6	1.5	0.6	0.0	1.9	1.0	0.0		0.0	0.3	0.0	0.5	0.1		0.3	0.0		0.4	1.6	0.0	0.2	1.4	0.0	0.2	0.5	0.0	10.8			0.1		0.0	0.0	0.0	1.6	3.4	3.1	0.8	0.6	1.7	0.4	0.4	0.9	1.3	1.7	0.1	0.4	0.8	0.3	0.0	0.4	0.1	1.7	0.7	1.8	3.9	0.7	1.3	0.3	0.0	0.1	5.0	0.8	2.0	1.9	0.7	0.0	1.1	1.5	0.0	0.8	0.4	0.0	0.0	0.7	5.1	1.0	0.8	1.2	1.8	0.6	2.9	0.8	2.7	1.8	8.1	1.6	0.7	2.0	1.0	4.2	0.4	0.7	1.4	0.3	0.6	1.3	1.8	0.7	4.3	3.4	3.4	0.6	0.5	0.5	3.1	0.8	1.1	1.2	0.2	0.4	1.6	1.2	0.7	0.7	1.5	1.0	1.7	1.4	0.6	0.3	3.4	1.1	0.4										
DNAJC6	"KIAA0473, PARK19"	ENSG00000116675	"DnaJ heat shock protein family (Hsp40) member C6"	O75061	1	65248219-65415869	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Chaperone, Hydrolase, Protein phosphatase"	"Disease mutation, Neurodegeneration, Parkinson disease, Parkinsonism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	8	"brain: 91.4"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 20.9;HEL: 55.8;K-562: 21.7"	"Cancer enhanced"	"Detected in many"		"glioma: 5.9"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"gdT-cell: 1.5"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031182, HPA054917"	Enhanced		Approved	"Nucleoplasm,Plasma membrane,Cytosol"				Cytosol	"Nucleoplasm, Plasma membrane"	"HPA031182: AB_10611957, HPA054917: "	"unprognostic (6.99e-2)"	"unprognostic (2.00e-3)"	"unprognostic (3.19e-1)"	"unprognostic (7.94e-7)"	"unprognostic (1.59e-1)"	"unprognostic (7.61e-3)"	"unprognostic (1.87e-4)"	"unprognostic (2.98e-1)"	"unprognostic (1.89e-1)"	"unprognostic (4.14e-1)"	"unprognostic (4.22e-3)"	"unprognostic (1.53e-1)"	"prognostic favourable (2.81e-4)"	"unprognostic (1.43e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.36e-1)"	"unprognostic (8.67e-3)"	2.1	12.1	18.6	2.2	28.5	5.0	2.0	24.2	91.4	2.2	2.8	26.9	0.0	2.3	1.9	1.8	1.7	2.4	2.3	9.0	25.0	26.7	8.5	1.6	2.7	1.6	28.8	23.8	1.9	3.4	2.1	7.5	8.0	40.5	2.5	3.0	2.2	1.7	2.1	1.6	2.1	2.3	2.2	28.7	3.2	2.9	3.2	21.1	0.0	3.0	0.0	1.7	1.8	0.6	0.5	0.5	0.0	0.0	0.6	1.5	0.3	3.5	0.9	0.0	1.6	0.7	0.2	8.3	7.0	11.4	11.5	11.3	0.9	0.1	3.3	0.6	2.9	0.8	5.0	1.1	9.1	20.9	2.4	55.8	1.9	0.2	0.0	1.8	1.4	1.0	0.8	1.1	4.9	0.2	21.7	0.4	2.3	0.6	0.7	0.0	2.3	0.7	0.0	1.7	0.1	8.7	0.0	13.9	9.6	4.1	5.5	1.9	2.6	0.1	2.1	1.7	1.2	0.2	2.0	2.1	1.3	1.0	4.7	1.4	2.8	0.0	0.0	0.0	1.5	0.0	0.1	0.5	0.5	0.9	0.0	0.0	0.4	0.6	0.0	0.6	0.0	0.5	0.0	0.3	18.6	28.5	24.2	37.4	25.0	26.7	28.8	23.8	40.5	21.1
DPYSL2	"CRMP2, DHPRP2, DRP-2, DRP2"	ENSG00000092964	"Dihydropyrimidinase like 2"	Q16555	8	26514022-26658178	"Plasma proteins, Predicted intracellular proteins"	"Differentiation, Neurogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 137.0"	"Cell line enhanced"	"Detected in many"		"ASC diff: 60.4;Karpas-707: 62.2"	"Cancer enhanced"	"Detected in all"		"glioma: 89.3"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"classical monocyte: 24.0;intermediate monocyte: 26.7;myeloid DC: 25.5;non-classical monocyte: 16.2;plasmacytoid DC: 15.1"	"Group enriched"	"Detected in many"	6	"dendritic cells: 25.5;monocytes: 26.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002381, CAB018719"	Supported		Supported	"Plasma membrane,Cytosol"			3900000	Cytosol	"Plasma membrane"	"CAB018719: AB_2085366, HPA002381: AB_1847244"	"unprognostic (2.88e-2)"	"unprognostic (1.01e-2)"	"unprognostic (9.51e-2)"	"unprognostic (3.16e-3)"	"unprognostic (8.23e-2)"	"unprognostic (1.68e-2)"	"unprognostic (1.51e-1)"	"unprognostic (9.95e-3)"	"unprognostic (5.48e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.79e-2)"	"unprognostic (4.13e-2)"	"unprognostic (5.58e-2)"	"unprognostic (9.32e-3)"	"unprognostic (1.23e-1)"	"unprognostic (3.27e-2)"	"prognostic unfavourable (5.41e-5)"	31.6	21.7	53.5	13.4	48.1	3.0	21.3	51.8	137.0	14.6	12.2	54.7	3.9	7.1	14.2	8.1	12.0	14.7	18.0	27.2	52.9	48.6	12.1	11.2	45.3	9.9	56.5	45.4	25.8	7.5	5.1	7.2	25.6	46.9	9.8	12.4	8.2	6.5	10.3	10.9	10.2	9.7	19.9	70.1	19.0	8.5	7.5	44.9	5.8	7.7	5.2	12.3	14.0	13.1	3.2	25.5	0.6	26.7	4.0	4.6	8.8	4.7	22.7	22.4	11.9	60.4	27.9	2.2	9.2	21.4	8.8	11.5	8.8	6.8	7.0	6.7	28.7	4.6	23.5	9.2	8.4	15.8	2.0	7.9	8.6	12.4	38.7	1.7	3.2	34.5	13.3	24.0	14.0	17.6	0.2	62.2	8.8	3.0	13.5	1.7	17.5	4.4	18.0	9.0	4.6	14.7	5.4	10.2	21.5	11.2	0.1	6.0	1.7	3.2	31.7	20.0	8.1	16.5	4.0	8.8	9.0	5.5	28.9	10.4	10.1	0.4	24.0	0.2	3.5	26.7	1.2	3.2	3.1	2.3	25.5	1.7	1.6	2.1	0.6	4.0	16.2	15.1	4.6	8.8	53.5	48.1	51.8	68.4	52.9	48.6	56.5	45.4	46.9	44.9
DQX1	FLJ23757	ENSG00000144045	"DEAQ-box RNA dependent ATPase 1"	Q8TE96	2	74518131-74526336	"Enzymes, Predicted intracellular proteins"		"Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	11	"intestine: 41.0"	"Group enriched"	"Detected in some"	4	"HBEC3-KT: 6.4;Hep G2: 18.0;hTCEpi: 6.6"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"plasmacytoid DC: 1.4"	"Low lineage specificity"	"Detected in single"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA039158	Enhanced		Approved	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		"HPA039158: AB_10960125"	"unprognostic (2.17e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.20e-2)"	"unprognostic (9.95e-2)"	"unprognostic (2.20e-1)"	"unprognostic (1.18e-1)"	"unprognostic (6.49e-2)"	"unprognostic (3.93e-1)"	"unprognostic (4.54e-2)"	"unprognostic (1.68e-1)"	"unprognostic (7.67e-2)"	"unprognostic (2.21e-2)"	"unprognostic (0.00e+0)"	"unprognostic (1.13e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.29e-1)"	"unprognostic (6.16e-3)"	0.1	0.0	0.1	2.1	0.2	0.0	0.1	0.1	0.1	0.8	13.3	0.2	0.1	14.7	0.1	0.1	3.7	0.2	3.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	1.0	0.1	0.2	5.1	0.1	0.6	0.1	0.1	1.5	41.0	0.3	0.1	0.2	2.9	0.1	0.1	0.2	0.1	0.7	1.5	1.1	1.4	0.7	1.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.1	0.5	0.1	0.3	0.0	0.0	0.7	0.1	6.4	0.1	0.0	0.3	0.4	0.1	18.0	0.0	0.2	0.3	0.0	6.6	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.2	0.3	0.0	0.1	0.1	0.1	0.0	1.2	0.0	0.1	0.0	2.5	0.0	0.6	0.0	0.0	0.8	0.2	0.1	0.0	0.1	0.2	0.2	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.1	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1
DRP2		ENSG00000102385	"Dystrophin related protein 2"	Q13474	X	101219769-101264497	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"brain: 20.3"	"Cell line enhanced"	"Detected in some"		"RH-30: 11.0;TIME: 18.5;U-87 MG: 4.5"	"Cancer enhanced"	"Detected in single"		"glioma: 1.4"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002949			Approved	"Nuclear speckles,Plasma membrane"				"Nuclear speckles, Plasma membrane"		"HPA002949: AB_1078706"	"unprognostic (8.47e-4)"	"unprognostic (3.56e-3)"	"unprognostic (1.01e-2)"	"unprognostic (5.58e-4)"	"unprognostic (1.74e-2)"	"unprognostic (2.47e-2)"	"unprognostic (7.93e-3)"	"unprognostic (2.94e-3)"	"unprognostic (1.27e-2)"	"unprognostic (5.46e-3)"	"unprognostic (1.42e-1)"	"unprognostic (4.61e-2)"	"unprognostic (4.44e-16)"	"unprognostic (3.71e-4)"	"unprognostic (4.22e-1)"	"unprognostic (9.03e-2)"	"unprognostic (1.25e-1)"	1.1	1.5	9.3	1.2	17.2	1.1	0.8	0.4	20.3	1.7	2.8	1.2	0.0	1.1	2.5	2.7	1.3	1.0	1.3	0.9	5.8	4.2	0.7	0.6	0.8	0.8	4.6	10.1	4.4	0.6	0.6	2.4	0.7	2.6	4.1	1.8	0.5	0.7	3.1	0.7	0.8	1.2	2.2	3.1	0.7	0.7	1.6	2.2	0.9	0.6	0.0	0.8	1.1	1.1	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.6	2.3	0.1	0.1	0.2	0.1	0.4	0.1	0.3	1.0	0.0	0.4	0.3	0.3	0.1	0.0	0.3	0.0	0.7	0.1	0.2	0.2	0.5	0.0	0.2	0.1	0.4	1.5	0.0	0.7	0.0	1.4	0.0	0.9	1.6	0.0	1.3	0.5	0.1	0.1	0.3	11.0	0.0	0.0	0.0	0.0	0.4	0.1	0.2	0.0	0.0	0.1	18.5	0.2	0.7	0.2	0.4	0.0	0.1	0.0	4.5	0.4	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.9	0.0	9.3	17.2	0.4	20.3	5.8	4.2	4.6	10.1	2.6	2.2
DSEL	"C18orf4, DE-epi2, FLJ11477, NCAG1"	ENSG00000171451	"Dermatan sulfate epimerase-like"	Q8IZU8	18	67506582-67516980	"Predicted membrane proteins"		Isomerase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ: 19.5;BJ hTERT+: 11.3;LHCN-M2: 24.3;U-138 MG: 25.3"	"Cancer enhanced"	"Detected in many"		"glioma: 6.1"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"naive CD8 T-cell: 3.2"	"Lineage enriched"	"Detected in single"	5	"T-cells: 3.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA060942			Approved	"Nucleoplasm,Plasma membrane"				"Plasma membrane"	Nucleoplasm	"HPA060942: "	"unprognostic (2.49e-1)"	"unprognostic (5.00e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.19e-5)"	"unprognostic (1.56e-1)"	"unprognostic (2.71e-1)"	"unprognostic (2.40e-3)"	"unprognostic (7.11e-2)"	"unprognostic (4.91e-1)"	"unprognostic (2.83e-1)"	"unprognostic (2.19e-2)"	"unprognostic (2.47e-1)"	"unprognostic (7.95e-3)"	"unprognostic (3.25e-2)"	"unprognostic (1.24e-1)"	"unprognostic (9.70e-3)"	"unprognostic (1.16e-4)"	10.2	3.4	8.8	3.2	15.5	1.6	9.4	7.9	12.8	10.9	4.5	15.7	2.5	2.2	5.7	4.0	3.1	7.1	8.3	5.1	8.6	8.4	9.0	7.1	6.0	1.9	13.2	4.5	7.6	3.6	3.6	1.3	11.5	9.7	4.8	3.5	2.4	2.3	4.9	1.9	3.2	2.7	7.4	11.1	4.5	3.1	3.4	10.9	0.0	2.8	1.1	1.6	3.6	8.4	0.2	0.1	0.6	0.1	0.3	3.2	0.3	0.0	0.0	2.3	0.0	4.6	6.8	0.3	19.5	11.3	5.0	2.1	0.0	0.0	0.0	0.0	9.8	0.1	0.4	0.8	4.8	0.0	0.0	0.0	2.2	0.0	3.9	0.0	0.0	6.9	1.3	3.0	7.2	0.9	0.0	0.2	24.3	0.0	0.0	0.0	0.3	2.0	0.2	5.1	0.0	2.2	0.0	0.9	1.1	1.8	0.0	0.0	0.0	0.0	1.7	25.3	0.7	1.8	2.2	0.1	0.0	0.0	5.3	0.0	2.1	0.6	0.1	0.2	0.2	0.0	1.7	0.1	0.8	1.2	0.0	0.2	0.5	3.2	0.5	0.3	0.1	0.1	0.2	0.3	8.8	15.5	7.9	9.9	8.6	8.4	13.2	4.5	9.7	10.9
DUS1L	"DUS1, PP3111"	ENSG00000169718	"Dihydrouridine synthase 1 like"	Q6P1R4	17	82057506-82065887	"Predicted intracellular proteins"	"tRNA processing"	Oxidoreductase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA023384	Uncertain		Approved	"Plasma membrane"				"Plasma membrane"		"HPA023384: AB_1847879"	"unprognostic (4.42e-2)"	"unprognostic (2.19e-2)"	"unprognostic (4.30e-2)"	"unprognostic (3.03e-2)"	"unprognostic (1.73e-3)"	"unprognostic (1.84e-1)"	"unprognostic (4.01e-2)"	"unprognostic (5.17e-2)"	"unprognostic (1.10e-1)"	"unprognostic (4.16e-3)"	"unprognostic (5.23e-3)"	"unprognostic (3.13e-1)"	"prognostic unfavourable (5.89e-5)"	"unprognostic (4.17e-2)"	"unprognostic (8.57e-2)"	"unprognostic (3.47e-1)"	"unprognostic (1.70e-3)"	21.4	17.5	12.4	29.1	16.5	37.1	20.2	21.4	20.3	17.7	29.5	14.1	26.8	30.8	18.1	23.4	26.0	18.5	27.9	23.8	13.0	10.9	19.8	54.6	21.5	31.2	18.9	16.0	20.1	59.6	15.2	23.5	16.5	12.9	26.9	14.8	16.0	45.4	18.9	44.1	40.8	28.0	19.6	10.5	30.9	28.9	23.7	12.4	28.0	22.8	26.2	30.4	17.0	18.5	5.0	10.6	6.3	6.0	7.9	9.8	2.9	35.8	23.1	8.0	9.5	6.4	6.4	25.8	12.7	5.7	12.3	8.8	21.0	16.1	29.4	14.8	7.1	24.1	9.9	13.0	5.0	11.6	60.4	18.6	32.2	36.6	14.3	28.8	23.2	9.6	16.4	8.1	10.3	13.8	32.1	14.9	6.2	56.1	39.8	24.8	9.7	33.8	30.6	9.5	31.6	9.1	23.6	43.0	27.0	9.7	40.7	26.0	23.8	27.7	10.5	20.1	20.4	17.2	31.9	37.3	10.3	23.8	12.7	21.5	13.8	4.2	5.0	6.3	6.0	5.1	8.7	5.0	6.1	7.0	4.8	5.0	9.8	8.1	1.7	7.9	6.0	10.6	9.8	2.9	12.4	16.5	21.4	20.3	13.0	10.9	18.9	16.0	12.9	12.4
DUSP15	"bA243J16.5, bA243J16.6, C20orf57, FLJ20645, VHY"	ENSG00000149599	"Dual specificity phosphatase 15"	Q9H1R2	20	31847637-31870747	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"testis: 75.1"	"Cell line enhanced"	"Detected in some"		"CACO-2: 5.3;REH: 17.4;SH-SY5Y: 5.0;SK-MEL-30: 4.3;U-2 OS: 4.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	14	"naive B-cell: 1.6"	"Lineage enriched"	"Detected in single"	14	"B-cells: 1.6"					"Low region specificity"	"Detected in all"			HPA076649	Enhanced		Approved	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		"HPA076649: "	"unprognostic (3.84e-2)"	"unprognostic (2.30e-1)"	"unprognostic (2.28e-1)"	"unprognostic (9.01e-3)"	"unprognostic (3.88e-2)"	"unprognostic (2.36e-1)"	"unprognostic (1.47e-2)"	"unprognostic (2.24e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.76e-1)"	"unprognostic (1.48e-5)"	"unprognostic (7.31e-2)"	"prognostic favourable (5.40e-7)"	"unprognostic (2.79e-2)"	"unprognostic (1.93e-1)"	"unprognostic (3.11e-3)"	"unprognostic (2.55e-1)"	1.1	2.1	2.8	0.6	4.0	0.5	1.3	1.2	3.7	1.6	0.8	4.2	6.9	0.9	1.4	10.4	0.6	0.7	1.1	2.7	2.8	3.1	15.4	0.6	0.8	1.0	4.9	2.3	2.1	1.8	10.6	2.7	1.1	5.9	1.9	0.5	5.3	2.1	9.3	2.4	0.7	1.0	2.3	5.2	1.0	1.1	75.1	1.4	0.0	3.5	0.1	0.6	0.7	0.8	1.6	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.2	0.2	1.6	0.0	0.3	0.0	0.0	0.0	0.9	0.0	5.3	0.1	1.0	2.2	0.3	0.0	0.4	0.0	0.0	0.0	0.6	0.5	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	3.7	0.7	0.0	17.4	2.0	0.1	0.0	0.0	2.4	5.0	2.8	0.0	4.3	1.3	1.0	0.0	0.0	4.2	0.0	0.0	1.8	0.0	0.0	0.0	0.6	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	4.0	1.2	3.7	2.8	3.1	4.9	2.3	5.9	1.4
DXO	DOM3Z	ENSG00000204348	"Decapping exoribonuclease"	O77932	6	31969810-31972292	"Predicted intracellular proteins"		"Exonuclease, Hydrolase, Nuclease, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 32.8"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 14.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046708	Enhanced		Approved	"Nucleoplasm,Plasma membrane,Cytosol"				"Nucleoplasm, Cytosol"	"Plasma membrane"	"HPA046708: "	"unprognostic (4.56e-2)"	"unprognostic (2.21e-1)"	"unprognostic (1.80e-1)"	"unprognostic (4.07e-3)"	"unprognostic (1.93e-1)"	"unprognostic (2.00e-3)"	"unprognostic (3.43e-3)"	"unprognostic (4.18e-3)"	"unprognostic (3.10e-2)"	"unprognostic (2.64e-3)"	"prognostic favourable (5.87e-4)"	"unprognostic (4.29e-2)"	"prognostic unfavourable (4.77e-6)"	"unprognostic (9.17e-2)"	"unprognostic (7.24e-2)"	"unprognostic (2.01e-1)"	"unprognostic (2.23e-3)"	4.3	18.4	8.3	8.0	11.0	4.2	7.0	15.5	12.4	7.1	5.0	6.5	8.6	7.8	6.4	6.4	4.0	7.9	6.0	8.4	7.7	6.5	8.5	8.7	5.1	4.3	9.0	6.5	10.5	12.3	9.4	12.4	4.7	7.4	7.6	4.2	5.8	5.5	6.8	5.6	3.4	4.1	6.3	4.9	7.2	7.6	32.8	7.3	3.4	8.8	4.7	4.3	6.4	5.5	2.2	3.2	1.5	1.9	3.0	3.3	1.5	3.0	1.3	0.4	14.1	1.7	1.0	1.5	1.6	2.6	4.4	3.6	2.2	2.9	1.0	3.1	5.8	4.1	1.5	3.2	1.6	1.9	4.4	1.9	2.9	2.8	3.9	0.0	2.7	2.2	2.9	1.8	3.0	6.6	2.4	3.2	1.8	4.4	0.1	2.3	0.7	0.1	0.1	2.0	1.8	5.2	0.7	7.3	5.5	3.3	1.4	3.7	0.0	4.4	0.9	0.8	4.8	2.8	3.6	1.9	3.4	2.4	2.6	4.6	2.1	0.0	1.0	1.5	1.1	1.9	3.3	1.4	1.4	1.8	3.2	2.2	1.3	1.6	0.6	3.0	1.2	1.2	0.6	1.5	8.3	11.0	15.5	9.4	7.7	6.5	9.0	6.5	7.4	7.3
EEF1AKMT1	N6AMT2	ENSG00000150456	"EEF1A lysine methyltransferase 1"	Q8WVE0	13	20728731-20773958	"Predicted intracellular proteins"		"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040417, HPA042543"	Uncertain		Approved	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		"HPA040417: , HPA042543: "	"unprognostic (4.14e-1)"	"unprognostic (5.11e-2)"	"unprognostic (8.57e-2)"	"prognostic favourable (1.82e-4)"	"unprognostic (9.14e-2)"	"unprognostic (3.44e-1)"	"unprognostic (2.24e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.51e-2)"	"unprognostic (1.39e-1)"	"unprognostic (2.39e-3)"	"unprognostic (3.51e-1)"	"unprognostic (1.06e-1)"	"unprognostic (5.81e-2)"	"unprognostic (4.31e-2)"	12.1	14.1	15.2	8.9	13.8	3.9	13.4	20.9	14.1	12.2	9.4	9.5	8.6	5.9	14.8	19.9	8.0	15.2	8.4	12.4	12.2	14.7	11.5	17.3	7.8	8.1	14.3	14.7	14.5	10.3	9.1	19.1	8.5	11.7	14.1	8.1	10.6	12.8	12.7	15.5	7.2	5.9	12.5	16.2	8.1	8.1	8.2	14.0	11.3	12.9	8.2	8.6	8.9	8.6	10.7	8.8	0.7	4.4	13.1	11.2	5.7	5.7	4.5	3.7	6.1	15.7	16.3	9.2	7.6	5.8	6.7	3.5	6.2	6.5	9.4	5.7	8.3	4.7	5.0	6.5	7.0	6.0	4.4	12.0	2.1	11.8	8.7	23.7	2.4	11.1	5.8	5.0	11.2	12.0	6.9	1.3	19.0	15.9	7.9	21.1	6.4	3.3	9.9	4.0	1.8	9.5	6.7	8.6	5.1	6.5	3.3	8.5	3.4	21.9	7.0	4.6	0.0	10.3	3.3	1.8	3.3	10.1	4.0	16.4	3.3	0.0	4.4	0.7	7.7	3.3	8.1	10.7	9.0	7.6	7.2	4.9	11.2	9.8	0.6	13.1	3.4	8.8	9.5	5.7	15.2	13.8	20.9	14.1	12.2	14.7	14.3	14.7	11.7	14.0
EEPD1	KIAA1706	ENSG00000122547	"Endonuclease/exonuclease/phosphatase family domain containing 1"	Q7L9B9	7	36153149-36301543	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 13.3;HDLM-2: 14.0;PC-3: 17.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"eosinophil: 23.2;neutrophil: 21.9"	"Group enriched"	"Detected in many"	6	"granulocytes: 23.2;T-cells: 11.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA053668			Approved	"Nuclear speckles,Vesicles,Plasma membrane"				"Nuclear speckles"	"Vesicles, Plasma membrane"	"HPA053668: "	"unprognostic (1.30e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.54e-3)"	"unprognostic (5.21e-3)"	"unprognostic (1.14e-1)"	"unprognostic (4.76e-1)"	"unprognostic (1.19e-2)"	"unprognostic (3.75e-2)"	"unprognostic (7.89e-2)"	"unprognostic (8.77e-2)"	"unprognostic (7.74e-2)"	"unprognostic (2.62e-1)"	"unprognostic (2.82e-1)"	"unprognostic (1.07e-2)"	"unprognostic (6.52e-2)"	"unprognostic (2.23e-2)"	"unprognostic (4.59e-2)"	20.3	5.1	4.9	6.4	8.6	8.1	22.5	3.3	19.3	9.6	15.2	11.8	6.5	11.0	12.5	5.6	6.5	5.4	18.4	6.2	6.4	5.4	3.7	15.2	8.7	4.6	13.3	3.5	6.9	8.1	2.4	3.3	4.6	5.6	8.2	4.5	5.7	3.8	4.3	39.7	10.2	23.6	9.1	10.2	7.5	10.5	3.4	7.7	11.5	2.2	4.4	3.6	6.1	10.9	0.1	1.5	23.2	2.8	1.7	11.5	2.0	1.6	4.6	1.4	4.5	13.3	2.9	0.1	1.1	5.7	0.9	1.6	0.9	3.5	4.5	1.5	1.7	1.9	1.9	2.2	0.8	14.0	3.2	0.6	0.4	8.4	1.2	0.7	4.4	5.9	1.4	0.5	0.4	0.1	5.5	0.5	1.0	1.8	4.6	11.2	6.5	17.8	1.2	1.6	1.0	2.8	3.7	3.5	2.5	0.4	0.6	1.7	1.4	5.4	0.4	1.8	5.3	1.2	1.3	3.5	3.8	0.0	4.4	3.0	1.1	10.0	2.8	23.2	1.5	1.7	2.6	0.1	11.5	3.3	1.5	0.0	2.6	0.7	21.9	1.7	0.7	1.3	5.1	2.0	4.9	8.6	3.3	7.5	6.4	5.4	13.3	3.5	5.6	7.7
EFCAB1	FLJ11767	ENSG00000034239	"EF-hand calcium binding domain 1"	Q9HAE3	8	48710789-48735311	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"fallopian tube: 61.9"	"Cell line enhanced"	"Detected in some"		"A-431: 8.9;ASC diff: 3.9;ASC TERT1: 9.1;CAPAN-2: 4.4;hTEC/SVTERT24-B: 3.7;SCLC-21H: 7.0"	"Cancer enhanced"	"Detected in some"		"endometrial cancer: 2.9"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"neutrophil: 4.1"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA023527, HPA069955"	Enhanced		Approved	"Nucleoplasm,Plasma membrane"				Nucleoplasm	"Plasma membrane"	"HPA023527: AB_2231065, HPA069955: "	"unprognostic (5.29e-3)"	"unprognostic (7.39e-3)"	"unprognostic (1.05e-1)"	"unprognostic (2.67e-3)"	"unprognostic (4.67e-2)"	"unprognostic (2.77e-1)"	"unprognostic (9.81e-2)"	"unprognostic (1.62e-1)"	"unprognostic (2.52e-2)"	"unprognostic (1.85e-1)"	"unprognostic (5.94e-3)"	"unprognostic (7.81e-2)"	"unprognostic (4.87e-3)"	"unprognostic (4.81e-2)"	"unprognostic (1.99e-1)"	"unprognostic (2.51e-1)"	"unprognostic (3.47e-3)"	0.6	1.5	5.4	0.5	9.5	0.9	2.5	0.2	4.1	8.1	0.8	14.0	10.3	0.9	8.6	19.0	0.9	61.9	0.9	0.6	9.1	8.4	0.6	0.9	16.5	0.5	2.7	3.9	13.7	1.8	0.4	2.0	0.8	23.9	4.2	0.7	1.9	1.8	4.6	0.5	3.5	1.1	2.7	1.4	0.6	0.8	19.7	3.0	0.0	0.5	0.3	0.6	1.4	2.1	1.0	0.0	4.1	0.0	1.1	1.1	0.3	8.9	0.0	1.1	0.0	3.9	9.1	0.0	0.1	0.9	0.0	0.3	0.0	4.4	0.0	0.0	0.2	2.4	0.0	1.1	0.3	0.1	0.0	0.0	0.0	0.0	0.9	0.0	0.1	3.2	0.3	3.7	1.5	0.0	0.0	0.0	0.8	0.0	0.0	0.1	0.5	0.3	0.1	0.0	0.0	0.0	2.1	7.0	0.5	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.5	0.5	0.0	1.1	1.0	0.7	0.8	0.0	0.8	0.5	0.3	4.1	1.1	0.0	0.0	0.7	0.3	5.4	9.5	0.2	4.1	9.1	8.4	2.7	3.9	23.9	3.0
EFCAB2	"CFAP200, DRC8, MGC12458"	ENSG00000203666	"EF-hand calcium binding domain 2"	Q5VUJ9	1	244969705-245127164	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HMC-1: 34.2;THP-1: 30.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 10.8"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031206, HPA031207"	Approved		Approved	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		"HPA031206: AB_10599710, HPA031207: AB_10599946"	"unprognostic (1.36e-2)"	"unprognostic (9.04e-2)"	"unprognostic (1.09e-1)"	"unprognostic (2.84e-2)"	"unprognostic (3.13e-2)"	"unprognostic (1.21e-1)"	"unprognostic (4.47e-2)"	"unprognostic (9.86e-2)"	"unprognostic (2.85e-2)"	"unprognostic (3.02e-1)"	"unprognostic (4.34e-3)"	"unprognostic (8.41e-2)"	"unprognostic (1.48e-2)"	"unprognostic (2.25e-2)"	"unprognostic (1.64e-1)"	"prognostic unfavourable (6.51e-4)"	"unprognostic (4.88e-2)"	11.0	12.5	16.7	5.6	18.6	10.8	14.7	20.1	15.5	11.6	7.3	23.6	13.9	3.0	18.7	19.5	9.6	32.1	13.1	13.7	18.0	14.3	12.5	6.5	11.2	7.8	22.3	12.3	10.6	12.1	14.6	20.6	14.7	16.3	9.2	11.3	11.8	7.4	16.0	15.5	6.1	6.5	13.2	20.9	6.4	10.5	24.4	21.9	5.4	23.7	13.5	9.1	11.5	16.0	3.6	10.8	4.9	1.8	2.9	0.8	1.2	3.1	3.9	8.9	2.3	3.2	7.6	10.9	3.9	4.2	5.1	4.7	10.0	8.5	10.8	8.5	4.9	2.5	3.6	2.3	3.2	1.1	2.1	5.2	15.6	4.4	6.9	5.3	34.2	6.6	4.8	6.8	6.4	7.8	19.9	8.8	4.4	3.2	1.1	14.6	11.4	3.0	20.5	1.3	2.8	13.0	5.3	7.0	9.5	6.9	2.6	5.7	2.6	30.1	1.2	6.3	2.3	3.4	14.2	3.0	5.0	7.2	5.0	15.3	5.1	1.2	1.7	2.8	0.5	1.8	0.8	3.6	0.7	0.4	5.5	3.3	0.6	0.6	4.9	2.9	1.3	10.8	0.8	1.2	16.7	18.6	20.1	15.5	18.0	14.3	22.3	12.3	16.3	21.9
EFCAB7	"KIAA1799, RP4-534K7.1"	ENSG00000203965	"EF-hand calcium binding domain 7"	A8K855	1	63523372-63572693	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 9.8"	"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029611, HPA029612, HPA029613"	Enhanced		Approved	"Nucleoplasm,Nucleoli,Plasma membrane,Cytosol"				"Nucleoplasm, Nucleoli"	"Plasma membrane, Cytosol"	"HPA029611: AB_10599972, HPA029612: AB_10600533, HPA029613: AB_10601004"	"unprognostic (8.81e-2)"	"unprognostic (5.24e-2)"	"unprognostic (5.13e-2)"	"unprognostic (1.64e-1)"	"prognostic favourable (3.65e-4)"	"unprognostic (1.70e-2)"	"unprognostic (6.53e-4)"	"unprognostic (2.99e-1)"	"unprognostic (5.81e-3)"	"unprognostic (1.69e-1)"	"unprognostic (6.28e-2)"	"unprognostic (1.66e-1)"	"unprognostic (3.78e-2)"	"unprognostic (2.18e-1)"	"unprognostic (6.97e-2)"	"unprognostic (9.90e-2)"	"unprognostic (2.73e-1)"	4.3	8.4	12.7	3.5	16.7	3.1	9.3	24.5	19.5	9.4	5.1	3.7	6.4	3.2	9.6	9.8	5.7	12.6	7.2	9.7	11.4	11.8	8.8	2.8	6.2	5.2	8.1	10.8	12.8	4.9	16.3	31.6	5.1	13.7	8.7	5.0	3.5	5.3	8.2	10.8	4.9	3.4	7.5	9.4	4.2	5.0	20.0	10.2	11.5	9.1	2.4	5.2	7.3	12.9	3.3	1.7	9.8	3.3	1.8	2.9	1.1	6.2	5.2	6.9	4.4	7.3	10.9	3.5	4.1	4.4	7.0	8.7	1.7	4.9	4.4	9.7	2.3	5.8	5.9	3.9	8.4	8.1	4.1	3.5	9.8	3.6	4.7	4.9	3.2	5.9	9.5	8.2	5.6	5.9	4.4	7.2	4.6	1.3	9.3	3.3	3.0	5.3	6.0	10.4	4.3	10.8	3.4	14.8	5.7	7.7	4.4	9.9	4.5	3.5	1.6	3.9	3.5	11.7	3.8	4.8	8.3	5.1	7.3	3.5	5.8	9.8	0.7	0.2	2.1	0.4	2.9	3.3	2.4	2.5	1.3	2.8	2.5	2.4	0.1	1.8	3.3	1.7	2.7	1.1	12.7	16.7	24.5	19.5	11.4	11.8	8.1	10.8	13.7	10.2
EFHC2	"FLJ22843, MRX74"	ENSG00000183690	"EF-hand domain containing 2"	Q5JST6	X	44147882-44343672	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 20.6;fallopian tube: 20.8"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 5.1;HEL: 5.3;HMC-1: 17.6"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in all"		"pons and medulla: 20.6"	"Group enriched"	"Detected in some"	5	"basophil: 14.1;NK-cell: 6.6"	"Group enriched"	"Detected in many"	5	"granulocytes: 14.1;NK-cells: 6.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA034492, HPA057359"	Approved	Supported	Approved	"Nucleoplasm,Nucleoli fibrillar center,Plasma membrane"				"Nucleoplasm, Nucleoli fibrillar center"	"Plasma membrane"	"HPA034492: AB_10671227, HPA057359: "	"unprognostic (1.93e-1)"	"unprognostic (7.80e-3)"	"unprognostic (7.35e-2)"	"unprognostic (2.75e-1)"	"unprognostic (6.83e-3)"	"unprognostic (5.07e-2)"	"unprognostic (4.29e-2)"	"unprognostic (1.75e-2)"	"unprognostic (3.50e-2)"	"unprognostic (2.90e-2)"	"unprognostic (3.88e-2)"	"unprognostic (1.86e-2)"	"unprognostic (7.89e-2)"	"unprognostic (1.06e-1)"	"unprognostic (6.13e-4)"	"unprognostic (1.64e-3)"	"unprognostic (4.97e-2)"	0.7	0.6	4.0	0.8	6.2	1.9	1.2	1.6	3.1	4.6	1.6	6.5	3.7	0.6	5.4	12.6	2.9	20.8	3.0	6.0	4.8	3.9	2.0	0.1	4.5	0.5	1.5	2.0	5.2	0.3	0.9	6.9	1.3	20.6	2.9	0.6	0.6	9.6	5.8	0.1	4.7	0.8	2.6	1.4	0.6	1.6	10.1	3.1	0.4	3.7	1.4	0.9	1.7	1.4	0.1	0.4	14.1	0.0	6.6	2.1	1.4	0.0	0.8	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	5.1	0.0	0.1	0.0	0.0	0.4	0.0	0.1	0.0	0.1	5.3	0.0	0.0	0.0	0.0	17.6	0.3	0.3	0.3	0.0	0.0	1.4	0.0	0.0	0.0	0.0	2.3	0.6	0.1	0.3	0.0	0.0	1.4	0.0	0.3	0.5	0.0	0.0	0.0	0.9	0.0	0.1	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	14.1	0.0	0.0	2.1	0.0	0.8	0.1	0.8	0.1	0.4	0.1	0.7	1.0	1.9	6.6	0.0	0.0	0.0	1.4	4.0	6.2	1.6	3.1	4.8	3.9	1.5	2.0	20.6	3.1
EHD3	PAST3	ENSG00000013016	"EH domain containing 3"	Q9NZN3	2	31234337-31269447	"Plasma proteins, Predicted intracellular proteins"	"Cilium biogenesis/degradation, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 37.4;esophagus: 29.1"	"Cell line enhanced"	"Detected in many"		"BJ: 25.1;BJ hTERT+: 62.1;HEL: 24.1;U-266/70: 15.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"memory B-cell: 17.8;naive B-cell: 4.4"	"Lineage enriched"	"Detected in many"	9	"B-cells: 17.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049890, HPA049986, HPA066751"	Approved		Approved	"Plasma membrane"			41000000	"Plasma membrane"		"HPA049890: , HPA049986: , HPA066751: "	"unprognostic (3.44e-1)"	"unprognostic (8.88e-2)"	"unprognostic (2.21e-1)"	"unprognostic (3.79e-2)"	"unprognostic (3.70e-2)"	"unprognostic (1.89e-1)"	"unprognostic (5.49e-2)"	"unprognostic (1.21e-1)"	"unprognostic (3.74e-2)"	"unprognostic (9.72e-2)"	"unprognostic (9.92e-3)"	"unprognostic (1.06e-1)"	"prognostic unfavourable (1.02e-4)"	"unprognostic (4.88e-3)"	"unprognostic (9.41e-2)"	"unprognostic (4.79e-3)"	"unprognostic (4.92e-3)"	2.7	7.1	15.0	5.6	16.3	2.0	3.3	10.6	37.4	5.6	2.2	7.3	0.0	1.9	3.9	3.4	29.1	4.9	3.6	14.8	16.7	8.9	15.0	10.8	4.8	6.3	9.6	21.6	2.9	1.4	8.7	6.0	11.3	13.3	5.7	2.1	2.8	4.8	4.9	2.3	3.0	2.9	4.8	9.4	5.8	1.9	1.6	6.6	1.2	2.5	1.5	10.4	7.8	4.2	17.8	0.4	1.0	1.9	0.6	1.7	7.8	0.5	2.6	1.4	1.2	2.5	3.8	0.2	25.1	62.1	2.4	2.2	0.0	0.3	0.1	0.9	8.2	0.2	0.0	1.6	1.7	1.0	2.2	24.1	0.1	0.0	8.6	0.0	0.0	6.0	0.7	2.4	1.0	0.0	0.0	0.1	1.8	3.9	0.3	0.0	5.6	1.3	0.8	0.1	0.5	1.9	2.8	0.7	3.9	0.2	0.4	0.0	0.3	0.0	0.0	1.8	1.7	0.1	2.0	15.6	1.9	0.0	4.8	0.0	3.9	0.4	0.4	0.3	1.7	0.8	0.9	17.8	0.9	1.1	0.4	4.4	0.8	0.4	1.0	0.6	1.9	0.0	0.4	7.8	15.0	16.3	10.6	32.7	16.7	8.9	9.6	21.6	13.3	6.6
EHD4	PAST4	ENSG00000103966	"EH domain containing 4"	Q9H223	15	41895939-41972578	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HUVEC TERT2: 33.6;TIME: 55.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049890, HPA049986, HPA052729, HPA066751"	Approved		Approved	"Plasma membrane"			410000	"Plasma membrane"		"HPA049890: , HPA049986: , HPA052729: , HPA066751: "	"unprognostic (1.45e-1)"	"unprognostic (1.37e-1)"	"unprognostic (4.34e-3)"	"unprognostic (3.36e-2)"	"unprognostic (3.46e-2)"	"unprognostic (4.48e-3)"	"unprognostic (1.52e-1)"	"unprognostic (3.36e-3)"	"unprognostic (2.25e-1)"	"unprognostic (3.74e-1)"	"unprognostic (6.93e-2)"	"unprognostic (2.35e-1)"	"unprognostic (5.05e-2)"	"unprognostic (3.49e-2)"	"unprognostic (3.19e-2)"	"unprognostic (8.27e-2)"	"unprognostic (2.72e-1)"	26.1	5.0	3.3	12.9	5.0	8.0	17.9	1.9	5.6	11.4	11.4	4.7	11.3	4.7	20.8	16.4	18.1	10.5	17.4	35.4	4.3	2.6	14.5	22.8	19.9	24.3	7.2	2.0	14.1	14.1	13.9	6.5	14.4	7.5	14.1	9.3	17.4	11.1	12.0	10.5	16.1	16.0	11.6	7.1	11.1	10.0	7.5	4.3	5.3	19.1	9.0	13.7	14.4	10.1	2.6	13.3	7.7	12.7	3.6	6.8	6.2	8.9	3.1	3.0	3.1	1.5	2.2	2.6	4.8	10.1	8.5	12.0	13.1	5.2	1.8	12.9	6.0	9.1	4.5	10.4	6.3	11.1	3.8	2.7	4.6	2.2	3.8	1.2	8.0	1.8	4.1	8.6	9.5	33.6	2.8	2.1	6.8	3.8	1.2	1.4	2.3	10.8	0.0	8.0	2.9	7.6	18.2	5.0	2.1	3.5	7.5	5.4	7.4	1.7	55.3	2.7	5.2	9.9	23.1	5.9	9.4	3.9	3.4	3.0	23.1	0.9	12.7	7.7	3.8	11.2	5.8	2.0	6.0	4.8	13.3	2.6	2.6	3.7	2.1	3.6	4.4	2.2	6.8	6.2	3.3	5.0	1.9	5.6	4.3	2.6	7.2	2.0	7.5	4.3
EIF2B2	"EIF-2Bbeta, EIF2B"	ENSG00000119718	"Eukaryotic translation initiation factor 2B subunit beta"	P49770	14	75002911-75012366	"Disease related genes, Predicted intracellular proteins"	"Protein biosynthesis"	"Initiation factor"	"Disease mutation, Leukodystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA005841, CAB037105, HPA048028"	Enhanced		Approved	"Nucleoplasm,Plasma membrane,Focal adhesion sites"				"Plasma membrane, Focal adhesion sites"	Nucleoplasm	"CAB037105: AB_1840834, HPA005841: AB_1078725, HPA048028: "	"unprognostic (1.10e-1)"	"unprognostic (4.41e-2)"	"unprognostic (5.70e-2)"	"unprognostic (6.71e-2)"	"unprognostic (7.64e-2)"	"unprognostic (3.45e-3)"	"prognostic unfavourable (2.26e-6)"	"unprognostic (1.48e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.65e-2)"	"unprognostic (4.95e-2)"	"unprognostic (1.01e-1)"	"prognostic favourable (2.95e-4)"	"unprognostic (4.15e-2)"	"unprognostic (2.74e-1)"	"unprognostic (1.44e-1)"	"unprognostic (3.28e-2)"	11.8	20.1	11.6	9.2	12.3	9.1	11.6	11.0	16.4	13.2	13.9	13.2	9.2	9.8	11.6	15.8	14.3	10.4	12.6	15.0	11.5	12.0	19.6	18.8	10.3	11.6	13.6	11.4	12.3	12.9	32.3	11.9	20.4	15.7	13.6	12.2	11.7	11.1	14.8	29.0	12.5	13.1	11.0	14.8	12.1	10.9	20.1	11.0	17.7	33.4	11.2	12.7	14.9	9.7	4.2	5.1	7.7	3.9	6.5	8.1	4.8	5.0	6.1	5.0	5.7	5.8	4.8	6.6	3.3	5.4	6.4	7.4	7.7	5.2	4.5	2.1	5.1	3.9	7.7	7.6	9.6	2.7	5.8	3.9	5.4	5.3	7.5	2.9	4.7	4.4	7.3	8.1	8.4	21.8	3.5	4.4	13.6	14.9	4.6	3.6	3.6	9.1	2.9	5.9	3.7	9.0	6.1	5.4	4.3	3.4	4.9	7.2	7.9	2.8	5.6	4.9	4.8	2.2	4.1	7.6	6.2	5.3	5.4	3.7	3.7	7.7	3.9	2.8	6.7	3.9	5.6	4.2	5.9	5.4	5.1	4.1	4.4	4.6	2.2	6.5	3.7	4.2	8.1	4.8	11.6	12.3	11.0	16.4	11.5	12.0	13.6	11.4	15.7	11.0
EIF5B	"DKFZp434I036, FLJ10524, IF2, KIAA0741"	ENSG00000158417	"Eukaryotic translation initiation factor 5B"	O60841	2	99337353-99401326	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Protein biosynthesis"	"Hydrolase, Initiation factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034648, HPA040095"	Approved		Approved	"Plasma membrane,Cytosol"			11000	Cytosol	"Plasma membrane"	"HPA034648: AB_10601902, HPA040095: "	"unprognostic (1.23e-1)"	"unprognostic (6.94e-2)"	"unprognostic (2.01e-1)"	"unprognostic (5.03e-2)"	"unprognostic (4.65e-2)"	"unprognostic (5.88e-3)"	"prognostic unfavourable (7.15e-10)"	"unprognostic (6.80e-2)"	"unprognostic (9.84e-3)"	"prognostic favourable (8.99e-4)"	"unprognostic (1.68e-2)"	"unprognostic (2.36e-1)"	"prognostic unfavourable (1.42e-6)"	"unprognostic (6.89e-2)"	"unprognostic (3.24e-2)"	"unprognostic (1.43e-1)"	"unprognostic (7.93e-3)"	24.5	16.0	25.2	22.4	32.6	11.5	22.6	27.7	26.0	23.7	25.1	10.5	19.9	14.8	19.4	28.7	30.8	14.5	15.0	61.7	26.0	22.3	28.8	32.1	17.9	19.2	26.9	23.0	22.3	24.6	26.8	27.5	26.4	28.5	26.0	20.3	7.1	22.3	29.1	105.8	25.3	19.3	31.5	37.6	27.0	20.7	22.6	33.8	17.8	18.2	29.2	22.8	40.1	31.9	15.9	20.2	11.6	12.1	14.1	14.9	4.5	33.7	16.9	19.3	25.1	23.4	27.8	32.0	29.8	18.8	19.9	19.8	38.9	24.2	38.7	25.9	22.2	19.4	33.7	28.9	35.2	23.4	20.2	46.5	17.3	51.1	18.6	45.5	28.8	18.7	20.4	27.6	28.3	28.9	51.3	19.4	28.5	27.4	28.8	42.2	30.1	24.9	25.2	28.7	31.6	40.7	28.4	16.4	15.5	16.2	37.4	24.0	15.2	30.1	31.7	30.9	30.3	16.1	26.5	14.4	20.4	31.6	22.5	50.5	22.7	11.6	8.8	9.8	12.7	9.5	14.9	15.3	13.4	12.5	6.4	15.9	13.2	14.0	2.3	14.1	12.1	20.2	9.0	4.5	25.2	32.6	27.7	26.0	26.0	22.3	26.9	23.0	28.5	33.8
ELMO3	"CED-12, CED12, ELMO-3, FLJ13824"	ENSG00000102890	"Engulfment and cell motility 3"	Q96BJ8	16	67199111-67204029	"Predicted intracellular proteins"	"Apoptosis, Phagocytosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BEWO: 16.7;CAPAN-2: 24.5;HaCaT: 23.2;T-47d: 22.9"	"Low cancer specificity"	"Detected in all"			"Region enhanced"	"Detected in many"		"cerebellum: 6.7"	"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			HPA021484	Approved		Approved	"Plasma membrane,Cell Junctions"				"Plasma membrane, Cell Junctions"		"HPA021484: AB_1848129"	"unprognostic (4.49e-3)"	"unprognostic (2.04e-1)"	"unprognostic (1.10e-2)"	"unprognostic (8.08e-2)"	"unprognostic (1.39e-1)"	"unprognostic (6.16e-3)"	"unprognostic (3.14e-1)"	"unprognostic (8.17e-3)"	"unprognostic (1.73e-1)"	"unprognostic (8.06e-2)"	"unprognostic (3.40e-2)"	"unprognostic (6.95e-3)"	"prognostic favourable (2.77e-5)"	"unprognostic (3.47e-1)"	"unprognostic (2.66e-1)"	"unprognostic (1.84e-1)"	"unprognostic (1.97e-2)"	1.1	0.8	0.6	7.8	1.8	2.5	4.6	6.7	1.4	2.8	30.3	0.5	32.0	18.9	2.6	9.8	13.1	4.8	16.0	0.9	0.7	0.8	13.3	3.9	6.9	1.4	0.5	0.5	1.2	26.6	6.5	28.7	13.7	1.0	13.2	5.1	0.9	25.1	28.8	0.5	19.1	37.7	1.7	0.5	2.8	12.8	8.7	0.6	1.1	18.2	9.7	9.2	6.8	6.0	1.2	0.8	2.1	0.4	0.4	1.0	0.1	10.6	1.2	1.2	1.5	0.2	0.3	16.7	0.6	0.3	0.8	0.7	7.0	24.5	1.5	0.8	0.3	23.2	1.1	10.7	0.1	0.7	1.4	1.5	1.9	2.3	0.5	0.9	3.8	0.2	7.9	0.6	0.6	0.8	1.4	0.7	0.4	8.9	0.9	4.5	1.6	0.9	2.2	1.1	2.3	1.0	1.4	8.2	1.8	1.5	7.3	0.7	22.9	1.6	1.4	1.9	2.3	1.1	1.1	2.5	0.8	2.8	0.9	2.1	0.9	0.0	0.4	1.0	1.0	0.0	0.1	1.2	0.8	0.1	0.5	1.1	0.6	0.2	2.1	0.4	0.1	0.8	0.5	0.1	0.6	1.8	6.7	1.4	0.7	0.8	0.5	0.5	1.0	0.6
ELN	"SVAS, WBS, WS"	ENSG00000049540	Elastin	P15502	7	74027789-74069907	"Disease related genes, Plasma proteins, Predicted secreted proteins"			"Williams-Beuren syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"ASC diff: 16.5;BJ: 22.9;fHDF/TERT166: 32.8;U-2197: 130.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB010750, HPA018111, HPA056941"	Supported		Approved	"Plasma membrane"	"Secreted to extracellular matrix"		2900000	"Plasma membrane"		"CAB010750: AB_476930, HPA018111: AB_1848109, HPA056941: "	"unprognostic (1.51e-2)"	"unprognostic (4.86e-2)"	"unprognostic (2.50e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.57e-2)"	"unprognostic (2.72e-2)"	"unprognostic (3.70e-3)"	"unprognostic (1.23e-1)"	"unprognostic (3.33e-2)"	"unprognostic (2.00e-3)"	"unprognostic (2.88e-1)"	"unprognostic (1.09e-1)"	"unprognostic (2.18e-3)"	"unprognostic (1.79e-2)"	"unprognostic (3.90e-2)"	"prognostic unfavourable (6.29e-4)"	"unprognostic (1.62e-3)"	35.0	8.8	4.3	14.9	3.6	0.0	24.8	27.8	5.8	23.3	12.1	12.9	9.1	3.2	22.3	26.0	30.1	17.1	30.8	41.5	5.4	3.0	8.3	3.7	49.7	7.5	4.4	9.2	10.6	35.3	0.7	6.1	22.5	13.7	25.1	4.6	34.3	16.8	14.5	6.0	23.6	9.2	34.7	9.9	10.7	16.0	8.1	6.4	0.9	11.9	10.3	4.4	34.0	21.7	0.4	0.0	0.0	0.0	0.0	0.3	1.1	0.0	0.3	0.1	0.0	16.5	0.1	0.1	22.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0	32.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	1.3	0.1	0.0	8.8	0.1	0.0	0.0	4.5	10.7	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	130.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	4.3	3.6	27.8	5.8	5.4	3.0	4.4	9.2	13.7	6.4
EMP3	YMP	ENSG00000142227	"Epithelial membrane protein 3"	P54852	19	48321509-48330553	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 165.9"	"Cell line enhanced"	"Detected in many"		"NB-4: 114.2"	"Cancer enhanced"	"Detected in all"		"melanoma: 195.4"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA062030			Approved	"Vesicles,Plasma membrane"				"Vesicles, Plasma membrane"		"HPA062030: "	"unprognostic (5.06e-3)"	"unprognostic (4.41e-1)"	"unprognostic (1.83e-1)"	"unprognostic (9.28e-3)"	"unprognostic (1.33e-2)"	"unprognostic (4.83e-3)"	"unprognostic (1.49e-2)"	"unprognostic (1.02e-1)"	"unprognostic (9.31e-2)"	"unprognostic (4.72e-2)"	"unprognostic (3.41e-2)"	"unprognostic (1.79e-1)"	"prognostic unfavourable (2.31e-7)"	"prognostic unfavourable (3.13e-4)"	"unprognostic (1.16e-1)"	"unprognostic (2.41e-1)"	"unprognostic (2.90e-3)"	27.6	23.4	10.4	26.5	12.6	66.2	28.7	7.2	8.4	50.6	40.3	9.2	14.6	8.4	45.9	22.6	26.9	26.1	21.1	37.9	10.8	6.9	15.6	7.0	36.1	48.0	15.2	6.7	41.4	6.4	2.2	6.1	29.9	12.7	30.7	15.4	24.7	11.3	23.1	13.2	16.3	20.8	46.7	19.1	27.8	19.2	18.2	8.2	16.2	11.6	13.4	25.6	36.8	30.6	44.9	54.8	165.9	91.0	59.7	119.1	124.8	5.5	62.3	3.4	10.0	55.3	86.4	0.1	38.4	70.0	50.9	45.1	6.0	20.1	0.7	8.7	85.3	1.0	3.7	4.2	31.3	18.3	1.6	26.6	16.4	3.6	46.4	13.1	27.8	46.8	0.8	52.2	36.0	21.8	17.5	45.7	77.8	0.9	1.9	114.2	4.7	15.8	1.6	12.0	27.0	43.6	0.0	0.1	0.2	17.4	0.1	9.9	0.2	20.1	35.8	46.0	20.0	36.4	30.1	24.1	29.9	1.7	27.2	17.3	31.2	165.9	77.2	105.6	109.2	91.0	90.4	44.9	114.8	106.6	54.8	35.4	65.7	78.2	85.7	59.7	86.6	40.8	119.1	124.8	10.4	12.6	7.2	8.4	10.8	6.9	15.2	6.7	12.7	8.2
ENG	"CD105, END, HHT1, ORW, ORW1"	ENSG00000106991	Endoglin	P17813	9	127815012-127854756	"Cancer-related genes, Candidate cardiovascular disease genes, CD markers, Disease related genes, Plasma proteins, Predicted membrane proteins"	"Angiogenesis, Cell adhesion"		"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HUVEC TERT2: 66.9;TIME: 136.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"classical monocyte: 12.2;intermediate monocyte: 17.7;myeloid DC: 6.4;NK-cell: 4.6;non-classical monocyte: 13.0"	"Group enriched"	"Detected in many"	4	"dendritic cells: 6.4;monocytes: 17.7;NK-cells: 4.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000096, HPA011862, HPA067440, CAB072873"	Enhanced		Supported	"Nuclear bodies,Plasma membrane"			260000000	"Plasma membrane"	"Nuclear bodies"	"CAB000096: AB_563482, CAB072873: , HPA011862: AB_1846217, HPA067440: "	"unprognostic (2.28e-1)"	"unprognostic (1.13e-1)"	"unprognostic (3.87e-2)"	"unprognostic (2.96e-2)"	"unprognostic (1.77e-1)"	"prognostic favourable (6.61e-4)"	"prognostic favourable (5.62e-6)"	"unprognostic (2.15e-1)"	"unprognostic (4.06e-1)"	"unprognostic (3.87e-2)"	"unprognostic (2.20e-2)"	"unprognostic (8.98e-2)"	"prognostic unfavourable (4.26e-4)"	"unprognostic (3.33e-3)"	"unprognostic (7.35e-2)"	"unprognostic (2.84e-1)"	"unprognostic (1.27e-1)"	40.3	19.3	6.4	26.6	10.5	5.5	52.7	3.9	8.6	26.3	14.0	7.6	18.5	11.2	27.0	25.2	17.2	23.2	28.3	105.4	8.0	5.0	40.8	26.8	66.7	44.1	10.6	7.0	66.4	9.6	8.6	12.5	60.2	10.1	23.1	6.4	35.5	9.9	51.7	24.1	10.1	14.5	23.1	8.7	52.4	11.6	37.2	7.7	6.7	35.4	19.3	11.0	20.3	44.8	1.1	6.4	0.3	17.7	4.6	2.3	4.6	0.1	0.1	0.9	0.0	16.8	11.5	29.6	19.5	14.0	10.4	6.1	0.0	0.1	0.1	9.5	35.8	0.3	0.0	3.1	3.4	0.0	0.0	5.5	11.0	0.6	13.1	2.6	0.0	19.7	0.7	13.5	4.9	66.9	0.0	0.1	12.1	0.1	0.0	0.2	0.2	0.5	8.7	1.7	0.1	0.0	0.0	0.1	0.2	10.3	9.0	2.6	1.8	3.9	136.5	34.1	1.8	22.2	0.0	0.7	0.1	0.1	9.2	6.8	11.2	0.0	12.2	0.3	1.3	17.7	0.4	0.4	2.1	2.3	6.4	1.1	1.3	2.0	0.3	4.6	13.0	2.4	0.8	4.6	6.4	10.5	3.9	8.6	8.0	5.0	10.6	7.0	10.1	7.7
EPB41L4A	NBL4	ENSG00000129595	"Erythrocyte membrane protein band 4.1 like 4A"	Q9HCS5	5	112142441-112419316	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"EFO-21: 19.6;HeLa: 22.2;RT4: 13.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA036580	Uncertain		Approved	"Nucleoplasm,Plasma membrane"				"Plasma membrane"	Nucleoplasm	"HPA036580: AB_10669908"	"unprognostic (1.40e-1)"	"unprognostic (1.90e-1)"	"unprognostic (1.92e-3)"	"unprognostic (3.64e-2)"	"unprognostic (4.73e-2)"	"unprognostic (5.59e-3)"	"unprognostic (4.40e-2)"	"unprognostic (8.38e-2)"	"unprognostic (1.90e-1)"	"unprognostic (3.97e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.23e-3)"	"prognostic favourable (3.65e-5)"	"unprognostic (1.68e-1)"	"unprognostic (3.35e-2)"	"unprognostic (2.73e-1)"	"unprognostic (1.92e-1)"	21.4	3.7	3.5	5.0	4.0	2.1	19.0	2.1	6.1	7.3	3.0	1.7	22.1	1.9	6.1	11.3	13.6	6.2	11.7	9.3	4.0	3.1	10.0	4.8	21.9	6.9	3.7	2.0	4.9	4.2	14.3	4.3	8.9	3.7	5.3	3.8	10.5	7.7	22.0	6.8	7.2	3.2	5.9	4.3	6.7	4.3	4.8	1.9	2.1	15.7	8.2	6.9	5.5	12.2	3.6	0.5	1.3	1.2	0.4	4.8	0.9	0.5	3.4	9.1	0.9	0.0	0.0	1.9	1.3	0.0	0.0	0.0	1.8	7.7	3.8	19.6	0.0	4.6	0.6	4.3	0.0	0.6	3.2	6.0	22.2	1.2	0.1	1.6	2.0	0.0	1.9	0.0	0.0	5.7	1.1	3.5	0.0	1.1	2.7	2.1	1.7	0.6	1.4	6.9	0.8	5.3	13.4	7.6	3.9	6.7	3.3	2.6	10.0	0.8	9.8	0.4	1.5	1.2	2.7	3.5	0.7	2.9	0.9	3.2	0.5	1.3	0.4	0.2	4.8	0.6	2.7	3.6	1.5	1.4	0.5	3.3	2.4	4.7	0.5	0.4	1.2	0.3	1.4	0.9	3.5	4.0	2.1	3.9	4.0	3.1	3.7	2.0	3.7	1.9
EPB41L4B	EHM2	ENSG00000095203	"Erythrocyte membrane protein band 4.1 like 4B"	Q9H329	9	109171975-109320964	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 28.1;pancreas: 59.8"	"Cell line enhanced"	"Detected in many"		"BEWO: 17.4;hTCEpi: 27.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042862	Approved		Approved	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		"HPA042862: AB_10794534"	"prognostic unfavourable (1.02e-4)"	"unprognostic (6.58e-2)"	"unprognostic (2.33e-2)"	"unprognostic (1.20e-1)"	"unprognostic (2.31e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.40e-2)"	"unprognostic (6.19e-2)"	"unprognostic (2.72e-2)"	"unprognostic (1.40e-1)"	"unprognostic (3.60e-1)"	"unprognostic (6.20e-2)"	"unprognostic (8.82e-4)"	"unprognostic (1.46e-3)"	"unprognostic (1.43e-1)"	"unprognostic (4.65e-2)"	"unprognostic (1.29e-1)"	6.5	4.2	7.3	1.2	14.6	0.0	4.8	4.9	11.4	1.1	18.4	1.5	7.1	15.1	0.7	5.9	0.7	3.2	1.8	3.5	2.9	3.5	1.9	28.1	1.7	0.2	1.6	6.8	4.7	59.8	3.3	0.9	1.1	2.7	2.2	18.7	2.4	8.0	3.5	2.2	5.6	16.1	0.3	2.2	0.2	9.4	2.7	1.3	0.4	14.6	1.3	1.2	1.2	1.3	0.8	0.0	0.1	0.0	0.0	0.0	0.0	4.5	5.7	0.4	0.4	0.4	0.0	17.4	0.6	0.2	2.0	1.0	9.8	4.5	0.0	1.2	0.5	7.5	11.6	6.1	2.1	4.8	2.7	0.0	1.8	13.9	1.2	0.2	0.0	0.1	27.3	0.8	9.4	0.1	0.1	0.0	2.8	11.6	0.2	0.1	7.5	8.5	0.0	0.0	0.3	7.0	6.9	7.2	0.7	1.8	12.1	0.0	2.8	0.0	0.2	4.1	4.2	1.3	1.6	0.0	0.0	0.0	3.0	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.3	14.6	4.9	11.4	2.9	3.5	1.6	6.8	2.7	1.3
ERAP1	"A-LAP, ARTS-1, ERAAP1, KIAA0525, PILS-AP"	ENSG00000164307	"Endoplasmic reticulum aminopeptidase 1"	Q9NZ08	5	96760810-96808100	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Adaptive immunity, Immunity"	"Aminopeptidase, Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB025095, HPA042317"	Approved		Approved	"Nucleoplasm,Plasma membrane,Cytosol"	"Secreted to blood"		27000000	"Nucleoplasm, Cytosol"	"Plasma membrane"	"CAB025095: , HPA042317: "	"unprognostic (2.33e-3)"	"unprognostic (3.45e-1)"	"unprognostic (1.84e-3)"	"unprognostic (1.34e-1)"	"unprognostic (1.86e-1)"	"unprognostic (4.38e-1)"	"unprognostic (1.88e-3)"	"unprognostic (5.37e-2)"	"unprognostic (1.45e-1)"	"unprognostic (7.94e-2)"	"unprognostic (4.52e-2)"	"unprognostic (3.23e-1)"	"unprognostic (7.09e-2)"	"unprognostic (1.36e-1)"	"unprognostic (3.93e-2)"	"unprognostic (1.19e-1)"	"unprognostic (5.14e-2)"	23.8	13.6	9.3	22.7	11.9	11.6	23.3	14.2	14.6	14.5	23.8	10.1	11.2	30.8	14.7	13.4	12.3	14.3	19.9	16.1	9.7	6.8	13.3	23.7	17.8	16.4	13.5	7.6	15.5	16.5	11.1	39.4	28.2	11.4	13.4	21.9	8.5	13.9	15.2	23.1	17.7	39.7	10.6	17.1	19.5	16.5	5.4	13.8	55.5	13.5	9.8	17.8	15.9	14.1	14.9	15.2	19.8	17.5	19.8	21.8	10.7	7.3	4.7	6.3	5.9	35.0	34.3	18.4	5.4	17.5	13.1	23.0	5.9	26.7	22.0	11.3	10.4	7.6	5.2	11.1	8.2	39.8	2.2	7.1	3.1	4.0	40.1	3.4	13.2	14.2	4.8	15.0	4.6	18.0	3.7	21.4	7.8	3.4	31.6	3.5	3.1	3.0	23.5	8.6	10.9	9.8	11.4	2.3	1.6	8.6	5.8	8.4	5.1	16.4	14.3	11.3	3.8	1.9	8.9	8.0	15.0	17.1	12.1	11.6	6.6	19.8	13.2	15.6	21.2	11.4	19.7	13.0	18.5	18.2	9.5	14.9	21.8	17.4	14.4	19.8	17.5	15.2	12.3	10.7	9.3	11.9	14.2	14.6	9.7	6.8	13.5	7.6	11.4	13.8
EVA1A	"FAM176A, FLJ13391, TMEM166"	ENSG00000115363	"Eva-1 homolog A, regulator of programmed cell death"	Q9H8M9	2	75469302-75569722	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Apoptosis, Autophagy"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 69.4;pancreas: 32.3"	"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 27.1;U-138 MG: 36.4"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"naive CD4 T-cell: 1.1;naive CD8 T-cell: 1.0"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA008055	Approved		Supported	"Vesicles,Plasma membrane"				Vesicles	"Plasma membrane"	"HPA008055: AB_1080308"	"unprognostic (2.72e-1)"	"unprognostic (2.61e-2)"	"unprognostic (4.14e-3)"	"unprognostic (1.01e-1)"	"unprognostic (1.36e-2)"	"unprognostic (3.60e-2)"	"unprognostic (5.02e-2)"	"unprognostic (1.77e-2)"	"unprognostic (1.77e-1)"	"prognostic favourable (5.67e-4)"	"unprognostic (7.33e-2)"	"unprognostic (1.22e-1)"	"prognostic favourable (5.80e-4)"	"unprognostic (8.19e-2)"	"unprognostic (4.37e-2)"	"unprognostic (2.43e-2)"	"unprognostic (9.07e-2)"	0.6	0.3	0.3	0.7	0.5	0.0	1.2	0.3	0.2	3.7	0.6	0.1	11.4	0.5	1.6	5.1	0.5	1.3	0.4	0.6	0.3	0.3	23.6	69.4	15.2	0.1	0.8	0.0	0.8	32.3	0.8	0.8	26.6	0.5	0.6	0.2	5.7	14.3	13.5	0.9	1.5	1.1	0.7	0.4	5.9	0.4	2.2	0.3	3.3	1.2	0.8	0.8	0.3	0.6	0.8	0.0	0.0	0.0	0.0	1.1	0.7	0.3	4.6	0.5	0.1	1.0	7.1	0.5	21.7	14.6	19.3	9.9	0.1	0.4	0.0	2.0	27.1	3.0	0.5	4.6	12.2	0.0	0.3	0.0	0.8	14.3	0.7	0.0	0.0	5.0	2.7	23.8	11.0	12.0	0.0	0.0	14.8	0.0	0.0	0.0	1.0	7.5	2.4	0.0	0.0	10.7	0.1	0.3	0.5	2.0	0.1	16.5	0.0	0.1	9.8	36.4	15.3	0.6	22.6	0.2	0.0	0.0	20.6	0.0	19.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	1.1	1.0	0.0	0.0	0.0	0.0	0.0	0.7	0.3	0.5	0.3	0.2	0.3	0.3	0.8	0.0	0.5	0.3
EXOC1	"BM-102, FLJ10893, SEC3, SEC3L1, Sec3p"	ENSG00000090989	"Exocyst complex component 1"	Q9NV70	4	55853616-55905034	"Predicted intracellular proteins, Transporters"	"Antiviral defense, Exocytosis, Host-virus interaction, Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037706, HPA044873"	Uncertain		Approved	"Plasma membrane,Microtubules,Cytosol"				"Plasma membrane"	"Microtubules, Cytosol"	"HPA037706: AB_10670525, HPA044873: "	"unprognostic (7.10e-3)"	"unprognostic (4.48e-2)"	"unprognostic (8.85e-2)"	"unprognostic (9.22e-2)"	"unprognostic (9.81e-2)"	"unprognostic (2.63e-1)"	"prognostic unfavourable (2.63e-4)"	"unprognostic (2.84e-3)"	"unprognostic (4.65e-2)"	"unprognostic (2.04e-2)"	"unprognostic (4.03e-3)"	"unprognostic (1.55e-1)"	"unprognostic (1.94e-1)"	"unprognostic (3.11e-1)"	"unprognostic (2.93e-2)"	"unprognostic (6.24e-2)"	"prognostic favourable (5.50e-5)"	21.2	19.7	20.7	21.0	24.0	12.9	25.3	22.8	40.7	18.4	20.2	18.2	14.6	18.9	20.8	24.6	32.7	18.3	17.9	19.8	26.9	23.6	18.7	11.4	26.2	29.2	24.7	22.8	18.2	14.9	29.7	20.0	23.4	30.7	16.8	22.4	12.9	20.3	19.2	14.6	31.6	20.5	18.4	29.1	23.7	17.5	18.5	21.5	19.1	19.0	15.8	21.9	18.8	21.4	7.3	11.7	16.4	18.1	10.1	9.2	6.3	11.3	6.6	11.9	13.7	20.5	25.8	8.0	16.1	16.2	13.2	13.9	4.6	19.9	11.0	11.3	17.3	13.6	9.7	12.8	19.0	5.8	6.7	10.2	8.2	5.3	19.4	11.0	14.5	20.8	17.5	13.7	15.2	21.4	14.6	10.9	28.6	7.2	8.0	11.2	7.5	12.6	9.4	8.9	8.9	14.7	12.5	8.9	15.8	9.6	15.9	13.3	10.1	11.9	25.8	16.4	13.4	14.0	13.8	13.1	6.5	9.8	21.3	12.4	15.4	15.2	12.1	10.4	5.8	15.7	7.5	7.3	8.2	8.2	11.7	6.7	7.4	5.4	16.4	10.1	18.1	5.3	9.2	6.3	20.7	24.0	22.8	40.7	26.9	23.6	24.7	22.8	30.7	21.5
EXOC3L1	"EXOC3L, FLJ35539, FLJ35587"	ENSG00000179044	"Exocyst complex component 3 like 1"	Q86VI1	16	67184366-67190204	"Predicted intracellular proteins"	Exocytosis			"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 26.6"	"Cell line enhanced"	"Detected in some"		"BEWO: 3.1;HUVEC TERT2: 5.8;SCLC-21H: 11.0;TIME: 3.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Cell type enhanced"	"Detected in some"		"neutrophil: 1.8;non-classical monocyte: 2.0"	"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA029574	Uncertain		Approved	"Vesicles,Plasma membrane"				"Vesicles, Plasma membrane"		"HPA029574: AB_10602495"	"unprognostic (1.15e-2)"	"unprognostic (4.91e-2)"	"unprognostic (6.87e-3)"	"unprognostic (2.09e-3)"	"unprognostic (2.33e-1)"	"unprognostic (2.46e-2)"	"unprognostic (6.77e-2)"	"unprognostic (3.98e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.26e-2)"	"unprognostic (6.48e-3)"	"unprognostic (2.88e-1)"	"unprognostic (6.64e-3)"	"unprognostic (3.40e-1)"	"unprognostic (1.23e-1)"	"unprognostic (3.26e-1)"	"unprognostic (1.35e-1)"	4.5	2.4	0.3	1.8	0.9	0.0	2.4	0.4	1.2	1.4	0.6	0.3	0.3	0.8	3.6	0.8	1.2	0.9	1.5	4.5	1.3	0.2	3.3	1.4	8.7	1.8	0.3	0.8	2.0	1.0	0.4	1.1	6.0	1.0	1.6	0.3	2.4	1.1	0.5	1.8	0.7	1.0	0.8	1.0	26.6	0.7	1.0	0.3	0.3	4.1	1.0	0.5	1.0	0.5	0.0	0.7	1.8	2.0	0.0	0.0	0.3	0.2	0.1	1.2	0.4	0.0	0.1	3.1	0.4	0.0	0.0	0.0	1.4	0.3	0.1	1.7	0.0	0.1	0.0	0.0	0.0	0.2	0.3	0.7	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	5.8	0.5	0.0	0.1	0.2	0.3	0.1	0.5	0.6	1.3	1.2	0.2	0.0	0.2	11.0	1.3	1.4	0.3	0.1	1.0	0.1	3.9	0.2	0.2	0.2	0.1	0.2	0.1	0.1	0.8	0.0	0.3	0.0	1.1	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	1.8	0.0	2.0	0.0	0.0	0.3	0.3	0.9	0.4	1.2	1.3	0.2	0.3	0.8	1.0	0.3
EXOC7	"BLOM4, EXO70, Exo70p, KIAA1067, YJL085W"	ENSG00000182473	"Exocyst complex component 7"	Q9UPT5	17	76081017-76121576	"Predicted intracellular proteins, Transporters"	"Exocytosis, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA022840, HPA022842"	Supported		Approved	"Vesicles,Plasma membrane,Cytosol"				Cytosol	"Vesicles, Plasma membrane"	"HPA022840: AB_1848316, HPA022842: AB_1848317"	"unprognostic (5.20e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.80e-1)"	"unprognostic (3.49e-2)"	"unprognostic (2.37e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.02e-1)"	"unprognostic (2.47e-2)"	"unprognostic (7.39e-3)"	"unprognostic (1.53e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.18e-1)"	23.2	22.2	30.5	18.2	37.1	27.5	20.4	27.8	46.2	23.8	24.4	33.0	20.8	19.1	28.7	20.8	31.8	32.6	21.3	27.5	29.2	23.5	21.0	22.6	21.2	17.6	20.9	28.2	31.5	24.1	40.5	29.3	24.0	34.6	30.0	17.0	27.0	29.2	27.9	24.0	21.8	21.6	31.1	21.7	21.4	19.6	14.5	23.0	23.7	29.5	14.1	26.4	30.2	20.5	12.8	13.7	29.6	34.4	15.5	17.9	19.0	21.2	26.4	24.4	19.7	23.2	16.5	25.4	19.5	26.1	35.4	25.7	22.2	14.4	11.0	14.3	34.1	17.5	14.7	19.0	23.8	9.5	19.9	18.3	20.7	23.4	16.2	20.3	19.0	23.0	15.0	27.4	13.4	39.2	12.2	11.3	22.0	19.5	32.6	9.0	12.8	28.2	17.6	41.8	11.2	20.4	44.1	13.3	31.1	22.1	16.4	15.1	26.9	16.8	25.6	38.0	22.9	25.0	21.4	15.6	5.7	10.2	22.7	9.2	19.6	21.1	19.2	29.6	17.9	26.6	12.3	12.4	13.7	15.3	13.7	12.8	14.5	12.2	22.2	15.5	34.4	5.9	14.8	19.0	30.5	37.1	27.8	46.2	29.2	23.5	20.9	28.2	34.6	23.0
F2RL1	"GPR11, PAR2"	ENSG00000164251	"F2R like trypsin receptor 1"	P55085	5	76818933-76835315	"G-protein coupled receptors, Predicted membrane proteins, Transporters"	"Immunity, Inflammatory response, Innate immunity"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 64.1"	"Cell line enhanced"	"Detected in many"		"HUVEC TERT2: 23.6;PC-3: 34.4;RPTEC TERT1: 57.0"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in many"	5	"pons and medulla: 7.8"	"Cell type enriched"	"Detected in many"	4	"neutrophil: 24.9"	"Lineage enriched"	"Detected in many"	4	"granulocytes: 24.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB012989, HPA014091"	Approved		Approved	"Plasma membrane"				"Plasma membrane"		"CAB012989: AB_2533199, HPA014091: "	"unprognostic (1.29e-2)"	"unprognostic (4.05e-2)"	"prognostic favourable (3.88e-4)"	"unprognostic (1.98e-2)"	"unprognostic (8.22e-2)"	"prognostic unfavourable (5.88e-4)"	"unprognostic (1.36e-1)"	"prognostic unfavourable (8.92e-4)"	"unprognostic (6.13e-2)"	"unprognostic (4.07e-1)"	"unprognostic (2.16e-3)"	"unprognostic (1.52e-2)"	"prognostic favourable (5.86e-7)"	"unprognostic (1.11e-1)"	"unprognostic (1.74e-1)"	"unprognostic (3.76e-2)"	"unprognostic (9.73e-2)"	0.6	1.1	1.0	7.2	1.4	0.1	2.9	0.4	0.8	2.4	34.0	1.1	25.3	17.4	1.0	2.2	6.4	2.9	13.6	3.6	1.1	0.9	28.9	7.4	2.8	3.7	0.8	0.4	1.2	16.6	1.3	3.2	2.8	7.8	6.0	21.4	1.1	7.1	23.7	0.3	24.8	64.1	0.7	1.5	3.5	16.8	0.8	0.5	0.6	9.6	5.8	3.1	5.3	3.9	0.3	2.7	24.9	5.7	0.3	2.3	2.0	8.6	14.3	1.2	0.0	0.4	1.1	9.2	0.4	4.7	0.2	0.7	12.3	22.4	0.0	19.3	1.0	14.9	7.5	6.6	0.4	0.0	7.0	0.2	0.3	8.7	3.1	0.0	0.0	1.6	19.0	2.2	14.2	23.6	0.1	0.0	0.0	4.7	1.0	0.0	1.5	34.4	0.0	0.0	0.2	57.0	16.1	0.6	0.1	3.4	3.4	0.0	1.4	0.0	15.6	0.0	9.0	0.0	0.0	1.3	0.2	0.0	5.1	0.0	0.4	4.6	5.7	1.0	0.3	1.9	1.2	0.3	2.3	1.2	2.7	0.1	2.2	1.3	24.9	0.3	0.3	0.3	0.6	2.0	1.0	1.4	0.4	0.8	1.1	0.9	0.8	0.4	7.8	0.5
FABP2	I-FABP	ENSG00000145384	"Fatty acid binding protein 2"	P12104	4	119317250-119322390	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	Transport		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	47	"intestine: 358.6"	"Cell line enhanced"	"Detected in some"		"BEWO: 2.8;Hep G2: 2.4;NB-4: 3.8;RPMI-8226: 3.2;SH-SY5Y: 2.6"	"Group enriched"	"Detected in some"	9	"colorectal cancer: 3.2;pancreatic cancer: 1.6;stomach cancer: 2.7"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"basophil: 2.1;neutrophil: 7.6"	"Lineage enriched"	"Detected in single"	8	"granulocytes: 7.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA034607, CAB047325, CAB047326"	Enhanced		Approved	"Plasma membrane,Actin filaments,Cytosol"			46000	"Actin filaments, Cytosol"	"Plasma membrane"	"CAB047325: , CAB047326: , HPA034607: AB_10601317"		"unprognostic (3.94e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.05e-1)"				"unprognostic (4.58e-1)"		"unprognostic (1.51e-2)"	"unprognostic (2.61e-2)"		"unprognostic (1.69e-4)"	"unprognostic (1.93e-1)"	"unprognostic (1.02e-1)"			0.1	0.2	0.1	0.8	0.1	0.0	0.1	0.1	0.1	0.1	47.0	0.0	0.0	50.0	0.1	0.0	0.1	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.1	5.9	0.1	0.1	0.0	0.1	0.1	358.6	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.5	0.5	7.6	0.7	0.9	0.5	0.0	0.2	0.3	0.2	0.4	0.0	0.0	2.8	0.4	0.0	0.0	0.0	0.4	0.3	0.4	0.1	0.0	0.3	0.0	0.2	0.1	0.1	0.3	0.1	0.4	2.4	0.0	0.5	0.4	0.2	0.0	0.2	0.1	0.0	0.2	0.5	0.0	0.1	0.4	3.8	0.2	0.5	0.3	0.2	3.2	0.0	0.5	1.0	2.6	0.1	0.4	0.0	0.3	0.1	0.9	0.4	0.4	1.4	0.1	0.7	0.2	0.6	0.3	0.2	0.1	2.1	0.7	0.7	0.4	0.3	0.4	0.2	0.4	0.3	0.2	0.5	0.5	0.5	7.6	0.9	0.2	0.5	0.5	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0
FABP5	"E-FABP, KFABP, PA-FABP"	ENSG00000164687	"Fatty acid binding protein 5"	Q01469	8	81280363-81284777	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transporters"	Transport		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 237.0;tongue: 204.1;vagina: 141.9"	"Cell line enhanced"	"Detected in many"		"Daudi: 92.9;MOLT-4: 90.8"	"Cancer enhanced"	"Detected in all"		"cervical cancer: 268.3;head and neck cancer: 288.8"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"CAB017831, CAB040577, HPA051895"	Enhanced		Supported	"Plasma membrane,Cytosol"	"Intracellular and membrane"		28000000	Cytosol	"Plasma membrane"	"CAB017831: , CAB040577: , HPA051895: "	"unprognostic (8.76e-2)"	"unprognostic (7.28e-2)"	"unprognostic (1.54e-2)"	"unprognostic (9.04e-2)"	"unprognostic (1.33e-3)"	"unprognostic (1.37e-1)"	"unprognostic (1.95e-3)"	"unprognostic (4.03e-3)"	"unprognostic (2.71e-1)"	"unprognostic (3.13e-1)"	"unprognostic (6.16e-2)"	"unprognostic (3.57e-2)"	"prognostic unfavourable (4.69e-10)"	"unprognostic (1.99e-1)"	"unprognostic (3.72e-1)"	"unprognostic (1.61e-1)"	"unprognostic (6.60e-2)"	41.4	1.5	8.5	11.8	13.2	8.5	37.3	5.5	8.9	78.7	20.6	7.9	2.2	8.0	5.7	3.1	237.0	2.1	8.5	27.1	8.5	9.8	1.6	2.7	24.8	15.1	7.6	5.0	2.0	8.7	0.7	1.9	30.0	19.1	4.4	18.2	4.2	32.9	1.6	9.4	42.9	9.7	4.5	23.0	14.9	15.6	3.8	10.6	6.6	4.4	204.1	25.7	19.5	141.9	6.8	20.3	2.5	5.9	8.2	5.2	4.3	5.7	16.5	10.1	0.0	48.4	4.5	0.0	11.8	0.6	9.2	11.7	0.1	7.9	92.9	6.8	2.9	5.4	24.6	18.9	7.9	47.2	53.4	33.5	11.8	25.0	4.3	32.0	8.7	3.5	38.9	11.4	23.5	53.0	9.6	10.1	5.5	5.6	90.8	16.4	13.4	64.3	40.5	0.0	9.8	14.8	71.8	42.0	15.9	5.7	1.9	4.4	0.0	16.5	7.5	0.0	26.3	0.1	0.1	12.5	4.9	66.2	4.2	30.7	14.8	2.5	5.0	0.3	2.3	5.9	3.7	6.8	2.7	5.2	20.3	3.3	1.3	4.5	2.0	8.2	2.0	20.1	3.5	4.3	8.5	13.2	5.5	8.9	8.5	9.8	7.6	5.0	19.1	10.6
FAIM	"FAIM1, FLJ10582"	ENSG00000158234	"Fas apoptotic inhibitory molecule"	Q9NVQ4	3	138608606-138633376	"Predicted intracellular proteins"	Apoptosis			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"seminal vesicle: 61.9"	"Cell line enhanced"	"Detected in many"		"U-698: 44.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA042440, HPA052209"	Approved		Approved	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		"HPA042440: , HPA052209: "	"unprognostic (6.45e-2)"	"unprognostic (8.21e-3)"	"unprognostic (5.97e-2)"	"unprognostic (1.11e-1)"	"unprognostic (3.24e-1)"	"unprognostic (8.31e-2)"	"prognostic unfavourable (3.96e-5)"	"unprognostic (4.84e-2)"	"unprognostic (4.15e-2)"	"unprognostic (9.23e-3)"	"unprognostic (2.29e-1)"	"unprognostic (2.63e-2)"	"prognostic favourable (6.63e-4)"	"unprognostic (4.76e-2)"	"unprognostic (3.51e-1)"	"unprognostic (3.43e-1)"	"unprognostic (6.98e-2)"	13.7	6.6	12.3	6.7	11.6	2.6	19.0	7.8	9.9	24.5	6.8	10.2	38.5	4.7	9.6	15.1	8.8	28.5	9.0	4.7	12.2	12.5	15.4	6.0	7.6	7.2	13.9	7.1	8.4	27.5	7.2	15.4	6.1	10.7	11.4	6.0	9.1	7.2	61.9	6.1	6.2	4.2	7.2	19.6	3.7	6.7	5.4	9.1	13.2	15.2	9.3	9.6	10.3	13.2	13.9	5.0	11.1	2.6	13.9	9.1	3.4	26.5	5.2	0.5	4.7	5.1	9.6	19.1	8.2	5.0	8.7	7.5	8.9	7.8	0.0	7.3	10.7	7.0	22.7	4.7	9.8	21.8	23.7	5.0	14.4	12.9	5.7	0.0	1.6	13.5	9.1	3.2	5.0	9.4	3.2	6.8	5.4	10.1	0.1	22.5	10.3	5.2	26.8	6.2	0.7	13.8	13.2	9.0	7.6	14.6	8.1	20.5	13.7	6.6	5.7	1.8	4.1	8.9	3.9	0.0	0.1	44.7	7.2	0.0	7.1	11.1	2.4	1.7	9.1	2.6	8.5	13.9	5.0	7.2	5.0	7.9	3.4	8.5	0.3	13.9	1.7	3.5	5.4	3.4	12.3	11.6	7.8	8.2	12.2	12.5	13.9	7.1	10.7	9.1
FAM129A	"C1orf24, GIG39, NIBAN"	ENSG00000135842	"Family with sequence similarity 129 member A"	Q9BZQ8	1	184790724-184974550	"Cancer-related genes, Predicted intracellular proteins"	"Stress response, Translation regulation"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"smooth muscle: 129.1;urinary bladder: 90.3"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in many"	5	"neutrophil: 32.7"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 32.7"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"HPA028172, HPA028231, HPA028657"	Approved		Supported	"Plasma membrane,Cytosol"			40000	"Plasma membrane, Cytosol"		"HPA028172: AB_10599602, HPA028231: AB_10601886, HPA028657: AB_10601680"	"unprognostic (4.61e-3)"	"unprognostic (3.45e-2)"	"unprognostic (1.64e-3)"	"unprognostic (9.46e-2)"	"unprognostic (2.77e-1)"	"unprognostic (3.87e-1)"	"unprognostic (3.23e-2)"	"unprognostic (1.30e-2)"	"unprognostic (1.68e-1)"	"unprognostic (6.32e-2)"	"unprognostic (4.12e-1)"	"unprognostic (1.32e-1)"	"unprognostic (2.94e-3)"	"unprognostic (9.01e-3)"	"unprognostic (4.38e-2)"	"unprognostic (3.73e-2)"	"prognostic unfavourable (4.52e-4)"	10.1	3.5	1.1	16.9	1.8	2.3	7.8	0.8	1.3	13.0	39.3	1.0	14.9	2.5	14.6	11.0	32.3	10.7	30.4	52.2	1.1	1.1	1.8	1.2	6.1	10.7	3.0	0.5	8.0	27.3	0.8	1.9	2.9	1.7	34.6	5.1	13.8	59.3	14.7	21.4	4.1	8.3	129.1	2.1	6.5	30.0	4.1	1.3	4.9	4.7	14.7	8.7	90.3	20.3	0.5	2.3	32.7	1.5	2.6	5.3	0.8	13.6	0.1	0.0	0.0	9.8	14.9	0.5	7.0	14.4	6.1	7.7	0.0	5.8	0.0	4.6	18.0	15.4	0.8	0.5	9.8	27.2	1.1	5.7	2.9	0.0	22.8	18.5	6.5	13.6	22.3	17.7	21.5	0.0	1.3	28.9	0.1	0.0	0.6	3.2	3.7	1.4	4.3	3.3	0.2	8.4	0.2	0.7	0.7	0.1	0.0	10.0	3.0	5.9	1.1	12.1	0.0	2.1	14.4	24.3	9.6	2.9	23.7	7.7	11.8	7.1	1.5	4.7	2.5	0.9	2.1	0.5	2.2	2.3	2.3	0.1	0.2	0.9	32.7	2.6	0.3	0.2	5.3	0.8	1.1	1.8	0.8	1.3	1.1	1.1	3.0	0.5	1.7	1.3
FAM163B	C9orf166	ENSG00000196990	"Family with sequence similarity 163 member B"	P0C2L3	9	133578415-133586197	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"brain: 41.7"	"Cell line enriched"	"Detected in some"	21	"SH-SY5Y: 39.0"	"Cancer enriched"	"Detected in some"	6	"glioma: 3.2"					"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA067336	Supported		Approved	"Nuclear bodies,Plasma membrane,Cytosol"				"Nuclear bodies, Plasma membrane, Cytosol"		"HPA067336: "	"unprognostic (2.94e-2)"	"unprognostic (6.87e-3)"	"unprognostic (2.65e-2)"	"unprognostic (2.70e-1)"	"unprognostic (1.23e-2)"	"unprognostic (9.05e-2)"	"unprognostic (1.02e-2)"	"unprognostic (3.48e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.16e-1)"	"unprognostic (3.31e-3)"	"unprognostic (7.61e-2)"	"unprognostic (5.75e-4)"	"unprognostic (1.07e-1)"	"unprognostic (9.54e-2)"	"unprognostic (1.65e-1)"	"unprognostic (4.73e-4)"	0.1	8.2	10.0	0.0	2.7	0.0	0.0	3.2	41.7	0.0	0.4			0.0	0.0	0.3	0.0	0.0	0.4	1.2	6.1	3.9	0.1	2.7	0.0	1.3	3.3		0.0	0.1	0.0	0.0	0.6		0.0	0.4		0.4	0.7	0.0	0.0	0.0	0.0	0.9	0.0	0.1	0.8			0.0		0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.2	0.0	0.5	0.1	0.0	0.0	0.0	1.8	39.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
FAM171A1	"C10orf38, FLJ12884"	ENSG00000148468	"Family with sequence similarity 171 member A1"	Q5VUB5	10	15211643-15371062	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 43.9"	"Cell line enhanced"	"Detected in many"		"TIME: 42.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"gdT-cell: 2.6;MAIT T-cell: 6.8;memory CD4 T-cell: 3.8;memory CD8 T-cell: 3.3;naive CD4 T-cell: 7.4;naive CD8 T-cell: 3.7"	"Lineage enriched"	"Detected in single"	23	"T-cells: 7.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051345	Approved		Approved	"Nucleoplasm,Plasma membrane"			96000	"Plasma membrane"	Nucleoplasm	"HPA051345: "	"unprognostic (3.60e-2)"	"unprognostic (7.15e-2)"	"unprognostic (2.21e-1)"	"unprognostic (5.28e-2)"	"unprognostic (1.57e-1)"	"unprognostic (4.11e-2)"	"unprognostic (9.84e-2)"	"unprognostic (9.19e-2)"	"unprognostic (2.28e-1)"	"unprognostic (3.97e-2)"	"unprognostic (3.09e-2)"	"unprognostic (1.87e-1)"	"prognostic favourable (2.71e-5)"	"unprognostic (3.08e-1)"	"unprognostic (1.86e-1)"	"prognostic unfavourable (4.90e-6)"	"unprognostic (3.28e-2)"	6.9	3.7	22.1	5.5	37.9	0.2	4.6	11.1	31.8	8.8	16.1	25.3	6.5	13.7	9.7	4.8	4.7	11.8	9.3	7.0	24.1	17.5	17.8	6.2	5.3	3.7	25.1	14.3	10.9	13.8	8.9	1.9	2.9	21.5	8.4	12.9	2.5	10.0	9.4	5.1	2.4	8.9	9.0	43.9	8.5	10.3	2.4	21.9	0.6	4.3	1.1	4.6	6.0	6.2	0.0	0.0	0.0	0.0	0.3	7.4	1.3	0.0	6.2	12.9	4.9	5.2	9.9	0.1	7.8	1.5	3.9	3.4	1.1	7.3	0.0	9.4	20.2	0.6	9.1	0.1	4.5	2.5	14.4	18.1	2.0	17.9	5.7	0.0	14.7	7.8	1.9	10.7	1.5	19.7	7.1	0.0	12.5	0.5	3.1	0.0	12.3	3.5	12.2	6.8	1.9	4.9	0.0	8.9	11.4	4.3	0.1	0.0	0.0	0.2	42.0	5.4	22.9	19.6	8.2	2.6	0.7	0.0	12.0	0.0	4.1	0.0	0.0	0.0	2.6	0.0	6.8	0.0	3.8	3.3	0.0	0.0	7.4	3.7	0.0	0.3	0.0	0.0	0.7	1.3	22.1	37.9	11.1	23.1	24.1	17.5	25.1	14.3	21.5	21.9
FAM193A	"C4orf8, RES4-22"	ENSG00000125386	"Family with sequence similarity 193 member A"	P78312	4	2536631-2732565	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043116	Approved		Approved	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		"HPA043116: AB_10795767"	"unprognostic (1.56e-1)"	"unprognostic (1.95e-1)"	"unprognostic (2.54e-1)"	"unprognostic (1.17e-3)"	"unprognostic (1.97e-1)"	"unprognostic (3.66e-3)"	"unprognostic (6.34e-3)"	"unprognostic (1.02e-1)"	"unprognostic (7.16e-2)"	"unprognostic (4.84e-1)"	"prognostic favourable (4.80e-4)"	"unprognostic (1.38e-2)"	"unprognostic (2.15e-1)"	"unprognostic (5.58e-2)"	"unprognostic (3.47e-2)"	"unprognostic (5.55e-2)"	"unprognostic (4.96e-3)"	17.1	14.1	17.8	25.5	17.7	22.4	19.7	33.0	23.2	17.4	14.5	18.2	21.3	15.3	23.5	16.0	12.1	16.4	17.2	11.9	16.7	14.3	12.4	13.7	20.2	17.3	18.0	11.8	23.7	17.4	20.4	21.5	15.3	16.1	16.4	11.9	18.8	16.4	19.3	18.1	16.6	15.8	16.0	13.9	17.0	14.7	29.1	17.2	26.3	15.4	13.7	16.0	14.6	30.7	2.5	3.9	5.7	6.3	3.2	2.9	1.0	7.0	8.8	16.5	9.4	10.0	10.3	9.0	10.8	9.2	10.6	9.0	9.0	11.5	13.9	6.7	11.8	6.1	11.4	7.7	8.7	8.6	7.5	20.7	10.9	9.3	12.2	12.4	14.6	11.3	8.2	10.4	10.7	10.5	14.5	15.3	8.7	7.4	20.3	20.2	13.5	10.0	20.0	8.7	6.8	7.1	9.2	14.5	12.5	9.2	6.4	9.3	11.8	12.8	14.1	16.3	9.7	8.8	14.0	15.5	11.4	13.4	9.2	10.4	11.5	5.7	2.2	1.8	2.2	1.5	1.5	1.5	1.9	2.9	1.4	2.5	1.9	2.7	4.2	3.2	6.3	3.9	1.4	1.0	17.8	17.7	33.0	23.2	16.7	14.3	18.0	11.8	16.1	17.2
FAM210B	"C20orf108, dJ1167H4.1, DKFZP434A1114"	ENSG00000124098	"Family with sequence similarity 210 member B"	Q96KR6	20	56358915-56368663	"Predicted intracellular proteins, Predicted membrane proteins"	"Differentiation, Erythrocyte maturation"		"Tumor suppressor"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"SK-MEL-30: 71.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042652	Approved		Approved	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		"HPA042652: "	"unprognostic (3.29e-1)"	"prognostic favourable (5.44e-4)"	"unprognostic (3.24e-2)"	"unprognostic (1.66e-3)"	"unprognostic (1.26e-1)"	"unprognostic (3.34e-2)"	"unprognostic (9.45e-2)"	"prognostic favourable (4.26e-4)"	"unprognostic (1.77e-1)"	"unprognostic (2.24e-2)"	"unprognostic (7.60e-2)"	"unprognostic (2.90e-1)"	"prognostic favourable (1.44e-10)"	"unprognostic (1.08e-1)"	"unprognostic (3.27e-2)"	"unprognostic (1.84e-1)"	"unprognostic (3.00e-1)"	19.8	47.7	13.2	9.3	22.8	30.5	29.0	13.4	12.3	23.4	18.1	10.9	24.0	10.7	22.3	24.7	24.4	18.5	29.5	48.1	13.0	12.9	15.2	43.2	16.3	11.8	15.2	9.3	50.5	21.8	13.1	15.1	17.6	13.7	30.9	13.8	21.4	29.0	33.5	54.2	17.5	15.0	19.9	11.1	12.2	16.3	11.1	9.7	5.9	19.8	25.7	12.3	22.8	30.9	1.9	2.8	10.3	5.6	2.2	4.0	1.5	4.7	1.8	7.3	17.8	21.3	24.1	14.3	5.8	13.2	10.7	12.4	3.3	2.3	0.4	3.0	10.0	13.8	3.9	16.9	18.0	0.7	6.1	2.9	4.4	31.8	14.0	0.3	1.8	20.6	18.9	6.0	8.6	17.1	22.1	3.1	13.1	4.9	2.4	1.3	6.2	11.6	0.0	15.2	3.8	5.5	5.6	10.2	18.4	14.2	31.0	71.6	13.7	2.7	11.8	9.6	6.4	15.2	3.5	2.5	2.5	0.1	7.6	1.8	6.2	3.3	3.8	10.3	2.9	5.6	2.2	1.9	3.4	4.0	2.8	1.8	3.6	3.4	1.7	2.2	2.4	2.4	3.7	1.5	13.2	22.8	13.4	12.3	13.0	12.9	15.2	9.3	13.7	9.7
FAM222A	"C12orf34, FLJ14721"	ENSG00000139438	"Family with sequence similarity 222 member A"	Q5U5X8	12	109714228-109770507	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 37.9"	"Cell line enriched"	"Detected in many"	4	"SH-SY5Y: 50.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040181, HPA058774"	Uncertain		Approved	"Nucleoplasm,Plasma membrane,Focal adhesion sites,Mitochondria"				"Nucleoplasm, Plasma membrane"	"Focal adhesion sites, Mitochondria"	"HPA040181: AB_10796448, HPA058774: "	"unprognostic (8.59e-3)"	"prognostic favourable (1.82e-5)"	"unprognostic (1.43e-1)"	"unprognostic (1.57e-1)"	"unprognostic (1.92e-1)"	"unprognostic (2.05e-2)"	"unprognostic (1.46e-2)"	"unprognostic (1.03e-1)"	"unprognostic (6.66e-2)"	"unprognostic (8.17e-2)"	"prognostic favourable (4.81e-4)"	"unprognostic (1.15e-1)"	"unprognostic (4.16e-2)"	"prognostic favourable (8.59e-4)"	"unprognostic (3.93e-2)"	"unprognostic (2.77e-1)"	"unprognostic (1.24e-1)"	1.8	16.0	7.3	2.3	17.4	2.0	3.0	15.1	25.5	1.6	3.3	37.9	0.0	10.0	1.5	2.7	2.1	1.4	2.6	4.4	11.7	9.6	7.7	2.7	1.8	1.7	23.2	7.9	7.8	6.9	1.5	13.1	1.3	15.1	2.3	3.0	10.3	7.3	2.1	2.8	4.7	5.1	1.8	27.8	6.3	8.0	17.4	23.0	0.0	1.4	0.0	2.1	1.4	2.4	0.2	0.6	0.9	0.2	0.0	0.2	0.0	0.8	1.3	0.7	1.6	0.4	0.0	0.5	0.2	0.1	0.7	0.1	11.7	0.2	0.1	1.0	0.3	0.5	0.8	0.0	0.2	7.5	1.7	1.4	0.3	2.6	0.1	1.1	1.5	0.0	0.0	0.1	0.0	0.0	0.5	0.2	0.1	4.7	0.3	1.5	1.3	2.3	0.9	3.4	0.5	1.5	0.6	8.3	50.2	1.0	1.6	3.3	1.9	1.2	0.1	0.2	1.4	0.6	1.0	1.3	1.6	1.0	0.1	0.8	1.6	0.0	0.2	0.9	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.6	0.0	0.0	7.3	17.4	15.1	13.7	11.7	9.6	23.2	7.9	15.1	23.0
FAM45A		ENSG00000119979	"Family with sequence similarity 45 member A"	Q8TCE6	10	119104086-119137984	"Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041159			Approved	"Plasma membrane,Centrosome,Cytosol"				"Plasma membrane, Centrosome, Cytosol"		"HPA041159: AB_10793871"	"unprognostic (1.75e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.73e-2)"	"unprognostic (1.90e-1)"	"unprognostic (3.12e-1)"	"unprognostic (1.88e-2)"	"unprognostic (2.13e-1)"	"unprognostic (3.08e-1)"	"unprognostic (3.05e-2)"	"unprognostic (4.46e-2)"	"unprognostic (2.64e-2)"	"unprognostic (6.68e-2)"	"unprognostic (2.92e-1)"	"unprognostic (1.38e-2)"	"unprognostic (2.65e-1)"	"unprognostic (3.20e-2)"	12.2	13.2	16.2	8.5	20.0	17.0	9.5	10.2	17.6	11.6	12.5	10.2	6.5	7.6	9.4	10.7	16.0	9.0	8.5	10.8	13.5	10.4	16.6	18.9	8.6	6.8	10.6	17.6	17.3	8.8	11.6	5.4	10.8	18.4	8.9	11.0	7.7	10.7	8.3	14.0	12.0	9.7	9.8	13.5	8.4	9.7	7.1	11.5	10.1	14.8	10.8	9.9	13.1	14.7	2.3	9.9	30.2	19.2	3.8	10.0	6.0	8.3	9.8	12.5	14.4	21.4	21.4	5.5	11.9	29.8	10.7	10.3	9.5	11.2	5.9	4.5	14.6	12.6	10.6	10.4	9.3	10.0	6.0	1.3	3.4	8.3	24.4	3.5	2.8	22.2	8.9	7.8	11.0	14.4	2.8	6.7	13.4	6.7	4.4	6.0	7.5	4.0	4.8	15.7	4.3	10.3	8.9	2.1	8.3	8.5	8.9	17.4	8.6	12.3	14.6	7.6	3.9	7.8	6.0	7.3	2.7	6.5	12.3	15.3	3.4	23.0	15.1	30.2	4.2	18.3	3.4	2.3	6.3	5.5	9.9	1.9	3.1	4.1	20.1	3.8	19.2	2.5	10.0	6.0	16.2	20.0	10.2	17.6	13.5	10.4	10.6	17.6	18.4	11.5
FAM47E	"FLJ42946, LOC100129583"	ENSG00000189157	"Family with sequence similarity 47 member E"	Q6ZV65	4	76214040-76283780	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"U-266/70: 8.0"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"naive B-cell: 3.1;plasmacytoid DC: 2.3"	"Group enriched"	"Detected in many"	5	"B-cells: 3.1;dendritic cells: 2.3"									HPA053331	Uncertain		Approved	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		"HPA053331: "	"unprognostic (1.59e-1)"	"unprognostic (1.76e-2)"	"unprognostic (3.68e-2)"	"unprognostic (3.90e-4)"	"unprognostic (1.37e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.04e-1)"	"unprognostic (5.63e-2)"	"unprognostic (1.06e-1)"	"unprognostic (2.21e-2)"	"unprognostic (3.73e-2)"	"unprognostic (1.31e-1)"	"unprognostic (2.16e-8)"	"unprognostic (1.01e-1)"	"unprognostic (1.84e-2)"	"unprognostic (3.04e-2)"	"unprognostic (3.01e-2)"	5.5	6.8	12.5	0.8	8.5	1.2	8.9	2.4	14.8	3.7	3.2	9.2	4.4	4.3	2.4	15.5	1.6	23.5	5.1	3.2	10.1	13.7	9.1	11.2	4.8	0.9	10.7	15.5	1.2	9.7	9.9	10.3	10.0	12.1	5.2	3.8	2.7	5.4	4.0	9.5	2.0	4.2	3.0	13.3	1.8	6.0	9.2	6.2	0.0	13.2	1.5	0.9	2.6	1.1	3.1	2.3	0.1	0.4	0.1	0.5	0.1	0.8	3.6	3.3	0.9	2.5	0.4	0.7	0.4	2.3	0.7	0.8	4.2	3.2	0.2	1.0	1.2	1.1	1.5	0.8	1.3	3.4	0.2	0.2	2.0	5.9	1.5	0.8	0.6	1.5	0.9	1.0	0.9	0.5	0.3	2.1	1.1	5.2	0.3	0.4	0.7	1.8	0.5	0.9	0.5	4.5	3.0	5.6	4.1	1.5	1.9	0.6	1.9	0.4	0.9	0.7	0.7	2.1	0.6	8.0	1.9	0.3	2.4	0.3	1.1	0.0	0.4	0.1	0.2	0.0	0.5	0.2	0.2	0.1	0.2	3.1	0.4	0.1	0.1	0.1	0.4	2.3	0.0	0.1	12.5	8.5	2.4	14.8	10.1	13.7	10.7	15.5	12.1	6.2
FAM72A	"LMPIP, MGC57827, RP11-312O7.1, UGENE"	ENSG00000196550	"Family with sequence similarity 72 member A"	Q5TYM5	1	206186179-206204414	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in some"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"											"HPA043271, HPA067321"	Uncertain		Approved	"Vesicles,Plasma membrane,Cytosol"				Vesicles	"Plasma membrane, Cytosol"	"HPA043271: , HPA067321: "	"unprognostic (3.61e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.80e-1)"	"unprognostic (5.20e-5)"	"unprognostic (3.61e-1)"	"unprognostic (1.19e-3)"	"unprognostic (1.01e-5)"	"unprognostic (7.70e-3)"	"unprognostic (1.45e-2)"	"unprognostic (5.58e-3)"	"unprognostic (2.87e-2)"	"unprognostic (1.03e-1)"	"unprognostic (4.44e-16)"	"unprognostic (1.82e-1)"	"unprognostic (1.94e-2)"	"unprognostic (4.83e-2)"	"unprognostic (3.89e-1)"	3.4	2.5	1.9	4.7	1.6	6.3	3.2	8.0	1.3	0.8	1.5			2.4	0.6	0.0	2.5	1.8	2.2	0.9	2.4	1.8	1.0	1.3	2.4	8.9	2.6		0.8	0.7	2.3	0.4	2.8		0.5	1.7		0.7	0.2	0.2	5.0	2.2	1.3	3.1	6.3	0.8	6.3			0.5		6.2	1.1	1.2	2.1	5.6	1.2	9.2	0.6	3.6	2.4	9.7	8.0	8.4	3.6	1.2	1.5	10.1	7.0	3.0	8.1	6.1	4.7	14.6	25.1	6.0	1.8	11.7	9.7	3.8	9.7	13.8	8.0	11.3	7.3	6.3	0.8	19.5	12.8	2.1	0.7	7.2	12.8	5.0	22.5	17.3	5.0	5.7	12.1	17.5	15.2	10.7	13.4	14.6	18.9	4.5	1.5	8.4	4.9	5.0	4.6	4.1	9.7	10.6	2.6	6.5	7.5	8.4	11.5	14.0	20.5	22.5	5.3	16.0	8.9	0.0	7.5	0.0	0.9	9.2	0.2	2.1	1.8	1.8	5.6	0.8	0.2	0.4	1.2	0.6	5.4	2.3	3.6	2.4										
FAM72B	RP11-439A17.6	ENSG00000188610	"Family with sequence similarity 72 member B"	Q86X60	1	121167646-121185539	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"bone marrow: 6.5;lymphoid tissue: 9.3"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"							"Cell type enhanced"	"Detected in some"		"myeloid DC: 3.3"	"Low lineage specificity"	"Detected in many"											"HPA043271, HPA067321"	Uncertain		Approved	"Vesicles,Plasma membrane,Cytosol"				Vesicles	"Plasma membrane, Cytosol"	"HPA043271: , HPA067321: "	"unprognostic (8.53e-2)"	"unprognostic (1.97e-2)"	"unprognostic (1.63e-3)"	"unprognostic (1.25e-3)"	"unprognostic (4.36e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.26e-4)"	"unprognostic (8.22e-5)"	"unprognostic (1.30e-2)"	"unprognostic (1.79e-2)"	"unprognostic (1.36e-4)"	"unprognostic (2.46e-2)"	"unprognostic (0.00e+0)"	"unprognostic (2.39e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.17e-2)"	"unprognostic (5.30e-2)"	1.0	0.8	1.3	4.1	1.0	6.5	0.6	5.1	1.0	0.5	1.0			1.3	0.4	0.2	3.0	0.5	1.0	0.2	1.6	0.9	0.3	0.4	0.8	9.3	1.4		0.4	0.1	1.5	0.1	1.4		0.2	1.3		0.5	0.0	0.0	2.1	1.3	0.7	1.4	3.2	0.9	3.6			0.2		7.9	0.9	0.9	0.8	3.3	0.1	2.4	0.8	1.4	1.1	11.9	4.4	7.4	3.6	0.7	1.1	5.8	6.4	2.7	7.5	6.3	0.1	6.3	26.6	8.9	1.2	7.5	10.1	3.6	11.6	17.6	7.5	11.5	4.9	5.3	0.4	19.9	10.3	0.6	0.4	5.9	12.0	4.5	15.0	16.4	5.4	5.0	10.0	16.4	13.9	9.1	15.0	15.8	12.1	2.9	1.4	8.0	4.6	4.8	3.7	3.7	5.0	15.6	1.5	6.2	10.5	12.0	11.2	14.6	18.1	26.3	5.5	21.7	14.3	0.0	2.4	0.0	0.0	0.9	0.0	0.8	0.4	0.5	3.3	0.3	0.0	0.1	0.1	0.8	1.1	0.4	1.4	1.1										
FAM72C	RP5-998N21.9	ENSG00000263513	"Family with sequence similarity 72 member C"	H0Y354	1	143955364-143971965	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Tissue enhanced"	"Detected in some"		"bone marrow: 3.6;lymphoid tissue: 6.4"	"Cell line enhanced"	"Detected in many"		"U-266/84: 29.0"	"Low cancer specificity"	"Detected in single"							"Cell type enhanced"	"Detected in some"		"T-reg: 2.2"	"Low lineage specificity"	"Detected in many"											"HPA043271, HPA067321"	Uncertain		Approved	"Vesicles,Plasma membrane,Cytosol"				Vesicles	"Plasma membrane, Cytosol"	"HPA043271: , HPA067321: "	"unprognostic (2.18e-1)"	"unprognostic (1.50e-1)"	"unprognostic (6.45e-3)"	"unprognostic (2.69e-2)"	"unprognostic (2.21e-1)"	"unprognostic (3.98e-3)"	"unprognostic (9.46e-5)"	"unprognostic (1.23e-3)"	"unprognostic (4.36e-1)"	"unprognostic (7.26e-2)"	"unprognostic (1.04e-2)"	"unprognostic (1.95e-1)"	"unprognostic (0.00e+0)"	"unprognostic (2.95e-1)"	"unprognostic (4.70e-2)"	"unprognostic (5.82e-2)"	"unprognostic (1.47e-2)"	0.1	0.0		1.6		3.6	0.0		0.0	0.0	0.2			0.5	0.0	0.0	0.5	0.0	0.0	0.0			0.0	0.0	0.0	6.1			0.0	0.0	0.0		0.3		0.0	0.6		0.0	0.0	0.0	1.5	0.0	0.1		0.5	0.1	1.9			0.0		6.4	0.4		1.1	0.4	0.0	1.0	1.7	2.2	0.6	8.5	5.0	6.1	2.7	0.3	0.8	5.8	4.3	1.4	5.7	4.4	0.7	10.3	20.4	5.6	0.5	8.3	8.1	2.6	6.3	7.0	4.8	8.8	4.4	1.5	0.3	17.9	8.0	0.1	0.0	4.5	11.8	2.5	15.4	9.6	0.3	0.6	10.6	13.9	4.8	3.2	13.5	4.3	14.5	1.0	1.1	3.0	5.5	4.1	2.4	2.3	5.9	15.4	1.7	4.6	7.6	6.0	9.3	20.1	29.0	12.1	2.4	11.2	2.9	0.0	1.0	0.0	0.1	0.3	0.0	1.1	0.4	0.5	0.4	0.0	0.1	0.0	0.0	1.7	0.6	0.1	2.2	0.6										
FAM72D		ENSG00000215784	"Family with sequence similarity 72 member D"	Q6L9T8	1	145096000-145112696	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 17.7"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in some"			"Cell type enhanced"	"Detected in some"		"intermediate monocyte: 1.7"	"Low lineage specificity"	"Detected in many"											"HPA043271, HPA067321"	Uncertain		Approved	"Vesicles,Plasma membrane,Cytosol"				Vesicles	"Plasma membrane, Cytosol"	"HPA043271: , HPA067321: "	"unprognostic (2.70e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.73e-1)"	"unprognostic (4.03e-3)"	"unprognostic (1.26e-1)"	"unprognostic (7.10e-3)"	"unprognostic (5.88e-5)"	"unprognostic (7.65e-4)"	"unprognostic (6.72e-2)"	"unprognostic (2.36e-2)"	"unprognostic (1.22e-2)"	"unprognostic (1.46e-1)"	"unprognostic (0.00e+0)"	"unprognostic (6.63e-2)"	"unprognostic (1.72e-1)"	"unprognostic (9.74e-2)"	"unprognostic (6.50e-2)"	1.1	0.7	0.8	7.2	0.8	5.5	0.7	4.0	0.9	0.6	1.1	0.6	0.4	1.4	0.8	0.4	4.4	0.2	0.5	0.4	1.0	0.7	0.5	0.4	1.3	7.6	1.0	0.4	0.4	0.4	0.3	0.4	1.5	0.8	0.4	1.6	0.4	0.6	0.4	0.4	2.9	2.0	0.5	1.1	3.3	0.8	6.7	0.4	17.7	0.4	2.7	7.4	1.1	2.5	0.1	0.7	0.1	1.7	0.0	1.0	0.5	8.3	5.1	6.0	2.4	0.2	0.5	6.6	4.8	1.4	6.1	3.8	3.4	7.6	13.7	4.9	0.7	8.9	7.3	1.4	7.2	11.0	7.3	6.8	2.5	5.0	0.1	12.2	7.7	0.3	0.5	4.8	9.3	2.7	13.6	19.2	4.0	6.3	8.2	11.9	11.4	7.1	7.3	7.6	16.2	2.1	1.1	5.9	5.0	3.6	3.3	2.2	9.3	7.9	1.2	4.5	5.0	3.8	8.6	14.5	22.8	21.3	0.0	9.7	5.1	0.0	1.2	0.0	0.0	1.7	0.0	0.1	0.2	0.0	0.7	0.0	0.0	0.0	0.1	0.0	0.6	0.0	1.0	0.5	0.8	0.8	4.0	0.9	1.0	0.7	1.0	0.4	0.8	0.4
FANCG	"FAG, XRCC9"	ENSG00000221829	"Fanconi anemia complementation group G"	O15287	9	35073835-35080016	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"DNA damage, DNA repair"		"Cancer-related genes, Disease mutation, Fanconi anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB008105, HPA045335"	Approved		Supported	"Nucleoli,Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"	Nucleoli	"CAB008105: AB_2231542, HPA045335: "	"unprognostic (9.41e-2)"	"unprognostic (2.62e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.09e-1)"	"unprognostic (5.83e-3)"	"prognostic unfavourable (2.02e-4)"	"unprognostic (8.92e-2)"	"unprognostic (1.42e-2)"	"unprognostic (2.27e-3)"	"unprognostic (9.01e-2)"	"unprognostic (5.62e-2)"	"prognostic unfavourable (2.38e-7)"	"unprognostic (1.14e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.24e-1)"	"unprognostic (2.10e-1)"	5.8	5.0	4.4	7.1	6.5	14.9	7.5	13.9	8.5	6.2	5.9	5.3	8.4	6.7	6.8	3.2	9.2	8.6	4.7	5.9	7.6	4.0	5.2	4.5	5.1	9.9	8.7	4.4	9.2	17.0	6.7	4.8	7.6	6.6	7.0	5.5	3.5	8.7	9.7	2.9	8.9	6.5	6.4	4.2	8.6	5.8	8.9	7.6	25.6	9.3	4.8	9.2	6.8	6.9	6.8	4.8	8.9	2.5	8.8	9.2	3.4	15.7	19.5	14.3	13.2	3.2	5.1	12.0	11.1	8.0	21.8	20.9	9.3	9.9	15.6	7.7	3.5	9.7	11.9	10.2	8.3	18.2	7.2	11.1	20.9	5.7	0.9	11.3	12.9	4.2	2.0	19.0	8.6	11.1	7.3	21.0	10.9	14.0	19.1	15.5	14.9	15.1	19.8	16.9	11.0	5.1	6.7	6.9	12.6	7.3	10.4	4.1	13.5	8.1	6.7	10.3	20.7	13.2	14.9	5.7	10.8	9.4	9.2	8.4	14.1	8.9	0.8	7.7	7.4	2.5	6.5	6.8	6.1	5.7	2.2	6.5	4.8	5.0	1.3	8.8	2.3	4.8	9.2	3.4	4.4	6.5	13.9	8.5	7.6	4.0	8.7	4.4	6.6	7.6
FBLN7	"FLJ37440, TM14"	ENSG00000144152	"Fibulin 7"	Q53RD9	2	112138385-112188216	"Predicted intracellular proteins, Predicted secreted proteins"	"Cell adhesion"	Heparin-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"AF22: 17.4;BJ hTERT+: 12.4;SCLC-21H: 11.2;SH-SY5Y: 9.0;U-2197: 18.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	25	"memory CD4 T-cell: 18.5;naive CD4 T-cell: 16.2;T-reg: 17.4"	"Lineage enriched"	"Detected in single"	36	"T-cells: 18.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA034992			Approved	"Plasma membrane,Cell Junctions"	"Secreted to extracellular matrix"		27000	"Plasma membrane"	"Cell Junctions"	"HPA034992: AB_10601469"	"unprognostic (1.72e-1)"	"unprognostic (1.47e-1)"	"unprognostic (5.88e-2)"	"unprognostic (4.88e-3)"	"unprognostic (1.24e-1)"	"unprognostic (1.70e-3)"	"unprognostic (4.34e-2)"	"unprognostic (4.80e-2)"	"unprognostic (5.77e-2)"	"unprognostic (2.01e-1)"	"unprognostic (7.91e-2)"	"unprognostic (2.02e-2)"	"unprognostic (2.35e-2)"	"unprognostic (3.11e-2)"	"unprognostic (8.10e-2)"	"unprognostic (1.21e-2)"	"unprognostic (9.33e-2)"	7.5	5.8	2.9	9.0	3.4	1.1	10.4	10.3	16.4	12.4	2.3	1.6	4.1	1.7	6.5	8.2	2.9	10.5	7.1	3.3	4.0	3.8	2.5	6.6	3.7	11.8	6.9	4.2	2.8	3.4	16.7	27.4	13.6	10.5	4.7	2.0	14.7	3.9	9.0	1.9	7.1	3.8	3.2	2.2	7.3	4.1	2.0	1.1	8.7	14.9	5.5	9.5	3.6	10.4	0.0	0.5	0.0	0.0	0.0	18.5	3.5	0.0	0.1	17.4	0.0	1.9	1.4	0.0	3.8	12.4	4.2	6.6	0.0	0.1	0.0	0.1	5.7	0.0	0.0	0.0	1.9	0.0	0.0	0.0	1.3	0.8	0.9	0.0	0.0	1.3	0.1	7.0	0.0	1.0	0.0	0.0	1.4	0.0	0.4	0.0	0.4	0.3	0.0	0.0	4.4	0.2	0.0	11.2	9.0	0.0	0.0	0.5	0.4	0.1	3.6	0.6	0.5	18.0	0.5	0.0	0.0	0.0	0.5	0.0	1.5	0.0	0.0	0.0	0.2	0.0	0.7	0.0	18.5	0.2	0.0	0.0	16.2	0.5	0.0	0.0	0.0	0.5	17.4	3.5	2.9	3.4	10.3	16.4	4.0	3.8	6.9	4.2	10.5	1.1
FBP2		ENSG00000130957	"Fructose-bisphosphatase 2"	O00757	9	94558720-94593793	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Carbohydrate metabolism, Gluconeogenesis"	"Allosteric enzyme, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	8	"brain: 33.7;skeletal muscle: 134.7;tongue: 45.6"	"Cell line enhanced"	"Detected in some"		"BEWO: 7.2;CACO-2: 3.7;HMC-1: 4.0;MCF7: 5.3;PC-3: 3.7;SiHa: 5.0"	"Low cancer specificity"	"Detected in some"			"Region enriched"	"Detected in single"	36	"pons and medulla: 33.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"HPA012513, HPA055286, HPA077371"	Enhanced		Approved	"Nucleoplasm,Plasma membrane"				"Nucleoplasm, Plasma membrane"		"HPA012513: AB_1848446, HPA055286: , HPA077371: "	"unprognostic (3.88e-2)"	"unprognostic (3.54e-4)"	"unprognostic (2.38e-1)"	"unprognostic (6.03e-2)"		"unprognostic (2.21e-1)"	"unprognostic (1.54e-2)"	"unprognostic (9.40e-4)"	"unprognostic (3.95e-3)"	"unprognostic (5.11e-2)"	"unprognostic (2.39e-2)"	"unprognostic (4.69e-2)"	"unprognostic (2.53e-1)"	"unprognostic (1.36e-2)"	"unprognostic (2.03e-1)"		"unprognostic (1.48e-4)"	2.0	0.4	0.1	0.0	0.1	0.0	0.2	0.1	0.9	0.1	0.1	3.8	4.4	1.0	0.1	1.0	1.6	0.1	0.0	0.1	0.7	0.1	0.1	0.1	0.2	0.1	0.1	0.0	0.1	1.2	4.1	0.1	0.0	33.7	0.2	0.0	5.0	1.4	1.8	134.7	0.1	0.1	0.1	0.2	0.1	9.0	0.4	0.0	0.0	0.2	45.6	2.7	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	2.3	0.0	2.5	0.0	0.0	7.2	0.0	0.0	0.1	0.0	3.7	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	1.5	0.2	0.0	1.9	2.0	0.0	0.0	4.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	5.3	0.0	0.0	0.0	3.7	0.0	0.0	0.1	0.0	2.4	0.6	0.1	5.0	1.2	0.0	0.4	0.1	0.0	0.0	2.3	2.2	0.0	0.0	0.1	1.0	0.2	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.9	0.7	0.1	0.1	0.0	33.7	0.0
FBRSL1	KIAA1545	ENSG00000112787	"Fibrosin like 1"	Q9HCM7	12	132489551-132585188	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"NB-4: 34.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							HPA049880	Enhanced		Approved	"Nucleoplasm,Plasma membrane,Cytosol"				"Nucleoplasm, Cytosol"	"Plasma membrane"	"HPA049880: "	"unprognostic (2.02e-1)"	"unprognostic (6.67e-2)"	"unprognostic (1.88e-2)"	"unprognostic (7.75e-2)"	"unprognostic (3.21e-1)"	"unprognostic (2.59e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.83e-1)"	"unprognostic (2.25e-1)"	"unprognostic (1.57e-1)"	"unprognostic (2.77e-3)"	"prognostic unfavourable (9.82e-4)"	"prognostic favourable (1.17e-4)"	"unprognostic (1.13e-1)"	"unprognostic (3.39e-1)"	"unprognostic (1.09e-2)"	"prognostic favourable (7.21e-4)"	7.6	4.7	4.3	4.9	6.6	5.2	3.2	13.0	9.9	3.4	4.9	2.9	2.9	7.0	4.8	4.6	4.5	4.7	9.6	4.4	4.8	3.1	4.3	5.2	4.2	4.5	9.8	5.5	5.1	12.7	3.9	7.9	4.5	4.5	5.4	1.8	5.0	9.7	4.4	17.9	4.7	7.3	2.9	2.9	10.9	6.1	6.1	4.5	8.0	4.0	2.9	8.6	4.5	3.2	2.8	3.6	4.1	2.0	0.7	1.9	0.9	4.5	7.3	3.4	5.9	1.4	1.7	25.7	4.3	1.1	2.8	1.7	13.4	2.6	6.9	7.6	1.3	8.6	3.6	2.2	0.9	6.0	18.2	8.8	4.2	10.1	2.9	9.2	9.7	1.6	4.1	2.8	1.8	2.6	19.2	1.5	1.1	11.7	12.0	34.2	9.2	13.0	19.0	3.8	4.8	2.2	4.3	13.7	10.6	4.1	6.5	5.2	7.1	9.6	4.2	3.1	7.8	5.8	5.4	9.3	4.8	4.5	3.4	9.3	3.9	2.3	1.5	4.1	1.2	1.3	1.3	2.8	1.2	1.2	1.2	2.6	1.1	1.6	1.7	0.7	2.0	3.6	1.9	0.9	4.3	6.6	13.0	9.9	4.8	3.1	9.8	5.5	4.5	4.5
FBXO16	FBX16	ENSG00000214050	"F-box protein 16"	Q8IX29	8	28348287-28490318	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"epididymis: 22.9;pituitary gland: 42.3"	"Cell line enhanced"	"Detected in many"		"AF22: 15.4;Karpas-707: 17.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	8	"plasmacytoid DC: 11.5"	"Lineage enriched"	"Detected in many"	8	"dendritic cells: 11.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA058676, HPA076472"	Approved		Approved	"Nucleoplasm,Vesicles,Plasma membrane,Cytosol"				"Nucleoplasm, Vesicles, Plasma membrane, Cytosol"		"HPA058676: , HPA076472: "	"unprognostic (3.44e-1)"	"unprognostic (1.44e-1)"	"unprognostic (3.37e-3)"	"unprognostic (5.56e-3)"	"unprognostic (1.87e-1)"	"unprognostic (1.40e-2)"	"unprognostic (2.55e-3)"	"unprognostic (4.95e-3)"	"unprognostic (6.49e-2)"	"prognostic favourable (6.70e-5)"	"unprognostic (3.41e-3)"	"unprognostic (4.90e-2)"	"unprognostic (7.15e-2)"	"unprognostic (1.71e-2)"	"unprognostic (4.85e-2)"	"unprognostic (2.72e-2)"	"unprognostic (2.07e-1)"	0.9	2.3	7.3	1.3	17.6	2.6	3.4	15.8	9.9	5.4	2.0	1.1	7.6	2.6	1.8	22.9	1.1	5.7	2.1	2.0	4.2	6.8	4.0	7.2	1.9	1.5	4.4	7.5	1.2	6.3	7.2	42.3	1.0	6.3	4.3	2.6	4.6	5.9	7.3	1.1	0.8	3.8	1.2	2.1	1.7	2.7	4.8	1.4	0.0	8.7	0.2	3.3	1.9	1.1	0.6	11.5	1.4	0.3	0.1	0.5	0.2	12.0	2.5	15.4	6.0	0.4	0.0	0.4	0.1	0.6	2.4	4.5	2.4	3.6	4.6	5.6	0.1	4.1	1.7	2.5	2.3	1.8	2.9	2.2	0.2	1.3	0.3	2.6	1.6	0.2	8.3	0.6	2.5	0.0	0.8	17.8	1.0	4.1	0.3	3.6	3.3	3.5	0.1	3.6	7.1	3.2	2.1	10.0	4.2	0.3	2.5	6.7	10.7	4.5	0.5	1.3	4.7	2.7	2.2	3.9	3.4	3.9	5.2	0.6	2.7	0.5	0.3	0.1	0.2	0.2	0.5	0.4	0.4	0.3	0.9	0.6	0.2	0.3	1.4	0.1	0.2	11.5	0.3	0.2	7.3	17.6	15.8	9.9	4.2	6.8	4.4	7.5	6.3	1.4
FBXO41	"Fbx41, KIAA1940"	ENSG00000163013	"F-box protein 41"	Q8TF61	2	73254682-73284431	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 33.3"	"Cell line enhanced"	"Detected in many"		"Daudi: 26.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"intermediate monocyte: 2.6"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA055246, HPA058386"			Approved	"Nucleoplasm,Plasma membrane,Cytosol"				"Nucleoplasm, Cytosol"	"Plasma membrane"	"HPA055246: , HPA058386: "	"unprognostic (1.15e-3)"	"unprognostic (9.36e-2)"	"unprognostic (2.17e-2)"	"prognostic unfavourable (5.76e-4)"	"unprognostic (1.74e-2)"	"unprognostic (5.85e-2)"	"unprognostic (1.55e-3)"	"unprognostic (1.58e-1)"	"unprognostic (7.97e-3)"	"unprognostic (7.55e-2)"	"unprognostic (9.13e-3)"	"unprognostic (4.35e-2)"	"prognostic unfavourable (1.08e-5)"	"unprognostic (3.08e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.97e-1)"	"unprognostic (1.11e-2)"	1.5	3.6	21.9	5.9	19.3	4.2	2.1	21.7	33.3	1.2	2.1	1.7	0.9	2.2	1.9	3.6	1.6	2.0	2.7	1.1	18.8	10.6	0.8	1.1	2.2	9.4	5.9	17.8	2.5	4.1	9.8	7.3	1.1	6.8	3.0	2.4	0.8	3.7	3.3	0.6	3.4	2.7	2.1	2.1	7.5	2.5	2.4	3.5	2.1	1.5	0.0	9.0	2.8	0.8	0.5	0.9	0.0	2.6	1.1	0.7	0.4	3.5	1.7	0.6	0.0	0.1	0.1	0.8	0.7	0.6	1.2	1.5	4.0	2.1	26.5	0.1	0.1	2.9	3.7	2.3	1.2	11.0	0.3	8.1	4.0	1.6	0.9	12.2	6.2	1.5	0.9	0.0	0.9	0.2	1.6	4.4	1.2	0.9	4.2	11.4	2.7	1.6	14.9	6.8	12.9	0.7	1.2	9.2	3.4	4.5	1.9	2.8	2.6	5.1	0.2	4.1	3.6	3.7	0.7	5.2	2.2	12.6	1.0	13.4	1.7	0.0	0.5	0.0	0.6	2.6	0.7	0.5	0.4	0.0	0.9	0.2	0.4	0.4	0.0	1.1	0.1	0.7	0.2	0.4	21.9	19.3	21.7	33.3	18.8	10.6	5.9	17.8	6.8	3.5
FCGBP	FC(GAMMA)BP	ENSG00000275395	"Fc fragment of IgG binding protein"		19	39863323-39934626	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"				"Group enriched"	"Detected in many"	5	"cervix, uterine: 13.9;gallbladder: 46.6;intestine: 43.3;stomach 1: 17.0;thyroid gland: 20.9"	"Cell line enhanced"	"Detected in some"		"A549: 9.7;Daudi: 3.0;RH-30: 10.9;RPMI-8226: 3.8;U-266/70: 3.6"	"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			"HPA003517, HPA003564"	Enhanced		Approved	"Golgi apparatus,Plasma membrane,Cytokinetic bridge"				"Plasma membrane"	"Golgi apparatus, Cytokinetic bridge"	"HPA003517: AB_1078838, HPA003564: AB_2231648"	"unprognostic (1.65e-2)"	"unprognostic (1.92e-2)"	"unprognostic (1.62e-3)"	"unprognostic (1.77e-2)"	"unprognostic (2.04e-2)"	"prognostic favourable (1.28e-5)"	"prognostic unfavourable (4.74e-5)"	"unprognostic (1.36e-2)"	"unprognostic (1.83e-1)"	"prognostic unfavourable (9.70e-6)"	"unprognostic (9.44e-2)"	"unprognostic (3.03e-2)"	"unprognostic (5.92e-3)"	"unprognostic (8.60e-2)"	"unprognostic (1.82e-1)"	"prognostic unfavourable (4.27e-4)"	"unprognostic (2.08e-1)"	1.7	0.6	1.7	5.9	1.8	0.0	2.7	0.2	1.6	13.9	43.3	0.8	0.7	15.2	0.2	0.4	0.2	0.0	46.6	0.7	0.6		0.6	0.2	0.6	0.2	0.9	0.6	0.6	0.2	0.0	1.2	1.5	1.1	0.4	16.7	0.3	1.3	1.2	0.2	2.8	16.9	0.2	2.1	0.2	17.0	0.4	0.9	0.5	20.9	0.2	0.5	0.2	0.2	0.6	2.3	0.0	0.9	1.3	3.2	0.6	0.0	9.7	0.0	0.2	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	3.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.8	0.3	0.1	0.3	1.0	0.2	0.0	0.0	0.0	0.1	0.4	0.0	0.4	2.8	1.2	0.3	0.7	0.2	10.9	3.8	0.2	1.3	0.2	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.1	0.0	3.6	0.4	0.2	0.0	0.0	0.0	0.0	0.2	0.0	1.6	0.9	0.3	0.0	0.7	1.4	2.3	0.6	0.9	3.2	0.0	1.3	0.5	0.0	0.2	0.6										
FCHSD2	"KIAA0769, SH3MD3"	ENSG00000137478	"FCH and double SH3 domains 2"	O94868	11	72836745-73142261	"Predicted intracellular proteins"	"Endocytosis, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"RPMI-8226: 53.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038545, HPA038546"	Uncertain		Approved	"Nuclear speckles,Plasma membrane,Actin filaments,Focal adhesion sites"				"Nuclear speckles, Plasma membrane, Actin filaments"	"Focal adhesion sites"	"HPA038545: , HPA038546: AB_10673013"	"unprognostic (1.80e-2)"	"unprognostic (1.50e-2)"	"prognostic favourable (1.71e-4)"	"unprognostic (1.63e-1)"	"unprognostic (3.14e-2)"	"unprognostic (2.62e-3)"	"unprognostic (1.41e-2)"	"unprognostic (2.62e-1)"	"unprognostic (1.27e-2)"	"unprognostic (2.56e-1)"	"unprognostic (3.69e-2)"	"unprognostic (6.16e-2)"	"unprognostic (2.89e-3)"	"unprognostic (2.02e-1)"	"unprognostic (4.70e-1)"	"unprognostic (2.92e-1)"	"unprognostic (1.23e-1)"	18.5	15.1	28.4	41.5	27.8	19.0	26.5	16.9	25.2	13.2	11.4	17.0	6.8	7.0	12.7	10.2	9.7	11.5	18.1	19.2	24.8	21.4	10.6	13.3	26.2	31.7	19.7	12.1	26.3	9.2	10.2	7.6	24.1	17.6	11.2	11.2	12.5	11.1	11.7	7.4	7.0	14.4	16.4	15.6	30.8	10.1	17.4	26.3	19.2	11.9	4.8	33.0	17.9	11.3	16.8	19.0	11.6	4.8	1.1	2.4	2.0	5.1	4.4	9.1	11.9	3.7	9.3	8.5	9.1	19.5	5.6	4.7	3.4	7.5	27.9	11.2	11.7	7.4	5.3	5.3	7.5	9.6	2.7	22.5	5.0	11.2	9.6	11.0	2.9	5.6	5.8	5.5	6.7	13.4	4.9	18.2	7.2	5.5	13.3	18.9	2.0	5.4	20.3	14.2	53.2	8.8	6.9	4.6	6.5	3.3	6.2	11.9	4.5	8.1	17.2	18.0	6.9	12.5	2.8	17.5	9.7	24.8	3.1	18.3	5.2	11.0	4.8	10.5	1.7	3.1	1.2	13.0	1.8	2.0	4.8	16.8	2.1	2.4	11.6	1.1	1.6	19.0	1.8	2.0	28.4	27.8	16.9	20.2	24.8	21.4	19.7	12.1	17.6	26.3
FGD1	"FGDY, ZFYVE3"	ENSG00000102302	"FYVE, RhoGEF and PH domain containing 1"	P98174	X	54445454-54496166	"Disease related genes, Plasma proteins, Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000911	Uncertain		Approved	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		"HPA000911: AB_1078853"	"unprognostic (2.49e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.64e-2)"	"prognostic unfavourable (2.10e-4)"	"unprognostic (1.17e-1)"	"unprognostic (1.02e-1)"	"unprognostic (3.36e-2)"	"unprognostic (8.74e-2)"	"unprognostic (1.57e-2)"	"unprognostic (2.94e-2)"	"unprognostic (2.77e-3)"	"unprognostic (1.49e-1)"	"unprognostic (3.40e-3)"	"unprognostic (1.70e-2)"	"unprognostic (4.92e-2)"	"unprognostic (3.41e-2)"	"unprognostic (9.40e-3)"	5.9	7.7	15.6	5.9	10.9	1.6	7.1	16.3	15.6	12.3	7.2	3.7	3.4	4.5	12.4	4.4	9.3	7.6	7.8	9.2	9.6	7.1	5.1	1.9	4.6	4.0	4.8	11.2	13.7	6.9	6.9	5.4	9.4	5.7	6.5	3.8	6.8	7.7	7.9	3.3	11.8	5.5	11.9	3.7	5.8	5.2	4.6	4.8	0.0	5.6	7.3	4.3	7.6	7.8	1.6	0.6	0.5	2.6	1.2	3.2	1.1	13.8	5.9	11.4	14.9	5.3	9.5	5.5	8.3	8.4	7.0	5.7	1.8	1.2	0.8	6.8	12.8	5.4	9.6	5.9	3.9	1.4	8.4	0.5	4.5	2.1	5.7	0.7	0.5	7.7	3.7	10.7	5.1	6.3	2.2	0.5	5.5	2.9	1.6	1.5	11.2	9.3	8.0	6.5	0.5	6.0	0.8	10.6	10.0	9.1	0.8	13.7	10.0	1.2	6.1	8.8	7.8	19.3	7.6	1.0	2.0	1.5	9.7	1.6	4.8	0.0	0.6	0.5	2.0	1.3	2.0	1.5	1.6	2.2	0.6	1.6	3.2	1.8	0.0	1.2	2.6	0.2	1.4	1.1	15.6	10.9	16.3	15.6	9.6	7.1	4.8	11.2	5.7	4.8
FGR	"c-fgr, p55c-fgr, SRC2"	ENSG00000000938	"FGR proto-oncogene, Src family tyrosine kinase"	P09769	1	27612064-27635277	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Immunity, Innate immunity"	"Kinase, Transferase, Tyrosine-protein kinase"	Proto-oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"adipose tissue: 20.8;blood: 68.0;bone marrow: 73.6;lung: 30.9;lymphoid tissue: 54.3"	"Group enriched"	"Detected in some"	4	"Daudi: 29.4;U-266/70: 54.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA002024	Enhanced		Approved	"Plasma membrane,Aggresome"				"Plasma membrane"	Aggresome	"HPA002024: AB_1078503"	"unprognostic (2.66e-2)"	"unprognostic (1.51e-2)"	"unprognostic (6.32e-2)"	"unprognostic (9.74e-3)"	"unprognostic (6.66e-3)"	"unprognostic (6.71e-2)"	"unprognostic (5.77e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.81e-2)"	"unprognostic (7.45e-2)"	"unprognostic (2.79e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.94e-2)"	"unprognostic (6.26e-2)"	"unprognostic (3.93e-2)"	"unprognostic (2.30e-1)"	"unprognostic (8.12e-3)"	20.8	2.6	2.2	23.6	4.5	73.6	5.6	1.1	4.2	2.9	2.8	1.5	4.2	1.6	4.0	2.3	2.2	6.3	5.3	8.5	2.6	2.3	3.0	4.2	30.9	34.1	6.6	1.7	1.9	2.4	0.4	1.2	3.3	4.2	2.5	1.8	2.1	2.9	2.6	4.4	1.7	3.7	6.4	4.8	54.3	2.5	2.6	4.1	1.9	2.9	2.5	7.8	5.1	6.1	13.3	28.9	40.8	68.0	36.3	29.6	55.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	29.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.5	10.4	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.2	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.0	0.0	54.6	0.7	2.2	0.0	6.7	0.0	3.1	52.4	32.3	29.6	68.0	1.7	7.7	2.6	13.6	28.9	13.3	1.3	12.8	40.8	36.3	55.6	1.3	0.1	55.0	2.2	4.5	1.1	4.2	2.6	2.3	6.6	1.7	4.2	4.1
FHIT	"AP3Aase, FRA3B"	ENSG00000189283	"Fragile histidine triad"	P49789	3	59749310-61251459	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Apoptosis, Transcription, Transcription regulation"	Hydrolase	"Cancer-related genes, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"RPMI-8226: 11.9;U-266/70: 24.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	5	"naive CD4 T-cell: 38.3"	"Lineage enriched"	"Detected in all"	14	"T-cells: 38.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002684, HPA018840, HPA018909"	Enhanced		Approved	"Nucleoli fibrillar center,Plasma membrane"				"Nucleoli fibrillar center, Plasma membrane"		"CAB002684: , HPA018840: AB_1848538, HPA018909: AB_1848537"	"unprognostic (2.36e-3)"	"unprognostic (6.38e-2)"	"unprognostic (1.59e-1)"	"unprognostic (4.42e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.08e-2)"	"unprognostic (1.18e-1)"	"unprognostic (3.16e-2)"	"unprognostic (2.77e-2)"	"unprognostic (8.49e-2)"	"unprognostic (2.36e-1)"	"unprognostic (6.77e-2)"	"prognostic favourable (1.36e-4)"	"unprognostic (1.54e-1)"	"unprognostic (5.96e-2)"	"unprognostic (1.29e-2)"	"unprognostic (1.80e-2)"	6.4	24.0	13.7	8.0	17.5	9.0	12.1	4.7	13.3	7.9	8.0	21.0	12.4	8.2	6.2	9.5	5.1	9.2	13.0	14.9	15.3	13.8	30.9	10.7	5.2	9.3	19.5	9.3	8.9	11.8	16.3	15.2	4.1	14.4	5.8	7.8	14.0	11.4	9.9	11.6	7.0	7.6	9.1	17.1	6.0	8.1	10.5	18.2	3.7	15.6	5.7	6.9	7.3	6.1	1.6	2.4	1.8	1.8	2.6	38.3	4.7	0.0	0.0	1.0	0.0	0.6	0.0	1.6	0.1	0.1	0.0	0.0	1.8	3.0	2.6	0.5	0.1	0.0	10.0	2.1	0.0	1.4	3.4	2.2	1.3	4.1	2.6	5.6	0.1	6.8	4.1	0.1	5.1	0.0	1.6	8.3	0.1	2.5	10.1	4.5	0.8	0.6	7.5	0.0	11.9	11.2	1.3	2.1	2.8	1.0	6.9	6.5	0.4	0.1	0.0	1.2	0.4	0.1	1.5	24.4	7.4	0.0	2.7	0.0	1.4	1.8	1.8	0.2	0.9	1.2	0.5	1.6	6.9	0.7	2.2	1.4	38.3	6.7	0.3	2.6	0.4	2.4	7.4	4.7	13.7	17.5	4.7	13.3	15.3	13.8	19.5	9.3	14.4	18.2
FHL1	"bA535K18.1, FHL1B, FLH1A, KYO-T, MGC111107, SLIM1, XMPMA"	ENSG00000022267	"Four and a half LIM domains 1"	Q13642	X	136146702-136211359	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	Differentiation	"Developmental protein"	"Disease mutation, Emery-Dreifuss muscular dystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"skeletal muscle: 557.6;tongue: 239.4"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 57.7;fHDF/TERT166: 52.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"NK-cell: 20.6"	"Group enriched"	"Detected in many"	4	"dendritic cells: 12.5;NK-cells: 20.6;T-cells: 11.4"	"Low region specificity"	"Detected in all"							"HPA001040, HPA001391, CAB020817"	Enhanced		Supported	"Plasma membrane,Cytosol"			18000000	Cytosol	"Plasma membrane"	"CAB020817: , HPA001040: AB_1848541, HPA001391: AB_1848542"	"unprognostic (2.16e-1)"	"unprognostic (5.13e-2)"	"unprognostic (1.33e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.61e-3)"	"unprognostic (1.76e-2)"	"unprognostic (2.51e-2)"	"unprognostic (9.34e-2)"	"unprognostic (7.12e-3)"	"unprognostic (1.20e-1)"	"unprognostic (2.21e-3)"	"unprognostic (1.72e-1)"	"unprognostic (6.17e-3)"	"unprognostic (4.04e-2)"	"unprognostic (7.52e-2)"	"unprognostic (2.05e-3)"	"prognostic unfavourable (2.11e-4)"	61.9	4.1	7.6	11.0	9.5	0.7	30.6	6.3	7.2	31.5	30.6	3.9	10.0	5.0	25.5	27.7	43.2	14.2	11.7	79.0	6.1	8.1	3.3	2.5	13.7	2.5	5.5	8.1	6.7	2.4	13.4	5.0	13.5	4.4	23.4	10.0	13.5	16.5	30.1	557.6	4.9	11.4	77.7	4.3	2.5	22.1	5.7	3.0	0.6	18.2	239.4	22.1	47.0	14.3	3.4	12.5	0.7	0.4	20.6	11.4	6.2	0.0	9.4	13.1	12.3	28.5	11.5	0.2	36.7	57.7	7.3	17.8	0.0	2.7	0.1	12.8	52.2	0.1	25.3	31.3	6.2	0.1	29.2	0.1	7.8	0.0	26.7	0.0	6.1	21.4	5.1	8.9	28.1	7.7	0.0	5.5	17.2	0.4	5.1	0.3	4.0	11.1	14.4	0.5	7.8	0.2	0.0	9.2	13.8	1.3	0.0	2.6	0.0	0.5	21.6	34.1	15.8	1.3	9.2	1.4	3.2	0.2	2.5	0.2	3.8	0.0	0.4	0.0	3.2	0.0	8.6	3.4	11.4	4.5	1.8	2.3	7.6	2.3	0.7	20.6	0.0	12.5	1.2	6.2	7.6	9.5	6.3	7.2	6.1	8.1	5.5	8.1	4.4	3.0
FIGN		ENSG00000182263	"Fidgetin, microtubule severing factor"	Q5HY92	2	163593396-163736012	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"AF22: 17.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	54	"basophil: 5.4"	"Lineage enriched"	"Detected in single"	54	"granulocytes: 5.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA034987, HPA057919"	Approved		Approved	"Nucleoplasm,Vesicles,Plasma membrane,Cell Junctions,Cytosol"				"Nucleoplasm, Plasma membrane, Cytosol"	"Vesicles, Cell Junctions"	"HPA034987: AB_10669681, HPA057919: "	"unprognostic (3.93e-2)"	"unprognostic (8.30e-3)"	"unprognostic (1.48e-1)"	"unprognostic (7.68e-5)"	"unprognostic (3.45e-2)"	"unprognostic (8.98e-4)"	"unprognostic (5.23e-3)"	"unprognostic (7.65e-3)"	"unprognostic (2.33e-1)"	"unprognostic (1.64e-1)"	"unprognostic (2.07e-2)"	"unprognostic (3.24e-2)"	"unprognostic (3.85e-3)"	"unprognostic (3.22e-2)"	"unprognostic (2.69e-1)"	"unprognostic (4.10e-2)"	"unprognostic (3.78e-2)"	8.5	7.6	9.6	2.9	13.7	2.8	5.2	5.1	11.9	6.8	5.9	5.5	3.7	2.1	3.3	5.0	2.9	4.5	4.4	10.1	8.8	4.3	7.2	7.9	4.3	2.5	8.7	4.7	14.3	7.2	1.8	12.1	4.4	7.7	4.8	3.4	4.3	8.4	9.9	3.6	3.2	3.6	5.6	9.1	8.7	4.5	4.4	10.5	0.0	3.1	3.0	1.6	4.1	6.3	0.0	0.0	5.4	0.0	0.0	0.0	0.0	5.7	2.1	17.3	0.0	0.0	0.0	6.4	2.2	1.5	1.6	3.0	0.0	2.1	0.0	6.2	2.4	0.8	5.7	2.4	1.3	0.0	4.3	0.0	4.0	4.1	1.4	0.0	0.0	0.8	2.1	3.1	8.5	3.7	0.0	0.0	4.7	1.4	0.0	0.0	7.3	2.7	0.0	5.8	0.0	4.0	1.9	2.7	2.3	0.0	1.6	1.5	1.8	0.0	0.3	7.2	6.5	0.0	4.6	1.0	0.0	0.0	2.1	0.0	3.9	5.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.6	13.7	5.1	11.9	8.8	4.3	8.7	4.7	7.7	10.5
FILIP1L	"DOC-1, GIP130"	ENSG00000168386	"Filamin A interacting protein 1 like"	Q4L180	3	99830141-100114513	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 26.8;HDLM-2: 25.0;TIME: 46.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"non-classical monocyte: 5.9"	"Low lineage specificity"	"Detected in many"			"Region enriched"	"Detected in some"	7	"olfactory region: 22.1"	"Low region specificity"	"Detected in all"			HPA043133	Approved		Approved	"Plasma membrane"				"Plasma membrane"		"HPA043133: AB_10793991"	"unprognostic (9.14e-2)"	"unprognostic (2.16e-1)"	"unprognostic (7.73e-2)"	"unprognostic (5.25e-2)"	"unprognostic (6.68e-2)"	"unprognostic (1.06e-2)"	"unprognostic (4.40e-2)"	"unprognostic (1.29e-1)"	"unprognostic (2.08e-2)"	"unprognostic (2.18e-1)"	"unprognostic (1.02e-1)"	"unprognostic (3.32e-1)"	"prognostic unfavourable (9.40e-4)"	"unprognostic (2.46e-2)"	"unprognostic (9.44e-2)"	"unprognostic (5.30e-2)"	"unprognostic (1.82e-3)"	29.0	7.5	11.7	22.1	2.4	0.0	15.2	1.3	7.4	36.2	28.3	0.9	27.2	6.9	52.5	50.0	25.3	17.8	24.3	23.8	4.0	2.1	12.5	6.7	15.9	10.9	2.9	6.5	65.6	10.3	7.7	3.1	14.6	9.4	36.7	7.7	5.5	6.1	36.8	44.8	9.5	19.2	86.3	2.2	27.1	25.1	19.9	1.3	2.5	11.7	53.4	5.8	49.8	16.2	1.5	4.4	0.5	5.9	1.0	0.4	0.5	18.4	0.0	7.2	0.0	12.0	10.2	0.6	9.4	18.9	16.5	18.7	5.6	0.0	0.0	1.6	26.8	2.2	0.0	4.6	19.6	25.0	0.2	1.5	0.0	7.3	6.0	0.4	0.0	8.1	1.7	1.8	0.0	7.3	1.1	0.1	2.4	0.1	1.6	0.3	0.4	0.0	0.0	8.5	0.2	11.0	0.3	0.6	1.2	0.1	0.1	0.0	0.0	3.3	46.6	2.9	0.0	0.6	4.9	1.3	0.0	0.1	2.1	0.1	0.0	0.3	1.0	0.2	0.3	2.2	0.1	1.4	0.4	0.3	4.4	1.5	0.2	0.2	0.5	1.0	5.9	0.8	0.3	0.5	11.7	2.4	1.3	7.4	4.0	2.1	2.9	6.5	9.4	1.3
FKBP2	"FKBP-13, PPIase"	ENSG00000173486	"FK506 binding protein 2"	P26885	11	64241003-64244132	"Enzymes, Predicted intracellular proteins"		"Isomerase, Rotamase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"plasmacytoid DC: 119.6"	"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB025561, HPA049405"	Enhanced		Approved	"Plasma membrane"	"Intracellular and membrane"		400000	"Plasma membrane"		"CAB025561: , HPA049405: "	"unprognostic (4.94e-2)"	"unprognostic (1.12e-1)"	"unprognostic (5.77e-2)"	"unprognostic (2.66e-3)"	"unprognostic (7.40e-2)"	"unprognostic (1.92e-2)"	"unprognostic (8.64e-2)"	"unprognostic (1.62e-1)"	"unprognostic (3.23e-1)"	"unprognostic (5.91e-3)"	"unprognostic (5.86e-2)"	"unprognostic (7.18e-2)"	"unprognostic (1.70e-2)"	"unprognostic (1.58e-1)"	"unprognostic (5.23e-1)"	"unprognostic (2.30e-1)"	"unprognostic (3.57e-2)"	18.2	35.8	28.9	20.2	35.5	12.1	20.2	18.8	27.1	31.3	28.0	20.3	87.8	39.0	24.4	102.7	20.8	25.5	30.3	28.0	29.7	35.7	40.3	89.6	18.8	17.0	39.3	24.8	22.1	107.2	34.0	57.2	59.2	29.0	26.1	21.9	19.4	59.3	116.6	11.8	18.5	30.2	19.7	28.5	20.9	31.1	19.8	20.6	12.4	63.2	18.6	18.8	21.3	23.9	21.3	119.6	29.0	25.4	20.0	30.7	15.5	24.0	31.7	17.2	34.7	37.2	21.3	24.4	29.2	29.6	22.1	20.6	31.2	54.2	17.8	46.5	35.8	31.5	13.6	24.2	10.5	22.1	11.8	19.8	42.2	31.9	48.9	16.4	27.8	24.7	36.1	29.2	32.4	17.5	14.8	53.4	26.2	39.8	17.9	25.9	20.0	28.6	16.0	17.0	64.9	39.9	24.1	24.0	20.9	20.0	56.7	32.1	21.8	14.2	16.6	26.6	23.7	42.2	15.6	32.5	10.1	14.5	35.6	17.3	30.0	29.0	24.5	3.4	24.1	25.4	30.7	21.3	19.2	23.3	23.2	20.5	13.0	18.1	9.1	20.0	20.8	119.6	7.1	15.5	28.9	35.5	18.8	27.1	29.7	35.7	39.3	24.8	29.0	20.6
FLAD1	"FAD1, PP591"	ENSG00000160688	"Flavin adenine dinucleotide synthetase 1"	Q8NFF5	1	154983338-154993111	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Nucleotidyltransferase, Transferase"	"Disease mutation, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028476, HPA028486, HPA028563"	Approved		Supported	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		"HPA028476: AB_10599974, HPA028486: AB_10600206, HPA028563: AB_10602286"	"unprognostic (2.64e-1)"	"unprognostic (2.60e-1)"	"unprognostic (2.72e-1)"	"unprognostic (3.84e-2)"	"unprognostic (7.34e-2)"	"unprognostic (1.45e-1)"	"prognostic unfavourable (3.04e-4)"	"unprognostic (1.31e-1)"	"unprognostic (2.32e-1)"	"unprognostic (8.08e-2)"	"unprognostic (6.51e-2)"	"unprognostic (9.74e-2)"	"prognostic unfavourable (2.55e-6)"	"unprognostic (1.67e-2)"	"unprognostic (5.06e-2)"	"unprognostic (5.50e-2)"	"unprognostic (1.17e-2)"	16.5	16.5	20.3	15.5	18.9	12.1	17.4	15.9	20.8	14.1	16.4	19.3	14.7	19.6	15.9	21.2	19.8	16.7	11.8	16.1	18.2	10.4	19.0	36.5	13.5	20.0	20.8	15.6	14.5	19.0	13.6	12.0	18.5	15.9	18.7	19.0	16.1	16.2	16.3	26.3	23.3	23.9	17.6	12.4	22.9	16.1	19.1	18.9	15.7	20.8	18.4	22.0	15.5	15.4	25.1	24.5	15.2	24.1	14.9	26.4	22.7	13.1	21.2	13.5	23.0	11.8	8.7	25.7	10.0	8.3	14.6	12.5	18.8	16.3	15.4	20.2	9.2	17.3	25.8	20.7	9.5	16.0	19.4	12.5	16.8	13.2	16.1	18.0	16.3	12.4	27.2	16.6	17.8	16.9	20.0	12.5	12.3	28.4	12.4	12.6	29.4	22.0	20.9	6.7	35.3	13.9	18.4	22.8	31.3	15.6	35.4	19.7	30.3	27.4	10.7	9.2	12.7	11.8	15.7	19.6	24.3	26.5	11.1	14.7	14.7	15.2	23.0	14.8	24.0	20.9	26.4	25.1	22.1	22.7	24.1	20.5	20.5	20.2	5.2	14.9	24.1	24.5	23.3	22.7	20.3	18.9	15.9	20.8	18.2	10.4	20.8	15.6	15.9	18.9
FLT4	"PCL, VEGFR3"	ENSG00000037280	"Fms related tyrosine kinase 4"	P35916	5	180601506-180649624	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, RAS pathway related proteins"	Angiogenesis	"Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 56.3"	"Cell line enhanced"	"Detected in some"		"AN3-CA: 8.3;BEWO: 10.2;HEK 293: 12.6;HL-60: 7.4;HUVEC TERT2: 8.1;T-47d: 12.0;TIME: 12.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in some"	5	"MAIT T-cell: 7.7"	"Lineage enriched"	"Detected in single"	35	"T-cells: 7.7"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"CAB000099, HPA046519, HPA067906"	Approved		Approved	"Nucleoplasm,Plasma membrane,Cell Junctions"	"Secreted to blood"		270000000	"Plasma membrane"	"Nucleoplasm, Cell Junctions"	"CAB000099: , HPA046519: , HPA067906: "	"unprognostic (7.35e-2)"	"unprognostic (1.63e-1)"	"unprognostic (9.45e-3)"	"unprognostic (3.81e-1)"	"unprognostic (9.26e-2)"	"unprognostic (3.20e-3)"	"unprognostic (1.13e-2)"	"unprognostic (1.80e-2)"	"unprognostic (2.19e-1)"	"unprognostic (1.70e-1)"	"unprognostic (2.13e-2)"	"unprognostic (3.69e-1)"	"unprognostic (1.88e-2)"	"unprognostic (9.41e-3)"	"unprognostic (1.83e-1)"	"unprognostic (8.26e-2)"	"unprognostic (1.32e-1)"	14.8	7.1	1.6	4.9	6.0	0.7	28.5	1.3	2.7	6.3	7.3	1.9	2.1	3.1	7.3	6.2	5.7	9.2	5.3	6.4	1.7	0.9	11.7	10.2	14.1	23.6	2.0	0.8	5.8	2.3	2.3	6.2	56.3	2.1	4.9	1.4	6.7	3.3	4.4	4.8	2.8	4.7	4.7	1.5	14.5	2.4	3.5	2.0	0.3	19.4	4.4	2.3	6.1	14.7	0.0	0.1	0.2	0.0	0.0	7.7	0.2	0.1	2.0	2.7	8.3	0.0	0.0	10.2	0.2	0.1	0.0	0.0	0.3	0.3	0.2	0.8	0.1	0.3	2.8	0.1	0.2	0.1	12.6	1.0	0.4	0.4	0.1	7.4	0.2	0.2	0.0	0.1	0.3	8.1	0.3	0.3	1.7	4.5	0.1	0.4	5.8	0.5	6.5	0.0	0.1	0.1	0.2	0.2	0.9	0.1	0.2	0.0	12.0	0.2	12.7	0.1	5.9	0.2	0.1	0.2	0.1	0.0	0.0	0.2	0.1	0.1	0.0	0.0	0.9	0.0	7.7	0.0	0.4	1.6	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.1	0.0	0.2	1.6	6.0	1.3	2.7	1.7	0.9	2.0	0.8	2.1	2.0
FMN2		ENSG00000155816	"Formin 2"	Q9NZ56	1	240014348-240475189	"Disease related genes, Predicted intracellular proteins"	"DNA damage, Protein transport, Stress response, Transport"	"Actin-binding, Developmental protein"	"Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 41.0;parathyroid gland: 26.6"	"Cell line enhanced"	"Detected in some"		"BJ: 26.5;fHDF/TERT166: 26.1;LHCN-M2: 28.7;U-138 MG: 19.0;WM-115: 29.6"	"Group enriched"	"Detected in some"	8	"glioma: 5.9;testis cancer: 3.1"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"naive CD4 T-cell: 2.3"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"							HPA050649			Approved	"Plasma membrane,Actin filaments"				"Plasma membrane, Actin filaments"		"HPA050649: "	"unprognostic (1.55e-2)"	"unprognostic (8.21e-2)"	"unprognostic (4.01e-2)"	"unprognostic (8.06e-2)"	"unprognostic (2.77e-1)"	"unprognostic (1.76e-1)"	"unprognostic (7.97e-3)"	"unprognostic (2.11e-2)"	"unprognostic (2.93e-1)"	"unprognostic (3.92e-2)"	"unprognostic (3.35e-3)"	"unprognostic (4.08e-1)"	"unprognostic (1.11e-2)"	"unprognostic (8.03e-3)"	"unprognostic (9.78e-2)"	"unprognostic (3.10e-2)"	"unprognostic (1.40e-3)"	1.2	7.3	17.1	1.3	14.5	0.9	1.3	17.2	41.0	1.1	3.2	9.4	0.0	1.4	2.5	2.1	2.1	3.7	2.0	0.9	16.2	11.8	2.9	0.9	1.4	0.9	9.9	15.5	3.9	2.1	26.6	5.6	1.2	12.2	2.9	3.0	1.4	1.3	3.6	0.9	1.0	1.3	2.7	12.3	1.2	1.2	3.4	12.3	0.0	1.3	0.0	1.0	1.2	0.4	0.5	0.4	0.6	0.3	0.4	2.3	0.0	0.0	0.8	2.8	0.0	7.2	5.5	0.0	26.5	14.0	10.5	5.7	0.0	0.0	0.0	0.0	26.1	0.0	0.4	0.0	10.3	0.0	2.1	0.0	0.4	0.0	0.0	0.0	0.0	0.6	0.0	3.4	0.6	0.0	0.0	0.0	28.7	0.0	0.0	0.0	0.9	0.8	0.0	0.1	0.0	0.0	0.0	4.4	3.9	0.0	0.1	0.1	1.1	0.0	0.1	19.0	0.1	7.1	6.9	0.0	0.0	0.0	3.7	0.0	29.6	0.6	0.3	0.1	0.3	0.2	0.2	0.1	0.9	0.1	0.1	0.5	2.3	1.4	0.5	0.4	0.1	0.4	0.3	0.0	17.1	14.5	17.2	19.3	16.2	11.8	9.9	15.5	12.2	12.3
FMNL2	"FHOD2, KIAA1902"	ENSG00000157827	"Formin like 2"	Q96PY5	2	152335237-152649834	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 74.1"	"Cell line enhanced"	"Detected in many"		"BEWO: 56.7;hTERT-HME1: 36.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"intermediate monocyte: 1.7;non-classical monocyte: 4.2"	"Lineage enriched"	"Detected in single"	5	"monocytes: 4.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA005464	Enhanced		Approved	"Golgi apparatus,Plasma membrane,Cytosol"				Cytosol	"Golgi apparatus, Plasma membrane"	"HPA005464: AB_1848965"	"unprognostic (1.19e-1)"	"unprognostic (6.92e-2)"	"unprognostic (8.75e-3)"	"unprognostic (3.06e-2)"	"unprognostic (7.40e-2)"	"unprognostic (9.45e-2)"	"prognostic unfavourable (9.04e-4)"	"unprognostic (1.34e-2)"	"unprognostic (1.98e-1)"	"unprognostic (1.38e-1)"	"unprognostic (2.54e-1)"	"unprognostic (4.66e-2)"	"unprognostic (5.68e-2)"	"unprognostic (1.05e-1)"	"unprognostic (2.58e-1)"	"unprognostic (3.73e-2)"	"unprognostic (1.58e-1)"	15.1	13.6	26.2	7.0	44.6	0.8	9.4	18.3	55.0	8.5	6.6	55.0	1.4	5.8	13.6	10.2	4.6	6.7	11.1	4.8	32.0	20.6	9.7	5.3	17.9	8.2	63.4	27.9	35.9	7.4	17.8	10.2	35.9	39.2	8.9	8.4	5.4	20.1	8.2	31.0	4.0	5.5	10.7	74.1	12.0	8.2	5.8	56.7	1.3	14.5	3.2	5.4	9.1	11.6	0.0	0.9	0.0	4.2	0.0	0.1	0.0	4.0	4.3	13.6	7.5	16.5	17.8	56.7	4.1	8.5	7.4	10.4	4.6	0.2	0.0	8.9	3.6	4.7	6.5	13.2	11.8	0.0	6.8	0.0	2.8	19.9	4.7	1.1	0.2	11.6	8.2	14.3	36.9	13.0	0.1	0.1	4.0	1.1	0.2	1.2	8.7	8.8	7.3	2.9	5.9	21.6	2.8	13.9	11.3	3.5	1.3	14.4	0.3	0.4	14.4	11.2	0.3	3.7	7.1	0.3	0.1	0.0	10.4	0.9	22.7	0.0	0.1	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	4.2	0.9	0.1	0.0	26.2	44.6	18.3	36.7	32.0	20.6	63.4	27.9	39.2	56.7
FOXN3	"C14orf116, CHES1"	ENSG00000053254	"Forkhead box N3"	O00409	14	89124871-89619149	"Predicted intracellular proteins, Transcription factors"	"Cell cycle, Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"U-266/84: 37.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA059209	Approved		Approved	"Nucleoplasm,Plasma membrane"				Nucleoplasm	"Plasma membrane"	"HPA059209: "	"unprognostic (1.69e-1)"	"unprognostic (6.13e-3)"	"unprognostic (2.08e-1)"	"unprognostic (1.84e-1)"	"unprognostic (4.09e-2)"	"unprognostic (2.03e-1)"	"unprognostic (3.03e-1)"	"unprognostic (1.34e-2)"	"unprognostic (8.75e-2)"	"unprognostic (1.09e-1)"	"unprognostic (2.64e-1)"	"unprognostic (1.19e-1)"	"prognostic favourable (9.58e-5)"	"unprognostic (2.22e-2)"	"unprognostic (1.88e-1)"	"unprognostic (5.53e-2)"	"unprognostic (2.11e-1)"	26.8	14.5	12.6	23.2	11.3	33.9	35.2	46.9	10.7	17.2	28.4	15.3	12.2	18.2	19.3	11.2	21.0	17.4	11.9	20.2	12.8	7.8	7.5	15.4	14.1	20.1	11.3	7.4	28.8	15.1	35.0	10.1	11.3	13.2	15.7	11.1	17.8	13.4	12.6	44.3	29.5	31.1	25.1	14.0	13.2	15.9	12.6	13.2	34.0	8.8	18.4	19.9	25.7	31.7	9.6	19.3	21.4	14.2	17.3	24.3	15.2	0.1	2.6	7.2	4.3	29.5	9.5	4.9	5.5	5.8	5.1	8.4	2.6	2.1	8.6	2.9	8.7	1.9	12.4	8.0	7.6	36.9	2.3	2.8	5.3	8.9	9.5	5.6	5.1	22.4	4.6	0.4	3.5	10.9	3.3	24.5	8.6	3.3	11.0	5.6	7.6	4.8	17.4	24.6	7.9	0.5	8.8	3.8	12.9	8.1	8.1	2.2	4.4	16.1	19.1	8.8	11.8	8.6	8.3	21.8	37.1	15.4	3.0	9.9	5.1	21.4	13.0	18.8	24.3	14.2	19.5	7.8	16.4	20.8	19.3	9.6	21.5	20.5	5.4	17.3	8.7	4.3	19.2	15.2	12.6	11.3	46.9	10.7	12.8	7.8	11.3	7.4	13.2	13.2
FP565260.3		ENSG00000277117			21	5022493-5040666	"Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in many"		"brain: 9.2"	"Cell line enhanced"	"Detected in many"		"BEWO: 16.3;REH: 12.7;SiHa: 10.9"	"Low cancer specificity"	"Detected in some"							"Cell type enhanced"	"Detected in some"		"naive B-cell: 5.3"	"Low lineage specificity"	"Detected in many"											HPA029179			Approved	"Plasma membrane,Cytoplasmic bodies"				"Plasma membrane, Cytoplasmic bodies"		"HPA029179: "	"unprognostic (3.34e-2)"	"unprognostic (1.52e-1)"	"unprognostic (2.82e-1)"	"unprognostic (3.58e-4)"	"unprognostic (6.66e-4)"	"unprognostic (1.24e-2)"	"unprognostic (1.12e-1)"	"unprognostic (3.36e-1)"	"unprognostic (2.46e-1)"	"unprognostic (6.63e-2)"	"unprognostic (1.14e-1)"	"unprognostic (7.43e-2)"	"unprognostic (2.13e-1)"	"unprognostic (3.17e-1)"	"unprognostic (3.60e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.09e-1)"	1.5	0.2	0.6	3.4	4.5	2.4	1.9	0.4	7.0	2.6	2.0	9.2	0.6	4.3	0.8	1.7	1.4	2.1	2.6	2.9	2.2		2.5	2.3	1.2	4.5	4.2	3.1	0.2	1.8	0.0	0.0	1.9	4.3	1.3	1.6	0.1	1.3	1.0	0.7	3.1	2.8	0.7	2.6	2.3	4.1	0.5	3.6	0.0	1.0	1.9	5.7	1.6	1.2	5.3	0.9	0.0	3.0	0.0	1.1	0.8	0.2	0.6	0.0	1.1	0.3	0.7	16.3	1.3	1.0	0.2	0.0	3.9	0.7	8.7	2.6	0.0	3.1	1.0	1.2	0.2	0.2	0.8	0.0	0.5	2.1	0.2	6.7	6.4	0.1	1.7	0.9	0.8	0.9	1.0	0.3	0.1	2.2	0.0	4.0	0.6	5.3	12.7	0.4	8.9	0.4	5.5	0.7	0.0	10.9	9.7	0.1	2.9	9.0	0.3	0.0	2.5	0.0	0.2	6.0	6.1	5.7	6.9	3.8	1.5	0.0	0.6	0.0	0.0	3.0	0.3	2.9	0.5	0.2	0.7	5.3	0.1	0.5	0.0	0.0	0.6	0.9	1.1	0.8										
FRMD3	"EPB41L4O, MGC20553"	ENSG00000172159	"FERM domain containing 3"	A2A2Y4	9	83242990-83538546	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 48.5;skeletal muscle: 42.1"	"Cell line enhanced"	"Detected in some"		"HEL: 11.6;RPMI-8226: 39.2;SCLC-21H: 14.5"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 27.3"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"classical monocyte: 2.8;intermediate monocyte: 4.7;neutrophil: 3.8;non-classical monocyte: 2.1"	"Group enriched"	"Detected in many"	6	"granulocytes: 3.8;monocytes: 4.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017285	Approved		Approved	"Nucleoplasm,Golgi apparatus,Plasma membrane"				"Golgi apparatus, Plasma membrane"	Nucleoplasm	"HPA017285: "	"unprognostic (4.45e-2)"	"unprognostic (1.85e-1)"	"unprognostic (1.93e-1)"	"unprognostic (6.44e-2)"	"unprognostic (2.66e-1)"	"unprognostic (2.23e-1)"	"unprognostic (8.13e-2)"	"unprognostic (3.93e-1)"	"unprognostic (3.94e-2)"	"unprognostic (1.06e-1)"	"unprognostic (2.23e-1)"	"unprognostic (5.87e-2)"	"prognostic favourable (7.24e-4)"	"unprognostic (3.12e-1)"	"unprognostic (1.88e-1)"	"prognostic favourable (1.79e-4)"	"unprognostic (1.68e-3)"	12.7	4.6	3.5	2.8	2.3	3.0	16.8	2.0	3.0	4.6	7.1	1.7	14.3	1.9	5.5	9.8	4.1	1.9	2.9	48.5	3.2	4.5	11.7	0.7	2.9	0.9	3.6	1.7	1.4	1.4	8.9	6.1	8.7	2.9	5.1	4.1	5.3	2.1	35.3	42.1	1.6	10.9	3.5	2.8	4.3	2.2	6.1	0.8	0.0	8.8	11.1	0.7	3.8	5.0	0.6	0.6	3.8	4.7	0.4	0.6	9.2	0.0	2.2	1.9	0.1	0.4	0.1	0.1	2.0	0.1	0.0	0.0	0.2	2.6	0.4	2.4	0.9	0.1	0.1	0.0	0.0	0.1	0.1	11.6	2.5	1.4	0.1	0.0	0.1	0.5	0.0	0.0	0.1	1.3	0.0	0.0	2.5	0.3	0.0	0.0	0.2	3.6	0.0	1.5	39.2	3.2	5.1	14.5	7.0	0.7	0.1	0.4	0.8	0.4	2.2	0.1	0.3	0.0	1.4	0.2	0.1	0.0	0.5	3.8	1.4	0.0	2.8	0.0	0.4	4.7	0.6	0.5	0.2	0.1	0.4	0.6	0.1	0.0	3.8	0.4	2.1	0.6	0.0	9.2	3.5	2.3	2.0	3.0	3.2	4.5	3.6	1.7	2.9	0.8
FSD1L	"CCDC10, CSDUFD1, FSD1CL, FSD1NL"	ENSG00000106701	"Fibronectin type III and SPRY domain containing 1 like"	Q9BXM9	9	105447796-105552433	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035138	Approved		Approved	"Plasma membrane,Actin filaments"				"Plasma membrane"	"Actin filaments"	"HPA035138: AB_10601324"	"unprognostic (9.28e-2)"	"unprognostic (4.04e-3)"	"unprognostic (1.73e-1)"	"unprognostic (1.88e-3)"	"unprognostic (3.93e-2)"	"unprognostic (1.82e-2)"	"unprognostic (3.17e-5)"	"unprognostic (4.20e-2)"	"unprognostic (5.65e-2)"	"unprognostic (9.64e-3)"	"unprognostic (2.66e-3)"	"unprognostic (3.32e-2)"	"unprognostic (8.28e-2)"	"unprognostic (2.92e-1)"	"unprognostic (1.87e-1)"	"unprognostic (8.07e-2)"	"unprognostic (1.22e-3)"	2.5	6.9	9.5	3.9	15.2	4.1	3.2	11.1	19.6	3.6	4.9	8.3	6.7	8.6	4.3	6.3	2.2	14.5	3.0	7.4	10.0	13.0	4.2	1.8	4.3	3.0	11.3	8.7	2.8	3.2	7.6	18.9	2.0	20.6	3.2	4.8	7.6	2.3	3.8	11.1	2.4	6.7	3.3	15.5	2.8	4.2	12.2	7.4	2.0	4.1	6.0	3.1	2.4	2.3	5.5	2.1	1.2	2.9	1.7	2.5	0.9	3.5	4.0	6.3	3.7	1.7	3.5	2.1	3.1	2.1	3.1	2.7	2.0	1.3	9.4	1.3	3.1	1.4	4.8	1.8	4.3	11.3	1.5	1.6	5.2	2.4	2.3	5.5	3.6	1.8	1.6	4.2	6.6	2.4	1.9	5.5	2.2	1.2	8.8	2.9	4.0	2.5	11.2	4.2	0.7	2.5	0.8	13.0	6.2	3.6	0.9	2.6	4.2	1.6	2.7	4.9	3.1	4.1	4.4	3.0	10.2	2.5	3.2	3.0	1.6	1.2	2.9	0.1	1.7	1.6	0.8	5.5	2.5	1.8	1.8	2.3	0.3	1.1	1.2	1.7	1.5	2.1	0.6	0.9	9.5	15.2	11.1	14.8	10.0	13.0	11.3	8.7	20.6	7.4
FTCD		ENSG00000160282	"Formimidoyltransferase cyclodeaminase"	O95954	21	46136262-46155567	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Histidine metabolism"	"Lyase, Multifunctional enzyme, Transferase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"liver: 126.8"	"Cell line enriched"	"Detected in some"	29	"Hep G2: 44.4"	"Cancer enriched"	"Detected in some"	8	"liver cancer: 87.3"	"Low region specificity"	"Detected in single"			"Cell type enhanced"	"Detected in single"		"T-reg: 2.5"	"Lineage enriched"	"Detected in single"	25	"T-cells: 2.5"									"HPA020073, HPA030928, HPA030929, HPA036114"	Enhanced		Approved	"Plasma membrane,Cytosol"			580000	Cytosol	"Plasma membrane"	"HPA020073: AB_1849005, HPA030928: AB_2673664, HPA030929: AB_2673665, HPA036114: AB_2674947"	"unprognostic (1.71e-1)"	"unprognostic (2.27e-1)"	"unprognostic (4.62e-5)"	"unprognostic (2.90e-2)"	"unprognostic (1.13e-1)"	"unprognostic (2.96e-1)"	"prognostic favourable (1.70e-4)"	"unprognostic (1.85e-1)"	"unprognostic (2.67e-1)"	"unprognostic (1.99e-1)"	"prognostic favourable (6.78e-5)"	"unprognostic (1.80e-1)"	"prognostic favourable (5.78e-4)"	"unprognostic (3.80e-2)"	"unprognostic (3.60e-1)"	"unprognostic (9.37e-2)"	"unprognostic (2.10e-1)"	0.2	0.0	0.6	0.2	1.6	0.0	0.2	0.2	0.7	0.2	0.3	0.2	0.2	0.3	0.2	2.0	0.2	0.0	0.2	0.2	0.5	0.4	25.9	126.8	0.2	0.2	0.4	0.2	0.2	1.0	0.0	0.2	0.2	0.2	0.3	0.0	0.2	0.2	0.2	0.2	0.0	0.4	0.2	0.2	0.2	0.1	1.5	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.0	0.0	0.0	0.0	0.0	2.5	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.0	44.4	0.0	0.2	0.1	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.3	0.0	0.0	0.9	0.0	0.1	0.1	0.0	0.1	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.2	0.0	0.1	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.5	0.5	0.0	0.0	0.5	0.7	0.0	0.0	0.0	0.0	2.5	0.1	0.6	1.6	0.2	0.7	0.5	0.4	0.4	0.2	0.2	0.2
FXYD3	"MAT-8, PLML"	ENSG00000089356	"FXYD domain containing ion transport regulator 3"	Q14802	19	35115879-35124324	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Potassium transport, Sodium transport, Sodium/potassium transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 160.2;salivary gland: 141.7"	"Cell line enhanced"	"Detected in some"		"HaCaT: 88.3;hTCEpi: 160.7;RT4: 83.9;SK-BR-3: 82.6;WM-115: 59.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	5	"plasmacytoid DC: 3.2"	"Lineage enriched"	"Detected in single"	5	"dendritic cells: 3.2"									HPA010856	Enhanced		Approved	"Nucleoplasm,Plasma membrane"	"Intracellular and membrane"			Nucleoplasm	"Plasma membrane"	"HPA010856: AB_1078915"	"unprognostic (2.18e-3)"	"unprognostic (2.78e-2)"	"unprognostic (8.37e-3)"	"unprognostic (3.31e-3)"	"unprognostic (6.38e-2)"	"unprognostic (3.02e-1)"	"unprognostic (2.64e-3)"	"unprognostic (1.60e-1)"	"unprognostic (3.59e-1)"	"unprognostic (1.03e-1)"	"unprognostic (2.32e-2)"	"unprognostic (3.88e-1)"	"prognostic unfavourable (1.15e-6)"	"unprognostic (4.17e-2)"	"unprognostic (2.08e-1)"	"unprognostic (5.06e-2)"	"unprognostic (7.69e-3)"	0.4	0.1	1.6	29.5	2.3	0.0	20.4	1.7	2.1	30.0	133.2	1.1	2.3	8.6	3.9	2.9	82.1	9.0	56.6	0.8	1.4	0.3	2.1	0.5	35.8	0.3	2.1	0.8	1.9	28.9	0.0	3.7	41.9	2.2	58.4	160.2	15.8	141.7	3.5	0.5	64.2	36.4	7.5	1.8	0.4	50.6	0.7	1.0	2.5	0.5	93.2	49.8	48.7	42.5	0.3	3.2	0.6	0.1	0.0	0.2	0.5	15.9	0.0	0.0	0.0	0.0	0.0	15.1	0.0	0.0	0.0	0.0	0.5	23.2	0.0	0.0	0.0	88.3	0.0	33.3	0.0	0.0	0.0	0.1	0.7	0.0	0.0	0.0	0.0	0.0	160.7	0.0	0.0	0.0	0.0	0.1	0.0	29.2	0.0	0.2	0.0	0.1	0.0	0.0	0.1	0.0	83.9	19.7	0.2	0.1	82.6	6.1	15.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	59.1	0.1	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.3	0.1	0.2	0.6	0.0	0.0	3.2	0.0	0.5	1.6	2.3	1.7	2.1	1.4	0.3	2.1	0.8	2.2	1.0
FYB1	"ADAP, FYB, FYB-120/130, SLAP-130"	ENSG00000082074	"FYN binding protein 1"	O15117	5	39105255-39274528	"Disease related genes, Predicted intracellular proteins"			"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 153.7;lymphoid tissue: 63.5"	"Group enriched"	"Detected in some"	4	"HEL: 18.4;MOLT-4: 62.6;REH: 18.4;U-937: 24.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 153.7"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB025336, HPA026796"	Enhanced		Approved	"Nucleoplasm,Plasma membrane"			6600000	"Plasma membrane"	Nucleoplasm	"CAB025336: , HPA026796: AB_10964126"	"unprognostic (5.65e-2)"	"unprognostic (2.92e-2)"	"unprognostic (1.56e-2)"	"unprognostic (6.26e-2)"	"unprognostic (4.08e-1)"	"unprognostic (3.29e-2)"	"unprognostic (2.60e-1)"	"unprognostic (1.97e-1)"	"unprognostic (1.24e-1)"	"unprognostic (5.63e-2)"	"unprognostic (5.35e-2)"	"unprognostic (3.21e-1)"	"prognostic unfavourable (2.24e-4)"	"unprognostic (2.40e-1)"	"unprognostic (4.14e-2)"	"unprognostic (8.99e-2)"	"unprognostic (1.51e-1)"	7.0	3.5	6.3	36.0	18.3	22.1	3.9	1.8	10.1	3.5	4.4	8.3	0.3	4.1	2.7	6.5	4.9	4.2	7.9	3.5	6.8	6.6	5.7	6.2	13.8	35.5	15.5	2.7	2.6	2.5	1.3	3.5	8.7	11.7	3.8	5.3	3.0	5.4	1.5	1.9	2.4	11.7	5.6	29.4	41.5	5.2	3.5	12.2	63.5	4.1	1.8	28.0	10.1	3.6	0.1	11.9	153.7	41.3	8.6	28.7	30.8	0.0	1.3	0.0	0.0	0.1	0.0	7.0	0.0	0.3	0.0	0.1	0.1	0.1	0.0	0.0	0.0	5.1	0.0	0.1	0.0	0.0	0.0	18.4	0.0	0.0	0.0	6.9	5.9	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	62.6	3.9	0.0	0.0	18.4	0.0	0.0	0.3	1.2	0.0	0.0	0.0	0.1	1.8	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.4	0.0	24.3	0.0	11.9	33.8	32.3	7.9	38.6	5.5	0.1	22.5	13.8	11.9	0.1	28.7	17.3	153.7	8.6	41.3	3.0	21.7	30.8	6.3	18.3	1.8	10.1	6.8	6.6	15.5	2.7	11.7	12.2
FZD4	"CD344, EVR1"	ENSG00000174804	"Frizzled class receptor 4"	Q9ULV1	11	86945679-86955391	"CD markers, Disease related genes, G-protein coupled receptors, Potential drug targets, Predicted membrane proteins"	"Wnt signaling pathway"	"Developmental protein, G-protein coupled receptor, Receptor, Transducer"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 75.7"	"Cell line enhanced"	"Detected in many"		"ASC diff: 25.4;Hep G2: 31.8;HSkMC: 18.3;HUVEC TERT2: 36.0;TIME: 17.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA042328, HPA074833"	Approved		Approved	"Nucleoplasm,Plasma membrane"				"Plasma membrane"	Nucleoplasm	"HPA042328: AB_10962494, HPA074833: "	"unprognostic (6.49e-2)"	"unprognostic (1.49e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.03e-1)"	"unprognostic (5.87e-2)"	"unprognostic (5.51e-2)"	"unprognostic (1.82e-1)"	"unprognostic (6.97e-2)"	"unprognostic (3.33e-2)"	"unprognostic (3.79e-2)"	"unprognostic (1.36e-2)"	"unprognostic (2.22e-1)"	"prognostic favourable (8.60e-5)"	"unprognostic (1.05e-2)"	"unprognostic (9.96e-2)"	"unprognostic (9.22e-2)"	"unprognostic (1.97e-1)"	75.7	5.3	3.4	6.0	4.8	0.5	57.8	1.5	4.3	11.5	9.0	1.4	32.6	2.0	13.1	13.5	6.3	9.6	8.7	12.5	3.1	2.2	17.0	8.9	19.0	4.7	2.9	3.2	12.8	6.0	4.4	10.1	7.3	5.5	9.3	4.3	20.0	7.1	56.0	17.9	3.7	5.4	8.6	2.8	8.6	8.2	5.5	1.6	0.5	11.4	11.1	3.0	8.3	20.7	0.4	0.2	0.8	0.4	1.4	0.3	0.0	0.5	0.4	1.0	2.0	25.4	6.6	1.4	3.2	2.9	1.2	1.3	2.7	0.3	0.0	0.7	1.0	1.0	1.2	0.5	1.0	0.1	0.8	1.0	0.8	31.8	7.5	0.0	0.0	18.3	0.2	1.1	0.2	36.0	1.4	0.1	0.8	0.8	0.0	0.0	1.5	7.2	0.0	1.9	0.0	3.5	5.2	0.2	0.3	1.3	0.3	0.5	4.6	0.0	17.6	3.0	2.0	3.6	0.6	0.1	0.5	0.0	0.4	0.0	0.8	0.7	0.3	0.1	0.3	0.2	0.1	0.2	0.3	0.2	0.1	0.4	0.2	0.3	0.8	1.4	0.4	0.2	0.0	0.0	3.4	4.8	1.5	4.3	3.1	2.2	2.9	3.2	5.5	1.6
FZD6	Hfz6	ENSG00000164930	"Frizzled class receptor 6"	O60353	8	103298433-103332866	"Disease related genes, G-protein coupled receptors, Potential drug targets, Predicted membrane proteins"	"Wnt signaling pathway"	"Developmental protein, G-protein coupled receptor, Receptor, Transducer"	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"hTCEpi: 41.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"NK-cell: 7.9"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017991	Approved		Approved	"Plasma membrane"				"Plasma membrane"		"HPA017991: AB_1849138"	"unprognostic (8.22e-3)"	"unprognostic (2.64e-1)"	"unprognostic (4.75e-2)"	"unprognostic (2.57e-1)"	"unprognostic (1.22e-2)"	"unprognostic (6.99e-2)"	"unprognostic (4.01e-2)"	"unprognostic (2.74e-1)"	"unprognostic (2.43e-1)"	"unprognostic (2.66e-1)"	"prognostic unfavourable (1.20e-6)"	"unprognostic (3.62e-2)"	"unprognostic (1.83e-1)"	"unprognostic (2.86e-1)"	"unprognostic (1.32e-1)"	"unprognostic (4.92e-2)"	"unprognostic (7.54e-2)"	13.1	9.2	3.4	5.2	3.8	0.5	13.3	4.3	5.9	12.1	10.7	3.5	8.6	4.0	12.0	16.4	17.9	17.8	12.3	9.6	3.7	3.8	17.4	5.8	17.1	4.7	4.2	2.9	11.6	14.4	21.3	27.2	14.1	10.0	12.4	4.9	11.6	15.3	8.8	4.3	16.9	7.7	12.7	4.2	6.1	8.0	7.2	1.5	10.9	21.2	18.7	14.7	15.9	11.3	1.7	1.0	0.2	0.0	7.9	2.2	0.5	19.4	4.0	9.4	0.0	2.2	7.0	5.8	10.4	11.4	9.3	6.1	2.1	15.0	0.0	17.8	9.2	28.9	5.3	21.5	16.5	4.4	6.4	10.3	4.5	2.6	31.1	0.0	0.0	7.9	41.5	9.8	30.4	19.0	1.0	8.5	9.9	8.0	9.1	0.8	2.2	6.9	0.7	4.5	0.0	18.8	12.3	3.3	2.6	14.5	7.6	18.8	0.0	3.5	1.5	2.2	10.9	8.3	10.6	2.2	1.1	4.2	6.1	0.0	13.4	0.0	0.0	0.2	0.6	0.0	0.0	0.9	2.1	0.9	1.0	1.7	2.2	1.0	0.0	7.9	0.0	0.2	0.6	0.5	3.4	3.8	4.3	5.9	3.7	3.8	4.2	2.9	10.0	1.5
GAB1		ENSG00000109458	"GRB2 associated binding protein 1"	Q13480	4	143336762-143474568	"Predicted intracellular proteins, RAS pathway related proteins"			"Deafness, Disease mutation, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 64.0"	"Cell line enhanced"	"Detected in many"		"REH: 37.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"NK-cell: 7.4"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB034333, HPA066404"	Approved		Approved	"Nucleoli fibrillar center,Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"	"Nucleoli fibrillar center"	"CAB034333: AB_2107855, HPA066404: "	"unprognostic (1.14e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.32e-3)"	"unprognostic (1.66e-1)"	"unprognostic (4.71e-2)"	"unprognostic (1.79e-2)"	"unprognostic (4.17e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.35e-2)"	"unprognostic (8.20e-2)"	"unprognostic (2.10e-1)"	"unprognostic (2.20e-1)"	"prognostic favourable (3.91e-5)"	"unprognostic (4.99e-2)"	"unprognostic (2.70e-1)"	"unprognostic (1.68e-1)"	"unprognostic (1.91e-1)"	9.2	8.4	15.0	7.3	33.3	8.8	9.7	5.8	22.0	10.1	17.0	64.0	10.2	10.4	17.7	13.1	18.2	8.6	11.1	26.2	19.5	11.4	12.9	7.9	15.6	5.0	35.7	19.0	18.1	7.0	17.2	6.3	18.0	30.5	7.8	20.3	15.4	11.7	13.9	11.2	11.1	10.4	15.9	32.3	6.2	11.0	7.9	41.7	1.0	7.8	6.0	7.3	9.9	11.9	3.1	3.4	5.9	2.3	7.4	0.4	0.4	3.3	0.7	8.7	6.3	4.4	4.3	11.4	2.3	7.8	2.8	5.0	6.5	5.7	0.1	0.7	3.3	1.9	8.3	2.7	3.2	0.4	2.0	6.1	1.9	3.0	3.0	0.8	1.2	5.2	4.9	3.4	2.3	3.7	2.0	11.2	1.9	4.9	0.5	0.0	2.5	2.7	37.3	4.3	4.3	4.4	4.1	2.0	6.2	1.6	6.8	2.9	4.4	0.8	2.8	3.6	2.9	1.7	1.7	18.1	8.8	13.4	2.4	2.4	2.9	5.9	0.6	0.7	0.0	0.8	0.4	1.3	0.1	0.0	0.8	3.1	0.0	0.0	4.0	7.4	2.3	3.4	0.0	0.4	15.0	33.3	5.8	22.0	19.5	11.4	35.7	19.0	30.5	41.7
GADL1		ENSG00000144644	"Glutamate decarboxylase like 1"	Q6ZQY3	3	30726200-30894765	"Enzymes, Predicted intracellular proteins"		"Decarboxylase, Lyase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in many"	6	"skeletal muscle: 21.6"	"Cell line enhanced"	"Detected in many"		"HAP1: 9.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA039160, HPA040229"	Uncertain		Approved	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		"HPA039160: AB_10796222, HPA040229: AB_10796118"	"unprognostic (4.96e-2)"	"unprognostic (1.30e-2)"	"unprognostic (9.83e-2)"	"unprognostic (1.39e-2)"	"unprognostic (5.60e-2)"	"unprognostic (7.32e-2)"		"unprognostic (5.05e-3)"	"unprognostic (8.37e-2)"	"unprognostic (1.23e-2)"	"unprognostic (2.02e-3)"	"unprognostic (1.63e-1)"	"unprognostic (1.98e-5)"	"unprognostic (8.81e-2)"	"unprognostic (4.54e-2)"	"unprognostic (4.39e-1)"	"unprognostic (1.06e-1)"	0.5	0.3	0.2	0.2	0.3	1.0	0.4	0.5	0.7	0.4	0.2	0.0	0.0	0.1	0.2	1.6	1.4	0.2	2.0	2.3	0.2	0.3	0.7	0.2	1.6	0.3	0.3	0.8	0.5	0.3	0.1	0.6	0.5	2.1	0.5	0.1	0.3	0.3	0.0	21.6	0.8	0.2	2.5	0.7	0.5	0.2	1.1	0.0	0.0	1.2	3.3	0.7	0.5	0.3	1.7	0.5	1.9	0.8	0.5	1.3	0.3	1.3	0.3	0.8	1.1	0.9	0.5	1.5	0.6	0.3	0.3	0.2	1.3	1.2	1.1	0.5	0.2	0.9	9.7	0.3	0.4	1.7	0.5	1.6	1.5	0.5	0.4	0.9	3.3	0.4	0.5	0.7	0.3	0.6	1.2	4.0	0.9	1.1	0.6	1.3	1.8	0.5	1.9	2.1	1.0	1.0	1.5	1.1	0.9	1.1	0.7	2.9	1.1	0.8	5.0	1.5	1.4	1.9	0.7	1.6	0.8	0.7	0.6	0.9	1.9	1.9	0.7	0.8	1.0	0.6	0.8	1.2	0.9	0.6	0.4	1.7	1.1	1.0	1.7	0.5	0.8	0.5	1.3	0.3	0.2	0.3	0.5	0.7	0.2	0.3	0.3	0.8	2.1	0.0
GAGE1	CT4.1	ENSG00000205777	"G antigen 1"	Q13068	X	49589496-49608536	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	37	"testis: 36.8"	"Cell line enriched"	"Detected in some"	4	"AN3-CA: 243.3"	"Not detected"	"Not detected"							"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"											HPA043232	Supported		Approved	"Golgi apparatus,Plasma membrane,Cytosol"				"Plasma membrane"	"Golgi apparatus, Cytosol"	"HPA043232: "																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	36.8			0.0		0.0	0.0	0.0	0.6	1.0	0.7	0.8	0.1	0.7	0.0	0.0	0.0	0.0	243.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	56.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	22.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	6.7	0.1	0.3	0.3	0.7	0.0	0.2	0.3	0.3	0.0	0.0	0.6	0.1	0.3	0.7	0.1	0.8	1.0	0.1	0.0										
GAGE12C		ENSG00000237671	"G antigen 12C"	A1L429	X	49532211-49539538	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in single"	57	"testis: 23.7"	"Group enriched"	"Detected in some"	11	"U-2 OS: 7.6;U-266/84: 27.1"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA043232	Supported		Approved	"Golgi apparatus,Plasma membrane,Cytosol"				"Plasma membrane"	"Golgi apparatus, Cytosol"	"HPA043232: "																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	23.7			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	1.5	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	7.6	0.0	0.0	0.0	27.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0										
GAGE12D		ENSG00000227488	"G antigen 12D"	A1L429	X	49541767-49549094	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in single"	57	"testis: 23.7"	"Group enriched"	"Detected in some"	11	"U-2 OS: 7.6;U-266/84: 27.1"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA043232	Supported		Approved	"Golgi apparatus,Plasma membrane,Cytosol"				"Plasma membrane"	"Golgi apparatus, Cytosol"	"HPA043232: "																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	23.7			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	1.5	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	7.6	0.0	0.0	0.0	27.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0										
GAGE12F		ENSG00000236362	"G antigen 12F"	"P0CL80, P0CL82, O76087"	X	49551278-49568218	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	8	"blood: 16.2;testis: 58.6"	"Group enriched"	"Detected in some"	4	"AN3-CA: 133.5;K-562: 130.6"	"Not detected"	"Not detected"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"											HPA043232	Supported		Approved	"Golgi apparatus,Plasma membrane,Cytosol"				"Plasma membrane"	"Golgi apparatus, Cytosol"	"HPA043232: "																		0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0			0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0		0.2	0.0	0.0	0.1	0.0		0.0	0.0		0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	4.9	58.6			0.0		0.0	0.0	0.0	7.0	8.5	3.1	9.1	9.6	14.7	16.2	1.1	0.0	0.0	133.5	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	130.6	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	32.0	0.0	0.5	6.7	0.8	0.0	0.1	0.0	7.7	0.0	0.0	0.0	16.7	0.9	9.1	3.1	3.9	7.5	2.5	7.0	10.3	7.2	0.0	6.2	8.5	7.5	0.9	9.6	6.3	8.5	14.7	16.2										
GAGE12G		ENSG00000215269	"G antigen 12G"	"P0CL81, O76087, P0CL82"	X	49570434-49577754	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	33	"blood: 7.4;stomach 1: 14.0"	"Cell line enriched"	"Detected in some"	7	"AN3-CA: 145.5"	"Not detected"	"Not detected"							"Cell type enhanced"	"Detected in many"		"T-reg: 7.4"	"Low lineage specificity"	"Detected in many"											HPA043232	Supported		Approved	"Golgi apparatus,Plasma membrane,Cytosol"				"Plasma membrane"	"Golgi apparatus, Cytosol"	"HPA043232: "																		0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0			0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.2	0.0	0.0	0.1	0.0		0.0	0.0		0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.0	0.0			0.0		0.0	0.0	0.0	2.6	1.4	1.3	2.5	0.4	7.4	6.2	0.0	0.0	0.0	145.5	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.8	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	21.4	0.0	0.0	1.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.4	0.4	2.5	1.3	0.8	2.2	1.3	1.5	3.6	0.5	0.0	2.6	0.6	3.2	0.0	0.4	1.8	1.4	7.4	6.2										
GAGE12H		ENSG00000224902	"G antigen 12H"	A6NDE8	X	49579983-49587301	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at transcript level"		"Tissue enriched"	"Detected in single"	223	"testis: 22.3"	"Group enriched"	"Detected in some"	52	"A-431: 19.2;U-266/84: 56.6"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA043232	Supported		Approved	"Golgi apparatus,Plasma membrane,Cytosol"				"Plasma membrane"	"Golgi apparatus, Cytosol"	"HPA043232: "																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	22.3			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.5	0.0	0.0	0.0	56.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
GAGE12J	GAGE11	ENSG00000224659	"G antigen 12J"	A6NER3	X	49322057-49329384	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	12	"testis: 20.2"	"Group enriched"	"Detected in some"	5	"AN3-CA: 47.2;K-562: 47.3"	"Not detected"	"Not detected"							"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"											HPA043232	Supported		Approved	"Golgi apparatus,Plasma membrane,Cytosol"				"Plasma membrane"	"Golgi apparatus, Cytosol"	"HPA043232: "																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.1	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	20.2			0.0		0.0	0.0	0.0	0.8	0.6	0.4	0.7	0.8	1.6	0.0	0.0	0.0	0.0	47.2	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	47.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.8	9.7	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.5	0.2	0.4	0.8	0.7	0.9	0.0	0.7	1.6	0.4	0.4	0.8	0.5	0.6	1.4	0.0										
GAGE13	GAGE12A	ENSG00000274274	"G antigen 13"		X	49331616-49338952	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"				"Tissue enriched"	"Detected in some"	17	"testis: 26.8"	"Cell line enriched"	"Detected in some"	6	"AN3-CA: 126.9"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA043232	Supported		Approved	"Golgi apparatus,Plasma membrane,Cytosol"				"Plasma membrane"	"Golgi apparatus, Cytosol"	"HPA043232: "																		0.0	0.0		0.0		0.0	0.0		0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0			0.0	0.0	0.0		0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	26.8			0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	126.9	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	4.6	0.6	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	21.3	0.0	0.1	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6										
GAGE2A	"CT4.2, GAGE2"	ENSG00000189064	"G antigen 2A"	Q6NT46	X	49589529-49596827	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	34	"testis: 46.7"	"Group enriched"	"Detected in some"	5	"Karpas-707: 19.2;T-47d: 66.1;WM-115: 72.7"	"Low cancer specificity"	"Detected in many"							"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"											HPA043232	Supported		Approved	"Golgi apparatus,Plasma membrane,Cytosol"				"Plasma membrane"	"Golgi apparatus, Cytosol"	"HPA043232: "															"unprognostic (1.29e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	46.7			0.0		0.0	0.0	0.0	1.0	0.7	0.4	0.7	0.5	0.6	1.3	0.0	0.0	0.0	0.3	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.8	0.0	0.0	0.0	0.0	0.0	0.1	19.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.8	0.0	66.1	0.0	0.0	10.7	2.3	0.0	0.0	0.2	2.8	0.0	0.6	0.0	72.7	0.4	0.6	0.1	0.1	0.7	0.0	1.0	0.5	0.6	0.0	0.4	0.5	0.2	0.0	0.5	0.6	0.7	0.6	1.3										
GAGE2E	GAGE8	ENSG00000275113	"G antigen 2E"		X	49341192-49345922	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Group enriched"	"Detected in some"	52	"blood: 5.8;stomach 1: 18.4;testis: 4.9"	"Cell line enhanced"	"Detected in some"		"AN3-CA: 141.3;K-562: 67.6;T-47d: 34.2"	"Not detected"	"Not detected"							"Cell type enhanced"	"Detected in many"		"T-reg: 5.8"	"Low lineage specificity"	"Detected in many"											HPA043232	Approved		Approved	"Golgi apparatus,Plasma membrane,Cytosol"				"Plasma membrane"	"Golgi apparatus, Cytosol"	"HPA043232: "																		0.0	0.0		0.0		0.0	0.0		0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0			0.0	0.0	0.0		0.0		0.0	0.0		0.1	0.0	0.0	0.0	0.0	0.0		0.0	18.4	4.9			0.0		0.0	0.0		2.5	2.6	0.7	1.2	0.7	5.8	0.2	0.0	0.0	0.0	141.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	67.6	1.6	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	34.2	0.0	0.4	8.7	0.3	0.0	0.0	0.1	2.6	0.0	0.1	0.0	14.8	0.7	1.2	0.3	1.0	0.0	0.0	1.5	0.4	2.2	0.0	2.5	4.9	0.0	0.7	0.7	0.0	2.6	5.8	0.2										
GALE	SDR1E1	ENSG00000117308	UDP-galactose-4-epimerase	Q14376	1	23795599-23800804	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Carbohydrate metabolism, Galactose metabolism"	Isomerase	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"CAPAN-2: 54.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007340			Approved	"Nucleoplasm,Plasma membrane,Cytosol"				"Nucleoplasm, Plasma membrane, Cytosol"		"HPA007340: AB_1078934"	"unprognostic (1.65e-1)"	"unprognostic (1.78e-1)"	"unprognostic (5.25e-2)"	"unprognostic (1.41e-2)"	"unprognostic (3.03e-3)"	"unprognostic (1.17e-2)"	"unprognostic (3.19e-3)"	"unprognostic (1.84e-1)"	"unprognostic (1.59e-1)"	"unprognostic (2.65e-1)"	"unprognostic (1.56e-2)"	"unprognostic (1.34e-1)"	"unprognostic (2.25e-1)"	"unprognostic (7.51e-2)"	"unprognostic (2.12e-1)"	"prognostic favourable (2.68e-4)"	"unprognostic (1.41e-2)"	4.4	5.5	4.8	5.6	6.1	1.8	5.0	4.3	8.7	9.1	22.3	3.2	12.4	20.0	3.0	6.0	26.2	6.4	34.7	3.7	4.0	4.1	18.2	26.1	7.7	3.9	3.7	5.2	2.4	15.9	7.7	3.5	29.4	3.5	4.8	23.8	5.5	32.1	6.9	1.7	3.9	30.4	4.1	3.6	8.6	46.7	3.4	2.6	3.7	2.3	9.8	19.6	8.1	8.4	3.1	10.6	2.0	18.6	19.4	5.2	4.7	16.2	19.5	7.8	12.4	2.9	4.1	7.6	11.1	15.0	19.7	14.7	17.8	54.5	3.8	15.6	6.5	18.0	6.9	28.4	15.0	8.2	4.5	10.9	9.9	19.3	29.8	4.7	3.2	8.8	15.0	18.1	45.5	16.9	12.1	1.0	14.0	17.3	7.7	5.0	2.2	19.0	9.2	7.6	4.9	31.9	10.9	3.0	6.9	20.1	18.3	19.7	13.4	3.9	9.2	14.4	21.4	14.8	13.6	5.0	12.1	5.0	15.2	20.0	7.7	1.1	7.7	1.7	5.1	15.5	5.2	3.1	3.1	4.1	10.6	1.0	3.6	2.5	2.0	19.4	18.6	3.0	5.1	4.7	4.8	6.1	4.3	8.7	4.0	4.1	3.7	5.2	3.5	2.6
GALNT10	GalNAc-T10	ENSG00000164574	"Polypeptide N-acetylgalactosaminyltransferase 10"	Q86SR1	5	154190730-154420984	"Enzymes, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"ovary: 43.7"	"Cell line enhanced"	"Detected in many"		"TIME: 48.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007525	Approved		Approved	"Nucleoplasm,Golgi apparatus,Plasma membrane"	"Intracellular and membrane"		830000	"Plasma membrane"	"Nucleoplasm, Golgi apparatus"	"HPA007525: AB_1849443"	"unprognostic (6.99e-2)"	"unprognostic (4.33e-2)"	"unprognostic (9.85e-2)"	"prognostic favourable (3.33e-6)"	"unprognostic (1.63e-1)"	"unprognostic (6.98e-2)"	"unprognostic (6.95e-3)"	"unprognostic (2.38e-1)"	"unprognostic (3.34e-1)"	"prognostic unfavourable (5.69e-4)"	"unprognostic (2.88e-3)"	"unprognostic (2.63e-1)"	"unprognostic (1.54e-1)"	"unprognostic (7.76e-3)"	"unprognostic (1.22e-1)"	"unprognostic (1.61e-2)"	"unprognostic (3.08e-1)"	9.5	13.5	8.4	15.4	9.1	10.1	8.7	3.2	6.2	15.9	10.6	14.4	1.0	8.8	4.9	11.5	5.9	9.2	17.8	7.7	6.9	7.5	6.8	3.4	10.1	11.5	7.2	5.2	43.7	9.2	14.1	9.7	5.2	10.1	8.3	9.4	31.6	11.6	2.4	5.6	4.0	12.4	14.1	7.7	16.7	13.8	4.3	9.2	5.6	10.6	4.2	9.3	7.5	10.0	4.7	3.1	5.7	3.8	3.9	7.5	2.1	7.4	25.4	6.2	5.4	13.2	11.8	4.8	21.5	12.0	8.6	8.2	3.5	17.1	4.8	15.2	36.1	1.3	2.8	16.8	7.9	12.6	2.0	13.3	4.8	4.8	10.2	2.8	13.0	14.6	3.9	6.9	10.3	16.4	3.0	15.4	14.6	7.7	0.3	2.0	2.4	5.2	1.5	3.3	4.8	11.9	5.1	0.8	2.0	9.5	35.6	2.8	13.8	2.2	48.2	20.9	5.0	5.1	22.8	4.4	4.3	2.6	13.7	5.7	6.3	3.4	2.7	5.3	7.5	3.6	6.6	4.5	4.3	4.8	3.1	4.7	1.9	5.3	5.7	3.9	3.8	2.7	3.5	2.1	8.4	9.1	3.2	6.2	6.9	7.5	7.2	5.2	10.1	9.2
GAS2		ENSG00000148935	"Growth arrest specific 2"	O43903	11	22625642-22813055	"Predicted intracellular proteins"	"Apoptosis, Cell cycle, Cell shape, Growth arrest"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 37.2;lymphoid tissue: 19.6;pancreas: 22.7"	"Group enriched"	"Detected in some"	10	"Hep G2: 19.6;Karpas-707: 40.2;SCLC-21H: 11.7;U-266/84: 13.4"	"Cancer enhanced"	"Detected in many"		"liver cancer: 4.0"	"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA058904	Enhanced		Approved	"Nucleoplasm,Nucleoli,Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"	"Nucleoplasm, Nucleoli"	"HPA058904: "	"unprognostic (5.48e-3)"	"unprognostic (1.00e-1)"	"unprognostic (6.85e-2)"	"unprognostic (1.16e-2)"	"unprognostic (7.87e-2)"	"unprognostic (2.08e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.23e-1)"	"unprognostic (3.71e-2)"	"unprognostic (1.70e-2)"	"unprognostic (3.30e-5)"	"prognostic favourable (6.13e-4)"	"unprognostic (5.85e-2)"	"unprognostic (4.22e-2)"	"unprognostic (7.94e-2)"	"unprognostic (3.58e-2)"	0.7	1.1	2.1	1.1	3.6	0.4	0.9	0.9	2.2	1.2	0.7	1.4	1.2	2.0	1.1	1.3	1.0	1.5	2.7	3.6	2.1	2.5	5.3	37.2	1.3	1.1	4.3	1.2	2.3	22.7	0.5	4.8	0.7	4.5	1.3	0.7	0.5	2.2	0.9	4.8	1.0	1.8	0.6	8.6	1.5	2.6	1.1	3.2	19.6	1.1	3.0	1.0	1.8	0.7	1.0	0.6	0.3	0.0	0.1	1.7	0.1	0.0	0.0	0.8	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.3	0.0	0.0	0.0	0.4	0.0	0.0	0.7	0.2	0.1	0.0	19.6	0.2	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.7	40.2	0.0	0.1	0.1	0.0	0.1	0.0	0.4	0.2	2.0	0.0	0.5	11.7	0.6	0.0	0.0	0.2	0.0	0.0	0.8	0.0	0.2	0.5	0.0	0.5	13.4	0.0	0.2	0.0	0.2	0.0	0.0	0.3	0.2	0.0	1.7	1.0	0.4	0.0	0.0	0.9	1.6	0.4	0.0	0.1	0.0	0.6	0.3	0.1	2.1	3.6	0.9	2.2	2.1	2.5	4.3	1.2	4.5	3.2
GAS2L1	GAR22	ENSG00000185340	"Growth arrest specific 2 like 1"	Q99501	22	29306582-29312785	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"ductus deferens: 40.5"	"Cell line enhanced"	"Detected in many"		"U-138 MG: 33.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"classical monocyte: 2.0;eosinophil: 3.1"	"Group enriched"	"Detected in many"	10	"dendritic cells: 1.1;granulocytes: 3.1;monocytes: 2.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019858	Approved		Approved	"Plasma membrane,Cell Junctions"				"Plasma membrane"	"Cell Junctions"	"HPA019858: AB_1849486"	"unprognostic (3.66e-1)"	"unprognostic (5.22e-2)"	"unprognostic (1.38e-1)"	"unprognostic (4.95e-3)"	"unprognostic (1.77e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.84e-3)"	"unprognostic (8.99e-2)"	"unprognostic (1.28e-1)"	"unprognostic (6.05e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.21e-1)"	"prognostic favourable (8.44e-4)"	"unprognostic (4.23e-2)"	"unprognostic (9.04e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.19e-2)"	15.1	10.7	15.2	5.3	13.4	5.4	7.6	10.5	19.8	4.5	5.6	6.8	40.5	17.9	5.1	8.4	8.6	4.6	4.3	7.0	12.9	8.1	6.0	6.6	7.5	2.2	11.3	10.2	2.9	10.0	4.6	6.8	4.3	9.5	7.1	2.2	3.2	12.7	22.9	4.9	22.4	13.0	4.5	10.0	11.5	8.3	16.6	8.8	0.0	4.5	9.2	3.5	3.9	4.7	0.0	1.1	3.1	2.0	0.0	0.2	1.2	8.2	9.6	1.5	6.1	2.4	2.3	9.6	12.3	3.8	5.2	2.7	4.3	5.9	0.0	5.6	6.5	25.1	2.5	7.0	0.9	11.2	1.2	10.8	7.6	3.0	3.0	0.1	7.6	2.4	4.8	5.0	2.0	6.9	5.1	1.7	3.7	7.0	0.2	6.0	2.2	21.7	0.2	4.3	0.7	3.1	5.3	0.5	8.1	9.5	12.8	6.8	12.7	1.7	14.7	33.1	22.8	14.7	12.3	0.1	0.1	0.1	14.6	0.4	8.1	0.0	2.0	3.1	0.0	0.3	0.0	0.0	0.1	0.0	1.1	0.0	0.2	0.0	0.5	0.0	1.4	0.0	0.0	1.2	15.2	13.4	10.5	19.8	12.9	8.1	11.3	10.2	9.5	8.8
GAS7	"KIAA0394, MGC1348"	ENSG00000007237	"Growth arrest specific 7"	O60861	17	9910609-10198551	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"Differentiation, Neurogenesis"	"Developmental protein"	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 86.2"	"Cell line enriched"	"Detected in some"	9	"WM-115: 107.7"	"Cancer enhanced"	"Detected in all"		"melanoma: 54.6"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"classical monocyte: 17.6"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004838, HPA064678"	Enhanced		Approved	"Plasma membrane,Actin filaments,Focal adhesion sites"				"Plasma membrane"	"Actin filaments, Focal adhesion sites"	"HPA004838: AB_2667263, HPA064678: "	"unprognostic (1.68e-2)"	"unprognostic (2.84e-3)"	"unprognostic (1.80e-1)"	"unprognostic (1.28e-3)"	"unprognostic (1.15e-1)"	"unprognostic (1.01e-2)"	"unprognostic (7.32e-2)"	"unprognostic (7.16e-2)"	"unprognostic (2.88e-1)"	"unprognostic (1.50e-2)"	"unprognostic (2.48e-1)"	"unprognostic (1.79e-1)"	"unprognostic (1.94e-3)"	"unprognostic (6.48e-2)"	"unprognostic (8.78e-2)"	"unprognostic (3.08e-2)"	"prognostic unfavourable (6.89e-4)"	19.1	6.5	22.1	15.4	40.3	18.7	10.8	86.2	64.7	22.6	9.3	33.4	1.7	5.2	9.7	4.4	17.0	12.6	11.5	23.1	25.8	15.0	1.5	2.1	9.9	5.9	28.1	25.0	5.9	2.8	1.4	1.7	11.0	14.2	3.7	8.7	7.7	4.0	8.2	3.9	21.2	7.4	16.3	33.8	10.0	4.2	11.8	22.2	2.7	2.5	2.7	7.2	11.7	7.8	0.4	3.6	11.0	17.6	2.8	2.1	4.4	0.0	0.1	0.1	0.2	3.4	4.8	0.0	0.1	0.0	0.5	0.2	0.0	0.0	1.3	0.3	1.3	0.0	0.0	0.0	0.3	0.0	0.3	0.0	0.2	0.1	1.1	0.3	9.9	0.9	0.0	1.0	0.0	0.0	0.0	0.1	0.0	0.0	10.4	3.1	0.5	0.0	2.7	0.0	9.6	0.0	0.0	0.0	0.6	0.0	0.0	12.4	0.5	4.9	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.1	7.0	107.7	0.4	17.6	10.8	2.1	4.7	0.7	0.3	0.2	1.0	3.6	0.4	0.2	1.0	11.0	2.8	3.1	0.6	0.0	4.4	22.1	40.3	86.2	38.8	25.8	15.0	28.1	25.0	14.2	22.2
GAS8	"DRC4, GAS11"	ENSG00000141013	"Growth arrest specific 8"	O95995	16	90019629-90044975	"Disease related genes, Plasma proteins, Predicted intracellular proteins"			"Ciliopathy, Primary ciliary dyskinesia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"MCF7: 25.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041311, HPA048238"	Approved		Approved	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		"HPA041311: , HPA048238: "	"unprognostic (2.23e-3)"	"unprognostic (1.26e-1)"	"unprognostic (1.73e-1)"	"prognostic favourable (3.01e-4)"	"unprognostic (1.73e-1)"	"unprognostic (3.91e-1)"	"unprognostic (1.96e-1)"	"unprognostic (1.82e-1)"	"unprognostic (1.16e-1)"	"unprognostic (4.47e-1)"	"prognostic favourable (7.67e-4)"	"unprognostic (3.06e-2)"	"prognostic favourable (1.09e-7)"	"unprognostic (1.98e-1)"	"unprognostic (2.46e-1)"	"unprognostic (2.03e-1)"	"unprognostic (4.19e-2)"	7.1	11.1	8.5	6.5	13.2	2.3	7.6	13.5	12.2	11.7	6.8	10.0	10.8	4.1	12.7	16.2	7.8	26.5	11.6	21.0	8.7	9.8	12.4	6.3	9.9	4.0	8.9	8.9	12.8	12.9	23.2	22.0	3.5	10.1	8.9	4.6	11.0	16.2	12.6	18.8	4.2	4.2	8.4	7.5	4.2	7.6	16.1	6.4	1.7	15.5	5.5	5.2	6.6	5.1	2.5	4.8	4.3	5.0	0.0	3.7	2.3	10.6	8.6	1.1	5.4	5.1	3.9	9.2	2.1	5.4	8.8	2.6	8.6	8.1	0.6	5.9	4.4	10.6	3.6	6.3	1.9	0.0	6.4	2.2	5.5	9.8	5.7	1.2	1.8	5.2	3.6	6.6	3.0	5.2	8.5	1.2	3.7	25.6	1.5	5.4	7.2	4.5	0.4	10.1	0.6	11.0	5.2	9.1	6.6	11.3	6.1	12.9	11.5	5.0	3.6	5.4	6.3	2.9	5.1	2.0	3.2	0.0	13.8	1.7	9.4	4.3	3.1	3.7	1.8	5.0	1.8	1.2	2.8	3.7	4.4	2.5	2.3	2.0	4.0	0.0	3.1	4.8	3.5	2.3	8.5	13.2	13.5	12.2	8.7	9.8	8.9	8.9	10.1	6.4
GCA	GCL	ENSG00000115271	Grancalcin	P28676	2	162318840-162371595	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	5	"blood: 112.7;bone marrow: 116.0;brain: 30.2;lymphoid tissue: 51.8"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"eosinophil: 41.1;neutrophil: 112.7"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 112.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA035033, HPA035034"	Enhanced		Supported	"Plasma membrane,Cytosol"			890000	Cytosol	"Plasma membrane"	"HPA035033: AB_10669854, HPA035034: AB_10669900"	"unprognostic (9.62e-2)"	"unprognostic (9.76e-2)"	"unprognostic (3.33e-1)"	"unprognostic (3.82e-2)"	"unprognostic (2.60e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.33e-3)"	"unprognostic (1.36e-1)"	"unprognostic (8.87e-2)"	"unprognostic (2.49e-2)"	"unprognostic (1.20e-1)"	"unprognostic (9.78e-2)"	"unprognostic (6.56e-2)"	"unprognostic (5.80e-2)"	"unprognostic (3.07e-1)"	"unprognostic (3.06e-2)"	"unprognostic (1.32e-2)"	13.1	6.8	13.4	24.8	21.3	116.0	7.8	6.9	15.8	6.0	7.7	15.3	3.2	8.2	4.6	11.0	5.0	7.2	9.7	11.2	15.9	13.0	8.5	7.6	15.6	51.8	26.0	9.7	4.4	11.5	4.8	8.1	10.6	24.6	5.7	8.6	3.7	6.9	4.9	2.2	3.7	7.8	7.7	30.2	50.0	10.3	10.7	20.8	5.8	7.4	2.5	10.3	10.0	6.3	3.1	8.9	112.7	18.2	0.3	1.3	8.4	1.3	2.1	5.8	0.0	1.4	1.2	0.2	2.1	6.1	3.4	6.2	4.8	16.3	1.9	15.0	0.1	0.8	2.2	6.9	4.2	9.1	9.2	17.1	1.5	9.1	1.7	21.4	5.0	1.5	2.4	3.1	0.7	0.4	0.3	6.6	0.2	16.8	0.4	12.4	3.7	8.3	7.4	1.4	9.6	17.9	9.6	3.8	6.5	2.8	12.6	10.6	8.6	9.6	0.4	0.8	6.2	9.7	3.2	6.3	11.7	0.3	5.3	8.4	4.0	4.4	18.2	41.1	0.4	10.7	0.5	3.0	0.6	0.6	8.9	3.1	1.1	0.7	112.7	0.3	8.0	2.2	1.3	8.4	13.4	21.3	6.9	15.8	15.9	13.0	26.0	9.7	24.6	20.8
GCC1	"FLJ22035, GCC1P, GCC88, MGC20706"	ENSG00000179562	"GRIP and coiled-coil domain containing 1"	Q96CN9	7	127580618-127593611	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019369, HPA021323"	Enhanced		Supported	"Golgi apparatus,Plasma membrane,Cytosol"				"Golgi apparatus"	"Plasma membrane, Cytosol"	"HPA019369: AB_1849552, HPA021323: AB_1849554"	"unprognostic (1.09e-1)"	"unprognostic (4.96e-2)"	"unprognostic (1.83e-1)"	"unprognostic (9.51e-2)"	"unprognostic (1.07e-1)"	"unprognostic (7.20e-2)"	"unprognostic (1.26e-1)"	"unprognostic (2.54e-2)"	"unprognostic (1.83e-1)"	"unprognostic (5.08e-2)"	"unprognostic (4.81e-2)"	"unprognostic (4.50e-3)"	"unprognostic (1.17e-3)"	"unprognostic (4.17e-3)"	"unprognostic (1.22e-1)"	"unprognostic (8.65e-2)"	"unprognostic (9.96e-2)"	11.5	14.1	13.4	11.0	13.7	17.7	14.2	13.9	12.8	11.6	10.2	12.8	8.6	9.6	13.2	10.3	14.1	10.7	12.2	9.0	10.2	7.9	9.8	17.8	10.4	12.3	19.8	7.6	13.6	12.7	14.8	14.5	13.6	13.0	11.5	9.6	8.4	13.8	11.0	12.5	14.5	12.9	8.4	12.1	15.5	12.7	20.7	17.9	15.7	11.8	9.5	14.4	10.3	29.2	8.4	7.9	15.6	9.1	10.2	11.6	8.8	8.2	11.2	5.0	10.7	11.1	7.7	6.9	7.3	8.5	7.3	9.2	9.3	5.7	7.6	4.4	6.7	9.2	7.1	8.0	7.9	10.7	6.5	5.6	6.1	4.9	16.5	9.7	9.4	7.2	21.9	7.8	15.5	6.9	9.1	8.8	8.2	8.3	9.3	8.4	10.3	8.8	6.7	5.4	8.7	6.3	6.4	7.9	11.4	7.8	37.2	14.5	6.3	7.0	8.8	10.9	3.5	9.4	8.3	24.2	10.5	4.9	10.7	9.9	11.0	5.8	8.1	15.0	9.1	8.2	11.6	8.4	8.2	8.9	7.9	8.0	6.8	6.7	15.6	10.2	9.1	4.6	7.6	8.8	13.4	13.7	13.9	12.8	10.2	7.9	19.8	7.6	13.0	17.9
GCLM	GLCLR	ENSG00000023909	"Glutamate-cysteine ligase modifier subunit"	P48507	1	93885205-93909456	"Cancer-related genes, Predicted intracellular proteins"	"Glutathione biosynthesis"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009568, HPA023696, CAB040554"	Uncertain		Approved	"Nucleoplasm,Plasma membrane,Cytosol"			1000000	"Nucleoplasm, Cytosol"	"Plasma membrane"	"CAB009568: AB_2107835, CAB040554: , HPA023696: AB_1849560"	"unprognostic (2.31e-1)"	"unprognostic (7.92e-2)"	"unprognostic (8.85e-3)"	"unprognostic (1.56e-2)"	"unprognostic (2.83e-2)"	"unprognostic (4.64e-2)"	"prognostic unfavourable (9.83e-6)"	"unprognostic (2.37e-1)"	"unprognostic (1.07e-1)"	"unprognostic (3.53e-1)"	"unprognostic (3.51e-2)"	"unprognostic (3.89e-2)"	"unprognostic (2.19e-2)"	"unprognostic (1.09e-2)"	"unprognostic (1.79e-1)"	"unprognostic (2.43e-1)"	"unprognostic (2.34e-3)"	10.3	17.5	7.0	6.0	7.7	11.3	23.9	5.7	8.9	4.5	22.8	4.2	11.5	16.6	3.5	6.5	8.8	12.8	12.5	7.7	6.8	8.9	17.8	41.7	8.4	10.4	9.2	5.7	4.6	6.9	6.3	5.1	10.3	8.7	5.3	5.2	6.4	6.7	6.4	19.2	3.4	20.0	3.4	7.7	6.9	6.1	3.2	2.8	5.6	15.0	23.0	8.6	8.9	8.0	3.2	1.9	3.3	0.7	4.6	6.7	1.2	14.0	22.2	2.4	4.8	8.3	5.2	9.5	16.8	10.5	12.8	9.6	3.7	8.3	5.3	33.7	10.8	14.2	3.6	6.8	10.3	14.4	4.9	37.1	15.2	16.0	15.6	13.6	5.9	6.4	2.6	26.0	4.2	13.9	14.7	7.9	9.2	2.7	9.8	3.1	8.4	10.6	4.6	7.4	7.8	9.1	16.4	5.8	2.4	15.8	12.5	5.8	2.8	8.5	14.6	13.4	7.9	25.2	25.1	7.1	9.1	5.5	11.1	7.7	4.7	3.3	0.7	1.3	5.3	0.4	3.1	2.6	5.0	6.7	0.6	3.2	3.2	3.2	2.9	4.6	0.5	1.9	1.3	1.2	7.0	7.7	5.7	8.9	6.8	8.9	9.2	5.7	8.7	2.8
GFOD1	"ADG-90, C6orf114, FLJ20330"	ENSG00000145990	"Glucose-fructose oxidoreductase domain containing 1"	Q9NXC2	6	13357830-13487662	"Predicted intracellular proteins, Predicted secreted proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HEL: 18.4;HMC-1: 28.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"eosinophil: 12.8;NK-cell: 11.4"	"Group enriched"	"Detected in many"	5	"granulocytes: 12.8;NK-cells: 11.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029096	Uncertain		Approved	"Nucleoplasm,Plasma membrane,Cytosol"	"Secreted - unknown location"			"Nucleoplasm, Cytosol"	"Plasma membrane"	"HPA029096: AB_10602320"	"unprognostic (5.00e-2)"	"unprognostic (1.34e-2)"	"unprognostic (1.08e-1)"	"prognostic unfavourable (2.29e-5)"	"unprognostic (8.49e-2)"	"unprognostic (1.95e-3)"	"unprognostic (1.36e-2)"	"unprognostic (2.81e-1)"	"unprognostic (2.34e-2)"	"unprognostic (3.11e-2)"	"unprognostic (6.49e-2)"	"unprognostic (1.15e-1)"	"prognostic unfavourable (6.72e-5)"	"unprognostic (9.79e-2)"	"unprognostic (1.61e-1)"	"unprognostic (3.56e-1)"	"unprognostic (4.66e-3)"	15.7	3.8	9.4	4.6	11.5	17.5	8.7	28.5	22.3	5.4	5.0	4.0	0.5	3.5	4.0	2.6	12.1	4.3	11.8	18.5	11.9	7.1	2.1	6.6	8.2	6.6	6.3	14.2	1.7	2.3	3.9	3.3	6.8	6.6	4.4	5.2	1.5	3.4	3.0	15.5	4.7	5.6	8.3	4.2	12.0	8.2	1.5	4.1	1.9	3.9	4.5	6.9	4.7	7.6	2.3	0.2	12.8	0.8	11.4	1.4	0.8	7.2	0.7	0.6	1.3	1.1	1.1	0.8	0.6	0.3	0.4	0.2	0.2	0.5	9.9	10.4	0.7	6.5	2.0	3.1	0.4	0.7	3.7	18.4	3.8	3.8	1.5	5.2	28.5	0.6	2.5	0.9	2.7	5.6	0.5	0.9	0.8	2.3	1.2	3.2	1.0	2.1	4.0	1.3	5.1	0.3	1.4	3.4	0.6	2.4	0.4	2.3	0.6	0.5	7.5	0.9	2.0	2.1	3.3	8.3	4.7	11.9	0.8	3.1	0.2	0.1	0.4	12.8	1.4	0.7	0.2	2.3	0.2	0.6	0.2	1.9	0.1	0.5	0.3	11.4	0.8	0.0	0.1	0.8	9.4	11.5	28.5	18.7	11.9	7.1	6.3	14.2	6.6	4.1
GINM1	"C6orf72, dJ12G14.2"	ENSG00000055211	"Glycoprotein integral membrane 1"	Q9NU53	6	149566294-149591748	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA017210, HPA041679"	Approved		Approved	"Nucleoli fibrillar center,Plasma membrane"			8700	"Nucleoli fibrillar center, Plasma membrane"		"HPA017210: AB_1845743, HPA041679: "	"unprognostic (6.09e-3)"	"unprognostic (2.19e-2)"	"unprognostic (2.38e-1)"	"unprognostic (2.48e-1)"	"unprognostic (7.24e-2)"	"unprognostic (1.32e-3)"	"unprognostic (3.18e-2)"	"unprognostic (1.27e-1)"	"unprognostic (2.31e-1)"	"unprognostic (8.23e-2)"	"unprognostic (1.05e-1)"	"unprognostic (2.10e-2)"	"unprognostic (2.09e-2)"	"unprognostic (2.88e-2)"	"unprognostic (2.64e-2)"	"unprognostic (4.87e-2)"	"unprognostic (4.79e-3)"	32.1	26.3	21.3	17.8	34.7	20.0	51.5	26.1	27.6	28.8	25.7	22.4	29.0	14.2	29.3	36.9	21.5	24.1	24.3	48.2	20.3	18.3	51.3	29.6	28.4	32.9	43.6	21.4	31.7	28.3	27.1	17.5	34.0	23.0	23.6	19.8	21.7	20.7	40.1	29.2	20.9	17.3	36.7	31.3	18.6	22.8	31.0	30.2	11.5	41.5	21.6	13.1	28.6	22.6	16.8	12.6	23.7	16.0	8.0	8.1	7.7	7.7	5.6	9.1	12.3	49.3	29.6	14.9	26.8	31.4	20.3	25.5	7.3	10.5	5.8	14.8	25.2	16.1	5.9	13.3	26.7	9.6	13.1	5.5	5.4	8.7	18.8	10.8	5.3	32.8	11.6	17.2	11.9	21.8	7.1	9.6	19.1	10.0	6.8	8.1	3.2	6.0	7.2	16.4	4.3	28.9	6.9	5.8	5.6	26.6	15.8	5.5	9.9	11.0	15.2	11.0	11.6	28.0	17.6	9.5	11.0	7.2	20.4	9.8	10.1	11.9	13.7	17.1	6.8	13.2	7.9	16.8	8.1	7.4	10.0	11.7	7.9	6.4	23.7	8.0	16.0	12.6	7.5	7.7	21.3	34.7	26.1	27.6	20.3	18.3	43.6	21.4	23.0	30.2
GIPC1	"C19orf3, GIPC, GLUT1CBP, Hs.6454, NIP, RGS19IP1, SEMCAP, SYNECTIN, TIP-2"	ENSG00000123159	"GIPC PDZ domain containing family member 1"	O14908	19	14477760-14496149	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043958, HPA061786"	Approved		Approved	"Nucleoplasm,Plasma membrane,Cell Junctions"				"Plasma membrane, Cell Junctions"	Nucleoplasm	"HPA043958: AB_10963436, HPA061786: AB_2756319"	"unprognostic (2.80e-1)"	"unprognostic (1.16e-1)"	"unprognostic (8.21e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.82e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.18e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.19e-1)"	"unprognostic (4.82e-2)"	"unprognostic (3.53e-2)"	"unprognostic (7.72e-2)"	"unprognostic (1.04e-2)"	"unprognostic (7.17e-3)"	"unprognostic (1.70e-1)"	"unprognostic (1.16e-1)"	"unprognostic (8.82e-2)"	16.4	15.1	17.4	12.0	21.0	2.0	11.2	12.1	28.8	19.4	51.0	29.7	15.3	14.2	11.9	14.9	71.2	14.4	21.2	17.9	16.9	14.8	18.7	16.9	20.5	7.9	18.3	23.0	10.2	15.1	6.5	12.4	24.0	23.0	14.0	23.9	15.2	22.1	19.6	26.8	40.4	13.3	15.8	21.8	10.8	35.7	6.5	16.6	11.1	18.2	26.0	24.7	17.1	26.3	2.0	4.0	2.4	1.2	1.5	12.1	1.9	65.4	30.4	9.3	14.6	8.6	8.7	7.4	24.6	12.4	20.3	18.4	16.3	24.8	0.9	46.3	17.3	37.6	8.0	20.6	6.9	6.8	14.2	12.8	20.8	15.8	26.5	1.3	15.8	10.0	20.6	12.3	10.8	13.6	5.9	11.3	10.2	48.8	4.2	2.6	10.1	30.5	4.3	7.8	8.7	25.0	57.4	8.7	9.7	13.7	33.9	31.5	21.3	7.1	23.5	28.7	15.8	40.0	26.2	10.6	13.4	3.3	24.0	10.4	30.1	2.4	0.8	0.1	5.8	1.2	5.4	2.0	5.9	5.9	1.2	1.0	4.9	3.9	0.3	1.5	0.5	4.0	12.1	1.9	17.4	21.0	12.1	28.8	16.9	14.8	18.3	23.0	23.0	16.6
GLIS2	NPHP7	ENSG00000126603	"GLIS family zinc finger 2"	Q9BZE0	16	4314761-4339597	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Differentiation, Neurogenesis, Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding, Repressor"	"Ciliopathy, Nephronophthisis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"U-2197: 27.5"	"Low cancer specificity"	"Detected in all"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA056976			Approved	"Nucleoplasm,Plasma membrane,Cytosol"				"Nucleoplasm, Plasma membrane, Cytosol"		"HPA056976: "	"unprognostic (2.86e-1)"	"unprognostic (3.27e-2)"	"unprognostic (5.96e-2)"	"prognostic unfavourable (1.59e-5)"	"unprognostic (3.76e-1)"	"unprognostic (5.15e-2)"	"unprognostic (8.13e-2)"	"unprognostic (6.65e-2)"	"unprognostic (3.94e-1)"	"unprognostic (2.37e-3)"	"unprognostic (3.59e-1)"	"unprognostic (2.48e-1)"	"prognostic favourable (8.06e-6)"	"unprognostic (1.59e-3)"	"unprognostic (3.18e-2)"	"unprognostic (1.24e-2)"	"unprognostic (4.40e-3)"	3.6	6.0	1.5	2.3	1.6	0.0	2.4	4.3	2.4	5.0	4.4			1.2	5.8	1.0	1.2	4.3	7.4	8.4	0.9	1.2	11.5	0.3	7.8	1.4	1.4		8.0	3.2	2.2	5.3	5.7		5.6	0.2		3.0	5.8	1.1	1.5	1.2	4.3	0.2	0.8	2.7	1.9			5.3		0.5	5.6	2.7	0.3	0.0	0.2	0.0	0.0	0.1	0.0	4.0	10.4	1.7	3.8	1.4	5.6	3.5	4.4	4.2	1.6	1.2	2.8	2.9	0.0	7.7	4.8	2.5	1.0	4.5	0.1	4.6	0.0	0.0	7.9	1.4	6.1	0.0	0.8	3.3	1.1	1.4	0.7	1.5	0.3	1.8	1.1	2.6	0.1	0.8	3.7	1.8	6.7	2.3	4.7	0.0	0.1	0.7	3.6	5.1	2.2	1.0	6.1	0.7	3.4	2.3	3.9	27.5	1.3	0.8	0.5	1.2	0.9	0.2	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0										
GMIP	ARHGAP46	ENSG00000089639	"GEM interacting protein"	Q9P107	19	19629476-19643667	"Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 32.7;bone marrow: 31.0;lymphoid tissue: 40.0"	"Cell line enhanced"	"Detected in many"		"HMC-1: 43.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042484, HPA045481"	Enhanced		Enhanced	"Nucleoplasm,Plasma membrane,Cytosol"				"Nucleoplasm, Cytosol"	"Plasma membrane"	"HPA042484: , HPA045481: "	"unprognostic (7.54e-2)"	"unprognostic (5.35e-3)"	"unprognostic (3.10e-3)"	"unprognostic (4.54e-3)"	"unprognostic (1.44e-1)"	"unprognostic (1.24e-3)"	"unprognostic (1.23e-2)"	"unprognostic (4.29e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.30e-1)"	"unprognostic (6.85e-2)"	"unprognostic (6.75e-3)"	"prognostic unfavourable (3.97e-5)"	"prognostic favourable (3.03e-4)"	"unprognostic (4.92e-2)"	"unprognostic (2.54e-1)"	"prognostic favourable (5.15e-4)"	6.1	2.8	3.5	20.3	4.9	31.0	4.0	0.9	4.1	2.9	6.9	4.3	2.7	7.0	2.7	3.2	6.2	4.4	7.9	3.3	4.3	3.4	4.2	3.9	11.7	28.0	4.2	2.5	2.4	4.6	10.6	3.0	3.9	3.4	4.1	4.6	2.7	6.0	4.5	1.5	4.9	15.3	2.9	4.9	40.0	11.1	2.2	3.1	26.8	6.2	2.7	23.2	6.1	4.5	6.6	6.7	32.7	13.9	4.2	6.4	4.6	4.4	2.0	2.7	3.0	3.0	1.6	11.0	2.8	2.4	1.7	1.6	1.6	5.9	10.8	5.7	1.9	5.3	1.7	3.0	1.1	3.7	2.8	3.4	3.2	1.7	0.9	9.6	43.0	2.0	2.1	1.8	0.9	3.8	2.3	3.9	1.8	6.5	6.0	15.9	1.6	3.7	10.4	1.2	6.2	3.2	10.5	2.3	7.1	3.8	4.0	1.6	3.7	13.8	6.8	3.1	1.8	3.5	2.0	2.0	0.8	8.9	2.0	12.6	2.1	2.9	8.3	21.5	6.4	10.6	5.9	5.9	4.0	5.7	6.7	6.6	4.5	4.6	32.7	4.2	13.9	6.1	4.5	4.6	3.5	4.9	0.9	4.1	4.3	3.4	4.2	2.5	3.4	3.1
GNAQ	"G-ALPHA-q, GAQ"	ENSG00000156052	"G protein subunit alpha q"	P50148	9	77716087-78031458	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"		Transducer	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 18.4"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 18.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010036, HPA048886"	Uncertain		Approved	"Nuclear speckles,Plasma membrane,Cytosol"			28000000	"Nuclear speckles"	"Plasma membrane, Cytosol"	"CAB010036: AB_631536, HPA048886: "	"unprognostic (2.10e-1)"	"unprognostic (8.53e-2)"	"unprognostic (1.45e-1)"	"unprognostic (4.37e-2)"	"unprognostic (1.87e-1)"	"unprognostic (6.83e-3)"	"unprognostic (1.05e-1)"	"unprognostic (3.84e-2)"	"unprognostic (2.46e-1)"	"unprognostic (2.16e-1)"	"unprognostic (1.85e-1)"	"unprognostic (1.44e-1)"	"prognostic favourable (1.11e-7)"	"unprognostic (1.90e-1)"	"unprognostic (3.13e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.01e-1)"	12.7	12.6	24.3	9.9	20.8	21.8	11.6	12.5	29.6	13.1	16.6	17.1	9.1	7.9	13.7	11.2	13.1	10.0	11.6	5.6	24.2	18.3	12.1	12.3	23.1	11.8	19.1	14.6	13.5	8.5	12.7	7.6	12.1	14.3	13.0	16.0	10.4	9.8	15.9	5.9	5.1	9.0	18.2	23.9	5.8	15.5	6.0	14.8	18.6	13.3	4.0	4.8	14.5	13.1	0.8	2.8	18.4	3.5	3.3	2.0	1.2	12.1	13.9	12.3	13.5	15.6	16.0	17.8	16.5	12.5	7.3	8.8	4.2	10.0	0.0	13.4	15.1	20.0	9.1	10.0	9.1	0.4	5.3	33.3	12.1	8.5	14.1	20.3	12.5	10.9	12.3	14.1	14.4	17.8	5.8	0.1	12.8	15.4	23.4	12.9	10.0	2.0	8.7	15.1	0.1	16.5	26.1	13.8	21.1	11.9	10.1	12.4	9.1	7.6	22.3	12.8	0.8	17.4	9.6	0.1	0.0	0.1	8.8	12.0	13.2	18.4	2.2	4.6	0.8	1.9	1.6	0.8	1.8	1.0	2.4	0.8	2.0	1.6	7.7	3.3	3.5	2.8	1.9	1.2	24.3	20.8	12.5	24.0	24.2	18.3	19.1	14.6	14.3	14.8
GNB1		ENSG00000078369	"G protein subunit beta 1"	P62873	1	1785285-1891117	"Cancer-related genes, Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, RAS pathway related proteins, Transporters"		Transducer	"Cancer-related genes, Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040736	Supported		Approved	"Golgi apparatus,Plasma membrane"			60000000	"Plasma membrane"	"Golgi apparatus"	"HPA040736: "	"unprognostic (9.49e-2)"	"unprognostic (4.91e-3)"	"unprognostic (1.24e-1)"	"unprognostic (1.56e-1)"	"unprognostic (3.34e-1)"	"unprognostic (9.07e-3)"	"prognostic unfavourable (3.61e-6)"	"unprognostic (1.99e-2)"	"unprognostic (3.60e-1)"	"unprognostic (7.27e-2)"	"unprognostic (8.47e-3)"	"unprognostic (1.95e-1)"	"unprognostic (9.76e-2)"	"unprognostic (1.08e-1)"	"unprognostic (4.62e-2)"	"unprognostic (1.14e-1)"	"unprognostic (7.90e-2)"	55.2	42.1	84.7	55.1	82.3	41.7	37.8	78.8	112.5	44.0	52.1	46.4	26.0	55.4	44.3	31.2	41.7	38.8	36.6	39.6	74.7	65.7	43.9	38.7	47.1	47.1	68.5	52.1	45.0	33.9	48.9	36.9	45.3	56.6	40.1	41.0	70.7	37.6	41.7	19.7	35.5	65.3	51.2	61.0	51.0	40.8	31.4	39.2	44.5	37.6	19.5	45.6	42.2	54.1	7.7	18.8	18.4	13.2	10.6	9.9	6.0	54.0	51.2	60.8	42.4	34.8	38.3	23.5	76.8	51.3	69.8	54.8	41.7	54.2	56.5	56.6	77.4	28.6	60.9	55.7	63.8	86.6	30.0	54.8	48.5	47.4	43.8	32.9	60.2	33.8	39.3	66.6	62.0	56.6	33.9	51.1	66.5	33.7	72.1	25.9	35.0	41.5	70.4	47.0	44.6	47.8	33.7	74.8	85.3	71.2	46.4	62.3	32.4	45.2	86.2	61.5	41.3	47.8	55.7	34.7	60.4	129.3	52.6	69.5	34.6	7.4	11.1	17.1	8.7	13.2	8.0	7.4	8.7	9.7	10.9	7.7	5.9	6.5	18.4	10.6	13.2	18.8	9.9	6.0	84.7	82.3	78.8	112.5	74.7	65.7	68.5	52.1	56.6	39.2
GNB3		ENSG00000111664	"G protein subunit beta 3"	P16520	12	6839954-6847393	"Disease related genes, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins"		Transducer	"Congenital stationary night blindness, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	8	"pituitary gland: 27.0;retina: 79.9"	"Cell line enhanced"	"Detected in many"		"Daudi: 8.4;NTERA-2: 10.1;U-698: 25.4"	"Cancer enhanced"	"Detected in some"		"testis cancer: 3.1"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in single"		"memory B-cell: 1.5"	"Lineage enriched"	"Detected in single"	9	"B-cells: 1.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA040736	Uncertain		Approved	"Golgi apparatus,Plasma membrane"				"Plasma membrane"	"Golgi apparatus"	"HPA040736: "	"unprognostic (3.86e-2)"	"unprognostic (1.58e-1)"	"unprognostic (4.96e-2)"	"unprognostic (8.75e-2)"	"unprognostic (2.53e-2)"	"unprognostic (5.74e-3)"	"unprognostic (5.98e-2)"	"unprognostic (4.43e-3)"	"unprognostic (1.19e-1)"	"unprognostic (1.98e-1)"	"unprognostic (2.25e-5)"	"unprognostic (3.21e-2)"	"unprognostic (4.77e-11)"	"unprognostic (2.43e-1)"	"unprognostic (6.48e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.07e-2)"	0.8	1.6	0.9	1.4	2.0	0.5	0.8	6.9	1.6	1.1	1.0	0.8	0.8	2.3	2.7	0.8	0.8	1.0	1.1	5.4	1.0	1.3	0.8	0.8	0.8	1.4	1.1	0.8	3.5	0.8	3.2	27.0	0.8	1.6	1.6	0.4	79.9	2.6	1.8	1.5	0.6	1.6	4.1	0.9	0.9	0.9	0.8	0.8	0.8	1.2	1.0	1.8	2.1	0.8	1.5	0.0	0.1	0.0	0.0	0.1	0.0	0.2	0.4	4.9	0.8	0.6	0.8	0.5	2.9	0.6	1.6	1.1	1.0	0.2	8.4	0.0	3.1	0.3	4.8	0.2	1.5	0.7	1.1	2.1	2.6	0.7	0.5	0.6	1.4	1.2	0.2	1.5	2.1	1.3	0.8	0.7	0.4	0.4	0.4	0.4	10.1	0.3	0.3	1.7	0.5	0.3	0.2	0.8	1.2	0.2	0.0	0.6	0.0	0.5	2.6	1.3	2.0	2.4	3.8	0.7	0.5	25.4	0.6	0.4	0.7	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.4	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.9	2.0	6.9	1.5	1.0	1.3	1.1	0.8	1.6	0.8
GNG2		ENSG00000186469	"G protein subunit gamma 2"	P59768	14	51826195-51979342	"Predicted intracellular proteins, RAS pathway related proteins"		Transducer		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 68.4;brain: 50.5;testis: 55.7"	"Cell line enhanced"	"Detected in many"		"AF22: 20.5;fHDF/TERT166: 36.3;MOLT-4: 28.2;SH-SY5Y: 23.9;WM-115: 65.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003534, CAB018380"	Uncertain	Supported	Approved	"Vesicles,Plasma membrane"				"Plasma membrane"	Vesicles	"CAB018380: AB_631547, HPA003534: AB_1079004"	"unprognostic (6.11e-2)"	"unprognostic (5.78e-3)"	"unprognostic (2.06e-3)"	"unprognostic (6.55e-2)"	"unprognostic (1.33e-1)"	"unprognostic (4.01e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.03e-1)"	"unprognostic (5.72e-2)"	"unprognostic (1.24e-1)"	"prognostic favourable (1.64e-4)"	"unprognostic (8.47e-2)"	"prognostic unfavourable (3.90e-6)"	"unprognostic (9.82e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.08e-1)"	"unprognostic (3.59e-2)"	22.0	10.4	50.5	17.4	18.5	25.0	11.7	4.9	46.1	5.9	13.0	5.2	1.6	6.8	5.7	4.7	6.5	3.5	7.9	6.6	30.9	50.3	4.0	5.6	8.5	19.4	10.7	20.7	7.1	3.3	1.6	12.2	8.6	8.9	6.6	9.1	8.3	4.5	4.4	2.3	3.5	9.9	8.8	8.5	41.2	7.3	55.7	2.5	39.6	3.9	4.3	19.5	8.5	4.0	8.0	13.9	68.4	34.9	5.0	36.5	27.6	0.0	0.8	20.5	12.8	3.1	4.1	0.3	3.3	4.2	1.6	1.3	1.6	0.0	0.0	0.4	36.3	0.0	2.7	0.0	1.1	9.2	0.3	0.0	0.2	0.0	1.6	1.8	0.1	6.8	0.0	1.6	0.1	0.0	0.0	1.7	10.4	0.0	28.2	3.0	10.9	2.5	10.0	1.6	0.5	1.7	0.0	3.0	23.9	0.0	0.0	8.8	0.0	0.0	0.0	5.0	0.8	0.1	2.5	0.0	0.0	1.4	4.1	10.0	65.4	68.4	13.5	36.0	36.5	23.3	24.6	8.0	20.3	29.7	13.9	7.3	12.9	22.8	39.9	5.0	34.9	6.0	28.8	27.6	50.5	18.5	4.9	44.2	30.9	50.3	10.7	20.7	8.9	2.5
GPBP1	"DKFZp761C169, vasculin"	ENSG00000062194	"GC-rich promoter binding protein 1"	Q86WP2	5	57173948-57264679	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA037773	Approved		Approved	"Vesicles,Plasma membrane,Cytosol"				"Vesicles, Cytosol"	"Plasma membrane"	"HPA037773: AB_10671721"	"unprognostic (1.53e-1)"	"unprognostic (2.23e-2)"	"unprognostic (1.57e-1)"	"unprognostic (3.49e-1)"	"unprognostic (8.30e-2)"	"unprognostic (9.68e-3)"	"unprognostic (1.24e-2)"	"unprognostic (3.19e-2)"	"unprognostic (6.85e-3)"	"unprognostic (3.70e-1)"	"unprognostic (5.93e-2)"	"unprognostic (5.48e-2)"	"unprognostic (3.75e-2)"	"unprognostic (1.65e-1)"	"unprognostic (4.89e-2)"	"unprognostic (2.57e-1)"	"prognostic favourable (4.15e-5)"	25.6	33.1	33.8	27.0	37.8	38.0	37.2	53.9	34.0	30.6	23.5	29.7	20.3	20.8	29.0	33.1	25.5	32.4	24.5	25.4	32.5	28.4	27.1	28.4	29.9	34.0	41.5	34.0	46.7	23.5	37.6	43.9	35.6	33.2	27.6	24.9	19.7	27.2	26.9	37.3	24.6	25.8	22.0	42.4	31.5	24.0	46.9	37.2	49.9	35.1	20.3	33.7	29.4	50.2	31.7	18.9	35.5	18.9	33.5	37.7	27.1	21.7	17.4	33.4	28.1	21.9	21.8	30.8	16.6	28.3	27.6	35.6	28.2	25.3	28.9	19.5	17.0	15.0	28.5	19.2	34.9	16.4	19.6	23.7	19.9	23.4	25.5	17.1	24.6	17.7	29.8	22.4	31.5	22.2	24.1	47.6	22.0	27.3	27.0	30.0	20.8	12.2	29.2	27.4	28.4	21.2	22.7	30.1	23.3	24.3	21.8	26.5	42.6	29.3	14.7	10.1	20.6	14.6	24.0	36.3	30.3	32.2	16.9	25.9	18.8	35.5	17.1	32.3	28.1	17.7	35.2	31.7	34.0	33.1	18.9	26.8	37.7	34.9	33.2	33.5	18.9	13.4	35.3	27.1	33.8	37.8	53.9	34.0	32.5	28.4	41.5	34.0	33.2	37.2
GPBP1L1	SP192	ENSG00000159592	"GC-rich promoter binding protein 1 like 1"	Q9HC44	1	45627304-45688113	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA028593	Approved		Approved	"Nucleoplasm,Plasma membrane,Focal adhesion sites"				Nucleoplasm	"Plasma membrane, Focal adhesion sites"	"HPA028593: AB_10602906"	"unprognostic (1.39e-1)"	"unprognostic (8.41e-2)"	"unprognostic (1.44e-3)"	"unprognostic (6.60e-2)"	"unprognostic (6.35e-2)"	"unprognostic (1.97e-3)"	"unprognostic (2.42e-3)"	"unprognostic (9.79e-2)"	"unprognostic (3.91e-2)"	"unprognostic (1.94e-3)"	"unprognostic (1.12e-2)"	"unprognostic (4.11e-1)"	"unprognostic (1.25e-2)"	"unprognostic (6.63e-2)"	"unprognostic (4.51e-1)"	"unprognostic (7.56e-3)"	"unprognostic (6.13e-2)"	29.9	20.5	16.9	21.2	23.7	24.9	25.2	24.4	18.6	27.4	36.9	33.3	29.7	31.6	26.3	23.8	34.8	22.5	19.7	23.9	17.3	17.0	30.2	38.9	28.3	29.1	33.2	12.4	24.7	46.9	24.4	36.6	25.7	22.1	26.4	37.2	29.8	33.5	35.3	29.6	31.0	58.0	25.7	28.2	30.6	26.2	33.2	27.2	40.5	37.7	30.3	35.4	32.5	27.5	13.5	17.8	29.8	22.1	20.0	20.0	15.4	15.8	9.8	17.1	18.1	20.2	19.7	23.4	12.6	21.0	18.3	23.1	9.8	17.8	22.0	16.5	17.3	16.6	18.7	19.0	23.3	25.1	13.3	28.6	11.4	15.2	27.9	28.4	26.5	14.3	41.7	14.3	41.0	23.1	24.3	19.6	20.8	8.5	25.2	25.7	24.3	11.2	16.6	22.3	16.2	21.0	15.7	21.1	14.1	20.8	30.8	32.1	14.0	33.6	19.6	13.2	13.9	14.2	19.1	19.2	17.8	16.3	13.9	23.8	13.8	16.4	16.6	29.8	17.8	21.2	18.9	13.5	17.6	17.4	17.8	11.5	19.4	18.9	17.7	20.0	22.1	10.2	20.0	15.4	16.9	23.7	24.4	18.6	17.3	17.0	33.2	12.4	22.1	27.2
GPC4	K-glypican	ENSG00000076716	"Glypican 4"	O75487	X	133300103-133415490	"Plasma proteins, Predicted membrane proteins"			"Deafness, Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in some"	4	"AF22: 50.7;EFO-21: 17.4;HAP1: 29.1;NTERA-2: 26.6;RPTEC TERT1: 66.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA030834, HPA030836"	Approved		Approved	"Nucleoplasm,Plasma membrane"	"Intracellular and membrane"		170000	"Plasma membrane"	Nucleoplasm	"HPA030834: , HPA030836: AB_10601327"	"unprognostic (9.60e-2)"	"unprognostic (8.67e-2)"	"unprognostic (2.29e-1)"	"unprognostic (8.21e-2)"	"unprognostic (8.51e-3)"	"unprognostic (5.90e-3)"	"unprognostic (5.68e-2)"	"prognostic favourable (3.51e-4)"	"unprognostic (2.54e-2)"	"unprognostic (1.26e-1)"	"unprognostic (5.87e-3)"	"unprognostic (1.30e-1)"	"prognostic favourable (1.25e-5)"	"unprognostic (1.97e-1)"	"unprognostic (2.89e-1)"	"unprognostic (2.75e-1)"	"unprognostic (2.72e-1)"	39.7	9.9	16.3	10.7	5.3	0.3	6.8	3.7	4.9	14.6	21.6	8.2	3.4	10.0	11.7	16.3	18.6	11.2	23.7	9.6	9.5	5.0	39.6	2.4	25.6	7.1	5.1	6.6	12.4	12.5	9.4	20.4	26.9	9.5	10.3	10.7	9.3	12.2	11.6	20.3	4.3	11.3	16.9	7.9	6.5	19.8	7.2	6.4	5.2	12.4	11.6	2.0	17.1	11.7	0.9	0.6	0.1	0.7	0.0	0.0	0.2	0.0	0.0	50.7	2.0	2.2	0.3	6.3	0.3	0.0	0.0	0.0	0.0	0.1	0.0	17.4	0.2	0.0	29.1	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	9.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	26.6	0.7	0.1	4.6	0.0	66.9	1.9	0.0	0.3	0.2	0.0	0.0	0.7	0.7	0.0	5.2	6.2	0.0	3.2	0.0	0.0	0.0	0.0	0.0	7.6	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.9	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	16.3	5.3	3.7	4.9	9.5	5.0	5.1	6.6	9.5	6.4
GPR173	SREB3	ENSG00000184194	"G protein-coupled receptor 173"	Q9NS66	X	53049091-53080615	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"brain: 23.2"	"Cell line enhanced"	"Detected in many"		"HAP1: 10.3"	"Cancer enhanced"	"Detected in many"		"glioma: 8.8"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"basophil: 5.7"	"Group enriched"	"Detected in many"	4	"granulocytes: 5.7;NK-cells: 1.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003905			Approved	"Plasma membrane,Cytosol"				Cytosol	"Plasma membrane"	"HPA003905: AB_1078922"	"unprognostic (2.68e-1)"	"unprognostic (2.33e-1)"	"unprognostic (4.95e-3)"	"prognostic unfavourable (2.88e-6)"	"unprognostic (3.87e-2)"	"unprognostic (8.58e-2)"	"unprognostic (2.73e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.92e-1)"	"unprognostic (1.70e-2)"	"prognostic favourable (2.33e-5)"	"unprognostic (1.03e-1)"	"prognostic unfavourable (2.47e-4)"	"unprognostic (1.08e-4)"	"unprognostic (2.83e-1)"	"unprognostic (3.92e-2)"	"unprognostic (6.95e-2)"	2.5	5.2	8.2	3.0	9.4	2.2	3.1	15.4	23.2	4.2	2.8	11.6	0.8	1.8	6.4	5.0	2.4	7.7	3.3	4.2	7.9	10.0	2.4	1.1	2.8	2.1	7.3	11.2	15.0	1.3	1.3	14.6	4.5	9.7	3.2	2.6	6.4	2.0	5.4	4.6	3.9	2.1	4.5	6.5	4.0	2.1	2.4	9.6	0.7	3.1	0.1	1.5	3.3	2.8	0.9	0.7	5.7	0.4	1.8	0.7	0.0	0.0	0.0	8.2	0.5	4.7	2.8	0.0	1.3	3.0	2.2	2.6	0.8	0.1	0.2	2.0	2.8	0.7	10.3	0.0	1.9	0.6	1.0	0.5	8.4	0.3	6.8	0.5	0.1	6.6	0.0	3.3	4.7	3.5	0.0	5.7	3.2	4.2	0.0	0.0	6.3	3.6	0.1	2.5	0.3	0.5	0.4	5.9	8.3	0.0	0.4	0.0	1.1	0.1	6.5	3.6	5.2	2.3	1.1	0.2	0.3	0.7	2.5	0.0	2.0	5.7	0.2	0.3	0.7	0.1	0.5	0.3	0.2	0.1	0.1	0.9	0.5	0.4	1.2	1.8	0.4	0.7	0.0	0.0	8.2	9.4	15.4	15.1	7.9	10.0	7.3	11.2	9.7	9.6
GPR27	SREB1	ENSG00000170837	"G protein-coupled receptor 27"	Q9NS67	3	71754050-71756496	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"brain: 23.2;parathyroid gland: 29.6"	"Cell line enhanced"	"Detected in some"		"EFO-21: 12.8;HL-60: 12.2;MCF7: 10.5;NTERA-2: 21.1;RPTEC TERT1: 10.1;SH-SY5Y: 8.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	8	"eosinophil: 3.7;neutrophil: 10.5"	"Lineage enriched"	"Detected in single"	12	"granulocytes: 10.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029395	Approved		Approved	"Nucleoplasm,Plasma membrane,Actin filaments,Cytosol"				Nucleoplasm	"Plasma membrane, Actin filaments, Cytosol"	"HPA029395: AB_10602907"	"prognostic favourable (5.63e-4)"	"unprognostic (2.99e-1)"	"unprognostic (3.23e-2)"	"unprognostic (3.22e-1)"	"unprognostic (7.14e-3)"	"unprognostic (1.50e-2)"	"unprognostic (2.17e-2)"	"unprognostic (1.18e-2)"	"unprognostic (3.22e-1)"	"prognostic favourable (1.21e-6)"	"unprognostic (2.97e-3)"	"unprognostic (4.97e-2)"	"unprognostic (1.51e-2)"	"unprognostic (1.21e-2)"	"unprognostic (2.71e-2)"	"unprognostic (1.45e-2)"	"unprognostic (6.79e-2)"	1.7	4.5	14.9	1.7	23.2	14.5	4.3	4.4	15.4	3.4	1.0	5.8	1.7	0.6	5.5	3.3	2.7	7.7	1.2	3.5	12.8	12.4	3.2	0.9	2.4	5.5	10.6	8.8	5.0	2.6	29.6	5.1	2.0	5.9	5.7	0.7	3.3	1.7	5.1	1.8	1.9	0.7	3.3	16.8	3.7	2.4	4.2	3.6	0.0	6.8	1.2	0.5	2.1	2.8	0.0	0.2	10.5	0.8	0.0	0.4	0.1	0.0	0.8	1.4	1.7	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	12.8	0.0	0.0	3.2	0.0	0.0	0.0	5.4	0.0	0.0	0.0	0.0	12.2	0.7	0.0	2.2	0.0	0.9	0.0	0.0	0.0	0.0	10.5	0.8	0.2	21.1	0.0	0.0	0.0	0.0	10.1	5.7	2.2	8.0	2.8	0.0	0.0	7.4	0.0	0.0	0.0	5.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.8	3.7	0.1	0.2	0.0	0.0	0.1	0.0	0.2	0.0	0.4	0.1	10.5	0.0	0.1	0.0	0.0	0.1	14.9	23.2	4.4	9.9	12.8	12.4	10.6	8.8	5.9	3.6
GPR63	"PSP24(beta), PSP24B"	ENSG00000112218	"G protein-coupled receptor 63"	Q9BZJ6	6	96794126-96837463	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 7.8;HHSteC: 12.7;Karpas-707: 19.0"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA039103	Approved		Approved	"Nucleoplasm,Plasma membrane,Cytosol"				"Nucleoplasm, Plasma membrane, Cytosol"		"HPA039103: AB_10672841"	"unprognostic (8.22e-2)"	"unprognostic (2.77e-1)"	"unprognostic (1.71e-2)"	"unprognostic (1.02e-2)"	"unprognostic (1.83e-1)"	"unprognostic (1.33e-1)"	"unprognostic (2.65e-2)"	"unprognostic (1.15e-1)"	"unprognostic (3.39e-1)"	"unprognostic (2.53e-2)"	"unprognostic (7.29e-3)"	"unprognostic (3.00e-1)"	"unprognostic (2.03e-3)"	"unprognostic (1.67e-1)"	"unprognostic (1.34e-1)"	"unprognostic (2.34e-1)"	"unprognostic (2.30e-2)"	1.8	3.4	3.8	3.1	11.0	0.8	1.6	7.5	10.7	3.3	3.9	1.6	1.0	5.1	1.9	1.5	2.0	2.8	2.7	1.9	3.2	2.2	1.4	0.5	1.4	0.9	2.2	6.4	4.0	5.0	3.9	4.3	2.5	10.1	3.3	6.2	2.5	1.7	2.2	1.0	1.7	3.6	3.6	1.4	1.3	4.1	8.0	5.2	2.5	2.3	0.0	0.9	2.2	4.8	0.8	0.9	2.6	0.6	1.4	1.1	0.1	0.0	0.1	1.5	0.3	2.1	0.8	0.4	0.9	0.0	0.0	0.2	0.2	1.1	0.0	0.0	0.1	1.1	4.9	2.2	0.0	7.8	3.7	4.6	0.4	0.0	12.7	2.9	0.5	2.4	0.4	0.0	3.4	0.0	3.3	19.0	0.4	0.4	2.2	0.0	4.9	0.7	0.0	1.7	3.8	0.3	0.2	2.2	1.4	0.3	3.0	0.5	1.2	0.6	0.0	1.3	1.9	0.2	1.7	1.5	0.8	0.1	0.8	1.8	1.0	0.8	0.6	0.2	0.6	0.2	0.3	0.7	1.1	0.6	0.1	0.8	1.0	0.9	2.6	1.4	0.2	0.9	0.3	0.1	3.8	11.0	7.5	10.7	3.2	2.2	2.2	6.4	10.1	5.2
GRAP2	"GADS, GRBLG, GrbX, Grf40, Mona"	ENSG00000100351	"GRB2-related adaptor protein 2"	O75791	22	39901082-39973721	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"lymphoid tissue: 138.0"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 9.4;HEL: 18.1;K-562: 17.3;MOLT-4: 47.7"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	7	"gdT-cell: 19.5;MAIT T-cell: 14.4;memory CD4 T-cell: 14.4;memory CD8 T-cell: 21.1;naive CD4 T-cell: 12.2;naive CD8 T-cell: 22.5;T-reg: 12.0"	"Lineage enriched"	"Detected in many"	9	"T-cells: 22.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA005788, CAB022073"	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Cytosol"			260000	"Nucleoplasm, Cytosol"	"Plasma membrane"	"CAB022073: , HPA005788: AB_1079021"	"unprognostic (1.96e-4)"	"unprognostic (1.82e-4)"	"unprognostic (4.19e-2)"	"unprognostic (8.91e-4)"	"unprognostic (2.92e-2)"	"unprognostic (5.56e-5)"	"unprognostic (1.27e-2)"	"unprognostic (8.41e-3)"	"unprognostic (4.69e-2)"	"unprognostic (9.29e-2)"	"unprognostic (5.17e-3)"	"unprognostic (2.83e-2)"	"unprognostic (1.75e-3)"	"unprognostic (2.10e-1)"	"unprognostic (2.20e-2)"	"unprognostic (1.34e-1)"	"unprognostic (8.06e-2)"	1.6	0.4	0.3	7.7	0.7	7.6	1.5	0.3	0.4	1.1	2.3	0.6	0.4	2.9	2.3	1.6	1.6	1.2	3.5	2.8	0.6	0.4	1.2	1.8	6.4	12.6	0.9	0.4	1.0	0.8	0.0	0.6	1.1	0.6	2.4	1.9	1.2	2.4	1.2	0.5	1.4	6.2	2.0	2.2	13.2	2.9	2.4	0.3	138.0	1.3	1.5	11.3	3.0	1.9	2.1	0.4	2.5	0.2	1.7	22.5	25.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.4	0.0	18.1	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	17.3	0.0	0.0	0.0	47.7	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.3	1.8	0.2	0.0	19.5	0.1	14.4	1.0	14.4	21.1	0.4	2.1	12.2	22.5	2.5	1.7	0.1	0.3	12.0	25.9	0.3	0.7	0.3	0.4	0.6	0.4	0.9	0.4	0.6	0.3
GRID2IP		ENSG00000215045	"Grid2 interacting protein"	A4D2P6	7	6497462-6551436	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"brain: 23.6"	"Cell line enriched"	"Detected in some"	4	"REH: 8.7"	"Low cancer specificity"	"Detected in some"			"Region enhanced"	"Detected in many"		"cerebellum: 23.6"	"Cell type enhanced"	"Detected in single"		"NK-cell: 1.1"	"Low lineage specificity"	"Detected in single"			"Group enriched"	"Detected in some"	5	"cerebellum: 25.2;thalamus: 7.9"	"Group enriched"	"Detected in many"	5	"cerebellum: 14.3;midbrain: 10.0;pons and medulla: 9.7;thalamus: 14.7"	HPA045381			Approved	"Plasma membrane"				"Plasma membrane"		"HPA045381: AB_10962495"	"unprognostic (1.77e-1)"	"unprognostic (2.64e-1)"	"unprognostic (3.39e-4)"	"unprognostic (1.19e-3)"	"unprognostic (5.52e-2)"	"unprognostic (2.50e-2)"	"unprognostic (2.82e-1)"	"unprognostic (2.37e-2)"	"unprognostic (1.92e-3)"	"unprognostic (2.06e-3)"	"unprognostic (1.64e-1)"	"unprognostic (3.40e-2)"	"unprognostic (3.38e-2)"	"unprognostic (5.54e-2)"	"unprognostic (8.08e-2)"	"unprognostic (1.87e-1)"	"unprognostic (3.17e-1)"	0.2	1.7	0.8	0.6	3.6	1.1	1.1	23.6	6.6	0.6	1.4	6.5	0.0	1.8	0.4	0.1	1.2	1.1	0.6	0.3	1.6	1.6	0.7	0.3	1.2	0.5	0.7	1.2	0.9	1.8	3.9	3.0	0.2	5.5	2.3	0.7	0.3	2.1	1.6	0.2	3.4	1.6	0.0	1.5	1.4	2.2	1.2	6.8	2.5	1.6	0.0	0.6	0.9	0.8	0.7	0.2	0.0	0.2	1.1	0.4	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.4	0.7	0.0	0.0	0.0	0.5	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.6	0.7	0.0	0.2	0.0	8.7	0.3	0.2	0.1	0.3	0.1	1.1	0.0	0.8	0.0	2.0	0.2	0.1	0.0	0.9	0.0	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.7	0.2	0.0	0.0	0.6	0.4	0.0	0.0	1.1	0.2	0.2	0.0	0.1	0.8	3.6	23.6	6.6	1.6	1.6	0.7	1.2	5.5	6.8
GRK3	"ADRBK2, BARK2"	ENSG00000100077	"G protein-coupled receptor kinase 3"	P35626	22	25564849-25729294	"Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 28.0"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 22.6;SH-SY5Y: 20.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	9	"classical monocyte: 4.8;eosinophil: 5.6;intermediate monocyte: 8.0;memory B-cell: 4.9;myeloid DC: 3.7;naive B-cell: 6.2;non-classical monocyte: 7.4;plasmacytoid DC: 3.2"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000804	Uncertain		Approved	"Nucleoplasm,Plasma membrane"				Nucleoplasm	"Plasma membrane"	"HPA000804: AB_1078281"	"unprognostic (1.02e-1)"	"unprognostic (4.38e-2)"	"unprognostic (5.68e-3)"	"unprognostic (4.33e-2)"	"unprognostic (2.09e-1)"	"unprognostic (3.67e-2)"	"unprognostic (3.29e-1)"	"unprognostic (1.78e-2)"	"unprognostic (1.97e-1)"	"unprognostic (3.54e-1)"	"unprognostic (1.95e-3)"	"unprognostic (5.79e-2)"	"unprognostic (1.01e-3)"	"unprognostic (1.74e-1)"	"unprognostic (2.87e-3)"	"unprognostic (1.89e-2)"	"prognostic favourable (1.29e-4)"	28.0	6.0	11.9	12.4	10.8	7.0	11.3	7.9	18.9	4.7	4.0	3.1	0.7	3.0	5.7	3.1	2.7	9.1	5.0	4.6	15.7	8.3	3.0	3.4	9.4	14.1	9.7	9.8	4.1	8.4	4.4	8.2	4.5	9.6	8.2	4.3	4.8	3.7	1.9	1.4	4.1	6.1	6.2	4.9	23.2	4.0	14.8	2.7	11.6	4.5	1.3	15.2	6.7	2.5	6.2	3.7	5.6	8.0	0.0	0.4	1.6	0.0	2.1	6.5	2.1	4.5	0.6	9.4	0.7	2.0	2.0	3.5	3.4	3.7	11.8	0.2	0.1	0.1	6.4	4.8	6.1	22.6	4.2	5.4	0.7	7.4	0.2	17.5	9.2	1.1	3.3	1.4	2.5	0.3	0.5	0.0	2.4	2.9	12.5	1.2	4.6	0.0	5.6	10.3	2.0	0.0	3.5	15.1	20.5	1.1	0.0	4.9	1.8	7.0	0.2	0.0	13.3	0.1	2.5	1.4	4.6	9.2	8.7	6.2	2.0	0.6	4.8	5.6	0.0	8.0	0.3	4.9	0.0	0.3	3.7	6.2	0.1	0.2	0.3	0.0	7.4	3.2	0.4	1.6	11.9	10.8	7.9	18.9	15.7	8.3	9.7	9.8	9.6	2.7
GSR		ENSG00000104687	"Glutathione-disulfide reductase"	P00390	8	30678061-30727999	"Cancer-related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001538, CAB008632"	Approved		Supported	"Plasma membrane,Cytosol"			110000000	Cytosol	"Plasma membrane"	"CAB008632: AB_1616690, HPA001538: AB_1078986"	"unprognostic (1.23e-1)"	"prognostic favourable (3.37e-4)"	"prognostic favourable (4.08e-5)"	"unprognostic (2.89e-3)"	"unprognostic (1.62e-1)"	"unprognostic (3.50e-1)"	"prognostic unfavourable (3.26e-5)"	"unprognostic (3.61e-2)"	"unprognostic (1.01e-1)"	"unprognostic (4.15e-2)"	"unprognostic (2.83e-2)"	"unprognostic (6.92e-3)"	"prognostic favourable (1.80e-4)"	"unprognostic (2.31e-3)"	"unprognostic (2.26e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.29e-1)"	8.9	14.4	6.8	10.7	9.1	7.9	6.2	9.1	11.8	18.6	18.7	7.1	18.4	20.4	13.2	12.0	19.4	8.8	17.3	11.9	5.0	5.7	27.9	17.8	10.8	9.7	4.9	6.0	11.8	17.6	22.9	7.2	8.9	6.8	16.4	17.2	10.9	12.0	17.4	14.7	6.5	31.8	9.3	4.5	13.6	17.7	7.9	4.2	17.0	9.2	11.8	12.0	23.9	14.5	2.5	4.7	19.0	5.7	2.6	7.3	2.1	12.0	51.0	8.3	6.4	8.9	10.0	8.0	5.4	11.8	7.7	10.3	15.0	6.4	23.6	26.7	6.9	13.6	12.5	11.7	8.4	6.1	11.6	23.7	17.6	50.1	24.0	7.2	38.3	16.6	7.4	11.5	4.6	10.9	19.6	10.5	17.3	11.0	25.5	8.5	14.7	9.1	9.8	9.5	11.4	15.2	30.6	6.3	8.1	7.4	17.3	12.9	7.5	8.2	14.7	3.2	8.9	7.6	8.0	5.8	6.4	15.1	10.2	10.2	10.5	19.0	4.6	11.5	4.2	4.2	7.3	2.5	3.8	4.6	4.7	2.0	2.4	3.1	6.5	2.6	5.7	2.9	3.2	2.1	6.8	9.1	9.1	11.8	5.0	5.7	4.9	6.0	6.8	4.2
GTSE1	"B99, GTSE-1"	ENSG00000075218	"G2 and S-phase expressed 1"	Q9NYZ3	22	46296741-46330810	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 20.0;testis: 22.3"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA029457			Approved	"Plasma membrane,Centrosome"				Centrosome	"Plasma membrane"	"HPA029457: "	"unprognostic (1.97e-1)"	"unprognostic (3.07e-2)"	"unprognostic (1.71e-3)"	"unprognostic (2.59e-1)"	"unprognostic (7.16e-2)"	"unprognostic (2.40e-2)"	"prognostic unfavourable (1.90e-10)"	"prognostic unfavourable (4.66e-4)"	"unprognostic (1.09e-1)"	"unprognostic (8.37e-2)"	"prognostic unfavourable (1.29e-4)"	"unprognostic (3.49e-3)"	"unprognostic (0.00e+0)"	"unprognostic (6.52e-3)"	"unprognostic (3.25e-1)"	"unprognostic (1.14e-1)"	"unprognostic (4.85e-2)"	1.1	1.3	0.3	10.4	0.8	10.2	1.3	1.0	1.1	1.2	2.5	0.7	0.1	4.1	1.1	1.3	6.6	0.4	0.4	0.8	1.0	0.3	0.9	0.9	1.3	9.0	0.6	0.4	0.9	0.5	0.0	0.9	2.8	1.8	0.6	2.6	0.7	1.5	0.1	0.3	2.4	3.3	1.0	0.6	4.6	2.4	22.3	0.3	20.0	0.5	5.8	8.8	1.1	2.1	1.4	1.9	3.0	0.2	1.8	1.6	0.9	21.5	10.2	20.2	15.9	0.4	1.2	9.7	18.7	8.8	27.4	22.6	10.7	8.2	20.4	5.0	7.2	11.3	18.1	4.7	17.6	12.2	19.5	13.6	14.4	8.2	0.0	24.4	16.7	0.2	0.3	11.7	6.0	11.8	10.4	25.7	16.3	12.0	21.8	12.0	14.1	11.6	21.7	22.7	13.4	4.5	3.9	10.5	14.3	17.9	11.7	8.2	9.9	9.4	9.3	15.6	29.6	12.7	19.6	14.7	7.0	20.7	9.9	11.8	22.7	0.1	0.2	1.5	1.3	0.1	0.4	1.4	0.6	0.6	0.3	0.6	0.4	0.3	3.0	1.8	0.1	1.9	1.6	0.9	0.3	0.8	1.0	1.1	1.0	0.3	0.6	0.4	1.8	0.3
GUCA1A	"C6orf131, COD3, CORD14, dJ139D8.6, GCAP, GCAP1, GUCA, GUCA1"	ENSG00000048545	"Guanylate cyclase activator 1A"	P43080	6	42155406-42180056	"Disease related genes, Predicted intracellular proteins"	"Sensory transduction, Vision"		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	8	"retina: 91.2;testis: 62.2"	"Group enriched"	"Detected in some"	8	"NTERA-2: 7.0;SH-SY5Y: 8.8"	"Cancer enriched"	"Detected in single"	9	"testis cancer: 3.5"	"Region enhanced"	"Detected in many"		"basal ganglia: 10.0"	"Cell type enriched"	"Detected in single"	84	"plasmacytoid DC: 8.4"	"Lineage enriched"	"Detected in single"	84	"dendritic cells: 8.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA005561	Enhanced		Approved	"Plasma membrane"				"Plasma membrane"		"HPA005561: "	"unprognostic (1.91e-2)"	"unprognostic (3.92e-3)"	"unprognostic (2.49e-2)"	"unprognostic (9.16e-2)"	"unprognostic (1.04e-4)"	"unprognostic (9.70e-2)"		"unprognostic (6.71e-3)"	"unprognostic (1.89e-1)"	"unprognostic (1.59e-2)"	"unprognostic (3.08e-3)"	"unprognostic (2.79e-1)"		"unprognostic (1.51e-1)"	"unprognostic (1.54e-1)"		"unprognostic (1.16e-1)"	0.2	0.2	2.7	0.3	10.0	0.2	0.2	0.1	1.6	0.2	0.2	0.1	0.1	0.1	0.1	0.4	0.2	0.1	0.2	0.1	1.5	5.4	0.1	0.1	0.2	0.3	1.1	0.1	0.1	0.1	0.1	0.1	0.2	0.3	0.2	0.2	91.2	0.2	0.1	0.1	0.2	0.2	0.3	0.2	0.1	0.1	62.2	0.1	0.1	0.1	0.1	0.5	0.3	0.1	0.0	8.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.1	0.1	0.0	0.6	0.6	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.4	0.0	0.0	2.7	10.0	0.1	0.8	1.5	5.4	1.1	0.1	0.3	0.1
HAPLN3	"EXLD1, HsT19883"	ENSG00000140511	"Hyaluronan and proteoglycan link protein 3"	Q96S86	15	88877288-88895626	"Predicted membrane proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 25.4;lymphoid tissue: 23.6"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 20.6;U-2 OS: 20.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"T-reg: 25.4"	"Lineage enriched"	"Detected in many"	5	"T-cells: 25.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA039237	Uncertain		Approved	"Plasma membrane,Cytosol"	"Secreted to extracellular matrix"			"Plasma membrane, Cytosol"		"HPA039237: AB_10805357"	"unprognostic (1.67e-2)"	"unprognostic (1.04e-3)"	"unprognostic (2.57e-1)"	"unprognostic (2.53e-2)"	"unprognostic (3.27e-1)"	"unprognostic (2.24e-2)"	"unprognostic (4.21e-1)"	"unprognostic (3.82e-1)"	"unprognostic (3.37e-3)"	"unprognostic (7.37e-3)"	"unprognostic (1.13e-3)"	"unprognostic (4.30e-1)"	"prognostic unfavourable (4.18e-13)"	"unprognostic (1.95e-1)"	"unprognostic (3.01e-2)"	"unprognostic (6.12e-2)"	"unprognostic (1.12e-1)"	9.9	1.3	1.1	20.6	2.7	4.4	8.7	1.0	2.3	5.3	2.6	1.1	0.3	1.4	4.4	4.9	5.7	6.0	4.7	9.8	3.2	1.0	3.0	0.8	8.7	23.6	3.1	0.9	5.2	2.3	0.9	2.2	2.7	3.6	5.2	1.1	3.2	6.4	1.6	4.2	6.0	4.1	4.7	6.2	6.9	3.6	1.9	1.8	5.7	7.2	7.6	10.9	6.0	5.6	0.8	1.1	0.7	0.6	4.8	25.4	3.2	1.2	4.3	0.9	9.6	2.7	3.0	3.0	2.6	0.6	1.0	1.3	2.7	4.0	0.0	7.6	3.3	1.0	9.1	1.2	0.0	20.6	8.0	3.0	0.2	0.0	0.4	0.0	0.1	1.1	0.5	1.9	0.1	4.5	0.0	5.9	0.4	0.1	0.0	0.0	7.1	0.1	0.0	0.4	7.2	1.8	0.1	0.1	2.6	0.5	0.5	3.6	0.0	0.3	0.8	6.9	20.6	5.2	0.4	0.9	0.0	0.0	2.5	0.0	5.9	0.7	0.6	0.0	0.6	0.3	3.0	0.1	10.0	4.1	1.1	0.8	10.2	4.5	0.1	4.8	0.1	0.4	25.4	3.2	1.1	2.7	1.0	2.3	3.2	1.0	3.1	0.9	3.6	1.8
HCFC2	HCF-2	ENSG00000111727	"Host cell factor C2"	Q9Y5Z7	12	104064457-104106524	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006227	Approved		Supported	"Nucleoplasm,Plasma membrane,Cytosol"				Nucleoplasm	"Plasma membrane, Cytosol"	"HPA006227: AB_1079042"	"unprognostic (4.22e-3)"	"unprognostic (1.22e-1)"	"unprognostic (1.08e-1)"	"unprognostic (7.66e-2)"	"unprognostic (3.15e-2)"	"unprognostic (2.11e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.07e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.43e-2)"	"unprognostic (2.71e-2)"	"unprognostic (4.54e-2)"	"unprognostic (4.23e-3)"	"unprognostic (1.16e-2)"	"unprognostic (2.24e-1)"	"unprognostic (1.19e-2)"	"unprognostic (7.23e-2)"	11.5	10.0	11.9	4.7	13.2	3.2	12.9	3.8	11.1	11.5	14.4	9.1	8.7	7.2	12.6	7.5	9.1	8.5	8.1	7.7	9.3	5.8	8.5	10.2	9.1	5.9	12.5	8.1	11.8	9.1	10.4	14.3	10.6	10.0	10.8	6.3	6.8	8.0	14.6	17.5	7.4	7.5	19.0	10.2	6.8	9.9	19.2	11.0	9.1	10.1	5.1	5.0	12.8	10.3	1.8	2.2	2.8	5.0	2.5	3.2	1.7	1.9	2.1	2.2	1.9	12.4	12.4	1.6	8.5	3.9	6.5	3.8	1.0	0.9	1.9	3.0	6.6	2.1	2.7	1.5	7.1	3.2	2.6	1.9	2.0	0.9	8.4	1.6	3.1	7.7	4.2	4.1	3.4	5.0	2.2	4.0	11.6	1.7	2.8	3.7	0.4	4.4	2.3	7.3	1.2	2.9	1.3	3.2	2.4	4.2	3.0	3.2	4.8	1.7	7.5	10.4	1.4	5.3	2.8	5.1	1.5	1.7	4.9	2.1	4.1	1.3	2.0	2.8	2.6	3.7	3.1	1.6	2.5	3.2	2.2	1.8	3.0	3.2	0.5	2.5	5.0	1.2	2.8	1.7	11.9	13.2	3.8	11.1	9.3	5.8	12.5	8.1	10.0	11.0
HCK	JTK9	ENSG00000101336	"HCK proto-oncogene, Src family tyrosine kinase"	P08631	20	32052188-32101856	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Exocytosis, Host-virus interaction, Immunity, Inflammatory response, Innate immunity, Phagocytosis"	"Kinase, Transferase, Tyrosine-protein kinase"	Proto-oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"blood: 107.1;lymphoid tissue: 72.6"	"Group enriched"	"Detected in some"	8	"THP-1: 22.6;U-937: 64.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	15	"classical monocyte: 50.8;eosinophil: 62.5;intermediate monocyte: 96.5;myeloid DC: 31.6;neutrophil: 73.0;non-classical monocyte: 107.1"	"Group enriched"	"Detected in many"	15	"dendritic cells: 31.6;granulocytes: 73.0;monocytes: 107.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB005195, HPA063768"	Approved		Approved	"Nucleoplasm,Plasma membrane"				"Plasma membrane"	Nucleoplasm	"CAB005195: AB_631619, HPA063768: "	"unprognostic (6.22e-2)"	"unprognostic (6.16e-3)"	"unprognostic (2.26e-2)"	"unprognostic (7.98e-2)"	"unprognostic (8.83e-2)"	"unprognostic (5.50e-2)"	"unprognostic (4.09e-2)"	"unprognostic (1.72e-2)"	"unprognostic (4.34e-2)"	"unprognostic (1.59e-1)"	"unprognostic (4.08e-2)"	"unprognostic (1.21e-1)"	"prognostic unfavourable (1.66e-4)"	"unprognostic (4.92e-2)"	"unprognostic (4.42e-2)"	"unprognostic (6.95e-2)"	"unprognostic (1.12e-1)"	12.3	5.8	5.9	40.8	13.1	20.8	4.0	1.8	5.3	3.0	5.8	6.1	0.9	5.9	2.5	5.7	3.1	5.9	6.5	8.8	6.0	3.7	4.0	7.9	20.9	50.3	11.2	1.2	3.4	2.8	0.7	2.9	8.8	8.0	3.8	5.9	3.1	4.1	1.9	3.1	2.8	7.8	10.2	9.1	72.6	3.7	2.6	8.2	5.8	3.3	1.2	16.4	9.4	3.5	4.7	31.6	73.0	107.1	1.1	0.1	40.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.3	0.0	0.0	0.4	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.5	0.0	0.0	0.0	1.5	0.1	0.0	0.1	0.0	0.2	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	22.6	0.0	0.0	0.1	0.0	0.0	0.6	0.1	3.3	0.0	64.8	0.0	0.5	50.8	62.5	0.1	96.5	0.1	4.7	0.1	0.1	31.6	3.7	0.1	0.0	73.0	1.1	107.1	2.8	0.1	40.2	5.9	13.1	1.8	5.3	6.0	3.7	11.2	1.2	8.0	8.2
HELZ	"DHRC, HUMORF5, KIAA0054"	ENSG00000198265	"Helicase with zinc finger"	P42694	17	67070438-67245989	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028276	Approved		Approved	"Nucleoli,Plasma membrane,Actin filaments"				Nucleoli	"Plasma membrane, Actin filaments"	"HPA028276: AB_10601814"	"unprognostic (3.16e-1)"	"unprognostic (2.10e-2)"	"unprognostic (7.56e-3)"	"unprognostic (1.29e-1)"	"unprognostic (4.83e-2)"	"unprognostic (4.71e-2)"	"unprognostic (5.85e-2)"	"unprognostic (5.31e-2)"	"unprognostic (3.60e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.51e-1)"	"unprognostic (4.98e-2)"	"unprognostic (1.33e-3)"	"unprognostic (1.42e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.31e-1)"	17.9	12.9	11.2	14.3	14.3	17.7	12.6	24.3	17.7	14.4	14.0	11.6	12.9	7.9	17.0	13.0	9.1	11.1	11.5	11.1	12.0	9.7	11.8	17.3	14.8	14.6	10.7	6.2	20.5	13.9	34.1	33.5	19.2	16.5	11.9	10.9	12.2	12.4	10.9	18.9	9.0	15.6	12.2	13.5	17.3	11.7	16.4	12.7	34.1	15.3	8.8	13.9	15.3	11.9	4.8	4.4	4.3	4.9	4.0	11.0	3.2	7.5	7.6	9.2	9.5	11.7	6.5	14.2	6.7	6.7	8.8	9.7	11.0	6.0	15.6	5.6	9.0	8.0	17.6	8.5	14.2	6.0	5.5	19.9	8.3	9.0	5.6	16.4	12.2	7.7	8.2	8.7	11.1	13.6	13.8	10.0	7.4	9.6	21.1	5.7	5.6	7.3	14.3	16.8	6.8	7.1	10.7	9.3	8.5	10.6	8.9	11.6	10.5	10.2	12.2	11.4	13.1	6.2	6.0	8.2	9.6	11.8	5.6	10.2	11.8	3.6	4.9	4.3	8.8	4.5	11.0	2.9	5.4	5.3	4.4	4.8	3.3	4.5	3.7	4.0	2.9	3.6	4.8	3.2	11.2	14.3	24.3	17.7	12.0	9.7	10.7	6.2	16.5	12.7
HENMT1	"C1orf59, FLJ30525, HEN1"	ENSG00000162639	"HEN methyltransferase 1"	Q5T8I9	1	108648290-108661526	"Enzymes, Predicted intracellular proteins"	"RNA-mediated gene silencing"	"Methyltransferase, RNA-binding, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 28.8;testis: 45.2"	"Cell line enhanced"	"Detected in many"		"MOLT-4: 23.9;NB-4: 26.7;THP-1: 20.0;U-937: 35.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Region enriched"	"Detected in single"	16	"cerebellum: 18.1"	"HPA028464, HPA028497"	Uncertain		Approved	"Plasma membrane,Focal adhesion sites"				"Plasma membrane, Focal adhesion sites"		"HPA028464: AB_10600103, HPA028497: AB_10601552"	"unprognostic (1.82e-1)"	"prognostic favourable (2.56e-4)"	"prognostic favourable (9.95e-4)"	"unprognostic (2.92e-3)"	"unprognostic (1.91e-1)"	"unprognostic (3.88e-3)"	"unprognostic (2.01e-2)"	"unprognostic (1.49e-1)"	"unprognostic (7.01e-2)"	"unprognostic (1.25e-1)"	"unprognostic (2.95e-1)"	"unprognostic (1.19e-1)"	"prognostic unfavourable (2.48e-5)"	"unprognostic (2.53e-1)"	"unprognostic (2.43e-1)"	"unprognostic (2.18e-1)"	"unprognostic (1.65e-1)"	3.5	2.2	6.7	5.1	10.2	7.7	5.5	3.6	11.6	6.1	4.4	4.2	1.4	3.4	2.8	3.4	1.9	1.8	4.5	3.1	9.5	10.1	1.8	1.4	4.9	9.8	8.2	5.6	3.8	1.5	0.6	3.9	3.8	10.7	2.7	6.6	1.3	2.4	2.6	2.0	2.6	5.2	2.5	6.9	8.0	3.2	45.2	2.5	10.3	1.7	1.2	7.3	5.5	1.6	5.4	10.6	18.2	12.0	22.9	28.8	15.9	5.9	3.0	0.2	0.0	0.2	0.2	0.0	1.4	0.5	3.5	0.5	8.9	9.4	0.0	3.3	2.7	0.0	0.0	0.0	2.2	1.9	0.0	15.1	11.5	0.0	3.1	8.9	13.5	2.9	0.1	0.7	0.0	0.7	0.0	6.8	0.1	15.1	23.9	26.7	8.8	1.3	10.4	0.0	0.5	0.0	6.5	14.9	0.0	12.8	3.6	0.0	0.0	20.0	0.1	0.0	11.8	6.4	0.0	4.1	5.2	0.0	0.0	35.2	0.1	16.0	8.8	18.2	28.8	10.1	26.0	5.4	14.2	26.0	10.6	2.9	11.8	21.7	8.6	22.9	12.0	8.5	13.1	15.9	6.7	10.2	3.6	11.6	9.5	10.1	8.2	5.6	10.7	2.5
HERC2	"D15F37S1, jdf2, p528"	ENSG00000128731	"HECT and RLD domain containing E3 ubiquitin protein ligase 2"	O95714	15	28111040-28322152	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"DNA damage, DNA repair, Ubl conjugation pathway"	Transferase	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEL: 32.6"	"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017188, HPA048389, HPA074166"	Approved		Supported	"Plasma membrane,Cytosol"				Cytosol	"Plasma membrane"	"CAB017188: , HPA048389: , HPA074166: "	"unprognostic (1.59e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.92e-1)"	"unprognostic (6.64e-2)"	"unprognostic (6.62e-2)"	"unprognostic (5.74e-2)"	"unprognostic (9.17e-2)"	"unprognostic (2.08e-1)"	"unprognostic (1.87e-1)"	"unprognostic (4.11e-2)"	"unprognostic (9.40e-3)"	"unprognostic (3.60e-2)"	"prognostic favourable (1.41e-7)"	"unprognostic (7.66e-2)"	"unprognostic (2.10e-1)"	"unprognostic (2.34e-2)"	"unprognostic (1.71e-1)"	2.5	3.3	3.2	2.2	4.5	3.9	3.1	7.0	5.7	3.2	4.6			2.7	4.4	1.7	2.8	4.1	2.1	4.6	3.5	3.6	3.3	1.6	2.5	2.1	3.8		8.5	3.6	9.2	3.5	2.7		3.0	3.0		2.3	3.3	8.2	3.1	3.1	4.1	4.1	2.3	3.4	3.2			5.6		2.4	3.3	2.3	1.0	1.1	0.5	0.4	0.2	1.1	0.4	5.1	10.1	7.0	2.9	5.9	4.4	2.0	3.7	4.4	4.8	4.6	5.2	0.6	5.1	4.5	6.3	5.2	7.4	3.6	3.5	3.1	4.8	32.6	11.7	1.7	2.2	7.6	2.6	3.7	2.9	5.7	7.1	6.3	12.5	2.1	4.5	2.3	1.7	2.5	2.1	4.4	6.1	10.0	0.4	1.6	11.1	7.8	4.5	8.9	2.5	2.9	3.0	9.0	9.4	8.9	5.8	3.4	5.5	1.4	1.9	4.8	4.1	3.6	4.7	0.0	0.4	0.5	1.1	0.1	0.6	0.5	0.2	0.5	1.1	1.0	0.9	0.5	0.0	0.2	0.3	0.9	0.4	0.4										
HIF3A	"bHLHe17, IPAS, MOP7, PASD7"	ENSG00000124440	"Hypoxia inducible factor 3 alpha subunit"	Q9Y2N7	19	46297046-46343433	"Predicted intracellular proteins, Transcription factors"	"Angiogenesis, Apoptosis, Stress response, Transcription, Transcription regulation"	"Developmental protein, Repressor"	"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"ASC TERT1: 8.1;HHSteC: 16.5;HSkMC: 14.5;TIME: 13.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041141	Approved		Supported	"Nucleoplasm,Plasma membrane,Cytosol"				"Nucleoplasm, Cytosol"	"Plasma membrane"	"HPA041141: AB_10803997"	"unprognostic (9.20e-2)"	"unprognostic (2.99e-1)"	"unprognostic (5.48e-2)"	"prognostic unfavourable (6.90e-9)"	"unprognostic (4.12e-2)"	"unprognostic (2.35e-2)"	"unprognostic (3.57e-3)"	"unprognostic (1.30e-1)"	"unprognostic (3.32e-2)"	"unprognostic (1.38e-2)"	"unprognostic (3.76e-2)"	"unprognostic (7.07e-2)"	"unprognostic (3.41e-4)"	"unprognostic (1.55e-2)"	"unprognostic (1.61e-1)"	"unprognostic (4.45e-4)"	"unprognostic (5.98e-2)"	15.8	7.7	17.9	4.9	9.8	2.5	8.7	10.6	11.1	15.8	16.1	4.7	6.7	3.1	8.1	10.3	11.6	9.8	9.2	31.2	21.4	6.8	4.5	2.1	13.5	5.2	10.8	8.3	17.7	5.1	2.1	12.1	42.4	9.8	9.7	4.5	10.0	4.3	13.1	12.3	3.6	7.0	26.9	11.2	21.7	14.1	3.3	11.4	0.0	3.2	5.6	2.0	18.8	14.6	1.0	1.3	3.3	1.1	0.5	0.7	0.1	0.0	0.0	1.3	0.3	3.8	8.1	0.4	0.0	0.0	0.0	0.0	1.8	0.1	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.2	0.0	16.5	0.1	0.6	14.5	0.0	0.0	0.0	2.9	0.0	0.2	0.0	0.0	0.0	0.2	0.7	0.0	0.1	0.0	0.0	0.0	0.2	0.1	0.4	0.0	0.1	0.0	0.0	0.1	13.3	0.0	0.1	0.1	0.0	0.2	0.1	0.1	0.6	0.1	0.0	3.3	0.4	0.8	0.4	0.4	0.4	0.5	0.4	0.4	0.2	1.0	0.6	0.7	3.1	0.5	1.1	1.3	0.2	0.1	17.9	9.8	10.6	11.1	21.4	6.8	10.8	8.3	9.8	11.4
HIP1R	"FLJ14000, HIP12, HIP3, ILWEQ, KIAA0655"	ENSG00000130787	"Huntingtin interacting protein 1 related"	O75146	12	122834453-122862960	"Cancer-related genes, Predicted intracellular proteins"	Endocytosis	Actin-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"memory B-cell: 9.5;naive B-cell: 12.3"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017187, HPA038135, HPA038136"	Enhanced		Supported	"Vesicles,Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"	Vesicles	"CAB017187: , HPA038135: AB_2675851, HPA038136: AB_2675852"	"unprognostic (4.52e-1)"	"unprognostic (6.39e-2)"	"unprognostic (7.07e-2)"	"unprognostic (6.55e-3)"	"unprognostic (8.67e-2)"	"unprognostic (1.00e-2)"	"unprognostic (1.02e-2)"	"unprognostic (8.11e-2)"	"unprognostic (6.37e-2)"	"unprognostic (1.76e-1)"	"unprognostic (1.39e-2)"	"unprognostic (6.72e-2)"	"prognostic favourable (6.50e-7)"	"unprognostic (2.18e-2)"	"unprognostic (2.84e-1)"	"unprognostic (2.54e-3)"	"prognostic favourable (7.26e-4)"	9.8	14.5	24.6	13.2	26.5	11.6	8.0	11.5	31.6	4.6	11.6	40.5	19.7	29.2	4.0	9.1	7.0	4.0	7.8	10.8	29.5	21.7	16.2	9.0	6.3	15.3	31.4	20.6	3.2	27.7	7.4	15.6	5.2	18.0	8.6	5.4	2.9	52.0	24.1	5.7	26.5	21.3	3.0	27.4	11.1	30.4	4.0	30.6	8.1	8.1	5.9	12.6	7.4	6.5	12.3	0.0	2.7	0.0	0.6	3.2	1.6	17.3	5.0	3.8	15.6	1.1	3.0	18.7	2.7	4.5	2.8	2.2	7.7	5.2	16.5	9.2	2.0	15.0	4.6	10.0	0.2	2.6	6.6	0.3	5.7	8.1	3.5	1.3	11.8	1.8	7.1	3.8	6.4	19.3	4.3	0.9	1.6	24.9	7.8	4.0	3.5	6.0	4.1	4.8	5.7	9.4	21.0	3.8	8.5	3.2	8.5	4.5	17.4	0.7	15.2	1.8	13.4	5.5	2.6	11.9	6.3	9.8	2.9	2.8	1.5	0.0	0.0	2.7	2.9	0.0	1.7	9.5	1.8	2.2	0.0	12.3	3.2	2.0	0.2	0.6	0.0	0.0	0.4	1.6	24.6	26.5	11.5	19.8	29.5	21.7	31.4	20.6	18.0	30.6
HPS3	"BLOC2S1, SUTAL"	ENSG00000163755	"HPS3, biogenesis of lysosomal organelles complex 2 subunit 1"	Q969F9	3	149129584-149173732	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"			"Albinism, Disease mutation, Hermansky-Pudlak syndrome"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046281, HPA052778"	Approved		Approved	"Golgi apparatus,Plasma membrane"				"Golgi apparatus, Plasma membrane"		"HPA046281: AB_10961641, HPA052778: "	"unprognostic (1.47e-2)"	"unprognostic (7.83e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.11e-3)"	"unprognostic (1.28e-1)"	"unprognostic (1.50e-1)"	"prognostic unfavourable (6.04e-4)"	"unprognostic (1.33e-1)"	"unprognostic (1.75e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.82e-2)"	"unprognostic (1.08e-1)"	"prognostic unfavourable (4.38e-4)"	"unprognostic (2.00e-1)"	"unprognostic (1.28e-1)"	"unprognostic (3.03e-1)"	"unprognostic (3.06e-2)"	14.4	17.6	10.5	16.1	11.5	6.3	18.8	8.1	11.8	13.0	11.7	12.8	6.2	13.7	17.1	10.3	10.2	12.4	11.5	8.9	9.9	8.7	15.3	10.1	12.1	25.1	11.5	10.4	18.7	13.8	10.1	11.8	13.3	11.9	13.4	11.8	13.9	13.4	11.5	5.9	8.9	16.3	13.4	17.1	19.8	12.5	8.5	12.6	23.8	13.7	4.5	19.9	16.3	17.9	16.3	19.9	16.1	15.4	9.3	16.0	10.7	24.8	13.9	8.3	8.6	11.7	15.1	6.2	10.2	20.3	13.5	17.5	4.7	16.6	6.4	13.2	12.3	8.6	9.1	7.0	17.6	15.6	7.3	2.9	6.7	5.1	10.4	7.9	4.8	9.8	7.2	13.0	5.4	13.8	3.3	15.5	17.2	15.4	5.6	11.2	20.0	11.2	6.8	5.5	17.1	7.4	12.6	2.5	6.6	8.8	9.4	19.0	10.1	10.5	6.9	13.6	2.4	13.7	14.9	12.8	5.0	15.8	20.2	15.6	3.3	16.1	12.8	11.9	13.4	15.4	16.0	16.3	12.2	13.8	19.9	13.3	9.5	12.5	5.8	9.3	10.1	11.3	10.5	10.7	10.5	11.5	8.1	11.8	9.9	8.7	11.5	10.4	11.9	12.6
HS6ST3		ENSG00000185352	"Heparan sulfate 6-O-sulfotransferase 3"	Q8IZP7	13	96090839-96839562	"Predicted intracellular proteins"		Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 18.7"	"Cell line enriched"	"Detected in some"	6	"RT4: 19.2"	"Low cancer specificity"	"Detected in many"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA078257			Approved	"Nucleoplasm,Nuclear membrane,Plasma membrane,Actin filaments"	"Intracellular and membrane"		9800	"Nucleoplasm, Nuclear membrane"	"Plasma membrane, Actin filaments"	"HPA078257: "	"unprognostic (2.34e-2)"	"unprognostic (1.90e-2)"	"unprognostic (2.82e-2)"	"unprognostic (1.72e-2)"	"unprognostic (4.88e-2)"	"unprognostic (2.78e-2)"		"unprognostic (1.55e-1)"		"unprognostic (3.67e-3)"	"unprognostic (8.11e-3)"	"unprognostic (1.19e-1)"	"prognostic favourable (6.12e-5)"	"unprognostic (1.54e-4)"	"unprognostic (2.24e-1)"	"unprognostic (1.57e-3)"	"unprognostic (9.89e-2)"	0.9	4.5	1.5	0.0	1.9	0.0	0.0	0.4	18.7	1.9	0.0			0.2	2.1	2.2	0.2	0.1	0.0	0.2	3.2	2.7	0.7	0.0	0.0	0.0	0.9		0.0	2.1	0.0	0.7	0.0		0.1	0.0		0.0	0.1	0.6	0.1	0.0	1.6	0.4	0.0	0.7	0.1			2.4		0.0	5.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.1	0.0	0.0	1.2	0.0	1.3	0.0	0.0	0.2	0.0	0.6	0.0	0.0	0.3	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	19.2	1.0	0.8	0.1	0.1	0.0	0.5	0.0	0.2	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
HSH2D	"ALX, FLJ14886, HSH2"	ENSG00000196684	"Hematopoietic SH2 domain containing"	Q96JZ2	19	16134028-16158575	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 47.4;lymphoid tissue: 33.8"	"Cell line enhanced"	"Detected in some"		"HL-60: 13.4;HMC-1: 18.5;NB-4: 43.6;RPMI-8226: 19.6;U-937: 42.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in all"		"basophil: 47.4"	"Low lineage specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA036616			Approved	"Plasma membrane,Focal adhesion sites,Cytosol"				"Plasma membrane"	"Focal adhesion sites, Cytosol"	"HPA036616: AB_10671962"	"unprognostic (1.69e-1)"	"unprognostic (2.97e-2)"	"prognostic unfavourable (9.46e-6)"	"unprognostic (1.06e-1)"	"unprognostic (5.50e-3)"	"unprognostic (5.21e-3)"	"unprognostic (9.35e-2)"	"unprognostic (4.78e-2)"	"unprognostic (4.21e-3)"	"unprognostic (9.96e-2)"	"unprognostic (1.57e-2)"	"unprognostic (2.22e-2)"	"prognostic unfavourable (6.49e-6)"	"unprognostic (9.17e-3)"	"unprognostic (6.18e-2)"	"unprognostic (3.21e-2)"	"prognostic favourable (3.47e-5)"	1.2	1.1	1.2	31.5	1.1	19.2	1.2	1.1	1.1	1.4	8.9	0.0	5.2	5.5	1.1	6.2	2.0	1.5	10.3	1.2	1.1	1.1	1.3	1.5	6.0	16.7	1.0	0.0	1.1	4.8	0.9	3.7	2.3	0.3	2.2	4.0	1.0	8.8	5.2	1.1	1.1	12.1	0.7	1.1	21.8	5.4	1.1	0.0	8.5	1.7	2.4	33.8	4.7	1.1	14.5	6.0	47.4	8.4	19.0	4.3	3.6	4.6	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.7	6.8	12.9	0.2	0.0	0.2	0.0	0.1	0.0	0.7	0.0	0.2	0.1	0.8	0.0	13.4	18.5	0.0	0.0	0.0	0.0	0.0	0.0	12.2	0.0	2.8	0.0	43.6	0.0	0.0	0.9	0.0	19.6	0.1	1.8	0.0	0.0	0.0	0.4	0.1	0.1	5.0	0.0	0.0	0.0	0.0	0.0	1.9	12.6	7.1	0.0	42.8	0.0	47.4	3.7	23.0	4.3	5.0	3.9	14.5	1.9	2.8	6.0	8.6	1.8	2.3	43.7	19.0	8.4	1.8	2.9	3.6	1.2	1.1	1.1	1.1	1.1	1.1	1.0	0.0	0.3	0.0
HSPG2	"perlecan, PRCAN, SJS1"	ENSG00000142798	"Heparan sulfate proteoglycan 2"	P98160	1	21822245-21937297	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	Angiogenesis		"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"smooth muscle: 104.4"	"Cell line enhanced"	"Detected in many"		"EFO-21: 45.8;HUVEC TERT2: 101.1;TIME: 80.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	12	"plasmacytoid DC: 3.0"	"Lineage enriched"	"Detected in single"	12	"dendritic cells: 3.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"CAB009820, HPA018892, CAB020718"	Approved		Approved	"Nucleoplasm,Plasma membrane,Cytosol"	"Secreted to extracellular matrix"		1700000000	"Nucleoplasm, Plasma membrane, Cytosol"		"CAB009820: AB_2119229, CAB020718: , HPA018892: AB_1850597"	"unprognostic (1.61e-1)"	"unprognostic (1.57e-2)"	"unprognostic (4.93e-2)"	"unprognostic (9.60e-2)"	"unprognostic (2.38e-2)"	"unprognostic (8.56e-2)"	"unprognostic (4.55e-1)"	"unprognostic (1.90e-2)"	"unprognostic (9.35e-2)"	"unprognostic (2.19e-3)"	"unprognostic (5.82e-2)"	"unprognostic (2.83e-1)"	"unprognostic (1.21e-3)"	"unprognostic (1.17e-2)"	"unprognostic (4.86e-2)"	"unprognostic (1.46e-2)"	"prognostic unfavourable (2.82e-4)"	54.8	12.8	1.1	22.9	1.5	0.2	19.8	0.8	1.5	37.3	32.3	2.4	37.2	6.2	62.8	37.6	32.7	20.6	60.0	30.2	1.2	1.2	15.7	8.9	12.5	7.8	2.5	1.2	19.8	9.4	4.6	3.4	24.6	3.8	32.0	2.5	24.6	15.5	22.3	20.8	12.2	13.7	104.4	1.8	16.4	18.9	11.4	0.7	3.4	16.9	20.1	8.5	66.2	28.2	0.2	3.0	0.0	0.0	0.0	0.2	0.0	6.8	6.4	2.1	7.5	22.1	16.8	8.5	10.4	2.7	3.0	2.8	7.7	14.1	0.5	45.8	16.1	4.3	0.5	5.1	0.7	0.1	0.7	2.3	6.8	5.6	4.6	0.0	0.6	10.1	1.5	3.1	0.9	101.1	3.1	0.9	4.1	1.9	0.0	3.1	1.9	2.9	1.0	9.0	0.9	5.8	0.9	0.2	0.6	7.9	3.3	4.6	1.3	1.1	80.7	6.0	7.8	4.6	0.3	0.0	1.0	0.3	1.5	0.0	8.9	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.1	0.2	0.1	0.0	0.0	0.0	3.0	0.0	0.0	1.1	1.5	0.8	1.5	1.2	1.2	2.5	1.2	3.8	0.7
HUNK		ENSG00000142149	"Hormonally up-regulated Neu-associated kinase"	P57058	21	31873315-32044633	"Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"AF22: 10.4;BEWO: 12.9;RH-30: 14.2;SCLC-21H: 11.6;SiHa: 10.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA027295, HPA027372"	Approved		Approved	"Nucleoplasm,Plasma membrane"				"Nucleoplasm, Plasma membrane"		"HPA027295: , HPA027372: "	"unprognostic (9.09e-3)"	"unprognostic (7.29e-2)"	"unprognostic (1.42e-1)"	"unprognostic (5.95e-3)"	"unprognostic (1.99e-1)"	"unprognostic (2.12e-4)"	"unprognostic (4.00e-2)"	"unprognostic (6.90e-2)"	"unprognostic (5.07e-1)"	"unprognostic (2.27e-1)"	"unprognostic (9.09e-2)"	"unprognostic (1.13e-1)"	"prognostic favourable (7.48e-5)"	"unprognostic (8.84e-2)"	"unprognostic (2.22e-1)"	"unprognostic (1.39e-1)"	"unprognostic (6.69e-2)"	1.7	1.9	2.7	2.9	3.5	0.5	2.1	3.2	6.4	1.1	5.9	0.2	12.6	2.4	9.0	3.4	1.1	3.3	1.0	1.7	3.7	3.2	6.0	1.3	1.7	0.7	1.2	2.1	1.8	15.7	0.2	4.7	7.6	1.4	4.0	6.5	9.1	1.5	11.1	0.6	5.0	4.4	4.1	0.9	0.4	2.1	1.8	0.2	0.4	1.1	2.2	1.0	3.8	7.7	1.0	0.7	1.7	0.5	0.5	0.5	0.1	0.0	3.0	10.4	0.1	0.0	0.0	12.9	1.0	0.0	0.2	0.0	4.1	0.1	0.0	0.4	4.8	0.0	6.2	0.0	0.0	0.0	3.1	0.0	2.7	2.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.2	0.9	7.9	0.1	0.1	14.2	0.0	1.1	0.0	11.6	7.7	10.2	0.8	0.4	4.2	1.1	0.0	0.0	7.4	0.0	0.0	0.1	0.0	1.4	0.0	0.0	4.9	0.8	0.5	0.5	0.5	0.3	0.3	0.5	0.5	0.3	0.2	1.0	0.5	0.5	1.7	0.5	0.3	0.7	0.4	0.1	2.7	3.5	3.2	6.4	3.7	3.2	1.2	2.1	1.4	0.2
HYDIN	"CILD5, DKFZp434D0513, KIAA1864, PPP1R31"	ENSG00000157423	"HYDIN, axonemal central pair apparatus protein"	Q4G0P3	16	70807378-71230722	"Disease related genes, Predicted intracellular proteins"			"Ciliopathy, Kartagener syndrome, Primary ciliary dyskinesia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 21.5;pituitary gland: 23.6;testis: 19.1"	"Cell line enhanced"	"Detected in some"		"RPTEC TERT1: 5.2;SiHa: 10.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"HPA067155, HPA074129"	Enhanced		Approved	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		"HPA067155: , HPA074129: "	"unprognostic (8.90e-2)"	"unprognostic (1.04e-2)"	"unprognostic (8.65e-2)"	"unprognostic (4.88e-4)"	"unprognostic (4.25e-3)"	"unprognostic (1.81e-1)"	"unprognostic (3.87e-2)"	"unprognostic (2.45e-1)"	"unprognostic (3.95e-1)"	"unprognostic (3.42e-1)"	"unprognostic (4.90e-2)"	"unprognostic (3.21e-1)"	"unprognostic (2.52e-5)"	"unprognostic (2.13e-3)"	"unprognostic (1.02e-2)"	"unprognostic (1.42e-1)"	"unprognostic (3.97e-2)"	0.8	0.9	6.3	1.2	13.9	1.7	1.5	2.9	4.2	2.1	1.2	13.3	4.4	1.0	2.4	18.4	0.9	14.5	1.9	1.0	6.9	4.3	3.5	1.8	7.1	1.1	2.3	4.1	7.2	1.6	9.0	23.6	0.7	21.5	1.4	0.8	3.9	0.9	1.5	0.8	1.7	1.1	1.0	3.1	1.5	1.1	19.1	3.8	0.0	3.2	0.0	0.6	1.2	0.8	0.9	1.1	3.7	1.3	0.7	1.2	0.2	0.1	0.1	2.1	0.2	0.0	0.0	0.4	0.0	0.0	0.1	0.1	0.9	0.3	0.2	0.3	0.3	0.7	0.3	0.2	1.6	0.4	0.5	0.1	0.1	0.2	0.4	0.5	0.2	0.4	0.5	0.0	0.0	0.0	0.4	0.1	0.1	0.0	0.7	0.8	1.3	0.7	0.2	0.2	0.8	5.2	0.7	2.4	0.5	10.9	0.3	0.4	0.7	0.0	0.3	0.3	0.8	0.1	0.3	1.8	0.1	1.0	0.9	0.2	0.6	1.5	1.0	0.8	1.2	0.9	1.2	0.6	1.0	1.1	0.3	0.9	0.9	0.8	3.7	0.7	1.3	1.1	0.6	0.2	6.3	13.9	2.9	4.2	6.9	4.3	2.3	4.1	21.5	3.8
HYI	HT036	ENSG00000178922	"Hydroxypyruvate isomerase (putative)"	Q5T013	1	43451003-43453989	"Enzymes, Predicted intracellular proteins"		Isomerase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"ductus deferens: 130.4;seminal vesicle: 80.0"	"Cell line enhanced"	"Detected in many"		"HUVEC TERT2: 38.7;WM-115: 32.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 21.6"	"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA040092	Uncertain		Approved	"Golgi apparatus,Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"	"Golgi apparatus"	"HPA040092: AB_10795374"	"prognostic favourable (9.18e-4)"	"unprognostic (1.67e-1)"	"prognostic unfavourable (4.96e-4)"	"unprognostic (2.68e-2)"	"unprognostic (3.86e-1)"	"unprognostic (4.40e-2)"	"prognostic unfavourable (5.55e-4)"	"unprognostic (2.75e-2)"	"unprognostic (1.42e-1)"	"unprognostic (2.34e-2)"	"unprognostic (1.10e-2)"	"unprognostic (4.43e-2)"	"prognostic unfavourable (2.75e-5)"	"unprognostic (5.10e-2)"	"unprognostic (7.93e-2)"	"unprognostic (3.58e-2)"	"prognostic favourable (2.72e-5)"	16.5	12.5	11.6	12.1	10.1	5.3	12.8	11.3	9.7	14.6	16.5	13.0	130.4	23.4	15.8	14.8	8.4	15.3	16.7	10.9	9.2	10.0	15.9	25.8	17.8	6.7	10.9	9.3	25.1	34.0	13.8	11.2	10.8	9.0	15.6	7.5	15.0	20.8	80.0	8.8	8.4	22.1	13.4	14.3	7.6	14.1	4.5	11.1	4.9	12.8	9.6	6.4	10.7	11.3	3.2	21.6	6.2	1.2	4.8	5.4	3.0	17.2	2.2	0.7	1.2	3.4	6.3	0.0	15.1	13.5	19.0	12.7	8.8	30.1	0.0	1.1	9.7	3.2	0.0	15.9	7.8	4.2	6.2	2.8	7.9	0.0	22.4	0.0	0.0	3.7	4.6	21.5	0.0	38.7	0.2	0.0	12.7	0.3	2.5	2.9	3.2	4.4	13.3	0.0	0.1	13.2	0.6	8.2	6.1	16.8	9.5	3.7	2.4	21.6	17.8	1.2	0.0	3.4	29.3	0.0	0.0	0.0	1.0	4.0	32.8	6.2	1.1	2.4	3.3	0.9	4.1	3.2	5.4	2.6	4.1	2.7	5.1	1.5	0.1	4.8	1.2	21.6	0.5	3.0	11.6	10.1	11.3	9.7	9.2	10.0	10.9	9.3	9.0	11.1
HYLS1	FLJ32915	ENSG00000198331	"HYLS1, centriolar and ciliogenesis associated"	Q96M11	11	125883614-125900648	"Disease related genes, Predicted intracellular proteins"	"Cilium biogenesis/degradation"		"Ciliopathy, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 28.6"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041210	Enhanced		Supported	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		"HPA041210: AB_10794987"	"unprognostic (2.46e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.49e-1)"	"unprognostic (2.35e-1)"	"unprognostic (3.53e-3)"	"unprognostic (1.17e-2)"	"prognostic unfavourable (1.92e-4)"	"unprognostic (3.28e-1)"	"unprognostic (1.04e-3)"	"unprognostic (6.56e-3)"	"unprognostic (7.63e-2)"	"unprognostic (4.81e-3)"	"unprognostic (3.00e-2)"	"unprognostic (2.19e-1)"	"unprognostic (2.49e-1)"	"unprognostic (1.03e-1)"	"unprognostic (4.56e-2)"	4.3	4.3	6.5	3.6	8.8	2.8	5.2	12.3	11.6	5.9	5.5	2.7	6.0	7.0	5.3	8.3	5.7	5.0	3.2	5.7	6.7	7.2	8.7	7.2	3.1	6.7	5.0	8.6	5.0	3.4	3.4	5.5	5.1	7.6	6.2	6.0	2.2	3.9	7.6	3.7	5.7	6.7	7.1	3.5	5.6	6.2	28.6	4.3	7.6	5.1	4.6	9.6	5.0	3.8	11.8	14.3	3.2	6.0	4.6	10.3	4.7	4.6	10.4	3.8	2.8	7.5	5.1	6.6	12.0	4.8	11.2	7.6	0.1	7.8	2.0	5.0	10.5	7.1	5.4	4.2	13.1	11.5	3.8	1.5	1.1	2.1	5.6	5.3	8.0	3.3	4.9	11.1	12.7	8.1	2.6	12.8	14.6	7.9	3.8	15.9	8.4	17.5	8.1	0.0	6.9	12.0	7.9	5.4	3.3	12.7	9.8	4.7	24.2	11.7	7.3	0.8	9.8	8.9	2.0	4.7	4.7	4.9	2.4	11.6	9.8	3.2	5.5	1.1	8.1	6.0	7.6	11.5	10.2	9.4	6.7	11.8	10.3	7.4	0.9	4.6	4.2	14.3	10.3	4.7	6.5	8.8	12.3	11.6	6.7	7.2	5.0	8.6	7.6	4.3
ICAM2	CD102	ENSG00000108622	"Intercellular adhesion molecule 2"	P13598	17	64002594-64020634	"CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 74.5;lymphoid tissue: 63.9"	"Group enriched"	"Detected in many"	6	"HUVEC TERT2: 163.3;TIME: 41.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA071155			Approved	"Plasma membrane,Cytosol"			1200000000	"Plasma membrane"	Cytosol	"HPA071155: "	"unprognostic (9.43e-3)"	"unprognostic (3.31e-2)"	"unprognostic (5.15e-2)"	"unprognostic (1.15e-1)"	"unprognostic (8.97e-2)"	"unprognostic (1.64e-3)"	"unprognostic (1.34e-1)"	"unprognostic (3.74e-1)"	"unprognostic (8.28e-2)"	"unprognostic (2.15e-1)"	"unprognostic (4.18e-2)"	"unprognostic (1.55e-2)"	"unprognostic (9.07e-2)"	"unprognostic (1.48e-1)"	"unprognostic (3.93e-2)"	"unprognostic (6.04e-2)"	"unprognostic (2.29e-1)"	36.0	3.6	8.4	13.0	11.5	8.3	34.1	3.5	7.7	9.4	9.7	5.6	2.8	6.4	9.8	5.2	9.5	7.4	8.8	22.8	9.5	8.9	10.5	8.7	27.9	24.0	12.3	3.1	6.3	7.4	3.1	4.5	36.8	9.1	7.9	8.5	8.1	8.8	4.3	17.1	5.5	10.8	13.9	10.5	63.9	8.0	4.0	7.4	14.3	11.6	9.0	18.0	12.8	23.6	49.0	30.9	56.5	74.5	26.0	65.3	67.5	0.0	0.0	0.0	0.0	1.3	1.5	0.4	0.1	0.1	0.0	0.1	0.3	6.8	11.5	2.1	0.0	0.0	0.1	0.0	0.2	2.5	0.0	10.3	0.6	1.2	0.2	1.7	0.0	0.0	0.0	0.1	0.0	163.3	8.4	6.7	0.0	0.0	12.8	1.5	0.0	0.0	7.8	0.0	15.9	0.8	1.6	0.0	0.0	0.0	0.0	0.0	0.0	1.3	41.2	0.0	0.1	0.8	0.0	6.4	2.2	10.2	0.0	2.1	0.0	56.5	30.0	8.9	45.8	66.5	52.8	36.5	60.1	42.8	30.9	49.0	65.3	40.7	3.6	26.0	74.5	10.0	64.5	67.5	8.4	11.5	3.5	7.7	9.5	8.9	12.3	3.1	9.1	7.4
ICOS	"AILIM, CD278"	ENSG00000163600	"Inducible T cell costimulator"	Q9Y6W8	2	203936748-203961577	"CD markers, Disease related genes, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"blood: 18.4;bone marrow: 13.8;lymphoid tissue: 51.8"	"Group enriched"	"Detected in some"	100	"HEL: 5.9;MOLT-4: 15.3"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in many"		"T-reg: 18.4"	"Lineage enriched"	"Detected in single"	58	"T-cells: 18.4"	"Low region specificity"	"Detected in single"							"CAB032575, HPA034865"	Approved		Approved	"Plasma membrane,Actin filaments"	"Intracellular and membrane"			"Plasma membrane"	"Actin filaments"	"CAB032575: AB_2122593, HPA034865: "	"unprognostic (2.66e-2)"	"unprognostic (2.13e-3)"	"unprognostic (4.19e-4)"	"unprognostic (2.35e-5)"	"unprognostic (1.07e-1)"	"prognostic favourable (1.80e-4)"	"unprognostic (9.38e-2)"	"unprognostic (2.89e-2)"	"unprognostic (1.49e-2)"	"unprognostic (3.51e-4)"	"unprognostic (7.50e-2)"	"unprognostic (2.12e-1)"	"unprognostic (2.86e-5)"	"unprognostic (7.05e-2)"	"unprognostic (2.48e-2)"	"unprognostic (1.93e-1)"	"unprognostic (8.82e-3)"	1.5	0.3	0.2	15.6	0.2	13.8	0.7	0.2	0.2	0.8	1.2	0.0	0.2	0.5	1.2	0.5	1.1	1.2	1.6	0.5	0.2	0.2	1.0	0.8	4.0	19.4	0.3	0.0	0.6	0.3	0.0	0.4	0.1	0.1	0.7	1.1	0.7	2.9	0.0	0.2	0.6	6.2	0.3	0.4	6.1	1.0	0.6	0.0	51.8	1.4	2.4	28.9	3.0	0.9	0.0	0.0	0.0	0.0	0.3	18.4	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	2.9	0.0	10.5	4.6	0.0	0.0	11.0	5.0	0.0	0.3	0.0	0.0	18.4	3.0	0.2	0.2	0.2	0.2	0.2	0.2	0.3	0.0	0.1	0.0
ICOSLG	"B7-H2, B7H2, B7RP-1, B7RP1, CD275, GL50, ICOS-L, ICOSL, KIAA0653"	ENSG00000160223	"Inducible T cell costimulator ligand"	O75144	21	44217014-44240966	"CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Adaptive immunity, B-cell activation, Immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 14.1"	"Cell line enhanced"	"Detected in many"		"Daudi: 14.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"naive B-cell: 6.5"	"Low lineage specificity"	"Detected in many"											"CAB026037, HPA029179"	Uncertain		Approved	"Plasma membrane,Cytoplasmic bodies"			150000000	"Plasma membrane, Cytoplasmic bodies"		"CAB026037: , HPA029179: "	"unprognostic (3.03e-2)"	"unprognostic (1.40e-4)"	"unprognostic (3.52e-2)"	"unprognostic (1.94e-2)"	"unprognostic (6.74e-2)"	"unprognostic (9.40e-2)"	"unprognostic (6.94e-2)"	"unprognostic (3.71e-1)"	"unprognostic (1.40e-1)"	"unprognostic (3.76e-2)"	"unprognostic (1.40e-1)"	"unprognostic (2.42e-1)"	"unprognostic (3.00e-2)"	"unprognostic (3.11e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.84e-1)"	2.3	3.0	5.3	3.9	7.1	14.1	2.3	2.3	5.9	2.9	2.3	2.3	2.3	1.8	2.3	2.3	4.0	2.7	3.5	3.7	8.8	3.7	5.3	2.7	2.3	6.5	6.5	2.3	2.3	2.3	0.0	2.3	2.3	2.3	2.3	1.2	2.3	2.3	2.3	2.3	5.5	2.9	2.3	8.4	3.2	4.2	2.3	2.3	2.3	2.3	2.3	4.5	2.4	2.6	6.5	1.6	1.0	0.8	0.5	1.1	0.4	0.3	3.3	0.1	2.8	0.8	1.1	7.7	0.7	0.6	0.4	0.2	5.6	0.4	14.0	2.1	0.3	4.2	1.9	1.3	0.2	1.4	1.4	0.4	2.7	1.6	0.7	6.0	10.3	1.1	1.9	0.9	0.9	0.8	2.3	1.3	0.2	3.6	0.3	7.9	2.0	3.5	11.9	0.9	8.2	0.6	7.4	1.4	0.0	9.3	13.2	0.3	3.8	8.6	0.8	0.4	3.3	0.3	0.2	12.1	8.2	11.7	4.3	5.6	1.8	0.6	0.8	0.4	0.3	0.8	0.3	3.7	0.8	0.5	0.5	6.5	0.8	1.1	1.0	0.5	0.5	1.6	0.4	0.4	5.3	7.1	2.3	2.3	8.8	3.7	6.5	2.3	2.3	2.3
IFFO2		ENSG00000169991	"Intermediate filament family orphan 2"	Q5TF58	1	18904281-18956686	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skin 1: 76.8"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 49.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	11	"basophil: 10.6"	"Lineage enriched"	"Detected in many"	11	"granulocytes: 10.6"									"HPA015987, HPA064603"	Approved		Approved	"Nucleoplasm,Plasma membrane"				"Nucleoplasm, Plasma membrane"		"HPA015987: AB_2121678, HPA064603: "	"unprognostic (1.43e-1)"	"unprognostic (1.06e-2)"	"unprognostic (2.81e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.39e-1)"	"unprognostic (2.08e-2)"	"unprognostic (2.03e-2)"	"unprognostic (1.78e-1)"	"unprognostic (4.34e-2)"	"unprognostic (2.27e-3)"	"unprognostic (3.24e-3)"	"unprognostic (7.42e-2)"	"unprognostic (3.24e-2)"	"unprognostic (5.24e-3)"	"unprognostic (2.72e-1)"	"unprognostic (4.71e-1)"	"unprognostic (1.36e-1)"	3.5	5.1	3.8	5.0	7.8	5.7	8.9	22.3	6.4	6.7	4.6	6.2	4.9	1.4	4.7	2.2	28.7	3.6	4.8	2.7	4.4	4.0	4.9	8.9	5.0	5.3	6.8	3.6	2.4	14.5	13.0	4.0	4.7	9.3	6.6	2.0	3.4	7.9	6.5	4.3	76.8	2.5	13.5	8.9	3.9	2.9	1.4	4.6	3.2	4.3	33.2	11.3	6.3	8.8	0.8	0.6	10.6	0.3	0.3	1.0	0.1	8.2	13.5	3.6	10.0	2.3	1.9	5.9	6.2	4.1	3.4	2.4	18.5	9.7	0.1	8.1	4.7	20.8	2.7	13.3	2.8	49.4	2.4	0.1	2.5	7.2	1.7	1.4	15.9	1.2	13.5	4.6	5.9	7.3	0.6	1.6	2.2	1.7	1.3	1.3	1.5	3.2	4.6	2.2	3.5	2.0	5.3	11.7	0.6	4.7	6.7	4.6	1.8	0.7	19.8	4.6	6.4	2.7	18.0	3.6	3.9	0.2	3.1	2.0	5.4	10.6	0.3	0.0	0.6	0.3	0.8	0.8	0.5	0.7	0.1	0.3	0.5	1.0	0.1	0.3	0.0	0.6	0.5	0.1	3.8	7.8	22.3	6.4	4.4	4.0	6.8	3.6	9.3	4.6
IFRD1	"PC4, TIS7"	ENSG00000006652	"Interferon related developmental regulator 1"	O00458	7	112422968-112481017	"Predicted intracellular proteins, Predicted membrane proteins"	Differentiation	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 93.0"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	6	"eosinophil: 25.6;neutrophil: 44.2"	"Lineage enriched"	"Detected in all"	12	"granulocytes: 44.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA024122	Approved		Approved	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		"HPA024122: AB_1851452"	"unprognostic (2.29e-1)"	"unprognostic (3.47e-1)"	"unprognostic (1.10e-1)"	"unprognostic (9.82e-3)"	"unprognostic (1.36e-2)"	"unprognostic (2.39e-1)"	"unprognostic (5.73e-3)"	"unprognostic (1.37e-1)"	"unprognostic (2.48e-2)"	"prognostic favourable (5.45e-4)"	"unprognostic (6.41e-2)"	"unprognostic (2.93e-3)"	"unprognostic (1.50e-3)"	"unprognostic (4.81e-2)"	"unprognostic (1.98e-1)"	"unprognostic (2.89e-1)"	"unprognostic (4.70e-2)"	19.5	18.0	16.7	12.9	19.6	83.1	24.0	14.3	15.7	10.7	18.3	15.6	11.7	18.7	15.7	12.5	12.7	11.4	12.7	16.0	15.2	13.3	11.9	14.1	19.2	7.9	30.9	13.2	16.9	93.0	12.5	23.1	18.7	16.9	14.7	11.7	11.2	14.3	11.0	37.6	12.3	19.0	23.9	28.2	11.7	17.7	17.9	22.0	7.5	16.5	13.5	7.4	14.7	37.5	3.8	2.9	44.2	3.2	3.4	3.7	2.6	15.0	10.2	15.8	14.8	27.0	17.5	14.6	14.9	14.3	19.4	17.4	16.8	12.8	7.3	28.6	7.8	9.0	10.9	12.6	26.5	12.4	15.6	8.2	18.8	16.0	30.9	11.1	6.5	13.4	27.1	20.4	23.4	8.0	25.1	16.5	7.8	13.6	14.1	18.8	35.9	17.8	12.3	6.3	13.6	5.9	4.2	25.4	13.1	17.0	14.5	48.3	5.6	12.0	6.9	32.9	7.0	25.7	45.0	14.8	17.5	20.0	9.0	31.0	37.7	5.7	3.2	25.6	3.6	2.8	2.8	3.8	3.5	3.4	2.9	3.0	3.4	3.3	44.2	3.4	2.8	2.1	3.7	2.6	16.7	19.6	14.3	15.7	15.2	13.3	30.9	13.2	16.9	22.0
IGFL2	UNQ645	ENSG00000204866	"IGF like family member 2"	Q6UWQ7	19	46143106-46161299	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	7	"skin 1: 26.8;tongue: 24.8"	"Cell line enriched"	"Detected in single"	42	"CACO-2: 42.2"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	24	"memory CD4 T-cell: 2.4"	"Lineage enriched"	"Detected in single"	24	"T-cells: 2.4"									HPA059137	Uncertain		Approved	"Nucleoplasm,Plasma membrane"	"Secreted in other tissues"			Nucleoplasm	"Plasma membrane"	"HPA059137: "	"unprognostic (1.53e-1)"	"unprognostic (7.87e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.69e-2)"	"unprognostic (7.30e-2)"	"unprognostic (9.74e-2)"	"unprognostic (1.92e-1)"	"unprognostic (1.81e-1)"	"unprognostic (1.84e-1)"	"unprognostic (1.68e-1)"	"unprognostic (4.26e-3)"	"unprognostic (9.63e-3)"	"unprognostic (4.14e-9)"	"unprognostic (1.27e-1)"	"unprognostic (2.76e-2)"	"unprognostic (8.73e-2)"	"unprognostic (9.91e-3)"	1.5	0.0	0.4	0.1	0.1	0.0	1.8	0.1	0.4	0.3	0.3	0.1	0.1	0.0	0.1	0.5	1.0	0.0	0.1	1.1	0.1	0.1	0.1	0.1	0.8	1.2	0.4	0.1	0.1	0.1	3.4	0.1	1.6	0.9	0.1	0.7	0.1	0.5	0.1	0.1	26.8	0.1	0.1	0.3	0.1	0.0	2.4	0.1	0.4	0.1	24.8	0.1	0.1	0.4	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.8	0.2	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	42.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.1	0.0	0.0	0.8	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.1	0.4	0.1	0.1	0.4	0.1	0.9	0.1
IKZF3	"Aiolos, ZNFN1A3"	ENSG00000161405	"IKAROS family zinc finger 3"	Q9UKT9	17	39757715-39864188	"Predicted intracellular proteins, Transcription factors"	"B-cell activation, Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 17.7;lymphoid tissue: 55.1"	"Group enriched"	"Detected in some"	4	"Daudi: 26.5;Karpas-707: 14.0;U-266/70: 16.9;U-266/84: 18.8;U-698: 43.1"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"B-cells: 8.3;T-cells: 17.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA024377, HPA073266"	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Cytosol"				Nucleoplasm	"Plasma membrane, Cytosol"	"HPA024377: AB_1859477, HPA073266: "	"unprognostic (5.43e-3)"	"prognostic favourable (6.85e-6)"	"unprognostic (6.10e-2)"	"unprognostic (1.01e-1)"	"unprognostic (2.93e-2)"	"prognostic favourable (4.16e-4)"	"unprognostic (1.36e-2)"	"unprognostic (3.14e-3)"	"prognostic favourable (5.42e-4)"	"unprognostic (8.03e-3)"	"unprognostic (1.65e-1)"	"unprognostic (3.19e-1)"	"prognostic unfavourable (7.38e-4)"	"unprognostic (9.13e-2)"	"unprognostic (2.20e-1)"	"unprognostic (5.51e-2)"	"unprognostic (1.05e-3)"	1.7	0.7	0.5	41.7	0.5	3.1	1.0	0.5	0.5	1.1	4.5	0.0	0.6	1.8	1.2	0.6	3.6	1.2	2.4	0.9	0.6	0.6	1.5	1.4	5.3	30.5	0.6	0.0	0.9	0.9	0.0	0.7	0.4	0.1	1.5	1.7	1.2	5.5	1.3	0.6	0.8	11.3	1.2	0.9	41.0	3.3	2.6	0.1	55.1	1.6	1.8	54.1	4.0	1.3	8.3	0.3	0.7	0.1	2.6	17.7	4.1	0.1	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	26.5	0.0	0.0	0.1	0.0	0.0	0.0	5.9	0.1	1.6	0.1	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.7	14.0	0.0	0.1	2.3	0.9	0.1	0.0	0.1	0.1	4.8	0.0	1.6	0.1	0.1	0.5	0.2	0.0	0.1	0.3	0.1	0.1	0.2	0.1	0.0	16.9	18.8	43.1	0.0	0.1	0.0	0.5	0.1	0.4	16.3	0.1	17.7	8.3	6.7	12.1	0.0	7.7	2.8	7.5	0.7	2.6	0.1	0.3	10.6	4.1	0.5	0.5	0.5	0.5	0.6	0.6	0.6	0.0	0.1	0.1
IL12RB1	"CD212, IL12RB"	ENSG00000096996	"Interleukin 12 receptor subunit beta 1"	P42701	19	18058995-18098944	"CD markers, Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"		Receptor	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 28.6;lymphoid tissue: 21.4"	"Cell line enhanced"	"Detected in some"		"Daudi: 10.4;HDLM-2: 17.6;Karpas-707: 30.1;U-698: 8.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA074414			Approved	"Plasma membrane"	"Intracellular and membrane"			"Plasma membrane"		"HPA074414: "	"unprognostic (7.70e-3)"	"prognostic favourable (3.41e-4)"	"unprognostic (9.08e-3)"	"unprognostic (1.18e-4)"	"unprognostic (2.91e-1)"	"unprognostic (1.33e-3)"	"unprognostic (2.27e-1)"	"unprognostic (8.99e-2)"	"unprognostic (1.65e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.51e-1)"	"unprognostic (2.94e-1)"	"prognostic unfavourable (5.90e-5)"	"unprognostic (1.49e-1)"	"unprognostic (2.21e-2)"	"unprognostic (4.34e-2)"	"unprognostic (2.93e-2)"	1.9	1.5	1.3	17.5	2.1	5.6	1.2	0.5	1.0	0.9	3.4	2.4	1.1	2.9	1.0	2.4	1.3	1.5	2.5	1.4	1.3	1.2	1.8	1.8	5.0	16.0	2.0	0.2	1.1	1.3	1.2	1.1	2.4	1.4	1.7	2.0	1.1	6.6	0.2	0.9	1.0	8.0	1.0	2.4	21.4	2.3	0.7	2.2	10.1	1.3	0.7	16.9	3.8	1.0	4.9	5.9	6.2	14.0	16.2	28.6	9.0	0.2	0.1	0.1	0.2	0.0	0.1	0.5	0.1	0.1	0.2	0.6	0.2	1.0	10.4	0.1	0.1	0.2	0.1	0.0	0.0	17.6	0.2	1.2	0.3	0.2	0.4	0.7	1.7	0.0	0.0	0.3	0.1	0.0	0.2	30.1	0.0	0.1	4.9	0.2	0.1	0.1	3.5	0.1	0.4	0.0	0.0	0.2	0.1	0.2	0.2	0.2	0.2	5.7	0.2	0.3	0.3	0.1	0.1	3.6	5.4	8.8	0.4	6.0	0.7	3.3	5.1	3.6	22.8	14.0	28.6	4.9	15.5	18.3	5.9	3.7	8.7	15.2	6.2	16.2	13.2	3.5	20.5	9.0	1.3	2.1	0.5	1.0	1.3	1.2	2.0	0.2	1.4	2.2
IL13	"ALRH, BHR1, IL-13, MGC116786, MGC116788, MGC116789, P600"	ENSG00000169194	"Interleukin 13"	P35225	5	132656263-132661110	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted secreted proteins"		Cytokine	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"testis: 20.7"	"Cell line enriched"	"Detected in single"	177	"HDLM-2: 29.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA042421			Approved	"Plasma membrane,Cytosol"	"Secreted to blood"	33773		"Plasma membrane, Cytosol"		"HPA042421: AB_10795504"	"unprognostic (2.17e-1)"	"unprognostic (2.29e-2)"	"unprognostic (7.48e-2)"	"unprognostic (2.18e-2)"	"unprognostic (1.92e-1)"	"unprognostic (5.21e-3)"	"unprognostic (1.79e-1)"	"unprognostic (2.69e-1)"	"unprognostic (5.20e-1)"	"unprognostic (7.10e-2)"	"unprognostic (3.61e-3)"	"unprognostic (3.34e-1)"	"unprognostic (5.97e-4)"	"unprognostic (4.70e-2)"	"unprognostic (2.05e-1)"	"unprognostic (7.39e-2)"	"unprognostic (1.38e-1)"	0.3	0.0	0.1	0.8	0.1	0.3	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.6	0.1	3.0	0.0	0.0	0.1	0.0	0.0	1.8	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	3.1	0.2	0.2	0.6	0.0	0.0	0.0	0.0	20.7	0.0	2.9	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	29.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.1	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0
IL13RA2	"CD213a2, CT19, IL-13R, IL13BP"	ENSG00000123496	"Interleukin 13 receptor subunit alpha 2"	Q14627	X	115003975-115019977	"Cancer-related genes, CD markers, Predicted membrane proteins"		Receptor	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pituitary gland: 16.1;testis: 31.5"	"Group enriched"	"Detected in some"	9	"PC-3: 26.4;U-2197: 84.9;U-251 MG: 57.0;U-87 MG: 33.8"	"Cancer enhanced"	"Detected in many"		"glioma: 17.2"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in some"		"olfactory region: 8.7"	"Low region specificity"	"Detected in many"			"HPA045831, HPA067363"			Approved	"Nucleoplasm,Vesicles,Plasma membrane,Cell Junctions"				"Plasma membrane, Cell Junctions"	"Nucleoplasm, Vesicles"	"HPA045831: , HPA067363: "	"unprognostic (1.97e-1)"	"unprognostic (2.83e-1)"	"unprognostic (6.62e-4)"	"unprognostic (7.39e-2)"	"unprognostic (8.45e-2)"	"unprognostic (1.80e-1)"	"prognostic favourable (3.55e-4)"	"unprognostic (3.54e-1)"	"unprognostic (2.85e-1)"	"unprognostic (1.92e-2)"	"unprognostic (2.20e-3)"	"unprognostic (2.19e-2)"	"unprognostic (1.53e-5)"	"unprognostic (1.58e-1)"	"unprognostic (1.63e-1)"	"unprognostic (9.70e-3)"	"unprognostic (1.20e-1)"	0.5	4.8	3.7	3.9	11.3	0.0	0.8	0.3	3.1	1.2	0.4	2.1	5.7	0.3	0.9	4.4	0.5	0.1	0.8	0.6	5.1	11.2	3.5	9.6	1.0	0.1	1.2	2.6	0.1	0.1	0.5	16.1	2.1	3.9	4.3	0.7	1.6	0.8	3.7	0.0	0.1	0.3	0.4	0.6	0.2	0.1	31.5	1.4	0.0	1.3	0.2	0.2	1.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.1	0.7	0.0	5.8	5.5	0.0	0.0	0.0	0.0	0.0	0.1	2.9	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	1.0	0.1	0.9	5.4	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	26.4	0.0	0.0	0.0	0.4	0.0	0.0	1.3	0.4	0.0	0.1	0.0	0.0	0.0	3.0	0.0	84.9	57.0	0.0	0.0	0.0	33.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.7	11.3	0.3	3.1	5.1	11.2	1.2	2.6	3.9	1.4
IL16	"FLJ16806, FLJ42735, HsT19289, IL-16, LCF, prIL-16"	ENSG00000172349	"Interleukin 16"	Q14005	15	81159575-81314058	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Chemotaxis, Host-virus interaction, Transcription, Transcription regulation"	Cytokine	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 75.7;lymphoid tissue: 97.9"	"Cell line enhanced"	"Detected in some"		"Daudi: 12.2;HEL: 12.9;HMC-1: 23.3;RPMI-8226: 22.1;U-266/70: 27.7;U-698: 11.4;U-937: 15.5"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in all"	6	"cerebellum: 40.1"	"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in some"	13	"cerebellum: 61.1;hippocampal formation: 29.7"	"Region enriched"	"Detected in single"	38	"cerebellum: 96.7"	"CAB005247, HPA018467, HPA048861"	Enhanced		Supported	"Nuclear speckles,Plasma membrane,Midbody ring,Cytosol"	"Secreted to blood"	125370	14000	"Nuclear speckles"	"Plasma membrane, Midbody ring, Cytosol"	"CAB005247: AB_2124730, HPA018467: AB_1851642, HPA048861: "	"unprognostic (8.23e-3)"	"unprognostic (2.70e-3)"	"unprognostic (1.97e-2)"	"unprognostic (9.61e-4)"	"unprognostic (2.01e-1)"	"unprognostic (5.26e-4)"	"unprognostic (2.63e-2)"	"unprognostic (6.72e-3)"	"unprognostic (2.25e-1)"	"unprognostic (3.91e-1)"	"unprognostic (1.47e-1)"	"unprognostic (6.21e-2)"	"unprognostic (3.16e-3)"	"unprognostic (1.21e-1)"	"unprognostic (3.23e-2)"	"unprognostic (5.26e-2)"	"unprognostic (1.29e-1)"	8.8	2.4	4.1	48.0	5.8	19.5	7.8	40.1	4.3	4.7	4.8	4.6	0.9	3.8	5.4	2.9	3.4	9.7	5.6	5.1	4.9	2.1	2.5	3.9	14.7	58.0	5.8	2.3	3.7	1.7	0.7	1.4	3.0	6.7	3.5	5.9	3.4	13.5	1.5	1.8	6.1	19.2	3.3	7.8	38.2	5.0	2.2	5.5	97.9	3.7	2.4	54.8	8.7	5.4	43.3	37.1	75.7	35.0	49.3	60.5	66.5	0.0	0.0	0.0	0.0	8.2	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.2	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	12.9	0.0	0.0	0.4	9.1	23.3	0.4	0.0	0.0	0.2	0.1	1.3	4.9	0.0	0.0	0.7	9.7	0.0	0.0	0.0	0.0	22.1	0.0	0.0	0.0	0.0	0.0	0.0	4.4	0.0	2.0	0.1	0.1	0.1	0.4	0.0	27.7	2.3	11.4	0.8	15.5	0.7	52.7	27.4	75.7	43.1	35.0	48.6	43.3	45.1	47.1	37.1	39.9	60.5	48.6	69.1	49.3	33.7	28.0	47.0	66.5	4.1	5.8	40.1	4.3	4.9	2.1	5.8	2.3	6.7	5.5
IL1R1	"CD121A, D2S1473, IL1R, IL1RA"	ENSG00000115594	"Interleukin 1 receptor type 1"	P14778	2	102064544-102179874	"Cancer-related genes, CD markers, FDA approved drug targets, Predicted membrane proteins, Predicted secreted proteins, Transporters"	"Inflammatory response"	Receptor	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 93.4;ASC TERT1: 41.7;HHSteC: 29.3;HSkMC: 115.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"neutrophil: 4.0"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA001237, HPA005823, CAB007779, HPA029560"	Approved		Approved	"Nucleoplasm,Vesicles,Plasma membrane,Cytosol"	"Secreted to blood"		1000000	"Nucleoplasm, Vesicles"	"Plasma membrane, Cytosol"	"CAB007779: AB_562073, HPA001237: , HPA005823: , HPA029560: "	"unprognostic (6.16e-3)"	"unprognostic (3.55e-2)"	"unprognostic (3.33e-1)"	"unprognostic (1.22e-1)"	"unprognostic (4.26e-2)"	"unprognostic (7.10e-2)"	"unprognostic (2.01e-1)"	"unprognostic (3.36e-2)"	"unprognostic (1.44e-1)"	"unprognostic (3.16e-1)"	"unprognostic (4.26e-2)"	"unprognostic (7.77e-2)"	"prognostic unfavourable (6.92e-6)"	"unprognostic (2.48e-2)"	"unprognostic (6.95e-2)"	"unprognostic (4.83e-2)"	"unprognostic (7.73e-2)"	48.6	25.2	2.6	18.2	5.2	4.0	92.4	2.4	3.9	47.8	21.0	2.5	34.3	5.2	15.2	30.2	18.2	17.1	25.8	27.0	4.2	2.5	23.7	74.8	40.5	28.0	5.6	1.1	25.1	17.1	16.9	7.3	66.2	10.9	26.0	8.4	8.6	12.7	36.4	15.5	13.5	13.0	15.1	10.0	19.2	15.6	13.4	2.8	3.5	33.6	9.0	9.6	32.0	36.4	0.1	0.1	4.0	0.5	0.8	1.8	0.2	0.2	1.8	0.0	1.5	93.4	41.7	0.6	3.9	17.7	2.8	4.2	0.8	0.4	0.0	2.9	7.8	0.7	0.0	0.3	2.3	7.7	0.0	0.1	0.4	4.3	29.3	0.0	0.0	115.0	0.3	3.1	0.7	1.2	0.4	0.1	4.0	0.7	0.0	0.1	0.1	0.1	0.0	0.2	0.0	2.6	1.9	0.0	0.0	1.7	1.1	0.0	1.6	0.1	0.0	8.0	0.5	13.4	0.3	0.0	0.0	0.0	3.1	0.0	0.5	0.6	0.5	0.1	0.0	0.0	0.7	0.1	1.1	0.0	0.1	0.1	0.0	0.1	4.0	0.8	0.0	0.1	1.8	0.2	2.6	5.2	2.4	3.9	4.2	2.5	5.6	1.1	10.9	2.8
ILDR2	C1orf32	ENSG00000143195	"Immunoglobulin like domain containing receptor 2"	Q71H61	1	166895711-166975482	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 14.6;testis: 18.0"	"Cell line enhanced"	"Detected in some"		"AF22: 9.8;MOLT-4: 5.1;U-2 OS: 12.6;U-251 MG: 6.6"	"Cancer enhanced"	"Detected in some"		"glioma: 4.3"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA012545, HPA012815"	Uncertain		Approved	"Plasma membrane"				"Plasma membrane"		"HPA012545: AB_2126894, HPA012815: "	"unprognostic (9.14e-2)"	"unprognostic (5.05e-2)"	"unprognostic (8.27e-2)"	"unprognostic (2.16e-1)"	"unprognostic (5.89e-2)"	"unprognostic (5.33e-2)"	"unprognostic (2.89e-5)"	"unprognostic (2.09e-1)"	"unprognostic (8.55e-2)"	"unprognostic (4.51e-2)"	"unprognostic (1.52e-1)"	"unprognostic (2.58e-1)"	"unprognostic (9.17e-2)"	"unprognostic (5.87e-3)"	"unprognostic (4.92e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.36e-1)"	0.8	1.1	9.8	0.9	6.4	1.4	0.5	2.1	14.6	0.7	2.9	3.6	0.1	0.7	0.9	1.4	0.9	0.8	1.3	3.1	7.2	7.7	6.3	1.3	1.4	1.0	2.7	8.0	0.8	0.7	0.5	3.3	0.8	3.1	2.3	1.2	2.8	0.8	2.8	0.8	0.7	0.8	2.0	2.3	0.7	0.7	18.0	3.1	1.9	0.9	0.0	1.1	0.9	0.3	0.0	0.4	0.3	0.0	0.0	0.3	0.5	0.0	0.0	9.8	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	1.2	1.0	1.8	0.3	0.0	0.0	0.0	0.0	0.0	2.3	1.9	0.0	0.0	0.2	0.0	3.2	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	5.1	0.0	3.4	0.0	0.0	0.3	0.7	0.7	0.2	1.3	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	12.6	0.0	6.6	2.3	0.0	0.5	1.4	1.3	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.3	0.0	0.3	0.0	0.0	0.1	0.0	0.5	9.8	6.4	2.1	11.4	7.2	7.7	2.7	8.0	3.1	3.1
IPCEF1	"KIAA0403, PIP3-E"	ENSG00000074706	"Interaction protein for cytohesin exchange factors 1"	Q8WWN9	6	154154496-154356792	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in many"	7	"blood: 30.1;bone marrow: 15.2;brain: 26.4;lymphoid tissue: 12.4;thyroid gland: 36.9"	"Group enriched"	"Detected in some"	5	"HMC-1: 19.3;THP-1: 9.8;U-937: 10.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"											"HPA028708, HPA028710"	Enhanced		Approved	"Nucleoli,Nuclear speckles,Plasma membrane,Cytoplasmic bodies"				"Nuclear speckles, Plasma membrane"	"Nucleoli, Cytoplasmic bodies"	"HPA028708: AB_10601916, HPA028710: "	"unprognostic (1.23e-2)"	"unprognostic (8.93e-3)"	"unprognostic (4.18e-2)"	"unprognostic (5.63e-3)"	"unprognostic (2.05e-1)"	"unprognostic (6.55e-3)"	"unprognostic (1.30e-3)"	"unprognostic (2.57e-2)"	"unprognostic (3.87e-1)"	"unprognostic (5.84e-2)"	"unprognostic (3.27e-2)"	"unprognostic (4.87e-2)"	"unprognostic (5.01e-2)"	"unprognostic (8.64e-2)"	"unprognostic (5.45e-2)"	"unprognostic (1.42e-2)"	"unprognostic (1.51e-4)"	1.3	0.7	5.3	6.9	12.9	15.2	1.9	20.0	26.4	3.4	1.6	5.5	0.0	1.1	1.7	1.8	1.9	2.5	3.2	1.0	3.8	4.6	3.4	2.4	2.0	12.4	3.9	14.1	1.3	1.4	0.4	1.3	2.0	5.5	1.3	1.6	0.0	1.4	0.8	0.7	1.2	2.9	1.3	4.2	6.4	2.6	1.5	4.9	10.0	36.9	0.0	11.7	2.4	1.1	0.0	7.1	30.1	6.3	6.0	13.5	5.3	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.4	0.0	0.0	0.0	1.7	0.0	0.0	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.1	1.4	0.0	0.0	0.0	0.1	19.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	1.1	1.0	0.4	0.2	0.2	0.5	0.9	2.1	0.3	0.3	0.0	0.1	0.0	0.0	9.8	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	10.2	0.0	1.4	6.3	30.1	6.1	2.8	13.1	0.0	7.7	5.8	7.1	0.0	13.5	7.9	19.3	6.0	3.4	0.2	9.9	5.3	5.3	12.9	20.0	26.4	3.8	4.6	3.9	14.1	5.5	4.9
IQGAP2		ENSG00000145703	"IQ motif containing GTPase activating protein 2"	Q13576	5	76403249-76708132	"Plasma proteins, Predicted intracellular proteins"		Calmodulin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 66.1"	"Cell line enhanced"	"Detected in many"		"CACO-2: 21.5;Hep G2: 17.8;HMC-1: 63.8;RPMI-8226: 23.3;U-937: 16.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"hippocampal formation: 34.4"	"Low region specificity"	"Detected in all"			"CAB004241, HPA037403, HPA037404"	Uncertain		Approved	"Vesicles,Plasma membrane"			8400000	"Vesicles, Plasma membrane"		"CAB004241: AB_2125909, HPA037403: , HPA037404: "	"unprognostic (9.46e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.48e-1)"	"unprognostic (9.03e-3)"	"unprognostic (8.85e-2)"	"prognostic favourable (5.65e-4)"	"unprognostic (5.96e-2)"	"unprognostic (1.14e-1)"	"unprognostic (2.34e-1)"	"unprognostic (2.14e-1)"	"unprognostic (1.41e-1)"	"prognostic favourable (9.44e-12)"	"unprognostic (3.29e-2)"	"unprognostic (9.89e-2)"	"unprognostic (1.52e-2)"	"unprognostic (1.27e-2)"	11.1	11.3	1.4	14.7	1.7	6.3	8.0	1.1	1.2	6.1	21.6	0.6	36.2	16.8	2.6	14.7	3.3	2.7	21.7	4.2	1.6	1.6	13.2	66.1	7.8	13.0	1.3	0.7	4.2	14.8	25.5	2.3	42.5	2.1	9.1	6.8	15.2	18.9	34.3	1.4	3.7	35.7	3.4	2.0	16.5	12.4	30.7	0.4	7.7	12.8	2.8	7.7	4.3	4.2	0.6	7.8	14.9	3.2	4.1	5.9	1.3	0.0	2.8	9.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	21.5	0.0	0.2	0.8	0.0	0.0	3.6	0.0	0.0	2.4	3.5	7.9	2.1	17.8	0.0	4.4	63.8	0.0	0.0	0.0	0.0	0.3	6.9	6.4	0.0	0.0	3.8	12.1	4.4	0.1	1.4	0.0	23.3	0.0	0.0	0.1	0.9	5.0	0.2	0.0	0.0	2.6	0.1	0.0	0.1	0.0	0.0	5.9	0.0	5.5	0.0	16.7	0.9	14.9	3.2	1.8	4.8	2.4	4.0	0.6	5.0	4.1	2.9	0.2	2.0	3.6	6.3	4.1	3.1	7.8	5.9	1.3	1.4	1.7	1.1	1.2	1.6	1.6	1.3	0.7	2.1	0.4
ISLR	HsT17563	ENSG00000129009	"Immunoglobulin superfamily containing leucine rich repeat"	O14498	15	74173671-74176872	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"ASC diff: 33.1;ASC TERT1: 17.8;fHDF/TERT166: 74.3;HSkMC: 13.5;RPMI-8226: 22.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in all"	5	"olfactory region: 145.0"	"Low region specificity"	"Detected in many"			"HPA040326, HPA050811"	Approved		Approved	"Golgi apparatus,Plasma membrane"	"Secreted - unknown location"		110000000	"Plasma membrane"	"Golgi apparatus"	"HPA040326: , HPA050811: "	"unprognostic (2.58e-1)"	"unprognostic (1.36e-2)"	"unprognostic (3.54e-2)"	"unprognostic (3.06e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.76e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.21e-1)"	"unprognostic (6.76e-3)"	"unprognostic (1.16e-2)"	"unprognostic (6.81e-2)"	"unprognostic (8.93e-3)"	"prognostic unfavourable (4.89e-8)"	"unprognostic (1.64e-2)"	"unprognostic (3.42e-2)"	"unprognostic (2.28e-1)"	"unprognostic (9.86e-3)"	24.6	6.8	3.3	10.4	4.6	0.1	21.4	2.0	12.1	72.8	19.7	2.9	13.2	4.1	67.3	36.3	23.0	22.1	29.6	17.7	1.7	1.7	8.0	2.5	10.2	5.8	3.3	7.2	80.2	3.4	1.2	13.8	31.5	3.9	32.2	4.0	36.4	10.0	17.9	12.5	13.6	8.8	27.5	9.0	9.8	10.3	16.3	0.6	1.3	18.9	17.0	9.9	27.9	35.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.1	0.0	33.1	17.8	0.1	5.1	0.0	0.0	0.0	0.0	2.0	0.0	0.3	74.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	13.5	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	22.8	0.0	0.0	0.2	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	3.9	0.0	0.1	0.5	0.0	0.2	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	4.6	2.0	12.1	1.7	1.7	3.3	7.2	3.9	0.6
ITGA2B	"CD41, CD41B, GP2B, PPP1R93"	ENSG00000005961	"Integrin subunit alpha 2b"	P08514	17	44372180-44389505	"Cancer-related genes, Candidate cardiovascular disease genes, CD markers, Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"	"Integrin, Receptor"	"Cancer-related genes, Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 28.5;epididymis: 25.2;lymphoid tissue: 22.8"	"Group enriched"	"Detected in some"	13	"HEL: 69.4;HMC-1: 118.6"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in some"	10	"basophil: 28.5"	"Lineage enriched"	"Detected in single"	54	"granulocytes: 28.5"	"Low region specificity"	"Detected in single"							"CAB018611, HPA031168, HPA031169, HPA031170, HPA031171"	Enhanced		Approved	"Plasma membrane"			1100000000	"Plasma membrane"		"CAB018611: AB_2265153, HPA031168: AB_10670151, HPA031169: AB_10669671, HPA031170: AB_10696214, HPA031171: AB_10669773"	"unprognostic (6.11e-2)"	"unprognostic (3.23e-2)"	"unprognostic (1.23e-1)"	"unprognostic (4.85e-2)"	"unprognostic (1.59e-2)"	"unprognostic (3.98e-3)"	"unprognostic (4.23e-5)"	"unprognostic (1.25e-1)"	"unprognostic (1.33e-2)"	"unprognostic (7.22e-2)"	"unprognostic (2.97e-3)"	"unprognostic (1.30e-1)"	"unprognostic (8.83e-9)"	"unprognostic (7.82e-2)"	"unprognostic (1.85e-1)"	"unprognostic (1.95e-1)"	"unprognostic (2.25e-1)"	0.7	0.2	1.4	0.4	1.0	15.2	0.6	3.8	2.4	1.2	0.9	0.4	0.4	0.1	1.1	25.2	0.7	1.9	1.4	10.6	0.9	1.6	1.0	0.4	6.5	0.5	0.7	0.8	2.1	2.5	0.1	2.5	1.9	1.1	0.6	0.3	0.6	0.4	1.6	0.8	0.1	0.6	0.4	0.8	22.8	0.2	3.0	0.4	0.4	5.2	1.0	0.6	0.7	1.9	0.0	0.5	28.5	0.2	0.0	0.2	11.1	0.0	0.1	0.7	0.0	0.0	0.0	2.8	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.4	69.4	0.0	0.6	0.0	0.0	118.6	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	7.2	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.6	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	28.5	0.2	2.1	0.1	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	2.8	0.0	0.0	0.5	0.0	11.1	1.4	1.0	3.8	2.4	0.9	1.6	0.7	0.8	1.1	0.4
ITGA4	CD49d	ENSG00000115232	"Integrin subunit alpha 4"	P13612	2	181457202-181536187	"Cancer-related genes, CD markers, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"	"Integrin, Receptor"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 38.4;lymphoid tissue: 101.6"	"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 38.7;HEL: 61.5;MOLT-4: 71.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Region enriched"	"Detected in many"	7	"cerebellum: 26.0"	HPA074961			Approved	"Plasma membrane"	"Intracellular and membrane"		100000	"Plasma membrane"		"HPA074961: "	"unprognostic (5.31e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.99e-2)"	"unprognostic (3.94e-2)"	"unprognostic (3.76e-1)"	"prognostic favourable (8.29e-4)"	"unprognostic (1.27e-1)"	"unprognostic (1.11e-2)"	"unprognostic (1.76e-1)"	"unprognostic (2.67e-2)"	"unprognostic (1.85e-1)"	"unprognostic (1.94e-1)"	"prognostic unfavourable (3.08e-5)"	"unprognostic (2.26e-2)"	"unprognostic (8.64e-3)"	"unprognostic (2.49e-1)"	"unprognostic (2.57e-2)"	3.8	1.7	1.3	39.7	1.1	19.2	3.2	2.4	1.9	6.7	4.8	0.5	1.1	3.8	3.0	3.1	2.9	2.1	6.9	1.7	2.9	1.3	3.0	2.5	13.6	33.7	1.2	0.5	1.8	1.6	0.0	1.3	7.1	0.9	3.8	4.9	2.9	7.5	2.0	1.0	1.5	11.6	2.4	1.6	36.0	4.4	1.2	0.2	101.6	2.6	1.5	14.3	6.0	4.1	11.0	19.1	38.4	38.3	8.8	15.9	16.2	0.0	0.2	1.0	0.0	9.1	13.8	0.0	8.9	11.2	4.8	10.1	0.0	0.0	7.1	0.0	38.7	5.3	3.1	0.1	5.8	0.0	0.7	61.5	0.2	0.0	0.9	27.2	1.5	9.8	0.0	0.3	0.0	0.4	0.0	10.4	3.0	0.0	71.7	19.1	0.8	0.0	15.7	4.5	1.0	0.0	0.0	1.6	0.6	0.0	0.0	0.3	0.0	18.0	4.8	1.5	0.9	0.1	1.8	20.4	15.1	4.0	0.8	13.5	20.6	6.7	16.2	38.4	12.9	38.3	9.7	11.0	14.6	15.9	19.1	10.0	8.5	10.4	2.1	8.8	37.5	5.0	3.7	16.2	1.3	1.1	2.4	1.9	2.9	1.3	1.2	0.5	0.9	0.2
ITGA7		ENSG00000135424	"Integrin subunit alpha 7"	Q13683	12	55684568-55716043	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion, Cell shape"	"Integrin, Receptor"	"Congenital muscular dystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 66.4;skeletal muscle: 81.3"	"Cell line enhanced"	"Detected in many"		"ASC diff: 29.5;hTEC/SVTERT24-B: 27.9;LHCN-M2: 16.9;SK-MEL-30: 20.4;U-87 MG: 25.2"	"Cancer enhanced"	"Detected in all"		"glioma: 35.3"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA008427	Uncertain		Approved	"Nuclear speckles,Vesicles,Plasma membrane"			770000	"Plasma membrane"	"Nuclear speckles, Vesicles"	"HPA008427: AB_1851823"	"unprognostic (4.71e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.00e-3)"	"unprognostic (3.02e-3)"	"unprognostic (2.50e-1)"	"unprognostic (2.36e-1)"	"unprognostic (1.66e-2)"	"unprognostic (2.20e-1)"	"unprognostic (2.20e-2)"	"unprognostic (3.57e-1)"	"prognostic favourable (1.75e-4)"	"unprognostic (2.85e-2)"	"unprognostic (5.89e-2)"	"unprognostic (1.79e-1)"	"unprognostic (5.10e-1)"	"unprognostic (2.98e-2)"	"prognostic unfavourable (9.59e-5)"	46.2	3.4	6.1	7.2	6.8	0.9	20.6	3.6	7.6	6.3	22.4	5.7	5.9	6.6	15.1	13.5	11.6	12.9	14.8	66.4	7.8	2.6	3.1	4.1	3.4	2.9	3.9	7.6	5.1	1.9	3.4	3.1	1.0	5.7	8.9	3.7	5.6	3.3	14.6	81.3	3.6	7.2	33.3	4.5	2.4	10.3	2.9	5.3	0.2	6.5	10.6	2.2	13.6	14.1	0.5	1.7	0.0	1.0	0.0	0.8	0.3	0.1	1.7	3.2	5.2	29.5	5.9	0.3	2.2	3.7	5.0	5.2	3.5	2.8	0.9	3.2	1.4	0.4	2.2	0.1	4.5	0.1	1.6	0.3	1.1	1.3	0.2	0.1	1.1	8.3	0.0	27.9	0.1	0.0	0.4	0.6	16.9	2.1	0.1	1.2	9.0	0.2	0.0	12.2	0.2	0.1	0.0	0.4	1.2	0.2	0.0	20.4	0.3	5.7	0.0	0.5	5.5	0.3	3.5	1.3	0.9	0.3	25.2	3.4	0.3	0.0	0.7	0.0	0.4	1.0	0.0	0.1	0.0	0.8	1.7	0.5	0.3	0.4	0.0	0.0	1.0	0.6	0.0	0.3	6.1	6.8	3.6	7.6	7.8	2.6	3.9	7.6	5.7	5.3
ITGA9	"ALPHA-RLC, ITGA4L, RLC"	ENSG00000144668	"Integrin subunit alpha 9"	Q13797	3	37452115-37823514	"Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"	"Integrin, Receptor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"AF22: 4.6;CACO-2: 10.6;HEL: 8.5;HMC-1: 5.0;SH-SY5Y: 12.7;WM-115: 6.6"	"Cancer enhanced"	"Detected in all"		"thyroid cancer: 23.6"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"basophil: 2.1"	"Lineage enhanced"	"Detected in single"		"granulocytes: 2.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA030609	Approved		Approved	"Nucleoplasm,Vesicles,Plasma membrane,Cell Junctions"	"Intracellular and membrane"		250000	Vesicles	"Nucleoplasm, Plasma membrane, Cell Junctions"	"HPA030609: AB_10600815"	"unprognostic (2.35e-2)"	"unprognostic (3.36e-2)"	"unprognostic (5.58e-2)"	"unprognostic (3.94e-2)"	"unprognostic (4.48e-2)"	"unprognostic (2.85e-2)"	"unprognostic (3.10e-1)"	"unprognostic (8.87e-3)"	"unprognostic (3.23e-1)"	"unprognostic (2.31e-1)"	"unprognostic (2.04e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.78e-2)"	"unprognostic (1.50e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.72e-2)"	"unprognostic (3.16e-2)"	8.5	15.5	3.1	5.3	3.7	5.8	9.6	1.6	5.7	17.9	11.1	2.9	5.8	4.6	17.3	7.5	12.3	6.9	17.8	25.0	4.5	2.0	4.6	13.6	8.3	16.8	3.4	2.7	7.5	2.1	2.4	3.0	7.3	2.6	10.0	5.3	8.4	4.7	8.7	3.7	3.5	8.7	16.2	4.0	30.5	10.9	10.2	2.7	1.0	35.4	7.2	3.6	7.4	8.4	0.0	0.7	2.1	0.2	0.0	0.0	0.4	0.2	0.0	4.6	0.3	0.0	0.3	0.1	0.1	0.0	0.0	0.0	10.6	0.0	3.4	1.5	0.0	0.2	4.1	0.0	0.0	0.1	0.6	8.5	0.2	0.2	0.2	0.0	5.0	0.0	0.0	0.0	0.0	0.0	0.5	0.2	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.4	0.3	0.0	0.2	0.6	12.7	0.1	0.6	0.7	0.0	3.3	0.1	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.1	0.2	6.6	2.1	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.4	3.1	3.7	1.6	5.7	4.5	2.0	3.4	2.7	2.6	2.7
ITGB5		ENSG00000082781	"Integrin subunit beta 5"	P18084	3	124761948-124901418	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion, Host-virus interaction"	"Host cell receptor for virus entry, Integrin, Receptor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"A549: 74.0;WM-115: 77.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"gdT-cell: 2.1"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001820, CAB022050"	Approved		Approved	"Plasma membrane,Mitochondria"			95000	"Plasma membrane, Mitochondria"		"CAB022050: , HPA001820: AB_1079142"	"unprognostic (2.63e-1)"	"unprognostic (1.04e-1)"	"unprognostic (3.57e-1)"	"unprognostic (4.44e-2)"	"unprognostic (1.37e-2)"	"unprognostic (6.07e-2)"	"unprognostic (3.49e-3)"	"unprognostic (3.16e-3)"	"unprognostic (1.68e-1)"	"unprognostic (1.53e-2)"	"prognostic unfavourable (1.40e-4)"	"unprognostic (1.16e-1)"	"unprognostic (2.16e-3)"	"unprognostic (2.49e-3)"	"unprognostic (1.12e-1)"	"unprognostic (1.01e-1)"	"unprognostic (4.38e-3)"	72.5	13.8	9.7	9.7	10.0	0.8	50.1	5.7	8.2	34.2	18.8	14.8	28.0	12.9	31.7	17.2	25.6	13.9	29.1	32.9	9.4	5.1	19.6	22.1	20.4	3.5	12.0	6.2	17.4	12.1	8.9	8.4	36.4	13.0	23.0	10.1	27.1	18.6	23.1	15.9	33.3	16.1	25.1	9.0	18.7	12.4	17.0	8.7	2.8	18.8	16.2	10.9	24.4	27.1	0.1	1.1	0.4	0.6	0.9	2.1	5.8	29.6	74.0	5.3	13.4	50.2	14.6	27.5	31.8	19.7	5.9	9.6	14.7	38.8	0.1	15.5	54.0	23.8	4.8	16.5	5.2	0.3	3.2	10.5	11.4	15.5	8.8	0.0	19.3	8.7	3.8	14.9	7.8	19.8	9.3	15.9	20.3	30.2	0.1	0.1	23.8	8.2	0.0	8.5	11.2	16.8	6.5	0.1	11.1	23.6	35.1	26.8	19.8	0.6	51.0	22.4	33.8	19.4	16.4	2.7	2.8	0.2	23.4	0.1	77.2	0.4	0.6	0.2	2.1	0.2	0.0	0.0	0.2	0.0	1.1	0.1	0.3	0.4	0.4	0.9	0.4	0.1	0.0	5.8	9.7	10.0	5.7	8.2	9.4	5.1	12.0	6.2	13.0	8.7
ITGB8		ENSG00000105855	"Integrin subunit beta 8"	P26012	7	20330702-20415754	"Cancer-related genes, Predicted membrane proteins"	"Cell adhesion"	"Integrin, Receptor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"AF22: 16.3;EFO-21: 21.0;RPTEC TERT1: 32.6;WM-115: 46.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	105	"basophil: 13.8"	"Lineage enriched"	"Detected in single"	105	"granulocytes: 13.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027796, HPA027797"	Enhanced		Approved	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		"HPA027796: AB_10600299, HPA027797: AB_10600879"	"unprognostic (8.32e-3)"	"unprognostic (1.42e-1)"	"unprognostic (1.03e-1)"	"unprognostic (3.37e-3)"	"unprognostic (5.63e-2)"	"unprognostic (3.53e-1)"	"unprognostic (1.75e-1)"	"unprognostic (1.46e-1)"	"unprognostic (4.36e-2)"	"unprognostic (1.75e-2)"	"unprognostic (2.49e-3)"	"unprognostic (8.47e-2)"	"prognostic favourable (1.77e-4)"	"unprognostic (2.90e-1)"	"unprognostic (1.56e-1)"	"unprognostic (4.63e-2)"	"unprognostic (6.92e-3)"	4.7	4.1	18.0	5.8	20.0	1.2	12.7	7.8	24.3	22.1	4.6	19.4	9.0	4.6	10.5	19.0	8.8	10.4	11.7	3.9	19.4	12.5	28.1	1.7	3.7	1.3	29.3	14.5	7.1	17.5	8.1	7.7	10.7	22.8	9.6	4.4	37.5	16.6	13.1	0.9	8.5	6.0	7.0	23.1	0.8	6.2	8.7	24.0	0.0	3.4	1.3	9.0	6.8	9.9	0.0	0.0	13.8	0.1	0.0	0.1	0.0	10.0	0.4	16.3	2.0	1.4	5.7	0.0	0.0	0.1	0.1	0.5	0.1	2.5	0.0	21.0	0.7	11.2	0.7	1.6	0.2	0.0	0.2	0.0	7.8	0.0	0.7	0.0	0.0	0.6	4.6	0.2	0.8	0.8	0.0	3.0	0.3	0.0	0.0	0.0	1.2	1.8	0.0	1.4	0.0	32.6	0.8	0.2	0.7	3.1	0.0	8.1	0.2	0.0	1.1	4.3	2.8	1.2	2.1	3.8	0.0	0.0	1.0	0.0	46.6	13.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	18.0	20.0	7.8	14.2	19.4	12.5	29.3	14.5	22.8	24.0
ITM2A	"BRICD2A, E25A"	ENSG00000078596	"Integral membrane protein 2A"	O43736	X	79360384-79367667	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 100.7"	"Cell line enriched"	"Detected in some"	8	"MOLT-4: 187.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"basophil: 26.5;eosinophil: 16.8;gdT-cell: 23.2;MAIT T-cell: 17.0;memory CD4 T-cell: 44.6;memory CD8 T-cell: 36.5;naive CD4 T-cell: 48.0;naive CD8 T-cell: 22.6;NK-cell: 25.2;T-reg: 32.4"	"Group enriched"	"Detected in many"	7	"granulocytes: 26.5;NK-cells: 25.2;T-cells: 48.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000296			Approved	"Golgi apparatus,Vesicles,Plasma membrane"				Vesicles	"Golgi apparatus, Plasma membrane"	"HPA000296: "	"unprognostic (1.05e-2)"	"unprognostic (5.22e-3)"	"unprognostic (2.77e-3)"	"unprognostic (5.65e-2)"	"unprognostic (1.73e-2)"	"unprognostic (1.06e-3)"	"prognostic favourable (3.66e-6)"	"unprognostic (1.57e-1)"	"unprognostic (4.94e-2)"	"unprognostic (9.85e-2)"	"unprognostic (1.33e-2)"	"unprognostic (2.57e-1)"	"unprognostic (1.04e-2)"	"unprognostic (1.56e-1)"	"unprognostic (3.31e-1)"	"unprognostic (2.18e-1)"	"unprognostic (4.30e-1)"	27.2	4.1	27.0	9.1	37.8	13.6	27.4	7.8	25.8	21.8	11.0	16.1	6.5	5.4	16.4	19.4	14.8	15.3	10.6	42.1	33.6	22.5	7.7	2.2	19.0	28.5	34.8	19.5	69.6	6.3	2.7	9.3	10.6	25.8	16.7	11.9	16.2	28.2	8.8	13.2	10.3	8.8	20.9	33.9	8.4	9.6	8.0	12.5	100.7	31.1	14.1	16.5	14.7	16.6	4.7	1.1	26.5	0.2	25.2	48.0	22.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	24.3	0.3	0.0	0.4	0.0	7.6	0.0	0.0	0.0	12.2	14.2	2.3	0.0	0.0	0.0	0.0	8.6	0.0	0.0	0.0	187.9	8.5	2.8	0.0	0.0	0.0	0.0	7.3	0.0	0.0	2.1	0.0	0.1	0.0	0.2	0.2	0.3	0.0	0.2	0.0	0.1	23.7	0.0	0.0	0.0	0.0	0.9	26.5	0.1	16.8	23.2	0.2	17.0	4.6	44.6	36.5	0.1	4.7	48.0	22.6	0.8	25.2	0.2	1.1	32.4	22.6	27.0	37.8	7.8	25.8	33.6	22.5	34.8	19.5	25.8	12.5
ITSN2	"KIAA1256, PRO2015, SH3D1B, SH3P18, SWA, SWAP"	ENSG00000198399	"Intersectin 2"	Q9NZM3	2	24202864-24360714	"Predicted intracellular proteins"	"Differentiation, Endocytosis, Host-virus interaction"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036475	Approved		Approved	"Vesicles,Plasma membrane"				"Vesicles, Plasma membrane"		"HPA036475: AB_10670718"	"unprognostic (2.36e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.24e-1)"	"unprognostic (5.95e-2)"	"unprognostic (4.64e-1)"	"prognostic favourable (2.98e-4)"	"unprognostic (3.32e-2)"	"unprognostic (3.83e-2)"	"unprognostic (2.77e-1)"	"unprognostic (1.66e-1)"	"unprognostic (2.69e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.66e-1)"	"unprognostic (2.39e-1)"	"unprognostic (2.72e-2)"	"unprognostic (2.41e-2)"	"unprognostic (2.12e-2)"	16.8	18.8	13.4	30.7	14.8	41.4	16.6	15.2	18.3	17.4	16.8	11.5	17.9	11.3	15.1	11.8	31.4	13.3	12.6	17.3	12.0	10.3	15.3	17.7	23.6	31.7	15.0	11.7	16.4	42.6	16.1	27.2	15.9	14.3	19.1	13.5	9.9	17.2	17.2	23.5	20.5	20.2	18.0	13.3	27.8	16.2	9.6	17.0	27.0	35.1	15.6	31.8	19.8	22.9	27.2	10.6	43.0	20.4	8.9	13.0	6.8	15.9	7.8	1.9	5.7	5.7	7.6	17.6	9.7	9.2	4.5	5.4	7.5	8.6	24.8	8.6	8.1	7.3	8.8	6.1	7.6	19.7	8.2	33.7	4.8	8.4	9.6	17.2	19.5	5.9	7.2	7.9	13.9	14.2	9.5	18.9	7.1	6.5	7.1	8.5	3.6	7.7	8.9	22.7	7.4	8.0	30.2	1.3	4.0	7.7	8.3	11.7	5.7	9.3	19.5	9.7	8.5	8.0	9.0	20.8	22.9	26.0	7.7	16.0	8.5	20.6	11.4	19.9	12.4	13.9	13.0	24.1	10.8	10.8	10.6	27.2	11.0	9.9	43.0	8.9	20.4	7.0	11.2	6.8	13.4	14.8	15.2	18.3	12.0	10.3	15.0	11.7	14.3	17.0
JAG1	"AGS, AHD, AWS, CD339, HJ1, JAGL1"	ENSG00000101384	"Jagged 1"	P78504	20	10637684-10673999	"CD markers, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Notch signaling pathway"	"Developmental protein"	"Deafness, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 55.8;hTERT-HME1: 34.5;U-251 MG: 46.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"eosinophil: 2.4"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"CAB010343, HPA021555"	Supported		Approved	"Golgi apparatus,Plasma membrane"			14000000	"Golgi apparatus, Plasma membrane"		"CAB010343: AB_649685, HPA021555: AB_1851969"	"unprognostic (2.23e-1)"	"unprognostic (2.04e-2)"	"unprognostic (1.78e-1)"	"unprognostic (4.15e-2)"	"unprognostic (1.21e-1)"	"unprognostic (6.42e-2)"	"unprognostic (4.21e-2)"	"unprognostic (8.94e-3)"	"unprognostic (6.07e-2)"	"unprognostic (5.20e-2)"	"prognostic unfavourable (4.10e-6)"	"unprognostic (5.48e-2)"	"unprognostic (1.71e-3)"	"unprognostic (2.22e-1)"	"unprognostic (1.66e-1)"	"unprognostic (3.10e-1)"	"unprognostic (1.41e-3)"	27.7	5.6	6.8	14.5	5.4	9.7	56.5	2.9	6.7	34.2	20.1	4.3	17.4	7.2	26.1	22.8	33.9	16.7	23.1	18.8	5.4	5.1	12.9	3.8	22.0	12.4	5.4	4.0	14.7	22.2	21.7	6.0	36.3	6.0	19.2	12.7	21.4	11.2	23.4	16.8	34.8	11.7	21.4	13.0	14.2	13.4	9.1	3.8	1.5	14.5	24.6	16.1	18.7	31.4	0.0	0.9	2.4	2.0	0.4	0.1	0.4	1.0	5.2	16.4	20.1	3.1	3.0	0.6	0.6	3.0	0.8	0.4	4.6	2.8	0.1	15.4	0.6	21.9	2.4	55.8	0.7	0.0	1.1	1.7	0.5	21.9	1.5	7.0	0.1	1.2	16.6	2.7	34.5	5.4	0.0	2.2	1.5	0.0	0.0	5.0	4.7	5.2	1.3	1.0	3.2	7.8	6.4	0.7	0.5	1.6	1.1	6.6	0.1	0.8	20.4	3.7	2.6	3.0	46.9	0.9	0.1	0.2	2.4	2.5	2.9	0.0	2.0	2.4	0.0	0.2	0.0	0.0	0.0	0.0	0.7	0.0	0.1	0.0	1.6	0.4	0.3	0.9	0.0	0.4	6.8	5.4	2.9	6.7	5.4	5.1	5.4	4.0	6.0	3.8
JAK2	JTK10	ENSG00000096968	"Janus kinase 2"	O60674	9	4984390-5128183	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Adaptive immunity, Immunity, Innate immunity"	"Chromatin regulator, Kinase, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Disease mutation, FDA approved drug targets, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"ASC diff: 18.9;HDLM-2: 26.7;HEL: 54.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 40.8"	"Lineage enriched"	"Detected in all"	4	"granulocytes: 40.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB013089, HPA040820, HPA043870"	Approved		Supported	"Nucleoplasm,Plasma membrane,Focal adhesion sites"				Nucleoplasm	"Plasma membrane, Focal adhesion sites"	"CAB013089: AB_2533647, HPA040820: , HPA043870: "	"unprognostic (2.24e-3)"	"unprognostic (2.76e-2)"	"unprognostic (1.50e-2)"	"unprognostic (7.67e-2)"	"unprognostic (5.50e-2)"	"unprognostic (3.09e-2)"	"unprognostic (1.48e-1)"	"unprognostic (7.36e-2)"	"unprognostic (1.09e-1)"	"unprognostic (5.49e-3)"	"unprognostic (1.58e-1)"	"unprognostic (1.72e-2)"	"unprognostic (3.85e-1)"	"unprognostic (4.53e-2)"	"unprognostic (3.43e-2)"	"unprognostic (1.96e-1)"	"unprognostic (7.37e-3)"	19.8	8.8	11.5	19.0	10.5	19.0	17.7	14.7	14.4	17.8	10.6	7.0	10.3	7.2	14.8	13.6	12.4	13.4	14.6	27.6	10.3	6.7	7.7	5.6	16.1	19.4	7.0	10.5	15.9	6.7	10.1	7.5	12.0	10.0	12.0	7.4	9.4	7.2	7.4	14.4	19.0	12.3	10.4	11.7	21.5	14.1	10.1	9.0	13.6	8.6	6.5	13.5	13.9	15.6	2.1	9.6	40.8	7.5	3.4	2.1	2.5	2.5	1.4	1.4	2.5	18.9	4.9	0.4	3.4	2.9	2.6	1.7	0.1	0.8	0.1	0.8	2.0	0.8	1.5	2.1	1.9	26.7	0.5	54.8	2.9	0.7	3.9	3.7	2.8	4.0	0.9	1.1	1.8	2.4	3.9	6.4	4.7	0.9	0.9	5.2	1.3	1.7	1.9	2.7	0.7	2.0	1.3	1.6	0.9	1.0	1.5	1.0	0.7	6.5	5.0	4.0	1.3	4.1	2.4	1.2	2.2	0.5	5.2	1.8	2.0	40.8	7.5	13.4	2.1	7.3	1.7	2.1	1.6	1.2	9.6	1.9	0.9	1.1	7.1	3.4	5.8	3.6	1.6	2.5	11.5	10.5	14.7	14.4	10.3	6.7	7.0	10.5	10.0	9.0
JAK3	"JAK-3, JAK3_HUMAN, JAKL, L-JAK, LJAK"	ENSG00000105639	"Janus kinase 3"	P52333	19	17824780-17848071	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins"	"Adaptive immunity, Immunity, Innate immunity"	"Kinase, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Disease mutation, FDA approved drug targets, SCID"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"lymphoid tissue: 68.3"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 20.1;HEL: 9.0;HMC-1: 9.2;Karpas-707: 23.5;U-266/70: 9.1;U-266/84: 13.5;U-937: 13.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA070314	Enhanced		Approved	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		"HPA070314: "	"unprognostic (5.59e-3)"	"prognostic favourable (6.42e-5)"	"unprognostic (5.71e-2)"	"unprognostic (2.34e-1)"	"unprognostic (6.13e-3)"	"unprognostic (1.11e-3)"	"unprognostic (4.21e-2)"	"unprognostic (2.60e-1)"	"unprognostic (2.38e-2)"	"unprognostic (2.36e-1)"	"unprognostic (3.58e-2)"	"unprognostic (1.94e-1)"	"prognostic unfavourable (2.89e-14)"	"unprognostic (2.28e-1)"	"unprognostic (2.21e-2)"	"unprognostic (4.43e-2)"	"unprognostic (7.61e-2)"	6.8	1.7	4.0	24.5	8.5	12.0	2.7	2.4	3.1	1.9	2.3	1.0	0.0	2.2	1.7	2.0	2.5	3.5	3.6	4.3	2.7	2.8	3.8	2.0	8.4	68.3	7.5	0.0	11.0	2.0	0.4	2.3	4.1	5.3	3.0	2.4	1.6	6.1	1.5	0.7	1.3	9.5	2.5	8.4	36.1	3.2	1.8	5.8	20.9	3.4	1.7	28.8	5.3	2.4	7.4	4.5	16.9	9.6	8.4	15.0	6.8	0.1	0.3	0.3	1.0	0.4	1.4	0.2	0.5	0.0	0.0	0.1	0.0	0.9	0.4	1.9	0.4	0.1	0.0	0.2	0.0	20.1	0.0	9.0	0.0	0.8	0.7	0.0	9.2	5.0	0.2	0.0	0.0	0.2	0.0	23.5	0.0	0.4	3.6	0.0	0.1	0.7	4.6	0.0	0.4	0.5	0.0	0.0	0.3	0.1	0.2	0.0	2.0	1.3	0.4	0.0	0.4	0.0	0.0	9.1	13.5	2.5	0.1	13.7	0.2	1.2	4.9	0.2	12.6	9.6	14.5	6.5	15.0	13.1	4.5	7.4	14.9	13.0	16.9	8.4	8.8	3.7	11.8	6.8	4.0	8.5	2.4	3.1	2.7	2.8	7.5	0.0	5.3	5.8
JMJD4	FLJ12517	ENSG00000081692	"Jumonji domain containing 4"	Q9H9V9	1	227730425-227735411	"Predicted intracellular proteins"		"Dioxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027260, HPA052861"	Uncertain		Approved	"Vesicles,Plasma membrane"				"Plasma membrane"	Vesicles	"HPA027260: AB_10602608, HPA052861: "	"unprognostic (1.80e-1)"	"unprognostic (1.37e-1)"	"unprognostic (4.86e-2)"	"unprognostic (2.29e-1)"	"unprognostic (1.43e-1)"	"unprognostic (2.86e-1)"	"unprognostic (1.23e-1)"	"unprognostic (6.19e-2)"	"unprognostic (1.74e-2)"	"unprognostic (4.31e-2)"	"unprognostic (8.69e-3)"	"unprognostic (8.68e-3)"	"prognostic unfavourable (3.16e-4)"	"unprognostic (4.45e-2)"	"unprognostic (2.82e-1)"	"unprognostic (2.05e-1)"	"unprognostic (4.68e-1)"	10.1	17.5	9.6	8.3	8.3	5.9	13.1	10.1	17.1	10.1	12.0	9.7	13.1	7.9	11.7	12.8	10.0	13.5	11.7	11.7	10.0	9.6	8.7	19.8	7.9	25.0	9.7	10.0	14.9	17.5	9.5	14.4	12.0	6.3	12.2	4.6	11.8	18.2	11.6	14.9	9.8	8.7	8.3	7.2	13.7	8.6	20.1	3.2	21.5	9.7	11.1	14.4	8.5	6.8	8.5	11.6	2.9	6.4	13.2	12.7	7.0	10.6	15.8	5.2	5.7	5.6	3.2	19.0	6.7	7.1	10.5	6.5	13.5	9.2	14.4	10.3	6.4	10.9	3.5	10.8	1.2	7.7	17.0	8.8	7.9	10.4	10.0	9.2	4.4	5.7	6.9	10.0	7.4	5.4	11.4	4.8	5.1	9.0	11.2	4.8	8.9	24.9	10.4	6.3	12.9	6.2	10.0	10.1	6.8	6.4	23.0	8.6	18.4	10.0	4.6	5.4	5.4	6.4	12.4	8.9	2.7	5.5	5.3	4.5	14.6	2.9	6.4	2.3	10.2	6.4	11.7	8.3	7.9	7.2	5.8	8.5	12.7	11.0	0.6	13.2	3.4	11.6	8.8	7.0	9.6	8.3	10.1	17.1	10.0	9.6	9.7	10.0	6.3	3.2
KANK3	"ANKRD47, FLJ46061"	ENSG00000186994	"KN motif and ankyrin repeat domains 3"	Q6NY19	19	8322584-8343262	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"HUVEC TERT2: 9.1;TIME: 16.4;U-266/70: 6.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"granulocytes: 1.0;NK-cells: 3.6;T-cells: 3.5"	"Low region specificity"	"Detected in all"			"Region enriched"	"Detected in all"	5	"olfactory region: 34.0"	HPA051153	Approved		Approved	"Plasma membrane"				"Plasma membrane"		"HPA051153: AB_2681365"	"unprognostic (1.56e-1)"	"unprognostic (1.63e-4)"	"unprognostic (1.54e-2)"	"unprognostic (8.95e-3)"	"unprognostic (1.07e-1)"	"unprognostic (2.84e-3)"	"unprognostic (1.82e-3)"	"unprognostic (3.26e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.39e-2)"	"unprognostic (1.34e-2)"	"unprognostic (4.77e-1)"	"prognostic favourable (1.69e-5)"	"unprognostic (5.03e-2)"	"unprognostic (1.67e-1)"	"unprognostic (2.86e-1)"	"unprognostic (3.24e-1)"	23.3	3.6	5.2	3.8	4.8	1.2	13.2	2.7	6.5	3.8	5.6	1.6	2.9	4.0	5.4	6.2	4.7	5.2	3.4	9.6	6.2	2.9	7.7	2.3	19.0	6.3	4.4	1.6	3.1	3.1	1.6	3.5	18.3	4.8	3.3	1.2	6.4	3.4	2.8	15.5	3.5	4.0	3.5	2.8	21.0	3.1	2.5	5.0	0.3	7.9	3.0	1.6	2.5	6.7	0.5	0.3	1.0	0.3	3.6	3.5	0.7	0.1	0.7	0.3	0.6	0.0	0.0	0.3	0.1	0.1	0.0	0.1	0.8	0.2	0.0	2.6	0.0	0.1	0.6	2.9	0.0	0.8	1.6	0.4	0.4	0.5	0.1	0.2	1.5	0.0	0.9	0.0	0.0	9.1	0.0	0.4	0.0	0.5	0.0	0.5	0.6	0.3	1.5	0.0	0.7	0.1	0.2	0.0	0.1	0.0	0.8	0.1	0.6	0.0	16.4	0.1	1.5	0.4	0.1	6.8	0.2	0.3	0.2	0.1	0.2	0.8	0.3	0.1	3.5	0.1	1.6	0.3	1.9	0.6	0.1	0.5	0.8	1.3	1.0	3.6	0.1	0.3	1.3	0.7	5.2	4.8	2.7	6.5	6.2	2.9	4.4	1.6	4.8	5.0
KATNB1		ENSG00000140854	"Katanin regulatory subunit B1"	Q9BVA0	16	57735730-57757250	"Disease related genes, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"		"Disease mutation, Lissencephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041165, HPA041839"	Enhanced		Supported	"Plasma membrane,Microtubules,Cytosol"				"Plasma membrane, Cytosol"	Microtubules	"HPA041165: AB_10795584, HPA041839: AB_10795598"	"unprognostic (1.37e-1)"	"unprognostic (2.76e-2)"	"unprognostic (1.56e-1)"	"prognostic favourable (9.24e-4)"	"unprognostic (2.54e-1)"	"unprognostic (2.51e-1)"	"prognostic unfavourable (3.93e-4)"	"unprognostic (1.42e-1)"	"unprognostic (2.92e-1)"	"unprognostic (1.75e-1)"	"prognostic favourable (8.44e-4)"	"unprognostic (2.89e-2)"	"unprognostic (1.03e-3)"	"unprognostic (2.20e-1)"	"unprognostic (1.29e-1)"	"unprognostic (6.88e-2)"	"unprognostic (1.54e-1)"	6.9	9.1	15.3	9.3	21.4	18.7	6.3	13.2	29.0	7.0	7.4	8.8	6.7	9.4	6.6	5.8	11.0	18.7	5.9	8.5	16.0	14.5	5.8	10.3	8.0	8.8	9.3	14.1	7.0	9.4	9.5	8.0	7.9	10.6	6.3	5.2	6.2	11.9	8.0	7.1	21.4	8.5	6.0	6.9	8.0	9.1	32.7	8.1	10.8	7.2	10.3	8.6	7.4	6.4	5.8	9.8	24.6	11.6	8.4	12.4	10.5	7.4	13.6	7.5	9.6	4.1	3.7	13.3	5.3	7.0	13.9	7.7	11.3	6.7	6.1	10.6	3.3	10.1	10.0	10.5	6.3	4.1	28.6	7.9	7.6	15.5	4.4	17.2	29.8	3.8	6.5	10.9	6.4	8.2	15.5	3.0	5.4	8.0	24.9	22.4	13.2	23.7	20.0	9.3	22.0	4.1	3.6	38.0	11.4	8.5	10.4	6.2	3.9	8.9	5.8	9.7	8.5	8.5	11.4	6.9	5.5	7.4	13.5	13.4	5.9	24.1	10.1	24.6	12.4	11.2	12.4	5.6	10.5	9.9	9.8	5.8	10.1	10.0	15.5	8.4	11.6	7.4	10.9	10.5	15.3	21.4	13.2	29.0	16.0	14.5	9.3	14.1	10.6	8.1
KCNB2	Kv2.2	ENSG00000182674	"Potassium voltage-gated channel subfamily B member 2"	Q92953	8	72537391-72938349	"FDA approved drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 9.7;lymphoid tissue: 8.6;pituitary gland: 9.2"	"Group enriched"	"Detected in some"	5	"HaCaT: 3.2;HDLM-2: 3.0;HEK 293: 7.4;SCLC-21H: 6.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA065970			Approved	"Nucleoli,Plasma membrane,Midbody"				"Plasma membrane"	"Nucleoli, Midbody"	"HPA065970: "	"unprognostic (9.87e-3)"	"unprognostic (1.71e-1)"	"unprognostic (7.57e-2)"	"unprognostic (1.10e-3)"	"unprognostic (1.22e-1)"	"unprognostic (1.34e-1)"		"unprognostic (1.44e-2)"		"unprognostic (2.72e-1)"	"unprognostic (6.93e-5)"	"unprognostic (5.53e-3)"	"unprognostic (3.30e-2)"	"unprognostic (1.62e-1)"	"unprognostic (3.35e-2)"	"unprognostic (3.26e-1)"		0.8	1.9	3.8	0.6	5.3	0.4	0.7	0.3	9.7	0.5	0.7	0.0	0.0	1.2	0.4	0.4	1.1	2.1	0.5	0.4	7.1	3.1	0.5	0.4	0.6	0.5	0.9	7.8	0.4	2.4	0.4	9.2	0.5	3.2	0.7	0.7	4.2	0.5	0.5	0.4	0.4	1.6	0.5	1.6	8.6	2.4	1.7	0.4	0.9	0.4	0.0	0.9	0.6	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.1	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	3.0	7.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	6.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	5.3	0.3	9.7	7.1	3.1	0.9	7.8	3.2	0.4
KCNJ15	"IRKK, Kir1.3, Kir4.2"	ENSG00000157551	"Potassium voltage-gated channel subfamily J member 15"	Q99712	21	38155549-38307357	"Predicted intracellular proteins, Predicted membrane proteins, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Voltage-gated channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 74.8;kidney: 99.7"	"Cell line enhanced"	"Detected in some"		"ASC TERT1: 28.0;HBEC3-KT: 26.9;LHCN-M2: 12.3;RPTEC TERT1: 26.8;RT4: 31.4"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 29.6"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in some"	21	"neutrophil: 74.8"	"Lineage enriched"	"Detected in many"	21	"granulocytes: 74.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA016702	Approved		Approved	"Vesicles,Plasma membrane,Cytosol"				"Plasma membrane"	"Vesicles, Cytosol"	"HPA016702: AB_1855560"	"unprognostic (6.34e-2)"	"unprognostic (5.04e-2)"	"unprognostic (7.92e-2)"	"unprognostic (2.07e-3)"	"unprognostic (1.21e-1)"	"unprognostic (3.54e-3)"	"unprognostic (2.72e-3)"	"unprognostic (3.03e-2)"	"unprognostic (6.79e-2)"	"unprognostic (2.89e-3)"	"unprognostic (3.77e-2)"	"unprognostic (1.95e-2)"	"prognostic favourable (4.09e-10)"	"unprognostic (9.46e-3)"	"unprognostic (1.82e-1)"	"unprognostic (5.27e-2)"	"prognostic favourable (1.95e-4)"	6.0	0.3	0.4	5.3	0.3	3.2	1.4	0.2	0.3	3.5	0.4	0.2	27.1	0.2	0.5	12.8	6.0	0.8	17.7	1.0	0.2	0.1	99.7	1.5	34.1	0.8	0.5	0.2	0.6	16.7	0.0	0.3	1.0	0.6	4.0	0.0	0.2	14.4	26.8	1.0	1.7	0.2	0.9	0.4	6.8	10.7	1.1	0.2	0.4	36.8	3.2	1.9	11.3	4.3	0.0	0.2	74.8	3.5	0.0	0.0	0.7	0.6	0.0	0.1	0.2	5.5	28.0	0.2	0.4	1.9	0.0	0.0	0.0	0.2	0.1	0.0	2.9	9.4	0.0	26.9	0.2	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	8.2	2.7	7.0	1.5	1.3	0.1	0.2	12.3	0.0	0.0	0.0	0.0	0.2	0.5	0.1	0.2	26.8	31.4	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.6	0.1	1.4	0.0	0.7	0.1	0.0	2.2	1.6	0.1	0.0	3.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	74.8	0.0	0.0	0.0	0.0	0.7	0.4	0.3	0.2	0.3	0.2	0.1	0.5	0.2	0.6	0.2
KCNK6	"K2p6.1, TWIK-2"	ENSG00000099337	"Potassium two pore domain channel subfamily K member 6"	Q9Y257	19	38319844-38332076	"Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HEL: 21.7;HMC-1: 24.3;T-47d: 13.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"basophil: 16.2"	"Group enriched"	"Detected in many"	5	"dendritic cells: 8.9;granulocytes: 16.2;monocytes: 5.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB022637, HPA040184"	Uncertain		Approved	"Plasma membrane,Actin filaments,Cytosol"				"Plasma membrane, Cytosol"	"Actin filaments"	"CAB022637: , HPA040184: "	"unprognostic (7.98e-2)"	"unprognostic (2.57e-1)"	"unprognostic (1.29e-1)"	"prognostic favourable (1.45e-6)"	"unprognostic (3.76e-1)"	"unprognostic (6.88e-2)"	"unprognostic (1.87e-1)"	"unprognostic (3.08e-2)"	"unprognostic (4.31e-1)"	"unprognostic (4.91e-1)"	"unprognostic (4.10e-3)"	"unprognostic (3.15e-1)"	"prognostic unfavourable (1.04e-5)"	"unprognostic (1.07e-2)"	"unprognostic (3.46e-1)"	"unprognostic (5.88e-2)"	"unprognostic (4.59e-3)"	3.0	2.0	2.1	7.4	2.5	2.8	4.9	0.8	2.0	25.3	9.2	1.7	10.6	3.8	20.1	5.2	21.7	8.6	13.1	4.3	2.1	1.0	2.8	2.7	7.1	8.9	2.0	1.3	8.0	21.3	0.2	1.7	11.6	2.3	7.3	8.3	2.3	29.0	13.5	0.9	15.1	10.1	13.4	3.7	12.7	7.0	2.0	2.2	4.2	1.7	17.5	18.8	14.3	12.5	1.2	8.9	16.2	5.4	0.6	1.9	1.5	5.3	1.9	0.3	0.3	3.1	2.0	0.4	4.6	2.2	1.2	1.6	1.5	5.8	0.4	2.2	6.5	6.9	2.5	10.4	0.8	0.2	0.2	21.7	1.0	0.2	2.8	1.6	24.3	0.5	9.4	1.5	2.9	3.1	0.3	1.7	3.4	11.6	1.5	1.4	0.3	1.3	2.3	0.4	1.6	4.2	0.5	0.3	0.5	0.5	0.5	0.2	13.7	6.1	3.5	0.4	2.7	2.5	0.2	0.6	0.1	0.6	0.4	7.8	0.2	16.2	5.4	11.7	1.3	4.8	1.1	1.2	1.7	1.6	8.9	1.1	1.5	1.1	4.2	0.6	5.1	2.5	1.9	1.5	2.1	2.5	0.8	2.0	2.1	1.0	2.0	1.3	2.3	2.2
KCNK7	K2p7.1	ENSG00000173338	"Potassium two pore domain channel subfamily K member 7"	Q9Y2U2	11	65592855-65595996	"Predicted intracellular proteins, Predicted membrane proteins, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"skin 1: 35.0;tongue: 20.7"	"Cell line enhanced"	"Detected in many"		"SCLC-21H: 12.1"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 4.4"	"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in some"	12	"basophil: 4.8;naive B-cell: 2.9;neutrophil: 3.6"	"Group enriched"	"Detected in many"	12	"B-cells: 2.9;granulocytes: 4.8"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			HPA077577			Approved	"Plasma membrane"				"Plasma membrane"		"HPA077577: "	"unprognostic (1.12e-2)"	"unprognostic (1.21e-1)"	"unprognostic (6.08e-2)"	"unprognostic (5.71e-2)"	"unprognostic (8.59e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.68e-3)"	"unprognostic (8.53e-2)"	"unprognostic (1.69e-1)"	"unprognostic (2.87e-1)"	"unprognostic (6.90e-2)"	"unprognostic (4.88e-2)"	"unprognostic (1.49e-2)"	"unprognostic (2.65e-1)"	"unprognostic (3.57e-1)"	"unprognostic (1.16e-1)"	"unprognostic (8.11e-2)"	0.6	0.6	0.8	0.3	0.7	3.9	2.6	1.6	2.1	1.4	0.5	0.8	0.3	0.4	0.4	0.3	10.8	0.6	0.3	0.5	0.8	0.4	0.3	0.3	0.3	0.3	0.6	1.1	0.6	0.3	0.1	0.3	0.5	0.4	0.3	0.1	0.3	0.8	0.4	1.8	35.0	0.5	0.3	0.7	0.5	0.3	0.3	0.5	0.7	0.3	20.7	5.7	0.3	3.4	2.9	0.0	4.8	0.2	0.2	0.3	0.1	0.5	2.3	0.1	0.7	0.0	0.0	0.2	0.2	0.0	0.5	0.1	0.2	1.6	0.7	0.7	0.2	3.7	0.0	0.0	0.0	0.8	2.6	0.8	1.1	1.0	0.0	0.0	0.6	0.1	0.0	0.2	0.0	0.0	1.4	2.2	0.7	1.7	0.9	0.7	1.0	2.1	1.5	0.0	0.3	1.0	0.2	12.1	2.7	0.5	0.7	1.2	0.6	2.1	0.0	0.6	1.8	1.9	0.1	2.0	1.3	0.4	1.3	1.0	1.0	4.8	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	2.9	0.1	0.0	3.6	0.2	0.2	0.0	0.0	0.1	0.8	0.7	1.6	2.1	0.8	0.4	0.6	1.1	0.4	0.5
KCNK9	"K2p9.1, TASK-3, TASK3"	ENSG00000169427	"Potassium two pore domain channel subfamily K member 9"	Q9NPC2	8	139600838-139703056	"Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel"	"Disease mutation, FDA approved drug targets, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	8	"adrenal gland: 9.4;brain: 15.4"	"Group enriched"	"Detected in some"	7	"PC-3: 6.5;SCLC-21H: 2.8;SH-SY5Y: 2.1"	"Low cancer specificity"	"Detected in some"			"Region enhanced"	"Detected in many"		"cerebellum: 15.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA075842			Approved	"Plasma membrane"				"Plasma membrane"		"HPA075842: "	"unprognostic (1.84e-2)"	"unprognostic (2.57e-1)"	"unprognostic (1.58e-1)"	"unprognostic (8.96e-8)"	"unprognostic (1.91e-1)"	"unprognostic (8.17e-3)"	"unprognostic (2.19e-3)"	"unprognostic (1.65e-1)"	"unprognostic (3.87e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.00e-2)"	"unprognostic (3.21e-1)"	"unprognostic (5.12e-6)"	"unprognostic (2.94e-2)"	"unprognostic (1.64e-1)"	"unprognostic (9.99e-3)"	"unprognostic (1.76e-1)"	0.2	9.4	0.5	0.5	1.0	0.1	0.1	15.4	7.7	1.3	0.5	0.0	0.0	0.1	0.3	0.1	0.2	0.3	0.1	0.2	1.6	1.4	0.1	0.1	0.1	0.1	0.7	1.7	0.1	0.1	0.1	1.1	0.2	6.6	0.1	0.2	0.2	0.1	0.1	1.4	0.1	0.1	0.6	0.6	0.1	0.3	0.5	0.0	0.1	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	6.5	0.0	0.0	0.0	0.0	0.0	2.8	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.5	1.0	15.4	3.7	1.6	1.4	0.7	1.7	6.6	0.0
KIAA0556	"JBTS26, KATNIP"	ENSG00000047578	KIAA0556	O60303	16	27550133-27780369	"Disease related genes, Predicted intracellular proteins"			"Ciliopathy, Joubert syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 11.0"	"Group enriched"	"Detected in all"	4	"granulocytes: 11.0;NK-cells: 5.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035089, HPA035090"	Enhanced		Approved	"Nuclear speckles,Plasma membrane"				"Nuclear speckles"	"Plasma membrane"	"HPA035089: AB_10671509, HPA035090: AB_10601129"	"unprognostic (1.81e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.55e-1)"	"unprognostic (3.65e-3)"	"unprognostic (7.76e-2)"	"prognostic favourable (3.00e-4)"	"unprognostic (2.72e-2)"	"unprognostic (3.58e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.22e-1)"	"unprognostic (2.94e-1)"	"unprognostic (2.12e-1)"	"unprognostic (1.47e-3)"	"unprognostic (2.98e-1)"	"unprognostic (2.11e-1)"	"unprognostic (1.50e-3)"	"unprognostic (1.45e-1)"	6.1	6.2	7.1	8.7	10.9	7.9	6.8	6.3	10.8	8.4	8.2	12.0	13.2	6.5	15.1	13.1	11.2	38.6	7.5	7.0	7.1	6.7	9.7	5.0	8.2	5.6	6.5	7.3	8.2	11.7	14.9	19.0	6.8	8.6	11.9	9.8	11.8	9.8	9.7	4.1	11.0	7.9	8.4	9.3	7.9	12.1	22.8	8.4	8.7	20.9	5.0	11.1	7.6	9.0	1.4	1.5	11.0	2.0	5.5	1.8	0.4	5.3	11.0	6.2	5.8	9.4	8.7	10.4	7.3	7.9	6.5	8.8	9.7	9.0	4.6	10.5	10.4	9.0	7.9	9.4	13.0	21.1	5.5	3.6	11.1	5.6	5.7	4.8	9.2	9.2	8.3	14.3	15.4	12.7	5.8	3.9	9.1	12.3	5.3	6.0	3.8	4.5	7.6	7.6	5.0	11.9	7.5	8.0	5.1	7.3	6.6	4.0	14.7	4.3	11.0	8.3	5.3	6.4	6.3	5.2	4.4	4.9	9.5	4.8	7.4	9.5	2.0	3.8	0.8	1.3	0.8	0.9	0.4	1.4	1.3	1.4	1.8	0.3	11.0	5.5	0.5	1.5	1.5	0.4	7.1	10.9	6.3	10.8	7.1	6.7	6.5	7.3	8.6	8.4
KIAA0895		ENSG00000164542	KIAA0895	Q8NCT3	7	36324221-36390125	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"SCLC-21H: 27.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021036, HPA061066"	Uncertain		Approved	"Nucleoplasm,Plasma membrane,Cell Junctions,Cytosol"				Nucleoplasm	"Plasma membrane, Cell Junctions, Cytosol"	"HPA021036: , HPA061066: "	"unprognostic (4.94e-2)"	"unprognostic (9.59e-2)"	"unprognostic (2.93e-1)"	"unprognostic (1.39e-1)"	"unprognostic (8.85e-2)"	"unprognostic (1.15e-3)"	"unprognostic (3.79e-3)"	"unprognostic (3.43e-1)"	"unprognostic (3.74e-1)"	"unprognostic (4.71e-3)"	"unprognostic (1.46e-1)"	"unprognostic (3.49e-1)"	"unprognostic (4.51e-2)"	"unprognostic (6.68e-2)"	"unprognostic (3.06e-2)"	"unprognostic (2.35e-2)"	"unprognostic (5.24e-2)"	1.5	9.9	8.1	1.3	11.0	2.8	5.2	28.9	13.5	3.7	3.0	5.8	6.0	3.0	4.6	9.1	3.6	8.6	4.6	2.6	6.2	8.1	13.1	10.4	4.2	0.7	4.2	8.2	12.7	12.4	18.6	14.7	2.0	8.0	4.6	2.1	6.6	4.1	4.7	2.1	7.8	1.7	4.4	4.7	1.2	14.3	27.1	4.9	2.1	5.5	1.5	0.9	2.3	2.7	0.6	0.5	1.3	0.1	0.5	1.5	0.4	7.2	4.4	9.1	8.9	0.2	0.2	2.0	1.9	2.2	4.3	5.3	1.9	3.7	0.0	2.0	0.4	4.2	11.8	3.8	3.8	0.6	7.5	0.1	6.9	1.7	1.6	1.1	0.2	1.0	7.0	3.9	4.9	0.1	2.9	0.1	0.4	2.3	3.6	2.5	0.4	1.0	1.4	0.3	0.0	9.9	0.8	27.9	9.7	3.6	8.5	2.5	8.5	1.2	0.0	0.6	2.2	1.3	2.8	4.1	9.2	0.0	1.7	0.3	2.1	0.8	0.1	0.3	0.1	0.1	1.3	0.3	0.9	0.2	0.1	0.6	1.4	0.6	1.3	0.5	0.1	0.5	1.5	0.4	8.1	11.0	28.9	13.5	6.2	8.1	4.2	8.2	8.0	4.9
KIAA1958	FLJ39294	ENSG00000165185	KIAA1958	Q8N8K9	9	112486847-112669397	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA020625	Approved		Approved	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		"HPA020625: AB_1852451"	"unprognostic (3.09e-3)"	"unprognostic (1.04e-1)"	"unprognostic (1.61e-2)"	"unprognostic (1.33e-1)"	"unprognostic (7.48e-2)"	"unprognostic (2.08e-2)"	"unprognostic (2.01e-1)"	"unprognostic (4.95e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.65e-2)"	"unprognostic (2.73e-2)"	"unprognostic (7.67e-2)"	"unprognostic (5.48e-3)"	"unprognostic (3.14e-2)"	"unprognostic (1.82e-1)"	"unprognostic (2.10e-2)"	"unprognostic (2.58e-1)"	2.6	14.7	8.6	2.8	14.4	8.7	6.3	21.2	11.7	10.4	3.0	10.8	5.6	3.7	7.0	3.1	3.6	6.3	3.1	2.8	7.8	5.2	11.7	6.9	7.8	2.9	14.0	6.2	19.9	10.8	4.1	8.0	1.9	11.3	3.5	3.4	5.5	5.5	8.0	2.7	4.0	3.9	6.5	10.6	3.2	8.8	11.0	16.5	4.7	5.0	0.4	2.9	3.8	4.8	2.1	2.4	2.6	2.8	2.4	2.7	1.5	2.9	4.2	17.3	5.0	1.2	0.3	8.3	2.2	0.7	2.7	3.0	7.7	2.0	9.5	2.6	7.2	2.6	12.6	1.2	3.8	2.9	5.1	3.7	5.7	5.4	0.7	5.6	4.7	0.5	1.0	3.5	1.7	2.1	8.6	2.4	0.8	3.4	8.7	3.2	9.5	2.0	7.1	9.9	2.7	3.6	4.1	8.9	9.4	3.7	3.9	2.2	3.5	5.7	0.4	0.9	5.2	0.6	2.7	4.5	8.1	5.7	1.2	3.9	0.7	1.4	2.8	0.2	2.1	0.9	0.9	0.3	0.8	1.6	0.9	2.1	2.0	2.7	2.6	2.4	0.8	2.4	0.4	1.5	8.6	14.4	21.2	11.7	7.8	5.2	14.0	6.2	11.3	16.5
KIF17	"KIAA1405, KIF17B, KIF3X, KLP-2, OSM-3"	ENSG00000117245	"Kinesin family member 17"	Q9P2E2	1	20664014-20718017	"Plasma proteins, Predicted intracellular proteins"	"Protein transport, Transport"	"Motor protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 5.2;testis: 19.4"	"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 3.7;hTERT-HME1: 8.2;U-2 OS: 4.9"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"amygdala: 2.4;basal ganglia: 5.2;cerebral cortex: 3.6;hippocampal formation: 1.8;hypothalamus: 3.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA032085	Enhanced		Approved	"Nucleoplasm,Plasma membrane"				Nucleoplasm	"Plasma membrane"	"HPA032085: AB_10669917"	"unprognostic (4.15e-3)"	"unprognostic (8.60e-3)"	"unprognostic (6.43e-2)"	"unprognostic (1.12e-2)"	"unprognostic (7.68e-2)"	"unprognostic (3.70e-1)"	"unprognostic (1.07e-2)"	"unprognostic (1.04e-1)"	"unprognostic (7.11e-2)"	"unprognostic (1.08e-1)"	"unprognostic (7.34e-3)"	"unprognostic (8.73e-2)"	"unprognostic (3.63e-3)"	"unprognostic (1.08e-2)"	"unprognostic (2.26e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.20e-2)"	0.1	0.4	2.4	0.2	5.2	0.1	0.1	0.0	3.9	0.4	0.2	0.4	0.0	0.3	0.4	0.8	0.1	3.1	0.2	0.2	1.8	3.5	0.2	0.1	0.4	0.1	0.4	0.7	0.6	0.1	0.2	1.5	0.7	0.5	0.4	0.1	0.0	0.1	0.8	0.1	0.1	0.2	0.9	0.3	0.1	0.1	19.4	0.0	0.0	0.9	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	1.5	0.9	0.0	0.0	0.1	0.2	2.7	3.7	1.5	0.9	0.4	1.0	0.0	1.2	1.9	0.0	1.3	0.9	1.1	0.0	0.3	0.0	0.0	0.4	1.6	0.0	0.0	0.3	0.8	1.0	8.2	0.0	0.6	0.0	1.8	0.1	0.0	0.0	2.5	1.7	0.0	0.1	0.0	0.6	0.0	0.6	1.5	0.4	0.0	0.3	0.0	0.0	0.0	0.6	4.9	0.5	0.3	0.1	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	5.2	0.0	3.6	1.8	3.5	0.4	0.7	0.5	0.0
KIF19	"FLJ37300, KIF19A"	ENSG00000196169	"Kinesin family member 19"	Q2TAC6	17	74326210-74355820	"Predicted intracellular proteins"		"Motor protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 29.9;fallopian tube: 25.2"	"Cell line enriched"	"Detected in single"	11	"SCLC-21H: 9.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"gdT-cell: 5.5"	"Lineage enriched"	"Detected in single"	55	"T-cells: 5.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043638, HPA073303"	Enhanced		Approved	"Plasma membrane,Actin filaments,Centrosome"				"Plasma membrane"	"Actin filaments, Centrosome"	"HPA043638: AB_10962579, HPA073303: "	"unprognostic (1.59e-3)"	"unprognostic (1.05e-1)"	"unprognostic (1.00e-1)"	"unprognostic (5.37e-3)"	"unprognostic (9.64e-2)"	"unprognostic (1.64e-1)"	"unprognostic (2.70e-2)"	"unprognostic (2.81e-1)"	"unprognostic (1.03e-1)"	"unprognostic (9.83e-3)"	"unprognostic (1.05e-3)"	"unprognostic (1.14e-1)"	"unprognostic (1.59e-9)"	"unprognostic (5.16e-5)"	"unprognostic (2.72e-1)"	"unprognostic (1.67e-2)"	"unprognostic (1.53e-1)"	1.6	0.9	9.3	1.6	29.5	1.1	1.1	25.8	14.1	2.1	3.1	17.4	0.0	6.6	1.1	1.1	1.1	25.2	1.6	1.1	11.9	6.6	0.9	1.6	3.1	1.0	25.0	4.2	1.1	3.0	0.9	0.3	0.8	6.5	0.9	2.1	0.8	2.5	1.3	1.0	0.8	5.2	1.6	6.2	11.6	2.2	1.2	29.9	0.0	2.3	0.0	1.0	1.3	1.3	0.0	0.0	0.0	0.0	0.0	5.5	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	9.8	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.5	0.0	0.6	0.0	0.9	1.6	0.0	0.0	0.7	2.4	0.0	0.0	0.0	0.0	0.0	0.7	9.3	29.5	25.8	14.1	11.9	6.6	25.0	4.2	6.5	29.9
KIF21B	"DKFZP434J212, KIAA0449"	ENSG00000116852	"Kinesin family member 21B"	O75037	1	200969390-201023700	"Plasma proteins, Predicted intracellular proteins"		"Motor protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 34.3;brain: 20.4"	"Cell line enhanced"	"Detected in many"		"Daudi: 16.4;HMC-1: 17.5;Karpas-707: 20.7;RPMI-8226: 17.6;U-266/70: 37.8;U-266/84: 17.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 8.0"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027249, HPA027274"	Approved		Approved	"Plasma membrane,Mitotic spindle,Cytosol"				"Plasma membrane"	"Mitotic spindle, Cytosol"	"HPA027249: AB_10602241, HPA027274: AB_1852483"	"unprognostic (3.49e-2)"	"unprognostic (1.82e-1)"	"unprognostic (4.70e-2)"	"unprognostic (2.15e-1)"	"unprognostic (2.28e-1)"	"unprognostic (3.92e-3)"	"unprognostic (1.32e-2)"	"unprognostic (1.80e-1)"	"unprognostic (2.18e-1)"	"unprognostic (3.03e-1)"	"unprognostic (1.54e-3)"	"unprognostic (7.14e-2)"	"unprognostic (1.41e-4)"	"unprognostic (5.98e-3)"	"unprognostic (2.64e-1)"	"unprognostic (6.81e-2)"	"unprognostic (5.81e-4)"	2.2	1.6	19.8	10.0	12.9	34.3	1.5	3.7	20.4	1.5	2.8	6.0	1.0	2.7	1.4	1.0	1.5	1.4	2.9	1.5	15.1	12.5	1.4	1.7	4.3	15.7	8.3	12.7	1.4	1.5	11.3	0.9	1.6	7.1	1.2	2.6	8.6	2.1	1.7	0.9	1.3	6.1	1.5	4.3	11.5	3.2	11.1	4.9	10.8	1.2	0.0	9.1	3.7	1.1	0.9	0.2	8.0	0.5	2.4	1.7	0.6	0.5	0.6	4.9	0.2	0.0	0.0	1.3	0.0	0.0	0.1	0.0	0.3	0.1	16.4	0.2	0.0	0.1	0.5	0.1	0.1	0.8	0.1	3.9	0.1	0.1	0.4	12.0	17.5	0.4	1.7	0.1	0.3	0.6	1.8	20.7	0.0	0.0	9.5	4.3	2.1	0.0	3.3	0.0	17.6	0.1	0.0	3.4	0.4	0.2	0.2	0.2	0.0	3.6	1.1	0.0	1.5	0.0	0.1	37.8	17.5	8.2	1.7	5.2	0.1	8.0	0.1	1.0	1.6	0.4	1.7	0.9	1.2	1.7	0.1	0.7	1.0	1.1	2.0	2.4	0.5	0.2	1.0	0.6	19.8	12.9	3.7	20.0	15.1	12.5	8.3	12.7	7.1	4.9
KIF26A	"DKFZP434N178, KIAA1236"	ENSG00000066735	"Kinesin family member 26A"	Q9ULI4	14	104138723-104180894	"Predicted intracellular proteins"		"Motor protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"HeLa: 16.8;MCF7: 14.3;NTERA-2: 12.6;REH: 10.9;SCLC-21H: 11.7;SH-SY5Y: 23.8"	"Group enriched"	"Detected in many"	5	"stomach cancer: 3.8;testis cancer: 14.6"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA046882, HPA060346"	Uncertain		Approved	"Nucleoplasm,Plasma membrane,Cytosol"				"Nucleoplasm, Plasma membrane, Cytosol"		"HPA046882: , HPA060346: "	"unprognostic (3.01e-1)"	"unprognostic (3.20e-1)"	"unprognostic (3.95e-1)"	"unprognostic (1.77e-2)"	"unprognostic (2.79e-1)"	"unprognostic (1.12e-1)"	"unprognostic (5.49e-3)"	"unprognostic (1.69e-1)"	"unprognostic (1.21e-2)"	"unprognostic (3.31e-3)"	"unprognostic (5.24e-3)"	"unprognostic (7.01e-2)"	"prognostic unfavourable (7.78e-4)"	"unprognostic (7.96e-2)"	"unprognostic (1.72e-1)"	"unprognostic (9.12e-2)"	"unprognostic (4.68e-3)"	12.0	6.8	1.8	4.9	2.1	5.0	15.9	1.3	3.9	8.9	3.3	1.5	4.9	1.7	5.9	3.9	2.1	3.7	4.9	10.1	1.6	2.6	3.4	2.5	8.5	2.5	1.9	2.8	23.5	9.4	1.6	4.4	6.8	2.0	2.5	1.6	6.9	2.5	4.0	9.1	3.9	2.5	2.3	1.0	9.3	2.5	4.1	0.9	1.9	2.3	5.6	0.9	2.6	8.6	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.0	0.6	2.3	0.0	0.0	4.1	0.2	0.0	0.0	0.0	1.8	0.0	0.0	3.2	0.0	1.5	1.8	0.0	0.0	0.0	2.9	0.0	16.8	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.4	0.0	0.0	0.0	14.3	0.0	0.0	12.6	1.2	10.9	4.8	1.1	0.0	0.0	11.7	23.8	2.6	0.4	0.0	0.2	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.8	2.1	1.3	3.5	1.6	2.6	1.9	2.8	2.0	0.9
KIF26B	FLJ10157	ENSG00000162849	"Kinesin family member 26B"	Q2KJY2	1	245154985-245709431	"Predicted intracellular proteins"		"Developmental protein, Motor protein"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"HSkMC: 10.4;REH: 18.5;SH-SY5Y: 10.1;U-937: 9.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	58	"plasmacytoid DC: 6.3"	"Lineage enriched"	"Detected in single"	58	"dendritic cells: 6.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027709, HPA028478, HPA028561, HPA028562"	Enhanced		Approved	"Plasma membrane,Microtubules"				"Plasma membrane, Microtubules"		"HPA027709: AB_10600215, HPA028478: AB_10601231, HPA028561: AB_10601960, HPA028562: AB_10602417"	"unprognostic (3.66e-1)"	"unprognostic (5.67e-2)"	"unprognostic (7.90e-3)"	"unprognostic (4.50e-3)"	"unprognostic (3.23e-2)"	"unprognostic (1.49e-1)"	"unprognostic (4.17e-2)"	"unprognostic (1.61e-1)"	"unprognostic (9.63e-2)"	"prognostic unfavourable (1.24e-4)"	"unprognostic (8.30e-3)"	"unprognostic (3.63e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.13e-2)"	"unprognostic (5.77e-2)"	"unprognostic (1.17e-4)"	"unprognostic (7.22e-3)"	0.7	3.9	7.1	3.0	6.3	0.7	2.1	10.2	9.7	5.2	1.7	8.7	6.0	1.2	3.7	2.9	1.3	2.1	4.2	1.3	5.6	7.2	3.2	1.1	2.7	1.7	7.8	4.6	1.2	1.8	1.4	1.4	7.6	9.6	3.7	0.8	1.1	1.2	7.7	0.9	2.7	1.1	2.3	4.9	1.1	2.9	2.9	3.7	1.3	3.4	1.2	1.4	4.0	0.8	0.0	6.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.8	2.5	0.5	0.8	1.9	2.0	1.5	0.1	0.1	3.1	0.0	0.0	3.4	0.4	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.0	1.5	0.3	0.3	10.4	0.6	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	18.5	0.1	0.0	1.8	0.0	2.6	10.1	0.0	0.0	0.0	0.0	1.0	0.3	1.9	0.1	0.0	0.8	0.0	0.0	0.0	0.3	9.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	6.3	0.0	0.0	7.1	6.3	10.2	9.7	5.6	7.2	7.8	4.6	9.6	3.7
KLF9	BTEB1	ENSG00000119138	"Kruppel like factor 9"	Q13886	9	70384597-70414624	"Predicted intracellular proteins, Transcription factors"	"Biological rhythms, Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 22.4;ASC TERT1: 31.1;HHSteC: 40.0;HSkMC: 26.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029308			Approved	"Nucleoplasm,Plasma membrane,Cytosol"				Nucleoplasm	"Plasma membrane, Cytosol"	"HPA029308: AB_10601923"	"unprognostic (2.12e-2)"	"unprognostic (2.56e-1)"	"unprognostic (3.12e-1)"	"unprognostic (2.69e-2)"	"unprognostic (5.86e-2)"	"unprognostic (1.37e-1)"	"unprognostic (3.64e-3)"	"unprognostic (4.34e-1)"	"unprognostic (5.55e-1)"	"unprognostic (9.47e-2)"	"unprognostic (7.86e-2)"	"unprognostic (3.44e-1)"	"prognostic favourable (6.59e-6)"	"unprognostic (1.43e-3)"	"unprognostic (1.75e-1)"	"unprognostic (3.17e-2)"	"unprognostic (1.02e-2)"	35.9	15.3	6.8	8.8	25.8	6.1	25.7	42.6	21.4	10.2	20.0	9.7	16.1	6.0	19.6	13.2	17.0	22.2	17.8	18.2	8.4	4.0	26.2	36.7	22.6	5.1	26.3	8.0	22.1	21.3	13.0	8.6	3.9	14.7	12.4	11.0	20.4	31.4	10.7	38.9	12.6	17.6	25.0	12.0	8.6	16.7	5.5	25.2	1.9	24.0	20.3	5.4	15.4	11.9	2.8	1.7	2.8	0.7	0.7	2.8	0.6	0.1	0.2	0.0	2.8	22.4	31.1	0.3	1.4	9.7	0.5	1.1	0.0	1.3	0.0	1.1	2.6	0.0	4.2	6.5	1.0	0.0	3.3	1.4	4.8	0.8	40.0	0.7	4.0	26.6	6.7	0.4	9.5	8.5	2.8	5.9	3.6	0.4	0.1	2.1	0.2	1.4	0.0	1.3	3.7	1.8	0.0	0.3	1.9	13.2	7.7	15.1	2.5	2.3	11.6	2.6	1.9	2.9	0.7	4.3	4.5	0.2	2.3	2.3	12.8	2.8	0.5	0.3	1.6	0.3	2.3	2.8	2.1	1.6	1.2	2.5	2.8	1.6	0.0	0.7	0.7	1.7	2.2	0.6	6.8	25.8	42.6	21.4	8.4	4.0	26.3	8.0	14.7	25.2
KLHDC7B	MGC16635	ENSG00000130487	"Kelch domain containing 7B"	Q96G42	22	50548033-50551022	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 8.4;parathyroid gland: 12.5"	"Cell line enriched"	"Detected in some"	4	"HMC-1: 46.4"	"Cancer enhanced"	"Detected in many"		"cervical cancer: 42.3;urothelial cancer: 40.7"	"Low region specificity"	"Detected in some"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"HPA000518, HPA076540"	Uncertain		Approved	"Plasma membrane"				"Plasma membrane"		"HPA000518: AB_1079213, HPA076540: "	"prognostic favourable (1.30e-4)"	"unprognostic (3.18e-2)"	"unprognostic (2.74e-2)"	"unprognostic (2.21e-1)"	"unprognostic (3.96e-2)"	"unprognostic (6.04e-3)"	"unprognostic (3.91e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.07e-2)"	"unprognostic (7.13e-2)"	"unprognostic (3.33e-3)"	"unprognostic (2.48e-1)"	"unprognostic (2.09e-3)"	"unprognostic (2.89e-1)"	"unprognostic (4.69e-2)"	"unprognostic (3.49e-1)"	"unprognostic (1.02e-1)"	0.4	0.4	0.3	3.9	1.2	1.2	0.7	0.3	1.5	1.3	0.3	0.3	0.3	0.3	0.3	0.3	0.7	0.2	0.3	0.3	0.3	0.1	8.4	1.1	1.1	4.0	0.3	0.3	0.8	0.3	12.5	2.2	0.3	0.9	0.7	0.0	0.8	3.0	0.3	0.3	0.3	2.0	0.3	0.3	5.4	0.5	0.3	0.3	6.5	2.9	0.3	1.7	3.0	0.3	3.8	2.0	2.4	4.0	1.4	5.7	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.3	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.6	0.0	46.4	0.0	0.5	0.0	0.1	0.0	0.0	5.4	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.1	0.0	0.0	2.4	2.2	0.2	4.5	4.0	3.3	3.8	4.7	5.7	2.0	3.1	5.2	4.3	0.4	1.4	2.8	0.7	4.1	2.5	0.3	1.2	0.3	1.5	0.3	0.1	0.3	0.3	0.9	0.3
KLHL6	FLJ00029	ENSG00000172578	"Kelch like family member 6"	Q8WZ60	3	183487531-183555689	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 43.2"	"Cell line enhanced"	"Detected in some"		"Daudi: 15.0;U-266/70: 30.9;U-266/84: 16.0;U-698: 45.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA024512	Uncertain		Approved	"Plasma membrane,Microtubules,Mitotic spindle,Centriolar satellite"				"Centriolar satellite"	"Plasma membrane, Microtubules, Mitotic spindle"	"HPA024512: AB_2131015"	"unprognostic (8.46e-2)"	"unprognostic (3.67e-4)"	"unprognostic (1.48e-2)"	"unprognostic (6.03e-4)"	"unprognostic (5.15e-2)"	"unprognostic (1.30e-3)"	"unprognostic (1.39e-1)"	"unprognostic (5.05e-2)"	"unprognostic (7.43e-2)"	"unprognostic (9.62e-2)"	"unprognostic (8.24e-2)"	"unprognostic (2.68e-1)"	"prognostic unfavourable (3.53e-4)"	"unprognostic (1.81e-1)"	"unprognostic (3.68e-2)"	"unprognostic (2.42e-1)"	"unprognostic (5.73e-2)"	4.4	1.2	1.4	43.2	3.3	2.9	2.2	0.5	1.8	1.7	4.1	2.4	0.5	2.3	1.1	0.3	1.7	4.2	2.3	1.9	1.8	1.3	1.4	1.4	8.0	23.8	4.4	0.0	0.7	0.8	0.2	1.0	1.8	2.8	1.4	2.2	0.8	4.6	0.6	0.7	0.8	9.9	0.7	8.8	15.1	3.5	0.7	2.3	21.4	1.6	0.5	34.5	2.8	2.7	4.4	5.2	13.3	3.3	2.8	4.8	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.0	0.0	0.0	0.0	0.0	0.0	0.0	7.8	0.0	9.6	0.0	0.0	0.0	2.6	10.1	0.0	0.0	0.0	0.0	1.7	0.1	6.9	0.0	0.0	3.1	1.4	0.0	0.0	5.3	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.9	0.0	0.0	0.0	0.0	30.9	16.0	45.3	0.0	2.9	0.0	7.1	3.3	13.3	0.8	2.7	0.9	4.4	3.0	1.3	2.3	3.3	3.6	2.2	3.1	2.8	3.0	5.2	4.8	2.7	1.4	3.3	0.5	1.8	1.8	1.3	4.4	0.0	2.8	2.3
KLHL7	"KLHL6, RP42, SBBI26"	ENSG00000122550	"Kelch like family member 7"	Q8IXQ5	7	23105758-23177914	"Disease related genes, Predicted intracellular proteins"	"Ubl conjugation pathway"		"Disease mutation, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA029491, HPA029492"	Uncertain		Enhanced	"Nucleoplasm,Plasma membrane,Cytosol"				"Nucleoplasm, Cytosol"	"Plasma membrane"	"HPA029491: AB_10599605, HPA029492: AB_10600881"	"unprognostic (1.24e-2)"	"unprognostic (4.45e-1)"	"unprognostic (1.77e-1)"	"unprognostic (4.55e-2)"	"unprognostic (1.29e-2)"	"unprognostic (1.65e-2)"	"prognostic unfavourable (7.96e-4)"	"unprognostic (3.78e-1)"	"unprognostic (6.10e-2)"	"unprognostic (6.41e-3)"	"unprognostic (1.30e-1)"	"unprognostic (1.51e-1)"	"prognostic favourable (8.98e-5)"	"unprognostic (2.46e-2)"	"unprognostic (3.55e-3)"	"unprognostic (3.23e-2)"	"unprognostic (2.27e-2)"	7.5	14.6	9.2	5.6	13.0	8.2	10.3	12.6	15.1	8.8	5.7	7.9	4.7	5.9	9.1	9.9	7.7	7.4	7.6	37.1	8.1	8.7	9.2	7.7	6.4	5.8	8.3	9.7	9.6	5.9	7.1	6.1	6.5	15.9	8.1	6.3	8.6	7.2	6.8	7.4	8.6	5.8	8.1	10.6	5.8	5.2	40.7	6.2	9.6	7.2	5.1	6.7	6.9	7.1	5.5	5.5	32.0	8.7	4.2	8.0	6.0	10.8	9.3	25.7	30.3	12.6	11.0	9.4	9.6	14.3	14.2	16.6	11.3	7.9	10.7	7.8	11.7	11.8	9.8	6.8	12.0	2.8	7.1	7.0	8.1	14.5	9.4	14.2	5.5	9.7	8.8	16.2	13.4	18.0	12.3	11.7	23.1	12.5	11.8	22.6	35.4	11.2	10.5	14.4	9.8	13.3	9.4	15.5	15.1	20.9	10.4	9.8	8.6	7.5	7.7	12.0	12.5	26.3	11.4	18.5	15.0	25.5	7.9	15.1	14.3	18.7	7.8	32.0	6.8	8.7	7.1	4.5	7.3	6.4	5.5	5.5	5.5	5.4	7.4	4.2	7.5	4.0	8.0	6.0	9.2	13.0	12.6	15.1	8.1	8.7	8.3	9.7	15.9	6.2
KLRC1	"CD159a, NKG2, NKG2-A, NKG2-B"	ENSG00000134545	"Killer cell lectin like receptor C1"	P26715	12	10442264-10454685	"CD markers, Predicted intracellular proteins, Predicted membrane proteins"		Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	7	"blood: 64.3;lymphoid tissue: 22.1"	"Cell line enhanced"	"Detected in some"		"HeLa: 9.3;Karpas-707: 3.8"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	7	"gdT-cell: 45.7;NK-cell: 64.3"	"Group enriched"	"Detected in many"	42	"NK-cells: 64.3;T-cells: 45.7"									HPA058052			Approved	"Plasma membrane"				"Plasma membrane"		"HPA058052: "	"unprognostic (8.17e-3)"	"unprognostic (2.13e-2)"	"unprognostic (1.48e-2)"	"unprognostic (4.58e-7)"	"unprognostic (3.57e-1)"	"unprognostic (1.17e-2)"	"unprognostic (1.05e-1)"	"unprognostic (3.68e-2)"	"unprognostic (3.73e-4)"	"unprognostic (4.13e-2)"	"unprognostic (6.49e-2)"	"unprognostic (2.54e-1)"	"unprognostic (1.18e-4)"	"unprognostic (1.88e-1)"	"unprognostic (3.23e-1)"	"unprognostic (2.45e-1)"	"unprognostic (1.92e-3)"	2.4	0.5	1.2	5.8	1.4	5.6	2.3	1.0	2.7	1.7	3.3	0.7	1.2	1.5	5.5	3.9	1.7	2.5	2.4	2.6	1.6	1.3	1.9	2.0	5.9	10.3	2.3	0.6	1.2	1.4	0.3	1.3	3.6	1.5	1.9	2.5	2.0	3.1	0.3	0.5	1.0	5.0	2.1	2.6	22.1	5.2	1.4	0.5	3.5	1.9	3.0	2.9	2.9	1.8	0.1	0.0	1.2	0.1	64.3	45.7	5.1	0.4	1.6	0.1	0.1	0.6	0.4	0.8	0.0	0.0	0.8	1.7	0.0	1.3	0.2	0.1	0.4	0.3	0.6	2.8	1.1	0.9	0.4	2.1	9.3	0.0	0.1	0.6	0.4	1.0	0.0	0.3	0.0	0.8	1.3	3.8	0.8	0.0	0.2	2.8	0.0	0.0	0.9	0.2	0.3	0.2	0.0	0.5	0.1	0.8	0.0	0.3	0.3	0.0	2.6	0.4	0.0	0.0	0.3	0.0	0.0	0.7	2.2	0.8	0.0	0.2	0.0	0.0	45.7	0.0	5.8	0.1	0.0	7.9	0.0	0.0	0.0	6.9	1.2	64.3	0.1	0.0	0.0	5.1	1.2	1.4	1.0	0.9	1.6	1.3	2.3	0.6	1.5	0.5
KLRC2	"CD159c, NKG2-C"	ENSG00000205809	"Killer cell lectin like receptor C2"	P26717	12	10426854-10442300	"CD markers, Predicted intracellular proteins, Predicted membrane proteins"		Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"blood: 32.8;brain: 16.2"	"Cell line enhanced"	"Detected in some"		"HEL: 6.1;HeLa: 19.0;HSkMC: 4.6;U-87 MG: 3.1"	"Cancer enriched"	"Detected in single"	8	"glioma: 3.6"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"gdT-cell: 10.7;NK-cell: 32.8"	"Group enriched"	"Detected in many"	92	"NK-cells: 32.8;T-cells: 10.7"									HPA058052			Approved	"Plasma membrane"				"Plasma membrane"		"HPA058052: "	"unprognostic (9.05e-4)"	"unprognostic (2.54e-2)"	"unprognostic (3.77e-2)"	"unprognostic (2.51e-3)"	"unprognostic (2.83e-1)"	"unprognostic (9.49e-4)"	"unprognostic (1.27e-1)"	"unprognostic (8.74e-2)"	"unprognostic (2.88e-1)"	"unprognostic (4.00e-3)"	"unprognostic (2.88e-2)"	"unprognostic (9.16e-3)"	"unprognostic (1.55e-9)"	"unprognostic (8.10e-2)"	"unprognostic (2.34e-1)"	"unprognostic (8.93e-2)"	"unprognostic (5.31e-3)"	0.5	0.2	8.2	0.6	4.6	2.8	1.1	1.2	16.2	0.4	1.9	2.3	0.1	1.0	1.4	1.0	0.8	0.6	1.7	0.2	6.1	5.4	0.1	1.1	1.4	1.5	6.2	2.6	1.5	0.1	0.0	0.1	0.6	3.7	0.3	1.3	0.1	0.5	0.3	0.1	0.2	1.8	0.1	4.1	8.1	3.2	0.5	1.7	2.2	0.2	0.1	2.0	1.2	0.1	0.0	0.0	0.2	0.0	32.8	10.7	1.7	0.0	1.0	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	6.1	19.0	0.3	0.0	0.6	0.0	4.6	0.1	0.0	0.4	0.0	0.1	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	1.2	0.2	0.4	0.0	0.0	0.0	0.0	0.6	3.1	0.1	0.1	0.0	0.0	0.0	10.7	0.0	0.2	0.0	0.0	4.7	0.0	0.0	0.0	3.7	0.2	32.8	0.0	0.0	0.0	1.7	8.2	4.6	1.2	3.6	6.1	5.4	6.2	2.6	3.7	1.7
KMT2D	"ALR, CAGL114, MLL2, MLL4, TNRC21"	ENSG00000167548	"Lysine methyltransferase 2D"	O14686	12	49018975-49059774	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator, Methyltransferase, Transferase"	"Cancer-related genes, Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"neutrophil: 5.9"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							HPA035977	Approved		Approved	"Nucleoplasm,Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"	Nucleoplasm	"HPA035977: AB_10670673"	"unprognostic (8.33e-2)"	"unprognostic (1.49e-1)"	"unprognostic (9.14e-2)"	"unprognostic (2.52e-1)"	"unprognostic (8.07e-2)"	"unprognostic (6.91e-3)"	"unprognostic (7.35e-2)"	"unprognostic (2.29e-1)"	"unprognostic (3.57e-1)"	"unprognostic (5.14e-2)"	"unprognostic (7.23e-2)"	"unprognostic (3.07e-1)"	"unprognostic (1.68e-2)"	"unprognostic (7.10e-2)"	"unprognostic (1.87e-1)"	"unprognostic (3.20e-2)"	"unprognostic (7.60e-2)"	12.1	7.6	4.9	6.7	10.8	26.1	6.8	11.7	10.5	9.5	6.5	5.8	13.0	5.5	15.7	7.4	8.8	8.9	5.8	9.1	6.1	3.5	6.2	6.5	22.9	9.6	6.7	3.3	9.7	11.6	13.3	9.2	12.9	13.7	6.7	6.6	9.8	7.6	8.0	16.1	13.6	9.4	7.1	9.1	13.6	8.3	7.3	5.7	6.2	11.0	6.1	7.6	7.0	6.3	2.0	2.2	5.9	0.5	1.5	0.8	0.6	17.0	16.2	16.4	13.2	17.0	11.4	17.6	9.0	9.4	11.7	6.3	28.4	7.2	17.7	11.7	12.6	11.6	21.6	10.0	9.8	10.3	17.3	22.5	16.9	15.2	11.7	26.7	22.6	9.7	14.3	16.4	17.0	17.4	28.2	9.8	13.2	18.7	13.2	24.9	15.5	14.0	19.9	10.1	6.4	9.8	18.9	13.7	11.6	13.9	13.7	9.5	13.6	23.4	23.1	9.2	16.5	8.1	15.1	14.0	9.0	17.2	10.6	13.8	6.9	0.6	0.5	3.0	0.8	0.2	0.4	0.3	0.3	0.5	0.3	2.0	0.3	0.8	5.9	1.5	0.1	2.2	0.0	0.6	4.9	10.8	11.7	10.5	6.1	3.5	6.7	3.3	13.7	5.7
KNSTRN	"C15orf23, FLJ14502, kinastrin, SKAP, TRAF4AF1"	ENSG00000128944	"Kinetochore localized astrin/SPAG5 binding protein"	Q9Y448	15	40382721-40394246	"Disease related genes, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	4	"blood: 26.2;lymphoid tissue: 18.4;testis: 40.1;thyroid gland: 59.8"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			HPA042027	Enhanced		Enhanced	"Plasma membrane,Mitotic spindle,Centriolar satellite"				"Mitotic spindle, Centriolar satellite"	"Plasma membrane"	"HPA042027: AB_10797378"	"unprognostic (2.35e-3)"	"unprognostic (6.83e-2)"	"unprognostic (3.01e-1)"	"unprognostic (5.23e-3)"	"unprognostic (6.19e-2)"	"unprognostic (2.28e-2)"	"unprognostic (1.54e-3)"	"unprognostic (2.47e-3)"	"unprognostic (1.23e-1)"	"unprognostic (2.55e-1)"	"prognostic unfavourable (3.43e-5)"	"unprognostic (6.31e-2)"	"prognostic unfavourable (7.88e-9)"	"unprognostic (1.70e-1)"	"unprognostic (1.58e-1)"	"unprognostic (2.67e-1)"	"unprognostic (1.52e-2)"	5.5	4.4	6.7	5.5	6.3	7.3	9.0	8.1	7.0	3.3	4.5	4.0	8.0	5.3	3.9	7.8	6.2	3.4	2.5	4.1	6.0	5.3	4.2	7.0	4.1	8.0	4.6	7.1	3.4	3.5	6.0	4.2	7.4	6.8	4.4	6.3	2.5	6.4	5.0	7.5	4.2	4.1	5.9	4.3	4.8	6.2	40.1	4.5	18.4	59.8	6.0	9.1	3.8	3.7	5.9	11.0	10.0	26.2	5.5	5.5	4.0	31.1	14.7	29.3	19.2	6.5	10.1	15.3	21.7	16.9	44.8	39.6	31.4	13.8	12.1	11.1	14.5	36.1	31.2	20.1	40.6	21.4	15.2	35.8	33.0	19.8	6.1	19.2	18.7	5.2	11.6	22.6	22.6	25.1	25.8	21.0	37.6	15.8	16.6	15.5	18.4	22.3	17.1	22.1	14.0	15.6	13.0	28.6	19.9	18.1	19.9	4.8	20.9	13.8	12.8	21.6	22.2	22.0	29.9	18.0	29.1	21.7	13.4	25.7	17.6	4.8	10.3	10.0	4.8	14.5	4.4	5.9	3.6	4.4	11.0	5.4	3.5	3.6	5.9	5.5	26.2	7.5	5.5	4.0	6.7	6.3	8.1	7.0	6.0	5.3	4.6	7.1	6.8	4.5
KPTN	2E4	ENSG00000118162	"Kaptin, actin binding protein"	Q9Y664	19	47475144-47484268	"Disease related genes, Predicted intracellular proteins"		Actin-binding	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	5	"plasmacytoid DC: 18.5"	"Lineage enriched"	"Detected in many"	5	"dendritic cells: 18.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041710, HPA041796"	Approved		Approved	"Nucleoplasm,Plasma membrane,Cytosol"				Cytosol	"Nucleoplasm, Plasma membrane"	"HPA041710: AB_10961904, HPA041796: AB_10962832"	"unprognostic (4.80e-3)"	"unprognostic (2.22e-1)"	"unprognostic (7.24e-2)"	"unprognostic (1.53e-1)"	"unprognostic (5.54e-2)"	"unprognostic (3.47e-2)"	"prognostic unfavourable (7.91e-6)"	"unprognostic (9.30e-2)"	"unprognostic (2.24e-1)"	"unprognostic (2.21e-2)"	"unprognostic (5.51e-2)"	"unprognostic (2.59e-2)"	"prognostic unfavourable (7.82e-4)"	"unprognostic (1.40e-1)"	"unprognostic (8.72e-2)"	"unprognostic (2.04e-1)"	"unprognostic (2.34e-1)"	6.0	5.8	7.1	5.3	15.6	8.9	6.2	17.2	11.0	4.6	5.4	5.7	3.4	6.0	4.5	3.0	7.3	3.6	4.4	6.5	9.5	7.1	5.8	6.8	4.5	5.5	13.0	6.3	2.7	5.5	9.2	8.9	6.3	8.9	6.5	4.2	3.7	17.6	3.9	8.7	5.4	5.1	4.8	8.5	5.0	3.9	3.9	9.6	12.5	4.8	6.2	3.9	5.1	4.7	1.4	18.5	2.6	3.8	0.9	1.3	1.7	6.2	10.9	8.6	5.3	8.8	6.9	6.0	3.5	6.6	19.1	11.9	7.8	7.4	7.5	2.7	6.2	7.2	7.3	12.5	5.3	7.0	11.3	3.2	7.4	7.0	7.9	6.3	9.1	7.9	8.2	6.3	5.9	7.2	6.3	7.3	5.5	4.8	11.2	27.0	7.7	6.6	8.1	4.3	3.2	5.9	9.3	18.4	14.1	5.8	6.6	4.3	5.5	9.2	4.1	4.5	5.2	2.4	7.8	1.8	2.9	3.3	4.1	4.1	6.8	0.0	3.0	1.2	1.2	2.5	0.4	1.3	0.8	1.0	3.6	1.4	1.1	0.9	2.6	0.9	3.8	18.5	1.3	1.7	7.1	15.6	17.2	11.0	9.5	7.1	13.0	6.3	8.9	9.6
KRT75	K6HF	ENSG00000170454	"Keratin 75"	O95678	12	52424070-52434525	"Disease related genes, Plasma proteins, Predicted intracellular proteins"			"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"skin 1: 22.9;tongue: 18.8"	"Group enriched"	"Detected in some"	6	"PC-3: 21.7;U-2 OS: 29.1"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 36.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"hippocampal formation: 0.1"	"HPA019367, HPA076201"	Enhanced		Approved	"Plasma membrane,Cytosol"			2200000000	Cytosol	"Plasma membrane"	"HPA019367: AB_1852239, HPA076201: "	"unprognostic (2.83e-2)"	"unprognostic (2.81e-2)"	"unprognostic (1.65e-2)"	"unprognostic (5.79e-2)"	"unprognostic (8.85e-3)"	"unprognostic (2.67e-1)"		"unprognostic (2.17e-2)"	"unprognostic (1.72e-1)"	"unprognostic (6.60e-2)"	"unprognostic (9.20e-2)"	"unprognostic (5.19e-2)"		"unprognostic (2.45e-1)"	"unprognostic (8.98e-2)"		"unprognostic (1.94e-1)"	0.4	0.0	0.0	0.0	0.0	0.0	4.0	0.0	0.4	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	22.9	0.0	0.0	0.0	0.1	0.0	0.4	0.0	3.5	0.0	18.8	3.3	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	21.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	29.1	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0
KRT77	KRT1B	ENSG00000189182	"Keratin 77"	Q7Z794	12	52689626-52703463	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	12	"skin 1: 77.7"	"Cell line enriched"	"Detected in single"	90	"HaCaT: 8.9"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	5	"amygdala: 9.3;basal ganglia: 6.7;cerebral cortex: 4.7;hippocampal formation: 8.3;hypothalamus: 6.3"	"Not detected"	"Not detected"			HPA045934	Enhanced		Approved	"Nuclear membrane,Plasma membrane"			2100000000	"Nuclear membrane, Plasma membrane"		"HPA045934: AB_10960065"	"unprognostic (3.52e-2)"	"unprognostic (1.54e-1)"				"unprognostic (1.41e-1)"		"unprognostic (3.79e-1)"	"unprognostic (2.61e-1)"						"unprognostic (2.11e-1)"		"unprognostic (2.06e-1)"	0.1	0.0	0.1	0.1	0.1	0.0	6.4	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	1.2	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	77.7	0.1	0.1	0.1	0.1	0.0	0.1	0.1	4.6	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
KRTAP25-1	KAP25.1	ENSG00000232263	"Keratin associated protein 25-1"	Q3LHN0	21	30289145-30289514	"Predicted intracellular proteins"				"No human protein/transcript evidence"	"No human protein/transcript evidence"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA031438	Uncertain		Approved	"Nuclear membrane,Plasma membrane,Cytosol"				"Nuclear membrane"	"Plasma membrane, Cytosol"	"HPA031438: AB_10610000"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
LAMA4	LAMA3	ENSG00000112769	"Laminin subunit alpha 4"	Q16363	6	112108760-112254939	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Cell adhesion"		"Cardiomyopathy, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC diff: 51.3;ASC TERT1: 78.1;HSkMC: 60.8;HUVEC TERT2: 64.1;TIME: 58.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA015693, CAB078156"	Enhanced		Approved	"Plasma membrane,Cytosol"	"Secreted to extracellular matrix"		350000	"Plasma membrane, Cytosol"		"CAB078156: , HPA015693: AB_1852687"	"unprognostic (1.87e-2)"	"unprognostic (6.48e-2)"	"unprognostic (8.37e-2)"	"unprognostic (2.39e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.15e-1)"	"unprognostic (2.52e-2)"	"unprognostic (5.07e-2)"	"unprognostic (4.59e-2)"	"unprognostic (2.93e-2)"	"unprognostic (9.06e-2)"	"unprognostic (1.78e-1)"	"prognostic unfavourable (2.00e-4)"	"unprognostic (4.40e-3)"	"unprognostic (1.85e-1)"	"unprognostic (2.80e-2)"	"unprognostic (1.15e-2)"	42.3	3.6	5.8	20.7	5.4	0.0	21.7	3.7	4.6	28.7	28.6	4.7	12.9	6.3	41.0	24.8	29.7	29.6	23.3	13.8	5.1	4.1	4.6	1.8	27.9	8.8	5.5	2.1	19.9	1.6	3.6	5.6	25.4	5.0	21.3	13.2	18.4	22.9	15.7	5.7	6.8	13.1	53.6	3.6	0.4	15.6	9.4	2.5	1.1	9.1	15.2	6.6	35.6	19.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	51.3	78.1	0.0	12.8	7.7	1.3	0.2	0.0	4.8	0.0	8.5	22.2	0.0	0.5	0.0	0.2	0.0	6.6	0.0	6.4	0.0	10.5	0.0	0.0	60.8	0.0	9.3	0.0	64.1	0.0	0.0	0.2	0.0	0.0	0.0	0.1	1.8	0.0	0.0	0.0	21.0	0.3	0.0	0.3	1.9	0.0	9.9	0.0	0.0	58.6	21.1	1.1	23.6	4.3	0.0	0.0	0.0	5.3	0.0	27.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.8	5.4	3.7	4.6	5.1	4.1	5.5	2.1	5.0	2.5
LAMC1	LAMB2	ENSG00000135862	"Laminin subunit gamma 1"	P11047	1	183023460-183145592	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Cell adhesion"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC diff: 167.8;ASC TERT1: 92.4;HSkMC: 104.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	13	"memory B-cell: 1.1;naive B-cell: 3.2;plasmacytoid DC: 1.3"	"Group enriched"	"Detected in many"	15	"B-cells: 3.2;dendritic cells: 1.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001908, HPA001909, CAB004486, CAB078163"	Enhanced		Approved	"Endoplasmic reticulum,Plasma membrane"	"Secreted to extracellular matrix"		90000000	"Endoplasmic reticulum, Plasma membrane"		"CAB004486: AB_627870, CAB078163: , HPA001908: AB_1079229, HPA001909: AB_1079230"	"unprognostic (1.46e-1)"	"unprognostic (1.05e-2)"	"unprognostic (8.30e-2)"	"unprognostic (8.84e-3)"	"unprognostic (3.75e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.55e-2)"	"unprognostic (1.54e-2)"	"unprognostic (1.38e-2)"	"unprognostic (2.71e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.88e-3)"	"unprognostic (1.10e-3)"	"unprognostic (1.53e-1)"	"unprognostic (1.54e-1)"	"prognostic unfavourable (8.85e-5)"	49.0	6.8	2.9	11.3	4.0	0.2	51.5	5.9	3.4	30.4	27.7	2.8	12.8	4.9	30.5	28.7	31.5	21.5	25.9	39.5	3.4	2.0	10.0	6.8	22.5	10.6	3.9	2.7	22.7	9.8	7.4	4.1	73.1	3.5	23.9	11.4	11.7	11.6	17.3	32.2	15.6	17.6	41.3	3.0	4.7	22.3	16.1	2.7	3.5	21.7	16.4	7.3	40.2	37.6	3.2	1.3	0.0	0.1	0.0	0.0	0.2	5.1	8.4	27.7	7.8	167.8	92.4	42.0	38.0	38.2	15.3	9.1	24.9	5.9	1.8	17.6	18.2	12.9	5.2	10.0	11.8	0.0	5.3	0.0	7.6	9.0	26.4	1.6	0.9	104.0	5.4	18.3	14.5	26.7	0.0	5.7	18.6	2.2	0.0	1.7	11.2	1.6	1.3	23.4	0.9	24.8	13.7	1.8	5.2	10.0	0.0	9.7	2.1	4.3	49.2	18.8	7.4	17.3	9.5	2.2	0.0	1.2	15.5	1.2	18.1	0.0	0.1	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.2	2.9	4.0	5.9	3.4	3.4	2.0	3.9	2.7	3.5	2.7
LAMP2	CD107b	ENSG00000005893	"Lysosomal associated membrane protein 2"	P13473	X	120427827-120469365	"CD markers, Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters"	Autophagy		"Disease mutation, Glycogen storage disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"ASC diff: 113.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 112.9"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 112.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005272, HPA029100, HPA029101"	Supported		Approved	"Vesicles,Plasma membrane"			820000000	"Vesicles, Plasma membrane"		"CAB005272: AB_647855, HPA029100: AB_10795022, HPA029101: "	"unprognostic (2.99e-3)"	"unprognostic (5.26e-2)"	"unprognostic (2.66e-3)"	"unprognostic (1.74e-1)"	"unprognostic (3.10e-1)"	"unprognostic (2.50e-2)"	"unprognostic (4.84e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.55e-1)"	"unprognostic (9.73e-2)"	"unprognostic (1.11e-2)"	"unprognostic (2.50e-2)"	"unprognostic (2.85e-1)"	"unprognostic (6.78e-2)"	"unprognostic (2.66e-1)"	"unprognostic (5.53e-3)"	21.8	33.6	39.9	16.1	87.9	22.6	27.1	16.2	55.5	33.0	18.3	88.7	27.9	25.1	20.8	37.5	34.6	22.4	43.3	20.9	52.5	30.3	55.0	83.7	25.3	14.3	131.0	36.9	22.7	27.4	28.8	20.2	35.4	58.6	37.3	19.7	17.2	47.8	32.9	32.4	26.9	20.5	21.1	84.3	17.9	23.6	11.9	116.9	21.2	33.7	14.3	15.4	21.1	27.0	3.7	11.6	112.9	21.7	5.4	5.8	10.5	11.8	11.7	8.6	11.1	113.5	38.8	23.9	20.5	35.8	20.0	37.4	9.7	21.2	8.4	18.1	35.6	20.0	12.5	15.5	32.6	9.4	8.9	6.6	13.0	13.0	37.8	29.0	18.4	42.0	31.2	26.6	17.6	27.2	7.6	30.0	32.3	21.9	8.0	14.8	6.7	10.4	6.2	14.6	15.0	29.2	8.8	2.9	4.6	22.0	22.4	43.8	13.3	32.4	28.1	28.7	13.9	36.9	55.3	15.1	14.4	5.5	27.4	35.1	68.7	4.9	21.7	41.3	5.0	18.7	4.0	3.1	4.8	4.7	11.6	3.7	4.3	4.1	112.9	5.4	17.3	6.3	5.8	10.5	39.9	87.9	16.2	55.5	52.5	30.3	131.0	36.9	58.6	116.9
LAPTM4A	"HUMORF13, KIAA0108, LAPTM4, MBNT, Mtrp"	ENSG00000068697	"Lysosomal protein transmembrane 4 alpha"	Q15012	2	20032650-20052028	"Predicted membrane proteins"	Transport			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"ASC diff: 131.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031402, HPA031404, HPA068554"	Approved		Approved	"Golgi apparatus,Vesicles,Plasma membrane"				"Golgi apparatus, Vesicles"	"Plasma membrane"	"HPA031402: AB_10669882, HPA031404: AB_10670293, HPA068554: "	"unprognostic (2.01e-1)"	"unprognostic (1.98e-2)"	"unprognostic (1.44e-1)"	"unprognostic (5.73e-1)"	"unprognostic (6.04e-2)"	"unprognostic (3.00e-2)"	"unprognostic (1.53e-3)"	"unprognostic (5.37e-2)"	"unprognostic (1.27e-1)"	"unprognostic (3.65e-2)"	"prognostic unfavourable (4.37e-4)"	"unprognostic (8.70e-2)"	"unprognostic (1.05e-2)"	"unprognostic (7.78e-3)"	"unprognostic (2.18e-2)"	"unprognostic (7.98e-3)"	"unprognostic (2.36e-1)"	59.2	63.8	23.4	20.1	22.8	19.8	53.6	15.9	23.4	85.7	44.0	25.9	181.0	26.0	80.3	57.4	50.4	53.0	49.9	50.1	22.3	19.0	95.9	83.0	48.7	24.3	22.0	17.3	72.7	63.6	28.9	46.5	137.6	24.9	64.9	28.4	56.8	49.9	175.6	33.6	41.2	44.9	56.4	21.6	34.8	40.7	83.3	18.6	13.7	75.3	37.9	37.7	65.3	57.8	27.2	37.4	82.4	53.4	16.5	19.4	48.0	36.9	20.5	12.6	26.1	131.1	97.5	47.2	47.0	59.0	32.2	36.6	16.0	36.4	6.5	10.9	57.0	36.8	10.4	22.5	29.5	16.0	16.7	10.0	24.2	45.6	50.6	7.6	27.6	65.0	45.9	31.2	35.9	33.2	7.5	12.5	47.6	21.3	4.5	10.1	27.8	18.8	8.0	36.9	12.3	78.7	31.0	20.0	19.3	43.7	36.1	29.5	15.6	6.3	42.3	54.2	19.4	46.5	30.1	20.9	29.9	10.5	42.8	15.3	21.4	82.4	53.4	38.5	14.2	44.2	17.1	27.2	17.0	15.7	37.4	26.2	19.4	17.3	28.1	16.5	50.3	31.3	15.9	48.0	23.4	22.8	15.9	23.4	22.3	19.0	22.0	17.3	24.9	18.6
LCP1	"CP64, L-PLASTIN, LC64P, PLS2"	ENSG00000136167	"Lymphocyte cytosolic protein 1"	P13796	13	46125920-46211871	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"		Actin-binding	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 188.6;lymphoid tissue: 118.2"	"Cell line enhanced"	"Detected in many"		"Daudi: 82.6;HDLM-2: 75.5;HL-60: 80.2;HMC-1: 85.1;THP-1: 74.8;U-698: 106.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019493, CAB020673"	Enhanced		Approved	"Plasma membrane,Actin filaments,Cytosol"			2200000000	"Plasma membrane, Cytosol"	"Actin filaments"	"CAB020673: , HPA019493: AB_1855457"	"unprognostic (2.79e-2)"	"unprognostic (8.20e-3)"	"unprognostic (1.19e-2)"	"unprognostic (3.95e-3)"	"unprognostic (1.19e-1)"	"unprognostic (2.84e-2)"	"unprognostic (2.70e-1)"	"unprognostic (4.99e-2)"	"unprognostic (6.70e-3)"	"unprognostic (2.54e-1)"	"unprognostic (5.47e-2)"	"unprognostic (3.63e-1)"	"unprognostic (3.32e-3)"	"unprognostic (2.51e-1)"	"unprognostic (1.02e-1)"	"unprognostic (7.50e-2)"	"unprognostic (2.92e-1)"	57.1	10.0	5.6	44.3	9.4	71.2	8.7	3.9	4.6	3.6	6.2	4.5	5.0	4.5	5.3	43.1	6.2	8.3	8.9	5.5	4.3	3.8	7.2	12.2	33.7	59.1	12.0	1.0	5.7	3.9	0.1	2.8	24.7	7.7	21.5	8.1	5.5	9.5	2.5	3.5	6.8	21.7	6.5	11.9	112.9	6.1	8.2	9.2	118.2	4.5	4.1	68.7	14.0	7.1	25.4	79.3	133.5	127.6	43.2	67.2	188.6	3.3	0.0	0.1	0.0	0.0	0.0	40.1	0.0	0.1	0.3	0.2	22.1	0.1	82.6	17.6	0.0	0.1	0.0	0.0	0.3	75.5	19.6	17.8	0.0	0.0	0.0	80.2	85.1	0.2	0.0	0.1	0.1	0.0	9.3	55.0	0.0	0.1	56.8	55.5	0.0	0.8	42.3	0.1	59.0	0.0	22.8	0.1	0.7	0.1	8.8	0.6	0.4	74.8	0.2	2.1	1.3	0.1	2.4	13.1	27.3	106.3	1.6	48.9	0.3	57.1	96.6	54.3	67.2	127.6	60.8	25.4	40.4	55.5	79.3	18.3	25.2	42.3	133.5	43.2	118.1	20.8	40.5	188.6	5.6	9.4	3.9	4.6	4.3	3.8	12.0	1.0	7.7	9.2
LCTL	"FLJ33279, KLG, KLPH"	ENSG00000188501	"Lactase like"	Q6UWM7	15	66547179-66565979	"Cancer-related genes, Predicted membrane proteins"	"Sensory transduction, Vision"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"brain: 10.4"	"Cell line enhanced"	"Detected in some"		"EFO-21: 6.4;NTERA-2: 5.9;U-2 OS: 16.6;U-251 MG: 7.0"	"Group enriched"	"Detected in some"	5	"glioma: 1.5;melanoma: 0.6"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"neutrophil: 3.9"	"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA071640			Approved	"Endoplasmic reticulum,Plasma membrane"				"Plasma membrane"	"Endoplasmic reticulum"	"HPA071640: "	"unprognostic (4.60e-2)"	"unprognostic (5.46e-2)"	"unprognostic (8.70e-2)"	"unprognostic (1.56e-2)"	"unprognostic (3.22e-3)"	"unprognostic (3.53e-2)"	"unprognostic (6.67e-2)"	"unprognostic (1.06e-2)"	"unprognostic (2.59e-2)"	"unprognostic (1.04e-1)"	"unprognostic (3.47e-1)"	"unprognostic (4.51e-3)"	"unprognostic (4.44e-16)"	"unprognostic (6.06e-2)"	"unprognostic (3.39e-1)"	"unprognostic (5.48e-2)"	"unprognostic (1.39e-1)"	0.4	0.7	6.0	0.9	4.3	3.1	0.4	0.7	3.1	0.4	0.5	3.1	0.0	1.4	0.8	0.9	0.7	0.3	1.0	0.4	3.3	1.2	0.4	0.4	0.4	1.0	5.3	3.1	0.6	0.7	0.2	0.4	0.3	4.9	0.4	0.3	1.1	0.6	0.3	3.0	2.6	0.7	0.4	10.4	0.8	0.7	1.5	2.3	0.0	0.5	0.0	0.2	0.3	0.3	0.9	0.6	3.9	0.7	1.0	0.5	0.2	0.3	0.3	3.2	0.3	0.1	0.1	0.8	0.8	0.0	0.1	0.4	0.4	0.4	0.5	6.4	0.2	0.7	0.0	0.0	0.2	0.2	0.2	0.7	1.0	1.6	0.0	0.2	0.4	0.4	0.0	0.3	0.0	0.0	0.4	0.4	0.2	0.1	0.3	0.4	5.9	0.1	0.2	3.5	0.3	0.0	0.4	0.4	0.3	0.1	0.3	1.8	0.4	0.5	0.4	1.7	16.6	0.6	7.0	0.2	0.2	0.2	2.2	0.7	3.0	1.6	0.7	0.5	0.5	0.4	0.3	0.4	0.5	0.3	0.2	0.9	0.5	0.4	3.9	1.0	0.4	0.6	0.5	0.2	6.0	4.3	0.7	2.7	3.3	1.2	5.3	3.1	4.9	2.3
LENG1		ENSG00000105617	"Leukocyte receptor cluster member 1"	Q96BZ8	19	54155161-54159882	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"AF22: 5.6;HaCaT: 8.1;HDLM-2: 5.0;HSkMC: 3.8;LHCN-M2: 4.7;U-87 MG: 5.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043541	Approved		Approved	"Nucleoplasm,Plasma membrane"				"Plasma membrane"	Nucleoplasm	"HPA043541: AB_10961190"	"unprognostic (8.75e-2)"	"unprognostic (4.36e-2)"	"unprognostic (2.72e-2)"	"unprognostic (2.30e-1)"	"unprognostic (5.69e-2)"	"unprognostic (1.91e-1)"	"unprognostic (1.10e-1)"	"unprognostic (8.73e-2)"	"unprognostic (6.42e-2)"	"unprognostic (5.22e-2)"	"prognostic favourable (8.12e-4)"	"unprognostic (7.51e-2)"	"prognostic favourable (3.72e-4)"	"unprognostic (2.21e-1)"	"unprognostic (2.84e-1)"	"unprognostic (4.82e-2)"	"unprognostic (1.14e-2)"	9.6	8.0	8.2	8.0	11.1	6.1	7.3	10.1	9.5	7.5	10.8	11.5	10.8	7.6	13.4	8.7	6.1	11.9	9.6	12.7	8.2	7.9	7.6	7.2	8.9	6.3	11.2	7.6	10.3	9.7	7.3	8.5	7.3	10.3	9.3	10.7	6.6	21.6	10.4	13.1	9.9	14.8	7.5	10.8	21.8	8.8	12.3	13.1	10.1	10.8	7.6	6.8	8.2	15.8	3.8	3.2	4.1	3.3	2.8	3.8	0.8	0.1	0.4	5.6	0.2	0.5	0.2	0.4	0.8	0.1	0.5	0.3	0.2	0.0	0.0	0.2	0.0	8.1	0.3	0.2	0.2	5.0	1.2	0.0	0.5	0.1	0.0	0.0	0.5	3.8	0.6	0.2	0.4	0.1	0.1	0.0	4.7	0.6	0.4	0.5	0.0	0.5	0.0	0.1	0.7	0.5	0.5	0.2	0.1	0.3	0.0	0.3	0.2	0.1	0.7	0.4	0.4	0.2	0.4	0.1	0.2	0.0	5.5	0.1	2.6	1.0	2.7	4.1	2.5	3.3	2.8	1.6	3.7	3.8	2.2	3.8	3.7	2.9	3.7	2.8	1.6	3.2	2.7	0.8	8.2	11.1	10.1	9.5	8.2	7.9	11.2	7.6	10.3	13.1
LGALS3	"GALIG, LGALS2, MAC-2"	ENSG00000131981	"Galectin 3"	P17931	14	55124110-55145413	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Differentiation, Immunity, Innate immunity, mRNA processing, mRNA splicing"	"IgE-binding protein"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 93.8;CAPAN-2: 74.5;SK-MEL-30: 175.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"classical monocyte: 67.4;intermediate monocyte: 55.4;myeloid DC: 41.7;non-classical monocyte: 44.2;T-reg: 25.9"	"Group enriched"	"Detected in all"	12	"dendritic cells: 41.7;monocytes: 67.4;T-cells: 25.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"HPA003162, CAB005191"	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Cytosol"	"Secreted to blood"		2300000	"Nucleoplasm, Cytosol"	"Plasma membrane"	"CAB005191: AB_2136784, HPA003162: AB_1078937"	"unprognostic (1.42e-1)"	"unprognostic (9.79e-2)"	"unprognostic (1.14e-1)"	"unprognostic (3.15e-1)"	"unprognostic (2.46e-2)"	"unprognostic (3.34e-2)"	"unprognostic (1.73e-3)"	"unprognostic (1.00e-1)"	"unprognostic (2.13e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.08e-3)"	"unprognostic (5.97e-2)"	"unprognostic (8.52e-2)"	"unprognostic (1.44e-1)"	"unprognostic (2.96e-2)"	"unprognostic (2.65e-3)"	"unprognostic (7.60e-3)"	95.7	11.0	10.4	50.9	13.6	29.8	53.2	6.5	11.7	54.1	127.1	6.1	42.4	75.7	50.3	30.7	76.1	26.1	83.9	42.3	8.4	5.7	19.9	3.9	65.5	16.6	8.5	9.4	58.9	24.2	0.5	11.0	78.7	5.5	51.7	93.7	25.7	78.3	51.7	31.3	76.1	182.4	48.2	8.7	11.1	36.9	20.4	5.7	5.5	18.0	65.7	41.7	41.1	44.4	1.3	41.7	3.6	67.4	2.5	25.9	37.2	22.4	7.2	0.2	0.1	46.8	93.8	27.4	18.0	37.9	5.0	8.9	15.5	74.5	0.0	9.5	20.9	22.5	0.4	18.8	2.8	26.6	0.3	0.0	8.0	7.1	35.5	0.0	0.0	29.3	28.7	5.7	12.1	7.8	0.1	21.7	11.3	15.1	0.0	5.4	0.4	20.2	0.0	0.9	1.6	46.8	30.0	0.6	1.7	42.1	0.0	175.1	18.5	2.4	14.2	23.7	3.3	8.8	0.3	12.1	38.3	0.1	34.1	1.4	2.5	1.7	67.4	3.4	1.8	55.4	11.4	1.3	6.8	5.1	41.7	0.4	0.3	1.0	3.6	2.5	44.2	1.1	25.9	37.2	10.4	13.6	6.5	11.7	8.4	5.7	8.5	9.4	5.5	5.7
LGALS8	PCTA-1	ENSG00000116977	"Galectin 8"	O00214	1	236518000-236552981	"Predicted intracellular proteins"	Autophagy			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"basophil: 38.5"	"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA012734, HPA030491"	Approved		Approved	"Plasma membrane"				"Plasma membrane"		"HPA012734: , HPA030491: AB_10602345"	"unprognostic (2.03e-2)"	"unprognostic (1.54e-1)"	"unprognostic (2.38e-2)"	"unprognostic (3.80e-3)"	"unprognostic (2.02e-3)"	"unprognostic (4.71e-3)"	"unprognostic (3.93e-2)"	"prognostic favourable (9.40e-4)"	"unprognostic (9.96e-2)"	"unprognostic (1.41e-1)"	"unprognostic (2.12e-1)"	"unprognostic (1.78e-3)"	"prognostic unfavourable (4.93e-7)"	"unprognostic (1.41e-1)"	"unprognostic (1.57e-1)"	"unprognostic (3.15e-2)"	"unprognostic (8.21e-2)"	27.8	14.0	15.0	17.0	30.5	28.9	18.6	21.7	22.6	14.1	14.8	9.5	10.7	15.5	13.6	19.2	18.5	12.4	17.2	36.0	16.2	14.8	18.5	34.1	21.0	28.2	13.7	17.0	18.3	18.8	22.5	22.7	43.1	25.2	19.8	14.9	10.0	22.4	17.5	7.7	25.3	18.1	15.3	18.1	41.3	13.6	39.9	14.6	19.9	16.8	13.0	16.4	20.7	14.6	4.4	12.7	38.5	14.2	5.3	8.9	9.3	17.6	9.2	1.3	6.9	16.5	14.1	20.5	13.1	15.0	16.4	19.1	12.5	21.5	0.5	12.8	10.8	19.8	3.6	18.8	15.4	10.2	2.8	11.9	8.0	22.3	20.8	15.8	28.3	12.9	15.0	14.7	5.0	18.1	14.1	8.9	11.8	10.9	7.5	3.1	4.8	6.9	9.1	0.3	1.1	11.6	28.7	4.5	9.2	8.5	27.8	4.7	20.6	12.5	13.2	0.3	8.2	9.8	16.4	3.4	2.6	0.4	17.0	22.2	10.4	38.5	14.2	7.2	5.4	12.9	7.4	4.4	7.8	5.8	12.7	2.9	5.2	5.4	6.7	5.3	8.7	5.8	8.9	9.3	15.0	30.5	21.7	22.6	16.2	14.8	13.7	17.0	25.2	14.6
LGR6	FLJ14471	ENSG00000133067	"Leucine rich repeat containing G protein-coupled receptor 6"	Q9HBX8	1	202193901-202319781	"G-protein coupled receptors, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Wnt signaling pathway"	"G-protein coupled receptor, Receptor, Transducer"	"Tumor suppressor"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 49.6"	"Cell line enhanced"	"Detected in some"		"A549: 16.3;CAPAN-2: 14.5;HaCaT: 7.8;HeLa: 3.9"	"Cancer enhanced"	"Detected in many"		"ovarian cancer: 17.8"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"gdT-cell: 14.3;memory CD8 T-cell: 8.3;naive CD8 T-cell: 4.7"	"Lineage enriched"	"Detected in single"	41	"T-cells: 14.3"	"Region enriched"	"Detected in some"	9	"olfactory region: 30.0"					HPA008556	Approved		Approved	"Nucleoplasm,Plasma membrane"				"Plasma membrane"	Nucleoplasm	"HPA008556: "	"unprognostic (4.72e-3)"	"unprognostic (5.29e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.89e-2)"	"prognostic unfavourable (4.35e-4)"	"unprognostic (1.08e-1)"	"unprognostic (5.13e-2)"	"unprognostic (9.23e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.54e-2)"	"unprognostic (4.01e-2)"	"unprognostic (7.89e-2)"	"unprognostic (1.00e-2)"	"unprognostic (1.17e-3)"	"unprognostic (2.08e-1)"	"unprognostic (1.70e-1)"	"unprognostic (7.83e-2)"	1.1	0.1	0.9	0.8	3.2	1.8	7.9	6.0	2.4	2.6	2.2	1.5	0.5	0.2	1.6	7.3	4.4	13.8	49.6	12.3	0.7	3.3	0.9	1.4	6.9	1.1	6.8	0.2	2.2	0.5	0.1	15.9	0.9	9.3	6.7	1.1	0.8	8.5	2.5	0.3	3.2	1.6	2.6	1.6	5.3	0.7	4.9	3.9	0.2	4.1	2.6	3.4	3.2	2.9	0.0	0.0	0.0	0.0	0.3	14.3	2.5	0.0	16.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.5	0.0	1.6	0.0	7.8	0.0	0.0	0.0	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.3	0.0	0.9	0.0	1.7	8.3	0.0	0.0	0.7	4.7	0.0	0.3	0.0	0.0	0.4	2.5	0.9	3.2	6.0	2.4	0.7	3.3	6.8	0.2	9.3	3.9
LINGO1	"FLJ14594, LERN1, LRRN6A"	ENSG00000169783	"Leucine rich repeat and Ig domain containing 1"	Q96FE5	15	77613027-77820900	"Predicted intracellular proteins, Predicted membrane proteins"			"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"brain: 67.2"	"Cell line enhanced"	"Detected in some"		"AF22: 13.2;AN3-CA: 11.0;HAP1: 16.6;HEK 293: 11.7;MCF7: 7.1;NTERA-2: 31.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA074653	Enhanced		Approved	"Plasma membrane"			8400	"Plasma membrane"		"HPA074653: "	"unprognostic (1.06e-1)"	"unprognostic (7.07e-2)"	"unprognostic (2.16e-2)"	"unprognostic (1.48e-2)"	"unprognostic (3.09e-1)"	"unprognostic (2.20e-1)"	"unprognostic (2.84e-2)"	"unprognostic (3.77e-2)"	"unprognostic (3.40e-1)"	"unprognostic (1.10e-1)"	"unprognostic (7.36e-2)"	"unprognostic (2.74e-2)"	"prognostic unfavourable (3.23e-7)"	"unprognostic (2.07e-1)"	"unprognostic (7.06e-2)"	"unprognostic (2.85e-1)"	"unprognostic (2.59e-2)"	3.0	1.6	27.4	1.7	21.8	0.8	1.3	9.1	67.2	3.8	2.0	5.9	0.0	2.0	3.3	2.7	1.4	3.1	2.5	9.7	29.8	12.2	2.2	1.1	1.1	1.3	10.3	21.8	1.7	2.7	1.1	0.5	6.1	6.8	1.7	1.5	1.8	3.4	2.5	1.0	3.0	1.5	4.5	6.8	3.3	2.0	3.7	3.9	0.0	1.7	0.0	1.1	3.2	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	13.2	11.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.8	0.0	0.0	16.6	0.0	0.0	0.0	11.7	0.0	0.0	0.2	0.2	0.0	0.0	0.1	0.3	0.0	0.0	0.0	1.7	0.1	0.0	7.1	0.0	0.0	31.3	0.0	0.0	0.0	0.2	0.0	0.0	2.4	0.7	0.0	1.3	2.8	0.2	0.2	1.1	0.0	2.9	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	27.4	21.8	9.1	47.5	29.8	12.2	10.3	21.8	6.8	3.9
LMCD1		ENSG00000071282	"LIM and cysteine rich domains 1"	Q9NZU5	3	8501707-8574673	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 189.9"	"Cell line enhanced"	"Detected in many"		"HHSteC: 29.8;HSkMC: 41.7;hTEC/SVTERT24-B: 30.6;U-2197: 27.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	6	"T-reg: 17.0"	"Lineage enriched"	"Detected in many"	6	"T-cells: 17.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA024059	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Cell Junctions,Cytosol"				"Nucleoplasm, Cytosol"	"Plasma membrane, Cell Junctions"	"HPA024059: AB_1852950"	"unprognostic (2.46e-1)"	"unprognostic (1.79e-1)"	"unprognostic (5.13e-3)"	"unprognostic (1.30e-1)"	"unprognostic (2.28e-2)"	"unprognostic (2.10e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.38e-1)"	"unprognostic (2.96e-1)"	"unprognostic (8.21e-3)"	"unprognostic (4.29e-1)"	"unprognostic (2.54e-2)"	"prognostic unfavourable (8.66e-5)"	"unprognostic (3.80e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.01e-3)"	"unprognostic (3.68e-3)"	38.6	3.3	1.6	10.1	1.8	0.0	36.4	3.9	1.9	11.7	4.4	3.8	5.2	1.9	22.3	20.8	8.3	11.9	15.4	15.9	2.3	1.7	5.5	2.2	25.9	3.8	2.4	1.7	17.9	8.5	5.8	2.0	14.1	4.5	16.1	1.6	4.6	19.2	7.0	189.9	5.7	3.3	72.9	3.7	14.3	10.6	9.3	1.3	0.8	4.6	34.3	7.1	29.4	15.7	1.8	2.7	0.0	0.3	0.0	17.0	0.2	2.9	16.6	2.8	2.1	20.7	11.7	2.9	12.1	6.2	6.7	16.5	12.2	3.7	0.0	1.4	14.0	0.2	1.6	3.1	2.7	5.0	1.1	3.6	1.1	2.4	29.8	0.0	0.3	41.7	0.0	30.6	0.2	3.2	0.0	0.0	8.6	2.1	0.0	0.0	5.4	0.7	0.0	9.2	0.0	6.1	1.1	0.1	6.9	2.0	10.1	6.3	13.2	0.0	1.5	6.7	13.5	27.0	8.1	1.6	1.9	0.8	1.3	0.9	8.7	0.0	0.0	0.0	0.0	0.3	0.1	1.8	2.6	0.5	2.7	0.3	0.0	0.0	0.0	0.0	0.0	0.9	17.0	0.2	1.6	1.8	3.9	1.9	2.3	1.7	2.4	1.7	4.5	1.3
LMTK2	"AATYK2, BREK, cprk, KIAA1079, KPI-2, KPI2, LMR2, PPP1R100"	ENSG00000164715	"Lemur tyrosine kinase 2"	Q8IWU2	7	98106885-98209633	"Enzymes, Predicted membrane proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"neutrophil: 4.8"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA010657, HPA041836"	Uncertain		Approved	"Nuclear speckles,Plasma membrane,Centriolar satellite,Cytosol"				"Nuclear speckles, Centriolar satellite"	"Plasma membrane, Cytosol"	"HPA010657: AB_1079259, HPA041836: "	"unprognostic (7.36e-2)"	"unprognostic (3.16e-1)"	"unprognostic (1.59e-1)"	"unprognostic (2.60e-3)"	"unprognostic (2.47e-2)"	"unprognostic (2.45e-1)"	"unprognostic (2.35e-2)"	"unprognostic (1.23e-1)"	"unprognostic (4.96e-1)"	"prognostic unfavourable (8.03e-4)"	"unprognostic (1.23e-1)"	"unprognostic (4.65e-1)"	"prognostic favourable (1.12e-7)"	"unprognostic (1.88e-1)"	"unprognostic (3.92e-1)"	"unprognostic (2.16e-2)"	"unprognostic (6.38e-3)"	5.1	10.3	13.7	5.6	21.3	17.3	5.6	16.6	34.3	7.3	13.8	6.1	5.6	12.6	6.1	6.3	12.7	6.4	7.9	16.9	11.0	10.1	10.1	8.5	10.0	5.1	7.5	18.9	8.0	21.0	22.2	10.0	4.8	13.2	7.9	11.8	5.4	10.5	6.5	17.5	11.5	13.8	5.7	5.5	6.8	9.4	8.0	6.9	7.2	8.7	5.7	7.4	8.3	8.1	0.6	0.7	4.8	0.9	0.3	1.6	0.5	9.9	11.7	9.1	9.3	4.9	3.9	8.5	4.1	4.5	4.1	4.9	9.2	9.1	5.2	11.9	5.3	10.9	10.5	6.3	6.4	7.4	7.4	3.5	10.5	9.2	6.0	6.3	6.4	2.7	8.8	8.4	11.4	6.1	9.2	11.1	3.7	13.5	6.6	3.8	11.1	5.7	7.3	6.2	10.3	6.8	17.5	6.5	13.1	8.3	15.2	6.0	4.2	2.6	7.4	8.5	14.0	16.9	9.4	4.9	8.6	10.5	5.7	5.0	10.1	1.2	0.6	0.5	0.8	0.3	0.5	0.6	0.9	0.9	0.3	0.6	1.1	1.6	4.8	0.3	0.9	0.7	0.8	0.5	13.7	21.3	16.6	34.3	11.0	10.1	7.5	18.9	13.2	6.9
LNX2	"MGC46315, PDZRN1"	ENSG00000139517	"Ligand of numb-protein X 2"	Q8N448	13	27545911-27620404	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA040698	Approved		Approved	"Vesicles,Plasma membrane,Cytosol"				Vesicles	"Plasma membrane, Cytosol"	"HPA040698: AB_10673138"	"unprognostic (4.97e-2)"	"unprognostic (1.97e-2)"	"unprognostic (3.29e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.15e-1)"	"unprognostic (2.65e-2)"	"unprognostic (1.12e-1)"	"unprognostic (8.38e-2)"	"unprognostic (1.16e-1)"	"unprognostic (9.27e-3)"	"unprognostic (4.21e-2)"	"unprognostic (8.79e-2)"	"prognostic favourable (7.09e-13)"	"unprognostic (4.18e-3)"	"unprognostic (1.67e-1)"	"unprognostic (2.21e-1)"	"unprognostic (2.84e-2)"	4.6	10.3	2.5	6.7	4.2	2.7	9.8	7.6	4.1	6.0	13.2	2.3	8.3	12.2	4.4	4.3	12.4	4.1	9.7	8.8	2.8	2.9	9.2	24.5	22.1	4.9	3.4	3.1	6.3	24.7	7.6	9.6	10.8	3.7	7.0	9.3	10.2	12.1	9.9	8.0	7.6	19.6	6.5	3.3	4.6	9.0	10.3	2.6	13.4	9.9	4.2	10.0	6.2	8.5	1.6	0.8	5.3	0.9	3.3	2.8	0.6	5.1	2.8	5.4	5.9	5.7	2.6	5.7	4.6	4.0	4.5	4.1	10.2	10.3	7.8	4.0	4.0	9.8	9.6	12.2	5.9	4.7	4.0	9.9	6.0	7.4	9.0	5.3	6.3	2.2	19.0	3.1	12.5	8.1	3.0	3.0	6.5	6.3	7.8	3.5	6.0	3.2	7.2	10.6	4.0	9.9	9.0	13.9	2.9	6.3	12.7	8.0	8.9	4.1	10.3	2.6	3.6	2.6	3.7	2.9	4.9	8.1	1.7	5.1	3.6	5.3	0.9	2.4	1.7	0.3	2.3	1.6	1.8	2.1	0.8	1.3	1.9	1.8	1.1	3.3	0.7	0.4	2.8	0.6	2.5	4.2	7.6	4.1	2.8	2.9	3.4	3.1	3.7	2.6
LONRF1	"FLJ23749, RNF191"	ENSG00000154359	"LON peptidase N-terminal domain and ring finger 1"	Q17RB8	8	12721894-12756073	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Karpas-707: 31.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023584, HPA024814"	Uncertain		Approved	"Plasma membrane,Centrosome,Cytosol"				"Plasma membrane, Cytosol"	Centrosome	"HPA023584: AB_1853233, HPA024814: AB_1853235"	"unprognostic (2.59e-1)"	"unprognostic (2.17e-3)"	"unprognostic (1.35e-2)"	"unprognostic (3.56e-1)"	"unprognostic (9.09e-2)"	"unprognostic (3.96e-3)"	"unprognostic (3.13e-1)"	"unprognostic (5.78e-2)"	"unprognostic (2.74e-3)"	"unprognostic (1.18e-1)"	"unprognostic (5.83e-2)"	"unprognostic (3.39e-1)"	"unprognostic (5.46e-3)"	"unprognostic (8.97e-2)"	"unprognostic (8.90e-2)"	"unprognostic (3.08e-3)"	"unprognostic (1.15e-1)"	16.5	7.6	7.6	4.9	9.9	4.9	10.4	9.9	8.4	14.0	8.1	6.3	8.8	2.2	11.1	13.0	12.9	11.2	9.4	6.5	8.9	5.3	6.3	9.3	8.1	8.7	6.9	6.9	20.4	10.3	12.6	4.9	9.6	5.5	12.8	4.2	13.9	7.9	10.9	18.4	29.7	5.3	10.0	6.1	9.2	6.9	16.1	4.5	6.2	8.6	7.3	7.3	10.6	19.0	1.1	0.9	2.4	2.1	0.1	1.6	0.2	0.6	1.6	8.4	2.6	8.9	4.3	5.6	2.1	3.5	2.3	3.2	0.5	2.1	12.9	0.5	3.6	1.0	6.6	2.5	2.6	2.0	3.7	4.2	0.3	3.4	8.3	1.1	1.6	4.0	4.6	1.4	5.1	3.6	0.6	31.8	1.5	2.3	5.5	3.7	8.6	0.5	3.1	5.7	2.3	2.0	5.6	17.7	2.1	1.2	2.8	16.4	0.6	5.7	1.6	1.2	2.1	5.0	1.6	2.4	10.7	6.8	6.8	3.9	3.8	0.0	0.5	2.4	0.5	1.8	1.6	1.0	1.0	0.6	0.4	1.1	0.0	0.0	1.9	0.1	2.1	0.9	0.0	0.2	7.6	9.9	9.9	8.4	8.9	5.3	6.9	6.9	5.5	4.5
LONRF3	"FLJ22612, RNF127"	ENSG00000175556	"LON peptidase N-terminal domain and ring finger 3"	Q496Y0	X	118974614-119018355	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HeLa: 9.3;K-562: 11.0;PC-3: 12.6;SiHa: 11.4;SK-MEL-30: 10.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"MAIT T-cell: 7.4"	"Lineage enriched"	"Detected in single"	8	"T-cells: 7.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA050422, HPA061162"	Uncertain		Approved	"Nucleoplasm,Plasma membrane"				Nucleoplasm	"Plasma membrane"	"HPA050422: , HPA061162: "	"unprognostic (1.80e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.92e-1)"	"unprognostic (4.24e-2)"	"unprognostic (1.64e-1)"	"unprognostic (6.06e-3)"	"unprognostic (1.29e-2)"	"unprognostic (3.21e-1)"	"unprognostic (8.01e-2)"	"prognostic unfavourable (4.32e-4)"	"unprognostic (4.29e-2)"	"unprognostic (2.31e-3)"	"unprognostic (6.34e-2)"	"unprognostic (6.16e-2)"	"unprognostic (1.70e-1)"	"unprognostic (1.27e-3)"	3.8	3.9	4.2	2.1	3.4	4.6	10.8	15.8	6.1	1.9	4.1	2.0	1.6	2.9	2.4	3.1	1.7	2.5	3.9	3.9	5.0	1.9	3.6	15.4	11.8	0.8	1.7	3.7	2.0	8.1	0.4	3.5	0.9	4.4	3.0	5.5	4.1	8.1	3.0	13.8	1.4	2.3	10.8	2.7	1.1	4.5	2.7	2.5	0.0	9.9	1.9	1.1	4.7	6.6	0.0	0.1	0.8	0.8	0.0	7.4	0.7	3.8	5.7	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.6	4.8	0.0	2.8	0.0	0.0	1.2	0.0	0.1	0.1	3.2	4.9	9.3	5.5	3.2	4.2	0.6	0.0	0.0	0.0	0.0	1.5	11.0	0.0	0.8	4.7	0.0	1.8	0.0	12.6	0.0	2.6	0.0	3.5	1.6	0.2	0.0	11.4	0.3	10.0	0.0	3.7	0.2	0.1	0.2	0.0	6.1	1.2	4.9	0.0	2.7	4.3	2.5	0.0	0.8	0.0	4.5	0.0	7.4	0.0	2.0	1.5	0.1	0.0	1.1	1.6	0.8	0.0	0.0	0.0	0.7	0.7	4.2	3.4	15.8	6.1	5.0	1.9	1.7	3.7	4.4	2.5
LPIN1	KIAA0188	ENSG00000134324	"Lipin 1"	Q14693	2	11677595-11827409	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism, Transcription, Transcription regulation"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 88.4"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA024591, HPA038021"	Approved		Approved	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		"HPA024591: , HPA038021: AB_10669514"	"unprognostic (1.97e-1)"	"unprognostic (2.47e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.87e-2)"	"unprognostic (9.17e-2)"	"unprognostic (2.69e-2)"	"unprognostic (8.20e-2)"	"unprognostic (5.28e-3)"	"unprognostic (1.09e-1)"	"unprognostic (1.07e-2)"	"unprognostic (2.45e-3)"	"unprognostic (2.55e-2)"	"unprognostic (1.06e-1)"	"unprognostic (5.58e-3)"	"unprognostic (1.25e-1)"	"unprognostic (9.60e-2)"	"unprognostic (4.02e-1)"	18.1	10.1	13.0	10.7	18.3	6.0	22.1	20.0	16.4	10.5	8.6	10.9	7.3	8.9	11.0	15.0	20.0	7.0	10.4	12.8	11.6	11.9	7.6	13.2	8.0	15.4	13.2	11.2	19.3	7.5	17.2	32.0	9.0	17.9	9.6	7.1	9.0	14.4	11.6	88.4	6.5	9.2	11.0	10.3	8.4	7.6	39.0	13.2	8.3	8.1	14.0	19.2	10.4	21.7	6.5	9.6	11.6	2.8	8.0	11.1	3.2	5.4	6.5	5.4	12.1	25.1	27.9	2.8	7.6	13.2	5.0	8.6	2.3	5.4	2.7	1.0	6.5	5.9	6.1	16.8	4.6	11.2	3.4	6.7	3.6	3.5	8.8	4.6	31.6	25.1	7.5	20.5	7.8	9.5	9.2	24.3	3.6	2.1	4.3	4.0	5.6	6.6	6.0	10.0	17.0	12.5	3.5	15.1	11.9	2.7	6.6	17.3	1.6	2.6	6.7	7.9	7.1	5.0	6.6	38.2	29.5	5.1	11.1	8.3	5.8	9.5	2.8	11.6	10.3	2.1	11.1	6.5	9.6	9.7	2.5	5.0	8.4	7.1	1.1	8.0	2.1	9.6	10.5	3.2	13.0	18.3	20.0	14.4	11.6	11.9	13.2	11.2	17.9	13.2
LRCH2	KIAA1495	ENSG00000130224	"Leucine rich repeats and calponin homology domain containing 2"	Q5VUJ6	X	115110616-115234072	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HAP1: 17.8;U-266/70: 11.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003233	Approved		Approved	"Nucleoli,Plasma membrane"				Nucleoli	"Plasma membrane"	"HPA003233: AB_2265929"	"unprognostic (9.74e-2)"	"unprognostic (9.48e-2)"	"unprognostic (1.14e-2)"	"unprognostic (4.22e-5)"	"unprognostic (2.88e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.42e-1)"	"unprognostic (9.39e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.01e-2)"	"unprognostic (1.84e-1)"	"unprognostic (4.29e-5)"	"unprognostic (1.09e-3)"	"unprognostic (1.34e-1)"	"unprognostic (7.75e-2)"	"unprognostic (1.16e-2)"	5.1	8.7	11.6	3.4	10.2	0.7	3.3	11.2	10.6	11.2	11.6	5.5	4.0	1.6	9.9	4.5	3.6	4.6	5.3	4.7	7.9	8.9	2.6	1.0	5.7	1.8	5.7	4.6	13.8	1.6	1.3	20.9	13.7	7.6	16.4	4.2	2.5	1.3	14.5	1.2	1.1	3.2	13.7	6.4	3.7	3.6	4.3	7.9	0.0	4.8	0.4	1.1	11.6	6.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.4	3.9	5.5	4.6	0.0	3.5	7.6	3.4	7.9	0.0	0.0	0.1	0.0	4.6	0.3	17.8	0.0	5.2	0.0	4.8	0.0	0.0	0.0	4.4	0.0	0.1	2.7	0.0	1.4	0.2	4.6	0.0	0.0	0.0	0.0	0.0	0.0	5.1	5.2	0.0	3.8	0.0	4.3	0.5	0.0	6.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	4.9	11.8	2.0	0.0	1.5	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.6	10.2	11.2	8.4	7.9	8.9	5.7	4.6	7.6	7.9
LRP12	"FLJ12929, ST7"	ENSG00000147650	"LDL receptor related protein 12"	Q9Y561	8	104489231-104589024	"Predicted membrane proteins"	Endocytosis	Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	6	"basophil: 22.6"	"Lineage enriched"	"Detected in many"	22	"granulocytes: 22.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017245	Uncertain		Approved	"Nucleoli fibrillar center,Plasma membrane,Mitochondria"				"Nucleoli fibrillar center, Plasma membrane, Mitochondria"		"HPA017245: AB_1857532"	"unprognostic (2.17e-1)"	"unprognostic (6.80e-2)"	"unprognostic (2.20e-1)"	"prognostic unfavourable (2.67e-4)"	"unprognostic (2.07e-1)"	"unprognostic (2.15e-3)"	"unprognostic (4.87e-4)"	"unprognostic (2.96e-2)"	"unprognostic (3.96e-1)"	"unprognostic (4.59e-2)"	"unprognostic (1.32e-1)"	"unprognostic (3.39e-2)"	"unprognostic (9.89e-2)"	"unprognostic (7.56e-3)"	"unprognostic (4.88e-2)"	"unprognostic (1.45e-1)"	"unprognostic (4.05e-3)"	6.1	5.3	10.7	4.0	23.4	2.1	4.7	11.3	16.3	7.4	5.1	4.3	5.1	3.3	18.2	4.5	4.6	6.9	8.1	14.2	8.7	6.5	7.2	1.6	4.8	1.6	4.6	9.5	6.9	5.4	13.0	11.0	5.6	7.1	7.4	5.3	3.3	5.0	6.8	11.8	5.1	3.1	20.2	4.1	3.8	3.8	5.0	5.2	18.0	7.4	3.4	2.4	6.2	5.4	0.0	0.3	22.6	0.4	0.4	1.0	0.2	7.4	4.3	8.9	15.6	10.1	8.1	2.0	21.4	21.4	7.5	10.5	0.9	7.4	0.0	8.6	20.2	3.3	3.6	9.1	16.1	13.8	3.4	11.6	2.0	0.3	6.3	0.1	9.4	10.7	6.5	12.5	10.2	3.8	2.4	0.0	26.7	1.2	10.6	0.2	2.2	7.6	0.8	8.7	1.6	6.0	0.3	11.4	7.0	6.8	0.3	18.2	2.1	2.3	10.6	20.6	13.4	6.6	13.7	10.1	7.9	0.0	11.1	0.0	22.5	22.6	0.2	3.5	0.1	0.4	1.0	0.0	0.7	0.0	0.1	0.0	0.2	0.1	0.1	0.4	0.3	0.3	0.0	0.2	10.7	23.4	11.3	16.3	8.7	6.5	4.6	9.5	7.1	5.2
LRRC15	LIB	ENSG00000172061	"Leucine rich repeat containing 15"	Q8TF66	3	194355247-194369743	"Plasma proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"placenta: 48.1"	"Cell line enhanced"	"Detected in some"		"fHDF/TERT166: 47.8;U-138 MG: 9.3;U-87 MG: 25.8"	"Cancer enhanced"	"Detected in many"		"breast cancer: 25.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA035503	Uncertain		Approved	"Vesicles,Plasma membrane"			1800000	Vesicles	"Plasma membrane"	"HPA035503: AB_10961253"	"unprognostic (3.20e-2)"	"unprognostic (1.45e-2)"	"unprognostic (3.11e-1)"	"unprognostic (6.30e-2)"	"unprognostic (1.19e-2)"	"unprognostic (2.04e-1)"	"unprognostic (7.11e-2)"	"unprognostic (2.95e-2)"	"unprognostic (1.84e-1)"	"unprognostic (3.53e-2)"	"unprognostic (3.97e-2)"	"unprognostic (1.88e-3)"	"unprognostic (1.22e-8)"	"unprognostic (5.81e-2)"	"unprognostic (1.11e-1)"	"unprognostic (5.62e-3)"	"unprognostic (7.54e-3)"	3.3	0.5	0.5	3.1	0.6	0.0	5.3	0.5	0.5	4.6	2.1	0.2	0.0	0.4	3.5	0.3	1.0	1.3	2.0	1.8	0.5	0.5	0.5	0.5	2.5	0.8	0.5	0.0	3.1	0.8	0.0	0.5	48.1	0.3	0.6	4.2	0.7	1.6	0.0	1.0	9.1	0.8	0.7	0.5	1.3	1.9	0.9	0.0	1.1	1.8	7.7	7.7	2.7	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.7	0.0	0.0	0.1	0.0	0.0	0.4	47.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	9.3	1.5	1.2	0.0	0.0	0.0	0.0	25.8	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.6	0.5	0.5	0.5	0.5	0.5	0.0	0.3	0.0
LRRC45	MGC20806	ENSG00000169683	"Leucine rich repeat containing 45"	Q96CN5	17	82023302-82031151	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023372, HPA023382, HPA024768"	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Centrosome,Cytosol"				"Centrosome, Cytosol"	"Nucleoplasm, Plasma membrane"	"HPA023372: AB_1853317, HPA023382: AB_1853318, HPA024768: AB_10602348"	"unprognostic (6.69e-2)"	"unprognostic (6.10e-2)"	"unprognostic (6.86e-2)"	"unprognostic (1.38e-2)"	"unprognostic (6.92e-2)"	"unprognostic (4.41e-3)"	"unprognostic (4.70e-3)"	"unprognostic (1.23e-1)"	"unprognostic (6.10e-2)"	"unprognostic (1.78e-3)"	"unprognostic (6.17e-3)"	"unprognostic (7.46e-2)"	"prognostic unfavourable (1.54e-4)"	"unprognostic (1.22e-3)"	"unprognostic (1.24e-1)"	"unprognostic (4.79e-2)"	"unprognostic (3.58e-1)"	5.1	4.9	7.1	7.0	9.3	12.0	4.5	20.3	10.8	4.6	7.0	5.7	9.5	11.1	4.4	5.0	8.0	10.5	5.8	3.1	7.7	3.9	5.9	12.9	5.6	6.5	8.3	4.7	3.7	15.5	4.5	4.8	4.9	6.5	6.6	3.6	4.9	13.6	5.0	4.3	10.2	9.4	5.2	3.3	7.6	10.4	3.1	9.9	7.1	9.8	6.8	6.5	5.0	5.1	2.3	3.3	5.0	3.2	2.8	4.6	3.1	9.7	11.1	3.4	6.9	1.4	1.9	13.2	6.8	2.8	4.1	3.5	9.9	6.7	7.3	6.2	1.3	11.4	3.2	4.1	0.9	4.4	20.9	4.6	20.2	13.3	1.1	5.4	11.6	1.8	1.7	2.4	0.6	6.0	3.2	3.2	1.0	16.5	12.1	18.1	3.5	14.9	10.0	6.6	4.0	2.6	9.0	10.5	10.2	3.1	16.3	5.7	13.3	6.3	3.5	7.2	9.1	11.4	11.5	6.3	1.6	1.1	3.9	4.7	7.5	5.0	3.2	3.6	3.9	2.4	4.0	1.5	4.5	4.6	2.2	2.3	2.4	3.1	0.2	2.8	1.0	3.3	3.8	3.1	7.1	9.3	20.3	10.8	7.7	3.9	8.3	4.7	6.5	9.9
LRRC69		ENSG00000214954	"Leucine rich repeat containing 69"	Q6ZNQ3	8	91101832-91219236	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 6.6"	"Cell line enhanced"	"Detected in some"		"HEK 293: 6.8;U-266/70: 17.5;U-266/84: 9.7"	"Low cancer specificity"	"Detected in some"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA046337	Uncertain		Approved	"Plasma membrane"				"Plasma membrane"		"HPA046337: "	"unprognostic (1.63e-2)"	"unprognostic (1.02e-1)"	"unprognostic (4.69e-1)"	"unprognostic (3.28e-1)"	"unprognostic (2.78e-1)"	"unprognostic (3.17e-1)"	"unprognostic (3.51e-2)"	"unprognostic (3.50e-2)"	"unprognostic (2.49e-2)"	"unprognostic (1.47e-1)"	"unprognostic (9.18e-2)"	"unprognostic (1.88e-1)"	"unprognostic (3.09e-6)"	"unprognostic (6.91e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.43e-1)"	"unprognostic (8.68e-5)"	0.8	0.9	0.2	1.5	0.2	0.0	1.0	0.0	0.1	0.7	0.5			0.1	0.5	1.9	0.7	0.4	0.5	1.1	0.1	0.1	0.9	0.7	0.7	1.9	0.3		0.4	0.7	0.3	0.6	0.5		1.0	1.5		1.1	0.3	0.6	3.5	0.6	1.4	0.3	1.2	0.6	6.6			1.3		1.1	1.0	0.8	1.9	2.0	1.5	1.1	0.4	2.3	0.1	0.6	0.7	0.2	0.5	0.7	1.5	1.2	0.4	0.1	0.3	0.3	1.1	0.9	1.0	0.5	0.2	0.6	0.7	1.2	0.3	0.3	6.8	1.4	1.7	0.5	0.2	0.5	1.1	0.4	1.1	0.4	0.8	0.1	1.1	0.6	0.4	0.2	0.3	0.5	0.7	0.4	0.8	0.0	0.7	0.2	0.7	0.0	0.2	0.0	0.4	1.0	1.6	1.2	0.2	0.3	0.7	0.2	0.9	17.5	9.7	4.0	0.1	2.2	0.9	1.3	0.6	1.5	1.5	1.1	1.5	1.2	1.6	0.6	0.1	1.9	2.3	1.2	0.1	0.4	0.6	2.0	2.1	0.1										
LRRC7	"densin-180, KIAA1365"	ENSG00000033122	"Leucine rich repeat containing 7"	Q96NW7	1	69568398-70151945	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"brain: 29.1"	"Group enriched"	"Detected in some"	6	"HaCaT: 10.3;HEL: 30.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	6	"eosinophil: 1.4;naive CD4 T-cell: 1.7;naive CD8 T-cell: 1.3"	"Group enriched"	"Detected in many"	14	"granulocytes: 1.4;T-cells: 1.7"	"Low region specificity"	"Detected in many"							HPA005625			Supported	"Nucleoplasm,Plasma membrane,Centrosome,Cytosol"				"Plasma membrane, Cytosol"	"Nucleoplasm, Centrosome"	"HPA005625: AB_1853340"	"unprognostic (2.81e-2)"	"unprognostic (1.62e-2)"	"unprognostic (1.51e-1)"	"unprognostic (2.98e-3)"	"unprognostic (2.47e-1)"	"unprognostic (1.73e-1)"	"unprognostic (1.04e-1)"	"unprognostic (3.50e-2)"	"unprognostic (4.84e-3)"	"unprognostic (2.92e-2)"	"unprognostic (1.06e-3)"	"unprognostic (1.46e-1)"	"unprognostic (5.64e-6)"	"unprognostic (1.31e-2)"	"unprognostic (1.74e-2)"	"unprognostic (5.13e-3)"	"unprognostic (2.08e-3)"	1.0	1.3	20.2	1.0	29.1	1.0	0.8	0.5	21.9	1.2	1.9	5.0	0.0	1.0	1.2	1.0	1.3	0.8	3.2	2.8	15.4	5.8	2.8	1.2	0.8	0.9	4.4	17.6	1.0	2.7	0.7	0.4	1.2	2.4	1.5	2.4	0.2	0.9	1.1	2.8	1.1	1.3	1.2	2.5	0.8	0.8	5.8	7.6	0.0	6.7	0.0	0.8	0.9	0.5	0.0	0.1	1.4	0.0	0.0	1.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.3	3.3	0.0	10.3	0.2	0.0	0.0	0.0	0.5	30.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	3.5	0.4	0.3	0.0	0.0	0.0	0.0	0.0	1.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.6	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	1.7	1.3	0.0	0.0	0.0	0.0	0.0	0.1	20.2	29.1	0.5	19.2	15.4	5.8	4.4	17.6	2.4	7.6
LRRFIP2	HUFI-2	ENSG00000093167	"LRR binding FLII interacting protein 2"	Q9Y608	3	37052656-37183689	"Predicted intracellular proteins, Transcription factors"	"Wnt signaling pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035956, HPA042023"	Uncertain		Approved	"Plasma membrane,Actin filaments"			1000000	"Plasma membrane, Actin filaments"		"HPA035956: AB_10671238, HPA042023: "	"unprognostic (2.03e-3)"	"prognostic favourable (6.31e-4)"	"unprognostic (1.16e-2)"	"unprognostic (7.90e-2)"	"unprognostic (2.48e-1)"	"unprognostic (2.97e-1)"	"unprognostic (5.41e-2)"	"unprognostic (1.82e-1)"	"unprognostic (3.09e-2)"	"unprognostic (2.56e-2)"	"unprognostic (4.99e-3)"	"unprognostic (1.98e-1)"	"unprognostic (4.13e-3)"	"unprognostic (2.62e-1)"	"unprognostic (1.37e-1)"	"unprognostic (4.84e-3)"	"unprognostic (3.76e-2)"	15.4	17.3	23.0	17.5	22.0	27.5	21.9	30.0	22.8	35.7	35.8	26.5	17.7	24.7	28.2	20.0	33.0	15.7	22.8	47.4	23.8	25.3	19.8	33.9	18.7	19.3	24.2	19.4	20.6	16.9	33.9	18.3	16.9	24.4	30.3	24.8	19.6	19.3	19.5	58.5	23.2	37.1	27.3	31.2	29.7	17.0	47.2	24.8	11.6	20.6	33.6	21.6	23.7	25.1	7.1	9.8	22.7	17.2	11.9	8.8	7.5	15.3	8.6	9.9	7.8	13.3	20.4	8.7	41.9	41.8	23.7	27.2	8.0	7.1	6.1	6.9	40.4	8.0	7.2	20.7	38.8	13.5	5.7	10.9	12.2	7.8	19.0	8.6	6.6	9.0	14.9	30.8	31.9	16.3	8.6	10.7	19.6	3.9	7.3	4.6	6.5	11.0	3.5	28.3	6.1	16.6	6.0	3.6	5.7	16.2	15.0	13.5	8.6	8.9	15.7	18.2	12.2	26.6	19.7	8.3	14.9	9.3	10.7	7.7	25.7	12.2	15.0	22.7	6.6	10.4	8.5	7.1	7.0	7.0	9.8	5.4	5.2	6.2	14.0	11.9	17.2	5.5	8.8	7.5	23.0	22.0	30.0	22.8	23.8	25.3	24.2	19.4	24.4	24.8
LRRIQ3	"LRRC44, MGC22773"	ENSG00000162620	"Leucine rich repeats and IQ motif containing 3"	A6PVS8	1	74026015-74198187	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"testis: 34.1"	"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA030799	Approved		Approved	"Nucleoplasm,Plasma membrane"				"Plasma membrane"	Nucleoplasm	"HPA030799: AB_10601337"	"unprognostic (5.94e-3)"	"unprognostic (6.00e-2)"	"unprognostic (6.49e-3)"	"unprognostic (1.63e-1)"	"unprognostic (6.62e-2)"	"unprognostic (2.78e-1)"	"unprognostic (2.27e-2)"	"unprognostic (2.27e-1)"	"unprognostic (8.17e-2)"	"unprognostic (2.44e-1)"	"unprognostic (1.12e-3)"	"unprognostic (1.71e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.88e-2)"	"unprognostic (4.65e-2)"	1.8	1.3	0.9	0.9	2.7	0.2	0.9	0.3	1.5	0.8	0.4	1.1	0.1	0.3	0.4	1.2	0.6	2.8	0.6	0.6	1.0	1.1	3.5	1.7	1.6	0.9	2.5	1.4	2.5	0.6	2.1	7.2	0.3	2.4	0.6	0.3	0.6	0.8	0.6	0.4	0.3	0.4	0.2	1.3	1.6	0.5	34.1	1.0	1.4	1.9	0.0	0.8	0.5	0.4	3.9	1.1	1.9	1.1	1.1	4.0	0.9	0.4	1.9	0.3	0.8	2.1	0.8	1.3	1.2	0.9	1.7	1.8	0.2	2.8	2.8	2.5	0.2	0.3	4.3	4.0	2.1	6.8	0.1	2.5	0.6	1.3	0.3	4.4	1.4	1.4	2.2	2.9	1.1	0.8	2.1	3.9	2.7	0.0	1.7	0.7	2.2	1.3	2.1	1.6	2.8	2.5	0.3	2.1	1.4	0.3	0.3	6.0	1.7	2.5	0.3	0.3	1.4	1.0	2.3	4.0	1.4	2.2	3.0	0.5	2.2	0.0	0.2	1.9	2.3	1.1	2.9	3.9	2.6	2.9	0.3	2.0	2.5	3.5	0.0	1.1	0.3	1.1	4.0	0.9	0.9	2.7	0.3	1.5	1.0	1.1	2.5	1.4	2.4	1.0
LSR	"ILDR3, LISCH7"	ENSG00000105699	"Lipolysis stimulated lipoprotein receptor"	Q86X29	19	35248330-35267964	"Predicted intracellular proteins, Predicted membrane proteins"		Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 106.3;pancreas: 98.6"	"Cell line enhanced"	"Detected in many"		"A-431: 89.3;CACO-2: 39.1;CAPAN-2: 41.6;HaCaT: 37.5;RT4: 36.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007270	Approved		Approved	"Nucleoplasm,Plasma membrane,Cytosol"			2100000	"Nucleoplasm, Cytosol"	"Plasma membrane"	"HPA007270: AB_1079253"	"unprognostic (3.90e-1)"	"unprognostic (1.12e-1)"	"unprognostic (2.34e-2)"	"unprognostic (2.67e-3)"	"unprognostic (2.28e-2)"	"unprognostic (6.07e-3)"	"unprognostic (1.55e-1)"	"unprognostic (9.84e-2)"	"unprognostic (2.17e-1)"	"unprognostic (2.70e-2)"	"unprognostic (2.23e-2)"	"unprognostic (3.42e-2)"	"prognostic favourable (8.09e-4)"	"unprognostic (1.64e-1)"	"unprognostic (1.84e-1)"	"unprognostic (2.99e-2)"	"unprognostic (1.54e-2)"	5.0	11.2	2.9	20.9	4.0	0.9	12.4	2.0	4.5	8.7	32.8	4.0	24.4	29.5	6.5	21.4	20.3	10.6	58.2	2.6	3.4	3.1	15.7	106.3	21.1	17.0	4.1	2.6	4.8	98.6	6.2	13.4	36.6	7.1	11.2	15.4	40.9	26.2	33.8	1.9	16.8	39.5	1.8	3.8	9.1	46.7	21.0	1.9	3.4	24.0	20.1	20.9	9.9	9.5	5.3	0.3	5.9	0.2	6.1	7.1	3.2	89.3	1.5	0.1	0.2	0.2	0.1	16.2	0.2	0.3	0.4	0.3	39.1	41.6	3.5	13.8	0.2	37.5	8.3	13.7	0.0	5.4	15.1	0.0	1.2	17.3	0.3	0.0	0.1	0.2	15.3	0.3	4.5	0.1	14.1	3.2	0.2	31.7	0.1	0.1	12.8	0.5	0.7	0.1	9.7	8.6	36.2	7.1	0.2	7.5	24.4	6.7	20.9	0.5	0.0	0.7	8.6	0.5	0.4	5.1	9.0	8.1	0.6	0.1	2.2	5.9	0.2	0.2	3.3	0.0	3.3	5.3	7.1	6.7	0.1	4.1	5.5	6.0	0.1	6.1	0.0	0.3	4.8	3.2	2.9	4.0	2.0	4.5	3.4	3.1	4.1	2.6	7.1	1.9
LUZP2		ENSG00000187398	"Leucine zipper protein 2"	Q86TE4	11	24496970-25082631	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"adrenal gland: 11.1;brain: 32.7"	"Group enriched"	"Detected in some"	4	"HaCaT: 14.3;HAP1: 7.1"	"Group enriched"	"Detected in some"	7	"glioma: 3.5;prostate cancer: 4.5"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"neutrophil: 1.9"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"							"HPA039007, HPA046161"	Enhanced	Supported	Approved	"Nucleoplasm,Plasma membrane,Cytosol"	"Secreted in brain"			"Nucleoplasm, Cytosol"	"Plasma membrane"	"HPA039007: , HPA046161: "	"unprognostic (4.49e-2)"	"unprognostic (2.74e-2)"	"unprognostic (8.63e-2)"	"unprognostic (3.50e-1)"	"unprognostic (5.22e-3)"	"unprognostic (3.38e-1)"	"unprognostic (4.88e-2)"	"unprognostic (5.67e-4)"	"unprognostic (2.40e-1)"	"unprognostic (5.66e-2)"	"unprognostic (6.16e-3)"	"unprognostic (4.09e-2)"	"unprognostic (5.18e-3)"	"unprognostic (9.41e-3)"	"unprognostic (4.18e-2)"	"unprognostic (2.17e-1)"	"unprognostic (9.64e-2)"	1.2	11.1	14.5	0.9	10.8	0.9	1.6	2.6	32.7	0.9	2.1	5.9	0.0	0.9	1.0	0.8	0.9	0.8	1.0	1.0	10.3	13.8	1.0	2.3	1.1	0.8	13.7	5.6	0.8	0.8	0.7	1.9	0.8	26.7	4.5	1.7	0.0	1.0	0.9	0.8	0.9	1.1	1.2	30.0	0.9	0.9	1.6	14.5	0.0	0.8	0.9	0.8	1.6	0.3	0.5	0.4	1.9	0.3	0.3	0.3	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	14.3	7.1	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.6	0.3	0.0	0.2	0.2	0.0	1.5	0.1	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	1.5	0.3	0.4	0.2	0.1	0.2	0.2	0.1	0.3	0.1	0.5	0.3	0.2	1.9	0.3	0.2	0.4	0.1	0.0	14.5	10.8	2.6	9.3	10.3	13.8	13.7	5.6	26.7	14.5
LYST	"CHS, CHS1"	ENSG00000143669	"Lysosomal trafficking regulator"	Q99698	1	235661041-235883640	"Disease related genes, Predicted intracellular proteins"	"Protein transport, Transport"		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 38.8"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 13.4;SK-MEL-30: 12.4;THP-1: 43.9;U-937: 16.8"	"Cancer enhanced"	"Detected in all"		"melanoma: 11.1"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 13.0"	"Group enriched"	"Detected in all"	5	"granulocytes: 13.0;monocytes: 5.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA053366, HPA055725"			Supported	"Nucleoplasm,Plasma membrane,Centriolar satellite"				Nucleoplasm	"Plasma membrane, Centriolar satellite"	"HPA053366: , HPA055725: "	"unprognostic (1.56e-2)"	"unprognostic (1.54e-1)"	"unprognostic (9.92e-2)"	"unprognostic (8.85e-2)"	"unprognostic (1.96e-2)"	"unprognostic (4.32e-2)"	"unprognostic (4.11e-2)"	"unprognostic (7.79e-2)"	"unprognostic (4.08e-2)"	"unprognostic (1.95e-1)"	"unprognostic (1.55e-1)"	"unprognostic (9.31e-2)"	"prognostic unfavourable (5.27e-5)"	"unprognostic (1.59e-1)"	"unprognostic (1.54e-1)"	"unprognostic (6.29e-2)"	"unprognostic (1.99e-1)"	10.3	5.2	6.4	9.0	8.8	31.3	10.6	10.5	7.1	8.8	5.3	3.8	3.4	3.4	6.8	4.3	6.6	5.6	5.8	4.7	4.3	2.4	5.0	6.1	10.9	7.8	4.2	6.0	6.2	5.0	9.1	12.6	5.5	5.3	6.0	5.0	9.6	8.2	4.8	3.9	11.7	6.3	9.8	9.2	11.3	8.4	6.4	6.3	38.8	8.5	4.0	7.6	9.3	10.6	1.6	1.7	13.0	5.9	1.7	1.0	0.7	3.7	0.8	0.4	0.9	5.9	6.8	0.6	1.4	5.6	1.5	1.4	0.0	1.0	0.5	0.5	3.0	1.8	0.5	0.7	1.3	13.4	1.2	1.2	0.8	0.3	1.0	1.8	1.6	2.2	3.6	1.8	4.6	1.2	0.1	0.8	1.1	0.1	2.3	3.8	0.1	0.4	0.1	0.5	0.0	4.3	4.1	2.4	0.5	1.5	0.0	12.4	0.5	43.9	2.6	1.1	0.5	1.2	1.2	0.9	0.0	0.0	1.9	16.8	3.1	0.4	3.1	5.7	0.6	3.5	1.0	1.1	0.3	0.7	1.7	1.6	0.2	0.5	13.0	1.7	5.9	0.2	0.2	0.7	6.4	8.8	10.5	7.1	4.3	2.4	4.2	6.0	5.3	6.3
LZTS1	FEZ1	ENSG00000061337	"Leucine zipper tumor suppressor 1"	Q9Y250	8	20246165-20303963	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle"		"Tumor suppressor"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"brain: 19.0;parathyroid gland: 64.9"	"Cell line enhanced"	"Detected in some"		"SK-MEL-30: 35.9;U-698: 11.0;WM-115: 24.3"	"Cancer enhanced"	"Detected in all"		"melanoma: 59.2"	"Group enriched"	"Detected in many"	5	"amygdala: 13.3;basal ganglia: 19.0;cerebral cortex: 19.0;hippocampal formation: 8.9;olfactory region: 8.8"	"Cell type enhanced"	"Detected in single"		"gdT-cell: 2.2"	"Low lineage specificity"	"Detected in single"			"Group enriched"	"Detected in many"	5	"amygdala: 47.8;basal ganglia: 76.8;cerebral cortex: 46.2;hippocampal formation: 41.3;olfactory region: 26.1"	"Group enriched"	"Detected in many"	10	"amygdala: 28.4;basal ganglia: 66.4;cerebral cortex: 45.3;hippocampal formation: 38.6;olfactory region: 47.4"	"HPA006294, HPA022046"	Approved		Approved	"Nucleoli,Plasma membrane"				"Plasma membrane"	Nucleoli	"HPA006294: AB_1079288, HPA022046: AB_1853455"	"unprognostic (7.76e-2)"	"unprognostic (1.02e-1)"	"unprognostic (3.49e-3)"	"prognostic unfavourable (3.03e-4)"	"unprognostic (6.27e-2)"	"unprognostic (1.96e-1)"	"unprognostic (7.29e-2)"	"unprognostic (5.76e-2)"	"unprognostic (1.41e-2)"	"unprognostic (9.06e-3)"	"unprognostic (6.81e-2)"	"unprognostic (3.63e-2)"	"prognostic unfavourable (9.28e-6)"	"unprognostic (3.35e-2)"	"unprognostic (2.71e-1)"	"unprognostic (1.11e-1)"	"unprognostic (6.82e-3)"	2.4	2.1	13.3	1.8	19.0	0.8	1.9	0.6	19.0	1.6	1.1	2.2	0.4	1.1	2.2	1.5	3.5	1.4	3.5	2.3	8.9	2.6	1.9	1.1	4.0	1.5	2.5	8.8	1.7	1.6	64.9	1.4	5.8	1.9	1.7	1.1	10.3	1.3	1.7	1.6	4.2	1.2	2.7	0.8	1.1	1.3	6.6	1.5	0.3	2.0	0.9	1.1	1.9	1.0	0.2	0.1	0.7	0.1	0.1	2.2	0.5	0.0	0.0	4.7	4.0	0.0	0.0	0.5	2.3	0.0	2.0	1.8	0.1	0.0	5.2	1.7	1.4	0.1	0.2	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.8	0.5	0.0	0.8	0.0	0.0	0.0	0.0	6.9	0.0	9.0	0.0	5.9	0.0	0.0	7.5	0.0	1.3	0.2	7.2	6.2	0.0	0.0	35.9	0.0	0.2	0.0	2.5	1.7	0.0	0.7	0.0	0.0	11.0	0.0	0.5	24.3	0.2	0.1	0.0	2.2	0.0	0.8	0.0	0.7	0.4	0.0	0.2	0.2	0.3	0.7	0.1	0.0	0.1	0.0	0.5	13.3	19.0	0.6	19.0	8.9	2.6	2.5	8.8	1.9	1.5
MADD	"DENN, KIAA0358, RAB3GEP"	ENSG00000110514	"MAP kinase activating death domain"	Q8WXG6	11	47269161-47330031	"Predicted intracellular proteins, Predicted membrane proteins"	Apoptosis	"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 66.3"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 20.8"	"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038568	Uncertain		Supported	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		"HPA038568: AB_10795030"	"unprognostic (3.16e-1)"	"unprognostic (1.81e-1)"	"unprognostic (8.51e-3)"	"prognostic favourable (6.62e-5)"	"unprognostic (1.27e-1)"	"unprognostic (6.36e-3)"	"unprognostic (4.82e-3)"	"unprognostic (1.16e-1)"	"unprognostic (1.91e-1)"	"unprognostic (3.78e-2)"	"prognostic favourable (5.69e-5)"	"unprognostic (1.53e-1)"	"unprognostic (3.55e-1)"	"unprognostic (8.07e-2)"	"unprognostic (1.06e-1)"	"unprognostic (2.76e-1)"	"prognostic favourable (8.25e-4)"	7.7	18.2	18.3	11.5	27.6	16.9	8.7	66.3	46.5	9.2	10.8	15.5	13.1	8.6	9.4	8.9	6.9	9.4	8.6	13.8	20.2	18.4	9.8	7.7	11.0	13.2	15.5	19.8	14.0	12.2	18.8	26.7	11.2	20.7	12.5	12.0	16.0	10.2	14.0	16.1	14.0	9.8	10.5	11.3	12.3	13.2	19.4	11.0	14.6	8.4	6.0	12.2	11.0	7.8	3.5	4.1	20.8	5.8	4.5	5.7	4.4	6.3	13.3	14.6	13.0	10.0	7.0	3.3	9.0	12.1	11.5	12.5	9.7	6.0	13.6	2.9	9.9	12.7	11.8	6.3	10.0	15.0	12.0	24.1	24.7	8.3	7.2	16.3	33.2	6.7	6.8	6.0	7.6	10.5	15.4	10.0	10.1	9.0	7.7	17.6	8.7	9.2	10.6	23.5	8.9	5.9	30.6	23.1	15.1	11.6	13.7	7.9	10.8	12.4	8.9	10.8	6.8	15.3	6.0	11.9	12.3	7.7	10.0	11.6	10.1	20.8	2.6	4.8	4.8	4.6	4.2	3.5	3.4	4.0	4.1	3.3	4.0	3.1	0.7	4.5	5.8	2.2	5.7	4.4	18.3	27.6	66.3	44.6	20.2	18.4	15.5	19.8	20.7	11.0
MAMDC2	MGC21981	ENSG00000165072	"MAM domain containing 2"	Q7Z304	9	70043581-70226970	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"ASC diff: 22.6;HHSteC: 23.6;LHCN-M2: 29.4;TIME: 28.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Cell type enriched"	"Detected in single"	4	"NK-cell: 2.6"	"Lineage enriched"	"Detected in single"	4	"NK-cells: 2.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA021814, HPA022249"	Uncertain		Approved	"Nuclear speckles,Plasma membrane"	"Secreted in other tissues"			"Nuclear speckles, Plasma membrane"		"HPA021814: AB_1853508, HPA022249: AB_2139157"	"unprognostic (1.88e-1)"	"unprognostic (3.16e-3)"	"unprognostic (2.21e-3)"	"unprognostic (2.71e-2)"	"unprognostic (4.30e-2)"	"unprognostic (8.49e-2)"	"unprognostic (1.27e-2)"	"unprognostic (8.25e-2)"	"unprognostic (5.91e-2)"	"unprognostic (3.65e-2)"	"unprognostic (1.92e-1)"	"unprognostic (3.67e-1)"	"unprognostic (3.03e-2)"	"unprognostic (4.23e-3)"	"unprognostic (2.35e-1)"	"prognostic unfavourable (7.78e-4)"	"unprognostic (2.79e-3)"	9.0	4.3	0.6	11.1	0.5	0.0	14.7	0.6	0.8	32.3	27.7	0.3	9.1	4.3	40.7	33.7	31.6	28.7	44.9	13.5	0.6	0.6	2.0	1.0	42.4	2.3	0.7	0.8	35.5	2.4	1.0	0.8	2.6	1.3	13.9	6.6	16.1	5.4	10.8	15.5	5.0	14.2	46.3	2.6	12.0	10.7	20.0	0.0	0.3	6.8	24.6	6.1	36.4	27.5	0.0	0.3	0.0	0.0	2.6	0.6	0.0	0.1	0.0	0.2	0.0	22.6	7.7	0.7	4.4	1.9	1.0	1.8	0.0	0.5	0.0	0.3	0.8	3.6	0.0	0.3	0.9	0.0	0.0	0.0	7.3	0.0	23.6	0.0	0.0	1.4	0.2	0.6	0.4	1.9	0.0	0.2	29.4	0.0	0.0	0.0	3.1	0.0	0.0	3.5	2.7	9.9	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	28.3	0.0	0.8	0.0	0.8	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.6	0.3	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.6	0.5	0.6	0.8	0.6	0.6	0.7	0.8	1.3	0.0
MAP2K7	"Jnkk2, MKK7, PRKMK7"	ENSG00000076984	"Mitogen-activated protein kinase kinase 7"	O14733	19	7903843-7914478	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Apoptosis, Stress response"	"Kinase, Serine/threonine-protein kinase, Transferase, Tyrosine-protein kinase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA001633, CAB004262, HPA064711"	Supported		Approved	"Golgi apparatus,Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"	"Golgi apparatus"	"CAB004262: AB_627925, HPA001633: AB_1079516, HPA064711: "	"unprognostic (1.77e-1)"	"unprognostic (5.04e-2)"	"unprognostic (1.06e-2)"	"unprognostic (2.16e-1)"	"unprognostic (4.24e-2)"	"prognostic favourable (8.54e-5)"	"unprognostic (1.80e-3)"	"unprognostic (2.55e-1)"	"unprognostic (2.69e-2)"	"unprognostic (1.69e-2)"	"unprognostic (1.27e-3)"	"unprognostic (1.56e-1)"	"unprognostic (3.54e-2)"	"unprognostic (3.71e-2)"	"unprognostic (6.05e-2)"	"unprognostic (1.73e-2)"	"prognostic favourable (1.56e-4)"	16.3	14.9	13.5	16.4	16.4	23.8	13.6	28.7	21.5	14.3	15.6	23.2	15.1	19.3	19.1	9.9	13.6	13.1	14.3	15.8	14.6	11.9	12.8	15.9	12.5	15.9	17.2	13.9	18.4	22.3	13.9	17.0	16.4	16.2	14.4	7.9	14.2	23.0	13.4	61.6	21.3	18.7	14.1	12.5	19.4	14.8	21.5	16.5	9.8	13.7	17.3	12.8	15.4	15.2	3.0	2.6	4.8	2.7	3.3	2.5	1.0	12.7	7.3	6.4	10.4	5.1	5.0	11.9	8.4	4.1	5.7	6.0	10.5	7.8	15.2	13.6	4.4	11.7	5.5	6.4	2.2	12.1	27.4	10.7	9.7	7.8	6.6	9.9	13.6	5.7	8.4	4.5	5.2	5.2	15.6	20.0	3.3	6.7	14.2	24.2	11.2	16.5	14.1	6.9	15.4	5.1	10.7	11.7	11.8	5.7	10.1	11.7	10.8	11.4	7.7	17.5	10.0	12.3	11.3	29.0	13.4	14.3	8.7	14.7	7.0	0.0	2.7	1.9	2.3	2.5	1.5	2.1	1.9	2.0	1.3	3.0	1.7	2.5	4.8	3.3	1.5	2.6	0.7	1.0	13.5	16.4	28.7	21.5	14.6	11.9	17.2	13.9	16.2	16.5
MAP3K21	"KIAA1804, MLK4"	ENSG00000143674	"Mitogen-activated protein kinase kinase kinase 21"	Q5TCX8	1	233327768-233385148	"Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pancreas: 28.9"	"Cell line enhanced"	"Detected in many"		"HEK 293: 18.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	6	"NK-cell: 5.0"	"Lineage enriched"	"Detected in single"	6	"NK-cells: 5.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA007636	Uncertain		Approved	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		"HPA007636: AB_1079392"	"unprognostic (3.29e-2)"	"unprognostic (5.10e-2)"	"unprognostic (2.00e-1)"	"unprognostic (2.42e-3)"	"unprognostic (4.30e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.82e-2)"	"unprognostic (1.84e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.25e-1)"	"unprognostic (2.09e-1)"	"unprognostic (8.21e-2)"	"unprognostic (3.76e-2)"	"unprognostic (2.23e-1)"	"unprognostic (1.71e-1)"	"unprognostic (9.22e-2)"	"unprognostic (4.84e-2)"	0.6	3.2	2.0	3.4	2.2	1.3	2.2	10.0	3.3	1.5	11.4	0.6	9.1	9.9	0.8	5.2	2.4	3.9	3.9	0.7	1.3	2.1	12.5	13.3	5.6	0.5	0.9	1.7	0.8	28.9	4.4	2.6	1.0	1.2	1.3	6.0	1.0	3.7	2.5	0.4	2.7	17.2	0.3	0.9	0.7	10.1	12.4	0.6	0.5	2.4	0.8	1.3	1.1	1.6	0.5	0.8	0.1	0.3	5.0	0.2	0.1	7.3	12.5	0.2	0.0	0.0	0.0	6.3	0.2	0.0	0.3	0.5	6.9	6.4	0.7	5.2	0.1	3.9	9.4	3.8	0.8	13.6	18.0	0.1	7.0	0.0	0.4	11.9	2.9	0.1	5.1	0.2	7.3	0.4	0.1	2.4	0.0	1.6	3.8	4.3	8.9	5.5	0.0	0.0	13.1	8.6	3.1	9.2	2.5	4.3	0.2	0.0	3.7	3.8	0.0	0.0	1.2	0.0	7.3	2.2	2.8	0.0	1.2	3.3	0.3	0.0	0.3	0.0	0.0	0.1	0.0	0.3	0.2	0.1	0.8	0.5	0.0	0.0	0.1	5.0	0.0	0.2	0.2	0.1	2.0	2.2	10.0	3.3	1.3	2.1	0.9	1.7	1.2	0.6
MAP3K6	"ASK2, MAPKKK6, MEKK6"	ENSG00000142733	"Mitogen-activated protein kinase kinase kinase 6"	O95382	1	27355184-27366892	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skin 1: 63.9"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			HPA051192	Approved		Approved	"Nucleoplasm,Plasma membrane,Actin filaments,Cytosol"				Nucleoplasm	"Plasma membrane, Actin filaments, Cytosol"	"HPA051192: "	"unprognostic (1.19e-2)"	"unprognostic (2.77e-3)"	"unprognostic (2.62e-2)"	"unprognostic (1.97e-2)"	"prognostic unfavourable (2.13e-4)"	"prognostic favourable (7.26e-4)"	"prognostic unfavourable (8.76e-4)"	"unprognostic (9.10e-2)"	"unprognostic (2.79e-1)"	"unprognostic (6.91e-2)"	"unprognostic (6.56e-2)"	"unprognostic (1.25e-1)"	"unprognostic (4.65e-3)"	"unprognostic (4.95e-2)"	"unprognostic (2.79e-1)"	"unprognostic (7.07e-3)"	"unprognostic (1.50e-1)"	37.5	6.3	7.4	6.9	8.6	1.3	22.1	12.6	8.3	19.9	9.0	2.7	8.9	3.3	13.1	10.3	25.7	12.8	12.4	14.9	6.2	2.6	13.6	5.0	21.7	5.5	11.4	1.9	11.7	8.3	8.2	15.8	7.3	9.8	13.9	5.9	15.7	11.5	9.7	6.3	63.9	6.2	16.0	11.7	8.7	9.0	6.7	7.0	0.6	12.0	16.1	14.3	14.3	18.3	2.7	3.3	5.1	6.9	1.1	7.6	2.4	7.4	6.9	6.2	6.9	8.7	15.3	1.6	9.3	5.4	7.0	5.3	2.0	10.0	0.1	8.3	14.1	11.8	2.1	6.5	3.5	6.2	5.1	0.5	16.0	3.1	2.7	0.5	0.6	12.2	15.9	7.3	2.6	4.7	2.3	4.1	11.1	18.4	0.3	8.4	1.9	5.7	2.7	4.1	1.7	10.5	7.8	2.3	3.4	9.8	8.6	7.3	4.6	6.4	9.8	17.6	7.4	19.7	4.8	3.3	4.1	0.1	15.6	6.1	5.1	1.8	1.5	5.1	5.3	3.3	7.6	2.7	5.5	5.9	3.3	2.3	4.4	3.6	2.4	1.1	6.9	0.0	5.6	2.4	7.4	8.6	12.6	8.3	6.2	2.6	11.4	1.9	9.8	7.0
MAP4K5	"GCKR, KHS, KHS1"	ENSG00000012983	"Mitogen-activated protein kinase kinase kinase kinase 5"		14	50418501-50561126	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"				"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 26.1"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 26.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036696	Uncertain		Approved	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		"HPA036696: AB_10672362"	"unprognostic (1.39e-1)"	"unprognostic (1.00e-1)"	"unprognostic (3.80e-1)"	"unprognostic (1.66e-1)"	"unprognostic (4.41e-2)"	"unprognostic (1.43e-1)"	"unprognostic (8.58e-3)"	"unprognostic (4.13e-2)"	"unprognostic (6.31e-2)"	"unprognostic (2.24e-2)"	"unprognostic (1.53e-3)"	"unprognostic (7.34e-2)"	"unprognostic (1.78e-2)"	"unprognostic (3.71e-2)"	"unprognostic (1.40e-1)"	"unprognostic (9.58e-3)"	"unprognostic (2.02e-2)"	17.4	11.8	23.4	12.1	44.4	16.5	19.7	24.6	32.3	25.8	17.1	43.5	13.4	11.3	29.9	12.1	18.7	17.4	19.3	10.3	24.4	14.0	10.9	8.7	15.2	9.9	48.8	17.1	29.9	13.3	16.7	17.5	17.3	26.0	16.6	15.1	9.1	16.9	19.9	10.7	24.8	12.7	22.3	30.7	13.0	14.4	6.8	51.1	8.4	15.3	8.7	11.2	19.3	21.2	5.0	2.7	26.1	1.8	5.4	3.9	1.0	23.1	7.0	17.1	14.7	15.9	16.7	16.8	27.3	24.7	18.6	16.6	8.8	16.3	16.0	16.3	25.0	16.6	15.9	14.7	28.5	13.2	11.6	9.8	12.3	7.9	13.5	8.7	15.5	12.1	12.1	16.4	17.2	24.4	9.2	10.5	27.3	8.7	11.8	8.4	8.3	13.8	14.3	26.1	6.0	18.4	18.1	5.5	12.6	15.4	10.8	10.6	12.0	6.7	24.8	24.3	17.0	16.5	12.8	7.7	7.8	10.7	9.1	6.1	17.3	26.1	1.5	13.5	3.9	1.8	2.2	3.2	2.4	3.3	1.6	5.0	2.6	2.7	0.6	5.4	1.1	2.7	0.5	1.0	23.4	44.4	24.6	32.3	24.4	14.0	48.8	17.1	26.0	51.1
MARCH10	"FLJ35757, MARCH-X, RNF190"	ENSG00000173838	"Membrane associated ring-CH-type finger 10"	Q8NA82	17	62701314-62808344	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	10	"testis: 80.2"	"Cell line enhanced"	"Detected in some"		"BEWO: 3.8;EFO-21: 7.2;HSkMC: 3.2;SCLC-21H: 12.4"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"gdT-cell: 3.4"	"Lineage enriched"	"Detected in single"	5	"T-cells: 3.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA023322	Enhanced		Approved	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		"HPA023322: AB_1856351"	"unprognostic (2.79e-2)"	"unprognostic (2.32e-1)"	"unprognostic (9.60e-3)"	"unprognostic (6.95e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.21e-1)"		"unprognostic (1.03e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.39e-1)"	"unprognostic (7.99e-4)"	"unprognostic (3.16e-1)"	"unprognostic (2.85e-3)"	"unprognostic (1.38e-1)"	"unprognostic (4.83e-2)"	"unprognostic (9.37e-3)"	"unprognostic (2.66e-1)"	0.2	0.1	0.7	0.2	1.6	0.0	0.1	0.1	0.3	0.5	0.1	1.9	0.6	0.0	0.3	4.8	0.1	7.9	0.1	0.1	1.0	1.0	0.6	0.1	1.4	0.1	0.2	0.5	1.0	0.1	0.3	4.5	0.1	1.8	0.1	0.0	0.2	0.2	0.1	0.1	0.1	0.1	0.1	0.2	0.1	0.0	80.2	0.3	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.7	0.0	0.0	0.6	3.4	0.3	0.1	0.0	0.2	0.0	0.0	0.2	3.8	1.6	0.2	1.2	0.3	0.0	0.1	0.0	7.2	0.5	0.0	0.0	0.4	1.3	0.0	0.0	1.2	0.7	0.0	1.5	0.0	0.0	3.2	0.0	0.3	0.0	0.0	0.0	0.0	0.8	1.4	0.1	0.1	0.3	0.2	0.0	0.0	0.2	1.1	0.0	12.4	0.0	0.0	0.7	0.1	0.2	0.0	0.0	0.0	0.7	0.1	1.4	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	3.4	0.0	1.5	0.0	0.7	0.3	0.7	0.1	0.6	1.8	0.0	0.6	0.0	0.0	0.7	0.3	0.7	1.6	0.1	0.3	1.0	1.0	0.2	0.5	1.8	0.3
MAS1L	"dJ994E9.2, MAS-L, MRG"	ENSG00000204687	"MAS1 proto-oncogene like, G protein-coupled receptor"	P35410	6	29486697-29487956	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"cervix, uterine: 7.5;epididymis: 4.0"	"Cell line enriched"	"Detected in single"	39	"HEL: 3.8"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA017983	Uncertain		Approved	"Nucleoplasm,Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"	Nucleoplasm	"HPA017983: AB_1849332"	"unprognostic (3.66e-2)"										"unprognostic (2.51e-1)"	"unprognostic (2.30e-2)"	"unprognostic (5.22e-2)"	"unprognostic (1.65e-1)"				2.1	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	7.5	1.3			0.4	1.2	4.0	2.1	0.2	1.2	0.4	0.0	0.0	0.1	0.1	0.3	0.1	0.0		0.0	0.1	0.0	0.0	0.0		0.8	1.1		1.5	0.3	0.2	1.7	1.5	1.1	0.0	0.0	0.5	0.3			0.0		0.5	0.6	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
MAT2B	"MATIIbeta, SDR23E1"	ENSG00000038274	"Methionine adenosyltransferase 2B"	Q9NZL9	5	163503114-163519336	"Predicted intracellular proteins"	"One-carbon metabolism"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037721, HPA037722"	Uncertain		Approved	"Plasma membrane"			1000000	"Plasma membrane"		"HPA037721: AB_10672389, HPA037722: AB_10671718"	"unprognostic (1.22e-2)"	"unprognostic (2.80e-2)"	"unprognostic (1.80e-3)"	"unprognostic (1.64e-1)"	"unprognostic (5.06e-1)"	"unprognostic (2.12e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.77e-1)"	"unprognostic (9.72e-2)"	"unprognostic (1.68e-1)"	"unprognostic (5.19e-3)"	"unprognostic (3.57e-2)"	"prognostic favourable (4.51e-7)"	"unprognostic (1.06e-1)"	"unprognostic (1.09e-2)"	"unprognostic (2.16e-2)"	"unprognostic (1.37e-3)"	25.1	32.5	25.2	29.1	28.6	12.1	23.9	37.1	39.6	25.3	41.6	20.1	25.1	38.9	28.0	29.0	27.9	31.9	20.4	41.8	24.2	28.6	48.4	37.2	26.6	41.7	24.7	24.9	35.9	16.4	25.7	17.1	23.9	27.6	30.7	31.4	24.3	28.6	26.8	28.7	20.9	57.2	21.3	21.4	45.5	24.9	18.1	17.7	50.8	53.3	20.1	41.0	32.5	32.9	60.4	34.5	82.4	46.0	62.4	86.8	98.8	19.2	16.8	29.5	16.0	21.9	21.8	17.7	17.2	19.7	19.9	29.1	11.7	36.7	20.6	36.3	18.8	15.9	24.4	35.8	26.3	67.9	20.2	18.7	19.6	17.4	28.8	19.7	12.7	18.1	29.6	25.2	19.6	43.0	14.9	26.0	24.3	11.3	27.1	23.6	11.1	11.4	31.2	14.3	33.9	32.5	21.0	11.6	17.0	22.9	15.5	24.9	21.6	26.6	34.5	21.7	14.1	14.4	29.8	22.2	21.5	18.8	15.8	36.0	14.6	82.4	38.3	75.6	58.7	44.6	64.3	60.4	64.8	63.2	34.5	56.6	66.2	63.6	58.8	62.4	46.0	27.8	86.8	98.8	25.2	28.6	37.1	39.6	24.2	28.6	24.7	24.9	27.6	17.7
MBP		ENSG00000197971	"Myelin basic protein"	P02686	18	76978827-77133683	"Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"			"Autoimmune encephalomyelitis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	43	"brain: 1297.7"	"Cell line enhanced"	"Detected in many"		"HL-60: 28.4;SK-MEL-30: 59.1"	"Group enriched"	"Detected in all"	9	"glioma: 47.5;melanoma: 20.8"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002300, HPA049222, HPA064368"	Enhanced	Supported	Approved	"Plasma membrane"				"Plasma membrane"		"CAB002300: AB_563893, HPA049222: , HPA064368: "	"unprognostic (9.36e-2)"	"unprognostic (7.60e-2)"	"unprognostic (1.28e-2)"	"unprognostic (1.22e-1)"	"unprognostic (6.93e-2)"	"unprognostic (2.81e-1)"	"unprognostic (1.14e-1)"	"unprognostic (3.31e-1)"	"unprognostic (9.87e-2)"	"unprognostic (2.90e-2)"	"unprognostic (5.25e-2)"	"unprognostic (1.95e-1)"	"prognostic favourable (4.48e-12)"	"unprognostic (2.90e-1)"	"unprognostic (5.99e-2)"	"unprognostic (1.33e-1)"	"unprognostic (6.03e-2)"	4.0	3.4	271.6	6.1	244.9	10.1	4.5	28.7	418.9	5.6	5.5	487.7	0.0	5.9	4.4	3.6	6.4	9.0	5.7	6.8	355.0	247.6	6.2	5.9	6.2	7.1	645.5	43.4	3.7	6.8	16.4	0.7	2.7	242.9	4.5	5.6	0.4	5.0	4.9	29.9	7.9	6.2	3.8	1297.7	7.6	5.1	2.9	224.3	0.0	6.8	0.0	7.7	6.0	0.6	3.4	6.8	23.7	4.7	15.4	17.1	5.6	7.4	6.5	0.0	0.2	11.0	16.4	2.6	0.1	0.2	0.2	0.1	0.9	11.5	4.6	1.3	0.5	14.7	1.1	6.5	0.2	17.8	1.6	2.9	1.1	1.5	6.9	28.4	19.8	2.3	5.5	5.9	9.1	1.9	0.0	1.0	0.0	0.9	1.1	14.6	0.6	5.2	0.4	0.1	10.2	10.4	10.1	0.5	0.1	0.9	0.0	59.1	0.2	17.4	0.0	0.0	0.1	0.0	0.8	0.0	0.1	4.9	1.7	18.0	0.7	11.0	4.7	17.8	13.2	4.6	8.0	3.4	9.4	17.1	5.3	3.3	5.7	10.5	23.7	15.4	4.4	6.8	7.9	5.6	271.6	244.9	28.7	127.7	355.0	247.6	645.5	43.4	242.9	224.3
MCAM	"CD146, MUC18"	ENSG00000076706	"Melanoma cell adhesion molecule"	P43121	11	119308529-119321521	"CD markers, Plasma proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"HUVEC TERT2: 125.3;TIME: 122.3;WM-115: 97.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"MAIT T-cell: 2.2"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002147, HPA008848"	Enhanced		Approved	"Plasma membrane"			2600000000	"Plasma membrane"		"CAB002147: AB_563499, HPA008848: AB_1078445"	"unprognostic (6.45e-2)"	"prognostic unfavourable (7.61e-4)"	"unprognostic (7.03e-2)"	"unprognostic (1.22e-2)"	"unprognostic (6.67e-2)"	"unprognostic (2.34e-1)"	"unprognostic (2.23e-2)"	"unprognostic (8.42e-2)"	"unprognostic (2.09e-2)"	"unprognostic (1.45e-1)"	"unprognostic (1.58e-1)"	"unprognostic (9.39e-2)"	"prognostic unfavourable (5.14e-4)"	"unprognostic (8.75e-3)"	"unprognostic (7.84e-2)"	"unprognostic (2.31e-1)"	"unprognostic (2.79e-3)"	88.2	8.9	6.4	18.5	10.3	0.4	86.1	17.7	13.4	22.3	33.2	13.3	11.7	8.3	40.1	32.5	27.6	29.3	50.9	32.0	7.1	8.2	7.5	3.8	23.8	13.0	7.4	8.1	23.6	6.2	54.5	3.9	47.4	11.1	22.9	9.7	25.0	9.4	44.9	21.1	10.5	15.6	67.1	6.5	9.6	25.0	18.4	5.4	2.2	13.1	15.7	4.8	55.0	24.3	0.8	0.0	0.3	0.0	0.0	2.2	0.0	0.0	0.5	0.5	0.0	2.5	0.0	2.6	0.3	0.0	3.3	1.5	1.9	0.1	0.1	10.7	1.1	0.3	4.3	0.9	1.7	6.0	1.5	0.1	12.0	2.1	5.9	0.0	0.0	1.7	0.0	4.6	2.1	125.3	4.0	0.1	0.6	0.0	0.1	1.0	2.2	0.4	0.1	16.7	3.5	3.0	0.0	1.4	0.4	9.6	0.2	27.5	0.4	0.1	122.3	0.3	17.9	0.0	9.6	0.2	0.2	0.0	4.9	0.0	97.3	0.0	0.0	0.0	0.0	0.0	2.2	0.8	0.6	1.1	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.0	1.3	0.0	6.4	10.3	17.7	13.4	7.1	8.2	7.4	8.1	11.1	5.4
MCF2L2	"ARHGEF22, KIAA0861"	ENSG00000053524	"MCF.2 cell line derived transforming sequence-like 2"	Q86YR7	3	183178043-183428778	"Disease related genes, Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"	"Diabetes mellitus"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 16.4;brain: 23.7"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 9.2;Karpas-707: 8.1;REH: 5.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	4	"T-reg: 4.6"	"Lineage enriched"	"Detected in single"	8	"T-cells: 4.6"					"Low region specificity"	"Detected in all"			"HPA038946, HPA038947"	Uncertain		Approved	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		"HPA038946: AB_10670914, HPA038947: AB_10672655"	"unprognostic (2.17e-2)"	"unprognostic (4.42e-1)"	"unprognostic (3.08e-1)"	"unprognostic (1.95e-3)"	"unprognostic (1.98e-1)"	"unprognostic (2.87e-2)"	"unprognostic (3.70e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.46e-1)"	"unprognostic (5.08e-2)"	"unprognostic (4.80e-4)"	"unprognostic (1.32e-1)"	"unprognostic (8.75e-6)"	"unprognostic (1.09e-1)"	"unprognostic (5.47e-2)"	"unprognostic (2.95e-1)"	"unprognostic (1.78e-1)"	0.9	16.4	12.8	1.4	14.9	1.1	1.1	11.3	23.7	1.3	1.4	3.6	0.0	0.9	1.3	1.3	1.3	1.0	1.5	1.1	12.2	7.6	1.4	0.8	1.2	1.7	5.6	13.0	1.2	1.2	10.5	8.9	0.8	7.3	2.1	1.4	7.5	0.8	1.6	1.4	1.0	1.2	1.4	4.5	5.3	1.2	5.5	4.3	0.0	0.9	0.0	2.1	1.6	0.4	0.1	0.0	0.6	0.0	0.1	4.6	0.2	0.1	0.6	0.2	1.7	0.1	0.2	0.4	0.0	0.1	0.3	0.0	1.2	0.2	1.5	0.2	0.1	0.0	0.3	0.2	0.1	9.2	1.4	3.9	0.3	0.0	0.3	1.2	0.8	0.3	0.0	0.0	0.6	0.7	1.2	8.1	0.4	1.2	1.2	0.8	1.3	1.6	5.3	0.0	1.5	0.4	0.1	2.5	0.9	1.0	0.0	2.0	0.5	0.8	0.6	0.0	0.9	0.1	0.1	3.2	3.4	1.7	0.8	1.4	0.1	0.1	0.0	0.1	0.4	0.0	1.0	0.0	1.0	0.6	0.0	0.1	0.0	0.9	0.6	0.1	0.0	0.0	4.6	0.2	12.8	14.9	11.3	23.7	12.2	7.6	5.6	13.0	7.3	4.3
MERTK	"c-Eyk, mer, RP38, Tyro12"	ENSG00000153208	"MER proto-oncogene, tyrosine kinase"	Q12866	2	111898479-112029561	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Disease mutation, Proto-oncogene, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"CACO-2: 20.8;Hep G2: 21.6;HUVEC TERT2: 21.5;RT4: 12.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	10	"intermediate monocyte: 10.3;non-classical monocyte: 6.4"	"Lineage enriched"	"Detected in single"	48	"monocytes: 10.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036196, HPA075622"	Approved		Approved	"Endoplasmic reticulum,Plasma membrane,Midbody,Cytosol"			29000000	"Plasma membrane"	"Endoplasmic reticulum, Midbody, Cytosol"	"HPA036196: AB_10670676, HPA075622: "	"unprognostic (2.17e-2)"	"unprognostic (8.10e-2)"	"unprognostic (4.85e-2)"	"unprognostic (2.68e-1)"	"unprognostic (2.44e-1)"	"unprognostic (1.77e-1)"	"unprognostic (1.07e-1)"	"prognostic favourable (4.74e-4)"	"unprognostic (6.84e-2)"	"unprognostic (1.25e-1)"	"unprognostic (6.22e-2)"	"unprognostic (3.72e-1)"	"prognostic favourable (4.43e-5)"	"unprognostic (5.13e-2)"	"unprognostic (2.11e-1)"	"unprognostic (5.86e-2)"	"unprognostic (2.05e-2)"	20.1	55.1	13.1	12.5	17.8	1.9	31.8	6.2	13.8	10.8	13.8	6.8	27.7	11.5	11.3	25.4	8.4	12.8	11.7	7.1	16.5	6.3	14.2	18.9	12.7	30.3	8.1	10.1	12.9	9.0	23.9	14.3	18.4	18.6	14.1	7.9	20.4	6.8	24.9	6.4	6.4	12.8	13.6	12.2	38.4	12.3	17.3	9.8	1.7	9.9	2.0	8.4	14.1	26.6	0.0	0.2	0.1	10.3	0.0	0.0	0.3	0.5	0.9	4.3	9.7	0.2	0.1	6.9	0.0	0.1	0.5	1.0	20.8	1.3	0.1	4.6	0.0	0.1	5.7	0.0	0.8	0.8	3.0	3.7	0.0	21.6	0.1	0.1	0.8	0.2	0.0	5.0	0.3	21.5	1.1	2.0	1.6	0.9	0.0	4.9	2.7	3.4	1.4	1.2	1.6	10.9	12.9	0.1	4.1	0.1	0.3	1.7	0.0	0.2	3.2	0.6	2.0	0.0	0.0	1.7	2.5	0.0	0.0	0.8	0.0	0.0	0.8	0.0	0.0	10.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	6.4	0.1	0.0	0.3	13.1	17.8	6.2	13.8	16.5	6.3	8.1	10.1	18.6	9.8
METAP1	"KIAA0094, MAP1A, MetAP1A"	ENSG00000164024	"Methionyl aminopeptidase 1"	P53582	4	98995620-99062813	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Aminopeptidase, Hydrolase, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB025485, HPA037997, HPA037998"	Approved		Approved	"Nucleoplasm,Plasma membrane,Cytosol"			11000	Cytosol	"Nucleoplasm, Plasma membrane"	"CAB025485: , HPA037997: , HPA037998: "	"unprognostic (1.79e-1)"	"unprognostic (3.39e-1)"	"prognostic favourable (7.22e-4)"	"unprognostic (1.58e-2)"	"unprognostic (6.53e-2)"	"unprognostic (2.15e-1)"	"prognostic unfavourable (3.08e-5)"	"unprognostic (1.09e-1)"	"unprognostic (1.51e-3)"	"unprognostic (2.05e-1)"	"prognostic unfavourable (2.28e-5)"	"unprognostic (2.00e-1)"	"prognostic favourable (1.72e-4)"	"unprognostic (5.50e-2)"	"unprognostic (8.51e-2)"	"unprognostic (1.15e-3)"	"prognostic favourable (9.31e-4)"	12.1	8.3	10.0	16.0	10.1	11.8	18.6	9.2	13.8	16.0	17.9	7.0	22.9	13.4	24.1	25.9	37.2	14.0	12.3	27.9	9.5	7.1	14.3	13.7	10.7	12.6	7.9	9.8	11.3	13.0	7.8	14.4	9.2	9.9	19.1	19.3	7.5	19.0	21.5	27.2	16.4	15.2	27.8	10.1	13.9	11.6	46.8	8.1	27.0	10.8	21.8	19.1	36.6	22.6	12.7	11.7	10.4	11.1	12.5	19.2	10.8	21.7	21.5	18.9	20.2	15.0	24.1	21.0	31.2	20.1	26.7	25.5	24.1	32.5	32.2	12.5	25.2	21.9	33.1	31.2	37.1	22.5	15.8	28.8	15.7	25.8	16.3	38.9	24.1	17.3	22.7	22.6	24.1	21.9	22.5	19.5	28.5	16.5	34.0	18.6	23.2	17.5	22.4	29.5	17.2	42.8	28.2	25.9	15.3	10.4	32.3	12.3	12.4	14.9	17.8	21.6	27.5	19.7	27.1	14.1	19.9	25.5	18.6	19.9	21.4	10.4	9.4	4.2	14.9	11.1	19.2	12.7	15.4	14.5	11.7	10.1	15.1	13.5	2.3	12.5	10.7	5.8	13.4	10.8	10.0	10.1	9.2	13.8	9.5	7.1	7.9	9.8	9.9	8.1
METAP2	"MAP2, MNPEP, p67"	ENSG00000111142	"Methionyl aminopeptidase 2"	P50579	12	95473520-95515839	"Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"		"Aminopeptidase, Hydrolase, Protease"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB013025, HPA019095"	Enhanced		Supported	"Plasma membrane,Cytosol"			22000	"Plasma membrane, Cytosol"		"CAB013025: AB_2533993, HPA019095: AB_1853823"	"unprognostic (1.91e-1)"	"unprognostic (1.02e-1)"	"unprognostic (5.92e-2)"	"unprognostic (2.44e-1)"	"unprognostic (3.27e-2)"	"unprognostic (2.57e-2)"	"prognostic unfavourable (4.51e-6)"	"unprognostic (1.25e-1)"	"unprognostic (2.28e-2)"	"unprognostic (1.40e-2)"	"unprognostic (8.53e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.49e-1)"	"unprognostic (2.51e-1)"	"unprognostic (1.07e-1)"	"unprognostic (2.95e-2)"	"unprognostic (1.03e-1)"	24.2	36.4	25.8	49.9	33.7	39.1	25.1	25.9	32.3	23.9	26.2	16.3	102.5	16.6	28.7	25.4	30.1	22.5	21.7	30.7	29.6	24.0	26.0	46.8	22.1	32.6	29.1	23.4	29.4	31.9	21.0	36.1	25.1	42.9	24.2	24.0	10.1	22.1	140.7	94.4	28.7	19.7	26.1	48.2	25.2	22.2	26.3	27.7	32.1	24.1	29.0	55.2	33.4	37.3	39.4	31.8	21.3	27.1	25.7	32.0	16.2	33.2	28.1	30.1	23.3	18.3	29.4	23.1	32.8	23.0	32.4	23.0	40.8	16.0	97.0	20.7	23.4	21.5	33.8	25.1	37.3	23.0	29.1	43.4	21.4	28.7	19.6	53.7	21.3	25.4	26.9	30.6	30.1	34.4	56.1	11.0	24.0	21.9	39.7	36.7	36.8	42.0	31.3	26.0	31.8	22.2	35.4	23.4	30.7	29.2	23.9	28.7	28.8	25.6	29.5	18.6	18.1	20.8	34.6	15.9	41.4	104.0	10.6	30.3	23.4	21.3	27.1	11.1	23.8	19.1	29.2	39.4	26.7	26.6	24.4	37.6	32.0	29.7	1.2	25.7	22.3	31.8	25.3	16.2	25.8	33.7	25.9	32.3	29.6	24.0	29.1	23.4	42.9	27.7
METTL15	"FLJ33979, METT5D1"	ENSG00000169519	"Methyltransferase like 15"	A6NJ78	11	28108248-28527041	"Predicted intracellular proteins"		"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039885			Approved	"Golgi apparatus,Plasma membrane,Actin filaments"				"Golgi apparatus, Plasma membrane"	"Actin filaments"	"HPA039885: "	"unprognostic (2.57e-1)"	"unprognostic (2.64e-1)"	"unprognostic (1.00e-2)"	"unprognostic (3.21e-2)"	"unprognostic (2.66e-2)"	"unprognostic (1.83e-1)"	"unprognostic (4.17e-2)"	"unprognostic (1.95e-1)"	"unprognostic (2.94e-2)"	"unprognostic (7.93e-2)"	"unprognostic (6.31e-3)"	"unprognostic (2.28e-1)"	"prognostic favourable (7.95e-5)"	"unprognostic (7.77e-2)"	"unprognostic (1.38e-1)"	"unprognostic (6.58e-2)"	"unprognostic (6.84e-3)"	10.3	17.5	11.2	13.4	11.2	4.3	12.4	16.0	13.4	13.6	13.4	12.2	15.0	9.9	21.0	14.8	10.8	11.8	12.3	14.7	11.3	12.0	15.4	17.9	9.6	9.5	10.5	10.1	12.3	11.4	18.8	32.6	11.1	13.6	12.9	13.8	15.5	12.4	13.7	16.9	10.0	9.8	13.3	12.7	9.8	10.3	11.8	11.2	16.5	15.3	11.0	14.3	10.6	9.8	6.4	3.3	6.0	2.7	7.6	6.8	2.9	7.2	7.8	7.9	6.0	9.8	15.9	5.5	8.9	6.8	9.0	9.3	5.2	4.9	16.6	5.3	7.3	6.1	10.3	9.1	17.5	10.2	9.1	5.2	5.8	6.0	11.0	9.7	4.7	8.9	13.6	5.0	13.1	8.7	11.0	7.6	10.6	4.9	6.7	6.1	6.1	5.8	3.7	17.2	6.0	13.5	4.1	7.0	5.8	7.3	6.6	10.4	13.0	6.0	6.5	8.3	6.4	10.5	7.8	5.1	6.0	9.7	11.7	9.9	8.9	3.1	2.7	6.0	4.2	1.7	5.3	6.4	5.2	5.5	3.0	3.3	5.6	6.8	1.3	7.6	2.2	3.3	5.5	2.9	11.2	11.2	16.0	13.4	11.3	12.0	10.5	10.1	13.6	11.2
MKLN1	TWA2	ENSG00000128585	"Muskelin 1"	Q9UL63	7	131110096-131496636	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	5	"neutrophil: 12.4"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 12.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA022817, HPA041810"	Approved		Approved	"Vesicles,Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"	Vesicles	"HPA022817: AB_1853974, HPA041810: "	"unprognostic (1.97e-1)"	"unprognostic (2.83e-2)"	"unprognostic (1.23e-1)"	"unprognostic (3.92e-3)"	"unprognostic (1.03e-1)"	"unprognostic (4.20e-2)"	"unprognostic (1.44e-3)"	"unprognostic (4.58e-2)"	"unprognostic (1.94e-2)"	"unprognostic (1.97e-1)"	"unprognostic (2.43e-3)"	"unprognostic (1.55e-1)"	"unprognostic (9.18e-3)"	"unprognostic (1.70e-1)"	"unprognostic (4.13e-1)"	"unprognostic (1.13e-2)"	"unprognostic (2.32e-1)"	22.7	21.1	22.1	15.7	27.6	12.8	34.4	27.5	25.8	18.8	15.0	11.7	26.6	14.2	19.3	19.8	11.8	19.6	11.6	16.7	21.9	14.4	23.0	22.8	19.3	18.7	26.6	17.5	23.2	12.6	20.9	28.8	18.2	25.0	26.4	12.2	10.0	18.1	28.9	28.6	15.4	13.5	20.8	30.3	13.1	14.4	16.9	24.0	14.7	18.0	9.9	12.0	17.8	21.5	2.3	1.6	12.4	1.6	0.9	2.3	0.5	8.3	9.6	8.4	8.5	20.8	18.8	5.1	8.1	18.8	9.2	11.9	4.4	7.2	8.7	5.5	10.0	5.8	8.8	7.7	15.1	8.4	4.3	3.7	7.5	5.1	10.0	6.1	5.4	11.2	5.4	12.5	6.2	8.4	13.5	6.3	11.4	3.1	7.1	6.6	9.6	5.1	4.5	9.9	6.0	10.3	4.9	4.4	9.4	15.8	15.8	7.3	3.1	7.7	8.5	7.2	4.1	13.1	6.5	15.4	5.7	14.9	24.8	7.4	10.5	1.2	1.0	1.7	1.6	1.1	1.2	1.2	1.5	1.3	1.0	2.3	2.3	1.9	12.4	0.9	1.6	1.6	0.9	0.5	22.1	27.6	27.5	25.8	21.9	14.4	26.6	17.5	25.0	24.0
MKRN3	"D15S9, MGC88288, RNF63, ZFP127, ZNF127"	ENSG00000179455	"Makorin ring finger protein 3"	Q13064	15	23565678-23630075	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 14.4"	"Cell line enhanced"	"Detected in many"		"K-562: 17.5"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"naive CD8 T-cell: 5.7"	"Lineage enriched"	"Detected in many"	4	"T-cells: 5.7"	"Low region specificity"	"Detected in many"							HPA029494	Uncertain		Approved	"Nucleoplasm,Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"	Nucleoplasm	"HPA029494: AB_10603873"	"unprognostic (3.18e-1)"	"unprognostic (1.26e-1)"	"unprognostic (4.26e-1)"	"unprognostic (1.86e-3)"	"unprognostic (1.04e-3)"	"unprognostic (1.15e-2)"	"unprognostic (6.27e-4)"	"unprognostic (1.51e-1)"	"unprognostic (8.52e-2)"	"unprognostic (7.05e-2)"	"unprognostic (4.97e-3)"	"unprognostic (2.86e-1)"	"unprognostic (1.05e-4)"	"unprognostic (5.37e-2)"	"unprognostic (1.52e-1)"	"unprognostic (8.91e-2)"	"unprognostic (9.78e-2)"	1.0	0.7	5.1	1.2	10.4	4.0	1.2	1.0	11.1	0.5	1.1	8.4	0.0	1.3	1.3	3.2	5.6	0.9	0.8	0.8	6.4	3.4	1.1	0.7	1.0	1.9	14.4	3.0	1.2	1.7	0.5	3.8	8.5	5.1	1.2	0.8	3.1	5.2	1.0	1.4	1.2	1.9	0.8	8.2	1.5	0.9	5.7	13.3	5.0	0.9	1.1	1.7	0.7	0.6	1.0	0.9	1.3	0.5	0.4	5.7	0.7	4.7	3.4	3.0	3.1	0.0	0.0	7.1	0.3	0.0	2.9	2.0	8.5	0.0	0.2	0.1	0.0	8.2	1.3	0.0	0.7	0.0	0.3	6.8	9.1	0.3	0.2	8.0	6.1	0.1	0.0	6.0	0.0	0.0	17.5	7.5	0.8	0.0	8.4	3.5	0.0	10.4	6.0	1.1	4.2	0.0	0.1	0.7	2.4	0.0	3.4	0.0	2.7	2.4	0.1	8.0	6.7	0.4	5.6	9.4	11.5	5.6	4.7	0.1	0.1	1.3	0.5	0.4	1.8	0.2	1.0	1.0	0.6	1.4	0.2	0.9	2.0	5.7	1.3	0.4	0.3	0.9	0.4	0.7	5.1	10.4	1.0	6.8	6.4	3.4	14.4	3.0	5.1	13.3
MLF2	NTN4	ENSG00000089693	"Myeloid leukemia factor 2"	Q15773	12	6747996-6767475	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA010811, HPA010859"	Enhanced		Approved	"Nucleoplasm,Plasma membrane,Cytosol"				Nucleoplasm	"Plasma membrane, Cytosol"	"HPA010811: AB_1079389, HPA010859: AB_1079388"	"unprognostic (1.65e-1)"	"unprognostic (6.55e-2)"	"unprognostic (4.42e-1)"	"unprognostic (9.88e-3)"	"unprognostic (1.76e-1)"	"unprognostic (4.19e-2)"	"unprognostic (1.52e-1)"	"unprognostic (4.15e-2)"	"unprognostic (1.31e-1)"	"unprognostic (9.11e-2)"	"unprognostic (3.37e-1)"	"unprognostic (6.23e-2)"	"unprognostic (1.38e-1)"	"unprognostic (5.83e-2)"	"unprognostic (4.72e-1)"	"unprognostic (8.44e-2)"	"unprognostic (3.63e-1)"	31.4	45.6	55.8	23.3	65.4	36.9	24.9	50.5	100.5	28.6	30.9	44.0	23.9	36.5	32.1	30.5	39.3	31.7	28.6	44.1	54.4	47.2	37.9	77.4	24.8	21.5	40.2	42.5	28.3	33.4	43.3	31.1	32.5	44.8	38.4	27.6	28.2	43.1	36.7	45.3	33.6	35.1	35.9	33.7	21.8	27.7	21.0	30.7	26.0	36.3	28.9	29.4	29.3	23.6	17.0	38.9	86.7	20.1	11.8	14.8	16.9	39.0	64.6	33.2	58.5	31.1	31.7	51.1	38.4	46.2	66.2	58.1	62.4	38.8	28.2	10.2	50.0	32.8	40.9	55.6	41.2	44.4	37.9	19.9	34.2	35.7	34.4	21.1	27.5	29.7	45.4	51.1	39.2	26.9	25.0	11.8	46.0	55.4	29.0	32.7	107.4	22.3	18.6	30.6	25.0	55.2	49.3	21.2	42.0	34.7	61.4	37.1	17.8	35.0	26.5	39.5	52.6	41.6	56.1	14.3	16.2	37.4	52.7	18.4	46.4	35.4	20.1	73.9	14.8	18.0	14.3	15.3	11.5	13.9	22.6	17.0	12.2	13.5	86.7	11.8	19.5	38.9	11.2	16.9	55.8	65.4	50.5	100.5	54.4	47.2	40.2	42.5	44.8	30.7
MMACHC	"cblC, DKFZP564I122"	ENSG00000132763	"Methylmalonic aciduria (cobalamin deficiency) cblC type, with homocystinuria"	Q9Y4U1	1	45500053-45513382	"Disease related genes, Predicted intracellular proteins"		Oxidoreductase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 30.1"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027394, HPA027399, HPA027402"	Uncertain		Supported	"Nucleoplasm,Plasma membrane,Cytosol"				Nucleoplasm	"Plasma membrane, Cytosol"	"HPA027394: AB_10601669, HPA027399: AB_10601987, HPA027402: AB_2672255"	"unprognostic (3.34e-1)"	"unprognostic (1.63e-1)"	"unprognostic (7.03e-3)"	"unprognostic (3.14e-2)"	"unprognostic (4.05e-1)"	"unprognostic (1.16e-2)"	"unprognostic (9.04e-2)"	"unprognostic (1.03e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.05e-2)"	"unprognostic (3.88e-2)"	"unprognostic (6.81e-2)"	"unprognostic (2.61e-3)"	"unprognostic (2.08e-3)"	"unprognostic (8.83e-2)"	"unprognostic (2.50e-2)"	"unprognostic (2.58e-2)"	3.5	7.4	5.8	3.3	10.2	2.2	6.1	3.6	12.2	5.4	6.3	11.8	3.2	5.6	4.1	5.6	4.0	6.2	2.9	11.1	6.2	5.1	7.6	30.1	2.7	3.1	7.3	6.9	6.4	9.8	9.5	5.4	2.9	8.5	3.9	7.6	4.0	11.9	7.5	14.7	3.8	4.1	4.2	6.7	3.6	4.5	7.3	5.7	4.1	4.4	3.7	3.6	3.9	3.1	2.1	3.6	5.0	6.1	2.6	3.9	1.1	6.8	3.6	6.1	9.3	5.8	3.5	7.6	5.3	3.6	9.7	8.8	7.3	4.3	10.7	7.0	4.4	5.7	11.2	12.7	8.9	2.9	10.3	8.3	5.9	8.2	5.5	11.8	3.0	5.0	7.2	10.7	11.8	4.6	9.4	6.1	7.4	7.3	7.9	3.8	10.0	8.3	9.8	2.5	11.9	5.7	5.4	9.8	5.0	8.0	13.3	17.4	7.7	4.3	2.1	6.9	9.4	7.7	2.9	9.2	7.4	6.3	5.0	5.7	6.3	5.0	1.6	1.6	1.7	2.4	2.8	2.0	2.0	1.4	1.7	2.1	3.9	2.0	3.5	2.6	6.1	3.6	1.4	1.1	5.8	10.2	3.6	12.2	6.2	5.1	7.3	6.9	8.5	5.7
MMP10	STMY2	ENSG00000166670	"Matrix metallopeptidase 10"	P09238	11	102770503-102780628	"Cancer-related genes, Enzymes, FDA approved drug targets, Predicted secreted proteins"	"Collagen degradation"	"Hydrolase, Metalloprotease, Protease"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"endometrium 1: 89.4"	"Cell line enhanced"	"Detected in some"		"BJ: 12.3;HUVEC TERT2: 15.8;SCLC-21H: 5.0"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 102.2"	"Region enriched"	"Detected in single"	9	"pons and medulla: 2.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							CAB002159	Uncertain		Approved	"Plasma membrane,Cytosol"	"Secreted to extracellular matrix"			Cytosol	"Plasma membrane"	"CAB002159: AB_564103"	"unprognostic (8.76e-2)"	"unprognostic (3.38e-1)"	"unprognostic (1.98e-3)"	"unprognostic (2.72e-3)"	"unprognostic (7.17e-3)"	"unprognostic (1.52e-2)"	"unprognostic (5.67e-8)"	"unprognostic (2.08e-3)"	"unprognostic (2.20e-1)"	"unprognostic (1.75e-1)"	"unprognostic (1.67e-2)"	"unprognostic (2.67e-1)"	"unprognostic (6.99e-5)"	"unprognostic (2.66e-2)"	"unprognostic (7.98e-2)"	"unprognostic (5.46e-2)"	"prognostic favourable (7.12e-4)"	0.1	0.1	0.0	2.6	0.2	0.1	0.1	0.0	0.3	1.7	0.5	0.0	0.0	0.4	89.4	0.1	0.2	0.1	0.5	0.1	0.0	0.1	0.1	3.6	11.0	0.1	0.0	0.0	0.5	0.3	0.1	0.9	19.8	2.8	3.2	0.2	0.0	2.9	0.1	0.1	0.1	0.7	0.1	0.0	0.2	3.3	0.5	0.0	1.2	0.1	0.0	1.9	0.6	5.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.8	0.2	0.0	0.0	0.2	12.3	0.7	0.1	0.1	0.3	0.0	0.0	3.6	1.9	2.8	0.0	1.4	0.0	0.0	0.2	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.4	0.6	15.8	0.7	0.0	0.0	0.0	0.0	0.3	2.9	1.7	0.0	0.0	0.0	0.0	0.7	5.0	0.0	2.5	0.0	0.0	0.0	0.0	2.0	3.8	1.2	0.4	0.5	0.0	0.0	0.0	0.6	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.1	0.0	0.0	2.8	0.0
MMP15	"MT2-MMP, MTMMP2, SMCP-2"	ENSG00000102996	"Matrix metallopeptidase 15"	P51511	16	58025566-58046901	"Cancer-related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Hydrolase, Metalloprotease, Protease"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 43.2"	"Cell line enhanced"	"Detected in many"		"BEWO: 36.8;Hep G2: 19.1;SK-BR-3: 18.5;WM-115: 30.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	30	"plasmacytoid DC: 2.9"	"Lineage enriched"	"Detected in single"	30	"dendritic cells: 2.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002611, HPA040390"	Uncertain		Approved	"Nucleoplasm,Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"	Nucleoplasm	"CAB002611: , HPA040390: "	"unprognostic (1.76e-2)"	"unprognostic (7.32e-2)"	"unprognostic (2.69e-1)"	"unprognostic (6.85e-2)"	"unprognostic (3.09e-1)"	"unprognostic (1.68e-1)"	"unprognostic (6.88e-3)"	"unprognostic (1.40e-1)"	"unprognostic (3.02e-2)"	"unprognostic (1.24e-2)"	"unprognostic (4.81e-2)"	"unprognostic (1.81e-1)"	"prognostic favourable (8.54e-8)"	"unprognostic (3.63e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.28e-1)"	"prognostic favourable (3.08e-4)"	5.9	2.3	2.0	5.5	3.0	0.1	7.7	3.7	7.2	3.3	19.5	4.2	16.3	22.6	2.9	1.7	2.5	3.6	15.9	17.6	2.3	3.7	8.4	26.4	6.1	2.0	2.5	2.2	2.1	10.3	7.3	5.2	28.5	10.4	3.6	8.2	9.5	4.7	14.7	3.4	2.3	43.2	3.4	3.4	5.2	14.7	28.0	2.1	1.1	26.8	2.5	2.2	3.3	4.2	0.0	2.9	0.0	0.0	0.0	0.0	0.0	5.7	4.3	2.3	11.8	2.4	0.1	36.8	0.5	0.3	2.1	0.4	3.4	14.8	0.0	7.0	0.6	8.1	1.9	1.7	0.6	0.0	3.9	0.0	1.9	19.1	3.1	0.1	7.7	1.2	3.0	0.3	0.9	1.4	4.7	0.0	0.7	2.8	0.2	0.9	6.7	1.2	2.8	0.3	3.1	6.5	2.1	0.6	4.1	7.7	18.5	3.5	2.0	3.1	1.3	0.1	3.7	1.4	0.5	0.0	0.0	0.1	0.7	0.9	30.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	2.0	3.0	3.7	7.2	2.3	3.7	2.5	2.2	10.4	2.1
MMP24	MT5-MMP	ENSG00000125966	"Matrix metallopeptidase 24"	Q9Y5R2	20	35226654-35277000	"Enzymes, FDA approved drug targets, Predicted membrane proteins, Predicted secreted proteins"	"Cell adhesion"	"Hydrolase, Metalloprotease, Protease"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"brain: 38.5"	"Cell line enhanced"	"Detected in some"		"A549: 19.6;CACO-2: 29.9;EFO-21: 8.8;RPTEC TERT1: 13.5;U-2 OS: 10.1"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in all"	5	"cerebellum: 38.5"	"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Region enriched"	"Detected in all"	5	"cerebellum: 91.3"	"HPA049280, HPA078816"	Approved		Approved	"Nucleoli,Plasma membrane"	"Secreted to extracellular matrix"			"Nucleoli, Plasma membrane"		"HPA049280: , HPA078816: "	"unprognostic (1.52e-3)"	"unprognostic (1.36e-1)"	"unprognostic (1.18e-1)"	"unprognostic (4.51e-4)"	"unprognostic (2.47e-2)"	"unprognostic (7.61e-3)"	"unprognostic (1.22e-1)"	"unprognostic (4.59e-2)"	"unprognostic (2.32e-2)"	"unprognostic (8.82e-2)"	"unprognostic (9.20e-3)"	"unprognostic (7.12e-2)"	"prognostic favourable (8.17e-11)"	"unprognostic (3.32e-2)"	"unprognostic (5.63e-2)"	"unprognostic (1.69e-2)"	"unprognostic (9.90e-4)"	1.6	1.3	4.0	0.4	7.8	0.6	0.4	38.5	8.9	0.7	0.3	1.3	0.2	2.8	1.6	0.9	0.2	2.8	0.6	1.0	2.7	3.2	8.6	0.9	6.1	0.3	1.8	1.5	0.9	8.0	0.0	3.8	0.6	1.7	2.2	0.1	0.5	0.4	6.0	0.2	1.5	1.7	2.5	0.9	0.6	0.7	0.4	1.4	0.2	0.8	0.2	0.2	0.5	0.2	0.8	0.4	2.2	0.8	0.6	1.2	0.3	0.3	19.6	0.0	0.1	0.1	0.0	0.6	1.1	1.2	2.1	1.1	29.9	5.3	0.0	8.8	1.3	0.3	4.6	0.0	0.9	0.1	0.2	1.0	0.5	0.3	0.0	0.0	0.2	0.1	0.1	0.1	0.0	0.0	0.0	0.3	0.2	0.2	0.1	0.1	7.5	1.3	0.0	0.1	0.0	13.5	0.1	7.8	5.4	1.4	0.5	0.2	0.3	0.1	0.3	4.2	10.1	1.0	0.4	0.1	0.1	0.0	0.9	0.1	0.6	1.0	0.6	0.1	1.0	0.7	1.2	0.6	0.7	0.8	0.4	0.8	0.6	0.6	2.2	0.6	0.8	0.2	0.0	0.3	4.0	7.8	38.5	5.3	2.7	3.2	1.8	1.5	1.7	1.4
MOCS1	MOCOD	ENSG00000124615	"Molybdenum cofactor synthesis 1"	Q9NZB8	6	39899578-39934551	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Molybdenum cofactor biosynthesis"	Lyase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"CACO-2: 26.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"naive CD4 T-cell: 2.9;naive CD8 T-cell: 2.5"	"Group enriched"	"Detected in many"	9	"NK-cells: 1.5;T-cells: 2.9"	"Low region specificity"	"Detected in all"							"HPA045783, HPA058177, HPA075505"	Uncertain		Approved	"Plasma membrane,Cytosol"				Cytosol	"Plasma membrane"	"HPA045783: AB_10960058, HPA058177: , HPA075505: "	"unprognostic (1.22e-1)"	"prognostic unfavourable (1.07e-5)"	"unprognostic (3.26e-2)"	"unprognostic (1.44e-1)"	"unprognostic (9.03e-2)"	"unprognostic (1.99e-1)"	"unprognostic (2.61e-2)"	"unprognostic (4.85e-2)"	"unprognostic (3.14e-2)"	"unprognostic (1.08e-1)"	"prognostic favourable (6.07e-5)"	"unprognostic (5.34e-3)"	"unprognostic (1.21e-1)"	"unprognostic (3.97e-3)"	"unprognostic (2.78e-1)"	"unprognostic (2.93e-1)"	"unprognostic (6.21e-2)"	26.6	9.6	4.6	5.3	7.9	0.2	27.1	5.9	8.7	6.4	17.5	10.5	5.0	15.4	10.1	8.7	6.9	7.9	8.0	18.0	6.2	2.3	17.5	34.9	19.6	9.2	9.5	6.2	9.0	10.9	4.5	6.3	30.2	7.0	6.7	5.2	11.2	5.9	7.6	19.9	7.1	13.1	8.9	7.1	3.5	6.5	4.0	7.6	0.2	15.4	5.9	3.1	9.7	7.7	0.0	0.1	0.0	0.2	1.5	2.9	0.8	0.0	1.4	5.0	8.0	13.5	5.2	10.1	5.4	9.9	7.8	7.1	26.4	0.1	0.0	5.7	5.4	0.4	6.0	6.6	6.1	0.0	5.4	0.0	0.0	8.3	8.6	0.0	2.2	9.1	2.4	5.4	3.0	6.7	5.4	0.5	7.9	3.4	10.2	0.0	4.5	2.9	0.0	3.8	0.8	4.8	5.1	4.1	5.2	0.0	3.2	4.6	3.4	1.0	10.4	7.9	6.8	5.1	2.8	0.0	1.0	0.0	0.9	0.0	2.8	0.0	0.1	0.0	1.2	0.0	0.0	0.0	0.6	0.5	0.1	0.0	2.9	2.5	0.0	1.5	0.2	0.0	0.0	0.8	4.6	7.9	5.9	8.7	6.2	2.3	9.5	6.2	7.0	7.6
MPI		ENSG00000178802	"Mannose phosphate isomerase"	P34949	15	74890005-74902219	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		Isomerase	"Congenital disorder of glycosylation, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007200	Approved		Approved	"Plasma membrane,Cytosol"			170000	Cytosol	"Plasma membrane"	"HPA007200: AB_1854079"	"unprognostic (1.38e-1)"	"unprognostic (7.18e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.65e-3)"	"unprognostic (7.34e-2)"	"prognostic unfavourable (2.39e-4)"	"unprognostic (1.79e-1)"	"unprognostic (2.76e-1)"	"unprognostic (3.20e-1)"	"unprognostic (2.93e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.27e-1)"	"unprognostic (3.34e-2)"	"unprognostic (2.11e-1)"	"unprognostic (1.15e-1)"	"unprognostic (2.09e-1)"	"unprognostic (6.58e-2)"	13.6	33.3	24.2	11.2	26.2	7.4	14.7	19.2	33.7	16.7	22.6	26.1	15.3	32.6	15.7	26.8	17.1	20.7	13.4	28.8	22.7	22.2	22.5	30.2	10.6	16.2	28.1	28.3	23.2	34.2	24.7	15.0	11.4	37.4	20.6	23.1	18.3	18.6	17.9	33.3	11.7	27.4	16.4	21.7	14.7	14.3	23.5	17.7	16.4	17.1	15.0	16.6	15.6	11.7	12.8	10.2	2.4	7.4	17.7	27.1	12.9	10.4	14.5	12.0	13.6	27.5	13.4	10.5	9.0	14.8	15.5	21.8	14.3	13.9	14.9	19.7	13.1	26.1	23.8	26.3	14.8	11.3	29.8	26.6	13.8	15.3	19.6	12.2	7.9	17.8	6.8	14.6	26.3	21.0	8.9	12.2	20.0	8.9	13.1	5.4	6.6	12.4	13.5	11.3	36.4	18.2	11.9	22.5	9.8	10.5	19.0	11.3	26.1	8.5	9.5	9.3	8.0	6.9	8.7	30.3	17.9	9.7	19.5	17.8	6.7	0.7	7.2	2.4	13.5	7.4	17.5	12.8	18.3	15.4	10.2	12.5	27.1	19.7	1.1	17.7	6.3	8.5	22.7	12.9	24.2	26.2	19.2	33.7	22.7	22.2	28.1	28.3	37.4	17.7
MPIG6B	"C6orf25, G6b, G6b-B, NG31"	ENSG00000204420	"Megakaryocyte and platelet inhibitory receptor G6b"	O95866	6	31718594-31726714	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"		"Heparin-binding, Receptor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 33.2"	"Cell line enriched"	"Detected in single"	17	"HEL: 11.4"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in single"			"Group enriched"	"Detected in some"	4	"NK-cell: 3.0;plasmacytoid DC: 1.8"	"Group enriched"	"Detected in many"	4	"dendritic cells: 1.8;NK-cells: 3.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA054404, HPA073017"			Approved	"Endoplasmic reticulum,Golgi apparatus,Plasma membrane,Cytosol"	"Intracellular and membrane"		7400000	"Endoplasmic reticulum, Golgi apparatus"	"Plasma membrane, Cytosol"	"HPA054404: , HPA073017: "	"unprognostic (1.45e-1)"	"unprognostic (1.25e-1)"	"unprognostic (2.93e-1)"	"unprognostic (1.77e-2)"	"unprognostic (1.23e-1)"	"unprognostic (6.53e-2)"	"unprognostic (3.53e-2)"	"unprognostic (2.71e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.43e-2)"	"unprognostic (2.70e-1)"	"unprognostic (1.71e-2)"	"unprognostic (1.82e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.34e-1)"	"unprognostic (2.55e-2)"	"unprognostic (1.71e-2)"	0.8	0.2	0.0	1.2	0.5	5.3	0.7	0.1	0.4	1.0	0.9	0.0	0.0	0.9	1.0	0.8	2.0	0.7	1.5	7.4	0.2	0.0	0.4	0.5	7.6	2.8	1.0	0.0	2.7	0.2	0.2	0.2	1.4	0.7	0.9	0.2	1.1	1.8	0.3	1.2	10.5	0.8	1.9	0.6	33.2	0.4	2.7	0.1	1.2	1.0	1.4	0.8	1.6	1.6	0.2	1.8	0.5	0.1	3.0	0.1	5.7	0.0	0.0	0.6	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.4	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.2	0.4	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.3	0.0	0.4	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.1	0.0	0.1	0.0	0.2	0.0	0.1	0.0	0.1	0.1	0.0	0.5	3.0	0.1	1.8	0.0	5.7	0.0	0.5	0.1	0.4	0.2	0.0	1.0	0.0	0.7	0.1
MPP5	"FLJ12615, PALS1"	ENSG00000072415	"Membrane palmitoylated protein 5"	Q8N3R9	14	67241109-67335819	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"A-431: 53.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000993, HPA063890"	Enhanced		Uncertain	"Nucleoplasm,Plasma membrane,Cytosol"				Nucleoplasm	"Plasma membrane, Cytosol"	"HPA000993: AB_1079407, HPA063890: AB_2732707"	"unprognostic (3.65e-1)"	"unprognostic (3.82e-3)"	"unprognostic (4.56e-2)"	"unprognostic (9.20e-2)"	"unprognostic (9.86e-2)"	"unprognostic (1.36e-1)"	"prognostic unfavourable (5.62e-4)"	"unprognostic (1.48e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.93e-3)"	"unprognostic (9.89e-3)"	"prognostic favourable (1.71e-12)"	"unprognostic (2.28e-1)"	"unprognostic (1.82e-1)"	"unprognostic (6.90e-2)"	"unprognostic (6.87e-2)"	7.1	9.2	14.8	6.8	29.2	7.0	10.1	9.4	18.0	9.0	12.5	15.9	13.7	18.5	6.9	20.8	14.4	7.2	9.0	7.3	16.4	17.0	28.8	17.2	11.5	4.5	30.6	10.2	6.4	8.6	22.9	11.4	27.9	20.5	15.8	11.6	7.6	15.9	18.6	14.6	8.6	18.7	11.9	23.3	6.2	9.7	8.2	25.4	6.8	24.1	6.9	5.8	9.1	9.1	3.6	2.4	3.7	2.8	6.7	4.4	1.2	53.7	8.6	8.7	7.0	5.1	4.6	7.7	16.4	8.6	12.1	8.1	8.5	16.5	4.6	7.8	13.3	11.3	5.0	9.4	18.5	2.2	3.4	4.2	9.1	5.8	5.9	1.6	3.2	4.8	3.6	7.0	8.9	6.7	4.4	2.0	19.2	7.2	5.1	1.9	2.9	5.9	4.6	13.9	5.5	10.9	13.4	4.9	3.5	10.2	10.0	5.6	10.3	3.3	10.3	15.4	32.7	5.4	7.2	3.2	2.8	7.0	10.2	3.7	5.3	0.4	2.2	3.7	1.7	2.8	1.4	3.6	2.0	1.9	2.4	1.9	4.4	2.4	0.8	6.7	2.3	2.4	1.1	1.2	14.8	29.2	9.4	18.0	16.4	17.0	30.6	10.2	20.5	25.4
MRNIP	"C5orf45, DKFZp686L2452, LOC51149, MGC65027, MGC78537"	ENSG00000161010	"MRN complex interacting protein"	Q6NTE8	5	179835133-179862173	"Predicted intracellular proteins"	"DNA damage, DNA repair"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043975	Uncertain		Approved	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		"HPA043975: "	"unprognostic (4.97e-2)"	"unprognostic (2.79e-1)"	"unprognostic (7.98e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.63e-1)"	"unprognostic (5.15e-3)"	"unprognostic (1.68e-3)"	"unprognostic (2.51e-2)"	"unprognostic (1.10e-1)"	"unprognostic (6.11e-2)"	"unprognostic (3.63e-3)"	"unprognostic (2.05e-2)"	"prognostic unfavourable (2.64e-5)"	"unprognostic (1.18e-1)"	"unprognostic (3.73e-1)"	"unprognostic (7.00e-2)"	"unprognostic (1.43e-3)"	6.6	6.3	11.8	10.7	12.2	4.6	10.8	30.0	16.1	14.8	8.5	14.2	14.3	7.8	13.7	16.1	4.8	23.5	7.7	7.8	12.6	11.8	8.8	6.0	8.8	14.1	16.0	13.4	21.1	9.7	11.2	22.7	5.0	12.1	11.1	8.4	12.9	9.1	19.8	5.8	12.0	11.0	11.7	10.1	13.3	7.1	8.0	14.7	2.7	11.6	3.5	14.0	8.6	10.5	10.7	5.5	2.9	1.0	4.0	8.1	2.8	1.2	2.8	4.4	10.7	9.0	8.1	5.4	3.1	2.8	3.9	5.8	4.5	4.2	5.1	3.7	1.4	3.4	5.0	10.1	3.0	4.8	4.9	1.7	4.8	3.1	5.5	2.1	2.1	6.1	8.2	4.5	3.5	4.3	2.5	2.4	4.0	5.2	3.3	2.2	2.2	2.5	4.0	1.7	3.7	7.0	1.0	8.4	2.6	1.5	4.4	3.6	5.5	1.8	1.0	2.4	2.0	1.9	2.1	2.9	1.8	3.6	2.3	3.6	1.7	1.3	0.7	2.9	3.4	0.7	4.5	10.7	5.1	4.2	0.9	10.3	8.1	5.9	1.1	4.0	1.0	5.5	2.9	2.8	11.8	12.2	30.0	16.1	12.6	11.8	16.0	13.4	12.1	14.7
MRPL42	"HSPC204, MRP-L31, MRPL31, MRPS32, PTD007, RPML31"	ENSG00000198015	"Mitochondrial ribosomal protein L42"	Q9Y6G3	12	93467488-93516213	"Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA039398	Approved		Supported	"Plasma membrane,Mitochondria"				"Plasma membrane, Mitochondria"		"HPA039398: AB_10673529"	"unprognostic (9.32e-2)"	"unprognostic (4.18e-2)"	"unprognostic (4.50e-2)"	"unprognostic (3.89e-2)"	"unprognostic (1.27e-2)"	"unprognostic (1.75e-1)"	"prognostic unfavourable (7.49e-4)"	"unprognostic (6.13e-2)"	"unprognostic (3.66e-2)"	"unprognostic (1.95e-1)"	"unprognostic (2.18e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.51e-1)"	"unprognostic (2.45e-2)"	"unprognostic (4.92e-1)"	"unprognostic (1.62e-1)"	"prognostic favourable (8.12e-4)"	18.4	35.6	16.7	13.9	23.6	14.6	22.5	23.2	24.4	22.0	21.5	16.6	16.3	17.0	18.7	16.5	26.7	20.5	15.1	24.2	16.8	16.4	31.0	28.9	16.0	15.3	21.4	16.7	18.4	16.3	26.1	35.8	18.5	26.2	19.3	26.4	13.7	17.8	19.0	15.1	15.8	18.4	19.8	20.4	18.8	18.1	34.5	17.1	25.7	19.5	14.9	21.5	19.1	21.0	29.9	18.8	23.3	23.1	29.3	32.0	21.0	17.0	18.3	29.5	23.9	17.6	26.6	25.0	21.1	21.4	32.2	26.2	24.6	13.7	24.0	9.2	19.3	15.4	38.0	28.5	49.5	28.1	29.3	27.7	12.6	30.6	24.2	32.0	13.9	19.6	31.2	28.0	41.5	31.2	36.5	13.1	36.7	18.1	35.9	25.1	44.1	33.8	29.7	14.9	29.3	35.6	35.0	36.2	19.7	18.1	30.2	22.7	29.9	17.7	15.4	23.7	13.5	15.0	28.3	15.7	22.8	26.5	9.3	25.3	35.5	18.0	17.7	23.3	19.0	23.1	24.4	29.9	24.9	20.9	18.8	23.9	26.1	26.8	7.4	29.3	21.5	13.3	32.0	21.0	16.7	23.6	23.2	24.4	16.8	16.4	21.4	16.7	26.2	17.1
MRPL44	"FLJ12701, FLJ13990"	ENSG00000135900	"Mitochondrial ribosomal protein L44"	Q9H9J2	2	223957404-223967714	"Disease related genes, Predicted intracellular proteins, Ribosomal proteins"		"Endonuclease, Hydrolase, Nuclease, Ribonucleoprotein, Ribosomal protein, RNA-binding"	"Disease mutation, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038147, HPA038148"	Approved		Approved	"Nucleoplasm,Plasma membrane,Mitochondria"				Mitochondria	"Nucleoplasm, Plasma membrane"	"HPA038147: AB_10671521, HPA038148: "	"unprognostic (5.21e-2)"	"unprognostic (3.48e-1)"	"unprognostic (3.38e-2)"	"unprognostic (3.00e-1)"	"unprognostic (7.05e-2)"	"unprognostic (1.58e-1)"	"prognostic unfavourable (1.29e-4)"	"unprognostic (2.16e-2)"	"unprognostic (3.32e-1)"	"unprognostic (7.65e-2)"	"unprognostic (8.33e-2)"	"unprognostic (6.65e-2)"	"prognostic favourable (2.02e-4)"	"unprognostic (2.47e-2)"	"unprognostic (1.14e-1)"	"unprognostic (9.93e-2)"	"unprognostic (2.49e-1)"	16.4	29.2	15.3	16.8	16.4	32.7	26.7	15.1	24.2	11.7	17.9	12.8	9.2	16.0	13.9	12.6	18.3	14.1	14.8	29.0	14.6	16.9	31.0	38.9	13.0	24.1	15.2	17.0	13.5	26.1	11.0	12.7	17.3	13.8	13.3	19.6	11.8	14.1	13.9	35.3	14.7	15.5	12.3	15.6	18.8	14.9	18.4	12.8	23.6	16.2	22.9	21.0	14.1	11.3	31.5	28.2	39.8	30.1	21.2	26.9	23.3	11.9	10.1	15.1	17.4	14.3	17.0	24.0	13.5	15.1	22.0	23.3	35.9	15.0	18.1	14.7	11.5	16.0	24.5	18.6	20.4	17.0	17.4	19.7	11.7	28.1	21.1	21.8	15.2	19.9	23.3	13.3	17.9	21.5	18.8	14.4	17.6	13.8	16.2	27.6	22.6	10.6	19.2	18.6	11.1	29.3	10.1	20.6	11.9	9.9	22.3	32.5	18.8	31.5	14.1	14.7	11.4	12.5	10.8	15.9	11.0	25.9	14.9	20.8	16.1	31.5	30.1	22.6	20.5	29.1	25.9	31.5	22.1	24.4	28.2	27.0	26.9	23.5	39.8	21.2	25.6	22.6	22.2	23.3	15.3	16.4	15.1	24.2	14.6	16.9	15.2	17.0	13.8	12.8
MS4A12	"FLJ20217, Ms4a10"	ENSG00000071203	"Membrane spanning 4-domains A12"	Q9NXJ0	11	60492778-60507430	"Predicted membrane proteins"		Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	41	"intestine: 64.7;lymphoid tissue: 28.6"	"Cell line enhanced"	"Detected in some"		"HeLa: 1.5;LHCN-M2: 2.1;NTERA-2: 3.0;RH-30: 4.2;U-2 OS: 1.7"	"Cancer enriched"	"Detected in some"	8	"colorectal cancer: 6.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA048616, HPA057657"	Enhanced		Approved	"Nucleoli,Endoplasmic reticulum,Golgi apparatus,Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"	"Nucleoli, Endoplasmic reticulum, Golgi apparatus"	"HPA048616: , HPA057657: "			"unprognostic (2.64e-2)"						"unprognostic (2.33e-1)"			"unprognostic (1.49e-1)"		"unprognostic (3.26e-1)"	"unprognostic (2.83e-1)"	"unprognostic (9.20e-3)"		0.1	0.0	0.1	28.6	0.1	0.0	0.1	0.1	0.1	0.1	57.7	0.1	0.1	0.0	0.1	0.1	0.1	0.2	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	64.7	0.1	0.1	0.1	0.1	0.0	0.2	1.1	0.1	0.1	0.0	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.1	1.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	3.0	0.0	0.2	4.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	1.7	0.0	0.3	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
MS4A14	"DKFZp434H092, FLJ32856, MS4A16, NYD-SP21"	ENSG00000166928	"Membrane spanning 4-domains A14"	Q96JA4	11	60378530-60417756	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"		Receptor		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 79.3;testis: 53.6"	"Cell line enriched"	"Detected in single"	24	"THP-1: 14.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"intermediate monocyte: 6.8;non-classical monocyte: 9.2"	"Lineage enriched"	"Detected in many"	5	"monocytes: 9.2"									HPA058973			Approved	"Nucleoplasm,Plasma membrane"				Nucleoplasm	"Plasma membrane"	"HPA058973: "	"unprognostic (1.78e-1)"	"unprognostic (1.76e-1)"	"unprognostic (5.75e-2)"	"unprognostic (1.77e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.79e-2)"	"unprognostic (1.24e-1)"	"unprognostic (3.45e-2)"	"unprognostic (4.00e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.77e-1)"	"unprognostic (2.14e-1)"	"unprognostic (4.50e-6)"	"unprognostic (3.73e-2)"	"unprognostic (7.16e-3)"	"unprognostic (8.40e-2)"	"unprognostic (7.11e-2)"	14.5	4.4	2.0	4.6	2.3	1.5	5.4	0.8	1.5	2.4	3.9	1.9	1.1	1.5	1.9	6.4	1.8	1.3	2.3	6.4	2.5	2.3	3.5	13.3	18.0	11.3	2.4	0.1	1.3	1.5	1.2	3.2	6.0	2.4	3.0	2.2	4.5	2.1	1.6	1.3	1.3	4.0	2.4	5.5	79.3	1.5	53.6	1.5	3.7	1.7	0.7	3.0	2.4	1.7	0.5	1.8	0.1	9.2	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	14.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.5	0.0	0.0	4.3	0.0	0.0	6.8	0.0	0.0	0.0	0.0	1.8	0.5	0.0	0.0	0.1	0.0	9.2	0.0	0.0	0.9	2.0	2.3	0.8	1.5	2.5	2.3	2.4	0.1	2.4	1.5
MS4A15		ENSG00000166961	"Membrane spanning 4-domains A15"	Q8N5U1	11	60756953-60776732	"Predicted membrane proteins"		Receptor		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	9	"blood: 9.9;lung: 32.4"	"Group enriched"	"Detected in some"	4	"HEL: 9.0;Karpas-707: 3.7;MOLT-4: 4.0;U-266/70: 13.2;U-266/84: 5.6"	"Cancer enhanced"	"Detected in many"		"lung cancer: 6.3"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"T-reg: 9.9"	"Lineage enriched"	"Detected in single"	15	"T-cells: 9.9"	"Region enriched"	"Detected in single"	28	"olfactory region: 205.0"	"Region enriched"	"Detected in single"	29	"olfactory region: 39.1"	HPA054563			Approved	"Plasma membrane,Cytosol"				"Plasma membrane"	Cytosol	"HPA054563: "	"unprognostic (1.85e-1)"	"unprognostic (4.31e-3)"	"unprognostic (8.59e-2)"	"unprognostic (5.89e-4)"	"unprognostic (4.49e-1)"	"unprognostic (1.09e-3)"		"unprognostic (3.92e-3)"	"unprognostic (5.43e-3)"	"unprognostic (1.20e-1)"	"unprognostic (7.30e-2)"	"unprognostic (3.14e-1)"	"unprognostic (1.04e-9)"	"unprognostic (7.02e-2)"	"unprognostic (8.63e-2)"	"unprognostic (2.75e-1)"	"unprognostic (1.47e-1)"	0.3	0.2	0.3	0.3	0.3	0.0	1.3	0.3	0.3	0.3	0.3	0.3	0.3	0.6	1.8	0.3	0.4	1.0	0.3	0.3	0.3	0.2	0.3	0.3	32.4	0.3	0.3	0.3	2.4	0.3	0.0	0.3	1.1	0.3	0.3	0.5	0.3	0.3	1.9	0.3	0.2	1.4	1.7	0.3	0.3	0.2	0.6	0.3	0.3	0.3	0.3	1.0	0.7	0.3	0.2	0.0	0.0	0.0	0.6	9.9	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.1	0.0	0.0	0.0	0.0	0.2	0.1	9.0	0.0	0.0	0.0	0.1	0.2	0.1	0.0	0.0	0.0	0.0	1.6	3.7	0.0	0.0	4.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.1	0.0	0.0	0.0	0.5	0.0	0.0	13.2	5.6	0.9	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.2	2.9	0.5	0.0	0.0	1.8	0.7	0.0	0.6	0.0	0.0	9.9	0.7	0.3	0.3	0.3	0.3	0.3	0.2	0.3	0.3	0.3	0.3
MTCP1	"P13MTCP1, p8MTCP1"	ENSG00000214827	"Mature T cell proliferation 1"	P56278	X	155061622-155147937	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"			"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HeLa: 14.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA032040			Approved	"Nucleoplasm,Plasma membrane"				Nucleoplasm	"Plasma membrane"	"HPA032040: "	"unprognostic (2.42e-2)"	"unprognostic (2.07e-2)"	"unprognostic (1.14e-1)"	"unprognostic (6.29e-3)"	"unprognostic (8.30e-2)"	"unprognostic (4.10e-1)"	"unprognostic (2.40e-5)"	"unprognostic (9.30e-2)"	"unprognostic (1.17e-1)"	"unprognostic (4.94e-2)"	"unprognostic (5.72e-2)"	"unprognostic (1.15e-2)"	"prognostic unfavourable (4.52e-8)"	"unprognostic (1.55e-3)"	"unprognostic (1.06e-2)"	"unprognostic (1.39e-2)"	"unprognostic (1.75e-2)"	6.4	7.1	4.1	5.3	5.3	7.2	15.8	4.4	4.8	6.0	6.2	3.4	7.7	5.7	6.0	8.2	7.0	6.1	4.4	30.1	4.7	2.9	6.7	12.8	8.5	15.5	4.5	2.7	9.1	20.7	3.9	6.5	3.5	6.4	5.8	6.1	3.9	7.3	7.0	11.4	12.0	6.7	8.7	7.2	6.7	6.2	16.1	3.8	2.5	8.2	5.4	7.2	6.9	4.0	0.2	0.0	0.8	0.7	0.5	2.0	0.1	1.4	4.9	2.4	3.8	1.6	1.3	2.6	3.0	1.5	1.9	4.7	4.2	7.4	2.6	3.0	0.6	4.7	3.1	3.5	2.3	1.8	3.1	1.2	14.0	2.3	1.3	2.8	3.2	2.4	1.6	3.1	3.0	1.7	1.1	4.8	1.3	2.0	3.7	6.0	1.1	0.8	3.9	2.5	6.0	2.4	2.0	1.2	1.8	2.1	1.2	2.1	2.1	1.3	1.8	2.2	3.8	2.1	2.2	10.5	4.5	5.1	4.2	3.4	3.1	0.0	0.6	0.8	1.1	0.0	2.0	0.2	1.2	0.4	0.0	0.1	0.2	1.4	0.0	0.5	0.7	0.0	0.0	0.1	4.1	5.3	4.4	4.8	4.7	2.9	4.5	2.7	6.4	3.8
MTPN	"GCDP, MYOTROPHIN, V-1"	ENSG00000105887	Myotrophin	P58546	7	135926761-135977353	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019735	Approved		Approved	"Plasma membrane,Cytosol"			48000000	"Plasma membrane, Cytosol"		"HPA019735: AB_1858710"	"unprognostic (5.97e-2)"	"unprognostic (2.53e-2)"	"unprognostic (8.52e-2)"	"unprognostic (3.62e-3)"	"unprognostic (2.20e-2)"	"unprognostic (1.95e-1)"	"prognostic unfavourable (1.19e-4)"	"unprognostic (2.06e-3)"	"unprognostic (3.30e-2)"	"unprognostic (8.11e-2)"	"prognostic unfavourable (3.05e-4)"	"unprognostic (4.50e-2)"	"unprognostic (1.83e-2)"	"unprognostic (2.60e-2)"	"unprognostic (2.43e-1)"	"unprognostic (9.00e-3)"	"unprognostic (4.86e-3)"	31.0	22.1	40.2	28.5	53.2	55.1	39.6	34.4	50.0	30.9	21.4	20.4	16.0	17.2	29.5	21.9	62.1	27.0	23.7	31.6	38.0	31.6	25.1	20.5	31.6	49.3	24.2	32.4	22.0	10.7	29.2	22.5	26.3	22.9	23.4	23.6	21.5	22.2	24.0	27.4	19.1	23.1	27.9	23.3	42.4	17.6	23.4	19.9	36.4	36.9	24.9	42.8	26.1	30.5	37.9	24.6	50.6	43.5	12.8	16.7	17.0	27.2	21.6	23.9	35.7	34.3	40.8	12.5	43.2	43.9	27.7	30.4	24.6	29.4	48.1	32.0	53.1	17.4	22.3	33.9	51.4	35.6	22.0	32.9	23.4	16.0	28.2	44.0	47.4	29.8	33.6	33.0	31.0	43.1	39.0	29.1	52.2	20.8	44.4	32.6	33.8	30.7	25.8	18.3	39.2	30.1	22.6	30.8	56.2	35.2	21.9	33.2	16.1	26.9	46.2	42.0	19.2	41.7	40.7	24.3	35.7	71.1	67.1	38.7	89.2	25.4	21.4	22.6	16.7	28.9	14.3	30.9	10.4	12.5	24.6	37.9	6.9	9.9	50.6	12.8	43.5	24.2	9.0	17.0	40.2	53.2	34.4	50.0	38.0	31.6	24.2	32.4	22.9	19.9
MUC20	"FLJ14408, KIAA1359"	ENSG00000176945	"Mucin 20, cell surface associated"	Q8N307	3	195720882-195741123	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"kidney: 50.6"	"Cell line enriched"	"Detected in some"	8	"SK-BR-3: 24.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in single"		"naive CD8 T-cell: 1.2"	"Lineage enhanced"	"Detected in single"		"T-cells: 1.2"									HPA042249			Approved	"Nucleoplasm,Plasma membrane,Cytosol"	"Secreted to extracellular matrix"		11000	"Nucleoplasm, Cytosol"	"Plasma membrane"	"HPA042249: "	"unprognostic (1.85e-1)"	"unprognostic (4.64e-2)"	"unprognostic (1.05e-2)"	"unprognostic (1.83e-3)"	"unprognostic (2.12e-1)"	"unprognostic (1.59e-2)"	"unprognostic (2.06e-1)"	"unprognostic (2.41e-1)"	"unprognostic (3.99e-4)"	"unprognostic (7.66e-2)"	"unprognostic (2.84e-2)"	"unprognostic (1.14e-1)"	"prognostic favourable (1.57e-4)"	"unprognostic (2.05e-1)"	"unprognostic (2.56e-1)"	"unprognostic (3.98e-3)"	"unprognostic (1.17e-1)"	1.7	1.2	1.1	3.4	2.1	1.2	1.8	2.5	1.2	6.3	15.2	1.1	4.7	3.2	1.5	5.2	15.9	5.7	8.7	1.1	1.1	0.7	50.6	4.8	6.4	1.1	1.1	1.1	4.6	7.6	1.0	4.6	13.3	1.1	4.9	7.6	1.2	10.6	1.8	2.5	2.1	4.1	2.0	1.1	1.6	2.3	1.8	1.1	3.0	3.9	1.9	14.9	10.6	26.6	0.4	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.2	0.5	0.2	0.0	0.6	0.0	0.1	0.0	0.0	0.0	2.9	0.1	0.5	0.0	1.3	0.1	0.0	0.0	0.7	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.4	0.0	0.1	0.4	0.0	0.5	0.1	0.8	0.1	0.8	0.0	1.9	1.0	0.3	0.0	24.8	0.1	0.1	0.0	0.0	0.2	0.7	0.8	0.1	1.1	1.3	0.0	0.2	0.1	0.2	0.0	0.0	0.0	0.5	0.0	0.4	0.0	0.2	0.0	0.0	0.4	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	1.1	2.1	2.5	1.2	1.1	0.7	1.1	1.1	1.1	1.1
MYL4	"ALC1, AMLC, GT1, PRO1957"	ENSG00000198336	"Myosin light chain 4"	P12829	17	47200446-47223679	"Disease related genes, Plasma proteins, Predicted intracellular proteins"		"Motor protein, Muscle protein, Myosin"	"Atrial fibrillation, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	68	"heart muscle: 712.3"	"Cell line enriched"	"Detected in some"	4	"HEL: 107.4"	"Group enriched"	"Detected in some"	7	"testis cancer: 2.4;thyroid cancer: 11.7"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	11	"plasmacytoid DC: 5.2"	"Lineage enriched"	"Detected in single"	11	"dendritic cells: 5.2"	"Group enriched"	"Detected in many"	6	"amygdala: 25.9;cerebral cortex: 83.3;hippocampal formation: 27.8"	"Low region specificity"	"Detected in all"			"HPA046859, HPA051884, HPA063034"	Enhanced		Approved	"Plasma membrane"			140000	"Plasma membrane"		"HPA046859: , HPA051884: , HPA063034: "	"unprognostic (2.43e-2)"	"unprognostic (9.57e-2)"	"unprognostic (2.25e-1)"	"unprognostic (5.51e-2)"	"unprognostic (2.33e-1)"	"unprognostic (4.12e-3)"	"unprognostic (5.06e-3)"	"unprognostic (1.34e-1)"	"unprognostic (1.13e-1)"	"unprognostic (6.52e-2)"	"unprognostic (2.10e-2)"	"unprognostic (7.37e-2)"	"unprognostic (1.00e-6)"	"unprognostic (1.92e-4)"	"unprognostic (2.54e-1)"	"unprognostic (6.51e-3)"	"unprognostic (1.50e-1)"	0.1	0.0	0.0	0.1	0.0	10.4	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.1	0.0	0.0	712.3	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.1	0.7	0.0	0.0	0.7	0.1	0.0	0.0	0.8	3.3	0.0	0.5	0.0	0.0	0.1	0.0	0.1	0.2	0.7	0.0	0.1	0.6	4.6	0.1	0.1	0.2	0.2	5.2	0.0	0.4	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.0	107.4	0.0	0.0	0.0	0.0	0.0	4.4	0.0	0.0	0.0	0.2	25.4	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.1	5.2	0.0	0.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0
MYO3A	DFNB30	ENSG00000095777	"Myosin IIIA"	Q8NEV4	10	25934071-26212536	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Hearing, Sensory transduction, Vision"	"Actin-binding, Kinase, Motor protein, Myosin, Serine/threonine-protein kinase, Transferase"	"Deafness, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pituitary gland: 8.1;testis: 12.5"	"Cell line enhanced"	"Detected in some"		"AF22: 2.3;CAPAN-2: 2.2;HEK 293: 2.6;SCLC-21H: 2.4;U-2 OS: 4.3;U-698: 10.9"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"basal ganglia: 5.0;cerebral cortex: 1.9;hypothalamus: 1.3;pons and medulla: 5.4"	"Cell type enriched"	"Detected in single"	12	"naive B-cell: 1.1"	"Lineage enriched"	"Detected in single"	12	"B-cells: 1.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"HPA048951, HPA051893"	Approved		Supported	"Plasma membrane,Actin filaments,Cytoplasmic bodies"				"Actin filaments, Cytoplasmic bodies"	"Plasma membrane"	"HPA048951: , HPA051893: "	"unprognostic (5.00e-3)"	"unprognostic (3.36e-2)"	"unprognostic (1.53e-1)"	"unprognostic (3.20e-3)"	"unprognostic (2.96e-1)"	"unprognostic (4.37e-2)"		"unprognostic (5.29e-2)"	"unprognostic (2.74e-1)"	"unprognostic (4.31e-2)"	"unprognostic (1.03e-1)"	"unprognostic (5.66e-3)"	"unprognostic (7.96e-3)"	"unprognostic (6.34e-2)"	"unprognostic (1.46e-2)"	"unprognostic (6.62e-2)"	"unprognostic (9.69e-2)"	0.8	0.7	0.4	0.3	5.0	0.5	1.5	0.3	1.9	2.1	0.6	0.1	0.7	0.4	0.3	3.2	0.9	1.1	0.3	0.3	0.5	1.3	0.9	0.2	1.0	0.3	0.2	0.0	0.5	2.1	0.2	8.1	0.2	5.4	0.5	1.1	3.8	0.2	0.6	0.3	2.2	0.6	1.0	0.4	0.3	0.9	12.5	0.8	0.0	1.3	1.4	0.9	0.5	0.9	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	1.6	0.0	0.0	1.2	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.3	0.0	0.0	0.0	0.0	10.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	5.0	0.3	1.9	0.5	1.3	0.2	0.0	5.4	0.8
MYO5B	KIAA1119	ENSG00000167306	"Myosin VB"	Q9ULV0	18	49822813-50195093	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Protein transport, Transport"	"Actin-binding, Calmodulin-binding, Motor protein, Myosin"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"intestine: 92.2"	"Cell line enhanced"	"Detected in many"		"A-431: 20.6;HaCaT: 32.6;RH-30: 50.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"NK-cell: 2.4"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"HPA040593, HPA040902, HPA069773"	Enhanced		Approved	"Plasma membrane"				"Plasma membrane"		"HPA040593: AB_10795525, HPA040902: AB_10796230, HPA069773: "	"unprognostic (2.51e-1)"	"unprognostic (2.15e-2)"	"unprognostic (2.12e-2)"	"unprognostic (6.17e-3)"	"unprognostic (2.14e-1)"	"unprognostic (8.84e-3)"	"unprognostic (1.32e-1)"	"unprognostic (2.59e-1)"	"unprognostic (4.13e-2)"	"unprognostic (3.46e-1)"	"prognostic unfavourable (2.26e-5)"	"unprognostic (4.48e-2)"	"prognostic favourable (1.45e-11)"	"unprognostic (2.17e-3)"	"unprognostic (1.50e-1)"	"unprognostic (6.56e-2)"	"unprognostic (3.28e-1)"	2.0	1.2	1.1	12.7	1.3	0.0	5.2	0.4	2.5	7.5	56.9	1.0	13.7	23.5	1.8	10.4	20.3	4.6	20.6	2.0	1.8	1.2	19.1	13.9	9.4	0.6	0.7	1.5	1.7	16.4	9.3	10.5	13.5	2.1	6.0	17.5	8.4	21.6	8.7	0.6	14.5	92.2	0.8	0.7	0.9	13.1	5.5	0.3	2.4	16.3	14.9	17.4	4.0	11.8	1.0	0.1	0.0	0.0	2.4	0.6	0.0	20.6	5.6	0.1	0.1	0.0	0.0	11.3	0.1	0.8	0.4	0.0	14.6	8.8	0.0	5.2	0.0	32.6	7.4	8.8	0.4	0.0	2.2	0.0	2.5	10.3	0.0	0.0	0.0	0.0	7.8	0.2	5.4	0.7	0.1	8.1	0.8	8.0	0.0	0.0	1.5	2.3	0.0	50.5	3.5	18.6	4.2	11.2	0.2	7.9	9.3	0.0	5.5	0.0	0.4	0.0	11.4	0.1	2.1	5.5	3.4	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.6	1.0	0.4	0.1	0.0	0.0	0.2	0.4	0.0	2.4	0.0	0.1	0.1	0.0	1.1	1.3	0.4	2.5	1.8	1.2	0.7	1.5	2.1	0.3
MYO9A	"FLJ11061, FLJ13244, MGC71859"	ENSG00000066933	"Myosin IXA"	B2RTY4	15	71822289-72118577	"Plasma proteins, Predicted intracellular proteins"		"Actin-binding, GTPase activation, Motor protein, Myosin"	"Congenital myasthenic syndrome, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039812, HPA040071"	Approved		Approved	"Plasma membrane"				"Plasma membrane"		"HPA039812: AB_10961421, HPA040071: AB_10961117"	"unprognostic (7.53e-2)"	"unprognostic (2.40e-1)"	"unprognostic (1.96e-1)"	"unprognostic (2.42e-3)"	"unprognostic (1.63e-1)"	"unprognostic (8.69e-3)"	"unprognostic (3.77e-2)"	"unprognostic (3.56e-2)"	"unprognostic (1.26e-1)"	"unprognostic (5.50e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.34e-1)"	"prognostic favourable (2.14e-4)"	"unprognostic (3.44e-1)"	"unprognostic (4.41e-1)"	"unprognostic (1.25e-1)"	"unprognostic (4.23e-2)"	10.5	6.0	13.8	9.6	17.9	6.1	14.8	18.3	16.4	13.3	11.1	7.5	10.6	3.4	15.0	11.0	11.2	10.8	7.5	9.3	9.5	9.3	19.6	5.5	12.2	8.4	9.1	12.0	17.5	5.0	15.9	14.7	10.5	14.6	11.9	9.2	9.1	8.3	11.3	12.9	12.0	8.0	14.4	9.0	10.0	9.7	35.6	11.2	9.1	18.4	6.6	8.8	11.9	13.9	6.1	9.3	5.2	3.4	3.7	7.6	1.3	6.3	9.7	6.4	4.6	9.9	11.7	3.8	6.0	6.6	6.1	6.3	4.7	4.4	28.4	3.6	11.9	6.0	12.9	6.9	8.2	6.2	7.5	7.1	5.5	2.0	6.3	7.2	5.8	6.6	7.0	7.2	10.4	7.7	4.6	6.8	8.2	3.9	4.1	2.9	3.4	4.0	2.9	12.4	2.7	7.5	9.5	3.6	4.0	7.7	6.8	6.2	5.3	3.5	10.3	12.3	6.0	19.8	6.8	4.3	10.8	7.6	7.3	6.0	5.4	2.2	2.2	5.2	5.6	2.0	7.6	4.7	5.4	4.6	2.2	6.1	5.7	5.3	0.3	3.7	3.4	9.3	4.5	1.3	13.8	17.9	18.3	16.4	9.5	9.3	9.1	12.0	14.6	11.2
N4BP2	B3BP	ENSG00000078177	"NEDD4 binding protein 2"	Q86UW6	4	40056826-40158252	"Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 35.6"	"Cell line enhanced"	"Detected in many"		"MOLT-4: 20.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036770, HPA042607, HPA072549"	Approved		Approved	"Nucleoplasm,Plasma membrane,Cytosol"				Nucleoplasm	"Plasma membrane, Cytosol"	"HPA036770: AB_10672477, HPA042607: , HPA072549: "	"unprognostic (5.03e-2)"	"unprognostic (3.42e-1)"	"unprognostic (7.94e-3)"	"unprognostic (1.15e-1)"	"unprognostic (1.50e-1)"	"unprognostic (3.99e-3)"	"unprognostic (2.88e-1)"	"unprognostic (1.01e-1)"	"unprognostic (3.66e-2)"	"unprognostic (2.65e-2)"	"unprognostic (9.55e-3)"	"unprognostic (4.49e-2)"	"unprognostic (2.14e-2)"	"unprognostic (1.24e-1)"	"unprognostic (9.31e-2)"	"unprognostic (6.85e-3)"	"unprognostic (1.45e-1)"	3.5	3.1	3.4	7.4	5.1	7.0	5.8	6.1	3.2	5.5	4.3	1.2	7.1	4.7	7.0	6.6	5.2	4.8	3.8	3.5	2.5	3.6	3.2	11.3	7.5	9.2	1.9	1.6	7.0	13.1	2.5	14.3	11.9	2.8	4.9	4.5	4.3	10.7	11.0	2.9	5.4	5.3	3.2	3.1	4.3	3.8	3.5	2.1	35.6	7.2	3.5	7.8	5.6	5.2	2.4	8.1	5.7	1.2	10.6	4.5	1.2	1.5	1.6	9.3	1.5	0.6	3.1	7.6	1.7	1.9	1.0	2.2	2.9	3.1	8.2	3.4	1.6	1.1	5.9	1.9	2.4	2.6	1.9	3.7	1.4	1.4	1.6	9.9	8.8	3.4	2.7	1.7	3.7	2.7	8.1	3.6	2.0	1.5	20.0	4.3	4.6	1.3	11.7	11.0	1.9	0.8	3.6	3.8	6.6	1.6	1.3	1.5	1.1	2.7	3.6	1.1	5.9	0.7	1.3	5.9	5.9	5.6	1.1	3.6	2.3	5.7	1.1	0.5	2.3	1.2	2.4	1.7	3.0	1.7	1.7	2.4	4.5	2.5	0.3	10.6	1.0	8.1	1.3	1.2	3.4	5.1	6.1	3.2	2.5	3.6	1.9	1.6	2.8	2.1
NAB1		ENSG00000138386	"NGFI-A binding protein 1"	Q13506	2	190646746-190692766	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002738	Uncertain		Approved	"Nucleoplasm,Golgi apparatus,Plasma membrane"				"Nucleoplasm, Plasma membrane"	"Golgi apparatus"	"HPA002738: AB_1079447"	"unprognostic (1.44e-1)"	"unprognostic (2.65e-2)"	"unprognostic (6.02e-3)"	"unprognostic (4.04e-3)"	"unprognostic (9.05e-2)"	"unprognostic (9.45e-2)"	"unprognostic (7.12e-3)"	"unprognostic (6.41e-2)"	"unprognostic (2.13e-2)"	"unprognostic (1.79e-2)"	"prognostic unfavourable (1.01e-4)"	"unprognostic (3.52e-1)"	"unprognostic (7.23e-3)"	"unprognostic (1.71e-1)"	"unprognostic (1.90e-1)"	"unprognostic (1.13e-1)"	"unprognostic (3.85e-2)"	19.1	10.3	12.1	12.5	13.7	7.6	28.3	28.2	15.7	18.5	19.9	10.4	7.2	7.4	16.2	26.4	32.3	14.1	13.9	21.2	12.1	9.7	10.6	18.6	12.5	13.8	14.5	12.0	15.7	9.3	16.4	20.2	12.8	12.4	16.3	12.9	19.8	15.9	17.5	6.9	33.2	10.9	13.3	14.3	9.3	18.4	12.3	12.4	13.6	19.0	15.7	13.0	13.0	25.8	1.4	1.7	5.4	6.1	4.6	6.0	1.4	12.1	9.1	23.1	8.0	9.0	15.8	40.0	12.4	19.7	9.4	10.7	22.0	13.6	13.6	14.7	9.8	31.3	13.2	16.0	18.7	43.6	11.2	16.0	32.4	10.5	5.8	6.7	8.1	9.1	25.7	20.0	6.1	14.6	15.7	11.8	14.5	6.0	9.7	7.0	8.1	12.5	12.0	16.7	5.4	7.1	11.9	20.9	17.0	14.7	5.0	13.1	4.0	10.6	10.1	19.8	15.8	11.2	7.4	9.4	10.0	10.2	20.9	6.2	15.4	0.0	2.6	1.1	2.7	2.0	4.0	1.4	2.8	3.5	1.7	0.9	2.9	3.1	5.4	4.6	6.1	1.6	6.0	1.4	12.1	13.7	28.2	15.7	12.1	9.7	14.5	12.0	12.4	12.4
NAIF1	"bA379C10.2, C9orf90, DKFZp762G199"	ENSG00000171169	"Nuclear apoptosis inducing factor 1"	Q69YI7	9	128061233-128068206	"Predicted intracellular proteins"	Apoptosis			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA054898, HPA064931"			Approved	"Nucleoplasm,Plasma membrane,Cytosol"				Nucleoplasm	"Plasma membrane, Cytosol"	"HPA054898: , HPA064931: "	"unprognostic (7.09e-2)"	"unprognostic (5.92e-2)"	"unprognostic (1.20e-2)"	"unprognostic (5.56e-3)"	"unprognostic (1.58e-1)"	"unprognostic (2.17e-1)"	"prognostic unfavourable (1.61e-4)"	"unprognostic (1.60e-1)"	"unprognostic (6.15e-2)"	"unprognostic (9.41e-2)"	"prognostic favourable (1.02e-5)"	"unprognostic (3.08e-1)"	"prognostic favourable (8.30e-5)"	"unprognostic (8.48e-2)"	"unprognostic (2.47e-1)"	"unprognostic (6.67e-2)"	"unprognostic (3.92e-2)"	7.1	7.2	4.5	5.1	4.5	11.3	10.3	5.6	5.5	6.0	4.5	2.4	10.9	6.0	6.3	5.1	7.1	5.4	6.6	7.4	5.5	3.4	5.2	8.3	9.3	8.3	3.8	4.2	5.4	7.3	3.4	4.5	7.3	5.3	6.0	3.7	5.5	6.5	9.5	7.1	5.5	6.2	5.2	4.8	9.0	5.5	15.6	2.9	12.5	6.2	6.1	7.8	5.5	16.3	3.4	2.2	4.5	3.0	1.6	3.4	1.5	4.8	4.1	2.6	6.8	2.5	2.2	6.0	3.7	2.2	3.1	2.5	3.3	3.8	5.8	3.2	2.3	3.6	2.7	2.8	2.6	17.8	3.7	4.3	5.0	1.9	4.1	5.9	12.2	2.0	3.3	2.4	3.9	2.8	10.1	3.7	2.9	5.5	5.7	7.2	2.9	7.1	5.5	4.2	5.3	2.4	3.0	3.8	4.4	3.5	5.0	3.8	3.9	5.9	1.9	3.7	11.7	3.1	4.2	6.1	12.7	3.9	3.5	3.9	4.9	0.0	2.2	3.3	1.7	2.0	1.4	1.1	3.4	2.5	2.2	3.4	2.6	2.2	4.5	1.6	3.0	1.7	0.9	1.5	4.5	4.5	5.6	5.5	5.5	3.4	3.8	4.2	5.3	2.9
NAPG		ENSG00000134265	"NSF attachment protein gamma"	Q99747	18	10525905-10552761	"Predicted intracellular proteins"	"ER-Golgi transport, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 54.1"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008208, HPA011389"	Enhanced		Approved	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		"HPA008208: AB_1854305, HPA011389: AB_1854306"	"unprognostic (1.23e-1)"	"unprognostic (7.64e-3)"	"unprognostic (6.96e-2)"	"unprognostic (1.53e-1)"	"unprognostic (9.83e-2)"	"unprognostic (2.28e-1)"	"unprognostic (1.28e-1)"	"unprognostic (4.59e-2)"	"unprognostic (1.55e-2)"	"unprognostic (2.77e-3)"	"unprognostic (1.46e-3)"	"unprognostic (5.85e-2)"	"prognostic favourable (8.14e-4)"	"unprognostic (3.81e-2)"	"unprognostic (2.87e-1)"	"unprognostic (4.97e-2)"	"unprognostic (6.96e-2)"	11.0	14.0	20.5	9.1	31.2	6.1	12.1	24.0	40.2	11.6	11.6	17.8	4.9	9.3	11.0	12.7	12.3	11.3	13.5	19.3	26.3	20.8	16.9	13.3	9.6	8.7	24.1	21.4	7.6	12.4	12.8	10.5	13.7	54.1	14.3	14.1	10.1	10.7	11.6	9.0	8.8	10.3	12.5	25.2	8.5	13.4	7.1	11.9	6.9	14.8	8.2	10.6	12.6	8.7	8.4	4.7	15.2	7.1	6.6	7.1	3.6	5.7	3.4	6.1	5.2	17.5	12.0	8.9	12.3	17.7	12.0	15.4	7.6	8.8	7.7	9.9	16.8	5.7	8.0	11.1	17.3	6.6	4.9	5.6	6.0	7.8	16.8	15.5	10.6	12.6	12.9	13.8	10.3	11.3	9.1	18.3	17.5	8.0	11.9	6.6	4.7	5.2	5.3	10.1	12.8	14.1	13.6	24.3	6.4	10.0	10.6	14.1	4.9	10.3	12.6	19.1	9.2	17.4	12.9	11.8	12.1	8.5	12.8	10.9	8.7	11.3	5.7	15.2	6.5	7.1	5.8	8.4	5.2	6.3	4.2	4.1	7.1	6.1	9.7	6.6	6.9	4.7	5.1	3.6	20.5	31.2	24.0	40.2	26.3	20.8	24.1	21.4	54.1	11.9
NARFL	"FLJ21988, HPRN, IOP1, NAR1, PRN"	ENSG00000103245	"Nuclear prelamin A recognition factor like"	Q9H6Q4	16	729753-741329	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"REH: 55.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040851	Approved		Approved	"Plasma membrane,Cytosol"				Cytosol	"Plasma membrane"	"HPA040851: AB_10794427"	"unprognostic (6.31e-2)"	"prognostic favourable (1.32e-5)"	"unprognostic (7.61e-2)"	"unprognostic (8.25e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.27e-3)"	"unprognostic (8.85e-2)"	"unprognostic (3.76e-2)"	"unprognostic (2.23e-1)"	"unprognostic (8.39e-2)"	"unprognostic (4.45e-3)"	"unprognostic (3.02e-1)"	"prognostic favourable (9.83e-5)"	"unprognostic (2.49e-2)"	"unprognostic (8.15e-2)"	"unprognostic (2.62e-1)"	"unprognostic (8.33e-3)"	10.2	11.9	16.4	15.3	19.7	15.0	10.3	21.8	28.8	10.0	12.6	21.6	21.1	20.9	11.1	19.2	15.2	13.7	10.6	20.9	18.1	14.2	16.1	17.6	9.1	16.2	15.1	9.8	11.3	18.4	18.5	13.1	11.1	16.7	15.7	8.1	14.3	25.4	17.5	24.1	14.9	15.5	8.7	14.1	15.0	14.5	8.7	13.1	18.4	12.6	13.7	18.9	11.7	11.3	16.0	11.8	8.3	10.9	13.9	12.9	9.4	3.5	10.4	4.1	6.0	4.3	3.0	10.0	5.1	3.8	7.1	6.2	7.4	8.8	5.0	7.8	3.2	8.0	4.0	6.2	2.5	9.3	9.2	4.2	6.0	6.0	5.5	7.5	6.1	3.8	7.8	4.2	3.5	5.2	7.8	4.8	3.4	13.2	6.7	3.4	3.4	6.7	55.6	6.3	9.1	4.3	3.6	4.7	6.6	6.0	14.6	5.1	13.3	7.6	5.5	5.9	5.6	6.5	4.5	6.4	4.5	14.0	4.1	4.3	7.7	2.7	10.9	8.3	11.5	9.9	8.9	16.0	11.7	9.5	11.8	10.5	9.5	12.9	2.3	13.9	10.6	9.5	11.1	9.4	16.4	19.7	21.8	28.8	18.1	14.2	15.1	9.8	16.7	13.1
NCKAP5	"ERIH1, ERIH2, NAP5"	ENSG00000176771	"NCK associated protein 5"	O14513	2	132671799-133568463	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 18.3;lung: 19.2"	"Cell line enriched"	"Detected in some"	6	"AF22: 31.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	8	"basophil: 3.1"	"Lineage enriched"	"Detected in single"	8	"granulocytes: 3.1"	"Low region specificity"	"Detected in all"							"HPA034639, HPA044859"	Uncertain		Approved	"Nucleoli,Golgi apparatus,Plasma membrane,Cytosol"				Nucleoli	"Golgi apparatus, Plasma membrane, Cytosol"	"HPA034639: AB_10669678, HPA044859: "	"unprognostic (2.54e-1)"	"unprognostic (1.95e-2)"	"unprognostic (2.30e-2)"	"unprognostic (2.58e-2)"	"unprognostic (2.49e-2)"	"unprognostic (3.13e-1)"	"unprognostic (7.07e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.96e-2)"	"unprognostic (1.82e-2)"	"unprognostic (1.46e-1)"	"unprognostic (2.93e-1)"	"unprognostic (1.06e-11)"	"unprognostic (4.56e-2)"	"unprognostic (1.17e-1)"	"unprognostic (8.95e-2)"	"unprognostic (1.03e-1)"	3.6	2.0	6.6	1.5	6.3	0.2	5.4	5.2	5.6	3.1	5.8	6.2	0.9	3.8	3.6	6.2	6.9	1.0	1.5	4.6	6.0	3.9	16.3	6.7	19.2	2.2	6.6	4.7	4.5	1.8	2.2	1.3	4.6	4.2	1.6	1.9	7.5	7.8	1.0	1.1	3.7	18.3	1.0	6.3	2.9	3.0	2.1	6.6	0.3	2.1	5.4	2.3	1.3	3.1	0.0	0.3	3.1	0.0	0.0	0.0	0.0	0.0	1.5	31.7	0.0	0.0	0.3	0.1	0.5	5.6	0.5	0.5	0.0	0.0	2.4	0.0	0.3	0.1	0.2	0.4	1.8	0.0	0.2	0.0	4.7	0.0	0.0	0.0	0.0	0.3	2.6	3.0	0.4	0.5	0.0	0.0	0.9	0.3	0.0	0.0	0.7	1.0	0.3	0.0	1.2	0.7	0.7	0.1	1.0	0.0	1.1	1.6	0.5	0.0	1.6	0.2	0.2	4.6	0.0	0.1	0.0	0.9	0.3	0.0	0.4	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.6	6.3	5.2	5.6	6.0	3.9	6.6	4.7	4.2	6.6
NDC1	"FLJ10407, NET3, TMEM48"	ENSG00000058804	"NDC1 transmembrane nucleoporin"	Q9BTX1	1	53765460-53838860	"Predicted membrane proteins, Transporters"	"mRNA transport, Protein transport, Translocation, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA069751, HPA070882"	Approved		Supported	"Nuclear membrane,Plasma membrane,Actin filaments"				"Nuclear membrane"	"Plasma membrane, Actin filaments"	"HPA069751: , HPA070882: "	"unprognostic (2.51e-1)"	"unprognostic (1.93e-1)"	"prognostic favourable (4.48e-5)"	"unprognostic (6.96e-3)"	"unprognostic (1.31e-1)"	"unprognostic (1.36e-3)"	"prognostic unfavourable (7.52e-7)"	"unprognostic (3.46e-3)"	"unprognostic (1.53e-2)"	"unprognostic (2.01e-1)"	"prognostic unfavourable (3.58e-4)"	"unprognostic (9.27e-2)"	"unprognostic (6.22e-3)"	"unprognostic (3.00e-3)"	"unprognostic (4.38e-2)"	"unprognostic (9.24e-2)"	"unprognostic (6.07e-2)"	8.8	6.7	3.3	8.6	5.7	4.9	12.9	10.9	7.7	4.8	8.4	5.1	1.9	6.2	6.0	5.4	11.0	5.3	2.9	5.5	4.3	2.8	4.9	11.7	4.4	10.6	8.0	1.5	4.6	6.0	7.6	5.5	5.5	6.6	4.0	10.7	5.5	6.4	3.7	7.1	6.8	6.5	5.0	7.5	7.1	5.8	17.4	7.5	9.1	5.8	6.7	13.0	6.4	5.8	5.5	3.8	2.0	7.2	4.0	8.2	3.4	19.6	10.4	14.2	14.5	5.2	5.3	16.7	13.5	10.1	21.2	17.2	15.3	13.2	38.9	8.9	6.0	23.8	23.9	14.1	30.1	9.7	17.2	18.9	15.3	13.0	4.9	30.4	10.8	3.2	5.6	20.9	12.5	12.8	21.6	5.6	11.6	7.1	14.8	12.1	33.6	16.6	16.8	22.9	21.3	9.9	13.6	8.6	10.9	12.1	23.6	11.6	18.3	16.1	7.4	11.1	11.1	15.2	24.2	6.2	15.3	27.7	9.2	23.1	13.8	0.0	3.2	2.0	4.5	7.2	6.9	5.5	4.3	4.0	3.8	4.1	8.2	6.3	0.2	4.0	4.5	3.3	4.7	3.4	3.3	5.7	10.9	7.7	4.3	2.8	8.0	1.5	6.6	7.5
NEDD1	"GCP-WD, TUBGCP7"	ENSG00000139350	"Neural precursor cell expressed, developmentally down-regulated 1"	Q8NHV4	12	96907223-96953777	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"BJ: 46.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038591	Approved		Approved	"Nucleoplasm,Plasma membrane,Centrosome"				"Nucleoplasm, Centrosome"	"Plasma membrane"	"HPA038591: AB_10674688"	"unprognostic (7.93e-2)"	"unprognostic (3.18e-1)"	"unprognostic (7.00e-2)"	"unprognostic (1.19e-2)"	"unprognostic (2.21e-1)"	"unprognostic (5.92e-2)"	"prognostic unfavourable (1.94e-4)"	"prognostic unfavourable (3.70e-4)"	"unprognostic (1.81e-2)"	"unprognostic (9.29e-2)"	"unprognostic (1.83e-2)"	"unprognostic (1.56e-1)"	"unprognostic (2.46e-3)"	"unprognostic (7.29e-2)"	"unprognostic (2.28e-1)"	"unprognostic (1.34e-1)"	"unprognostic (5.59e-2)"	10.7	6.2	5.7	10.0	6.6	9.8	9.8	2.5	7.1	10.8	9.3	7.1	1.7	4.9	13.5	8.3	11.6	10.0	5.5	8.3	6.0	4.4	12.6	5.4	9.4	10.3	7.0	3.7	13.3	7.7	14.9	13.5	7.9	6.5	11.9	7.2	6.3	8.5	6.3	25.5	7.8	10.3	15.4	8.4	14.5	7.2	17.8	8.3	30.6	11.9	24.3	10.7	15.1	9.6	9.4	5.9	19.9	11.1	15.6	14.0	7.3	13.4	8.9	15.4	9.4	7.7	6.9	10.9	46.8	16.6	21.6	18.7	5.8	5.0	8.3	4.5	37.4	12.1	10.4	10.8	29.2	15.9	8.9	10.4	5.9	5.1	6.4	14.1	9.4	5.1	8.9	13.1	10.2	10.5	6.0	6.1	15.4	5.5	25.7	6.4	8.5	28.5	13.6	15.7	8.2	8.8	8.8	4.8	8.5	13.1	7.4	8.1	10.0	5.0	7.5	13.6	10.5	9.7	11.0	6.0	7.3	11.1	4.2	7.2	16.4	10.0	6.9	19.9	12.1	11.1	13.7	9.4	13.4	12.9	5.9	8.1	14.0	10.9	5.4	15.6	7.8	4.6	14.0	7.3	5.7	6.6	2.5	7.1	6.0	4.4	7.0	3.7	6.5	8.3
NEDD9	"CAS-L, CASS2, HEF1"	ENSG00000111859	"Neural precursor cell expressed, developmentally down-regulated 9"	Q14511	6	11183298-11382348	"Plasma proteins, Predicted intracellular proteins"	"Cell adhesion, Cell cycle, Cell division, Growth regulation, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adipose tissue: 72.8"	"Cell line enhanced"	"Detected in many"		"EFO-21: 49.0;HSkMC: 24.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB009720, HPA038768, HPA039270"	Uncertain		Approved	"Nucleoplasm,Plasma membrane,Cytosol"				Cytosol	"Nucleoplasm, Plasma membrane"	"CAB009720: , HPA038768: , HPA039270: "	"unprognostic (2.83e-3)"	"unprognostic (2.33e-2)"	"unprognostic (1.08e-2)"	"unprognostic (6.93e-2)"	"unprognostic (2.12e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.62e-1)"	"unprognostic (9.54e-2)"	"unprognostic (3.05e-2)"	"unprognostic (2.09e-1)"	"unprognostic (2.90e-1)"	"unprognostic (1.64e-1)"	"unprognostic (5.59e-3)"	"unprognostic (2.25e-2)"	"unprognostic (2.37e-1)"	"unprognostic (2.41e-1)"	"unprognostic (1.05e-1)"	72.8	4.7	4.5	14.9	5.6	3.3	35.7	2.2	5.9	14.0	16.6	5.1	14.2	7.1	17.3	21.7	10.3	11.5	15.3	17.3	4.6	4.1	34.6	9.5	58.4	15.0	4.9	3.9	11.1	7.9	4.2	6.1	32.6	6.6	13.4	14.7	12.8	15.4	15.4	22.4	12.3	17.9	12.4	5.3	25.7	10.9	12.2	4.3	18.8	15.8	6.8	18.6	17.6	9.9	5.8	6.0	34.8	19.8	5.1	8.3	6.3	1.5	10.0	9.3	0.1	6.4	0.8	9.8	2.3	2.8	4.3	8.0	3.2	0.6	3.1	49.0	5.0	4.3	12.5	4.7	5.6	1.4	0.3	0.3	1.5	21.1	3.0	3.3	0.1	24.5	1.4	2.8	0.4	7.3	0.0	2.6	9.7	0.4	1.9	1.3	1.4	1.0	0.5	0.2	1.8	2.1	13.7	0.2	1.7	0.4	11.0	19.0	0.8	2.6	18.6	2.9	5.2	0.3	5.6	2.8	11.3	3.9	0.0	2.7	12.7	9.1	5.5	15.4	8.3	12.2	6.8	5.0	5.6	8.0	6.0	5.8	3.0	4.7	34.8	5.1	19.8	3.7	5.0	6.3	4.5	5.6	2.2	5.9	4.6	4.1	4.9	3.9	6.6	4.3
NGFR	"CD271, p75NTR, TNFRSF16"	ENSG00000064300	"Nerve growth factor receptor"	P08138	17	49495293-49515017	"Cancer-related genes, CD markers, Predicted intracellular proteins, Predicted membrane proteins, RAS pathway related proteins"	"Apoptosis, Biological rhythms, Differentiation, Neurogenesis"	"Developmental protein, Receptor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in some"	7	"RH-30: 54.7;WM-115: 60.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	7	"plasmacytoid DC: 4.2"	"Lineage enriched"	"Detected in single"	7	"dendritic cells: 4.2"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"basal ganglia: 13.1;hypothalamus: 8.2;pons and medulla: 3.7"	"CAB000143, CAB001995, HPA004765"	Enhanced		Approved	"Nucleoplasm,Plasma membrane"			100000	Nucleoplasm	"Plasma membrane"	"CAB000143: , CAB001995: , HPA004765: AB_1079233"	"unprognostic (6.25e-3)"	"unprognostic (1.06e-3)"	"unprognostic (3.39e-3)"	"unprognostic (6.67e-2)"	"unprognostic (1.46e-2)"	"unprognostic (2.26e-1)"	"unprognostic (8.22e-2)"	"unprognostic (4.94e-2)"	"unprognostic (1.08e-2)"	"unprognostic (4.10e-3)"	"unprognostic (1.85e-2)"	"unprognostic (1.25e-1)"	"unprognostic (3.37e-2)"	"unprognostic (4.01e-2)"	"unprognostic (3.06e-2)"	"unprognostic (2.77e-3)"	"prognostic unfavourable (3.40e-4)"	30.9	24.0	1.2	9.2	7.4	1.0	11.7	6.1	4.5	7.6	9.4	10.4	7.9	3.2	6.8	15.0	11.3	12.6	10.8	22.2	2.4	2.9	4.8	29.1	1.4	11.6	13.8	1.3	7.6	6.2	2.8	6.7	16.7	15.9	17.7	3.4	20.2	17.2	9.7	4.8	8.4	5.0	10.7	22.4	18.9	4.9	12.2	4.4	0.4	25.8	7.4	7.0	13.1	6.8	0.0	4.2	0.0	0.4	0.0	0.5	0.2	0.0	0.0	1.7	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	1.3	0.4	1.2	0.0	0.1	0.2	0.1	0.0	1.0	0.1	0.0	0.1	5.8	0.0	0.1	0.4	0.0	0.0	0.0	7.9	0.1	0.0	0.0	1.0	0.0	1.0	54.7	0.0	0.0	0.0	0.5	0.3	0.0	0.0	3.6	0.1	0.0	0.0	0.0	0.9	0.1	2.7	0.0	0.0	0.0	0.0	0.5	60.7	0.0	0.0	0.0	0.5	0.2	0.1	0.0	0.3	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.4	4.2	0.0	0.2	1.2	7.4	6.1	4.0	2.4	2.9	13.8	1.3	15.9	4.4
NHSL2		ENSG00000204131	"NHS like 2"	Q5HYW2	X	71910818-72161750	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 27.1"	"Group enriched"	"Detected in some"	4	"AF22: 16.5;EFO-21: 19.5;HUVEC TERT2: 18.0;TIME: 10.4;U-937: 13.1"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 13.5"	"Group enriched"	"Detected in many"	4	"dendritic cells: 3.5;granulocytes: 13.5;monocytes: 5.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049771	Uncertain		Approved	"Plasma membrane,Cell Junctions"				"Cell Junctions"	"Plasma membrane"	"HPA049771: "	"unprognostic (9.71e-3)"	"unprognostic (1.96e-1)"	"unprognostic (1.92e-1)"	"unprognostic (4.56e-2)"	"unprognostic (1.40e-1)"	"unprognostic (5.50e-2)"	"unprognostic (2.88e-2)"	"unprognostic (5.72e-4)"	"unprognostic (5.46e-2)"	"unprognostic (3.36e-2)"	"unprognostic (1.50e-2)"	"unprognostic (1.91e-1)"	"unprognostic (1.61e-2)"	"unprognostic (4.27e-3)"	"unprognostic (9.99e-2)"	"unprognostic (7.76e-2)"	"unprognostic (4.37e-4)"	7.8	2.3	11.0	4.8	22.5	3.4	5.2	27.1	9.4	6.6	5.5	1.5	0.9	1.3	8.7	2.7	5.5	3.8	7.4	3.6	4.9	3.2	2.0	1.6	5.5	1.3	2.2	4.9	3.1	1.6	3.1	6.1	3.7	4.3	6.4	3.3	6.2	2.6	8.7	2.8	2.3	2.6	11.7	2.4	4.5	3.4	9.6	2.7	0.3	5.3	4.6	1.6	6.3	4.4	0.0	3.5	13.5	5.7	0.9	1.8	1.7	0.2	0.4	16.5	0.0	0.2	0.7	0.1	0.5	3.0	0.1	0.2	0.1	0.0	0.1	19.5	1.6	0.0	1.0	0.0	0.4	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.9	0.3	0.0	0.6	0.0	18.0	0.0	2.7	0.1	0.1	0.1	1.3	3.1	0.0	0.0	0.9	0.0	0.1	1.8	0.4	3.8	0.0	0.0	0.0	0.0	1.1	10.4	0.0	1.0	1.3	0.0	0.0	0.0	0.1	0.7	13.1	0.0	4.1	5.7	11.8	1.8	3.9	1.7	0.0	1.0	1.6	3.5	0.0	0.1	0.2	13.5	0.9	3.0	0.0	0.1	1.7	11.0	22.5	27.1	9.4	4.9	3.2	2.2	4.9	4.3	2.7
NKX2-8	"Nkx2-9, NKX2.8, NKX2H"	ENSG00000136327	"NK2 homeobox 8"	O15522	14	36580579-36582607	"Plasma proteins, Predicted intracellular proteins, Transcription factors"		"Developmental protein, DNA-binding"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"brain: 9.6;lung: 7.7;testis: 22.9"	"Cell line enhanced"	"Detected in some"		"EFO-21: 1.9;HaCaT: 9.7;HEK 293: 2.3;PC-3: 5.7;SiHa: 2.3"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"pons and medulla: 5.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"pons and medulla: 2.3"	"Low region specificity"	"Detected in some"			HPA062879	Uncertain		Approved	"Nucleoplasm,Plasma membrane"				Nucleoplasm	"Plasma membrane"	"HPA062879: "	"unprognostic (6.03e-2)"	"unprognostic (1.75e-1)"		"unprognostic (1.37e-3)"	"unprognostic (2.27e-1)"	"unprognostic (3.45e-4)"		"unprognostic (2.36e-1)"	"unprognostic (8.34e-2)"	"unprognostic (7.80e-2)"	"unprognostic (3.66e-1)"	"unprognostic (3.11e-1)"		"unprognostic (8.39e-3)"	"unprognostic (4.60e-2)"	"unprognostic (2.70e-1)"	"unprognostic (6.13e-2)"	0.3	0.3	0.2	0.4	0.7	0.3	0.3	0.0	1.2	0.3	0.3	2.0	0.0	0.3	0.3	0.3	5.3	0.3	0.3	0.3	0.3	2.0	0.3	0.3	7.7	0.3	2.0	0.0	0.3	0.3	1.5	2.1	0.3	5.7	0.4	0.3	0.0	2.0	0.3	0.3	1.1	0.3	0.3	9.6	0.3	0.3	22.9	0.5	0.0	4.2	1.6	0.8	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.9	0.0	9.7	0.0	0.4	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.1	0.0	0.0	0.0	0.0	0.1	0.0	1.2	0.0	0.0	0.0	5.7	0.0	0.0	0.0	0.0	0.5	1.4	0.0	2.3	0.4	0.2	0.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.7	0.0	1.2	0.3	2.0	2.0	0.0	5.7	0.5
NLRX1	"CLR11.3, NOD9"	ENSG00000160703	"NLR family member X1"	Q86UT6	11	119166568-119184016	"Predicted intracellular proteins"	"Host-virus interaction, Immunity, Innate immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"esophagus: 34.9;lymphoid tissue: 37.5;tongue: 38.9"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"eosinophil: 14.3"	"Lineage enriched"	"Detected in many"	4	"granulocytes: 14.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA061516	Supported		Supported	"Plasma membrane,Cell Junctions,Mitochondria"			35000	Mitochondria	"Plasma membrane, Cell Junctions"	"HPA061516: "	"unprognostic (7.58e-2)"	"unprognostic (3.71e-1)"	"unprognostic (6.36e-2)"	"prognostic favourable (2.47e-5)"	"unprognostic (5.60e-3)"	"unprognostic (2.59e-2)"	"unprognostic (2.06e-1)"	"unprognostic (2.43e-2)"	"unprognostic (8.80e-2)"	"unprognostic (1.17e-1)"	"unprognostic (3.49e-1)"	"unprognostic (3.29e-1)"	"prognostic favourable (2.59e-6)"	"unprognostic (3.06e-2)"	"unprognostic (1.70e-1)"	"unprognostic (2.83e-2)"	"unprognostic (4.22e-2)"	4.8	6.1	1.9	3.3	3.7	3.6	3.6	2.5	4.9	8.9	5.1	2.9	8.0	2.9	5.6	5.3	34.9	6.7	4.9	8.7	2.9	1.6	4.3	4.4	3.4	3.4	1.8	2.7	2.9	6.2	5.6	2.5	3.3	3.0	4.4	2.0	5.4	5.6	4.8	14.3	11.6	3.2	4.6	2.4	4.5	4.0	3.2	1.3	3.8	4.3	38.9	37.5	5.3	8.5	0.6	2.0	14.3	3.3	1.3	1.3	1.9	4.0	12.0	1.3	9.6	4.1	4.8	1.9	5.4	6.3	2.7	4.7	0.6	10.1	7.3	16.7	6.9	10.2	3.7	3.1	0.9	9.4	3.9	9.6	4.1	6.5	6.3	3.3	5.6	5.3	13.0	3.5	6.9	5.5	0.1	4.9	2.8	10.8	5.6	8.1	5.9	6.8	11.1	1.6	2.4	6.5	5.2	1.8	6.3	8.0	4.3	3.5	13.9	9.9	6.4	5.4	4.9	4.8	2.8	1.7	1.9	2.4	0.8	10.3	3.8	2.8	3.3	14.3	0.9	1.5	1.0	0.6	0.8	1.3	2.0	0.4	1.0	1.1	8.1	1.3	1.3	0.9	1.3	1.9	1.9	3.7	2.5	4.9	2.9	1.6	1.8	2.7	3.0	1.3
NMB	"MGC17211, MGC2277, MGC3936"	ENSG00000197696	"Neuromedin B"	P08949	15	84655129-84658563	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	4	"adipose tissue: 37.2;brain: 28.5;breast: 59.9"	"Cell line enhanced"	"Detected in many"		"A-431: 27.5"	"Cancer enhanced"	"Detected in all"		"glioma: 93.8"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Region enriched"	"Detected in many"	16	"olfactory region: 206.6"	"Group enriched"	"Detected in many"	6	"olfactory region: 80.6;pons and medulla: 17.5"	CAB019302	Approved		Approved	"Nucleoplasm,Vesicles,Plasma membrane"	"Secreted to blood"			"Nucleoplasm, Vesicles"	"Plasma membrane"	"CAB019302: "	"unprognostic (2.44e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.34e-3)"	"unprognostic (3.79e-1)"	"prognostic favourable (3.43e-4)"	"unprognostic (3.81e-1)"	"unprognostic (6.45e-2)"	"unprognostic (1.45e-2)"	"unprognostic (2.17e-1)"	"unprognostic (4.36e-1)"	"unprognostic (7.24e-2)"	"unprognostic (2.10e-1)"	"prognostic unfavourable (2.25e-4)"	"unprognostic (7.92e-3)"	"unprognostic (1.45e-1)"	"unprognostic (1.71e-2)"	"unprognostic (1.00e-1)"	37.2	8.0	4.6	2.8	7.5	3.3	59.9	2.4	28.5	4.0	6.5	13.7	1.0	2.3	3.1	3.2	2.5	5.0	4.5	7.0	7.0	12.2	4.4	1.9	3.8	3.6	6.6	3.5	3.4	3.3	2.7	4.2	1.4	5.6	1.9	2.1	2.6	4.6	1.8	2.0	1.8	1.4	2.9	9.9	2.0	2.5	6.4	4.8	2.2	8.9	4.9	1.9	4.7	8.5	7.0	10.4	5.9	0.8	1.3	6.4	2.6	27.5	10.5	1.9	0.4	5.5	2.4	0.2	1.7	3.3	3.7	5.1	3.7	7.6	1.2	4.4	4.4	4.9	10.6	2.1	2.1	10.3	13.3	4.2	4.1	17.1	1.4	2.8	4.6	2.5	0.8	5.8	2.2	5.4	0.0	0.4	2.0	16.1	2.6	9.3	7.8	3.0	8.3	0.0	12.2	3.5	2.2	1.0	12.0	2.7	1.6	12.5	1.8	11.0	1.3	0.7	3.7	3.5	2.6	0.2	3.0	2.6	8.5	15.9	4.4	0.0	0.8	5.9	6.3	0.6	2.3	4.9	5.0	6.4	3.5	7.0	4.8	3.6	1.2	1.3	0.3	10.4	5.6	2.6	4.6	7.5	2.4	8.5	7.0	12.2	6.6	3.5	5.6	4.8
NME1	"NDPKA, NM23, NM23-H1"	ENSG00000239672	"NME/NM23 nucleoside diphosphate kinase 1"	P15531	17	51153536-51162428	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"	"Differentiation, Endocytosis, Neurogenesis, Nucleotide metabolism"	"Kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008467, CAB040571, HPA041113"	Supported		Supported	"Nucleoplasm,Plasma membrane,Cytosol"	"Intracellular and membrane"		28000000	Cytosol	"Nucleoplasm, Plasma membrane"	"CAB040571: , HPA008467: AB_1079492, HPA041113: "	"unprognostic (2.24e-1)"	"unprognostic (2.01e-1)"	"unprognostic (3.48e-3)"	"unprognostic (5.96e-2)"	"unprognostic (9.71e-2)"	"unprognostic (2.33e-3)"	"prognostic unfavourable (2.60e-5)"	"unprognostic (4.54e-2)"	"unprognostic (3.35e-1)"	"unprognostic (2.33e-3)"	"unprognostic (2.90e-2)"	"unprognostic (1.01e-1)"	"prognostic unfavourable (2.07e-9)"	"unprognostic (9.01e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.83e-1)"	"unprognostic (9.46e-2)"	25.0	29.5	38.0	28.1	30.1	27.9	29.0	19.6	41.9	16.4	25.4	13.1	10.1	15.1	17.3	22.5	30.1	22.2	13.4	14.1	41.7	39.4	19.6	56.0	14.2	28.5	34.2	34.2	15.6	43.6	13.7	17.3	16.9	38.9	14.5	36.8	14.9	34.3	14.7	14.8	22.4	12.4	29.6	20.5	22.4	13.4	11.6	11.3	19.0	18.8	32.7	41.4	22.8	15.2	24.9	36.2	0.6	19.5	17.2	20.3	18.4	47.6	95.2	32.9	45.9	13.8	22.1	55.3	37.2	25.8	77.1	58.5	74.9	28.9	83.9	38.8	34.4	25.6	62.8	63.2	66.0	40.7	84.6	55.0	73.9	103.9	28.0	60.2	25.2	21.0	39.8	58.0	54.3	46.4	81.1	27.9	45.6	80.7	71.5	69.3	39.4	86.8	43.9	64.9	77.2	59.2	33.3	45.7	52.6	19.5	53.4	34.6	55.6	40.8	29.2	49.8	45.2	30.9	76.3	36.0	83.0	98.8	30.1	51.1	37.8	0.2	15.2	0.6	13.4	19.5	20.3	24.9	14.4	14.6	36.2	17.3	16.4	17.8	0.4	17.2	11.5	20.7	12.1	18.4	38.0	30.1	19.6	41.9	41.7	39.4	34.2	34.2	38.9	11.3
NMT1	NMT	ENSG00000136448	"N-myristoyltransferase 1"	P30419	17	45051610-45109016	"Enzymes, Predicted intracellular proteins"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA022949, HPA022963"	Supported		Supported	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		"HPA022949: AB_1854534, HPA022963: AB_1854535"	"unprognostic (1.40e-1)"	"unprognostic (2.87e-1)"	"unprognostic (1.30e-2)"	"unprognostic (6.14e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.64e-1)"	"prognostic unfavourable (4.94e-4)"	"unprognostic (4.96e-3)"	"unprognostic (3.86e-1)"	"unprognostic (3.04e-2)"	"unprognostic (2.19e-1)"	"unprognostic (1.98e-1)"	"unprognostic (3.77e-3)"	"unprognostic (1.01e-2)"	"unprognostic (4.89e-2)"	"unprognostic (4.17e-3)"	"unprognostic (9.45e-2)"	28.8	32.6	44.9	28.2	37.3	12.0	26.1	34.5	64.3	23.7	24.4	17.2	22.9	23.4	27.3	29.3	26.6	30.9	17.3	26.8	37.7	29.6	28.8	36.6	26.7	27.2	27.7	43.6	29.3	21.8	41.6	23.7	32.7	38.1	23.7	23.1	18.1	34.9	30.1	75.5	28.8	24.8	30.1	36.6	28.2	23.4	26.1	34.0	20.7	29.4	18.6	30.9	25.1	43.3	10.2	18.2	7.6	9.3	7.4	10.0	3.3	16.9	22.4	19.4	17.1	35.1	22.7	20.4	18.9	25.0	36.8	30.4	25.0	14.6	20.4	27.4	26.0	16.0	33.3	26.5	34.2	51.8	23.2	20.3	15.0	24.7	23.1	26.1	24.5	28.6	24.1	27.4	21.8	24.7	32.2	10.4	20.5	14.5	31.7	17.8	18.1	23.5	21.7	28.9	15.5	29.1	15.7	16.2	14.6	11.9	10.9	17.1	23.6	20.7	19.8	22.5	17.3	18.1	25.1	16.1	22.8	20.4	24.1	14.7	23.8	6.5	8.1	7.6	7.9	9.3	7.2	10.2	7.8	9.3	6.6	7.6	10.0	7.6	5.3	7.4	6.9	18.2	7.5	3.3	44.9	37.3	34.5	64.3	37.7	29.6	27.7	43.6	38.1	34.0
NPL	"C1orf13, DHDPS1, NPL1"	ENSG00000135838	"N-acetylneuraminate pyruvate lyase"	Q9BXD5	1	182789293-182830384	"Enzymes, Predicted intracellular proteins"	"Carbohydrate metabolism"	Lyase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 76.0"	"Cell line enhanced"	"Detected in many"		"Karpas-707: 11.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 76.0"	"Group enriched"	"Detected in many"	36	"granulocytes: 76.0;monocytes: 23.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA028345, HPA075808"	Enhanced		Approved	"Vesicles,Plasma membrane"			190000	Vesicles	"Plasma membrane"	"HPA028345: AB_10610145, HPA075808: "	"unprognostic (2.43e-2)"	"unprognostic (5.71e-3)"	"unprognostic (1.72e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.57e-1)"	"unprognostic (3.06e-1)"	"prognostic unfavourable (8.05e-4)"	"unprognostic (4.41e-2)"	"unprognostic (6.54e-3)"	"unprognostic (1.45e-1)"	"unprognostic (1.49e-1)"	"unprognostic (6.18e-2)"	"prognostic unfavourable (6.63e-4)"	"unprognostic (2.11e-1)"	"unprognostic (2.93e-2)"	"unprognostic (2.35e-2)"	"unprognostic (7.44e-2)"	14.9	6.8	10.9	14.2	12.3	12.4	5.3	3.5	10.2	3.9	5.3	15.0	11.4	2.4	2.5	23.7	8.0	4.1	10.1	4.7	9.2	8.7	37.4	15.4	14.3	20.4	16.0	8.6	2.8	3.2	2.5	2.5	32.9	15.4	4.4	7.4	3.9	5.7	5.8	2.4	6.5	4.8	5.8	15.3	32.1	4.0	4.0	14.4	3.1	3.4	1.3	10.9	11.8	5.5	0.7	1.3	76.0	23.6	0.0	1.3	10.3	2.7	0.5	0.8	0.0	2.4	2.4	0.7	0.9	1.8	1.0	0.5	0.0	1.2	7.3	1.3	0.0	1.1	1.6	2.0	0.2	0.0	1.2	11.6	0.3	0.1	1.3	4.3	6.9	1.9	7.7	0.2	0.0	0.1	8.7	11.7	1.8	0.9	0.2	2.9	9.3	0.9	1.1	0.6	8.9	0.2	6.1	2.6	3.9	4.2	0.2	3.7	2.4	7.1	0.2	1.0	2.0	0.6	0.1	8.4	10.1	7.4	2.1	7.8	3.0	3.6	23.6	18.0	1.0	20.8	0.9	0.3	0.8	0.9	1.3	0.7	0.7	0.9	76.0	0.0	16.0	0.2	1.3	10.3	10.9	12.3	3.5	10.2	9.2	8.7	16.0	8.6	15.4	14.4
NPR1	"ANPa, ANPRA, GUCY2A, NPRA"	ENSG00000169418	"Natriuretic peptide receptor 1"	P16066	1	153678637-153693992	"Enzymes, FDA approved drug targets, Predicted membrane proteins"	"cGMP biosynthesis"	"Lyase, Receptor, Vasoactive"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"breast: 98.4"	"Cell line enriched"	"Detected in some"	6	"ASC diff: 59.1"	"Cancer enhanced"	"Detected in all"		"ovarian cancer: 39.2"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in many"	5	"olfactory region: 23.0"	"Region enhanced"	"Detected in many"		"olfactory region: 11.1"	HPA031087			Approved	"Nucleoplasm,Nucleoli,Plasma membrane"				Nucleoli	"Nucleoplasm, Plasma membrane"	"HPA031087: AB_10601975"	"unprognostic (2.54e-1)"	"unprognostic (3.03e-3)"	"unprognostic (6.31e-2)"	"prognostic unfavourable (3.97e-4)"	"unprognostic (1.55e-1)"	"unprognostic (6.60e-2)"	"unprognostic (1.54e-2)"	"unprognostic (2.03e-1)"	"unprognostic (2.46e-1)"	"unprognostic (3.27e-2)"	"prognostic favourable (2.49e-4)"	"unprognostic (1.27e-1)"	"unprognostic (6.69e-2)"	"unprognostic (1.16e-2)"	"unprognostic (1.09e-1)"	"unprognostic (4.06e-1)"	"unprognostic (1.74e-2)"	41.1	4.3	0.5	5.9	0.9	0.1	98.4	0.5	0.8	8.1	8.2	0.3	7.3	1.2	16.8	11.1	8.7	25.0	9.3	19.6	0.9	0.5	28.7	3.7	34.8	8.6	0.7	0.0	19.5	4.2	7.8	4.5	11.8	2.5	4.9	1.5	2.0	2.0	9.0	6.9	3.4	4.6	15.6	2.2	1.2	5.0	6.4	0.2	0.8	7.6	5.1	1.1	11.6	26.5	0.0	0.5	0.0	0.3	0.0	0.0	0.0	0.0	0.4	0.0	0.0	59.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	9.8	0.0	7.1	0.0	0.0	0.1	0.0	0.1	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	5.5	0.0	0.0	0.7	0.0	0.0	0.0	0.6	0.0	2.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.9	0.5	0.8	0.9	0.5	0.7	0.0	2.5	0.2
NPTXR		ENSG00000221890	"Neuronal pentraxin receptor"	O95502	22	38818452-38843982	"Plasma proteins, Predicted intracellular proteins"		Receptor		"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"brain: 73.6"	"Cell line enhanced"	"Detected in many"		"SCLC-21H: 14.8;SiHa: 11.0;U-87 MG: 42.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in single"							"Low region specificity"	"Detected in all"			HPA001079	Enhanced		Approved	"Nucleoplasm,Plasma membrane,Cytosol"	"Intracellular and membrane"		280000	"Plasma membrane, Cytosol"	Nucleoplasm	"HPA001079: AB_1078414"	"unprognostic (6.29e-2)"	"prognostic favourable (3.93e-4)"	"unprognostic (6.82e-3)"	"prognostic unfavourable (2.85e-4)"	"unprognostic (9.55e-2)"	"unprognostic (6.93e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.65e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.52e-3)"	"unprognostic (1.37e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.49e-2)"	"unprognostic (9.22e-2)"	"unprognostic (8.65e-2)"	"unprognostic (2.77e-2)"	2.3	3.8	39.1	1.8	17.5	0.8	1.9	16.2	73.6	5.8	2.6	4.3	0.5	1.5	5.6	3.3	2.7	6.1	2.0	10.5	57.4	15.2	1.3	0.8	1.7	1.6	5.6	20.7	6.2	3.6	5.9	2.0	0.9	4.5	6.2	1.7	1.0	3.2	5.6	0.9	1.2	1.4	5.7	3.3	2.1	2.0	1.6	4.0	0.0	2.5	0.0	1.6	2.5	1.9	0.3	0.2	0.6	0.2	0.6	2.3	0.4	0.4	2.9	0.1	0.8	5.9	0.6	0.0	1.9	0.4	3.8	1.3	2.9	0.6	0.0	3.4	0.5	0.4	0.8	0.1	1.2	0.2	1.0	0.0	0.1	4.4	0.6	0.0	0.1	1.9	0.1	3.4	0.0	0.1	3.5	0.1	0.1	4.4	0.0	0.2	3.5	1.0	0.7	0.0	6.9	0.9	7.9	14.8	0.9	11.0	0.0	0.3	4.7	1.1	0.2	6.8	4.2	0.0	0.3	1.0	0.0	0.0	42.5	8.6	3.5	0.5	0.2	0.1	1.8	0.0	1.3	0.1	1.0	2.3	0.0	0.3	1.5	1.2	0.6	0.6	0.1	0.2	0.0	0.4	39.1	17.5	16.2	49.0	57.4	15.2	5.6	20.7	4.5	4.0
NRCAM	"Bravo, KIAA0343"	ENSG00000091129	"Neuronal cell adhesion molecule"	Q92823	7	108147623-108456717	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 82.0"	"Cell line enhanced"	"Detected in some"		"A549: 26.0;AF22: 25.2;EFO-21: 47.1;HMC-1: 50.3;SH-SY5Y: 31.0"	"Cancer enriched"	"Detected in all"	7	"glioma: 57.2"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	6	"naive CD8 T-cell: 5.5"	"Lineage enriched"	"Detected in single"	15	"T-cells: 5.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA012606	Approved		Approved	"Nucleoplasm,Vesicles,Plasma membrane"	"Intracellular and membrane"		70000000	Nucleoplasm	"Vesicles, Plasma membrane"	"HPA012606: AB_1854636"	"unprognostic (2.66e-1)"	"unprognostic (2.65e-1)"	"unprognostic (2.52e-3)"	"unprognostic (2.18e-2)"	"unprognostic (4.08e-3)"	"unprognostic (1.01e-2)"	"unprognostic (4.47e-3)"	"unprognostic (1.66e-1)"	"unprognostic (1.73e-1)"	"unprognostic (4.81e-2)"	"unprognostic (9.10e-3)"	"unprognostic (4.33e-2)"	"unprognostic (2.22e-2)"	"unprognostic (9.70e-3)"	"unprognostic (6.42e-2)"	"unprognostic (6.51e-3)"	"unprognostic (3.28e-2)"	2.5	28.7	24.5	2.3	23.7	1.2	1.6	16.6	82.0	5.0	1.6	10.5	9.5	1.5	2.6	26.6	1.5	3.7	6.3	1.1	19.1	15.9	5.8	1.3	2.7	1.6	11.8	21.2	2.1	21.5	1.2	14.6	6.4	21.7	1.6	1.6	0.7	2.4	12.1	1.0	1.6	1.5	1.6	10.8	4.2	2.3	2.2	9.9	0.0	4.0	0.0	2.9	1.5	0.8	0.1	0.0	0.3	0.0	0.0	5.5	0.6	0.0	26.0	25.2	0.0	3.1	0.6	0.5	0.1	0.1	0.2	0.4	10.5	0.0	0.0	47.1	0.2	0.1	0.5	0.4	0.2	0.0	3.3	0.0	0.2	0.2	0.0	0.2	50.3	4.2	0.0	0.0	0.1	16.2	0.0	0.2	0.4	9.7	0.1	0.0	3.4	0.0	0.0	7.4	8.5	5.8	0.0	4.9	31.0	0.3	0.0	0.5	0.0	0.0	17.2	1.1	0.2	0.0	4.2	0.0	0.1	0.2	0.1	0.0	14.5	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.9	5.5	0.0	0.0	0.0	0.0	0.0	0.6	24.5	23.7	16.6	34.7	19.1	15.9	11.8	21.2	21.7	9.9
NRSN1	"p24, VMP"	ENSG00000152954	"Neurensin 1"	Q8IZ57	6	24126122-24154900	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in many"	5	"brain: 67.2"	"Cell line enhanced"	"Detected in some"		"SCLC-21H: 14.3;SH-SY5Y: 11.4"	"Cancer enriched"	"Detected in single"	17	"glioma: 3.1"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"basophil: 1.8"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019681, HPA061006"	Uncertain		Approved	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		"HPA019681: , HPA061006: "	"unprognostic (1.22e-1)"		"unprognostic (4.26e-2)"	"unprognostic (8.00e-3)"	"unprognostic (8.01e-3)"					"unprognostic (1.70e-1)"	"unprognostic (4.53e-3)"	"unprognostic (7.29e-2)"	"unprognostic (1.36e-3)"	"unprognostic (2.40e-3)"	"unprognostic (1.45e-1)"	"unprognostic (1.57e-1)"		1.3	6.9	21.5	1.7	27.7	1.7	1.3	5.3	67.2	1.3	1.7	2.1	0.0	1.7	1.5	1.4	1.4	1.3	1.5	1.4	15.3	25.0	1.5	1.4	1.4	1.5	12.4	25.4	1.3	2.6	1.4	12.9	1.3	27.4	1.4	1.7	0.3	1.5	1.3	3.3	1.5	1.6	1.6	6.7	1.5	1.9	1.6	5.0	0.0	1.4	0.0	1.3	1.3	0.1	0.5	0.2	1.8	0.2	0.1	0.3	0.0	0.7	0.0	0.3	0.7	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.2	0.6	0.1	1.6	0.0	0.3	0.1	0.0	0.1	1.6	0.6	0.0	0.1	0.2	0.0	0.1	0.2	0.1	0.0	0.1	0.0	0.0	1.9	1.2	0.1	0.2	0.3	0.9	0.7	2.5	0.5	0.2	0.5	0.0	0.0	14.3	11.4	0.0	0.1	0.9	1.7	3.4	0.2	0.4	0.6	0.1	0.4	0.8	2.2	0.9	0.7	0.0	1.3	1.8	0.1	0.3	0.2	0.2	0.1	0.2	0.1	0.1	0.0	0.5	0.1	0.3	1.0	0.1	0.2	0.2	0.0	0.0	21.5	27.7	5.3	34.1	15.3	25.0	12.4	25.4	27.4	5.0
NTNG2	"KIAA1857, Lmnt2, NTNG1"	ENSG00000196358	"Netrin G2"	Q96CW9	9	132161676-132244534	"Predicted intracellular proteins"	"Differentiation, Neurogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 38.9;brain: 32.0"	"Cell line enhanced"	"Detected in some"		"HL-60: 4.7;HMC-1: 11.9;NB-4: 27.0;U-937: 7.0"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	6	"neutrophil: 4.0"	"Lineage enriched"	"Detected in single"	10	"granulocytes: 4.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA065089, HPA071290"	Approved		Approved	"Plasma membrane,Cytokinetic bridge,Midbody ring"	"Intracellular and membrane"			"Plasma membrane"	"Cytokinetic bridge, Midbody ring"	"HPA065089: , HPA071290: "	"unprognostic (5.01e-2)"	"unprognostic (2.95e-2)"	"unprognostic (4.12e-2)"	"unprognostic (1.01e-1)"	"unprognostic (3.59e-1)"	"unprognostic (7.67e-2)"	"unprognostic (2.73e-2)"	"unprognostic (2.87e-1)"	"unprognostic (4.86e-2)"	"unprognostic (1.47e-1)"	"unprognostic (2.62e-2)"	"prognostic favourable (6.06e-4)"	"unprognostic (9.30e-12)"	"unprognostic (1.66e-1)"	"unprognostic (3.23e-1)"	"unprognostic (3.84e-2)"	"unprognostic (2.00e-1)"	1.2	1.4	11.9	1.6	10.9	38.9	0.6	4.4	32.0	1.0	0.8	11.5	0.2	1.8	0.7	0.9	0.8	0.7	1.4	4.6	11.4	3.1	0.8	0.8	2.0	1.9	4.4	7.4	0.6	1.8	11.9	1.0	1.1	11.7	7.4	0.7	10.7	1.3	1.8	0.9	0.8	1.1	0.8	5.3	2.8	1.2	1.8	2.8	0.0	0.7	0.0	1.0	1.1	0.9	0.1	0.1	4.0	0.2	0.0	0.4	0.0	0.0	0.3	0.2	0.4	0.4	0.1	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.8	0.1	0.0	0.1	0.0	0.6	4.7	11.9	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.1	0.2	27.0	1.0	0.1	0.3	0.3	0.1	0.0	0.0	3.3	3.0	0.1	0.0	0.0	0.0	0.4	0.1	0.6	2.1	2.6	0.1	0.1	0.0	0.0	0.9	7.0	0.7	0.6	0.2	0.6	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	4.0	0.0	0.1	0.1	0.1	0.0	11.9	10.9	4.4	32.0	11.4	3.1	4.4	7.4	11.7	2.8
NUDCD3	"KIAA1068, NudCL"	ENSG00000015676	"NudC domain containing 3"	Q8IVD9	7	44379121-44490880	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019136, HPA019528, HPA019529"	Enhanced		Approved	"Nucleoplasm,Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"	Nucleoplasm	"HPA019136: AB_1852370, HPA019528: AB_1852372, HPA019529: AB_1852374"	"unprognostic (3.72e-2)"	"unprognostic (9.28e-3)"	"unprognostic (2.33e-2)"	"unprognostic (2.05e-3)"	"unprognostic (2.18e-3)"	"unprognostic (2.05e-2)"	"unprognostic (4.73e-2)"	"unprognostic (2.30e-2)"	"unprognostic (2.18e-1)"	"unprognostic (3.96e-2)"	"unprognostic (2.28e-1)"	"unprognostic (5.62e-2)"	"prognostic favourable (9.16e-4)"	"unprognostic (3.51e-2)"	"unprognostic (1.58e-2)"	"unprognostic (1.45e-1)"	"unprognostic (6.50e-2)"	8.3	6.3	15.3	5.4	20.8	7.3	7.2	10.9	26.0	7.8	5.8	7.7	6.4	4.0	6.9	7.3	8.0	10.3	6.7	19.5	15.2	13.0	6.0	5.8	7.2	6.2	12.5	16.8	9.3	6.8	12.8	4.7	5.3	10.1	8.4	5.7	6.1	7.1	9.9	18.3	7.0	5.0	8.8	10.1	5.8	5.9	9.9	7.1	4.1	8.1	4.8	6.6	6.3	5.3	4.7	2.8	3.2	3.1	2.5	4.7	3.5	3.1	5.9	4.3	7.8	5.4	4.5	1.7	5.1	5.0	5.9	6.3	4.0	2.2	10.0	3.8	6.7	3.7	5.9	6.8	3.5	5.7	6.3	2.8	3.6	2.9	5.0	4.8	1.8	3.9	4.6	4.4	5.2	7.3	7.1	3.2	4.4	2.8	2.1	4.5	5.4	7.8	3.2	4.7	3.7	3.4	4.8	4.7	13.4	3.0	5.6	2.3	4.2	6.9	7.0	4.2	4.4	2.7	4.1	9.2	9.5	5.1	4.5	5.7	7.3	2.0	2.8	3.2	4.6	2.7	4.7	3.5	4.4	3.8	2.6	4.7	4.6	4.0	1.8	2.5	3.1	2.8	4.4	3.5	15.3	20.8	10.9	26.0	15.2	13.0	12.5	16.8	10.1	7.1
NUDT16L1	SDOS	ENSG00000168101	"Nudix hydrolase 16 like 1"	Q9BRJ7	16	4693694-4695859	"Predicted intracellular proteins"		RNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044186, HPA063605"	Approved		Approved	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		"HPA044186: AB_10968571, HPA063605: "	"unprognostic (1.35e-2)"	"unprognostic (1.70e-1)"	"unprognostic (6.65e-2)"	"unprognostic (2.17e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.34e-2)"	"unprognostic (3.14e-1)"	"prognostic favourable (2.79e-4)"	"unprognostic (2.51e-1)"	"unprognostic (1.89e-1)"	"unprognostic (6.12e-3)"	"unprognostic (6.81e-2)"	"prognostic favourable (1.02e-6)"	"unprognostic (2.78e-1)"	"unprognostic (1.47e-1)"	"unprognostic (4.08e-2)"	"unprognostic (6.81e-3)"	11.2	21.7	19.3	13.2	22.1	19.3	11.0	25.3	33.1	13.6	20.6	15.9	25.5	21.7	10.4	17.1	14.0	16.5	16.8	31.8	19.7	17.5	20.1	27.2	15.2	18.5	18.3	15.8	13.9	14.8	15.7	19.6	10.5	13.4	19.7	12.2	16.3	16.8	16.3	22.4	10.9	18.6	8.9	16.2	15.9	15.3	13.0	15.9	18.2	21.6	14.2	15.9	10.5	9.8	30.1	40.4	44.9	27.0	28.5	39.6	42.7	7.3	12.2	11.1	14.9	8.4	6.5	10.2	8.8	6.7	10.7	6.8	13.6	5.9	7.7	12.9	10.5	8.6	11.9	12.0	5.0	11.3	20.1	8.5	10.5	16.4	9.2	12.1	10.1	10.0	11.2	9.0	5.6	7.9	15.4	9.7	10.4	28.6	18.2	18.0	17.6	14.0	25.5	11.8	12.1	12.8	9.2	22.0	16.5	12.9	13.5	5.8	20.0	28.5	10.2	8.8	13.4	20.8	8.0	16.9	10.0	12.9	5.5	16.3	18.0	23.1	27.0	44.9	27.2	22.5	32.6	28.8	33.3	32.4	24.5	30.1	39.6	33.6	33.3	28.5	24.0	40.4	36.7	42.7	19.3	22.1	25.3	33.1	19.7	17.5	18.3	15.8	13.4	15.9
NUP35	MP44	ENSG00000163002	"Nucleoporin 35"	Q8NFH5	2	183117513-183161680	"Predicted intracellular proteins, Transporters"	"mRNA transport, Protein transport, Translocation, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA018401, HPA018410, HPA018441"	Enhanced		Supported	"Nucleoplasm,Nuclear membrane,Plasma membrane"				"Nucleoplasm, Nuclear membrane"	"Plasma membrane"	"HPA018401: AB_1854719, HPA018410: AB_1854721, HPA018441: AB_1854720"	"unprognostic (6.18e-3)"	"unprognostic (3.15e-1)"	"unprognostic (1.83e-1)"	"unprognostic (3.58e-3)"	"unprognostic (1.37e-1)"	"unprognostic (9.91e-2)"	"prognostic unfavourable (5.02e-4)"	"unprognostic (3.95e-1)"	"unprognostic (6.21e-3)"	"prognostic favourable (3.45e-4)"	"unprognostic (2.32e-2)"	"unprognostic (1.61e-3)"	"unprognostic (1.78e-3)"	"unprognostic (6.78e-2)"	"unprognostic (3.47e-2)"	"unprognostic (1.24e-1)"	"unprognostic (3.96e-2)"	8.8	10.9	9.1	13.7	21.4	4.1	15.3	18.9	12.6	9.2	8.6	5.6	5.8	7.3	9.6	9.0	11.7	10.6	9.1	7.9	11.1	6.8	11.9	16.4	9.5	9.3	11.5	5.1	13.1	17.2	8.9	13.1	9.0	8.8	9.3	10.7	7.3	9.7	9.6	9.1	10.9	7.1	10.5	7.6	7.8	9.3	25.8	9.7	19.1	10.3	12.6	12.7	8.0	10.2	8.9	3.8	1.7	6.8	5.9	10.5	5.0	9.9	10.7	16.8	9.9	6.1	5.9	12.2	12.1	9.8	18.3	17.5	19.7	12.2	17.1	11.3	6.3	8.7	23.0	13.4	29.6	15.2	15.3	16.0	9.0	21.0	4.6	11.6	10.9	4.3	7.1	15.5	14.9	10.7	14.4	12.6	13.9	11.6	13.4	13.8	28.5	33.3	16.4	13.2	12.1	16.8	12.3	14.8	10.4	11.2	13.1	12.7	8.5	8.1	5.6	14.4	10.2	11.6	13.4	8.5	18.4	18.1	9.8	8.5	19.3	0.0	4.8	1.7	6.1	6.3	10.5	8.9	7.8	7.5	3.8	7.9	9.6	8.4	0.1	5.9	6.8	3.6	7.7	5.0	9.1	21.4	18.9	12.6	11.1	6.8	11.5	5.1	8.8	9.7
NUS1	"C6orf68, MGC7199, NgBR, TANGO14"	ENSG00000153989	"NUS1 dehydrodolichyl diphosphate synthase subunit"	Q96E22	6	117675502-117710640	"Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins"	"Angiogenesis, Differentiation, Lipid metabolism"	"Developmental protein, Receptor, Transferase"	"Congenital disorder of glycosylation, Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA027504	Supported		Approved	"Vesicles,Plasma membrane"				Vesicles	"Plasma membrane"	"HPA027504: AB_10603124"	"unprognostic (1.21e-2)"	"prognostic unfavourable (6.99e-4)"	"unprognostic (1.09e-2)"	"unprognostic (2.31e-1)"	"unprognostic (1.21e-1)"	"unprognostic (8.26e-3)"	"unprognostic (1.42e-3)"	"unprognostic (2.42e-2)"	"unprognostic (8.62e-2)"	"unprognostic (2.99e-1)"	"unprognostic (2.62e-1)"	"unprognostic (8.35e-2)"	"unprognostic (1.00e-1)"	"unprognostic (2.27e-1)"	"unprognostic (3.22e-2)"	"unprognostic (1.56e-1)"	"unprognostic (7.97e-2)"	8.4	10.2	14.7	9.3	14.7	7.0	10.0	8.8	13.4	29.6	9.2	6.8	2.0	7.1	9.6	13.5	9.5	8.8	7.1	8.2	12.7	9.9	13.1	17.4	9.5	8.4	16.4	15.7	8.8	28.9	15.0	20.0	10.6	16.2	9.6	9.3	7.1	13.8	14.9	7.9	6.1	14.4	8.5	7.3	9.1	10.6	5.6	12.2	7.2	16.5	3.1	8.7	9.1	18.0	2.4	8.1	3.3	4.9	4.1	4.5	2.3	10.0	7.4	16.1	18.0	16.3	21.4	39.6	18.5	19.3	15.5	17.9	16.8	11.3	23.9	20.1	17.0	9.2	23.9	18.1	28.9	17.9	22.0	27.3	12.5	30.1	25.1	34.4	16.1	18.7	20.6	16.9	34.7	15.9	32.6	21.3	23.1	11.4	16.1	21.9	18.7	13.6	15.6	11.6	17.1	30.7	10.1	19.1	15.1	11.1	14.5	13.6	9.2	36.1	13.9	9.6	11.9	15.3	26.5	29.6	22.1	25.4	22.7	26.5	19.1	3.3	3.0	1.8	3.1	3.0	4.5	2.4	3.7	4.1	3.2	2.1	3.1	4.0	0.2	4.1	4.9	8.1	3.4	2.3	14.7	14.7	8.8	13.4	12.7	9.9	16.4	15.7	16.2	12.2
OAS3		ENSG00000111331	"2'-5'-oligoadenylate synthetase 3"	Q9Y6K5	12	112938352-112973249	"Enzymes, Predicted intracellular proteins"	"Antiviral defense, Immunity, Innate immunity"	"Nucleotidyltransferase, RNA-binding, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"BJ hTERT+ SV40 Large T+: 64.0;BJ hTERT+ SV40 Large T+ RasG12V: 70.0;RT4: 17.5;U-266/84: 19.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Not detected"	"Not detected"							"HPA041253, HPA041372"	Uncertain		Supported	"Nucleoplasm,Plasma membrane,Cytosol"			21000	"Nucleoplasm, Cytosol"	"Plasma membrane"	"HPA041253: AB_10794990, HPA041372: AB_10795590"	"unprognostic (8.47e-2)"	"unprognostic (9.13e-2)"	"unprognostic (1.27e-2)"	"unprognostic (4.39e-3)"	"unprognostic (2.59e-2)"	"unprognostic (1.45e-1)"	"unprognostic (4.14e-3)"	"unprognostic (8.06e-3)"	"unprognostic (3.19e-1)"	"unprognostic (1.73e-2)"	"unprognostic (2.29e-3)"	"unprognostic (2.48e-1)"	"prognostic unfavourable (2.23e-5)"	"unprognostic (4.25e-2)"	"unprognostic (1.37e-2)"	"unprognostic (3.29e-2)"	"unprognostic (2.93e-2)"	36.9	4.9	5.1	11.2	5.4	18.3	7.0	2.9	5.5	10.5	6.8	5.5	3.2	7.3	10.0	11.8	17.9	4.2	9.4	6.7	4.5	5.3	10.3	7.1	19.9	13.3	5.1	5.1	6.1	3.2	3.3	4.6	19.3	8.7	5.6	6.9	8.9	24.7	3.4	3.3	6.0	9.3	8.3	6.2	22.0	9.5	3.0	3.3	21.3	9.9	6.7	13.5	9.9	8.2	2.6	4.8	10.1	14.7	5.0	3.8	3.9	6.3	9.5	0.0	1.5	0.3	1.4	0.8	1.2	8.3	64.0	70.0	7.2	5.8	0.4	2.3	2.9	5.4	1.2	7.7	5.4	4.7	0.3	4.9	4.4	2.3	1.2	1.7	2.7	0.5	2.5	9.1	0.5	3.3	0.1	1.0	0.8	4.1	2.7	0.9	0.5	5.5	3.9	3.4	0.1	3.0	17.5	0.2	0.0	5.8	2.2	5.7	7.6	0.5	2.2	1.7	1.2	1.5	2.6	0.5	19.1	0.1	1.4	4.8	5.2	0.9	7.9	1.6	2.0	8.6	2.5	2.6	3.0	3.0	4.8	1.3	2.2	2.6	10.1	5.0	14.7	0.2	3.8	3.9	5.1	5.4	2.9	5.5	4.5	5.3	5.1	5.1	8.7	3.3
OBSCN	"ARHGEF30, KIAA1556, KIAA1639, UNC89"	ENSG00000154358	"Obscurin, cytoskeletal calmodulin and titin-interacting RhoGEF"	Q5VST9	1	228208130-228378874	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	Differentiation	"Calmodulin-binding, Developmental protein, Kinase, Muscle protein, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"skeletal muscle: 180.2;tongue: 48.4"	"Cell line enhanced"	"Detected in many"		"HeLa: 16.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Cell type enhanced"	"Detected in some"		"naive CD4 T-cell: 3.2"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in single"							"HPA021186, HPA065801"	Enhanced		Approved	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		"HPA021186: AB_1854761, HPA065801: "	"unprognostic (8.47e-3)"	"unprognostic (1.56e-1)"	"unprognostic (9.99e-2)"	"prognostic unfavourable (1.64e-4)"	"unprognostic (5.30e-3)"	"unprognostic (6.36e-2)"	"unprognostic (4.54e-3)"	"unprognostic (1.82e-1)"	"unprognostic (8.81e-2)"	"unprognostic (1.93e-2)"	"unprognostic (3.38e-1)"	"unprognostic (1.45e-1)"	"unprognostic (1.57e-3)"	"unprognostic (1.34e-1)"	"unprognostic (1.77e-1)"	"unprognostic (3.53e-1)"	"unprognostic (1.16e-2)"	2.5	0.9	0.5	0.9	4.4	0.6	0.7	3.1	0.6	0.6	0.8	0.5	0.5	0.6	0.8	4.4	2.4	1.0	0.6	21.2	0.5	0.7	1.6	0.5	1.0	1.0	0.5	0.5	1.7	1.4	0.4	2.4	0.5	0.9	1.7	0.3	5.2	2.6	1.1	180.2	1.1	0.8	0.5	0.6	1.4	0.5	0.7	0.6	0.5	2.2	48.4	3.5	0.6	0.7	1.0	1.1	0.1	0.4	0.6	3.2	0.7	2.9	2.8	8.0	4.5	0.2	0.1	5.6	1.5	0.5	1.0	0.9	2.0	2.1	5.7	8.1	0.5	1.0	0.4	1.1	0.2	2.1	5.1	1.9	16.0	0.0	2.0	1.3	6.1	3.0	1.0	0.4	0.2	0.4	5.3	1.3	0.3	5.0	2.0	1.6	8.8	1.7	8.1	0.1	1.3	4.6	1.5	3.0	9.0	0.2	2.9	1.1	8.0	3.7	0.7	0.0	9.3	0.2	0.1	4.7	0.9	1.4	0.0	0.8	2.1	0.1	0.4	0.0	0.9	0.1	0.9	0.5	0.9	0.7	0.9	1.0	3.2	0.5	0.1	0.6	0.1	1.1	0.8	0.7	0.5	4.4	3.1	0.6	0.5	0.7	0.5	0.5	0.9	0.6
OCA2	"BEY, BEY1, BEY2, D15S12, EYCL, EYCL2, EYCL3, P"	ENSG00000104044	"OCA2 melanosomal transmembrane protein"	Q04671	15	27754875-28099358	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	Transport		"Albinism, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"retina: 37.9;skin 1: 12.3"	"Group enriched"	"Detected in some"	6	"SH-SY5Y: 5.8;SK-MEL-30: 22.2"	"Cancer enriched"	"Detected in many"	17	"melanoma: 19.5"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			HPA036402			Approved	"Plasma membrane,Cytosol"				"Plasma membrane"	Cytosol	"HPA036402: "	"unprognostic (6.07e-3)"	"unprognostic (1.97e-2)"	"unprognostic (3.25e-1)"	"unprognostic (2.82e-2)"	"unprognostic (4.60e-4)"	"unprognostic (7.11e-2)"	"unprognostic (1.10e-1)"	"unprognostic (4.12e-2)"	"unprognostic (3.47e-2)"	"unprognostic (4.95e-2)"	"unprognostic (1.96e-2)"	"unprognostic (1.60e-2)"	"unprognostic (2.20e-6)"	"unprognostic (2.61e-1)"	"unprognostic (4.21e-1)"	"unprognostic (3.28e-2)"	"unprognostic (2.28e-2)"	0.4	0.1	0.9	1.3	4.8	0.0	0.3	0.2	2.9	2.4	0.3	3.6	0.2	0.0	0.4	1.7	2.9	1.6	0.5	0.2	1.3	3.6	0.4	0.4	1.2	3.1	0.3	0.4	0.4	0.2	0.0	1.0	2.9	9.5	0.9	0.2	37.9	1.9	2.7	0.4	12.3	0.2	0.2	0.2	2.0	0.1	2.6	0.2	0.3	7.0	0.5	1.5	0.8	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	1.2	0.0	0.0	0.5	0.0	0.0	0.0	2.2	0.0	0.1	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.6	0.0	0.0	0.5	0.0	0.0	0.1	5.8	0.0	0.0	22.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.9	4.8	0.2	2.9	1.3	3.6	0.3	0.4	9.5	0.2
ODC1	ODC	ENSG00000115758	"Ornithine decarboxylase 1"	P11926	2	10439968-10448504	"Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Polyamine biosynthesis"	"Decarboxylase, Lyase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001536, CAB035996"	Approved		Approved	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		"CAB035996: , HPA001536: AB_1079521"	"unprognostic (2.33e-1)"	"unprognostic (3.41e-1)"	"unprognostic (7.25e-3)"	"unprognostic (5.21e-3)"	"unprognostic (4.22e-2)"	"unprognostic (2.70e-1)"	"prognostic unfavourable (3.07e-5)"	"unprognostic (3.06e-2)"	"unprognostic (4.18e-2)"	"unprognostic (6.27e-2)"	"unprognostic (3.04e-1)"	"unprognostic (6.65e-2)"	"unprognostic (1.67e-3)"	"unprognostic (1.18e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.26e-2)"	"unprognostic (5.86e-2)"	13.2	8.2	11.6	33.5	11.1	41.8	9.1	7.2	11.8	11.7	17.4	11.5	33.8	8.6	22.9	21.6	16.5	16.5	30.0	33.8	9.7	10.6	31.5	48.7	14.2	42.3	11.3	6.5	29.2	48.7	13.4	35.4	6.9	11.2	26.3	20.7	18.2	11.0	27.2	64.2	9.6	14.9	26.2	10.2	20.4	19.2	54.6	6.3	31.0	16.4	19.8	39.6	16.1	14.6	13.4	10.8	2.4	2.4	1.2	4.4	3.0	18.6	15.0	20.9	24.7	3.7	11.2	48.5	27.0	13.4	25.6	11.9	79.7	8.7	98.9	13.6	16.5	3.4	63.9	30.7	31.2	37.6	26.7	45.1	25.8	48.6	30.4	76.2	10.8	7.5	8.3	57.9	72.7	20.5	75.0	32.2	14.2	12.3	75.4	30.0	38.1	49.0	53.8	65.7	66.6	15.5	13.7	29.2	24.9	33.9	10.4	13.7	7.0	34.2	14.3	20.8	42.9	26.8	58.0	15.0	45.4	89.9	18.7	50.5	12.8	0.0	1.3	2.4	2.7	2.4	3.2	13.4	3.8	4.4	3.0	11.0	2.7	4.3	0.5	1.2	1.5	10.8	3.8	3.0	11.6	11.1	7.2	11.8	9.7	10.6	11.3	6.5	11.2	6.3
ODR4	"C1orf27, FLJ20505, odr-4, TTG1"	ENSG00000157181	"Odr-4 GPCR localization factor homolog"	Q5SWX8	1	186375838-186421378	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015988, HPA031352"	Uncertain		Approved	"Nucleoplasm,Plasma membrane"				"Nucleoplasm, Plasma membrane"		"HPA015988: AB_1845644, HPA031352: "	"unprognostic (1.19e-2)"	"unprognostic (4.23e-2)"	"unprognostic (1.12e-2)"	"unprognostic (3.07e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.30e-2)"	"unprognostic (2.11e-1)"	"unprognostic (8.57e-2)"	"unprognostic (8.11e-3)"	"prognostic favourable (9.92e-4)"	"unprognostic (1.15e-2)"	"unprognostic (9.85e-2)"	"unprognostic (2.18e-2)"	"unprognostic (1.34e-1)"	"unprognostic (3.50e-2)"	"unprognostic (1.03e-2)"	"unprognostic (4.20e-2)"	11.9	15.9	18.2	7.0	22.9	12.2	13.7	27.7	18.7	13.9	10.3	11.4	16.2	12.5	9.6	16.6	9.5	9.1	10.3	11.8	14.3	11.3	16.1	20.0	10.4	6.1	21.9	14.0	12.1	26.5	44.8	26.5	13.4	16.0	16.1	12.8	9.7	18.3	15.3	10.3	9.5	14.8	9.0	21.3	10.1	12.8	8.1	19.1	9.0	19.0	10.1	6.9	10.4	9.7	4.1	8.6	4.4	11.8	10.6	6.2	4.6	8.0	9.1	10.2	8.0	12.4	11.9	19.3	13.2	8.4	8.6	8.6	17.9	18.7	5.8	15.9	6.5	20.9	7.4	7.1	8.4	5.1	7.6	5.4	11.6	10.1	11.5	8.9	6.7	9.0	14.4	10.0	16.2	9.2	20.2	11.7	10.4	8.5	6.3	8.8	14.0	3.1	7.2	6.9	15.8	17.1	8.3	7.3	11.4	10.0	21.7	15.4	18.9	7.7	8.4	12.1	7.6	8.3	12.3	14.3	8.6	9.0	6.7	4.8	10.9	1.5	10.5	2.7	3.8	10.0	5.5	4.1	4.8	5.0	8.6	3.1	6.0	4.6	4.4	10.6	11.8	5.4	6.2	4.6	18.2	22.9	27.7	18.7	14.3	11.3	21.9	14.0	16.0	19.1
OPHN1	"ARHGAP41, MRX60, OPN1"	ENSG00000079482	"Oligophrenin 1"	O60890	X	68042344-68433913	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Endocytosis, Neurogenesis"	"GTPase activation"	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002919	Approved		Approved	"Nucleoplasm,Plasma membrane"				"Nucleoplasm, Plasma membrane"		"HPA002919: AB_1079526"	"unprognostic (1.21e-1)"	"unprognostic (3.21e-2)"	"unprognostic (1.96e-1)"	"unprognostic (7.31e-2)"	"unprognostic (3.85e-3)"	"unprognostic (4.32e-2)"	"unprognostic (3.52e-2)"	"unprognostic (3.09e-3)"	"unprognostic (2.22e-1)"	"unprognostic (6.62e-2)"	"unprognostic (4.37e-2)"	"unprognostic (2.30e-1)"	"unprognostic (2.21e-4)"	"unprognostic (1.98e-1)"	"unprognostic (1.29e-2)"	"unprognostic (2.08e-3)"	"unprognostic (2.64e-3)"	5.8	8.2	21.9	2.4	22.6	3.6	7.1	12.3	21.6	9.9	4.9	10.7	3.2	3.5	9.7	4.8	6.1	5.3	4.5	4.1	19.5	9.7	7.0	1.7	6.6	2.0	9.6	12.2	7.1	4.0	6.6	4.8	20.7	9.1	16.2	5.1	7.9	7.2	8.0	7.8	8.6	4.1	6.3	6.2	2.9	5.9	2.9	12.4	0.1	7.2	2.0	2.3	3.9	6.2	2.7	3.3	4.1	1.7	1.7	1.2	0.3	15.1	3.8	2.4	5.9	5.5	5.7	3.9	2.8	3.9	5.3	6.4	2.4	3.1	0.7	10.8	3.4	4.1	2.1	1.2	8.2	0.4	1.5	3.2	4.3	2.4	1.8	0.8	3.8	3.2	3.9	4.9	4.8	4.3	2.1	1.4	3.1	7.8	0.5	0.8	4.6	3.2	0.4	4.8	0.7	6.9	5.8	0.9	2.3	5.5	7.0	12.4	4.7	1.3	4.7	3.6	5.8	12.7	3.6	2.1	2.5	0.5	2.7	1.9	2.6	1.1	1.7	0.6	1.2	0.9	1.0	1.3	1.0	0.8	0.7	2.7	1.1	1.2	4.1	1.7	1.2	3.3	0.7	0.3	21.9	22.6	12.3	18.6	19.5	9.7	9.6	12.2	9.1	12.4
OR2C3	"OR2C4, OR2C5P, OST742"	ENSG00000196242	"Olfactory receptor family 2 subfamily C member 3"	Q8N628	1	247524677-247536440	"G-protein coupled receptors, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"blood: 4.2;testis: 4.6"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 1.8"	"Not detected"	"Not detected"							"Group enriched"	"Detected in some"	12	"basophil: 4.2;plasmacytoid DC: 1.3"	"Group enriched"	"Detected in many"	18	"dendritic cells: 1.3;granulocytes: 4.2"									HPA058578			Approved	"Plasma membrane"				"Plasma membrane"		"HPA058578: "									"unprognostic (1.96e-1)"			"unprognostic (7.29e-2)"		"unprognostic (3.45e-2)"	"unprognostic (1.03e-1)"			0.2	0.4	0.1	0.0	0.1	0.1	0.2	0.4	0.1	0.9	0.1			0.0	0.2	0.9	0.1	0.1	0.3	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1		0.3	0.2	1.3	0.1	0.4		0.7	0.0		0.1	0.0	0.5	0.1	0.1	0.4	0.1	0.1	0.1	4.6			0.1		0.0	0.2	0.1	0.0	1.3	4.2	0.0	0.1	0.1	0.0	0.5	0.3	0.6	0.2	0.0	0.2	0.3	0.4	0.0	0.0	0.0	0.3	1.8	0.6	0.2	0.0	0.3	0.0	0.1	0.0	0.7	0.5	0.1	0.2	0.1	0.1	0.2	0.5	0.5	0.0	0.1	0.0	0.1	1.2	0.7	0.1	0.0	0.4	0.2	0.2	0.3	0.0	0.3	0.0	0.0	0.4	0.8	0.3	0.0	0.3	0.5	0.6	0.3	0.7	0.4	1.2	0.1	0.1	0.0	0.2	0.3	0.5	0.1	0.5	4.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	1.3	0.1	0.0										
OSBPL10		ENSG00000144645	"Oxysterol binding protein like 10"	Q9BXB5	3	31657890-32077580	"Predicted intracellular proteins"	"Lipid biosynthesis, Lipid metabolism, Lipid transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"smooth muscle: 39.6"	"Cell line enhanced"	"Detected in many"		"hTERT-HME1: 31.4;RPTEC TERT1: 33.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	17	"memory B-cell: 11.5;naive B-cell: 6.6"	"Lineage enriched"	"Detected in single"	22	"B-cells: 11.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003636			Approved	"Golgi apparatus,Plasma membrane,Cytosol"				"Golgi apparatus, Plasma membrane, Cytosol"		"HPA003636: AB_1079529"	"unprognostic (5.28e-3)"	"unprognostic (2.06e-2)"	"unprognostic (4.21e-2)"	"unprognostic (1.44e-2)"	"unprognostic (1.98e-1)"	"unprognostic (2.79e-1)"	"unprognostic (3.29e-2)"	"unprognostic (3.63e-2)"	"unprognostic (8.55e-2)"	"unprognostic (1.43e-1)"	"prognostic unfavourable (3.14e-4)"	"unprognostic (2.15e-1)"	"prognostic favourable (1.51e-4)"	"unprognostic (5.86e-2)"	"unprognostic (7.64e-2)"	"unprognostic (2.23e-2)"	"prognostic unfavourable (4.85e-4)"	11.7	3.5	3.8	8.7	4.3	1.0	6.7	1.4	7.6	8.6	5.6	0.4	5.9	2.5	11.8	6.7	10.0	5.5	16.7	2.9	2.6	2.6	14.5	1.6	4.6	8.2	3.1	3.6	4.1	2.5	1.3	12.0	16.5	2.5	12.8	6.0	8.5	7.3	16.6	2.0	5.5	7.3	39.6	1.2	9.5	4.4	24.0	1.2	0.4	4.3	4.3	15.1	25.2	11.8	11.5	0.1	0.5	0.0	0.0	0.0	0.2	6.1	3.5	0.6	12.4	1.1	2.3	20.9	1.7	1.9	1.6	2.3	8.6	4.5	14.6	16.7	0.4	3.7	2.7	14.6	1.9	0.1	2.7	0.0	8.6	5.5	0.9	0.0	0.1	2.4	12.4	2.5	31.4	7.1	0.0	0.0	6.8	5.1	0.0	0.0	7.8	8.9	0.1	0.2	0.2	33.1	2.5	0.9	0.1	3.1	5.4	1.7	3.6	0.0	5.0	2.0	21.5	0.2	8.2	1.4	1.0	14.0	2.8	0.0	12.6	0.2	0.0	0.1	0.0	0.0	0.0	11.5	0.0	0.0	0.0	6.6	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.2	3.8	4.3	1.4	7.6	2.6	2.6	3.1	3.6	2.5	1.2
OSBPL6	ORP6	ENSG00000079156	"Oxysterol binding protein like 6"	Q9BZF3	2	178194481-178402891	"Plasma proteins, Predicted intracellular proteins"	"Lipid transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 33.4"	"Cell line enhanced"	"Detected in many"		"HEL: 24.5;hTERT-HME1: 26.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"neutrophil: 2.2"	"Group enriched"	"Detected in many"	8	"granulocytes: 2.2;T-cells: 1.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA032131	Enhanced		Approved	"Plasma membrane"				"Plasma membrane"		"HPA032131: AB_10670963"	"unprognostic (6.22e-2)"	"unprognostic (1.53e-1)"	"unprognostic (2.47e-1)"	"unprognostic (5.95e-3)"	"unprognostic (5.26e-2)"	"unprognostic (1.40e-2)"	"unprognostic (7.55e-2)"	"unprognostic (4.81e-2)"	"unprognostic (3.32e-1)"	"unprognostic (1.03e-1)"	"unprognostic (3.03e-3)"	"unprognostic (3.49e-2)"	"unprognostic (1.15e-5)"	"unprognostic (1.11e-2)"	"unprognostic (1.30e-1)"	"unprognostic (3.73e-4)"	"unprognostic (4.44e-6)"	2.4	2.8	9.2	1.9	10.5	0.8	3.2	10.2	18.4	1.9	1.7	3.2	0.2	1.6	1.8	1.7	4.1	2.1	2.2	5.9	7.5	6.3	4.5	8.7	6.3	2.0	4.9	8.0	2.8	2.3	1.2	15.1	1.4	11.3	5.3	2.1	2.5	2.9	2.9	33.4	11.6	5.6	2.6	4.3	2.0	1.7	2.4	4.3	0.0	4.1	6.3	1.7	1.5	2.3	0.2	0.1	2.2	0.0	0.2	1.4	0.6	0.0	0.5	4.3	8.7	3.6	4.0	3.3	7.1	3.7	6.3	7.7	0.7	0.1	0.0	0.3	6.5	0.1	10.1	5.8	10.7	0.1	5.2	24.5	1.5	0.0	2.3	4.0	0.1	2.7	9.2	13.8	26.8	3.0	0.4	3.0	8.2	3.5	0.0	0.0	5.2	5.2	0.0	8.8	1.5	0.4	0.0	3.3	1.9	3.2	0.9	7.0	1.2	0.0	5.8	7.2	4.5	4.8	8.2	16.7	6.5	0.0	8.6	0.0	3.3	0.5	0.0	0.0	0.0	0.0	1.2	0.0	0.6	0.8	0.0	0.2	1.4	0.1	2.2	0.2	0.0	0.1	0.0	0.6	9.2	10.5	10.2	18.4	7.5	6.3	4.9	8.0	11.3	4.3
OSCAR		ENSG00000170909	"Osteoclast associated, immunoglobulin-like receptor"	Q8IYS5	19	54094668-54102692	"Predicted intracellular proteins, Predicted membrane proteins"		Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"blood: 20.6;bone marrow: 18.9;lung: 40.4;lymphoid tissue: 20.2"	"Cell line enhanced"	"Detected in some"		"EFO-21: 13.3;HHSteC: 9.1;hTERT-HME1: 4.7;NB-4: 5.3;U-937: 16.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	34	"classical monocyte: 20.6;eosinophil: 11.7;intermediate monocyte: 12.8;myeloid DC: 9.4;neutrophil: 18.3;non-classical monocyte: 11.2"	"Group enriched"	"Detected in many"	75	"dendritic cells: 9.4;granulocytes: 18.3;monocytes: 20.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA073996			Approved	"Nucleoplasm,Plasma membrane,Cytosol"	"Intracellular and membrane"		72000000	"Nucleoplasm, Plasma membrane, Cytosol"		"HPA073996: "	"unprognostic (9.09e-2)"	"unprognostic (6.79e-3)"	"unprognostic (8.47e-3)"	"unprognostic (2.14e-1)"	"unprognostic (2.12e-2)"	"unprognostic (9.04e-2)"	"unprognostic (1.39e-1)"	"unprognostic (3.86e-1)"	"unprognostic (8.57e-2)"	"unprognostic (1.15e-1)"	"unprognostic (2.05e-2)"	"unprognostic (3.01e-1)"	"prognostic unfavourable (2.71e-5)"	"unprognostic (1.84e-1)"	"unprognostic (2.88e-2)"	"unprognostic (9.69e-2)"	"unprognostic (4.28e-2)"	4.5	1.0	1.4	3.8	2.8	18.9	1.4	0.4	1.5	1.3	0.9	3.5	0.0	0.4	0.7	1.3	1.2	2.2	2.3	1.1	3.8	1.9	1.0	1.7	40.4	4.7	3.5	0.4	1.2	0.7	0.3	0.5	2.2	4.0	0.8	0.7	1.0	1.3	0.8	0.7	1.9	1.0	2.8	5.6	20.2	1.3	0.6	2.4	1.7	1.0	0.0	1.2	1.7	3.1	0.0	9.4	18.3	20.6	0.0	0.2	7.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.2	0.1	0.4	0.0	13.3	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	9.1	0.7	0.0	0.0	0.2	0.6	4.7	0.0	0.0	0.4	0.1	0.1	0.0	5.3	0.3	1.0	0.0	0.5	0.3	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	3.8	0.0	0.3	0.7	0.0	0.0	0.0	0.0	0.5	0.5	16.5	0.0	0.0	20.6	11.7	0.1	12.8	0.0	0.0	0.1	0.2	9.4	0.0	0.0	0.0	18.3	0.0	11.2	0.4	0.1	7.0	1.4	2.8	0.4	1.4	3.8	1.9	3.5	0.4	4.0	2.4
OSCP1	"C1orf102, NOR1"	ENSG00000116885	"Organic solute carrier partner 1"	Q8WVF1	1	36415827-36450451	"Predicted intracellular proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"fallopian tube: 35.8;testis: 49.9"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028436, HPA052655"	Approved		Approved	"Nucleoplasm,Nucleoli,Plasma membrane"				"Nucleoplasm, Nucleoli"	"Plasma membrane"	"HPA028436: AB_10600885, HPA052655: "	"unprognostic (3.46e-3)"	"unprognostic (7.57e-2)"	"unprognostic (4.67e-2)"	"prognostic favourable (6.88e-4)"	"unprognostic (1.28e-2)"	"unprognostic (4.81e-2)"	"unprognostic (3.38e-2)"	"unprognostic (4.52e-2)"	"unprognostic (5.52e-2)"	"unprognostic (8.80e-2)"	"unprognostic (2.21e-2)"	"unprognostic (3.87e-2)"	"prognostic favourable (2.18e-6)"	"unprognostic (1.20e-1)"	"unprognostic (2.04e-2)"	"unprognostic (1.02e-2)"	"unprognostic (4.20e-2)"	3.9	5.3	6.2	1.5	14.0	1.2	6.0	3.6	12.7	6.2	3.6	6.5	7.5	1.8	6.3	14.1	3.2	35.8	5.5	4.7	6.5	8.9	11.9	1.8	6.7	1.3	4.9	5.3	5.9	6.2	15.7	15.7	8.9	7.8	6.4	2.5	6.7	5.3	6.8	2.4	3.4	1.3	5.0	3.2	0.9	3.5	49.9	3.2	1.3	11.1	3.5	2.4	3.2	2.6	0.8	3.8	0.3	1.7	0.3	3.1	0.8	5.1	4.9	6.1	7.1	7.3	7.2	1.1	3.1	7.7	7.8	5.4	0.1	4.6	1.1	5.9	5.7	4.1	0.2	5.9	5.1	0.9	4.7	0.0	3.3	0.5	9.1	0.6	0.9	8.1	9.7	11.0	4.8	5.3	0.1	1.3	6.1	3.7	2.7	1.9	6.2	2.1	2.9	2.5	0.9	12.8	1.8	16.5	7.3	5.9	2.8	4.1	6.0	0.8	4.6	5.7	2.1	10.2	5.3	2.3	2.3	0.5	10.9	0.1	3.8	0.0	0.7	0.0	0.9	1.7	0.0	0.4	0.9	0.7	1.8	0.8	2.2	3.1	0.3	0.3	0.2	3.8	2.2	0.8	6.2	14.0	3.6	12.7	6.5	8.9	4.9	5.3	7.8	3.2
OSGEP	"GCPL1, KAE1, OSGEP1, PRSMG1, TCS3"	ENSG00000092094	"O-sialoglycoprotein endopeptidase"	Q9NPF4	14	20446411-20455105	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"tRNA processing"	"Acyltransferase, Transferase"	"Disease mutation, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039751	Uncertain		Supported	"Nucleoplasm,Plasma membrane"				Nucleoplasm	"Plasma membrane"	"HPA039751: AB_10794754"	"prognostic favourable (1.48e-4)"	"unprognostic (4.15e-3)"	"unprognostic (1.29e-1)"	"unprognostic (4.33e-3)"	"unprognostic (1.54e-2)"	"unprognostic (3.95e-2)"	"unprognostic (5.54e-3)"	"unprognostic (2.80e-3)"	"unprognostic (2.98e-1)"	"unprognostic (1.05e-1)"	"unprognostic (3.35e-3)"	"unprognostic (1.22e-1)"	"prognostic unfavourable (4.64e-6)"	"unprognostic (4.83e-2)"	"unprognostic (1.86e-2)"	"unprognostic (2.53e-2)"	"unprognostic (9.91e-2)"	11.2	14.2	13.2	13.1	14.5	10.7	14.4	21.3	18.3	14.3	15.6	18.6	11.6	8.8	16.0	19.2	12.9	13.1	13.6	15.8	13.4	10.2	12.3	22.2	12.4	16.9	13.4	12.5	12.4	12.4	10.6	20.8	13.6	15.5	10.8	14.0	14.5	12.4	18.6	19.6	9.9	12.4	16.8	12.3	18.8	13.6	5.7	15.2	16.2	15.7	9.6	18.7	16.6	11.0	24.5	28.8	23.4	19.1	13.0	14.2	15.7	6.3	10.3	3.4	10.0	5.9	4.1	10.5	5.0	6.6	12.8	12.4	14.2	7.5	13.3	6.5	6.3	5.6	10.3	10.1	8.0	10.5	13.2	8.4	8.7	18.2	4.4	14.4	12.0	3.1	3.1	15.3	8.1	8.4	8.1	7.6	10.0	11.9	14.1	6.3	5.1	20.4	22.5	6.4	7.5	7.2	7.3	13.3	2.6	8.9	9.4	6.8	6.3	13.7	3.9	5.4	13.2	6.8	6.0	2.3	12.5	18.2	3.3	22.5	6.5	5.1	19.1	23.4	13.7	17.6	11.9	20.5	14.2	12.0	28.8	24.5	11.3	12.9	8.7	13.0	13.6	12.4	12.9	15.7	13.2	14.5	21.3	18.3	13.4	10.2	13.4	12.5	15.5	15.2
OSR2	FLJ90037	ENSG00000164920	"Odd-skipped related transciption factor 2"	Q8N2R0	8	98944403-98952104	"Predicted intracellular proteins, Transcription factors"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"endometrium 1: 47.9"	"Cell line enriched"	"Detected in some"	17	"ASC diff: 111.2"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"eosinophil: 1.0"	"Low lineage specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA052425, HPA063486"	Uncertain		Approved	"Nucleoplasm,Plasma membrane"				"Plasma membrane"	Nucleoplasm	"HPA052425: , HPA063486: "	"unprognostic (1.72e-1)"	"unprognostic (1.92e-3)"	"unprognostic (1.03e-1)"	"unprognostic (5.94e-2)"	"unprognostic (1.57e-1)"	"prognostic favourable (2.44e-5)"	"unprognostic (1.70e-2)"	"unprognostic (1.15e-2)"	"unprognostic (1.89e-2)"	"unprognostic (3.73e-3)"	"unprognostic (3.01e-2)"	"unprognostic (6.19e-2)"	"unprognostic (1.57e-7)"	"unprognostic (1.37e-2)"	"unprognostic (2.39e-1)"	"unprognostic (2.56e-4)"	"unprognostic (8.54e-3)"	10.6	2.4	0.5	4.2	0.7	0.0	10.9	0.6	0.5	41.7	3.1	0.5	10.2	0.0	47.9	18.9	4.6	37.6	7.3	1.9	0.5	0.0	1.3	0.5	1.3	2.0	0.8	0.5	36.3	1.4	0.6	1.0	7.7	0.7	20.9	0.8	0.5	1.4	23.7	3.5	6.7	7.4	15.3	0.8	0.5	1.3	27.0	0.6	0.8	1.8	1.8	3.0	6.7	24.1	0.0	0.0	1.0	0.0	0.0	0.6	0.6	6.1	0.8	0.0	0.8	111.2	3.5	0.8	3.4	6.6	2.7	2.7	0.6	0.7	0.0	0.5	5.2	2.4	0.5	0.9	1.3	0.2	2.5	0.1	0.6	0.3	1.8	0.1	0.1	3.5	1.9	0.4	0.3	0.0	0.7	0.0	0.1	2.8	0.5	1.0	0.0	0.5	2.6	0.3	0.2	0.2	0.5	0.2	0.0	0.3	1.4	0.0	0.8	1.4	0.0	0.4	0.0	2.7	0.2	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.5	0.7	0.6	0.5	0.5	0.0	0.8	0.5	0.7	0.6
P3H3	"GRCB, HSU47926, LEPREL2"	ENSG00000110811	"Prolyl 3-hydroxylase 3"	Q8IVL6	12	6828410-6839851	"Enzymes, Predicted intracellular proteins"		"Dioxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BJ: 22.2;NTERA-2: 15.8;U-251 MG: 15.3"	"Low cancer specificity"	"Detected in all"							"Cell type enhanced"	"Detected in some"		"MAIT T-cell: 2.1;naive CD4 T-cell: 1.7"	"Lineage enriched"	"Detected in single"	21	"T-cells: 2.1"	"Low region specificity"	"Detected in all"			"Region enriched"	"Detected in many"	4	"cerebellum: 17.6"	HPA043695	Approved		Approved	"Nucleoli,Plasma membrane,Cytosol"	"Intracellular and membrane"			"Plasma membrane, Cytosol"	Nucleoli	"HPA043695: AB_10797146"	"unprognostic (2.54e-1)"	"unprognostic (6.66e-2)"	"unprognostic (1.14e-1)"	"unprognostic (3.34e-2)"	"unprognostic (5.76e-2)"	"unprognostic (6.55e-2)"	"unprognostic (2.66e-1)"	"unprognostic (2.92e-1)"	"unprognostic (6.90e-2)"	"unprognostic (1.44e-1)"	"prognostic favourable (4.91e-4)"	"unprognostic (1.29e-1)"	"prognostic unfavourable (1.64e-4)"	"unprognostic (2.58e-2)"	"unprognostic (9.67e-2)"	"unprognostic (2.27e-1)"	"unprognostic (7.77e-3)"	3.7	3.1	1.2	2.2	2.6	0.3	3.0	10.7	2.5	12.1	2.7	0.0	7.6	1.1	11.0	8.5	2.5	2.1	5.6	4.4	1.2		1.1	0.4	1.6	1.9	0.0	2.2	9.3	3.6	12.1	7.4	2.5	0.8	5.6	0.5	8.1	5.9	6.5	0.5	1.8	1.7	8.8	0.5	1.0	2.8	2.1	0.1	0.0	3.5	1.2	1.4	5.9	4.7	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.9	4.2	8.0	4.9	6.0	0.1	22.2	12.8	7.1	7.8	0.3	0.0	0.0	0.3	8.3	0.0	2.5	0.2	1.6	0.0	10.6	0.5	2.3	1.0	3.5	0.5	0.0	6.5	0.2	3.4	1.9	7.4	2.0	0.0	3.3	0.0	0.0	0.2	15.8	0.6	0.0	3.9	0.1	0.3	0.0	1.6	6.0	0.0	0.0	2.5	0.1	0.1	13.0	6.9	10.3	10.6	15.3	0.0	0.1	0.2	5.9	0.0	2.7	0.0	0.0	0.0	0.3	0.0	2.1	0.0	0.0	0.9	0.0	0.0	1.7	0.3	0.0	0.0	0.0	0.0	0.1	0.0										
PAIP1		ENSG00000172239	"Poly(A) binding protein interacting protein 1"	Q9H074	5	43526267-43557758	"Predicted intracellular proteins"	"Translation regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA073653, HPA076187"	Approved		Approved	"Plasma membrane,Cytosol"			18000	"Plasma membrane, Cytosol"		"HPA073653: , HPA076187: "	"unprognostic (4.70e-2)"	"unprognostic (4.30e-2)"	"unprognostic (5.37e-2)"	"unprognostic (2.65e-2)"	"unprognostic (1.62e-2)"	"unprognostic (4.74e-2)"	"unprognostic (1.13e-3)"	"unprognostic (2.98e-1)"	"unprognostic (3.17e-2)"	"unprognostic (1.62e-2)"	"prognostic unfavourable (4.79e-4)"	"unprognostic (3.54e-1)"	"unprognostic (1.73e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.30e-1)"	30.1	26.6	26.9	15.4	26.0	20.6	35.9	22.7	32.6	30.2	27.8	25.0	19.6	18.3	28.4	26.0	26.1	22.8	23.3	45.6	26.8	24.4	34.0	38.3	21.3	20.8	28.6	21.5	24.8	23.5	30.9	24.0	29.0	23.0	32.1	24.3	21.3	23.4	31.7	62.8	16.6	24.2	38.7	33.4	21.0	23.8	44.3	27.3	29.9	38.5	20.6	18.6	31.5	36.8	14.1	35.0	23.4	12.4	12.5	16.4	10.9	22.6	20.2	39.7	38.4	41.7	33.0	32.5	20.0	44.7	38.3	33.4	18.8	28.0	15.1	34.8	28.3	14.9	61.9	24.1	39.1	12.5	24.0	11.9	40.5	29.6	36.8	17.7	18.8	34.9	46.9	25.8	48.8	36.4	27.5	20.5	38.1	24.4	19.5	24.5	19.7	26.1	15.3	30.0	21.2	47.5	28.0	22.6	34.3	64.2	24.8	44.4	35.3	25.8	20.2	34.8	28.8	17.3	25.1	15.5	26.3	22.7	20.3	27.5	29.9	17.4	12.4	23.4	10.5	10.4	14.0	14.1	13.1	14.5	12.4	13.2	16.4	13.0	4.6	12.5	11.1	35.0	11.4	10.9	26.9	26.0	22.7	32.6	26.8	24.4	28.6	21.5	23.0	27.3
PALLD	"CGI-151, KIAA0992, SIH002"	ENSG00000129116	"Palladin, cytoskeletal associated protein"	Q8WX93	4	168497066-168928457	"Disease related genes, Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"smooth muscle: 203.3"	"Cell line enhanced"	"Detected in many"		"LHCN-M2: 64.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 13.6"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035905, CAB070159"	Enhanced		Supported	"Plasma membrane,Actin filaments,Cytosol"				"Plasma membrane, Actin filaments"	Cytosol	"CAB070159: AB_1726016, HPA035905: "	"unprognostic (3.59e-2)"	"unprognostic (3.99e-1)"	"unprognostic (2.55e-2)"	"unprognostic (5.03e-3)"	"unprognostic (2.51e-1)"	"unprognostic (7.03e-2)"	"unprognostic (2.60e-1)"	"unprognostic (2.40e-2)"	"unprognostic (3.57e-2)"	"unprognostic (4.21e-2)"	"unprognostic (2.38e-1)"	"unprognostic (3.86e-1)"	"unprognostic (8.54e-2)"	"unprognostic (1.39e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.50e-1)"	"prognostic unfavourable (3.28e-4)"	17.3	8.9	8.5	19.6	7.5	0.1	28.1	2.1	6.7	58.4	71.9	5.7	46.4	6.7	82.2	25.6	84.3	31.3	30.8	95.0	9.2	3.2	12.7	3.6	24.9	17.0	4.6	4.7	28.0	3.0	25.6	3.9	14.0	6.0	71.4	17.9	9.2	11.4	50.9	30.5	8.9	16.8	203.3	6.7	25.8	31.4	14.1	6.9	2.2	12.7	17.2	5.8	140.3	82.7	0.2	2.2	13.6	3.2	0.6	5.1	1.5	17.6	8.7	19.4	12.0	17.9	19.5	27.3	12.1	30.5	10.7	15.2	0.2	1.0	7.6	3.1	5.2	3.7	11.8	30.8	13.7	16.0	3.6	0.1	25.1	2.2	31.3	0.0	0.2	29.7	19.2	19.1	28.7	4.5	0.0	0.1	64.4	0.8	5.1	0.3	5.6	5.2	1.7	18.0	0.1	1.2	3.5	2.0	10.5	22.8	1.7	1.6	10.8	0.1	14.5	11.2	42.4	4.7	19.6	10.9	0.1	0.3	9.4	0.2	3.1	13.6	3.2	0.0	5.1	1.9	0.2	0.1	0.6	2.7	2.2	0.2	0.6	2.0	0.8	0.6	1.2	0.2	0.5	1.5	8.5	7.5	2.1	6.7	9.2	3.2	4.6	4.7	6.0	6.9
PALM2		ENSG00000243444	"Paralemmin 2"	Q8IXS6	9	109640788-109946703	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 17.9;liver: 19.7"	"Cell line enhanced"	"Detected in many"		"hTEC/SVTERT24-B: 5.8;RH-30: 20.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"neutrophil: 1.1"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in many"							"HPA074153, HPA076866"			Approved	"Plasma membrane"				"Plasma membrane"		"HPA074153: , HPA076866: "	"unprognostic (7.68e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.44e-2)"	"unprognostic (1.17e-3)"	"unprognostic (3.14e-3)"	"unprognostic (1.11e-1)"	"unprognostic (2.51e-2)"	"unprognostic (2.77e-2)"	"unprognostic (2.36e-2)"	"unprognostic (3.35e-1)"	"unprognostic (7.62e-2)"	"unprognostic (1.09e-1)"	"unprognostic (5.59e-2)"	"unprognostic (2.50e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.74e-6)"	"unprognostic (8.39e-2)"	14.8	6.1	8.1	2.0	11.1	1.2	6.7	1.7	17.9	4.3	2.4	9.1	0.0	1.8	4.9	1.7	2.4	3.8	3.0	7.6	6.3	1.8	2.7	19.7	4.8	1.5	5.0	9.7	2.3	2.2	1.4	1.6	3.1	8.4	2.4	2.4	0.0	3.2	1.4	2.5	3.1	2.0	2.2	4.9	1.5	2.2	2.7	8.7	0.0	4.3	0.0	1.4	2.8	2.6	0.5	0.1	1.1	0.2	0.3	0.1	0.0	0.1	0.5	0.5	0.0	0.4	0.9	0.2	0.4	1.2	0.7	1.7	0.3	0.7	0.1	0.1	1.8	1.7	0.0	0.6	1.2	0.1	0.9	0.0	2.4	0.2	0.0	0.0	0.1	2.0	0.8	5.8	0.9	0.0	0.0	0.0	2.4	0.5	0.0	0.0	3.4	1.3	0.0	20.4	0.4	2.8	0.4	3.8	0.0	5.0	0.2	1.6	2.0	0.4	0.2	2.0	2.9	0.1	1.6	0.1	0.7	0.1	1.6	0.0	2.4	0.3	0.2	0.1	0.0	0.0	0.0	0.2	0.1	0.0	0.1	0.5	0.1	0.0	1.1	0.3	0.1	0.1	0.0	0.0	8.1	11.1	1.7	12.7	6.3	1.8	5.0	9.7	8.4	8.7
PALM2-AKAP2		ENSG00000157654	"PALM2-AKAP2 readthrough"		9	109780309-110172512	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in many"		"adipose tissue: 41.0;heart muscle: 26.8"	"Cell line enhanced"	"Detected in many"		"ASC diff: 15.4;hTEC/SVTERT24-B: 14.8;RH-30: 29.1;U-251 MG: 13.0;WM-115: 17.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA058905, HPA074153, HPA076866"	Uncertain		Approved	"Nucleoplasm,Nuclear bodies,Plasma membrane"				"Plasma membrane"	"Nucleoplasm, Nuclear bodies"	"HPA058905: , HPA074153: , HPA076866: "	"unprognostic (7.12e-2)"	"unprognostic (1.64e-6)"	"unprognostic (7.90e-2)"	"unprognostic (3.67e-2)"	"unprognostic (2.45e-1)"	"unprognostic (3.19e-1)"	"unprognostic (9.91e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.75e-1)"	"unprognostic (8.37e-3)"	"unprognostic (2.40e-2)"	"unprognostic (2.77e-1)"	"unprognostic (1.19e-1)"	"unprognostic (2.05e-3)"	"unprognostic (7.77e-2)"	"unprognostic (1.98e-4)"	"unprognostic (3.36e-5)"	41.0	2.8	1.6	3.3	1.6	0.1	19.6	0.7	4.7	4.8	2.3	1.5	2.1	1.1	15.2	4.7	2.1	2.5	5.0	26.8	1.8	2.4	2.4	24.8	9.7	1.2	1.9	0.5	5.9	1.1	1.6	1.1	9.2	3.0	3.2	0.6	1.1	2.0	3.6	4.5	1.8	1.0	7.8	1.4	0.5	1.1	1.4	0.9	0.0	3.8	2.5	0.3	5.2	8.9	0.0	0.0	0.0	0.0	0.0	0.5	0.9	0.0	0.0	3.3	0.0	15.4	5.5	1.3	5.4	5.3	1.6	3.6	0.0	0.1	0.0	0.5	5.6	2.0	0.0	1.2	4.5	0.2	1.6	0.0	5.0	0.1	0.1	0.0	0.0	7.0	0.1	14.8	2.4	0.1	0.0	0.0	5.7	0.0	0.0	0.0	4.3	1.4	0.0	29.1	0.0	4.0	0.0	1.7	0.0	2.1	0.2	7.4	0.6	0.0	0.1	3.4	8.5	0.3	13.0	0.0	0.2	0.0	4.2	0.0	17.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.9	1.6	1.6	0.7	3.0	1.8	2.4	1.9	0.5	3.0	0.9
PALM3		ENSG00000187867	"Paralemmin 3"	A6NDB9	19	14053365-14059159	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 26.5;testis: 19.7"	"Group enriched"	"Detected in some"	4	"AN3-CA: 21.7;CACO-2: 23.2;HAP1: 19.4;NTERA-2: 14.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA052794, HPA056119"	Enhanced		Approved	"Nucleoplasm,Nuclear bodies,Plasma membrane"				"Nucleoplasm, Nuclear bodies"	"Plasma membrane"	"HPA052794: , HPA056119: "	"unprognostic (3.67e-2)"	"unprognostic (9.08e-2)"	"unprognostic (4.72e-2)"	"prognostic unfavourable (7.87e-4)"	"unprognostic (2.14e-2)"	"unprognostic (1.47e-1)"	"unprognostic (4.66e-2)"	"unprognostic (7.62e-2)"	"unprognostic (1.97e-1)"	"unprognostic (3.91e-1)"	"unprognostic (3.93e-2)"	"unprognostic (3.88e-2)"	"unprognostic (2.09e-2)"	"unprognostic (1.06e-1)"	"unprognostic (5.68e-2)"	"unprognostic (1.10e-2)"	"unprognostic (1.72e-3)"	0.2	0.2	4.3	0.9	1.9	0.0	2.1	3.7	3.6	2.9	0.5	3.2	0.2	2.7	0.4	11.1	0.2	1.5	1.6	0.2	4.2	2.8	12.9	26.5	2.4	0.2	1.7	4.3	0.4	11.7	1.8	0.2	0.7	10.1	1.8	0.2	1.1	6.9	8.0	0.2	0.2	0.8	0.9	2.7	0.2	13.0	19.7	4.9	0.2	6.8	0.2	1.0	3.9	1.9	0.9	0.2	0.0	0.3	0.0	1.8	0.0	1.6	1.5	3.6	21.7	0.3	0.1	4.4	0.4	0.1	1.2	0.6	23.2	0.5	0.0	0.2	0.4	0.1	19.4	0.0	0.3	0.0	1.3	0.1	0.5	2.6	0.0	0.0	0.1	0.0	0.0	1.6	0.0	0.1	4.5	0.0	0.0	3.6	0.2	0.1	14.0	1.3	0.0	0.0	0.0	0.0	1.8	2.7	3.6	0.1	0.0	0.0	1.3	0.0	0.2	0.0	4.9	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.5	0.1	0.9	0.8	0.3	0.0	0.1	0.9	1.8	1.8	0.0	0.0	0.1	0.2	0.5	0.0	4.3	1.9	3.7	3.6	4.2	2.8	1.7	4.3	10.1	4.9
PALMD	"C1orf11, FLJ20271, PALML"	ENSG00000099260	Palmdelphin	Q9NP74	1	99645943-99694541	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 84.9;skeletal muscle: 106.9"	"Cell line enhanced"	"Detected in some"		"HUVEC TERT2: 42.5;LHCN-M2: 13.7;TIME: 59.6;U-87 MG: 26.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA017959, HPA030549"	Supported		Supported	"Plasma membrane,Actin filaments,Focal adhesion sites"				"Actin filaments"	"Plasma membrane, Focal adhesion sites"	"HPA017959: AB_1854949, HPA030549: "	"unprognostic (1.48e-2)"	"unprognostic (1.15e-2)"	"unprognostic (2.05e-2)"	"prognostic favourable (9.42e-4)"	"unprognostic (7.67e-2)"	"prognostic favourable (5.90e-5)"	"unprognostic (1.54e-2)"	"unprognostic (2.10e-1)"	"unprognostic (3.93e-2)"	"unprognostic (1.64e-1)"	"unprognostic (8.32e-2)"	"unprognostic (6.18e-2)"	"unprognostic (5.19e-2)"	"unprognostic (1.63e-2)"	"unprognostic (1.88e-1)"	"unprognostic (2.70e-1)"	"unprognostic (8.08e-2)"	84.9	18.6	8.3	6.2	4.3	0.0	46.4	1.1	3.7	17.1	6.5	3.9	4.0	1.3	18.6	10.1	16.2	8.7	5.3	59.0	5.6	3.4	5.1	20.9	10.6	3.4	3.9	3.8	17.4	2.2	4.4	4.7	16.8	19.0	8.1	2.6	7.9	34.0	4.4	106.9	18.0	3.5	12.2	4.1	2.3	2.8	7.5	2.2	2.1	3.4	48.2	6.2	6.9	11.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.3	0.7	2.9	0.0	0.1	0.0	0.0	0.0	0.0	5.5	7.1	0.0	0.0	0.0	1.1	0.5	0.0	0.0	42.5	6.0	0.0	13.7	0.1	0.0	0.0	0.0	1.8	0.0	10.6	0.0	0.0	2.2	0.2	0.1	0.0	2.7	0.0	0.6	0.0	59.6	0.0	0.1	4.6	0.0	0.0	0.0	0.0	26.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.3	4.3	1.1	3.7	5.6	3.4	3.9	3.8	19.0	2.2
PARD6G	"PAR-6G, PAR6gamma"	ENSG00000178184	"Par-6 family cell polarity regulator gamma"	Q9BYG4	18	80157232-80247546	"Predicted intracellular proteins"	"Cell cycle, Cell division"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skin 1: 37.0"	"Cell line enhanced"	"Detected in many"		"HMC-1: 21.1;hTCEpi: 19.7;RT4: 15.8;U-2 OS: 17.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"basophil: 2.5"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA047017	Uncertain		Approved	"Plasma membrane"				"Plasma membrane"		"HPA047017: "	"unprognostic (1.11e-1)"	"unprognostic (4.39e-2)"	"unprognostic (9.88e-2)"	"unprognostic (4.40e-2)"	"unprognostic (2.97e-1)"	"unprognostic (5.48e-3)"	"prognostic unfavourable (3.19e-4)"	"unprognostic (1.80e-1)"	"unprognostic (9.96e-2)"	"unprognostic (4.27e-2)"	"unprognostic (1.17e-1)"	"unprognostic (4.09e-2)"	"unprognostic (6.86e-3)"	"unprognostic (9.65e-2)"	"unprognostic (1.01e-1)"	"unprognostic (4.85e-1)"	"unprognostic (2.72e-1)"	2.9	2.2	3.1	4.0	3.1	0.8	8.8	2.0	4.3	15.1	5.0	3.1	8.2	2.1	9.5	6.1	17.3	6.7	4.5	3.0	4.3	4.1	5.5	3.5	2.6	10.4	2.8	2.4	8.9	3.1	2.1	3.7	5.7	3.7	8.8	2.5	4.0	7.0	6.6	2.0	37.0	2.9	8.2	2.6	2.4	2.5	2.4	1.8	6.9	20.7	14.1	11.2	8.4	10.7	0.5	0.5	2.5	0.4	0.6	1.0	0.1	1.6	2.4	10.2	7.7	0.3	0.4	7.4	1.9	0.4	1.7	0.2	0.7	0.7	0.0	0.8	0.8	7.6	3.6	10.9	1.6	0.3	3.2	0.1	1.9	5.8	0.5	2.1	21.1	3.4	19.7	0.2	1.0	0.8	0.7	0.5	2.4	2.8	1.9	0.2	3.1	2.9	0.0	6.7	0.8	0.3	15.8	4.3	4.4	2.3	1.3	10.8	1.5	1.9	0.6	3.4	17.0	1.2	0.9	0.5	0.6	0.1	1.1	0.5	6.3	2.5	0.2	0.4	0.3	0.2	0.2	0.3	0.3	1.0	0.2	0.5	0.4	0.5	1.2	0.6	0.4	0.5	0.1	0.1	3.1	3.1	2.0	4.3	4.3	4.1	2.8	2.4	3.7	1.8
PARP6	pART17	ENSG00000137817	"Poly(ADP-ribose) polymerase family member 6"	Q2NL67	15	72241181-72272999	"Enzymes, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026991	Approved		Approved	"Plasma membrane"				"Plasma membrane"		"HPA026991: AB_1854989"	"unprognostic (3.88e-2)"	"prognostic favourable (3.17e-5)"	"prognostic unfavourable (3.37e-4)"	"unprognostic (3.36e-1)"	"unprognostic (7.13e-2)"	"unprognostic (3.05e-1)"	"unprognostic (2.37e-2)"	"unprognostic (1.33e-1)"	"unprognostic (2.00e-1)"	"unprognostic (2.64e-1)"	"unprognostic (8.55e-2)"	"unprognostic (6.92e-2)"	"prognostic unfavourable (8.02e-8)"	"unprognostic (6.81e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.45e-1)"	"unprognostic (4.42e-2)"	13.7	16.6	28.0	12.8	32.4	25.1	26.5	46.6	41.2	15.5	16.2	16.9	18.2	14.1	23.3	23.8	14.0	17.0	20.2	18.4	26.1	22.4	14.3	9.0	15.7	16.8	19.9	21.8	26.3	20.9	20.6	30.8	17.0	19.4	19.3	14.3	14.5	21.3	18.8	23.9	20.3	14.4	19.6	14.2	18.2	18.2	25.1	15.8	9.6	21.7	12.5	15.8	16.3	15.8	4.1	4.0	12.1	5.3	4.3	4.3	2.9	7.2	13.1	13.8	17.9	14.8	12.4	11.2	6.2	9.4	10.3	15.2	8.6	13.2	10.0	3.9	9.4	9.5	15.2	8.4	5.9	11.8	13.7	14.5	22.9	0.1	12.4	7.4	13.9	15.9	20.8	9.6	26.6	6.9	7.3	11.5	8.3	13.2	6.3	13.1	6.4	0.0	11.8	9.8	7.8	9.6	14.4	39.0	20.7	10.4	8.5	17.0	10.8	8.6	6.5	13.0	11.9	16.9	9.4	13.0	11.9	10.8	9.4	14.6	9.0	1.7	5.3	12.1	3.8	4.4	2.7	3.3	2.7	4.0	4.0	4.1	4.3	3.2	5.7	4.3	4.9	3.1	4.2	2.9	28.0	32.4	46.6	41.2	26.1	22.4	19.9	21.8	19.4	15.8
PAWR	"par-4, PAR4"	ENSG00000177425	"Pro-apoptotic WT1 regulator"	Q96IZ0	12	79574979-79691097	"Predicted intracellular proteins"	"Apoptosis, Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	8	"memory B-cell: 5.0;naive B-cell: 6.2;NK-cell: 2.9"	"Group enriched"	"Detected in many"	8	"B-cells: 6.2;NK-cells: 2.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA012640, CAB020779"	Approved		Approved	"Plasma membrane,Actin filaments"				"Plasma membrane"	"Actin filaments"	"CAB020779: , HPA012640: AB_1855748"	"unprognostic (2.42e-1)"	"unprognostic (5.58e-2)"	"unprognostic (9.77e-3)"	"unprognostic (5.39e-2)"	"unprognostic (9.44e-3)"	"unprognostic (4.21e-3)"	"unprognostic (9.21e-2)"	"unprognostic (1.37e-1)"	"unprognostic (4.78e-1)"	"unprognostic (3.03e-1)"	"unprognostic (2.42e-3)"	"unprognostic (4.97e-3)"	"unprognostic (2.22e-2)"	"unprognostic (2.58e-2)"	"unprognostic (4.64e-1)"	"unprognostic (2.22e-1)"	"unprognostic (4.23e-2)"	10.3	6.1	3.4	16.1	8.9	2.1	16.4	6.2	3.3	27.4	16.6	3.8	20.1	9.4	35.0	19.3	20.8	20.4	20.2	5.6	5.5	3.3	14.4	15.5	14.6	5.0	5.7	2.6	22.1	15.1	14.6	19.0	24.8	5.3	21.8	12.6	7.9	14.3	21.1	2.7	14.5	15.0	31.5	3.6	6.1	10.8	15.4	4.9	6.7	24.5	8.4	8.6	27.5	26.2	6.2	0.3	0.5	0.0	2.9	0.4	0.1	19.7	18.4	3.3	0.1	1.7	0.7	22.1	12.6	3.7	6.4	3.9	22.7	7.5	13.2	23.5	7.0	22.0	11.5	9.5	9.2	5.4	15.5	0.0	10.6	9.8	9.2	0.2	0.3	1.6	20.2	5.0	29.0	10.7	0.7	1.8	7.0	15.0	3.1	0.0	16.0	10.1	0.0	7.5	8.5	12.2	15.0	9.7	0.0	22.6	12.0	2.0	10.7	0.1	15.6	9.8	8.7	0.3	8.4	5.9	7.5	9.6	1.6	0.0	4.2	0.5	0.0	0.1	0.1	0.0	0.0	5.0	0.3	0.2	0.3	6.2	0.4	0.4	0.5	2.9	0.0	0.2	0.0	0.1	3.4	8.9	6.2	3.3	5.5	3.3	5.7	2.6	5.3	4.9
PCBD2	"DCOH2, DCOHM"	ENSG00000132570	"Pterin-4 alpha-carbinolamine dehydratase 2"	Q9H0N5	5	134904906-135007959	"Enzymes, Predicted intracellular proteins"	"Tetrahydrobiopterin biosynthesis"	Lyase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 47.0"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA036428	Uncertain		Approved	"Plasma membrane"				"Plasma membrane"		"HPA036428: AB_10670103"	"unprognostic (3.70e-2)"	"unprognostic (3.53e-2)"	"unprognostic (3.54e-3)"	"unprognostic (1.36e-2)"	"unprognostic (2.92e-1)"	"unprognostic (1.98e-1)"	"unprognostic (4.22e-1)"	"unprognostic (6.43e-2)"	"unprognostic (4.49e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.22e-1)"	"unprognostic (5.18e-2)"	"unprognostic (1.87e-3)"	"unprognostic (4.57e-2)"	"unprognostic (6.34e-2)"	"unprognostic (9.32e-3)"	"unprognostic (1.50e-1)"	4.9	8.1	5.4	7.0	6.6	6.6	5.3	3.0	4.4	3.9	8.7	6.5	9.4	8.0	6.5	8.4	9.3	4.9	6.9	13.8	5.0	5.3	9.2	9.8	6.5	5.0	5.6	5.2	5.1	12.9	9.6	6.1	4.8	6.8	4.7	6.4	9.6	14.2	7.9	47.0	6.7	12.7	7.6	7.0	5.5	7.1	5.5	5.8	5.3	8.3	13.5	8.1	5.6	5.5	8.2	11.5	7.2	10.1	6.3	6.6	4.3	7.7	7.5	8.0	6.0	5.6	4.7	5.9	6.2	4.8	3.5	3.6	13.9	19.8	9.2	10.4	4.2	5.3	5.4	5.9	3.3	12.9	3.6	5.3	7.9	8.3	5.4	6.0	3.8	2.5	5.8	3.7	8.5	4.1	7.6	13.9	6.2	15.9	6.3	10.2	4.5	7.3	10.0	7.5	8.2	6.5	6.5	6.0	7.9	9.3	4.8	7.7	13.4	7.9	4.5	6.8	5.1	5.9	7.8	10.8	14.8	6.3	6.1	7.3	4.4	2.7	10.1	7.2	5.1	6.3	5.0	8.2	6.3	5.3	8.6	8.2	5.4	5.3	3.3	6.3	6.1	11.5	6.6	4.3	5.4	6.6	3.0	4.1	5.0	5.3	5.6	5.2	6.8	5.8
PCDH17	"PCDH68, PCH68"	ENSG00000118946	"Protocadherin 17"	O14917	13	57631810-57729311	"Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 18.2;lymphoid tissue: 32.7"	"Cell line enhanced"	"Detected in some"		"AF22: 15.8;HEK 293: 9.9;U-87 MG: 6.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	13	"eosinophil: 1.2"	"Lineage enriched"	"Detected in single"	13	"granulocytes: 1.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA026817	Uncertain		Approved	"Vesicles,Plasma membrane,Cytosol"			31000	Cytosol	"Vesicles, Plasma membrane"	"HPA026817: AB_1855044"	"unprognostic (1.02e-2)"	"unprognostic (2.39e-1)"	"unprognostic (1.19e-1)"	"unprognostic (6.52e-2)"	"unprognostic (6.98e-3)"	"unprognostic (1.95e-2)"	"unprognostic (8.26e-4)"	"unprognostic (3.56e-1)"	"unprognostic (2.38e-2)"	"unprognostic (2.82e-1)"	"unprognostic (5.40e-2)"	"unprognostic (1.03e-1)"	"prognostic unfavourable (3.31e-5)"	"unprognostic (1.07e-2)"	"unprognostic (1.80e-1)"	"unprognostic (2.35e-1)"	"unprognostic (3.40e-2)"	2.0	2.4	8.0	2.1	11.2	0.3	0.9	4.6	18.2	2.9	1.2	6.2	0.3	1.1	2.6	1.3	1.7	2.5	3.6	2.3	6.5	12.1	1.6	1.4	13.5	0.9	7.4	4.8	0.8	6.2	2.0	1.0	4.7	4.4	1.2	1.2	1.1	1.0	1.1	1.8	0.6	0.7	2.6	4.4	32.7	1.8	8.9	7.7	0.0	3.4	0.4	0.8	3.4	0.8	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	15.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.6	2.7	0.0	0.0	1.8	0.0	0.0	0.0	9.9	0.4	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.1	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.2	0.0	0.4	0.0	2.5	0.5	0.0	0.0	0.0	0.0	0.0	0.0	2.6	1.4	0.0	1.0	0.0	0.0	0.0	6.0	0.0	0.8	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.0	11.2	4.6	7.8	6.5	12.1	7.4	4.8	4.4	7.7
PCDHA1		ENSG00000204970	"Protocadherin alpha 1"	Q9Y5I3	5	140786136-141012347	"Predicted membrane proteins, Predicted secreted proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"brain: 7.1;testis: 3.1"	"Cell line enriched"	"Detected in some"	7	"T-47d: 14.1"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA035969	Enhanced		Approved	"Plasma membrane"	"Secreted - unknown location"			"Plasma membrane"		"HPA035969: AB_10673492"	"unprognostic (2.76e-5)"	"unprognostic (1.19e-1)"	"unprognostic (3.74e-2)"	"unprognostic (1.09e-4)"	"unprognostic (7.38e-2)"	"unprognostic (2.86e-2)"	"unprognostic (2.26e-3)"	"unprognostic (1.25e-2)"	"unprognostic (1.91e-2)"	"unprognostic (1.81e-1)"	"unprognostic (9.01e-5)"	"unprognostic (2.46e-2)"	"unprognostic (1.91e-1)"	"unprognostic (7.57e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.77e-3)"	"unprognostic (1.29e-1)"	0.2	1.5	4.6	0.2	4.4	0.1	0.2	3.3	7.1	0.2	0.3			0.7	0.5	0.1	0.2	0.2	0.4	0.1	5.0	3.7	0.6	0.1	0.2	0.3	3.4		0.2	0.2	1.0	1.4	0.1		0.2	0.2		0.1	0.1	0.1	0.1	0.6	0.2	3.4	0.2	0.3	3.1			0.2		0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.4	0.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.3	0.6	0.0	0.0	0.1	0.0	0.0	0.0	1.4	1.0	0.0	0.2	1.8	14.1	0.5	0.0	1.5	1.0	0.7	0.1	0.0	0.1	0.0	0.4	0.1	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
PCDHA12	PCDH-ALPHA12	ENSG00000251664	"Protocadherin alpha 12"	Q9UN75	5	140875302-141012344	"Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 14.6"	"Cell line enhanced"	"Detected in some"		"A549: 10.0;AN3-CA: 4.0;hTCEpi: 6.2;PC-3: 7.6;RT4: 7.5;SH-SY5Y: 4.3"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in many"		"cerebellum: 14.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA035812	Approved		Approved	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		"HPA035812: "	"unprognostic (3.95e-2)"	"unprognostic (7.74e-2)"	"unprognostic (7.55e-2)"	"unprognostic (3.87e-2)"	"unprognostic (2.74e-2)"			"unprognostic (2.24e-2)"		"unprognostic (2.08e-2)"	"unprognostic (4.29e-2)"	"unprognostic (1.07e-2)"	"unprognostic (1.98e-4)"	"unprognostic (3.18e-4)"	"unprognostic (1.11e-1)"	"unprognostic (3.21e-3)"	"unprognostic (6.97e-2)"	1.0	1.7	0.9	0.3	1.2	0.0	0.9	14.6	3.7	3.5	0.4	1.1	0.0	0.1	1.0	0.5	0.2	1.9	4.3	0.3	1.0	0.7	3.8	1.7	5.7	0.2	0.5	0.8	0.3	2.4	0.9	4.6	0.0	2.3	0.4	0.1	1.5	5.7	0.3	0.1	0.2	0.2	0.6	0.8	0.2	0.3	2.1	0.2	0.0	3.4	0.0	0.1	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.0	2.4	4.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.9	0.1	0.0	0.0	0.0	0.0	6.2	0.0	0.2	0.0	0.0	0.0	0.0	1.3	0.0	0.0	2.4	7.6	0.0	0.0	0.0	0.3	7.5	0.3	4.3	0.0	0.9	0.1	1.6	0.0	0.0	0.2	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	1.2	14.6	3.7	1.0	0.7	0.5	0.8	2.3	0.2
PCDHA5	"CNR6, CNRN6, CNRS6, CRNR6, PCDH-ALPHA5"	ENSG00000204965	"Protocadherin alpha 5"	Q9Y5H7	5	140821604-141012344	"Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	5	"brain: 13.6"	"Cell line enhanced"	"Detected in some"		"A549: 2.6;EFO-21: 7.3;T-47d: 7.5;WM-115: 2.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in many"							HPA044557	Approved		Approved	"Nuclear speckles,Plasma membrane,Mitochondria"				"Plasma membrane"	"Nuclear speckles, Mitochondria"	"HPA044557: AB_10970597"	"unprognostic (4.95e-2)"	"unprognostic (6.23e-2)"	"unprognostic (2.06e-1)"	"unprognostic (8.81e-4)"	"unprognostic (5.10e-2)"	"unprognostic (6.25e-3)"	"unprognostic (6.74e-2)"	"unprognostic (9.79e-2)"	"unprognostic (2.46e-2)"	"unprognostic (4.49e-2)"	"unprognostic (1.44e-2)"	"unprognostic (1.10e-4)"	"unprognostic (9.30e-4)"	"unprognostic (1.07e-1)"	"unprognostic (1.39e-1)"	"unprognostic (8.17e-5)"	"unprognostic (2.11e-1)"	0.9	1.2	3.4	0.5	3.6	0.6	0.6	13.6	10.2	0.6	0.6	0.4	0.0	0.5	1.2	0.5	0.4	0.5	1.1	0.3	1.6	2.0	1.1	0.4	0.7	0.4	1.3	5.1	0.6	1.2	0.4	2.5	0.4	2.3	0.6	0.5	0.0	0.4	0.4	0.4	0.5	0.5	0.7	1.1	0.4	0.7	0.9	0.1	0.0	0.5	0.0	0.3	0.5	0.2	0.6	0.6	1.6	0.5	0.3	0.3	0.2	0.0	2.6	0.9	0.9	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	7.3	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.6	1.5	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.0	0.3	0.0	7.5	0.1	0.1	0.0	1.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	2.8	1.5	0.5	0.5	0.3	0.3	0.2	0.4	0.3	0.2	0.1	0.6	0.3	0.3	1.6	0.3	0.4	0.6	0.2	0.2	3.4	3.6	13.6	7.2	1.6	2.0	1.3	5.1	2.3	0.1
PCDHB11	"ME2, PCDH-BETA11"	ENSG00000197479	"Protocadherin beta 11"	Q9Y5F2	5	141199582-141203779	"Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"AN3-CA: 8.0;EFO-21: 11.6;U-2 OS: 4.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"											HPA045042	Uncertain		Approved	"Plasma membrane"				"Plasma membrane"		"HPA045042: "	"unprognostic (1.32e-1)"	"unprognostic (3.47e-2)"	"unprognostic (7.21e-2)"	"unprognostic (1.76e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.56e-1)"	"unprognostic (2.82e-2)"	"unprognostic (1.42e-1)"	"unprognostic (6.78e-2)"	"unprognostic (1.29e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.89e-1)"	"unprognostic (3.87e-3)"	"unprognostic (4.96e-2)"	"unprognostic (1.37e-2)"	"unprognostic (9.79e-2)"	"unprognostic (6.47e-3)"	13.6	2.4	2.8	2.0	4.1	1.1	3.4	8.8	5.0	8.6	3.1	1.4	0.0	1.4	4.9	3.4	4.1	3.1	3.1	3.0	1.4	1.8	5.0	1.3	2.9	1.0	1.5	3.7	11.0	12.0	15.8	3.6	2.2	3.0	4.5	1.7	6.8	3.3	3.6	2.0	2.9	1.8	5.1	1.6	2.2	2.9	2.6	1.3	0.0	2.8	2.3	1.1	5.5	4.2	1.2	1.0	2.8	0.9	1.4	0.8	0.1	0.0	0.2	2.5	8.0	0.1	0.3	1.7	0.2	0.8	0.0	0.0	0.0	0.2	0.0	11.6	0.7	0.1	0.4	0.2	0.0	0.0	0.0	0.0	0.6	0.1	0.0	0.2	0.2	0.2	0.3	0.0	0.0	0.1	0.1	2.0	0.4	0.2	0.0	0.2	0.3	0.4	0.0	3.1	0.0	0.1	0.3	3.3	0.5	1.8	0.2	1.0	1.9	0.0	0.4	0.1	4.2	3.3	0.1	0.1	0.1	0.1	2.1	0.2	2.0	2.2	0.9	0.8	0.8	0.5	0.5	0.6	0.6	0.5	0.3	1.2	0.5	0.7	2.8	1.4	0.4	1.0	0.4	0.1	2.8	4.1	8.8	5.0	1.4	1.8	1.5	3.7	3.0	1.3
PCDHB12	PCDH-BETA12	ENSG00000120328	"Protocadherin beta 12"	Q9Y5F1	5	141208697-141212571	"Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"AN3-CA: 4.7;ASC diff: 4.6;EFO-21: 5.3;RH-30: 5.7;U-2 OS: 4.4;U-2197: 4.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA045042	Uncertain		Approved	"Plasma membrane"				"Plasma membrane"		"HPA045042: "	"unprognostic (1.43e-2)"	"unprognostic (3.22e-3)"	"unprognostic (4.18e-3)"	"unprognostic (8.43e-2)"	"unprognostic (3.95e-3)"	"unprognostic (7.87e-3)"	"unprognostic (1.46e-1)"	"unprognostic (2.95e-2)"	"unprognostic (3.63e-1)"	"unprognostic (9.13e-3)"	"unprognostic (4.86e-2)"	"unprognostic (2.94e-2)"	"unprognostic (4.37e-3)"	"unprognostic (3.22e-3)"	"unprognostic (4.97e-3)"	"unprognostic (3.83e-2)"	"unprognostic (6.41e-3)"	4.2	2.5	4.4	1.9	5.0	0.4	3.4	9.1	7.5	5.8	3.3	2.5	1.5	1.3	8.0	3.5	1.8	4.9	3.9	3.9	3.1	2.2	2.6	1.5	3.6	0.9	3.0	6.4	8.3	4.0	3.6	13.9	2.0	3.7	4.5	1.8	3.2	1.9	3.9	1.8	1.6	1.7	6.8	3.9	2.6	2.1	3.1	2.7	0.0	1.9	1.2	0.9	3.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	4.7	4.6	2.7	0.7	0.1	3.3	0.3	0.4	0.0	0.0	0.0	5.3	0.5	0.1	0.1	0.0	0.2	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.1	0.1	1.2	0.0	0.0	0.4	0.0	1.2	1.2	0.3	0.0	0.0	0.1	1.0	0.8	5.7	0.0	0.0	0.0	2.8	1.6	0.0	0.0	1.0	3.7	0.8	0.3	0.7	4.4	4.3	0.1	0.0	0.0	0.0	2.8	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.4	5.0	9.1	7.5	3.1	2.2	3.0	6.4	3.7	2.7
PCDHB16	"KIAA1621, ME1, PCDH-BETA16, PCDH3X, PCDHB8a"	ENSG00000272674	"Protocadherin beta 16"	Q9NRJ7	5	141181399-141186399	"Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pituitary gland: 17.5"	"Cell line enhanced"	"Detected in some"		"AN3-CA: 11.9;T-47d: 6.6;U-138 MG: 26.3;U-2197: 7.0"	"Low cancer specificity"	"Detected in many"							"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"											HPA014668			Approved	"Vesicles,Plasma membrane"				"Vesicles, Plasma membrane"		"HPA014668: AB_1855055"	"unprognostic (3.44e-3)"	"unprognostic (4.03e-2)"	"unprognostic (8.14e-2)"	"unprognostic (8.60e-2)"	"unprognostic (2.78e-2)"	"unprognostic (1.36e-2)"	"unprognostic (1.17e-1)"	"unprognostic (4.03e-2)"	"unprognostic (3.13e-2)"	"unprognostic (7.55e-3)"	"unprognostic (3.49e-2)"	"unprognostic (9.57e-2)"	"unprognostic (3.55e-2)"	"unprognostic (7.49e-3)"	"unprognostic (2.00e-2)"	"unprognostic (7.92e-3)"	"unprognostic (2.83e-3)"	3.7	2.6	2.1	1.4	2.7	0.2	2.5	9.7	3.1	8.4	1.1	5.3	0.0	0.4	6.4	6.2	3.3	2.8	2.5	4.5	1.8		2.5	1.0	3.2	0.5	1.7	0.4	9.8	2.6	10.9	17.5	1.5	3.4	6.2	1.1	7.1	2.2	1.1	3.6	1.5	1.1	3.5	2.5	1.1	0.5	2.3	5.0	0.0	3.1	0.0	0.3	6.5	3.3	0.9	1.0	1.4	0.6	0.9	0.8	0.1	0.0	0.0	0.6	11.9	5.3	3.8	0.3	0.5	2.7	0.0	0.2	0.0	0.2	0.0	4.4	0.6	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	1.1	6.4	0.3	0.0	0.0	0.9	0.1	0.0	2.2	0.0	0.3	0.1	0.4	1.7	0.2	0.4	2.0	6.6	0.0	0.3	26.3	1.3	7.0	1.3	0.0	0.0	0.0	6.3	0.0	3.3	0.7	0.5	0.4	0.6	0.5	0.3	0.6	0.5	0.6	0.3	0.9	0.8	0.6	1.4	0.9	0.6	1.0	0.5	0.1										
PCDHGA1	PCDH-GAMMA-A1	ENSG00000204956	"Protocadherin gamma subfamily A, 1"	Q9Y5H4	5	141330571-141512981	"Predicted membrane proteins"	"Cell adhesion"			"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"brain: 11.7"	"Cell line enhanced"	"Detected in many"		"LHCN-M2: 6.9;T-47d: 11.3;WM-115: 5.1"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"							"HPA008755, HPA010580, HPA036547"	Uncertain		Uncertain	"Nucleoplasm,Vesicles,Plasma membrane,Cytosol"				"Vesicles, Plasma membrane"	"Nucleoplasm, Cytosol"	"HPA008755: AB_1079577, HPA010580: , HPA036547: AB_10669798"	"unprognostic (9.50e-4)"	"unprognostic (2.39e-2)"	"unprognostic (9.88e-2)"	"unprognostic (4.42e-3)"	"unprognostic (3.39e-1)"	"unprognostic (3.97e-2)"	"unprognostic (2.42e-1)"	"unprognostic (5.61e-3)"	"unprognostic (1.70e-2)"	"unprognostic (6.89e-2)"	"unprognostic (2.86e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.07e-3)"	"unprognostic (4.76e-2)"	"unprognostic (1.38e-1)"	"unprognostic (2.73e-2)"	"unprognostic (1.45e-3)"	1.4	1.3	2.7	0.9	11.7	1.0	1.1	6.8	7.9	1.4	1.2	2.7	0.5	1.0	2.8	3.9	1.3	1.1	0.8	3.9	3.5	2.8	1.2	0.5	1.2	1.0	2.5	2.5	2.9	2.5	2.8	6.1	2.3	5.4	1.5	0.9	2.4	1.1	1.0	1.7	1.5	0.6	1.8	2.4	1.1	0.8	2.7	1.1	0.0	1.3	0.6	0.7	1.2	0.9	1.2	0.9	2.7	0.5	0.8	1.0	0.2	0.1	0.4	0.5	1.9	1.2	2.0	0.3	1.7	1.1	0.5	1.0	0.4	0.2	0.5	2.8	1.0	0.2	0.2	0.3	1.1	0.3	0.3	0.2	0.4	0.3	0.3	0.1	0.2	1.7	0.5	0.0	0.7	0.1	0.2	0.8	6.9	0.1	0.2	0.8	0.3	0.3	3.0	2.6	0.3	0.3	0.3	1.7	2.1	0.2	0.9	1.7	11.3	0.4	0.8	3.2	0.7	1.6	0.4	0.3	1.0	0.2	3.8	0.2	5.1	2.7	0.5	0.5	0.7	0.4	0.4	0.7	0.7	0.5	0.2	1.2	1.0	0.8	1.1	0.8	0.5	0.9	0.6	0.2	2.7	11.7	6.8	6.1	3.5	2.8	2.5	2.5	5.4	1.1
PCDHGA12	"CDH21, FIB3, KIAA0588, PCDH-GAMMA-A12"	ENSG00000253159	"Protocadherin gamma subfamily A, 12"	O60330	5	141430589-141512979	"Plasma proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 18.9"	"Cell line enhanced"	"Detected in some"		"BJ: 7.6;BJ hTERT+: 12.6;fHDF/TERT166: 18.7;HHSteC: 6.1;HSkMC: 14.0;TIME: 6.0"	"Cancer enhanced"	"Detected in many"		"melanoma: 5.8"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"memory B-cell: 3.7"	"Low lineage specificity"	"Detected in many"											"HPA008755, HPA010580"	Uncertain		Uncertain	"Nucleoplasm,Vesicles,Plasma membrane,Cytosol"				"Vesicles, Plasma membrane"	"Nucleoplasm, Cytosol"	"HPA008755: AB_1079577, HPA010580: "	"unprognostic (3.17e-3)"	"unprognostic (2.71e-2)"	"unprognostic (1.04e-2)"	"unprognostic (2.67e-1)"	"unprognostic (2.74e-1)"	"unprognostic (5.06e-2)"	"unprognostic (1.99e-1)"	"unprognostic (9.01e-3)"	"unprognostic (1.19e-1)"	"unprognostic (4.65e-4)"	"unprognostic (2.98e-1)"	"unprognostic (3.02e-1)"	"unprognostic (1.28e-4)"	"unprognostic (8.30e-3)"	"unprognostic (1.57e-1)"	"unprognostic (2.42e-1)"	"unprognostic (6.85e-3)"	5.1	12.7	14.8	2.8	18.9	0.7	2.4	4.7	13.8	4.9	1.8	8.6	0.6	1.4	5.4	2.3	3.5	2.7	11.3	6.5	15.7	5.6	3.1	2.8	6.5	1.6	4.7	7.3	6.2	3.6	2.0	2.7	6.5	8.4	3.5	1.7	3.4	1.7	4.9	1.9	5.1	1.5	5.3	8.4	3.7	2.2	1.6	12.4	0.4	3.0	0.6	1.7	4.5	3.6	3.7	0.9	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.5	0.6	1.2	0.1	7.6	12.6	0.0	0.0	0.0	0.0	0.4	0.0	18.7	2.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	6.1	0.0	0.0	14.0	0.0	3.7	0.0	4.4	0.0	0.0	2.6	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.0	6.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	1.1	0.0	0.0	0.0	0.0	0.0	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	14.8	18.9	4.7	10.4	15.7	5.6	4.7	7.3	8.4	12.4
PCDHGA2	PCDH-GAMMA-A2	ENSG00000081853	"Protocadherin gamma subfamily A, 2"	Q9Y5H1	5	141338760-141512979	"Plasma proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"ASC TERT1: 9.9;BJ: 5.4;fHDF/TERT166: 6.4;HSkMC: 5.1"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Low region specificity"	"Detected in all"			"HPA008755, HPA010580, HPA038625"	Approved		Approved	"Nucleoplasm,Nucleoli,Vesicles,Plasma membrane,Focal adhesion sites,Cytosol"				"Vesicles, Plasma membrane"	"Nucleoplasm, Nucleoli, Focal adhesion sites, Cytosol"	"HPA008755: AB_1079577, HPA010580: , HPA038625: "	"unprognostic (2.43e-3)"	"unprognostic (2.10e-2)"	"unprognostic (1.32e-2)"	"unprognostic (4.54e-1)"	"unprognostic (2.92e-1)"	"unprognostic (1.14e-1)"	"unprognostic (3.01e-1)"	"unprognostic (2.82e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.18e-1)"	"unprognostic (9.01e-2)"	"unprognostic (4.32e-2)"	"unprognostic (8.45e-3)"	"unprognostic (9.68e-3)"	"unprognostic (1.04e-2)"	"unprognostic (1.18e-2)"	"unprognostic (2.23e-4)"	5.1	4.3	6.7	2.1	8.0	0.6	4.2	5.2	12.6	6.6	2.6	4.6	1.0	0.9	6.5	5.7	2.4	5.5	5.5	11.1	6.5	4.6	3.3	2.4	4.6	1.1	6.0	2.3	15.3	8.4	9.2	10.6	2.2	7.8	5.3	1.4	13.8	3.3	5.8	2.6	2.9	1.4	5.2	5.6	1.9	2.1	10.4	3.5	0.0	4.3	1.2	1.1	3.2	5.8	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.5	0.3	3.9	9.9	0.1	5.4	2.1	0.5	0.9	0.1	0.1	0.1	0.7	6.4	0.2	0.0	0.4	1.3	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	5.1	0.2	0.1	0.3	2.0	0.0	0.1	0.9	0.0	0.0	0.1	0.0	0.1	1.4	0.3	0.2	0.8	0.0	0.3	0.7	0.0	3.6	0.1	0.7	0.0	3.3	0.9	0.5	0.3	0.1	0.0	0.4	0.0	2.3	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.7	8.0	5.2	7.2	6.5	4.6	6.0	2.3	7.8	3.5
PCDHGA3	PCDH-GAMMA-A3	ENSG00000254245	"Protocadherin gamma subfamily A, 3"	Q9Y5H0	5	141343829-141512979	"Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"AF22: 11.0;BJ: 3.6;EFO-21: 8.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008755, HPA010580"	Uncertain		Uncertain	"Nucleoplasm,Vesicles,Plasma membrane,Cytosol"				"Vesicles, Plasma membrane"	"Nucleoplasm, Cytosol"	"HPA008755: AB_1079577, HPA010580: "	"unprognostic (6.47e-2)"	"unprognostic (4.79e-2)"	"unprognostic (1.48e-2)"	"unprognostic (1.64e-1)"	"unprognostic (4.53e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.35e-1)"	"unprognostic (1.85e-1)"	"unprognostic (7.44e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.28e-1)"	"unprognostic (3.17e-2)"	"unprognostic (2.43e-1)"	"unprognostic (2.32e-3)"	"unprognostic (7.12e-3)"	"unprognostic (3.31e-2)"	"unprognostic (2.52e-4)"	4.0	4.5	11.7	1.4	10.5	0.7	2.5	6.9	13.7	4.7	1.3	7.9	0.0	0.7	4.5	3.5	1.5	2.9	3.5	12.2	8.5	5.8	2.5	2.5	2.6	1.0	6.6	7.7	8.6	3.6	1.8	6.3	5.7	8.7	3.0	1.3	4.6	2.9	3.2	1.5	1.9	1.1	3.6	6.0	1.5	1.2	5.2	3.8	0.0	3.3	1.3	1.0	1.7	2.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.0	0.1	0.2	1.5	0.0	3.6	0.3	0.0	0.1	0.0	0.0	0.1	8.9	0.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.9	0.0	0.0	0.0	1.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.6	0.1	0.4	0.1	0.0	0.0	0.5	0.3	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.7	10.5	6.9	13.7	8.5	5.8	6.6	7.7	8.7	3.8
PCDHGA4	PCDH-GAMMA-A4	ENSG00000262576	"Protocadherin gamma subfamily A, 4"	Q9Y5G9	5	141355025-141512979	"Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"ASC TERT1: 10.2;BJ: 5.6;HSkMC: 5.9;HUVEC TERT2: 5.6;U-87 MG: 8.1"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	7	"MAIT T-cell: 1.9"	"Lineage enriched"	"Detected in single"	7	"T-cells: 1.9"	"Low region specificity"	"Detected in all"							"HPA008755, HPA010580"	Uncertain		Uncertain	"Nucleoplasm,Vesicles,Plasma membrane,Cytosol"				"Vesicles, Plasma membrane"	"Nucleoplasm, Cytosol"	"HPA008755: AB_1079577, HPA010580: "	"unprognostic (1.27e-2)"	"unprognostic (4.55e-3)"	"unprognostic (2.00e-2)"	"unprognostic (6.54e-4)"	"unprognostic (1.87e-2)"	"unprognostic (1.06e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.20e-2)"	"unprognostic (5.62e-2)"	"unprognostic (3.76e-1)"	"unprognostic (6.31e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.94e-2)"	"unprognostic (1.30e-2)"	"unprognostic (2.30e-2)"	"unprognostic (1.65e-1)"	"unprognostic (2.31e-4)"	5.4	4.7	6.5	1.8	8.3	0.5	3.0	8.5	11.2	4.8	2.0	10.4	1.5	1.2	5.0	3.0	1.9	3.4	3.1	4.8	6.3	5.9	2.0	2.7	3.6	0.9	5.6	8.1	5.8	6.7	8.5	3.4	2.8	6.1	4.1	1.4	3.5	4.3	4.2	1.5	1.8	1.2	5.0	5.9	1.3	1.4	2.7	4.0	0.0	2.6	2.7	0.9	2.3	2.5	0.3	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.2	1.0	0.6	4.5	10.2	0.0	5.6	4.5	0.3	1.1	0.0	0.1	0.9	1.9	4.7	0.1	0.1	0.2	0.6	0.0	0.5	0.0	0.0	0.0	1.8	0.0	0.4	5.9	0.2	0.1	0.0	5.6	0.2	0.3	2.4	0.8	0.3	0.2	0.2	0.2	0.3	1.6	0.1	0.3	0.0	0.8	1.7	0.2	0.3	1.1	2.1	0.0	3.6	2.4	0.7	3.1	0.4	0.2	0.3	0.2	8.1	0.0	1.6	0.0	0.0	0.0	0.0	0.0	1.9	0.2	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	6.5	8.3	8.5	9.3	6.3	5.9	5.6	8.1	6.1	4.0
PCDHGA5	"CDH-GAMMA-A5, ME3, PCDH-GAMMA-A5"	ENSG00000253485	"Protocadherin gamma subfamily A, 5"	Q9Y5G8	5	141364232-141512979	"Plasma proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"brain: 19.1"	"Group enriched"	"Detected in some"	7	"ASC diff: 18.4;ASC TERT1: 7.3"	"Cancer enhanced"	"Detected in single"		"prostate cancer: 1.5"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							"HPA008755, HPA010580"	Uncertain		Uncertain	"Nucleoplasm,Vesicles,Plasma membrane,Cytosol"				"Vesicles, Plasma membrane"	"Nucleoplasm, Cytosol"	"HPA008755: AB_1079577, HPA010580: "	"unprognostic (3.61e-2)"	"unprognostic (1.04e-2)"	"unprognostic (5.28e-2)"	"unprognostic (4.83e-1)"	"unprognostic (6.60e-3)"	"unprognostic (5.71e-2)"	"unprognostic (8.46e-2)"	"unprognostic (6.53e-3)"	"unprognostic (4.07e-1)"	"unprognostic (9.40e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.12e-1)"	"unprognostic (5.90e-2)"	"unprognostic (3.93e-2)"	"unprognostic (1.55e-2)"	"unprognostic (8.38e-4)"	4.0	2.7	6.1	1.8	9.1	0.9	3.9	19.1	9.6	9.0	2.7	7.7	4.1	1.0	7.6	3.2	3.3	4.7	4.5	4.9	6.9	4.0	1.5	1.2	3.3	1.3	3.2	3.8	6.6	1.7	3.3	3.7	2.7	4.6	5.6	1.6	4.1	2.5	4.0	1.5	3.0	1.5	4.3	6.3	1.4	1.7	1.7	3.7	0.0	1.8	0.9	1.0	2.5	4.2	0.9	0.8	1.6	0.6	1.9	0.7	0.2	0.0	0.4	0.3	0.1	18.4	7.3	0.0	0.8	0.1	0.1	0.3	0.0	0.0	0.8	0.3	0.3	0.0	0.0	0.3	0.2	0.0	0.2	0.0	0.2	0.1	0.2	0.1	0.1	1.8	0.2	0.0	0.0	0.6	0.1	0.6	0.7	0.3	0.5	0.7	0.1	0.3	0.9	0.6	0.1	0.0	0.0	0.2	0.3	0.1	0.3	0.3	1.6	0.0	1.0	0.6	0.2	1.0	0.7	0.1	1.0	0.1	0.3	0.2	0.7	1.5	0.6	0.6	0.7	0.3	0.3	0.6	0.6	0.4	0.1	0.9	0.7	0.7	1.6	1.9	0.2	0.8	0.4	0.2	6.1	9.1	19.1	9.6	6.9	4.0	3.2	3.8	4.6	3.7
PCDHGA6	PCDH-GAMMA-A6	ENSG00000253731	"Protocadherin gamma subfamily A, 6"	Q9Y5G7	5	141373914-141512979	"Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"brain: 19.6"	"Cell line enhanced"	"Detected in some"		"SCLC-21H: 11.0;T-47d: 6.4;WM-115: 13.7"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							"HPA008755, HPA010580"	Uncertain		Uncertain	"Nucleoplasm,Vesicles,Plasma membrane,Cytosol"				"Vesicles, Plasma membrane"	"Nucleoplasm, Cytosol"	"HPA008755: AB_1079577, HPA010580: "	"unprognostic (4.49e-2)"	"unprognostic (8.91e-3)"	"unprognostic (5.45e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.49e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.25e-1)"	"unprognostic (2.07e-2)"	"unprognostic (3.86e-3)"	"unprognostic (2.02e-2)"	"unprognostic (5.26e-2)"	"unprognostic (7.44e-2)"	"unprognostic (5.21e-2)"	"unprognostic (1.11e-1)"	"unprognostic (4.19e-3)"	4.1	3.8	6.1	2.3	8.4	0.8	2.9	19.6	10.8	7.9	3.4	8.3	2.9	1.0	6.9	4.7	2.6	4.3	3.6	3.7	5.0	4.3	2.8	1.7	3.3	1.4	2.9	4.7	9.7	2.5	2.5	4.5	6.9	3.3	4.0	1.6	5.8	4.1	5.3	2.1	4.7	1.5	6.1	2.8	2.8	1.7	2.2	2.9	0.2	3.8	1.2	1.5	4.6	3.6	1.3	0.7	2.8	0.6	0.5	0.8	0.2	0.1	0.3	3.1	0.5	1.5	5.3	0.1	2.3	0.8	1.2	1.2	0.0	0.2	2.1	3.0	3.6	0.5	0.1	0.5	0.8	0.0	0.3	0.0	0.3	0.3	0.8	0.1	0.1	5.7	0.4	0.3	0.1	1.8	0.3	1.3	0.4	0.5	0.7	1.8	0.3	0.1	1.5	0.4	0.0	0.4	0.1	11.0	0.9	0.1	0.3	0.7	6.4	0.1	5.4	0.9	0.4	0.8	0.8	0.4	1.8	0.4	0.9	0.7	13.7	1.8	0.6	0.3	0.8	0.3	0.3	0.8	0.6	0.2	0.1	1.3	0.3	0.5	2.8	0.5	0.3	0.7	0.5	0.2	6.1	8.4	19.6	10.8	5.0	4.3	2.9	4.7	3.3	2.9
PCDHGA7	PCDH-GAMMA-A7	ENSG00000253537	"Protocadherin gamma subfamily A, 7"	Q9Y5G6	5	141382739-141512979	"Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 14.9"	"Cell line enhanced"	"Detected in some"		"ASC TERT1: 9.9;BJ hTERT+: 17.3;SH-SY5Y: 15.5;T-47d: 6.8"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"							"HPA008755, HPA010580"	Uncertain		Uncertain	"Nucleoplasm,Vesicles,Plasma membrane,Cytosol"				"Vesicles, Plasma membrane"	"Nucleoplasm, Cytosol"	"HPA008755: AB_1079577, HPA010580: "	"unprognostic (1.00e-2)"	"unprognostic (4.73e-3)"	"unprognostic (1.42e-1)"	"unprognostic (7.49e-2)"	"unprognostic (2.10e-1)"	"unprognostic (6.85e-2)"	"unprognostic (2.61e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.85e-1)"	"unprognostic (5.78e-2)"	"unprognostic (3.72e-2)"	"unprognostic (1.66e-1)"	"unprognostic (3.56e-1)"	"unprognostic (4.21e-3)"	"unprognostic (6.30e-2)"	"unprognostic (4.99e-2)"	"unprognostic (1.42e-3)"	1.7	2.0	3.1	1.3	9.0	0.6	2.1	5.3	14.9	3.5	3.0	7.1	2.1	1.0	4.2	4.1	2.2	3.3	1.9	3.0	5.1	3.3	3.2	1.9	2.2	1.0	5.1	6.6	4.7	2.5	4.6	3.4	4.8	5.4	3.7	1.5	5.8	2.6	3.3	1.6	3.8	1.2	3.0	6.3	1.3	1.4	2.1	5.1	0.0	6.6	1.5	1.0	2.4	2.5	0.1	0.0	0.0	0.0	0.0	0.8	0.0	0.0	1.4	1.9	0.0	5.8	9.9	0.0	2.6	17.3	3.5	5.2	0.0	0.0	0.4	4.3	0.5	0.1	0.0	0.1	2.9	0.0	0.3	0.0	0.4	0.1	1.0	0.0	0.0	4.3	0.1	0.0	0.6	1.4	0.0	0.1	0.0	0.1	0.5	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.3	15.5	0.0	0.1	0.1	6.8	0.0	5.2	0.1	0.1	2.5	0.0	0.1	1.5	0.0	0.4	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.8	0.0	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	3.1	9.0	5.3	7.7	5.1	3.3	5.1	6.6	5.4	5.1
PCDHGA8	"KIAA0327, PCDH-GAMMA-A8"	ENSG00000253767	"Protocadherin gamma subfamily A, 8"	Q9Y5G5	5	141390157-141512979	"Predicted membrane proteins"	"Cell adhesion"			"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"ductus deferens: 7.1"	"Low cell line specificity"	"Detected in some"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	4	"basophil: 2.9;neutrophil: 2.8"	"Lineage enriched"	"Detected in single"	4	"granulocytes: 2.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008755, HPA010580"	Uncertain		Uncertain	"Nucleoplasm,Vesicles,Plasma membrane,Cytosol"				"Vesicles, Plasma membrane"	"Nucleoplasm, Cytosol"	"HPA008755: AB_1079577, HPA010580: "	"unprognostic (3.28e-2)"	"unprognostic (2.27e-2)"	"unprognostic (4.86e-2)"	"unprognostic (3.38e-2)"	"unprognostic (2.80e-1)"	"unprognostic (4.10e-2)"	"unprognostic (7.68e-2)"	"unprognostic (2.30e-2)"	"unprognostic (1.83e-2)"	"unprognostic (2.23e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.35e-2)"	"unprognostic (1.49e-3)"	"unprognostic (7.59e-2)"	"unprognostic (3.92e-2)"	"unprognostic (3.38e-1)"	"unprognostic (1.99e-3)"	0.6	0.7	0.8	0.7	0.6	2.5	0.7	2.3	2.2	1.2	1.2	1.0	7.1	0.4	2.3	1.5	2.1	0.7	0.9	2.0	1.4	0.5	0.5	0.9	1.1	0.7	0.5	0.4	2.6	0.6	0.2	1.9	1.4	3.5	0.9	0.8	0.4	0.8	0.5	2.2	2.5	1.1	0.7	1.6	0.7	0.7	1.0	1.3	1.1	2.4	0.4	0.6	0.6	1.2	0.7	0.4	2.9	0.4	0.5	0.3	0.1	0.3	0.2	1.1	0.6	1.1	2.6	0.6	2.4	1.6	1.7	0.7	0.2	0.4	1.1	1.0	1.8	0.4	0.0	0.0	1.3	0.3	0.2	0.3	0.5	0.3	0.1	0.4	0.8	1.4	0.1	0.5	0.1	0.4	0.2	0.9	0.2	0.2	0.5	0.7	2.7	0.1	1.0	0.2	0.1	0.1	0.3	0.7	0.7	0.3	0.9	0.4	1.2	1.7	2.5	2.6	0.9	0.6	0.2	0.3	0.3	0.4	1.3	0.4	1.3	2.9	0.4	0.5	0.3	0.2	0.2	0.4	0.3	0.2	0.1	0.7	0.2	0.3	2.8	0.5	0.3	0.4	0.2	0.1	0.8	0.6	2.3	2.2	1.4	0.5	0.5	0.4	3.5	1.3
PCDHGA9	PCDH-GAMMA-A9	ENSG00000261934	"Protocadherin gamma subfamily A, 9"	Q9Y5G4	5	141402932-141512979	"Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"EFO-21: 5.9;HSkMC: 6.6;TIME: 7.2;U-87 MG: 8.3"	"Cancer enhanced"	"Detected in some"		"glioma: 3.1"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			"HPA008755, HPA010580"	Uncertain		Uncertain	"Nucleoplasm,Vesicles,Plasma membrane,Cytosol"				"Vesicles, Plasma membrane"	"Nucleoplasm, Cytosol"	"HPA008755: AB_1079577, HPA010580: "	"unprognostic (1.98e-2)"	"unprognostic (7.47e-3)"	"unprognostic (9.86e-3)"	"unprognostic (2.22e-1)"	"unprognostic (4.68e-2)"	"unprognostic (4.96e-2)"	"unprognostic (1.61e-1)"	"unprognostic (2.15e-1)"	"unprognostic (2.39e-1)"	"unprognostic (1.87e-3)"	"unprognostic (2.26e-1)"	"unprognostic (1.79e-1)"	"unprognostic (4.48e-3)"	"unprognostic (1.94e-2)"	"unprognostic (8.83e-2)"	"unprognostic (2.71e-1)"	"unprognostic (1.83e-2)"	5.6	5.4	12.0	2.6	12.6	0.9	3.7	11.5	17.3	6.9	2.7	11.2	0.1	2.1	7.6	3.9	4.8	6.3	6.5	3.2	10.3	8.5	3.0	2.8	5.0	2.1	9.6	7.1	9.1	3.0	3.8	3.0	3.6	10.9	5.2	2.7	7.7	3.8	7.3	1.9	5.5	2.0	5.9	13.0	3.6	2.9	2.0	5.9	0.0	4.6	1.4	2.5	4.8	3.7	0.5	0.3	1.0	0.5	0.2	1.0	0.0	0.0	0.3	1.0	2.5	0.2	0.5	0.4	1.2	0.0	1.0	1.1	0.4	0.6	2.0	5.9	3.1	0.1	0.2	0.3	1.1	0.1	0.5	0.0	0.2	0.0	1.8	0.1	0.4	6.6	0.3	0.6	0.5	1.6	0.1	0.3	0.5	0.6	0.3	0.7	0.3	0.1	0.3	0.7	0.0	0.3	0.3	0.7	1.8	0.6	0.1	0.8	1.5	0.7	7.2	0.5	0.5	0.1	3.9	0.3	0.1	0.1	8.3	0.2	1.4	1.0	0.5	0.3	1.0	0.3	0.6	0.3	0.4	0.2	0.1	0.5	0.4	0.7	1.0	0.2	0.2	0.3	0.1	0.0	12.0	12.6	11.5	16.2	10.3	8.5	9.6	7.1	10.9	5.9
PCDHGB1	PCDH-GAMMA-B1	ENSG00000254221	"Protocadherin gamma subfamily B, 1"	Q9Y5G3	5	141350102-141512979	"Predicted membrane proteins"	"Cell adhesion"			"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in many"	6	"brain: 32.2;pituitary gland: 13.7"	"Cell line enhanced"	"Detected in some"		"ASC diff: 14.9;ASC TERT1: 7.7;T-47d: 9.6"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	14	"naive CD8 T-cell: 1.3"	"Lineage enriched"	"Detected in single"	14	"T-cells: 1.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008755, HPA010580, HPA076182"	Uncertain		Approved	"Nucleoplasm,Vesicles,Plasma membrane,Focal adhesion sites,Midbody"				"Vesicles, Plasma membrane"	"Nucleoplasm, Focal adhesion sites, Midbody"	"HPA008755: AB_1079577, HPA010580: , HPA076182: "	"unprognostic (1.53e-2)"	"unprognostic (1.94e-3)"	"unprognostic (3.21e-1)"	"unprognostic (4.38e-3)"	"unprognostic (2.98e-1)"	"unprognostic (8.36e-3)"	"unprognostic (2.37e-1)"	"unprognostic (9.57e-2)"	"unprognostic (8.57e-2)"	"unprognostic (1.06e-1)"	"unprognostic (3.44e-2)"	"unprognostic (4.78e-2)"	"unprognostic (6.33e-2)"	"unprognostic (3.15e-2)"	"unprognostic (8.75e-2)"	"unprognostic (1.93e-1)"	"unprognostic (7.63e-3)"	2.3	2.7	8.2	1.4	7.5	1.0	2.1	4.3	32.2	2.5	1.4	9.4	0.1	1.2	3.7	2.0	1.7	1.9	2.1	2.2	7.6	5.7	2.1	1.3	2.4	1.2	5.5	5.0	4.1	2.8	1.4	13.7	1.6	7.0	2.5	1.4	2.6	1.7	3.1	1.1	1.4	1.3	3.0	6.9	1.4	1.2	1.5	5.6	0.0	2.5	0.0	1.2	1.4	1.2	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.1	2.1	1.8	0.0	14.9	7.7	0.1	1.4	3.6	0.5	0.8	0.2	0.5	0.5	4.7	0.5	0.6	0.4	0.2	0.5	0.0	0.9	0.0	0.2	1.3	0.2	0.0	0.1	1.2	0.0	0.0	0.0	0.1	0.2	0.2	3.3	1.9	0.4	0.3	0.2	0.0	0.0	2.8	0.1	0.0	0.0	1.1	0.8	0.0	0.9	0.1	9.6	0.0	1.1	0.2	1.6	1.2	0.0	0.0	2.6	0.3	2.9	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	8.2	7.5	4.3	9.6	7.6	5.7	5.5	5.0	7.0	5.6
PCDHGB3	PCDH-GAMMA-B3	ENSG00000262209	"Protocadherin gamma subfamily B, 3"	Q9Y5G1	5	141370264-141512979	"Plasma proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"ASC diff: 13.2;ASC TERT1: 10.7;TIME: 6.7"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA008755, HPA010580, HPA035822, HPA035823"	Uncertain		Approved	"Nucleoplasm,Vesicles,Plasma membrane,Cytosol"				"Plasma membrane"	"Nucleoplasm, Vesicles, Cytosol"	"HPA008755: AB_1079577, HPA010580: , HPA035822: , HPA035823: "	"unprognostic (6.93e-3)"	"unprognostic (9.10e-4)"	"unprognostic (1.35e-1)"	"unprognostic (7.05e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.24e-1)"	"unprognostic (7.83e-2)"	"unprognostic (1.92e-1)"	"unprognostic (6.08e-2)"	"unprognostic (2.04e-1)"	"unprognostic (3.51e-2)"	"unprognostic (5.81e-2)"	"unprognostic (3.11e-1)"	"unprognostic (3.62e-2)"	"unprognostic (3.89e-2)"	"unprognostic (2.80e-3)"	4.1	1.7	3.3	1.6	6.5	0.5	3.1	3.5	5.6	3.0	3.0	7.2	0.7	0.7	4.9	3.7	3.3	3.3	2.9	4.6	3.3	2.3	2.9	2.0	2.5	3.7	1.9	3.8	5.2	4.2	4.6	5.4	2.3	2.6	2.6	2.2	3.1	6.6	2.6	1.9	3.3	1.4	4.3	2.9	2.4	2.3	1.5	2.8	0.3	3.4	3.2	3.5	2.7	4.6	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.7	0.4	0.3	13.2	10.7	0.2	1.4	2.4	0.9	1.1	0.0	0.0	2.2	0.4	4.3	0.6	0.0	0.3	0.7	0.0	0.3	0.0	0.3	0.1	0.6	0.1	0.0	2.6	0.6	0.2	0.1	1.2	0.3	1.0	0.3	0.4	0.7	1.0	0.1	0.1	1.8	0.7	0.0	0.2	0.1	3.0	0.6	0.0	0.0	0.3	0.8	0.0	6.7	0.6	0.1	0.7	0.7	0.3	2.0	0.2	0.6	0.6	1.1	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	3.3	6.5	3.5	5.6	3.3	2.3	1.9	3.8	2.6	2.8
PCDHGC3	"PC-43, PC43, PCDH-GAMMA-C3, PCDH2"	ENSG00000240184	"Protocadherin gamma subfamily C, 3"	Q9UN70	5	141475947-141512979	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 99.3"	"Cell line enhanced"	"Detected in many"		"ASC diff: 43.0;ASC TERT1: 41.2;HSkMC: 40.4;U-138 MG: 51.8;WM-115: 77.2"	"Group enriched"	"Detected in all"	6	"glioma: 55.0;melanoma: 20.7"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	22	"plasmacytoid DC: 15.2"	"Lineage enriched"	"Detected in single"	22	"dendritic cells: 15.2"									"HPA008755, HPA010580, HPA077289"	Approved		Approved	"Plasma membrane"			74000	"Plasma membrane"		"HPA008755: AB_1079577, HPA010580: , HPA077289: "	"unprognostic (2.52e-1)"	"unprognostic (4.83e-3)"	"unprognostic (1.17e-1)"	"unprognostic (6.76e-2)"	"unprognostic (3.76e-1)"	"unprognostic (3.44e-2)"	"unprognostic (4.30e-1)"	"unprognostic (1.87e-1)"	"unprognostic (1.70e-1)"	"prognostic unfavourable (6.19e-4)"	"unprognostic (2.03e-1)"	"unprognostic (2.22e-1)"	"prognostic unfavourable (8.18e-4)"	"unprognostic (3.72e-2)"	"unprognostic (5.66e-2)"	"unprognostic (9.55e-2)"	"prognostic unfavourable (6.00e-4)"	14.9	15.0	52.8	7.0	49.0	0.5	11.2	30.1	99.3	28.0	8.7	38.9	2.4	3.8	20.6	27.6	12.8	15.7	14.6	11.0	40.2	25.2	7.1	8.0	20.9	4.2	32.0	24.9	16.6	4.4	18.8	7.9	17.7	25.8	17.1	10.2	17.3	8.4	20.1	5.8	18.3	5.6	19.8	28.1	5.3	6.6	4.8	24.1	0.9	5.4	6.4	7.1	8.6	11.1	0.6	15.2	0.0	0.0	0.0	0.1	0.0	2.7	1.6	10.7	2.8	43.0	41.2	0.1	14.0	37.5	7.0	7.5	0.0	2.7	9.3	9.1	24.4	10.2	1.4	4.4	6.7	0.0	4.2	0.0	0.2	0.2	13.3	0.1	0.3	40.4	6.7	10.4	8.6	4.6	0.0	0.3	17.5	5.1	0.2	1.0	0.4	0.0	6.3	21.7	0.0	3.7	3.0	3.5	15.2	3.7	0.1	23.0	8.7	13.0	5.6	51.8	2.7	10.1	15.1	0.0	0.1	0.1	12.4	0.0	77.2	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.1	0.2	0.1	0.0	0.0	0.0	0.0	15.2	0.0	0.0	52.8	49.0	30.1	38.9	40.2	25.2	32.0	24.9	25.8	24.1
PCDHGC5	PCDH-GAMMA-C5	ENSG00000240764	"Protocadherin gamma subfamily C, 5"	Q9Y5F6	5	141489121-141512979	"Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	15	"brain: 43.7"	"Cell line enhanced"	"Detected in some"		"U-138 MG: 16.3;U-251 MG: 7.0;U-87 MG: 10.0"	"Group enriched"	"Detected in some"	13	"glioma: 3.1;head and neck cancer: 0.8"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	5	"amygdala: 129.6;basal ganglia: 118.6;cerebral cortex: 130.2;hippocampal formation: 113.0;olfactory region: 85.4"					"HPA008755, HPA010580, HPA076140"	Supported		Uncertain	"Nucleoplasm,Vesicles,Plasma membrane,Cytosol"				"Vesicles, Plasma membrane"	"Nucleoplasm, Cytosol"	"HPA008755: AB_1079577, HPA010580: , HPA076140: "	"unprognostic (2.86e-3)"	"unprognostic (7.63e-4)"	"unprognostic (2.00e-1)"	"unprognostic (3.52e-3)"	"unprognostic (5.42e-2)"	"unprognostic (1.14e-1)"	"unprognostic (5.65e-2)"	"unprognostic (2.38e-2)"	"unprognostic (2.14e-1)"	"unprognostic (3.16e-2)"	"unprognostic (3.90e-1)"	"unprognostic (1.66e-2)"	"unprognostic (1.01e-9)"	"unprognostic (6.87e-3)"	"unprognostic (3.89e-2)"	"unprognostic (3.13e-1)"	"unprognostic (3.77e-3)"	1.0	1.1	7.4	1.1	34.5	0.9	1.1	3.0	43.7	1.1	1.0	2.8	0.0	0.9	1.4	1.3	1.0	1.2	1.2	2.8	11.8	2.8	0.9	0.9	1.1	0.9	2.2	10.0	1.1	1.0	1.0	1.1	1.0	2.3	1.3	1.0	0.0	0.9	1.6	1.6	1.5	0.9	2.0	0.8	1.0	1.0	1.3	1.1	0.0	1.0	0.0	1.0	1.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.4	1.7	0.2	0.8	0.6	0.5	0.6	0.0	0.0	0.5	1.6	2.4	0.1	0.0	0.4	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	3.6	0.0	0.0	0.0	0.0	1.1	0.1	0.0	0.0	0.0	0.9	0.8	0.3	0.0	0.0	0.0	0.2	0.4	0.0	0.0	0.0	0.1	0.2	0.1	16.3	0.2	0.2	7.0	0.0	0.0	0.0	10.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.4	34.5	3.0	39.2	11.8	2.8	2.2	10.0	2.3	1.1
PCLO	"ACZ, DKFZp779G1236, KIAA0559"	ENSG00000186472	"Piccolo presynaptic cytomatrix protein"	Q9Y6V0	7	82754013-83162930	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"			Neurodegeneration	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 50.3"	"Group enriched"	"Detected in some"	28	"REH: 61.0;U-2 OS: 70.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"							"HPA015858, HPA029579, CAB079012"	Approved	Supported	Approved	"Nuclear speckles,Plasma membrane"				"Nuclear speckles, Plasma membrane"		"CAB079012: , HPA015858: AB_1855071, HPA029579: AB_10602044"	"unprognostic (1.32e-2)"	"unprognostic (1.99e-1)"	"unprognostic (9.33e-2)"	"unprognostic (1.31e-1)"	"unprognostic (2.08e-2)"	"unprognostic (1.52e-1)"	"unprognostic (4.49e-3)"	"unprognostic (6.14e-2)"	"unprognostic (4.61e-2)"	"unprognostic (1.82e-1)"	"unprognostic (3.00e-1)"	"unprognostic (1.56e-1)"	"unprognostic (4.79e-6)"	"unprognostic (5.15e-2)"	"unprognostic (2.42e-2)"	"unprognostic (1.36e-5)"	"unprognostic (6.62e-5)"	3.1	7.9	8.8	0.8	26.3	0.4	4.7	50.3	19.4	3.2	3.9	1.6	0.4	2.9	1.0	7.3	2.3	2.0	1.9	2.2	9.8	5.7	8.2	0.6	1.8	0.6	4.6	12.6	1.9	4.0	11.4	19.2	1.0	9.1	4.9	3.5	3.6	2.5	5.0	0.6	2.6	2.4	0.7	5.3	1.1	2.9	4.5	4.4	0.0	8.4	0.0	0.8	1.0	2.5	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.3	0.4	0.0	0.1	0.0	0.0	0.1	0.1	0.1	0.2	0.0	0.1	0.0	0.0	0.2	0.1	1.3	0.5	0.5	0.0	0.1	0.0	0.2	0.0	0.0	0.2	0.0	0.1	0.4	0.0	2.3	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.4	1.1	61.0	1.0	0.0	0.4	0.2	1.1	0.8	0.0	0.6	0.1	0.7	0.1	0.0	0.0	70.0	0.3	0.1	0.0	0.0	0.1	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	8.8	26.3	50.3	19.4	9.8	5.7	4.6	12.6	9.1	4.4
PCMTD1	FLJ10883	ENSG00000168300	"Protein-L-isoaspartate (D-aspartate) O-methyltransferase domain containing 1"	Q96MG8	8	51817575-51899186	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA025696, HPA061444"	Approved		Approved	"Nucleoplasm,Plasma membrane"				"Plasma membrane"	Nucleoplasm	"HPA025696: AB_1855077, HPA061444: "	"unprognostic (3.16e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.47e-1)"	"unprognostic (2.79e-1)"	"unprognostic (1.41e-1)"	"unprognostic (6.73e-3)"	"unprognostic (2.58e-2)"	"unprognostic (2.53e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.66e-1)"	"unprognostic (2.18e-2)"	"unprognostic (8.38e-2)"	"unprognostic (3.73e-1)"	"unprognostic (2.48e-2)"	"unprognostic (1.13e-1)"	"unprognostic (3.11e-3)"	"unprognostic (3.11e-3)"	22.0	24.1	13.1	18.2	17.1	9.0	41.1	24.3	21.7	22.8	24.4	11.7	33.2	14.8	29.0	24.5	21.6	21.5	22.1	26.1	13.5	12.6	21.5	16.7	29.2	21.0	18.4	11.4	33.3	53.8	57.9	34.2	19.2	15.6	22.8	14.8	15.0	39.8	38.8	45.7	18.0	18.7	38.5	18.9	24.3	19.6	10.4	16.9	27.8	33.6	23.6	15.5	28.4	28.6	16.5	15.4	32.4	12.1	22.3	15.2	10.6	6.5	4.2	14.5	2.5	21.4	20.0	8.2	8.6	15.4	3.7	5.9	1.9	15.1	6.3	12.2	11.6	16.2	2.5	10.1	6.5	8.0	4.9	7.2	7.5	4.4	28.3	2.6	7.4	19.9	19.5	4.6	12.7	17.4	5.5	20.6	5.8	2.7	15.1	6.6	5.6	1.9	4.7	2.8	8.0	15.0	13.0	9.5	8.1	6.1	8.0	8.7	7.9	4.0	14.3	3.3	4.4	5.0	3.1	12.6	9.4	2.2	9.9	6.2	4.0	19.6	9.6	22.9	10.2	12.1	12.4	16.2	13.0	12.1	9.7	16.5	15.2	13.4	32.4	22.3	12.1	15.4	13.8	10.6	13.1	17.1	24.3	21.7	13.5	12.6	18.4	11.4	15.6	16.9
PDCD7	"ES18, HES18"	ENSG00000090470	"Programmed cell death 7"	Q8N8D1	15	65117379-65133836	"Predicted intracellular proteins"	Apoptosis			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049388	Approved		Approved	"Nucleoli,Plasma membrane"				"Plasma membrane"	Nucleoli	"HPA049388: "	"unprognostic (7.71e-3)"	"unprognostic (3.25e-1)"	"unprognostic (4.09e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.54e-1)"	"unprognostic (1.22e-1)"	"unprognostic (6.68e-3)"	"unprognostic (2.36e-2)"	"unprognostic (3.18e-3)"	"unprognostic (8.18e-2)"	"unprognostic (3.28e-2)"	"unprognostic (5.36e-2)"	"prognostic unfavourable (1.00e-4)"	"unprognostic (5.29e-2)"	"unprognostic (3.42e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.62e-2)"	16.0	16.8	22.4	17.6	26.9	13.1	23.8	43.7	28.5	19.0	19.4	21.3	12.6	14.6	23.8	19.8	23.2	18.6	12.7	14.4	21.0	16.3	13.7	15.6	21.5	19.5	22.9	24.7	26.5	16.6	16.5	15.7	17.4	20.6	17.4	14.3	15.0	14.2	19.0	17.5	16.4	15.4	20.4	17.5	18.7	15.1	27.4	32.1	19.7	18.0	12.7	21.5	18.4	18.6	5.9	4.0	4.0	3.2	7.1	4.5	1.4	8.6	7.2	12.3	12.7	12.4	17.6	7.5	10.0	11.1	12.3	9.5	8.7	9.7	16.7	10.9	8.0	16.5	31.4	7.1	8.9	10.1	8.4	16.2	6.2	7.6	11.5	22.0	11.0	10.1	11.0	6.7	12.8	9.7	20.6	13.7	10.7	6.6	23.1	15.8	14.9	6.6	20.4	15.9	18.6	7.5	13.9	10.2	12.2	11.2	9.5	14.6	7.6	18.2	9.8	12.8	12.5	7.4	15.3	24.6	28.0	12.1	11.5	24.4	6.4	4.0	3.2	1.8	4.5	2.6	3.8	4.8	4.3	4.1	2.8	5.9	4.5	4.5	0.8	7.1	2.5	4.0	3.1	1.4	22.4	26.9	43.7	28.5	21.0	16.3	22.9	24.7	20.6	32.1
PDE3A	CGI-PDE	ENSG00000172572	"Phosphodiesterase 3A"	Q14432	12	20369245-20684381	"Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted membrane proteins"		Hydrolase	"Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 62.2"	"Cell line enhanced"	"Detected in some"		"AF22: 7.7;HEL: 14.2;HeLa: 38.7;HUVEC TERT2: 6.9;SH-SY5Y: 14.5;U-138 MG: 11.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Region enhanced"	"Detected in many"		"cerebellum: 35.4"	"HPA014492, HPA074258"	Uncertain		Approved	"Plasma membrane"			23000	"Plasma membrane"		"HPA014492: AB_1855120, HPA074258: "	"unprognostic (2.59e-2)"	"unprognostic (2.94e-2)"	"unprognostic (1.25e-1)"	"unprognostic (3.23e-1)"	"unprognostic (2.27e-1)"	"unprognostic (1.21e-1)"	"unprognostic (3.50e-2)"	"unprognostic (1.67e-2)"	"unprognostic (8.14e-2)"	"unprognostic (1.49e-1)"	"unprognostic (4.25e-1)"	"unprognostic (3.37e-1)"	"prognostic unfavourable (1.72e-6)"	"unprognostic (5.58e-2)"	"unprognostic (5.94e-2)"	"unprognostic (4.28e-2)"	"unprognostic (2.76e-4)"	7.1	1.0	1.7	4.7	2.0	0.0	3.8	3.5	1.4	7.8	15.9	1.0	2.0	2.1	7.8	3.5	9.1	4.9	5.5	62.2	1.6	1.4	3.7	1.8	3.9	3.3	1.9	1.1	7.1	6.5	1.0	2.8	13.8	2.7	6.3	9.0	12.0	7.8	4.2	2.0	1.4	21.4	6.0	1.8	2.1	5.5	2.3	0.7	0.0	2.8	1.9	0.9	4.0	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.2	7.7	0.0	1.8	1.3	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	14.2	38.7	0.2	0.6	0.0	0.0	1.8	0.0	0.4	0.0	6.9	0.0	0.0	0.0	0.0	0.0	0.0	1.3	1.1	0.0	0.0	0.0	2.1	0.0	0.1	14.5	0.0	0.0	0.0	0.0	0.0	0.2	11.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	1.7	2.0	3.5	1.4	1.6	1.4	1.9	1.1	2.7	0.7
PDHX	"DLDBP, E3BP, OPDX, PDX1, proX"	ENSG00000110435	"Pyruvate dehydrogenase complex component X"	O00330	11	34915829-35020591	"Disease related genes, Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 70.5"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038484, HPA038485"	Enhanced		Approved	"Nucleoplasm,Plasma membrane,Mitochondria"				"Nucleoplasm, Plasma membrane"	Mitochondria	"HPA038484: AB_10669645, HPA038485: AB_10669540"	"unprognostic (1.60e-1)"	"unprognostic (1.91e-1)"	"unprognostic (1.42e-2)"	"unprognostic (1.06e-1)"	"unprognostic (2.03e-1)"	"unprognostic (8.34e-3)"	"unprognostic (3.56e-3)"	"unprognostic (1.94e-1)"	"unprognostic (2.14e-1)"	"unprognostic (5.41e-2)"	"unprognostic (2.60e-2)"	"unprognostic (2.08e-1)"	"prognostic favourable (1.83e-5)"	"unprognostic (2.24e-1)"	"unprognostic (8.28e-2)"	"unprognostic (9.53e-2)"	"unprognostic (2.82e-1)"	13.5	14.9	13.4	8.6	17.2	4.2	10.4	13.9	23.3	9.2	13.3	10.6	9.3	12.2	8.9	8.6	10.9	6.7	7.7	46.1	14.4	12.8	15.0	25.7	7.8	6.8	14.7	14.1	7.7	13.1	14.6	14.7	15.8	22.1	12.0	12.7	8.9	12.4	14.1	70.5	8.8	12.3	11.5	12.0	6.6	13.7	15.7	9.0	5.9	9.1	19.0	8.7	13.0	10.7	12.8	19.5	12.1	21.7	15.0	14.9	9.8	9.1	23.9	13.8	5.5	10.2	12.0	13.5	17.0	13.9	19.3	18.7	30.8	8.4	12.5	11.2	14.4	17.7	26.7	14.3	19.2	11.2	22.4	11.8	25.2	35.4	22.0	22.2	13.9	12.3	17.8	10.5	14.4	13.9	25.2	11.6	15.1	15.5	13.7	13.7	11.3	14.3	12.1	24.7	10.9	28.8	24.0	14.6	10.6	15.0	22.7	23.3	25.5	13.7	9.6	14.4	16.2	14.7	18.8	11.1	21.9	15.5	11.2	11.0	14.5	8.6	13.6	12.1	11.5	15.0	10.8	12.8	10.9	9.4	19.5	11.7	13.3	9.6	2.8	15.0	21.7	5.2	14.9	9.8	13.4	17.2	13.9	23.3	14.4	12.8	14.7	14.1	22.1	9.0
PDLIM1	"CLIM1, CLP-36, CLP36, hCLIM1"	ENSG00000107438	"PDZ and LIM domain 1"	O00151	10	95237572-95291024	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HaCaT: 95.1;HHSteC: 92.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"eosinophil: 39.1;memory B-cell: 49.1;naive B-cell: 44.9"	"Group enriched"	"Detected in many"	6	"B-cells: 49.1;granulocytes: 39.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA017010, CAB072838, CAB072840"	Approved		Supported	"Plasma membrane,Cell Junctions,Actin filaments"			210000000	"Actin filaments"	"Plasma membrane, Cell Junctions"	"CAB072838: , CAB072840: , HPA017010: AB_1855147"	"unprognostic (1.61e-1)"	"unprognostic (2.87e-2)"	"unprognostic (2.58e-2)"	"prognostic favourable (1.14e-5)"	"unprognostic (3.18e-2)"	"unprognostic (7.54e-2)"	"unprognostic (2.07e-1)"	"unprognostic (8.99e-2)"	"unprognostic (2.26e-1)"	"unprognostic (2.82e-3)"	"unprognostic (5.77e-2)"	"unprognostic (6.56e-2)"	"unprognostic (1.27e-2)"	"unprognostic (2.00e-1)"	"unprognostic (1.97e-1)"	"unprognostic (4.21e-3)"	"unprognostic (1.11e-1)"	60.9	6.4	2.9	32.3	3.7	2.7	69.9	3.6	3.7	30.6	78.8	3.0	24.3	27.8	30.0	35.6	48.3	28.0	38.4	107.5	3.0	2.4	19.8	49.0	78.8	91.6	6.3	2.2	23.3	20.5	11.7	6.7	53.0	16.5	34.7	34.7	12.8	34.5	27.4	150.1	26.4	96.3	27.2	8.6	52.9	28.3	14.3	3.6	23.4	76.9	54.9	41.9	65.0	38.9	49.1	6.8	39.1	0.5	1.7	3.2	9.2	33.9	21.9	1.5	0.0	8.1	5.5	35.3	10.4	32.4	27.1	44.5	46.2	52.7	0.0	2.9	28.1	95.1	11.1	60.2	27.5	0.0	17.2	33.8	6.5	74.9	92.7	0.0	1.7	15.8	31.7	13.8	50.0	48.4	7.3	8.6	6.4	6.0	0.1	0.5	3.1	17.7	28.5	1.2	11.9	13.9	32.3	6.1	2.5	11.2	10.3	0.1	8.4	14.9	42.6	10.6	2.5	0.0	0.0	4.1	0.0	11.1	11.6	0.0	5.0	0.0	0.5	39.1	2.8	0.1	0.0	49.1	0.5	3.2	6.8	44.9	0.1	2.0	1.7	1.7	0.3	0.7	0.4	9.2	2.9	3.7	3.6	3.7	3.0	2.4	6.3	2.2	16.5	3.6
PDZD2	"KIAA0300, PDZK3"	ENSG00000133401	"PDZ domain containing 2"	O15018	5	31639410-32110931	"Predicted intracellular proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 28.8"	"Cell line enhanced"	"Detected in some"		"BEWO: 8.9;SiHa: 12.4;SK-BR-3: 11.5;T-47d: 6.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"CAB020784, HPA036503, HPA036504, HPA064387, HPA076072"	Uncertain		Approved	"Plasma membrane,Cytosol"	"Intracellular and membrane"			Cytosol	"Plasma membrane"	"CAB020784: , HPA036503: , HPA036504: , HPA064387: , HPA076072: "	"unprognostic (3.65e-2)"	"unprognostic (4.06e-2)"	"unprognostic (6.63e-2)"	"unprognostic (5.42e-5)"	"unprognostic (2.39e-1)"	"unprognostic (9.67e-3)"	"unprognostic (2.55e-1)"	"unprognostic (6.49e-2)"	"unprognostic (3.38e-2)"	"unprognostic (2.45e-2)"	"unprognostic (1.71e-2)"	"unprognostic (1.93e-1)"	"unprognostic (2.33e-3)"	"unprognostic (4.13e-2)"	"unprognostic (6.92e-2)"	"unprognostic (7.67e-2)"	"unprognostic (1.79e-1)"	16.3	1.3	7.8	1.0	28.8	0.3	5.6	3.6	18.1	2.9	1.9	5.1	2.4	0.8	3.0	7.4	6.1	2.8	1.2	19.6	6.6	4.8	9.5	0.4	10.0	0.5	5.4	8.8	16.7	1.5	0.8	2.6	11.9	11.5	2.0	1.1	4.3	2.3	2.5	2.6	11.1	1.1	2.9	3.2	0.5	2.0	6.2	6.1	0.3	1.3	0.7	2.0	1.1	2.9	0.4	0.7	0.7	0.6	0.2	1.0	0.0	0.1	0.0	3.4	0.1	0.0	0.0	8.9	0.0	0.0	0.6	0.6	0.0	0.0	0.0	5.0	0.0	4.7	1.8	1.0	0.0	0.0	0.4	0.0	2.7	0.0	0.0	0.0	2.7	0.3	0.6	0.2	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	3.2	0.8	0.0	0.0	0.0	3.9	0.1	0.1	0.8	12.4	11.5	0.0	6.0	0.0	0.0	0.0	2.4	0.0	0.5	0.0	0.0	2.9	0.0	0.0	1.2	0.4	0.5	0.4	0.5	0.1	1.0	0.1	0.3	0.1	0.1	0.4	0.1	0.1	0.7	0.2	0.6	0.7	0.0	0.0	7.8	28.8	3.6	18.1	6.6	4.8	5.4	8.8	11.5	6.1
PDZD8	"bA129M16.2, FLJ34427, PDZK8"	ENSG00000165650	"PDZ domain containing 8"	Q8NEN9	10	117277274-117375467	"Predicted intracellular proteins"	"Host-virus interaction, Lipid transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 61.7"	"Cell line enhanced"	"Detected in all"		"HEL: 51.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA015716, HPA051610"	Uncertain		Approved	"Nucleoli fibrillar center,Plasma membrane"	"Intracellular and membrane"			"Nucleoli fibrillar center"	"Plasma membrane"	"HPA015716: AB_1855162, HPA051610: "	"unprognostic (1.12e-1)"	"unprognostic (2.87e-1)"	"unprognostic (9.65e-3)"	"unprognostic (2.75e-2)"	"unprognostic (6.29e-2)"	"unprognostic (3.36e-2)"	"unprognostic (2.42e-1)"	"unprognostic (1.43e-1)"	"unprognostic (2.53e-1)"	"unprognostic (3.10e-2)"	"prognostic unfavourable (6.10e-4)"	"unprognostic (1.90e-2)"	"unprognostic (5.37e-3)"	"unprognostic (7.60e-3)"	"unprognostic (1.44e-2)"	"unprognostic (3.18e-2)"	"unprognostic (2.01e-2)"	8.1	7.8	12.2	5.1	13.3	61.7	8.2	8.7	12.9	9.1	14.8	11.4	32.8	14.0	10.7	15.1	11.4	7.7	10.3	7.0	12.0	10.4	13.5	21.1	7.4	3.7	14.7	7.4	10.1	20.1	18.9	8.6	6.0	12.9	7.3	12.0	6.3	12.4	21.3	6.7	6.6	13.7	7.6	14.8	5.0	10.6	23.2	12.4	8.9	7.5	5.4	4.2	8.0	15.3	1.0	1.7	5.7	2.0	2.5	2.5	0.5	5.1	8.8	3.2	6.2	5.6	5.0	1.8	4.9	4.3	2.2	1.8	4.4	6.9	6.0	4.5	7.5	7.7	5.6	5.3	4.4	3.8	4.9	51.0	3.6	4.3	4.1	21.2	4.8	4.9	6.3	4.0	12.0	3.9	4.6	6.3	5.5	2.0	4.1	2.7	2.5	7.9	3.3	12.4	2.6	6.6	3.7	2.5	4.1	5.3	2.2	3.9	1.5	3.1	6.3	3.7	4.1	6.7	8.4	3.4	2.9	4.4	4.6	9.7	3.2	2.7	1.4	5.7	2.2	1.1	2.5	0.9	1.8	1.8	1.7	1.0	1.5	2.0	5.6	2.5	2.0	1.3	0.8	0.5	12.2	13.3	8.7	12.9	12.0	10.4	14.7	7.4	12.9	12.4
PFDN1	PFD1	ENSG00000113068	"Prefoldin subunit 1"	O60925	5	140245039-140303121	"Predicted intracellular proteins, Predicted membrane proteins"		Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006499	Approved		Approved	"Nucleoli,Plasma membrane,Cytosol"			10000	"Plasma membrane, Cytosol"	Nucleoli	"HPA006499: AB_1079596"	"unprognostic (2.73e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.37e-1)"	"unprognostic (3.00e-2)"	"unprognostic (6.11e-2)"	"unprognostic (5.66e-3)"	"prognostic unfavourable (8.81e-5)"	"unprognostic (2.12e-2)"	"unprognostic (2.19e-1)"	"unprognostic (1.89e-1)"	"unprognostic (1.50e-1)"	"unprognostic (2.33e-1)"	"unprognostic (4.10e-1)"	"unprognostic (8.60e-3)"	"unprognostic (2.53e-1)"	"unprognostic (3.53e-2)"	"unprognostic (3.00e-1)"	36.1	24.8	39.5	18.8	38.8	26.4	25.8	28.5	48.7	23.1	27.0	29.3	15.8	20.9	28.2	29.6	26.8	22.5	18.6	46.7	38.2	34.7	32.7	20.2	24.2	21.6	38.8	35.3	20.6	18.1	26.5	19.9	26.9	45.6	24.3	23.0	19.8	23.1	24.4	69.5	20.9	22.0	32.1	37.1	23.1	19.2	19.6	24.1	23.7	24.4	28.7	25.5	23.0	19.2	38.9	36.3	45.6	46.4	39.5	45.1	37.2	38.5	18.1	32.4	18.6	21.2	21.8	31.3	52.8	26.3	40.7	45.3	38.6	24.7	26.0	53.4	28.1	14.4	23.4	51.9	47.9	27.5	23.6	23.1	18.6	24.9	24.9	47.5	18.1	23.2	27.6	34.5	36.4	44.6	20.7	17.1	34.1	17.2	32.3	32.6	21.4	27.2	22.8	46.1	19.1	45.4	17.7	18.3	19.4	39.6	34.8	30.2	23.7	28.1	57.3	28.7	28.5	16.9	47.2	16.6	42.7	67.5	29.0	31.4	33.3	43.2	31.1	45.6	33.4	46.4	35.3	38.9	38.4	38.4	36.3	35.9	38.5	34.6	5.1	39.5	44.1	33.9	45.1	37.2	39.5	38.8	28.5	48.7	38.2	34.7	38.8	35.3	45.6	24.1
PGAP3	"CAB2, MGC9753, PER1, PERLD1, PP1498"	ENSG00000161395	"Post-GPI attachment to proteins 3"	Q96FM1	17	39671122-39696797	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"GPI-anchor biosynthesis"		"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enriched"	"Detected in many"	6	"SK-BR-3: 54.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA016591	Approved		Approved	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		"HPA016591: AB_1855203"	"unprognostic (1.29e-1)"	"unprognostic (8.64e-2)"	"unprognostic (1.65e-1)"	"unprognostic (6.53e-3)"	"unprognostic (9.19e-2)"	"unprognostic (1.68e-2)"	"prognostic favourable (3.94e-4)"	"unprognostic (1.61e-2)"	"unprognostic (1.90e-2)"	"prognostic unfavourable (6.82e-4)"	"unprognostic (1.57e-2)"	"unprognostic (7.79e-2)"	"prognostic favourable (3.89e-4)"	"unprognostic (5.16e-2)"	"unprognostic (1.31e-1)"	"unprognostic (9.05e-2)"	"unprognostic (1.94e-2)"	6.8	8.2	8.9	7.6	14.3	3.4	10.2	6.4	17.3	11.3	19.2	10.0	15.1	12.5	8.3	16.5	16.2	14.0	19.7	9.9	11.3	7.3	13.7	20.7	9.5	6.5	6.3	10.7	9.7	22.7	16.0	10.1	39.2	6.1	11.2	11.7	14.2	16.7	15.6	5.0	16.0	20.7	7.3	5.5	8.1	13.4	9.0	7.3	4.4	20.3	8.7	15.8	8.1	8.9	7.8	5.3	4.0	10.5	9.0	15.1	6.3	1.4	3.8	3.1	2.9	3.3	3.4	3.2	1.7	4.1	2.7	2.5	2.2	9.6	1.6	8.1	3.3	5.0	1.0	1.1	1.3	3.4	3.1	2.0	2.2	3.6	4.5	5.0	5.2	6.3	6.2	1.3	2.8	0.9	1.9	3.8	2.4	3.4	1.0	4.5	3.1	0.8	1.2	1.9	4.6	4.4	4.8	2.9	1.9	4.7	54.7	2.7	4.6	4.9	1.3	2.9	3.1	1.4	1.3	3.4	0.7	0.5	3.3	1.9	3.3	2.4	6.7	4.0	15.1	10.5	8.3	7.8	10.6	12.3	5.3	7.6	10.5	10.1	1.7	9.0	3.8	3.6	5.1	6.3	8.9	14.3	6.4	17.3	11.3	7.3	6.3	10.7	6.1	7.3
PGRMC2	"DG6, PMBP"	ENSG00000164040	"Progesterone receptor membrane component 2"	O15173	4	128269237-128288829	"Predicted intracellular proteins, Predicted membrane proteins"		Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HHSteC: 88.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA041172, HPA058652"	Approved		Approved	"Nuclear bodies,Plasma membrane,Cytosol"			64000	"Nuclear bodies, Plasma membrane, Cytosol"		"HPA041172: AB_2677345, HPA058652: AB_2683786"	"unprognostic (6.16e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.41e-2)"	"prognostic favourable (3.62e-4)"	"unprognostic (6.03e-2)"	"unprognostic (6.57e-3)"	"unprognostic (2.53e-2)"	"unprognostic (2.57e-1)"	"unprognostic (1.31e-1)"	"unprognostic (8.24e-2)"	"unprognostic (9.04e-2)"	"unprognostic (3.80e-2)"	"prognostic favourable (9.60e-4)"	"unprognostic (3.12e-2)"	"unprognostic (1.82e-1)"	"unprognostic (2.51e-2)"	"unprognostic (6.03e-2)"	47.9	29.5	18.3	13.3	20.4	12.8	38.3	17.7	19.3	27.3	46.6	14.8	42.5	46.8	26.1	20.2	32.8	21.1	31.2	27.2	18.4	18.4	36.5	64.7	22.4	13.6	17.4	18.5	24.1	41.6	25.6	34.4	95.6	18.0	29.4	24.8	22.0	29.8	33.4	17.9	46.0	69.1	29.5	16.3	16.7	35.1	19.3	19.2	15.3	33.1	15.7	16.2	35.1	33.8	3.2	6.0	4.7	2.5	2.6	4.8	1.4	23.5	8.7	16.0	12.9	69.6	36.7	16.1	32.3	36.1	24.0	32.1	9.0	24.3	16.6	37.9	41.5	13.7	14.6	16.0	30.2	9.5	8.4	11.1	22.9	17.0	88.1	16.1	8.3	28.8	32.4	20.1	24.9	21.5	18.5	21.0	34.4	7.3	14.8	7.5	12.6	7.8	11.9	12.8	11.4	35.4	8.3	12.7	12.0	18.1	20.5	18.3	15.8	7.3	39.8	20.3	16.6	20.7	14.9	24.3	19.7	17.8	22.2	14.4	13.8	4.7	2.5	4.6	3.9	2.1	1.9	3.2	4.8	3.9	1.4	2.7	4.4	4.0	2.2	2.6	1.8	6.0	4.7	1.4	18.3	20.4	17.7	19.3	18.4	18.4	17.4	18.5	18.0	19.2
PHACTR4	"FLJ13171, PPP1R124"	ENSG00000204138	"Phosphatase and actin regulator 4"	Q8IZ21	1	28369582-28500369	"Predicted intracellular proteins"	Neurogenesis	"Actin-binding, Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028985	Approved		Approved	"Plasma membrane,Intermediate filaments,Cytosol"				"Plasma membrane, Cytosol"	"Intermediate filaments"	"HPA028985: AB_10602142"	"unprognostic (1.55e-1)"	"unprognostic (2.61e-2)"	"unprognostic (4.50e-3)"	"unprognostic (1.73e-1)"	"unprognostic (5.27e-1)"	"prognostic favourable (1.05e-4)"	"unprognostic (9.65e-3)"	"unprognostic (8.77e-2)"	"unprognostic (2.03e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.04e-1)"	"unprognostic (2.94e-2)"	"unprognostic (3.08e-1)"	"unprognostic (4.81e-2)"	"unprognostic (3.03e-2)"	"unprognostic (2.26e-2)"	11.0	12.3	10.0	17.2	17.4	11.5	11.6	18.7	15.2	17.2	14.2	16.5	11.7	9.9	22.7	12.1	37.0	15.1	12.6	10.7	11.4	7.9	16.4	18.7	13.8	10.4	15.3	8.9	15.3	15.4	22.3	18.1	11.6	12.1	13.7	15.8	15.4	18.1	10.3	14.9	19.1	15.4	15.7	13.6	14.4	12.1	15.7	18.5	17.8	15.2	18.1	30.0	12.1	20.6	5.3	5.6	4.0	6.3	4.8	7.7	3.4	12.2	8.4	19.0	13.6	4.8	5.4	2.8	8.8	9.0	19.4	20.2	8.1	13.9	11.8	8.1	10.5	8.7	13.1	8.8	17.4	8.8	7.3	24.6	14.5	12.5	7.3	14.6	28.4	4.8	8.2	12.4	21.9	25.5	12.4	8.2	12.3	3.8	10.3	3.7	14.4	5.8	10.9	18.1	8.8	10.0	11.1	10.1	12.6	19.8	8.2	10.3	11.1	5.4	16.5	9.5	17.7	6.6	17.0	6.3	9.0	10.0	9.1	12.4	9.9	3.4	4.6	4.0	7.7	4.1	6.8	3.3	5.9	7.2	4.5	5.3	4.0	5.4	3.5	4.8	6.3	5.6	2.7	3.4	10.0	17.4	18.7	15.2	11.4	7.9	15.3	8.9	12.1	18.5
PHF20L1	"CGI-72, FLJ13649, FLJ21615, MGC64923, TDRD20B"	ENSG00000129292	"PHD finger protein 20 like 1"	A8MW92	8	132775358-132848807	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA025060, HPA028417"	Uncertain		Approved	"Nucleoplasm,Plasma membrane"				"Nucleoplasm, Plasma membrane"		"HPA025060: AB_10599822, HPA028417: AB_10602278"	"unprognostic (9.12e-3)"	"unprognostic (2.29e-1)"	"unprognostic (2.77e-1)"	"unprognostic (2.10e-3)"	"unprognostic (1.25e-1)"	"unprognostic (1.51e-1)"	"unprognostic (2.79e-2)"	"unprognostic (7.53e-2)"	"unprognostic (9.66e-2)"	"unprognostic (1.24e-2)"	"unprognostic (8.85e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.70e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.78e-1)"	"unprognostic (2.24e-2)"	"unprognostic (7.83e-2)"	14.5	19.9	15.3	15.7	26.6	27.1	17.6	22.2	22.0	15.7	14.2	12.6	11.7	11.6	17.6	13.0	16.0	12.4	13.6	22.5	15.9	10.5	13.6	16.4	12.9	13.5	11.8	14.8	16.9	12.7	22.4	18.6	15.1	12.9	13.1	12.9	10.0	14.9	14.6	27.0	9.5	12.9	14.5	12.9	15.4	12.8	15.9	13.7	38.9	28.5	9.2	14.7	14.7	16.9	2.4	4.0	14.7	4.3	3.0	3.4	1.6	9.9	10.0	16.5	9.5	13.0	15.5	5.9	14.7	11.6	10.1	10.0	5.6	6.9	11.4	12.9	14.7	5.9	11.1	7.8	12.7	19.2	7.9	12.3	11.9	3.9	13.6	9.8	8.8	11.5	9.8	10.5	15.8	11.2	15.1	18.1	15.0	10.0	31.8	4.4	7.3	13.4	15.6	11.0	9.8	8.3	8.6	40.9	12.0	9.3	6.7	11.9	13.1	11.1	14.4	16.5	13.2	10.7	14.0	10.8	14.0	14.7	14.6	17.4	14.6	3.7	4.3	7.5	2.5	2.5	2.5	2.2	2.3	2.9	4.0	2.4	3.4	2.7	14.7	3.0	3.8	3.3	2.6	1.6	15.3	26.6	22.2	22.0	15.9	10.5	11.8	14.8	12.9	13.7
PHLDB3	FLJ40193	ENSG00000176531	"Pleckstrin homology like domain family B member 3"	Q6NSJ2	19	43474954-43504935	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA043425	Approved		Approved	"Nuclear speckles,Plasma membrane,Cytosol"				"Nuclear speckles"	"Plasma membrane, Cytosol"	"HPA043425: AB_10797142"	"unprognostic (2.50e-2)"	"unprognostic (4.22e-3)"	"unprognostic (3.06e-2)"	"unprognostic (4.13e-2)"	"unprognostic (1.02e-1)"	"unprognostic (5.22e-3)"	"unprognostic (4.43e-1)"	"unprognostic (1.93e-1)"	"unprognostic (2.15e-1)"	"unprognostic (3.60e-2)"	"prognostic favourable (6.36e-6)"	"unprognostic (4.62e-2)"	"prognostic unfavourable (4.11e-5)"	"prognostic unfavourable (5.77e-4)"	"unprognostic (2.06e-1)"	"unprognostic (2.05e-1)"	"unprognostic (2.37e-1)"	2.7	8.5	6.6	11.7	5.9	3.6	6.0	2.1	5.2	8.7	4.8	1.8	7.1	5.8	8.8	6.5	28.4	7.3	15.9	4.5	5.2	2.9	4.8	9.6	4.0	7.8	3.5	5.8	9.5	7.7	6.8	7.9	6.4	3.2	11.7	2.2	6.7	11.1	7.6	9.0	28.7	9.4	7.5	3.0	6.4	5.4	18.7	3.0	12.2	5.7	15.2	23.2	9.3	14.8	4.4	8.1	0.9	3.3	2.6	5.5	2.3	5.3	5.6	2.4	5.9	2.1	4.4	15.3	3.8	3.4	3.9	2.7	5.7	5.6	3.2	12.2	2.3	6.2	1.7	6.7	0.7	7.5	5.3	3.5	5.4	6.8	5.3	1.3	6.8	3.7	8.6	4.1	2.5	3.4	6.2	4.9	1.9	8.4	5.4	0.3	1.4	4.6	6.4	3.1	2.1	1.8	18.1	0.1	5.1	4.9	10.7	4.6	7.6	4.5	4.3	2.5	6.7	3.0	3.6	12.6	13.7	3.5	2.3	2.6	4.1	0.3	3.3	0.5	4.0	2.3	2.9	3.7	3.7	3.0	6.9	4.4	5.5	4.8	0.9	2.6	0.2	8.1	3.6	2.3	6.6	5.9	2.1	5.2	5.2	2.9	3.5	5.8	3.2	3.0
PHOSPHO1		ENSG00000173868	"Phosphoethanolamine/phosphocholine phosphatase"	Q8TCT1	17	49223362-49230766	"Enzymes, Predicted intracellular proteins"	"Mineral balance"	Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"blood: 80.0;testis: 52.3"	"Cell line enhanced"	"Detected in some"		"Daudi: 9.2;EFO-21: 6.2;HDLM-2: 6.5"	"Low cancer specificity"	"Detected in some"			"Group enriched"	"Detected in many"	4	"cerebral cortex: 10.2;pons and medulla: 8.2"	"Group enriched"	"Detected in some"	171	"eosinophil: 30.6;neutrophil: 80.0"	"Lineage enriched"	"Detected in single"	248	"granulocytes: 80.0"	"Low region specificity"	"Detected in all"							HPA065025			Approved	"Plasma membrane,Actin filaments"				"Actin filaments"	"Plasma membrane"	"HPA065025: "	"unprognostic (1.37e-1)"	"unprognostic (3.01e-3)"	"unprognostic (7.53e-2)"	"unprognostic (4.41e-3)"	"unprognostic (1.57e-1)"	"unprognostic (4.70e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.39e-2)"	"unprognostic (2.04e-1)"	"unprognostic (6.88e-2)"	"unprognostic (1.02e-2)"	"unprognostic (2.88e-1)"	"unprognostic (2.03e-1)"	"unprognostic (1.45e-1)"	"unprognostic (1.62e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.87e-1)"	2.5	1.3	1.1	2.9	1.9	15.3	0.7	1.0	10.2	0.6	0.6	0.2	0.2	2.5	0.9	2.7	0.9	1.3	2.1	1.0	1.7	1.3	1.0	0.9	2.5	2.0	2.1	1.5	1.1	1.0	0.1	0.8	7.6	8.2	0.9	0.0	1.6	0.9	0.5	2.2	1.1	2.6	0.3	1.5	12.6	0.7	52.3	0.1	0.0	0.8	0.1	0.1	1.4	1.3	0.0	0.0	80.0	0.3	0.0	0.0	0.1	0.0	1.2	0.0	2.1	0.1	0.2	0.0	0.3	0.4	0.0	0.2	2.9	0.0	9.2	6.2	0.0	0.0	1.7	0.5	0.1	6.5	0.2	1.2	1.2	0.4	0.0	0.0	1.1	0.5	0.0	0.6	0.0	0.0	0.0	0.0	0.7	0.1	0.0	0.4	0.0	1.7	1.8	3.5	0.0	0.1	0.0	0.0	0.0	0.3	0.1	0.0	0.2	0.2	3.7	0.5	3.0	2.0	0.0	0.3	0.3	0.6	2.7	3.5	0.3	0.0	0.1	30.6	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	80.0	0.0	0.3	0.0	0.0	0.1	1.1	1.9	1.0	10.2	1.7	1.3	2.1	1.5	8.2	0.1
PI3	"cementoin, ELAFIN, ESI, SKALP, WAP3, WFDC14"	ENSG00000124102	"Peptidase inhibitor 3"	P19957	20	45174876-45176544	"Plasma proteins, Predicted secreted proteins"		"Protease inhibitor, Serine protease inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 157.1;esophagus: 200.8;lymphoid tissue: 173.5;tongue: 468.6"	"Group enriched"	"Detected in some"	6	"EFO-21: 27.0;HaCaT: 32.8;PC-3: 55.7"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 2666.5"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	1121	"neutrophil: 157.1"	"Lineage enriched"	"Detected in single"	1571	"granulocytes: 157.1"									"CAB009449, HPA017737"	Enhanced		Approved	"Plasma membrane"	"Secreted to blood"		2100000	"Plasma membrane"		"CAB009449: AB_2252354, HPA017737: AB_1848107"	"prognostic favourable (6.94e-4)"	"unprognostic (3.61e-2)"	"unprognostic (1.00e-1)"	"unprognostic (8.30e-2)"	"unprognostic (7.34e-2)"	"unprognostic (1.85e-1)"	"unprognostic (3.20e-3)"	"unprognostic (5.53e-3)"	"unprognostic (1.75e-1)"	"prognostic unfavourable (3.84e-6)"	"prognostic unfavourable (6.89e-4)"	"unprognostic (8.54e-3)"	"prognostic unfavourable (1.94e-8)"	"unprognostic (1.23e-1)"	"unprognostic (7.38e-2)"	"unprognostic (1.04e-2)"	"unprognostic (5.91e-3)"	0.4	0.0	0.2	8.8	0.2	0.0	0.7	0.2	0.2	85.3	9.3	0.2	0.4	0.1	7.7	0.2	200.8	0.3	4.8	0.6	0.2	0.0	0.3	0.6	3.1	0.8	0.2	0.2	0.3	0.4	0.0	0.2	0.6	0.3	1.0	3.7	0.3	35.6	0.4	0.2	6.4	3.2	0.6	0.2	1.4	0.7	5.1	0.2	23.4	0.2	468.6	173.5	1.6	118.7	0.0	0.0	157.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.1	0.0	0.9	0.6	0.4	27.0	0.0	32.8	0.0	6.7	0.0	0.3	0.0	0.1	2.0	0.2	0.0	0.2	0.0	0.0	6.4	5.3	0.5	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	55.7	0.0	0.3	0.0	6.4	0.1	0.0	0.0	4.6	0.6	0.0	0.0	0.0	0.2	0.3	3.2	0.0	0.2	0.1	0.4	0.1	4.3	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	157.1	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.2	0.2	0.2	0.0	0.2	0.2	0.3	0.2
PI4K2A	"DKFZP761G1923, PI4KII, PIK42A"	ENSG00000155252	"Phosphatidylinositol 4-kinase type 2 alpha"	Q9BTU6	10	97640686-97676434	"Enzymes, Predicted intracellular proteins"		"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB030649, HPA076857"	Approved		Approved	"Plasma membrane"				"Plasma membrane"		"CAB030649: , HPA076857: "	"unprognostic (1.34e-1)"	"unprognostic (3.50e-2)"	"prognostic unfavourable (4.21e-5)"	"unprognostic (1.80e-2)"	"unprognostic (2.12e-1)"	"unprognostic (1.75e-2)"	"unprognostic (2.84e-3)"	"unprognostic (1.60e-2)"	"unprognostic (1.39e-3)"	"unprognostic (1.38e-2)"	"unprognostic (1.02e-2)"	"unprognostic (1.65e-1)"	"unprognostic (9.92e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.45e-1)"	"unprognostic (2.90e-1)"	17.2	23.0	13.8	10.7	21.2	22.8	9.5	16.8	33.8	12.0	9.1	16.8	9.5	10.9	12.8	15.5	18.3	8.9	16.1	15.2	14.5	17.9	14.7	17.1	15.0	11.0	15.9	15.7	10.6	9.5	23.2	15.5	19.9	30.7	10.3	10.2	23.8	10.1	12.7	11.3	15.3	9.9	15.0	9.9	14.4	8.8	14.9	7.5	8.2	12.0	8.8	11.8	13.6	11.2	4.1	3.7	1.1	3.4	1.9	4.0	1.6	12.0	9.1	7.5	13.4	16.2	11.7	6.1	12.1	26.7	19.1	20.3	8.2	12.0	4.4	7.2	15.3	11.7	8.4	24.1	15.9	5.3	7.1	3.9	6.4	7.4	15.5	3.5	5.6	12.3	20.6	20.0	35.6	9.7	6.1	7.2	13.2	6.1	7.6	2.7	4.8	8.6	3.6	7.8	4.3	13.1	11.3	2.5	8.4	10.2	2.6	15.0	7.1	5.6	10.7	9.1	6.8	10.8	9.3	6.4	7.5	7.2	16.9	2.1	2.9	0.0	3.4	0.0	4.0	2.3	2.8	4.1	1.7	3.4	3.7	1.9	1.4	2.6	1.1	1.9	1.6	1.7	3.1	1.6	13.8	21.2	16.8	33.8	14.5	17.9	15.9	15.7	30.7	7.5
PI4KA	"PI4K-ALPHA, pi4K230, PIK4CA"	ENSG00000241973	"Phosphatidylinositol 4-kinase alpha"	P42356	22	20707691-20859417	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Kinase, Transferase"	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 48.0"	"Cell line enhanced"	"Detected in all"		"K-562: 51.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009092, HPA075515"	Approved		Approved	"Nucleoplasm,Plasma membrane"			18000	Nucleoplasm	"Plasma membrane"	"CAB009092: AB_2164033, HPA075515: "	"unprognostic (8.06e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.20e-2)"	"unprognostic (4.45e-2)"	"unprognostic (1.21e-1)"	"unprognostic (5.01e-3)"	"unprognostic (3.19e-2)"	"prognostic favourable (5.24e-4)"	"unprognostic (2.08e-1)"	"unprognostic (4.21e-2)"	"unprognostic (1.88e-2)"	"unprognostic (1.29e-1)"	"prognostic favourable (7.22e-5)"	"unprognostic (1.37e-1)"	"unprognostic (1.33e-1)"	"unprognostic (2.35e-1)"	"unprognostic (1.50e-1)"	7.7	9.2	28.8	10.5	34.2	12.5	6.5	14.1	48.0	9.7	8.8	10.1	4.9	9.1	9.7	6.1	8.3	8.4	8.0	8.5	30.4	19.2	9.0	12.6	9.0	11.2	19.0	25.9	10.2	8.6	25.6	12.5	10.4	19.3	9.8	8.9	10.8	6.8	10.6	7.1	6.6	10.0	13.2	6.8	10.2	9.9	13.1	8.2	17.9	9.9	2.9	10.2	8.4	4.8	5.0	12.5	7.6	5.5	9.1	7.7	2.9	9.7	8.2	7.3	10.9	20.8	12.6	10.4	8.9	13.5	13.1	12.8	6.4	4.2	18.4	5.3	17.8	8.6	13.8	8.5	8.0	15.6	21.2	18.9	11.2	7.3	10.4	18.7	15.2	11.2	5.4	11.1	6.2	10.6	51.5	15.6	10.1	13.5	16.3	6.4	5.7	8.5	16.4	15.9	3.4	7.3	15.6	17.9	13.1	11.6	13.5	9.2	11.4	8.6	10.7	23.9	12.4	8.8	7.4	12.0	12.2	14.6	15.8	13.5	9.9	3.1	5.5	7.3	5.1	5.4	4.9	4.6	5.6	6.1	3.6	5.0	5.7	7.7	7.6	9.1	4.6	12.5	5.8	2.9	28.8	34.2	14.1	48.0	30.4	19.2	19.0	25.9	19.3	8.2
PIEZO2	"C18orf30, C18orf58, FAM38B, FAM38B2, FLJ23144, FLJ23403, FLJ34907, HsT748, HsT771"	ENSG00000154864	"Piezo type mechanosensitive ion channel component 2"	Q9H5I5	18	10666483-11148762	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Sensory transduction, Transport"	"Ion channel"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 10.3"	"Cell line enhanced"	"Detected in some"		"AF22: 9.4;BJ hTERT+ SV40 Large T+: 10.5;BJ hTERT+ SV40 Large T+ RasG12V: 14.6;HeLa: 23.4;U-266/70: 14.9;U-698: 9.7"	"Low cancer specificity"	"Detected in many"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"							"HPA015986, HPA031974, HPA031975, HPA040616"	Enhanced		Approved	"Nucleoplasm,Vesicles,Plasma membrane,Cytosol"				"Vesicles, Plasma membrane"	"Nucleoplasm, Cytosol"	"HPA015986: AB_1848395, HPA031974: AB_10603675, HPA031975: , HPA040616: "	"unprognostic (1.36e-1)"	"unprognostic (1.92e-1)"	"unprognostic (9.21e-2)"	"unprognostic (2.53e-2)"	"unprognostic (7.84e-2)"	"unprognostic (3.16e-2)"	"unprognostic (3.87e-2)"	"unprognostic (4.34e-3)"	"unprognostic (6.55e-2)"	"unprognostic (3.89e-2)"	"unprognostic (6.06e-2)"	"unprognostic (2.23e-1)"	"prognostic unfavourable (9.57e-7)"	"unprognostic (1.12e-3)"	"unprognostic (1.09e-1)"	"unprognostic (9.04e-2)"	"unprognostic (1.83e-2)"	0.9	0.3	3.1	0.9	2.3	0.0	1.9	0.1	3.6	0.9	3.3			0.0	0.3	1.6	5.8	0.8	5.9	0.0	5.2	2.1	0.9	4.5	7.4	0.5	5.8		0.6	1.7	0.0	0.6	0.0		3.4	1.3		0.0	3.3	0.0	0.8	0.9	1.9	10.3	2.7	1.4	0.9			1.3		0.2	4.6	0.4	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	1.1	9.4	0.0	0.0	0.0	0.0	0.5	2.7	10.5	14.6	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	6.7	0.0	0.3	0.0	23.4	5.5	3.3	0.0	0.0	0.0	0.1	2.7	0.7	3.2	0.0	0.2	1.6	0.0	0.1	0.0	2.9	0.0	0.0	0.0	4.1	0.0	3.2	8.1	0.0	0.1	0.0	0.5	0.0	2.7	0.0	0.0	3.8	0.2	0.5	14.9	0.1	9.7	0.0	0.0	6.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
PIGW	"FLJ37433, Gwt1"	ENSG00000277161	"Phosphatidylinositol glycan anchor biosynthesis class W"	Q7Z7B1	17	36535020-36539310	"Disease related genes, Predicted membrane proteins"	"GPI-anchor biosynthesis"	"Acyltransferase, Transferase"	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA023499			Approved	"Plasma membrane"				"Plasma membrane"		"HPA023499: "	"unprognostic (4.96e-3)"	"unprognostic (3.84e-2)"	"unprognostic (5.40e-3)"	"unprognostic (7.39e-2)"	"unprognostic (2.32e-1)"	"unprognostic (7.71e-2)"	"unprognostic (8.14e-3)"	"unprognostic (1.05e-1)"	"unprognostic (1.89e-1)"	"unprognostic (4.62e-2)"	"unprognostic (1.98e-1)"	"unprognostic (3.29e-1)"	"unprognostic (1.73e-2)"	"unprognostic (1.41e-1)"	"unprognostic (8.96e-2)"	"unprognostic (1.08e-3)"	"unprognostic (1.88e-1)"	3.0	2.4	2.5	4.9	2.9	3.0	4.5	1.8	6.4	2.5	3.8	2.4	0.4	3.3	3.2	4.4	5.7	2.0	2.7	3.5	2.3		6.7	12.0	2.9	4.7	3.6	2.2	4.3	4.8	3.3	6.0	2.6	6.3	2.1	4.8	3.7	3.7	2.8	6.5	5.0	3.9	3.1	3.2	4.3	3.3	3.4	2.2	4.0	4.1	8.1	5.5	2.4	1.2	4.4	6.2	1.1	4.9	4.8	5.8	3.3	7.3	9.7	6.8	6.2	2.9	2.6	8.9	8.9	3.8	8.1	6.6	8.5	7.7	11.0	2.7	4.8	10.4	11.9	4.9	11.0	6.1	12.6	9.4	6.1	6.8	2.3	19.4	10.4	3.0	5.7	8.9	3.9	4.5	15.9	6.9	5.6	5.4	9.5	5.7	9.7	6.5	8.5	16.0	10.8	4.3	9.6	13.5	10.2	12.7	4.6	6.2	17.0	3.0	6.1	13.8	16.8	13.3	15.7	5.9	18.5	13.2	3.7	9.8	12.4	1.1	2.8	0.5	3.6	4.2	5.6	2.5	4.7	3.6	6.2	4.4	5.8	5.2	0.9	4.8	4.9	2.9	2.4	3.3										
PIK3AP1	"BCAP, FLJ35564"	ENSG00000155629	"Phosphoinositide-3-kinase adaptor protein 1"	Q6ZUJ8	10	96593312-96720514	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 38.9;liver: 38.4;lymphoid tissue: 32.0;salivary gland: 29.7"	"Cell line enhanced"	"Detected in some"		"Daudi: 24.1;NB-4: 17.4;REH: 51.7;THP-1: 26.4;U-698: 32.9;U-937: 27.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"intermediate monocyte: 15.5;memory B-cell: 17.5;naive B-cell: 16.2;non-classical monocyte: 38.9"	"Group enriched"	"Detected in all"	6	"B-cells: 17.5;monocytes: 38.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB026136, HPA038452"	Enhanced		Approved	"Nucleoplasm,Plasma membrane,Cytosol"	"Intracellular and membrane"			"Plasma membrane, Cytosol"	Nucleoplasm	"CAB026136: , HPA038452: "	"unprognostic (2.83e-2)"	"unprognostic (4.61e-3)"	"unprognostic (7.32e-2)"	"unprognostic (1.70e-1)"	"unprognostic (1.79e-1)"	"unprognostic (1.49e-1)"	"unprognostic (4.60e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.33e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.96e-1)"	"unprognostic (2.10e-1)"	"unprognostic (5.11e-2)"	"unprognostic (1.28e-1)"	"unprognostic (4.69e-2)"	"unprognostic (5.45e-1)"	"unprognostic (1.13e-1)"	5.8	2.2	2.9	16.8	7.1	14.7	4.8	1.0	3.0	1.4	2.2	3.2	0.0	1.9	1.3	2.3	1.3	2.0	8.5	3.3	3.1	2.4	6.2	38.4	6.0	19.5	5.3	0.5	3.3	16.1	0.3	3.0	10.9	5.1	1.8	2.7	1.6	29.7	0.8	1.1	1.5	6.6	2.4	7.3	32.0	1.9	1.7	4.3	2.0	2.4	0.6	19.2	4.1	2.2	17.5	4.4	4.7	38.9	4.5	4.8	4.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.8	0.4	24.1	2.5	0.0	0.0	5.1	0.0	0.2	13.4	0.8	3.7	0.0	0.4	0.0	10.0	2.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.3	17.4	0.2	0.3	51.7	1.2	5.6	0.0	0.0	1.0	0.6	0.0	0.0	0.3	0.0	26.4	0.0	0.0	0.8	0.0	0.2	0.2	0.0	32.9	0.0	27.1	0.0	1.7	5.4	3.3	4.8	15.5	1.7	17.5	0.1	1.5	4.4	16.2	0.0	1.2	4.7	4.5	38.9	3.9	0.1	4.2	2.9	7.1	1.0	3.0	3.1	2.4	5.3	0.5	5.1	4.3
PIK3R6	"C17orf38, FLJ34500, HsT41028, p87PIKAP"	ENSG00000276231	"Phosphoinositide-3-kinase regulatory subunit 6"	Q5UE93	17	8802723-8867677	"Predicted intracellular proteins"	Angiogenesis			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 32.1;lymphoid tissue: 12.2"	"Cell line enriched"	"Detected in some"	8	"HMC-1: 57.5"	"Low cancer specificity"	"Detected in many"							"Cell type enriched"	"Detected in many"	4	"eosinophil: 32.1"	"Lineage enriched"	"Detected in many"	7	"granulocytes: 32.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA023077	Approved		Approved	"Nucleoplasm,Golgi apparatus,Plasma membrane,Cytosol"				"Nucleoplasm, Golgi apparatus"	"Plasma membrane, Cytosol"	"HPA023077: AB_1854909"	"unprognostic (4.29e-2)"	"unprognostic (8.56e-3)"	"unprognostic (9.39e-2)"	"unprognostic (5.96e-3)"	"unprognostic (2.46e-1)"	"unprognostic (5.25e-3)"	"unprognostic (4.50e-3)"	"unprognostic (2.29e-2)"	"unprognostic (3.12e-2)"	"unprognostic (3.14e-1)"	"unprognostic (2.20e-2)"	"unprognostic (1.38e-1)"	"prognostic unfavourable (1.50e-6)"	"unprognostic (3.45e-1)"	"unprognostic (3.91e-2)"	"unprognostic (2.68e-1)"	"unprognostic (8.98e-2)"	2.2	0.0	2.1	12.2	5.4	5.3	1.0	0.0	3.7	1.5	1.9	2.5	1.4	3.5	2.6	2.3	1.2	0.4	6.6	2.6	3.1		0.0	0.6	3.4	4.4	2.5	0.0	0.3	0.8	0.3	0.0	1.4	3.2	2.4	1.5	1.4	0.9	0.7	1.0	1.8	5.2	2.2	3.1	6.3	2.3	1.1	2.7	6.9	0.0	0.8	6.4	3.0	3.3	1.3	4.9	32.1	4.3	0.5	0.2	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.4	0.0	7.3	0.0	0.0	0.0	0.0	57.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.9	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	7.7	3.4	32.1	0.2	4.3	0.2	1.3	0.0	0.1	4.9	0.1	0.0	0.1	0.5	0.5	3.3	0.0	0.0	1.4										
PITPNM3	"ACKR6, CORD5, NIR1, RDGBA3"	ENSG00000091622	"PITPNM family member 3"	Q9BZ71	17	6451264-6556494	"Disease related genes, Predicted intracellular proteins"			"Cone-rod dystrophy, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 23.0;lymphoid tissue: 43.3;ovary: 24.2"	"Cell line enhanced"	"Detected in some"		"HaCaT: 11.1;HeLa: 8.6;hTCEpi: 32.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	58	"neutrophil: 5.8"	"Lineage enriched"	"Detected in single"	58	"granulocytes: 5.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA022432, HPA059005"	Enhanced		Approved	"Plasma membrane"				"Plasma membrane"		"HPA022432: AB_2670936, HPA059005: AB_2683876"	"unprognostic (2.97e-2)"	"unprognostic (8.60e-3)"	"unprognostic (1.45e-2)"	"unprognostic (1.52e-1)"	"unprognostic (2.69e-2)"	"prognostic favourable (3.67e-6)"	"unprognostic (1.25e-2)"	"unprognostic (6.86e-2)"	"unprognostic (3.66e-2)"	"unprognostic (3.01e-2)"	"unprognostic (2.99e-3)"	"unprognostic (3.58e-2)"	"unprognostic (2.41e-1)"	"unprognostic (9.60e-2)"	"unprognostic (1.61e-1)"	"unprognostic (3.55e-1)"	"unprognostic (2.63e-1)"	1.1	2.4	17.9	1.2	18.8	0.5	1.7	18.7	23.0	2.4	4.5	0.7	3.4	1.5	1.9	3.4	9.4	4.3	3.8	0.8	7.2	5.2	1.5	1.6	3.1	0.6	2.9	11.9	24.2	0.9	1.9	0.7	0.6	2.5	2.7	3.6	2.3	1.9	8.3	1.1	14.3	1.4	3.8	0.9	43.3	3.2	2.4	1.5	0.0	2.4	0.7	2.1	1.3	2.5	0.0	0.0	5.8	0.0	0.0	0.0	0.0	5.4	0.5	0.4	0.2	0.0	0.1	0.4	0.4	0.1	0.5	0.3	0.3	3.9	0.1	2.1	0.1	11.1	0.2	2.3	0.2	0.2	0.4	0.1	8.6	0.1	0.6	0.2	0.3	0.1	32.3	0.6	1.8	0.3	0.1	0.0	0.3	0.5	0.0	0.1	0.6	1.6	0.1	1.2	0.0	0.8	0.1	0.3	0.3	5.0	2.4	0.1	0.8	0.0	0.2	0.3	2.1	0.4	1.3	0.3	0.1	0.0	0.4	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.8	0.0	0.0	0.0	0.0	0.0	17.9	18.8	18.7	23.0	7.2	5.2	2.9	11.9	2.5	1.5
PKD2L2	TRPP5	ENSG00000078795	"Polycystin 2 like 2, transient receptor potential cation channel"	Q9NZM6	5	137887968-137942747	"Predicted intracellular proteins, Predicted membrane proteins, Voltage-gated ion channels"	"Ion transport, Transport"	"Ion channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"blood: 7.5;testis: 29.3"	"Cell line enhanced"	"Detected in many"		"Karpas-707: 5.8;U-266/70: 4.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"HPA041903, HPA043634"	Approved		Approved	"Plasma membrane,Cytosol"				"Plasma membrane"	Cytosol	"HPA041903: , HPA043634: "	"unprognostic (7.53e-3)"	"unprognostic (2.21e-2)"	"unprognostic (1.90e-1)"	"unprognostic (3.59e-1)"	"unprognostic (4.04e-1)"	"unprognostic (1.21e-2)"	"unprognostic (3.06e-1)"	"unprognostic (1.40e-4)"	"unprognostic (1.64e-2)"	"unprognostic (2.13e-2)"	"unprognostic (3.00e-2)"	"unprognostic (5.85e-2)"	"unprognostic (1.05e-3)"	"unprognostic (2.21e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.28e-2)"	"unprognostic (1.22e-1)"	0.5	1.5	2.0	0.6	2.5	2.2	1.2	1.7	1.9	0.5	0.3	0.7	0.7	0.3	0.5	1.0	0.5	0.4	0.6	1.7	1.0	0.8	0.4	0.3	0.4	1.3	1.2	1.3	0.6	1.1	0.0	1.5	0.2	1.8	0.5	0.1	0.2	0.7	0.0	3.3	0.8	0.3	0.0	0.7	1.0	0.6	29.3	0.4	0.0	1.0	0.0	0.2	0.4	0.6	3.9	3.5	7.5	1.7	1.9	1.9	0.8	1.6	1.2	0.2	0.1	0.4	0.5	1.7	0.6	0.0	0.0	0.0	0.1	3.2	2.3	3.4	0.0	0.7	0.1	0.0	0.1	1.5	1.0	1.3	4.2	0.1	0.0	0.4	1.8	0.1	0.2	0.0	0.0	0.6	1.5	5.8	0.8	0.5	1.1	2.3	0.6	1.0	0.0	0.1	0.0	0.0	2.3	0.8	0.9	1.4	0.2	0.9	0.4	0.5	0.5	1.0	1.8	0.6	1.0	4.6	3.3	0.4	2.2	0.7	1.7	7.1	1.7	3.0	1.8	1.2	1.0	2.5	1.6	1.4	0.9	3.9	1.9	1.7	7.5	1.9	1.0	3.5	1.1	0.8	2.0	2.5	1.7	1.9	1.0	0.8	1.2	1.3	1.8	0.4
PKN2	"Pak-2, PRK2, PRKCL2, STK7"	ENSG00000065243	"Protein kinase N2"	Q16513	1	88684222-88836255	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Apoptosis, Cell adhesion, Cell cycle, Cell division, Cilium biogenesis/degradation, Host-virus interaction, Transcription, Transcription regulation"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in all"	5	"neutrophil: 35.7"	"Lineage enriched"	"Detected in all"	8	"granulocytes: 35.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034861, HPA057913"	Approved		Supported	"Nucleoplasm,Nuclear bodies,Plasma membrane,Intermediate filaments,Centrosome,Cytosol"				"Nucleoplasm, Intermediate filaments"	"Nuclear bodies, Plasma membrane, Centrosome, Cytosol"	"HPA034861: , HPA057913: "	"unprognostic (7.52e-2)"	"unprognostic (1.46e-1)"	"prognostic favourable (5.67e-4)"	"unprognostic (5.95e-2)"	"unprognostic (3.39e-2)"	"unprognostic (2.51e-2)"	"unprognostic (4.64e-3)"	"unprognostic (1.38e-1)"	"unprognostic (4.43e-2)"	"unprognostic (1.27e-2)"	"unprognostic (2.90e-3)"	"unprognostic (1.23e-1)"	"unprognostic (1.51e-2)"	"unprognostic (5.98e-2)"	"unprognostic (2.38e-1)"	"unprognostic (1.01e-2)"	"unprognostic (1.99e-1)"	21.9	20.7	12.2	21.2	13.7	33.5	27.6	25.6	16.6	28.6	39.3	12.6	15.1	22.9	20.0	20.2	28.2	17.1	13.3	16.2	10.3	8.9	15.9	15.9	26.0	16.4	13.7	8.7	27.2	18.9	24.6	29.7	20.8	13.3	19.6	23.6	14.1	19.5	25.1	15.9	17.5	49.0	17.5	12.5	18.0	15.9	12.4	16.2	29.1	20.3	14.4	13.1	21.9	22.0	4.0	3.7	35.7	4.5	1.4	3.0	1.0	23.3	9.2	18.2	10.9	12.2	13.9	11.8	13.8	12.8	15.6	16.2	9.7	16.8	9.2	16.5	13.1	18.4	17.7	10.5	21.3	3.3	12.9	6.8	19.0	8.3	10.7	6.7	2.0	11.4	11.0	12.2	14.8	17.7	11.3	6.7	16.7	4.7	7.7	5.8	9.1	10.7	7.4	27.7	3.8	13.8	46.0	8.8	5.8	20.7	12.0	17.8	8.9	6.1	16.5	13.2	11.9	16.9	14.4	3.7	3.2	6.3	5.5	6.6	5.0	4.9	4.5	6.8	2.6	2.5	2.3	3.3	2.3	2.4	2.1	4.0	3.0	2.6	35.7	1.4	3.2	3.7	1.8	1.0	12.2	13.7	25.6	16.6	10.3	8.9	13.7	8.7	13.3	16.2
PKP1	B6P	ENSG00000081277	"Plakophilin 1"	Q13835	1	201283452-201332993	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell adhesion"	"Developmental protein"	"Ectodermal dysplasia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 80.1;skin 1: 137.6;tongue: 129.6"	"Group enriched"	"Detected in some"	5	"HaCaT: 44.0;HBEC3-KT: 26.9;hTCEpi: 96.0;hTERT-HME1: 25.5;PC-3: 36.4"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 295.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA027221, CAB033130"	Enhanced		Approved	"Nucleoplasm,Plasma membrane"			2700000	"Nucleoplasm, Plasma membrane"		"CAB033130: AB_2164139, HPA027221: AB_10599737"	"unprognostic (3.55e-3)"	"unprognostic (7.63e-2)"	"unprognostic (1.99e-1)"	"unprognostic (2.13e-1)"	"unprognostic (1.03e-1)"	"unprognostic (7.17e-2)"	"unprognostic (2.40e-2)"	"unprognostic (3.48e-2)"	"unprognostic (1.49e-1)"	"unprognostic (5.02e-2)"	"unprognostic (2.20e-3)"	"unprognostic (2.67e-1)"	"unprognostic (9.17e-3)"	"unprognostic (2.52e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.45e-1)"	"unprognostic (6.59e-3)"	10.1	0.1	0.0	0.1	0.0	0.1	7.0	0.0	0.4	19.7	0.5	0.0	2.5	0.1	1.5	1.9	80.1	0.3	0.1	0.1	0.0	0.0	0.1	0.1	1.4	0.1	0.0	0.2	0.1	0.1	0.1	0.0	1.6	0.0	6.8	0.1	4.9	10.1	3.9	2.1	137.6	0.2	0.1	0.0	0.1	0.1	0.1	0.0	9.2	0.1	129.6	37.2	1.2	27.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	44.0	0.0	26.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	96.0	1.0	25.5	0.0	0.0	0.0	0.0	7.0	0.0	0.0	0.0	36.4	0.0	0.0	0.0	0.0	0.2	0.0	0.0	3.4	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.2	0.0	0.0
PLCB1	"KIAA0581, PLC-I, PLC154"	ENSG00000182621	"Phospholipase C beta 1"	Q9NQ66	20	8077251-8968360	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Lipid degradation, Lipid metabolism"	"Hydrolase, Transducer"	Epilepsy	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"parathyroid gland: 56.7"	"Cell line enhanced"	"Detected in many"		"CACO-2: 21.6;Hep G2: 32.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004275, CAB005334, HPA034743, HPA057910"	Enhanced		Approved	"Plasma membrane"			5400	"Plasma membrane"		"CAB004275: AB_628118, CAB005334: AB_632196, HPA034743: , HPA057910: "	"unprognostic (2.32e-1)"	"unprognostic (1.02e-1)"	"unprognostic (6.63e-2)"	"unprognostic (9.77e-2)"	"unprognostic (9.87e-2)"	"unprognostic (2.37e-1)"	"unprognostic (1.27e-4)"	"unprognostic (1.13e-1)"	"unprognostic (3.16e-2)"	"unprognostic (1.91e-1)"	"unprognostic (7.12e-3)"	"unprognostic (6.57e-2)"	"unprognostic (2.87e-3)"	"unprognostic (3.20e-2)"	"unprognostic (4.41e-2)"	"unprognostic (1.71e-2)"	"unprognostic (2.12e-1)"	5.6	7.0	13.8	4.4	27.7	3.4	5.9	7.5	31.1	6.5	9.9	2.1	20.6	5.5	8.0	10.3	4.5	7.4	6.6	8.6	15.7	9.1	10.0	3.1	4.0	1.6	9.3	14.5	3.2	10.8	56.7	4.6	14.2	5.5	10.4	3.6	1.3	19.7	22.2	9.8	2.3	4.5	12.3	4.0	2.9	5.5	2.6	8.0	4.1	3.1	1.9	1.1	8.6	6.3	0.5	0.8	2.8	3.3	2.4	5.2	0.4	0.0	0.6	2.3	0.1	4.3	8.1	3.1	9.7	6.4	2.5	1.5	21.6	2.4	1.0	4.1	1.8	0.0	1.7	0.0	1.9	0.0	2.1	0.4	1.6	32.5	1.1	0.5	0.3	0.5	0.4	3.4	0.0	5.1	3.3	12.6	0.0	2.9	0.4	1.5	7.3	3.5	6.9	0.0	5.7	1.9	8.0	8.3	3.6	0.0	2.0	0.4	9.6	3.1	0.9	8.3	3.7	0.6	6.0	9.5	11.0	16.3	4.2	5.9	14.3	0.8	3.3	2.8	3.6	0.7	5.2	0.2	1.0	1.3	0.4	0.5	0.5	1.1	2.1	2.4	0.4	0.8	0.2	0.4	13.8	27.7	7.5	30.8	15.7	9.1	9.3	14.5	5.5	8.0
PLCD3		ENSG00000161714	"Phospholipase C delta 3"	Q8N3E9	17	45108967-45133354	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Lipid degradation, Lipid metabolism"	"Hydrolase, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 63.6"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA025711, HPA053665"	Approved		Approved	"Plasma membrane"				"Plasma membrane"		"HPA025711: AB_1855320, HPA053665: "	"unprognostic (3.58e-2)"	"unprognostic (1.66e-1)"	"unprognostic (2.77e-2)"	"unprognostic (1.27e-2)"	"unprognostic (2.66e-1)"	"unprognostic (4.14e-3)"	"unprognostic (8.13e-3)"	"prognostic unfavourable (2.89e-6)"	"unprognostic (2.96e-1)"	"unprognostic (9.53e-2)"	"unprognostic (1.34e-3)"	"unprognostic (6.21e-2)"	"unprognostic (3.18e-2)"	"unprognostic (2.07e-1)"	"unprognostic (1.62e-1)"	"prognostic favourable (4.28e-4)"	"unprognostic (3.34e-3)"	5.7	12.0	10.1	4.8	16.5	2.4	6.6	12.2	12.9	5.0	24.9	14.0	2.8	2.9	6.3	6.4	8.9	5.8	9.4	13.1	11.6	6.6	3.6	1.2	4.5	1.7	13.9	11.4	9.9	2.7	1.5	3.0	5.7	19.5	5.8	13.7	10.3	4.7	5.7	63.6	9.9	2.8	12.9	15.0	2.0	17.9	5.4	14.6	0.0	2.3	20.1	2.8	17.5	10.5	1.3	0.9	2.9	1.5	1.3	0.9	0.5	9.0	22.8	1.7	3.3	2.5	5.4	11.5	5.0	11.2	4.6	4.4	5.6	16.7	0.3	18.1	11.7	20.9	2.6	21.5	1.8	4.5	8.6	0.3	24.0	7.1	12.9	0.5	1.3	5.8	8.7	4.3	5.7	2.8	1.9	0.7	4.9	14.3	1.4	2.1	2.0	22.5	3.2	3.8	0.6	14.7	18.2	0.4	3.0	5.4	9.1	4.9	19.3	1.0	5.7	2.9	16.0	3.8	5.8	0.8	1.0	0.7	4.7	0.6	2.3	2.3	1.5	2.4	0.9	1.5	0.6	1.0	0.7	0.6	0.5	1.3	0.9	0.8	2.9	1.3	0.3	0.9	0.6	0.5	10.1	16.5	12.2	11.5	11.6	6.6	13.9	11.4	19.5	14.6
PLCD4		ENSG00000115556	"Phospholipase C delta 4"	Q9BRC7	2	218607765-218637184	"Enzymes, Predicted intracellular proteins"	"Lipid degradation, Lipid metabolism"	"Guanine-nucleotide releasing factor, Hydrolase, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"retina: 23.0;skeletal muscle: 62.5;smooth muscle: 33.1"	"Cell line enhanced"	"Detected in many"		"SH-SY5Y: 21.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB009914, HPA038139, HPA038140"	Enhanced		Approved	"Nuclear membrane,Plasma membrane,Cytosol"				Cytosol	"Nuclear membrane, Plasma membrane"	"CAB009914: AB_2252306, HPA038139: AB_2675855, HPA038140: AB_2675856"	"unprognostic (2.11e-1)"	"unprognostic (1.72e-1)"	"unprognostic (1.76e-2)"	"unprognostic (5.65e-5)"	"unprognostic (7.77e-2)"	"unprognostic (1.45e-2)"	"unprognostic (7.06e-3)"	"unprognostic (2.86e-2)"	"unprognostic (3.15e-1)"	"unprognostic (8.87e-3)"	"unprognostic (7.54e-5)"	"unprognostic (3.28e-2)"	"unprognostic (2.49e-1)"	"unprognostic (1.86e-1)"	"unprognostic (6.32e-2)"	"unprognostic (8.46e-3)"	"unprognostic (3.09e-1)"	1.1	2.5	1.5	1.0	1.6	0.5	1.0	0.9	2.4	0.6	6.4	0.3	3.8	0.9	0.8	1.1	3.7	0.6	0.9	0.9	1.0	1.5	3.9	0.5	0.7	0.7	1.6	1.0	0.7	0.4	1.4	4.7	0.6	2.6	6.4	1.5	23.0	1.4	0.6	62.5	0.8	1.4	33.1	1.1	0.5	3.5	3.9	0.5	0.0	1.4	6.8	0.5	9.6	5.3	0.9	1.2	0.3	0.4	0.9	0.9	1.0	0.6	1.5	2.1	0.4	0.2	1.4	1.2	1.2	2.6	0.4	1.4	2.4	0.3	1.4	1.8	0.4	1.0	0.0	1.5	0.3	0.5	1.8	1.2	3.5	1.9	0.2	1.2	0.6	3.0	0.1	1.9	0.5	2.7	1.0	1.1	2.2	1.8	0.4	1.2	0.7	3.4	0.9	0.8	0.5	4.3	3.0	2.3	21.1	1.0	0.8	0.3	2.5	0.5	6.0	1.5	1.2	0.7	0.7	0.5	0.8	0.9	4.6	0.3	1.6	0.0	0.4	0.0	0.5	0.0	0.1	0.0	0.3	0.9	0.3	0.9	0.7	0.8	0.3	0.9	0.0	1.2	0.7	1.0	1.5	1.6	0.9	2.4	1.0	1.5	1.6	1.0	2.6	0.5
PLEKHA4	PEPP1	ENSG00000105559	"Pleckstrin homology domain containing A4"	Q9H4M7	19	48837097-48868632	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 27.4;ASC TERT1: 18.7;BJ hTERT+ SV40 Large T+ RasG12V: 21.8;SK-MEL-30: 31.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"HPA042978, HPA048473"	Uncertain		Approved	"Plasma membrane,Cytokinetic bridge,Centriolar satellite,Cytosol"				"Plasma membrane, Cytosol"	"Cytokinetic bridge, Centriolar satellite"	"HPA042978: , HPA048473: "	"prognostic favourable (1.97e-4)"	"unprognostic (4.39e-1)"	"unprognostic (8.16e-2)"	"unprognostic (2.85e-2)"	"unprognostic (3.98e-1)"	"unprognostic (4.20e-2)"	"prognostic unfavourable (8.68e-4)"	"unprognostic (5.09e-2)"	"unprognostic (1.01e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.18e-2)"	"unprognostic (2.95e-1)"	"unprognostic (3.84e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.08e-3)"	"unprognostic (6.38e-2)"	14.0	10.2	5.0	10.1	7.7	0.3	11.4	4.5	5.5	9.4	14.6	6.1	3.5	4.7	13.2	5.6	8.7	10.2	9.7	19.3	3.9	3.0	9.7	10.8	9.6	5.7	28.9	2.6	22.8	11.4	3.1	13.3	5.2	12.4	9.7	3.4	12.5	6.0	8.1	8.9	5.9	5.1	23.3	13.5	8.0	7.9	6.2	4.4	7.4	12.9	5.8	6.3	11.0	7.3	7.4	2.0	1.4	0.7	1.2	5.3	1.6	3.7	0.2	4.3	27.4	6.3	18.7	3.5	3.0	10.7	11.7	21.8	2.5	1.0	0.1	5.2	4.1	1.1	1.5	1.5	1.8	0.0	1.4	0.9	0.6	2.7	4.9	0.0	6.2	9.6	0.9	6.8	0.4	3.4	3.9	2.3	3.2	2.3	1.3	0.2	0.6	0.3	0.1	13.7	0.2	3.6	0.0	0.0	4.8	1.2	1.1	31.5	1.7	1.2	0.5	3.7	3.0	4.8	0.7	12.4	10.3	2.2	4.4	0.3	9.9	0.0	0.6	1.4	3.1	0.7	2.3	3.0	3.0	2.0	0.2	7.4	5.3	4.7	0.3	1.2	0.5	2.0	1.0	1.6	5.0	7.7	4.5	5.5	3.9	3.0	28.9	2.6	12.4	4.4
PLEKHH2	"KIAA2028, PLEKHH1L"	ENSG00000152527	"Pleckstrin homology, MyTH4 and FERM domain containing H2"	Q8IVE3	2	43637273-43767987	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 10.1;RPTEC TERT1: 8.3"	"Cancer enhanced"	"Detected in many"		"renal cancer: 6.4"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA077225			Approved	"Nucleoplasm,Nuclear bodies,Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"	"Nucleoplasm, Nuclear bodies"	"HPA077225: "	"unprognostic (1.11e-1)"	"unprognostic (1.05e-1)"	"unprognostic (3.49e-2)"	"unprognostic (1.59e-1)"	"unprognostic (2.16e-1)"	"unprognostic (4.27e-3)"	"unprognostic (1.77e-1)"	"unprognostic (2.32e-2)"	"unprognostic (2.94e-2)"	"unprognostic (6.99e-2)"	"unprognostic (2.81e-1)"	"unprognostic (2.53e-2)"	"unprognostic (1.92e-3)"	"unprognostic (3.03e-2)"	"unprognostic (1.29e-1)"	"unprognostic (8.57e-3)"	"unprognostic (1.82e-2)"	10.1	2.7	3.7	9.2	6.5	0.3	7.5	5.4	5.6	27.2	8.5	2.9	3.6	4.1	30.0	9.5	5.2	9.8	8.1	3.7	4.2	2.7	8.7	1.8	21.7	3.0	3.4	3.3	19.4	2.5	9.6	1.8	4.2	8.3	7.9	5.0	7.4	3.8	7.8	5.4	6.9	5.7	13.1	9.7	4.7	4.1	4.2	4.0	0.0	4.7	4.7	4.3	11.1	8.6	0.8	0.6	1.4	0.4	0.7	1.0	0.0	0.6	5.1	2.1	0.1	4.2	10.1	0.4	0.7	2.6	1.0	2.7	0.0	1.8	1.3	0.3	0.8	3.4	0.6	0.8	2.0	0.1	1.5	0.1	0.7	0.2	0.6	0.0	0.7	2.9	0.8	2.6	0.1	2.3	4.8	0.2	0.9	1.4	0.9	0.2	1.1	5.1	0.0	6.1	0.1	8.3	0.3	1.6	0.8	0.5	0.0	5.1	0.7	0.2	0.2	6.0	1.7	0.3	1.8	1.2	0.3	0.0	2.4	0.0	0.6	0.8	0.4	0.4	0.4	0.2	0.4	0.3	0.7	0.5	0.2	0.8	1.0	0.6	1.4	0.7	0.3	0.6	0.5	0.0	3.7	6.5	5.4	5.6	4.2	2.7	3.4	3.3	8.3	4.0
PLEKHO2	"DKFZp761K2312, PLEKHQ1, PP1628, pp9099"	ENSG00000241839	"Pleckstrin homology domain containing O2"	Q8TD55	15	64841883-64868007	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 57.9"	"Cell line enhanced"	"Detected in many"		"ASC diff: 30.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"dendritic cells: 10.4;granulocytes: 30.2;monocytes: 26.6"									HPA040055	Approved		Approved	"Nucleoplasm,Plasma membrane,Cytosol"			450000	"Plasma membrane, Cytosol"	Nucleoplasm	"HPA040055: AB_10793954"	"unprognostic (4.32e-2)"	"unprognostic (7.32e-3)"	"unprognostic (8.60e-2)"	"unprognostic (9.10e-2)"	"unprognostic (1.11e-1)"	"unprognostic (2.90e-2)"	"unprognostic (3.05e-2)"	"unprognostic (2.80e-1)"	"unprognostic (7.70e-2)"	"unprognostic (2.05e-2)"	"unprognostic (8.67e-2)"	"unprognostic (1.02e-1)"	"unprognostic (3.08e-3)"	"unprognostic (1.12e-1)"	"unprognostic (4.20e-2)"	"unprognostic (1.78e-1)"	"unprognostic (5.85e-3)"	22.1	17.4	12.9	19.9	16.6	29.4	12.4	6.2	9.9	10.3	12.2	11.5	5.2	6.8	11.9	13.3	10.7	13.0	17.4	9.3	13.3	8.0	8.1	8.2	22.4	19.6	10.1	8.7	10.4	5.7	5.1	6.4	22.6	17.2	10.5	5.6	17.0	6.1	10.2	5.9	6.0	9.4	16.9	14.5	57.9	10.2	7.0	11.3	5.1	18.6	6.6	13.8	17.1	14.1	4.0	10.4	30.2	26.6	2.7	5.4	10.3	2.7	1.8	3.4	3.4	30.8	17.7	8.1	8.0	12.0	8.5	8.8	2.1	1.7	7.3	4.2	16.2	0.9	3.9	3.2	5.0	11.2	1.2	7.3	0.8	2.5	23.7	8.1	10.9	12.8	2.9	10.6	3.4	11.8	2.1	26.1	11.3	0.8	1.7	8.8	6.6	1.6	6.3	8.3	5.2	1.3	1.9	0.2	3.0	3.3	1.1	10.9	1.2	11.1	15.2	6.6	6.1	6.2	3.3	9.7	15.2	2.5	7.1	10.6	3.8	7.0	14.3	9.2	5.4	20.4	5.0	4.0	3.1	5.0	10.4	2.6	1.3	2.7	30.2	2.7	26.6	1.2	4.1	10.3	12.9	16.6	6.2	9.9	13.3	8.0	10.1	8.7	17.2	11.3
PLPPR5	"LPPR5, PAP2, PAP2D, PRG5"	ENSG00000117598	"Phospholipid phosphatase related 5"	Q32ZL2	1	98890245-99005032	"Predicted membrane proteins"		Hydrolase		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	6	"brain: 18.6;testis: 5.5"	"Group enriched"	"Detected in some"	7	"PC-3: 12.0;SH-SY5Y: 21.5"	"Group enriched"	"Detected in some"	13	"glioma: 2.7;renal cancer: 1.5"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018072, HPA059085"	Uncertain		Approved	"Plasma membrane,Cytosol"				"Plasma membrane"	Cytosol	"HPA018072: AB_1854958, HPA059085: "	"unprognostic (2.57e-1)"	"unprognostic (1.63e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.68e-2)"	"unprognostic (2.01e-1)"	"unprognostic (2.26e-1)"		"unprognostic (1.11e-1)"	"unprognostic (3.18e-1)"	"unprognostic (1.43e-1)"	"unprognostic (2.07e-1)"		"prognostic unfavourable (6.22e-4)"	"unprognostic (1.81e-2)"	"unprognostic (1.28e-1)"		"unprognostic (2.33e-1)"	0.5	1.8	7.8	0.7	8.7	0.5	0.5	0.8	18.6	1.4	0.6	2.1	0.0	0.7	0.7	0.5	0.6	0.5	0.6	0.5	8.0	6.6	0.7	0.5	0.7	0.5	2.5	4.5	0.6	1.6	0.5	0.3	0.5	3.6	0.6	0.8	1.8	0.5	1.0	0.9	0.6	0.7	0.6	1.0	0.5	0.7	5.5	1.8	0.0	0.5	0.0	0.5	0.6	0.1	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	12.0	0.0	0.0	0.0	0.5	0.1	0.4	21.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	7.8	8.7	0.8	11.6	8.0	6.6	2.5	4.5	3.6	1.8
PLS3	T-plastin	ENSG00000102024	"Plastin 3"	P13797	X	115561174-115650861	"Disease related genes, Plasma proteins, Predicted intracellular proteins"		Actin-binding	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"NK-cell: 4.2;plasmacytoid DC: 13.1"	"Group enriched"	"Detected in many"	6	"dendritic cells: 13.1;NK-cells: 4.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020433, HPA076083"	Approved		Approved	"Plasma membrane,Cytosol"			110000000	"Plasma membrane, Cytosol"		"HPA020433: , HPA076083: "	"unprognostic (1.32e-1)"	"unprognostic (1.85e-2)"	"unprognostic (6.10e-2)"	"unprognostic (4.37e-2)"	"unprognostic (9.63e-2)"	"prognostic unfavourable (6.07e-5)"	"unprognostic (2.40e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.83e-2)"	"unprognostic (1.31e-1)"	"prognostic unfavourable (4.59e-4)"	"unprognostic (2.23e-1)"	"prognostic unfavourable (1.01e-4)"	"unprognostic (5.15e-2)"	"unprognostic (1.54e-1)"	"prognostic favourable (3.72e-4)"	"prognostic unfavourable (7.04e-4)"	41.9	11.0	11.8	9.8	12.5	0.2	24.6	3.6	16.7	43.8	14.3	13.9	24.1	6.0	37.4	27.6	54.4	21.5	23.6	18.8	12.2	8.2	40.7	100.5	64.7	6.0	14.7	13.7	44.4	8.9	2.7	4.6	21.9	22.7	21.6	9.2	10.6	16.6	31.4	17.7	38.4	8.2	34.6	14.5	31.6	13.3	14.9	13.0	5.1	64.8	34.7	12.5	38.7	29.0	0.0	13.1	0.4	0.1	4.2	1.5	0.2	27.8	28.7	25.1	7.3	25.4	23.8	38.3	29.1	32.9	27.9	33.8	31.1	23.2	0.1	84.2	23.9	35.9	26.6	47.3	45.4	0.4	33.3	2.7	35.6	13.0	23.0	0.0	1.3	15.0	22.8	43.2	30.4	60.4	0.0	0.0	26.6	8.1	0.0	0.3	33.3	34.4	0.0	16.8	0.6	33.3	15.1	0.0	5.2	61.1	15.2	12.2	8.4	0.4	66.0	45.3	7.7	46.1	58.1	1.1	4.0	0.5	19.8	0.1	18.7	0.4	0.0	0.0	0.1	0.1	0.0	0.0	0.4	0.1	0.4	0.0	0.0	0.0	0.1	4.2	0.0	13.1	1.5	0.2	11.8	12.5	3.6	16.7	12.2	8.2	14.7	13.7	22.7	13.0
PLVAP	"FELS, gp68, PV-1, PV1"	ENSG00000130300	"Plasmalemma vesicle associated protein"	Q9BX97	19	17351448-17377350	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"			"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 128.3"	"Cell line enriched"	"Detected in some"	28	"EFO-21: 109.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Cell type enriched"	"Detected in some"	6	"plasmacytoid DC: 22.1"	"Lineage enriched"	"Detected in many"	6	"dendritic cells: 22.1"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			HPA002279	Supported		Approved	"Plasma membrane,Centrosome,Cytosol"			53000	Cytosol	"Plasma membrane, Centrosome"	"HPA002279: AB_1079636"	"unprognostic (3.19e-1)"	"unprognostic (8.22e-2)"	"unprognostic (7.87e-2)"	"unprognostic (2.38e-2)"	"unprognostic (1.93e-2)"	"unprognostic (2.49e-3)"	"unprognostic (4.17e-3)"	"unprognostic (1.01e-1)"	"unprognostic (2.35e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.53e-2)"	"unprognostic (8.96e-2)"	"unprognostic (4.24e-3)"	"unprognostic (4.70e-3)"	"unprognostic (1.51e-1)"	"unprognostic (2.58e-1)"	"unprognostic (8.17e-2)"	128.3	9.8	0.8	16.4	0.9	0.0	56.3	0.4	1.5	28.7	29.8	3.2	12.8	20.2	32.0	19.8	27.4	16.6	43.1	18.9	1.1	0.4	33.7	4.6	13.1	34.6	0.9	0.5	14.3	22.9	13.8	16.1	12.6	2.7	26.1	5.2	26.3	16.0	10.4	20.7	11.5	23.7	13.5	1.2	77.8	22.1	9.5	0.7	3.8	88.3	13.9	15.2	30.1	87.7	0.0	22.1	0.0	3.8	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	109.6	0.0	0.0	0.0	0.0	0.0	0.2	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	3.9	0.0	0.4	0.0	0.0	0.1	0.4	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	3.8	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.6	22.1	0.0	0.3	0.8	0.9	0.4	1.5	1.1	0.4	0.9	0.5	2.7	0.7
PLXNA4	"DKFZp434G0625PRO34003, FAYV2820, KIAA1550, PLXNA4A, PLXNA4B"	ENSG00000221866	"Plexin A4"	Q9HCM2	7	132123332-132648688	"Predicted intracellular proteins, Predicted membrane proteins"		Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 23.2;breast: 34.7"	"Cell line enhanced"	"Detected in some"		"ASC diff: 14.9;HMC-1: 9.9;RH-30: 10.7;TIME: 32.6"	"Cancer enhanced"	"Detected in many"		"glioma: 3.3"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	5	"plasmacytoid DC: 6.1"	"Lineage enriched"	"Detected in many"	5	"dendritic cells: 6.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029919, HPA052141, HPA075592"	Approved		Approved	"Plasma membrane"	"Intracellular and membrane"			"Plasma membrane"		"HPA029919: AB_10671093, HPA052141: , HPA075592: "	"unprognostic (2.05e-2)"	"unprognostic (3.59e-2)"	"unprognostic (2.08e-2)"	"prognostic unfavourable (1.61e-6)"	"unprognostic (5.76e-2)"	"unprognostic (1.21e-2)"	"unprognostic (1.28e-2)"	"unprognostic (2.43e-2)"	"unprognostic (2.19e-1)"	"unprognostic (7.99e-2)"	"unprognostic (7.64e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.69e-5)"	"unprognostic (1.67e-1)"	"unprognostic (2.28e-1)"	"unprognostic (5.90e-2)"	"unprognostic (1.42e-3)"	23.2	5.1	8.7	3.5	9.0	1.1	34.7	3.9	15.1	16.2	2.0	1.0	0.8	1.5	2.3	1.0	7.7	3.0	4.2	6.9	9.7	7.2	2.0	1.3	1.8	2.5	4.0	6.6	6.2	1.0	1.0	1.6	6.7	6.6	1.4	2.1	0.7	1.2	2.4	1.7	4.1	1.4	5.1	1.5	2.4	2.8	2.4	1.8	0.0	3.3	0.0	1.3	2.1	9.4	0.0	6.1	0.0	0.0	1.1	0.2	0.0	0.0	0.0	0.1	0.0	14.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	4.7	0.0	0.0	0.0	0.0	9.9	0.1	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	10.7	1.1	0.0	0.0	0.2	5.6	0.0	0.0	0.0	0.0	0.0	32.6	3.3	0.1	0.7	0.2	0.0	0.0	0.0	3.1	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	1.1	0.0	6.1	0.0	0.0	8.7	9.0	3.9	15.1	9.7	7.2	4.0	6.6	6.6	1.8
PNCK	"CaMK1b, MGC45419"	ENSG00000130822	"Pregnancy up-regulated nonubiquitous CaM kinase"	Q6P2M8	X	153669730-153689010	"Enzymes, Predicted intracellular proteins"		"Calmodulin-binding, Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 35.4;seminal vesicle: 38.5"	"Cell line enriched"	"Detected in some"	8	"AN3-CA: 26.5"	"Cancer enhanced"	"Detected in many"		"renal cancer: 15.3"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007458	Approved		Approved	"Golgi apparatus,Plasma membrane,Cytosol"				"Plasma membrane"	"Golgi apparatus, Cytosol"	"HPA007458: AB_1079644"	"unprognostic (1.56e-1)"	"unprognostic (2.56e-1)"	"unprognostic (1.16e-2)"	"unprognostic (5.95e-3)"	"unprognostic (1.83e-2)"	"unprognostic (3.98e-2)"	"unprognostic (2.15e-4)"	"unprognostic (1.72e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.46e-2)"	"unprognostic (3.60e-1)"	"unprognostic (1.27e-1)"	"prognostic unfavourable (1.04e-6)"	"unprognostic (2.86e-3)"	"unprognostic (1.43e-1)"	"unprognostic (2.66e-1)"	"unprognostic (6.26e-3)"	1.6	1.8	21.4	2.2	35.4	0.6	0.9	3.7	24.9	0.9	21.9	0.9	6.9	3.8	4.2	3.1	14.5	2.9	2.9	3.8	19.5	17.0	1.0	0.5	0.7	0.6	6.1	15.5	0.7	0.5	1.4	0.3	2.4	3.8	12.6	4.2	0.4	0.7	38.5	2.2	1.4	5.2	15.3	2.6	0.7	5.5	4.7	1.7	0.0	0.5	0.0	0.7	10.4	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.3	26.5	0.0	0.0	2.8	0.3	0.3	0.0	0.0	0.0	0.1	0.0	0.8	0.0	0.3	0.4	0.0	0.0	0.0	3.2	0.0	0.0	0.4	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.1	0.5	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.1	0.2	3.1	0.0	0.1	2.1	0.2	0.3	0.0	0.2	1.1	0.0	0.2	0.2	0.0	0.2	0.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	21.4	35.4	3.7	23.2	19.5	17.0	6.1	15.5	3.8	1.7
PNISR	"bA98I9.2, C6orf111, DKFZp564B0769, FLJ14752, SFRS18, SRrp130"	ENSG00000132424	"PNN interacting serine and arginine rich protein"	Q8TF01	6	99398051-99425331	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038796, HPA075076"	Approved		Supported	"Nuclear speckles,Plasma membrane,Cytosol"				"Nuclear speckles"	"Plasma membrane, Cytosol"	"HPA038796: AB_10672652, HPA075076: "	"unprognostic (2.95e-1)"	"unprognostic (2.29e-1)"	"unprognostic (2.11e-1)"	"unprognostic (9.72e-3)"	"unprognostic (1.68e-2)"	"unprognostic (8.55e-3)"	"unprognostic (4.41e-2)"	"unprognostic (1.58e-3)"	"unprognostic (5.82e-2)"	"unprognostic (4.32e-3)"	"prognostic favourable (5.27e-4)"	"unprognostic (1.47e-2)"	"prognostic unfavourable (1.41e-4)"	"unprognostic (3.43e-2)"	"unprognostic (2.59e-1)"	"unprognostic (8.89e-2)"	"prognostic favourable (1.09e-4)"	24.7	28.5	48.9	28.3	49.8	53.7	29.9	123.3	69.7	35.5	38.3	22.8	39.9	26.7	43.1	58.7	19.8	29.4	22.3	31.0	46.9	17.5	25.5	21.7	26.6	42.2	48.0	29.8	49.3	24.7	34.7	83.9	21.7	41.0	34.1	28.2	24.1	30.8	34.5	39.4	31.9	34.4	31.5	61.0	39.3	28.2	17.4	57.1	32.1	44.7	18.0	30.7	29.5	30.3	18.0	13.1	20.4	7.4	15.6	12.3	2.2	11.3	7.7	41.3	28.3	14.7	21.9	19.1	18.0	9.9	10.8	13.4	13.8	20.7	34.9	12.1	10.1	17.4	20.7	15.7	21.9	28.6	23.1	20.2	38.3	13.8	11.2	28.0	28.7	21.5	22.4	12.0	15.7	15.7	23.5	22.9	14.2	11.4	13.3	32.2	23.1	7.1	26.9	11.6	12.4	21.2	19.7	16.7	22.1	9.0	11.7	15.4	15.6	24.7	17.3	10.9	12.8	10.6	15.4	15.9	11.0	32.0	16.4	28.9	12.6	6.9	7.4	6.6	8.6	4.2	8.5	12.0	8.4	6.8	3.3	18.0	12.3	11.8	20.4	15.6	4.8	13.1	7.7	2.2	48.9	49.8	123.3	69.7	46.9	17.5	48.0	29.8	41.0	57.1
POU2F3	"Epoc-1, OCT11, PLA-1, Skn-1a"	ENSG00000137709	"POU class 2 homeobox 3"	Q9UKI9	11	120236640-120319944	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in many"	5	"ductus deferens: 36.5;seminal vesicle: 13.2;skin 1: 38.2"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 7.1;SK-BR-3: 5.2;T-47d: 9.4"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA019652, HPA073468"	Enhanced		Approved	"Nucleoplasm,Nucleoli,Nuclear bodies,Plasma membrane,Cytosol"				Nucleoplasm	"Nucleoli, Nuclear bodies, Plasma membrane, Cytosol"	"HPA019652: AB_1855585, HPA073468: "	"unprognostic (1.75e-1)"	"unprognostic (2.12e-2)"	"unprognostic (6.37e-2)"	"unprognostic (2.41e-4)"	"unprognostic (2.60e-1)"	"unprognostic (4.46e-3)"	"unprognostic (8.56e-3)"	"unprognostic (9.34e-2)"	"unprognostic (3.45e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.40e-3)"	"unprognostic (2.08e-1)"	"unprognostic (1.27e-2)"	"unprognostic (9.69e-3)"	"unprognostic (1.70e-1)"	"prognostic favourable (8.14e-4)"	"unprognostic (1.45e-1)"	0.2	0.2	0.1	0.2	0.1	0.0	1.6	0.1	0.1	1.2	0.9	0.0	36.5	0.7	0.4	1.2	2.5	0.3	0.4	0.2	0.1	0.1	0.3	0.2	1.6	0.4	0.1	0.0	0.2	0.3	6.4	1.3	4.4	0.1	1.1	0.1	0.0	1.1	13.2	0.1	38.2	1.0	0.2	0.1	0.2	0.4	0.6	0.0	0.4	4.5	4.8	2.2	0.7	2.6	1.0	0.7	2.1	0.5	0.9	0.6	0.2	2.4	0.0	0.0	0.2	0.0	0.0	0.7	0.3	0.6	0.0	0.0	0.1	7.1	0.3	2.6	0.0	1.3	0.0	0.4	0.0	0.3	0.1	0.0	0.2	0.0	0.1	0.1	0.0	0.0	0.1	0.7	0.4	0.0	0.0	1.3	0.0	0.1	0.1	0.2	0.3	0.6	0.0	0.0	0.1	0.0	1.8	0.4	0.1	0.1	5.2	0.0	9.4	0.4	0.8	0.0	0.2	0.3	0.1	0.1	0.0	0.0	1.1	0.1	0.1	1.4	0.4	0.5	0.5	0.3	0.5	0.5	0.6	0.4	0.1	1.0	0.6	0.6	2.1	0.9	0.5	0.7	0.4	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.0
PPFIBP1	"hSGT2, hSgt2p, L2, SGT2"	ENSG00000110841	"PPFIA binding protein 1"	Q86W92	12	27523431-27695564	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"naive B-cell: 7.0"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA001924	Uncertain		Approved	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		"HPA001924: AB_1079665"	"unprognostic (5.27e-2)"	"unprognostic (5.71e-2)"	"unprognostic (3.10e-2)"	"prognostic unfavourable (6.29e-4)"	"unprognostic (4.73e-2)"	"unprognostic (6.94e-2)"	"unprognostic (1.47e-1)"	"prognostic unfavourable (5.11e-4)"	"unprognostic (7.33e-2)"	"unprognostic (3.84e-2)"	"prognostic unfavourable (2.56e-4)"	"unprognostic (1.92e-2)"	"prognostic favourable (5.11e-7)"	"unprognostic (8.54e-2)"	"unprognostic (7.54e-2)"	"unprognostic (2.64e-1)"	"unprognostic (4.09e-2)"	21.3	17.1	15.5	8.0	16.8	2.2	22.6	4.9	25.0	18.3	15.4	13.3	13.0	7.1	28.1	9.3	17.1	16.5	12.2	43.3	17.1	9.0	23.8	15.7	25.0	7.8	13.1	16.4	53.1	13.7	12.7	22.2	34.5	15.3	15.3	11.1	8.1	14.2	18.4	13.7	17.8	10.0	20.5	11.2	16.6	15.1	7.1	13.3	6.2	23.9	14.9	6.2	17.2	18.4	7.0	2.0	1.5	0.6	0.3	1.8	0.6	4.5	9.2	7.5	6.4	12.5	34.9	13.4	16.6	18.7	9.8	14.2	24.2	13.9	3.4	19.4	33.6	11.4	4.0	15.2	17.7	7.8	2.2	7.6	7.0	3.5	5.4	2.3	4.3	27.1	10.6	28.5	29.3	33.5	4.0	3.5	34.8	3.5	2.1	0.6	13.4	7.1	3.5	18.7	1.3	14.5	10.1	0.6	3.1	8.3	4.4	23.1	5.7	3.5	32.5	27.7	9.3	15.1	16.9	0.0	0.0	0.2	30.7	3.3	43.6	1.5	0.6	0.3	0.7	0.2	1.4	0.7	1.3	0.7	0.6	7.0	1.3	1.3	1.5	0.3	0.2	2.0	1.8	0.6	15.5	16.8	4.9	25.0	17.1	9.0	13.1	16.4	15.3	13.3
PPM1A	"MGC9201, PP2CA, PP2Calpha"	ENSG00000100614	"Protein phosphatase, Mg2+/Mn2+ dependent 1A"	P35813	14	60245752-60299087	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029209	Approved		Supported	"Plasma membrane,Cytosol"			850000	Cytosol	"Plasma membrane"	"HPA029209: "	"unprognostic (3.14e-1)"	"unprognostic (2.14e-1)"	"unprognostic (5.64e-2)"	"unprognostic (1.85e-1)"	"unprognostic (4.00e-2)"	"unprognostic (2.30e-2)"	"unprognostic (4.50e-2)"	"unprognostic (1.11e-1)"	"unprognostic (3.43e-1)"	"unprognostic (2.89e-2)"	"unprognostic (7.96e-2)"	"unprognostic (1.29e-1)"	"prognostic favourable (1.57e-9)"	"unprognostic (1.58e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.57e-2)"	"unprognostic (1.37e-1)"	16.2	11.7	13.8	15.0	18.3	64.0	15.1	20.5	28.6	15.5	32.4	13.3	9.4	19.1	17.4	12.7	15.2	10.7	10.8	37.1	13.5	16.1	22.8	26.7	14.6	11.8	15.6	19.1	12.1	13.3	18.2	12.2	15.8	24.3	16.5	19.4	12.3	18.7	13.5	56.1	16.7	25.2	15.0	13.8	11.6	14.9	29.7	12.7	23.4	13.3	11.6	13.4	15.2	16.5	4.0	2.7	8.0	2.1	4.7	4.5	1.9	47.8	10.8	9.4	8.0	14.4	13.4	12.0	13.2	15.5	9.8	9.3	6.1	14.1	28.8	12.6	14.9	10.7	9.7	13.6	17.2	25.9	5.5	17.7	7.7	9.5	12.1	20.0	12.7	11.3	16.3	11.5	15.8	9.6	9.8	23.0	11.9	21.0	26.0	4.7	8.8	9.1	9.4	21.8	9.3	11.8	23.0	16.0	12.0	13.7	16.0	11.1	16.1	8.8	13.2	20.5	20.5	8.9	9.3	17.9	10.1	33.7	9.4	7.9	10.3	6.7	1.8	5.1	3.5	1.8	3.8	1.7	2.8	3.1	2.7	4.0	2.2	2.1	8.0	4.7	2.1	1.6	4.5	1.9	13.8	18.3	20.5	28.6	13.5	16.1	15.6	19.1	24.3	12.7
PPM1F	"CAMKP, CaMKPase, FEM-2, KIAA0015, POPX2"	ENSG00000100034	"Protein phosphatase, Mg2+/Mn2+ dependent 1F"	P49593	22	21919420-21952837	"Enzymes, Plasma proteins, Predicted intracellular proteins"	Apoptosis	"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"K-562: 54.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 17.7"	"Group enriched"	"Detected in many"	7	"dendritic cells: 5.5;granulocytes: 17.7;monocytes: 13.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030989, HPA030990"	Approved		Approved	"Nucleoplasm,Plasma membrane"			780000	Nucleoplasm	"Plasma membrane"	"HPA030989: AB_10669549, HPA030990: AB_10601249"	"unprognostic (6.26e-2)"	"unprognostic (2.50e-1)"	"unprognostic (1.82e-1)"	"unprognostic (2.11e-1)"	"unprognostic (2.51e-1)"	"unprognostic (4.77e-3)"	"unprognostic (4.88e-3)"	"unprognostic (1.94e-1)"	"unprognostic (1.70e-1)"	"unprognostic (1.65e-2)"	"unprognostic (1.45e-2)"	"unprognostic (4.81e-2)"	"prognostic unfavourable (6.03e-5)"	"unprognostic (6.44e-2)"	"unprognostic (3.02e-2)"	"unprognostic (3.30e-1)"	"unprognostic (4.11e-2)"	25.0	15.6	14.0	21.8	14.3	24.3	18.4	16.9	16.3	18.1	13.2	7.6	12.5	9.6	17.6	9.7	23.6	12.3	13.1	17.0	13.9	14.9	13.2	8.5	21.6	15.1	11.6	10.1	14.4	10.7	8.3	7.7	28.1	14.5	15.6	4.9	11.2	11.2	16.5	15.8	15.5	11.1	15.4	15.5	31.4	10.5	6.7	10.9	6.2	10.9	15.1	10.2	15.8	37.6	0.7	5.5	17.7	13.9	1.7	1.4	2.8	9.1	9.8	6.3	6.1	3.5	6.2	7.9	10.4	6.2	9.2	6.3	4.4	3.7	5.5	13.0	7.3	11.0	2.7	6.4	3.3	7.8	8.8	21.3	4.5	4.2	5.8	7.8	5.8	5.8	1.9	9.0	4.2	35.8	54.2	2.3	11.8	8.4	4.6	6.1	2.6	10.7	7.0	16.2	1.6	3.1	3.9	2.5	9.8	9.9	3.3	8.5	4.1	5.5	30.1	11.1	11.3	10.1	9.9	4.6	3.7	6.1	11.2	15.0	21.2	0.0	7.7	3.3	1.0	12.9	0.7	0.7	0.7	0.6	5.5	0.6	0.7	0.8	17.7	1.7	13.9	1.4	1.4	2.8	14.0	14.3	16.9	16.3	13.9	14.9	11.6	10.1	14.5	10.9
PPP1CA	"PP-1A, PP1A, PP1alpha, PPP1A"	ENSG00000172531	"Protein phosphatase 1 catalytic subunit alpha"	P62136	11	67398183-67421183	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Carbohydrate metabolism, Cell cycle, Cell division, Glycogen metabolism, Host-virus interaction"	"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 177.2"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004545, HPA046833"	Approved		Supported	"Nucleoplasm,Plasma membrane,Cytosol"			8100000	"Nucleoplasm, Plasma membrane, Cytosol"		"CAB004545: AB_628177, HPA046833: "	"unprognostic (1.03e-1)"	"unprognostic (5.82e-3)"	"unprognostic (1.10e-1)"	"unprognostic (2.67e-1)"	"unprognostic (2.09e-1)"	"unprognostic (1.51e-2)"	"unprognostic (3.15e-3)"	"unprognostic (3.93e-2)"	"unprognostic (2.07e-1)"	"unprognostic (3.89e-2)"	"unprognostic (5.05e-3)"	"unprognostic (8.00e-2)"	"unprognostic (1.66e-1)"	"unprognostic (9.96e-2)"	"unprognostic (7.69e-2)"	"prognostic favourable (1.17e-4)"	"unprognostic (7.60e-2)"	28.4	35.4	24.2	42.0	32.3	42.1	25.1	19.6	33.4	23.9	39.6	22.1	29.9	33.9	19.6	25.8	59.7	22.8	28.6	33.0	21.8	17.1	43.7	55.0	27.6	49.3	19.9	19.9	20.1	53.3	23.1	21.6	44.0	19.3	27.2	33.2	23.2	49.7	31.1	39.0	34.4	47.3	20.5	21.3	53.7	35.1	15.7	19.4	77.7	38.5	40.5	63.9	25.5	25.7	78.8	76.6	126.2	118.0	68.2	113.9	177.2	46.2	53.4	31.7	46.6	15.8	19.4	32.3	22.9	26.9	46.3	35.2	76.3	55.9	39.8	39.1	34.8	40.5	36.6	47.7	28.5	41.8	24.8	38.2	25.2	40.0	34.5	48.5	49.4	21.8	31.6	39.4	23.2	46.4	35.5	33.0	37.4	105.5	61.5	95.4	52.5	42.3	43.7	43.9	34.5	45.4	38.3	24.8	41.2	26.6	47.8	70.7	57.2	33.6	33.0	35.7	36.6	42.1	29.6	33.1	30.6	45.2	42.8	33.4	37.6	81.4	80.1	126.2	88.6	100.5	69.3	78.8	79.8	90.5	76.6	77.0	49.1	69.2	93.3	68.2	118.0	54.4	113.9	177.2	24.2	32.3	19.6	33.4	21.8	17.1	19.9	19.9	19.3	19.4
PPP1R12B	"MGC131980, MGC87886, MYPT2, PP1bp55"	ENSG00000077157	"Protein phosphatase 1 regulatory subunit 12B"	O60237	1	202348699-202592706	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"endometrium 1: 105.2"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	7	"neutrophil: 15.9"	"Lineage enriched"	"Detected in many"	7	"granulocytes: 15.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA024171, HPA024640"	Enhanced		Approved	"Plasma membrane,Actin filaments"				"Plasma membrane, Actin filaments"		"HPA024171: AB_1854266, HPA024640: AB_1854265"	"unprognostic (5.24e-2)"	"unprognostic (8.59e-2)"	"unprognostic (1.38e-1)"	"unprognostic (2.75e-2)"	"unprognostic (3.04e-1)"	"unprognostic (5.45e-3)"	"unprognostic (3.12e-2)"	"unprognostic (9.13e-3)"	"unprognostic (4.05e-2)"	"unprognostic (3.74e-2)"	"unprognostic (2.79e-2)"	"unprognostic (1.80e-1)"	"unprognostic (3.60e-3)"	"unprognostic (6.98e-3)"	"unprognostic (1.27e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.19e-1)"	10.6	2.8	6.9	8.1	9.0	1.8	7.7	13.9	10.5	55.3	62.0	15.0	31.0	5.8	105.2	9.4	37.4	21.9	17.4	83.1	5.8	4.5	5.0	2.9	8.1	4.2	10.1	9.2	18.7	2.3	2.0	4.5	8.4	9.5	36.4	16.3	13.7	5.7	50.3	17.6	5.3	14.1	59.5	7.3	6.9	20.8	3.4	11.1	1.3	5.0	11.2	3.5	35.1	11.4	2.3	1.7	15.9	1.8	0.7	1.7	0.5	2.7	5.4	4.2	3.9	5.9	4.3	6.8	2.1	2.2	2.2	2.1	2.3	4.8	3.0	1.1	3.9	8.6	6.2	3.3	2.4	3.9	3.8	3.0	7.9	1.5	1.4	6.5	3.5	3.4	3.8	3.2	3.3	1.8	4.5	3.6	3.9	2.0	4.8	4.1	2.8	1.1	3.2	10.7	4.4	1.8	9.8	5.1	3.9	4.1	4.9	2.4	4.3	3.0	2.3	3.2	1.9	2.3	1.8	5.3	5.0	3.3	3.0	5.3	12.6	1.8	1.8	1.3	1.7	0.9	1.4	1.7	1.1	1.0	1.4	2.3	1.4	1.0	15.9	0.7	1.4	1.7	1.6	0.5	6.9	9.0	13.9	10.5	5.8	4.5	10.1	9.2	9.5	11.1
PPP1R16A	"MGC14333, MYPT3"	ENSG00000160972	"Protein phosphatase 1 regulatory subunit 16A"	Q96I34	8	144477969-144502121	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 23.3"	"Cell line enhanced"	"Detected in many"		"MCF7: 25.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							HPA023755	Uncertain		Approved	"Plasma membrane"				"Plasma membrane"		"HPA023755: AB_1854268"	"unprognostic (9.63e-2)"	"unprognostic (4.51e-2)"	"unprognostic (5.45e-3)"	"unprognostic (3.11e-1)"	"unprognostic (5.60e-2)"	"unprognostic (3.75e-2)"	"unprognostic (4.64e-3)"	"unprognostic (2.65e-1)"	"unprognostic (3.68e-2)"	"unprognostic (2.20e-2)"	"unprognostic (1.52e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.29e-2)"	"unprognostic (1.03e-1)"	"unprognostic (9.45e-2)"	"unprognostic (2.79e-2)"	3.0	3.8	6.5	3.1	6.8	2.2	3.0	3.3	4.8	3.0	11.1	3.0	3.0	20.5	3.0	3.0	3.0	6.7	3.0	3.0	6.5	4.6	6.5	5.3	3.0	3.0	3.1	3.0	3.0	5.7	4.0	10.2	3.0	3.0	3.4	1.6	3.0	5.4	4.5	3.4	3.7	23.3	3.0	3.0	3.0	7.8	7.4	3.0	3.0	6.8	3.0	3.0	3.0	3.0	2.5	3.2	0.7	4.1	0.7	3.2	2.1	15.6	12.7	2.1	8.1	0.8	1.5	10.4	4.3	2.7	3.4	2.7	3.3	11.2	2.6	11.4	1.6	10.4	1.1	3.5	0.5	5.3	6.3	3.1	12.3	3.5	2.6	2.2	4.3	1.5	4.8	3.9	1.1	2.4	12.2	3.3	1.2	25.7	7.7	10.2	3.9	16.1	8.2	1.0	5.2	3.0	5.2	6.7	12.9	7.9	7.3	6.5	17.3	4.7	4.0	3.9	18.2	10.6	8.1	2.1	2.1	0.9	12.4	4.3	3.4	0.0	2.3	0.0	3.2	3.4	2.8	2.5	2.3	2.9	3.2	0.5	1.7	3.1	0.7	0.7	4.1	1.8	1.7	2.1	6.5	6.8	3.3	4.8	6.5	4.6	3.1	3.0	3.0	3.0
PPP1R18	"KIAA1949, phostensin"	ENSG00000146112	"Protein phosphatase 1 regulatory subunit 18"	Q6NYC8	6	30676389-30687895	"Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 54.5"	"Cell line enhanced"	"Detected in many"		"HMC-1: 34.6;U-937: 36.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in all"	4	"eosinophil: 54.5"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 54.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044745, HPA051000"	Enhanced		Approved	"Nucleoplasm,Plasma membrane"				"Plasma membrane"	Nucleoplasm	"HPA044745: AB_2679070, HPA051000: AB_2681304"	"unprognostic (3.25e-2)"	"unprognostic (1.19e-1)"	"prognostic unfavourable (4.71e-4)"	"unprognostic (1.01e-1)"	"unprognostic (2.11e-2)"	"unprognostic (1.59e-2)"	"unprognostic (2.90e-2)"	"unprognostic (3.37e-2)"	"unprognostic (2.44e-1)"	"unprognostic (1.18e-1)"	"unprognostic (3.61e-2)"	"unprognostic (2.40e-1)"	"prognostic unfavourable (1.11e-16)"	"unprognostic (1.73e-1)"	"unprognostic (4.42e-2)"	"unprognostic (9.33e-2)"	"unprognostic (4.76e-2)"	17.2	7.1	5.6	24.7	7.9	34.0	16.1	1.7	4.7	12.6	15.9	6.2	4.6	5.3	17.5	7.3	11.5	10.9	13.9	10.1	6.5	3.4	6.1	8.3	20.2	44.9	7.2	1.8	14.9	4.0	2.3	2.9	13.3	6.0	11.2	3.7	7.3	7.9	6.1	6.6	9.5	11.3	13.9	9.8	37.4	9.1	4.9	6.2	48.2	7.8	7.8	23.6	18.2	18.0	4.2	3.4	54.5	4.1	10.2	11.9	5.2	9.9	1.6	5.9	7.2	4.3	11.5	0.2	5.9	6.9	5.3	3.6	1.2	2.0	9.7	5.4	10.4	6.6	2.9	6.5	2.7	8.1	0.6	23.3	2.9	1.2	3.4	6.1	34.6	7.0	7.6	13.0	11.7	4.2	4.3	4.9	6.2	1.0	8.6	12.0	0.0	0.4	27.5	5.2	7.9	3.1	0.6	0.4	2.0	5.5	2.1	11.0	1.6	8.3	14.1	20.8	5.3	0.0	14.7	1.8	9.5	12.0	6.0	36.0	24.2	8.1	2.8	54.5	11.7	4.1	8.5	3.1	5.7	11.9	1.8	4.2	4.7	9.0	13.2	10.2	3.0	3.4	9.4	5.2	5.6	7.9	1.7	4.7	6.5	3.4	7.2	1.8	6.0	6.2
PPP1R9A	"FLJ20068, KIAA1222, Neurabin-I"	ENSG00000158528	"Protein phosphatase 1 regulatory subunit 9A"	Q9ULJ8	7	94907202-95296415	"Plasma proteins, Predicted intracellular proteins"	"Differentiation, Neurogenesis"	"Actin-binding, Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HAP1: 10.3;RH-30: 10.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"basophil: 5.8;NK-cell: 10.9"	"Group enriched"	"Detected in many"	6	"granulocytes: 5.8;NK-cells: 10.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027726, HPA075591"	Approved		Approved	"Plasma membrane"				"Plasma membrane"		"HPA027726: AB_1855653, HPA075591: "	"unprognostic (1.05e-1)"	"unprognostic (6.59e-2)"	"unprognostic (5.90e-2)"	"unprognostic (1.63e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.12e-1)"	"unprognostic (8.62e-2)"	"unprognostic (6.19e-2)"	"unprognostic (1.45e-1)"	"prognostic favourable (7.17e-4)"	"unprognostic (2.26e-2)"	"unprognostic (1.89e-1)"	"prognostic favourable (8.63e-6)"	"unprognostic (2.74e-1)"	"unprognostic (4.85e-2)"	"unprognostic (8.47e-2)"	"unprognostic (8.79e-3)"	2.9	11.7	11.0	1.9	23.5	0.8	8.1	10.9	19.7	5.2	8.7	7.4	7.7	3.0	5.4	9.2	3.2	9.6	4.4	8.2	11.5	9.7	8.2	1.1	6.4	0.9	8.1	13.7	5.0	14.3	16.5	15.5	4.5	12.7	4.2	6.8	5.7	14.2	5.3	6.7	1.1	3.0	5.1	9.1	3.2	6.2	10.0	11.2	0.0	10.9	1.3	1.0	4.2	1.4	1.3	0.3	5.8	0.1	10.9	0.2	0.2	0.0	9.3	5.8	6.5	0.0	0.0	4.7	0.4	0.1	0.8	0.7	5.1	3.1	0.0	7.9	0.4	0.0	10.3	0.0	1.2	0.0	4.0	9.5	3.8	5.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	4.0	0.1	0.0	4.8	1.7	0.0	10.3	0.0	9.6	7.6	6.2	6.5	0.0	0.8	1.3	1.9	0.0	0.0	0.1	3.8	0.1	3.3	6.3	9.1	0.0	0.1	0.0	0.7	5.8	0.0	0.5	0.0	0.0	0.2	0.9	0.0	0.0	0.0	1.3	0.0	0.0	0.0	10.9	0.1	0.3	0.0	0.2	11.0	23.5	10.9	18.3	11.5	9.7	8.1	13.7	12.7	11.2
PPP2R1B	"PP2A-Abeta, PR65B"	ENSG00000137713	"Protein phosphatase 2 scaffold subunit Abeta"	P30154	11	111726908-111766427	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 94.9"	"Cell line enhanced"	"Detected in all"		"U-698: 59.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004034, HPA018908"	Approved		Approved	"Nucleoplasm,Plasma membrane,Centrosome,Cytosol"				Cytosol	"Nucleoplasm, Plasma membrane, Centrosome"	"CAB004034: AB_490763, HPA018908: AB_1855655"	"unprognostic (8.37e-2)"	"unprognostic (3.87e-2)"	"unprognostic (4.84e-3)"	"unprognostic (3.27e-3)"	"unprognostic (3.43e-1)"	"unprognostic (4.93e-2)"	"prognostic favourable (3.80e-4)"	"unprognostic (4.58e-1)"	"unprognostic (8.20e-3)"	"unprognostic (2.26e-1)"	"unprognostic (1.72e-1)"	"unprognostic (8.41e-2)"	"unprognostic (1.25e-3)"	"unprognostic (1.25e-1)"	"unprognostic (5.30e-1)"	"unprognostic (2.12e-2)"	"unprognostic (1.22e-1)"	31.6	7.2	7.1	7.6	9.8	7.7	13.5	14.8	7.1	7.9	8.2	13.6	5.7	7.7	6.3	5.6	7.9	5.0	7.8	4.6	7.4	5.0	10.3	94.9	5.4	6.2	12.6	3.4	8.7	18.5	5.4	19.4	6.7	9.8	4.6	8.5	6.6	8.8	4.0	6.2	6.7	9.4	5.9	8.7	4.2	11.9	28.6	13.9	10.1	6.1	7.2	9.4	6.0	5.1	11.5	14.7	9.9	11.9	14.1	14.3	12.0	12.8	8.6	12.4	8.4	12.5	6.8	12.5	12.7	8.9	9.5	8.7	29.2	13.5	16.3	9.6	8.2	12.2	18.4	10.4	12.2	11.2	5.7	15.9	5.1	12.7	6.2	18.5	12.7	7.7	6.3	10.7	7.9	11.7	19.2	21.7	10.4	4.2	20.0	7.5	15.3	9.4	15.4	8.3	19.9	14.1	14.2	4.1	11.0	11.4	10.5	2.1	12.1	6.9	12.6	11.1	13.4	5.5	8.1	2.3	5.7	59.6	3.9	21.7	14.0	5.4	10.0	9.9	13.7	11.9	13.4	10.4	13.9	12.7	14.7	11.5	12.3	13.1	2.5	14.1	10.7	6.3	14.3	12.0	7.1	9.8	14.8	7.1	7.4	5.0	12.6	3.4	9.8	13.9
PPP3R1	"CALNB1, CNB, CNB1"	ENSG00000221823	"Protein phosphatase 3 regulatory subunit B, alpha"	P63098	2	68178857-68256237	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 78.2"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 6.4"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005610, HPA047157"	Approved		Approved	"Plasma membrane,Cytosol"			43000	"Plasma membrane, Cytosol"		"CAB005610: AB_325975, HPA047157: "	"unprognostic (2.12e-1)"	"unprognostic (2.09e-2)"	"unprognostic (1.55e-1)"	"prognostic unfavourable (9.08e-6)"	"unprognostic (5.90e-2)"	"unprognostic (1.86e-1)"	"prognostic unfavourable (5.37e-4)"	"unprognostic (3.59e-1)"	"unprognostic (3.96e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.13e-2)"	"unprognostic (1.74e-1)"	"prognostic unfavourable (1.70e-5)"	"unprognostic (5.24e-3)"	"unprognostic (5.35e-1)"	"unprognostic (8.70e-2)"	"unprognostic (1.24e-1)"	25.8	20.1	43.3	15.9	66.2	32.3	25.7	47.9	78.2	14.8	14.0	7.7	6.9	13.1	16.6	14.2	15.7	10.5	14.7	10.2	56.2	28.7	11.3	29.6	15.5	18.8	23.7	45.1	13.6	9.8	9.4	8.9	18.5	25.4	14.3	14.8	6.8	12.1	16.6	41.7	17.1	12.0	18.5	21.6	16.5	12.6	10.4	16.5	12.7	12.6	7.7	20.1	14.4	13.3	1.0	1.8	6.4	1.4	0.9	1.4	0.9	17.4	14.9	20.2	13.9	14.0	16.2	20.6	25.5	21.7	28.7	25.4	21.5	15.9	24.4	8.8	17.2	11.9	21.3	18.4	35.1	17.2	15.2	79.3	12.2	19.8	27.6	31.1	26.8	16.3	16.7	22.3	22.9	19.2	19.1	27.9	20.9	15.1	26.3	27.4	23.7	12.7	19.2	26.7	38.9	17.8	18.7	26.7	18.8	14.6	20.8	18.3	9.8	14.5	20.2	24.8	22.8	18.7	21.9	15.8	17.4	36.2	18.1	32.7	15.5	3.2	1.2	2.9	0.7	0.8	1.4	0.5	0.8	0.5	1.3	1.0	0.9	1.4	6.4	0.9	1.4	1.8	0.9	0.9	43.3	66.2	47.9	78.2	56.2	28.7	23.7	45.1	25.4	16.5
PPP3R2	PPP3RL	ENSG00000188386	"Protein phosphatase 3 regulatory subunit B, beta"	Q96LZ3	9	101591615-101595021	"FDA approved drug targets, Predicted intracellular proteins"			"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	90	"testis: 81.9"	"Cell line enhanced"	"Detected in single"		"Karpas-707: 1.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"							HPA047157	Uncertain		Approved	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		"HPA047157: "												"unprognostic (8.81e-2)"			"unprognostic (2.65e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	81.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.6	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0
PPP4C	"PP4, PPX"	ENSG00000149923	"Protein phosphatase 4 catalytic subunit"	P60510	16	30075978-30085377	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043837	Supported		Supported	"Nucleoplasm,Plasma membrane,Cytosol"				Nucleoplasm	"Plasma membrane, Cytosol"	"HPA043837: "	"unprognostic (1.20e-1)"	"unprognostic (1.33e-2)"	"unprognostic (2.68e-1)"	"unprognostic (4.74e-2)"	"unprognostic (2.16e-1)"	"unprognostic (5.79e-3)"	"unprognostic (3.28e-3)"	"unprognostic (2.60e-3)"	"unprognostic (3.82e-1)"	"unprognostic (1.29e-1)"	"unprognostic (2.52e-1)"	"unprognostic (3.17e-2)"	"unprognostic (1.98e-2)"	"unprognostic (3.78e-2)"	"unprognostic (9.36e-2)"	"unprognostic (9.96e-2)"	"unprognostic (1.88e-1)"	24.7	26.6	13.5	26.1	14.1	26.7	18.6	16.0	15.9	19.2	28.4	14.5	20.5	22.5	19.2	28.4	39.1	17.7	31.9	28.5	12.6	12.1	28.9	52.3	27.4	25.3	12.5	12.8	22.5	26.3	23.9	16.2	51.6	11.9	18.3	17.4	18.8	22.0	14.9	26.0	26.1	38.8	15.9	11.9	36.2	22.6	39.0	9.5	59.7	27.1	26.5	37.9	22.2	21.1	19.5	30.3	57.3	28.2	12.4	23.6	12.0	30.3	34.1	22.8	31.8	21.6	18.2	35.4	27.1	30.2	35.7	39.7	30.0	39.7	23.7	34.9	31.9	24.8	28.2	33.6	21.1	29.6	50.5	16.1	21.2	66.2	32.8	22.6	30.5	26.4	29.8	32.5	20.6	41.4	31.3	21.7	27.2	87.6	39.3	41.2	43.3	18.2	44.0	23.7	41.2	33.7	31.3	22.2	32.8	13.3	40.2	23.1	37.0	38.5	26.3	20.9	21.9	16.8	20.8	37.2	40.9	27.7	29.8	29.1	25.2	21.4	26.9	57.3	18.3	28.2	13.1	17.0	19.2	20.6	30.3	19.5	17.2	15.2	56.9	12.4	24.5	23.5	23.6	12.0	13.5	14.1	16.0	15.9	12.6	12.1	12.5	12.8	11.9	9.5
PPTC7	TA-PP2C	ENSG00000196850	"PTC7 protein phosphatase homolog"	Q8NI37	12	110533245-110583320	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 53.8"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039335, HPA040614"	Approved		Approved	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		"HPA039335: AB_10805474, HPA040614: AB_10795526"	"unprognostic (2.44e-1)"	"unprognostic (2.38e-2)"	"unprognostic (1.11e-1)"	"unprognostic (9.44e-2)"	"unprognostic (2.38e-1)"	"unprognostic (3.46e-2)"	"unprognostic (2.14e-1)"	"unprognostic (3.51e-2)"	"unprognostic (1.47e-2)"	"prognostic unfavourable (1.43e-5)"	"prognostic unfavourable (6.76e-4)"	"unprognostic (1.09e-1)"	"prognostic favourable (4.48e-5)"	"unprognostic (5.34e-2)"	"unprognostic (2.83e-1)"	"unprognostic (5.01e-3)"	"unprognostic (1.83e-1)"	10.4	15.3	6.5	10.3	9.6	26.2	10.3	8.3	12.9	9.7	11.8	5.7	4.9	7.5	9.3	4.6	12.6	7.8	8.8	35.3	9.0	9.0	12.6	11.9	13.1	10.9	10.4	6.8	8.9	7.5	13.0	12.7	6.9	15.3	7.7	9.8	8.0	12.9	8.2	53.8	13.4	11.7	13.1	7.4	9.4	8.4	8.2	6.5	16.1	8.0	15.5	13.1	12.4	12.4	2.1	1.4	6.1	1.7	1.7	2.4	0.6	12.0	6.9	5.9	6.2	14.8	13.1	8.5	5.6	7.4	6.1	6.2	7.8	4.8	21.2	5.8	5.4	11.8	11.9	12.9	12.4	15.4	9.8	18.8	7.4	8.4	14.1	20.7	15.5	11.2	21.3	8.6	25.5	11.6	13.9	6.1	9.9	3.1	18.3	17.8	8.4	12.9	15.3	8.0	12.9	25.4	13.6	9.6	7.5	10.5	14.6	12.3	6.9	11.1	13.2	5.6	6.0	17.1	9.3	17.6	19.4	23.7	9.5	11.5	11.0	0.1	1.7	1.3	2.3	1.5	2.4	1.3	1.9	1.8	1.3	2.1	2.2	1.9	6.1	1.7	1.1	1.4	1.3	0.6	6.5	9.6	8.3	12.9	9.0	9.0	10.4	6.8	15.3	6.5
PRC1	ASE1	ENSG00000198901	"Protein regulator of cytokinesis 1"	O43663	15	90966038-90995629	"Predicted intracellular proteins"	"Cell cycle, Cell division"		Oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 43.3;lymphoid tissue: 44.5;testis: 44.3"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	6	"basophil: 18.9;T-reg: 5.8"	"Group enriched"	"Detected in many"	6	"granulocytes: 18.9;T-cells: 5.8"	"Low region specificity"	"Detected in single"							"HPA034521, HPA048816"	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Microtubules,Cytokinetic bridge,Midbody"				"Plasma membrane, Microtubules, Cytokinetic bridge, Midbody"	Nucleoplasm	"HPA034521: AB_10670169, HPA048816: "	"unprognostic (1.14e-1)"	"unprognostic (3.98e-2)"	"unprognostic (9.21e-2)"	"unprognostic (1.75e-3)"	"unprognostic (2.39e-1)"	"unprognostic (3.43e-2)"	"prognostic unfavourable (2.11e-4)"	"unprognostic (1.24e-3)"	"unprognostic (3.86e-3)"	"unprognostic (1.65e-2)"	"prognostic unfavourable (2.76e-5)"	"unprognostic (2.49e-2)"	"prognostic unfavourable (0.00e+0)"	"unprognostic (3.09e-2)"	"unprognostic (1.79e-1)"	"unprognostic (7.90e-2)"	"unprognostic (3.92e-2)"	3.2	2.8	3.5	13.0	3.8	43.3	3.6	12.5	5.8	3.4	9.3	1.6	0.2	6.1	3.5	4.7	15.0	2.6	2.8	3.5	5.1	4.9	2.3	1.9	5.8	9.2	3.4	4.7	3.6	3.8	1.6	1.5	10.4	5.2	2.4	9.9	2.7	3.9	1.0	2.5	9.9	6.6	5.4	3.5	5.8	5.0	44.3	0.8	44.5	1.8	15.3	16.5	3.5	4.9	0.9	2.0	18.9	0.4	2.0	5.8	0.7	32.4	39.7	33.2	22.6	3.5	6.0	17.8	46.8	27.7	51.9	39.7	26.5	31.7	12.4	18.6	29.8	44.3	37.8	20.0	49.1	22.9	41.9	25.6	51.9	24.3	0.8	12.6	22.2	1.5	2.6	29.4	30.2	29.0	21.3	26.6	48.2	28.2	12.9	19.3	13.0	17.0	13.6	41.5	16.6	23.1	24.7	30.3	24.0	44.5	24.8	16.1	29.7	25.0	17.3	34.3	30.3	28.3	67.4	8.6	22.8	15.3	15.0	31.4	52.3	18.9	0.4	2.0	0.5	0.0	0.3	0.9	1.0	1.0	1.8	0.4	0.9	0.4	0.2	2.0	0.2	2.0	5.8	0.7	3.5	3.8	12.5	5.8	5.1	4.9	3.4	4.7	5.2	0.8
PRDX6	"1-Cys, aiPLA2, AOP2, KIAA0106, MGC46173, NSGPx, p29, PRX"	ENSG00000117592	"Peroxiredoxin 6"	P30041	1	173477266-173488807	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Lipid degradation, Lipid metabolism"	"Antioxidant, Hydrolase, Multifunctional enzyme, Oxidoreductase, Peroxidase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA006983, CAB008663"	Supported		Supported	"Plasma membrane,Cytosol"			180000000	"Plasma membrane, Cytosol"		"CAB008663: AB_1620994, HPA006983: AB_1079595"	"unprognostic (9.92e-2)"	"unprognostic (1.50e-1)"	"unprognostic (3.67e-1)"	"unprognostic (2.99e-3)"	"unprognostic (1.96e-1)"	"prognostic unfavourable (1.23e-5)"	"unprognostic (5.71e-3)"	"unprognostic (2.80e-2)"	"unprognostic (5.27e-3)"	"unprognostic (3.96e-3)"	"unprognostic (3.19e-3)"	"unprognostic (1.59e-1)"	"prognostic unfavourable (9.51e-4)"	"unprognostic (2.50e-1)"	"unprognostic (7.12e-2)"	"unprognostic (1.15e-1)"	"unprognostic (4.73e-3)"	80.0	42.1	32.8	30.8	38.9	21.8	106.3	19.8	32.8	27.2	46.7	37.4	35.8	12.1	30.8	54.1	39.9	40.2	22.3	70.5	29.0	23.9	45.9	116.1	29.2	37.5	34.0	28.2	31.5	39.3	63.9	19.1	36.9	30.3	40.0	56.0	21.3	22.6	35.4	128.0	25.7	20.2	40.5	19.7	23.1	33.2	44.9	24.1	17.4	46.9	68.6	25.7	36.5	46.2	17.2	37.9	14.3	23.9	12.0	25.0	30.6	51.2	15.8	26.2	29.0	101.5	49.6	22.1	104.7	35.7	43.7	31.1	29.7	34.5	33.4	33.5	85.8	29.9	34.2	33.7	35.6	29.3	31.6	22.1	27.0	33.5	57.3	23.1	7.3	41.1	34.2	24.0	33.7	42.8	49.2	6.9	49.6	10.5	15.7	30.5	57.5	97.9	18.8	30.3	34.0	65.5	11.7	12.2	22.6	36.1	42.5	24.0	35.9	32.7	28.8	17.1	19.5	25.8	28.4	10.5	15.4	27.4	20.4	20.1	15.5	13.9	23.9	12.9	17.0	20.6	18.9	17.2	17.6	21.1	29.3	13.6	23.2	25.0	14.3	12.0	17.5	37.9	20.4	30.6	32.8	38.9	19.8	32.8	29.0	23.9	34.0	28.2	30.3	24.1
PRIMA1	PRIMA	ENSG00000175785	"Proline rich membrane anchor 1"	Q86XR5	14	93718298-93788481	"Predicted membrane proteins"	"Neurotransmitter degradation"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"intestine: 26.2"	"Cell line enhanced"	"Detected in some"		"HAP1: 7.3;Hep G2: 4.7;NTERA-2: 3.0;SCLC-21H: 12.9;SH-SY5Y: 7.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in many"		"basal ganglia: 16.2"	"Low region specificity"	"Detected in all"			"HPA046671, HPA060047"	Approved		Approved	"Nucleoli,Plasma membrane,Cytosol"				"Plasma membrane"	"Nucleoli, Cytosol"	"HPA046671: , HPA060047: "	"unprognostic (3.60e-2)"	"unprognostic (1.97e-1)"	"unprognostic (7.54e-2)"	"prognostic unfavourable (6.99e-5)"	"unprognostic (1.03e-2)"	"unprognostic (3.73e-2)"	"unprognostic (1.07e-1)"	"unprognostic (5.81e-2)"	"unprognostic (2.93e-1)"	"unprognostic (1.05e-1)"	"unprognostic (8.94e-2)"	"unprognostic (6.61e-3)"	"prognostic unfavourable (2.62e-7)"	"unprognostic (2.33e-2)"	"unprognostic (2.67e-1)"	"unprognostic (7.94e-4)"	"unprognostic (4.57e-3)"	4.6	6.0	4.2	5.9	16.7	0.4	2.4	4.5	8.2	7.7	26.2	21.7	4.2	4.6	7.9	7.9	13.7	10.7	3.3	4.8	5.8	3.3	1.2	0.7	1.0	0.7	20.2	4.0	6.9	1.2	0.6	0.3	2.2	15.5	8.6	7.6	9.9	4.6	10.2	0.7	2.1	11.6	14.9	24.3	0.7	12.1	1.8	14.7	0.0	1.3	0.9	4.4	4.7	7.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	7.3	0.0	0.0	0.2	0.4	0.0	0.0	4.7	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	3.0	0.0	0.0	0.0	0.3	0.0	0.0	12.9	7.3	0.4	0.0	0.0	1.5	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.2	16.7	4.5	8.2	5.8	3.3	20.2	4.0	15.5	14.7
PRKCH	"PKC-L, PKCL, PRKCL"	ENSG00000027075	"Protein kinase C eta"	P24723	14	61187559-61550976	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	Differentiation	"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BEWO: 29.9;HUVEC TERT2: 39.2;MOLT-4: 26.0;RT4: 16.5;TIME: 25.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	12	"gdT-cell: 30.0;MAIT T-cell: 23.9;memory CD4 T-cell: 23.0;memory CD8 T-cell: 35.3;naive CD4 T-cell: 28.5;naive CD8 T-cell: 27.6;NK-cell: 27.3;T-reg: 18.6"	"Group enriched"	"Detected in many"	14	"NK-cells: 27.3;T-cells: 35.3"	"Group enriched"	"Detected in many"	6	"basal ganglia: 25.0;thalamus: 19.5"	"Low region specificity"	"Detected in many"			"HPA026294, HPA053709"	Approved		Approved	"Plasma membrane,Cytosol"				Cytosol	"Plasma membrane"	"HPA026294: AB_10603988, HPA053709: "	"unprognostic (1.42e-1)"	"unprognostic (3.89e-3)"	"unprognostic (1.78e-1)"	"unprognostic (1.96e-3)"	"unprognostic (1.04e-1)"	"prognostic favourable (8.55e-6)"	"unprognostic (1.14e-2)"	"unprognostic (2.97e-2)"	"unprognostic (4.14e-1)"	"unprognostic (1.94e-1)"	"unprognostic (7.96e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.52e-3)"	"unprognostic (1.13e-1)"	"unprognostic (4.14e-2)"	"unprognostic (6.98e-2)"	"unprognostic (4.73e-3)"	17.5	5.4	5.0	21.6	22.0	11.2	14.7	2.8	6.1	13.6	10.3	6.2	6.9	5.1	19.1	7.0	20.1	8.6	12.7	10.1	6.8	4.4	8.1	5.5	24.1	27.6	5.9	2.5	7.1	5.9	8.8	15.5	22.7	7.2	9.8	5.0	9.1	24.7	10.8	9.1	15.9	16.0	10.5	5.7	25.9	6.0	4.3	6.4	54.6	15.1	10.6	34.6	13.2	14.4	0.4	2.2	1.5	0.7	27.3	35.3	17.9	6.2	2.2	0.3	1.7	1.0	0.2	29.9	0.1	0.5	0.3	0.3	0.6	3.7	0.1	4.5	0.0	4.4	0.2	4.8	0.5	0.7	2.8	0.0	0.7	0.2	0.4	0.0	0.9	0.8	5.0	0.2	3.4	39.2	0.0	0.1	2.2	11.5	26.0	0.2	0.5	3.0	2.2	1.1	0.0	0.0	16.5	1.1	1.9	0.7	5.8	3.6	5.7	0.5	25.7	0.7	5.2	0.7	0.3	0.5	0.1	0.2	1.1	0.3	1.2	0.1	0.7	0.5	30.0	0.4	23.9	0.4	23.0	35.3	2.2	0.3	28.5	27.6	1.5	27.3	0.2	0.7	18.6	17.9	5.0	22.0	2.8	6.1	6.8	4.4	5.9	2.5	7.2	6.4
PROM2		ENSG00000155066	"Prominin 2"	Q8N271	2	95274453-95291308	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"A-431: 23.2;CAPAN-2: 41.1;HaCaT: 22.2;hTCEpi: 24.1;MCF7: 18.2;RT4: 25.0;SK-BR-3: 35.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"CAB046005, HPA063728"	Enhanced		Approved	"Nucleoplasm,Plasma membrane,Cell Junctions"				"Nucleoplasm, Plasma membrane"	"Cell Junctions"	"CAB046005: AB_2284371, HPA063728: "	"prognostic unfavourable (2.16e-4)"	"unprognostic (1.60e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.86e-2)"	"unprognostic (1.76e-1)"	"unprognostic (7.30e-2)"	"unprognostic (2.23e-1)"	"unprognostic (1.70e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.12e-1)"	"prognostic unfavourable (2.90e-4)"	"unprognostic (1.26e-1)"	"prognostic unfavourable (1.55e-6)"	"unprognostic (1.46e-2)"	"unprognostic (4.59e-1)"	"unprognostic (5.24e-2)"	"unprognostic (2.50e-2)"	0.3	0.2	0.5	2.9	0.6	0.0	9.3	1.1	0.5	11.4	5.2	0.3	22.2	4.4	1.4	22.5	42.6	2.2	37.2	0.5	0.6	0.5	18.8	0.4	1.3	0.3	0.6	0.3	1.5	8.6	8.1	1.5	12.5	0.3	11.6	4.2	0.3	35.6	20.0	1.3	26.7	2.6	2.7	0.7	0.4	11.5	1.8	0.3	1.7	5.7	21.6	22.2	20.0	14.8	0.0	0.2	0.6	0.0	0.0	0.3	0.0	23.2	0.0	0.0	0.2	0.1	0.0	11.8	0.0	0.0	0.1	0.1	0.2	41.1	0.0	0.0	0.0	22.2	0.0	12.7	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	24.1	0.0	0.1	0.0	0.0	0.0	0.0	18.2	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	25.0	0.2	0.0	0.0	35.9	0.0	11.3	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.2	0.1	0.0	0.0	0.1	0.1	0.6	0.0	0.0	0.2	0.2	0.0	0.5	0.6	1.1	0.5	0.6	0.5	0.6	0.3	0.3	0.3
PRR7	MGC10772	ENSG00000131188	"Proline rich 7, synaptic"	Q8TB68	5	177446445-177456286	"Predicted intracellular proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 28.5"	"Cell line enhanced"	"Detected in many"		"PC-3: 17.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA046636	Uncertain		Approved	"Nucleoplasm,Plasma membrane,Cytosol"				"Nucleoplasm, Plasma membrane, Cytosol"		"HPA046636: "	"unprognostic (3.69e-1)"	"unprognostic (9.07e-2)"	"unprognostic (1.16e-1)"	"unprognostic (3.48e-2)"	"unprognostic (4.08e-2)"	"unprognostic (7.94e-3)"	"prognostic unfavourable (1.50e-4)"	"unprognostic (1.55e-1)"	"unprognostic (1.01e-1)"	"unprognostic (4.75e-2)"	"unprognostic (5.86e-2)"	"unprognostic (2.76e-2)"	"prognostic unfavourable (1.98e-4)"	"unprognostic (8.84e-3)"	"unprognostic (2.22e-1)"	"unprognostic (3.76e-2)"	"unprognostic (1.69e-1)"	1.9	2.4	12.5	3.2	22.0	15.1	1.7	4.1	28.5	1.1	2.9	9.8	0.0	2.9	1.7	1.3	1.9	3.2	1.9	1.1	14.1	7.6	1.5	2.2	2.0	3.6	4.8	8.4	1.2	4.0	2.6	6.2	1.3	6.2	2.0	1.4	4.7	5.2	1.5	1.7	8.8	2.6	1.2	4.4	4.9	4.6	3.2	4.6	1.2	1.2	0.8	2.3	1.5	0.9	3.2	3.0	10.8	0.6	2.0	7.3	1.5	7.1	2.8	0.8	5.6	0.0	0.4	2.4	3.4	0.6	1.0	1.3	0.6	3.8	6.9	8.9	0.5	6.0	0.4	3.0	0.4	6.0	8.9	2.1	2.6	2.1	0.6	4.1	5.0	0.6	1.3	0.4	0.2	0.4	1.0	4.9	0.9	9.6	3.4	10.6	1.3	17.1	9.8	2.6	6.9	1.2	0.5	13.9	9.9	1.3	3.3	15.9	3.0	0.6	2.6	5.7	9.5	5.0	8.1	2.7	1.5	3.3	5.5	6.7	4.1	2.4	0.1	10.8	3.0	0.5	7.3	2.1	3.4	5.1	0.1	3.2	3.2	4.1	4.8	2.0	0.6	3.0	2.5	1.5	12.5	22.0	4.1	28.5	14.1	7.6	4.8	8.4	6.2	4.6
PRRG1	PRGP1	ENSG00000130962	"Proline rich and Gla domain 1"	O14668	X	37349275-37457295	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 43.4"	"Cell line enhanced"	"Detected in many"		"RPTEC TERT1: 38.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"basophil: 2.6"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA078129			Approved	"Nucleoplasm,Vesicles,Plasma membrane"				"Vesicles, Plasma membrane"	Nucleoplasm	"HPA078129: "	"unprognostic (8.82e-2)"	"prognostic unfavourable (4.65e-4)"	"unprognostic (8.34e-2)"	"unprognostic (2.08e-3)"	"unprognostic (1.92e-1)"	"unprognostic (5.11e-3)"	"unprognostic (2.24e-2)"	"unprognostic (7.23e-3)"	"unprognostic (1.01e-2)"	"unprognostic (1.74e-2)"	"prognostic unfavourable (1.22e-4)"	"unprognostic (8.21e-2)"	"prognostic favourable (2.05e-7)"	"unprognostic (1.43e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.08e-2)"	"unprognostic (1.48e-1)"	11.6	5.5	12.0	3.1	22.0	0.7	5.8	2.6	18.7	6.7	5.7	35.9	4.6	4.1	6.2	2.5	5.9	4.0	12.4	8.5	17.9	10.7	14.9	10.7	6.3	2.5	31.0	9.9	6.2	2.6	1.2	2.3	10.6	21.3	5.1	6.0	3.0	3.9	11.6	19.3	3.1	4.3	7.5	43.4	4.0	3.4	2.4	23.7	0.0	11.6	2.9	1.6	5.9	4.5	0.6	0.2	2.6	1.7	0.2	0.4	0.1	14.7	3.4	2.7	2.7	9.2	7.5	1.2	6.2	8.4	2.3	4.0	8.1	9.5	0.0	10.9	4.9	4.8	7.4	4.7	3.9	0.0	2.4	2.6	3.5	2.7	11.3	0.0	3.4	11.6	4.0	4.4	3.7	11.7	1.2	0.0	7.8	1.1	0.0	0.0	3.3	7.0	0.0	6.1	0.0	38.6	0.7	0.0	0.0	4.6	7.3	2.8	0.0	1.6	8.3	3.5	2.1	6.8	1.9	0.0	0.0	0.0	3.5	0.0	3.3	2.6	1.7	0.1	0.2	0.5	0.2	0.6	0.1	0.3	0.1	0.4	0.2	0.4	0.8	0.2	0.2	0.2	0.2	0.1	12.0	22.0	2.6	13.9	17.9	10.7	31.0	9.9	21.3	23.7
PRRT3	FLJ33674	ENSG00000163704	"Proline rich transmembrane protein 3"	Q5FWE3	3	9945542-9952394	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"brain: 26.0;fallopian tube: 10.8;parathyroid gland: 24.7;pituitary gland: 6.9"	"Cell line enhanced"	"Detected in many"		"ASC diff: 12.5;MCF7: 15.8;SK-BR-3: 23.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035127, HPA035128, HPA069859"	Approved		Approved	"Nucleoplasm,Plasma membrane,Cytosol"	"Intracellular and membrane"		18000	"Plasma membrane"	"Nucleoplasm, Cytosol"	"HPA035127: AB_10602822, HPA035128: , HPA069859: "	"unprognostic (1.55e-1)"	"unprognostic (8.41e-2)"	"unprognostic (3.42e-1)"	"unprognostic (2.38e-3)"	"unprognostic (1.27e-1)"	"unprognostic (3.41e-2)"	"unprognostic (1.15e-4)"	"unprognostic (2.27e-3)"	"unprognostic (1.37e-2)"	"unprognostic (2.76e-2)"	"unprognostic (2.20e-3)"	"unprognostic (3.60e-1)"	"unprognostic (1.01e-4)"	"unprognostic (2.25e-1)"	"unprognostic (1.39e-1)"	"unprognostic (4.64e-2)"	"unprognostic (2.09e-1)"	1.4	2.9	8.4	1.8	11.9	2.1	2.0	13.4	26.0	2.4	1.4	4.2	0.0	1.0	2.0	2.2	1.7	10.8	1.9	1.6	5.9	3.2	1.5	0.9	1.4	1.8	2.7	8.3	2.9	2.9	24.7	6.9	0.8	11.4	4.0	0.8	1.8	2.0	2.9	1.5	2.5	1.2	1.7	2.3	1.5	1.5	3.9	3.2	1.2	3.4	0.0	2.0	2.1	1.8	1.8	1.5	0.9	0.6	1.7	3.8	1.0	0.2	0.7	2.5	3.3	12.5	1.7	0.8	1.2	2.4	1.4	3.3	0.2	2.4	1.3	0.3	2.9	0.2	0.9	3.1	0.6	6.7	1.4	0.5	1.3	0.0	1.2	0.3	1.2	3.2	0.2	1.2	0.5	0.6	0.7	3.3	1.8	15.8	3.0	0.2	6.1	1.5	1.8	0.3	1.3	0.7	0.2	4.8	3.2	1.2	23.8	0.4	6.4	0.2	0.6	0.3	3.4	0.6	0.9	4.3	4.4	0.4	7.9	0.2	0.9	0.9	0.6	0.5	3.3	0.3	3.7	1.6	3.4	3.3	0.2	1.8	3.8	3.5	0.8	1.7	0.4	1.5	0.6	1.0	8.4	11.9	13.4	26.0	5.9	3.2	2.7	8.3	11.4	3.2
PRRT4		ENSG00000224940	"Proline rich transmembrane protein 4"	C9JH25	7	128350325-128361685	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"bone marrow: 49.0"	"Cell line enriched"	"Detected in some"	5	"SH-SY5Y: 70.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"naive CD4 T-cell: 1.5"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"HPA046373, HPA052681"	Uncertain		Approved	"Nucleoplasm,Peroxisomes,Plasma membrane"	"Intracellular and membrane"			Nucleoplasm	"Peroxisomes, Plasma membrane"	"HPA046373: , HPA052681: "	"unprognostic (1.72e-1)"	"unprognostic (4.55e-2)"	"unprognostic (5.36e-3)"	"unprognostic (1.20e-4)"	"unprognostic (2.60e-1)"	"unprognostic (7.81e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.56e-1)"	"unprognostic (5.62e-3)"	"unprognostic (1.61e-1)"	"unprognostic (2.48e-4)"	"unprognostic (9.11e-2)"	"unprognostic (3.73e-4)"	"unprognostic (5.28e-3)"	"unprognostic (9.09e-2)"	"unprognostic (1.22e-2)"	"unprognostic (1.27e-2)"	12.1	1.9	2.0	5.9	11.3	49.0	6.8	6.5	3.1	1.6	2.7	0.6	0.0	0.6	0.7	0.5	1.9	1.0	1.1	2.4	1.7	6.2	0.5	0.7	0.8	0.6	1.6	2.4	1.0	0.6	0.8	0.0	0.6	2.9	0.8	0.7	3.4	1.9	1.3	4.2	1.5	0.8	1.0	2.8	1.3	1.6	0.7	1.5	0.7	0.7	1.7	1.0	2.0	3.2	0.0	0.4	0.4	0.4	0.0	1.5	0.4	0.0	0.0	0.1	0.1	0.4	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	2.7	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.7	13.8	0.3	0.0	3.8	0.2	0.3	0.0	0.0	0.1	70.3	0.1	0.0	0.1	0.0	1.8	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	7.9	0.0	0.0	0.4	0.0	0.3	0.0	0.0	0.0	0.2	0.5	0.0	0.0	1.5	0.7	0.4	0.0	0.0	0.4	0.0	0.4	2.0	11.3	6.5	3.1	1.7	6.2	1.6	2.4	2.9	1.5
PRTG	"FLJ25756, IGDCC5"	ENSG00000166450	Protogenin	Q2VWP7	15	55611546-55743090	"Predicted intracellular proteins, Predicted membrane proteins"		"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"retina: 16.5;thyroid gland: 23.9"	"Cell line enriched"	"Detected in many"	6	"AF22: 57.4"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	18	"non-classical monocyte: 1.7"	"Lineage enriched"	"Detected in single"	18	"monocytes: 1.7"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA032138			Approved	"Vesicles,Plasma membrane,Cytosol"				Cytosol	"Vesicles, Plasma membrane"	"HPA032138: AB_10669675"	"unprognostic (2.80e-1)"	"unprognostic (2.42e-2)"	"unprognostic (1.32e-1)"	"unprognostic (4.64e-2)"	"unprognostic (2.07e-2)"	"unprognostic (4.96e-4)"	"unprognostic (1.82e-4)"	"unprognostic (1.31e-1)"	"unprognostic (3.19e-1)"	"unprognostic (4.76e-3)"	"unprognostic (1.37e-1)"	"unprognostic (5.32e-2)"	"unprognostic (5.67e-2)"	"unprognostic (2.42e-6)"	"unprognostic (8.81e-2)"	"unprognostic (3.17e-2)"	"unprognostic (2.70e-1)"	1.3	2.2	1.5	1.1	1.8	0.6	2.4	1.2	2.2	4.7	1.4	3.6	1.1	0.7	11.0	4.6	0.7	2.4	1.0	1.3	1.6	1.6	2.6	0.6	5.0	0.6	3.0	2.0	4.5	0.6	6.4	2.7	6.5	4.3	1.4	0.9	16.5	0.9	1.4	3.9	0.6	0.9	2.9	3.5	0.5	1.5	6.5	2.3	0.0	23.9	0.8	0.9	1.2	1.6	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.5	1.2	57.4	1.2	0.0	0.0	5.8	0.4	1.7	1.4	2.1	9.6	0.3	0.0	2.4	0.0	0.0	0.2	0.1	2.0	0.0	3.0	0.4	0.4	3.6	0.4	0.4	0.0	0.2	0.0	0.6	1.0	1.0	1.0	0.0	0.8	0.8	0.0	0.0	2.3	1.4	0.0	9.1	0.0	1.1	0.1	0.7	3.3	0.5	0.7	3.1	0.2	0.1	0.1	0.8	0.6	0.0	1.5	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	1.5	1.8	1.2	2.2	1.6	1.6	3.0	2.0	4.3	2.3
PRX	KIAA1620	ENSG00000105227	Periaxin	Q9BXM0	19	40393768-40413366	"Disease related genes, Plasma proteins, Predicted intracellular proteins"			"Charcot-Marie-Tooth disease, Dejerine-Sottas syndrome, Disease mutation, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"brain: 42.1;lung: 31.7;retina: 20.6"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in all"	4	"midbrain: 42.1"	"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	21	"midbrain: 24.7"	HPA001868	Enhanced		Approved	"Golgi apparatus,Vesicles,Plasma membrane"				"Golgi apparatus, Vesicles, Plasma membrane"		"HPA001868: AB_2172440"	"unprognostic (1.29e-2)"	"unprognostic (3.04e-1)"	"unprognostic (2.72e-2)"	"unprognostic (9.72e-3)"	"unprognostic (2.92e-1)"	"unprognostic (1.74e-1)"	"unprognostic (1.39e-1)"	"unprognostic (3.54e-2)"	"unprognostic (5.82e-2)"	"unprognostic (3.23e-2)"	"unprognostic (2.07e-2)"	"unprognostic (3.28e-2)"	"unprognostic (2.03e-3)"	"unprognostic (4.42e-2)"	"unprognostic (2.29e-1)"	"unprognostic (1.38e-1)"	"unprognostic (9.97e-2)"	3.4	4.4	4.8	1.0	4.1	1.1	2.7	2.2	5.4	3.0	2.3	1.8	2.8	1.2	3.8	2.0	2.2	3.2	2.4	2.9	4.0	2.2	4.3	0.6	31.7	1.3	42.1	3.7	7.5	5.4	7.3	1.1	6.0	10.3	3.2	0.8	20.6	3.9	4.4	5.4	2.2	1.5	3.3	11.0	1.7	2.4	1.6	3.6	0.0	7.2	6.7	0.9	3.1	2.0	0.3	0.4	0.0	0.3	0.1	1.2	0.2	2.4	2.7	3.3	4.2	2.7	7.0	4.1	2.0	2.3	2.9	2.1	2.3	2.7	0.8	2.6	1.9	1.3	1.1	0.9	1.0	1.2	1.4	0.5	0.9	0.7	3.2	0.2	3.6	4.9	4.9	1.9	1.6	1.5	3.0	0.8	1.5	3.2	1.1	0.8	0.7	2.5	4.8	2.7	2.4	0.5	1.3	0.3	1.5	3.9	3.3	3.0	4.9	1.2	2.2	5.9	4.6	2.3	1.2	8.4	7.3	1.1	1.8	1.3	1.3	0.0	0.3	0.0	0.6	0.2	0.2	0.0	0.4	0.6	0.0	0.3	0.3	1.2	0.0	0.1	0.0	0.4	0.3	0.2	4.8	4.1	2.2	5.4	4.0	2.2	42.1	3.7	10.3	3.6
PSD	"EFA6, EFA6A, KIAA2011, PSD1, TYL"	ENSG00000059915	"Pleckstrin and Sec7 domain containing"	A5PKW4	10	102402617-102421539	"Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 66.8"	"Cell line enhanced"	"Detected in some"		"HSkMC: 10.1;MOLT-4: 5.4;SCLC-21H: 9.4;SH-SY5Y: 8.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA059237	Uncertain		Approved	"Nucleoplasm,Plasma membrane,Cytosol"				Nucleoplasm	"Plasma membrane, Cytosol"	"HPA059237: "	"unprognostic (2.43e-1)"	"unprognostic (1.74e-1)"	"unprognostic (5.62e-3)"	"unprognostic (1.53e-1)"	"unprognostic (3.16e-2)"	"unprognostic (2.90e-2)"	"unprognostic (7.73e-3)"	"unprognostic (1.75e-1)"	"unprognostic (9.59e-2)"	"unprognostic (7.59e-2)"	"unprognostic (2.24e-3)"	"unprognostic (4.71e-2)"	"unprognostic (1.52e-1)"	"unprognostic (2.61e-2)"	"unprognostic (8.50e-2)"	"unprognostic (2.24e-2)"	"unprognostic (5.50e-2)"	1.2	9.8	48.7	4.3	59.4	1.6	1.5	8.0	66.8	6.7	21.5	1.7	0.0	6.7	23.9	2.4	3.2	11.1	9.4	1.9	48.7	12.2	1.5	1.4	1.7	1.8	7.6	26.7	5.6	4.7	2.5	13.6	1.8	4.2	6.2	4.4	3.7	1.5	2.2	1.2	2.1	5.8	20.7	1.8	1.5	4.8	4.6	7.0	0.0	1.2	0.0	1.5	11.7	3.0	0.8	0.0	1.1	0.2	0.9	1.3	0.0	0.3	0.1	3.8	3.4	1.4	0.8	0.3	0.3	0.0	0.1	0.0	2.6	0.4	0.3	2.4	0.1	0.2	0.2	0.0	0.0	0.3	0.2	0.1	0.1	0.1	2.1	0.0	0.1	10.1	0.3	0.6	0.1	0.0	0.5	0.9	0.0	2.0	5.4	0.3	0.5	0.0	1.4	0.0	0.1	0.0	0.2	9.4	8.3	0.1	0.1	0.2	0.6	0.5	0.0	2.8	4.6	0.2	0.0	2.4	0.3	0.1	0.3	0.2	0.1	0.0	0.2	0.3	0.0	0.0	0.2	0.2	0.2	0.3	0.0	0.8	0.3	1.3	1.1	0.9	0.0	0.0	0.0	0.0	48.7	59.4	8.0	41.2	48.7	12.2	7.6	26.7	4.2	7.0
PSMC6	p42	ENSG00000100519	"Proteasome 26S subunit, ATPase 6"	P62333	14	52707172-52728587	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042823	Approved		Approved	"Nucleoplasm,Plasma membrane,Cytosol"			190000	"Nucleoplasm, Cytosol"	"Plasma membrane"	"HPA042823: "	"unprognostic (2.38e-2)"	"unprognostic (2.72e-2)"	"unprognostic (9.18e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.19e-2)"	"unprognostic (4.26e-3)"	"unprognostic (3.14e-3)"	"unprognostic (6.30e-2)"	"unprognostic (1.06e-1)"	"unprognostic (2.79e-2)"	"unprognostic (3.50e-2)"	"unprognostic (1.00e-2)"	"unprognostic (1.52e-2)"	"unprognostic (5.00e-2)"	"unprognostic (2.68e-1)"	"unprognostic (4.13e-2)"	"unprognostic (4.67e-1)"	30.4	31.1	29.1	23.0	36.8	19.9	30.7	30.1	40.9	26.4	26.4	19.7	29.8	25.6	27.8	27.0	38.0	26.1	19.3	39.7	30.6	28.3	36.1	45.7	21.6	25.7	29.9	35.0	27.8	25.2	26.5	34.7	37.1	44.0	25.5	28.8	14.7	23.4	25.3	73.3	23.0	26.4	29.5	30.1	28.2	24.9	15.5	31.1	30.0	28.6	44.9	32.9	31.6	24.5	37.6	43.1	37.0	40.9	29.8	48.5	40.6	46.5	30.2	36.4	26.9	25.4	26.6	39.3	36.7	35.3	59.7	45.0	37.8	38.3	40.6	46.0	31.8	35.6	46.2	32.1	62.8	38.9	20.1	29.7	24.8	40.3	30.8	42.1	28.9	19.7	32.2	30.1	30.5	37.4	44.1	17.6	43.4	42.7	32.8	29.2	29.3	41.6	28.0	63.8	18.1	39.3	47.5	26.2	19.4	32.6	20.5	31.3	42.1	30.8	28.6	33.3	46.7	25.7	37.6	12.5	31.6	45.4	21.5	28.9	30.1	35.8	36.5	37.0	32.1	40.9	37.1	37.6	39.6	34.9	43.1	34.2	38.2	37.3	30.6	29.8	39.9	22.4	48.5	40.6	29.1	36.8	30.1	40.9	30.6	28.3	29.9	35.0	44.0	31.1
PSMD9	"p27, Rpn4"	ENSG00000110801	"Proteasome 26S subunit, non-ATPase 9"	O00233	12	121888731-121918297	"Plasma proteins, Predicted intracellular proteins"		Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"HPA040512, HPA044220"	Enhanced		Supported	"Plasma membrane,Cytosol"			330000	Cytosol	"Plasma membrane"	"HPA040512: AB_2677014, HPA044220: AB_2678860"	"unprognostic (2.24e-1)"	"unprognostic (2.48e-3)"	"unprognostic (2.12e-1)"	"unprognostic (3.36e-1)"	"unprognostic (1.20e-2)"	"unprognostic (1.51e-1)"	"prognostic unfavourable (1.32e-5)"	"unprognostic (1.86e-1)"	"unprognostic (6.80e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.30e-1)"	"unprognostic (9.64e-3)"	"unprognostic (3.17e-2)"	"unprognostic (5.73e-2)"	"unprognostic (6.19e-2)"	"unprognostic (8.63e-2)"	25.6	10.7	11.5	12.9	12.1	27.8	18.7	15.3	12.0	9.6	22.1	9.2	14.8	19.5	14.4	13.6	12.3	10.7	12.5	13.9	10.6	11.2	19.2	19.8	12.3	14.8	10.6	9.0	13.0	28.6	4.9	8.3	8.7	12.7	9.5	4.8	9.4	15.3	14.2	28.6	12.4	16.3	15.7	11.6	14.8	24.7	13.6	8.7	13.8	10.9	17.1	9.2	8.2	11.8	24.5	36.7	29.6	26.3	14.9	25.9	27.3	20.5	31.6	2.6	4.8	4.4	4.5	5.5	21.0	6.8	10.5	6.0	23.0	2.5	15.3	17.8	10.8	8.4	7.5	11.0	6.3	29.6	16.6	12.5	14.7	11.4	11.0	8.8	8.9	8.0	5.2	11.8	4.5	6.3	11.2	2.2	6.6	24.1	17.5	6.6	5.5	24.7	13.4	7.2	9.4	5.1	20.7	5.5	7.7	21.1	3.1	11.3	9.1	4.4	16.6	10.1	11.6	19.7	14.6	12.0	25.9	22.3	18.1	11.5	9.2	20.3	26.3	29.6	20.9	25.4	16.7	24.5	20.1	18.9	22.2	19.5	15.8	13.6	24.1	14.9	22.0	36.7	25.9	27.3	11.5	12.1	15.3	12.0	10.6	11.2	10.6	9.0	12.7	8.7
PSTPIP2		ENSG00000152229	"Proline-serine-threonine phosphatase interacting protein 2"	Q9H939	18	45983536-46072272	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 38.1;bone marrow: 36.9;lymphoid tissue: 46.7"	"Cell line enhanced"	"Detected in many"		"HEL: 37.1;HMC-1: 41.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"eosinophil: 38.1"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040923, HPA040944"	Enhanced		Approved	"Nucleoplasm,Plasma membrane,Mitochondria"			7100000	"Plasma membrane, Mitochondria"	Nucleoplasm	"HPA040923: AB_10794429, HPA040944: AB_10795485"	"unprognostic (1.61e-1)"	"unprognostic (9.08e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.53e-2)"	"unprognostic (2.57e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.17e-2)"	"unprognostic (4.80e-3)"	"unprognostic (1.87e-1)"	"unprognostic (1.33e-1)"	"unprognostic (5.83e-2)"	"unprognostic (3.06e-1)"	"prognostic unfavourable (2.39e-7)"	"unprognostic (5.21e-2)"	"unprognostic (3.55e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.93e-1)"	4.6	3.3	1.8	6.1	3.1	36.9	4.9	0.6	2.1	3.4	3.4	0.9	2.7	2.0	2.7	2.8	4.4	2.9	4.4	4.0	4.5	1.2	3.3	8.6	7.4	11.5	3.4	0.4	3.1	3.9	2.2	3.9	11.6	3.5	5.8	3.0	3.5	4.5	8.8	16.6	5.9	3.1	4.1	4.6	46.7	4.3	1.9	3.2	3.0	1.8	6.5	5.6	4.6	3.0	0.0	8.9	38.1	12.4	0.9	3.9	6.3	1.0	0.0	1.4	0.0	0.3	2.6	7.8	5.5	2.7	2.0	1.7	4.2	1.5	0.0	0.3	1.8	13.5	7.6	10.4	2.5	0.0	1.2	37.1	1.8	0.0	2.2	2.1	41.2	1.9	13.0	1.9	6.2	3.9	8.8	0.0	8.6	1.3	0.3	0.0	0.8	0.0	0.0	2.8	1.8	4.2	13.6	0.1	0.8	0.9	3.8	0.1	12.2	4.3	2.8	0.2	3.1	0.3	0.0	0.0	0.1	0.0	0.5	0.0	0.1	20.7	9.0	38.1	3.9	12.4	1.3	0.0	2.3	2.8	8.9	0.0	2.8	3.3	4.9	0.9	11.9	0.3	1.4	6.3	1.8	3.1	0.6	2.1	4.5	1.2	3.4	0.4	3.5	3.2
PTCHD4	"C6orf138, dJ402H5.2, FLJ41841, PTCH53"	ENSG00000244694	"Patched domain containing 4"	Q6ZW05	6	47878028-48068689	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 11.3"	"Cell line enhanced"	"Detected in some"		"AF22: 10.8;BEWO: 14.4;Hep G2: 24.0;LHCN-M2: 11.4;TIME: 12.1;WM-115: 10.5"	"Group enriched"	"Detected in some"	6	"melanoma: 1.1;renal cancer: 1.6;thyroid cancer: 4.0"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041276	Uncertain		Approved	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		"HPA041276: AB_10796570"	"unprognostic (1.35e-4)"	"unprognostic (1.66e-2)"	"unprognostic (3.25e-1)"	"unprognostic (3.11e-3)"	"unprognostic (1.07e-2)"	"unprognostic (1.57e-3)"	"unprognostic (7.94e-2)"	"unprognostic (3.59e-3)"	"unprognostic (2.80e-1)"	"unprognostic (1.50e-1)"	"unprognostic (2.55e-1)"	"unprognostic (1.92e-1)"	"prognostic favourable (1.49e-6)"	"unprognostic (5.03e-4)"	"unprognostic (9.84e-2)"	"unprognostic (1.57e-2)"	"unprognostic (5.56e-3)"	2.1	0.7	4.6	0.1	7.4	0.2	1.3	2.7	11.3	3.8	1.2	0.3	0.0	0.6	1.7	3.7	1.9	3.2	1.4	1.4	2.2	1.3	2.2	2.1	3.1	0.2	1.4	5.5	1.1	1.1	0.4	3.9	1.9	1.8	2.3	1.2	1.6	2.1	6.4	0.6	0.3	0.4	1.9	1.3	0.2	0.5	0.9	0.8	0.0	3.6	0.0	0.3	2.8	1.3	0.4	0.4	0.8	0.2	0.1	0.2	0.0	0.0	0.0	10.8	0.0	1.8	5.3	14.4	1.6	3.4	0.1	0.4	0.0	0.7	0.0	0.0	0.9	0.0	0.0	1.0	0.1	0.0	0.0	0.0	0.3	24.0	0.5	0.0	0.0	7.9	7.7	0.0	0.1	1.6	0.0	0.0	11.4	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.3	0.0	2.5	0.6	0.0	0.0	0.0	0.0	0.0	12.1	2.6	1.7	0.0	0.2	0.0	0.0	0.0	3.6	0.0	10.5	0.8	0.1	0.5	0.2	0.2	0.1	0.1	0.1	0.1	0.1	0.4	0.2	0.2	0.8	0.1	0.2	0.4	0.0	0.0	4.6	7.4	2.7	11.3	2.2	1.3	1.4	5.5	1.8	0.8
PTPN12	"PTP-PEST, PTPG1"	ENSG00000127947	"Protein tyrosine phosphatase, non-receptor type 12"	Q05209	7	77537275-77640071	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007097	Approved		Approved	"Plasma membrane,Cytosol"			1100000	"Plasma membrane, Cytosol"		"HPA007097: AB_1079689"	"unprognostic (2.28e-1)"	"prognostic unfavourable (1.15e-4)"	"unprognostic (1.35e-1)"	"unprognostic (3.35e-2)"	"unprognostic (1.40e-3)"	"unprognostic (4.48e-3)"	"prognostic unfavourable (8.78e-4)"	"unprognostic (1.29e-1)"	"unprognostic (5.83e-2)"	"unprognostic (2.64e-1)"	"prognostic unfavourable (2.01e-4)"	"unprognostic (1.09e-1)"	"prognostic unfavourable (7.27e-6)"	"unprognostic (4.99e-2)"	"unprognostic (2.97e-1)"	"unprognostic (1.81e-1)"	"unprognostic (3.21e-1)"	29.6	15.1	14.3	20.5	19.6	29.7	25.1	15.7	22.7	20.0	28.9	8.1	13.8	8.8	20.7	9.6	22.0	18.1	19.8	45.6	17.3	12.6	16.9	14.8	34.7	17.4	15.3	13.4	19.0	10.7	12.4	19.8	36.0	18.6	14.1	13.8	9.9	12.8	17.1	17.6	17.6	14.6	23.0	24.0	25.0	14.4	13.9	17.7	9.7	16.7	11.9	12.9	23.2	61.2	2.5	3.9	9.9	4.9	12.8	3.8	2.8	17.5	10.8	25.7	13.1	18.1	18.9	13.8	18.4	23.4	14.5	20.7	5.3	27.6	2.1	5.9	21.5	12.6	8.6	18.4	29.3	5.1	4.8	11.0	10.9	21.7	17.7	6.2	7.4	15.4	20.6	31.5	40.8	30.6	13.2	3.1	46.2	12.0	0.8	17.4	20.7	12.4	3.7	20.6	1.1	24.9	9.5	3.2	17.1	22.6	20.7	17.9	10.0	23.0	22.2	31.4	19.0	11.4	34.6	3.2	1.7	5.4	18.5	16.3	54.4	3.7	4.2	6.6	3.6	2.9	1.4	2.5	1.2	2.7	3.9	1.1	0.6	3.8	9.9	12.8	4.9	0.3	1.5	2.8	14.3	19.6	15.7	22.7	17.3	12.6	15.3	13.4	18.6	17.7
PTPN21	"PTPD1, PTPRL10"	ENSG00000070778	"Protein tyrosine phosphatase, non-receptor type 21"	Q16825	14	88465778-88554733	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"RH-30: 22.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"CAB011468, HPA073999"	Approved		Approved	"Nucleoplasm,Golgi apparatus,Plasma membrane,Centriolar satellite,Cytosol"				"Plasma membrane, Cytosol"	"Nucleoplasm, Golgi apparatus, Centriolar satellite"	"CAB011468: AB_442979, HPA073999: "	"unprognostic (2.18e-1)"	"unprognostic (4.21e-2)"	"unprognostic (7.60e-2)"	"unprognostic (3.09e-2)"	"unprognostic (4.60e-2)"	"unprognostic (5.71e-2)"	"unprognostic (6.55e-2)"	"unprognostic (5.19e-3)"	"unprognostic (6.62e-2)"	"unprognostic (1.02e-2)"	"unprognostic (8.71e-3)"	"unprognostic (3.04e-3)"	"prognostic favourable (3.16e-9)"	"unprognostic (6.52e-2)"	"unprognostic (2.69e-1)"	"unprognostic (2.56e-1)"	"unprognostic (7.67e-2)"	10.5	4.7	5.3	8.6	7.3	0.0	13.2	4.4	5.8	10.7	8.7	10.7	7.4	4.9	10.6	10.7	8.9	8.3	12.7	17.4	7.4	4.2	8.1	6.0	15.3	1.6	6.6	4.2	15.8	7.8	10.6	3.9	15.6	6.4	11.9	6.5	12.6	6.5	10.5	8.8	24.2	10.5	15.7	7.3	3.7	7.4	15.2	6.5	0.8	16.0	8.4	3.1	12.0	26.1	0.8	0.0	0.0	0.1	0.0	0.1	0.0	3.5	2.9	7.6	2.9	8.1	7.0	7.8	9.6	7.4	5.7	7.9	5.1	6.5	0.0	2.3	12.2	3.4	1.1	3.4	8.4	0.2	1.7	0.0	3.1	2.1	9.0	0.0	0.1	4.7	6.7	4.8	5.7	4.6	1.1	0.1	14.6	2.9	0.0	0.1	2.2	5.6	0.0	22.7	0.0	4.9	2.6	0.5	8.8	5.5	13.8	3.2	6.8	1.4	9.0	10.6	8.4	4.3	6.5	0.3	1.1	0.0	3.9	0.1	4.2	0.0	0.1	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	5.3	7.3	4.4	5.8	7.4	4.2	6.6	4.2	6.4	6.5
PTPN22	"Lyp, Lyp1, Lyp2, PTPN8"	ENSG00000134242	"Protein tyrosine phosphatase, non-receptor type 22"	Q9Y2R2	1	113813811-113871759	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Autophagy, Immunity"	"Hydrolase, Protein phosphatase"	"Diabetes mellitus, Disease mutation, Systemic lupus erythematosus"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 23.6;lymphoid tissue: 46.0"	"Cell line enhanced"	"Detected in some"		"Daudi: 32.9;HL-60: 13.0;U-266/70: 14.2;U-698: 17.6;U-937: 13.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Region enriched"	"Detected in single"	10	"cerebellum: 5.9"	"Not detected"	"Not detected"			"HPA004912, CAB012209, HPA013350"	Approved		Uncertain	"Nucleoplasm,Vesicles,Plasma membrane"				Nucleoplasm	"Vesicles, Plasma membrane"	"CAB012209: , HPA004912: AB_10602069, HPA013350: AB_10601570"	"unprognostic (2.25e-2)"	"unprognostic (5.31e-3)"	"unprognostic (3.48e-1)"	"unprognostic (3.33e-4)"	"unprognostic (9.14e-2)"	"unprognostic (2.47e-3)"	"unprognostic (9.60e-2)"	"unprognostic (8.14e-2)"	"unprognostic (3.71e-1)"	"unprognostic (1.82e-1)"	"unprognostic (1.62e-1)"	"unprognostic (3.02e-1)"	"unprognostic (2.75e-6)"	"unprognostic (3.19e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.61e-1)"	"unprognostic (3.22e-2)"	4.2	1.4	0.5	17.1	0.8	23.6	1.9	1.0	0.5	2.4	3.3	0.3	1.0	4.1	2.0	2.2	2.0	1.7	3.2	2.5	0.6	0.7	3.4	1.8	9.0	14.9	0.7	0.4	1.5	2.4	0.0	0.9	0.9	1.0	1.7	2.8	1.3	2.7	3.0	0.6	1.0	9.9	0.9	2.1	19.0	3.1	1.1	0.4	46.0	1.5	2.4	12.8	4.8	1.7	7.2	6.2	17.2	3.5	7.5	14.9	4.6	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.4	0.2	0.0	0.3	0.0	0.2	32.9	0.0	0.1	0.0	0.0	0.0	0.2	3.1	0.0	4.6	0.0	0.0	0.1	13.0	10.3	2.9	0.0	1.4	0.1	5.1	0.0	7.5	5.0	0.1	9.2	7.4	0.0	0.0	0.5	3.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	4.8	2.3	7.8	0.1	0.1	0.2	14.2	3.0	17.6	5.4	13.4	0.0	10.2	3.5	17.2	12.8	0.9	14.9	7.2	6.5	10.1	6.2	4.7	3.9	9.4	1.7	7.5	0.4	3.7	10.0	4.6	0.5	0.8	1.0	0.5	0.6	0.7	0.7	0.4	1.0	0.4
PTPN4	PTPMEG	ENSG00000088179	"Protein tyrosine phosphatase, non-receptor type 4"	P29074	2	119759631-119983818	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	16	"NK-cells: 12.2;T-cells: 19.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019351	Uncertain		Approved	"Nucleoplasm,Plasma membrane,Cytosol"				Nucleoplasm	"Plasma membrane, Cytosol"	"HPA019351: AB_1855928"	"unprognostic (1.45e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.07e-1)"	"unprognostic (7.63e-2)"	"unprognostic (9.00e-2)"	"unprognostic (9.57e-2)"	"unprognostic (2.34e-1)"	"prognostic favourable (5.16e-4)"	"unprognostic (3.31e-2)"	"unprognostic (3.34e-3)"	"unprognostic (3.13e-1)"	"unprognostic (1.10e-1)"	"unprognostic (3.34e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.87e-1)"	"unprognostic (4.08e-2)"	"unprognostic (1.81e-1)"	6.8	6.9	10.0	5.9	12.2	7.3	7.2	37.4	16.9	9.6	5.5	7.2	5.2	8.1	7.2	6.6	6.9	8.9	6.3	8.9	10.2	8.4	12.0	6.6	8.0	7.9	7.3	13.1	8.9	6.3	11.6	16.3	4.1	8.3	6.2	4.0	7.1	7.9	6.6	11.2	5.8	5.5	4.7	7.3	9.2	8.9	7.7	6.5	18.9	22.5	6.8	6.5	5.3	5.8	0.5	0.3	0.9	0.4	12.2	19.3	4.7	7.3	4.3	5.7	7.6	5.1	5.3	9.7	3.3	9.4	1.9	5.2	6.4	11.4	5.3	8.0	3.7	6.5	4.4	5.2	5.1	12.3	3.7	3.6	4.1	6.1	3.4	3.7	2.7	4.8	9.8	8.8	4.0	8.3	6.2	5.4	5.0	5.6	5.1	4.3	7.5	7.1	3.5	9.8	7.4	6.9	10.0	7.4	9.2	4.6	5.9	3.8	2.8	2.4	10.4	0.2	6.5	2.2	4.0	9.3	13.0	6.7	4.9	0.2	3.1	0.2	0.2	0.9	19.3	0.3	15.6	0.5	9.6	15.1	0.3	0.5	3.2	11.0	0.7	12.2	0.4	0.3	5.6	4.7	10.0	12.2	37.4	16.9	10.2	8.4	7.3	13.1	8.3	6.5
PTPRB	PTPB	ENSG00000127329	"Protein tyrosine phosphatase, receptor type B"	P23467	12	70515866-70637440	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	Angiogenesis	"Hydrolase, Protein phosphatase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"EFO-21: 11.1;HUVEC TERT2: 27.5;TIME: 40.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	7	"memory B-cell: 3.5"	"Lineage enriched"	"Detected in single"	7	"B-cells: 3.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004782, HPA067868"	Uncertain		Approved	"Vesicles,Plasma membrane,Cell Junctions"			6700000	"Plasma membrane"	"Vesicles, Cell Junctions"	"CAB004782: , HPA067868: "	"unprognostic (3.18e-1)"	"unprognostic (2.99e-6)"	"unprognostic (1.56e-1)"	"unprognostic (1.80e-1)"	"unprognostic (3.55e-2)"	"unprognostic (1.77e-2)"	"prognostic favourable (6.05e-4)"	"unprognostic (4.59e-1)"	"unprognostic (2.22e-2)"	"unprognostic (1.85e-1)"	"unprognostic (2.28e-2)"	"unprognostic (1.40e-1)"	"prognostic favourable (1.02e-4)"	"unprognostic (2.91e-2)"	"unprognostic (7.18e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.38e-1)"	23.5	7.0	4.5	5.5	7.0	0.1	22.9	3.6	6.1	11.3	8.0	4.3	7.1	5.3	17.1	8.5	5.8	8.2	11.4	17.6	6.2	5.1	18.7	12.0	39.9	3.3	6.9	4.6	5.5	4.4	4.9	5.7	23.3	7.8	6.1	8.2	16.0	3.6	7.1	11.8	4.7	7.4	13.3	7.3	22.9	5.2	3.7	4.3	0.7	14.0	12.2	2.6	6.5	14.7	3.5	0.1	0.2	0.0	0.4	0.3	0.2	1.9	0.1	0.8	0.1	0.0	0.0	0.4	0.4	1.9	1.0	2.4	0.0	1.5	0.7	11.1	0.3	6.8	0.1	0.3	3.5	0.5	0.3	0.1	0.7	0.4	0.1	0.3	0.0	0.0	0.3	2.7	0.0	27.5	1.5	0.4	0.6	0.0	0.0	0.0	1.0	0.4	0.0	0.7	0.3	5.1	0.7	0.0	0.4	0.7	0.0	1.6	0.0	0.6	40.2	0.4	0.4	0.1	2.3	0.5	0.3	0.3	0.2	0.4	0.0	0.2	0.0	0.0	0.2	0.0	0.0	3.5	0.0	0.3	0.0	0.3	0.1	0.0	0.1	0.4	0.0	0.1	0.0	0.2	4.5	7.0	3.6	6.1	6.2	5.1	6.9	4.6	7.8	4.3
PTPRG	"PTPG, RPTPG"	ENSG00000144724	"Protein tyrosine phosphatase, receptor type G"	P23470	3	61561569-62297613	"Enzymes, Plasma proteins, Predicted membrane proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 35.5;HSkMC: 26.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"memory B-cell: 1.3"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000546, HPA064237"	Uncertain		Approved	"Plasma membrane"			520000000	"Plasma membrane"		"HPA000546: , HPA064237: "	"unprognostic (1.47e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.31e-2)"	"unprognostic (1.93e-1)"	"unprognostic (8.73e-2)"	"unprognostic (3.26e-1)"	"unprognostic (5.38e-2)"	"unprognostic (1.18e-2)"	"unprognostic (5.84e-2)"	"unprognostic (2.28e-1)"	"unprognostic (2.86e-1)"	"unprognostic (1.14e-1)"	"prognostic favourable (3.10e-6)"	"unprognostic (9.91e-2)"	"unprognostic (3.25e-1)"	"unprognostic (1.19e-1)"	"unprognostic (2.63e-2)"	22.2	18.0	12.9	10.1	10.7	1.2	26.1	8.1	16.4	17.2	13.9	5.2	12.0	5.6	15.8	19.0	6.4	13.1	15.7	12.4	24.5	9.9	20.2	8.2	38.9	10.2	8.3	10.5	16.6	6.0	58.6	11.9	13.1	15.1	11.3	8.9	23.3	7.9	17.2	19.2	6.6	8.4	17.4	12.7	9.2	8.7	11.4	5.0	0.1	21.7	7.0	3.2	10.0	14.6	1.3	0.9	0.0	0.0	0.0	0.0	0.0	0.0	2.1	11.4	0.0	35.5	18.1	5.5	7.0	11.6	7.5	10.2	5.3	0.2	0.2	4.1	8.3	0.1	5.5	5.5	12.0	0.6	3.1	0.5	0.0	6.1	11.9	2.9	0.0	26.3	2.2	10.7	13.0	8.1	0.0	7.0	6.8	3.0	0.0	0.0	7.0	0.0	4.6	3.5	0.2	7.8	3.3	0.8	1.8	1.7	0.0	2.7	0.0	0.1	18.5	10.6	10.1	16.9	5.9	2.2	2.6	0.0	8.1	1.3	12.7	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	12.9	10.7	8.1	16.4	24.5	9.9	8.3	10.5	15.1	5.0
PTPRM	"hR-PTPu, PTPRL1, RPTPU"	ENSG00000173482	"Protein tyrosine phosphatase, receptor type M"	P28827	18	7566782-8406861	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"	"Hydrolase, Protein phosphatase, Receptor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC diff: 34.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"memory CD8 T-cell: 7.2"	"Group enriched"	"Detected in many"	50	"dendritic cells: 2.7;T-cells: 7.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003891, CAB022442, CAB022443"	Supported		Approved	"Plasma membrane"			76000000	"Plasma membrane"		"CAB022442: , CAB022443: , HPA003891: "	"unprognostic (2.59e-1)"	"prognostic unfavourable (8.65e-5)"	"unprognostic (4.89e-2)"	"unprognostic (1.00e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.80e-1)"	"unprognostic (3.41e-2)"	"unprognostic (7.62e-2)"	"unprognostic (2.74e-2)"	"unprognostic (1.56e-2)"	"unprognostic (9.64e-2)"	"unprognostic (5.63e-2)"	"unprognostic (3.11e-3)"	"unprognostic (9.41e-2)"	"unprognostic (2.63e-2)"	"prognostic favourable (1.07e-4)"	31.4	14.1	9.5	6.3	22.2	0.6	23.6	10.4	17.2	11.0	13.6	6.2	28.1	4.7	15.4	10.9	8.1	13.6	18.1	33.5	10.5	15.0	16.9	6.5	22.0	7.8	8.5	12.0	15.7	7.6	16.3	21.9	18.3	23.2	10.6	6.6	18.3	7.4	21.8	26.0	7.3	8.7	14.1	9.3	12.1	11.0	12.2	9.1	2.9	31.1	7.3	6.3	18.6	25.3	0.0	2.7	0.0	0.0	0.0	7.2	1.4	1.5	11.3	5.4	0.0	34.8	24.1	13.1	13.8	12.2	9.3	13.8	10.3	2.4	0.0	13.6	16.6	0.1	0.0	4.8	12.9	0.1	2.5	0.0	7.5	5.0	9.9	0.0	0.1	27.4	10.2	5.1	14.7	9.3	0.0	4.7	7.4	0.2	4.5	0.1	0.9	2.5	0.1	4.7	20.9	22.8	19.4	0.4	3.0	0.4	0.0	11.6	0.0	0.0	9.6	19.2	12.1	9.1	2.4	0.4	0.1	0.0	16.4	0.0	3.5	0.0	0.0	0.0	4.5	0.0	1.8	0.0	6.0	7.2	0.1	0.0	1.7	3.1	0.0	0.0	0.0	2.7	1.0	1.4	9.5	22.2	10.4	17.2	10.5	15.0	8.5	12.0	23.2	9.1
PTX3	"TNFAIP5, TSG-14"	ENSG00000163661	"Pentraxin 3"	P26022	3	157436789-157443628	"Plasma proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 61.7;skeletal muscle: 67.7;urinary bladder: 77.0"	"Cell line enhanced"	"Detected in many"		"ASC diff: 84.6;ASC TERT1: 122.6;BJ hTERT+: 80.5;HHSteC: 157.4;HSkMC: 163.9;hTEC/SVTERT24-B: 86.6;TIME: 116.7;U-2197: 108.8"	"Cancer enhanced"	"Detected in many"		"glioma: 22.5"	"Group enriched"	"Detected in some"	6	"hippocampal formation: 1.1;pons and medulla: 3.6"	"Cell type enhanced"	"Detected in some"		"eosinophil: 3.2"	"Group enriched"	"Detected in many"	20	"dendritic cells: 1.3;granulocytes: 3.2;monocytes: 1.2"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			HPA069320	Approved		Approved	"Plasma membrane"	"Secreted to blood"	1090000	310000	"Plasma membrane"		"HPA069320: "	"unprognostic (1.93e-2)"	"unprognostic (4.96e-3)"	"unprognostic (1.35e-1)"	"prognostic unfavourable (8.35e-9)"	"unprognostic (5.79e-3)"	"prognostic unfavourable (6.36e-4)"	"unprognostic (6.03e-3)"	"prognostic unfavourable (8.75e-6)"	"unprognostic (2.45e-1)"	"unprognostic (6.69e-2)"	"unprognostic (7.60e-2)"	"unprognostic (2.63e-1)"	"unprognostic (2.76e-9)"	"unprognostic (6.03e-3)"	"unprognostic (5.98e-2)"	"unprognostic (2.15e-4)"	"unprognostic (1.92e-3)"	61.7	3.4	0.3	16.7	0.2	31.6	35.3	0.2	0.7	0.8	13.2	0.3	0.6	0.5	0.5	0.8	2.0	6.5	3.5	14.7	1.1	0.0	3.0	0.6	22.5	7.0	0.3	0.1	6.8	18.0	0.3	1.0	4.9	3.6	2.5	1.2	5.2	1.8	0.4	67.7	6.0	1.9	6.4	0.9	9.6	4.9	0.9	0.2	0.3	2.7	0.4	0.4	77.0	2.5	0.0	1.3	3.2	1.2	0.0	0.0	0.1	0.0	0.0	51.0	0.0	84.6	122.6	0.0	8.8	80.5	3.8	4.1	0.0	0.5	0.0	31.4	10.3	0.0	0.0	0.0	7.5	0.0	0.0	0.1	0.0	0.0	157.4	0.1	0.0	163.9	0.0	86.6	29.5	17.8	0.0	0.0	25.4	0.0	0.0	0.1	0.7	0.3	0.0	0.0	0.0	0.3	3.5	0.4	0.0	0.5	0.0	0.0	0.0	0.1	116.7	17.3	0.8	108.8	1.5	0.0	0.0	0.0	3.6	0.4	4.9	0.0	1.2	3.2	0.0	1.2	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.1	0.3	0.2	0.2	0.2	1.1	0.0	0.3	0.1	3.6	0.2
PURG	"PURG-A, PURG-B"	ENSG00000172733	"Purine rich element binding protein G"	Q9UJV8	8	30995802-31033715	"Predicted intracellular proteins, Transcription factors"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 14.7"	"Cell line enhanced"	"Detected in some"		"AF22: 8.8;HEK 293: 4.4;HUVEC TERT2: 4.3;NTERA-2: 6.9;SH-SY5Y: 8.3"	"Cancer enhanced"	"Detected in some"		"glioma: 1.9"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047746	Enhanced		Approved	"Nucleoplasm,Nucleoli,Plasma membrane"				"Nucleoplasm, Plasma membrane"	Nucleoli	"HPA047746: "	"unprognostic (3.37e-1)"	"unprognostic (2.15e-1)"	"unprognostic (6.69e-2)"	"unprognostic (7.33e-3)"	"unprognostic (3.65e-2)"	"unprognostic (1.78e-1)"	"unprognostic (3.51e-3)"	"unprognostic (1.10e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.62e-1)"	"unprognostic (4.79e-2)"	"unprognostic (8.72e-2)"	"unprognostic (1.46e-3)"	"unprognostic (1.03e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.83e-2)"	"unprognostic (5.30e-2)"	1.3	1.9	11.0	1.2	10.3	0.6	0.9	14.7	13.5	2.4	1.0	2.4	0.5	1.0	5.6	2.6	1.5	1.6	3.0	1.6	9.4	6.2	1.7	0.7	1.4	1.3	4.9	7.3	1.6	0.7	0.6	3.9	1.5	6.2	1.9	1.1	1.7	1.6	2.6	1.0	0.9	1.0	5.0	4.5	2.5	1.3	8.1	6.4	0.0	0.8	0.0	1.0	1.3	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.8	0.2	0.1	0.0	0.0	0.2	0.4	0.7	1.8	0.0	0.0	0.2	0.0	0.0	0.0	2.9	0.0	1.1	0.0	4.4	1.6	0.0	0.2	0.0	0.0	0.2	1.3	0.0	1.3	0.0	4.3	0.4	0.5	0.2	0.0	0.9	0.0	6.9	0.3	2.2	1.2	0.0	0.0	0.0	1.2	8.3	0.0	0.0	0.0	0.0	0.0	2.7	3.0	3.7	0.0	0.4	0.3	0.0	0.2	2.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.0	10.3	14.7	8.9	9.4	6.2	4.9	7.3	6.2	6.4
PXDC1	C6orf145	ENSG00000168994	"PX domain containing 1"	Q5TGL8	6	3722614-3752026	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 79.6"	"Cell line enhanced"	"Detected in many"		"HHSteC: 42.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	4	"memory B-cell: 4.2"	"Lineage enriched"	"Detected in single"	4	"B-cells: 4.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA019246			Approved	"Plasma membrane"				"Plasma membrane"		"HPA019246: "	"unprognostic (1.55e-1)"	"unprognostic (1.87e-2)"	"prognostic unfavourable (3.64e-4)"	"prognostic unfavourable (1.14e-4)"	"unprognostic (2.82e-2)"	"unprognostic (3.80e-2)"	"unprognostic (2.95e-1)"	"unprognostic (1.48e-1)"	"unprognostic (6.73e-2)"	"unprognostic (6.08e-2)"	"unprognostic (2.32e-1)"	"unprognostic (2.13e-1)"	"unprognostic (2.01e-2)"	"unprognostic (6.17e-3)"	"unprognostic (1.10e-1)"	"unprognostic (2.97e-1)"	"unprognostic (2.84e-1)"	26.3	5.5	5.9	5.9	6.5	0.4	30.6	3.2	6.6	11.1	10.3	6.4	5.3	10.7	10.1	14.4	13.9	8.3	18.5	10.8	6.5	4.4	13.4	79.6	14.2	5.8	7.5	3.1	6.2	10.0	3.4	4.3	32.9	6.2	9.1	3.1	7.5	12.3	8.1	11.9	11.7	16.9	20.6	7.0	6.1	8.9	3.9	6.9	1.0	16.8	11.5	5.8	14.9	21.0	4.2	0.3	0.5	0.0	0.0	0.9	0.3	11.5	4.9	8.1	5.4	25.6	19.3	26.0	21.0	16.2	18.0	13.9	8.1	2.3	0.0	13.7	34.4	8.7	1.6	5.8	8.6	11.7	1.6	0.0	3.5	7.2	42.8	0.0	0.0	17.5	19.0	11.1	24.0	19.6	0.0	1.5	14.0	0.7	0.0	0.1	0.3	5.9	0.6	4.3	0.4	6.8	9.7	0.9	0.4	14.0	14.4	28.3	1.1	0.7	20.5	15.3	6.5	5.9	14.3	0.0	0.0	0.0	3.4	0.0	9.9	0.0	0.0	0.0	0.0	0.0	0.3	4.2	0.1	0.0	0.3	0.2	0.0	0.0	0.5	0.0	0.0	0.0	0.9	0.3	5.9	6.5	3.2	6.6	6.5	4.4	7.5	3.1	6.2	6.9
RAB27B		ENSG00000041353	"RAB27B, member RAS oncogene family"	O00194	18	54717860-54895516	"Plasma proteins, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 30.0;stomach 1: 36.6"	"Cell line enhanced"	"Detected in many"		"HEL: 20.5;hTCEpi: 15.6;hTERT-HME1: 19.0;U-87 MG: 55.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"gdT-cell: 4.6;NK-cell: 5.0"	"Group enriched"	"Detected in many"	4	"NK-cells: 5.0;T-cells: 4.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB017712, HPA019849"	Enhanced		Approved	"Golgi apparatus,Plasma membrane,Cytosol"			37000000	"Golgi apparatus, Plasma membrane"	Cytosol	"CAB017712: , HPA019849: AB_1856000"	"unprognostic (1.59e-1)"	"unprognostic (5.20e-2)"	"unprognostic (9.89e-3)"	"unprognostic (7.51e-2)"	"unprognostic (8.89e-2)"	"unprognostic (1.84e-2)"	"unprognostic (1.52e-1)"	"unprognostic (2.73e-3)"	"unprognostic (6.82e-2)"	"unprognostic (8.12e-2)"	"prognostic unfavourable (2.13e-4)"	"unprognostic (1.39e-2)"	"unprognostic (1.20e-3)"	"unprognostic (1.42e-1)"	"unprognostic (1.84e-2)"	"unprognostic (5.75e-1)"	"unprognostic (1.29e-1)"	1.1	2.4	13.8	2.3	11.3	1.0	10.8	0.8	30.0	4.5	4.4	0.3	0.0	4.5	1.1	0.7	17.0	1.3	9.8	0.9	12.0	7.9	0.8	1.4	6.2	0.7	4.6	18.4	0.7	5.3	1.3	3.6	2.4	8.6	18.0	4.8	0.0	12.8	3.3	0.6	13.2	4.3	1.1	2.1	1.8	36.6	4.8	0.4	0.1	0.7	13.9	5.9	6.8	7.1	0.0	0.0	1.1	0.0	5.0	4.6	3.4	2.5	7.3	0.2	0.0	0.5	6.7	0.0	0.5	4.4	0.6	0.4	0.0	2.8	0.4	0.0	1.2	4.8	0.0	2.9	0.1	0.0	0.1	20.5	1.7	0.0	0.8	1.1	2.2	5.3	15.6	8.6	19.0	0.2	0.0	1.3	5.4	2.5	0.0	2.4	0.1	4.9	0.0	0.0	0.1	1.3	9.4	0.0	3.5	0.7	4.4	0.0	2.7	0.1	0.1	6.4	0.2	3.3	0.6	0.1	0.0	0.0	55.6	11.6	0.3	1.1	0.0	0.2	4.6	0.0	1.1	0.0	1.5	2.3	0.0	0.0	0.6	2.3	0.5	5.0	0.0	0.0	0.0	3.4	13.8	11.3	0.8	30.0	12.0	7.9	4.6	18.4	8.6	0.4
RAB3GAP2	"DKFZP434D245, KIAA0839, RAB3-GAP150, SPG69"	ENSG00000118873	"RAB3 GTPase activating non-catalytic protein subunit 2"	Q9H2M9	1	220148293-220272454	"Disease related genes, Predicted intracellular proteins"		"GTPase activation"	"Cataract, Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026273, HPA027299"	Approved		Supported	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		"HPA026273: AB_1856007, HPA027299: AB_1856008"	"prognostic unfavourable (3.05e-4)"	"unprognostic (2.80e-3)"	"unprognostic (1.76e-2)"	"unprognostic (6.07e-2)"	"unprognostic (5.20e-2)"	"unprognostic (1.69e-1)"	"unprognostic (2.40e-2)"	"unprognostic (7.00e-2)"	"unprognostic (4.61e-2)"	"unprognostic (1.75e-1)"	"unprognostic (4.63e-2)"	"unprognostic (2.13e-1)"	"unprognostic (7.75e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.17e-1)"	"unprognostic (3.99e-2)"	"unprognostic (1.56e-1)"	16.7	16.2	14.9	19.6	18.7	14.3	17.8	24.2	22.4	15.6	13.5	14.3	13.9	12.2	16.8	14.9	15.6	12.8	12.8	15.3	16.5	18.8	18.9	15.6	14.3	18.2	17.1	15.6	16.2	14.5	35.6	28.3	19.8	21.9	14.2	13.5	11.6	15.6	15.8	19.9	13.1	15.0	14.9	15.2	14.9	14.5	10.1	15.5	26.1	20.5	11.9	21.7	16.0	15.8	7.1	5.2	12.3	5.1	3.6	8.9	4.6	13.8	10.6	12.8	9.6	14.8	17.6	14.6	14.3	13.6	13.0	15.3	9.7	11.6	17.3	10.1	13.8	13.3	13.3	10.9	15.1	14.4	8.7	13.5	14.1	9.0	19.5	19.2	13.9	13.9	12.5	12.6	19.6	11.8	23.2	11.2	14.6	3.9	14.7	6.8	27.6	6.3	8.1	17.7	15.4	11.0	11.5	12.8	15.5	14.8	14.5	23.2	15.1	18.4	17.1	14.2	6.6	9.7	15.2	10.0	12.1	15.2	12.2	16.3	16.6	12.3	3.9	7.5	7.1	4.9	8.6	7.1	7.0	8.9	5.2	5.5	6.3	7.4	2.5	3.6	5.1	3.3	8.0	4.6	14.9	18.7	24.2	22.4	16.5	18.8	17.1	15.6	21.9	15.5
RAB43	"ISY1, RAB11B, RAB41"	ENSG00000172780	"RAB43, member RAS oncogene family"	Q86YS6	3	129087569-129122801	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"liver: 73.9"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 13.3"	"Group enriched"	"Detected in all"	5	"granulocytes: 13.3;T-cells: 3.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046840, HPA060085"	Enhanced		Supported	"Plasma membrane"				"Plasma membrane"		"HPA046840: , HPA060085: "	"unprognostic (3.01e-1)"	"unprognostic (1.14e-2)"	"unprognostic (3.08e-1)"	"unprognostic (1.01e-1)"	"unprognostic (5.08e-2)"	"unprognostic (1.91e-1)"	"unprognostic (9.36e-2)"	"unprognostic (3.17e-2)"	"unprognostic (4.16e-1)"	"unprognostic (8.68e-2)"	"unprognostic (3.14e-1)"	"unprognostic (3.08e-1)"	"unprognostic (2.46e-2)"	"unprognostic (9.32e-2)"	"unprognostic (5.82e-3)"	"unprognostic (1.42e-1)"	"unprognostic (2.71e-2)"	5.4	6.2	3.9	8.0	3.3	14.6	5.3	6.0	3.6	6.4	7.0	3.2	7.2	5.8	5.4	6.8	4.1	5.3	12.0	3.8	2.8	2.0	9.1	73.9	11.4	12.1	2.7	1.6	7.8	7.4	2.5	8.0	4.7	3.7	7.3	1.7	7.7	7.4	4.7	1.9	3.0	5.9	4.9	2.7	9.9	5.7	5.2	2.1	17.3	17.1	2.6	13.6	6.6	6.0	1.3	1.1	13.3	1.6	1.5	3.5	1.3	15.4	4.3	1.0	4.1	1.9	0.9	6.1	5.4	3.5	3.0	2.6	6.6	6.7	0.4	12.4	3.9	6.5	0.4	6.1	0.7	7.8	4.1	1.0	0.7	8.6	19.1	3.5	9.2	5.2	3.8	1.5	0.4	6.1	1.7	7.8	4.3	6.6	3.4	6.8	4.9	7.0	7.4	2.3	4.4	9.9	13.2	0.3	1.9	2.3	5.0	9.9	2.1	3.7	8.8	6.8	4.8	5.5	2.0	12.2	6.4	2.4	6.2	0.7	7.3	0.5	1.5	2.6	1.9	1.6	0.9	0.6	1.8	1.5	0.7	1.3	3.5	3.0	13.3	1.5	0.7	1.1	2.7	1.3	3.9	3.3	6.0	3.6	2.8	2.0	2.7	1.6	3.7	2.1
RAD52		ENSG00000002016	"RAD52 homolog, DNA repair protein"	P43351	12	912077-990053	"Cancer-related genes, Predicted intracellular proteins"	"DNA damage, DNA recombination, DNA repair"	DNA-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA028957			Approved	"Nuclear speckles,Plasma membrane"				"Nuclear speckles"	"Plasma membrane"	"HPA028957: "	"unprognostic (4.53e-1)"	"unprognostic (8.08e-3)"	"unprognostic (4.68e-2)"	"unprognostic (5.27e-2)"	"unprognostic (7.37e-2)"	"unprognostic (1.42e-2)"	"unprognostic (1.82e-3)"	"unprognostic (1.88e-1)"	"unprognostic (2.80e-2)"	"unprognostic (8.43e-2)"	"unprognostic (1.03e-2)"	"unprognostic (3.27e-1)"	"prognostic unfavourable (2.22e-6)"	"unprognostic (1.54e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.68e-1)"	"unprognostic (3.74e-2)"	7.4	8.5	12.4	8.1	15.1	5.0	10.0	18.8	15.9	12.6	11.7	14.5	13.6	9.4	12.5	14.2	8.2	11.0	9.0	7.8	14.3	7.3	9.9	10.5	6.9	8.9	15.0	9.6	17.6	11.4	9.6	15.6	8.5	15.0	10.5	11.7	9.5	8.4	11.0	16.5	14.9	10.4	12.8	17.0	10.3	8.8	6.8	20.9	9.4	14.6	4.3	9.7	9.7	13.3	7.0	9.6	7.4	3.8	4.0	6.0	1.4	3.1	12.2	9.6	10.7	10.5	7.9	10.3	6.4	5.9	7.0	7.0	11.7	11.2	10.0	2.0	6.3	9.4	7.3	4.3	6.3	13.5	6.5	11.2	11.8	8.1	5.9	12.0	3.4	4.6	7.5	7.4	22.8	5.9	7.4	5.8	6.8	6.7	8.1	11.9	12.4	8.0	8.3	9.4	3.7	7.3	5.8	3.4	3.9	8.2	8.9	4.5	8.2	5.9	5.8	9.9	11.9	7.7	6.6	2.2	3.5	10.5	5.1	5.1	3.6	7.4	3.4	2.0	4.6	2.9	6.0	4.8	4.9	4.0	4.4	7.0	5.7	5.2	2.8	4.0	3.8	9.6	4.4	1.4	12.4	15.1	18.8	15.9	14.3	7.3	15.0	9.6	15.0	20.9
RAI2		ENSG00000131831	"Retinoic acid induced 2"	Q9Y5P3	X	17800049-17861337	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enriched"	"Detected in some"	10	"ASC diff: 48.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"naive CD4 T-cell: 1.5;naive CD8 T-cell: 5.1"	"Lineage enriched"	"Detected in single"	11	"T-cells: 5.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051054	Uncertain		Approved	"Plasma membrane"				"Plasma membrane"		"HPA051054: "	"unprognostic (3.45e-2)"	"unprognostic (9.61e-2)"	"unprognostic (2.41e-1)"	"unprognostic (2.03e-2)"	"unprognostic (1.98e-1)"	"unprognostic (2.49e-2)"	"unprognostic (4.10e-2)"	"unprognostic (2.51e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.49e-1)"	"prognostic favourable (2.77e-4)"	"unprognostic (1.31e-2)"	"prognostic favourable (3.39e-14)"	"unprognostic (1.57e-2)"	"unprognostic (2.33e-1)"	"unprognostic (1.82e-2)"	"unprognostic (2.80e-2)"	23.6	9.7	2.5	10.1	4.0	0.0	28.5	4.0	4.9	41.0	13.7	1.7	15.0	3.5	29.6	17.8	12.2	27.9	21.2	16.1	2.4	2.7	9.4	1.9	14.5	12.9	2.4	1.8	32.7	7.7	4.6	11.1	7.1	2.9	28.3	4.5	10.7	6.6	18.7	7.2	8.3	8.8	20.4	2.7	2.4	12.0	16.2	2.1	2.0	15.1	6.3	5.9	24.2	53.6	0.0	0.0	0.0	0.0	0.4	5.1	0.4	0.0	0.0	0.1	0.0	48.4	4.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	3.9	0.1	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.0	0.8	0.2	0.0	0.0	0.0	2.6	0.0	0.5	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	1.5	5.1	0.0	0.4	0.0	0.0	0.0	0.4	2.5	4.0	4.0	4.9	2.4	2.7	2.4	1.8	2.9	2.1
RALGAPA2	"AS250, C20orf74, dJ1049G11.4, KIAA1272, RapGAPalpha2"	ENSG00000188559	"Ral GTPase activating protein catalytic alpha subunit 2"	Q2PPJ7	20	20389552-20712488	"Predicted intracellular proteins, Predicted membrane proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"RT4: 46.9;SCLC-21H: 26.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042707, HPA043622"	Uncertain		Supported	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		"HPA042707: , HPA043622: "	"unprognostic (7.40e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.69e-2)"	"unprognostic (1.09e-2)"	"unprognostic (2.36e-1)"	"unprognostic (3.34e-2)"	"unprognostic (3.36e-1)"	"unprognostic (3.29e-2)"	"unprognostic (1.95e-1)"	"unprognostic (3.56e-2)"	"unprognostic (1.74e-1)"	"unprognostic (8.23e-2)"	"prognostic favourable (3.77e-5)"	"unprognostic (6.52e-2)"	"unprognostic (1.54e-1)"	"unprognostic (3.48e-1)"	"unprognostic (5.33e-2)"	26.5	7.0	7.3	9.9	8.1	19.4	16.9	11.4	8.7	10.6	12.7	9.6	14.9	10.5	15.2	9.6	8.9	10.7	13.0	7.8	8.3	4.2	11.0	26.4	26.5	13.0	10.8	4.4	8.0	18.5	14.1	20.9	18.5	7.4	13.2	13.5	8.2	22.6	12.8	26.0	15.3	10.0	9.6	8.4	8.2	18.1	8.6	9.3	8.2	23.2	6.0	10.2	13.9	15.7	1.7	2.0	7.0	2.1	2.6	2.4	0.6	3.4	2.2	4.6	2.4	2.3	1.8	5.2	0.9	0.9	1.1	1.5	1.8	4.8	1.5	3.1	1.4	3.6	4.8	4.0	2.2	7.0	2.3	5.3	1.1	3.3	0.9	6.8	3.2	1.6	3.0	1.8	0.8	6.6	1.1	3.0	1.8	2.3	2.5	9.0	1.9	2.1	3.8	3.1	2.1	4.1	46.9	26.2	2.3	3.5	2.6	3.0	1.8	6.5	1.7	1.8	1.8	1.4	1.2	1.7	1.2	0.7	1.6	4.5	2.6	5.9	2.1	6.0	1.7	0.7	2.4	1.4	1.1	1.6	1.0	1.7	2.1	1.5	7.0	2.6	1.6	2.0	1.4	0.6	7.3	8.1	11.4	8.7	8.3	4.2	10.8	4.4	7.4	9.3
RAPSN	"CMS1D, CMS1E, RNF205"	ENSG00000165917	"Receptor associated protein of the synapse"	Q13702	11	47437757-47449178	"Disease related genes, Predicted intracellular proteins"			"Congenital myasthenic syndrome, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	11	"skeletal muscle: 45.3;tongue: 14.8"	"Cell line enriched"	"Detected in some"	4	"RH-30: 71.2"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"neutrophil: 2.6"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in single"							HPA039475	Approved		Approved	"Plasma membrane,Centrosome,Cytosol"				"Plasma membrane, Centrosome, Cytosol"		"HPA039475: AB_10794196"	"unprognostic (5.37e-2)"	"unprognostic (1.02e-1)"	"unprognostic (7.34e-2)"	"unprognostic (4.58e-2)"	"unprognostic (2.95e-2)"	"unprognostic (1.44e-1)"	"unprognostic (2.62e-2)"	"unprognostic (1.77e-3)"	"unprognostic (1.35e-1)"	"unprognostic (5.38e-2)"	"unprognostic (4.81e-2)"	"unprognostic (2.89e-2)"	"unprognostic (1.08e-2)"	"unprognostic (1.64e-4)"	"unprognostic (3.83e-1)"	"unprognostic (4.73e-3)"	"unprognostic (4.48e-2)"	1.7	0.8	0.2	0.1	0.2	0.2	0.1	0.0	0.2	0.0	0.4	0.0	0.0	0.1	0.0	2.7	0.7	0.1	0.1	1.4	0.4	0.0	0.1	0.2	0.2	0.1	0.7	0.0	0.0	0.1	0.0	0.0	1.2	0.3	0.4	0.0	0.3	0.8	0.0	45.3	0.2	0.2	0.1	0.2	0.3	0.1	0.2	0.1	0.1	0.4	14.8	0.4	0.0	0.0	0.2	0.1	2.6	0.5	0.0	0.7	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.3	1.4	0.1	0.0	0.0	0.0	0.0	0.0	17.1	0.0	0.0	0.0	0.0	0.0	0.0	71.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.2	0.6	0.0	0.2	0.0	0.1	0.1	0.0	0.2	0.7	0.0	2.6	0.0	0.1	0.1	0.0	0.0	0.2	0.2	0.0	0.2	0.4	0.0	0.7	0.0	0.3	0.1
RASAL1	RASAL	ENSG00000111344	"RAS protein activator like 1"	O95294	12	113098819-113136239	"Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins"	Differentiation	"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"parathyroid gland: 64.0"	"Cell line enhanced"	"Detected in some"		"Daudi: 8.3;EFO-21: 10.9;REH: 12.0;RPMI-8226: 26.8;RPTEC TERT1: 10.7;U-698: 22.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"amygdala: 21.7;cerebral cortex: 20.9;hippocampal formation: 33.7"	HPA041650	Approved		Approved	"Plasma membrane,Cell Junctions,Cytosol"				"Plasma membrane, Cytosol"	"Cell Junctions"	"HPA041650: "	"unprognostic (9.95e-2)"	"unprognostic (1.11e-2)"	"unprognostic (5.44e-3)"	"prognostic unfavourable (3.26e-5)"	"unprognostic (1.27e-2)"	"unprognostic (7.73e-3)"	"unprognostic (1.57e-2)"	"unprognostic (1.43e-2)"	"unprognostic (2.65e-1)"	"unprognostic (3.02e-3)"	"unprognostic (3.16e-2)"	"unprognostic (2.53e-1)"	"unprognostic (1.74e-2)"	"unprognostic (2.85e-3)"	"unprognostic (1.15e-1)"	"unprognostic (3.34e-2)"	"unprognostic (2.64e-1)"	0.9	10.4	8.6	2.5	11.2	1.2	1.6	0.4	18.2	2.5	2.1	18.8	3.7	1.2	0.9	0.9	16.9	2.2	1.8	0.8	11.8	4.9	7.4	0.9	0.9	1.7	7.3	10.9	0.8	1.4	64.0	3.9	1.0	4.0	0.9	1.7	0.0	22.4	7.4	0.8	8.0	1.1	0.9	1.8	1.0	9.6	1.1	8.4	0.0	8.0	6.0	5.0	1.0	3.7	0.4	0.2	1.3	0.2	0.3	1.6	0.3	0.4	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	2.1	8.3	10.9	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	2.3	0.0	0.0	0.3	0.0	12.0	0.0	26.8	10.7	0.0	0.3	0.0	0.0	4.0	0.0	1.6	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	22.8	0.0	0.0	0.0	1.3	0.2	0.1	0.1	0.0	1.6	0.2	0.9	0.4	0.0	0.4	1.2	0.5	0.4	0.3	0.0	0.2	0.4	0.3	8.6	11.2	0.4	18.2	11.8	4.9	7.3	10.9	4.0	8.4
RASAL2	nGAP	ENSG00000075391	"RAS protein activator like 2"	Q9UJF2	1	178094141-178484147	"Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"hTERT-HME1: 29.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"naive B-cell: 2.1"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018805, HPA020453"	Enhanced		Approved	"Plasma membrane,Focal adhesion sites"				"Plasma membrane, Focal adhesion sites"		"HPA018805: AB_1856085, HPA020453: AB_1856086"	"unprognostic (5.55e-3)"	"unprognostic (6.49e-2)"	"unprognostic (2.65e-1)"	"unprognostic (6.33e-2)"	"unprognostic (3.40e-2)"	"unprognostic (5.59e-2)"	"unprognostic (5.91e-2)"	"unprognostic (1.72e-2)"	"unprognostic (2.91e-1)"	"unprognostic (2.92e-2)"	"unprognostic (3.16e-3)"	"unprognostic (2.03e-1)"	"unprognostic (1.06e-2)"	"unprognostic (4.98e-2)"	"unprognostic (2.45e-1)"	"unprognostic (8.36e-2)"	"prognostic unfavourable (2.05e-4)"	13.5	3.8	4.2	2.8	5.1	0.4	7.1	2.7	8.5	9.5	4.2	3.7	4.2	2.4	10.9	5.5	24.4	5.8	9.0	15.5	3.8	5.9	7.1	2.7	9.2	1.5	4.0	6.5	6.3	5.0	6.1	6.7	21.2	5.6	5.0	4.3	10.7	9.6	4.5	8.3	7.5	3.3	7.1	3.8	2.9	3.7	9.0	2.7	0.0	5.0	13.1	4.8	5.6	13.2	2.1	0.5	1.4	0.6	0.3	0.1	0.0	16.1	5.3	7.0	2.3	4.7	6.4	9.7	8.1	7.9	6.9	5.2	8.5	8.6	0.0	13.5	7.9	13.6	5.6	12.9	6.4	0.0	3.1	0.0	5.6	3.3	5.6	2.3	0.3	20.1	2.5	8.2	29.6	6.2	0.5	0.0	9.5	1.6	0.0	1.9	5.2	1.0	0.1	2.8	0.0	3.7	2.1	5.4	2.6	6.3	4.9	4.9	5.7	2.6	11.7	9.2	9.3	9.5	10.8	3.5	0.0	0.0	7.2	1.2	6.5	1.4	0.4	0.1	0.1	0.3	0.0	0.6	0.0	0.0	0.2	2.1	0.1	0.1	0.8	0.3	0.6	0.5	0.0	0.0	4.2	5.1	2.7	7.1	3.8	5.9	4.0	6.5	5.6	2.7
RASD1	"AGS1, DEXRAS1"	ENSG00000108551	"Ras related dexamethasone induced 1"	Q9Y272	17	17494437-17496395	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"ASC diff: 33.7;HSkMC: 8.2;REH: 32.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	47	"plasmacytoid DC: 48.0"	"Lineage enriched"	"Detected in many"	47	"dendritic cells: 48.0"	"Group enriched"	"Detected in many"	5	"basal ganglia: 77.3;hippocampal formation: 60.2;thalamus: 58.1"	"Low region specificity"	"Detected in all"			HPA047896	Uncertain		Approved	"Nucleoplasm,Plasma membrane"				Nucleoplasm	"Plasma membrane"	"HPA047896: AB_10960535"	"unprognostic (1.59e-1)"	"unprognostic (1.32e-1)"	"unprognostic (3.28e-2)"	"unprognostic (3.31e-2)"	"unprognostic (6.40e-2)"	"unprognostic (8.13e-2)"	"unprognostic (8.65e-2)"	"unprognostic (7.60e-2)"	"unprognostic (5.50e-2)"	"unprognostic (2.11e-1)"	"unprognostic (3.17e-3)"	"unprognostic (2.92e-1)"	"unprognostic (7.40e-2)"	"unprognostic (1.11e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.38e-2)"	79.6	24.3	14.0	6.2	23.2	8.3	30.4	11.6	32.0	49.1	7.1	8.5	18.6	5.9	19.9	17.1	10.9	11.6	11.8	20.1	14.7	15.5	30.2	85.9	5.6	3.7	10.0	22.5	33.5	17.5	7.2	81.3	2.6	22.2	17.8	6.9	6.6	49.4	51.8	37.2	9.1	6.1	4.3	19.6	12.2	6.1	13.8	8.9	9.1	37.7	9.2	2.5	6.2	5.5	0.0	48.0	0.0	1.0	0.0	0.1	0.3	0.0	0.1	0.1	0.0	33.7	1.8	0.1	0.4	0.6	0.0	0.1	1.3	0.0	0.0	3.8	0.1	0.1	0.1	0.0	0.0	0.0	0.4	0.1	0.1	3.7	0.2	0.0	0.1	8.2	0.0	0.3	0.0	0.1	0.0	0.0	0.1	3.4	6.1	0.5	0.6	2.0	32.2	0.0	0.0	0.7	0.0	6.1	0.2	0.5	0.4	7.0	0.0	0.0	1.8	0.0	0.3	0.2	0.1	6.9	0.2	0.0	0.1	0.0	0.2	0.0	0.1	0.0	0.1	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	48.0	0.0	0.3	14.0	23.2	11.6	32.0	14.7	15.5	10.0	22.5	22.2	8.9
RASD2	"MGC:4834, Rhes, TEM2"	ENSG00000100302	"RASD family member 2"	Q96D21	22	35540868-35554001	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 71.0;seminal vesicle: 25.2"	"Cell line enhanced"	"Detected in some"		"hTCEpi: 4.0;SK-BR-3: 9.2;U-2 OS: 5.3;U-87 MG: 6.7"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in all"		"basal ganglia: 71.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in many"	8	"basal ganglia: 527.8"	"Region enriched"	"Detected in all"	8	"basal ganglia: 265.8"	HPA005839	Enhanced		Approved	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		"HPA005839: AB_1079745"	"unprognostic (1.76e-2)"	"unprognostic (1.98e-1)"	"unprognostic (3.33e-2)"	"unprognostic (7.00e-2)"	"unprognostic (1.43e-1)"	"unprognostic (7.07e-3)"	"unprognostic (9.76e-2)"	"unprognostic (5.49e-2)"	"unprognostic (2.06e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.04e-1)"	"unprognostic (9.00e-3)"	"prognostic unfavourable (2.22e-5)"	"unprognostic (3.75e-2)"	"unprognostic (1.61e-1)"	"unprognostic (8.42e-3)"	"unprognostic (6.22e-2)"	1.6	7.9	8.6	2.5	71.0	3.4	1.3	1.8	23.5	1.1	8.3	2.2	3.2	2.5	3.5	16.4	5.2	6.2	2.5	2.8	4.1	5.0	0.8	0.5	1.5	0.6	3.4	8.0	0.8	1.0	0.9	1.0	0.4	2.1	9.6	4.4	3.5	4.0	25.2	13.6	0.8	3.4	7.5	2.2	0.4	1.8	0.6	15.3	0.0	1.4	0.1	1.4	3.8	1.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.2	3.5	0.0	0.6	0.0	0.0	0.1	0.9	0.3	1.4	1.1	0.2	0.7	0.0	0.2	3.0	0.2	0.2	0.0	1.3	0.0	0.9	0.0	0.2	0.0	1.7	0.0	0.1	0.2	4.0	2.7	0.4	0.0	0.0	0.0	0.3	0.3	0.0	0.3	0.2	0.4	1.5	0.0	1.1	0.0	0.0	2.4	0.4	2.6	9.2	0.0	0.7	0.3	0.1	2.2	5.3	0.2	1.0	2.3	0.7	0.0	6.7	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	8.6	71.0	1.8	23.5	4.1	5.0	3.4	8.0	2.1	15.3
RASSF2	"CENP-34, KIAA0168"	ENSG00000101265	"Ras association domain family member 2"	P50749	20	4780023-4823645	"Predicted intracellular proteins"	"Cell cycle"		"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 106.1"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 19.2;BEWO: 20.1;Daudi: 20.5;HL-60: 24.1;NB-4: 31.2;U-937: 38.4"	"Cancer enhanced"	"Detected in all"		"glioma: 48.9"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051200	Uncertain		Supported	"Nucleoplasm,Golgi apparatus,Plasma membrane,Cytosol"				Nucleoplasm	"Golgi apparatus, Plasma membrane, Cytosol"	"HPA051200: "	"unprognostic (6.51e-2)"	"unprognostic (3.67e-3)"	"unprognostic (5.31e-2)"	"unprognostic (1.47e-2)"	"unprognostic (3.15e-1)"	"unprognostic (1.46e-3)"	"unprognostic (2.80e-1)"	"unprognostic (7.01e-2)"	"unprognostic (1.38e-2)"	"unprognostic (2.41e-2)"	"unprognostic (4.93e-2)"	"unprognostic (3.90e-1)"	"prognostic unfavourable (7.82e-4)"	"unprognostic (3.51e-2)"	"unprognostic (1.35e-1)"	"unprognostic (3.49e-1)"	"unprognostic (6.46e-2)"	8.3	5.1	26.5	21.5	26.9	38.6	3.6	10.2	45.8	14.9	4.1	59.5	0.1	2.7	13.0	11.6	5.2	9.8	7.8	2.4	33.2	22.4	2.0	3.0	10.1	26.2	54.7	8.7	3.5	1.7	0.7	2.6	4.5	39.7	3.9	5.0	19.8	2.0	4.8	1.2	2.2	5.7	18.6	106.1	14.9	3.3	9.9	27.3	4.7	2.5	0.6	34.2	10.7	2.7	7.9	14.1	42.1	17.9	2.4	4.7	10.6	0.0	4.8	11.9	19.2	0.1	0.0	20.1	1.1	3.3	0.2	0.0	1.1	0.0	20.5	1.9	1.0	0.0	1.7	0.0	0.3	7.3	0.7	13.4	0.0	0.2	0.0	24.1	13.7	0.0	0.0	0.4	0.0	7.8	0.0	8.1	0.0	0.0	3.5	31.2	2.6	0.3	5.5	1.3	7.8	0.0	9.5	0.1	0.9	0.0	0.3	0.6	0.0	15.4	0.2	0.5	2.6	0.2	1.5	0.1	1.9	12.6	0.1	38.4	0.1	21.1	17.9	29.5	2.4	15.4	4.7	7.9	3.9	3.3	14.1	5.3	2.6	2.1	42.1	2.4	16.8	9.4	3.4	10.6	26.5	26.9	10.2	19.3	33.2	22.4	54.7	8.7	39.7	27.3
RASSF3		ENSG00000153179	"Ras association domain family member 3"	Q86WH2	12	64507001-64697567	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"SK-MEL-30: 50.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in all"	6	"neutrophil: 44.4"	"Lineage enriched"	"Detected in all"	6	"granulocytes: 44.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB022664, CAB034035, HPA038469"	Supported		Supported	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		"CAB022664: , CAB034035: AB_2176848, HPA038469: AB_10671743"	"unprognostic (1.63e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.55e-1)"	"unprognostic (2.37e-2)"	"unprognostic (2.55e-3)"	"unprognostic (3.73e-1)"	"unprognostic (2.37e-1)"	"unprognostic (6.21e-2)"	"unprognostic (3.66e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.45e-3)"	"unprognostic (7.16e-2)"	"unprognostic (2.01e-1)"	"unprognostic (6.98e-2)"	"unprognostic (1.59e-2)"	22.4	13.8	4.2	24.0	4.5	5.9	48.4	2.5	4.5	15.3	64.1	6.5	21.6	8.3	18.5	12.5	27.0	9.4	30.1	37.4	4.6	4.4	5.8	6.4	19.4	22.2	7.4	2.9	13.6	10.0	1.0	4.3	16.0	7.6	26.5	17.8	14.1	18.9	21.2	16.0	5.0	18.0	80.1	10.8	25.7	25.6	6.9	5.5	7.6	5.3	6.3	14.5	57.4	30.9	5.5	3.2	44.4	6.6	4.1	7.9	0.9	9.7	11.0	3.5	6.7	3.8	5.5	21.4	4.3	22.3	5.8	6.8	7.9	10.4	15.4	9.1	3.0	4.3	10.6	4.4	7.0	12.6	4.1	10.0	4.9	8.9	10.5	10.6	7.1	3.7	3.9	13.2	9.9	24.5	5.3	7.6	6.7	9.3	6.9	6.9	7.8	6.7	11.2	11.3	6.5	7.5	11.9	7.9	8.3	7.2	1.4	50.9	6.3	6.7	35.4	4.7	5.8	4.9	4.6	7.1	7.5	10.0	5.7	9.3	13.6	5.9	6.6	4.2	5.1	6.3	4.2	5.5	7.6	5.6	3.2	3.7	7.7	7.9	44.4	4.1	5.9	3.0	7.7	0.9	4.2	4.5	2.5	4.5	4.6	4.4	7.4	2.9	7.6	5.5
RCSD1	"CapZIP, MGC21854, MK2S4"	ENSG00000198771	"RCSD domain containing 1"	Q6JBY9	1	167630093-167706249	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 56.4;lymphoid tissue: 70.8;skeletal muscle: 52.3"	"Cell line enhanced"	"Detected in some"		"Daudi: 47.6;REH: 47.7;RPMI-8226: 32.6;THP-1: 25.1;U-266/70: 31.9;U-698: 31.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016597, HPA073490"	Enhanced		Approved	"Plasma membrane"			150000	"Plasma membrane"		"HPA016597: , HPA073490: "	"unprognostic (2.13e-2)"	"unprognostic (7.38e-3)"	"unprognostic (6.50e-3)"	"unprognostic (1.37e-3)"	"unprognostic (1.08e-1)"	"prognostic favourable (2.97e-4)"	"unprognostic (5.51e-2)"	"unprognostic (8.90e-3)"	"unprognostic (3.65e-1)"	"unprognostic (8.48e-2)"	"unprognostic (1.01e-1)"	"unprognostic (6.33e-2)"	"unprognostic (2.53e-3)"	"unprognostic (3.19e-1)"	"unprognostic (3.58e-2)"	"unprognostic (6.94e-2)"	"unprognostic (3.97e-2)"	8.5	2.9	3.5	33.3	4.8	19.2	7.3	1.2	3.1	3.0	8.4	3.6	1.3	3.6	2.7	5.4	4.1	3.1	8.8	18.4	3.9	3.6	4.2	3.7	9.0	45.6	5.1	2.2	2.5	1.5	0.8	2.0	7.0	3.1	3.7	5.0	3.1	6.5	2.5	52.3	2.3	20.1	7.4	6.9	40.6	4.9	3.7	3.4	70.8	4.8	12.7	29.2	7.4	4.5	51.0	22.1	56.4	38.2	26.6	27.8	26.3	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	47.6	0.1	0.0	0.0	0.0	0.0	0.0	20.0	0.0	0.3	0.0	0.0	0.0	8.1	0.9	0.1	0.0	0.1	0.0	0.0	15.2	14.0	6.4	0.0	15.1	11.7	0.4	0.0	47.7	0.2	32.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	25.1	0.1	0.0	0.1	0.0	0.0	31.9	9.5	31.4	0.0	15.6	0.0	48.4	38.2	56.4	15.2	25.1	18.3	45.6	19.8	18.9	22.1	51.0	17.2	15.9	38.5	26.6	24.1	12.8	27.8	26.3	3.5	4.8	1.2	3.1	3.9	3.6	5.1	2.2	3.1	3.4
RELN	"PRO1598, RL"	ENSG00000189056	Reelin	P78509	7	103471784-103989516	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Cell adhesion"	"Developmental protein, Hydrolase, Protease, Serine protease"	"Disease mutation, Epilepsy, Lissencephaly"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 73.4;liver: 35.8"	"Cell line enhanced"	"Detected in some"		"Hep G2: 33.6;PC-3: 6.8;SCLC-21H: 8.2;SH-SY5Y: 8.9;TIME: 19.5"	"Cancer enhanced"	"Detected in many"		"liver cancer: 5.7"	"Region enriched"	"Detected in many"	11	"cerebellum: 73.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046512			Approved	"Plasma membrane,Focal adhesion sites"	"Secreted to extracellular matrix"		59000000	"Focal adhesion sites"	"Plasma membrane"	"HPA046512: "	"unprognostic (1.42e-1)"	"unprognostic (2.93e-3)"	"unprognostic (4.31e-2)"	"unprognostic (1.29e-4)"	"unprognostic (1.30e-1)"	"unprognostic (6.95e-2)"	"unprognostic (1.85e-1)"	"unprognostic (8.35e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.48e-2)"	"unprognostic (3.31e-3)"	"unprognostic (3.86e-1)"	"unprognostic (2.02e-2)"	"unprognostic (1.43e-2)"	"unprognostic (3.03e-1)"	"unprognostic (1.35e-1)"	"unprognostic (3.06e-2)"	2.7	5.9	5.7	1.2	5.3	0.5	6.3	73.4	6.7	2.9	2.1	0.8	0.0	1.1	1.0	3.0	1.7	4.4	1.9	3.2	5.7	5.3	1.2	35.8	1.6	7.9	1.8	2.5	1.3	1.0	0.3	0.8	0.4	5.1	1.2	2.1	10.6	1.1	2.1	0.4	1.1	1.9	2.4	3.2	1.1	0.8	1.5	0.0	0.0	2.6	1.7	0.9	1.7	2.5	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.2	0.0	0.0	0.0	0.0	0.0	3.6	0.0	1.2	0.0	0.1	0.0	0.0	2.4	0.0	33.6	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	6.8	0.0	1.4	0.0	0.0	0.0	8.2	8.9	0.0	0.0	0.0	0.0	0.0	19.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.7	5.3	73.4	6.7	5.7	5.3	1.8	2.5	5.1	0.0
REPS1		ENSG00000135597	"RALBP1 associated Eps domain containing 1"	Q96D71	6	138903493-138988261	"Predicted intracellular proteins"			"Disease mutation, Neurodegeneration"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029961, HPA029962"	Approved		Approved	"Vesicles,Plasma membrane,Cytosol"				"Vesicles, Plasma membrane, Cytosol"		"HPA029961: AB_10603233, HPA029962: "	"unprognostic (1.72e-3)"	"unprognostic (9.61e-2)"	"unprognostic (5.82e-3)"	"unprognostic (2.77e-2)"	"unprognostic (6.30e-3)"	"unprognostic (1.90e-1)"	"prognostic unfavourable (9.47e-4)"	"unprognostic (3.79e-1)"	"unprognostic (2.49e-1)"	"unprognostic (9.71e-3)"	"unprognostic (4.29e-3)"	"unprognostic (4.42e-2)"	"unprognostic (2.69e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.27e-1)"	"unprognostic (3.83e-2)"	"unprognostic (2.69e-2)"	9.5	9.4	18.9	11.5	22.0	15.5	18.4	25.9	25.5	12.9	12.9	14.8	15.3	11.7	17.5	32.5	20.9	14.6	14.0	17.7	17.7	17.6	12.1	23.1	11.5	13.3	15.1	19.4	17.0	13.9	32.8	28.3	14.0	20.0	13.6	13.7	13.6	21.6	13.4	12.1	22.6	12.2	16.3	10.8	15.8	12.4	27.7	11.7	30.7	13.9	13.5	18.4	14.7	14.3	4.6	6.2	8.0	7.5	5.2	6.9	2.0	12.7	10.1	19.4	24.1	10.9	19.6	21.2	12.5	13.8	14.7	17.7	24.0	11.2	15.5	10.6	17.3	15.1	22.0	18.8	19.5	16.4	18.9	13.0	6.1	14.5	16.6	41.1	21.1	15.9	15.5	26.8	32.6	15.1	17.3	16.0	18.7	21.6	23.2	22.5	18.4	9.6	27.3	11.9	8.8	12.1	19.4	17.3	17.1	11.5	17.6	16.4	8.4	28.4	14.7	8.2	13.7	22.2	17.1	15.8	14.3	21.7	9.7	17.0	11.9	8.0	2.3	3.2	4.2	6.5	6.9	4.6	5.4	5.8	3.4	3.4	5.5	6.5	1.5	5.2	7.5	6.2	5.4	2.0	18.9	22.0	25.9	25.5	17.7	17.6	15.1	19.4	20.0	11.7
RFLNB	"Cfm1, FAM101B, MGC45871, RefilinB"	ENSG00000183688	"Refilin B"	Q8N5W9	17	439978-445939	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"blood: 48.4;bone marrow: 40.9"	"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 27.4;HMC-1: 66.0;NB-4: 21.1;U-937: 18.3"	"Low cancer specificity"	"Detected in all"							"Cell type enhanced"	"Detected in many"		"basophil: 48.4"	"Lineage enriched"	"Detected in many"	16	"granulocytes: 48.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030879, HPA060388"	Enhanced		Approved	"Plasma membrane,Actin filaments,Cytosol"				"Actin filaments"	"Plasma membrane, Cytosol"	"HPA030879: , HPA060388: "	"unprognostic (1.52e-1)"	"unprognostic (1.12e-1)"	"unprognostic (2.87e-1)"	"unprognostic (3.14e-1)"	"unprognostic (3.52e-2)"	"unprognostic (2.34e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.94e-1)"	"unprognostic (2.87e-2)"	"unprognostic (2.48e-2)"	"unprognostic (1.31e-1)"	"prognostic unfavourable (1.54e-4)"	"unprognostic (3.45e-2)"	"unprognostic (9.22e-2)"	"unprognostic (1.43e-1)"	"unprognostic (9.03e-3)"	6.8	1.6	1.9	4.1	2.3	40.9	5.6	1.1	1.5	2.6	4.9			1.8	4.2	2.2	1.1	2.1	2.7	3.7	2.1	1.5	2.7	1.7	5.2	2.9	1.8		1.8	1.0	0.8	1.3	6.3		3.6	1.1		1.2	1.7	2.8	1.9	3.2	3.6	2.3	4.1	3.2	0.9			3.0		2.7	4.5	1.4	0.0	2.5	48.4	2.1	0.5	3.0	1.0	8.6	2.3	1.1	5.5	3.9	2.8	6.1	14.1	6.2	4.7	2.3	0.1	0.3	0.0	0.3	27.4	0.8	3.2	0.3	4.3	0.0	1.9	0.3	0.4	0.6	5.7	3.2	66.0	1.5	0.1	1.4	0.5	4.7	1.3	0.1	5.2	0.1	0.1	21.1	2.5	0.0	0.9	2.5	0.0	0.8	0.0	0.1	12.9	5.7	0.0	5.0	0.1	9.9	0.9	3.7	3.3	2.2	0.0	2.1	2.1	0.0	0.0	18.3	5.7	48.4	2.1	21.6	1.8	1.4	1.8	0.0	1.8	1.5	0.6	0.0	3.0	2.7	10.2	0.5	1.8	2.5	1.1	1.0										
RFPL1	RNF78	ENSG00000128250	"Ret finger protein like 1"	O75677	22	29438583-29442455	"Predicted intracellular proteins"	"Cell cycle"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	4	"brain: 20.4"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 10.9;HMC-1: 4.2;Karpas-707: 4.5;SH-SY5Y: 5.7;SiHa: 2.7;THP-1: 5.2"	"Not detected"	"Not detected"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"											"HPA048320, HPA072380"			Approved	"Nuclear speckles,Plasma membrane"				"Nuclear speckles"	"Plasma membrane"	"HPA048320: , HPA072380: "		"unprognostic (4.54e-1)"				"unprognostic (6.63e-8)"						"unprognostic (3.14e-3)"			"unprognostic (1.89e-1)"			0.0	3.3	0.2	0.1	0.7	0.0	0.0	0.4	20.4	0.2	0.0			0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.3	0.3	0.0	1.9	0.0	0.1	0.4		2.8	0.0	0.0	0.6	0.0		3.2	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.9	0.0	4.5			0.0		0.0	0.0	0.4	1.6	0.9	0.0	1.8	0.0	1.2	0.5	0.0	0.2	0.4	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	10.9	0.7	0.0	1.0	0.0	0.0	0.1	4.2	0.0	0.0	0.0	0.0	0.0	0.3	4.5	0.0	0.2	0.1	0.0	1.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	5.7	2.7	0.0	0.0	0.0	5.2	2.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.7	0.0	0.2	1.2	0.8	0.0	0.6	1.0	0.9	1.6	0.1	1.1	0.0	0.0	1.8	0.0	1.2	0.5										
RFPL2	RNF79	ENSG00000128253	"Ret finger protein like 2"	O75678	22	32190435-32203477	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	7	"brain: 7.9;prostate: 10.8"	"Cell line enhanced"	"Detected in some"		"A549: 2.4;REH: 1.0;SCLC-21H: 1.8;SK-MEL-30: 1.2"	"Cancer enriched"	"Detected in single"	15	"prostate cancer: 5.6"					"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"											"HPA046608, HPA048320, HPA072380"	Approved		Approved	"Nuclear speckles,Plasma membrane"				"Nuclear speckles"	"Plasma membrane"	"HPA046608: , HPA048320: , HPA072380: "	"unprognostic (3.81e-2)"	"unprognostic (4.05e-2)"	"unprognostic (8.29e-2)"	"unprognostic (9.66e-3)"	"unprognostic (2.54e-1)"	"unprognostic (9.90e-2)"	"unprognostic (2.59e-1)"	"unprognostic (6.02e-3)"	"unprognostic (2.22e-2)"	"unprognostic (3.44e-2)"	"unprognostic (8.64e-3)"	"prognostic favourable (4.16e-4)"	"unprognostic (2.04e-4)"	"unprognostic (6.02e-2)"	"unprognostic (3.28e-2)"	"unprognostic (5.62e-7)"	"unprognostic (3.50e-2)"	0.1	0.3	2.3	0.2	3.9	1.1	0.1	2.7	7.9	0.1	0.1			0.2	0.1	0.1	0.3	0.1	0.1	0.1	3.1	5.6	0.2	0.5	0.1	0.4	1.9		0.1	0.1	0.1	0.0	0.1		10.8	0.1		0.1	0.1	0.1	0.4	0.2	0.1	0.4	0.2	0.2	0.2			0.2		0.1	0.1	0.0	0.0	0.5	0.0	0.8	0.0	1.2	0.2	0.0	2.4	0.0	0.8	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.4	0.0	0.3	0.0	0.0	1.0	0.1	0.0	0.0	0.2	1.8	0.0	0.3	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.1	0.0	0.1	0.1	0.0	0.8	0.0	0.0	0.1	0.8	0.0	1.2	1.2	0.5	0.0	0.7	0.0	0.0	0.0	0.2	0.0	0.0	0.2										
RFPL3	RNF120	ENSG00000128276	"Ret finger protein like 3"	O75679	22	32354885-32361161	"Predicted intracellular proteins"	"Host-virus interaction"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	21	"testis: 23.4"	"Cell line enhanced"	"Detected in some"		"BEWO: 3.7;NB-4: 4.7;U-266/70: 5.5;U-266/84: 5.4"	"Not detected"	"Not detected"							"Cell type enhanced"	"Detected in single"		"memory CD4 T-cell: 1.1"	"Low lineage specificity"	"Detected in single"											"HPA048320, HPA072380"			Approved	"Nuclear speckles,Plasma membrane"				"Nuclear speckles"	"Plasma membrane"	"HPA048320: , HPA072380: "	"unprognostic (1.63e-1)"				"unprognostic (9.90e-2)"			"unprognostic (1.10e-1)"		"unprognostic (1.05e-1)"	"unprognostic (1.52e-2)"	"unprognostic (1.97e-1)"	"unprognostic (3.25e-2)"	"unprognostic (4.31e-2)"	"unprognostic (1.90e-1)"	"unprognostic (6.32e-2)"		0.0	0.0	0.3	0.0	0.3	1.0	0.0	0.7	0.4	0.2	0.0			0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.2	0.2	0.1	0.1	0.0	0.4	0.2		0.6	0.5	0.0	0.2	0.0		0.3	0.0		0.4	0.0	0.3	1.1	0.2	0.0	0.1	0.5	0.0	23.4			0.0		0.0	0.2	0.0	0.0	0.0	0.2	0.3	0.0	1.1	0.2	0.1	0.8	2.4	0.7	0.0	0.0	3.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.3	2.3	1.1	0.1	0.1	0.0	1.4	0.5	0.0	0.0	0.0	0.0	0.0	0.1	1.7	0.0	0.8	1.3	4.7	0.2	0.1	2.4	0.5	0.6	0.0	0.4	1.7	0.5	0.1	0.4	1.3	0.0	0.4	0.0	0.0	0.9	0.3	0.0	5.5	5.4	0.1	0.1	1.6	0.8	0.0	0.3	0.0	0.0	0.0	0.1	0.0	1.1	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2										
RGP1	KIAA0258	ENSG00000107185	"RGP1 homolog, RAB6A GEF complex partner 1"	Q92546	9	35749287-35758575	"Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020414, HPA021085"	Approved		Supported	"Plasma membrane,Cytosol"				Cytosol	"Plasma membrane"	"HPA020414: AB_1852289, HPA021085: AB_1852291"	"unprognostic (2.10e-1)"	"unprognostic (3.22e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.01e-2)"	"unprognostic (3.35e-2)"	"unprognostic (1.47e-1)"	"prognostic unfavourable (7.09e-4)"	"unprognostic (2.22e-1)"	"unprognostic (5.42e-2)"	"unprognostic (1.51e-3)"	"unprognostic (1.81e-3)"	"unprognostic (9.77e-2)"	"prognostic favourable (8.55e-13)"	"unprognostic (2.46e-2)"	"unprognostic (1.68e-1)"	"unprognostic (3.03e-3)"	"unprognostic (1.18e-1)"	13.4	18.2	12.0	11.4	16.8	7.1	12.3	13.7	24.8	12.2	17.7	18.3	23.8	14.9	15.3	12.5	14.0	12.3	12.1	17.6	11.6	11.2	16.7	14.2	13.2	9.8	10.7	14.8	15.0	17.6	32.6	18.3	14.1	13.0	12.9	19.1	15.4	18.3	22.5	25.8	13.1	17.2	14.1	10.6	12.8	16.5	13.2	13.7	11.2	17.3	11.9	13.0	13.5	10.6	4.0	2.1	3.4	1.9	3.7	3.7	0.9	11.7	11.0	12.9	10.7	12.1	13.1	7.6	9.3	13.5	12.9	12.1	9.4	4.5	9.1	6.7	11.8	6.7	12.3	17.5	10.7	12.1	7.3	7.8	21.1	7.0	11.4	8.4	11.1	13.1	22.5	13.6	16.6	15.3	5.3	5.1	11.7	5.5	2.6	3.0	5.4	13.0	8.6	9.2	6.4	11.3	8.2	9.5	10.2	8.2	11.6	7.5	9.6	4.0	19.3	10.4	13.2	7.1	7.7	7.6	10.5	9.7	14.8	3.6	13.3	3.4	0.9	1.4	2.6	1.5	3.7	2.8	1.9	3.0	0.6	4.0	2.3	2.4	2.3	3.7	1.9	2.1	1.6	0.9	12.0	16.8	13.7	24.8	11.6	11.2	10.7	14.8	13.0	13.7
RGS14		ENSG00000169220	"Regulator of G protein signaling 14"	O43566	5	177357837-177372601	"Predicted intracellular proteins"	"Cell cycle, Cell division"	"GTPase activation, Signal transduction inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 43.9;brain: 76.1"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 39.8;HMC-1: 35.6;NB-4: 15.7;RPMI-8226: 20.5"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in many"	4	"basal ganglia: 76.1"	"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in many"	11	"amygdala: 68.3;basal ganglia: 58.1;cerebral cortex: 46.1;hippocampal formation: 102.5"	"Group enriched"	"Detected in all"	5	"amygdala: 38.0;basal ganglia: 118.5;cerebral cortex: 32.0;hippocampal formation: 90.8"	"HPA046847, HPA061819"	Approved		Approved	"Nucleoplasm,Vesicles,Plasma membrane,Intermediate filaments"				Nucleoplasm	"Vesicles, Plasma membrane, Intermediate filaments"	"HPA046847: , HPA061819: "	"unprognostic (6.05e-3)"	"unprognostic (1.65e-2)"	"unprognostic (8.57e-2)"	"unprognostic (2.61e-1)"	"prognostic unfavourable (6.97e-4)"	"unprognostic (7.27e-2)"	"prognostic unfavourable (1.84e-6)"	"unprognostic (1.95e-2)"	"unprognostic (4.34e-2)"	"unprognostic (2.04e-3)"	"unprognostic (2.71e-1)"	"unprognostic (1.28e-1)"	"unprognostic (9.95e-2)"	"unprognostic (3.17e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.17e-2)"	"unprognostic (2.78e-2)"	1.9	1.5	7.7	12.5	76.1	17.5	1.3	0.4	8.8	1.7	2.6	1.9	0.6	5.1	1.3	1.4	3.2	6.6	3.4	0.7	17.1	1.9	2.1	6.9	4.3	15.5	2.5	3.6	0.8	1.5	0.1	0.9	1.0	0.8	1.2	0.5	0.7	5.2	1.8	1.6	3.5	5.7	1.2	0.7	12.8	3.7	0.7	4.4	24.2	4.3	1.7	12.9	4.9	1.6	9.2	12.2	43.9	12.3	6.5	20.7	12.4	1.8	0.4	0.7	0.4	0.0	0.0	1.2	0.0	0.0	0.1	0.2	1.1	3.7	4.7	2.6	0.0	3.8	0.0	1.2	0.0	39.8	0.1	7.4	0.1	1.5	0.2	5.7	35.6	0.6	0.3	0.2	0.2	0.2	1.2	9.6	0.0	0.1	7.6	15.7	0.6	1.0	3.5	0.0	20.5	0.4	0.1	0.1	0.7	0.0	0.1	3.0	1.3	9.0	0.3	0.0	0.7	0.0	3.4	5.1	2.4	2.0	0.6	10.8	0.8	18.6	12.3	43.9	20.5	11.4	20.7	9.2	19.1	18.7	12.2	8.0	16.0	14.3	43.0	6.5	11.6	5.4	18.2	12.4	7.7	76.1	0.4	8.8	17.1	1.9	2.5	3.6	0.8	4.4
RGS7BP	R7BP	ENSG00000186479	"Regulator of G protein signaling 7 binding protein"	Q6MZT1	5	64506257-64612312	"Predicted intracellular proteins"		"Signal transduction inhibitor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 31.1"	"Cell line enriched"	"Detected in some"	6	"HUVEC TERT2: 15.8"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039600	Approved		Uncertain	"Plasma membrane,Actin filaments,Cytosol"				"Plasma membrane, Cytosol"	"Actin filaments"	"HPA039600: "	"unprognostic (2.93e-1)"	"unprognostic (3.39e-1)"	"unprognostic (7.35e-2)"	"unprognostic (4.77e-2)"	"unprognostic (7.57e-2)"	"unprognostic (8.59e-2)"	"unprognostic (5.22e-2)"	"unprognostic (8.81e-3)"	"unprognostic (1.86e-2)"	"unprognostic (7.64e-2)"	"unprognostic (5.49e-3)"	"unprognostic (1.83e-1)"	"unprognostic (1.65e-3)"	"unprognostic (3.39e-3)"	"unprognostic (2.06e-3)"	"unprognostic (6.46e-2)"	"unprognostic (8.50e-3)"	2.8	4.7	10.2	1.1	22.6	0.4	1.1	10.4	31.1	6.0	1.3	1.5	0.5	1.6	3.7	5.7	2.7	10.9	2.7	3.7	10.8	4.3	3.3	1.7	2.2	0.8	4.0	16.0	3.8	0.8	0.7	1.7	0.4	8.2	7.8	1.4	1.8	2.7	10.9	0.7	1.0	1.7	2.3	1.9	1.3	1.5	1.5	6.7	0.0	1.0	0.0	0.6	2.0	1.3	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	15.8	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.1	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.2	22.6	10.4	25.1	10.8	4.3	4.0	16.0	8.2	6.7
RGS9BP	"FLJ45744, PERRS, R9AP, RGS9"	ENSG00000186326	"Regulator of G protein signaling 9 binding protein"	Q6ZS82	19	32675407-32678300	"Disease related genes, Predicted membrane proteins"	"Sensory transduction, Vision"	"Signal transduction inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"retina: 38.3;skeletal muscle: 15.8"	"Cell line enhanced"	"Detected in some"		"HEL: 10.4;HMC-1: 2.8"	"Not detected"	"Not detected"			"Region enriched"	"Detected in many"	6	"pons and medulla: 6.8"	"Cell type enhanced"	"Detected in some"		"gdT-cell: 1.4;memory CD8 T-cell: 1.5"	"Low lineage specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA049791	Enhanced		Approved	"Plasma membrane"				"Plasma membrane"		"HPA049791: "	"unprognostic (2.82e-2)"	"unprognostic (6.99e-3)"	"unprognostic (2.44e-3)"	"unprognostic (1.20e-7)"	"unprognostic (1.49e-1)"	"unprognostic (1.21e-2)"	"unprognostic (1.17e-2)"	"unprognostic (1.32e-1)"	"unprognostic (2.80e-1)"	"unprognostic (6.71e-2)"	"unprognostic (6.74e-2)"	"unprognostic (3.89e-2)"	"unprognostic (1.63e-3)"	"unprognostic (2.29e-1)"	"unprognostic (8.22e-2)"	"unprognostic (5.23e-2)"	"unprognostic (5.34e-2)"	0.4	0.5	0.8	0.3	1.1	0.3	0.4	0.2	0.7	0.3	0.4	1.4	0.2	0.4	0.3	0.6	1.1	0.4	0.3	6.7	1.0	0.8	0.9	0.3	0.9	0.3	1.1	0.3	0.3	0.4	0.4	0.6	0.4	6.8	1.3	0.3	38.3	0.5	0.6	15.8	0.6	0.3	7.4	1.3	0.4	0.4	0.9	0.9	0.1	0.4	4.3	0.3	2.3	1.0	0.0	0.3	0.0	0.9	0.5	1.5	0.0	0.2	0.2	0.0	0.9	0.5	0.2	0.5	0.0	0.5	0.3	0.2	0.2	0.3	0.4	0.5	0.1	0.0	1.8	0.1	0.1	0.5	0.2	10.4	0.3	0.0	0.2	0.3	2.8	0.0	0.5	0.0	0.4	0.0	0.9	1.5	0.2	0.4	0.0	1.7	0.0	2.0	0.1	0.4	0.2	0.0	0.1	0.3	0.1	0.0	1.1	0.1	1.0	0.5	0.0	0.5	0.7	0.2	0.3	0.6	0.7	0.1	0.3	0.6	0.8	0.0	0.3	0.0	1.4	0.9	0.0	0.0	0.2	1.5	0.3	0.0	0.0	0.4	0.0	0.5	0.3	0.0	0.0	0.0	0.8	1.1	0.2	0.7	1.0	0.8	1.1	0.3	6.8	0.9
RHD	"CD240D, DIIIc, RH, Rh30a, Rh4, RhII, RhPI"	ENSG00000187010	"Rh blood group D antigen"	Q02161	1	25272393-25330445	"Blood group antigen proteins, CD markers, Predicted membrane proteins, Transporters"		"Blood group antigen"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"blood: 10.0;bone marrow: 16.5;salivary gland: 7.1"	"Group enriched"	"Detected in some"	6	"HEL: 27.6;K-562: 8.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Cell type enhanced"	"Detected in many"		"neutrophil: 10.0"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 10.0"									"HPA060951, HPA077385"	Supported		Uncertain	"Nucleoplasm,Plasma membrane"				"Nucleoplasm, Plasma membrane"		"HPA060951: , HPA077385: "	"unprognostic (4.75e-3)"	"unprognostic (7.70e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.09e-2)"	"unprognostic (4.84e-2)"	"unprognostic (1.11e-2)"	"unprognostic (5.25e-2)"	"unprognostic (1.11e-2)"	"unprognostic (1.91e-1)"	"unprognostic (1.27e-2)"	"unprognostic (1.89e-1)"	"unprognostic (4.96e-3)"	"unprognostic (1.93e-1)"	"unprognostic (8.09e-2)"	"unprognostic (5.53e-2)"	"unprognostic (4.92e-3)"	0.3	0.3	0.3	0.5	0.5	16.5	0.3	1.5	1.4	0.6	0.3	0.3	0.3	0.3	0.4	0.3	0.3	0.3	0.4	0.9	0.3	0.2	0.3	0.3	2.5	0.8	0.3	0.3	0.9	0.3	0.1	0.4	0.3	1.1	0.5	0.0	0.3	7.1	0.3	4.1	2.5	0.4	0.3	0.4	1.8	0.3	0.5	0.3	0.3	0.4	2.3	0.3	0.3	0.3	2.0	0.6	10.0	1.4	1.4	1.4	1.2	0.1	0.0	0.2	0.2	0.1	0.0	0.4	0.1	0.0	0.1	0.0	0.1	0.3	0.4	0.1	0.0	0.2	0.0	0.0	0.0	0.5	0.1	27.6	0.6	0.2	0.0	0.3	0.2	0.1	0.1	0.1	0.1	0.1	8.5	0.7	0.0	0.1	0.2	0.2	3.1	0.1	0.2	0.1	0.1	0.0	0.1	0.5	0.3	0.1	0.2	0.1	0.2	0.4	0.4	0.5	0.2	0.4	0.1	0.3	0.1	0.1	0.4	0.2	0.1	4.9	1.4	2.8	1.0	0.6	1.1	1.3	1.3	0.8	0.2	2.0	1.4	1.3	10.0	1.4	0.8	0.6	0.9	1.2	0.3	0.5	1.5	1.4	0.3	0.2	0.3	0.3	1.1	0.3
RHOBTB2	"DBC2, KIAA0717"	ENSG00000008853	"Rho related BTB domain containing 2"	Q9BYZ6	8	22987417-23020199	"Predicted intracellular proteins"			"Disease mutation, Epilepsy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Daudi: 31.1;hTCEpi: 27.7;RT4: 46.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA060938	Approved		Approved	"Plasma membrane"				"Plasma membrane"		"HPA060938: "	"unprognostic (2.67e-3)"	"unprognostic (1.64e-1)"	"unprognostic (1.64e-1)"	"unprognostic (7.94e-2)"	"unprognostic (7.83e-3)"	"unprognostic (2.13e-2)"	"unprognostic (8.13e-2)"	"unprognostic (8.17e-2)"	"unprognostic (3.47e-3)"	"unprognostic (1.93e-2)"	"unprognostic (1.60e-2)"	"unprognostic (1.46e-2)"	"prognostic favourable (2.98e-4)"	"unprognostic (2.01e-1)"	"unprognostic (1.09e-1)"	"unprognostic (8.89e-3)"	"unprognostic (2.43e-1)"	5.9	7.4	14.8	6.4	33.2	2.0	5.3	5.1	36.9	4.4	8.1	7.2	24.4	7.7	6.3	5.2	4.6	6.6	6.0	17.6	14.0	9.1	6.0	1.9	31.0	12.2	9.8	14.4	15.9	7.2	5.8	9.0	10.0	8.0	5.7	2.5	11.2	5.6	22.6	10.9	3.5	19.7	6.1	4.0	10.4	6.9	7.0	6.5	5.5	14.9	2.8	14.5	13.7	3.4	7.8	2.9	4.5	1.6	4.4	2.8	1.1	2.4	4.8	3.9	6.2	4.8	3.3	5.3	3.4	4.5	5.3	4.1	12.4	2.4	31.1	5.2	4.9	4.9	1.9	19.0	2.6	2.6	1.1	3.3	6.6	3.5	2.3	1.9	7.0	4.3	27.7	5.6	2.8	3.8	0.8	3.0	3.5	7.1	1.2	3.1	4.1	3.4	1.6	6.3	2.1	3.8	46.6	2.5	4.7	2.6	7.9	5.2	1.5	5.1	4.7	6.7	4.9	12.0	3.8	7.8	7.5	11.2	6.5	2.9	5.2	4.5	1.0	1.3	2.8	1.6	1.9	7.8	0.8	1.3	1.0	7.1	1.1	1.1	0.2	4.4	1.6	2.9	1.4	1.1	14.8	33.2	5.1	36.9	14.0	9.1	9.8	14.4	8.0	6.5
RHOJ	"ARHJ, FLJ14445, RASL7B, TCL"	ENSG00000126785	"Ras homolog family member J"	Q9H4E5	14	63204114-63293219	"Predicted intracellular proteins"	Angiogenesis			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"AF22: 15.2;HUVEC TERT2: 88.4;TIME: 23.5;WM-115: 25.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003050	Uncertain		Approved	"Nucleoplasm,Nucleoli,Plasma membrane"				"Plasma membrane"	"Nucleoplasm, Nucleoli"	"HPA003050: AB_1079812"	"unprognostic (7.24e-2)"	"unprognostic (1.72e-1)"	"unprognostic (4.37e-2)"	"unprognostic (2.42e-1)"	"unprognostic (6.71e-2)"	"unprognostic (1.77e-2)"	"unprognostic (2.89e-1)"	"unprognostic (2.33e-2)"	"unprognostic (2.19e-1)"	"unprognostic (3.04e-3)"	"unprognostic (1.42e-2)"	"unprognostic (7.07e-2)"	"prognostic unfavourable (1.31e-4)"	"unprognostic (3.50e-3)"	"unprognostic (4.84e-2)"	"unprognostic (1.86e-2)"	"unprognostic (1.06e-3)"	17.0	2.9	11.4	6.4	12.0	0.2	14.3	7.3	15.8	15.1	12.0	3.4	7.9	5.8	22.8	14.7	12.4	15.6	20.0	13.0	11.3	4.6	7.3	4.0	18.6	7.0	8.0	9.8	11.9	3.6	3.3	6.5	7.3	6.8	15.9	8.8	14.8	7.2	11.8	5.8	6.0	8.4	25.3	5.4	9.4	9.4	4.7	8.5	0.0	13.1	13.9	3.9	16.9	9.2	1.2	0.9	2.6	0.8	1.4	0.6	0.1	0.0	0.0	15.2	0.0	0.0	0.0	0.0	2.5	10.2	0.9	1.5	0.0	0.0	0.0	1.4	0.2	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.9	88.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.0	23.5	0.0	0.2	0.1	1.4	0.0	0.0	0.0	0.0	0.0	25.4	1.0	0.8	0.6	0.5	0.4	0.3	0.7	0.4	0.4	0.2	1.2	0.6	0.6	2.6	1.4	0.2	0.9	0.2	0.1	11.4	12.0	7.3	15.8	11.3	4.6	8.0	9.8	6.8	8.5
RHOXF2	"CT107, PEPP-2, PEPP2, THG1"	ENSG00000131721	"Rhox homeobox family member 2"	Q9BQY4	X	120158561-120165630	"Predicted intracellular proteins, Transcription factors"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	21	"testis: 23.0"	"Cell line enhanced"	"Detected in some"		"K-562: 60.7;NB-4: 45.0;THP-1: 16.9;U-266/84: 27.0"	"Cancer enhanced"	"Detected in single"		"testis cancer: 0.8"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"											"HPA003314, CAB020794"	Enhanced		Approved	"Nucleoplasm,Plasma membrane"				"Plasma membrane"	Nucleoplasm	"CAB020794: , HPA003314: AB_1855193"					"unprognostic (1.60e-1)"										"unprognostic (5.04e-2)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	23.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.9	1.0	0.5	1.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.9	0.0	0.0	0.0	0.0	0.0	0.0	60.7	0.0	0.0	0.0	0.0	45.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.9	0.2	0.0	0.0	0.0	0.0	0.0	27.0	0.0	0.0	0.0	0.0	1.0	0.3	0.4	0.4	0.4	0.4	0.2	0.3	0.2	0.2	0.3	0.3	0.4	0.7	1.1	0.5	0.9	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
RHOXF2B		ENSG00000203989	"Rhox homeobox family member 2B"	P0C7M4	X	120070672-120077705	"Predicted intracellular proteins, Transcription factors"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	6	"blood: 2.6;testis: 9.4"	"Group enriched"	"Detected in some"	348	"HL-60: 46.0;K-562: 46.1;NB-4: 74.6"	"Not detected"	"Not detected"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"											HPA003314	Supported		Approved	"Nucleoplasm,Plasma membrane"				"Plasma membrane"	Nucleoplasm	"HPA003314: AB_1855193"																		0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0		0.3	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.9	0.3	0.0	0.0	0.0	0.2	0.0	9.4			0.0		0.0	0.0	0.0	1.0	1.6	2.6	1.3	1.7	1.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	46.0	0.0	0.0	0.0	0.0	0.0	0.0	46.1	0.0	0.0	0.0	0.0	74.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.6	0.7	0.8	0.5	0.9	1.0	0.7	0.5	0.7	0.7	1.0	0.7	0.7	1.4	1.7	1.3	1.6	0.5	0.2										
RILPL1	FLJ39378	ENSG00000188026	"Rab interacting lysosomal protein like 1"	Q5EBL4	12	123470054-123533718	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	4	"brain: 21.1;heart muscle: 43.8;skeletal muscle: 66.2"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041314	Approved		Approved	"Nucleoplasm,Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"	Nucleoplasm	"HPA041314: AB_10795587"	"unprognostic (2.21e-1)"	"unprognostic (1.26e-1)"	"unprognostic (3.71e-2)"	"unprognostic (5.36e-2)"	"unprognostic (3.12e-2)"	"unprognostic (2.99e-3)"	"unprognostic (1.94e-2)"	"unprognostic (1.61e-1)"	"unprognostic (2.65e-1)"	"unprognostic (1.75e-1)"	"unprognostic (2.30e-2)"	"unprognostic (8.30e-2)"	"unprognostic (4.25e-2)"	"unprognostic (2.98e-1)"	"unprognostic (2.32e-1)"	"unprognostic (6.07e-3)"	"unprognostic (2.81e-1)"	6.1	5.7	9.9	3.5	12.3	3.0	3.7	5.2	11.3	4.8	4.7	12.6	4.4	2.1	6.6	5.0	4.8	5.0	4.3	43.8	9.6	7.5	3.8	3.0	5.5	2.3	21.1	5.8	7.2	3.2	5.7	3.6	7.1	11.1	6.2	2.2	4.9	8.0	7.8	66.2	6.2	2.7	9.8	14.4	3.8	3.0	2.9	15.1	0.3	8.2	9.7	1.9	4.7	5.3	1.6	1.2	4.6	1.2	1.2	2.0	0.7	6.0	8.5	7.7	6.0	8.7	8.2	8.1	10.9	6.1	6.0	5.3	5.3	1.4	0.3	5.5	10.6	6.6	5.7	5.2	2.4	6.1	10.4	0.8	5.5	7.7	15.2	0.3	2.3	9.3	10.4	6.7	9.7	6.0	4.8	0.4	6.0	10.0	0.7	1.9	5.6	9.0	1.0	4.2	0.3	4.2	6.3	1.2	7.2	5.8	5.1	13.0	6.8	0.2	12.0	7.8	3.9	11.3	6.9	1.3	0.6	0.2	8.0	0.1	4.9	1.4	1.0	0.7	0.9	0.5	0.8	0.9	1.0	0.8	0.3	1.6	2.0	1.6	4.6	1.2	1.2	1.2	0.9	0.7	9.9	12.3	5.2	9.9	9.6	7.5	21.1	5.8	11.1	15.1
RIMS2	"KIAA0751, OBOE, RAB3IP3, RIM2"	ENSG00000176406	"Regulating synaptic membrane exocytosis 2"	Q9UQ26	8	103500748-104256094	"Predicted intracellular proteins"	Differentiation			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 51.1;brain: 28.7"	"Cell line enhanced"	"Detected in some"		"AF22: 6.0;Daudi: 11.7;RT4: 8.4;SCLC-21H: 20.7;U-2 OS: 5.5"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							"HPA046538, HPA066498, CAB079049"	Enhanced	Supported	Approved	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		"CAB079049: , HPA046538: , HPA066498: "	"unprognostic (2.98e-2)"	"unprognostic (7.14e-2)"	"unprognostic (4.47e-2)"	"unprognostic (5.51e-2)"	"unprognostic (2.82e-1)"	"unprognostic (7.09e-3)"	"unprognostic (2.02e-2)"	"unprognostic (1.16e-2)"	"unprognostic (7.61e-2)"	"unprognostic (8.01e-3)"	"unprognostic (1.40e-2)"	"unprognostic (6.34e-2)"	"unprognostic (1.67e-5)"	"unprognostic (8.12e-4)"	"unprognostic (1.04e-1)"	"unprognostic (1.61e-1)"	"unprognostic (9.08e-2)"	0.9	51.1	15.8	1.0	21.8	1.1	1.8	14.5	28.7	8.5	0.9	0.5	0.9	1.2	1.4	1.7	1.0	6.3	1.7	0.9	10.3	4.9	1.1	0.9	1.0	1.1	3.1	17.5	2.8	1.6	0.9	12.4	1.1	8.6	2.8	1.0	5.8	1.0	1.8	1.0	1.0	1.4	2.0	4.0	0.9	1.7	3.9	8.7	0.0	2.9	0.0	1.0	1.5	1.6	0.7	0.7	2.9	0.6	1.6	0.6	0.2	3.7	0.0	6.0	0.0	0.0	0.0	0.0	0.4	0.3	1.1	1.4	0.1	0.3	11.7	0.1	0.0	0.3	1.8	0.7	1.9	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.1	1.1	0.0	0.9	0.0	0.1	0.5	0.0	0.5	0.8	0.0	4.6	0.6	0.0	0.0	0.0	0.0	8.4	20.7	5.0	0.0	0.1	0.5	0.3	0.2	0.0	0.0	5.5	0.1	0.1	1.5	0.0	0.1	0.4	0.2	0.2	2.7	0.6	0.6	0.6	0.3	0.4	0.4	0.3	0.4	0.1	0.7	0.3	0.5	2.9	1.6	0.4	0.7	0.3	0.2	15.8	21.8	14.5	28.7	10.3	4.9	3.1	17.5	8.6	8.7
RIOK2	FLJ11159	ENSG00000058729	"RIO kinase 2"	Q9BVS4	5	97160867-97183260	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Ribosome biogenesis"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											HPA005681	Uncertain		Approved	"Plasma membrane,Cytosol"				Cytosol	"Plasma membrane"	"HPA005681: AB_1856286"	"unprognostic (6.36e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.13e-2)"	"unprognostic (8.04e-2)"	"unprognostic (1.38e-1)"	"unprognostic (4.51e-2)"	"unprognostic (2.71e-3)"	"unprognostic (3.08e-1)"	"unprognostic (3.90e-2)"	"unprognostic (1.11e-1)"	"unprognostic (8.76e-2)"	"unprognostic (6.63e-2)"	"unprognostic (1.26e-3)"	"unprognostic (3.60e-1)"	"unprognostic (9.98e-2)"	"unprognostic (1.43e-2)"	"unprognostic (1.39e-2)"	22.2	20.1	14.8	17.1	17.5	24.4	19.7	26.3	18.6	19.1	17.0	8.9	14.0	17.3	17.5	17.1	17.0	15.0	10.7	19.6	15.7	13.4	21.0	23.6	13.3	17.6	20.0	11.1	20.7	21.5	15.1	37.5	15.8	19.7	19.5	17.3	10.3	18.7	16.6	24.9	13.3	20.2	16.3	20.7	22.5	16.4	14.8	18.6	25.8	21.7	20.7	17.4	20.7	21.0	15.2	17.8	9.4	18.7	17.8	24.1	13.5	8.8	10.4	9.7	18.8	12.8	14.0	15.5	22.3	13.8	15.8	21.0	14.2	15.6	19.6	25.4	10.0	10.5	16.5	13.0	21.7	13.8	9.1	9.8	20.1	19.8	11.5	18.6	13.8	9.2	10.2	19.3	19.6	12.8	14.8	12.7	18.1	14.8	21.7	22.2	11.5	11.2	24.5	18.9	28.8	12.4	8.1	12.1	9.0	13.5	14.0	15.3	14.7	17.7	13.7	20.3	14.1	16.1	24.2	12.5	16.2	44.0	12.1	19.1	18.4	7.0	16.0	9.4	16.3	18.7	22.3	15.2	20.7	17.8	17.8	11.0	22.5	24.1	3.2	17.8	13.4	17.8	18.5	13.5	14.8	17.5	26.3	18.6	15.7	13.4	20.0	11.1	19.7	18.6
RIOK3	SUDD	ENSG00000101782	"RIO kinase 3"	O14730	18	23452823-23486603	"Enzymes, Predicted intracellular proteins"	"Antiviral defense, Immunity, Innate immunity, Ribosome biogenesis"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001620, HPA024184"	Approved		Approved	"Golgi apparatus,Plasma membrane,Centriolar satellite,Cytosol"				"Plasma membrane, Cytosol"	"Golgi apparatus, Centriolar satellite"	"HPA001620: AB_1079815, HPA024184: AB_1856289"	"unprognostic (7.99e-2)"	"unprognostic (1.71e-2)"	"unprognostic (2.39e-1)"	"unprognostic (3.03e-2)"	"unprognostic (1.05e-1)"	"unprognostic (7.48e-2)"	"unprognostic (8.98e-3)"	"unprognostic (1.01e-1)"	"unprognostic (5.10e-2)"	"unprognostic (4.20e-1)"	"prognostic unfavourable (4.10e-4)"	"prognostic unfavourable (5.80e-4)"	"unprognostic (3.90e-2)"	"unprognostic (1.46e-1)"	"unprognostic (5.44e-2)"	"unprognostic (1.39e-1)"	"unprognostic (2.71e-2)"	10.1	8.7	6.9	11.7	7.7	52.4	10.9	8.9	10.1	14.7	21.4	8.5	5.9	15.6	8.8	9.3	41.0	7.8	10.7	11.5	6.1	5.5	10.5	19.9	10.1	10.7	9.1	6.2	7.6	10.7	7.5	11.6	21.4	11.6	6.8	14.7	6.0	14.9	7.0	40.0	13.3	36.5	15.2	10.5	8.9	12.9	22.7	7.6	11.1	7.3	16.0	16.5	13.7	21.5	11.7	11.0	21.7	21.5	8.3	11.2	10.0	14.7	5.8	6.0	7.8	11.0	12.3	10.9	14.8	10.9	10.5	10.1	6.6	15.9	10.2	19.4	16.4	19.3	10.2	16.8	16.2	10.1	4.2	9.5	10.8	8.3	27.5	26.7	8.3	14.7	32.0	18.6	25.8	14.5	13.7	12.9	15.7	7.8	9.2	4.4	5.6	11.6	10.4	12.6	12.4	12.0	19.3	14.0	10.1	18.9	8.6	10.8	7.6	14.5	22.9	17.3	4.3	7.6	9.6	23.2	19.6	15.2	10.2	12.4	12.9	21.7	13.5	8.0	9.1	19.6	6.9	8.2	7.6	7.9	11.0	11.7	6.1	6.9	9.3	8.3	21.5	5.1	11.2	10.0	6.9	7.7	8.9	10.1	6.1	5.5	9.1	6.2	11.6	7.6
RNF114	"PSORS12, ZNF313"	ENSG00000124226	"Ring finger protein 114"	Q9Y508	20	49936336-49953892	"Enzymes, Predicted intracellular proteins"	"Differentiation, Spermatogenesis, Ubl conjugation pathway"	"Developmental protein, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"SK-BR-3: 108.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA021184	Enhanced		Supported	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		"HPA021184: AB_1859185"	"unprognostic (8.38e-2)"	"unprognostic (3.56e-2)"	"unprognostic (5.62e-2)"	"prognostic unfavourable (8.10e-6)"	"unprognostic (1.56e-1)"	"unprognostic (2.96e-1)"	"prognostic unfavourable (3.11e-4)"	"unprognostic (2.50e-2)"	"unprognostic (1.03e-2)"	"unprognostic (2.12e-1)"	"unprognostic (3.99e-1)"	"unprognostic (2.70e-2)"	"unprognostic (2.54e-3)"	"unprognostic (1.33e-1)"	"unprognostic (1.76e-1)"	"prognostic favourable (3.01e-4)"	"unprognostic (1.36e-2)"	23.2	21.3	24.4	18.3	25.7	31.2	20.6	26.7	23.1	24.0	29.7	32.6	21.1	29.5	20.3	23.4	20.2	23.6	20.1	21.9	23.0	25.3	30.3	31.6	24.4	24.0	28.3	19.4	28.4	36.8	16.1	21.6	40.6	23.7	24.5	21.3	27.1	27.8	24.1	43.8	15.2	33.9	17.6	29.3	36.3	24.2	101.9	24.1	28.3	37.9	20.0	24.1	22.6	25.0	28.5	32.5	43.4	44.6	23.7	29.4	34.9	15.6	15.4	7.9	8.3	16.3	11.3	23.3	14.0	15.9	29.0	12.3	45.7	12.9	7.6	28.0	7.4	12.6	11.8	14.1	10.0	13.7	8.6	9.6	10.3	32.1	14.3	17.4	11.6	9.8	13.0	11.1	7.6	6.9	18.0	8.9	8.5	52.6	14.6	18.1	8.2	22.1	16.0	8.3	13.7	15.3	12.8	12.1	8.7	17.1	108.1	21.6	28.8	16.2	9.1	26.3	12.2	13.8	16.1	18.3	19.1	14.4	14.9	11.4	14.5	38.5	42.5	35.7	22.0	39.2	24.6	28.2	24.6	22.4	32.5	28.5	29.4	23.7	43.4	23.7	44.6	26.7	28.8	34.9	24.4	25.7	26.7	23.1	23.0	25.3	28.3	19.4	23.7	24.1
RNF145	FLJ31951	ENSG00000145860	"Ring finger protein 145"	Q96MT1	5	159157409-159210053	"Enzymes, Predicted membrane proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036562	Uncertain		Approved	"Nucleoplasm,Plasma membrane,Cytosol"				"Nucleoplasm, Plasma membrane, Cytosol"		"HPA036562: AB_10696657"	"unprognostic (1.57e-1)"	"unprognostic (9.02e-3)"	"unprognostic (4.11e-2)"	"unprognostic (3.88e-2)"	"unprognostic (3.24e-2)"	"unprognostic (2.93e-2)"	"prognostic unfavourable (1.64e-6)"	"unprognostic (1.35e-1)"	"unprognostic (1.02e-2)"	"unprognostic (1.54e-1)"	"unprognostic (3.53e-1)"	"unprognostic (1.67e-1)"	"unprognostic (8.92e-3)"	"unprognostic (1.49e-1)"	"unprognostic (1.00e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.39e-1)"	13.3	20.1	23.9	15.6	23.0	7.1	24.1	30.2	27.3	11.3	11.7	5.7	5.3	4.7	12.6	13.6	26.7	11.4	20.8	16.8	22.0	8.4	8.2	6.1	30.7	36.3	17.5	9.7	14.1	6.0	26.9	29.0	21.9	18.5	11.8	12.6	10.2	17.8	14.8	5.5	14.9	11.0	13.8	12.4	12.7	11.2	7.9	18.0	12.4	14.3	8.0	19.6	19.3	15.7	8.9	2.7	14.4	2.6	2.1	6.2	1.3	20.1	20.0	30.7	36.8	32.5	14.5	6.0	16.2	28.3	15.0	24.4	6.9	16.8	6.9	29.1	14.2	26.5	24.2	21.3	26.5	28.5	8.6	14.6	22.7	5.7	13.9	9.6	14.0	8.9	38.5	13.9	20.5	14.7	14.5	26.8	14.0	0.5	10.9	3.0	13.2	10.2	14.6	13.4	13.8	20.0	7.0	11.2	20.7	16.3	17.5	26.6	12.3	8.8	15.6	16.8	15.5	13.4	28.6	5.9	8.3	6.5	19.6	12.0	36.0	2.8	2.6	14.4	3.2	2.5	3.7	8.9	4.7	3.8	1.9	4.4	6.2	4.3	9.7	2.1	2.2	2.7	5.7	1.3	23.9	23.0	30.2	27.3	22.0	8.4	17.5	9.7	18.5	18.0
RNF149	FLJ90504	ENSG00000163162	"Ring finger protein 149"	Q8NC42	2	101271219-101308701	"Enzymes, Predicted membrane proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 123.7"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in all"	6	"neutrophil: 123.7"	"Lineage enriched"	"Detected in all"	6	"granulocytes: 123.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA011424	Approved		Approved	"Vesicles,Plasma membrane"				"Vesicles, Plasma membrane"		"HPA011424: AB_1079825"	"unprognostic (2.56e-2)"	"unprognostic (4.70e-2)"	"unprognostic (1.96e-1)"	"unprognostic (3.49e-2)"	"unprognostic (3.17e-2)"	"unprognostic (5.17e-3)"	"unprognostic (4.16e-2)"	"unprognostic (4.77e-3)"	"unprognostic (5.61e-2)"	"unprognostic (1.43e-2)"	"unprognostic (5.69e-3)"	"unprognostic (1.51e-1)"	"prognostic unfavourable (2.04e-8)"	"unprognostic (1.39e-1)"	"unprognostic (6.16e-2)"	"unprognostic (2.70e-1)"	"prognostic favourable (2.91e-4)"	20.3	13.4	7.9	29.0	10.9	32.9	13.5	7.9	10.8	12.5	16.6	10.8	11.4	12.3	11.3	12.8	28.9	14.3	14.5	12.1	9.5	9.4	15.1	19.6	24.5	47.4	13.7	6.2	14.3	21.1	14.3	10.6	19.4	11.2	11.1	12.0	12.8	15.8	8.1	8.8	20.2	16.8	9.6	13.9	65.0	13.8	15.2	9.7	17.0	12.7	13.1	24.4	14.9	17.2	2.1	9.3	123.7	21.3	2.3	9.0	9.9	9.6	5.7	4.3	5.5	16.3	16.4	25.5	12.0	15.8	16.2	18.3	14.4	25.6	2.8	14.5	11.8	19.7	6.1	12.2	15.1	8.4	8.4	6.0	5.1	24.3	21.8	6.4	9.7	15.0	20.1	19.2	12.7	29.5	5.2	9.0	16.2	8.2	8.6	6.5	3.0	10.4	5.6	7.2	11.1	19.1	23.7	5.7	4.2	7.2	17.9	17.3	4.8	8.7	19.5	8.2	4.7	12.2	2.6	18.3	10.7	0.1	2.6	9.0	6.0	5.8	13.0	14.8	8.2	20.4	7.4	2.1	7.3	8.1	4.8	1.5	5.1	5.3	123.7	2.3	21.3	9.3	9.0	9.9	7.9	10.9	7.9	10.8	9.5	9.4	13.7	6.2	11.2	9.7
RNF165	"ARKL2, RNF111L2"	ENSG00000141622	"Ring finger protein 165"	Q6ZSG1	18	46326809-46463140	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"brain: 28.6"	"Cell line enhanced"	"Detected in some"		"AF22: 12.5;HaCaT: 6.8;HeLa: 6.7;RPMI-8226: 6.5;SCLC-21H: 12.9;SH-SY5Y: 14.7"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"MAIT T-cell: 1.1;NK-cell: 3.9;plasmacytoid DC: 1.5"	"Group enriched"	"Detected in many"	4	"dendritic cells: 1.5;NK-cells: 3.9;T-cells: 1.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA041615, HPA047798"	Uncertain		Approved	"Nucleoplasm,Plasma membrane"				"Nucleoplasm, Plasma membrane"		"HPA041615: , HPA047798: "	"unprognostic (6.46e-3)"	"unprognostic (7.25e-2)"	"unprognostic (4.55e-2)"	"unprognostic (1.24e-5)"	"unprognostic (3.43e-1)"	"unprognostic (4.57e-2)"	"unprognostic (5.18e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.04e-3)"	"unprognostic (1.95e-1)"	"unprognostic (1.23e-1)"	"unprognostic (2.07e-1)"	"unprognostic (1.87e-5)"	"unprognostic (3.53e-3)"	"unprognostic (1.90e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.64e-1)"	1.9	1.7	9.9	1.0	9.5	0.9	2.1	28.6	13.8	1.0	0.8	1.7	1.7	0.4	1.0	8.4	2.7	3.0	1.0	2.5	6.1	4.4	2.3	8.3	1.0	0.9	2.2	7.2	0.5	1.0	13.1	4.8	0.8	2.0	3.6	0.6	2.7	1.4	3.9	3.6	3.5	1.0	0.7	1.7	5.3	0.7	1.3	1.0	1.7	8.8	1.2	1.3	1.2	1.0	0.0	1.5	0.5	0.0	3.9	1.1	0.0	1.5	0.1	12.5	0.1	0.0	0.0	4.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	6.8	0.5	1.0	0.0	0.0	1.0	0.1	6.7	0.0	0.0	2.8	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.2	0.0	0.0	2.3	1.0	1.7	1.2	2.4	0.5	6.5	0.8	2.1	12.9	14.7	2.3	0.0	0.0	0.3	0.5	0.0	0.0	0.9	0.0	0.4	0.0	0.0	0.0	0.0	4.0	0.4	0.0	0.0	0.5	0.0	0.0	1.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	3.9	0.0	1.5	0.0	0.0	9.9	9.5	28.6	13.8	6.1	4.4	2.2	7.2	2.0	1.0
RNF166	"MGC14381, MGC2647"	ENSG00000158717	"Ring finger protein 166"	Q96A37	16	88696495-88706421	"Predicted intracellular proteins"	"Autophagy, Immunity, Innate immunity, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 63.9"	"Cell line enhanced"	"Detected in all"		"NB-4: 43.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042970			Approved	"Nucleoplasm,Plasma membrane,Cytosol"				Nucleoplasm	"Plasma membrane, Cytosol"	"HPA042970: AB_10796682"	"unprognostic (3.01e-2)"	"unprognostic (6.98e-3)"	"unprognostic (3.96e-2)"	"unprognostic (5.36e-3)"	"unprognostic (1.23e-1)"	"unprognostic (2.71e-2)"	"unprognostic (6.52e-2)"	"unprognostic (5.86e-2)"	"unprognostic (4.88e-2)"	"unprognostic (2.38e-2)"	"prognostic favourable (1.04e-4)"	"unprognostic (3.22e-2)"	"prognostic unfavourable (9.45e-6)"	"unprognostic (1.54e-1)"	"unprognostic (3.91e-2)"	"unprognostic (1.28e-1)"	"unprognostic (2.69e-2)"	9.2	8.1	9.2	22.8	8.9	63.9	10.5	13.7	15.3	6.7	7.2	11.2	3.7	12.0	8.1	8.3	6.4	9.1	12.3	10.0	8.6	7.3	9.6	9.7	20.8	30.5	8.9	6.5	9.7	11.4	5.3	8.5	7.5	8.4	8.9	4.9	11.0	12.1	6.0	14.8	8.2	16.0	8.3	11.1	47.2	10.9	9.2	9.1	21.6	8.8	7.8	23.8	9.7	6.7	2.0	11.8	28.7	12.5	5.5	17.1	9.7	4.1	6.7	5.2	8.2	2.5	2.2	9.9	4.2	2.7	5.0	2.3	4.5	2.7	5.0	5.5	2.4	4.6	3.0	2.8	2.0	2.6	9.0	6.8	4.9	7.6	6.8	6.7	8.7	2.6	2.7	4.0	3.2	5.2	11.3	3.7	2.0	8.2	15.6	43.8	8.5	9.0	14.7	3.3	13.0	2.2	1.9	4.8	5.4	9.6	2.0	5.2	5.7	22.9	7.2	3.8	5.6	5.6	5.1	8.4	4.9	12.2	3.3	25.5	5.2	3.0	12.5	28.7	17.1	9.1	14.8	2.0	10.4	14.8	11.8	1.9	8.7	12.5	20.4	5.5	10.5	7.3	10.5	9.7	9.2	8.9	13.7	15.3	8.6	7.3	8.9	6.5	8.4	9.1
RNF39	"HZFw1, LIRF"	ENSG00000204618	"Ring finger protein 39"	Q9H2S5	6	30070266-30075887	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 28.3;skin 1: 26.4"	"Cell line enhanced"	"Detected in some"		"A-431: 2.9;HEK 293: 2.6;U-266/84: 8.0"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"neutrophil: 1.3"	"Lineage enriched"	"Detected in single"	5	"granulocytes: 1.3"	"Group enriched"	"Detected in some"	4	"cerebral cortex: 8.0;hippocampal formation: 4.2"	"Group enriched"	"Detected in some"	6	"cerebellum: 17.9;cerebral cortex: 9.3;hippocampal formation: 5.7"	"CAB019278, HPA047115"	Uncertain		Approved	"Vesicles,Plasma membrane,Centrosome"				"Vesicles, Plasma membrane, Centrosome"		"CAB019278: , HPA047115: "	"unprognostic (1.05e-2)"	"unprognostic (3.75e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.53e-2)"	"unprognostic (5.72e-3)"	"unprognostic (3.08e-2)"	"unprognostic (4.05e-2)"	"unprognostic (1.38e-1)"	"unprognostic (2.22e-2)"	"unprognostic (1.59e-2)"	"unprognostic (4.45e-3)"	"unprognostic (3.61e-2)"	"unprognostic (2.06e-4)"	"unprognostic (5.61e-2)"	"unprognostic (1.31e-1)"	"unprognostic (2.04e-1)"	"unprognostic (2.57e-2)"	0.3	0.2	0.1	0.3	0.3	0.4	5.1	0.3	0.9	7.3	0.7	0.0	1.1	0.9	0.8	0.3	28.3	0.8	1.1	0.2	0.2	0.1	0.3	0.3	3.6	0.3	0.2	0.0	0.6	2.3	0.4	0.4	9.7	0.3	8.1	0.4	0.6	10.2	0.6	0.4	26.4	0.4	1.0	0.2	0.2	4.3	0.8	0.0	0.3	0.4	10.1	11.7	7.8	12.4	0.0	0.0	1.3	0.0	0.2	0.0	0.0	2.9	0.0	0.7	1.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.4	0.4	0.0	0.0	0.0	1.6	0.0	1.4	0.0	0.5	2.6	1.1	0.3	0.0	0.0	0.1	0.3	0.0	1.9	0.0	0.2	0.0	0.7	0.6	0.0	1.0	0.0	1.3	0.0	0.0	0.3	0.4	0.0	1.9	0.3	0.2	0.0	0.0	0.3	0.2	0.2	0.0	0.0	0.5	0.6	0.0	0.3	1.9	8.0	0.7	0.6	0.1	1.2	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.2	0.0	0.0	0.0	0.0	0.1	0.3	0.3	0.4	0.2	0.1	0.2	0.0	0.3	0.0
ROBO3	"FLJ21044, HGPPS, HGPS, RBIG1"	ENSG00000154134	"Roundabout guidance receptor 3"	Q96MS0	11	124865386-124881470	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Chemotaxis, Differentiation, Neurogenesis"	"Developmental protein, Receptor"	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"epididymis: 20.1"	"Cell line enriched"	"Detected in some"	11	"AF22: 20.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"eosinophil: 1.4"	"Low lineage specificity"	"Detected in many"			"Region enhanced"	"Detected in single"		"cerebral cortex: 2.0"	"Low region specificity"	"Detected in all"			HPA071053			Approved	"Vesicles,Plasma membrane"				"Plasma membrane"	Vesicles	"HPA071053: "	"unprognostic (1.30e-1)"	"unprognostic (2.17e-1)"	"unprognostic (4.95e-3)"	"unprognostic (3.42e-2)"	"unprognostic (3.84e-2)"	"unprognostic (6.25e-2)"	"unprognostic (6.95e-3)"	"unprognostic (9.65e-2)"	"unprognostic (1.56e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.32e-1)"	"unprognostic (7.15e-2)"	"unprognostic (3.75e-8)"	"unprognostic (7.27e-3)"	"unprognostic (2.21e-1)"	"unprognostic (1.47e-1)"	"unprognostic (4.91e-3)"	2.4	1.5	1.5	0.5	1.4	1.3	1.7	0.5	3.1	0.8	0.9	0.5	0.5	1.9	1.8	20.1	0.5	2.1	0.5	1.5	1.5	0.6	0.7	0.5	1.7	0.8	1.1	1.1	7.4	0.5	0.2	0.5	1.5	1.0	1.0	0.2	1.0	1.7	0.5	2.6	0.2	2.2	4.5	0.7	3.0	0.8	1.0	0.5	0.8	1.1	0.5	0.5	0.5	1.0	0.0	1.3	1.4	0.3	0.0	0.8	0.0	0.0	0.0	20.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.1	0.3	0.0	1.5	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.1	0.0	1.2	0.0	0.0	1.7	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.8	0.2	0.0	0.1	0.0	0.0	0.4	0.3	0.0	0.1	0.1	0.0	0.1	0.1	0.0	0.7	1.0	0.0	1.0	0.2	0.0	0.0	0.0	0.5	0.0	0.0	1.4	0.0	0.3	0.4	0.0	0.6	0.3	0.0	0.0	0.2	0.0	0.2	0.0	0.2	1.3	0.8	0.0	1.5	1.4	0.5	2.7	1.5	0.6	1.1	1.1	1.0	0.5
ROBO4	"ECSM4, FLJ20798, MRB"	ENSG00000154133	"Roundabout guidance receptor 4"	Q8WZ75	11	124883691-124898500	"Plasma proteins, Predicted membrane proteins"	"Angiogenesis, Differentiation"	"Developmental protein, Receptor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in some"	10	"HUVEC TERT2: 63.4;TIME: 56.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"myeloid DC: 1.2"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA065212			Approved	"Plasma membrane"			340000000	"Plasma membrane"		"HPA065212: "	"unprognostic (2.86e-1)"	"unprognostic (9.35e-2)"	"unprognostic (2.67e-1)"	"unprognostic (1.07e-1)"	"unprognostic (3.82e-2)"	"unprognostic (6.97e-2)"	"prognostic favourable (4.85e-4)"	"unprognostic (7.94e-2)"	"unprognostic (2.27e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.73e-3)"	"unprognostic (2.17e-1)"	"unprognostic (1.17e-2)"	"prognostic unfavourable (8.73e-4)"	"unprognostic (1.55e-1)"	"unprognostic (4.63e-1)"	"unprognostic (5.15e-2)"	33.3	4.5	4.0	5.6	4.5	0.6	21.6	2.0	5.5	11.1	4.4	4.3	3.7	2.8	10.8	7.8	5.3	7.7	8.5	15.5	4.9	3.0	10.6	6.5	24.9	5.8	4.7	2.8	5.9	3.5	3.8	3.8	23.6	5.5	6.0	1.8	9.2	2.9	4.5	12.5	4.5	4.7	8.4	3.6	33.3	4.3	3.9	3.3	1.0	11.6	9.8	2.5	6.2	5.9	0.0	1.2	0.5	0.2	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.8	0.1	0.3	0.0	0.0	0.0	6.1	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.3	0.7	63.4	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.8	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	56.9	0.3	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	4.0	4.5	2.0	5.5	4.9	3.0	4.7	2.8	5.5	3.3
ROM1	"ROM, TSPAN23"	ENSG00000149489	"Retinal outer segment membrane protein 1"	Q03395	11	62611722-62615120	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion, Sensory transduction, Vision"		"Disease mutation, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"retina: 108.1"	"Cell line enhanced"	"Detected in many"		"HSkMC: 17.8;U-266/84: 18.7"	"Cancer enriched"	"Detected in all"	6	"glioma: 14.9"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"NK-cell: 5.6"	"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA028910	Enhanced		Approved	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		"HPA028910: "	"unprognostic (1.54e-2)"	"unprognostic (1.37e-2)"	"unprognostic (4.24e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.65e-1)"	"unprognostic (2.02e-1)"	"unprognostic (4.05e-1)"	"prognostic favourable (2.20e-4)"	"unprognostic (2.20e-1)"	"unprognostic (9.87e-2)"	"unprognostic (7.65e-3)"	"unprognostic (3.50e-2)"	"prognostic unfavourable (2.85e-6)"	"unprognostic (2.61e-1)"	"unprognostic (4.65e-1)"	"unprognostic (1.02e-1)"	"unprognostic (7.24e-2)"	9.4	4.6	16.3	2.3	15.0	0.9	3.6	5.7	18.8	4.9	3.1	5.1	3.3	2.0	3.8	5.7	4.7	7.4	5.2	2.7	14.7	9.2	2.4	3.2	3.0	2.3	18.1	4.7	13.2	3.2	4.8	2.1	1.6	8.7	3.8	3.0	108.1	2.5	5.9	2.2	3.7	1.7	6.3	21.6	2.5	2.4	3.7	7.7	0.7	3.0	2.2	2.6	3.1	9.2	1.1	0.8	0.8	1.2	5.6	3.2	1.4	2.1	1.2	2.2	4.6	3.2	15.6	0.4	1.4	2.5	3.1	2.0	0.6	3.6	2.0	10.0	8.1	2.7	1.0	2.8	0.8	3.6	1.8	1.8	5.3	2.5	9.2	0.7	0.6	17.8	4.1	3.1	6.4	4.7	2.6	4.6	6.2	5.3	1.1	1.5	0.5	3.2	1.1	1.8	12.7	3.4	1.2	2.3	3.3	3.5	4.0	1.6	5.6	0.9	5.4	5.1	1.9	5.9	1.6	2.0	18.7	1.6	9.5	2.1	1.0	0.0	1.2	0.8	0.9	0.3	2.4	0.7	3.2	0.8	0.6	1.1	1.5	1.8	0.4	5.6	1.1	0.8	0.9	1.4	16.3	15.0	5.7	8.4	14.7	9.2	18.1	4.7	8.7	7.7
RPE		ENSG00000197713	Ribulose-5-phosphate-3-epimerase	Q96AT9	2	210002565-210022259	"Enzymes, Predicted intracellular proteins"	"Carbohydrate metabolism"	Isomerase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"HPA036498, HPA036499"	Approved		Approved	"Nucleoplasm,Plasma membrane,Cytosol"				Cytosol	"Nucleoplasm, Plasma membrane"	"HPA036498: , HPA036499: AB_10670109"	"unprognostic (5.07e-2)"	"unprognostic (8.15e-2)"	"unprognostic (3.06e-1)"	"unprognostic (2.34e-3)"	"unprognostic (2.00e-1)"	"unprognostic (2.53e-2)"	"prognostic unfavourable (1.42e-6)"	"unprognostic (1.59e-3)"	"unprognostic (1.69e-2)"	"unprognostic (1.28e-1)"	"prognostic unfavourable (7.00e-6)"	"unprognostic (2.33e-2)"	"unprognostic (2.55e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.95e-1)"	"unprognostic (2.89e-1)"	"unprognostic (5.84e-2)"	19.4	26.9	20.6	16.7	28.0	14.6	22.6	26.4	27.7	18.7	19.7	23.3	20.7	17.4	27.8	21.5	24.0	17.6	17.3	17.2	21.1	21.0	26.7	23.3	19.4	21.6	21.7	21.7	22.9	14.1	14.8	41.9	24.4	18.6	20.5	26.6	18.9	18.3	27.9	12.3	17.2	16.0	27.1	25.8	15.6	19.8	11.9	19.7	23.5	25.2	14.5	23.2	24.1	20.2	8.6	28.9	8.0	20.5	30.5	10.7	11.3	21.0	27.2	17.7	17.8	28.8	27.9	30.4	27.7	22.2	26.3	35.4	39.2	32.2	14.2	18.2	21.4	20.7	26.0	29.5	40.3	17.0	18.4	26.2	40.0	36.5	39.3	27.8	20.2	19.5	29.4	30.2	39.4	34.2	26.4	19.8	21.6	33.5	15.1	24.2	26.0	20.0	19.0	21.1	20.3	30.4	31.4	21.3	12.2	23.4	22.9	18.5	19.7	32.0	28.0	35.4	23.5	17.2	25.5	11.8	15.0	30.4	25.6	27.5	22.8	6.9	17.3	8.0	10.2	20.5	8.9	8.6	8.0	9.6	28.9	8.4	10.7	9.6	1.7	30.5	13.7	10.6	10.7	11.3	20.6	28.0	26.4	27.7	21.1	21.0	21.7	21.7	18.6	19.7
RPEL1		ENSG00000235376	"Ribulose-5-phosphate-3-epimerase like 1"	Q2QD12	10	103245887-103248016	"Enzymes, Predicted intracellular proteins"	"Carbohydrate metabolism"	Isomerase		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"blood: 1.4;brain: 1.2;pituitary gland: 1.2"	"Cell line enhanced"	"Detected in some"		"HeLa: 1.1;NB-4: 1.0"	"Not detected"	"Not detected"							"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"											"HPA036498, HPA036499"	Approved		Approved	"Nucleoplasm,Plasma membrane,Cytosol"				Cytosol	"Nucleoplasm, Plasma membrane"	"HPA036498: , HPA036499: AB_10670109"	"unprognostic (7.52e-2)"	"unprognostic (1.69e-1)"	"unprognostic (4.78e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.45e-1)"	"unprognostic (1.83e-1)"		"unprognostic (6.01e-2)"	"unprognostic (1.15e-1)"	"unprognostic (8.91e-2)"	"unprognostic (6.59e-2)"	"unprognostic (4.34e-1)"	"unprognostic (1.14e-1)"	"unprognostic (5.69e-2)"	"unprognostic (1.62e-1)"	"unprognostic (6.72e-2)"	"unprognostic (5.06e-2)"	0.0	0.1	0.1	1.0	0.3	0.1	0.1	1.2	0.2	0.0	0.0			0.3	0.4	0.4	0.1	0.0	0.0	0.1	0.1	0.3	0.3	0.0	0.0	0.4	0.1		0.0	0.8	0.0	1.2	0.2		0.1	0.0		0.0	0.0	0.4	0.0	0.4	0.0	0.2	0.1	0.0	0.2			0.1		0.1	0.0	0.0	0.4	1.0	0.3	0.7	1.4	0.6	0.2	0.5	0.5	0.1	0.0	0.0	0.0	0.2	0.3	0.2	0.0	0.2	0.4	0.7	0.1	0.4	0.0	0.2	0.0	0.0	0.0	0.6	0.0	0.3	1.1	0.3	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.1	1.0	0.7	0.0	0.0	0.1	0.3	0.5	0.2	0.3	0.1	0.3	0.4	0.2	0.1	0.4	0.0	0.1	0.9	0.1	0.2	0.3	0.1	0.3	0.7	0.4	0.1	0.3	0.7	0.2	0.5	0.7	0.5	0.4	0.4	0.3	1.0	0.4	0.5	0.6	0.0	1.4	0.4	0.3	0.4	0.2										
RPGRIP1L	"CORS3, FTM, JBTS7, KIAA1005, MKS5, NPHP8, PPP1R134"	ENSG00000103494	"RPGRIP1 like"	Q68CZ1	16	53598153-53703938	"Disease related genes, Predicted intracellular proteins"			"Ciliopathy, Disease mutation, Joubert syndrome, Meckel syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pituitary gland: 25.8"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039405, HPA040530"	Uncertain		Supported	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		"HPA039405: AB_10794636, HPA040530: "	"prognostic unfavourable (6.93e-4)"	"unprognostic (1.52e-1)"	"unprognostic (2.19e-3)"	"unprognostic (2.26e-2)"	"unprognostic (3.43e-2)"	"unprognostic (1.46e-2)"	"unprognostic (1.26e-4)"	"unprognostic (1.24e-1)"	"unprognostic (1.05e-1)"	"unprognostic (3.63e-1)"	"unprognostic (1.05e-1)"	"unprognostic (3.31e-1)"	"prognostic unfavourable (5.95e-4)"	"unprognostic (5.22e-3)"	"unprognostic (1.52e-1)"	"unprognostic (4.92e-4)"	"unprognostic (5.95e-2)"	3.0	6.5	8.0	3.8	13.8	2.7	6.1	5.3	12.7	6.3	3.3	2.4	6.8	2.4	7.3	7.8	3.9	11.7	4.9	3.3	9.1	9.9	5.5	2.2	3.5	3.1	5.9	13.2	6.5	3.2	18.5	25.8	3.8	9.0	5.2	3.5	1.7	3.4	5.3	2.3	3.6	2.0	6.3	3.5	1.9	3.5	20.9	4.7	3.1	7.6	2.3	3.1	4.4	3.6	4.9	2.0	1.8	1.0	2.1	5.6	1.3	8.9	11.2	10.1	9.2	12.1	11.8	4.4	10.0	6.6	9.4	2.7	6.1	7.3	6.0	7.2	10.3	10.5	8.4	9.6	16.7	3.6	5.9	2.2	9.4	6.1	5.0	5.4	4.1	7.4	5.9	10.5	6.5	7.0	5.5	3.5	13.8	3.4	8.9	3.8	6.4	5.3	15.1	13.8	7.2	12.1	2.4	17.5	6.6	12.4	5.2	4.6	7.9	4.3	6.3	10.2	7.3	8.4	8.9	4.6	5.2	10.7	15.5	3.3	6.0	1.7	0.9	1.1	3.6	1.0	3.5	3.2	2.6	3.3	0.8	4.9	2.6	5.6	1.8	2.1	1.0	2.0	2.1	1.3	8.0	13.8	5.3	12.7	9.1	9.9	5.9	13.2	9.0	4.7
RPIA		ENSG00000153574	"Ribose 5-phosphate isomerase A"	P49247	2	88691644-88750935	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		Isomerase	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042620, HPA057954"	Approved		Approved	"Nucleoplasm,Vesicles,Plasma membrane"			4100000	"Nucleoplasm, Vesicles, Plasma membrane"		"HPA042620: AB_10793980, HPA057954: "	"unprognostic (3.35e-2)"	"unprognostic (1.35e-2)"	"unprognostic (6.96e-2)"	"unprognostic (9.24e-2)"	"unprognostic (4.31e-1)"	"unprognostic (8.24e-2)"	"prognostic unfavourable (1.46e-5)"	"unprognostic (2.73e-3)"	"unprognostic (1.82e-3)"	"unprognostic (8.70e-2)"	"unprognostic (8.82e-2)"	"unprognostic (2.79e-1)"	"prognostic unfavourable (8.53e-6)"	"unprognostic (3.47e-2)"	"unprognostic (2.53e-1)"	"unprognostic (1.01e-2)"	"unprognostic (8.79e-3)"	12.9	8.8	6.6	15.6	7.0	43.0	12.1	11.1	6.4	8.1	12.7	6.1	11.0	12.4	11.1	7.3	18.3	8.5	14.0	10.9	5.0	4.9	6.8	6.2	9.0	16.2	7.2	3.8	11.7	26.5	3.6	11.4	26.1	6.5	8.8	13.4	6.0	12.6	8.5	17.6	9.2	12.7	7.7	5.1	15.4	10.4	8.9	7.6	30.7	9.6	10.5	19.3	8.1	11.8	18.5	14.1	21.4	12.5	13.3	22.4	11.6	8.5	5.0	10.2	8.0	7.2	7.4	22.3	4.8	4.5	7.9	5.4	17.8	11.4	43.7	10.4	5.5	5.2	12.6	4.0	12.5	20.7	16.5	17.5	3.2	17.5	7.3	32.0	12.9	6.8	3.4	7.0	11.0	11.1	18.7	7.6	7.4	13.4	35.1	28.0	9.2	8.2	18.4	12.1	10.6	6.5	13.8	7.3	8.3	5.7	7.4	11.0	4.0	13.2	6.3	4.7	12.4	15.4	13.6	5.9	4.8	43.7	4.8	29.1	6.7	5.5	9.7	21.4	11.1	9.8	14.2	18.5	15.5	16.4	14.1	15.4	22.4	18.4	2.3	13.3	12.5	6.8	12.6	11.6	6.6	7.0	11.1	6.4	5.0	4.9	7.2	3.8	6.5	7.6
RPL36A	"L36A, RPL44"	ENSG00000241343	"Ribosomal protein L36a"	P83881	X	101390824-101396154	"Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"HPA063979, HPA077586"	Uncertain		Supported	"Endoplasmic reticulum,Plasma membrane,Cytosol"				"Endoplasmic reticulum, Cytosol"	"Plasma membrane"	"HPA063979: , HPA077586: "	"unprognostic (3.38e-2)"	"unprognostic (2.11e-2)"	"unprognostic (7.04e-2)"	"unprognostic (2.06e-1)"	"unprognostic (1.02e-2)"	"unprognostic (4.19e-3)"	"unprognostic (4.15e-3)"	"unprognostic (1.28e-1)"	"unprognostic (2.86e-2)"	"unprognostic (2.77e-1)"	"unprognostic (2.19e-2)"	"unprognostic (8.17e-2)"	"prognostic unfavourable (8.81e-11)"	"unprognostic (1.87e-2)"	"unprognostic (4.50e-3)"	"unprognostic (3.57e-3)"	"unprognostic (4.06e-2)"	62.9	40.7	50.7	81.5	53.8	139.8	136.1	27.7	46.8	65.3	71.0	25.1	53.4	45.6	67.5	71.4	77.1	59.0	60.6	54.9	43.1	31.1	47.3	60.1	43.4	190.1	42.1	50.6	165.3	171.4	15.0	35.1	44.7	41.8	55.9	68.3	26.1	158.1	71.5	125.7	96.5	54.1	65.5	44.6	67.9	54.6	26.3	32.6	60.8	69.3	118.6	104.0	71.9	74.0	162.9	113.2	13.7	74.2	86.7	175.5	199.2	121.7	65.9	101.3	49.9	124.9	224.1	64.8	93.8	103.0	123.1	188.2	78.1	62.6	236.0	93.9	77.9	82.3	151.4	131.4	128.4	83.0	166.1	109.1	116.3	71.9	179.6	198.4	105.2	212.6	248.2	99.7	185.0	113.9	131.8	126.9	99.2	175.4	91.8	236.7	134.6	134.1	86.2	221.7	184.9	112.6	50.8	68.0	135.8	87.6	98.4	167.9	47.5	224.6	105.1	36.6	89.6	101.1	95.1	108.0	154.2	186.5	45.0	295.8	39.0	12.5	74.2	13.7	86.6	73.6	140.3	162.9	162.3	120.6	111.4	134.0	175.5	156.7	7.2	86.7	70.4	113.2	84.9	199.2	50.7	53.8	27.7	46.8	43.1	31.1	42.1	50.6	41.8	32.6
RPL36A-HNRNPH2		ENSG00000257529	"RPL36A-HNRNPH2 readthrough"		X	101391011-101412297	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ: 14.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											HPA077586			Approved	"Endoplasmic reticulum,Plasma membrane,Cytosol"				"Endoplasmic reticulum, Cytosol"	"Plasma membrane"	"HPA077586: "	"unprognostic (3.69e-1)"	"unprognostic (1.44e-2)"	"unprognostic (2.91e-1)"		"unprognostic (4.65e-3)"	"unprognostic (1.63e-1)"	"unprognostic (2.96e-1)"	"unprognostic (1.79e-1)"	"unprognostic (5.34e-2)"	"unprognostic (2.27e-2)"	"unprognostic (2.15e-2)"	"unprognostic (2.56e-1)"	"unprognostic (1.49e-3)"	"unprognostic (2.04e-4)"	"unprognostic (1.56e-1)"	"unprognostic (4.81e-2)"	"unprognostic (3.94e-1)"	6.7	6.0	3.7	8.5	5.0	7.2	6.1	15.3	5.2	5.9	9.9	1.4	4.9	1.5	6.7	7.2	6.9	4.5	5.8	5.1	3.7	5.4	4.3	5.8	4.5	22.1	4.6	4.6	12.7	19.7	1.5	3.6	4.2	3.5	5.2	4.5	1.5	18.1	7.2	14.0	5.3	4.4	6.4	5.0	6.5	4.3	2.5	2.3	5.9	6.9	13.1	6.2	7.3	7.5	16.2	19.8	13.6	16.1	10.6	14.3	22.4	3.7	0.0	5.1	1.0	2.3	5.1	1.7	14.6	0.7	3.0	2.2	0.0	2.2	3.4	4.5	2.0	0.4	4.3	0.6	1.0	4.3	1.7	4.1	2.7	1.3	3.9	3.5	1.7	5.5	2.8	1.6	1.1	1.8	1.4	4.3	3.9	0.6	5.6	2.2	0.3	2.0	7.1	5.3	2.8	1.3	0.6	3.1	4.5	1.8	1.6	1.8	1.7	2.0	2.1	0.5	2.8	2.5	2.5	3.7	6.3	1.2	1.4	3.4	3.1	7.5	14.9	13.6	13.1	16.1	11.5	16.2	12.3	12.4	19.8	15.4	14.3	13.6	4.7	10.6	9.9	10.7	9.0	22.4	3.7	5.0	15.3	5.2	3.7	5.4	4.6	4.6	3.5	2.3
RPL36AL	RPL36A	ENSG00000165502	"Ribosomal protein L36a like"	Q969Q0	14	49618519-49620685	"Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											HPA077586			Approved	"Endoplasmic reticulum,Plasma membrane,Cytosol"				"Endoplasmic reticulum, Cytosol"	"Plasma membrane"	"HPA077586: "	"unprognostic (1.55e-2)"	"unprognostic (2.44e-2)"	"unprognostic (8.73e-2)"	"unprognostic (3.15e-3)"	"unprognostic (1.52e-1)"	"unprognostic (2.55e-2)"	"unprognostic (1.31e-1)"	"unprognostic (6.37e-2)"	"unprognostic (4.18e-2)"	"unprognostic (1.38e-3)"	"unprognostic (2.29e-1)"	"unprognostic (4.72e-1)"	"unprognostic (1.16e-3)"	"unprognostic (8.32e-2)"	"unprognostic (2.80e-1)"	"prognostic favourable (2.83e-4)"	"unprognostic (1.00e-1)"	60.3	55.8	45.9	46.5	40.9	68.2	66.5	35.9	37.7	69.3	74.3	29.2	56.6	52.1	54.9	102.1	61.8	45.9	31.5	48.2	38.0	34.4	69.9	139.2	54.8	63.6	45.3	34.1	105.3	131.9	35.7	62.0	56.9	40.3	62.9	50.5	30.8	85.2	68.6	82.4	40.8	99.8	71.1	48.0	78.8	61.8	36.7	41.8	65.4	72.5	67.6	71.0	87.6	63.9	105.8	112.7	119.5	66.7	84.5	132.0	139.8	72.2	54.5	39.5	22.8	56.8	78.5	23.1	59.7	66.0	56.0	63.5	56.7	50.1	95.3	57.0	49.4	52.2	33.4	50.9	65.6	32.7	38.5	59.8	57.6	73.2	72.0	95.3	51.4	80.3	78.2	42.8	57.9	70.8	37.9	84.9	43.0	93.3	56.1	85.7	22.2	56.1	35.5	62.1	51.1	84.9	110.0	34.6	21.4	52.6	41.7	59.9	90.4	53.1	54.5	35.1	55.9	45.6	45.9	51.8	52.9	96.3	25.4	43.2	33.4	119.5	66.7	99.6	98.6	63.2	132.0	105.8	129.3	123.0	68.7	79.9	120.7	112.6	74.0	84.5	55.9	112.7	118.2	139.8	45.9	40.9	35.9	37.7	38.0	34.4	45.3	34.1	40.3	41.8
RRAD	"RAD, REM3"	ENSG00000166592	"RRAD, Ras related glycolysis inhibitor and calcium channel regulator"	P55042	16	66921679-66925644	"Predicted intracellular proteins"		Calmodulin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"skeletal muscle: 246.0"	"Group enriched"	"Detected in some"	8	"HDLM-2: 60.8;U-87 MG: 17.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA041755	Uncertain		Approved	"Nucleoplasm,Golgi apparatus,Plasma membrane"				"Plasma membrane"	"Nucleoplasm, Golgi apparatus"	"HPA041755: "	"unprognostic (1.40e-2)"	"unprognostic (2.78e-2)"	"unprognostic (9.77e-2)"	"unprognostic (3.84e-2)"	"unprognostic (1.36e-2)"	"unprognostic (1.11e-1)"	"unprognostic (3.74e-2)"	"unprognostic (2.37e-1)"	"unprognostic (1.66e-1)"	"unprognostic (2.46e-2)"	"unprognostic (2.12e-2)"	"unprognostic (1.08e-1)"	"unprognostic (2.06e-3)"	"unprognostic (3.46e-2)"	"unprognostic (3.33e-2)"	"unprognostic (2.04e-2)"	"unprognostic (4.80e-3)"	7.3	2.1	0.4	2.4	2.7	1.3	5.0	1.2	1.7	4.7	2.0	3.2	1.8	1.2	3.3	8.5	20.4	6.3	4.1	61.2	0.7	0.6	5.6	0.8	6.3	1.3	1.5	0.8	4.7	0.7	1.0	2.0	10.7	4.6	4.2	0.4	3.9	4.3	1.4	246.0	2.2	1.2	5.7	1.7	0.8	1.7	2.3	1.2	0.3	3.9	14.7	4.3	4.5	5.7	0.0	0.0	0.0	0.1	0.0	0.8	0.1	0.0	2.8	0.0	0.0	0.0	0.3	0.1	1.6	0.1	0.2	1.4	0.6	1.9	0.0	1.6	0.1	0.1	0.0	0.1	0.2	60.8	0.1	0.0	0.0	0.7	2.7	0.0	0.2	0.8	0.3	4.9	0.0	0.0	0.0	1.2	0.2	0.0	0.0	0.1	0.2	0.1	0.2	0.0	0.0	0.3	0.0	0.1	0.2	1.4	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.1	0.1	2.0	0.0	0.1	17.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.4	2.7	1.2	1.0	0.7	0.6	1.5	0.8	4.6	1.2
RSAD1	FLJ11164	ENSG00000136444	"Radical S-adenosyl methionine domain containing 1"	Q9HA92	17	50478800-50485975	"Predicted intracellular proteins"		Chaperone		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA022436, HPA022967"	Approved		Approved	"Nucleoplasm,Plasma membrane,Cytosol"				Cytosol	"Nucleoplasm, Plasma membrane"	"HPA022436: AB_2180789, HPA022967: AB_1856484"	"unprognostic (8.21e-2)"	"unprognostic (4.11e-3)"	"unprognostic (3.72e-2)"	"unprognostic (1.83e-2)"	"unprognostic (3.49e-2)"	"unprognostic (2.93e-2)"	"unprognostic (6.01e-2)"	"unprognostic (1.07e-2)"	"unprognostic (2.52e-1)"	"unprognostic (1.13e-2)"	"prognostic favourable (5.04e-4)"	"unprognostic (1.06e-1)"	"unprognostic (1.65e-2)"	"unprognostic (4.89e-2)"	"unprognostic (2.95e-1)"	"unprognostic (7.85e-2)"	"unprognostic (3.22e-2)"	13.5	22.2	16.1	16.8	23.9	8.9	14.1	32.2	20.3	16.8	13.1	12.7	13.5	13.9	13.8	15.1	8.8	12.9	13.6	25.7	13.7	11.6	18.5	28.2	14.0	16.6	19.0	13.7	20.9	46.0	20.3	12.9	10.1	16.3	12.8	14.9	12.6	21.4	14.0	37.0	13.5	12.0	13.7	23.6	16.7	16.0	8.8	19.1	11.6	15.8	20.9	14.0	11.7	12.4	7.4	5.8	3.8	4.6	6.7	10.9	5.1	6.2	21.4	10.3	16.9	17.6	14.5	3.7	11.0	10.8	14.2	12.1	21.1	8.0	17.1	24.5	7.7	6.0	11.6	15.4	12.3	18.8	21.1	22.9	9.6	20.5	12.3	13.8	16.1	10.5	17.0	9.4	18.3	13.8	17.6	16.3	11.9	14.7	23.0	10.1	4.1	23.1	9.5	11.8	15.3	17.2	9.6	5.6	19.3	2.8	13.3	14.2	19.9	14.1	9.7	14.9	15.9	11.3	12.9	25.4	17.8	6.6	11.1	19.8	10.3	1.1	4.1	3.8	9.5	4.6	9.9	5.1	8.2	9.4	5.1	7.4	10.9	10.5	0.0	6.7	4.3	5.8	6.2	5.1	16.1	23.9	32.2	20.3	13.7	11.6	19.0	13.7	16.3	19.1
RSBN1L	"FLJ42526, FLJ45813, MGC71764"	ENSG00000187257	"Round spermatid basic protein 1 like"	Q6PCB5	7	77696443-77783022	"Cancer-related genes, Predicted intracellular proteins"		"Dioxygenase, Oxidoreductase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 31.5"	"Lineage enriched"	"Detected in all"	4	"granulocytes: 31.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020406, HPA020413"	Approved		Supported	"Nuclear speckles,Plasma membrane"				"Nuclear speckles"	"Plasma membrane"	"HPA020406: AB_1856488, HPA020413: AB_2253910"	"unprognostic (2.02e-1)"	"unprognostic (2.61e-2)"	"unprognostic (2.41e-1)"	"unprognostic (1.72e-1)"	"unprognostic (1.34e-1)"	"unprognostic (3.62e-2)"	"unprognostic (2.43e-2)"	"prognostic favourable (3.74e-4)"	"unprognostic (1.27e-2)"	"unprognostic (3.78e-2)"	"unprognostic (1.25e-1)"	"unprognostic (9.02e-2)"	"unprognostic (7.30e-3)"	"unprognostic (1.93e-1)"	"unprognostic (1.46e-1)"	"unprognostic (2.25e-3)"	"unprognostic (1.53e-3)"	12.9	10.6	15.0	22.1	14.6	9.5	15.5	28.7	17.0	22.8	23.5	8.9	12.1	11.1	17.2	13.6	15.0	14.2	13.4	10.6	12.4	10.3	12.0	14.9	15.7	18.2	11.1	11.0	19.2	14.9	19.5	16.2	12.2	11.8	18.8	15.1	13.9	14.0	15.4	13.6	11.7	14.9	18.0	11.0	20.7	14.3	29.8	13.8	34.5	21.1	6.7	18.0	23.6	28.2	7.2	7.0	31.5	4.0	3.0	5.2	1.2	8.8	6.8	11.4	20.0	8.0	10.3	5.6	6.6	7.1	9.4	10.8	8.4	15.9	18.2	2.6	6.8	7.7	15.5	8.5	13.5	9.8	8.3	14.5	10.8	8.3	6.8	17.8	13.7	7.3	6.2	8.6	9.5	7.7	19.6	19.2	9.7	10.2	15.2	17.9	8.1	6.1	15.9	11.4	19.1	5.9	11.7	13.5	14.1	10.0	18.2	7.2	11.1	9.5	7.4	14.1	13.0	8.4	10.0	8.6	9.1	29.3	6.7	16.5	9.2	9.1	4.0	6.4	5.2	2.9	3.9	5.4	4.5	3.8	2.2	7.2	4.3	4.7	31.5	3.0	3.2	7.0	4.5	1.2	15.0	14.6	28.7	17.0	12.4	10.3	11.1	11.0	11.8	13.8
RSPH3	"dJ111C20.1, RSHL2, RSP3"	ENSG00000130363	"Radial spoke head 3 homolog"	Q86UC2	6	158972871-159000187	"Disease related genes, Predicted intracellular proteins"			"Ciliopathy, Primary ciliary dyskinesia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 13.0"	"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA039109, HPA040230"	Approved		Approved	"Vesicles,Plasma membrane,Cytosol"				"Vesicles, Plasma membrane, Cytosol"		"HPA039109: AB_10794423, HPA040230: AB_10796119"	"unprognostic (6.18e-3)"	"unprognostic (3.62e-3)"	"unprognostic (4.54e-2)"	"unprognostic (6.20e-2)"	"unprognostic (1.88e-1)"	"unprognostic (9.18e-2)"	"unprognostic (1.14e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.15e-1)"	"unprognostic (6.74e-3)"	"unprognostic (6.98e-2)"	"unprognostic (2.52e-1)"	"prognostic favourable (2.19e-4)"	"unprognostic (5.89e-2)"	"unprognostic (1.67e-1)"	"unprognostic (5.14e-2)"	"unprognostic (1.79e-2)"	4.9	9.0	7.1	3.8	9.8	3.1	6.2	6.3	12.7	6.8	8.2	7.0	14.3	11.3	7.4	12.8	15.5	10.7	6.0	6.6	8.0	6.8	10.7	5.4	8.5	2.6	4.8	10.6	7.3	8.6	25.9	14.4	5.5	10.4	8.9	6.5	5.5	10.3	14.9	3.8	7.6	12.2	6.6	6.0	3.9	7.5	24.3	7.0	2.1	12.8	5.1	3.9	9.1	8.4	2.3	5.8	13.0	7.7	1.8	1.8	1.6	9.9	5.1	2.3	5.4	5.4	6.9	2.9	7.1	8.2	2.8	3.7	2.0	6.0	2.1	6.5	7.5	7.6	1.5	6.6	3.2	4.8	4.4	2.7	5.0	3.4	5.2	2.5	1.9	8.5	11.8	4.6	8.9	2.7	3.1	3.4	4.6	5.6	1.5	3.1	1.5	3.4	2.4	0.4	2.1	8.8	3.2	3.5	4.4	13.2	4.4	2.5	5.4	6.2	6.4	2.9	7.4	5.6	3.8	3.6	6.9	1.8	12.5	3.3	4.6	0.7	5.2	0.6	0.8	3.6	1.8	1.3	1.2	1.6	5.4	2.3	1.0	1.4	13.0	1.8	7.7	5.8	1.4	1.6	7.1	9.8	6.3	12.7	8.0	6.8	4.8	10.6	10.4	7.0
RTL3	"FLJ38865, Mar3, Mart3, SIRH9, ZCCHC5, ZHC5"	ENSG00000179300	"Retrotransposon Gag like 3"	Q8N8U3	X	78656069-78659328	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"endometrium 1: 2.5;intestine: 2.6;smooth muscle: 2.7;stomach 1: 3.2"	"Cell line enhanced"	"Detected in some"		"BJ hTERT+ SV40 Large T+: 2.4;BJ hTERT+ SV40 Large T+ RasG12V: 2.6;fHDF/TERT166: 4.0;HBF TERT88: 5.4;hTEC/SVTERT24-B: 3.9;RH-30: 4.7;U-251 MG: 3.4"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA051991, HPA053174, HPA075136"	Uncertain		Approved	"Nucleoplasm,Golgi apparatus,Plasma membrane"				Nucleoplasm	"Golgi apparatus, Plasma membrane"	"HPA051991: , HPA053174: , HPA075136: "	"unprognostic (3.43e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.29e-1)"			"unprognostic (6.74e-2)"		"unprognostic (5.11e-2)"	"unprognostic (8.64e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.69e-2)"	"unprognostic (2.85e-1)"	"unprognostic (4.00e-6)"	"unprognostic (1.53e-2)"	"unprognostic (3.64e-1)"		"unprognostic (2.49e-1)"	0.6	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.2	2.6			0.2	2.5	0.2	0.5	0.4	0.5	2.3	0.0	0.0	0.0	0.0	0.6	0.0	0.0		0.2	0.2	0.0	0.0	0.0		0.2	0.5		0.7	0.0	0.1	0.3	1.1	2.7	0.0	0.0	3.2	0.0			0.1		0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	1.9	2.4	2.6	0.0	0.0	0.0	0.1	4.0	0.0	0.0	0.0	5.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	3.9	0.0	0.0	0.0	0.1	1.3	0.0	0.0	0.1	0.0	0.0	0.2	4.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.1	1.4	0.2	3.4	0.2	0.0	0.0	1.3	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
RTL4	"FLJ46608, Mar4, Mart4, SIRH11, ZCCHC16"	ENSG00000187823	"Retrotransposon Gag like 4"	Q6ZR62	X	112454500-112457112	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	4	"kidney: 3.5;liver: 4.7"	"Cell line enhanced"	"Detected in single"		"NTERA-2: 2.0"	"Group enriched"	"Detected in some"	8	"testis cancer: 1.4;thyroid cancer: 3.9"					"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA003272	Uncertain		Approved	"Nucleoplasm,Plasma membrane,Cytosol"				Nucleoplasm	"Plasma membrane, Cytosol"	"HPA003272: AB_2257414"							"unprognostic (9.86e-2)"						"unprognostic (2.04e-4)"		"unprognostic (6.35e-2)"	"unprognostic (5.33e-3)"		0.0	0.0	0.3	0.0	0.2	0.0	0.0	0.4	0.6	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.9	3.5	4.7	0.0	0.0	0.7		0.0	0.4	0.0	0.1	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2			0.3		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.0	0.0	0.1	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
RYR2	"ARVC2, ARVD2, VTSIP"	ENSG00000198626	"Ryanodine receptor 2"	Q92736	1	237042205-237833988	"Disease related genes, FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Transporters"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Calmodulin-binding, Developmental protein, Ion channel, Ligand-gated ion channel, Receptor"	"Cardiomyopathy, Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"heart muscle: 106.6"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 7.7;HEK 293: 10.4;K-562: 3.2;NB-4: 2.7;NTERA-2: 3.9;U-937: 4.8"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA020028	Approved		Approved	"Nucleoplasm,Plasma membrane,Cytosol"				"Nucleoplasm, Plasma membrane, Cytosol"		"HPA020028: AB_1856528"	"unprognostic (5.23e-3)"	"unprognostic (2.15e-2)"	"unprognostic (5.02e-4)"	"unprognostic (6.26e-2)"	"unprognostic (8.74e-2)"	"unprognostic (2.99e-3)"	"unprognostic (5.28e-2)"	"unprognostic (1.45e-3)"	"unprognostic (2.69e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.10e-1)"	"unprognostic (4.04e-2)"	"unprognostic (0.00e+0)"	"unprognostic (2.36e-2)"	"unprognostic (1.42e-1)"	"unprognostic (3.13e-2)"	"unprognostic (1.06e-2)"	1.1	0.9	6.2	0.9	18.7	0.5	1.1	14.8	10.5	1.3	1.2	0.0	1.2	0.7	1.1	0.7	1.8	1.0	1.8	106.6	5.7	1.1	0.9	0.9	1.4	0.6	1.0	7.3	2.2	4.2	0.5	2.0	1.1	1.6	2.0	0.8	0.2	0.9	1.4	0.9	1.0	1.0	4.6	1.0	1.0	1.2	1.1	3.0	0.0	2.7	0.0	0.6	1.2	1.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.6	0.3	0.0	0.3	0.5	0.0	0.0	7.7	10.4	2.1	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	3.2	0.2	0.0	0.0	0.0	2.7	3.9	0.4	0.0	0.1	0.1	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	4.8	0.0	0.0	0.0	0.0	0.1	0.0	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	6.2	18.7	14.8	10.5	5.7	1.1	1.0	7.3	1.6	3.0
S100A13		ENSG00000189171	"S100 calcium binding protein A13"	Q99584	1	153618787-153631360	"Predicted intracellular proteins, Predicted secreted proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"RPTEC TERT1: 99.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"NK-cell: 19.4"	"Group enriched"	"Detected in many"	5	"dendritic cells: 8.4;NK-cells: 19.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019592, CAB025494"	Approved		Approved	"Nucleoplasm,Nucleoli,Plasma membrane,Cytosol"	"Secreted in other tissues"			"Plasma membrane, Cytosol"	"Nucleoplasm, Nucleoli"	"CAB025494: , HPA019592: AB_10601499"	"unprognostic (1.50e-2)"	"unprognostic (9.09e-2)"	"unprognostic (2.08e-2)"	"unprognostic (1.45e-1)"	"unprognostic (7.77e-2)"	"unprognostic (9.72e-3)"	"unprognostic (1.75e-3)"	"unprognostic (9.93e-2)"	"unprognostic (6.48e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.21e-2)"	"unprognostic (4.83e-3)"	"prognostic unfavourable (1.97e-4)"	"unprognostic (3.43e-2)"	"unprognostic (8.10e-2)"	"unprognostic (1.82e-3)"	"unprognostic (1.72e-2)"	38.2	20.9	49.6	13.8	48.3	1.2	61.8	11.5	28.2	39.1	32.3	25.0	13.9	9.4	23.5	25.0	19.9	34.5	32.0	56.3	30.3	32.0	28.0	20.2	23.3	12.7	54.2	32.7	29.9	13.9	45.9	9.7	21.6	37.7	23.0	19.3	21.1	19.8	21.7	73.8	14.1	13.7	27.2	38.9	13.7	11.9	10.3	28.5	2.4	79.0	28.2	14.6	21.1	16.0	2.6	8.4	3.0	1.5	19.4	0.9	0.8	22.1	18.6	21.5	13.6	19.0	55.8	7.7	30.8	48.9	18.7	21.5	18.0	24.8	0.5	58.6	52.3	21.2	8.9	19.2	16.5	0.0	8.3	1.4	23.3	15.3	12.6	0.6	4.8	44.8	7.3	16.7	18.1	42.2	7.1	0.0	58.0	78.7	0.0	0.4	17.3	56.1	3.5	22.3	0.1	99.4	17.0	6.6	0.2	66.0	34.0	66.6	27.7	0.8	59.7	12.9	7.2	17.2	37.1	0.2	0.5	1.0	23.1	0.3	7.5	3.0	1.5	0.1	0.3	0.7	0.6	2.6	0.3	0.2	5.0	1.6	0.5	0.3	0.2	19.4	0.9	8.4	0.9	0.8	49.6	48.3	11.5	28.2	30.3	32.0	54.2	32.7	37.7	28.5
S100A14	"BCMP84, S100A15"	ENSG00000189334	"S100 calcium binding protein A14"	Q9HCY8	1	153614255-153616986	"Plasma proteins, Predicted intracellular proteins"	Apoptosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 256.0;tongue: 189.3"	"Group enriched"	"Detected in some"	10	"A-431: 62.5;HaCaT: 86.8;HBEC3-KT: 123.0;hTCEpi: 183.4;SK-BR-3: 129.6"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	11	"plasmacytoid DC: 1.1"	"Lineage enriched"	"Detected in single"	11	"dendritic cells: 1.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA027613	Enhanced		Approved	"Nuclear bodies,Plasma membrane,Cell Junctions,Cytosol"			110000	"Nuclear bodies, Plasma membrane, Cell Junctions, Cytosol"		"HPA027613: AB_10602298"	"unprognostic (1.73e-1)"	"unprognostic (1.85e-1)"	"unprognostic (1.48e-1)"	"unprognostic (3.94e-2)"	"unprognostic (1.75e-2)"	"unprognostic (6.27e-2)"	"unprognostic (2.30e-2)"	"unprognostic (9.48e-2)"	"unprognostic (2.50e-1)"	"unprognostic (2.16e-1)"	"unprognostic (2.75e-3)"	"unprognostic (2.89e-1)"	"unprognostic (3.16e-3)"	"unprognostic (8.41e-2)"	"unprognostic (1.80e-1)"	"unprognostic (4.81e-2)"	"unprognostic (9.53e-2)"	0.6	0.0	0.6	4.3	0.6	0.0	6.4	0.6	0.6	38.0	19.2	0.6	3.9	21.4	5.7	2.6	256.0	1.2	7.9	0.6	0.6	0.0	2.4	1.2	7.5	0.6	0.6	0.6	0.7	4.6	6.6	0.8	1.4	0.7	1.9	19.6	0.7	41.8	3.1	0.6	41.4	23.8	1.0	0.6	0.6	9.4	0.9	0.6	8.9	9.6	189.3	71.0	2.2	79.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	62.5	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	7.8	11.4	0.0	0.1	0.0	86.8	0.0	123.0	0.0	0.0	0.0	0.0	0.8	0.5	0.0	0.0	0.0	0.0	183.4	0.0	1.7	0.0	0.0	0.0	0.0	11.1	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.6	4.1	0.0	0.0	0.1	129.6	0.1	0.3	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.6	0.6	0.6	0.6	0.6	0.0	0.6	0.6	0.7	0.6
S100A16	"DT1P1A7, MGC17528, S100F"	ENSG00000188643	"S100 calcium binding protein A16"	Q96FQ6	1	153606886-153613145	"Predicted intracellular proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 223.9;tongue: 102.1"	"Cell line enhanced"	"Detected in many"		"HUVEC TERT2: 118.0;SK-BR-3: 143.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	7	"plasmacytoid DC: 2.0"	"Lineage enriched"	"Detected in single"	20	"dendritic cells: 2.0"	"Low region specificity"	"Detected in all"							HPA045841	Enhanced		Approved	"Plasma membrane,Cytosol"			92000	Cytosol	"Plasma membrane"	"HPA045841: AB_10966282"	"unprognostic (9.86e-3)"	"unprognostic (1.69e-1)"	"unprognostic (2.23e-2)"	"unprognostic (3.06e-1)"	"unprognostic (1.71e-1)"	"unprognostic (7.03e-2)"	"prognostic unfavourable (3.18e-4)"	"prognostic unfavourable (3.14e-5)"	"unprognostic (1.70e-1)"	"unprognostic (4.59e-1)"	"prognostic unfavourable (2.04e-4)"	"unprognostic (2.60e-1)"	"prognostic unfavourable (3.91e-5)"	"unprognostic (1.01e-1)"	"unprognostic (1.92e-1)"	"unprognostic (3.45e-2)"	"unprognostic (5.29e-3)"	20.1	5.5	9.3	8.0	7.2	0.0	11.9	3.4	8.3	37.2	21.1	8.3	3.2	16.2	8.7	7.2	223.9	7.6	18.2	9.5	6.7	5.4	14.3	27.0	18.3	7.5	7.1	5.7	15.3	4.1	6.5	3.3	14.9	7.2	9.3	14.5	5.1	35.5	5.4	9.8	43.1	31.2	10.6	5.9	13.4	10.6	12.3	4.6	3.2	11.3	102.1	87.5	11.3	51.3	0.0	2.0	0.0	0.0	0.0	0.0	0.0	56.5	27.2	1.4	3.2	9.4	35.7	3.7	32.4	29.8	26.6	23.7	25.5	31.6	0.0	52.0	48.4	41.5	0.0	72.6	15.6	0.1	0.0	0.0	23.7	7.5	10.8	0.0	0.0	16.9	69.7	64.4	50.7	118.0	0.7	0.0	58.5	75.0	0.0	0.1	6.0	73.7	0.0	16.4	0.1	100.3	20.3	0.0	0.1	23.8	143.0	4.7	44.4	0.3	63.3	16.0	25.7	15.4	73.1	0.0	0.2	0.1	47.6	0.0	10.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	9.3	7.2	3.4	8.3	6.7	5.4	7.1	5.7	7.2	4.6
S100A2	"CAN19, S100L"	ENSG00000196754	"S100 calcium binding protein A2"	P29034	1	153561108-153567890	"Cancer-related genes, Predicted intracellular proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"esophagus: 224.8;tongue: 246.5"	"Group enriched"	"Detected in some"	5	"HBEC3-KT: 656.0;RT4: 256.5"	"Cancer enhanced"	"Detected in all"		"head and neck cancer: 1229.1"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in many"		"basophil: 11.9"	"Lineage enriched"	"Detected in many"	4	"granulocytes: 11.9"					"Not detected"	"Not detected"			"CAB002600, CAB047340, HPA062451"	Enhanced		Approved	"Nucleoplasm,Nucleoli,Plasma membrane,Cytosol"			130000	"Nucleoplasm, Cytosol"	"Nucleoli, Plasma membrane"	"CAB002600: , CAB047340: , HPA062451: "	"unprognostic (8.47e-3)"	"unprognostic (5.54e-2)"	"unprognostic (1.57e-2)"	"unprognostic (1.42e-3)"	"unprognostic (1.98e-1)"	"unprognostic (3.20e-1)"	"unprognostic (4.21e-4)"	"unprognostic (9.00e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.23e-2)"	"prognostic unfavourable (2.04e-4)"	"unprognostic (3.52e-2)"	"unprognostic (8.91e-2)"	"unprognostic (1.35e-1)"	"unprognostic (2.70e-1)"	"unprognostic (1.39e-1)"	"unprognostic (2.68e-1)"	0.4	0.0	0.4	0.5	0.4	0.0	2.1	0.4	0.5	16.9	0.4	0.4	0.9	0.0	1.8	1.9	224.8	0.5	0.4	0.4	0.4	0.0	16.6	0.4	1.6	0.4	0.4	0.4	0.4	0.4	0.0	0.5	0.6	0.6	3.3	0.0	0.4	23.3	2.1	0.7	27.5	0.4	1.5	0.5	0.4	0.0	0.5	0.4	0.7	1.0	246.5	48.4	36.2	43.8	0.5	2.6	11.9	0.6	0.0	2.9	0.7	24.8	0.2	0.0	0.0	0.3	0.1	0.0	0.3	0.3	0.2	0.2	0.0	0.8	0.0	13.2	0.5	61.7	0.0	656.0	0.3	0.1	0.1	0.1	1.7	0.1	0.1	0.0	0.0	0.2	87.4	0.7	99.7	0.4	0.0	0.0	1.4	0.1	0.0	0.0	0.0	4.8	0.0	15.6	0.0	15.5	256.5	0.5	0.0	1.0	0.1	0.2	0.1	0.1	0.1	0.3	21.7	2.9	8.4	0.0	0.0	0.1	0.8	0.0	0.7	11.9	0.5	0.0	2.9	0.0	1.8	0.5	2.0	1.6	0.4	0.0	0.6	0.5	5.0	0.0	0.6	2.6	1.8	0.7	0.4	0.4	0.4	0.5	0.4	0.0	0.4	0.4	0.6	0.4
SAMHD1	"AGS5, HDDC1, Mg11, MOP-5, SBBI88"	ENSG00000101347	"SAM and HD domain containing deoxynucleoside triphosphate triphosphohydrolase 1"	Q9Y3Z3	20	36889773-36951901	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Antiviral defense, DNA damage, DNA repair, DNA replication, Host-virus interaction, Immunity, Innate immunity"	"Allosteric enzyme, Hydrolase"	"Aicardi-Goutieres syndrome, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 57.2;BJ hTERT+ SV40 Large T+: 24.3;BJ hTERT+ SV40 Large T+ RasG12V: 26.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"myeloid DC: 46.7"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047072	Enhanced		Supported	"Nucleoplasm,Plasma membrane"			100000	Nucleoplasm	"Plasma membrane"	"HPA047072: "	"unprognostic (1.09e-1)"	"unprognostic (7.30e-3)"	"unprognostic (1.65e-2)"	"unprognostic (3.85e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.91e-2)"	"unprognostic (2.15e-1)"	"unprognostic (4.07e-2)"	"unprognostic (2.03e-1)"	"unprognostic (3.63e-1)"	"unprognostic (1.88e-1)"	"unprognostic (1.04e-1)"	"prognostic unfavourable (5.12e-4)"	"unprognostic (1.44e-1)"	"unprognostic (9.06e-2)"	"unprognostic (3.18e-2)"	"unprognostic (2.72e-2)"	54.3	18.6	8.7	31.8	13.0	9.9	35.9	4.9	9.7	14.5	21.2	9.0	8.7	15.8	13.5	20.2	24.1	33.4	15.3	25.4	8.7	6.0	12.5	12.4	25.7	48.3	14.5	4.9	22.1	18.1	4.9	22.4	13.7	10.2	14.0	13.2	11.6	14.7	9.7	9.2	11.4	20.6	21.3	13.7	40.7	19.2	15.1	15.0	9.7	14.9	10.7	18.5	23.2	50.2	0.4	46.7	2.8	23.4	6.0	10.9	19.1	3.8	1.5	0.7	1.5	57.2	10.9	0.7	2.3	4.2	24.3	26.0	4.8	1.3	8.2	3.3	1.5	3.0	6.0	2.8	5.1	2.4	2.0	0.4	2.1	2.5	5.0	4.7	1.4	13.3	0.1	8.5	0.2	3.1	1.5	1.9	0.5	1.2	0.0	1.7	0.7	3.2	0.2	3.9	3.1	0.9	0.6	2.9	0.4	3.0	1.1	2.9	1.4	7.5	0.8	1.9	2.1	2.0	3.4	1.1	3.0	3.4	1.6	0.4	0.6	0.2	19.4	0.6	6.1	23.4	5.6	0.4	6.9	6.4	46.7	0.4	8.5	6.3	2.8	6.0	20.4	11.0	10.9	19.1	8.7	13.0	4.9	9.7	8.7	6.0	14.5	4.9	10.2	15.0
SAMSN1	"HACS1, NASH1, SASH2, SH3D6B, SLy2"	ENSG00000155307	"SAM domain, SH3 domain and nuclear localization signals 1"	Q9NSI8	21	14485228-14658821	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 53.6;bone marrow: 72.1;lymphoid tissue: 43.6"	"Group enriched"	"Detected in some"	4	"HEL: 59.5;K-562: 70.8;Karpas-707: 30.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 53.6;eosinophil: 49.9"	"Low lineage specificity"	"Detected in all"			"Region enriched"	"Detected in some"	7	"olfactory region: 25.4"	"Low region specificity"	"Detected in all"			"HPA010645, HPA017055, HPA046639"	Approved		Approved	"Nucleoplasm,Plasma membrane"				"Plasma membrane"	Nucleoplasm	"HPA010645: AB_1856559, HPA017055: AB_1856560, HPA046639: "	"unprognostic (7.62e-3)"	"unprognostic (1.46e-2)"	"unprognostic (1.03e-2)"	"unprognostic (3.11e-2)"	"unprognostic (2.44e-1)"	"unprognostic (3.91e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.01e-1)"	"unprognostic (2.17e-1)"	"unprognostic (6.13e-2)"	"unprognostic (2.10e-2)"	"unprognostic (1.28e-1)"	"prognostic unfavourable (4.52e-6)"	"unprognostic (9.14e-2)"	"unprognostic (3.05e-2)"	"unprognostic (2.17e-1)"	"unprognostic (1.68e-2)"	14.4	3.9	5.8	33.0	10.4	72.1	4.2	1.1	5.1	2.9	4.7	4.9	0.0	3.1	3.4	4.6	4.1	6.8	10.1	5.1	4.4	3.4	5.9	7.2	27.9	28.3	11.1	1.4	3.3	2.3	1.0	2.7	6.7	6.7	4.1	7.0	3.4	3.4	1.2	1.6	1.9	13.6	4.7	17.5	43.6	5.0	2.4	7.1	12.6	2.6	2.8	16.7	11.8	4.5	6.5	5.6	53.6	17.3	3.7	12.9	6.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.4	0.0	3.0	0.0	59.5	0.0	0.0	0.0	7.0	2.9	0.0	0.0	0.0	8.8	0.8	70.8	30.9	0.0	0.0	3.3	8.5	0.0	0.0	5.8	0.0	4.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	7.7	0.0	0.0	0.0	0.0	13.3	0.1	0.0	0.3	4.5	0.0	53.6	8.8	49.9	5.3	11.6	3.6	6.5	10.3	7.8	5.6	2.6	6.6	4.6	11.0	3.7	17.3	0.2	12.9	6.8	5.8	10.4	1.1	5.1	4.4	3.4	11.1	1.4	6.7	7.1
SASH3	"753P9, CXorf9, HACS2, SH3D6C, SLY"	ENSG00000122122	"SAM and SH3 domain containing 3"	O75995	X	129779979-129795201	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 61.8;bone marrow: 33.2;lymphoid tissue: 85.3"	"Cell line enhanced"	"Detected in some"		"Daudi: 43.9;HL-60: 15.4;MOLT-4: 31.3;NB-4: 23.8;REH: 23.5;U-698: 40.0;U-937: 31.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA001085	Enhanced		Approved	"Nucleoplasm,Nuclear bodies,Plasma membrane"				"Plasma membrane"	"Nucleoplasm, Nuclear bodies"	"HPA001085: AB_2184289"	"unprognostic (1.88e-2)"	"unprognostic (5.82e-3)"	"unprognostic (1.49e-3)"	"prognostic favourable (3.15e-4)"	"unprognostic (1.12e-1)"	"unprognostic (1.19e-3)"	"unprognostic (1.67e-1)"	"unprognostic (3.23e-3)"	"unprognostic (7.92e-3)"	"unprognostic (3.45e-1)"	"unprognostic (8.75e-2)"	"unprognostic (2.16e-1)"	"prognostic unfavourable (6.51e-5)"	"unprognostic (3.30e-1)"	"unprognostic (3.56e-2)"	"unprognostic (3.17e-2)"	"unprognostic (1.53e-1)"	7.8	3.4	2.8	34.6	5.2	33.2	2.7	0.7	2.2	2.0	3.3	4.0	0.2	3.9	1.9	2.1	2.9	3.4	3.6	2.0	3.3	2.4	3.3	3.0	10.6	38.2	5.2	1.1	1.3	1.8	0.2	1.8	2.5	4.2	2.7	3.5	1.6	7.8	0.8	0.9	1.1	18.8	2.4	6.2	55.7	4.2	0.8	4.0	85.3	2.5	2.0	38.6	7.0	2.0	22.0	27.6	53.7	44.2	33.4	46.9	61.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	43.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.9	0.0	0.0	0.0	15.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.7	0.0	0.0	31.3	23.8	0.0	0.0	23.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.3	0.1	0.0	0.1	0.0	0.0	0.0	8.9	40.0	0.0	31.1	0.0	7.9	29.4	53.7	46.9	44.1	38.7	19.1	26.7	43.1	27.6	22.0	19.3	30.0	29.1	33.4	44.2	12.7	32.3	61.8	2.8	5.2	0.7	2.2	3.3	2.4	5.2	1.1	4.2	4.0
SC5D	SC5DL	ENSG00000109929	Sterol-C5-desaturase	O75845	11	121292453-121308694	"Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism"	Oxidoreductase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 143.5"	"Cell line enhanced"	"Detected in all"		"AF22: 53.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA066283, HPA070248"	Approved		Approved	"Nucleoplasm,Endoplasmic reticulum,Plasma membrane,Cytosol"				"Nucleoplasm, Endoplasmic reticulum"	"Plasma membrane, Cytosol"	"HPA066283: , HPA070248: "	"unprognostic (4.78e-2)"	"unprognostic (7.29e-2)"	"unprognostic (2.26e-2)"	"unprognostic (2.36e-1)"	"unprognostic (3.98e-2)"	"prognostic unfavourable (3.30e-4)"	"unprognostic (2.79e-2)"	"unprognostic (7.96e-2)"	"prognostic unfavourable (3.98e-4)"	"unprognostic (4.03e-2)"	"unprognostic (3.18e-2)"	"unprognostic (1.01e-1)"	"prognostic favourable (1.07e-7)"	"unprognostic (4.29e-2)"	"unprognostic (2.51e-1)"	"unprognostic (2.29e-1)"	"unprognostic (1.98e-1)"	10.9	15.3	16.9	5.5	18.4	2.7	23.3	10.4	26.9	9.4	9.4	17.8	24.5	17.4	6.8	30.1	19.5	7.2	7.4	9.4	18.7	19.6	19.7	143.5	10.1	5.5	20.8	17.8	7.8	8.9	17.5	14.7	6.3	40.8	40.3	8.6	8.2	9.5	24.0	3.9	7.7	13.4	7.6	43.4	4.1	8.8	9.7	16.0	3.7	10.4	8.2	8.1	14.0	14.6	6.0	9.8	7.5	6.3	6.8	10.0	3.8	7.1	3.6	53.9	11.5	21.0	18.2	7.6	8.0	15.1	5.4	9.6	22.5	26.6	6.7	25.4	8.7	26.7	16.8	20.3	5.3	3.3	22.9	10.0	23.5	17.9	17.1	6.3	3.4	14.9	16.7	17.1	17.6	8.2	6.5	9.8	24.9	7.4	2.5	8.2	16.8	11.4	3.5	13.6	5.7	38.0	32.0	14.2	8.0	18.4	4.2	10.5	16.8	10.9	15.5	5.2	8.4	9.2	3.7	1.8	3.1	9.0	2.0	13.9	9.0	7.5	4.8	1.2	5.0	6.3	8.5	6.0	6.8	6.0	8.5	6.0	10.0	9.5	0.4	6.8	4.5	9.8	6.9	3.8	16.9	18.4	10.4	26.9	18.7	19.6	20.8	17.8	40.8	16.0
SCAMP4	FLJ33847	ENSG00000227500	"Secretory carrier membrane protein 4"	Q969E2	19	1905214-1926013	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043284	Approved		Approved	"Golgi apparatus,Vesicles,Lipid droplets,Plasma membrane"				"Golgi apparatus, Vesicles"	"Lipid droplets, Plasma membrane"	"HPA043284: AB_10806501"	"unprognostic (1.60e-1)"	"unprognostic (3.62e-1)"	"unprognostic (5.04e-2)"	"prognostic favourable (4.40e-6)"	"unprognostic (2.58e-1)"	"unprognostic (4.58e-1)"	"prognostic unfavourable (1.92e-5)"	"unprognostic (2.04e-1)"	"unprognostic (1.58e-1)"	"unprognostic (2.55e-1)"	"unprognostic (3.01e-3)"	"unprognostic (5.66e-2)"	"prognostic favourable (3.56e-4)"	"unprognostic (6.16e-2)"	"unprognostic (1.58e-1)"	"unprognostic (3.93e-2)"	"unprognostic (1.03e-1)"	17.3	16.5	17.1	16.0	21.7	10.2	18.4	16.5	28.2	19.5	13.2	46.3	21.1	19.3	16.3	20.4	22.0	37.2	19.4	8.5	19.3	19.5	19.9	21.5	19.3	13.9	22.1	14.6	23.7	28.0	12.7	23.2	24.2	27.6	19.5	9.8	21.4	41.1	21.4	9.1	19.2	18.9	12.1	42.1	17.2	21.8	15.9	20.3	10.3	23.8	10.6	18.2	15.7	13.9	6.4	14.2	2.5	5.9	7.1	5.0	3.7	22.8	22.9	10.4	25.4	21.0	13.1	12.5	14.9	13.9	16.3	19.9	18.6	22.1	9.4	14.5	11.9	27.4	9.9	15.1	6.1	14.8	8.9	6.5	8.1	17.8	27.0	6.5	10.1	20.1	9.6	14.2	8.6	11.1	14.8	10.7	9.4	27.4	8.7	12.7	17.1	7.7	10.9	7.6	14.2	20.1	20.3	14.8	19.5	9.4	22.7	12.4	22.1	17.1	11.8	20.1	13.9	35.9	15.7	26.0	25.6	8.4	26.6	11.0	12.9	1.9	5.2	2.0	5.0	5.9	2.7	6.4	3.5	3.2	5.7	4.6	2.1	3.7	2.5	7.1	5.0	14.2	2.7	3.7	17.1	21.7	16.5	28.2	19.3	19.5	22.1	14.6	27.6	20.3
SCHIP1	SCHIP-1	ENSG00000151967	"Schwannomin interacting protein 1"	P0DPB3	3	159839861-159897360	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in many"	6	"brain: 55.0;heart muscle: 65.9;skeletal muscle: 54.5"	"Cell line enhanced"	"Detected in some"		"AF22: 9.3;AN3-CA: 16.9;HUVEC TERT2: 20.0;NTERA-2: 10.3;SH-SY5Y: 58.2"	"Cancer enriched"	"Detected in single"	7	"glioma: 2.9"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"plasmacytoid DC: 9.7"	"Group enriched"	"Detected in many"	58	"dendritic cells: 9.7;granulocytes: 3.1"									"HPA003243, HPA069824"	Uncertain		Approved	"Nucleoplasm,Nuclear bodies,Plasma membrane,Cell Junctions,Cytosol"				"Plasma membrane, Cell Junctions, Cytosol"	"Nucleoplasm, Nuclear bodies"	"HPA003243: AB_1079877, HPA069824: "	"unprognostic (1.07e-1)"	"unprognostic (3.27e-2)"	"unprognostic (1.37e-2)"	"unprognostic (2.36e-5)"	"prognostic favourable (2.80e-4)"	"unprognostic (6.25e-2)"	"unprognostic (4.56e-3)"	"unprognostic (1.11e-1)"	"unprognostic (7.81e-2)"	"unprognostic (1.38e-1)"	"unprognostic (6.45e-3)"	"unprognostic (4.67e-2)"	"unprognostic (2.12e-1)"	"unprognostic (4.66e-4)"	"unprognostic (2.30e-1)"	"unprognostic (4.52e-2)"	"unprognostic (4.96e-1)"	6.1	3.9	30.1	1.5	22.0	2.0	1.9	23.9	55.0	3.7	3.6	21.1	0.0	2.2	4.7	2.0	4.2	3.4	3.0	65.9	29.6	17.9	3.5	1.9	3.1	1.7	22.8	24.1	1.8	1.6	1.4	6.0	10.3	15.6	6.2	2.3	0.7	2.9	2.6	54.5	1.4	1.9	5.9	28.9	5.1	2.0	2.7	24.3	0.0	2.0	7.6	1.6	1.9	0.6	0.0	9.7	3.1	0.0	0.1	0.0	0.1	0.0	0.0	9.3	16.9	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.8	0.0	0.4	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.9	0.3	0.1	3.9	20.0	0.0	0.0	1.2	0.0	0.0	0.0	10.3	0.0	0.0	1.9	0.0	0.4	0.0	0.0	58.2	0.0	0.0	0.0	0.0	1.0	3.7	0.2	0.5	0.1	0.8	0.7	0.0	0.0	0.2	0.7	0.4	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.1	0.0	9.7	0.0	0.1	30.1	22.0	23.9	28.9	29.6	17.9	22.8	24.1	15.6	24.3
SCN9A	"ETHA, Nav1.7, NE-NA, NENA, PN1"	ENSG00000169432	"Sodium voltage-gated channel alpha subunit 9"	Q15858	2	166195185-166376001	"Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Sodium transport, Transport"	"Ion channel, Sodium channel, Voltage-gated channel"	"Disease mutation, Epilepsy, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BJ: 17.3;BJ hTERT+: 12.9;HHSteC: 14.9"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in some"	17	"plasmacytoid DC: 18.6"	"Lineage enriched"	"Detected in single"	24	"dendritic cells: 18.6"	"Region enriched"	"Detected in some"	5	"hypothalamus: 10.9"	"Low region specificity"	"Detected in many"			"CAB013679, HPA061843"	Uncertain		Approved	"Plasma membrane,Actin filaments,Focal adhesion sites"				"Plasma membrane, Actin filaments, Focal adhesion sites"		"CAB013679: , HPA061843: "	"unprognostic (2.10e-1)"	"unprognostic (2.83e-1)"	"unprognostic (1.13e-1)"	"unprognostic (8.98e-5)"	"unprognostic (1.47e-3)"	"unprognostic (9.43e-3)"	"unprognostic (2.28e-2)"	"unprognostic (2.24e-1)"	"unprognostic (2.23e-1)"	"unprognostic (3.64e-1)"	"unprognostic (1.45e-1)"	"unprognostic (2.27e-1)"	"prognostic unfavourable (2.30e-5)"	"unprognostic (1.69e-3)"	"unprognostic (6.74e-2)"	"unprognostic (2.46e-2)"	"unprognostic (2.46e-1)"	6.6	4.2	3.8	2.8	9.1	4.2	2.7	0.9	4.4	1.8	10.2	0.5	0.1	1.4	0.9	3.8	2.6	1.2	5.8	2.9	2.8	15.9	4.8	8.3	4.5	3.5	4.1	2.3	2.1	4.8	0.6	11.3	9.2	7.3	2.0	7.0	1.7	1.8	1.9	0.9	1.8	4.2	5.2	2.5	12.4	1.7	16.2	0.4	10.3	1.4	1.9	1.2	3.6	1.8	0.0	18.6	0.7	0.1	0.4	0.0	0.0	0.0	1.9	0.1	0.0	7.5	6.5	0.0	17.3	12.9	4.0	1.4	0.5	0.1	0.0	0.0	2.1	0.0	5.0	0.6	6.7	0.0	1.6	1.3	1.5	1.4	14.9	0.0	0.0	0.4	0.2	6.9	1.3	0.8	4.3	5.0	0.6	0.0	2.6	0.0	1.5	0.5	0.7	2.5	6.5	1.8	7.3	0.8	7.3	0.0	0.0	0.3	0.2	0.0	0.0	0.0	1.1	0.1	0.3	0.1	0.0	0.0	2.5	0.0	1.4	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.7	0.4	0.1	18.6	0.0	0.0	3.8	9.1	0.9	4.4	2.8	15.9	4.1	2.3	7.3	0.4
SCUBE3	"CEGF3, FLJ34743"	ENSG00000146197	"Signal peptide, CUB domain and EGF like domain containing 3"	Q8IX30	6	35214419-35253079	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"thyroid gland: 38.0"	"Cell line enhanced"	"Detected in some"		"AF22: 10.4;ASC diff: 31.7;ASC TERT1: 42.6;HSkMC: 19.8;hTEC/SVTERT24-B: 12.1;U-138 MG: 11.8;WM-115: 10.0"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 9.2"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA040606	Uncertain		Approved	"Plasma membrane"	"Secreted to blood"	1890000	110000	"Plasma membrane"		"HPA040606: AB_10795383"	"unprognostic (1.45e-1)"	"unprognostic (1.79e-2)"	"unprognostic (2.22e-1)"	"unprognostic (2.41e-3)"	"unprognostic (1.52e-1)"	"unprognostic (1.27e-1)"	"unprognostic (4.43e-2)"	"unprognostic (5.01e-2)"	"unprognostic (2.00e-2)"	"unprognostic (7.41e-2)"	"unprognostic (1.57e-1)"	"unprognostic (2.64e-2)"	"unprognostic (4.83e-8)"	"unprognostic (1.54e-2)"	"unprognostic (2.12e-1)"	"prognostic unfavourable (1.38e-4)"	"unprognostic (3.06e-3)"	1.6	2.6	0.5	1.1	0.4	0.2	0.3	0.3	0.7	1.6	3.3	0.0	2.8	0.2	1.3	7.0	1.5	0.7	0.7	6.4	0.3	0.5	2.3	0.2	1.3	0.2	0.4	0.6	0.9	0.2	0.3	1.6	0.9	0.6	7.0	1.1	6.8	1.1	5.3	0.8	0.7	0.8	13.8	0.6	0.3	1.2	1.7	0.0	0.0	38.0	0.3	0.3	11.4	2.5	1.1	1.6	2.5	0.7	1.1	1.1	0.1	0.0	0.0	10.4	0.1	31.7	42.6	0.1	2.6	1.3	0.0	0.0	0.2	0.0	0.0	0.3	6.1	0.0	2.1	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	19.8	0.0	12.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	1.1	0.2	0.0	0.0	0.2	0.7	0.2	0.0	0.6	11.8	0.5	0.0	0.1	0.0	0.0	0.0	1.8	0.0	10.0	1.4	0.7	1.3	1.1	0.5	0.3	0.8	0.7	0.3	0.1	1.1	0.8	0.8	2.5	1.1	0.5	1.6	0.8	0.1	0.5	0.4	0.3	0.7	0.3	0.5	0.4	0.6	0.6	0.0
SDC2	"CD362, fibroglycan, HSPG, HSPG1, SYND2"	ENSG00000169439	"Syndecan 2"	P34741	8	96493351-96611780	"CD markers, Predicted membrane proteins"	"Differentiation, Neurogenesis"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 115.1;thyroid gland: 111.2"	"Cell line enhanced"	"Detected in many"		"AF22: 101.9;EFO-21: 47.8;fHDF/TERT166: 44.1;RPTEC TERT1: 53.2;U-138 MG: 49.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	7	"neutrophil: 13.9"	"Lineage enriched"	"Detected in many"	7	"granulocytes: 13.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB025123, HPA044416"	Uncertain		Approved	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		"CAB025123: , HPA044416: "	"unprognostic (1.25e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.25e-1)"	"unprognostic (3.61e-2)"	"unprognostic (6.52e-3)"	"unprognostic (4.18e-2)"	"unprognostic (2.43e-1)"	"unprognostic (2.35e-2)"	"unprognostic (2.89e-2)"	"unprognostic (4.56e-1)"	"unprognostic (1.48e-1)"	"unprognostic (6.16e-2)"	"unprognostic (1.56e-2)"	"unprognostic (1.45e-3)"	"unprognostic (1.91e-1)"	"unprognostic (2.50e-2)"	"unprognostic (1.23e-1)"	43.2	9.9	13.9	9.1	16.9	2.5	17.0	12.7	8.4	43.4	18.7	7.3	21.2	5.8	21.9	15.3	13.3	21.0	15.0	19.1	12.0	12.6	23.9	115.1	14.4	4.4	9.7	9.3	45.9	16.8	1.6	24.0	31.3	10.7	25.9	10.7	51.4	6.3	28.1	9.4	6.5	9.6	34.3	9.5	7.5	11.9	8.7	9.3	0.5	111.2	13.8	3.5	35.9	26.3	0.0	1.3	13.9	1.9	0.0	0.2	0.5	0.0	0.0	101.9	0.0	36.8	34.4	0.1	14.7	17.5	8.6	9.5	3.0	0.0	0.0	47.8	44.1	0.0	17.6	0.2	7.4	0.0	6.9	0.0	9.8	37.4	1.1	0.2	0.4	13.3	0.4	19.4	0.5	0.3	9.6	0.0	3.5	0.8	0.0	2.5	10.8	0.1	0.1	16.0	0.3	53.2	8.7	3.0	7.9	0.0	0.0	0.7	4.3	11.4	8.0	49.4	15.1	0.2	8.2	0.9	0.0	0.1	15.7	0.0	15.4	0.0	1.9	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.3	0.0	0.2	0.0	13.9	0.0	0.1	0.0	0.0	0.5	13.9	16.9	12.7	8.4	12.0	12.6	9.7	9.3	10.7	9.3
SDC4	"amphiglycan, ryudocan, SYND4"	ENSG00000124145	"Syndecan 4"	P31431	20	45325288-45348424	"Cancer-related genes, Predicted membrane proteins, Predicted secreted proteins, Transporters"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 141.1"	"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 73.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA005716, CAB013240"	Enhanced		Approved	"Golgi apparatus,Plasma membrane"	"Secreted to blood"			"Golgi apparatus"	"Plasma membrane"	"CAB013240: AB_2533250, HPA005716: AB_1080160"	"unprognostic (1.34e-2)"	"unprognostic (1.80e-1)"	"unprognostic (1.71e-2)"	"unprognostic (2.16e-1)"	"unprognostic (5.39e-2)"	"unprognostic (6.59e-3)"	"unprognostic (1.16e-1)"	"unprognostic (5.93e-2)"	"unprognostic (2.68e-1)"	"unprognostic (2.95e-2)"	"prognostic unfavourable (4.20e-4)"	"unprognostic (1.97e-1)"	"prognostic favourable (2.44e-7)"	"unprognostic (3.00e-1)"	"unprognostic (2.18e-1)"	"prognostic favourable (2.67e-4)"	"unprognostic (7.42e-2)"	15.9	26.2	19.9	15.7	24.3	3.5	40.5	6.9	20.1	20.4	24.8	19.2	9.0	13.3	17.6	14.7	42.4	27.4	26.2	19.5	19.8	12.1	56.6	141.1	56.7	4.8	23.5	20.5	14.7	36.6	6.2	12.5	23.0	30.9	19.5	22.3	21.8	47.6	17.5	25.5	45.5	13.8	38.7	23.0	9.0	46.9	33.7	15.7	2.0	26.5	25.2	23.5	34.4	16.4	0.7	2.8	2.0	3.1	1.4	8.1	1.2	22.6	2.9	1.6	0.1	40.4	24.9	69.8	29.0	39.6	32.8	23.6	34.5	57.9	0.0	13.0	36.4	29.4	1.1	73.7	40.0	6.5	1.0	0.7	2.4	13.4	44.1	0.1	1.2	33.5	49.4	13.5	33.1	4.3	1.1	0.0	18.9	22.5	0.0	2.0	2.9	9.1	0.0	14.6	0.0	54.0	30.2	0.6	2.3	39.8	24.7	7.1	17.9	1.3	8.1	25.1	20.9	2.5	18.6	1.2	0.9	0.1	39.5	2.3	14.9	2.0	3.1	0.7	1.3	1.1	4.1	0.6	4.1	1.6	2.8	0.7	0.9	1.1	1.6	1.4	1.1	2.5	8.1	1.2	19.9	24.3	6.9	20.1	19.8	12.1	23.5	20.5	30.9	15.7
SEC16B	"LZTR2, PGPR-p117, RGPR, Sec16S"	ENSG00000120341	"SEC16 homolog B, endoplasmic reticulum export factor"	Q96JE7	1	177923956-177984303	"Predicted intracellular proteins"	"ER-Golgi transport, Peroxisome biogenesis, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	9	"intestine: 43.4;liver: 47.4"	"Cell line enhanced"	"Detected in many"		"ASC TERT1: 8.4;CAPAN-2: 8.8;EFO-21: 6.7;HDLM-2: 6.8;RPMI-8226: 7.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA054292, HPA072913"	Enhanced		Approved	"Endoplasmic reticulum,Plasma membrane,Actin filaments"				"Endoplasmic reticulum, Plasma membrane"	"Actin filaments"	"HPA054292: , HPA072913: "	"unprognostic (2.31e-1)"	"unprognostic (1.90e-1)"	"unprognostic (6.78e-3)"	"unprognostic (6.07e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.33e-1)"	"unprognostic (6.39e-3)"	"unprognostic (1.22e-1)"	"unprognostic (2.27e-2)"	"unprognostic (1.50e-2)"	"unprognostic (4.76e-3)"	"unprognostic (2.43e-1)"	"unprognostic (7.34e-4)"	"unprognostic (6.67e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.05e-1)"	1.4	1.8	1.1	3.2	0.9	0.0	1.5	0.9	2.3	1.7	19.6	0.9	0.9	14.3	1.3	0.9	0.9	1.6	2.5	2.2	0.9	0.4	2.5	47.4	0.9	0.9	0.9	0.9	1.8	4.8	0.1	1.4	0.9	1.0	0.9	1.6	0.9	1.4	0.9	3.9	0.9	43.4	0.9	0.9	2.7	4.0	0.9	0.9	0.9	1.4	0.9	1.0	0.9	1.0	0.0	0.7	0.0	0.7	0.0	0.0	0.2	2.3	1.9	0.1	1.9	2.4	8.4	0.1	1.9	0.6	0.1	0.8	1.2	8.8	0.7	6.7	1.5	0.0	0.4	0.2	0.1	6.8	0.1	0.0	0.0	4.1	0.2	0.1	0.0	4.9	0.6	0.3	0.1	2.6	0.0	6.0	4.7	0.0	0.0	0.0	0.0	0.0	0.0	0.7	7.7	0.1	0.2	0.8	1.5	0.1	0.2	1.0	0.1	1.6	0.9	1.3	0.2	0.8	0.0	1.9	0.8	0.1	3.3	0.3	0.1	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.2	1.1	0.9	0.9	2.3	0.9	0.4	0.9	0.9	1.0	0.9
SEMA3C	"SEMAE, SemE"	ENSG00000075223	"Semaphorin 3C"	Q99985	7	80742538-80922359	"Predicted secreted proteins"	"Differentiation, Neurogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"RT4: 46.6;T-47d: 52.8;U-2197: 68.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	8	"basophil: 25.8"	"Lineage enriched"	"Detected in many"	8	"granulocytes: 25.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA042418			Approved	"Golgi apparatus,Plasma membrane,Cytosol"	"Secreted in other tissues"			"Golgi apparatus, Cytosol"	"Plasma membrane"	"HPA042418: AB_10797389"	"unprognostic (1.93e-2)"	"unprognostic (2.54e-3)"	"unprognostic (4.94e-1)"	"unprognostic (9.86e-2)"	"unprognostic (6.74e-2)"	"prognostic unfavourable (5.72e-5)"	"unprognostic (9.28e-3)"	"unprognostic (1.91e-3)"	"unprognostic (1.39e-2)"	"unprognostic (9.01e-2)"	"prognostic unfavourable (4.08e-5)"	"unprognostic (2.07e-2)"	"unprognostic (1.55e-3)"	"unprognostic (1.78e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.37e-2)"	"unprognostic (1.92e-2)"	27.1	4.1	3.7	11.9	5.6	0.2	25.1	1.2	6.8	37.0	31.7	7.6	21.6	4.3	26.9	25.1	20.0	7.1	16.4	12.4	5.2	6.1	5.8	1.1	12.3	0.3	13.1	3.0	23.5	1.5	0.0	4.1	5.9	25.5	29.6	14.1	27.4	13.6	19.7	7.3	9.7	10.6	48.8	8.5	8.9	13.3	11.6	6.0	0.2	2.5	15.2	1.5	35.5	14.5	0.0	2.0	25.8	3.2	0.0	0.0	0.8	1.2	15.0	31.3	0.1	7.0	17.1	0.0	10.2	11.8	5.2	6.6	2.4	28.4	0.0	0.4	3.4	6.1	0.1	9.2	8.5	0.0	3.1	1.9	13.5	0.1	8.5	0.1	0.0	7.4	6.1	12.7	12.6	0.1	0.1	0.0	8.7	21.8	0.0	0.0	0.2	2.4	0.0	15.1	0.2	27.1	46.6	0.1	16.1	28.6	7.4	1.7	52.8	0.0	24.5	28.4	13.0	68.4	17.9	0.2	0.0	0.0	10.7	0.0	28.1	25.8	3.2	0.5	0.0	1.4	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	1.5	0.0	1.0	1.8	0.0	0.8	3.7	5.6	1.2	6.8	5.2	6.1	13.1	3.0	25.5	6.0
SEMA3D	"coll-2, Sema-Z2"	ENSG00000153993	"Semaphorin 3D"	O95025	7	84995553-85186855	"Predicted intracellular proteins, Predicted secreted proteins"	"Differentiation, Neurogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 33.8;thyroid gland: 33.0"	"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 16.8;HaCaT: 17.1;TIME: 26.2"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"amygdala: 17.1"	"Cell type enriched"	"Detected in single"	5	"naive B-cell: 2.0"	"Lineage enriched"	"Detected in single"	5	"B-cells: 2.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA037522	Uncertain		Approved	"Golgi apparatus,Plasma membrane"	"Secreted in other tissues"		77000	"Golgi apparatus"	"Plasma membrane"	"HPA037522: AB_10672494"	"unprognostic (7.05e-2)"	"unprognostic (1.24e-1)"	"unprognostic (2.40e-1)"	"unprognostic (1.44e-2)"	"unprognostic (1.54e-1)"	"unprognostic (2.51e-1)"	"unprognostic (7.58e-3)"	"unprognostic (4.02e-3)"	"unprognostic (9.94e-2)"	"unprognostic (5.62e-2)"	"unprognostic (1.63e-1)"	"unprognostic (9.46e-2)"	"unprognostic (1.17e-2)"	"unprognostic (1.26e-3)"	"unprognostic (1.63e-1)"	"unprognostic (2.75e-3)"	"unprognostic (5.25e-3)"	4.1	2.2	17.1	1.9	2.3	0.1	4.3	0.8	2.8	4.6	2.9	1.8	2.5	1.4	1.9	7.4	1.3	3.9	1.4	2.0	3.6	2.7	3.0	1.0	3.6	6.1	2.4	3.1	4.1	0.8	0.4	1.5	0.6	5.4	6.2	2.6	2.6	5.6	2.9	0.7	2.1	2.7	3.2	4.8	33.8	2.4	4.3	2.5	0.0	33.0	0.6	1.1	4.7	3.9	2.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	7.3	0.0	0.0	0.0	0.3	4.5	4.9	5.4	2.6	0.0	0.0	0.0	1.4	16.8	17.1	1.9	0.0	3.6	0.0	3.5	0.0	2.0	0.0	0.0	0.0	0.0	0.1	0.0	0.9	4.4	8.2	0.0	0.0	0.0	0.0	0.0	0.0	0.8	4.5	1.2	5.4	3.9	1.7	0.0	0.1	0.6	0.0	0.0	0.2	0.2	0.0	26.2	0.0	1.7	0.2	0.0	3.3	1.9	0.0	0.1	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	17.1	2.3	0.8	2.2	3.6	2.7	2.4	3.1	5.4	2.5
SEMA4F	"SEMAM, SEMAW"	ENSG00000135622	"Ssemaphorin 4F"	O95754	2	74654228-74683853	"Predicted intracellular proteins, Predicted membrane proteins"	"Differentiation, Neurogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA064095, HPA065969"	Approved		Approved	"Nucleoplasm,Plasma membrane,Centrosome"				Nucleoplasm	"Plasma membrane, Centrosome"	"HPA064095: , HPA065969: "	"unprognostic (9.69e-2)"	"unprognostic (8.88e-3)"	"unprognostic (1.58e-2)"	"prognostic unfavourable (5.94e-5)"	"prognostic unfavourable (6.96e-4)"	"unprognostic (1.23e-2)"	"unprognostic (1.61e-3)"	"unprognostic (6.95e-2)"	"unprognostic (9.01e-3)"	"unprognostic (6.53e-2)"	"unprognostic (2.21e-2)"	"unprognostic (1.54e-1)"	"prognostic unfavourable (9.74e-6)"	"unprognostic (2.60e-2)"	"unprognostic (8.08e-2)"	"prognostic favourable (6.94e-4)"	"unprognostic (4.69e-2)"	8.1	5.1	15.5	3.5	15.5	1.3	5.7	12.9	21.3	5.2	3.8	3.3	2.3	1.9	6.6	6.7	2.7	5.6	3.5	4.9	17.2	12.2	4.8	2.1	8.1	5.1	5.3	16.5	9.1	4.6	13.7	10.2	3.5	7.8	5.2	4.2	3.6	5.0	5.7	3.0	4.9	3.0	7.0	5.7	4.7	4.3	7.2	3.8	2.9	4.7	1.3	4.9	3.5	4.7	2.8	0.2	1.4	0.4	2.5	5.6	2.1	7.1	4.9	5.3	7.5	8.7	4.8	3.3	5.0	10.4	9.1	8.4	2.0	4.1	2.4	5.4	7.9	2.1	7.7	8.5	10.1	6.3	6.6	4.2	2.0	4.0	3.1	0.9	6.7	4.4	7.4	6.1	3.2	3.9	0.3	0.1	5.3	2.1	3.8	0.7	2.9	4.7	0.0	6.9	0.0	7.1	3.4	3.3	8.0	7.2	3.0	9.0	3.5	0.5	4.2	15.5	7.5	3.7	9.1	5.8	5.8	0.3	18.9	0.3	8.3	0.5	0.2	1.4	5.6	0.1	3.2	2.8	3.0	4.9	0.2	2.1	3.3	3.9	0.8	2.5	0.4	0.1	2.2	2.1	15.5	15.5	12.9	21.3	17.2	12.2	5.3	16.5	7.8	3.8
SEMA6D	"FLJ11598, KIAA1479"	ENSG00000137872	"Semaphorin 6D"	Q8NFY4	15	47184101-47774223	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Differentiation, Neurogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 40.8;placenta: 36.7"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 13.9;SCLC-21H: 12.3;SH-SY5Y: 11.4;U-266/70: 9.1"	"Cancer enhanced"	"Detected in many"		"glioma: 8.9"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"neutrophil: 1.9"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043109			Approved	"Golgi apparatus,Plasma membrane"	"Intracellular and membrane"		480000	"Plasma membrane"	"Golgi apparatus"	"HPA043109: AB_10793941"	"unprognostic (2.00e-1)"	"unprognostic (4.62e-2)"	"unprognostic (3.10e-2)"	"unprognostic (3.83e-3)"	"unprognostic (1.38e-1)"	"unprognostic (3.85e-2)"	"unprognostic (1.98e-1)"	"unprognostic (2.17e-3)"	"unprognostic (1.24e-1)"	"unprognostic (5.36e-2)"	"unprognostic (7.96e-4)"	"unprognostic (1.42e-1)"	"prognostic favourable (5.96e-5)"	"unprognostic (3.74e-2)"	"unprognostic (8.56e-2)"	"unprognostic (3.30e-3)"	"unprognostic (2.39e-4)"	5.3	1.9	10.3	3.7	16.7	0.8	5.3	5.4	17.1	5.3	14.7	15.3	4.3	18.9	2.1	2.9	2.0	5.2	4.0	8.3	10.3	11.2	14.2	3.0	8.2	2.2	14.0	13.6	25.0	14.8	16.2	6.1	36.7	15.9	4.8	12.0	10.0	4.4	8.5	15.6	3.1	40.8	3.4	12.7	2.5	3.4	2.6	11.0	0.2	6.3	1.5	1.1	3.1	9.6	0.5	0.0	1.9	0.6	0.0	0.8	0.0	0.0	0.0	2.3	0.0	1.3	1.1	0.2	0.5	13.9	0.3	0.0	0.3	0.1	1.9	0.0	3.5	7.2	2.9	0.9	0.1	0.9	1.7	0.0	4.2	0.0	3.7	0.0	0.1	1.0	7.6	0.0	0.5	0.9	0.1	3.0	0.4	0.7	2.3	0.6	4.4	0.0	1.4	0.1	2.1	1.0	0.9	12.3	11.4	0.1	0.9	3.8	0.4	0.0	0.0	6.4	0.3	0.2	0.0	9.1	0.0	2.1	1.7	0.2	1.6	0.0	0.6	0.0	0.5	0.0	0.0	0.5	0.3	0.8	0.0	0.0	0.1	0.2	1.9	0.0	0.0	0.0	0.0	0.0	10.3	16.7	5.4	17.1	10.3	11.2	14.0	13.6	15.9	11.0
SENP5	MGC27076	ENSG00000119231	"SUMO1/sentrin specific peptidase 5"	Q96HI0	3	196867856-196934714	"Enzymes, Predicted intracellular proteins"	"Cell cycle, Cell division, Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006684			Supported	"Nucleoli,Plasma membrane"				Nucleoli	"Plasma membrane"	"HPA006684: "	"unprognostic (4.07e-2)"	"unprognostic (4.91e-3)"	"unprognostic (7.63e-2)"	"prognostic unfavourable (4.04e-4)"	"unprognostic (4.13e-1)"	"unprognostic (1.08e-1)"	"prognostic unfavourable (4.15e-4)"	"unprognostic (2.95e-1)"	"unprognostic (2.20e-1)"	"unprognostic (2.88e-1)"	"unprognostic (2.89e-1)"	"unprognostic (9.57e-3)"	"prognostic unfavourable (2.14e-5)"	"unprognostic (2.02e-1)"	"unprognostic (1.62e-1)"	"unprognostic (1.62e-2)"	"unprognostic (6.71e-2)"	13.8	13.5	20.0	15.3	20.0	25.7	16.1	28.3	23.8	15.0	15.1	16.1	14.5	11.3	14.6	16.2	16.3	12.9	14.4	15.9	18.9	21.7	13.6	19.5	15.2	15.9	19.4	18.4	17.5	15.7	19.8	21.5	17.8	23.5	15.1	14.0	12.0	13.2	15.9	17.8	16.4	13.0	16.8	18.2	17.1	14.0	36.6	16.4	19.3	14.1	9.2	21.1	14.9	20.1	8.9	7.8	15.8	8.7	7.6	8.9	4.2	13.1	6.0	9.6	8.6	8.1	9.8	7.6	8.4	9.0	9.1	14.7	10.4	5.2	12.3	23.4	9.2	9.1	9.9	4.5	14.9	6.6	6.5	16.7	8.9	7.3	9.5	13.7	7.9	8.4	12.1	9.3	9.9	8.9	11.0	19.1	10.6	11.3	12.9	8.1	7.4	11.9	8.3	7.7	8.3	4.5	7.5	6.0	8.0	9.4	10.6	10.3	17.8	10.5	10.0	8.9	9.2	12.2	17.1	20.4	35.7	26.5	12.0	11.1	10.1	15.8	7.6	7.1	8.9	8.1	8.1	8.9	8.6	8.8	5.0	8.5	8.0	8.6	14.9	7.6	8.7	7.8	6.9	4.2	20.0	20.0	28.3	23.8	18.9	21.7	19.4	18.4	23.5	16.4
SEPT2	"DIFF6, hNedd5, KIAA0158, NEDD5, Pnutl3"	ENSG00000168385	"Septin 2"	Q15019	2	241315100-241354027	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Differentiation, Mitosis, Spermatogenesis"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"CAB017190, HPA018481"	Supported		Enhanced	"Nucleoplasm,Plasma membrane,Actin filaments,Cytokinetic bridge"			8800000	"Actin filaments"	"Nucleoplasm, Plasma membrane, Cytokinetic bridge"	"CAB017190: , HPA018481: AB_1856684"	"unprognostic (6.31e-2)"	"unprognostic (5.27e-2)"	"unprognostic (2.95e-2)"	"unprognostic (4.03e-2)"	"prognostic favourable (8.21e-4)"	"unprognostic (3.32e-1)"	"prognostic unfavourable (3.66e-4)"	"unprognostic (1.96e-3)"	"unprognostic (1.83e-2)"	"unprognostic (5.69e-2)"	"unprognostic (1.11e-3)"	"unprognostic (3.16e-1)"	"unprognostic (9.58e-3)"	"unprognostic (8.11e-2)"	"unprognostic (9.53e-2)"	"unprognostic (1.40e-1)"	"unprognostic (2.17e-2)"	64.2	46.4	76.5	42.9	69.9	29.1	58.7	34.9	61.8	69.3	48.4	85.2	57.4	37.8	59.5	59.8	46.8	48.2	54.0	56.2	65.8	55.4	64.6	31.4	51.2	51.3	76.5	52.7	63.4	73.0	56.6	56.3	58.9	60.7	53.7	53.3	48.8	43.6	64.7	39.5	32.0	42.2	81.8	100.8	51.5	45.6	67.7	57.2	36.2	64.2	39.0	47.5	56.5	42.6	25.5	51.2	38.5	50.5	51.3	36.9	59.4	31.9	28.8	78.5	51.3	73.1	79.8	40.6	70.8	69.8	45.5	58.0	16.1	34.8	13.0	16.9	80.9	28.5	51.2	47.9	74.9	32.8	36.4	52.2	28.8	59.4	44.8	49.7	31.9	71.0	31.4	37.9	36.6	79.2	46.5	19.1	66.9	23.0	29.4	30.4	57.1	21.1	29.1	98.7	27.5	67.5	48.9	56.3	37.9	49.0	33.9	46.7	20.3	44.9	74.8	55.8	23.7	53.8	41.8	37.7	32.8	45.8	48.0	30.4	77.0	38.5	46.0	26.3	30.3	50.5	36.9	25.5	29.6	31.2	51.2	21.6	26.2	27.4	16.3	51.3	37.2	38.6	29.5	59.4	76.5	69.9	34.9	52.3	65.8	55.4	76.5	52.7	60.7	57.2
SEPT3	SEP3	ENSG00000100167	"Septin 3"	Q9UH03	22	41969475-41998221	"Predicted intracellular proteins"	"Cell cycle, Cell division"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	9	"brain: 101.6"	"Cell line enhanced"	"Detected in many"		"AF22: 13.5;SCLC-21H: 36.5"	"Cancer enhanced"	"Detected in many"		"glioma: 24.6"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"basophil: 2.1"	"Group enriched"	"Detected in many"	5	"dendritic cells: 1.2;granulocytes: 2.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003548, CAB017633"	Enhanced	Supported	Approved	"Nucleoplasm,Plasma membrane,Actin filaments"				"Nucleoplasm, Plasma membrane"	"Actin filaments"	"CAB017633: AB_2301476, HPA003548: AB_1079908"	"unprognostic (2.10e-1)"	"unprognostic (4.67e-2)"	"unprognostic (1.16e-2)"	"prognostic unfavourable (1.78e-4)"	"unprognostic (4.56e-2)"	"unprognostic (1.13e-1)"	"unprognostic (7.07e-3)"	"unprognostic (2.37e-1)"	"unprognostic (2.67e-3)"	"unprognostic (3.09e-2)"	"unprognostic (1.30e-2)"	"unprognostic (6.30e-2)"	"unprognostic (2.51e-2)"	"unprognostic (9.15e-2)"	"unprognostic (6.68e-2)"	"unprognostic (5.50e-2)"	"unprognostic (1.04e-1)"	1.3	4.4	31.3	1.4	26.9	1.3	2.0	35.9	101.6	1.4	1.5	5.6	0.0	1.4	1.4	2.2	1.3	1.2	1.5	1.2	28.9	17.2	1.4	1.2	1.7	1.5	13.2	24.3	1.2	2.0	10.7	1.0	4.9	13.4	2.1	1.5	1.0	1.3	1.2	1.2	2.2	1.4	1.4	7.3	1.3	1.5	2.4	5.3	0.0	1.7	0.0	1.5	1.4	0.1	0.3	1.2	2.1	0.0	0.1	0.2	0.0	0.7	0.8	13.5	10.1	0.1	0.0	6.7	0.1	0.1	0.9	0.4	0.2	1.5	10.9	0.4	0.1	0.0	7.0	0.0	0.3	4.5	2.3	0.0	0.2	0.0	0.1	0.0	0.4	0.1	0.5	0.0	0.0	0.0	0.0	1.7	0.0	1.1	1.8	0.1	9.2	0.3	8.7	0.0	0.6	0.0	1.3	36.5	7.6	5.4	0.0	8.9	1.3	3.3	0.0	0.0	4.8	0.4	0.5	7.2	6.2	0.1	0.1	4.4	1.4	2.1	0.0	0.1	0.1	0.0	0.2	0.3	0.2	0.0	1.2	0.0	0.2	0.1	0.0	0.1	0.0	0.9	0.2	0.0	31.3	26.9	35.9	42.1	28.9	17.2	13.2	24.3	13.4	5.3
SERINC2	"FKSG84, PRO0899, TDE2, TDE2L"	ENSG00000168528	"Serine incorporator 2"	Q96SA4	1	31409565-31434680	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 113.9"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 46.5;HaCaT: 53.0;HBEC3-KT: 83.7;hTCEpi: 47.6;RT4: 57.3;SK-BR-3: 47.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in some"	4	"plasmacytoid DC: 12.0"	"Lineage enriched"	"Detected in many"	4	"dendritic cells: 12.0"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA005974	Enhanced		Approved	"Nucleoplasm,Plasma membrane"				"Plasma membrane"	Nucleoplasm	"HPA005974: AB_10603239"	"unprognostic (1.41e-1)"	"unprognostic (3.70e-3)"	"unprognostic (8.78e-3)"	"prognostic favourable (1.69e-7)"	"unprognostic (6.78e-2)"	"unprognostic (5.31e-2)"	"prognostic unfavourable (2.11e-4)"	"prognostic unfavourable (5.70e-4)"	"unprognostic (3.12e-2)"	"unprognostic (3.19e-2)"	"unprognostic (1.11e-2)"	"unprognostic (1.09e-2)"	"unprognostic (3.74e-2)"	"unprognostic (1.39e-1)"	"unprognostic (2.48e-1)"	"unprognostic (4.63e-3)"	"unprognostic (2.67e-2)"	2.0	6.6	0.6	13.5	1.2	1.1	12.1	0.8	0.8	17.3	32.9	0.8	52.1	27.4	3.7	26.5	32.5	4.3	34.4	2.0	1.0	0.6	57.5	113.9	10.3	7.1	1.8	0.5	1.7	12.9	5.7	5.1	33.9	1.4	17.0	12.8	5.0	58.6	74.4	20.2	14.2	73.0	6.7	1.2	1.7	20.7	3.5	0.8	5.7	13.1	12.7	19.1	31.1	19.9	0.2	12.0	2.3	2.7	0.0	0.0	0.5	12.8	3.0	2.7	8.7	5.9	8.0	7.4	24.7	18.4	1.6	2.0	4.6	46.5	8.5	32.6	23.2	53.0	0.3	83.7	0.3	0.8	2.0	0.0	2.7	2.4	6.6	0.0	9.9	7.3	47.6	10.2	22.5	1.0	0.3	0.0	2.7	2.1	0.3	0.3	2.8	6.5	0.0	5.3	2.8	8.8	57.3	1.1	6.6	6.3	47.9	1.0	28.0	1.4	6.1	0.4	2.0	0.2	0.5	0.4	0.3	0.4	0.2	0.2	2.0	0.0	2.7	2.3	0.0	0.8	0.0	0.0	0.0	0.0	0.5	0.2	0.0	0.0	0.0	0.0	0.1	12.0	0.0	0.5	0.6	1.2	0.8	0.8	1.0	0.6	1.8	0.5	1.4	0.8
SERPINB3	"HsT1196, SCC, SCCA1, T4-A"	ENSG00000057149	"Serpin family B member 3"	P29508	18	63655197-63661963	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"		"Protease inhibitor, Serine protease inhibitor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"cervix, uterine: 50.7;esophagus: 140.0;vagina: 80.0"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 2.5;HaCaT: 8.9;SiHa: 5.5;U-2197: 11.3"	"Cancer enhanced"	"Detected in many"		"cervical cancer: 186.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"CAB018772, CAB036006, CAB036007, HPA048341, HPA049988, HPA055992"	Enhanced		Approved	"Plasma membrane,Cytosol"			11000000	Cytosol	"Plasma membrane"	"CAB018772: AB_2285759, CAB036006: , CAB036007: , HPA048341: , HPA049988: , HPA055992: "		"unprognostic (2.95e-3)"		"unprognostic (1.66e-1)"		"unprognostic (2.03e-1)"		"unprognostic (2.91e-2)"	"unprognostic (2.11e-1)"		"prognostic unfavourable (3.19e-4)"	"unprognostic (6.68e-2)"		"unprognostic (2.58e-1)"			"unprognostic (4.19e-3)"	0.2	0.0	0.2	0.2	0.2	0.0	0.2	0.2	0.2	50.7	0.2	0.2	0.2	0.0	3.8	0.2	140.0	0.0	0.2	0.2	0.2	0.0	0.2	0.2	5.4	0.2	0.2	0.2	0.2	0.2	0.0	2.4	0.2	0.2	1.1	0.0	0.2	13.0	0.2	0.2	7.1	0.2	0.2	0.2	0.2	0.0	0.2	0.2	1.4	0.2	21.3	3.1	13.1	80.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	2.5	0.1	0.0	0.1	8.9	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	1.9	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	5.5	0.0	0.0	0.0	0.0	0.3	0.0	0.0	11.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2
SFSWAP	"SFRS8, SWAP"	ENSG00000061936	"Splicing factor SWAP"	Q12872	12	131711081-131799737	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing, Transcription, Transcription regulation"	"Repressor, RNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039362, HPA040063"	Approved		Approved	"Nucleoplasm,Plasma membrane,Cytosol"				Nucleoplasm	"Plasma membrane, Cytosol"	"HPA039362: AB_10794089, HPA040063: AB_10795413"	"unprognostic (1.33e-2)"	"unprognostic (2.53e-2)"	"unprognostic (1.39e-3)"	"unprognostic (2.04e-1)"	"unprognostic (4.45e-2)"	"unprognostic (2.39e-3)"	"unprognostic (7.41e-3)"	"unprognostic (2.31e-1)"	"prognostic unfavourable (1.10e-4)"	"unprognostic (3.44e-1)"	"unprognostic (1.50e-2)"	"unprognostic (3.30e-2)"	"prognostic unfavourable (3.33e-8)"	"unprognostic (7.50e-2)"	"unprognostic (2.93e-2)"	"unprognostic (3.48e-1)"	"unprognostic (3.66e-2)"	20.2	15.0	17.7	23.2	24.0	47.1	17.9	31.1	23.8	16.6	15.7	31.1	11.6	20.4	25.7	15.1	15.7	15.7	16.5	11.9	20.5	15.9	15.7	12.3	16.4	20.7	27.0	17.2	21.4	19.8	19.5	18.0	16.6	16.6	14.7	9.9	16.9	22.1	15.5	27.4	30.0	19.0	17.3	21.1	23.7	18.4	17.5	26.4	21.9	17.1	15.9	16.8	16.7	20.5	6.6	11.0	8.5	6.4	8.4	5.5	2.6	13.7	12.4	8.8	9.3	7.1	5.9	19.8	10.7	7.4	12.7	8.7	12.1	6.7	16.9	10.0	7.9	12.9	12.4	9.8	7.4	5.2	19.5	15.3	6.7	14.1	7.6	19.7	15.2	6.6	11.3	11.4	13.8	7.8	21.2	6.7	5.6	17.2	16.6	30.0	23.0	20.7	19.4	8.9	13.3	7.3	10.1	13.8	15.6	10.1	8.5	12.7	12.3	15.5	10.0	10.5	13.8	8.1	11.8	19.3	21.0	17.1	10.4	13.6	14.0	3.0	6.4	2.6	5.2	4.4	5.0	3.5	4.6	4.2	4.5	6.6	4.9	5.5	8.5	8.4	5.0	11.0	3.8	2.6	17.7	24.0	31.1	23.8	20.5	15.9	27.0	17.2	16.6	26.4
SGCE	DYT11	ENSG00000127990	"Sarcoglycan epsilon"	O43556	7	94524204-94656572	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"			"Disease mutation, Dystonia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"gdT-cell: 2.9;memory B-cell: 6.4;naive B-cell: 9.2"	"Group enriched"	"Detected in many"	4	"B-cells: 9.2;T-cells: 2.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA074790			Approved	"Nucleoplasm,Golgi apparatus,Vesicles,Plasma membrane"			50000	"Vesicles, Plasma membrane"	"Nucleoplasm, Golgi apparatus"	"HPA074790: "	"unprognostic (3.16e-3)"	"unprognostic (9.06e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.20e-3)"	"unprognostic (1.12e-1)"	"prognostic unfavourable (1.61e-5)"	"unprognostic (1.19e-2)"	"unprognostic (2.82e-2)"	"unprognostic (6.93e-2)"	"unprognostic (3.37e-1)"	"unprognostic (6.80e-3)"	"unprognostic (9.69e-2)"	"unprognostic (5.71e-2)"	"prognostic unfavourable (1.35e-4)"	"unprognostic (1.43e-1)"	"unprognostic (2.04e-1)"	"unprognostic (2.44e-2)"	22.4	35.7	16.9	7.5	19.0	0.6	23.2	23.6	18.5	22.5	20.5	16.8	14.0	5.3	23.6	16.8	11.1	17.1	19.0	19.3	17.7	14.3	12.9	8.9	17.3	9.0	21.5	12.9	59.3	12.9	8.7	23.1	31.9	15.0	15.6	9.7	11.2	11.9	22.7	6.1	3.5	8.0	28.1	20.9	15.8	11.2	13.2	17.5	2.9	15.4	6.9	4.4	22.7	16.1	9.2	0.3	0.6	0.1	1.4	2.9	0.5	3.8	12.0	12.2	19.7	19.4	36.5	2.2	14.5	29.3	12.4	18.8	7.5	22.8	3.6	20.7	25.6	2.5	18.3	6.4	16.9	0.6	9.9	0.3	11.8	8.1	15.2	1.1	0.0	29.4	9.0	18.2	23.8	8.7	0.0	28.8	14.4	12.0	0.0	0.0	9.3	9.5	5.4	15.1	7.6	24.0	3.8	7.7	6.2	0.0	16.1	18.4	5.6	0.1	0.0	39.2	13.1	3.6	22.4	14.9	18.5	4.4	14.6	0.0	22.0	0.6	0.1	0.1	2.9	0.1	1.2	6.4	0.9	1.4	0.1	9.2	0.3	1.0	0.5	1.4	0.1	0.3	0.2	0.5	16.9	19.0	23.6	18.5	17.7	14.3	21.5	12.9	15.0	17.5
SGK494		ENSG00000167524	"Uncharacterized serine/threonine-protein kinase SgK494"		17	28607964-28614200	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"				"Tissue enhanced"	"Detected in many"		"brain: 25.8"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							HPA046590	Uncertain		Approved	"Nucleoplasm,Vesicles,Plasma membrane"				"Vesicles, Plasma membrane"	Nucleoplasm	"HPA046590: "	"unprognostic (1.83e-1)"	"unprognostic (9.42e-2)"	"unprognostic (2.84e-2)"	"unprognostic (2.30e-2)"	"unprognostic (2.11e-1)"	"unprognostic (2.06e-3)"	"unprognostic (9.33e-3)"	"unprognostic (2.63e-1)"	"unprognostic (8.62e-4)"	"unprognostic (2.09e-2)"	"unprognostic (6.81e-2)"	"unprognostic (3.45e-5)"	"unprognostic (1.20e-7)"	"unprognostic (2.67e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.28e-2)"	"unprognostic (4.66e-3)"	1.6	4.7	10.3	3.5	25.3	10.6	2.3	17.8	25.8	1.9	1.8	0.9	0.4	0.7	2.0	4.5	1.3	2.4	0.8	2.1	8.6	3.7	5.6	1.6	3.2	3.3	2.5	10.7	3.7	1.3	2.0	5.6	3.1	11.2	2.3	4.0	6.3	1.9	3.2	3.8	6.3	2.3	1.9	2.9	3.4	1.3	8.5	4.1	0.1	2.5	0.1	3.5	1.9	2.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	3.4	5.2	6.2	5.7	2.0	2.5	4.5	0.8	0.4	2.1	1.9	6.2	0.7	7.1	0.9	2.9	3.1	4.6	2.5	2.7	4.0	6.8	7.4	4.0	3.6	0.2	9.9	5.2	1.2	7.4	7.5	4.2	2.3	7.1	0.6	1.3	7.2	2.5	6.6	6.2	1.0	7.2	8.8	4.7	1.2	6.8	3.8	3.5	4.4	2.4	3.7	3.7	5.5	3.1	4.2	3.6	4.2	5.0	3.9	3.6	8.6	3.1	7.3	3.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.3	25.3	17.8	25.8	8.6	3.7	2.5	10.7	11.2	4.1
SH3BGR	21-GARP	ENSG00000185437	"SH3 domain binding glutamate rich protein"	P55822	21	39445855-39515506	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"skeletal muscle: 219.7"	"Cell line enhanced"	"Detected in many"		"U-266/70: 15.3;U-87 MG: 47.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 11.5"	"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"cerebellum: 34.0;midbrain: 14.7;olfactory region: 12.3;pons and medulla: 29.7"	"Low region specificity"	"Detected in all"			"CAB003685, HPA030690"	Enhanced		Approved	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		"CAB003685: AB_425682, HPA030690: "	"unprognostic (3.41e-2)"	"unprognostic (1.26e-1)"	"unprognostic (5.84e-3)"	"unprognostic (1.68e-3)"	"unprognostic (6.05e-2)"	"unprognostic (6.12e-3)"	"unprognostic (3.89e-2)"	"unprognostic (9.78e-2)"	"unprognostic (2.06e-1)"	"unprognostic (6.97e-3)"	"unprognostic (3.59e-2)"	"unprognostic (4.75e-1)"	"unprognostic (5.98e-3)"	"unprognostic (7.16e-2)"	"unprognostic (4.60e-2)"	"unprognostic (1.68e-2)"	"unprognostic (2.06e-2)"	2.4	5.2	7.2	1.2	7.3	0.9	2.9	1.1	4.3	2.9	6.1	3.0	2.0	1.9	2.1	6.6	5.3	2.1	5.0	30.0	6.6	5.4	3.2	2.8	1.5	0.9	7.5	5.0	1.8	2.8	2.1	4.5	1.1	6.1	5.8	2.0	1.2	3.2	5.2	219.7	0.9	1.4	12.4	7.9	1.2	2.9	3.7	5.9	0.1	3.9	41.5	2.2	7.3	8.6	2.7	11.5	2.6	1.7	2.8	4.0	1.2	1.0	1.3	1.7	2.5	3.7	4.3	0.5	1.9	0.9	0.9	0.7	0.7	2.2	3.3	5.1	5.0	0.1	0.9	1.5	1.4	2.0	3.4	3.3	0.6	1.3	7.6	1.2	0.7	3.5	6.2	3.2	6.3	1.0	2.5	4.3	3.5	4.1	2.2	1.9	1.7	2.9	3.5	6.4	2.1	4.6	0.8	4.8	2.0	2.9	2.4	3.1	9.0	0.6	0.8	2.5	0.3	1.5	3.7	15.3	3.2	3.3	47.5	2.9	3.3	2.3	0.7	0.0	1.2	1.7	3.1	2.7	1.1	1.8	1.9	1.4	4.0	3.0	2.6	2.8	1.7	11.5	0.7	1.2	7.2	7.3	1.1	4.3	6.6	5.4	7.5	5.0	6.1	5.9
SHANK3	"KIAA1650, prosap2, PSAP2, SPANK-2"	ENSG00000251322	"SH3 and multiple ankyrin repeat domains 3"		22	50674415-50733298	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"				"Tissue enhanced"	"Detected in many"		"brain: 32.4"	"Cell line enhanced"	"Detected in some"		"HEL: 6.3;TIME: 10.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003446	Enhanced		Approved	"Nucleoplasm,Plasma membrane"				"Nucleoplasm, Plasma membrane"		"HPA003446: AB_1079958"	"unprognostic (3.62e-1)"	"unprognostic (1.08e-2)"	"prognostic unfavourable (7.40e-4)"	"unprognostic (6.02e-2)"	"unprognostic (4.17e-1)"	"unprognostic (1.72e-3)"	"unprognostic (3.41e-2)"	"unprognostic (3.13e-1)"	"unprognostic (9.67e-2)"	"unprognostic (5.62e-2)"	"unprognostic (2.09e-2)"	"unprognostic (7.52e-2)"	"unprognostic (2.47e-2)"	"unprognostic (7.81e-2)"	"unprognostic (1.19e-1)"	"unprognostic (4.89e-2)"	"unprognostic (1.41e-1)"	9.5	5.4	23.5	1.3	26.1	2.6	8.7	13.0	32.4	3.5	2.0	2.4	0.1	5.2	3.8	3.4	2.5	2.8	1.1	4.4	21.6	2.4	2.9	5.1	5.3	2.9	2.5	18.1	1.6	7.6	7.9	1.0	1.7	2.6	1.9	1.9	0.6	8.5	3.4	3.6	3.1	6.6	1.5	2.0	12.3	1.3	3.4	6.4	0.2	4.1	1.4	2.6	5.3	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.9	0.6	2.9	0.5	0.5	0.0	0.6	0.0	0.2	0.0	0.6	1.6	0.0	1.2	0.2	0.6	0.9	0.4	0.0	0.0	0.0	6.3	0.4	1.7	1.5	0.8	0.3	1.5	1.0	0.1	0.3	2.0	0.1	0.1	0.1	0.9	0.5	0.2	1.3	1.8	1.7	0.0	0.7	0.3	0.5	1.2	1.9	1.7	0.0	0.8	0.3	0.3	10.0	0.2	1.7	0.6	0.4	0.1	0.1	0.0	0.1	0.5	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	23.5	26.1	13.0	32.4	21.6	2.4	2.5	18.1	2.6	6.4
SHROOM2	APXL	ENSG00000146950	"Shroom family member 2"	Q13796	X	9786456-9949443	"Plasma proteins, Predicted intracellular proteins"		"Actin-binding, Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"hTEC/SVTERT24-B: 12.4;RT4: 12.9;WM-115: 15.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"neutrophil: 1.1"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in many"							"HPA051646, HPA061435"	Approved		Approved	"Plasma membrane,Cell Junctions,Cytosol"				"Plasma membrane, Cell Junctions"	Cytosol	"HPA051646: , HPA061435: "	"unprognostic (8.65e-3)"	"unprognostic (1.36e-3)"	"unprognostic (4.68e-2)"	"unprognostic (4.06e-2)"	"unprognostic (6.99e-3)"	"unprognostic (8.05e-2)"	"unprognostic (9.96e-2)"	"unprognostic (1.28e-1)"	"unprognostic (2.51e-1)"	"unprognostic (6.54e-2)"	"unprognostic (2.82e-2)"	"unprognostic (9.73e-2)"	"prognostic favourable (1.35e-7)"	"unprognostic (1.56e-1)"	"unprognostic (3.34e-1)"	"unprognostic (1.93e-1)"	"unprognostic (7.67e-3)"	1.3	3.6	6.8	1.3	7.7	0.5	2.5	2.8	17.0	4.7	3.2	3.7	4.6	1.8	3.3	5.8	7.2	3.6	6.3	1.5	7.4	5.5	5.3	7.6	8.1	1.0	5.7	9.1	13.8	7.2	5.5	6.1	14.3	5.8	10.6	3.0	3.6	6.0	5.8	0.7	7.9	1.4	2.1	7.9	1.7	2.6	5.8	2.5	1.8	3.1	3.4	3.4	6.4	4.3	0.0	0.9	1.1	0.0	0.0	0.2	0.0	4.0	0.5	7.6	1.0	0.4	1.2	4.3	0.4	1.3	1.6	2.7	5.0	0.0	0.0	1.4	1.0	3.3	3.9	10.8	1.9	0.0	2.9	0.0	0.0	0.8	2.5	0.0	5.2	0.2	7.5	12.4	0.5	9.3	0.0	0.0	2.6	4.3	0.0	0.0	6.6	0.0	0.0	8.3	0.0	7.0	12.9	1.1	0.6	0.3	0.1	12.0	4.4	0.2	4.3	12.1	1.5	0.0	0.4	0.0	0.0	0.0	7.9	0.0	15.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.9	0.0	0.0	6.8	7.7	2.8	17.0	7.4	5.5	5.7	9.1	5.8	2.5
SHTN1	"KIAA1598, shootin-1, shootin1"	ENSG00000187164	"Shootin 1"	A0MZ66	10	116881482-117126586	"Predicted intracellular proteins"		"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 67.8"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	31	"classical monocyte: 14.0;intermediate monocyte: 8.8;myeloid DC: 13.2;non-classical monocyte: 4.0;plasmacytoid DC: 8.9"	"Group enriched"	"Detected in many"	43	"dendritic cells: 13.2;monocytes: 14.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037942, HPA037943"	Enhanced	Approved	Approved	"Nucleoplasm,Plasma membrane,Cytosol"				Nucleoplasm	"Plasma membrane, Cytosol"	"HPA037942: AB_2675748, HPA037943: AB_10671637"	"unprognostic (1.00e-1)"	"unprognostic (2.50e-2)"	"unprognostic (6.77e-3)"	"unprognostic (2.81e-1)"	"unprognostic (7.85e-2)"	"unprognostic (1.61e-1)"	"unprognostic (2.42e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.56e-1)"	"unprognostic (1.35e-1)"	"unprognostic (2.49e-1)"	"prognostic unfavourable (5.07e-4)"	"unprognostic (2.17e-2)"	"unprognostic (1.48e-1)"	"unprognostic (2.47e-1)"	"unprognostic (1.85e-1)"	"prognostic unfavourable (5.08e-6)"	3.5	6.5	51.5	6.8	50.1	1.6	8.7	9.8	34.1	5.5	7.0	42.3	0.3	6.7	4.4	8.4	5.4	5.2	6.5	2.6	58.9	37.0	7.8	12.1	9.8	4.5	67.8	22.7	6.8	10.9	18.6	20.4	5.4	36.3	7.3	8.6	2.0	9.9	3.0	0.9	9.6	7.8	3.8	67.4	7.0	9.0	9.9	54.5	0.4	11.9	1.4	4.1	4.0	2.4	0.0	13.2	0.3	14.0	0.0	0.2	3.5	15.6	8.8	0.9	1.9	0.0	0.0	8.8	1.3	3.5	2.7	5.2	9.9	10.4	0.0	2.7	4.9	8.1	7.0	5.9	2.8	0.0	7.3	0.0	9.3	6.1	1.2	2.8	2.5	0.4	5.2	2.7	5.1	6.5	4.3	0.0	1.9	6.3	0.0	0.1	3.4	6.0	0.0	11.9	3.5	7.3	2.1	9.8	3.9	10.6	15.4	9.6	12.4	2.5	11.2	0.9	6.6	0.0	7.7	1.7	0.0	0.0	4.9	0.0	4.8	0.0	14.0	0.1	0.0	8.8	0.0	0.0	0.0	0.0	13.2	0.0	0.1	0.0	0.3	0.0	4.0	8.9	0.2	3.5	51.5	50.1	9.8	30.2	58.9	37.0	67.8	22.7	36.3	54.5
SIN3B	KIAA0700	ENSG00000127511	"SIN3 transcription regulator family member B"	O75182	19	16829400-16880353	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA050329	Uncertain		Approved	"Nucleoplasm,Plasma membrane"				"Nucleoplasm, Plasma membrane"		"HPA050329: "	"unprognostic (2.71e-3)"	"unprognostic (8.89e-2)"	"unprognostic (1.32e-3)"	"unprognostic (6.22e-2)"	"unprognostic (1.24e-1)"	"unprognostic (2.05e-2)"	"unprognostic (5.44e-2)"	"unprognostic (9.89e-2)"	"unprognostic (5.42e-3)"	"unprognostic (2.77e-1)"	"prognostic favourable (4.37e-4)"	"prognostic unfavourable (3.58e-4)"	"unprognostic (1.18e-3)"	"unprognostic (8.45e-2)"	"unprognostic (1.49e-1)"	"unprognostic (9.36e-2)"	"unprognostic (1.06e-1)"	19.1	17.9	22.2	17.2	28.1	9.8	21.5	25.1	38.6	24.4	16.0	20.8	50.0	12.8	37.5	21.5	14.5	23.3	17.3	15.7	24.2	20.8	15.9	9.8	21.7	20.8	16.5	30.4	32.5	16.2	60.8	17.7	53.2	24.8	22.7	11.0	15.5	20.2	54.7	17.1	22.7	17.7	26.5	14.8	25.1	13.7	30.2	13.4	9.3	22.5	9.6	15.8	17.2	22.2	4.8	2.6	6.1	6.7	1.9	2.0	2.3	14.5	7.8	13.2	16.9	10.9	10.1	41.8	12.4	10.3	17.2	15.3	19.2	13.7	13.1	14.0	14.3	12.6	10.9	11.1	16.0	13.6	19.7	14.0	17.1	8.7	14.4	8.2	11.4	16.6	14.7	11.6	10.0	15.6	11.4	8.1	12.0	17.4	11.1	13.2	16.4	25.0	14.7	12.2	8.6	9.8	12.4	9.8	12.3	15.7	12.1	9.7	8.5	7.7	20.4	16.8	10.2	24.2	13.8	11.6	8.5	13.1	11.6	10.8	12.4	0.1	6.7	6.1	1.8	6.0	1.2	4.8	1.7	2.0	2.1	3.8	2.0	1.4	3.3	1.9	5.3	2.6	0.5	2.3	22.2	28.1	25.1	38.6	24.2	20.8	16.5	30.4	24.8	13.4
SIPA1	SPA1	ENSG00000213445	"Signal-induced proliferation-associated 1"	Q96FS4	11	65638097-65650930	"Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 47.1"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB020833, HPA039867"	Enhanced		Approved	"Nucleoplasm,Nucleoli,Golgi apparatus,Plasma membrane"				Nucleoli	"Nucleoplasm, Golgi apparatus, Plasma membrane"	"CAB020833: , HPA039867: "	"unprognostic (6.10e-2)"	"unprognostic (1.75e-1)"	"prognostic unfavourable (9.42e-4)"	"unprognostic (1.35e-2)"	"unprognostic (2.93e-1)"	"unprognostic (2.32e-2)"	"unprognostic (3.35e-2)"	"unprognostic (1.09e-1)"	"unprognostic (3.30e-2)"	"unprognostic (6.44e-2)"	"unprognostic (5.85e-2)"	"unprognostic (4.86e-2)"	"prognostic unfavourable (3.52e-6)"	"unprognostic (1.60e-1)"	"unprognostic (2.78e-2)"	"unprognostic (1.14e-2)"	"unprognostic (1.49e-1)"	10.5	9.1	7.5	27.1	12.0	29.8	10.0	2.6	8.7	8.9	10.8	9.4	2.9	7.7	10.9	3.0	7.6	9.0	9.9	8.0	8.4	4.6	9.5	7.8	17.6	33.2	11.5	4.7	7.7	4.6	2.7	4.2	11.9	10.3	8.6	3.9	8.2	8.7	6.8	5.4	4.2	17.2	9.0	14.3	47.1	8.1	3.0	10.5	25.3	7.7	4.6	32.7	8.5	7.8	6.6	2.8	14.1	5.2	5.8	7.4	3.0	0.7	6.2	4.4	9.5	2.6	5.4	10.5	7.1	6.0	5.5	5.4	1.9	6.8	9.8	16.0	3.5	3.6	1.6	2.3	1.8	10.6	3.9	23.9	9.1	3.3	4.6	9.6	10.3	5.5	1.1	7.7	1.0	16.2	13.5	4.5	2.7	2.7	3.8	16.5	3.0	5.7	17.5	2.4	8.7	2.1	0.5	1.7	10.1	3.5	6.1	14.5	4.6	14.9	22.7	6.9	13.9	7.5	1.4	6.8	5.3	22.0	9.4	15.4	19.8	4.0	4.1	10.2	7.4	4.8	5.5	5.3	3.7	4.8	2.8	6.6	2.9	4.4	14.1	5.8	5.2	2.7	3.5	3.0	7.5	12.0	2.6	8.7	8.4	4.6	11.5	4.7	10.3	10.5
SIPA1L1	"E6TP1, KIAA0440"	ENSG00000197555	"Signal induced proliferation associated 1 like 1"	O43166	14	71320449-71741229	"Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"U-138 MG: 40.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 18.7"	"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002875	Approved		Approved	"Plasma membrane,Actin filaments"				"Plasma membrane"	"Actin filaments"	"HPA002875: AB_1079974"	"unprognostic (1.50e-3)"	"unprognostic (2.99e-1)"	"unprognostic (3.34e-2)"	"unprognostic (5.64e-3)"	"unprognostic (4.19e-2)"	"unprognostic (4.14e-1)"	"unprognostic (7.89e-2)"	"unprognostic (4.86e-2)"	"unprognostic (3.09e-1)"	"unprognostic (8.62e-2)"	"unprognostic (2.61e-1)"	"unprognostic (5.27e-2)"	"prognostic favourable (6.80e-8)"	"unprognostic (1.02e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.42e-1)"	"unprognostic (7.03e-2)"	4.5	12.0	27.1	8.2	36.4	7.8	6.8	21.7	35.7	7.7	8.9	5.3	1.0	7.6	5.4	8.7	11.2	10.6	11.8	2.4	17.5	10.4	11.7	9.3	8.6	7.6	8.1	23.9	3.6	9.5	23.6	13.0	3.6	10.1	6.2	9.0	7.3	7.6	6.9	2.2	6.4	8.0	8.0	6.8	18.1	13.8	14.5	7.2	3.1	11.0	3.2	11.5	7.7	4.8	6.8	1.0	18.7	5.3	1.6	3.3	1.6	10.2	3.2	7.5	5.6	2.2	6.5	13.6	14.0	16.6	5.7	7.3	18.5	5.8	4.8	3.6	22.9	10.2	5.4	12.6	10.9	4.3	2.5	10.1	21.2	4.3	18.9	1.2	3.9	4.7	10.6	8.8	20.9	6.1	4.4	12.1	7.8	15.4	4.0	1.1	4.3	8.8	6.0	8.1	5.1	4.1	15.9	9.3	24.8	14.3	11.3	1.0	6.7	0.5	16.8	40.8	15.1	4.6	8.0	9.9	11.2	7.1	7.0	3.3	13.5	4.0	4.0	0.8	1.5	4.7	3.3	2.6	1.3	2.0	1.0	6.8	0.9	1.0	18.7	1.6	5.3	0.3	1.2	1.6	27.1	36.4	21.7	35.7	17.5	10.4	8.1	23.9	10.1	7.2
SKAP1	"SCAP1, SKAP55"	ENSG00000141293	"Src kinase associated phosphoprotein 1"	Q86WV1	17	48133440-48430275	"Predicted intracellular proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 50.9;lymphoid tissue: 52.1"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 19.6;HDLM-2: 10.1;HMC-1: 8.6;Karpas-707: 10.7;RPMI-8226: 12.6;RPTEC TERT1: 15.6;U-266/70: 9.7;U-266/84: 6.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA002969, CAB025882, CAB055513"	Enhanced		Approved	"Nucleoplasm,Plasma membrane,Cytosol"				"Nucleoplasm, Plasma membrane"	Cytosol	"CAB025882: , CAB055513: , HPA002969: AB_1079870"	"prognostic favourable (5.07e-4)"	"unprognostic (1.10e-2)"	"unprognostic (2.19e-2)"	"unprognostic (1.80e-2)"	"unprognostic (2.28e-2)"	"unprognostic (1.43e-2)"	"unprognostic (2.61e-2)"	"unprognostic (1.57e-2)"	"unprognostic (8.39e-2)"	"unprognostic (1.81e-1)"	"unprognostic (3.38e-1)"	"unprognostic (1.71e-1)"	"unprognostic (5.71e-2)"	"unprognostic (6.20e-2)"	"unprognostic (2.72e-1)"	"unprognostic (1.94e-1)"	"prognostic favourable (3.14e-4)"	1.9	9.4	0.5	28.0	0.6	2.9	4.5	0.4	0.6	5.9	3.8	0.6	10.9	1.1	2.2	10.6	2.1	8.0	6.2	2.1	1.3	1.1	12.9	2.0	5.2	20.0	0.7	0.4	2.4	2.8	11.6	17.5	0.7	1.2	3.0	2.4	1.6	10.2	7.4	0.5	1.2	6.1	1.2	1.9	11.7	2.2	7.8	0.6	52.1	1.8	1.3	27.7	5.1	4.3	11.9	0.1	2.1	0.2	22.3	50.9	22.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	19.6	0.0	2.0	0.0	0.0	0.0	0.0	0.0	10.1	0.2	0.0	0.0	0.0	0.0	0.0	8.6	0.0	0.0	0.0	0.0	0.0	0.0	10.7	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	12.6	15.6	0.0	0.0	0.0	1.0	0.0	0.1	5.3	0.0	0.0	0.0	0.0	0.0	0.0	9.7	6.9	0.0	0.0	0.0	0.0	2.1	0.1	0.3	35.9	0.0	30.1	2.8	29.6	32.2	0.1	11.9	26.1	28.9	0.7	22.3	0.2	0.1	50.9	22.3	0.5	0.6	0.4	0.6	1.3	1.1	0.7	0.4	1.2	0.6
SLAMF6	"CD352, KALI, KALIb, Ly108, NTB-A, NTBA, SF2000"	ENSG00000162739	"SLAM family member 6"	Q96DU3	1	160485030-160523262	"CD markers, Predicted membrane proteins"	"Adaptive immunity, Immunity, Innate immunity"	Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 28.6;lymphoid tissue: 51.9"	"Group enriched"	"Detected in some"	5	"Daudi: 32.6;U-698: 48.1"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"											"HPA051363, HPA051903"	Uncertain		Approved	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		"HPA051363: , HPA051903: "	"prognostic favourable (9.42e-4)"	"prognostic favourable (2.78e-4)"	"unprognostic (8.65e-2)"	"prognostic favourable (9.53e-4)"	"unprognostic (5.85e-2)"	"prognostic favourable (7.34e-5)"	"unprognostic (3.16e-3)"	"unprognostic (9.78e-2)"	"prognostic favourable (1.25e-4)"	"unprognostic (2.31e-3)"	"unprognostic (2.09e-1)"	"unprognostic (1.57e-1)"	"prognostic unfavourable (2.09e-6)"	"unprognostic (2.78e-1)"	"unprognostic (1.01e-1)"	"unprognostic (2.33e-2)"	"unprognostic (8.21e-3)"	3.9	0.8	0.4	21.0	0.4	1.2	1.0	0.4	0.4	1.1	3.8	0.3	0.4	1.1	1.0	0.6	2.3	1.6	2.8	1.2	0.4	0.4	2.1	1.6	4.7	51.9	0.6	0.4	0.6	0.8	0.0	0.6	1.7	0.7	1.4	1.5	1.5	5.6	1.0	0.5	0.7	11.9	0.4	0.8	29.6	2.3	0.9	0.2	12.9	1.8	0.6	30.4	4.1	1.3	15.2	0.3	8.4	1.0	15.9	28.6	7.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	32.6	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	2.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	7.8	0.5	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	5.1	48.1	0.0	0.2	0.0	2.5	0.1	8.4	22.9	0.3	15.8	14.7	14.6	28.6	0.1	15.2	8.2	16.4	1.0	15.9	1.0	0.3	16.8	7.4	0.4	0.4	0.4	0.4	0.4	0.4	0.6	0.4	0.7	0.2
SLC10A5		ENSG00000253598	"Solute carrier family 10 member 5"	Q5PT55	8	81693607-81696174	"Predicted membrane proteins, Transporters"	"Ion transport, Sodium transport, Symport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"brain: 5.1;liver: 10.3"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in some"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA025966	Uncertain		Approved	"Plasma membrane"				"Plasma membrane"		"HPA025966: AB_1856959"	"unprognostic (6.42e-2)"	"unprognostic (3.89e-1)"	"unprognostic (1.25e-2)"	"unprognostic (2.34e-2)"	"unprognostic (8.13e-3)"	"unprognostic (1.91e-1)"	"unprognostic (5.71e-2)"	"unprognostic (5.63e-2)"	"unprognostic (3.67e-1)"	"unprognostic (2.41e-1)"	"unprognostic (1.37e-1)"	"unprognostic (3.22e-1)"	"unprognostic (8.95e-2)"	"unprognostic (2.51e-1)"	"unprognostic (2.24e-1)"	"unprognostic (1.67e-1)"	"unprognostic (2.82e-7)"	0.0	0.3	0.9	0.1	2.3	0.0	0.2	5.1	1.8	0.3	2.5			2.9	0.3	0.9	0.2	0.3	1.4	0.1	0.9	2.1	1.8	10.3	0.3	0.0	0.8		0.4	1.0	0.3	1.9	0.0		0.5	3.5		0.3	0.2	0.1	0.4	3.5	0.2	0.3	0.3	3.4	0.0			0.8		0.0	0.3	0.1	0.0	0.5	0.0	0.0	0.3	0.4	0.0	0.9	0.4	1.0	1.1	0.9	1.7	0.9	1.1	0.5	0.4	0.7	0.4	0.6	1.1	1.6	0.3	1.1	1.3	0.9	1.6	0.8	2.9	2.2	3.0	1.7	0.5	0.1	0.3	0.4	2.6	0.8	2.0	0.5	1.9	1.4	1.6	0.8	0.6	1.4	0.5	0.6	0.4	0.4	0.7	1.4	3.7	2.6	1.1	0.8	0.8	0.4	1.9	0.7	1.1	1.3	1.8	1.7	1.7	1.8	2.6	0.2	1.3	0.1	1.3	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.3	0.0	0.5	0.0	0.0										
SLC12A2	"BSC, BSC2, NKCC1, PPP1R141"	ENSG00000064651	"Solute carrier family 12 member 2"	P55011	5	128083766-128189688	"FDA approved drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Potassium transport, Sodium transport, Symport, Transport"		"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 50.7;salivary gland: 61.2"	"Cell line enhanced"	"Detected in all"		"A549: 31.1;AF22: 32.1"	"Cancer enhanced"	"Detected in all"		"colorectal cancer: 54.3"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 9.8"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020130, HPA063697"	Approved		Approved	"Vesicles,Plasma membrane"				Vesicles	"Plasma membrane"	"HPA020130: AB_1854502, HPA063697: "	"unprognostic (4.61e-2)"	"unprognostic (2.63e-1)"	"unprognostic (4.20e-3)"	"prognostic favourable (8.60e-4)"	"unprognostic (3.99e-1)"	"unprognostic (5.65e-3)"	"unprognostic (1.44e-3)"	"unprognostic (1.81e-1)"	"unprognostic (3.30e-1)"	"unprognostic (2.95e-2)"	"unprognostic (7.22e-2)"	"unprognostic (1.39e-1)"	"prognostic favourable (7.09e-4)"	"unprognostic (1.63e-1)"	"unprognostic (2.30e-1)"	"unprognostic (3.79e-1)"	"unprognostic (3.88e-3)"	5.5	11.0	10.8	9.4	24.1	2.7	26.2	11.4	18.1	5.1	28.5	37.2	0.0	24.6	5.7	1.9	3.8	4.1	50.7	4.1	15.5	9.9	4.5	2.9	6.5	3.5	36.1	13.5	5.6	5.3	11.2	5.5	3.3	30.0	14.8	36.3	8.5	61.2	2.1	8.5	23.0	28.8	6.6	27.7	2.9	36.3	5.5	26.7	2.0	5.6	6.8	18.3	4.2	3.6	3.6	9.8	0.5	1.2	3.6	3.0	0.4	6.2	31.1	32.1	12.4	8.0	5.2	6.6	5.8	4.4	4.2	4.4	12.4	10.0	9.3	7.9	5.0	19.0	6.1	6.7	6.5	9.3	7.6	2.7	5.5	1.8	2.5	3.3	4.7	5.5	2.4	9.3	5.5	6.8	4.3	6.4	6.5	6.6	5.9	2.8	3.7	10.2	3.3	9.0	3.8	4.9	21.4	5.6	3.6	11.7	5.1	4.6	2.8	1.7	11.4	10.5	7.0	7.9	7.4	5.4	4.8	10.4	5.5	2.0	8.4	0.5	0.7	0.2	1.9	1.2	3.0	2.7	1.8	2.3	0.9	3.6	2.0	2.7	0.3	3.6	0.8	9.8	1.6	0.4	10.8	24.1	11.4	18.1	15.5	9.9	36.1	13.5	30.0	26.7
SLC16A2	"AHDS, DXS128, MCT7, MCT8, MRX22, XPCT"	ENSG00000147100	"Solute carrier family 16 member 2"	P36021	X	74421461-74533917	"Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Symport, Transport"		"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 43.6"	"Cell line enhanced"	"Detected in many"		"BJ: 35.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"gdT-cell: 1.0"	"Lineage enriched"	"Detected in single"	11	"T-cells: 1.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA072719			Approved	"Plasma membrane"				"Plasma membrane"		"HPA072719: "	"prognostic unfavourable (8.88e-5)"	"unprognostic (2.48e-1)"	"unprognostic (1.99e-1)"	"unprognostic (2.90e-3)"	"unprognostic (1.49e-1)"	"unprognostic (1.58e-2)"	"unprognostic (1.58e-3)"	"unprognostic (2.47e-2)"	"unprognostic (1.48e-1)"	"unprognostic (2.54e-1)"	"unprognostic (5.67e-2)"	"unprognostic (3.51e-1)"	"prognostic unfavourable (1.83e-4)"	"unprognostic (2.15e-2)"	"unprognostic (1.89e-1)"	"unprognostic (6.89e-3)"	"prognostic unfavourable (3.16e-4)"	13.5	24.4	10.9	5.4	12.2	0.7	4.9	5.9	14.3	9.9	5.5	8.4	1.8	4.1	9.4	2.7	5.2	6.7	10.5	10.7	8.0	5.9	9.4	43.6	6.0	1.6	4.2	8.0	14.7	6.6	12.7	12.6	10.0	8.2	9.2	2.6	11.1	5.8	7.0	3.5	2.2	3.0	7.6	4.1	1.9	4.2	1.8	5.1	6.4	13.6	4.3	3.0	5.0	5.8	0.0	0.0	0.0	0.0	0.0	1.0	0.0	3.3	4.1	3.0	16.9	8.1	4.2	0.0	35.2	10.9	14.3	8.2	0.0	0.3	0.0	0.5	13.6	0.6	0.4	14.9	8.4	2.3	1.3	0.0	0.0	0.0	0.6	0.0	0.0	6.3	3.6	7.4	8.7	0.0	0.0	0.0	3.3	0.0	0.2	1.0	11.2	3.1	6.7	8.1	0.0	7.0	0.0	0.7	5.3	3.9	19.7	0.1	0.2	0.4	0.0	13.9	3.7	15.2	17.4	0.0	0.0	0.0	15.3	0.0	0.3	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	10.9	12.2	5.9	14.3	8.0	5.9	4.2	8.0	8.2	5.1
SLC19A1	"FOLT, RFC1"	ENSG00000173638	"Solute carrier family 19 member 1"	P41440	21	45493572-45544411	"Cancer-related genes, Predicted membrane proteins, Transporters"	"Antiport, Transport"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 37.6"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	4	"neutrophil: 37.6"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 37.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA024802	Approved		Approved	"Plasma membrane"				"Plasma membrane"		"HPA024802: AB_10602892"	"unprognostic (4.31e-3)"	"prognostic unfavourable (4.15e-4)"	"unprognostic (5.23e-2)"	"unprognostic (2.02e-1)"	"unprognostic (3.11e-1)"	"unprognostic (3.04e-2)"	"unprognostic (7.34e-2)"	"unprognostic (2.87e-3)"	"unprognostic (4.04e-2)"	"unprognostic (4.09e-2)"	"unprognostic (2.85e-1)"	"unprognostic (2.39e-1)"	"prognostic unfavourable (1.07e-10)"	"unprognostic (1.44e-1)"	"unprognostic (2.31e-1)"	"unprognostic (7.97e-5)"	"unprognostic (3.10e-1)"	9.0	7.8	7.1	8.2	13.5	10.5	12.5	9.6	8.9	5.0	9.7	6.0	9.4	31.2	4.3	4.6	2.3	4.6	3.5	3.2	7.1	6.1	4.7	14.1	13.9	14.1	8.7	4.4	8.1	5.4	1.8	3.5	32.9	11.5	4.7	2.0	17.8	6.0	3.5	3.5	6.1	16.5	2.3	5.9	11.7	5.7	3.4	3.4	11.8	9.6	2.8	4.1	3.1	3.1	0.9	4.9	37.6	6.4	0.4	1.1	2.4	10.4	9.5	1.9	7.8	0.6	0.8	15.6	4.9	0.8	4.5	2.9	22.0	9.7	9.7	9.8	1.2	5.4	3.9	3.6	1.1	8.9	19.0	20.5	5.2	15.3	2.7	13.3	3.2	1.0	2.7	4.9	1.6	3.7	24.4	4.3	1.6	11.7	18.1	12.4	11.2	11.2	24.6	2.2	28.3	2.0	6.3	11.7	10.3	5.5	9.1	4.2	6.9	15.8	4.5	5.9	7.4	1.6	8.0	1.8	6.5	8.8	2.6	21.8	4.7	0.6	6.4	8.5	0.3	6.0	1.1	0.9	0.5	0.7	4.9	0.3	0.8	0.5	37.6	0.4	3.7	1.5	1.0	2.4	7.1	13.5	9.6	8.9	7.1	6.1	8.7	4.4	11.5	3.4
SLC19A3	THTR2	ENSG00000135917	"Solute carrier family 19 member 3"	Q9BZV2	2	227683763-227718031	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	Transport		"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 48.2;breast: 78.2;placenta: 27.5"	"Cell line enhanced"	"Detected in some"		"ASC diff: 14.1;BEWO: 7.2;CACO-2: 18.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"basophil: 8.6"	"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038898	Approved		Approved	"Nucleoplasm,Plasma membrane,Cytosol"				Nucleoplasm	"Plasma membrane, Cytosol"	"HPA038898: AB_10673481"	"unprognostic (3.37e-2)"	"unprognostic (3.59e-5)"	"unprognostic (1.95e-3)"	"unprognostic (1.24e-2)"	"unprognostic (1.22e-1)"	"unprognostic (6.82e-2)"	"unprognostic (1.93e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.19e-1)"	"unprognostic (2.04e-1)"	"unprognostic (4.67e-2)"	"unprognostic (3.12e-3)"	"unprognostic (7.28e-2)"	"unprognostic (8.20e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.71e-2)"	"unprognostic (7.01e-3)"	48.2	0.6	2.2	1.8	2.4	1.2	78.2	1.5	1.9	0.5	6.1	1.0	0.5	7.7	0.6	0.4	0.6	0.6	8.9	1.9	2.3	2.4	2.1	16.0	5.6	1.3	3.0	0.7	0.9	1.3	0.2	0.3	27.5	2.6	0.5	1.6	0.7	0.9	0.2	0.7	1.6	4.5	0.5	2.6	0.5	0.5	0.6	1.5	0.0	0.5	0.4	0.4	1.0	2.3	2.6	1.8	8.6	1.8	4.3	1.1	0.4	0.3	1.6	0.3	1.0	14.1	0.4	7.2	0.1	0.2	0.3	0.6	18.4	0.5	0.4	0.2	0.1	0.5	0.5	0.5	0.8	0.1	1.2	0.1	0.9	0.7	1.7	0.2	0.2	3.2	0.4	0.1	0.9	0.0	0.2	0.8	0.0	1.8	0.1	0.6	3.2	0.3	0.3	0.2	0.2	0.2	0.3	1.0	0.1	0.5	2.0	0.5	0.3	0.2	0.5	0.5	0.5	4.1	0.3	0.2	0.1	0.6	1.4	0.3	0.4	8.6	1.8	1.7	1.0	1.2	0.6	1.6	0.8	0.9	0.4	2.6	1.0	1.1	6.1	4.3	1.1	1.8	0.4	0.4	2.2	2.4	1.5	1.9	2.3	2.4	3.0	0.7	2.6	1.5
SLC27A1	"ACSVL5, FATP, FATP1, FLJ00336, MGC71751"	ENSG00000130304	"Solute carrier family 27 member 1"	Q6PCB7	19	17468769-17506168	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Fatty acid metabolism, Lipid metabolism, Lipid transport, Transport"	Ligase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 17.5;SK-MEL-30: 28.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA076520			Approved	"Plasma membrane,Mitochondria,Cytosol"				"Plasma membrane"	"Mitochondria, Cytosol"	"HPA076520: "	"unprognostic (1.48e-3)"	"unprognostic (3.03e-2)"	"unprognostic (5.72e-3)"	"unprognostic (5.84e-2)"	"unprognostic (2.16e-3)"	"unprognostic (4.36e-2)"	"unprognostic (8.56e-2)"	"unprognostic (3.36e-2)"	"unprognostic (9.03e-2)"	"unprognostic (1.85e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.28e-1)"	"prognostic favourable (4.70e-4)"	"unprognostic (5.01e-2)"	"unprognostic (2.25e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.12e-1)"	14.5	14.3	13.1	5.2	13.9	2.0	9.3	20.1	19.3	11.8	6.4	44.1	10.1	4.6	8.9	6.4	5.9	14.7	11.0	18.3	12.9	10.0	5.2	5.2	8.5	6.7	22.0	17.2	23.2	14.5	26.1	9.8	7.5	16.1	11.0	2.6	9.6	26.7	13.0	24.2	13.7	3.7	5.5	13.4	7.1	10.9	9.6	19.3	1.3	9.9	4.7	5.3	6.9	8.8	0.5	7.4	0.3	9.9	1.7	3.2	4.6	3.6	1.8	2.5	6.0	17.5	9.8	2.1	2.6	6.9	3.0	4.5	0.2	11.2	1.2	5.0	4.3	4.4	0.2	4.1	0.7	1.4	0.8	0.7	0.2	1.3	3.4	0.3	4.0	9.0	2.9	3.0	1.2	2.0	0.4	0.7	1.9	1.5	1.9	2.9	0.7	3.2	2.8	2.0	0.8	1.9	1.1	0.8	1.8	1.8	0.9	28.9	3.2	0.9	1.2	5.9	3.8	4.6	1.8	2.5	1.8	0.4	6.0	3.1	4.1	0.0	9.9	0.3	1.7	4.7	3.2	0.5	1.2	2.1	7.2	0.3	1.6	2.1	0.0	1.7	1.8	7.4	0.7	4.6	13.1	13.9	20.1	19.3	12.9	10.0	22.0	17.2	16.1	19.3
SLC2A14	"GLUT14, SLC2A3P3"	ENSG00000173262	"Solute carrier family 2 member 14"	Q8TDB8	12	7812512-7891148	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Differentiation, Spermatogenesis, Sugar transport, Transport"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"testis: 52.4"	"Group enriched"	"Detected in some"	4	"BEWO: 14.6;CACO-2: 23.7;Hep G2: 6.1"	"Cancer enriched"	"Detected in single"	35	"testis cancer: 7.1"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in many"		"neutrophil: 6.9"	"Lineage enriched"	"Detected in many"	4	"granulocytes: 6.9"									HPA006539	Supported		Approved	"Plasma membrane"				"Plasma membrane"		"HPA006539: AB_1078984"	"unprognostic (2.52e-1)"	"unprognostic (4.74e-3)"	"unprognostic (1.79e-1)"	"unprognostic (1.29e-1)"	"unprognostic (3.35e-2)"	"unprognostic (1.82e-3)"	"unprognostic (8.62e-2)"	"unprognostic (7.15e-2)"	"unprognostic (1.89e-1)"	"unprognostic (9.91e-3)"	"unprognostic (1.23e-1)"	"unprognostic (1.27e-1)"	"unprognostic (8.46e-4)"	"unprognostic (3.92e-2)"	"unprognostic (3.41e-1)"	"unprognostic (3.26e-2)"	"unprognostic (1.22e-2)"	0.4	3.1	0.1	0.1	0.6	3.0	0.4	0.1	0.2	0.4	0.4	0.3	0.1	0.0	0.3	0.8	0.8	0.1	0.3	0.1	0.2	0.3	0.1	2.0	0.2	0.2	0.1	0.1	2.7	7.4	0.0	0.6	0.5	0.3	0.6	0.2	0.1	0.1	0.1	0.1	0.1	0.7	0.2	0.1	0.1	0.0	52.4	0.2	0.1	0.1	0.1	0.1	0.6	0.1	0.6	0.4	6.9	0.7	1.3	1.7	0.2	0.0	0.4	0.3	0.3	0.2	0.8	14.6	0.0	0.0	0.0	0.2	23.7	0.1	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.2	0.0	2.4	0.6	6.1	0.0	0.0	3.5	0.0	0.1	0.0	0.0	0.0	1.0	0.1	0.0	0.1	0.1	0.1	2.7	0.0	0.2	0.1	0.1	0.0	0.4	0.1	0.0	0.0	0.4	0.0	0.0	1.5	0.3	0.1	0.6	0.4	0.1	0.1	0.1	0.3	0.3	0.0	0.3	5.5	0.7	1.8	1.0	0.2	1.2	0.5	1.0	0.8	0.4	0.6	0.7	0.9	6.9	1.3	0.2	0.3	1.7	0.2	0.1	0.6	0.1	0.2	0.2	0.3	0.1	0.1	0.3	0.2
SLC2A3	GLUT3	ENSG00000059804	"Solute carrier family 2 member 3"	P11169	12	7919230-7936275	"Predicted membrane proteins, Transporters"	"Sugar transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 166.3"	"Group enriched"	"Detected in many"	5	"BEWO: 148.6;CACO-2: 159.4"	"Cancer enriched"	"Detected in all"	7	"testis cancer: 107.9"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"basophil: 30.2;neutrophil: 55.6"	"Lineage enriched"	"Detected in all"	9	"granulocytes: 55.6"									"CAB002763, HPA006539"	Approved		Approved	"Plasma membrane"			33000000	"Plasma membrane"		"CAB002763: , HPA006539: AB_1078984"	"unprognostic (9.20e-2)"	"unprognostic (9.63e-3)"	"prognostic unfavourable (8.58e-4)"	"unprognostic (2.65e-1)"	"unprognostic (5.29e-3)"	"unprognostic (2.16e-3)"	"unprognostic (1.12e-1)"	"unprognostic (8.27e-2)"	"unprognostic (2.35e-1)"	"unprognostic (3.83e-2)"	"unprognostic (8.47e-3)"	"unprognostic (5.40e-2)"	"prognostic unfavourable (6.36e-8)"	"prognostic unfavourable (2.89e-5)"	"unprognostic (1.70e-1)"	"unprognostic (1.14e-2)"	"unprognostic (2.91e-3)"	48.8	10.0	9.5	25.2	10.5	166.3	26.4	13.1	24.3	9.4	10.0	6.8	1.8	4.2	10.3	8.2	13.2	8.0	25.6	22.8	10.8	13.6	10.3	14.1	32.4	12.8	13.3	3.3	18.8	6.1	6.9	10.9	43.9	13.7	15.0	6.9	14.8	3.8	3.9	13.6	7.4	5.8	18.7	15.4	16.4	7.0	10.6	12.5	3.3	15.7	7.0	13.6	51.8	10.5	1.8	2.4	55.6	4.6	3.6	6.4	3.5	0.0	0.7	6.8	2.6	2.5	8.9	148.6	2.4	2.6	2.4	5.6	159.4	1.0	0.1	0.0	1.6	0.0	0.2	0.3	4.3	4.6	0.2	9.2	0.6	21.0	6.9	3.3	13.5	3.6	0.2	6.3	2.9	2.2	4.2	2.2	2.1	0.0	0.2	3.6	30.1	0.0	0.2	0.8	0.1	0.0	0.0	0.0	0.0	0.0	0.2	3.1	0.0	0.4	2.2	3.0	1.6	5.8	0.2	0.0	6.4	0.5	8.8	1.5	1.6	30.2	4.6	7.0	6.4	0.5	5.3	1.8	4.4	4.9	2.4	1.7	2.8	3.8	55.6	3.6	0.2	0.1	5.8	3.5	9.5	10.5	13.1	13.3	10.8	13.6	13.3	3.3	13.7	12.5
SLC31A2	"COPT2, CTR2, hCTR2"	ENSG00000136867	"Solute carrier family 31 member 2"	O15432	9	113150942-113164137	"Predicted membrane proteins, Transporters"	"Copper transport, Ion transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in all"		"blood: 60.2;salivary gland: 125.5"	"Cell line enhanced"	"Detected in many"		"hTCEpi: 33.0;hTERT-HME1: 22.6;LHCN-M2: 26.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	12	"classical monocyte: 36.6;intermediate monocyte: 50.5;myeloid DC: 21.2;neutrophil: 54.5;non-classical monocyte: 60.2"	"Group enriched"	"Detected in many"	36	"dendritic cells: 21.2;granulocytes: 54.5;monocytes: 60.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA014861	Approved		Approved	"Nuclear speckles,Plasma membrane,Intermediate filaments"				"Nuclear speckles"	"Plasma membrane, Intermediate filaments"	"HPA014861: AB_1857098"	"unprognostic (2.26e-1)"	"unprognostic (7.20e-2)"	"unprognostic (3.79e-3)"	"unprognostic (1.09e-1)"	"unprognostic (1.10e-1)"	"unprognostic (4.81e-3)"	"unprognostic (5.63e-2)"	"unprognostic (3.31e-2)"	"unprognostic (2.24e-1)"	"unprognostic (3.44e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.86e-1)"	"unprognostic (6.05e-3)"	"unprognostic (1.76e-1)"	"unprognostic (3.56e-2)"	"unprognostic (1.25e-1)"	"unprognostic (8.89e-2)"	15.7	8.0	10.0	8.1	20.5	7.0	8.5	3.2	15.0	3.0	8.4	45.1	27.1	5.2	2.0	6.0	4.6	3.0	4.5	3.4	18.2	9.4	9.8	11.2	10.0	6.2	34.3	10.5	2.8	7.8	17.9	1.2	10.2	22.3	2.1	4.4	1.0	125.5	21.8	6.7	18.5	9.9	3.8	48.5	14.1	4.5	5.4	26.2	1.2	2.8	2.9	5.8	3.9	4.1	0.3	21.2	54.5	60.2	0.2	1.2	13.4	5.4	2.4	1.3	2.0	21.7	8.9	4.7	4.1	5.3	5.0	4.8	1.8	1.6	0.3	0.8	3.4	20.2	1.9	11.7	4.7	2.7	0.8	0.3	1.2	2.8	8.3	2.1	1.2	10.0	33.0	11.7	22.6	2.6	1.5	3.0	26.1	5.2	2.1	1.2	0.7	2.3	0.4	19.7	0.3	1.7	3.3	1.2	2.1	5.6	17.5	1.6	6.2	1.9	2.4	2.7	1.9	9.0	3.5	1.8	3.8	0.2	8.7	2.9	2.7	0.8	36.6	3.6	0.9	50.5	1.2	0.2	1.0	1.0	21.2	0.3	0.8	0.8	54.5	0.2	60.2	0.5	0.6	13.4	10.0	20.5	3.2	15.0	18.2	9.4	34.3	10.5	22.3	26.2
SLC36A4	"FLJ38932, PAT4"	ENSG00000180773	"Solute carrier family 36 member 4"	Q6YBV0	11	93144171-93197964	"Predicted membrane proteins, Transporters"	"Amino-acid transport, Symport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017887	Enhanced		Approved	"Golgi apparatus,Plasma membrane,Cytosol"				"Golgi apparatus, Plasma membrane, Cytosol"		"HPA017887: AB_2190238"	"unprognostic (1.23e-2)"	"unprognostic (1.08e-1)"	"unprognostic (2.17e-3)"	"unprognostic (1.32e-3)"	"unprognostic (3.66e-2)"	"unprognostic (8.77e-2)"	"unprognostic (1.08e-3)"	"unprognostic (7.83e-3)"	"unprognostic (3.06e-2)"	"unprognostic (7.97e-2)"	"unprognostic (2.09e-2)"	"unprognostic (8.04e-3)"	"unprognostic (7.07e-2)"	"unprognostic (4.40e-2)"	"unprognostic (1.74e-1)"	"unprognostic (9.45e-3)"	"unprognostic (4.20e-2)"	8.0	11.0	16.0	12.6	19.3	24.1	6.5	20.7	20.2	8.0	7.3	8.7	2.1	3.0	10.4	3.6	7.8	6.2	8.4	9.2	14.2	14.8	13.7	11.0	8.2	7.0	16.8	10.3	8.6	8.0	8.0	17.2	8.7	17.6	7.5	9.4	5.4	5.4	9.1	3.4	5.9	4.2	11.5	20.0	5.7	6.4	6.0	13.4	5.6	12.7	2.3	9.2	8.6	7.7	1.6	2.9	8.1	7.7	0.8	2.6	1.8	5.1	9.1	18.7	3.7	6.6	13.6	10.5	8.8	14.8	13.2	16.1	7.3	16.8	6.2	5.1	8.2	6.3	5.7	3.2	12.2	10.3	6.7	7.1	19.2	4.8	5.2	17.9	10.6	6.5	10.3	7.6	4.8	7.1	0.6	0.1	13.5	1.3	7.8	13.5	7.5	9.3	3.5	11.1	2.5	4.4	7.6	17.4	22.6	12.9	5.0	3.2	9.2	5.2	7.8	25.0	7.7	14.7	12.9	2.6	5.2	0.0	5.6	7.5	12.9	0.2	7.7	8.1	1.3	3.9	1.8	1.3	1.0	1.6	2.9	1.6	2.6	1.7	2.5	0.8	2.5	1.1	0.8	1.8	16.0	19.3	20.7	20.2	14.2	14.8	16.8	10.3	17.6	13.4
SLC38A5	"JM24, SN2"	ENSG00000017483	"Solute carrier family 38 member 5"	Q8WUX1	X	48458537-48470256	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"pancreas: 87.7"	"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 53.2;HeLa: 52.4;hTCEpi: 39.6;Karpas-707: 46.8;RPMI-8226: 86.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047411	Approved		Approved	"Vesicles,Plasma membrane,Cytosol"				"Vesicles, Plasma membrane"	Cytosol	"HPA047411: AB_10964355"	"unprognostic (2.81e-1)"	"unprognostic (4.87e-2)"	"unprognostic (7.92e-3)"	"unprognostic (1.58e-1)"	"unprognostic (1.29e-3)"	"unprognostic (1.26e-1)"	"unprognostic (7.75e-2)"	"unprognostic (5.79e-2)"	"unprognostic (1.52e-1)"	"unprognostic (3.80e-3)"	"prognostic unfavourable (2.13e-4)"	"unprognostic (2.99e-2)"	"prognostic unfavourable (2.22e-16)"	"unprognostic (1.27e-3)"	"unprognostic (1.45e-1)"	"unprognostic (2.86e-1)"	"unprognostic (2.20e-1)"	1.5	0.9	5.3	4.7	7.1	17.3	0.9	3.5	11.6	4.0	4.9	7.7	0.1	5.1	1.8	1.3	3.7	2.0	1.5	2.4	6.9	5.7	0.7	0.4	9.4	3.3	7.0	2.7	3.7	87.7	0.4	0.4	2.8	14.6	5.1	6.4	1.5	4.4	3.7	0.4	8.0	3.5	2.8	7.3	4.8	4.5	0.5	4.6	2.4	7.9	3.6	3.4	4.8	3.1	7.4	8.3	0.3	0.4	5.4	16.2	5.7	22.5	0.0	0.0	0.2	0.4	2.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	23.7	0.0	9.9	34.9	27.0	53.2	0.0	7.5	0.0	12.9	52.4	16.3	3.9	26.3	0.0	3.7	39.6	0.4	0.1	0.4	23.6	46.8	5.3	0.0	5.7	9.1	12.2	0.1	20.9	0.1	86.2	0.0	0.0	2.2	0.1	0.0	0.1	0.0	0.0	1.1	0.7	0.1	0.0	0.0	0.0	0.0	0.1	8.5	0.2	0.1	0.1	0.0	0.2	0.2	11.5	0.4	16.2	7.4	12.6	10.8	1.5	4.7	6.0	7.7	0.3	5.4	0.0	8.3	13.0	5.7	5.3	7.1	3.5	11.6	6.9	5.7	7.0	2.7	14.6	4.6
SLC38A6	NAT-1	ENSG00000139974	"Solute carrier family 38 member 6"	Q8IZM9	14	60981114-61083733	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Amino-acid transport, Ion transport, Sodium transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 34.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA018508	Approved		Approved	"Plasma membrane,Cell Junctions,Microtubules"				"Cell Junctions"	"Plasma membrane, Microtubules"	"HPA018508: AB_2190518"	"unprognostic (7.08e-2)"	"unprognostic (4.14e-2)"	"unprognostic (1.75e-1)"	"unprognostic (3.49e-1)"	"unprognostic (1.00e-1)"	"unprognostic (1.74e-2)"	"prognostic unfavourable (9.47e-6)"	"unprognostic (9.89e-3)"	"unprognostic (2.38e-1)"	"unprognostic (2.18e-2)"	"unprognostic (2.20e-1)"	"unprognostic (5.13e-2)"	"prognostic unfavourable (1.37e-5)"	"unprognostic (1.73e-1)"	"unprognostic (4.63e-2)"	"unprognostic (1.47e-1)"	"unprognostic (2.90e-1)"	26.1	16.9	8.3	6.7	16.6	4.0	11.4	9.7	14.0	8.1	7.1	5.2	5.5	4.5	10.0	20.5	5.0	8.4	14.4	5.4	8.8	8.6	16.9	9.2	12.2	9.6	8.6	10.9	9.9	6.1	23.8	21.5	13.7	14.3	8.1	10.1	10.9	11.7	6.4	4.1	4.6	5.6	8.0	7.6	10.8	6.4	10.9	6.5	8.8	9.7	7.1	7.2	11.6	8.1	2.4	5.2	0.2	8.6	0.7	5.2	3.4	7.1	10.0	3.3	5.9	34.2	12.4	2.3	5.5	16.4	5.2	4.9	2.5	19.7	1.7	9.4	4.9	6.3	3.1	5.6	4.8	2.5	1.5	3.0	4.1	6.6	11.2	1.5	5.9	9.8	2.4	5.0	5.9	6.8	4.1	3.7	18.0	4.1	2.8	3.9	2.0	6.6	0.5	9.5	5.5	15.1	4.0	1.5	1.3	4.6	3.3	8.8	4.8	2.6	7.3	8.1	3.5	9.4	3.0	0.7	2.1	0.6	16.5	1.4	6.3	0.0	8.4	0.1	2.2	8.6	2.6	2.4	4.0	2.9	4.4	2.2	3.3	4.3	0.2	0.7	5.4	5.2	5.2	3.4	8.3	16.6	9.7	14.0	8.8	8.6	8.6	10.9	14.3	6.5
SLC38A7	FLJ10815	ENSG00000103042	"Solute carrier family 38 member 7"	Q9NVC3	16	58665109-58685104	"Predicted membrane proteins, Transporters"	"Amino-acid transport, Ion transport, Sodium transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041777	Uncertain		Approved	"Nucleoplasm,Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"	Nucleoplasm	"HPA041777: AB_10796782"	"unprognostic (2.16e-3)"	"unprognostic (2.30e-2)"	"unprognostic (6.23e-3)"	"prognostic favourable (6.87e-4)"	"unprognostic (3.49e-1)"	"unprognostic (8.08e-3)"	"unprognostic (9.76e-3)"	"unprognostic (6.34e-3)"	"unprognostic (1.98e-2)"	"unprognostic (2.02e-1)"	"unprognostic (2.77e-1)"	"unprognostic (4.90e-2)"	"prognostic favourable (2.87e-4)"	"unprognostic (1.85e-1)"	"unprognostic (4.38e-2)"	"unprognostic (7.50e-2)"	"unprognostic (4.93e-3)"	7.0	11.1	10.6	6.7	10.0	2.7	7.2	7.7	13.7	6.2	5.3	10.6	6.8	4.8	6.0	7.4	6.0	4.2	6.5	13.8	7.2	7.2	7.4	12.1	5.2	4.3	6.1	11.0	4.7	5.0	16.9	10.2	8.4	8.3	5.2	6.9	8.9	6.1	5.6	9.6	5.3	4.9	8.5	5.8	10.3	5.4	27.1	6.6	4.2	8.0	8.1	5.1	6.5	6.3	2.8	6.1	2.5	8.6	2.3	5.2	6.6	4.3	6.8	6.8	10.4	14.2	8.5	12.8	10.3	12.0	14.5	10.2	6.4	6.8	2.7	5.9	14.3	10.6	6.5	7.2	8.6	1.7	5.9	3.1	5.7	10.3	21.5	6.5	9.0	17.1	15.2	10.1	6.7	14.9	9.2	4.2	10.5	5.2	2.5	3.8	7.4	10.2	9.4	7.3	7.5	6.4	10.1	5.0	7.6	15.5	10.7	4.5	5.0	2.7	11.6	8.0	6.1	13.8	3.1	6.2	4.0	3.2	10.8	3.9	5.9	0.2	8.6	2.5	5.2	8.4	3.1	1.9	3.3	3.8	6.1	2.8	2.7	2.9	0.8	2.3	7.5	2.1	2.2	6.6	10.6	10.0	7.7	13.7	7.2	7.2	6.1	11.0	8.3	6.6
SLC39A10	"DKFZp564L2123, FLJ90515, KIAA1265"	ENSG00000196950	"Solute carrier family 39 member 10"	Q9ULF5	2	195575977-195737702	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport, Zinc transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 41.0;thyroid gland: 39.9"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036512, HPA036513, HPA066087"	Approved		Approved	"Nucleoplasm,Plasma membrane,Cytosol"			49000	"Nucleoplasm, Cytosol"	"Plasma membrane"	"HPA036512: , HPA036513: AB_10670801, HPA066087: "	"unprognostic (1.06e-1)"	"unprognostic (3.87e-3)"	"unprognostic (5.33e-2)"	"unprognostic (1.33e-3)"	"prognostic favourable (1.46e-5)"	"unprognostic (7.40e-2)"	"prognostic unfavourable (4.39e-5)"	"unprognostic (2.10e-2)"	"unprognostic (8.73e-2)"	"unprognostic (2.84e-2)"	"prognostic unfavourable (3.23e-4)"	"unprognostic (8.46e-2)"	"unprognostic (9.71e-2)"	"unprognostic (1.34e-2)"	"unprognostic (3.68e-1)"	"unprognostic (2.47e-2)"	"unprognostic (6.89e-2)"	6.6	10.9	16.0	6.0	24.8	3.7	6.2	10.8	41.0	9.8	3.8	4.2	4.9	3.6	9.4	3.3	3.5	8.5	7.6	4.7	15.0	11.2	7.8	2.1	6.3	6.5	8.5	24.4	7.4	5.7	5.8	5.7	10.7	15.7	16.7	4.0	1.4	4.8	6.5	3.3	5.7	5.7	6.7	10.2	14.4	4.3	7.9	6.2	10.6	39.9	1.7	6.4	6.1	4.9	9.4	18.4	19.3	2.7	11.0	4.6	1.5	3.1	10.5	20.2	5.5	3.9	9.4	10.4	14.6	7.1	7.1	3.5	15.7	11.3	4.3	22.3	8.3	4.5	12.3	13.5	8.9	2.3	9.1	4.9	16.4	12.9	4.4	17.9	2.1	5.5	2.0	7.8	9.0	15.8	14.1	6.1	11.3	3.0	5.1	5.6	23.5	8.3	12.0	7.1	10.8	30.7	5.2	7.8	10.7	14.6	29.9	7.6	4.8	11.1	15.4	12.9	14.9	8.4	7.6	2.1	1.3	2.6	10.4	8.4	13.0	19.3	2.7	1.9	4.5	2.5	3.5	6.8	4.0	3.7	3.3	9.4	3.5	4.6	0.5	11.0	1.8	18.4	3.9	1.5	16.0	24.8	10.8	39.7	15.0	11.2	8.5	24.4	15.7	6.2
SLC39A14	"KIAA0062, NET34, ZIP14"	ENSG00000104635	"Solute carrier family 39 member 14"	Q15043	8	22367249-22434129	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Ion transport, Transport, Zinc transport"		"Disease mutation, Dystonia, Neurodegeneration, Parkinsonism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 135.5;pancreas: 77.2"	"Cell line enhanced"	"Detected in all"		"BJ hTERT+: 68.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							HPA016508	Approved		Approved	"Endoplasmic reticulum,Golgi apparatus,Plasma membrane"			950000	"Endoplasmic reticulum, Golgi apparatus, Plasma membrane"		"HPA016508: AB_1857148"	"unprognostic (1.67e-1)"	"unprognostic (6.67e-3)"	"prognostic favourable (5.00e-5)"	"unprognostic (9.83e-3)"	"unprognostic (9.21e-3)"	"unprognostic (8.99e-3)"	"unprognostic (1.99e-1)"	"unprognostic (2.91e-2)"	"unprognostic (4.95e-2)"	"unprognostic (5.66e-2)"	"unprognostic (6.64e-2)"	"unprognostic (1.53e-1)"	"prognostic unfavourable (3.79e-7)"	"unprognostic (4.88e-2)"	"unprognostic (8.73e-2)"	"unprognostic (1.63e-2)"	"unprognostic (1.11e-3)"	15.0	16.1	2.6	7.7	5.4	0.1	45.5	2.4	6.1	3.6	13.7	1.9	2.8	31.6	6.7	2.8	3.9	5.6	9.8	41.1	2.8	2.4	10.4	135.5	4.8	5.3	3.7	1.9	10.6	77.2	3.0	6.4	4.0	9.2	5.1	11.4	4.1	20.2	4.4	46.1	4.4	18.2	14.1	4.7	2.3	16.2	5.9	2.8	0.7	25.1	2.1	1.4	11.3	19.0	5.0	1.8	2.5	0.5	2.9	8.7	3.9	10.6	14.3	4.0	8.0	14.3	12.1	8.7	15.4	68.2	24.1	38.0	47.3	10.1	10.7	8.7	18.0	11.8	19.7	19.2	39.7	11.1	11.2	8.5	11.4	47.7	34.1	5.8	9.4	12.9	15.6	42.7	29.8	10.7	7.4	10.9	12.2	4.9	8.8	3.7	24.3	11.0	12.6	7.5	22.8	8.8	4.6	6.8	10.6	15.7	6.7	31.8	5.4	8.5	5.9	30.0	15.2	18.8	15.7	6.3	5.7	14.0	42.4	7.8	17.4	0.0	0.5	2.5	8.3	0.1	8.7	5.0	4.8	6.3	1.8	2.6	5.7	7.6	0.2	2.9	0.1	0.8	3.8	3.9	2.6	5.4	2.4	6.1	2.8	2.4	3.7	1.9	9.2	2.8
SLC39A2	ZIP2	ENSG00000165794	"Solute carrier family 39 member 2"	Q9NP94	14	20999255-21001871	"Predicted membrane proteins"	"Ion transport, Transport, Zinc transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"ductus deferens: 44.3;seminal vesicle: 50.6;skin 1: 23.8"	"Cell line enriched"	"Detected in single"	70	"HaCaT: 22.5"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"HPA030489, HPA073231"	Uncertain		Approved	"Plasma membrane,Cytoplasmic bodies"				"Plasma membrane"	"Cytoplasmic bodies"	"HPA030489: AB_10601488, HPA073231: "	"unprognostic (2.76e-2)"	"unprognostic (4.86e-2)"	"unprognostic (9.72e-2)"	"unprognostic (2.37e-1)"	"unprognostic (2.46e-1)"	"unprognostic (2.71e-1)"	"unprognostic (3.42e-1)"	"unprognostic (1.70e-1)"	"unprognostic (4.43e-1)"	"unprognostic (6.20e-3)"	"unprognostic (3.31e-1)"	"unprognostic (2.80e-1)"	"unprognostic (3.62e-2)"	"unprognostic (1.91e-1)"	"unprognostic (5.80e-2)"	"unprognostic (3.71e-1)"	"unprognostic (2.30e-3)"	0.1	0.1	0.1	0.0	0.1	0.0	1.3	0.3	0.4	5.6	1.2	0.0	44.3	0.0	0.8	0.0	13.0	0.3	0.1	0.2	0.4	0.0	0.1	0.1	0.1	0.0	0.2	0.1	0.1	0.0	0.4	0.2	1.0	0.2	8.5	0.8	0.4	2.7	50.6	0.1	23.8	0.1	0.2	0.1	0.1	0.0	0.1	0.0	1.3	0.1	6.1	3.3	1.2	9.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	22.5	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.2	0.2	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.3	0.4	0.4	0.0	0.2	0.1	0.2	0.0
SLC43A1	"PB39, POV1, R00504"	ENSG00000149150	"Solute carrier family 43 member 1"	O75387	11	57484534-57515786	"Predicted membrane proteins, Transporters"	"Amino-acid transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"gallbladder: 27.0;liver: 91.8;pancreas: 100.5"	"Cell line enhanced"	"Detected in many"		"Hep G2: 23.5;NB-4: 27.9;U-937: 26.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA018813, HPA018826"	Enhanced		Approved	"Golgi apparatus,Vesicles,Plasma membrane"				"Golgi apparatus, Vesicles, Plasma membrane"		"HPA018813: AB_1857164, HPA018826: AB_1857165"	"unprognostic (3.04e-1)"	"unprognostic (1.15e-1)"	"unprognostic (9.19e-2)"	"prognostic favourable (3.19e-4)"	"unprognostic (2.51e-2)"	"unprognostic (5.48e-2)"	"unprognostic (2.32e-1)"	"unprognostic (6.71e-3)"	"unprognostic (1.63e-1)"	"unprognostic (3.12e-2)"	"unprognostic (6.06e-2)"	"unprognostic (2.72e-1)"	"prognostic unfavourable (2.97e-5)"	"unprognostic (1.39e-2)"	"unprognostic (1.48e-1)"	"prognostic unfavourable (5.27e-4)"	"unprognostic (7.30e-2)"	4.7	3.3	0.8	2.2	0.8	9.3	7.4	0.7	1.3	6.0	4.8	0.9	3.9	2.5	5.0	6.8	4.1	3.3	27.0	3.2	0.7	0.6	3.4	91.8	2.9	3.3	0.8	1.1	6.5	100.5	0.1	1.3	1.8	0.7	6.2	2.8	11.4	14.9	2.1	7.5	5.6	2.6	7.0	0.9	2.5	7.6	3.1	0.7	0.8	7.4	2.9	3.1	7.6	3.5	3.1	8.2	8.1	6.0	6.9	11.1	5.2	0.4	0.6	0.7	7.9	10.3	7.6	0.1	4.1	5.3	1.2	3.0	2.5	1.1	22.7	1.0	3.0	0.3	7.0	0.4	1.5	1.1	1.8	11.7	0.2	23.5	13.6	20.4	2.9	9.6	1.7	2.0	9.2	5.2	16.3	4.2	1.5	0.8	0.1	27.9	2.6	5.3	19.4	3.9	10.1	0.2	0.0	9.3	1.4	0.7	0.1	9.1	0.6	10.4	2.1	1.2	2.9	10.4	0.6	4.8	1.5	13.3	0.6	26.9	1.6	8.1	6.0	0.7	11.1	2.4	9.5	3.1	5.2	8.0	8.2	1.7	5.1	7.2	0.5	6.9	0.1	1.9	9.1	5.2	0.8	0.8	0.7	1.3	0.7	0.6	0.8	1.1	0.7	0.7
SLC43A3	"DKFZp762A227, Eeg1, FOAP-13, PRO1659, SEEEG-1"	ENSG00000134802	"Solute carrier family 43 member 3"	Q8NBI5	11	57406954-57427580	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 149.9;thyroid gland: 69.0"	"Cell line enhanced"	"Detected in many"		"HL-60: 69.9;HMC-1: 61.7;RPMI-8226: 78.8;WM-115: 75.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Region enriched"	"Detected in many"	4	"olfactory region: 12.7"	"Low region specificity"	"Detected in all"			"HPA030551, HPA077244"	Approved		Approved	"Nucleoplasm,Vesicles,Plasma membrane"				Vesicles	"Nucleoplasm, Plasma membrane"	"HPA030551: AB_10604094, HPA077244: "	"unprognostic (2.64e-1)"	"unprognostic (7.63e-2)"	"unprognostic (9.67e-3)"	"unprognostic (7.41e-3)"	"unprognostic (6.59e-3)"	"unprognostic (5.30e-3)"	"unprognostic (1.29e-1)"	"unprognostic (4.91e-2)"	"unprognostic (1.36e-1)"	"unprognostic (2.26e-1)"	"unprognostic (5.73e-2)"	"unprognostic (3.97e-2)"	"prognostic unfavourable (3.97e-13)"	"unprognostic (8.16e-2)"	"unprognostic (1.77e-1)"	"unprognostic (8.34e-2)"	"unprognostic (1.00e-1)"	32.3	6.3	2.5	12.4	4.3	18.8	16.8	2.2	3.0	11.9	9.6	3.6	2.4	2.7	10.1	6.5	12.6	8.9	11.4	12.5	3.1	1.5	4.2	149.9	16.5	8.8	4.0	1.8	16.0	7.2	1.2	1.8	5.1	3.4	11.6	4.2	9.4	12.2	3.1	15.4	11.0	6.2	10.3	4.7	11.6	6.9	6.8	2.3	10.4	69.0	11.5	13.8	20.3	15.4	2.7	23.6	6.1	36.8	1.1	7.8	14.0	39.3	0.0	2.3	0.0	7.7	11.3	0.1	3.0	13.1	4.5	7.8	0.0	8.6	22.8	1.4	7.2	22.7	6.6	4.0	9.1	0.1	0.0	35.4	13.5	0.0	15.6	69.9	61.7	33.9	0.1	43.9	0.5	12.6	40.4	22.0	17.5	0.0	14.6	44.9	3.4	0.7	30.4	0.4	78.8	10.8	0.0	5.4	0.0	8.7	0.2	36.7	3.4	10.6	6.7	0.2	11.8	29.9	8.6	0.0	0.1	5.7	27.1	25.4	75.2	3.2	28.8	6.1	5.7	34.5	6.5	2.7	4.0	7.8	23.6	2.0	3.1	3.2	2.5	1.1	36.8	23.6	6.9	14.0	2.5	4.3	2.2	3.0	3.1	1.5	4.0	1.8	3.4	2.3
SLC45A4	KIAA1126	ENSG00000022567	"Solute carrier family 45 member 4"	Q5BKX6	8	141207166-141308305	"Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HMC-1: 17.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	7	"eosinophil: 9.4;neutrophil: 8.6"	"Lineage enriched"	"Detected in single"	19	"granulocytes: 9.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA023154	Uncertain		Approved	"Plasma membrane"				"Plasma membrane"		"HPA023154: AB_2191204"	"unprognostic (7.79e-3)"	"unprognostic (1.06e-1)"	"unprognostic (4.30e-2)"	"unprognostic (1.44e-1)"	"unprognostic (6.06e-2)"	"unprognostic (3.96e-2)"	"unprognostic (1.26e-1)"	"unprognostic (4.49e-3)"	"unprognostic (1.02e-1)"	"unprognostic (5.31e-2)"	"unprognostic (2.12e-1)"	"unprognostic (1.84e-1)"	"prognostic favourable (1.73e-6)"	"unprognostic (8.79e-3)"	"unprognostic (1.13e-1)"	"unprognostic (1.77e-2)"	"unprognostic (2.40e-2)"	5.6	3.9	6.9	7.6	7.0	10.2	4.3	10.0	19.1	14.2	6.6	2.7	8.5	5.4	6.7	8.9	5.0	11.6	6.9	9.3	8.2	5.9	12.2	1.6	10.1	7.6	5.1	8.4	5.0	14.2	5.4	20.6	17.8	11.5	9.5	3.9	11.4	15.6	16.3	6.4	7.4	6.0	4.3	3.0	6.8	24.4	28.5	2.9	6.6	8.7	1.8	6.4	7.8	4.4	0.0	0.4	9.4	0.1	0.2	0.5	0.1	4.1	9.5	3.4	5.4	0.2	0.3	15.1	2.3	1.5	2.1	1.7	5.9	10.9	0.9	10.3	0.9	3.4	1.8	1.1	1.0	6.5	2.8	2.6	2.7	0.0	1.7	1.0	17.1	0.8	1.5	1.6	0.8	1.4	5.0	0.7	0.6	10.0	9.2	2.1	4.5	3.8	2.8	0.2	2.7	7.4	7.4	5.3	4.3	2.5	0.8	4.0	1.7	6.2	0.7	0.0	2.3	3.6	4.5	3.4	10.8	1.1	2.1	4.0	4.0	1.3	0.1	9.4	0.2	0.1	0.2	0.0	0.2	0.5	0.1	0.0	0.2	0.2	8.6	0.2	0.1	0.4	0.2	0.1	6.9	7.0	10.0	19.1	8.2	5.9	5.1	8.4	11.5	2.9
SLC46A3	"DKFZp686A1775, FLJ42613"	ENSG00000139508	"Solute carrier family 46 member 3"	Q7Z3Q1	13	28700064-28718970	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 62.9;liver: 50.0"	"Cell line enhanced"	"Detected in many"		"RPTEC TERT1: 20.4;T-47d: 15.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039930	Uncertain		Approved	"Plasma membrane,Actin filaments,Cytosol"				"Plasma membrane, Cytosol"	"Actin filaments"	"HPA039930: AB_10673263"	"unprognostic (5.16e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.15e-1)"	"unprognostic (2.61e-1)"	"unprognostic (3.88e-1)"	"unprognostic (1.22e-1)"	"unprognostic (4.53e-3)"	"prognostic favourable (7.09e-4)"	"unprognostic (3.13e-1)"	"unprognostic (3.33e-1)"	"unprognostic (1.26e-1)"	"unprognostic (5.69e-2)"	"unprognostic (7.35e-2)"	"unprognostic (1.14e-1)"	"unprognostic (5.60e-2)"	"unprognostic (9.14e-3)"	"unprognostic (6.47e-3)"	6.9	14.2	3.8	5.9	5.7	1.4	6.4	7.6	6.5	8.3	19.6	6.9	2.8	24.0	5.2	7.4	3.1	4.1	12.7	8.1	4.2	4.2	10.4	50.0	6.0	11.4	4.7	3.9	5.0	5.5	4.2	18.2	5.0	6.6	5.3	10.1	17.4	10.3	5.6	8.2	4.0	62.9	4.5	5.1	11.6	4.8	9.3	3.7	11.8	6.8	3.0	6.9	6.1	4.7	9.1	10.4	22.6	15.9	5.6	11.2	7.4	0.0	2.0	0.0	5.5	4.5	1.8	0.1	2.0	11.1	2.2	3.2	0.1	4.7	3.8	3.7	2.8	0.4	2.5	1.0	3.3	2.8	4.9	2.5	0.0	0.0	8.4	0.0	3.3	7.2	2.1	3.3	5.4	4.0	2.7	0.0	10.5	2.0	6.2	0.4	0.2	1.7	2.6	9.9	0.1	20.4	0.6	0.9	0.3	0.0	10.1	4.0	15.0	3.3	1.5	1.1	2.1	0.3	11.7	3.1	1.5	0.5	0.6	0.0	2.0	22.6	8.0	3.0	9.8	11.5	8.4	6.6	7.9	9.6	10.4	9.1	11.2	10.6	8.2	5.6	15.9	9.7	9.2	7.4	3.8	5.7	7.6	6.5	4.2	4.2	4.7	3.9	6.6	3.7
SLC4A1AP	"HLC3, kanadaptin"	ENSG00000163798	"Solute carrier family 4 member 1 adaptor protein"	Q9BWU0	2	27663471-27694976	"Predicted intracellular proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036679	Approved		Supported	"Nucleoplasm,Vesicles,Plasma membrane"				"Nucleoplasm, Vesicles"	"Plasma membrane"	"HPA036679: "	"unprognostic (5.63e-2)"	"unprognostic (1.01e-1)"	"unprognostic (4.62e-2)"	"prognostic unfavourable (1.49e-4)"	"unprognostic (2.21e-1)"	"unprognostic (7.89e-3)"	"prognostic unfavourable (3.76e-7)"	"unprognostic (1.32e-1)"	"unprognostic (7.74e-2)"	"unprognostic (1.83e-2)"	"unprognostic (1.06e-1)"	"unprognostic (9.66e-2)"	"unprognostic (9.68e-2)"	"unprognostic (2.29e-2)"	"unprognostic (1.42e-1)"	"unprognostic (2.40e-2)"	"prognostic unfavourable (1.79e-4)"	12.3	16.1	18.8	14.2	27.0	12.7	13.9	27.4	29.0	11.5	11.3	15.8	8.7	11.6	12.8	12.2	14.2	12.3	9.8	18.6	17.9	19.6	15.3	15.0	12.8	14.6	17.0	20.5	15.2	13.3	23.8	16.0	14.5	29.1	12.6	12.3	9.0	12.4	12.1	26.0	15.1	12.0	12.5	15.4	13.1	12.5	29.9	16.8	16.1	14.6	14.9	15.1	11.1	11.0	16.7	13.3	40.8	17.9	22.5	19.5	14.1	21.6	12.6	12.8	11.9	13.2	12.2	18.8	18.0	12.5	19.0	15.6	18.4	15.9	13.7	16.8	14.4	15.5	20.4	14.0	17.1	19.1	16.7	15.8	13.3	20.2	16.1	22.5	15.1	10.9	17.8	18.9	18.0	19.3	22.8	15.0	17.5	13.2	15.1	22.1	12.9	12.5	12.6	28.0	15.8	19.6	10.1	13.9	13.7	14.0	19.2	17.3	11.6	14.8	19.5	17.8	16.1	12.3	21.0	24.8	35.1	44.0	19.3	18.2	14.1	40.8	17.7	24.2	17.6	16.9	17.4	13.5	16.1	15.3	13.3	16.7	19.5	16.5	16.5	22.5	17.9	10.7	17.1	14.1	18.8	27.0	27.4	29.0	17.9	19.6	17.0	20.5	29.1	16.8
SLC4A2	"AE2, BND3L, EPB3L1, HKB3, NBND3"	ENSG00000164889	"Solute carrier family 4 member 2"	P04920	7	151057210-151076527	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Anion exchange, Antiport, Ion transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 94.2;retina: 100.7"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in all"	7	"pons and medulla: 73.3"	"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			HPA019339	Enhanced		Approved	"Nuclear speckles,Plasma membrane,Cytosol"				"Nuclear speckles, Plasma membrane"	Cytosol	"HPA019339: AB_1844825"	"unprognostic (1.19e-1)"	"unprognostic (3.33e-3)"	"unprognostic (8.12e-3)"	"unprognostic (1.10e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.49e-1)"	"prognostic unfavourable (9.04e-6)"	"unprognostic (1.24e-1)"	"unprognostic (4.23e-1)"	"unprognostic (3.30e-1)"	"unprognostic (1.07e-1)"	"unprognostic (3.21e-1)"	"prognostic favourable (1.26e-4)"	"unprognostic (4.67e-3)"	"unprognostic (1.22e-1)"	"unprognostic (1.28e-1)"	"unprognostic (2.36e-2)"	9.9	13.5	4.7	10.4	7.4	6.7	10.5	3.0	8.6	12.4	18.6	29.0	6.0	12.1	16.2	6.3	7.7	10.8	14.1	11.9	10.1	3.8	35.5	94.2	12.3	7.2	10.4	4.8	12.6	34.1	30.6	5.3	31.4	73.3	10.5	4.0	100.7	11.9	8.3	8.7	9.5	26.0	10.7	10.4	10.1	27.1	6.5	8.5	8.8	9.7	7.0	5.9	11.7	10.6	2.5	5.6	2.1	4.2	0.5	2.7	1.9	15.6	51.8	10.2	21.0	10.2	6.0	23.3	19.0	10.3	15.6	13.5	29.5	25.1	9.4	41.8	9.0	15.4	10.4	9.2	2.9	27.1	15.5	12.3	25.2	15.0	16.7	6.3	39.8	8.7	8.1	17.7	4.5	8.7	38.2	8.0	12.0	30.1	18.2	11.0	24.3	19.3	14.4	5.6	11.0	12.7	11.9	8.4	30.6	17.4	32.9	16.2	13.6	12.6	18.6	21.0	10.7	20.6	28.0	8.6	11.6	5.3	32.1	16.0	42.1	0.0	4.2	2.1	2.7	3.9	1.9	2.5	2.1	1.8	2.4	1.0	2.4	2.4	1.0	0.5	2.5	5.6	1.0	1.9	4.7	7.4	3.0	8.6	10.1	3.8	10.4	4.8	73.3	8.5
SLC4A8	NBC3	ENSG00000050438	"Solute carrier family 4 member 8"	Q2Y0W8	12	51391317-51515763	"Predicted membrane proteins"	"Anion exchange, Antiport, Ion transport, Sodium transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 28.6;pituitary gland: 20.0;testis: 15.3"	"Cell line enhanced"	"Detected in many"		"BEWO: 17.2;HMC-1: 12.1;SCLC-21H: 12.9"	"Group enriched"	"Detected in some"	6	"breast cancer: 1.7;glioma: 2.7;testis cancer: 4.2"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA077895			Approved	"Plasma membrane"				"Plasma membrane"		"HPA077895: "	"unprognostic (4.01e-1)"	"unprognostic (8.15e-2)"	"unprognostic (2.49e-2)"	"unprognostic (6.39e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.96e-2)"	"unprognostic (3.46e-2)"	"unprognostic (7.72e-4)"	"unprognostic (3.13e-2)"	"unprognostic (7.03e-3)"	"unprognostic (1.07e-4)"	"unprognostic (1.70e-1)"	"unprognostic (9.60e-6)"	"unprognostic (1.35e-1)"	"unprognostic (2.57e-1)"	"unprognostic (3.21e-2)"	"unprognostic (2.47e-1)"	1.0	6.5	5.8	2.2	13.3	1.7	3.1	9.2	22.9	2.7	1.1	9.8	0.0	1.4	1.2	5.4	0.7	3.7	1.1	1.0	10.9	5.6	3.2	0.8	2.8	3.0	6.0	9.3	7.3	2.4	1.0	20.0	1.0	28.6	1.4	1.4	2.2	1.5	1.7	0.8	1.0	2.0	1.1	4.7	2.2	3.0	15.3	5.1	0.0	0.8	0.0	2.7	1.0	0.7	1.1	2.6	3.4	3.1	1.7	1.7	0.7	0.2	0.8	9.7	0.1	0.4	0.5	17.2	2.6	4.4	4.3	2.7	5.7	0.2	3.5	0.4	3.5	0.1	3.8	0.2	4.0	0.7	0.5	1.7	0.3	0.0	0.0	0.6	12.1	0.1	0.2	2.1	0.4	4.9	0.1	6.3	2.1	2.0	5.1	1.1	4.2	2.9	0.1	0.0	0.0	0.5	0.1	12.9	8.7	1.0	1.3	0.0	1.6	0.4	4.6	2.7	1.5	0.2	3.3	3.2	1.0	0.2	3.8	0.5	0.4	1.3	2.1	3.4	1.7	1.4	0.4	0.6	0.6	1.6	2.6	1.1	0.6	1.0	2.3	1.7	3.1	1.0	0.3	0.7	5.8	13.3	9.2	22.9	10.9	5.6	6.0	9.3	28.6	5.1
SLC5A3	"SMIT, SMIT1"	ENSG00000198743	"Solute carrier family 5 member 3"	P53794	21	34073570-34106262	"Predicted membrane proteins, Transporters"	"Ion transport, Sodium transport, Symport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"kidney: 46.0"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029791			Approved	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		"HPA029791: AB_10601892"	"unprognostic (9.70e-2)"	"unprognostic (4.99e-2)"	"unprognostic (2.23e-1)"	"unprognostic (7.57e-2)"	"unprognostic (1.07e-1)"	"unprognostic (4.54e-2)"	"unprognostic (4.48e-3)"	"unprognostic (1.63e-1)"	"unprognostic (3.02e-2)"	"unprognostic (2.55e-1)"	"prognostic unfavourable (1.98e-5)"	"unprognostic (1.30e-1)"	"prognostic unfavourable (4.72e-4)"	"unprognostic (1.82e-1)"	"unprognostic (1.82e-1)"	"unprognostic (2.21e-1)"	"unprognostic (8.60e-2)"	10.1	9.5	10.5	7.3	11.0	3.6	26.6	8.0	10.1	6.5	7.6	4.6	9.4	5.0	11.3	9.1	7.5	8.5	4.9	6.8	11.6	6.8	46.0	9.5	8.5	7.6	11.7	4.7	9.0	5.8	6.3	6.6	15.8	13.6	7.0	8.8	11.3	6.4	6.9	7.8	10.1	7.4	5.9	14.7	4.9	7.8	10.6	9.0	5.9	42.7	4.4	8.0	6.5	22.1	0.8	2.3	0.7	1.0	1.0	2.6	0.7	6.2	5.6	11.8	8.3	9.9	8.1	5.7	7.2	21.8	4.5	6.8	9.3	13.8	10.1	5.8	14.5	3.2	14.3	4.1	7.6	10.5	3.7	10.4	5.2	3.1	2.6	4.4	4.4	3.9	10.6	12.2	4.9	2.6	10.3	2.4	11.5	4.2	4.7	3.6	5.9	5.5	4.8	2.1	4.6	17.6	8.8	6.2	2.8	14.9	4.0	3.4	2.4	4.8	2.5	8.8	6.8	16.8	2.8	12.5	10.8	7.6	17.7	6.6	5.9	0.0	1.0	0.2	2.6	0.9	2.1	0.8	1.4	1.7	0.9	0.8	1.9	2.6	0.7	1.0	0.4	2.3	0.4	0.7	10.5	11.0	8.0	10.1	11.6	6.8	11.7	4.7	13.6	9.0
SLC7A6	"KIAA0245, LAT-2, LAT3, y+LAT-2"	ENSG00000103064	"Solute carrier family 7 member 6"	Q92536	16	68264516-68301823	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Amino-acid transport, Antiport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 58.8"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA050713	Uncertain		Approved	"Vesicles,Plasma membrane"				"Plasma membrane"	Vesicles	"HPA050713: "	"unprognostic (6.35e-2)"	"unprognostic (4.63e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.40e-2)"	"unprognostic (2.41e-1)"	"unprognostic (5.02e-2)"	"unprognostic (1.24e-3)"	"unprognostic (1.16e-1)"	"unprognostic (1.48e-1)"	"unprognostic (5.16e-2)"	"unprognostic (1.11e-1)"	"unprognostic (2.76e-2)"	"unprognostic (1.89e-3)"	"unprognostic (7.82e-2)"	"unprognostic (2.66e-1)"	"unprognostic (4.79e-3)"	"prognostic unfavourable (1.84e-4)"	25.9	7.6	5.4	12.9	6.7	6.9	18.7	9.0	8.0	5.3	7.1	3.4	6.7	3.6	5.5	14.0	4.0	7.1	4.7	13.1	5.3	3.3	5.4	2.3	9.8	16.3	3.3	4.6	3.0	3.2	2.5	11.1	16.3	5.4	6.6	10.8	9.0	5.8	5.1	58.8	8.4	9.4	8.3	3.4	9.4	5.3	5.2	3.7	31.8	15.0	8.0	19.6	5.7	8.0	7.2	16.2	5.9	3.6	6.7	12.6	1.7	9.3	9.5	7.1	7.6	21.1	12.7	20.0	11.0	8.0	16.4	13.8	40.8	7.1	18.6	8.7	14.1	14.3	13.8	13.7	17.9	3.8	9.9	9.9	18.8	12.9	3.9	11.6	9.0	8.5	12.0	12.8	6.4	11.0	14.5	3.3	8.9	5.0	15.2	8.1	5.3	3.5	19.3	4.5	15.6	5.7	8.2	10.5	5.7	31.7	8.9	3.7	13.3	6.3	16.1	10.9	8.3	9.1	13.7	7.1	13.3	21.2	6.9	8.6	7.3	2.5	3.6	3.0	4.9	1.7	6.1	6.6	7.3	4.6	3.4	7.2	12.6	7.4	5.9	6.7	1.4	16.2	3.1	1.7	5.4	6.7	9.0	8.0	5.3	3.3	3.3	4.6	5.4	3.7
SLC9A3R1	"EBP50, NHERF, NHERF1"	ENSG00000109062	"SLC9A3 regulator 1"	O14745	17	74748652-74769353	"Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"Wnt signaling pathway"		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"MCF7: 77.3;SK-BR-3: 63.1;T-47d: 122.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB001962, HPA009672, HPA027247"	Enhanced		Approved	"Vesicles,Plasma membrane,Centriolar satellite"			9600000	"Plasma membrane"	"Vesicles, Centriolar satellite"	"CAB001962: , HPA009672: AB_1857215, HPA027247: AB_10601162"	"unprognostic (1.29e-1)"	"unprognostic (4.58e-2)"	"unprognostic (1.73e-2)"	"unprognostic (5.51e-2)"	"unprognostic (5.83e-2)"	"unprognostic (1.73e-1)"	"prognostic unfavourable (9.83e-5)"	"unprognostic (7.41e-2)"	"unprognostic (5.61e-2)"	"unprognostic (5.38e-2)"	"unprognostic (7.53e-2)"	"unprognostic (4.49e-2)"	"unprognostic (1.56e-3)"	"unprognostic (7.81e-3)"	"unprognostic (5.53e-2)"	"unprognostic (3.84e-2)"	"unprognostic (2.08e-2)"	5.4	33.3	19.8	9.9	23.3	22.6	15.2	21.9	15.1	12.5	30.6	15.2	35.9	57.6	5.4	12.0	74.3	20.5	30.8	5.6	14.2	8.8	36.1	64.9	8.6	13.5	14.3	14.0	5.0	26.5	12.5	4.9	8.3	12.8	10.1	13.4	22.9	41.8	23.3	1.5	11.2	73.3	3.1	12.1	13.8	14.8	5.4	14.1	18.4	5.6	24.3	30.3	7.1	20.3	9.8	14.3	72.7	24.8	45.1	70.4	44.3	13.7	11.3	5.6	5.8	3.4	2.5	25.5	3.3	3.1	8.5	8.3	35.4	8.2	3.0	3.4	7.0	19.7	9.7	6.4	4.0	3.6	9.3	22.6	30.6	47.1	7.0	14.7	15.3	2.0	3.6	6.7	2.9	7.0	7.1	16.2	13.0	77.3	34.7	33.1	5.0	6.7	3.8	6.3	13.6	11.7	9.8	4.9	6.4	3.4	63.1	7.1	122.1	11.8	2.3	2.6	7.7	6.1	5.4	28.2	12.7	5.5	4.3	19.7	1.5	72.7	14.1	65.3	70.4	20.6	46.6	9.8	43.2	59.3	13.7	8.6	25.5	45.2	50.3	45.1	24.8	14.3	47.0	44.3	19.8	23.3	21.9	15.1	14.2	8.8	14.3	14.0	12.8	14.1
SLC9A4	NHE4	ENSG00000180251	"Solute carrier family 9 member A4"	Q6AI14	2	102473303-102533972	"Predicted membrane proteins, Transporters"	"Antiport, Ion transport, Sodium transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	6	"gallbladder: 23.2;kidney: 12.3;stomach 1: 33.9"	"Cell line enhanced"	"Detected in some"		"EFO-21: 3.0;HDLM-2: 5.0;RT4: 8.9"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	18	"hippocampal formation: 11.6;olfactory region: 8.3"	"Region enriched"	"Detected in single"	5	"olfactory region: 1.7"	HPA036096	Supported		Approved	"Nucleoplasm,Plasma membrane"				"Nucleoplasm, Plasma membrane"		"HPA036096: "	"unprognostic (1.41e-1)"	"unprognostic (3.76e-2)"	"unprognostic (9.31e-2)"	"unprognostic (3.09e-3)"	"unprognostic (7.58e-2)"	"unprognostic (1.46e-1)"		"unprognostic (7.17e-2)"	"unprognostic (5.35e-1)"	"unprognostic (9.44e-3)"	"unprognostic (3.26e-2)"	"unprognostic (1.30e-1)"	"unprognostic (2.46e-2)"	"unprognostic (3.12e-1)"	"unprognostic (5.04e-1)"	"unprognostic (2.50e-1)"	"unprognostic (1.98e-2)"	0.0	0.1	0.1	0.0	0.1	0.4	0.1	0.1	0.1	0.2	0.1	0.3	0.0	1.1	0.1	0.0	1.3	0.1	23.2	0.2	0.1	0.1	12.3	0.1	0.1	0.2	0.1	0.0	0.1	0.1	0.0	0.1	0.0	0.1	0.7	0.0	0.0	3.7	2.4	0.7	0.2	0.2	0.0	0.1	0.1	33.9	0.3	0.0	0.2	0.1	0.5	0.4	0.6	0.2	1.5	0.9	1.8	0.8	1.2	1.2	0.1	0.2	0.3	0.3	0.8	0.0	0.1	0.1	0.3	0.0	0.0	0.0	1.4	0.5	0.2	3.0	0.0	0.4	0.0	0.0	0.0	5.0	0.2	0.3	0.5	0.2	0.0	0.1	0.5	0.0	0.0	0.0	0.1	0.0	0.3	1.1	0.0	0.5	0.1	0.2	1.4	0.6	0.2	0.6	0.4	0.0	8.9	0.2	0.3	0.2	0.5	0.1	0.2	0.2	0.6	0.6	1.4	0.9	0.3	0.3	0.2	0.1	0.7	0.2	0.1	1.6	0.7	1.1	1.2	0.6	0.8	0.8	0.9	0.9	0.5	1.5	1.0	1.2	1.8	1.2	0.8	0.9	0.6	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.0
SLCO4C1	"OATP-H, OATP4C1, OATPX, SLC21A20"	ENSG00000173930	"Solute carrier organic anion transporter family member 4C1"	Q6ZQN7	5	102233986-102296549	"Predicted membrane proteins, Transporters"	"Differentiation, Ion transport, Spermatogenesis, Transport"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"kidney: 55.9"	"Cell line enhanced"	"Detected in some"		"Karpas-707: 7.9;RPTEC TERT1: 44.8;U-937: 11.3"	"Cancer enriched"	"Detected in many"	5	"renal cancer: 22.4"	"Low region specificity"	"Detected in some"			"Cell type enhanced"	"Detected in many"		"neutrophil: 10.0"	"Group enriched"	"Detected in many"	5	"granulocytes: 10.0;NK-cells: 2.6;T-cells: 4.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA058249			Approved	"Nucleoplasm,Plasma membrane,Cytosol"				"Plasma membrane"	"Nucleoplasm, Cytosol"	"HPA058249: "	"unprognostic (1.63e-2)"	"unprognostic (2.47e-2)"	"unprognostic (4.48e-4)"	"unprognostic (5.70e-6)"	"unprognostic (7.43e-2)"	"unprognostic (7.71e-3)"	"unprognostic (3.24e-3)"	"unprognostic (2.05e-3)"	"unprognostic (2.13e-1)"	"unprognostic (7.12e-2)"	"unprognostic (3.87e-3)"	"unprognostic (5.83e-2)"	"prognostic favourable (1.12e-4)"	"unprognostic (3.29e-2)"	"unprognostic (1.07e-1)"	"unprognostic (5.91e-2)"	"unprognostic (8.22e-2)"	0.4	0.4	0.3	0.7	0.7	5.4	0.3	0.2	1.8	0.3	1.9	0.0	5.2	1.4	0.2	0.6	0.3	0.3	1.6	1.1	0.3	0.4	55.9	5.2	11.0	0.2	0.3	1.0	0.3	0.9	0.0	0.7	0.1	0.2	0.4	0.5	0.0	3.2	11.8	0.3	0.6	2.1	0.0	0.3	1.6	0.4	1.3	0.0	1.5	1.0	0.3	0.1	0.7	1.1	0.1	0.4	10.0	1.1	2.6	4.3	1.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.9	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.3	0.5	0.0	0.4	0.1	0.7	0.0	0.4	0.0	0.0	0.0	0.0	0.0	7.9	0.0	0.5	0.0	0.1	0.3	0.0	0.0	0.0	0.5	44.8	0.0	0.3	0.2	0.0	0.1	0.0	0.0	1.0	0.0	0.0	0.3	0.0	0.0	0.7	0.0	0.0	0.0	11.3	0.0	7.9	1.1	7.5	4.3	0.0	0.4	0.0	0.7	2.3	0.4	0.1	0.2	1.5	10.0	2.6	0.0	0.3	0.0	1.0	0.3	0.7	0.2	1.8	0.3	0.4	0.3	1.0	0.2	0.0
SLIT1	"MEGF4, SLIL1, Slit-1, slit1, SLIT3"	ENSG00000187122	"Slit guidance ligand 1"	O75093	10	96998038-97185920	"Predicted secreted proteins"	"Differentiation, Neurogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"brain: 44.3"	"Cell line enriched"	"Detected in some"	15	"MOLT-4: 41.2"	"Group enriched"	"Detected in many"	10	"glioma: 9.2;prostate cancer: 2.2;thyroid cancer: 10.2"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"myeloid DC: 1.6;plasmacytoid DC: 1.6"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA006879			Approved	"Plasma membrane"	"Secreted in brain"			"Plasma membrane"		"HPA006879: AB_1078197"	"unprognostic (2.72e-1)"	"unprognostic (2.25e-2)"	"unprognostic (5.67e-3)"	"unprognostic (1.43e-5)"	"unprognostic (8.40e-2)"	"unprognostic (2.60e-3)"	"unprognostic (4.57e-2)"	"unprognostic (1.81e-2)"	"unprognostic (3.53e-1)"	"unprognostic (6.06e-2)"	"unprognostic (2.28e-3)"	"unprognostic (1.46e-1)"	"unprognostic (1.08e-5)"	"unprognostic (1.66e-1)"	"unprognostic (2.18e-1)"	"unprognostic (1.21e-1)"	"unprognostic (4.39e-3)"	1.2	0.8	13.4	0.9	16.1	0.9	0.8	0.4	44.3	0.8	0.9	0.5	0.0	0.9	0.8	0.7	0.8	1.0	0.8	0.8	13.9	10.5	0.8	0.7	1.0	0.9	4.6	13.2	0.8	1.4	0.8	8.0	0.8	2.2	1.1	0.8	0.3	0.8	0.7	0.9	0.8	0.9	0.8	1.4	0.9	1.1	2.0	0.3	3.3	3.6	0.0	0.9	0.8	0.0	0.0	1.6	0.4	0.7	0.0	0.0	0.2	0.0	0.0	2.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.2	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	41.2	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	2.6	1.1	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.9	0.0	0.0	0.0	0.7	0.0	0.0	0.1	0.0	0.0	0.7	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.4	0.0	0.4	1.6	0.0	0.2	13.4	16.1	0.4	24.8	13.9	10.5	4.6	13.2	2.2	0.3
SLK	"KIAA0204, se20-9, STK2"	ENSG00000065613	"STE20 like kinase"	Q9H2G2	10	103967201-104029233	"Enzymes, Plasma proteins, Predicted intracellular proteins"	Apoptosis	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA015757	Approved		Approved	"Plasma membrane,Cytosol"			17000	"Plasma membrane, Cytosol"		"HPA015757: AB_1857236"	"unprognostic (1.89e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.38e-1)"	"unprognostic (8.28e-2)"	"unprognostic (1.01e-1)"	"unprognostic (3.64e-1)"	"unprognostic (8.67e-2)"	"unprognostic (6.85e-2)"	"unprognostic (1.01e-1)"	"unprognostic (2.31e-1)"	"prognostic unfavourable (2.77e-5)"	"unprognostic (1.95e-1)"	"prognostic favourable (3.95e-5)"	"unprognostic (8.48e-2)"	"unprognostic (3.95e-1)"	"unprognostic (3.09e-2)"	"unprognostic (1.07e-1)"	15.2	11.2	13.7	11.0	36.7	14.6	16.1	16.7	13.1	16.6	19.0	9.9	10.9	9.1	17.0	12.1	40.2	12.1	13.6	17.2	10.6	7.1	14.9	12.2	17.1	10.1	11.2	13.4	17.2	12.5	22.6	13.1	17.4	12.8	19.3	13.6	11.4	19.8	12.7	19.3	16.6	15.5	29.8	13.0	12.1	15.7	10.2	12.8	12.0	15.8	21.6	12.5	24.9	23.6	1.4	2.2	6.5	1.4	1.3	3.6	0.7	21.2	12.4	14.9	10.6	16.1	22.5	6.3	13.3	17.7	9.9	9.3	7.9	22.9	11.3	8.3	13.7	23.2	7.8	16.8	14.5	9.0	10.8	11.5	10.2	6.6	12.1	13.7	10.0	11.5	22.1	13.4	39.2	17.8	14.3	7.8	13.0	7.4	9.6	7.6	3.7	8.0	9.4	18.3	5.8	13.0	24.5	3.5	6.1	11.5	11.2	11.0	5.8	9.9	26.9	7.3	7.6	13.4	15.5	9.5	11.6	7.2	10.8	18.4	4.7	1.2	1.4	3.3	3.6	1.2	3.6	1.1	2.2	2.2	1.2	1.4	1.5	2.5	6.5	1.3	1.0	2.2	1.4	0.7	13.7	36.7	16.7	13.1	10.6	7.1	11.2	13.4	12.8	12.8
SMAP1	"FLJ13159, SMAP-1"	ENSG00000112305	"Small ArfGAP 1"	Q8IYB5	6	70667776-70862015	"Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030574	Approved		Approved	"Golgi apparatus,Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"	"Golgi apparatus"	"HPA030574: AB_10601589"	"unprognostic (1.55e-1)"	"unprognostic (2.66e-3)"	"unprognostic (1.01e-3)"	"unprognostic (2.98e-3)"	"unprognostic (7.06e-2)"	"unprognostic (2.90e-2)"	"unprognostic (1.66e-3)"	"unprognostic (3.46e-1)"	"unprognostic (6.50e-2)"	"unprognostic (3.75e-2)"	"unprognostic (7.80e-2)"	"unprognostic (2.40e-2)"	"unprognostic (1.32e-1)"	"unprognostic (4.73e-2)"	"unprognostic (6.08e-2)"	"unprognostic (2.85e-1)"	"unprognostic (1.22e-1)"	18.7	14.8	19.9	17.8	25.1	15.1	15.3	20.7	30.2	14.4	25.2	14.5	18.5	24.5	16.2	17.7	29.3	10.5	16.3	20.5	20.5	18.6	14.1	17.2	14.4	18.3	19.2	18.1	15.2	33.9	27.1	11.5	14.8	25.0	17.2	27.0	13.0	18.6	15.2	32.6	21.0	29.6	18.7	15.7	14.8	20.7	29.6	13.0	26.6	20.0	17.5	20.1	18.9	16.6	12.5	11.7	24.0	15.5	20.2	21.9	16.3	26.2	8.3	13.3	16.1	12.3	16.3	21.4	11.8	13.6	9.9	9.8	12.4	7.9	13.8	12.9	14.5	8.4	12.5	12.6	16.9	15.9	17.4	15.2	7.8	10.4	8.2	11.1	13.0	10.6	14.6	11.1	13.6	15.6	14.5	16.9	15.5	15.4	8.3	13.6	9.8	9.8	15.7	49.3	22.7	17.9	16.2	18.6	13.2	7.5	10.8	7.5	14.3	16.8	14.9	8.0	13.8	5.2	10.4	15.8	14.1	7.1	6.1	13.1	11.0	24.0	13.7	14.6	16.3	15.0	18.5	12.5	21.9	18.6	11.7	11.1	11.2	14.4	19.3	20.2	15.5	11.5	20.5	16.3	19.9	25.1	20.7	30.2	20.5	18.6	19.2	18.1	25.0	13.0
SMOC1		ENSG00000198732	"SPARC related modular calcium binding 1"	Q9H4F8	14	69854131-70032366	"Disease related genes, Predicted secreted proteins"	Differentiation	"Developmental protein"	"Disease mutation, Microphthalmia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 62.2;liver: 48.0"	"Cell line enhanced"	"Detected in some"		"AF22: 19.4;HeLa: 53.3;HSkMC: 15.6;SiHa: 31.4;SK-BR-3: 13.8;U-266/70: 19.9;U-87 MG: 19.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	12	"plasmacytoid DC: 4.9"	"Lineage enriched"	"Detected in single"	50	"dendritic cells: 4.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004153, CAB034427"	Approved		Approved	"Plasma membrane"	"Secreted to extracellular matrix"		27000	"Plasma membrane"		"CAB034427: AB_2193382, HPA004153: AB_1080035"	"unprognostic (3.31e-1)"	"unprognostic (2.17e-3)"	"unprognostic (8.17e-2)"	"unprognostic (1.96e-2)"	"unprognostic (1.89e-2)"	"unprognostic (4.04e-1)"	"unprognostic (6.75e-3)"	"unprognostic (2.09e-3)"	"unprognostic (4.76e-2)"	"unprognostic (2.80e-2)"	"unprognostic (5.10e-2)"	"unprognostic (5.63e-2)"	"unprognostic (4.09e-2)"	"unprognostic (3.92e-1)"	"unprognostic (2.57e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.87e-1)"	7.4	10.7	23.0	1.4	10.8	1.1	2.9	5.2	62.2	8.6	2.2	32.0	19.4	3.0	2.2	10.3	1.3	7.1	1.5	4.7	22.6	16.2	2.1	48.0	1.4	1.8	23.8	8.5	1.8	26.4	1.1	2.4	9.0	21.7	42.9	2.0	14.7	3.6	35.8	8.7	1.2	2.3	1.9	15.0	19.5	3.5	24.7	16.9	0.0	2.9	0.6	1.5	1.7	3.6	0.0	4.9	0.0	0.0	0.0	0.0	0.0	0.0	1.4	19.4	0.0	3.9	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	7.5	0.0	53.3	7.8	0.0	0.0	0.0	15.6	4.5	0.6	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.7	0.0	0.0	0.0	0.7	0.1	31.4	13.8	0.0	0.0	0.0	0.1	0.1	1.4	0.0	0.0	19.9	0.0	0.0	19.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	4.9	0.0	0.0	23.0	10.8	5.2	11.2	22.6	16.2	23.8	8.5	21.7	16.9
SMPD2	"ISC1, nSMase"	ENSG00000135587	"Sphingomyelin phosphodiesterase 2"	O60906	6	109440763-109443919	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Lipid metabolism, Sphingolipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA018110, HPA018125"	Uncertain		Approved	"Vesicles,Plasma membrane,Cell Junctions"				"Vesicles, Plasma membrane"	"Cell Junctions"	"HPA018110: AB_1857292, HPA018125: AB_1857293"	"unprognostic (1.61e-1)"	"unprognostic (8.01e-2)"	"unprognostic (1.97e-1)"	"unprognostic (8.79e-3)"	"unprognostic (3.88e-2)"	"unprognostic (2.38e-1)"	"prognostic unfavourable (1.17e-4)"	"unprognostic (7.08e-2)"	"unprognostic (7.59e-2)"	"unprognostic (1.41e-1)"	"prognostic favourable (1.00e-3)"	"unprognostic (3.60e-2)"	"unprognostic (2.14e-3)"	"unprognostic (7.94e-2)"	"unprognostic (2.25e-1)"	"unprognostic (1.45e-2)"	"prognostic favourable (1.70e-4)"	6.0	6.8	4.2	20.2	4.9	8.5	8.5	5.4	6.4	9.0	12.6	9.8	16.4	10.5	6.1	16.0	17.2	17.4	12.6	5.1	4.9	3.7	10.2	7.8	8.4	9.4	4.7	4.2	6.7	15.5	17.9	8.8	19.5	4.8	10.1	10.2	8.4	16.6	11.9	3.3	16.9	15.4	7.8	4.3	10.1	11.1	35.1	4.7	18.3	10.5	13.5	23.0	6.3	10.1	18.3	13.4	9.3	7.8	6.2	8.0	5.3	8.9	10.4	5.5	8.6	9.6	5.3	18.3	3.0	11.1	7.5	7.2	9.7	7.3	4.9	6.4	6.4	11.5	5.5	13.2	4.5	6.2	14.2	5.7	10.7	6.0	8.1	6.2	6.7	5.6	15.3	6.7	13.3	6.9	10.9	8.7	3.7	12.9	10.0	13.5	1.5	5.0	7.0	2.6	5.3	13.7	15.3	7.2	6.0	5.7	17.8	13.4	5.7	11.9	4.4	3.4	4.9	2.7	11.2	5.9	1.5	3.1	6.6	5.9	6.0	5.7	7.8	9.3	6.6	7.5	7.3	12.8	7.4	8.0	10.2	18.3	5.6	5.7	2.3	6.2	6.6	13.4	7.2	5.3	4.2	4.9	5.4	6.4	4.9	3.7	4.7	4.2	4.8	4.7
SMPX	"DFN6, DFNX4"	ENSG00000091482	"Small muscle protein, X-linked"	Q9UHP9	X	21705972-21758163	"Disease related genes, Predicted intracellular proteins"			"Deafness, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	23	"heart muscle: 108.8;skeletal muscle: 155.8;tongue: 74.5"	"Cell line enhanced"	"Detected in some"		"CACO-2: 2.6;Hep G2: 6.7;HSkMC: 7.3;Karpas-707: 5.0;U-266/70: 7.4;U-266/84: 2.7"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 7.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA077360			Approved	"Plasma membrane"			45000	"Plasma membrane"		"HPA077360: "	"unprognostic (7.29e-2)"	"unprognostic (1.78e-1)"	"unprognostic (2.63e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.45e-1)"	"prognostic unfavourable (3.04e-5)"	"unprognostic (1.39e-2)"	"unprognostic (7.46e-2)"	"unprognostic (5.27e-1)"	"unprognostic (1.96e-2)"	"unprognostic (3.97e-2)"	"unprognostic (3.58e-2)"		"unprognostic (2.67e-2)"	"unprognostic (2.82e-1)"		"unprognostic (8.38e-2)"	1.4	0.0	0.1	0.6	0.1	0.0	0.2	0.6	0.9	0.1	4.0	0.0	0.0	0.1	0.1	4.7	4.0	0.1	0.1	108.8	0.1	0.2	0.0	0.2	0.0	0.1	0.7	0.3	0.2	0.1	0.0	0.0	0.0	0.0	1.6	0.5	0.0	3.6	0.1	155.8	0.0	0.9	1.8	0.1	0.0	1.5	0.1	0.0	0.0	1.0	74.5	4.9	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	6.7	0.0	0.0	0.0	7.3	0.0	0.0	0.0	0.0	0.0	5.0	0.4	0.0	0.0	0.0	0.6	0.0	0.0	1.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	7.4	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.6	0.9	0.1	0.2	0.7	0.3	0.0	0.0
SNAP25	"bA416N4.2, dJ1068F16.2, RIC-4, RIC4, SEC9, SNAP, SNAP-25"	ENSG00000132639	"Synaptosome associated protein 25"	P60880	20	10218830-10307418	"Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Transporters"			"Congenital myasthenic syndrome, Disease mutation, FDA approved drug targets, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	22	"brain: 356.9"	"Group enriched"	"Detected in some"	4	"Karpas-707: 10.8;SCLC-21H: 35.7;SH-SY5Y: 21.3;U-87 MG: 25.7"	"Group enriched"	"Detected in many"	6	"glioma: 28.9;pancreatic cancer: 6.4"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"plasmacytoid DC: 1.6"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000360, HPA001830, HPA071013"	Enhanced	Supported	Approved	"Vesicles,Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"	Vesicles	"CAB000360: AB_2286342, HPA001830: AB_1080039, HPA071013: "	"unprognostic (1.64e-3)"	"unprognostic (7.26e-3)"	"unprognostic (4.36e-2)"	"unprognostic (2.49e-7)"	"unprognostic (6.86e-3)"	"unprognostic (5.87e-3)"	"unprognostic (1.15e-2)"	"unprognostic (9.94e-2)"	"unprognostic (3.13e-1)"	"unprognostic (5.82e-3)"	"unprognostic (4.80e-3)"	"unprognostic (8.06e-2)"	"unprognostic (1.09e-1)"	"unprognostic (6.18e-3)"	"unprognostic (2.48e-1)"	"unprognostic (6.28e-3)"	"unprognostic (1.02e-2)"	2.2	16.4	81.0	3.3	60.0	2.1	3.4	202.9	356.9	2.2	2.8	3.4	3.7	3.2	4.6	6.4	2.2	4.0	2.8	2.4	86.5	37.1	2.5	2.3	2.6	2.2	46.7	65.2	3.7	4.1	2.1	5.5	2.3	97.7	3.1	2.8	4.0	2.2	11.9	2.1	2.2	3.3	4.7	13.9	2.1	4.3	3.2	7.4	0.0	2.3	0.0	2.2	2.6	0.1	0.0	1.6	0.7	0.0	0.0	0.6	0.3	0.0	2.1	1.7	0.0	0.2	0.0	0.0	0.9	0.0	2.2	0.6	0.0	0.0	0.0	1.9	0.0	0.4	0.2	0.0	4.4	0.2	0.1	0.0	2.9	0.3	1.6	0.0	0.2	2.0	0.0	1.8	0.0	0.0	0.0	10.8	0.7	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.4	0.0	35.7	21.3	0.3	0.0	0.0	0.0	2.9	0.0	2.3	3.1	0.0	1.0	0.0	5.5	0.0	25.7	0.0	2.1	0.0	0.0	0.7	0.1	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.6	0.6	0.3	81.0	60.0	202.9	163.5	86.5	37.1	46.7	65.2	97.7	7.4
SNRK	"FLJ20224, HSNFRK, KIAA0096"	ENSG00000163788	"SNF related kinase"	Q9NRH2	3	43286512-43424764	"Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HUVEC TERT2: 50.8;TIME: 29.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042163	Uncertain		Approved	"Nucleoplasm,Vesicles,Plasma membrane,Cell Junctions"				"Vesicles, Plasma membrane, Cell Junctions"	Nucleoplasm	"HPA042163: AB_10794645"	"prognostic favourable (9.28e-4)"	"unprognostic (8.46e-2)"	"unprognostic (2.79e-3)"	"unprognostic (6.41e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.16e-3)"	"unprognostic (2.00e-2)"	"unprognostic (1.08e-1)"	"unprognostic (2.63e-3)"	"unprognostic (4.25e-1)"	"unprognostic (2.32e-1)"	"unprognostic (4.68e-2)"	"prognostic favourable (9.41e-5)"	"unprognostic (9.21e-3)"	"unprognostic (2.04e-1)"	"unprognostic (7.06e-3)"	"unprognostic (7.38e-2)"	31.5	8.8	9.8	13.1	14.4	41.0	22.6	34.5	21.1	17.6	14.4	7.9	5.9	12.8	20.9	10.5	16.2	11.5	16.4	13.9	11.0	11.0	16.8	20.3	24.7	19.8	11.4	10.6	15.1	18.0	18.4	16.2	26.2	22.5	12.1	9.9	14.7	10.7	9.4	12.5	24.5	17.0	18.7	9.8	25.4	11.2	13.9	7.2	48.4	24.8	13.5	14.4	15.8	19.3	3.2	3.0	20.9	5.5	8.1	10.7	6.5	3.2	2.0	3.7	3.5	11.1	4.0	3.5	3.5	5.9	3.8	3.8	2.7	4.7	5.1	2.8	4.4	2.1	4.3	7.5	4.0	5.9	3.5	5.9	3.7	3.1	5.8	6.6	6.6	4.4	5.2	4.3	7.4	50.8	2.6	6.0	3.5	1.7	6.6	5.8	4.1	9.1	4.6	2.7	5.4	9.9	5.6	2.6	5.5	3.0	3.3	4.2	2.2	8.4	29.5	3.4	3.4	3.9	4.1	9.7	6.9	4.4	2.4	7.9	4.8	4.8	2.8	5.4	7.6	5.5	10.7	2.8	6.7	7.6	3.0	3.2	10.1	10.1	20.9	8.1	5.0	0.9	7.1	6.5	9.8	14.4	34.5	21.1	11.0	11.0	11.4	10.6	22.5	7.2
SOCS3	"CIS3, Cish3, SOCS-3, SSI-3"	ENSG00000184557	"Suppressor of cytokine signaling 3"	O14543	17	78356778-78360077	"Disease related genes, Predicted intracellular proteins"	"Growth regulation, Ubl conjugation pathway"	"Signal transduction inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 48.9;HSkMC: 24.9;U-266/70: 25.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"neutrophil: 11.6"	"Group enriched"	"Detected in many"	6	"granulocytes: 11.6;T-cells: 4.3"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"CAB012220, HPA068569"	Approved		Approved	"Plasma membrane,Cytosol"				Cytosol	"Plasma membrane"	"CAB012220: AB_443287, HPA068569: "	"prognostic favourable (4.80e-4)"	"unprognostic (2.67e-1)"	"unprognostic (5.05e-2)"	"unprognostic (1.64e-3)"	"unprognostic (4.41e-3)"	"unprognostic (2.48e-3)"	"unprognostic (1.81e-1)"	"unprognostic (1.46e-1)"	"unprognostic (6.88e-2)"	"unprognostic (9.61e-3)"	"unprognostic (1.84e-1)"	"unprognostic (2.00e-2)"	"prognostic unfavourable (9.34e-9)"	"unprognostic (1.08e-2)"	"unprognostic (8.80e-2)"	"unprognostic (7.59e-3)"	"unprognostic (8.40e-2)"	94.9	16.8	6.3	42.5	21.4	33.9	25.7	3.0	12.8	27.6	26.6	5.6	1.9	6.2	13.9	9.2	22.7	88.0	59.6	23.5	11.4	5.1	13.5	30.4	52.1	30.2	13.9	0.1	31.2	14.5	13.9	13.4	23.5	38.0	20.8	9.2	10.3	9.2	6.7	26.0	12.1	15.6	39.0	29.6	36.7	32.2	12.1	8.7	5.6	14.2	40.9	10.3	38.1	41.1	0.0	1.3	11.6	1.3	0.4	4.3	0.6	2.0	3.3	2.4	1.2	0.9	15.2	6.3	10.2	9.3	10.7	4.5	2.1	1.4	0.0	2.2	2.4	0.6	0.5	1.0	4.2	48.9	0.3	1.8	7.2	0.4	4.9	0.0	0.9	24.9	0.8	8.3	3.1	4.6	5.4	19.2	4.9	1.0	1.0	0.3	1.7	4.2	0.0	12.2	0.3	17.0	2.0	0.1	1.5	3.1	0.8	0.4	0.9	0.4	2.7	21.1	6.0	7.3	5.9	25.3	14.2	0.0	17.3	0.2	1.3	0.0	1.3	0.3	1.0	0.1	2.6	0.0	2.8	1.2	1.3	0.0	4.3	0.8	11.6	0.4	0.0	1.2	1.6	0.6	6.3	21.4	3.0	12.8	11.4	5.1	13.9	0.1	38.0	8.7
SOCS5	"CIS6, Cish5, CISH6, KIAA0671, SOCS-5"	ENSG00000171150	"Suppressor of cytokine signaling 5"	O75159	2	46698952-46763129	"Predicted intracellular proteins"	"Growth regulation, Ubl conjugation pathway"	"Signal transduction inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"BJ hTERT+: 44.9;fHDF/TERT166: 43.7;U-138 MG: 29.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020884, CAB025510"	Approved		Approved	"Nucleoplasm,Plasma membrane,Cytosol"				Cytosol	"Nucleoplasm, Plasma membrane"	"CAB025510: , HPA020884: AB_1857356"	"unprognostic (1.69e-1)"	"unprognostic (1.98e-2)"	"unprognostic (5.71e-2)"	"unprognostic (1.64e-2)"	"unprognostic (2.20e-2)"	"unprognostic (2.67e-1)"	"prognostic unfavourable (7.28e-4)"	"unprognostic (4.52e-2)"	"unprognostic (9.13e-2)"	"prognostic unfavourable (7.53e-4)"	"unprognostic (2.10e-3)"	"unprognostic (3.01e-1)"	"unprognostic (1.47e-3)"	"unprognostic (8.29e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.29e-1)"	12.2	10.1	16.9	5.6	24.9	6.2	21.3	26.4	14.9	13.6	9.4	6.3	7.6	4.8	14.0	8.8	8.2	9.6	11.2	11.2	11.9	8.1	9.1	6.3	10.1	9.9	9.1	10.8	23.8	6.0	14.8	9.0	6.9	11.8	9.9	6.5	5.8	9.3	13.0	8.8	6.9	6.8	13.6	10.8	8.1	7.2	9.5	8.8	10.9	9.8	5.0	6.1	9.4	9.0	4.8	1.3	6.3	3.7	2.3	3.3	1.6	5.1	3.9	3.4	5.0	11.0	15.9	4.2	24.2	44.9	11.9	7.0	3.7	2.5	2.6	4.7	43.7	2.5	3.7	3.8	15.2	2.6	3.4	4.1	3.7	4.4	6.8	2.4	4.6	12.6	5.8	10.1	4.0	4.0	3.6	2.9	7.5	1.8	2.1	3.9	3.8	3.2	2.7	5.8	3.3	4.8	3.9	2.7	7.4	5.9	3.9	4.6	1.6	3.4	4.5	29.7	6.6	9.8	4.7	3.6	2.2	2.2	13.5	4.7	9.2	1.2	1.1	6.3	2.4	1.0	3.0	4.5	1.5	1.6	1.2	4.8	2.7	3.3	1.1	2.3	3.7	1.3	2.5	1.6	16.9	24.9	26.4	14.9	11.9	8.1	9.1	10.8	11.8	8.8
SORCS1	sorCS1	ENSG00000108018	"Sortilin related VPS10 domain containing receptor 1"	Q8WY21	10	106573663-107164534	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"thyroid gland: 18.5"	"Group enriched"	"Detected in some"	12	"RH-30: 33.2;SH-SY5Y: 43.3"	"Cancer enhanced"	"Detected in some"		"melanoma: 3.2"	"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	24	"intermediate monocyte: 2.4"	"Lineage enriched"	"Detected in single"	24	"monocytes: 2.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA011948	Approved		Approved	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		"HPA011948: AB_1857366"	"unprognostic (5.86e-3)"	"unprognostic (8.45e-3)"	"unprognostic (1.55e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.05e-2)"	"unprognostic (2.92e-2)"	"unprognostic (3.52e-2)"	"unprognostic (5.58e-2)"	"unprognostic (6.82e-3)"	"unprognostic (5.81e-2)"	"unprognostic (6.48e-4)"	"unprognostic (2.51e-2)"	"unprognostic (8.89e-3)"	"unprognostic (2.22e-1)"	"unprognostic (2.69e-4)"	1.4	5.8	6.0	4.5	14.1	0.4	1.8	0.5	13.2	2.2	10.7	1.1	1.9	1.4	2.1	1.2	2.0	3.2	2.8	4.2	2.6	4.7	8.0	0.5	0.5	1.9	2.1	6.6	1.2	3.0	0.6	1.2	0.4	3.3	2.7	3.6	6.5	2.4	4.9	0.8	2.3	4.5	2.7	2.1	1.7	3.4	2.3	2.7	0.2	18.5	1.1	2.7	4.7	3.8	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.6	0.0	0.0	0.0	0.0	0.5	0.0	0.0	33.2	0.0	0.0	0.0	0.0	43.3	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.2	2.5	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.0	14.1	0.5	11.3	2.6	4.7	2.1	6.6	3.3	2.7
SPAG16	"DKFZp666P1710, FLJ22724, PF20, WDR29"	ENSG00000144451	"Sperm associated antigen 16"	Q8N0X2	2	213284379-214410501	"Predicted intracellular proteins"	"Cilium biogenesis/degradation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"T-47d: 33.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"							HPA037542	Uncertain		Approved	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		"HPA037542: AB_10672353"	"unprognostic (4.20e-2)"	"unprognostic (2.73e-1)"	"unprognostic (2.67e-1)"	"unprognostic (9.79e-2)"	"unprognostic (1.83e-1)"	"unprognostic (1.30e-1)"	"unprognostic (2.04e-2)"	"unprognostic (1.76e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.15e-1)"	"unprognostic (2.66e-1)"	"prognostic unfavourable (4.90e-4)"	"prognostic favourable (3.82e-4)"	"unprognostic (1.10e-2)"	"unprognostic (1.01e-1)"	"unprognostic (3.41e-1)"	"unprognostic (1.17e-1)"	11.1	13.0	28.2	5.4	29.8	1.7	15.8	12.0	22.0	16.7	11.5	21.9	23.1	13.7	14.0	24.8	16.0	34.8	17.0	15.7	27.7	24.6	22.6	13.8	8.1	7.7	31.5	22.0	20.2	11.2	24.0	32.8	7.3	25.7	17.1	13.1	11.1	11.8	19.8	6.1	18.2	7.9	14.3	36.9	5.7	19.2	34.3	18.1	10.5	19.9	11.4	9.8	14.8	11.9	7.5	4.1	1.1	1.1	12.1	10.6	3.0	12.3	4.9	14.2	0.0	9.7	17.5	0.1	6.8	8.2	8.8	9.4	9.8	13.7	5.2	8.1	7.5	8.8	6.4	8.2	18.9	0.0	5.1	2.7	12.6	12.6	10.9	2.9	0.0	14.9	11.4	7.9	4.6	3.6	8.6	5.9	8.8	0.0	9.7	0.0	7.8	4.1	10.4	14.9	0.2	14.2	12.1	10.4	12.3	7.8	7.2	9.6	33.7	1.2	3.7	8.6	5.1	4.5	7.0	9.7	4.4	0.2	14.0	0.0	3.8	1.1	0.2	0.7	7.1	1.1	10.1	7.5	8.0	8.9	2.5	7.3	10.6	9.2	0.4	12.1	0.8	4.1	7.4	3.0	28.2	29.8	12.0	22.0	27.7	24.6	31.5	22.0	25.7	18.1
SPART	"KIAA0610, SPG20, TAHCCP1"	ENSG00000133104	Spartin	Q8N0X7	13	36301638-36370180	"Disease related genes, Predicted intracellular proteins"			"Disease mutation, Hereditary spastic paraplegia, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in all"	4	"basophil: 45.8"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 45.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039053, HPA039054"	Approved		Supported	"Plasma membrane,Cytosol"				Cytosol	"Plasma membrane"	"HPA039053: AB_10672769, HPA039054: "	"unprognostic (3.73e-2)"	"unprognostic (9.39e-2)"	"unprognostic (3.06e-2)"	"unprognostic (4.60e-2)"	"unprognostic (2.21e-2)"	"unprognostic (1.10e-2)"	"unprognostic (9.18e-3)"	"unprognostic (9.58e-2)"	"unprognostic (3.36e-2)"	"unprognostic (2.22e-1)"	"unprognostic (7.62e-2)"	"unprognostic (8.14e-2)"	"unprognostic (1.54e-1)"	"unprognostic (9.26e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.54e-2)"	"unprognostic (5.79e-2)"	28.7	34.7	23.2	12.1	28.0	14.5	44.9	21.3	26.7	37.1	22.5	23.1	26.2	9.1	29.9	48.4	17.7	26.1	26.2	17.5	24.7	22.3	33.7	13.7	18.4	12.9	31.8	19.4	46.1	10.3	13.2	29.8	32.2	28.9	26.6	10.0	17.2	11.9	27.0	20.6	12.4	9.7	37.0	35.7	20.2	14.4	18.3	32.5	7.0	25.1	8.7	7.8	31.4	58.7	3.2	6.0	45.8	6.8	4.1	8.3	5.3	0.0	6.0	16.3	0.0	36.0	30.3	11.7	14.6	22.0	14.8	14.7	0.0	0.0	0.0	9.1	17.6	8.4	22.1	10.1	16.0	1.1	12.8	18.2	7.9	3.8	36.2	18.9	36.9	29.9	16.4	12.2	17.2	21.6	7.9	3.2	26.5	1.3	5.6	31.8	8.2	2.1	0.0	27.4	0.6	17.2	7.5	1.7	4.0	12.4	5.0	15.4	2.9	22.4	17.8	11.1	5.6	15.3	8.5	3.9	0.0	0.0	12.3	16.5	19.3	45.8	6.7	8.7	4.4	6.7	4.3	3.2	6.2	1.8	4.8	3.2	8.3	4.4	10.6	4.1	6.8	6.0	1.5	5.3	23.2	28.0	21.3	26.7	24.7	22.3	31.8	19.4	28.9	32.5
SPATA12		ENSG00000186451	"Spermatogenesis associated 12"	Q7Z6I5	3	57060441-57075432	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	11	"testis: 26.6"	"Cell line enhanced"	"Detected in some"		"HUVEC TERT2: 2.8;RH-30: 3.5;RPTEC TERT1: 2.2;U-2 OS: 2.3"	"Low cancer specificity"	"Detected in single"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	10	"classical monocyte: 1.0"	"Lineage enriched"	"Detected in single"	10	"monocytes: 1.0"									"HPA043323, HPA075578"	Enhanced		Approved	"Nucleoplasm,Plasma membrane,Cytosol"				"Nucleoplasm, Cytosol"	"Plasma membrane"	"HPA043323: AB_10796792, HPA075578: "	"unprognostic (2.31e-1)"	"unprognostic (2.18e-4)"	"unprognostic (3.47e-4)"	"unprognostic (2.21e-2)"	"unprognostic (2.66e-1)"	"unprognostic (8.79e-3)"	"unprognostic (1.69e-3)"	"unprognostic (3.82e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.29e-1)"	"unprognostic (6.80e-2)"	"unprognostic (1.76e-2)"	"unprognostic (4.71e-3)"	"unprognostic (7.29e-2)"	"unprognostic (1.62e-2)"	"unprognostic (1.14e-1)"	"unprognostic (2.44e-3)"	0.2	0.4	0.0	0.0	0.4	0.0	0.1	0.0	0.2	0.1	0.1	0.4	0.0	0.0	0.1	0.8	0.1	0.3	2.4	0.0	0.0	0.0	0.1	0.0	0.3	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.4	0.2	0.3	0.0	0.2	0.0	0.1	0.1	0.0	0.1	1.1	0.1	0.4	26.6	0.0	0.0	0.0	1.1	0.3	0.1	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.1	0.4	1.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	1.6	0.5	0.5	0.0	0.4	0.0	0.3	0.1	0.0	0.0	0.0	0.8	0.7	0.0	0.0	1.3	0.2	0.5	0.0	0.1	2.8	0.0	0.7	0.2	0.1	0.0	0.0	1.7	1.7	0.0	3.5	0.1	2.2	1.3	0.0	0.0	0.3	0.0	1.5	0.0	0.0	0.9	0.1	2.3	0.4	0.3	0.0	0.3	1.1	0.7	0.4	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.2	0.0	0.0	0.0	0.0	0.4	0.0
SPATC1L	C21orf56	ENSG00000160284	"Spermatogenesis and centriole associated 1 like"	Q9H0A9	21	46161148-46184476	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"K-562: 23.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"eosinophil: 23.6"	"Low lineage specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA018979, HPA019165, HPA029394"	Approved		Approved	"Vesicles,Plasma membrane,Cytosol"				"Vesicles, Plasma membrane, Cytosol"		"HPA018979: AB_1845696, HPA019165: AB_1845697, HPA029394: AB_10601148"	"unprognostic (1.46e-2)"	"unprognostic (3.88e-2)"	"unprognostic (3.95e-2)"	"unprognostic (4.86e-2)"	"unprognostic (6.36e-2)"	"unprognostic (1.71e-1)"	"unprognostic (4.45e-3)"	"unprognostic (2.16e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.27e-1)"	"prognostic favourable (2.16e-4)"	"unprognostic (5.56e-2)"	"unprognostic (2.35e-3)"	"unprognostic (1.07e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.91e-2)"	"unprognostic (2.58e-1)"	4.7	11.5	21.5	4.2	31.7	5.1	4.3	13.1	19.0	8.2	5.1	5.6	8.9	5.3	5.3	6.5	4.6	4.0	5.7	5.5	14.4	9.4	4.3	1.5	4.4	5.7	7.8	16.5	10.9	11.7	5.8	7.8	4.7	7.5	16.7	3.6	2.6	9.5	10.1	8.8	7.0	6.3	5.6	5.2	8.1	8.3	23.5	13.6	2.2	3.7	5.0	4.3	4.4	6.4	4.8	5.9	23.6	4.2	4.0	6.9	2.7	1.8	0.0	2.4	4.5	1.4	3.3	1.3	2.6	1.4	1.5	1.1	0.0	1.2	5.8	5.4	3.3	0.3	0.0	2.1	0.4	5.2	4.3	13.8	0.8	3.2	0.1	0.0	5.8	3.4	1.0	0.0	0.0	4.8	23.8	8.7	2.1	3.6	4.4	1.6	9.9	11.8	9.9	3.2	6.4	2.3	0.5	0.7	4.6	2.1	1.2	5.2	3.8	5.3	0.3	4.4	5.3	6.2	4.0	14.6	7.8	4.2	5.8	7.7	4.1	1.0	3.9	23.6	3.0	4.2	3.9	4.7	4.4	4.3	5.9	4.8	6.9	6.8	0.2	4.0	2.9	4.8	4.2	2.7	21.5	31.7	13.1	19.0	14.4	9.4	7.8	16.5	7.5	13.6
SPERT	"CBY2, NURIT"	ENSG00000174015	"Spermatid associated"	Q8NA61	13	45702311-45714559	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	21	"testis: 66.5"	"Cell line enhanced"	"Detected in some"		"EFO-21: 1.7;HDLM-2: 3.4;hTCEpi: 1.2;MCF7: 1.3;SCLC-21H: 1.2;SK-BR-3: 2.4"	"Low cancer specificity"	"Detected in single"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"T-reg: 3.2"	"Lineage enriched"	"Detected in single"	32	"T-cells: 3.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA039359, HPA040046"	Enhanced		Approved	"Plasma membrane,Cell Junctions"				"Plasma membrane, Cell Junctions"		"HPA039359: AB_10794088, HPA040046: AB_10796117"	"unprognostic (2.86e-1)"	"unprognostic (3.38e-1)"	"unprognostic (1.64e-2)"	"unprognostic (1.65e-1)"	"unprognostic (3.76e-2)"	"unprognostic (4.19e-4)"		"unprognostic (8.52e-2)"	"unprognostic (8.87e-2)"	"unprognostic (1.23e-1)"	"unprognostic (4.38e-1)"		"unprognostic (2.38e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.56e-2)"	"unprognostic (1.97e-2)"	"unprognostic (4.15e-3)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	66.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	1.7	0.8	0.0	0.1	0.0	0.0	3.4	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.2	0.0	2.4	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.2	0.7	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	3.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SPINK13	"HESPINTOR, LiESP6, MGC149260, SPINK5L3"	ENSG00000214510	"Serine peptidase inhibitor, Kazal type 13 (putative)"	Q1W4C9	5	148268180-148286254	"Predicted intracellular proteins, Predicted secreted proteins"		"Protease inhibitor, Serine protease inhibitor"		"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	14	"ductus deferens: 85.5;epididymis: 86.8;seminal vesicle: 26.7"	"Cell line enriched"	"Detected in some"	20	"HeLa: 99.6"	"Group enriched"	"Detected in some"	6	"cervical cancer: 0.9;lung cancer: 0.9;renal cancer: 3.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA036456	Uncertain		Approved	"Nucleoplasm,Plasma membrane"	"Secreted in male reproductive system"			"Plasma membrane"	Nucleoplasm	"HPA036456: AB_10673496"	"unprognostic (5.22e-2)"	"unprognostic (2.03e-1)"		"unprognostic (1.44e-1)"	"unprognostic (2.51e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.41e-2)"	"unprognostic (6.43e-3)"		"unprognostic (1.25e-3)"	"unprognostic (5.01e-3)"	"unprognostic (1.25e-1)"	"prognostic unfavourable (4.03e-10)"	"unprognostic (4.31e-2)"	"unprognostic (1.72e-1)"	"unprognostic (2.43e-1)"	"unprognostic (2.95e-2)"	0.1	4.6	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.2	2.2	0.0	85.5	0.0	0.4	86.8	0.1	1.0	0.1	0.8	0.0	0.1	2.1	0.0	0.1	0.1	0.0	0.0	1.4	0.4	0.0	1.0	0.1	0.0	4.0	0.0	0.0	0.1	26.7	0.1	0.2	0.0	0.1	0.0	0.0	2.9	2.7	0.0	0.0	0.4	0.1	0.1	0.4	0.1	0.4	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	99.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	5.0	0.0	0.0	0.0	4.9	0.0	0.0	0.4	0.0	0.1	0.2	0.0	0.0	0.0	0.1	0.0	0.1	0.4	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0
SPN	"CD43, GPL115, LSN"	ENSG00000197471	Sialophorin	P16150	16	29662979-29670876	"CD markers, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	7	"blood: 52.1;bone marrow: 33.1;lung: 25.0;lymphoid tissue: 79.7"	"Cell line enhanced"	"Detected in some"		"HEL: 54.9;HL-60: 48.8;HMC-1: 27.5;MOLT-4: 18.9;THP-1: 26.4;U-937: 34.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"non-classical monocyte: 52.1"	"Low lineage specificity"	"Detected in all"											"CAB002666, HPA055244"	Enhanced		Approved	"Plasma membrane"				"Plasma membrane"		"CAB002666: , HPA055244: "	"prognostic favourable (1.40e-4)"	"unprognostic (1.63e-3)"	"unprognostic (3.14e-2)"	"prognostic favourable (3.08e-5)"	"unprognostic (2.68e-2)"	"unprognostic (2.49e-3)"	"unprognostic (4.02e-2)"	"unprognostic (4.17e-2)"	"prognostic favourable (1.88e-4)"	"unprognostic (1.70e-1)"	"unprognostic (4.67e-2)"	"unprognostic (2.68e-1)"	"unprognostic (2.61e-2)"	"unprognostic (4.52e-2)"	"unprognostic (4.14e-2)"	"unprognostic (5.85e-2)"	"unprognostic (4.72e-2)"	5.7	1.0	1.2	12.9	2.7	33.1	1.6	0.7	1.5	1.3	2.8	2.6	0.0	2.3	1.5	0.6	1.9	1.7	2.8	3.9	1.2	1.4	1.8	1.9	25.0	18.3	3.7	0.2	1.0	1.6	0.2	1.0	0.8	2.3	1.6	2.6	1.6	5.0	0.6	0.8	1.6	6.8	1.0	4.6	15.9	2.0	0.6	1.9	79.7	1.6	1.7	17.4	2.6	1.4	1.0	8.8	3.5	52.1	17.5	26.5	10.7	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	54.9	0.0	0.4	0.0	48.8	27.5	0.0	0.0	0.0	0.0	0.0	17.1	13.4	0.1	0.0	18.9	12.2	0.0	0.0	17.1	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	26.4	0.1	0.0	0.0	0.0	0.0	0.0	0.9	7.2	0.0	34.8	0.0	2.4	5.5	3.5	26.5	24.3	14.5	1.0	10.7	18.1	8.8	0.3	7.6	13.2	0.9	17.5	52.1	7.0	9.1	10.7	1.2	2.7	0.7	1.5	1.2	1.4	3.7	0.2	2.3	1.9
SRD5A3	"FLJ13352, SRD5A2L, SRD5A2L1"	ENSG00000128039	"Steroid 5 alpha-reductase 3"	Q9H8P0	4	55346109-55373096	"Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins"		Oxidoreductase	"Cataract, Congenital disorder of glycosylation, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"SK-BR-3: 43.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA027006	Uncertain		Approved	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		"HPA027006: AB_1857469"	"unprognostic (1.12e-2)"	"unprognostic (1.01e-1)"	"unprognostic (4.02e-2)"	"prognostic favourable (9.39e-4)"	"unprognostic (1.50e-2)"	"unprognostic (4.81e-2)"	"prognostic unfavourable (1.80e-6)"	"unprognostic (9.31e-2)"	"unprognostic (5.28e-2)"	"unprognostic (1.81e-2)"	"unprognostic (3.29e-3)"	"unprognostic (1.18e-1)"	"prognostic unfavourable (4.85e-10)"	"unprognostic (4.16e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.43e-2)"	"unprognostic (9.52e-2)"	13.8	12.2	11.5	5.9	13.4	6.6	17.8	7.3	18.3	22.9	11.3	20.3	3.5	6.9	13.8	9.6	24.4	5.9	22.6	10.5	13.2	10.7	12.3	15.0	12.4	10.1	15.5	12.0	3.5	26.8	14.0	7.0	8.8	13.6	8.9	10.9	6.8	16.3	6.6	5.8	15.6	8.3	6.2	22.1	6.9	13.8	4.0	15.3	10.0	7.6	9.9	12.1	12.1	12.1	5.9	28.4	10.3	25.2	3.6	9.2	10.3	4.9	3.3	6.0	5.7	20.0	12.8	3.0	5.4	6.3	2.3	3.7	3.3	10.4	11.8	6.1	8.5	3.9	4.2	5.0	2.8	3.4	7.5	6.4	3.7	8.8	5.3	11.9	3.6	11.7	9.3	3.9	3.6	9.2	10.9	26.5	12.9	6.5	17.4	5.2	7.5	4.4	5.6	1.8	6.6	7.6	5.4	9.2	5.1	5.8	43.6	3.9	5.3	10.5	4.5	14.6	2.6	1.0	4.1	14.1	7.7	4.3	18.5	16.4	14.2	10.3	16.5	4.9	7.9	25.1	9.2	5.9	6.0	7.4	14.1	5.2	5.3	7.1	0.8	3.6	25.2	28.4	5.8	10.3	11.5	13.4	7.3	18.3	13.2	10.7	15.5	12.0	13.6	15.3
SRPK1	SFRSK1	ENSG00000096063	"SRSF protein kinase 1"	Q96SB4	6	35832966-35921342	"Enzymes, Predicted intracellular proteins"	"Chromosome partition, Differentiation, Host-virus interaction, mRNA processing, mRNA splicing"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016431, HPA056486"	Approved		Supported	"Nucleoplasm,Plasma membrane,Cytosol"				"Nucleoplasm, Cytosol"	"Plasma membrane"	"HPA016431: AB_1857478, HPA056486: AB_2683148"	"unprognostic (4.65e-3)"	"unprognostic (6.82e-3)"	"unprognostic (2.54e-3)"	"unprognostic (1.01e-3)"	"unprognostic (7.74e-2)"	"unprognostic (3.31e-2)"	"prognostic unfavourable (7.90e-6)"	"unprognostic (1.23e-2)"	"unprognostic (2.54e-3)"	"unprognostic (2.36e-2)"	"prognostic unfavourable (6.53e-5)"	"unprognostic (7.28e-2)"	"unprognostic (2.21e-3)"	"unprognostic (9.24e-2)"	"unprognostic (4.43e-1)"	"unprognostic (1.01e-1)"	"unprognostic (7.55e-3)"	13.5	7.1	8.1	15.4	11.7	32.1	11.7	22.5	17.8	12.8	23.8	7.8	10.8	20.3	15.2	7.9	24.9	8.9	10.8	8.7	8.9	7.8	17.8	18.9	14.9	14.6	8.0	8.3	9.5	26.0	11.7	17.7	27.9	9.6	10.5	28.7	12.4	17.6	9.4	19.9	26.2	25.7	11.3	7.9	19.0	13.9	32.7	7.6	21.0	8.5	17.0	19.8	15.2	15.7	4.3	2.8	24.6	3.4	5.0	6.7	2.9	29.3	11.1	16.4	24.5	9.2	12.0	20.8	18.0	17.4	16.9	18.0	31.3	9.9	39.2	15.3	11.1	15.1	32.0	21.5	30.3	26.7	23.1	20.6	13.1	27.1	8.2	30.4	10.1	7.7	11.7	19.4	25.4	21.1	43.6	16.6	14.1	10.4	31.3	23.7	13.4	12.2	22.1	19.7	24.2	16.9	49.3	35.1	12.9	18.5	17.6	12.5	9.9	20.3	15.2	15.9	12.4	10.7	22.6	9.8	21.6	36.8	6.3	35.4	14.1	24.5	2.1	13.7	4.3	2.5	6.1	4.3	5.7	5.7	2.8	3.3	4.8	5.2	24.6	5.0	3.4	1.6	6.7	2.9	8.1	11.7	22.5	17.8	8.9	7.8	8.0	8.3	9.6	7.6
SRPRB	"APMCF1, SR-beta"	ENSG00000144867	"SRP receptor beta subunit"	Q9Y5M8	3	133784033-133825772	"Predicted membrane proteins"		Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 104.0"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA011173	Approved		Approved	"Plasma membrane"			54000	"Plasma membrane"		"HPA011173: AB_1857484"	"unprognostic (5.44e-2)"	"unprognostic (1.32e-1)"	"unprognostic (6.40e-2)"	"unprognostic (1.58e-2)"	"unprognostic (2.61e-1)"	"unprognostic (2.02e-2)"	"prognostic unfavourable (3.12e-5)"	"unprognostic (1.99e-1)"	"unprognostic (3.60e-2)"	"unprognostic (6.07e-3)"	"unprognostic (8.45e-2)"	"unprognostic (1.31e-2)"	"unprognostic (3.79e-2)"	"unprognostic (5.08e-2)"	"unprognostic (7.37e-2)"	"unprognostic (6.47e-2)"	"unprognostic (2.26e-2)"	10.4	15.7	8.7	10.2	9.3	5.8	12.5	5.2	10.2	14.4	11.3	5.1	33.2	8.9	8.0	25.6	16.8	9.1	11.0	10.9	9.0	10.7	17.2	56.3	9.2	17.3	10.4	7.7	8.9	104.0	11.7	15.6	7.7	8.8	9.5	13.4	7.6	53.3	29.9	10.6	8.6	7.4	10.3	7.4	9.5	12.5	14.7	5.4	6.3	16.5	10.2	13.7	8.7	10.4	15.4	20.0	3.8	15.2	14.3	29.0	18.0	12.2	9.9	6.3	20.0	26.4	18.3	11.8	25.9	13.5	14.4	12.5	18.0	9.5	23.2	38.4	19.8	17.9	19.6	14.0	13.7	15.7	15.8	20.7	9.8	17.1	32.1	32.4	16.9	16.5	23.6	13.1	38.9	12.2	17.6	27.0	15.4	17.8	11.1	15.4	12.0	17.1	13.6	11.8	49.5	17.4	8.4	20.9	8.7	19.8	18.5	7.2	21.0	15.1	12.1	14.2	8.4	22.4	13.8	34.8	34.6	35.0	12.7	21.6	15.9	3.8	11.6	1.4	21.4	15.2	29.0	15.4	18.3	19.0	13.2	13.4	18.0	21.2	0.8	14.3	9.9	20.0	10.6	18.0	8.7	9.3	5.2	10.2	9.0	10.7	10.4	7.7	8.8	5.4
SRRM3	FLJ37078	ENSG00000177679	"Serine/arginine repetitive matrix 3"		7	76201900-76287288	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enriched"	"Detected in some"	7	"brain: 43.2"	"Group enriched"	"Detected in some"	11	"SCLC-21H: 14.1;SH-SY5Y: 10.4"	"Low cancer specificity"	"Detected in many"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019337			Approved	"Plasma membrane,Intermediate filaments,Microtubules"				"Plasma membrane"	"Intermediate filaments, Microtubules"	"HPA019337: AB_1848909"	"unprognostic (1.65e-1)"	"unprognostic (1.96e-1)"	"unprognostic (8.37e-3)"	"unprognostic (4.93e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.39e-1)"	"unprognostic (8.53e-2)"	"unprognostic (6.51e-2)"	"unprognostic (1.89e-3)"	"unprognostic (1.62e-2)"	"unprognostic (5.07e-3)"	"unprognostic (6.37e-2)"	"unprognostic (3.73e-3)"	"unprognostic (5.05e-1)"	"unprognostic (2.98e-1)"	"unprognostic (1.84e-1)"	"unprognostic (5.15e-2)"	0.6	6.2	8.1	0.7	18.1	0.4	0.4	43.2	14.6	0.4	0.6	0.0	0.0	0.9	0.7	1.1	0.5	0.5	0.5	0.5	5.1		0.5	0.4	0.5	0.4	0.0	10.9	0.6	0.5	0.5	4.4	0.4	10.0	0.5	0.7	1.8	0.6	0.5	0.6	0.5	0.6	0.5	0.6	0.4	1.6	2.9	2.9	0.0	0.4	0.0	0.4	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.4	0.3	0.2	0.3	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.1	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	14.1	10.4	0.0	0.0	0.1	0.4	0.0	0.0	0.0	1.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0										
SSFA2	"CS-1, KIAA1927, KRAP, SPAG13"	ENSG00000138434	"Sperm specific antigen 2"	P28290	2	181891833-181930738	"Plasma proteins, Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 85.5"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in all"	4	"dendritic cells: 3.8;granulocytes: 8.1;monocytes: 6.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034665, HPA039989"	Uncertain		Supported	"Nucleoplasm,Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"	Nucleoplasm	"HPA034665: , HPA039989: "	"unprognostic (1.68e-1)"	"unprognostic (3.27e-2)"	"unprognostic (2.17e-2)"	"unprognostic (4.70e-2)"	"unprognostic (8.77e-2)"	"unprognostic (8.87e-2)"	"unprognostic (2.13e-1)"	"unprognostic (4.74e-2)"	"unprognostic (5.63e-2)"	"unprognostic (1.23e-2)"	"prognostic unfavourable (8.19e-4)"	"unprognostic (6.95e-2)"	"prognostic favourable (2.91e-5)"	"unprognostic (3.39e-1)"	"unprognostic (5.54e-2)"	"unprognostic (4.95e-2)"	"prognostic unfavourable (5.79e-5)"	14.2	10.1	23.3	11.8	27.0	16.1	21.6	25.8	22.5	17.7	24.4	26.2	9.4	17.5	13.0	8.9	12.0	10.7	18.7	13.6	23.7	19.1	22.8	36.0	23.0	11.2	31.3	17.7	7.2	85.5	10.5	10.2	40.9	24.8	18.1	24.1	22.3	29.2	10.0	16.6	50.6	19.5	14.2	27.8	14.7	26.0	16.7	23.8	9.3	19.6	12.2	7.9	14.3	23.5	1.2	3.8	8.1	6.4	1.0	1.4	1.8	16.1	8.1	23.6	4.0	20.6	17.1	6.7	28.7	27.9	10.1	13.4	8.3	18.7	0.3	9.3	20.2	14.0	5.7	13.8	19.6	7.4	6.4	16.3	34.7	6.7	15.2	8.3	15.3	10.1	20.3	17.4	23.7	52.8	7.3	9.0	28.1	8.1	7.3	11.7	1.6	19.1	5.5	9.5	5.6	28.6	4.9	4.1	3.6	16.8	6.0	25.7	4.3	18.3	21.0	24.0	11.6	8.6	14.9	6.2	2.7	6.5	11.2	5.0	17.8	8.1	3.9	5.7	1.4	3.9	0.9	0.6	1.0	0.9	3.8	1.2	1.3	1.1	6.6	1.0	6.4	3.1	0.6	1.8	23.3	27.0	25.8	22.5	23.7	19.1	31.3	17.7	24.8	23.8
SSH3	"FLJ10928, FLJ20515"	ENSG00000172830	"Slingshot protein phosphatase 3"	Q8TE77	11	67303448-67312607	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HaCaT: 23.6;RT4: 35.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 10.8;eosinophil: 10.5"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 10.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019949, HPA019957"	Approved		Approved	"Nuclear speckles,Plasma membrane,Actin filaments,Cytosol"				"Nuclear speckles, Cytosol"	"Plasma membrane, Actin filaments"	"HPA019949: AB_1857498, HPA019957: AB_1857499"	"unprognostic (4.38e-2)"	"unprognostic (1.37e-1)"	"unprognostic (3.50e-3)"	"unprognostic (3.73e-2)"	"unprognostic (2.61e-3)"	"unprognostic (9.30e-2)"	"unprognostic (2.99e-1)"	"unprognostic (1.84e-1)"	"unprognostic (1.63e-1)"	"unprognostic (2.45e-2)"	"prognostic unfavourable (2.89e-4)"	"unprognostic (1.50e-1)"	"unprognostic (2.06e-2)"	"unprognostic (1.47e-1)"	"unprognostic (3.20e-1)"	"unprognostic (4.94e-3)"	"unprognostic (6.78e-3)"	8.6	5.5	5.6	6.8	9.7	8.1	13.5	17.8	9.4	14.6	15.9	15.4	19.5	12.4	10.1	10.6	27.0	15.2	20.5	7.7	6.0	6.1	10.3	7.5	9.0	3.5	13.6	5.4	17.1	12.0	11.3	7.4	20.0	8.5	19.8	9.2	11.9	19.1	30.5	5.2	18.2	13.6	13.1	9.3	6.9	13.9	4.2	9.7	0.8	12.8	14.0	13.2	33.3	18.6	0.3	1.6	10.8	2.3	1.5	2.2	1.0	6.1	6.7	0.1	0.2	4.7	4.9	7.3	4.0	5.4	2.1	2.0	7.2	16.3	0.3	12.5	3.7	23.6	2.2	17.0	1.1	1.3	2.5	1.5	10.8	2.9	3.3	0.3	6.0	4.3	15.8	3.1	3.2	2.4	0.0	0.6	2.5	20.8	0.2	3.0	1.5	5.4	7.6	0.2	1.1	6.9	35.7	1.4	2.2	9.4	14.0	4.4	19.6	5.2	3.8	1.7	3.7	4.7	1.1	0.6	0.3	0.2	4.8	2.7	1.6	10.8	1.4	10.5	2.2	2.3	1.7	0.3	2.1	1.8	1.6	0.2	0.8	0.9	4.5	1.5	1.1	1.1	1.8	1.0	5.6	9.7	17.8	9.4	6.0	6.1	13.6	5.4	8.5	9.7
ST8SIA5	SIAT8E	ENSG00000101638	"ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 5"	O15466	18	46667821-46759257	"Predicted membrane proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"adrenal gland: 12.8;brain: 36.4"	"Cell line enriched"	"Detected in some"	8	"WM-115: 51.7"	"Cancer enriched"	"Detected in single"	8	"glioma: 2.6"	"Region enhanced"	"Detected in many"		"cerebellum: 36.4"	"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043813, HPA046771"	Approved		Approved	"Plasma membrane,Midbody"				"Plasma membrane, Midbody"		"HPA043813: , HPA046771: "	"unprognostic (3.19e-2)"	"unprognostic (1.16e-1)"	"unprognostic (2.47e-2)"	"unprognostic (1.33e-4)"	"unprognostic (2.99e-2)"	"unprognostic (4.83e-2)"	"unprognostic (1.90e-2)"	"unprognostic (1.39e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.57e-2)"	"unprognostic (1.84e-2)"	"unprognostic (6.55e-2)"	"unprognostic (8.85e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.79e-2)"	0.6	12.8	3.6	0.6	7.8	0.9	0.5	36.4	16.1	0.5	0.5	1.0	0.0	0.7	0.5	0.9	0.4	0.7	0.6	7.2	4.0	1.8	1.5	0.4	0.5	0.5	2.0	6.9	0.7	0.4	4.9	0.7	0.4	4.1	0.6	0.5	0.0	0.4	0.5	8.2	0.7	0.5	0.5	2.5	0.5	0.7	0.9	0.7	0.0	0.6	0.0	0.5	0.5	0.1	0.8	0.4	1.5	0.4	0.5	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	3.5	3.0	0.1	0.0	0.0	6.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.9	0.0	51.7	1.0	0.4	0.2	0.2	0.2	0.2	0.4	0.2	0.2	0.0	0.8	0.3	0.3	1.5	0.5	0.2	0.4	0.1	0.0	3.6	7.8	36.4	16.1	4.0	1.8	2.0	6.9	4.1	0.7
STAB1	"CLEVER-1, FEEL-1, FELE-1, FEX1, KIAA0246, SCARH2, STAB-1"	ENSG00000010327	"Stabilin 1"	Q9NY15	3	52495338-52524495	"Predicted membrane proteins"	"Inflammatory response"	Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 90.8"	"Group enriched"	"Detected in some"	47	"HUVEC TERT2: 33.1;NB-4: 45.7;TIME: 40.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	68	"classical monocyte: 10.8;intermediate monocyte: 6.6;myeloid DC: 2.8"	"Group enriched"	"Detected in many"	69	"dendritic cells: 2.8;monocytes: 10.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA005434	Approved		Approved	"Nucleoplasm,Plasma membrane,Cytosol"			60000000	Cytosol	"Nucleoplasm, Plasma membrane"	"HPA005434: AB_1080097"	"unprognostic (1.18e-1)"	"unprognostic (2.89e-1)"	"prognostic unfavourable (7.59e-4)"	"unprognostic (3.63e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.49e-2)"	"unprognostic (1.08e-2)"	"unprognostic (2.23e-1)"	"unprognostic (2.38e-1)"	"unprognostic (4.00e-3)"	"unprognostic (2.66e-2)"	"unprognostic (3.19e-1)"	"prognostic unfavourable (3.88e-7)"	"unprognostic (3.16e-2)"	"unprognostic (9.40e-2)"	"unprognostic (4.70e-2)"	"unprognostic (1.08e-1)"	39.5	37.6	8.0	26.7	12.8	6.5	41.3	3.2	6.8	13.1	23.4	6.9	4.2	16.1	13.6	26.4	9.7	15.5	16.8	19.7	5.4	4.2	19.2	35.8	21.7	80.7	9.1	2.7	9.9	7.1	4.9	11.9	32.1	10.2	13.5	18.0	23.7	10.4	9.7	8.0	5.1	18.7	18.3	7.2	90.8	11.6	9.7	8.7	2.6	11.9	11.4	11.1	15.9	15.4	0.0	2.8	0.0	10.8	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.2	0.0	0.0	0.6	0.0	0.0	0.0	33.1	0.1	0.0	0.0	0.0	0.0	45.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	40.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.8	0.0	0.0	6.6	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	8.0	12.8	3.2	6.8	5.4	4.2	9.1	2.7	10.2	8.7
STAC2	24b2	ENSG00000141750	"SH3 and cysteine rich domain 2"	Q6ZMT1	17	39210536-39225872	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ductus deferens: 94.0;seminal vesicle: 101.5"	"Group enriched"	"Detected in some"	5	"HeLa: 25.6;U-87 MG: 11.7"	"Group enriched"	"Detected in many"	7	"breast cancer: 15.0;endometrial cancer: 3.2;glioma: 10.4;ovarian cancer: 4.2;renal cancer: 10.7"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA076925			Approved	"Plasma membrane"				"Plasma membrane"		"HPA076925: "	"unprognostic (1.70e-3)"	"unprognostic (1.05e-1)"	"unprognostic (3.09e-2)"	"prognostic unfavourable (4.05e-5)"	"prognostic unfavourable (5.61e-4)"	"unprognostic (1.42e-1)"	"unprognostic (8.66e-2)"	"unprognostic (2.94e-2)"	"unprognostic (1.17e-2)"	"prognostic unfavourable (6.66e-4)"	"unprognostic (1.12e-2)"	"unprognostic (5.16e-2)"	"unprognostic (2.35e-3)"	"unprognostic (2.05e-2)"	"unprognostic (1.94e-1)"	"unprognostic (3.54e-2)"	"unprognostic (3.17e-1)"	2.4	0.9	4.2	1.0	7.4	0.7	29.7	9.5	21.9	4.0	0.9	0.0	94.0	0.9	2.5	13.9	0.8	1.4	0.8	1.0	6.8	3.2	4.8	0.7	0.9	0.8	3.5	6.6	1.2	1.1	0.7	0.5	1.0	13.1	1.8	0.9	8.2	7.8	101.5	0.8	20.1	0.8	1.7	1.4	0.8	0.8	0.9	0.2	0.0	0.7	0.0	0.8	0.8	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.4	0.0	0.0	3.2	0.0	0.0	0.0	0.4	0.0	25.6	0.0	0.0	0.0	0.0	0.0	0.0	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.2	2.0	0.2	2.7	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	11.7	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.2	7.4	9.5	21.7	6.8	3.2	3.5	6.6	13.1	0.2
STAMBPL1	"ALMalpha, AMSH-FP, AMSH-LP, bA399O19.2, FLJ31524, KIAA1373"	ENSG00000138134	"STAM binding protein like 1"	Q96FJ0	10	88879734-88975153	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 18.6"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA040202	Uncertain		Approved	"Plasma membrane"				"Plasma membrane"		"HPA040202: AB_10805708"	"unprognostic (2.73e-1)"	"unprognostic (1.95e-1)"	"unprognostic (7.56e-2)"	"unprognostic (4.25e-2)"	"unprognostic (6.46e-2)"	"unprognostic (6.27e-2)"	"unprognostic (1.68e-2)"	"unprognostic (1.05e-2)"	"unprognostic (4.67e-2)"	"unprognostic (8.20e-2)"	"unprognostic (2.78e-1)"	"unprognostic (6.57e-2)"	"prognostic unfavourable (1.08e-5)"	"unprognostic (4.41e-2)"	"unprognostic (4.06e-2)"	"unprognostic (1.50e-1)"	"unprognostic (4.40e-3)"	3.9	15.9	3.7	6.8	5.1	2.8	2.1	12.4	8.9	2.0	5.8	3.4	1.5	4.5	2.7	1.5	2.7	1.2	2.9	4.8	3.3	3.4	1.5	1.7	2.9	11.3	2.6	14.8	8.5	1.8	2.2	6.6	1.5	4.1	1.9	8.0	1.5	1.5	1.5	1.5	3.4	6.1	1.8	3.1	6.0	3.1	18.6	3.2	1.5	1.5	1.5	9.5	3.9	2.7	10.5	15.2	4.3	0.6	13.1	14.7	4.5	6.7	8.0	0.5	0.3	8.0	15.3	0.0	14.2	14.0	9.1	8.2	0.3	12.9	8.2	1.0	7.7	3.3	2.0	2.9	9.3	7.3	5.0	2.1	5.7	0.4	5.4	9.0	2.9	5.5	0.7	15.3	4.9	0.2	0.0	3.7	24.5	1.4	15.1	10.8	3.0	6.2	1.5	6.0	1.8	3.5	2.6	4.6	5.5	1.8	0.6	16.1	1.0	1.9	2.0	8.1	5.9	9.8	8.8	8.7	8.2	7.6	8.9	9.2	7.7	4.3	0.6	4.2	6.3	0.6	8.2	10.5	9.2	7.9	0.9	7.0	9.9	5.9	0.9	13.1	0.3	15.2	14.7	4.5	3.7	5.1	12.4	8.9	3.3	3.4	2.6	14.8	4.1	3.2
STARD4		ENSG00000164211	"StAR related lipid transfer domain containing 4"	Q96DR4	5	111496033-111512590	"Predicted intracellular proteins"	"Lipid transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046177, HPA048081"	Approved		Approved	"Plasma membrane"				"Plasma membrane"		"HPA046177: , HPA048081: "	"unprognostic (1.13e-1)"	"unprognostic (7.07e-3)"	"unprognostic (1.53e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.21e-2)"	"prognostic unfavourable (4.80e-5)"	"unprognostic (1.31e-1)"	"unprognostic (1.11e-1)"	"unprognostic (4.26e-1)"	"unprognostic (6.27e-2)"	"unprognostic (1.39e-1)"	"prognostic unfavourable (5.89e-5)"	"unprognostic (2.00e-1)"	"unprognostic (3.82e-3)"	"unprognostic (4.01e-3)"	"prognostic unfavourable (2.84e-4)"	5.2	12.4	9.7	11.2	27.3	12.6	3.2	20.7	17.5	8.5	11.0	6.8	5.5	30.0	6.4	12.9	8.4	4.6	7.6	11.0	12.5	12.5	8.2	25.3	22.0	8.8	10.5	7.3	6.6	4.7	17.2	10.8	27.8	25.5	16.5	13.1	7.1	5.9	8.0	1.6	2.6	29.9	5.4	17.0	8.8	13.2	5.1	16.3	5.1	7.7	5.7	7.4	5.2	8.8	2.8	2.8	11.0	3.1	2.9	4.2	2.1	6.9	3.4	16.8	10.1	15.1	30.3	5.7	7.1	16.1	10.7	31.9	12.7	20.6	8.3	2.9	4.5	3.1	8.5	24.6	10.2	7.9	3.6	6.4	11.0	7.6	16.8	3.1	4.1	16.1	16.9	22.6	16.8	19.6	3.5	16.0	7.1	1.3	7.7	5.7	5.7	1.9	1.8	18.8	7.5	15.6	2.2	9.6	37.3	0.0	4.2	6.4	5.5	10.2	28.9	9.0	8.2	6.0	3.0	5.5	5.1	7.3	8.5	11.9	4.5	11.0	2.1	1.5	4.2	3.1	2.2	2.8	2.0	3.0	2.8	2.7	2.1	3.1	0.0	2.9	2.2	1.9	1.2	2.1	9.7	27.3	20.7	17.5	12.5	12.5	10.5	7.3	25.5	16.3
STIL	"MCPH7, SIL"	ENSG00000123473	"STIL, centriolar assembly protein"	Q15468	1	47250139-47314147	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"		"Developmental protein"	"Cancer-related genes, Disease mutation, Mental retardation, Primary microcephaly, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 36.0;testis: 23.8"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA046543			Approved	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		"HPA046543: "	"unprognostic (2.07e-1)"	"unprognostic (6.29e-2)"	"unprognostic (5.54e-3)"	"unprognostic (2.67e-3)"	"unprognostic (1.76e-1)"	"unprognostic (1.56e-2)"	"unprognostic (2.90e-5)"	"unprognostic (7.35e-3)"	"unprognostic (4.04e-3)"	"unprognostic (1.41e-1)"	"prognostic unfavourable (1.33e-4)"	"unprognostic (5.81e-2)"	"unprognostic (3.36e-14)"	"unprognostic (5.76e-3)"	"unprognostic (2.58e-1)"	"unprognostic (1.64e-1)"	"unprognostic (2.28e-1)"	1.2	1.4	1.3	10.8	2.4	11.0	2.9	1.4	2.2	1.2	4.1	0.9	2.5	3.6	1.5	2.2	5.8	0.9	1.7	2.0	1.4	1.2	1.5	1.6	1.7	5.0	1.3	1.5	1.2	1.5	0.9	0.9	5.5	1.1	1.7	6.4	0.8	3.6	0.5	0.8	4.2	4.0	1.3	1.2	3.4	2.2	23.8	1.0	36.0	1.1	3.5	7.1	1.3	2.1	1.9	1.6	5.4	0.7	3.3	1.2	0.5	16.9	9.1	13.1	11.7	0.9	2.3	8.3	15.0	7.2	16.8	17.7	9.8	8.4	20.0	7.1	7.4	11.3	15.3	7.8	18.1	14.9	6.9	22.5	11.3	8.6	0.5	18.1	11.5	0.8	1.3	14.4	9.4	11.1	15.9	19.0	12.6	7.7	17.6	5.7	15.8	7.5	11.5	21.3	9.6	4.7	10.2	11.7	7.0	16.1	11.9	7.7	7.7	10.4	6.5	15.8	16.1	11.4	20.2	6.3	13.0	19.6	7.4	13.9	14.7	4.3	0.7	1.1	1.1	0.4	0.5	1.7	1.2	1.0	0.5	1.9	0.8	0.8	5.4	3.3	0.3	1.6	1.1	0.5	1.3	2.4	1.4	2.2	1.4	1.2	1.3	1.5	1.1	1.0
STK10	"LOK, PRO2729"	ENSG00000072786	"Serine/threonine kinase 10"	O94804	5	172042073-172188386	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Cell cycle"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 40.9"	"Cell line enhanced"	"Detected in all"		"WM-115: 51.5"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in all"	5	"cerebellum: 27.5"	"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015083, CAB020840"	Enhanced		Approved	"Nucleoplasm,Plasma membrane"			24000	"Nucleoplasm, Plasma membrane"		"CAB020840: , HPA015083: "	"unprognostic (1.17e-1)"	"unprognostic (5.43e-2)"	"prognostic favourable (2.76e-4)"	"unprognostic (2.88e-1)"	"unprognostic (6.96e-3)"	"unprognostic (1.02e-1)"	"unprognostic (5.25e-3)"	"unprognostic (3.07e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.03e-1)"	"unprognostic (2.65e-1)"	"unprognostic (3.43e-1)"	"prognostic unfavourable (1.63e-4)"	"unprognostic (1.09e-1)"	"unprognostic (1.01e-2)"	"unprognostic (3.10e-1)"	"unprognostic (1.84e-1)"	15.0	4.7	2.6	25.8	4.4	38.3	13.5	27.5	3.0	3.6	5.0	4.8	3.4	4.7	4.4	4.4	3.6	4.2	11.0	9.0	2.4	2.5	5.3	4.5	15.4	40.9	5.4	1.9	3.5	4.1	2.5	3.7	16.2	4.5	4.3	4.0	5.6	7.8	2.5	3.1	9.0	12.2	5.7	4.6	33.0	6.2	13.1	3.5	20.6	4.6	3.1	23.7	9.5	11.3	5.0	10.3	22.3	30.8	7.4	18.0	15.6	7.7	7.2	4.5	6.7	5.2	6.5	11.5	10.1	8.4	7.3	6.8	3.7	10.2	9.3	5.4	12.4	9.0	2.0	12.3	4.8	12.2	3.3	11.2	3.0	2.1	7.5	11.3	13.3	6.4	2.6	9.9	8.3	6.3	1.0	13.1	5.1	12.4	8.1	25.5	1.8	5.7	13.4	3.5	6.2	3.0	9.8	3.0	3.7	5.8	8.1	27.6	2.9	24.0	8.7	8.2	4.1	5.7	5.4	11.1	16.3	5.9	10.8	17.5	51.5	7.1	10.8	10.0	18.0	21.4	13.3	5.0	9.4	12.8	10.3	4.4	5.6	9.6	22.3	7.4	30.8	3.2	12.2	15.6	2.6	4.4	27.5	3.0	2.4	2.5	5.4	1.9	4.5	3.5
STK17A	DRAK1	ENSG00000164543	"Serine/threonine kinase 17a"	Q9UEE5	7	43582758-43626786	"Enzymes, Plasma proteins, Predicted membrane proteins"	Apoptosis	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 43.3"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"											"HPA018138, HPA037979"	Uncertain		Approved	"Nuclear speckles,Plasma membrane"				"Nuclear speckles"	"Plasma membrane"	"HPA018138: , HPA037979: AB_10795247"	"unprognostic (1.81e-3)"	"unprognostic (1.08e-2)"	"unprognostic (2.67e-1)"	"unprognostic (5.41e-2)"	"unprognostic (5.11e-2)"	"unprognostic (3.35e-2)"	"unprognostic (1.03e-2)"	"unprognostic (9.15e-3)"	"unprognostic (2.07e-1)"	"unprognostic (6.34e-2)"	"unprognostic (1.36e-2)"	"unprognostic (6.61e-2)"	"unprognostic (2.99e-3)"	"unprognostic (3.76e-2)"	"unprognostic (3.08e-1)"	"unprognostic (1.97e-3)"	"unprognostic (3.66e-1)"	7.1	10.1	6.1	43.3	8.2	20.2	8.4	7.9	7.2	4.8	9.3	3.7	2.0	6.1	5.3	4.2	10.1	4.7	8.6	17.7	5.7	5.6	6.7	8.1	15.2	36.6	6.6	2.6	7.3	14.3	1.5	6.3	37.2	5.7	6.2	5.3	3.6	8.6	3.4	10.7	4.8	12.3	5.8	5.3	27.8	11.0	9.0	2.8	30.1	7.3	6.8	37.7	10.3	8.1	10.8	1.4	11.5	0.9	12.7	11.4	2.9	4.5	5.7	5.2	3.5	6.5	8.6	2.1	16.5	17.8	9.0	9.2	4.9	3.3	7.3	26.0	13.7	9.4	3.9	21.9	12.6	18.0	4.4	6.5	4.3	6.1	4.8	11.2	4.4	7.0	25.8	11.9	10.9	16.8	7.6	25.2	10.3	2.1	18.2	5.2	8.0	18.7	6.3	3.3	14.5	15.7	3.4	2.8	6.3	7.4	3.4	4.8	4.0	5.7	16.8	19.6	7.5	11.6	18.4	15.3	7.6	10.6	19.9	9.9	31.2	0.7	0.4	11.5	5.8	0.2	5.8	10.8	6.1	9.7	0.3	10.1	11.4	10.2	6.4	12.7	0.9	1.4	3.2	2.9	6.1	8.2	7.9	5.9	5.7	5.6	6.6	2.6	5.7	2.8
STX18	Ufe1	ENSG00000168818	"Syntaxin 18"	Q9P2W9	4	4415742-4542346	"Predicted intracellular proteins, Predicted membrane proteins"	"ER-Golgi transport, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"cervix, uterine: 98.6"	"Low cell line specificity"	"Detected in all"			"Cancer enhanced"	"Detected in all"		"endometrial cancer: 43.1"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003019	Approved		Approved	"Plasma membrane"				"Plasma membrane"		"HPA003019: AB_1857622"	"unprognostic (2.33e-1)"	"unprognostic (1.65e-1)"	"prognostic favourable (2.84e-4)"	"prognostic favourable (6.33e-8)"	"unprognostic (4.21e-1)"	"unprognostic (6.77e-2)"	"unprognostic (6.17e-3)"	"unprognostic (2.95e-2)"	"unprognostic (7.53e-2)"	"unprognostic (3.22e-3)"	"unprognostic (1.21e-1)"	"unprognostic (1.07e-2)"	"prognostic favourable (7.03e-4)"	"unprognostic (1.92e-2)"	"unprognostic (1.55e-1)"	"unprognostic (7.44e-2)"	"prognostic favourable (4.69e-4)"	14.0	17.6	12.4	16.0	18.4	9.2	11.0	11.2	15.9	98.6	19.7	19.5	12.2	15.0	46.5	11.9	11.5	38.9	16.1	11.0	11.3	14.2	24.2	14.0	9.8	10.4	14.5	12.3	12.4	18.5	12.2	24.1	17.5	17.3	12.3	11.9	12.7	12.2	14.7	19.0	11.0	19.6	13.5	14.8	14.2	15.0	28.5	10.3	18.1	10.1	9.8	15.0	11.8	12.3	11.2	25.5	7.1	13.0	10.8	13.4	9.3	14.0	9.2	10.9	11.1	9.4	13.8	14.6	16.2	14.9	15.6	13.0	19.3	20.6	18.8	39.2	15.0	7.6	19.3	9.5	15.4	7.8	9.6	11.8	12.1	23.3	14.1	20.4	10.0	12.9	8.3	13.2	9.6	13.1	11.3	16.7	11.1	7.5	18.5	14.5	14.5	19.1	16.7	8.2	14.9	16.0	8.6	13.9	12.3	12.2	8.2	14.2	12.0	10.0	14.8	9.4	10.3	8.6	17.4	12.0	18.2	21.7	11.5	15.8	11.7	4.8	10.6	7.1	10.9	10.4	13.4	11.2	10.1	9.9	16.0	9.3	8.5	9.8	2.1	10.8	13.0	25.5	9.1	9.3	12.4	18.4	11.2	15.9	11.3	14.2	14.5	12.3	17.3	10.3
STXBP4	"MGC50337, Synip"	ENSG00000166263	"Syntaxin binding protein 4"	Q6ZWJ1	17	54968727-55173632	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pituitary gland: 36.3"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB007760, HPA022138, HPA022888, HPA024227"	Approved		Approved	"Plasma membrane,Cytosol"				"Plasma membrane"	Cytosol	"CAB007760: AB_562350, HPA022138: AB_1857628, HPA022888: AB_1857629, HPA024227: AB_1857630"	"unprognostic (5.89e-2)"	"unprognostic (2.50e-2)"	"unprognostic (1.30e-3)"	"unprognostic (9.27e-2)"	"unprognostic (1.03e-3)"	"unprognostic (1.48e-1)"	"unprognostic (5.00e-5)"	"unprognostic (4.11e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.28e-2)"	"unprognostic (3.45e-2)"	"unprognostic (2.11e-1)"	"unprognostic (1.60e-2)"	"unprognostic (2.98e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.44e-1)"	7.7	6.4	5.5	4.3	6.0	3.4	5.2	10.6	4.7	9.9	6.4	4.2	7.5	6.3	12.0	7.2	5.1	7.3	6.6	5.9	6.7	4.7	14.5	3.8	8.0	3.2	4.2	4.5	9.9	5.4	19.3	36.3	4.7	6.8	9.5	4.6	7.6	4.5	9.4	4.0	3.7	5.1	13.2	8.6	5.0	5.5	5.6	5.1	7.2	7.9	2.7	3.5	9.6	8.2	3.2	2.9	4.0	1.2	5.1	2.9	0.7	5.4	8.2	7.5	6.7	6.4	6.3	3.1	4.3	4.1	5.6	5.5	4.8	3.0	3.7	9.1	4.2	3.3	9.7	4.3	10.3	5.6	5.5	4.9	5.6	9.8	2.7	3.0	1.5	7.2	1.3	8.0	1.9	5.5	7.8	3.0	6.6	2.4	10.0	1.9	5.4	5.9	4.3	8.8	2.2	9.9	3.3	7.3	5.5	6.6	1.1	3.6	9.6	2.1	4.3	7.8	6.2	4.8	4.5	2.6	2.5	6.4	5.1	4.0	4.7	4.0	1.1	0.1	2.6	0.8	2.9	2.1	2.3	1.7	1.4	3.2	2.1	2.7	0.3	5.1	1.2	2.9	2.1	0.7	5.5	6.0	10.6	4.7	6.7	4.7	4.2	4.5	6.8	5.1
STYK1	"DKFZp761P1010, NOK, SuRTK106"	ENSG00000060140	"Serine/threonine/tyrosine kinase 1"	Q6J9G0	12	10618939-10674318	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		"Kinase, Transferase, Tyrosine-protein kinase"	Proto-oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 15.8;stomach 1: 16.0"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 18.2;HDLM-2: 10.8;HMC-1: 11.9;HUVEC TERT2: 16.4;TIME: 15.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in some"	7	"NK-cell: 12.5"	"Lineage enriched"	"Detected in many"	7	"NK-cells: 12.5"	"Region enhanced"	"Detected in single"		"basal ganglia: 2.3"	"Not detected"	"Not detected"			"HPA040468, HPA048569"	Enhanced		Approved	"Nucleoplasm,Plasma membrane"				"Plasma membrane"	Nucleoplasm	"HPA040468: , HPA048569: "	"unprognostic (2.30e-1)"	"unprognostic (2.22e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.75e-1)"	"unprognostic (3.11e-2)"	"unprognostic (3.35e-2)"	"unprognostic (6.85e-2)"	"unprognostic (5.08e-3)"	"unprognostic (3.37e-1)"	"unprognostic (3.50e-1)"	"unprognostic (2.21e-3)"	"unprognostic (1.02e-1)"	"unprognostic (1.70e-14)"	"unprognostic (5.18e-3)"	"unprognostic (1.22e-1)"	"unprognostic (2.33e-1)"	"unprognostic (1.45e-2)"	0.6	0.3	2.6	2.3	10.6	1.0	3.8	0.1	13.4	2.2	14.4	0.7	0.5	2.1	0.5	1.1	8.9	1.9	6.2	0.1	1.8	1.6	0.5	0.3	1.2	2.4	1.8	4.2	0.4	0.3	0.0	8.4	3.4	2.1	10.6	15.8	0.0	7.8	2.6	0.2	2.6	10.3	0.6	0.6	1.0	16.0	0.3	0.7	0.0	0.4	0.6	2.8	4.3	3.6	0.0	0.0	0.4	0.0	12.5	1.9	0.2	2.9	0.1	0.0	0.4	0.0	0.0	0.9	4.8	0.5	2.2	2.1	1.6	18.2	0.2	3.1	1.2	0.8	0.9	5.0	4.8	10.8	0.3	0.7	1.3	0.1	0.0	1.4	11.9	0.2	0.2	3.4	0.2	16.4	0.2	0.2	5.2	1.7	0.1	0.8	2.7	1.3	0.0	1.4	0.2	1.6	9.4	0.6	0.0	2.7	2.9	0.0	2.3	0.3	15.2	0.6	2.5	0.3	0.6	0.0	0.6	0.1	2.1	0.1	3.5	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	1.3	0.4	12.5	0.0	0.0	0.0	0.2	2.6	10.6	0.1	13.4	1.8	1.6	1.8	4.2	2.1	0.7
SUCLG2		ENSG00000172340	"Succinate-CoA ligase GDP-forming beta subunit"	Q96I99	3	67360460-67654614	"Citric acid cycle related proteins, Enzymes, Plasma proteins, Predicted intracellular proteins"	"Tricarboxylic acid cycle"	Ligase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 90.9"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046705, HPA051998"	Enhanced		Supported	"Plasma membrane,Mitochondria"			290000	"Plasma membrane, Mitochondria"		"HPA046705: AB_2679762, HPA051998: AB_2681687"	"unprognostic (1.69e-1)"	"unprognostic (2.31e-1)"	"prognostic favourable (1.08e-4)"	"unprognostic (2.12e-1)"	"unprognostic (3.10e-1)"	"unprognostic (5.32e-2)"	"unprognostic (1.87e-2)"	"unprognostic (1.69e-1)"	"unprognostic (3.88e-1)"	"unprognostic (3.26e-2)"	"unprognostic (4.61e-3)"	"unprognostic (5.59e-2)"	"prognostic favourable (2.79e-10)"	"unprognostic (3.08e-2)"	"unprognostic (2.79e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.38e-1)"	17.0	19.3	8.8	26.5	10.0	3.4	12.4	2.4	7.2	15.3	38.9	9.5	16.4	31.4	11.5	18.3	18.6	9.9	27.9	23.6	6.6	6.2	38.3	90.9	14.6	21.1	9.8	6.5	16.5	20.9	5.9	8.5	8.5	7.6	14.0	34.5	9.6	21.0	17.3	57.0	9.3	42.4	23.5	8.6	24.7	25.4	6.5	8.1	9.6	16.4	27.0	16.7	19.9	13.2	19.2	10.2	5.8	18.2	27.1	31.1	18.9	13.8	12.1	12.0	14.6	20.2	35.1	14.7	16.6	24.4	19.6	21.9	13.4	31.0	17.7	5.4	23.4	7.1	9.3	23.0	25.5	7.5	6.4	16.1	11.0	20.8	26.1	21.1	11.3	26.2	20.0	15.3	35.3	20.8	12.2	16.3	42.6	9.7	7.9	6.7	11.2	7.5	5.5	18.6	26.5	33.2	21.6	2.3	8.2	26.4	30.6	22.0	23.5	13.6	18.1	19.5	12.8	21.4	19.7	11.1	16.2	12.5	28.6	16.5	22.9	5.8	15.3	5.2	13.8	18.2	16.7	19.2	20.0	17.4	10.2	16.7	31.1	23.7	0.7	27.1	14.8	4.0	18.5	18.9	8.8	10.0	2.4	7.2	6.6	6.2	9.8	6.5	7.6	8.1
SUGT1	SGT1	ENSG00000165416	"SGT1 homolog, MIS12 kinetochore complex assembly cochaperone"	Q9Y2Z0	13	52652709-52700909	"Plasma proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB015942, HPA043949"	Uncertain		Approved	"Nucleoplasm,Plasma membrane,Cytosol"				"Nucleoplasm, Cytosol"	"Plasma membrane"	"CAB015942: , HPA043949: "	"unprognostic (3.66e-2)"	"unprognostic (3.98e-2)"	"unprognostic (3.57e-1)"	"unprognostic (1.22e-1)"	"unprognostic (3.77e-2)"	"prognostic unfavourable (8.69e-4)"	"unprognostic (2.24e-1)"	"unprognostic (2.96e-1)"	"unprognostic (3.76e-1)"	"unprognostic (1.96e-3)"	"unprognostic (9.51e-2)"	"unprognostic (1.12e-1)"	"unprognostic (6.83e-2)"	"unprognostic (2.82e-3)"	"unprognostic (9.05e-2)"	"unprognostic (2.93e-2)"	"unprognostic (1.56e-1)"	22.7	29.9	40.0	23.1	44.8	26.2	27.9	39.7	42.7	17.9	24.0	23.0	14.9	25.8	19.4	20.6	27.1	19.2	18.9	33.8	34.0	28.8	30.8	34.3	19.8	23.5	35.9	28.9	20.8	28.6	14.0	39.8	24.4	36.0	18.1	26.5	14.2	22.5	16.8	26.1	23.1	24.8	21.4	31.1	21.3	23.1	31.2	43.5	15.2	21.6	19.5	27.4	21.8	48.3	17.5	23.4	29.0	19.1	17.5	25.3	13.6	15.2	16.7	24.8	18.8	24.6	20.1	23.8	33.7	22.3	21.1	16.9	36.4	38.5	33.6	9.6	20.8	26.5	30.5	19.3	31.1	27.8	12.7	31.2	21.9	27.5	17.9	24.2	23.5	13.9	17.6	21.8	16.6	35.3	29.1	11.1	32.2	10.8	22.5	44.5	29.0	16.1	26.0	14.4	14.5	36.6	17.2	8.2	10.5	17.4	14.3	15.8	14.7	23.1	25.3	17.7	20.7	20.3	28.7	8.7	12.3	30.0	10.6	19.5	25.3	29.0	16.8	26.8	14.9	19.1	14.6	17.5	19.4	20.0	18.6	16.3	14.9	16.5	2.3	17.5	18.2	23.4	25.3	13.6	40.0	44.8	39.7	42.7	34.0	28.8	35.9	28.9	36.0	43.5
SUPT6H	"KIAA0162, SPT6H"	ENSG00000109111	"SPT6 homolog, histone chaperone"	Q7KZ85	17	28662091-28702684	"Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction, mRNA processing, mRNA splicing, mRNA transport, Transcription, Transcription regulation, Transport"	Chaperone		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB012416, HPA036382"	Approved		Approved	"Nucleoplasm,Plasma membrane,Cytosol"				"Nucleoplasm, Cytosol"	"Plasma membrane"	"CAB012416: , HPA036382: "	"unprognostic (8.18e-2)"	"unprognostic (2.27e-1)"	"unprognostic (2.72e-1)"	"unprognostic (1.75e-2)"	"unprognostic (1.06e-1)"	"unprognostic (8.23e-2)"	"prognostic unfavourable (3.68e-5)"	"unprognostic (1.02e-1)"	"unprognostic (2.18e-2)"	"unprognostic (9.97e-3)"	"unprognostic (1.29e-2)"	"unprognostic (1.17e-1)"	"prognostic favourable (4.36e-5)"	"unprognostic (4.75e-2)"	"unprognostic (1.05e-1)"	"unprognostic (4.17e-2)"	"unprognostic (1.06e-2)"	27.6	30.0	30.0	24.1	32.8	56.3	25.6	31.9	35.7	28.0	30.1	28.5	23.2	19.9	38.6	28.4	24.4	24.1	25.0	23.8	25.7	22.0	24.1	32.6	26.3	26.0	25.7	32.8	33.1	28.8	40.7	34.5	31.9	24.3	26.9	21.8	33.2	28.2	29.2	50.1	38.6	28.7	40.0	29.8	33.1	28.5	23.4	29.0	27.2	27.6	18.4	29.4	30.7	27.1	5.7	8.2	14.4	6.1	5.4	5.6	3.4	17.7	37.2	18.7	21.3	22.8	15.3	14.4	24.4	26.1	28.8	25.9	34.5	7.9	18.9	12.8	24.3	21.2	27.3	17.7	29.9	35.1	24.3	26.4	30.0	21.3	19.1	27.6	29.5	21.0	10.7	30.6	20.4	18.9	25.8	22.4	20.5	21.2	27.3	11.8	14.5	12.1	14.0	34.4	15.4	14.2	35.2	14.3	18.9	28.6	45.2	15.5	27.7	19.6	29.7	22.8	18.8	21.6	31.0	28.5	21.8	27.7	25.7	12.5	18.8	14.4	5.9	5.4	5.2	3.9	5.5	5.6	4.3	5.6	4.8	5.7	4.4	3.8	9.0	5.4	6.1	8.2	3.8	3.4	30.0	32.8	31.9	35.7	25.7	22.0	25.7	32.8	24.3	29.0
SUSD2	"BK65A6.2, FLJ22778"	ENSG00000099994	"Sushi domain containing 2"	Q9UGT4	22	24181259-24189110	"Predicted membrane proteins"		Receptor	"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 100.1"	"Cell line enriched"	"Detected in some"	31	"SK-BR-3: 135.7"	"Cancer enhanced"	"Detected in all"		"testis cancer: 64.5"	"Region enhanced"	"Detected in many"		"pons and medulla: 9.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			HPA004117	Enhanced		Approved	"Plasma membrane"			3600000	"Plasma membrane"		"HPA004117: AB_1857674"	"unprognostic (5.24e-3)"	"unprognostic (1.60e-1)"	"unprognostic (1.74e-1)"	"unprognostic (7.30e-2)"	"unprognostic (1.27e-2)"	"unprognostic (5.40e-2)"	"unprognostic (5.20e-2)"	"unprognostic (1.89e-2)"	"unprognostic (5.87e-2)"	"unprognostic (1.20e-2)"	"unprognostic (9.74e-3)"	"unprognostic (8.97e-2)"	"prognostic unfavourable (3.29e-5)"	"unprognostic (2.72e-2)"	"unprognostic (2.82e-2)"	"unprognostic (1.88e-2)"	"unprognostic (3.33e-3)"	6.0	4.2	0.3	1.4	0.9	0.5	11.3	3.8	1.4	10.5	10.5	2.5	1.3	7.8	7.1	8.3	2.8	6.9	5.3	10.8	0.6	2.9	19.5	1.2	100.1	1.4	0.6	2.6	2.6	2.4	1.3	3.6	3.5	9.6	2.8	1.0	2.2	7.9	4.0	3.0	11.8	32.4	2.4	3.0	1.6	2.5	1.9	0.7	0.1	12.7	5.9	1.5	2.3	4.7	0.7	0.2	0.0	0.0	0.0	0.2	0.0	0.7	1.5	0.0	0.0	2.9	3.8	0.1	0.3	0.0	0.0	0.0	1.1	0.0	0.2	3.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.4	1.2	0.0	0.0	3.3	0.0	0.0	0.9	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.2	2.0	0.1	135.7	0.0	0.4	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.7	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.9	3.8	1.4	0.6	2.9	0.6	2.6	9.6	0.7
SYK		ENSG00000165025	"Spleen associated tyrosine kinase"	P43405	9	90801787-90898549	"Cancer-related genes, Enzymes, Predicted intracellular proteins"	"Adaptive immunity, Angiogenesis, Host-virus interaction, Immunity, Innate immunity"	"Kinase, Transferase, Tyrosine-protein kinase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 38.5"	"Cell line enhanced"	"Detected in many"		"Daudi: 38.7;HEL: 22.3;HL-60: 30.8;HMC-1: 20.5;REH: 25.8;THP-1: 23.7;U-698: 18.3;U-937: 21.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	15	"classical monocyte: 21.4;eosinophil: 23.3;intermediate monocyte: 19.0;memory B-cell: 23.1;myeloid DC: 24.9;naive B-cell: 17.5;neutrophil: 32.8;NK-cell: 8.7;non-classical monocyte: 16.4;plasmacytoid DC: 18.5"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA001384, CAB007773"	Enhanced		Approved	"Vesicles,Plasma membrane,Cytosol"			1000000	"Plasma membrane, Cytosol"	Vesicles	"CAB007773: AB_562232, HPA001384: AB_1080144"	"unprognostic (1.01e-1)"	"unprognostic (5.45e-2)"	"unprognostic (2.10e-1)"	"unprognostic (2.69e-2)"	"unprognostic (2.31e-1)"	"unprognostic (7.92e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.34e-1)"	"unprognostic (6.41e-2)"	"unprognostic (1.78e-2)"	"unprognostic (7.20e-2)"	"unprognostic (9.93e-2)"	"unprognostic (2.55e-3)"	"unprognostic (8.77e-2)"	"unprognostic (5.36e-3)"	"unprognostic (3.41e-2)"	"unprognostic (1.06e-2)"	7.2	3.3	6.0	38.1	9.6	18.2	6.7	1.1	4.5	3.7	10.3	6.7	1.5	12.3	2.3	6.7	16.2	6.9	6.6	5.5	7.2	3.2	8.6	2.5	13.7	36.4	9.1	2.5	2.1	8.9	25.9	3.1	5.0	6.1	4.1	8.3	2.8	8.9	1.8	1.4	8.3	22.2	3.5	11.3	38.5	7.4	5.5	7.9	30.5	18.1	7.8	32.2	8.6	7.5	23.1	24.9	32.8	21.4	8.7	0.1	10.2	6.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.5	38.7	1.1	0.0	6.0	0.8	3.2	0.0	0.0	5.3	22.3	0.0	0.0	0.0	30.8	20.5	0.0	4.4	0.0	0.4	0.0	0.6	3.1	0.0	4.7	0.0	13.5	0.2	0.0	25.8	0.0	10.6	0.8	5.8	2.0	1.8	0.0	2.7	0.0	2.5	23.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	18.3	0.0	21.7	0.0	1.4	21.4	23.3	0.1	19.0	0.1	23.1	0.0	0.0	24.9	17.5	0.0	0.0	32.8	8.7	16.4	18.5	0.0	10.2	6.0	9.6	1.1	4.5	7.2	3.2	9.1	2.5	6.1	7.9
SYNC	"SYNC1, SYNCOILIN"	ENSG00000162520	"Syncoilin, intermediate filament protein"	Q9H7C4	1	32680360-32703596	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 51.0"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 26.8;fHDF/TERT166: 38.9;U-138 MG: 34.1;U-2197: 18.1;WM-115: 22.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	5	"non-classical monocyte: 1.8"	"Lineage enriched"	"Detected in single"	5	"monocytes: 1.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA028311	Approved		Approved	"Golgi apparatus,Vesicles,Plasma membrane"				"Plasma membrane"	"Golgi apparatus, Vesicles"	"HPA028311: "	"unprognostic (3.99e-1)"	"unprognostic (6.04e-3)"	"unprognostic (2.02e-2)"	"unprognostic (7.60e-3)"	"unprognostic (1.99e-2)"	"unprognostic (5.07e-2)"	"unprognostic (5.05e-2)"	"unprognostic (5.44e-3)"	"unprognostic (1.71e-1)"	"unprognostic (1.79e-2)"	"unprognostic (5.04e-2)"	"unprognostic (3.71e-1)"	"unprognostic (1.32e-4)"	"unprognostic (1.56e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.45e-1)"	"unprognostic (8.15e-4)"	4.2	3.2	3.7	5.8	3.9	0.1	6.8	1.1	4.2	5.9	7.2	3.7	1.2	1.5	7.7	7.7	15.6	5.3	4.8	7.9	3.5	3.9	1.4	1.1	4.6	0.6	3.6	2.6	7.9	0.9	2.7	2.8	1.1	3.5	6.1	4.8	4.6	4.1	8.4	51.0	1.6	4.0	28.5	4.5	1.9	6.5	5.4	1.9	0.0	1.9	23.6	2.3	7.8	2.5	0.0	0.3	0.0	1.8	0.0	0.3	0.0	0.0	1.3	0.1	0.0	6.5	10.2	0.0	10.5	26.8	9.1	6.6	0.1	0.1	0.0	0.5	38.9	0.4	0.3	0.2	5.5	0.0	0.0	0.2	4.4	0.9	5.2	0.0	0.0	15.7	0.9	10.1	0.3	2.9	0.0	0.0	7.8	0.0	0.0	0.0	0.1	0.9	0.0	2.0	0.0	10.6	0.0	0.1	0.1	10.6	2.2	0.0	0.6	0.0	1.7	34.1	1.5	18.1	2.7	0.0	0.0	0.0	9.6	0.1	22.9	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.3	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	3.7	3.9	1.1	4.2	3.5	3.9	3.6	2.6	3.5	1.9
SYNGR3		ENSG00000127561	"Synaptogyrin 3"	O43761	16	1989660-1994275	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"brain: 55.3"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 25.1;HMC-1: 16.2;Karpas-707: 13.7;SK-BR-3: 17.1;U-266/70: 21.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"B-cells: 3.7;NK-cells: 4.6;T-cells: 2.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB034278, HPA042842"	Enhanced		Approved	"Plasma membrane"				"Plasma membrane"		"CAB034278: AB_2200905, HPA042842: "	"unprognostic (8.89e-3)"	"prognostic favourable (6.92e-4)"	"unprognostic (6.07e-3)"	"unprognostic (2.94e-3)"	"unprognostic (2.92e-2)"	"unprognostic (8.06e-3)"	"unprognostic (2.52e-1)"	"unprognostic (5.70e-2)"	"unprognostic (2.84e-2)"	"unprognostic (1.06e-1)"	"unprognostic (3.69e-3)"	"unprognostic (1.05e-1)"	"prognostic favourable (7.12e-7)"	"unprognostic (1.03e-1)"	"unprognostic (1.19e-1)"	"unprognostic (2.79e-1)"	"unprognostic (8.78e-2)"	1.1	11.1	20.3	3.7	21.8	1.6	1.1	24.2	55.3	1.5	2.3	2.6	0.0	2.2	1.0	1.0	1.3	1.1	1.3	1.4	14.6	40.8	1.7	1.0	1.3	4.0	27.1	20.1	1.5	1.0	9.4	3.1	5.4	28.2	1.3	2.2	0.9	2.1	1.1	0.9	1.1	2.5	1.7	4.4	2.2	2.1	4.2	2.0	0.0	1.0	0.0	4.7	1.4	0.2	3.7	0.7	0.0	0.8	4.6	2.7	0.9	0.4	2.1	1.9	0.2	0.2	0.2	2.4	0.9	1.6	0.8	0.6	3.2	1.5	3.1	0.7	0.7	1.8	2.1	0.3	0.2	25.1	1.5	0.0	2.7	1.5	1.1	0.0	16.2	0.5	0.1	0.0	0.5	0.2	9.0	13.7	0.4	2.4	0.1	0.1	10.1	0.9	0.0	0.2	2.4	1.3	0.0	4.5	5.7	2.3	17.1	0.2	2.3	0.2	0.3	0.5	7.9	0.0	0.3	21.6	2.5	3.6	0.3	2.8	0.3	0.0	0.8	0.0	0.9	0.3	2.1	3.2	1.7	2.7	0.7	3.7	2.0	0.8	0.0	4.6	0.7	0.0	1.6	0.9	20.3	21.8	24.2	39.3	14.6	40.8	27.1	20.1	28.2	2.0
SYPL2	Mg29	ENSG00000143028	"Synaptophysin like 2"	Q5VXT5	1	109466628-109482137	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	9	"skeletal muscle: 102.5;tongue: 25.6"	"Cell line enhanced"	"Detected in some"		"ASC diff: 19.8;ASC TERT1: 8.3;BJ: 8.4;BJ hTERT+: 26.7;fHDF/TERT166: 13.8;HAP1: 7.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA076657			Approved	"Plasma membrane,Cytosol"				Cytosol	"Plasma membrane"	"HPA076657: "	"unprognostic (1.82e-2)"	"unprognostic (1.81e-1)"	"unprognostic (2.90e-4)"	"unprognostic (6.63e-2)"	"unprognostic (1.35e-1)"	"unprognostic (9.36e-3)"	"unprognostic (2.84e-2)"	"unprognostic (2.57e-1)"	"unprognostic (2.35e-1)"	"unprognostic (3.11e-1)"	"unprognostic (2.34e-1)"	"unprognostic (1.08e-1)"	"prognostic favourable (3.05e-4)"	"unprognostic (2.54e-3)"	"unprognostic (3.40e-1)"	"unprognostic (9.46e-3)"	"unprognostic (6.39e-4)"	0.9	3.9	0.8	0.3	0.7	0.1	1.4	0.5	1.2	1.6	1.9	0.3	0.8	0.3	2.5	4.3	1.6	0.4	1.1	7.4	0.8	0.2	6.0	4.7	0.6	0.3	0.3	0.0	1.1	3.2	3.7	0.4	1.2	0.8	1.2	0.5	1.7	1.6	2.2	102.5	0.2	0.6	3.5	0.1	0.4	1.1	6.0	0.2	0.0	5.1	25.6	1.2	2.5	2.4	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	1.1	19.8	8.3	0.0	8.4	26.7	2.6	1.0	0.0	0.0	0.0	0.0	13.8	0.0	7.1	0.0	0.5	0.0	3.1	0.0	0.2	0.1	0.4	0.0	0.6	0.8	0.0	0.1	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.8	0.0	0.0	0.4	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.9	2.0	1.4	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.7	0.5	1.2	0.8	0.2	0.3	0.0	0.8	0.2
SYT4	"HsT1192, KIAA1342"	ENSG00000132872	"Synaptotagmin 4"	Q9H2B2	18	43267878-43277650	"Predicted intracellular proteins"	Differentiation			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 60.8;pituitary gland: 31.5"	"Cell line enriched"	"Detected in some"	11	"SH-SY5Y: 72.6"	"Cancer enhanced"	"Detected in some"		"pancreatic cancer: 4.1"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA010574	Approved		Supported	"Vesicles,Plasma membrane"				"Vesicles, Plasma membrane"		"HPA010574: AB_2668309"			"unprognostic (2.91e-3)"		"unprognostic (2.03e-1)"			"unprognostic (2.37e-2)"		"unprognostic (2.87e-1)"	"unprognostic (7.67e-3)"	"unprognostic (5.30e-3)"	"unprognostic (3.95e-2)"	"unprognostic (1.23e-3)"	"unprognostic (3.61e-1)"	"unprognostic (3.80e-2)"		1.4	17.5	5.7	2.2	24.1	1.0	0.9	60.8	54.6	0.9	1.7	0.9	0.0	1.7	0.9	0.9	1.0	0.9	1.0	1.4	12.9	19.9	1.0	0.9	1.8	1.0	5.9	16.0	1.3	4.7	0.9	31.5	1.0	22.3	1.5	1.7	0.4	1.0	9.8	0.9	1.0	1.7	1.5	5.0	0.9	4.6	2.4	1.4	0.0	1.3	0.0	0.9	0.9	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.3	72.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.7	24.1	60.8	35.7	12.9	19.9	5.9	16.0	22.3	1.4
TACR2	"NK2R, NKNAR, SKR, TAC2R"	ENSG00000075073	"Tachykinin receptor 2"	P21452	10	69403903-69416867	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"intestine: 56.3;smooth muscle: 35.5"	"Cell line enhanced"	"Detected in some"		"SK-MEL-30: 8.5;U-87 MG: 4.9"	"Cancer enhanced"	"Detected in many"		"stomach cancer: 6.7"	"Low region specificity"	"Detected in single"			"Cell type enhanced"	"Detected in some"		"intermediate monocyte: 4.2"	"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA076573			Approved	"Plasma membrane"				"Plasma membrane"		"HPA076573: "	"unprognostic (2.83e-1)"	"unprognostic (1.58e-3)"	"unprognostic (2.48e-2)"	"unprognostic (1.67e-1)"	"unprognostic (4.22e-1)"	"unprognostic (2.30e-1)"	"unprognostic (1.30e-2)"	"unprognostic (1.96e-2)"	"unprognostic (3.72e-1)"	"unprognostic (6.14e-2)"	"unprognostic (2.45e-2)"	"unprognostic (3.16e-2)"	"unprognostic (9.88e-4)"	"unprognostic (5.59e-3)"	"unprognostic (4.31e-3)"	"unprognostic (1.25e-3)"	"unprognostic (1.32e-1)"	1.6	0.1	0.5	3.1	0.5	0.1	1.2	0.5	1.1	11.1	56.3	0.2	0.4	4.1	12.3	0.9	19.6	7.2	1.2	1.9	0.5	0.3	0.2	0.5	0.8	0.5	0.2	0.4	2.0	0.8	0.0	0.1	0.1	0.4	14.9	8.2	0.2	0.4	0.9	1.1	0.4	14.2	35.5	0.8	0.5	16.5	0.9	0.5	0.1	0.4	0.8	0.4	19.4	3.1	1.2	2.0	0.5	4.2	0.1	0.8	0.3	1.9	1.2	0.4	0.6	3.0	0.2	0.2	0.5	0.3	0.5	0.7	0.7	0.3	0.2	0.5	0.5	0.7	0.1	0.1	0.0	0.4	0.5	1.6	0.6	1.9	0.3	0.0	3.0	0.5	0.7	0.0	0.0	0.2	0.4	2.5	0.0	0.8	0.1	0.5	0.4	1.9	0.1	0.0	0.0	0.0	1.0	0.8	0.6	1.3	2.6	8.5	1.1	0.2	0.8	3.0	0.4	1.2	1.0	1.2	1.3	0.2	4.9	0.3	1.7	0.5	1.5	0.1	0.3	4.2	0.4	1.2	0.8	0.3	2.0	0.6	0.4	0.2	0.2	0.1	1.7	0.3	0.1	0.3	0.5	0.5	0.5	1.1	0.5	0.3	0.2	0.4	0.4	0.5
TASP1	"C20orf13, dJ585I14.2, FLJ20212"	ENSG00000089123	"Taspase 1"	Q9H6P5	20	13389392-13638940	"Predicted intracellular proteins"		"Hydrolase, Protease, Threonine protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030824, HPA030825"	Uncertain		Approved	"Plasma membrane"				"Plasma membrane"		"HPA030824: AB_10600327, HPA030825: AB_10601575"	"unprognostic (1.29e-1)"	"unprognostic (1.68e-1)"	"unprognostic (8.61e-2)"	"unprognostic (1.20e-1)"	"unprognostic (2.47e-1)"	"unprognostic (6.46e-2)"	"unprognostic (3.44e-3)"	"unprognostic (9.85e-2)"	"unprognostic (9.85e-2)"	"unprognostic (6.95e-2)"	"unprognostic (1.59e-1)"	"unprognostic (3.13e-2)"	"unprognostic (2.21e-1)"	"unprognostic (1.04e-1)"	"unprognostic (2.70e-1)"	"prognostic unfavourable (6.78e-4)"	"unprognostic (1.67e-2)"	12.1	8.0	6.0	9.1	11.9	6.8	11.4	8.9	15.3	10.7	8.3	6.3	13.4	5.7	21.7	14.2	8.7	13.4	7.2	9.1	6.8	6.4	9.9	7.2	10.5	8.7	4.8	8.1	10.1	11.1	14.6	28.5	10.3	8.2	8.9	9.6	10.8	16.3	11.1	5.0	9.6	9.6	8.4	5.2	9.1	8.9	11.3	4.4	31.3	12.9	9.0	12.2	8.5	11.1	9.7	15.1	3.5	4.8	10.7	15.8	5.6	9.2	5.6	2.3	2.9	2.8	4.2	4.4	3.8	5.5	4.5	5.4	11.4	9.7	4.2	2.7	5.1	12.5	3.6	13.3	5.4	2.4	4.5	8.4	3.6	14.6	5.6	11.3	3.0	4.8	9.1	4.7	11.2	4.4	7.4	0.2	3.9	11.2	21.4	6.3	3.1	2.5	3.4	9.4	6.4	6.3	7.3	6.1	4.2	6.0	11.6	6.8	6.1	4.3	4.3	4.4	3.1	4.3	5.4	8.4	11.7	2.9	2.4	2.6	4.0	1.7	3.5	3.5	10.3	4.8	7.3	9.7	10.7	8.1	3.9	8.6	15.8	12.2	1.9	10.7	4.7	15.1	9.8	5.6	6.0	11.9	8.9	15.3	6.8	6.4	4.8	8.1	8.2	4.4
TAZ	"BTHS, CMD3A, EFE, EFE2, G4.5, TAZ1, XAP-2"	ENSG00000102125	Tafazzin	Q16635	X	154411518-154421726	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"			"Cardiomyopathy, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039557	Approved		Approved	"Plasma membrane"				"Plasma membrane"		"HPA039557: AB_10672899"	"unprognostic (1.14e-1)"	"prognostic favourable (5.70e-4)"	"unprognostic (4.94e-3)"	"unprognostic (1.43e-1)"	"unprognostic (8.29e-2)"	"unprognostic (7.84e-2)"	"unprognostic (1.56e-2)"	"unprognostic (8.21e-3)"	"unprognostic (1.69e-1)"	"unprognostic (1.62e-1)"	"unprognostic (4.68e-2)"	"unprognostic (8.39e-2)"	"prognostic unfavourable (1.22e-7)"	"unprognostic (4.00e-3)"	"unprognostic (4.20e-1)"	"unprognostic (1.41e-1)"	"unprognostic (3.79e-2)"	11.9	8.7	12.1	15.0	13.6	36.8	11.7	12.4	13.5	10.9	15.4	15.6	12.1	13.9	10.8	13.0	15.1	9.9	14.1	25.9	11.0	8.4	13.3	14.0	14.3	17.3	16.7	9.6	12.6	16.3	10.7	8.9	9.1	13.1	11.1	10.8	12.2	12.7	14.5	27.9	18.6	15.0	11.7	12.8	25.4	12.8	3.4	15.1	17.2	11.8	13.4	14.4	10.8	19.5	16.7	14.7	13.8	10.3	12.3	17.2	7.8	11.0	12.5	4.6	5.1	9.0	5.4	8.8	3.9	7.7	6.0	8.3	4.1	13.8	13.1	21.3	5.7	16.8	6.5	7.2	4.2	11.2	9.6	2.6	8.0	6.4	10.1	5.0	6.2	5.5	13.2	5.2	11.8	9.0	5.2	13.9	5.2	6.7	12.7	15.8	1.3	13.1	10.5	7.0	17.6	8.2	3.2	5.8	8.2	2.5	7.4	10.7	4.5	8.9	6.5	4.9	6.3	12.0	5.9	32.5	12.8	27.3	6.0	17.6	5.6	5.7	10.3	13.8	12.1	9.3	11.0	11.3	17.2	15.5	14.7	16.7	14.4	12.5	9.4	12.3	7.4	7.3	12.2	7.8	12.1	13.6	12.4	13.5	11.0	8.4	16.7	9.6	13.1	15.1
TBC1D9B	"GRAMD9B, KIAA0676"	ENSG00000197226	"TBC1 domain family member 9B"	Q66K14	5	179862066-179907859	"Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038350	Approved		Approved	"Nucleoplasm,Nucleoli fibrillar center,Plasma membrane"				"Plasma membrane"	"Nucleoplasm, Nucleoli fibrillar center"	"HPA038350: AB_10673170"	"unprognostic (5.06e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.60e-2)"	"unprognostic (9.53e-2)"	"unprognostic (9.45e-3)"	"unprognostic (4.25e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.84e-1)"	"unprognostic (1.10e-1)"	"unprognostic (5.08e-2)"	"unprognostic (2.01e-1)"	"unprognostic (2.28e-2)"	"unprognostic (3.95e-2)"	"unprognostic (1.86e-1)"	"unprognostic (4.01e-2)"	"prognostic unfavourable (3.99e-4)"	"unprognostic (8.22e-2)"	30.4	28.7	31.2	14.3	29.8	17.0	21.2	27.0	37.9	21.7	17.8	36.7	20.6	16.4	18.9	24.5	21.7	20.7	19.0	15.2	31.4	26.6	20.7	22.4	18.3	16.8	34.9	23.3	24.8	24.6	22.7	13.3	14.8	29.0	18.2	14.5	17.5	25.6	21.9	20.3	24.0	18.9	19.1	42.3	18.0	16.1	12.2	24.1	12.0	23.3	12.5	17.2	17.4	19.7	5.4	9.4	5.0	8.1	3.7	5.5	4.9	10.6	16.4	7.4	17.3	22.9	14.7	17.4	12.9	13.3	13.0	13.0	11.0	10.7	7.3	16.0	15.6	10.2	8.9	30.1	6.0	24.2	10.0	6.5	12.0	7.3	12.3	8.6	22.7	16.9	13.1	10.2	7.3	14.3	4.3	8.5	11.6	26.5	5.5	7.1	5.2	9.3	9.6	5.7	7.1	12.2	17.3	10.7	7.9	12.2	14.6	14.8	11.5	13.9	14.5	19.0	8.5	9.0	11.4	4.4	5.7	5.7	18.0	11.0	13.4	4.5	5.9	5.0	5.5	8.1	4.5	5.4	4.0	4.7	7.8	5.1	3.9	3.1	0.8	3.7	7.9	9.4	3.4	4.9	31.2	29.8	27.0	37.9	31.4	26.6	34.9	23.3	29.0	24.1
TCIM	"C8orf4, hTC-1, TC-1, TC1"	ENSG00000176907	"Transcriptional and immune response regulator"	Q9NR00	8	40153455-40155308	"Predicted intracellular proteins"	Apoptosis			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"A549: 14.4;AF22: 40.9;BJ: 15.4;BJ hTERT+: 40.4;EFO-21: 26.8;HeLa: 25.7;RPTEC TERT1: 20.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA027188	Approved		Approved	"Nucleoplasm,Plasma membrane,Cytosol"				Nucleoplasm	"Plasma membrane, Cytosol"	"HPA027188: AB_10601150"	"unprognostic (8.88e-2)"	"unprognostic (2.76e-2)"	"unprognostic (7.89e-3)"	"unprognostic (7.95e-2)"	"unprognostic (7.33e-3)"	"unprognostic (1.87e-3)"	"unprognostic (2.11e-1)"	"unprognostic (2.32e-1)"	"unprognostic (2.93e-2)"	"unprognostic (8.15e-2)"	"unprognostic (6.23e-2)"	"unprognostic (8.19e-2)"	"unprognostic (2.54e-2)"	"unprognostic (5.32e-3)"	"unprognostic (1.39e-1)"	"unprognostic (9.13e-3)"	"unprognostic (4.48e-2)"	23.5	5.9	1.8	23.2	4.5	0.0	16.0	0.6	5.9	32.1	24.1	1.0	15.6	6.0	14.3	20.3	22.2	4.3	22.1	38.3	2.0	1.7	44.5	54.7	96.5	5.0	2.7	4.3	11.9	24.4	28.9	6.2	50.2	2.3	29.6	15.2	7.9	89.9	16.3	20.2	4.0	21.2	72.4	4.3	26.7	10.7	4.9	1.4	1.3	15.8	14.4	4.8	35.8	8.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.4	40.9	0.0	0.0	0.0	0.0	15.4	40.4	0.0	0.2	0.2	0.0	0.0	26.8	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	25.7	6.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.2	0.0	0.1	0.2	0.0	0.0	0.0	0.0	20.4	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	12.9	0.0	0.3	0.1	0.2	0.3	0.4	0.0	5.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	4.5	0.6	5.9	2.0	1.7	2.7	4.3	2.3	1.4
TDP1	"FLJ11090, SCAN1"	ENSG00000042088	"Tyrosyl-DNA phosphodiesterase 1"	Q9NUW8	14	89954939-90044768	"Disease related genes, Predicted intracellular proteins"	"DNA damage, DNA repair"	"Exonuclease, Hydrolase, Nuclease"	"Disease mutation, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA071317	Approved		Supported	"Nucleoplasm,Plasma membrane"				Nucleoplasm	"Plasma membrane"	"HPA071317: "	"unprognostic (5.60e-3)"	"unprognostic (3.53e-1)"	"unprognostic (7.03e-3)"	"unprognostic (1.34e-1)"	"unprognostic (7.45e-2)"	"unprognostic (7.22e-2)"	"prognostic unfavourable (8.99e-5)"	"unprognostic (2.61e-1)"	"unprognostic (1.46e-2)"	"unprognostic (5.84e-3)"	"unprognostic (2.51e-1)"	"unprognostic (6.46e-2)"	"unprognostic (1.10e-1)"	"unprognostic (3.41e-1)"	"unprognostic (1.64e-1)"	"unprognostic (2.91e-2)"	"unprognostic (1.26e-1)"	5.5	6.3	6.9	10.8	10.4	11.4	8.3	11.0	10.8	6.6	7.1	7.3	8.4	5.9	9.1	5.6	11.1	8.8	6.2	3.5	5.5	6.3	6.8	5.9	5.5	16.1	6.2	8.1	6.8	7.0	5.5	11.0	7.5	6.3	5.7	9.6	6.1	8.1	4.2	3.1	7.7	7.9	5.8	5.7	11.7	7.0	23.3	3.7	29.8	4.5	4.4	21.0	7.6	7.0	16.4	11.2	15.5	10.6	16.3	23.2	10.7	13.7	7.8	17.5	15.9	4.4	6.1	13.9	13.3	10.9	16.4	15.0	5.6	14.9	17.6	10.0	9.0	14.2	7.7	12.3	24.0	17.8	8.3	17.8	7.2	6.9	3.8	29.7	10.3	4.4	5.5	11.5	10.8	20.7	12.2	18.5	19.4	14.5	22.7	16.0	4.2	18.5	17.3	33.1	13.9	10.5	11.3	13.1	9.0	11.3	33.0	4.2	13.1	12.7	16.5	7.2	6.8	9.8	11.8	13.6	23.7	21.5	15.3	13.4	10.3	15.5	6.6	10.7	14.5	10.6	14.3	16.4	15.7	16.3	10.4	13.5	17.7	18.2	4.5	16.3	9.7	11.2	23.2	10.7	6.9	10.4	11.0	10.8	5.5	6.3	6.2	8.1	6.3	3.7
TES	"DKFZP586B2022, TESS-2, TESTIN"	ENSG00000135269	"Testin LIM domain protein"	Q9UGI8	7	116210493-116258783	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"EFO-21: 50.9;hTCEpi: 57.6;SK-BR-3: 57.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in some"			"HPA015269, HPA018123"	Approved		Supported	"Plasma membrane,Cell Junctions,Focal adhesion sites,Cytosol"				"Focal adhesion sites, Cytosol"	"Plasma membrane, Cell Junctions"	"HPA015269: AB_1857899, HPA018123: AB_1857900"	"unprognostic (9.81e-2)"	"unprognostic (5.53e-3)"	"unprognostic (4.79e-2)"	"unprognostic (1.31e-1)"	"unprognostic (4.01e-1)"	"unprognostic (6.08e-3)"	"unprognostic (1.84e-3)"	"unprognostic (4.81e-3)"	"unprognostic (8.81e-3)"	"unprognostic (6.19e-3)"	"prognostic unfavourable (1.20e-5)"	"unprognostic (1.60e-2)"	"prognostic favourable (8.71e-5)"	"unprognostic (1.50e-1)"	"unprognostic (5.47e-2)"	"unprognostic (2.36e-2)"	"unprognostic (3.86e-1)"	12.1	2.9	1.2	36.4	1.5	8.6	22.1	0.8	1.2	42.4	53.1	1.5	43.9	9.3	47.6	21.2	22.6	19.5	15.3	7.9	1.6	1.4	14.3	4.6	16.8	20.3	1.9	0.7	17.1	12.3	3.1	4.2	21.2	3.3	26.1	16.8	5.0	19.0	50.9	5.2	9.1	27.4	84.5	3.0	19.1	25.2	18.4	0.7	17.1	26.3	11.2	18.4	71.6	33.9	26.8	21.9	56.8	39.6	49.0	40.5	34.7	24.2	5.1	5.8	0.0	2.6	6.6	13.7	12.7	6.2	2.3	2.3	12.8	27.0	0.0	50.9	8.8	24.9	3.1	18.6	5.8	12.0	10.0	2.4	12.0	6.3	15.6	11.0	0.0	14.8	57.6	8.2	20.9	6.6	2.4	8.6	0.6	5.0	0.0	0.1	3.8	14.7	0.0	0.0	9.5	24.0	9.3	2.7	25.2	18.5	57.8	14.0	0.0	4.5	11.2	0.1	0.3	18.7	0.1	20.3	9.8	0.2	1.6	5.6	19.2	56.8	20.2	53.4	40.5	32.6	39.0	26.8	31.0	36.6	21.9	23.8	31.0	35.0	10.5	49.0	39.6	5.4	31.5	34.7	1.2	1.5	0.8	1.2	1.6	1.4	1.9	0.7	3.3	0.7
TEX14	CT113	ENSG00000121101	"Testis expressed 14, intercellular bridge forming factor"	Q8IWB6	17	58556678-58692055	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Transporters"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	35	"testis: 52.7"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 8.9;Karpas-707: 11.6;MCF7: 4.7"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA030620, HPA077020"	Enhanced		Approved	"Vesicles,Plasma membrane,Cell Junctions,Cytosol"				"Plasma membrane, Cytosol"	"Vesicles, Cell Junctions"	"HPA030620: AB_10601598, HPA077020: "	"unprognostic (1.21e-2)"	"unprognostic (2.12e-1)"	"unprognostic (2.06e-1)"	"unprognostic (9.49e-2)"	"unprognostic (2.48e-1)"	"unprognostic (1.23e-2)"	"unprognostic (1.10e-1)"	"unprognostic (6.17e-2)"	"unprognostic (2.07e-2)"	"unprognostic (1.61e-3)"	"unprognostic (2.67e-2)"	"unprognostic (8.10e-2)"	"unprognostic (1.76e-9)"	"unprognostic (1.77e-1)"	"unprognostic (2.54e-1)"	"unprognostic (5.00e-3)"	"unprognostic (5.88e-2)"	0.1	0.1	0.2	0.1	0.3	1.5	0.1	0.9	0.2	0.1	0.1	0.1	0.1	0.0	0.1	0.2	0.1	0.2	0.1	0.1	0.3	0.2	0.1	0.1	0.2	0.1	0.2	0.1	0.3	0.1	0.0	0.1	0.1	0.4	0.2	0.0	0.1	0.1	0.1	0.3	0.1	0.2	0.1	0.5	0.2	0.0	52.7	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.2	0.0	0.8	0.2	0.1	0.0	0.2	2.5	0.0	0.0	0.3	0.0	0.0	0.1	0.2	0.0	0.0	0.7	0.2	0.0	0.0	0.3	0.0	0.2	8.9	1.3	0.3	0.0	0.0	0.0	0.2	0.1	0.0	0.0	1.2	0.0	0.0	0.1	11.6	0.0	4.7	0.4	0.1	0.6	0.1	0.5	0.4	1.7	0.0	0.1	1.4	0.2	0.0	0.0	0.6	0.4	0.1	0.0	0.1	0.3	0.0	0.0	2.0	0.5	1.1	0.1	0.1	0.1	0.0	0.2	0.0	0.2	0.0	0.5	0.0	0.8	0.4	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.3	0.9	0.2	0.3	0.2	0.2	0.1	0.4	0.1
TEX9		ENSG00000151575	"Testis expressed 9"	Q8N6V9	15	56244009-56445997	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pituitary gland: 49.7"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	10	"basophil: 4.1;memory B-cell: 14.4;naive B-cell: 6.8"	"Group enriched"	"Detected in many"	11	"B-cells: 14.4;granulocytes: 4.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039415	Uncertain		Approved	"Plasma membrane,Cytosol"				Cytosol	"Plasma membrane"	"HPA039415: AB_10672775"	"unprognostic (3.27e-1)"	"unprognostic (2.77e-2)"	"unprognostic (2.25e-1)"	"unprognostic (4.71e-3)"	"unprognostic (2.34e-1)"	"unprognostic (5.13e-2)"	"unprognostic (1.54e-2)"	"unprognostic (1.22e-1)"	"unprognostic (3.75e-2)"	"unprognostic (8.85e-2)"	"unprognostic (6.91e-3)"	"unprognostic (2.00e-2)"	"unprognostic (1.24e-2)"	"unprognostic (8.00e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.24e-1)"	1.7	5.4	5.3	9.0	14.8	2.0	7.6	4.0	2.3	7.0	4.6	7.8	6.0	8.5	5.7	11.6	7.3	21.6	6.2	1.6	6.1	7.5	11.9	1.2	5.8	4.1	4.0	3.2	7.5	4.1	13.5	49.7	1.0	25.2	5.4	3.5	9.2	9.0	4.5	0.9	4.1	9.6	2.3	4.9	5.5	9.0	19.3	4.0	2.0	14.8	2.0	8.2	2.7	2.2	14.4	0.3	4.1	0.6	0.4	0.8	0.8	5.7	5.2	11.6	10.3	2.9	8.4	1.5	1.3	4.8	3.6	4.4	1.4	5.1	11.5	5.5	0.9	5.2	4.9	5.4	4.2	1.4	6.0	6.6	5.3	3.8	0.9	3.0	1.3	4.6	10.1	4.1	3.1	0.1	3.7	1.3	1.9	3.2	4.7	2.6	5.6	2.3	1.9	5.4	4.2	12.1	3.3	18.5	7.4	6.4	3.9	4.0	11.0	3.4	0.6	15.5	4.7	5.0	4.6	1.6	11.7	8.8	6.1	1.3	3.0	4.1	0.1	0.1	0.3	0.6	0.1	14.4	0.4	0.3	0.2	6.8	0.2	0.8	0.3	0.4	0.3	0.3	0.5	0.8	5.3	14.8	4.0	2.3	6.1	7.5	4.0	3.2	25.2	4.0
TGM2	TGC	ENSG00000198959	"Transglutaminase 2"	P21980	20	38127387-38166578	"Enzymes, Predicted intracellular proteins"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 187.6;placenta: 212.7"	"Group enriched"	"Detected in many"	4	"CAPAN-2: 160.1;EFO-21: 53.8;HUVEC TERT2: 72.7;TIME: 94.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	9	"intermediate monocyte: 2.5;memory B-cell: 1.9;myeloid DC: 2.4"	"Group enriched"	"Detected in many"	23	"B-cells: 1.9;dendritic cells: 2.4;monocytes: 2.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002598, HPA021019, HPA029518"	Enhanced		Approved	"Plasma membrane,Cytosol"			1700000	Cytosol	"Plasma membrane"	"CAB002598: , HPA021019: AB_1858247, HPA029518: AB_10603133"	"unprognostic (7.80e-2)"	"unprognostic (1.51e-1)"	"unprognostic (5.22e-2)"	"unprognostic (1.40e-2)"	"unprognostic (1.56e-2)"	"unprognostic (5.61e-3)"	"unprognostic (2.81e-1)"	"unprognostic (3.32e-3)"	"unprognostic (3.29e-2)"	"unprognostic (9.78e-3)"	"prognostic unfavourable (2.97e-4)"	"unprognostic (6.99e-2)"	"prognostic unfavourable (1.67e-7)"	"unprognostic (1.60e-2)"	"unprognostic (1.93e-2)"	"unprognostic (6.70e-2)"	"unprognostic (6.40e-2)"	33.3	9.5	6.0	18.3	8.1	1.0	7.7	4.3	7.5	94.3	12.6	4.0	4.7	8.4	54.6	21.7	15.8	58.7	62.8	77.1	7.5	3.4	25.3	187.6	61.2	16.4	6.9	3.0	18.7	5.0	5.2	25.6	212.7	8.5	33.6	6.3	57.4	1.9	17.1	19.3	0.7	12.8	43.9	5.7	20.4	13.6	7.4	6.4	0.8	17.0	3.4	3.1	38.2	21.6	1.9	2.4	0.0	2.5	0.0	0.0	0.2	6.5	4.9	0.0	0.1	5.1	0.5	2.5	9.9	4.8	0.0	0.1	8.0	160.1	0.0	53.8	0.1	0.1	0.0	23.2	0.3	0.0	0.0	1.0	0.2	3.5	20.9	0.0	0.0	0.5	0.0	4.2	0.0	72.7	2.1	0.0	1.6	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	7.2	0.0	0.0	0.1	23.2	0.0	0.8	0.2	0.0	94.8	0.1	6.0	0.7	4.7	0.0	0.0	0.0	6.5	0.0	1.9	0.0	0.2	0.0	0.0	2.5	0.0	1.9	0.0	0.0	2.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	6.0	8.1	4.3	7.5	7.5	3.4	6.9	3.0	8.5	6.4
THBS1	"THBS, THBS-1, TSP, TSP-1, TSP1"	ENSG00000137801	"Thrombospondin 1"	P07996	15	39581079-39599466	"Cancer-related genes, Candidate cardiovascular disease genes, Plasma proteins, Predicted secreted proteins"	"Cell adhesion, Unfolded protein response"	Heparin-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 162.1;HUVEC TERT2: 157.6;LHCN-M2: 117.7;TIME: 229.8"	"Low cancer specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"basal ganglia: 3.4;pons and medulla: 8.1"	"Cell type enhanced"	"Detected in some"		"eosinophil: 14.1"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"CAB033678, HPA059756"	Approved		Approved	"Plasma membrane"	"Secreted to extracellular matrix"		1600000000	"Plasma membrane"		"CAB033678: AB_793044, HPA059756: "	"unprognostic (1.72e-2)"	"unprognostic (9.55e-3)"	"unprognostic (7.49e-2)"	"unprognostic (3.31e-1)"	"unprognostic (4.34e-2)"	"unprognostic (1.03e-3)"	"unprognostic (3.60e-1)"	"unprognostic (1.53e-2)"	"unprognostic (1.22e-1)"	"unprognostic (2.07e-1)"	"unprognostic (6.40e-2)"	"unprognostic (9.16e-2)"	"prognostic unfavourable (8.47e-5)"	"prognostic unfavourable (8.50e-4)"	"unprognostic (1.00e-1)"	"unprognostic (9.25e-3)"	"unprognostic (1.48e-3)"	79.6	15.2	0.9	81.4	3.4	19.3	41.0	0.7	1.3	25.7	42.7	2.5	6.6	5.0	72.8	30.5	22.7	40.8	57.7	49.0	1.0	1.0	23.4	27.2	118.4	38.8	1.1	0.8	60.9	14.0	1.3	7.7	38.1	8.1	31.9	18.3	8.4	38.0	13.2	22.6	9.2	23.0	63.5	4.5	58.0	46.5	27.5	0.2	0.6	14.0	21.4	18.4	111.8	78.9	0.0	0.5	14.1	7.4	7.5	2.6	8.6	11.5	3.9	3.1	1.1	13.1	15.4	0.0	67.0	54.8	18.4	12.1	11.4	8.7	0.0	25.3	162.1	41.2	0.1	32.7	9.3	3.0	0.0	2.9	2.3	2.9	2.9	0.0	0.8	34.5	2.4	15.3	34.5	157.6	0.0	0.1	117.7	0.8	0.0	0.2	0.5	1.4	0.0	8.1	0.0	27.6	29.4	0.0	0.0	19.0	1.0	1.1	11.7	0.2	229.8	64.5	15.3	75.9	76.9	0.1	0.1	0.1	2.1	0.0	68.9	0.2	7.4	14.1	0.8	0.8	2.6	0.0	0.4	0.5	0.5	0.0	0.1	0.1	1.4	7.5	0.1	0.3	0.0	8.6	0.9	3.4	0.7	1.0	1.0	1.0	1.1	0.8	8.1	0.2
THBS2	TSP2	ENSG00000186340	"Thrombospondin 2"	P35442	6	169215780-169254044	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted secreted proteins"	"Cell adhesion"	Heparin-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"breast: 84.6;urinary bladder: 67.4"	"Cell line enhanced"	"Detected in some"		"ASC diff: 81.9;ASC TERT1: 56.2;BJ hTERT+ SV40 Large T+ RasG12V: 27.2;HSkMC: 30.3;hTEC/SVTERT24-B: 29.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB017716, HPA044304"	Approved		Approved	"Nuclear speckles,Plasma membrane,Cytosol"	"Secreted to extracellular matrix"		22000000	"Plasma membrane"	"Nuclear speckles, Cytosol"	"CAB017716: , HPA044304: "	"unprognostic (2.85e-2)"	"unprognostic (1.41e-1)"	"unprognostic (5.87e-2)"	"unprognostic (8.90e-2)"	"unprognostic (3.64e-2)"	"unprognostic (8.73e-2)"	"unprognostic (2.93e-1)"	"unprognostic (5.10e-3)"	"unprognostic (1.39e-1)"	"unprognostic (4.71e-2)"	"unprognostic (4.00e-2)"	"unprognostic (2.56e-1)"	"prognostic unfavourable (3.77e-6)"	"unprognostic (2.19e-3)"	"unprognostic (4.38e-2)"	"unprognostic (4.16e-2)"	"unprognostic (2.48e-3)"	43.5	4.0	4.3	10.1	7.8	0.4	84.6	1.1	9.0	24.3	17.0	6.3	3.3	1.9	26.1	16.1	9.8	14.8	43.0	21.9	5.5	3.6	4.6	5.9	8.4	3.8	8.1	1.4	26.2	5.9	1.5	4.4	2.0	14.8	10.5	3.4	0.7	3.9	2.8	14.6	22.7	3.8	22.0	16.0	2.8	2.6	12.5	5.2	0.0	13.2	10.6	4.8	67.4	29.4	0.4	0.7	0.2	0.8	0.1	0.3	0.0	0.0	0.0	0.5	0.3	81.9	56.2	0.0	15.6	21.4	21.6	27.2	0.1	0.0	0.0	0.0	18.6	0.0	0.6	0.8	12.4	0.0	0.0	0.0	0.0	0.0	22.9	0.0	0.0	30.3	0.0	29.2	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.8	3.3	0.1	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	9.9	0.1	22.0	1.8	0.0	0.3	0.0	6.1	0.1	0.5	0.0	0.8	0.2	0.2	0.5	0.0	0.4	0.1	0.0	0.2	0.3	0.1	0.3	0.0	0.1	0.5	0.7	0.2	0.0	4.3	7.8	1.1	3.1	5.5	3.6	8.1	1.4	14.8	5.2
THY1	CD90	ENSG00000154096	"Thy-1 cell surface antigen"	P04216	11	119417378-119424985	"CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 97.7;smooth muscle: 91.5"	"Cell line enhanced"	"Detected in many"		"ASC diff: 52.6;BJ: 82.2;BJ hTERT+: 92.1;fHDF/TERT166: 144.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"MAIT T-cell: 1.7"	"Lineage enriched"	"Detected in single"	17	"T-cells: 1.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003733, CAB068243, CAB068244"	Enhanced		Approved	"Nucleoplasm,Plasma membrane"			9800000	Nucleoplasm	"Plasma membrane"	"CAB068243: , CAB068244: , HPA003733: AB_1846340"	"unprognostic (9.98e-2)"	"unprognostic (2.71e-1)"	"unprognostic (5.13e-2)"	"unprognostic (2.61e-1)"	"prognostic unfavourable (6.87e-4)"	"unprognostic (7.43e-2)"	"unprognostic (1.43e-3)"	"unprognostic (2.38e-2)"	"unprognostic (1.29e-1)"	"unprognostic (2.90e-3)"	"unprognostic (3.38e-2)"	"unprognostic (3.52e-1)"	"prognostic unfavourable (2.40e-6)"	"unprognostic (1.75e-2)"	"unprognostic (1.90e-2)"	"unprognostic (3.03e-2)"	"unprognostic (1.14e-2)"	28.7	5.9	42.0	23.2	72.4	0.4	7.0	17.6	97.7	26.9	9.0	7.2	2.1	3.5	20.3	13.9	9.8	7.5	31.6	4.3	63.4	41.1	46.6	2.6	6.5	10.9	29.8	34.8	3.2	5.0	7.3	5.5	19.1	53.8	4.6	13.6	8.5	2.9	15.7	1.4	4.2	4.6	91.5	9.3	6.7	5.7	4.0	6.9	3.1	12.0	1.0	10.8	36.9	7.2	0.0	0.0	0.0	0.0	0.0	1.7	0.3	0.0	0.3	12.3	0.0	52.6	38.1	0.0	82.2	92.1	29.5	32.7	0.0	0.0	0.0	0.0	144.0	0.0	0.4	0.1	22.6	7.0	0.0	4.4	1.5	0.0	16.3	0.0	0.0	28.2	0.0	37.4	1.3	0.0	0.0	0.0	22.7	0.0	0.0	0.0	19.7	0.1	0.0	5.8	0.0	0.0	0.0	2.1	5.6	0.0	0.0	0.0	0.1	0.2	0.0	42.4	14.1	12.2	12.1	0.0	2.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	42.0	72.4	17.6	97.7	63.4	41.1	29.8	34.8	53.8	6.9
TM2D2	BLP1	ENSG00000169490	"TM2 domain containing 2"	Q9BX73	8	38988808-38996824	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047152, HPA050547"	Approved		Approved	"Nucleoplasm,Vesicles,Plasma membrane"				"Nucleoplasm, Vesicles, Plasma membrane"		"HPA047152: , HPA050547: AB_2681168"	"prognostic unfavourable (7.49e-4)"	"unprognostic (1.49e-1)"	"prognostic favourable (1.71e-4)"	"unprognostic (2.55e-2)"	"unprognostic (7.02e-2)"	"unprognostic (2.98e-1)"	"unprognostic (5.17e-2)"	"unprognostic (1.41e-1)"	"unprognostic (3.69e-2)"	"unprognostic (2.43e-3)"	"unprognostic (4.58e-2)"	"unprognostic (1.18e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.07e-2)"	"unprognostic (8.61e-2)"	21.6	26.2	19.9	14.9	24.3	11.3	24.5	18.8	29.6	21.0	15.3	18.4	25.4	17.5	20.1	27.6	17.2	17.9	22.9	19.4	18.7	20.4	32.6	29.0	21.1	18.1	20.5	17.3	23.3	26.8	25.9	17.5	32.6	25.7	22.8	16.6	22.9	18.8	23.4	14.6	18.5	20.7	17.7	16.4	24.3	19.2	26.1	13.9	11.1	39.7	14.9	14.9	16.7	19.5	14.4	33.5	27.2	18.8	17.4	22.8	19.2	13.9	22.5	10.6	14.5	24.7	16.6	14.5	29.7	18.3	22.5	20.5	17.1	12.1	4.9	23.4	21.9	15.2	11.1	17.9	24.6	5.8	8.6	11.2	13.3	18.5	21.8	3.3	14.6	20.1	17.7	17.7	8.6	28.9	12.3	14.6	30.0	8.6	8.1	11.3	13.3	9.0	7.0	13.6	8.2	25.7	11.1	3.5	6.9	11.3	8.0	14.6	19.5	7.0	25.9	18.3	13.7	26.6	14.9	10.3	22.5	8.6	13.9	7.6	12.7	27.2	16.2	14.5	18.0	18.8	19.6	14.3	21.2	19.6	17.0	14.4	20.2	19.6	4.5	17.4	15.6	33.5	22.8	19.2	19.9	24.3	18.8	29.6	18.7	20.4	20.5	17.3	25.7	13.9
TM4SF4	il-TMP	ENSG00000169903	"Transmembrane 4 L six family member 4"	P48230	3	149473974-149503281	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"gallbladder: 196.0;intestine: 126.4;liver: 81.8"	"Group enriched"	"Detected in some"	6	"A549: 15.9;RPTEC TERT1: 24.6"	"Group enriched"	"Detected in many"	10	"liver cancer: 249.4;pancreatic cancer: 130.5"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"intermediate monocyte: 1.3"	"Lineage enriched"	"Detected in single"	13	"monocytes: 1.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA046430	Enhanced		Approved	"Plasma membrane,Cytosol"				"Plasma membrane"	Cytosol	"HPA046430: "	"unprognostic (1.91e-2)"	"unprognostic (1.71e-1)"	"unprognostic (2.15e-1)"	"unprognostic (1.66e-1)"		"unprognostic (2.27e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.33e-1)"		"unprognostic (4.96e-2)"	"unprognostic (2.73e-1)"	"unprognostic (1.98e-1)"	"unprognostic (7.60e-2)"	"unprognostic (1.83e-1)"	"unprognostic (4.66e-2)"	"unprognostic (1.91e-2)"	"unprognostic (4.97e-1)"	0.3	0.3	0.2	0.2	0.2	0.0	0.3	0.2	0.2	0.2	68.2	0.0	0.0	70.3	0.2	0.1	0.3	0.3	196.0	0.2	0.2	0.2	0.4	81.8	0.3	0.0	0.2	0.0	0.2	24.2	0.0	0.3	0.1	0.0	0.2	0.0	0.1	0.2	0.0	0.2	0.2	126.4	0.0	0.2	0.3	2.3	0.3	0.0	0.0	0.3	0.1	0.0	0.2	0.2	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	15.9	0.0	0.0	0.0	0.0	1.1	0.5	0.0	0.0	0.0	0.4	0.2	0.2	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.1	0.6	0.1	0.0	0.0	0.3	0.9	24.6	0.0	0.5	0.9	0.7	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.1	0.0	0.3	0.6	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.0	0.0	0.0
TMC5	FLJ13593	ENSG00000103534	"Transmembrane channel like 5"	Q6UXY8	16	19410496-19499113	"Predicted membrane proteins"	"Ion transport, Transport"	"Ion channel"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"intestine: 108.7"	"Cell line enriched"	"Detected in some"	6	"CAPAN-2: 38.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"HPA040810, HPA042037"	Enhanced		Approved	"Nucleoplasm,Plasma membrane"				"Plasma membrane"	Nucleoplasm	"HPA040810: AB_10795627, HPA042037: AB_10804126"	"unprognostic (2.47e-2)"	"unprognostic (3.68e-1)"	"unprognostic (3.50e-2)"	"unprognostic (2.74e-3)"	"unprognostic (1.01e-1)"	"unprognostic (3.64e-2)"	"prognostic unfavourable (7.96e-4)"	"unprognostic (1.21e-1)"	"unprognostic (1.59e-1)"	"unprognostic (9.74e-2)"	"unprognostic (3.27e-2)"	"unprognostic (3.71e-1)"	"unprognostic (2.28e-2)"	"unprognostic (2.69e-1)"	"unprognostic (7.88e-2)"	"unprognostic (8.88e-3)"	"unprognostic (1.75e-1)"	0.7	0.3	0.3	4.8	0.3	0.1	5.6	0.3	0.7	3.8	66.1	0.6	0.6	19.1	2.1	16.9	1.4	1.9	15.9	0.4	0.4	0.3	0.3	1.8	17.6	0.2	0.3	0.4	1.8	5.4	4.5	1.0	3.7	1.0	8.4	9.8	1.7	18.9	0.2	0.3	0.8	108.7	0.3	0.2	0.3	19.5	2.6	0.2	0.2	0.8	1.7	4.1	1.5	1.1	0.5	0.7	2.2	0.6	0.9	0.8	0.3	3.6	6.0	0.0	0.1	0.0	0.0	5.5	0.0	0.0	0.0	0.0	0.0	38.9	0.0	0.2	0.0	2.4	0.6	0.0	0.0	0.0	0.0	0.0	1.0	0.1	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.6	0.0	0.1	1.4	1.7	0.0	0.0	1.4	0.1	0.1	0.4	0.1	0.0	1.2	0.0	0.5	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.3	0.6	0.2	0.3	0.3	0.2	0.4	0.8	0.3	0.2	0.5	0.2	0.3	2.2	0.9	0.4	0.7	0.1	0.3	0.3	0.3	0.3	0.7	0.4	0.3	0.3	0.4	1.0	0.2
TMEM101	"FLJ23987, MGC4251"	ENSG00000091947	"Transmembrane protein 101"	Q96IK0	17	44011188-44023946	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039739			Approved	"Nucleoplasm,Plasma membrane,Cytosol"				Nucleoplasm	"Plasma membrane, Cytosol"	"HPA039739: "	"unprognostic (1.40e-3)"	"unprognostic (1.75e-1)"	"unprognostic (1.67e-1)"	"prognostic favourable (4.29e-4)"	"unprognostic (5.91e-2)"	"unprognostic (3.91e-3)"	"prognostic unfavourable (7.10e-4)"	"unprognostic (1.80e-2)"	"unprognostic (2.43e-1)"	"unprognostic (2.03e-1)"	"unprognostic (1.53e-1)"	"unprognostic (1.61e-1)"	"prognostic favourable (4.10e-5)"	"unprognostic (1.59e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.48e-1)"	"unprognostic (2.32e-2)"	11.0	10.9	8.4	7.3	14.2	5.1	58.9	6.3	16.5	22.7	11.4	13.7	7.7	8.4	33.3	14.5	15.1	19.2	15.4	12.4	8.7	8.6	37.2	12.0	11.4	16.1	9.5	9.4	13.0	27.8	10.7	8.5	17.8	11.6	13.9	8.6	11.5	20.9	59.7	15.5	13.8	9.5	11.6	10.1	11.0	13.6	16.9	8.9	10.0	25.4	12.9	13.2	12.5	11.6	23.8	25.9	11.7	25.0	23.8	27.2	17.8	9.6	23.7	8.5	7.0	20.3	19.6	8.5	10.1	15.4	20.1	19.2	17.6	25.3	10.9	2.8	10.4	14.9	9.8	17.6	15.4	11.8	19.8	8.2	19.0	35.6	17.5	13.1	14.3	17.5	20.1	14.2	20.2	17.5	16.8	21.5	12.5	12.9	14.1	15.1	4.0	26.8	12.3	18.4	19.8	16.7	7.9	11.1	8.8	6.5	0.2	24.1	11.7	25.3	10.5	18.5	12.4	8.0	19.8	22.4	15.4	5.0	19.4	12.5	16.4	11.7	24.9	8.6	19.4	25.0	21.8	22.7	24.5	22.3	25.9	23.8	27.2	22.1	9.1	23.8	17.8	25.2	25.1	17.8	8.4	14.2	6.3	16.5	8.7	8.6	9.5	9.4	11.6	8.9
TMEM108	"CT124, MGC3040"	ENSG00000144868	"Transmembrane protein 108"	Q6UXF1	3	133038391-133397792	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 25.6"	"Cell line enhanced"	"Detected in some"		"HMC-1: 11.6;LHCN-M2: 6.5;SCLC-21H: 10.0;SH-SY5Y: 44.3"	"Cancer enhanced"	"Detected in many"		"glioma: 4.3"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA063350	Enhanced		Approved	"Nucleoli,Vesicles,Plasma membrane,Cytosol"	"Intracellular and membrane"			"Plasma membrane, Cytosol"	"Nucleoli, Vesicles"	"HPA063350: "	"unprognostic (4.75e-2)"	"unprognostic (1.73e-2)"	"unprognostic (9.00e-2)"	"unprognostic (1.92e-2)"	"unprognostic (3.07e-3)"	"unprognostic (3.17e-1)"	"unprognostic (1.28e-1)"	"unprognostic (3.65e-2)"	"unprognostic (2.06e-4)"	"unprognostic (2.08e-1)"	"unprognostic (7.27e-4)"	"unprognostic (1.11e-1)"	"unprognostic (3.03e-4)"	"unprognostic (1.60e-3)"	"unprognostic (1.61e-2)"	"unprognostic (6.12e-2)"	"unprognostic (1.36e-2)"	2.2	15.1	12.7	2.2	13.8	0.7	2.4	15.6	21.7	3.2	1.8	7.5	0.2	1.1	3.7	1.3	12.7	2.4	1.6	8.4	10.0	8.1	1.0	0.6	12.1	2.5	5.3	13.7	0.8	1.0	6.1	2.8	9.1	4.9	4.0	2.2	16.1	1.8	3.2	25.6	2.2	2.0	10.4	4.4	2.0	2.2	16.8	4.3	0.0	4.1	1.5	3.3	12.0	1.3	0.8	0.4	1.0	0.4	0.6	0.8	0.6	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.3	0.4	0.8	3.9	0.0	0.0	0.0	0.0	11.6	0.1	0.0	0.0	0.0	0.6	0.0	0.0	6.5	0.3	0.0	0.1	1.8	0.0	0.0	2.2	0.0	0.5	0.0	10.0	44.3	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	1.6	0.6	0.0	0.3	0.8	0.0	1.7	1.0	0.3	0.2	0.5	0.3	0.3	0.3	0.2	0.5	0.0	0.8	0.3	0.4	0.9	0.6	0.4	0.4	0.8	0.6	12.7	13.8	15.6	21.7	10.0	8.1	5.3	13.7	4.9	4.3
TMEM121B	CECR6	ENSG00000183307	"Transmembrane protein 121B"	Q9BXQ6	22	17116299-17121367	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 19.1;prostate: 14.1"	"Cell line enhanced"	"Detected in some"		"AF22: 6.2;SCLC-21H: 14.7;THP-1: 11.8;U-937: 9.8"	"Cancer enhanced"	"Detected in some"		"prostate cancer: 6.0"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"classical monocyte: 3.2;intermediate monocyte: 1.4;neutrophil: 4.3"	"Group enriched"	"Detected in many"	7	"granulocytes: 4.3;monocytes: 3.2"	"Group enriched"	"Detected in many"	8	"amygdala: 22.5;basal ganglia: 24.0;cerebral cortex: 29.3;hippocampal formation: 26.2;olfactory region: 20.0"	"Low region specificity"	"Detected in many"			HPA068790	Approved		Approved	"Nucleoplasm,Vesicles,Plasma membrane"				Vesicles	"Nucleoplasm, Plasma membrane"	"HPA068790: "	"unprognostic (2.30e-1)"	"unprognostic (1.05e-1)"	"unprognostic (7.11e-3)"	"unprognostic (4.49e-3)"	"unprognostic (3.36e-1)"	"unprognostic (7.14e-3)"	"unprognostic (1.12e-3)"	"unprognostic (5.32e-2)"	"unprognostic (1.97e-1)"	"unprognostic (2.01e-2)"	"unprognostic (6.88e-4)"	"unprognostic (6.08e-2)"	"unprognostic (3.10e-4)"	"unprognostic (1.02e-2)"	"unprognostic (4.37e-2)"	"unprognostic (3.49e-3)"	"unprognostic (1.71e-1)"	1.3	1.8	7.4	2.2	12.0	2.2	2.0	8.1	19.1	1.0	0.8	2.4	0.0	1.1	1.1	2.3	0.8	1.2	1.0	2.3	7.1	4.0	0.8	0.8	0.9	0.8	2.9	6.9	0.9	2.7	0.8	2.0	1.9	2.3	14.1	1.0	0.2	1.2	1.0	2.8	1.5	0.9	1.3	2.5	1.1	1.0	2.4	4.2	0.0	0.6	0.0	0.8	1.0	0.3	0.0	0.5	4.3	3.2	0.0	0.0	0.6	0.0	0.0	6.2	0.8	0.0	0.0	0.0	0.1	0.1	0.3	0.4	0.2	0.0	0.2	0.1	0.0	0.0	0.7	0.0	0.2	0.1	1.0	0.0	0.0	0.0	0.0	0.7	0.5	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.3	0.0	0.8	3.1	2.2	0.1	0.2	3.0	0.0	0.3	0.1	14.7	2.2	0.0	0.0	0.3	0.0	11.8	0.6	0.7	0.3	0.2	0.0	0.2	0.3	0.9	0.0	9.8	0.3	0.0	3.2	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	4.3	0.0	0.0	0.0	0.0	0.6	7.4	12.0	8.1	18.0	7.1	4.0	2.9	6.9	2.3	4.2
TMEM139	FLJ90586	ENSG00000178826	"Transmembrane protein 139"	Q8IV31	7	143279957-143288048	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 25.1;kidney: 22.6;placenta: 28.0"	"Cell line enhanced"	"Detected in some"		"A-431: 9.5;CAPAN-2: 17.9;EFO-21: 12.6;RPTEC TERT1: 31.5;SK-BR-3: 11.1;T-47d: 30.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"intermediate monocyte: 3.2"	"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA036982, HPA036983"	Approved		Approved	"Plasma membrane,Focal adhesion sites"				"Plasma membrane"	"Focal adhesion sites"	"HPA036982: AB_2675413, HPA036983: AB_10672275"	"unprognostic (2.58e-1)"	"unprognostic (4.38e-1)"	"unprognostic (6.62e-3)"	"unprognostic (1.41e-1)"	"unprognostic (2.10e-1)"	"unprognostic (2.16e-3)"	"unprognostic (2.83e-2)"	"unprognostic (4.90e-2)"	"unprognostic (1.60e-1)"	"unprognostic (2.82e-2)"	"prognostic unfavourable (1.66e-4)"	"unprognostic (2.89e-1)"	"prognostic favourable (3.05e-5)"	"unprognostic (1.73e-1)"	"unprognostic (1.42e-2)"	"unprognostic (2.83e-2)"	"unprognostic (9.08e-3)"	1.5	2.2	0.9	2.8	1.9	0.0	2.1	0.6	1.6	6.3	14.7	6.0	1.5	22.7	1.6	3.5	0.4	4.6	4.8	2.3	1.6	1.1	22.6	7.8	5.5	0.1	4.2	0.7	0.9	9.6	6.4	2.0	28.0	4.8	1.6	2.9	1.4	6.1	2.2	0.1	1.1	25.1	0.4	13.4	0.8	2.0	3.0	2.1	0.1	8.8	0.4	0.7	2.1	2.4	0.5	0.3	0.9	3.2	0.0	2.0	0.4	9.5	0.7	0.1	0.0	0.0	0.0	6.4	0.1	0.0	0.0	0.0	2.2	17.9	0.1	12.6	0.0	8.1	0.0	4.1	0.0	0.1	0.0	0.0	1.1	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.6	0.6	0.4	0.0	0.7	0.1	0.1	0.0	31.5	2.4	0.1	0.0	0.4	11.1	0.0	30.3	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.9	0.0	3.2	0.0	0.5	1.3	0.8	0.0	0.0	1.1	0.6	0.0	0.0	2.4	0.3	2.0	0.4	0.9	1.9	0.6	1.6	1.6	1.1	4.2	0.7	4.8	2.1
TMEM176B	"LR8, MS4B2"	ENSG00000106565	"Transmembrane protein 176B"	Q3YBM2	7	150791285-150801360	"Predicted membrane proteins"	Differentiation			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 92.3;liver: 247.9"	"Group enriched"	"Detected in some"	17	"HSkMC: 117.6;THP-1: 37.5"	"Cancer enhanced"	"Detected in all"		"liver cancer: 537.9"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"classical monocyte: 92.3;intermediate monocyte: 68.0"	"Lineage enriched"	"Detected in many"	5	"monocytes: 92.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047509	Uncertain		Approved	"Nucleoplasm,Golgi apparatus,Plasma membrane"				"Golgi apparatus"	"Nucleoplasm, Plasma membrane"	"HPA047509: "	"unprognostic (5.21e-2)"	"unprognostic (7.86e-2)"	"unprognostic (1.30e-2)"	"unprognostic (8.27e-2)"	"unprognostic (3.35e-2)"	"unprognostic (6.96e-2)"	"unprognostic (7.23e-2)"	"unprognostic (2.74e-2)"	"unprognostic (5.31e-2)"	"unprognostic (1.47e-1)"	"unprognostic (5.72e-3)"	"unprognostic (7.50e-2)"	"unprognostic (3.11e-3)"	"unprognostic (5.56e-2)"	"unprognostic (2.17e-2)"	"unprognostic (1.53e-1)"	"unprognostic (4.05e-2)"	13.9	5.5	7.8	19.8	10.7	1.1	11.7	2.1	6.3	8.6	27.6	5.7	2.0	18.3	3.8	15.2	9.6	9.0	50.2	26.8	7.6	5.2	62.9	247.9	11.2	22.9	10.5	3.3	20.3	6.8	0.3	3.2	12.5	8.4	6.1	27.9	22.0	5.1	3.2	2.5	4.2	53.1	10.7	13.2	23.5	10.6	5.2	8.7	4.3	4.9	7.0	10.5	14.7	11.6	0.2	20.0	5.7	92.3	0.0	0.4	42.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	4.5	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	117.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	2.0	0.0	0.0	0.3	0.2	0.1	0.0	0.0	0.0	37.5	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.6	92.3	5.7	0.2	68.0	0.4	0.2	0.0	0.0	20.0	0.0	0.0	0.0	1.1	0.0	36.2	0.9	0.0	42.0	7.8	10.7	2.1	6.3	7.6	5.2	10.5	3.3	8.4	8.7
TMEM183A	C1orf37	ENSG00000163444	"Transmembrane protein 183A"	Q8IXX5	1	203007386-203024848	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA072607			Approved	"Nucleoplasm,Plasma membrane,Cell Junctions"				"Plasma membrane"	"Nucleoplasm, Cell Junctions"	"HPA072607: "	"unprognostic (2.94e-3)"	"unprognostic (1.60e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.33e-1)"	"unprognostic (3.41e-2)"	"unprognostic (5.99e-2)"	"prognostic unfavourable (2.62e-4)"	"unprognostic (6.46e-2)"	"unprognostic (3.21e-2)"	"unprognostic (4.82e-3)"	"unprognostic (5.28e-2)"	"unprognostic (7.84e-2)"	"unprognostic (4.83e-2)"	"unprognostic (6.01e-3)"	"unprognostic (9.55e-2)"	"unprognostic (3.65e-2)"	"unprognostic (1.32e-1)"	12.2	12.6	22.4	13.5	20.8	50.1	17.2	31.9	30.4	14.4	21.1	12.4	6.7	20.0	13.6	15.2	19.3	12.0	15.0	11.5	19.8	21.0	16.0	21.1	13.4	20.2	19.3	14.8	15.0	29.9	12.0	8.2	10.9	20.8	15.0	23.6	11.1	22.2	13.6	8.8	16.1	18.8	17.6	12.4	14.5	15.8	27.7	12.3	23.3	20.5	14.8	17.7	15.3	20.7	17.4	27.2	35.6	24.4	26.4	23.7	24.3	12.7	12.4	15.9	26.1	21.1	15.9	26.3	12.8	12.7	14.9	13.1	15.0	13.5	31.8	9.3	16.5	16.1	21.3	18.0	12.4	10.3	25.9	15.7	14.5	16.5	15.3	28.1	13.8	15.5	20.0	12.2	24.8	18.7	32.2	11.6	13.8	28.4	22.9	28.9	43.7	19.8	17.7	27.2	25.6	23.0	12.5	20.5	25.7	19.2	32.0	18.4	22.9	22.2	13.8	10.1	14.1	17.2	14.0	11.8	18.9	24.7	11.1	21.9	10.6	21.1	24.4	35.6	18.1	20.4	17.9	16.6	20.5	20.5	27.2	17.4	23.7	19.3	21.3	26.4	18.5	19.5	21.2	24.3	22.4	20.8	31.9	30.4	19.8	21.0	19.3	14.8	20.8	12.3
TMEM218		ENSG00000150433	"Transmembrane protein 218"	A2RU14	11	125096545-125111763	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038489	Uncertain		Approved	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		"HPA038489: AB_10672748"	"unprognostic (3.70e-2)"	"unprognostic (1.16e-1)"	"unprognostic (7.60e-2)"	"unprognostic (2.41e-3)"	"unprognostic (8.86e-2)"	"unprognostic (1.60e-1)"	"prognostic unfavourable (1.93e-5)"	"unprognostic (3.63e-2)"	"unprognostic (7.09e-3)"	"unprognostic (2.18e-1)"	"unprognostic (6.45e-2)"	"unprognostic (1.09e-1)"	"unprognostic (9.95e-2)"	"prognostic favourable (5.50e-4)"	"unprognostic (6.53e-2)"	"unprognostic (1.42e-1)"	"unprognostic (6.72e-2)"	24.2	19.0	14.0	13.2	15.7	7.0	13.5	11.9	12.4	14.7	12.3	16.8	12.3	12.5	17.5	16.3	12.8	20.8	16.5	10.4	14.1	9.3	13.1	13.6	11.9	13.7	13.6	10.0	17.8	19.7	12.8	17.4	8.8	10.5	17.4	9.4	18.0	15.0	11.1	9.7	8.8	12.4	14.7	11.7	17.5	13.3	7.8	11.3	10.0	13.0	12.0	12.4	14.2	13.6	18.0	28.7	18.5	25.2	19.1	14.0	15.4	7.7	15.2	9.7	11.7	9.0	12.5	5.8	7.7	5.9	6.0	7.9	1.5	23.0	9.8	19.5	4.7	9.0	6.0	7.4	8.0	13.6	8.6	21.9	4.2	6.2	8.8	6.8	8.2	9.8	9.8	10.7	12.8	8.8	8.8	12.5	10.4	4.0	1.7	14.4	7.9	14.5	10.1	11.7	7.4	5.4	7.8	8.4	12.6	10.6	4.2	5.4	20.2	9.9	11.1	7.4	6.8	8.7	8.4	7.2	6.0	8.0	6.0	14.3	13.0	18.5	25.2	10.1	14.0	18.8	12.2	18.0	13.3	13.2	28.7	13.7	11.5	13.5	9.6	19.1	17.4	24.9	11.7	15.4	14.0	15.7	11.9	12.4	14.1	9.3	13.6	10.0	10.5	11.3
TMEM222	"C1orf160, DKFZP564D0478"	ENSG00000186501	"Transmembrane protein 222"	Q9H0R3	1	27322145-27336400	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016579, HPA059374"	Approved		Approved	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		"HPA016579: , HPA059374: "	"unprognostic (3.65e-1)"	"unprognostic (5.27e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.39e-3)"	"unprognostic (1.52e-1)"	"unprognostic (1.33e-1)"	"unprognostic (4.11e-2)"	"unprognostic (1.16e-1)"	"unprognostic (2.51e-2)"	"unprognostic (1.96e-2)"	"unprognostic (2.62e-2)"	"unprognostic (1.45e-1)"	"unprognostic (3.29e-3)"	"unprognostic (5.28e-2)"	"unprognostic (1.56e-1)"	"unprognostic (3.83e-2)"	"unprognostic (7.80e-2)"	18.4	22.0	28.0	12.0	31.4	19.5	17.8	23.2	45.4	18.1	17.1	32.1	13.2	14.4	16.5	25.0	22.8	29.8	21.3	27.5	28.9	30.8	20.6	35.0	18.8	15.0	26.0	20.8	22.3	24.6	19.9	22.4	20.0	26.7	22.9	14.3	26.4	21.7	25.2	19.9	15.6	21.3	18.6	21.5	15.2	16.7	20.7	16.4	19.4	24.0	14.9	19.1	17.8	13.3	22.8	19.9	36.5	21.0	19.2	23.2	15.7	12.2	14.9	12.6	20.6	19.6	14.3	10.1	19.0	21.9	26.1	22.2	6.1	25.8	7.8	14.9	20.2	17.0	13.7	18.5	10.9	10.3	26.4	13.0	12.4	14.1	29.2	12.9	13.1	24.8	10.5	24.9	14.3	17.3	9.8	18.1	16.2	10.9	18.5	13.6	23.5	18.7	15.4	8.7	15.7	25.2	7.2	27.0	23.8	14.7	20.8	18.4	20.6	20.9	15.8	15.4	13.0	24.7	17.9	19.6	17.4	8.1	23.3	25.1	22.1	19.3	13.7	17.0	22.3	20.3	17.0	22.8	20.7	17.0	12.0	18.9	20.9	21.4	36.5	19.2	21.0	19.9	23.2	15.7	28.0	31.4	23.2	45.4	28.9	30.8	26.0	20.8	26.7	16.4
TMEM229A		ENSG00000234224	"Transmembrane protein 229A"	B2RXF0	7	124030916-124033023	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 10.6;intestine: 16.4;testis: 10.6"	"Cell line enriched"	"Detected in some"	44	"SH-SY5Y: 54.6"	"Cancer enhanced"	"Detected in some"		"glioma: 2.2"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA056391	Uncertain		Approved	"Plasma membrane"				"Plasma membrane"		"HPA056391: "					"unprognostic (2.52e-2)"			"unprognostic (3.04e-2)"	"unprognostic (2.30e-1)"	"unprognostic (2.50e-1)"	"unprognostic (2.89e-2)"	"unprognostic (8.21e-2)"		"unprognostic (4.74e-2)"	"unprognostic (2.31e-1)"		"unprognostic (4.31e-3)"	0.4	1.5	6.9	0.5	7.6	0.4	0.4	1.3	9.0	0.8	0.5	7.6	0.0	16.4	0.7	1.2	0.4	1.7	0.6	0.9	8.0	4.6	0.5	0.4	0.5	0.4	10.6	4.9	1.0	0.4	2.5	1.0	0.6	5.6	0.8	0.6	0.6	0.7	0.5	0.4	0.4	7.7	0.7	7.3	0.6	3.7	10.6	8.7	0.0	0.5	0.0	0.4	1.1	0.1	0.0	0.0	0.3	0.0	0.2	0.2	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	54.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.2	0.3	0.2	0.0	0.0	0.1	0.0	6.9	7.6	1.3	6.1	8.0	4.6	10.6	4.9	5.6	8.7
TMEM245	"C9orf5, CG-2"	ENSG00000106771	"Transmembrane protein 245"	Q9H330	9	109015152-109119945	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA023892	Approved		Approved	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		"HPA023892: AB_1845828"	"unprognostic (1.56e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.29e-1)"	"unprognostic (9.58e-2)"	"unprognostic (1.63e-1)"	"unprognostic (6.43e-2)"	"unprognostic (1.66e-1)"	"unprognostic (5.96e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.03e-1)"	"unprognostic (2.05e-1)"	"unprognostic (1.85e-1)"	"prognostic favourable (4.46e-9)"	"unprognostic (6.11e-2)"	"unprognostic (2.44e-1)"	"unprognostic (2.41e-1)"	"unprognostic (2.24e-2)"	16.5	35.5	14.4	7.2	18.1	4.0	24.2	15.7	20.6	14.0	19.2	14.7	22.0	7.7	18.4	17.3	14.6	18.7	15.3	25.2	12.6	14.9	29.0	16.2	20.5	12.3	14.5	14.8	29.0	20.3	43.2	14.9	17.5	13.7	16.4	10.7	22.1	14.5	22.3	29.8	9.2	16.8	23.1	13.6	10.4	17.2	12.2	14.3	12.3	52.1	8.9	7.5	20.8	11.2	3.5	3.5	6.3	3.3	5.4	9.0	2.7	13.5	18.1	13.4	4.5	31.6	18.2	29.6	19.6	15.2	21.2	16.8	24.3	27.3	12.3	20.2	14.9	21.5	17.0	12.6	25.1	15.9	7.3	15.2	15.1	14.3	13.8	11.5	12.0	19.4	12.9	20.6	19.1	17.7	10.1	13.6	24.0	8.9	15.3	5.3	14.9	16.4	8.8	26.6	7.6	22.6	13.3	7.4	7.3	13.0	13.0	13.0	17.3	6.5	19.4	16.5	12.4	15.4	22.3	9.1	23.4	3.9	23.0	6.2	23.9	6.3	2.6	2.2	4.0	1.8	4.9	2.7	6.8	5.6	2.5	3.5	9.0	6.2	1.0	5.4	3.3	3.5	6.5	2.7	14.4	18.1	15.7	20.6	12.6	14.9	14.5	14.8	13.7	14.3
TMEM254	"bA369J21.6, C10orf57, FLJ13263"	ENSG00000133678	"Transmembrane protein 254"	Q8TBM7	10	80078646-80092557	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA029105, HPA072613"	Approved		Approved	"Nucleoplasm,Plasma membrane"				"Plasma membrane"	Nucleoplasm	"HPA029105: , HPA072613: "	"unprognostic (9.40e-2)"	"unprognostic (1.76e-1)"	"unprognostic (9.52e-2)"	"unprognostic (5.74e-3)"	"unprognostic (5.39e-2)"	"unprognostic (6.04e-2)"	"unprognostic (3.66e-1)"	"unprognostic (3.90e-1)"	"unprognostic (1.64e-2)"	"unprognostic (1.87e-3)"	"unprognostic (3.68e-2)"	"unprognostic (1.46e-1)"	"unprognostic (7.65e-2)"	"unprognostic (2.46e-1)"	"unprognostic (1.21e-1)"	"unprognostic (3.45e-3)"	"unprognostic (5.96e-2)"	8.4	13.4	10.8	6.0	14.1	4.7	15.9	6.9	13.5	14.1	13.1	11.7	14.7	10.1	12.4	40.1	35.8	17.3	10.5	4.8	9.4	6.3	10.0	30.8	6.8	9.0	7.7	9.0	8.7	12.1	8.3	10.1	14.8	9.5	25.8	13.7	10.7	16.3	9.1	3.0	43.9	13.4	6.6	8.2	6.9	9.0	21.5	8.8	8.6	11.8	12.4	15.4	13.0	20.5	12.6	14.7	27.7	18.1	9.8	22.9	11.9	7.1	6.9	11.6	8.9	14.3	18.0	17.7	7.0	5.1	5.1	5.2	5.2	22.3	5.5	11.9	8.9	7.6	4.7	5.7	5.4	9.0	8.3	1.4	2.2	7.2	6.5	6.8	7.3	11.6	26.4	4.5	3.9	4.5	4.0	12.0	5.1	14.6	5.5	5.0	6.3	22.6	6.8	1.4	4.7	7.0	6.0	4.1	6.7	6.5	16.1	6.9	22.9	4.5	6.5	4.0	6.9	6.8	3.9	8.3	11.7	0.4	10.1	6.9	3.3	27.7	16.2	7.4	11.9	18.1	14.9	12.6	13.8	12.3	13.2	9.6	22.9	15.6	1.7	9.8	17.6	14.7	16.0	11.9	10.8	14.1	6.9	13.5	9.4	6.3	7.7	9.0	9.5	8.8
TMEM258	C11orf10	ENSG00000134825	"Transmembrane protein 258"	P61165	11	61768501-61792802	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044602	Approved		Approved	"Plasma membrane,Cytosol"				Cytosol	"Plasma membrane"	"HPA044602: AB_10961423"	"unprognostic (6.35e-2)"	"unprognostic (1.70e-1)"	"unprognostic (7.49e-2)"	"unprognostic (4.99e-3)"	"unprognostic (9.95e-2)"	"unprognostic (1.24e-2)"	"unprognostic (3.18e-2)"	"unprognostic (1.24e-1)"	"unprognostic (8.48e-2)"	"prognostic favourable (4.37e-4)"	"unprognostic (1.34e-3)"	"unprognostic (7.39e-2)"	"unprognostic (4.75e-3)"	"unprognostic (2.59e-2)"	"unprognostic (1.02e-1)"	"unprognostic (3.34e-2)"	"unprognostic (2.58e-1)"	15.3	23.1	18.9	16.5	22.5	23.9	31.0	16.2	25.2	28.2	21.6	19.7	34.6	17.7	21.2	81.8	18.1	26.7	22.4	36.6	19.5	15.8	19.0	32.0	33.2	35.9	24.7	19.0	32.2	117.2	6.8	29.1	19.8	18.8	20.0	24.5	13.3	54.0	31.0	22.2	14.0	16.1	18.4	20.1	19.7	21.2	19.9	19.4	17.3	25.3	24.8	22.9	15.7	19.1	53.3	107.7	87.4	51.7	31.0	51.4	50.2	24.0	41.7	36.3	28.8	56.5	55.1	20.2	19.3	31.8	19.2	22.3	35.9	43.5	17.1	36.8	45.4	26.0	31.4	37.1	25.4	25.1	28.0	14.4	45.7	55.2	53.4	30.0	16.8	46.6	57.4	23.7	62.5	35.4	35.4	65.8	31.1	80.0	21.1	52.4	45.1	28.6	23.6	24.4	109.4	39.8	39.5	28.7	30.1	17.3	36.9	34.1	40.9	60.2	17.5	22.0	19.9	28.3	13.7	42.9	33.8	28.3	31.1	18.4	22.8	87.4	51.7	59.1	40.6	43.7	49.7	53.3	48.3	45.1	42.6	42.3	41.6	41.1	39.8	31.0	42.2	107.7	51.4	50.2	18.9	22.5	16.2	25.2	19.5	15.8	24.7	19.0	18.8	19.4
TMEM268	"C9orf91, DKFZp547P234, FLJ38045"	ENSG00000157693	"Transmembrane protein 268"	Q5VZI3	9	114611206-114646422	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Karpas-707: 30.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 8.4"	"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017199	Approved		Approved	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		"HPA017199: AB_1845845"	"unprognostic (8.57e-2)"	"unprognostic (3.37e-1)"	"unprognostic (8.33e-2)"	"prognostic favourable (3.61e-4)"	"unprognostic (2.09e-1)"	"unprognostic (7.16e-2)"	"unprognostic (3.55e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.87e-1)"	"unprognostic (2.26e-2)"	"unprognostic (2.22e-3)"	"unprognostic (1.44e-1)"	"unprognostic (6.67e-2)"	"unprognostic (6.10e-2)"	"unprognostic (7.65e-3)"	"unprognostic (1.09e-2)"	"unprognostic (1.47e-1)"	9.1	9.0	9.6	8.5	15.8	3.8	9.7	4.4	31.0	7.3	6.6	5.1	3.4	4.3	7.7	7.6	4.8	5.7	4.8	3.7	12.5	9.1	3.8	6.3	6.6	10.6	8.5	15.3	10.2	5.6	15.1	4.6	5.9	8.7	15.9	6.8	11.1	8.9	9.1	5.0	4.3	6.4	8.8	7.7	15.5	7.5	4.8	5.0	10.3	7.9	2.0	11.4	7.8	5.4	4.3	8.4	2.3	2.5	1.5	1.9	0.9	2.5	4.6	2.2	4.6	6.2	4.6	1.7	2.5	4.5	3.5	3.6	3.4	1.0	11.5	2.2	2.9	4.5	4.3	2.1	3.0	5.8	2.9	3.6	3.4	2.1	10.7	7.4	1.7	4.0	3.7	4.9	5.2	2.3	7.1	30.1	2.5	7.7	8.7	2.2	5.7	4.5	9.9	2.5	9.7	2.0	2.1	7.5	4.7	8.5	11.1	22.8	14.8	6.9	1.3	3.4	4.1	1.4	4.6	16.7	15.6	12.4	1.9	6.3	6.4	0.5	2.5	0.5	1.3	2.1	0.5	2.3	1.3	0.7	1.4	4.3	1.9	1.5	2.3	1.5	1.8	8.4	0.2	0.9	9.6	15.8	4.4	31.0	12.5	9.1	8.5	15.3	8.7	5.0
TMEM50A	SMP1	ENSG00000183726	"Transmembrane protein 50A"	O95807	1	25337917-25362361	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA065192			Approved	"Plasma membrane,Actin filaments,Cytosol"				"Plasma membrane, Cytosol"	"Actin filaments"	"HPA065192: "	"unprognostic (2.41e-2)"	"unprognostic (2.74e-1)"	"unprognostic (5.17e-3)"	"prognostic favourable (8.64e-5)"	"unprognostic (1.45e-1)"	"unprognostic (2.04e-2)"	"prognostic unfavourable (3.34e-4)"	"unprognostic (7.39e-2)"	"unprognostic (7.92e-3)"	"unprognostic (2.53e-1)"	"unprognostic (1.02e-2)"	"unprognostic (2.44e-2)"	"unprognostic (2.39e-3)"	"unprognostic (6.66e-2)"	"unprognostic (2.91e-1)"	"unprognostic (3.91e-3)"	"unprognostic (3.44e-2)"	36.2	45.6	29.2	23.2	39.1	19.4	43.4	30.5	29.4	29.7	32.7	21.5	25.6	26.5	29.4	31.5	36.7	23.5	30.9	32.6	30.9	23.6	39.1	31.8	34.2	36.3	29.3	18.5	22.6	29.7	21.7	13.6	40.4	19.9	32.8	38.6	19.1	56.5	33.0	21.5	25.7	39.6	27.8	38.1	39.4	26.5	17.5	20.4	32.7	39.2	29.6	28.1	37.1	31.0	13.0	14.0	56.5	26.8	19.2	25.0	23.1	8.4	9.6	16.1	8.3	30.3	27.3	5.7	17.0	27.3	32.4	36.4	7.7	21.1	9.7	9.6	60.6	12.2	12.6	13.9	35.4	25.5	18.1	20.7	10.5	11.8	22.4	15.8	16.8	29.8	20.5	24.0	13.9	23.3	13.8	15.3	30.6	5.9	10.3	19.3	18.9	7.9	9.1	17.7	17.2	32.6	6.2	13.5	8.6	17.6	12.4	13.6	6.4	10.4	34.4	18.1	7.6	29.6	7.0	10.7	11.6	9.0	23.6	23.7	10.0	56.5	19.1	26.3	24.0	23.0	25.0	13.0	21.1	24.4	14.0	10.1	15.5	21.1	39.7	19.2	26.8	13.0	23.4	23.1	29.2	39.1	30.5	29.4	30.9	23.6	29.3	18.5	19.9	20.4
TMPRSS15	"ENTK, MGC133046, PRSS7"	ENSG00000154646	"Transmembrane serine protease 15"	P98073	21	18269116-18485879	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	67	"intestine: 154.6"	"Group enriched"	"Detected in some"	20	"U-138 MG: 19.8;U-87 MG: 55.3"	"Group enriched"	"Detected in some"	12	"liver cancer: 0.7;pancreatic cancer: 1.5;stomach cancer: 1.5"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"naive B-cell: 2.3"	"Low lineage specificity"	"Detected in single"			"Not detected"	"Not detected"			"Region enriched"	"Detected in many"	5	"olfactory region: 9.3"	"HPA015611, HPA034857, HPA072934"	Enhanced		Approved	"Nucleoli,Plasma membrane"				"Plasma membrane"	Nucleoli	"HPA015611: AB_1855791, HPA034857: , HPA072934: "					"unprognostic (9.26e-2)"	"unprognostic (4.14e-1)"		"unprognostic (3.52e-1)"	"unprognostic (8.33e-2)"	"unprognostic (1.19e-1)"	"unprognostic (7.20e-2)"	"unprognostic (4.70e-2)"		"unprognostic (6.35e-2)"	"unprognostic (5.92e-2)"			0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.0	0.0	0.0	80.5	0.0	0.0	154.6	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	42.4	0.0	0.1	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.3	0.0	0.5	0.1	0.6	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	1.9	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	1.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	19.8	0.0	0.1	0.0	0.3	0.0	0.0	55.3	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.3	0.1	0.5	0.6	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0
TMTC2	DKFZp762A217	ENSG00000179104	"Transmembrane and tetratricopeptide repeat containing 2"	Q8N394	12	82686880-83134870	"Predicted membrane proteins"		Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"AF22: 16.2;WM-115: 39.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"classical monocyte: 3.1;myeloid DC: 2.6"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026954, HPA026955"	Uncertain		Approved	"Plasma membrane,Actin filaments"				"Plasma membrane"	"Actin filaments"	"HPA026954: AB_2256025, HPA026955: AB_10602282"	"unprognostic (1.56e-1)"	"unprognostic (5.62e-2)"	"unprognostic (9.61e-2)"	"unprognostic (7.38e-2)"	"unprognostic (2.60e-2)"	"unprognostic (3.66e-2)"	"unprognostic (1.05e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.25e-1)"	"unprognostic (7.16e-2)"	"unprognostic (1.73e-3)"	"unprognostic (5.06e-2)"	"prognostic favourable (2.84e-5)"	"unprognostic (1.10e-1)"	"unprognostic (1.60e-1)"	"unprognostic (2.06e-2)"	"unprognostic (8.06e-2)"	4.7	1.7	9.1	8.9	19.7	2.9	5.9	8.1	15.7	8.1	12.5	27.3	15.2	4.6	8.5	7.4	11.4	15.4	11.9	3.1	13.4	8.7	10.6	1.7	9.6	2.8	17.6	15.3	3.1	6.6	6.5	4.7	5.1	14.3	9.9	9.1	2.5	8.3	30.3	2.0	7.4	6.2	10.4	22.5	2.2	13.1	4.6	18.0	0.4	7.9	1.1	4.3	10.5	11.5	0.8	2.6	0.0	3.1	0.0	0.3	0.9	0.8	3.2	16.2	0.1	2.1	2.1	1.4	1.0	0.3	0.8	0.1	0.2	1.7	0.0	0.2	5.8	1.4	4.6	2.4	0.2	3.6	2.7	0.0	2.4	0.1	0.2	1.0	0.5	0.5	2.1	0.1	0.8	1.3	0.0	2.2	0.2	1.6	0.8	4.2	0.6	2.7	0.0	0.6	0.3	1.5	7.1	4.3	7.8	1.5	2.3	10.5	2.4	0.2	0.8	2.8	0.9	3.6	1.3	4.0	2.8	0.6	0.6	1.8	39.5	0.0	3.1	0.0	0.1	1.0	0.3	0.8	0.3	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.9	9.1	19.7	8.1	11.6	13.4	8.7	17.6	15.3	14.3	18.0
TNFRSF10D	"CD264, DcR2, TRAILR4, TRUNDD"	ENSG00000173530	"TNF receptor superfamily member 10d"	Q9UBN6	8	23135588-23164030	"Cancer-related genes, CD markers, Predicted membrane proteins"	Apoptosis	Receptor	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HUVEC TERT2: 24.1;LHCN-M2: 60.9;WM-115: 57.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"naive CD4 T-cell: 9.0"	"Low lineage specificity"	"Detected in many"											HPA070971			Approved	"Plasma membrane,Actin filaments"				"Plasma membrane, Actin filaments"		"HPA070971: "	"unprognostic (1.49e-1)"	"prognostic unfavourable (1.70e-4)"	"unprognostic (1.41e-1)"	"unprognostic (8.78e-2)"	"unprognostic (8.13e-2)"	"unprognostic (7.49e-2)"	"unprognostic (2.69e-1)"	"unprognostic (7.06e-2)"	"unprognostic (3.56e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.61e-2)"	"unprognostic (1.32e-1)"	"unprognostic (2.12e-2)"	"unprognostic (2.70e-1)"	"unprognostic (1.35e-2)"	"unprognostic (6.32e-2)"	"unprognostic (1.72e-1)"	16.0	3.1	4.9	7.3	10.0	10.5	10.2	3.4	10.3	5.9	8.5	2.6	5.5	6.2	8.9	5.7	4.1	8.0	11.5	6.5	7.0	3.4	12.1	31.5	12.5	5.1	9.0	0.9	9.8	5.2	2.5	4.3	4.1	9.0	9.0	10.9	3.9	3.9	4.4	3.9	3.1	11.2	10.9	6.3	6.9	7.2	4.3	9.2	2.9	6.0	6.8	6.6	7.3	26.0	2.1	4.5	2.4	3.3	0.3	9.0	2.4	3.5	3.0	4.0	2.2	3.0	12.1	0.0	18.8	7.1	1.4	1.9	5.8	2.9	0.0	4.0	11.2	1.2	3.3	16.5	12.5	0.0	2.9	1.0	1.8	5.0	13.3	0.6	1.3	15.1	18.4	5.0	3.5	24.1	0.0	0.0	60.9	0.0	0.0	1.9	3.2	0.0	0.7	0.0	0.9	4.7	1.6	0.0	0.0	2.0	0.0	0.0	0.0	2.3	14.2	0.0	0.0	1.1	0.0	0.0	0.0	0.0	15.7	0.9	57.8	2.4	3.3	1.5	0.0	1.4	0.1	2.1	3.2	1.1	4.5	0.8	9.0	3.5	2.2	0.3	1.9	0.0	1.0	2.4	4.9	10.0	3.4	10.3	7.0	3.4	9.0	0.9	9.0	9.2
TNFRSF12A	"CD266, FN14, TweakR"	ENSG00000006327	"TNF receptor superfamily member 12A"	Q9NP84	16	3018445-3022383	"Cancer-related genes, CD markers, Predicted intracellular proteins, Predicted membrane proteins"	"Angiogenesis, Apoptosis, Cell adhesion, Differentiation"	"Developmental protein, Receptor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"placenta: 81.3"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in many"	5	"pons and medulla: 25.0"	"Group enriched"	"Detected in many"	8	"eosinophil: 38.1;neutrophil: 29.9"	"Lineage enriched"	"Detected in many"	9	"granulocytes: 38.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			HPA007853	Approved		Approved	"Plasma membrane,Cytosol"			170000	"Plasma membrane, Cytosol"		"HPA007853: AB_1858463"	"unprognostic (1.44e-1)"	"unprognostic (2.46e-3)"	"unprognostic (8.90e-2)"	"unprognostic (2.60e-1)"	"unprognostic (4.06e-3)"	"prognostic unfavourable (5.50e-4)"	"unprognostic (7.04e-3)"	"unprognostic (1.98e-3)"	"unprognostic (4.17e-3)"	"unprognostic (2.85e-1)"	"unprognostic (5.02e-3)"	"unprognostic (3.88e-1)"	"prognostic unfavourable (8.78e-4)"	"unprognostic (2.98e-2)"	"unprognostic (6.00e-2)"	"unprognostic (2.80e-3)"	"unprognostic (2.17e-2)"	10.8	14.2	2.4	11.3	5.1	2.7	21.2	0.9	3.0	8.0	18.9	3.2	4.1	14.5	11.6	10.2	10.7	6.4	28.1	27.0	5.0	2.6	50.4	36.2	23.0	2.6	4.8	0.5	6.4	47.0	51.1	20.0	81.3	25.0	11.1	1.9	2.8	17.3	6.9	23.3	5.0	31.0	16.8	4.3	3.9	13.2	5.3	3.3	1.2	11.5	11.5	4.7	14.8	5.2	0.0	4.1	38.1	3.5	2.0	2.4	1.1	24.3	19.8	2.2	4.1	4.0	9.2	13.1	51.3	37.2	44.0	28.3	8.5	43.5	0.1	68.0	34.1	27.0	0.5	37.5	16.9	0.9	1.3	0.1	6.6	7.2	27.8	0.4	1.8	8.5	26.0	46.2	55.4	12.7	2.7	0.3	46.3	46.0	0.0	3.2	10.7	43.4	0.2	24.7	1.0	44.5	4.8	2.5	0.8	36.6	17.0	30.3	8.9	0.7	22.3	79.3	36.6	52.4	84.2	0.8	0.3	0.3	24.7	2.2	62.3	3.5	3.5	38.1	1.8	2.0	2.4	0.0	0.8	1.5	4.1	0.0	0.4	0.8	29.9	2.0	1.3	0.1	1.0	1.1	2.4	5.1	0.9	3.0	5.0	2.6	4.8	0.5	25.0	3.3
TNFRSF25	"APO-3, DDR3, DR3, LARD, TNFRSF12, TR3, TRAMP, WSL-1, WSL-LR"	ENSG00000215788	"TNF receptor superfamily member 25"	Q93038	1	6461151-6466195	"Predicted membrane proteins, Predicted secreted proteins"	Apoptosis	Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"brain: 19.2;lymphoid tissue: 26.0;skin 1: 24.1"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 19.7;NB-4: 7.8;RPMI-8226: 19.3"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in many"	11	"cerebellum: 19.2"	"Cell type enhanced"	"Detected in many"		"T-reg: 9.5"	"Lineage enriched"	"Detected in single"	10	"T-cells: 9.5"	"Group enriched"	"Detected in some"	6	"amygdala: 1.2;cerebral cortex: 1.3;hippocampal formation: 2.3"	"Not detected"	"Not detected"			HPA069834			Approved	"Nucleoplasm,Plasma membrane,Actin filaments,Focal adhesion sites"	"Secreted - unknown location"			"Plasma membrane, Actin filaments, Focal adhesion sites"	Nucleoplasm	"HPA069834: "	"unprognostic (8.09e-3)"	"unprognostic (6.91e-3)"	"prognostic unfavourable (4.46e-4)"	"unprognostic (1.97e-1)"	"unprognostic (9.63e-3)"	"prognostic favourable (3.09e-4)"	"unprognostic (2.16e-1)"	"unprognostic (1.46e-1)"	"unprognostic (2.04e-1)"	"unprognostic (2.07e-1)"	"unprognostic (6.01e-2)"	"unprognostic (3.98e-2)"	"prognostic unfavourable (1.65e-7)"	"unprognostic (1.21e-1)"	"unprognostic (1.61e-1)"	"unprognostic (3.44e-1)"	"unprognostic (8.68e-3)"	2.2	1.6	1.2	20.3	1.6	0.4	1.4	19.2	1.8	1.4	13.4	0.7	0.6	2.8	1.2	0.6	4.1	2.4	2.1	2.3	1.8	0.9	1.4	2.3	6.3	13.9	1.1	0.6	1.1	0.6	1.4	14.0	4.1	1.3	1.9	1.3	1.1	10.5	2.3	0.8	24.1	11.2	0.6	0.6	18.9	0.8	1.0	0.8	11.7	1.1	3.2	26.0	3.2	1.5	0.0	0.4	0.0	0.9	0.6	9.5	1.3	1.4	0.3	0.8	1.5	0.0	0.4	0.8	0.6	0.4	0.2	0.0	1.2	2.1	0.0	2.9	0.0	3.1	0.4	3.6	0.0	19.7	1.4	0.8	1.1	0.0	0.6	0.0	0.0	0.0	2.4	1.2	3.1	3.1	0.0	0.0	0.0	1.6	0.0	7.8	1.0	5.3	0.6	0.2	19.3	0.8	0.5	3.8	5.2	0.0	1.9	0.1	1.6	2.1	1.6	1.0	1.5	0.0	1.5	0.0	3.5	0.0	1.8	0.0	0.0	0.0	0.0	0.0	1.7	0.3	8.0	0.0	6.9	3.2	0.4	0.0	6.4	1.1	0.0	0.6	0.9	0.0	9.5	1.3	1.2	1.6	19.2	1.8	1.8	0.9	1.1	0.6	1.3	0.8
TNFRSF9	"4-1BB, CD137, ILA"	ENSG00000049249	"TNF receptor superfamily member 9"	Q07011	1	7915894-7943165	"Cancer-related genes, CD markers, Predicted membrane proteins"		Receptor	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"blood: 13.5;lymphoid tissue: 18.3"	"Cell line enriched"	"Detected in some"	8	"HDLM-2: 45.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Group enriched"	"Detected in many"	5	"memory CD8 T-cell: 8.0;neutrophil: 6.6;NK-cell: 4.1;T-reg: 13.5"	"Group enriched"	"Detected in many"	5	"granulocytes: 6.6;NK-cells: 4.1;T-cells: 13.5"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA071425			Approved	"Nucleoli,Plasma membrane"				"Plasma membrane"	Nucleoli	"HPA071425: "	"unprognostic (7.23e-2)"	"unprognostic (1.72e-2)"	"unprognostic (8.26e-3)"	"unprognostic (1.32e-3)"	"unprognostic (1.10e-1)"	"unprognostic (1.98e-2)"	"unprognostic (2.52e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.19e-4)"	"unprognostic (9.47e-3)"	"unprognostic (2.17e-2)"	"unprognostic (2.02e-1)"	"prognostic unfavourable (2.69e-8)"	"unprognostic (1.64e-2)"	"unprognostic (2.25e-2)"	"unprognostic (1.19e-1)"	"unprognostic (9.55e-2)"	0.8	1.0	0.3	11.0	0.3	1.9	0.5	0.2	0.3	0.4	0.5	0.1	0.1	0.6	0.3	0.1	0.6	0.8	1.6	1.8	0.3	1.0	0.7	0.7	2.1	10.8	0.3	0.1	0.3	0.6	0.0	0.5	0.2	0.5	0.4	0.7	0.3	2.1	0.1	0.3	0.5	2.3	0.1	0.3	7.9	0.7	0.5	0.1	18.3	0.7	0.9	17.5	1.4	0.4	0.5	1.1	6.6	1.5	4.1	13.5	1.1	1.2	0.4	0.1	0.1	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.9	0.3	0.1	0.4	0.0	0.1	0.0	0.2	0.4	45.9	0.1	0.2	0.2	0.0	0.9	0.0	0.5	0.1	0.3	0.1	0.1	0.0	0.2	0.1	0.0	0.1	0.0	0.2	0.1	0.0	0.0	0.2	0.1	0.2	0.1	0.1	0.1	0.2	0.1	0.0	0.0	0.2	0.2	0.2	1.5	0.1	0.2	0.1	0.1	0.1	5.7	0.2	0.0	1.1	1.5	0.2	1.5	0.4	0.2	0.2	1.0	8.0	1.1	0.5	0.3	1.6	6.6	4.1	0.1	0.3	13.5	1.1	0.3	0.3	0.2	0.3	0.3	1.0	0.3	0.1	0.5	0.1
TNNI2	"AMCD2B, DA2B, FSSV"	ENSG00000130598	"Troponin I2, fast skeletal type"	P48788	11	1838989-1841680	"Disease related genes, Predicted intracellular proteins"		"Actin-binding, Muscle protein"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	13	"skeletal muscle: 635.0;tongue: 527.7"	"Group enriched"	"Detected in some"	6	"CAPAN-2: 22.7;hTCEpi: 65.2"	"Group enriched"	"Detected in many"	10	"cervical cancer: 12.7;head and neck cancer: 33.6;pancreatic cancer: 12.9;urothelial cancer: 39.8"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 46.4"	"Group enriched"	"Detected in many"	4	"dendritic cells: 46.4;granulocytes: 26.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"CAB018697, HPA055938"	Enhanced		Approved	"Plasma membrane,Intermediate filaments"			29000	"Plasma membrane"	"Intermediate filaments"	"CAB018697: AB_628400, HPA055938: "	"unprognostic (2.03e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.29e-2)"	"unprognostic (3.70e-1)"	"unprognostic (1.85e-1)"	"unprognostic (1.02e-2)"	"unprognostic (9.99e-3)"	"unprognostic (1.01e-1)"	"unprognostic (1.73e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.10e-1)"	"unprognostic (2.70e-1)"	"unprognostic (1.23e-3)"	"unprognostic (5.92e-3)"	"unprognostic (5.62e-2)"	"unprognostic (1.77e-1)"	"unprognostic (2.79e-2)"	13.9	0.1	0.1	0.1	0.1	0.5	0.6	0.1	0.1	0.1	0.1	0.0	0.0	0.1	0.1	16.5	11.6	0.1	0.6	0.1	0.1	0.1	0.1	0.1	0.5	0.2	0.1	0.0	0.1	0.5	0.0	0.1	0.3	0.0	1.2	0.1	0.0	15.7	0.4	635.0	4.8	0.2	0.1	0.2	0.4	0.1	0.1	0.0	0.0	3.0	527.7	11.5	2.1	0.1	2.3	46.4	26.7	8.6	0.2	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	1.5	22.7	0.6	0.1	0.0	1.1	0.0	0.8	0.0	0.0	0.0	0.0	0.0	1.3	0.1	0.0	0.0	5.4	65.2	0.0	1.5	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.8	1.4	0.0	0.6	0.0	0.6	0.0	0.4	0.0	7.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.4	0.0	6.1	3.1	26.7	0.0	6.5	0.0	1.9	0.0	0.0	4.3	2.3	0.0	0.0	21.1	0.2	8.6	46.4	0.0	1.3	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0
TOLLIP	IL-1RAcPIP	ENSG00000078902	"Toll interacting protein"	Q9H0E2	11	1274371-1309654	"Plasma proteins, Predicted intracellular proteins"	"Autophagy, Immunity, Inflammatory response, Innate immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038621, HPA038622"	Enhanced		Approved	"Plasma membrane,Cytosol"			34000	"Plasma membrane, Cytosol"		"HPA038621: AB_10673177, HPA038622: AB_10675946"	"unprognostic (8.39e-2)"	"unprognostic (1.89e-1)"	"unprognostic (2.18e-2)"	"unprognostic (6.08e-2)"	"prognostic unfavourable (5.45e-4)"	"unprognostic (8.89e-2)"	"unprognostic (2.51e-1)"	"unprognostic (8.53e-2)"	"unprognostic (2.17e-1)"	"unprognostic (1.55e-2)"	"unprognostic (1.90e-2)"	"unprognostic (2.74e-1)"	"prognostic favourable (1.11e-16)"	"unprognostic (2.72e-1)"	"unprognostic (1.46e-1)"	"unprognostic (3.21e-2)"	"unprognostic (1.29e-2)"	15.3	16.7	31.2	8.8	32.5	9.0	11.9	28.3	63.0	10.7	12.7	12.9	8.6	18.6	8.3	10.3	29.4	10.7	13.7	15.8	28.0	20.3	20.9	37.1	12.3	9.6	18.1	32.1	12.8	41.8	13.7	18.7	9.9	17.4	15.6	6.6	12.9	15.9	16.8	23.4	24.0	15.7	9.0	13.5	13.2	15.1	24.5	11.8	5.9	12.6	11.8	10.9	14.6	14.8	13.9	26.9	49.0	34.8	11.1	12.6	18.3	15.6	16.6	8.5	9.6	18.1	11.4	7.4	13.9	12.7	16.4	14.6	18.0	10.0	7.3	13.5	12.8	14.2	7.6	17.1	4.5	15.0	15.5	6.0	3.6	26.9	25.9	11.3	15.2	17.1	20.1	9.7	9.4	10.2	9.8	20.0	13.4	13.1	14.3	13.9	10.3	22.1	10.9	8.7	7.2	10.8	21.0	22.8	13.4	12.5	15.2	15.3	12.0	12.9	18.6	17.8	7.6	7.5	8.0	20.3	18.0	8.9	28.1	7.5	13.9	9.5	34.8	35.9	9.6	30.0	8.0	10.9	10.3	8.9	26.9	13.9	8.1	7.6	49.0	11.1	27.5	14.1	12.6	18.3	31.2	32.5	28.3	63.0	28.0	20.3	18.1	32.1	17.4	11.8
TOM1		ENSG00000100284	"Target of myb1 membrane trafficking protein"	O60784	22	35299275-35347994	"Cancer-related genes, Predicted intracellular proteins"	"Protein transport, Transport"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 83.8"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000818, HPA001749"	Approved		Approved	"Plasma membrane,Centriolar satellite,Cytosol"			14000	Cytosol	"Plasma membrane, Centriolar satellite"	"HPA000818: , HPA001749: AB_1080323"	"unprognostic (3.75e-1)"	"unprognostic (8.07e-2)"	"unprognostic (5.18e-2)"	"prognostic favourable (2.20e-5)"	"unprognostic (1.11e-2)"	"unprognostic (7.55e-2)"	"unprognostic (4.07e-3)"	"unprognostic (2.24e-1)"	"unprognostic (9.92e-2)"	"unprognostic (2.32e-1)"	"unprognostic (3.71e-1)"	"unprognostic (8.16e-2)"	"prognostic favourable (3.72e-5)"	"unprognostic (1.22e-1)"	"unprognostic (1.30e-1)"	"unprognostic (7.54e-3)"	"unprognostic (3.31e-2)"	17.0	21.2	9.5	10.2	13.8	31.1	13.7	10.2	24.6	16.0	14.6	12.0	7.5	17.4	14.1	15.5	31.6	11.7	15.4	19.1	8.8	15.2	16.1	27.4	17.5	8.2	11.6	11.3	12.1	11.8	21.8	16.8	39.0	23.2	10.2	6.4	17.5	37.0	10.1	83.8	29.1	18.6	7.1	8.4	10.6	8.4	13.6	8.7	10.0	14.8	25.9	19.9	12.1	17.6	4.6	15.2	40.9	31.2	4.6	14.7	17.0	6.6	6.7	3.9	6.3	27.9	16.6	18.4	6.5	19.7	12.7	14.3	9.3	6.2	2.6	12.1	20.3	3.1	4.0	6.8	4.6	7.5	9.1	2.2	7.6	19.3	26.3	4.2	10.1	22.4	8.6	17.9	6.1	8.8	4.3	6.6	6.2	6.4	3.4	9.9	3.0	3.9	6.2	5.6	5.6	5.0	5.0	6.7	5.2	14.8	15.4	14.5	7.8	7.0	9.2	15.1	13.1	11.5	3.2	7.7	4.8	6.8	20.3	4.4	4.9	5.9	31.2	13.1	6.4	18.9	5.3	4.6	9.8	6.1	15.2	4.0	7.9	5.3	40.9	4.6	19.4	8.1	14.7	17.0	9.5	13.8	10.2	24.6	8.8	15.2	11.6	11.3	23.2	8.7
TPD52L1	"D53, hD53"	ENSG00000111907	"Tumor protein D52 like 1"	Q16890	6	125119049-125264407	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adrenal gland: 95.2;salivary gland: 104.6"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 51.4;hTCEpi: 45.3;MCF7: 67.2;RPTEC TERT1: 52.1;SK-BR-3: 36.3;T-47d: 31.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027915, HPA027916"	Enhanced		Approved	"Plasma membrane,Cell Junctions,Cytosol"				"Plasma membrane, Cell Junctions, Cytosol"		"HPA027915: AB_10602074, HPA027916: AB_10601860"	"unprognostic (1.44e-1)"	"unprognostic (2.01e-2)"	"unprognostic (2.76e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.39e-1)"	"unprognostic (2.87e-2)"	"unprognostic (1.38e-2)"	"unprognostic (2.14e-1)"	"unprognostic (7.85e-2)"	"unprognostic (7.80e-2)"	"unprognostic (9.42e-3)"	"unprognostic (1.76e-1)"	"prognostic favourable (3.26e-4)"	"unprognostic (1.06e-1)"	"unprognostic (6.83e-2)"	"prognostic favourable (3.97e-4)"	"prognostic unfavourable (5.34e-4)"	10.3	95.2	31.5	4.3	47.5	1.0	25.7	2.6	32.9	10.5	8.5	9.2	31.0	4.3	6.2	27.6	43.3	13.9	10.8	26.0	21.4	9.5	11.7	22.0	4.7	2.9	15.4	12.8	9.0	18.0	10.3	8.7	4.0	16.1	16.6	5.8	13.0	104.6	32.7	34.4	11.8	4.6	27.1	5.5	1.4	10.3	2.6	18.2	0.0	23.5	20.1	11.0	18.1	14.6	1.1	0.9	5.9	1.2	5.3	1.7	1.0	6.9	7.9	0.0	51.4	0.4	0.1	12.2	1.1	1.1	0.0	0.1	12.5	8.9	0.0	26.4	5.8	15.9	1.5	11.0	0.0	0.1	11.0	0.1	11.0	0.1	1.1	0.0	0.0	1.4	45.3	0.0	5.9	0.0	5.5	0.1	0.9	67.2	0.0	0.1	0.8	4.3	0.0	0.0	0.0	52.1	1.8	1.7	0.0	13.3	36.3	0.8	31.0	0.1	0.0	0.3	1.1	0.1	0.3	0.0	0.0	0.0	0.1	0.0	0.1	2.7	1.2	0.8	0.8	0.6	0.8	0.8	1.3	0.6	0.5	1.1	1.7	1.2	5.9	5.3	0.3	0.9	0.4	1.0	31.5	47.5	2.6	32.9	21.4	9.5	15.4	12.8	16.1	18.2
TPRN	"C9orf75, DFNB79, FLJ90254"	ENSG00000176058	Taperin	Q4KMQ1	9	137191617-137204193	"Disease related genes, Predicted intracellular proteins"	Hearing		"Deafness, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 32.8;pancreas: 45.3"	"Cell line enhanced"	"Detected in many"		"MCF7: 28.4;T-47d: 27.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Region enriched"	"Detected in many"	5	"cerebellum: 40.9"	"HPA020899, HPA076667"	Approved		Approved	"Plasma membrane"				"Plasma membrane"		"HPA020899: AB_1845835, HPA076667: "	"unprognostic (5.41e-2)"	"prognostic favourable (2.13e-4)"	"unprognostic (2.94e-1)"	"unprognostic (9.28e-2)"	"unprognostic (1.68e-1)"	"unprognostic (2.61e-2)"	"unprognostic (3.59e-3)"	"unprognostic (8.20e-2)"	"unprognostic (9.96e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.89e-2)"	"unprognostic (4.77e-2)"	"prognostic favourable (5.16e-9)"	"unprognostic (1.96e-3)"	"unprognostic (6.35e-2)"	"unprognostic (1.51e-1)"	"unprognostic (5.44e-2)"	3.2	3.8	8.5	5.0	16.8	3.2	3.3	26.1	17.9	3.4	18.5	32.8	2.3	23.6	2.8	1.8	8.2	4.2	4.8	3.6	11.2	7.0	12.1	10.0	5.8	3.0	25.3	7.1	4.7	45.3	2.8	2.7	4.3	11.0	4.4	8.1	13.1	8.7	4.8	5.0	8.0	29.0	2.4	11.9	3.7	10.8	4.7	21.7	0.2	2.5	2.3	3.5	3.8	2.7	1.2	2.3	0.2	2.9	2.9	2.2	0.6	4.6	5.3	1.8	8.1	2.5	2.7	14.4	3.3	2.0	3.3	1.8	17.8	5.7	8.6	4.9	1.6	14.2	3.7	1.8	0.4	5.4	5.2	4.0	8.0	11.6	3.8	6.1	5.2	2.3	3.6	3.0	2.0	2.1	7.2	3.0	1.0	28.4	4.0	13.2	6.4	7.0	12.0	4.3	13.0	7.5	9.8	11.7	4.3	5.0	23.6	5.8	27.4	9.7	2.3	6.2	2.9	9.6	6.9	2.5	4.9	4.4	4.4	5.6	3.4	0.0	2.9	0.2	1.3	2.6	0.4	1.1	1.3	1.8	2.1	1.2	0.6	1.2	0.0	2.9	1.5	2.3	2.2	0.6	8.5	16.8	26.1	17.9	11.2	7.0	25.3	7.1	11.0	21.7
TRAF7	"DKFZp586I021, MGC7807, RFWD1, RNF119"	ENSG00000131653	"TNF receptor associated factor 7"	Q6Q0C0	16	2155698-2178129	"Cancer-related genes, Enzymes, Predicted intracellular proteins"	"Apoptosis, Transcription, Transcription regulation, Ubl conjugation pathway"	Transferase	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041229	Approved		Supported	"Vesicles,Plasma membrane"				Vesicles	"Plasma membrane"	"HPA041229: AB_10794194"	"unprognostic (1.94e-1)"	"unprognostic (5.97e-2)"	"unprognostic (1.13e-1)"	"unprognostic (4.23e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.65e-2)"	"unprognostic (2.77e-3)"	"unprognostic (7.08e-2)"	"unprognostic (3.52e-2)"	"unprognostic (1.52e-2)"	"unprognostic (1.08e-1)"	"unprognostic (9.23e-2)"	"unprognostic (6.07e-2)"	"unprognostic (2.99e-2)"	"unprognostic (2.43e-1)"	"unprognostic (8.48e-2)"	16.0	18.2	18.3	22.3	20.6	28.5	39.1	28.7	25.6	22.1	29.4	9.1	21.1	37.3	20.4	18.3	32.9	21.9	36.9	21.0	18.3	14.8	21.3	47.3	18.3	40.9	13.4	14.7	19.3	41.6	17.7	20.3	19.5	12.8	16.2	16.9	13.0	24.4	23.1	25.5	32.2	37.8	28.8	14.1	21.4	25.1	13.2	10.6	26.1	20.3	30.9	21.9	21.9	28.9	6.7	12.3	7.7	13.9	3.0	7.1	5.2	20.8	26.7	15.3	27.3	15.8	30.0	18.0	16.1	20.3	19.0	17.1	32.4	27.0	13.4	19.1	20.5	24.5	14.3	28.6	7.2	21.1	18.3	19.1	35.6	24.8	21.0	20.3	27.7	29.6	23.9	18.3	24.0	36.7	20.3	18.1	18.0	47.7	20.8	23.6	30.0	13.1	38.9	25.4	26.8	15.3	11.2	30.8	25.6	13.5	25.9	17.6	29.4	25.0	27.6	23.1	32.5	21.5	17.5	26.2	19.4	17.7	13.2	13.2	17.9	3.7	10.0	7.7	5.4	13.9	5.0	6.7	5.3	5.7	12.3	4.9	3.8	4.5	6.9	3.0	9.4	6.0	7.1	5.2	18.3	20.6	28.7	25.6	18.3	14.8	13.4	14.7	12.8	10.6
TRAPPC13	"C5orf44, FLJ13611, FLJ26957, MGC48585"	ENSG00000113597	"Trafficking protein particle complex 13"	A5PLN9	5	65624716-65666233	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA037777	Approved		Approved	"Nucleoplasm,Plasma membrane"				"Nucleoplasm, Plasma membrane"		"HPA037777: AB_10672464"	"unprognostic (3.66e-2)"	"unprognostic (3.27e-1)"	"unprognostic (1.54e-2)"	"unprognostic (7.22e-2)"	"unprognostic (4.79e-2)"	"unprognostic (1.16e-2)"	"unprognostic (2.55e-2)"	"unprognostic (2.49e-2)"	"unprognostic (5.70e-2)"	"unprognostic (5.75e-2)"	"unprognostic (3.49e-2)"	"unprognostic (1.92e-1)"	"prognostic favourable (8.66e-4)"	"unprognostic (2.89e-1)"	"unprognostic (2.58e-2)"	"unprognostic (2.53e-2)"	"unprognostic (6.25e-2)"	10.4	12.9	16.1	10.3	22.5	7.5	14.0	14.5	22.7	12.1	11.3	12.8	10.2	9.8	11.9	10.4	13.4	9.7	9.8	17.7	17.1	17.7	21.6	16.9	11.0	10.2	17.3	14.2	10.1	8.2	20.6	22.4	11.8	19.5	20.6	14.3	10.5	9.9	12.4	15.2	8.0	13.3	13.9	18.9	10.7	11.0	10.6	15.1	18.0	18.7	11.7	10.8	11.5	9.9	6.6	10.1	14.7	13.7	9.1	13.1	9.8	12.9	8.8	13.9	25.0	10.8	13.8	13.4	15.4	14.0	19.1	21.0	7.5	18.3	13.2	17.0	12.4	12.0	15.7	16.0	22.6	9.2	11.6	8.5	10.9	6.9	14.7	10.3	12.8	9.8	12.7	14.8	19.1	16.8	10.1	12.6	16.8	13.7	17.1	4.0	6.4	4.8	15.0	17.5	15.4	13.9	14.8	17.6	12.6	18.8	11.4	14.1	16.5	13.5	11.5	6.7	9.4	14.9	15.5	8.3	16.2	21.1	14.2	18.6	12.8	14.7	9.4	3.8	10.1	10.1	13.1	6.6	9.9	8.4	10.1	5.4	9.9	9.9	3.6	9.1	13.7	7.6	10.4	9.8	16.1	22.5	14.5	22.7	17.1	17.7	17.3	14.2	19.5	15.1
TRDN		ENSG00000186439	Triadin	Q13061	6	123216339-123637093	"Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"			"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 52.8;skeletal muscle: 215.5;tongue: 80.1"	"Cell line enhanced"	"Detected in some"		"HAP1: 1.5;K-562: 1.8;MCF7: 6.0;SCLC-21H: 1.2;SK-BR-3: 1.9"	"Cancer enhanced"	"Detected in some"		"head and neck cancer: 2.2"	"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	30	"basophil: 2.9"	"Lineage enriched"	"Detected in single"	30	"granulocytes: 2.9"	"Region enriched"	"Detected in single"	10	"olfactory region: 13.6"					"HPA038226, HPA058226"	Enhanced		Approved	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		"HPA038226: AB_10795574, HPA058226: "	"unprognostic (1.05e-2)"			"unprognostic (1.99e-1)"	"unprognostic (9.20e-2)"	"unprognostic (3.06e-3)"		"unprognostic (2.40e-1)"	"unprognostic (2.38e-1)"	"unprognostic (2.42e-1)"	"unprognostic (8.42e-2)"	"unprognostic (8.71e-2)"	"unprognostic (9.93e-3)"	"unprognostic (2.12e-1)"	"unprognostic (2.55e-2)"		"unprognostic (3.97e-2)"	3.8	0.4	0.4	0.0	0.5	0.0	0.3	0.2	0.2	0.3	0.1	0.0	0.7	0.1	0.3	9.2	3.0	1.9	0.1	52.8	1.6	1.3	0.1	0.1	0.1	0.1	1.6	0.1	1.5	0.1	0.0	3.2	0.1	1.3	1.9	0.1	1.3	2.0	0.2	215.5	0.1	0.1	0.2	3.4	0.1	0.1	0.7	0.5	0.0	1.2	80.1	1.6	0.1	0.1	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.5	0.0	0.0	0.0	0.0	0.5	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.2	0.0	6.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.7	0.0	0.2	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.5	0.2	0.2	1.6	1.3	1.6	0.1	1.3	0.5
TRIB1	"C8FW, GIG2, TRB1"	ENSG00000173334	"Tribbles pseudokinase 1"	Q96RU8	8	125430321-125438405	"Enzymes, Predicted intracellular proteins"		"Protein kinase inhibitor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 84.2;thyroid gland: 90.7"	"Cell line enhanced"	"Detected in many"		"HEL: 54.0;U-266/70: 33.1;U-266/84: 33.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"eosinophil: 10.8;neutrophil: 5.8;non-classical monocyte: 3.7;T-reg: 3.1"	"Group enriched"	"Detected in many"	11	"granulocytes: 10.8;monocytes: 3.7;T-cells: 3.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA063982			Approved	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		"HPA063982: "	"unprognostic (1.90e-3)"	"unprognostic (1.45e-1)"	"unprognostic (8.80e-3)"	"unprognostic (1.34e-2)"	"unprognostic (3.56e-1)"	"unprognostic (2.32e-1)"	"unprognostic (2.00e-1)"	"unprognostic (4.57e-2)"	"unprognostic (4.12e-2)"	"unprognostic (1.62e-2)"	"unprognostic (6.81e-3)"	"unprognostic (9.36e-2)"	"unprognostic (2.97e-3)"	"unprognostic (1.94e-1)"	"unprognostic (1.04e-2)"	"unprognostic (5.55e-2)"	"unprognostic (2.08e-2)"	26.7	6.5	5.9	17.6	6.5	84.2	13.3	4.3	6.1	10.4	12.4	4.4	6.6	4.9	6.2	6.7	10.9	10.9	21.0	11.1	4.3	4.0	16.6	63.5	28.9	14.6	4.2	3.9	6.4	23.6	20.9	7.2	15.5	4.5	12.1	13.3	15.0	14.5	9.1	22.3	10.4	16.9	11.3	3.1	15.9	18.5	5.6	3.1	9.2	90.7	17.6	12.1	12.4	9.0	0.2	0.5	10.8	3.7	0.0	3.1	0.1	4.0	4.6	0.6	1.3	1.3	2.6	7.3	2.6	3.7	1.9	0.6	6.2	5.4	7.4	2.5	1.9	3.1	2.0	2.6	1.7	3.2	9.7	54.0	2.0	12.0	3.4	27.0	4.9	2.5	3.9	8.1	18.4	5.7	4.7	23.5	0.2	4.3	2.5	4.2	4.5	9.0	5.1	0.9	8.0	15.9	15.5	3.9	1.4	6.5	7.1	25.7	1.8	1.3	2.9	2.1	2.8	2.1	3.3	33.1	33.0	10.3	3.8	0.1	5.0	0.0	0.9	10.8	0.0	1.2	0.0	0.2	0.1	0.0	0.5	0.0	0.0	0.0	5.8	0.0	3.7	0.3	3.1	0.1	5.9	6.5	4.3	6.1	4.3	4.0	4.2	3.9	4.5	3.1
TRIM16	EBBP	ENSG00000221926	"Tripartite motif containing 16"	O95361	17	15627960-15684311	"Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"esophagus: 52.9"	"Cell line enhanced"	"Detected in many"		"A549: 64.1;HaCaT: 51.8;HeLa: 46.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	8	"T-reg: 25.1"	"Lineage enriched"	"Detected in many"	11	"T-cells: 25.1"									"HPA023623, HPA066431"	Uncertain		Supported	"Plasma membrane,Cytosol"				Cytosol	"Plasma membrane"	"HPA023623: AB_1858273, HPA066431: "	"unprognostic (2.14e-1)"	"unprognostic (1.95e-1)"	"unprognostic (9.61e-2)"	"unprognostic (1.31e-2)"	"unprognostic (6.19e-2)"	"unprognostic (1.21e-1)"	"prognostic unfavourable (3.94e-4)"	"unprognostic (1.94e-3)"	"unprognostic (3.75e-2)"	"unprognostic (4.65e-1)"	"unprognostic (3.31e-3)"	"unprognostic (1.70e-1)"	"unprognostic (2.16e-3)"	"unprognostic (2.08e-1)"	"unprognostic (8.48e-2)"	"unprognostic (9.21e-3)"	"prognostic unfavourable (6.71e-4)"	6.1	13.5	7.4	4.8	12.8	7.0	6.7	7.4	11.7	16.0	5.0	7.8	6.6	10.2	7.0	2.8	52.9	4.0	7.5	6.5	8.0	4.4	5.7	2.2	6.2	10.9	11.3	5.6	3.7	6.2	1.9	5.7	15.8	9.8	4.1	5.2	5.0	14.7	5.7	11.4	15.6	5.5	5.4	5.9	4.6	14.4	5.5	7.8	4.7	7.4	5.3	16.3	11.7	23.3	0.4	1.5	0.6	2.3	0.5	25.1	1.3	20.1	64.1	2.0	4.4	9.5	11.0	2.1	3.3	11.8	4.1	5.8	3.8	26.3	2.1	12.7	14.5	51.8	5.8	14.9	2.8	26.6	3.7	1.0	46.7	2.0	15.9	1.1	2.2	6.0	9.4	9.0	5.2	8.8	1.2	10.5	11.2	7.1	4.4	2.6	3.0	3.9	1.9	16.6	1.5	21.3	26.1	1.4	4.1	14.6	16.6	5.0	2.5	2.8	13.7	5.2	6.2	2.5	11.4	2.5	2.7	0.2	8.1	2.8	13.2	0.1	2.3	0.6	0.8	0.6	0.5	0.3	3.0	0.9	1.5	0.4	0.8	1.6	0.5	0.5	0.3	0.3	25.1	1.3	7.4	12.8	7.4	11.7	8.0	4.4	11.3	5.6	9.8	7.8
TRIM16L	TRIM70	ENSG00000108448	"Tripartite motif containing 16 like"	Q309B1	17	18697998-18736118	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 22.5"	"Cell line enhanced"	"Detected in many"		"A549: 48.6;CAPAN-2: 20.9;HaCaT: 24.8;HeLa: 38.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"											HPA066431	Uncertain		Approved	"Plasma membrane,Cytosol"				Cytosol	"Plasma membrane"	"HPA066431: "	"unprognostic (1.20e-1)"	"unprognostic (1.46e-1)"	"unprognostic (2.00e-1)"	"unprognostic (7.89e-3)"	"unprognostic (5.66e-2)"	"unprognostic (3.97e-2)"	"prognostic unfavourable (2.87e-4)"	"unprognostic (7.08e-2)"	"unprognostic (5.79e-2)"	"unprognostic (6.28e-2)"	"unprognostic (2.34e-1)"	"unprognostic (3.11e-1)"	"unprognostic (1.37e-1)"	"unprognostic (5.74e-2)"	"unprognostic (1.42e-1)"	"prognostic unfavourable (2.29e-5)"	"unprognostic (1.13e-2)"	2.8	4.4	2.0	1.0	3.1	0.5	7.1	1.0	3.0	2.2	3.6	1.3	1.0	2.0	1.4	3.2	10.5	3.3	8.1	16.8	2.0	2.5	3.5	2.8	2.4	1.0	4.7	1.0	1.3	1.3	0.1	1.0	1.8	3.1	3.6	1.0	2.1	2.6	3.7	22.5	0.8	1.1	6.5	4.7	1.0	3.0	2.9	1.4	1.0	4.5	12.7	3.4	6.7	11.8	1.5	0.8	0.4	1.4	2.7	2.1	1.8	5.2	48.6	0.3	2.0	5.9	2.4	3.8	0.4	4.0	1.8	3.7	0.8	20.9	0.5	3.8	13.9	24.8	0.5	1.1	0.9	0.2	0.7	0.3	38.8	0.5	14.6	0.0	0.5	2.5	1.4	2.7	1.0	0.5	0.0	0.0	4.7	5.1	0.1	0.5	0.5	1.0	0.5	2.5	0.0	3.5	3.0	0.1	1.1	5.5	1.1	2.9	2.5	0.4	10.9	1.2	6.3	1.9	7.0	0.6	0.6	0.0	4.1	0.4	9.2	0.1	0.7	0.4	0.7	1.4	1.0	1.5	1.0	0.6	0.8	1.1	1.6	1.5	0.3	2.7	0.5	0.2	2.1	1.8	2.0	3.1	1.0	1.9	2.0	2.5	4.7	1.0	3.1	1.4
TRIM38	"RNF15, RORET"	ENSG00000112343	"Tripartite motif containing 38"	O00635	6	25962802-25991226	"Enzymes, Predicted intracellular proteins"	"Immunity, Innate immunity, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA031685	Approved		Approved	"Plasma membrane,Cell Junctions,Centrosome"				Centrosome	"Plasma membrane, Cell Junctions"	"HPA031685: AB_10603218"	"unprognostic (6.62e-2)"	"unprognostic (1.65e-3)"	"unprognostic (3.34e-1)"	"unprognostic (2.72e-2)"	"unprognostic (1.25e-1)"	"unprognostic (6.51e-2)"	"unprognostic (7.79e-2)"	"unprognostic (3.27e-2)"	"unprognostic (2.78e-2)"	"prognostic favourable (8.95e-5)"	"unprognostic (2.81e-2)"	"unprognostic (6.28e-2)"	"unprognostic (2.73e-1)"	"unprognostic (3.36e-1)"	"unprognostic (4.49e-2)"	"prognostic favourable (8.20e-5)"	"prognostic favourable (4.94e-9)"	13.3	8.4	2.5	15.7	2.3	12.0	7.9	1.1	3.4	17.2	12.1	3.1	20.5	6.7	26.2	22.3	15.7	8.9	9.2	5.8	2.8	2.3	26.1	8.8	14.0	14.4	3.7	1.8	11.5	4.3	1.0	4.3	10.3	3.5	15.5	7.8	9.2	9.8	16.5	9.0	5.3	14.6	13.1	4.5	17.6	6.6	5.3	2.9	16.6	13.7	9.5	20.1	18.0	15.4	16.5	10.1	12.1	12.9	6.7	7.9	6.3	3.5	2.0	0.3	4.3	10.3	13.9	3.6	4.5	8.9	8.7	14.5	1.5	3.8	7.9	7.4	5.5	5.6	2.7	4.4	5.2	7.9	1.8	3.5	3.3	1.4	13.7	4.2	7.4	13.8	3.2	5.4	1.9	7.5	2.3	4.4	10.3	1.7	4.0	4.8	1.4	2.7	6.2	4.3	8.2	10.4	7.0	0.1	0.1	3.4	7.1	12.0	1.0	5.5	7.7	1.6	2.7	2.7	3.0	5.1	3.7	8.9	4.2	5.2	9.6	10.1	10.6	4.7	7.6	12.9	7.4	14.3	6.5	6.8	10.1	16.5	6.2	6.7	12.1	6.7	11.4	9.5	7.9	6.3	2.5	2.3	1.1	3.4	2.8	2.3	3.7	1.8	3.5	2.9
TRIM4	RNF87	ENSG00000146833	"Tripartite motif containing 4"	Q9C037	7	99876958-99919600	"Enzymes, Predicted intracellular proteins"	"Immunity, Innate immunity, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA019356, HPA029461"	Approved		Supported	"Plasma membrane,Cytosol"				Cytosol	"Plasma membrane"	"HPA019356: AB_1856376, HPA029461: AB_10600834"	"unprognostic (1.88e-1)"	"unprognostic (2.97e-2)"	"unprognostic (3.37e-1)"	"unprognostic (3.46e-2)"	"unprognostic (1.80e-2)"	"unprognostic (7.06e-2)"	"unprognostic (1.22e-1)"	"unprognostic (5.42e-2)"	"unprognostic (3.85e-2)"	"unprognostic (2.67e-3)"	"unprognostic (2.48e-2)"	"unprognostic (1.60e-1)"	"prognostic favourable (7.36e-6)"	"unprognostic (1.00e-1)"	"unprognostic (2.38e-1)"	"unprognostic (7.46e-2)"	"unprognostic (5.65e-2)"	19.1	22.6	13.5	22.1	15.9	6.7	22.1	20.1	15.5	19.5	17.3	12.4	22.5	13.9	21.9	18.8	16.4	19.0	19.8	11.1	13.3	9.3	16.6	17.9	21.1	22.4	15.3	8.8	35.0	23.2	18.9	27.4	16.1	12.2	21.9	15.7	18.4	19.4	33.8	9.4	20.7	18.3	18.1	11.9	18.2	17.4	16.2	14.5	18.4	20.5	11.9	18.8	20.0	28.9	18.6	17.0	20.0	19.2	13.9	30.3	17.4	9.5	11.5	6.9	5.7	18.1	17.0	3.1	16.1	19.7	13.5	15.7	6.1	9.5	14.0	0.1	13.7	11.4	9.1	9.9	13.8	14.2	0.7	11.4	6.1	9.6	25.6	16.4	16.3	18.1	21.2	10.5	26.6	11.8	16.6	21.6	11.2	11.9	12.1	14.8	5.2	9.9	6.9	9.8	15.9	14.9	12.4	8.1	5.7	12.3	18.9	19.2	8.7	9.5	14.3	15.0	13.4	28.6	15.5	18.2	19.9	11.3	9.8	18.5	19.8	20.0	19.2	15.3	20.6	19.2	23.8	18.6	21.6	23.5	17.0	18.6	30.3	22.2	8.2	13.9	16.6	12.7	21.5	17.4	13.5	15.9	20.1	15.5	13.3	9.3	15.3	8.8	12.2	14.5
TRIM44	"DIPB, MC7"	ENSG00000166326	"Tripartite motif containing 44"	Q96DX7	11	35662805-35818007	"Disease related genes, Predicted intracellular proteins"			"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049053, HPA057633"	Approved		Approved	"Vesicles,Plasma membrane"				Vesicles	"Plasma membrane"	"HPA049053: , HPA057633: "	"unprognostic (2.73e-1)"	"unprognostic (2.74e-1)"	"unprognostic (1.37e-1)"	"unprognostic (5.53e-2)"	"unprognostic (3.91e-2)"	"unprognostic (1.81e-1)"	"prognostic unfavourable (5.24e-5)"	"unprognostic (9.06e-2)"	"unprognostic (5.29e-2)"	"unprognostic (2.67e-1)"	"unprognostic (1.02e-1)"	"unprognostic (8.57e-2)"	"unprognostic (1.49e-3)"	"unprognostic (2.15e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.52e-1)"	"unprognostic (3.00e-1)"	18.8	18.1	25.2	17.7	31.5	8.2	17.3	34.8	35.1	18.4	18.0	25.1	12.6	16.2	19.4	16.7	14.5	17.9	18.1	17.5	25.8	23.0	28.1	21.9	18.1	18.1	26.7	31.9	17.0	23.5	23.0	21.7	20.2	32.0	16.9	17.7	13.3	16.1	18.8	20.3	11.8	17.9	19.2	29.7	20.3	17.0	12.3	25.1	12.8	23.4	7.2	19.5	19.7	19.4	4.1	4.9	0.9	3.7	3.2	3.4	1.5	10.4	8.9	14.3	6.6	10.9	16.6	0.0	9.8	11.8	12.4	11.3	10.4	7.1	14.0	9.3	12.8	8.2	4.9	11.2	14.0	9.1	9.3	15.0	11.8	5.9	14.5	11.7	13.0	12.5	12.6	7.2	19.8	13.0	23.3	5.0	13.0	6.3	12.3	5.7	8.1	7.8	8.6	37.2	7.5	11.4	14.2	9.9	8.5	14.7	10.6	11.1	15.9	10.0	14.5	15.9	13.1	9.0	11.1	8.5	7.6	0.0	13.1	12.5	11.9	0.4	2.6	0.9	2.6	3.3	2.4	3.0	2.5	2.5	2.1	4.1	3.3	3.4	0.2	3.2	3.7	4.9	0.9	1.5	25.2	31.5	34.8	35.1	25.8	23.0	26.7	31.9	32.0	25.1
TRIM54	"MURF, MURF-3, RNF30"	ENSG00000138100	"Tripartite motif containing 54"	Q9BYV2	2	27282392-27307439	"Predicted intracellular proteins"	Differentiation	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"skeletal muscle: 187.1"	"Group enriched"	"Detected in some"	9	"HAP1: 8.2;NTERA-2: 17.6"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in single"		"cerebral cortex: 1.2"	"Cell type enriched"	"Detected in single"	16	"NK-cell: 7.0"	"Lineage enriched"	"Detected in single"	16	"NK-cells: 7.0"	"Region enhanced"	"Detected in some"		"amygdala: 3.2"	"Group enriched"	"Detected in some"	11	"cerebral cortex: 1.4;hippocampal formation: 0.8"	HPA019690	Uncertain		Approved	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		"HPA019690: AB_1858306"	"unprognostic (6.98e-3)"	"unprognostic (4.56e-3)"	"unprognostic (3.22e-2)"	"unprognostic (2.24e-2)"	"unprognostic (1.58e-3)"	"unprognostic (7.49e-2)"	"unprognostic (1.25e-7)"	"unprognostic (3.88e-3)"	"unprognostic (2.29e-1)"	"unprognostic (2.95e-1)"	"unprognostic (2.56e-3)"	"unprognostic (6.91e-2)"	"prognostic unfavourable (6.46e-4)"	"unprognostic (2.41e-2)"	"unprognostic (3.19e-1)"	"unprognostic (1.15e-1)"	"unprognostic (6.92e-2)"	2.1	1.8	0.5	0.0	0.0	0.0	0.0	0.0	1.2	0.1	0.0	0.0	0.0	0.9	0.1	6.3	1.6	0.0	0.0	35.3	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	1.8	0.0	187.1	0.0	0.4	0.0	0.0	0.1	0.0	3.5	0.0	0.0	1.3	40.3	2.2	0.1	0.0	0.3	0.0	0.0	0.0	7.0	0.4	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	8.2	0.0	0.0	0.0	0.3	0.0	1.4	1.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	17.6	0.0	0.6	0.7	0.1	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.1	0.1	0.9	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	1.2	0.3	0.0	0.0	0.1	0.0	0.0
TRIM71	"LIN-41, LIN41"	ENSG00000206557	"Tripartite motif containing 71"	Q2Q1W2	3	32818018-32897826	"Enzymes, Predicted intracellular proteins"	"RNA-mediated gene silencing, Ubl conjugation pathway"	"Developmental protein, RNA-binding, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"lung: 6.5;testis: 11.1"	"Cell line enhanced"	"Detected in some"		"AF22: 12.4;BEWO: 37.5;CACO-2: 8.8;Hep G2: 24.2;NTERA-2: 33.2"	"Cancer enriched"	"Detected in some"	28	"testis cancer: 28.6"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA038141, HPA038142"	Uncertain		Approved	"Plasma membrane,Actin filaments,Focal adhesion sites"				"Plasma membrane, Actin filaments, Focal adhesion sites"		"HPA038141: , HPA038142: AB_10697240"	"unprognostic (2.93e-2)"	"unprognostic (4.29e-3)"	"unprognostic (1.70e-1)"	"unprognostic (1.02e-2)"	"unprognostic (2.58e-2)"	"unprognostic (3.27e-2)"	"unprognostic (2.09e-2)"	"unprognostic (1.25e-1)"	"unprognostic (3.16e-2)"	"unprognostic (3.04e-1)"	"unprognostic (1.11e-2)"	"unprognostic (3.11e-1)"	"unprognostic (4.36e-6)"	"unprognostic (3.92e-2)"	"unprognostic (9.27e-2)"	"unprognostic (8.17e-2)"	"unprognostic (4.65e-2)"	0.1	0.0	0.7	0.1	1.9	0.5	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	2.7	0.7	2.2	0.0	6.5	0.0	0.2	0.0	0.1	0.0	0.0	0.5	1.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.1	0.1	11.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.5	0.3	0.0	0.1	0.0	0.0	0.0	12.4	0.0	0.0	0.0	37.5	0.0	0.0	0.0	0.0	8.8	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.6	0.0	24.2	0.0	0.6	0.2	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.2	2.6	33.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.2	0.0	0.2	0.3	0.0	0.1	0.0	0.0	0.1	0.1	0.1	0.3	0.0	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.7	1.9	0.0	0.5	2.7	0.7	0.2	0.0	1.9	0.0
TRIML2	"FLJ25801, SPRYD6"	ENSG00000179046	"Tripartite motif family like 2"	Q8N7C3	4	188091273-188109603	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"placenta: 9.8;testis: 6.2"	"Cell line enhanced"	"Detected in some"		"A549: 21.1;BEWO: 11.7;hTCEpi: 13.7;NTERA-2: 21.7"	"Cancer enriched"	"Detected in some"	33	"testis cancer: 24.4"	"Region enhanced"	"Detected in single"		"basal ganglia: 1.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA043838	Uncertain		Approved	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		"HPA043838: AB_10963835"	"unprognostic (3.32e-1)"	"unprognostic (1.99e-1)"		"unprognostic (1.30e-1)"	"unprognostic (9.82e-2)"	"unprognostic (1.21e-5)"		"unprognostic (3.06e-2)"	"unprognostic (1.65e-3)"		"unprognostic (2.65e-1)"		"unprognostic (0.00e+0)"	"unprognostic (2.26e-2)"	"unprognostic (1.20e-1)"		"unprognostic (1.28e-3)"	0.1	0.1	0.2	0.1	1.4	0.0	0.1	0.1	0.4	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.1	0.0	0.1	9.8	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	6.2	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	21.1	0.0	0.0	0.0	0.1	11.7	0.1	0.9	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.5	4.0	0.1	0.0	1.4	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	13.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	21.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.1	0.1	4.9	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.4	0.1	0.4	0.1	0.0	0.1	0.1	0.1	0.1
TRIP6	"MGC10556, MGC10558, MGC29959, MGC3837, MGC4423, OIP1, ZRP-1"	ENSG00000087077	"Thyroid hormone receptor interactor 6"	Q15654	7	100867138-100873454	"Predicted intracellular proteins"	"Cell adhesion, Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 7.7"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB046454, CAB046460, HPA052813"	Approved		Supported	"Plasma membrane,Focal adhesion sites,Cytosol"			12000	"Plasma membrane, Focal adhesion sites, Cytosol"		"CAB046454: AB_10604048, CAB046460: AB_2303907, HPA052813: "	"unprognostic (7.94e-3)"	"unprognostic (1.06e-1)"	"unprognostic (3.22e-3)"	"unprognostic (2.84e-3)"	"unprognostic (3.52e-2)"	"unprognostic (2.92e-2)"	"unprognostic (3.18e-2)"	"unprognostic (4.61e-3)"	"unprognostic (8.48e-2)"	"unprognostic (4.18e-2)"	"unprognostic (5.08e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.25e-2)"	"unprognostic (5.07e-2)"	"unprognostic (9.71e-2)"	"unprognostic (1.92e-1)"	"unprognostic (1.25e-1)"	15.5	14.7	10.9	16.2	11.2	6.0	18.1	4.2	7.3	36.7	14.6	9.4	22.5	4.4	28.2	30.8	27.2	18.5	43.5	14.5	8.7	7.7	21.6	24.1	18.4	5.8	11.7	9.4	22.0	19.2	28.0	6.5	13.6	9.7	22.1	3.9	22.7	23.0	38.2	8.3	23.9	6.5	25.5	9.7	7.9	9.9	17.5	7.8	7.3	26.6	30.6	12.6	25.0	23.6	3.1	7.7	0.2	4.7	0.0	1.7	0.5	26.6	11.0	5.7	27.3	8.6	10.1	28.7	16.6	17.8	22.8	21.4	10.4	30.7	1.1	17.6	18.7	19.9	8.4	32.1	5.9	3.8	11.4	0.1	18.3	0.1	22.8	12.8	1.5	18.2	21.1	15.2	23.9	11.7	16.7	0.2	19.7	46.8	0.2	20.2	19.7	9.8	10.0	5.7	2.7	14.1	6.6	2.1	0.3	13.9	42.1	16.5	4.5	16.4	17.9	33.6	31.7	36.4	38.8	0.2	0.4	0.1	20.9	1.6	50.5	0.0	1.9	0.2	0.2	3.0	0.6	3.1	1.5	1.3	3.1	2.5	1.7	0.7	0.2	0.0	4.7	7.7	1.3	0.5	10.9	11.2	4.2	7.3	8.7	7.7	11.7	9.4	9.7	7.8
TRMT1	"FLJ20244, TRM1"	ENSG00000104907	"TRNA methyltransferase 1"	Q9NXH9	19	13104902-13117567	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"tRNA processing"	"Methyltransferase, RNA-binding, Transferase, tRNA-binding"	"Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041130, HPA041380"	Approved		Approved	"Nucleoplasm,Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"	Nucleoplasm	"HPA041130: AB_10803995, HPA041380: AB_10793873"	"unprognostic (2.10e-2)"	"unprognostic (2.40e-3)"	"unprognostic (2.23e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.12e-2)"	"unprognostic (5.54e-2)"	"unprognostic (1.08e-3)"	"unprognostic (2.19e-2)"	"unprognostic (1.59e-1)"	"unprognostic (7.62e-2)"	"unprognostic (1.91e-2)"	"unprognostic (8.74e-3)"	"prognostic unfavourable (9.87e-7)"	"unprognostic (1.19e-3)"	"unprognostic (3.47e-2)"	"unprognostic (2.22e-1)"	"unprognostic (2.49e-2)"	15.5	15.0	19.1	19.8	23.5	23.1	16.6	19.5	22.6	15.0	16.3	17.3	15.5	14.9	19.2	19.0	17.6	19.6	19.4	13.2	15.7	13.4	14.4	17.3	13.5	26.8	22.1	14.7	29.1	23.8	16.3	14.4	14.4	21.9	18.1	14.5	10.9	14.9	15.6	21.4	22.1	16.1	16.5	12.4	25.0	16.3	16.8	20.1	12.2	15.6	12.1	19.6	17.3	18.8	11.2	14.9	3.1	15.7	4.3	10.2	8.5	15.3	10.4	11.3	19.1	11.5	14.7	16.2	17.3	8.7	19.1	16.6	11.1	12.7	19.3	22.7	9.3	14.3	18.8	15.2	8.9	12.6	26.3	15.3	26.7	18.6	20.8	30.7	18.1	20.8	20.5	19.9	18.7	14.0	33.2	6.2	11.8	17.0	12.4	33.2	26.7	24.4	21.0	14.5	26.6	11.9	15.7	26.8	12.2	10.8	22.5	18.0	8.7	17.2	15.6	27.6	10.7	16.6	30.3	10.7	20.7	17.8	12.9	32.5	14.3	1.2	15.7	0.5	8.1	11.9	7.7	10.4	8.6	7.7	14.9	11.2	10.2	7.7	3.1	4.3	7.5	8.8	5.6	8.5	19.1	23.5	19.5	22.6	15.7	13.4	22.1	14.7	21.9	20.1
TRMT10B	"bA3J10.9, FLJ31455, RG9MTD3"	ENSG00000165275	"TRNA methyltransferase 10B"	Q6PF06	9	37753803-37778972	"Enzymes, Predicted intracellular proteins"		"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA021800	Uncertain		Approved	"Nucleoplasm,Plasma membrane"				Nucleoplasm	"Plasma membrane"	"HPA021800: AB_1856214"	"unprognostic (1.00e-2)"	"unprognostic (1.78e-1)"	"unprognostic (3.35e-2)"	"unprognostic (3.89e-2)"	"unprognostic (2.42e-2)"	"unprognostic (7.68e-2)"	"unprognostic (7.78e-2)"	"prognostic favourable (3.91e-4)"	"unprognostic (5.49e-3)"	"unprognostic (1.71e-2)"	"prognostic favourable (5.34e-4)"	"unprognostic (1.40e-1)"	"unprognostic (6.62e-2)"	"unprognostic (1.76e-2)"	"unprognostic (1.68e-1)"	"unprognostic (9.58e-2)"	"unprognostic (2.33e-3)"	7.4	10.3	9.9	10.9	10.3	10.1	9.8	13.7	12.3	10.6	11.8	12.7	12.8	8.3	17.3	9.5	10.4	9.6	10.6	7.0	9.9	9.2	8.2	8.0	8.6	13.1	16.4	9.8	15.4	10.5	9.0	13.8	7.4	10.0	14.8	7.1	12.1	10.3	12.1	7.8	20.4	9.7	11.8	12.7	12.1	10.8	5.0	10.4	10.0	12.4	5.6	13.6	14.8	10.1	9.2	4.6	6.6	5.3	4.6	7.6	2.7	5.4	6.4	8.3	7.3	5.1	4.1	3.9	5.4	3.8	5.4	4.7	3.9	4.8	10.0	4.0	4.0	6.3	3.9	6.4	5.0	4.3	6.9	8.8	15.7	4.0	9.3	8.9	6.3	4.7	6.7	4.7	9.2	5.5	7.0	4.4	4.1	3.8	9.2	7.1	7.4	7.9	9.3	2.9	5.2	5.2	5.0	11.3	10.8	4.3	5.4	4.7	5.9	6.6	5.5	4.3	6.1	6.8	4.6	5.0	6.9	8.0	2.5	7.2	8.6	6.6	5.3	2.8	6.7	4.6	7.6	6.6	6.0	6.3	2.5	9.2	7.3	6.7	5.4	4.6	3.2	4.6	3.9	2.7	9.9	10.3	13.7	12.3	9.9	9.2	16.4	9.8	10.0	10.4
TRMT13	"CCDC76, FLJ10287, FLJ11219"	ENSG00000122435	"TRNA methyltransferase 13 homolog"	Q9NUP7	1	100133150-100150497	"Enzymes, Predicted intracellular proteins"	"tRNA processing"	"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA028494	Approved		Approved	"Nucleoplasm,Nuclear bodies,Plasma membrane,Cytosol"				"Nucleoplasm, Plasma membrane"	"Nuclear bodies, Cytosol"	"HPA028494: AB_10601254"	"unprognostic (1.12e-1)"	"unprognostic (3.33e-1)"	"unprognostic (5.76e-2)"	"unprognostic (2.37e-1)"	"unprognostic (9.17e-3)"	"unprognostic (4.97e-2)"	"prognostic unfavourable (5.81e-5)"	"unprognostic (1.16e-3)"	"unprognostic (3.28e-2)"	"unprognostic (8.08e-2)"	"unprognostic (3.22e-1)"	"unprognostic (1.02e-3)"	"prognostic unfavourable (6.89e-6)"	"unprognostic (3.12e-2)"	"unprognostic (7.71e-2)"	"unprognostic (1.99e-2)"	"unprognostic (1.70e-3)"	13.0	12.2	13.9	21.7	24.1	5.9	18.3	26.5	22.5	17.4	13.1	18.2	24.2	13.6	17.4	15.4	13.7	13.9	9.6	12.0	14.4	9.0	12.1	13.0	9.6	20.9	23.1	12.8	21.4	18.1	23.8	26.8	13.2	15.6	14.9	14.4	10.8	14.3	17.4	16.9	17.9	14.2	14.3	19.4	16.5	12.6	11.1	25.8	17.8	16.5	12.0	17.6	13.9	15.8	15.1	9.6	2.2	4.5	5.4	13.6	3.9	10.6	6.2	10.5	7.3	5.7	11.2	11.5	11.3	4.5	8.6	7.2	7.4	4.4	17.6	14.1	9.0	9.7	19.3	8.7	15.0	17.7	15.3	10.5	13.8	7.1	10.3	18.1	9.9	7.8	10.0	16.3	21.5	7.8	22.0	11.4	8.6	4.0	14.8	9.6	14.6	12.6	15.9	15.9	9.6	7.1	8.5	6.9	11.5	10.4	10.0	13.3	5.9	16.1	8.1	11.5	7.7	9.6	15.0	14.6	11.8	20.9	13.0	14.6	4.4	0.1	4.5	2.2	8.5	4.4	10.4	14.8	9.0	8.3	5.2	15.1	13.6	11.1	1.9	5.4	3.5	9.6	6.2	3.9	13.9	24.1	26.5	22.5	14.4	9.0	23.1	12.8	15.6	25.8
TRPM1	"CSNB1C, LTRPC1, MLSN1"	ENSG00000134160	"Transient receptor potential cation channel subfamily M member 1"	Q7Z4N2	15	31001061-31161273	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Voltage-gated ion channels"	"Ion transport, Sensory transduction, Transport, Vision"	"Ion channel, Ligand-gated ion channel, Receptor"	"Congenital stationary night blindness, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	9	"retina: 99.0"	"Cell line enriched"	"Detected in single"	122	"SK-MEL-30: 15.9"	"Cancer enriched"	"Detected in single"	179	"melanoma: 14.6"	"Low region specificity"	"Detected in single"			"Cell type enhanced"	"Detected in single"		"naive B-cell: 1.0"	"Low lineage specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA014779, HPA071139"	Enhanced		Uncertain	"Golgi apparatus,Plasma membrane,Centriolar satellite"				"Centriolar satellite"	"Golgi apparatus, Plasma membrane"	"HPA014779: , HPA071139: "	"unprognostic (5.28e-2)"	"unprognostic (1.35e-1)"		"unprognostic (9.89e-2)"	"unprognostic (3.07e-1)"	"unprognostic (1.97e-1)"	"unprognostic (1.70e-1)"	"unprognostic (1.29e-3)"	"unprognostic (2.83e-1)"	"unprognostic (2.89e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.45e-2)"	"unprognostic (2.58e-1)"	"unprognostic (7.84e-2)"	"unprognostic (6.20e-4)"	"unprognostic (1.48e-1)"	"unprognostic (2.63e-2)"	0.1	0.0	0.4	0.0	0.6	0.0	0.1	0.1	0.3	0.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.7	0.2	0.3	0.1	0.1	0.1	1.6	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	99.0	0.4	0.0	0.2	10.4	0.0	0.1	1.9	0.0	0.0	2.9	0.1	0.0	0.0	0.0	0.1	0.0	0.0	1.0	0.0	0.3	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.4	0.6	0.1	0.3	0.7	0.2	1.6	0.0	0.3	0.1
TRPM7	"CHAK1, LTRPC7, TRP-PLIK"	ENSG00000092439	"Transient receptor potential cation channel subfamily M member 7"	Q96QT4	15	50552473-50686815	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Calcium transport, Ion transport, Necrosis, Transport"	"Calcium channel, Ion channel, Kinase, Serine/threonine-protein kinase, Transferase"	"Amyotrophic lateral sclerosis, Neurodegeneration, Parkinsonism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"parathyroid gland: 91.8"	"Cell line enhanced"	"Detected in all"		"U-2197: 49.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035522, HPA052173"	Enhanced		Approved	"Vesicles,Plasma membrane,Cytosol"				"Plasma membrane"	"Vesicles, Cytosol"	"HPA035522: , HPA052173: "	"unprognostic (3.14e-2)"	"unprognostic (1.86e-1)"	"unprognostic (1.58e-1)"	"unprognostic (1.42e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.60e-2)"	"unprognostic (1.85e-2)"	"unprognostic (2.59e-2)"	"unprognostic (5.46e-3)"	"unprognostic (2.64e-1)"	"unprognostic (2.91e-1)"	"unprognostic (1.59e-2)"	"unprognostic (3.20e-2)"	"unprognostic (2.08e-1)"	"unprognostic (7.59e-2)"	"unprognostic (9.45e-2)"	"unprognostic (1.97e-1)"	13.3	10.8	6.6	14.7	9.0	12.8	12.1	19.5	9.3	11.8	11.7	8.1	9.7	9.9	16.5	10.7	9.4	11.0	8.2	19.1	5.5	4.9	16.0	20.0	10.8	10.6	12.4	5.2	16.6	11.6	91.8	14.6	14.3	10.2	9.7	10.3	28.6	11.5	13.5	10.8	11.7	12.8	12.8	9.8	11.1	10.3	6.9	10.0	14.5	12.6	6.9	12.6	12.9	12.3	7.0	4.7	4.4	3.4	5.7	7.6	2.0	8.3	8.3	7.0	7.7	20.2	15.2	8.5	10.6	14.7	6.7	8.9	11.4	4.6	18.2	5.2	12.2	14.1	9.3	7.8	9.7	10.1	5.6	14.5	12.8	6.0	18.4	15.0	11.3	14.1	9.2	7.6	14.4	5.4	16.4	14.0	12.2	13.1	9.6	7.3	5.3	5.1	10.6	9.7	8.9	9.4	19.8	5.8	7.4	7.3	11.6	14.2	7.3	16.3	8.2	10.7	5.1	49.9	12.1	9.5	21.0	17.5	11.7	30.7	9.9	3.8	3.4	3.9	6.6	3.2	7.6	5.6	4.8	4.4	3.7	7.0	4.4	5.2	4.4	5.7	3.2	4.7	4.8	2.0	6.6	9.0	19.5	9.3	5.5	4.9	12.4	5.2	10.2	10.0
TRPV3	VRL3	ENSG00000167723	"Transient receptor potential cation channel subfamily V member 3"	Q8NET8	17	3510502-3557995	"Disease related genes, FDA approved drug targets, Predicted membrane proteins"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Ion channel"	"Disease mutation, FDA approved drug targets, Palmoplantar keratoderma"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"intestine: 15.4;skeletal muscle: 29.1"	"Cell line enhanced"	"Detected in some"		"A-431: 3.5;BEWO: 5.3;CACO-2: 4.2;RH-30: 13.0;T-47d: 5.5;U-266/70: 3.5"	"Low cancer specificity"	"Detected in some"			"Region enhanced"	"Detected in some"		"basal ganglia: 2.4"	"Cell type enhanced"	"Detected in some"		"basophil: 2.9"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in some"			"Region enriched"	"Detected in many"	6	"cerebellum: 14.0"	HPA069550			Approved	"Plasma membrane,Centrosome,Cytosol"				"Plasma membrane"	"Centrosome, Cytosol"	"HPA069550: "	"unprognostic (1.84e-4)"	"unprognostic (2.25e-1)"	"unprognostic (5.22e-2)"	"unprognostic (3.92e-4)"	"unprognostic (4.87e-3)"	"unprognostic (2.96e-2)"	"unprognostic (6.66e-2)"	"unprognostic (4.88e-2)"	"unprognostic (7.02e-2)"	"unprognostic (2.68e-1)"	"unprognostic (4.88e-2)"	"unprognostic (3.69e-2)"	"unprognostic (0.00e+0)"	"unprognostic (1.12e-1)"	"unprognostic (1.77e-1)"	"unprognostic (8.64e-2)"	"unprognostic (2.93e-2)"	0.4	0.2	0.4	3.2	2.4	0.9	4.1	0.3	1.2	0.6	10.6	0.1	0.3	3.2	0.2	0.2	2.3	0.3	0.8	0.3	0.4	0.3	0.2	1.1	0.3	0.5	0.4	0.2	0.3	0.9	0.0	0.7	0.4	0.0	0.2	2.9	0.3	0.5	0.4	29.1	8.4	15.4	0.5	0.5	0.4	1.6	0.8	0.0	0.0	0.2	9.7	3.0	0.7	2.1	0.7	0.6	2.9	0.6	0.6	0.7	0.1	3.5	0.0	0.5	0.1	0.2	0.6	5.3	0.2	0.0	0.0	0.0	4.2	0.9	0.2	1.0	0.1	0.4	0.0	0.1	0.0	0.1	0.1	0.0	0.3	0.6	0.1	0.2	0.8	0.3	0.0	0.7	1.8	0.0	0.1	0.1	0.0	0.7	0.1	0.2	0.1	0.5	0.1	13.0	0.2	0.0	0.2	0.1	0.0	0.2	0.6	0.0	5.5	0.2	0.1	0.1	0.2	0.1	0.1	3.5	2.7	0.0	0.1	0.1	0.0	2.9	0.4	0.4	0.7	0.2	0.5	0.7	0.4	0.7	0.1	0.5	0.4	0.6	1.0	0.6	0.6	0.6	0.2	0.1	0.4	2.4	0.3	1.2	0.4	0.3	0.4	0.2	0.0	0.0
TSG101	"TSG10, VPS23"	ENSG00000074319	"Tumor susceptibility 101"	Q99816	11	18468336-18527232	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Growth regulation, Host-virus interaction, Protein transport, Transport"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB004283, HPA006161"	Approved		Supported	"Nucleoli,Plasma membrane,Cytosol"			14000	Cytosol	"Nucleoli, Plasma membrane"	"CAB004283: AB_671392, HPA006161: AB_1080408"	"unprognostic (1.42e-1)"	"unprognostic (7.91e-2)"	"unprognostic (2.11e-1)"	"unprognostic (6.77e-2)"	"unprognostic (1.82e-1)"	"unprognostic (2.72e-3)"	"prognostic unfavourable (3.74e-6)"	"unprognostic (5.67e-2)"	"unprognostic (2.08e-1)"	"unprognostic (2.00e-2)"	"unprognostic (4.15e-3)"	"unprognostic (4.27e-2)"	"prognostic favourable (5.52e-6)"	"unprognostic (1.92e-2)"	"unprognostic (1.02e-1)"	"unprognostic (4.02e-3)"	"unprognostic (1.06e-1)"	24.7	30.5	18.4	14.2	25.5	23.5	27.6	22.7	25.9	22.5	23.1	23.7	21.6	20.5	25.8	27.7	34.3	23.9	18.4	31.8	17.7	20.6	33.4	29.0	20.1	23.4	21.6	21.4	23.2	39.5	33.2	23.5	38.5	24.6	21.9	28.4	19.4	25.4	22.4	44.5	27.3	25.7	23.1	21.7	20.5	23.0	33.7	20.2	27.5	32.3	37.1	25.5	24.2	25.5	20.5	18.2	42.3	29.2	14.3	22.0	22.2	14.3	23.7	21.0	14.6	24.9	26.0	19.5	22.3	30.1	27.3	27.0	16.2	7.6	19.4	13.7	24.8	22.0	20.9	20.2	30.4	27.2	25.5	12.0	12.5	23.8	32.0	18.0	20.8	22.4	41.1	14.2	38.8	22.4	19.5	16.5	33.0	25.9	11.4	19.6	12.9	24.0	10.3	21.2	16.1	18.3	20.5	15.0	26.9	21.4	18.0	28.5	17.9	18.1	12.0	18.3	11.2	38.2	16.5	10.6	20.4	15.4	18.9	10.0	23.4	42.3	19.5	40.7	14.9	21.7	15.0	20.5	14.4	15.9	18.2	18.0	15.4	16.4	34.5	14.3	29.2	15.4	22.0	22.2	18.4	25.5	22.7	25.9	17.7	20.6	21.6	21.4	24.6	20.2
TSHZ3	"KIAA1474, TSH3, ZNF537"	ENSG00000121297	"Teashirt zinc finger homeobox 3"	Q63HK5	19	31274945-31349547	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 12.7;RH-30: 26.1;U-138 MG: 18.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"neutrophil: 4.9"	"Group enriched"	"Detected in many"	35	"granulocytes: 4.9;monocytes: 2.2;T-cells: 3.2"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"cerebral cortex: 20.4;hippocampal formation: 16.8"	"HPA008834, HPA071010"	Approved		Enhanced	"Nucleoplasm,Plasma membrane"				Nucleoplasm	"Plasma membrane"	"HPA008834: AB_1080731, HPA071010: "	"unprognostic (2.56e-1)"	"unprognostic (3.88e-1)"	"unprognostic (4.56e-2)"	"unprognostic (3.66e-1)"	"unprognostic (1.66e-3)"	"unprognostic (4.07e-2)"	"unprognostic (1.67e-1)"	"unprognostic (2.46e-1)"	"unprognostic (1.76e-1)"	"unprognostic (3.58e-3)"	"unprognostic (2.23e-1)"	"unprognostic (3.91e-2)"	"prognostic unfavourable (2.92e-4)"	"unprognostic (8.76e-3)"	"unprognostic (8.22e-2)"	"unprognostic (1.91e-2)"	"unprognostic (1.73e-3)"	5.7	3.3	4.4	4.0	6.6	1.0	5.2	1.1	17.3	13.0	11.6	0.7	2.4	2.5	19.4	8.5	5.6	9.5	11.5	4.6	3.3	2.0	2.8	1.3	4.9	1.2	1.6	8.0	28.0	1.5	1.1	7.2	4.8	2.8	9.5	3.7	4.9	2.8	8.9	1.6	2.5	4.3	16.4	3.3	4.5	6.1	3.3	1.2	0.0	8.5	1.7	0.7	11.1	11.4	0.0	0.0	4.9	2.2	0.0	3.2	0.7	0.0	1.1	0.4	0.0	5.8	12.7	0.0	3.3	4.8	2.1	3.7	0.0	0.7	0.0	0.0	8.2	0.5	1.5	3.1	4.6	0.0	1.3	0.0	0.0	0.0	11.2	2.8	5.2	7.5	2.8	7.6	3.9	0.0	0.0	0.0	9.6	0.5	0.0	0.0	0.5	0.0	3.2	26.1	0.0	0.0	0.0	0.0	8.0	0.0	0.0	2.5	0.0	1.9	0.0	18.5	5.9	2.1	4.7	0.0	0.0	0.0	12.0	4.8	0.5	0.0	2.2	0.0	3.2	0.8	0.1	0.0	0.9	1.0	0.0	0.0	0.3	0.8	4.9	0.0	0.4	0.0	0.7	0.7	4.4	6.6	1.1	17.3	3.3	2.0	1.6	8.0	2.8	1.2
TTC23	"FLJ12572, HCC-8"	ENSG00000103852	"Tetratricopeptide repeat domain 23"	Q5W5X9	15	99136323-99251223	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039806, HPA040369"	Uncertain		Approved	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		"HPA039806: AB_10793921, HPA040369: AB_10795381"	"prognostic favourable (3.17e-4)"	"unprognostic (5.41e-2)"	"unprognostic (1.45e-1)"	"prognostic favourable (1.07e-4)"	"unprognostic (1.40e-2)"	"unprognostic (6.53e-2)"	"unprognostic (9.25e-3)"	"unprognostic (2.56e-1)"	"unprognostic (6.18e-2)"	"unprognostic (1.76e-3)"	"unprognostic (1.88e-1)"	"unprognostic (3.24e-1)"	"unprognostic (3.21e-2)"	"unprognostic (1.11e-2)"	"unprognostic (4.31e-1)"	"unprognostic (7.99e-2)"	"unprognostic (1.23e-1)"	9.5	10.7	6.0	6.1	8.6	1.0	9.7	5.4	7.5	13.2	15.5	12.2	11.9	3.7	20.3	9.9	10.7	10.6	10.4	11.9	7.7	4.7	10.6	8.2	8.1	3.0	9.8	7.5	17.5	11.7	10.7	10.2	10.0	10.5	13.7	8.7	14.0	8.4	12.0	7.8	8.6	6.4	12.3	15.7	5.2	8.7	16.2	9.0	5.1	14.1	7.7	5.0	13.0	11.4	0.5	2.4	3.8	1.3	2.0	0.5	0.1	6.7	7.1	10.9	12.5	13.0	14.7	4.6	8.4	10.3	9.0	10.2	6.1	11.9	1.7	17.0	9.5	13.2	3.5	8.3	9.8	2.2	11.6	7.2	12.4	4.7	7.6	1.6	0.5	10.4	7.5	7.1	6.8	15.1	5.5	1.0	8.4	4.0	5.7	1.8	5.9	4.9	1.8	14.2	2.5	7.3	9.1	4.7	2.1	11.1	4.5	10.2	7.5	7.5	9.9	11.4	6.9	7.6	10.7	6.0	8.1	2.3	10.3	0.5	6.7	3.8	0.5	0.6	0.3	1.3	0.3	0.4	0.4	0.5	2.4	0.5	0.3	0.3	1.8	2.0	0.5	1.9	0.4	0.1	6.0	8.6	5.4	7.5	7.7	4.7	9.8	7.5	10.5	9.0
TTC7B	TTC7L1	ENSG00000165914	"Tetratricopeptide repeat domain 7B"	Q86TV6	14	90524564-90816479	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HMC-1: 33.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"basophil: 7.0;eosinophil: 9.7"	"Lineage enriched"	"Detected in many"	8	"granulocytes: 9.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA058363, HPA059577"	Enhanced		Supported	"Plasma membrane"			11000	"Plasma membrane"		"HPA058363: , HPA059577: "	"unprognostic (9.37e-2)"	"unprognostic (4.20e-2)"	"unprognostic (1.01e-2)"	"unprognostic (2.41e-2)"	"unprognostic (2.58e-1)"	"unprognostic (2.67e-4)"	"unprognostic (9.42e-2)"	"unprognostic (2.17e-1)"	"unprognostic (5.38e-2)"	"unprognostic (7.60e-2)"	"unprognostic (2.75e-3)"	"unprognostic (2.87e-2)"	"prognostic favourable (3.20e-6)"	"unprognostic (2.74e-2)"	"unprognostic (7.41e-2)"	"unprognostic (4.48e-2)"	"unprognostic (1.07e-2)"	16.2	9.0	29.1	6.6	20.1	6.7	7.1	40.6	33.7	10.0	7.9	10.9	5.6	3.8	11.0	5.0	11.8	5.7	7.0	23.8	26.0	15.9	7.7	6.7	8.9	2.8	14.7	18.3	9.9	17.2	6.7	7.0	19.2	20.3	10.1	3.6	8.8	8.6	11.1	37.4	3.2	4.2	13.1	8.8	10.6	6.1	2.7	8.1	0.3	5.9	2.5	2.1	8.1	4.8	0.4	0.7	9.7	0.6	0.5	1.2	0.7	8.3	7.6	9.0	6.6	8.4	10.0	29.7	6.8	5.9	9.2	9.9	2.0	2.2	0.1	10.8	7.7	0.1	5.8	4.8	8.9	15.3	6.3	18.9	3.9	1.8	8.5	0.4	33.2	7.4	3.2	4.9	6.1	13.1	10.5	15.7	8.8	9.0	0.2	7.4	5.1	6.6	16.4	14.9	2.8	2.9	6.3	13.8	9.5	6.8	2.8	14.5	4.0	5.8	14.9	9.4	7.5	6.8	11.1	5.4	2.6	0.1	13.6	1.8	9.2	7.0	0.3	9.7	0.2	0.6	0.3	0.3	0.3	0.2	0.4	0.4	0.3	0.2	1.4	0.5	0.2	0.7	1.2	0.7	29.1	20.1	40.6	27.8	26.0	15.9	14.7	18.3	20.3	8.1
TTLL12	KIAA0153	ENSG00000100304	"Tubulin tyrosine ligase like 12"	Q14166	22	43166622-43187133	"Plasma proteins, Predicted intracellular proteins"	"Immunity, Innate immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003054, CAB046029"	Approved		Approved	"Plasma membrane,Cytosol"			2100000	Cytosol	"Plasma membrane"	"CAB046029: AB_11128395, HPA003054: "	"unprognostic (2.45e-2)"	"unprognostic (3.47e-2)"	"unprognostic (7.37e-3)"	"unprognostic (5.40e-2)"	"unprognostic (2.65e-1)"	"unprognostic (3.50e-1)"	"prognostic unfavourable (2.84e-4)"	"unprognostic (5.81e-3)"	"unprognostic (2.24e-1)"	"unprognostic (6.08e-2)"	"unprognostic (4.75e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.17e-3)"	"unprognostic (1.40e-1)"	"unprognostic (6.66e-2)"	"unprognostic (2.81e-2)"	7.3	13.8	7.2	14.7	8.3	14.0	11.2	13.6	12.3	10.9	21.5	5.5	8.9	15.0	7.1	8.7	46.3	9.0	36.0	6.9	7.3	7.1	8.4	19.4	5.3	9.2	6.5	5.9	16.5	29.8	4.4	7.0	6.8	7.1	9.4	12.1	7.0	13.5	7.9	5.5	16.4	13.9	5.9	4.0	9.7	20.7	18.3	5.3	10.7	7.6	23.7	23.5	8.3	15.2	3.5	3.8	1.3	4.7	4.3	5.6	3.3	31.5	13.3	5.4	13.3	8.3	5.7	17.5	10.4	3.7	10.0	5.2	21.6	18.0	30.4	12.6	8.6	22.5	22.4	19.0	2.5	3.8	35.6	7.4	21.4	18.5	13.0	33.4	7.7	9.0	23.2	11.9	12.8	10.5	45.8	7.2	4.6	29.3	23.2	18.1	19.6	13.3	23.6	18.6	43.7	8.4	10.4	16.5	6.8	22.1	32.4	11.7	12.7	14.9	10.0	6.7	9.4	12.8	14.4	12.2	15.0	22.5	7.6	17.2	9.0	0.0	4.7	0.7	5.6	2.4	5.5	3.5	5.5	4.1	3.8	2.7	5.5	3.7	1.3	4.3	3.1	3.3	3.5	3.3	7.2	8.3	13.6	12.3	7.3	7.1	6.5	5.9	7.1	5.3
TXNIP	"ARRDC6, EST01027, HHCPA78, THIF, VDUP1"	ENSG00000265972	"Thioredoxin interacting protein"	Q9H3M7	1	145992435-145996600	"Cancer-related genes, Predicted intracellular proteins"	"Cell cycle, Transcription, Transcription regulation"		"Cancer-related genes, Tumor suppressor"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 110.2;HSkMC: 146.6;hTCEpi: 74.7"	"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031085, HPA053694"	Approved		Approved	"Plasma membrane,Cytosol"				"Plasma membrane"	Cytosol	"HPA031085: AB_10601706, HPA053694: AB_2682232"	"unprognostic (1.45e-1)"	"unprognostic (1.57e-2)"	"unprognostic (1.67e-2)"	"unprognostic (4.16e-2)"	"unprognostic (1.92e-2)"	"unprognostic (3.93e-2)"	"unprognostic (1.55e-2)"	"unprognostic (2.51e-1)"	"unprognostic (9.23e-2)"	"unprognostic (1.20e-1)"	"unprognostic (3.65e-2)"	"unprognostic (1.19e-1)"	"unprognostic (8.49e-3)"	"unprognostic (1.35e-2)"	"unprognostic (1.31e-1)"	"unprognostic (8.19e-2)"	"unprognostic (2.22e-3)"	127.7	10.6	4.1	17.0	4.6	10.5	73.6	2.5	6.0	45.9	49.8	16.1	25.0	6.3	39.3	22.8	41.0	20.3	20.4	55.3	4.8		34.8	11.7	52.3	82.6	6.5	4.2	34.1	25.8	9.3	20.2	19.1	8.3	47.4	16.1	18.8	18.5	19.5	97.0	15.3	27.7	34.6	9.2	39.0	13.6	23.1	6.0	29.0	85.3	16.0	41.5	52.5	32.3	64.9	35.5	134.9	58.3	65.3	90.0	132.5	6.0	0.0	1.4	0.1	33.5	110.2	3.3	7.2	14.5	6.5	9.0	3.8	8.2	1.7	42.9	1.9	1.6	1.4	13.7	17.6	7.9	0.7	4.9	2.2	3.5	1.5	20.1	10.3	146.6	74.7	13.3	23.5	2.5	19.5	13.5	3.3	8.2	3.3	19.3	4.0	5.4	3.0	12.1	52.3	17.1	13.4	6.9	11.2	31.1	9.0	24.6	3.2	28.8	6.1	18.2	1.1	34.0	11.8	19.0	18.1	1.5	4.4	9.3	9.5	94.7	53.3	123.0	90.0	58.3	83.1	58.8	76.5	79.9	35.5	64.9	76.0	80.3	134.9	65.3	49.9	16.7	70.6	132.5										
TYW3	"C1orf171, FLJ40918"	ENSG00000162623	"TRNA-yW synthesizing protein 3 homolog"	Q6IPR3	1	74733152-74766678	"Enzymes, Predicted intracellular proteins"	"tRNA processing"	"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029641	Approved		Approved	"Plasma membrane,Cytosol"				Cytosol	"Plasma membrane"	"HPA029641: AB_2272535"	"unprognostic (6.89e-3)"	"unprognostic (1.06e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.42e-1)"	"unprognostic (7.24e-2)"	"prognostic unfavourable (1.49e-7)"	"unprognostic (3.79e-1)"	"unprognostic (2.23e-1)"	"unprognostic (2.96e-1)"	"unprognostic (4.08e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.70e-1)"	"unprognostic (1.13e-1)"	"unprognostic (2.05e-1)"	"unprognostic (8.90e-2)"	"unprognostic (2.98e-3)"	16.5	19.7	13.7	13.5	17.7	11.9	18.3	15.0	19.9	20.4	17.7	7.5	13.7	9.5	21.0	15.2	20.6	16.4	10.0	21.1	11.1	12.9	20.4	17.0	11.3	14.3	16.2	17.2	30.0	14.4	22.2	34.3	13.5	17.0	20.7	12.3	8.6	13.8	15.7	12.3	10.5	10.9	24.7	15.6	16.0	14.8	12.3	18.1	12.3	23.5	14.3	16.9	23.5	33.3	9.7	9.0	6.0	8.0	13.6	13.9	5.2	8.4	7.1	12.4	8.8	14.1	15.4	18.8	14.6	13.4	14.0	12.3	15.1	7.2	22.3	13.4	12.6	6.9	14.1	16.9	17.6	13.8	12.2	17.5	21.8	29.2	9.2	34.9	11.3	11.7	17.1	17.8	17.3	12.4	30.3	17.1	17.9	7.2	17.0	11.7	32.8	16.7	16.1	25.8	10.0	12.0	11.1	9.6	8.2	6.9	19.1	22.4	10.4	12.8	8.0	6.2	17.0	16.8	17.5	9.9	17.9	15.6	13.9	12.7	17.8	6.0	6.0	1.6	10.3	8.0	9.9	9.7	9.1	9.3	9.0	8.8	13.2	13.9	0.5	13.6	5.9	8.7	8.4	5.2	13.7	17.7	15.0	19.9	11.1	12.9	16.2	17.2	17.0	18.1
UAP1	"AgX, AGX1, SPAG2"	ENSG00000117143	"UDP-N-acetylglucosamine pyrophosphorylase 1"	Q16222	1	162561506-162599842	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Nucleotidyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"hTERT-HME1: 105.7;U-251 MG: 68.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA014659	Approved		Supported	"Nucleoplasm,Plasma membrane,Cytosol"			19000	"Nucleoplasm, Plasma membrane, Cytosol"		"HPA014659: AB_1857409"	"unprognostic (2.32e-2)"	"unprognostic (2.45e-1)"	"unprognostic (2.07e-2)"	"unprognostic (1.28e-2)"	"unprognostic (2.71e-2)"	"unprognostic (1.46e-2)"	"unprognostic (1.37e-2)"	"unprognostic (1.47e-1)"	"unprognostic (2.09e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.29e-3)"	"unprognostic (4.96e-2)"	"prognostic unfavourable (5.12e-5)"	"unprognostic (1.59e-1)"	"unprognostic (2.04e-1)"	"unprognostic (3.51e-1)"	"unprognostic (3.45e-2)"	38.4	18.5	7.0	17.4	9.8	17.2	24.8	9.0	13.4	16.1	26.9	5.7	45.7	17.2	10.9	19.4	23.6	15.7	18.3	22.5	7.7	7.8	11.0	67.1	16.0	7.4	6.6	8.9	20.4	31.4	5.1	16.0	21.5	9.1	13.9	26.9	7.8	43.9	62.5	19.4	12.4	33.4	28.8	7.1	8.1	23.0	37.7	3.7	5.6	12.4	13.5	15.3	24.4	16.7	8.3	5.6	8.1	1.6	6.2	16.1	4.8	29.9	2.1	6.0	4.8	29.2	23.4	4.1	44.1	16.2	34.0	27.8	5.7	14.1	1.1	9.9	33.8	5.2	6.7	12.8	56.1	4.7	10.1	5.3	6.9	11.1	13.7	9.0	3.6	10.8	6.1	37.3	105.7	20.8	29.9	12.4	45.4	5.5	5.2	5.8	4.4	9.8	4.7	11.7	14.6	5.3	3.5	6.4	6.7	19.2	12.0	10.2	5.9	10.3	35.3	17.2	15.8	43.2	68.8	20.8	7.3	9.9	9.8	4.2	10.8	1.0	1.6	8.1	13.0	1.6	16.1	8.3	7.9	13.3	3.4	6.5	7.6	9.5	1.6	6.2	0.8	5.6	3.9	4.8	7.0	9.8	9.0	13.4	7.7	7.8	6.6	8.9	9.1	3.7
UBA3	"hUba3, NAE2, UBE1C"	ENSG00000144744	"Ubiquitin like modifier activating enzyme 3"	Q8TBC4	3	69054730-69080408	"Predicted intracellular proteins"	"Cell cycle, Ubl conjugation pathway"	Ligase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA034873, HPA034874, HPA065335"	Supported		Approved	"Nucleoplasm,Plasma membrane,Centrosome,Cytosol"			9600	"Plasma membrane, Cytosol"	"Nucleoplasm, Centrosome"	"HPA034873: AB_10670578, HPA034874: , HPA065335: "	"unprognostic (2.31e-1)"	"unprognostic (1.75e-1)"	"unprognostic (5.56e-3)"	"unprognostic (9.26e-2)"	"unprognostic (9.35e-3)"	"unprognostic (5.53e-2)"	"prognostic unfavourable (8.57e-4)"	"unprognostic (1.08e-1)"	"unprognostic (6.18e-2)"	"unprognostic (1.60e-3)"	"unprognostic (9.40e-2)"	"unprognostic (2.71e-2)"	"unprognostic (1.39e-3)"	"unprognostic (2.61e-3)"	"unprognostic (9.24e-2)"	"unprognostic (7.80e-3)"	"unprognostic (2.52e-1)"	19.1	25.3	29.7	22.2	31.0	53.7	26.8	30.9	31.4	20.3	19.7	31.3	15.9	16.1	22.8	25.4	25.4	19.5	18.4	38.2	23.8	22.7	24.7	17.6	19.3	28.7	37.5	21.2	20.4	15.1	17.9	28.0	27.8	40.8	22.6	22.6	21.8	28.0	20.4	25.0	27.6	21.9	24.0	30.2	27.8	17.3	13.5	31.9	28.4	18.2	17.2	31.0	22.9	20.4	18.9	22.3	35.6	27.8	20.2	22.2	26.0	26.8	11.4	28.1	17.1	26.3	34.9	21.7	24.1	27.3	26.3	26.5	14.1	19.0	20.5	7.0	25.9	15.5	21.6	27.6	30.0	37.3	13.7	27.7	21.5	14.2	20.3	27.1	23.3	27.4	18.5	24.8	20.8	33.8	11.4	17.6	34.6	9.6	17.8	18.3	24.9	9.8	13.9	20.8	18.8	41.9	34.4	12.1	16.9	25.4	18.5	20.6	12.6	26.7	25.6	20.0	17.6	25.9	33.4	20.2	32.3	24.4	20.5	30.2	25.4	34.7	25.4	35.6	14.3	27.8	16.1	18.9	18.9	17.6	22.3	16.0	17.9	18.0	24.4	20.2	27.7	11.4	22.2	26.0	29.7	31.0	30.9	31.4	23.8	22.7	37.5	21.2	40.8	31.9
UBA52	"CEP52, HUBCEP52, L40, MGC126879, MGC126881, MGC57125, RPL40"	ENSG00000221983	"Ubiquitin A-52 residue ribosomal protein fusion product 1"	P62987	19	18571730-18577550	"Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"HPA041344, HPA049132, HPA056624"	Supported		Approved	"Nucleoplasm,Endoplasmic reticulum,Plasma membrane,Cytosol"				"Endoplasmic reticulum, Cytosol"	"Nucleoplasm, Plasma membrane"	"HPA041344: , HPA049132: , HPA056624: "	"unprognostic (1.98e-2)"	"unprognostic (9.35e-2)"	"unprognostic (1.46e-1)"	"unprognostic (4.72e-2)"	"unprognostic (5.36e-3)"	"unprognostic (9.35e-2)"	"unprognostic (1.74e-3)"	"unprognostic (4.00e-2)"	"unprognostic (7.44e-2)"	"unprognostic (1.72e-1)"	"unprognostic (1.27e-1)"	"unprognostic (2.87e-1)"	"unprognostic (2.52e-3)"	"unprognostic (1.87e-1)"	"unprognostic (5.61e-2)"	"unprognostic (2.43e-1)"	"unprognostic (2.23e-1)"	84.7	73.8	71.1	76.4	76.5	167.0	101.5	32.8	71.1	83.2	73.0	48.7	67.8	47.7	79.0	93.2	102.7	78.8	82.0	85.9	58.2	50.2	74.1	135.5	67.7	182.7	64.0	59.0	150.3	225.2	56.5	62.8	71.6	55.5	75.8	74.0	51.6	96.0	75.2	191.4	104.6	68.0	91.9	72.0	101.1	75.5	89.5	52.1	121.2	97.6	131.7	145.1	99.9	161.7	200.5	157.0	75.1	132.4	109.7	205.0	246.6	104.6	83.7	62.9	104.8	163.3	155.4	155.9	80.9	112.4	134.4	107.3	151.5	98.2	151.9	83.7	133.3	71.0	121.5	143.8	127.2	40.7	189.8	83.1	130.1	170.8	119.0	180.2	106.5	179.8	196.8	92.1	134.0	134.6	131.4	210.6	114.6	175.3	143.9	161.7	140.7	181.3	119.1	62.8	173.8	129.5	159.2	82.0	99.2	58.7	142.4	140.2	63.1	233.3	99.9	67.5	56.4	142.0	142.9	129.7	172.1	150.3	91.8	204.8	91.3	50.7	132.4	69.8	119.4	107.2	162.2	200.5	178.5	142.6	147.6	199.1	205.0	165.6	75.1	109.7	96.1	157.0	138.5	246.6	71.1	76.5	32.8	71.1	58.2	50.2	64.0	59.0	55.5	52.1
UBAC1	"GBDR1, KPC2, UBADC1"	ENSG00000130560	"UBA domain containing 1"	Q9BSL1	9	135932969-135961380	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"skeletal muscle: 113.2"	"Cell line enhanced"	"Detected in all"		"HDLM-2: 59.3;K-562: 75.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA005651	Approved		Supported	"Golgi apparatus,Plasma membrane,Cytosol"			54000	"Plasma membrane, Cytosol"	"Golgi apparatus"	"HPA005651: AB_1858489"	"unprognostic (8.41e-2)"	"prognostic favourable (4.34e-6)"	"unprognostic (2.10e-1)"	"unprognostic (9.15e-2)"	"unprognostic (4.11e-1)"	"unprognostic (3.85e-2)"	"unprognostic (7.68e-3)"	"unprognostic (2.85e-1)"	"unprognostic (4.37e-2)"	"unprognostic (3.23e-1)"	"unprognostic (3.92e-3)"	"unprognostic (1.20e-1)"	"prognostic favourable (3.58e-7)"	"unprognostic (1.95e-3)"	"unprognostic (9.46e-2)"	"unprognostic (3.16e-2)"	"unprognostic (5.78e-2)"	7.6	5.7	12.4	5.8	13.4	27.1	6.2	10.9	12.7	6.1	11.0	8.0	6.8	9.9	6.2	10.3	10.0	9.4	5.1	22.2	11.0	8.6	8.8	7.6	6.4	5.8	11.6	7.4	7.8	6.7	6.9	6.6	9.3	8.7	7.4	7.8	7.7	9.2	9.2	113.2	15.7	9.6	9.3	10.1	5.7	6.1	10.9	7.8	3.9	6.1	21.9	9.0	7.6	8.3	3.2	9.7	5.1	18.8	2.2	3.6	4.0	8.9	10.5	7.5	10.8	5.6	6.6	14.0	7.9	6.7	9.8	7.9	14.5	11.5	10.8	7.6	6.4	30.7	10.4	9.1	4.4	59.3	9.8	9.0	18.9	8.1	5.9	11.7	8.7	6.2	12.0	6.2	6.0	8.1	75.2	8.8	7.7	18.5	9.6	12.1	17.7	17.9	10.8	14.1	14.3	7.0	5.8	11.6	12.8	11.4	10.3	8.0	8.7	12.7	6.6	5.6	8.4	6.6	9.7	5.1	9.6	12.9	10.3	10.7	7.6	3.4	11.3	5.1	3.1	17.2	3.3	3.2	3.6	2.1	9.7	2.0	1.9	2.2	2.5	2.2	18.8	1.0	2.7	4.0	12.4	13.4	10.9	12.7	11.0	8.6	11.6	7.4	8.7	7.8
UBAP1	UBAP	ENSG00000165006	"Ubiquitin associated protein 1"	Q9NZ09	9	34179005-34252523	"Predicted intracellular proteins"	"Protein transport, Transport"		"Disease mutation, Hereditary spastic paraplegia, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019804	Approved		Supported	"Vesicles,Plasma membrane,Cytosol"				Cytosol	"Vesicles, Plasma membrane"	"HPA019804: AB_1858494"	"unprognostic (1.83e-1)"	"unprognostic (4.30e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.70e-1)"	"unprognostic (3.54e-1)"	"unprognostic (3.29e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.59e-1)"	"unprognostic (2.01e-2)"	"unprognostic (6.53e-2)"	"unprognostic (1.25e-2)"	"unprognostic (3.63e-1)"	"prognostic favourable (7.49e-6)"	"unprognostic (1.24e-1)"	"unprognostic (1.49e-1)"	"unprognostic (2.46e-1)"	"unprognostic (1.17e-1)"	26.4	34.6	25.7	17.5	25.0	81.9	28.6	29.1	29.5	24.2	26.0	26.5	14.5	16.6	25.3	20.0	40.5	20.4	22.9	34.4	24.0	23.6	25.6	38.6	27.7	17.3	27.0	20.0	26.8	20.7	26.7	19.2	26.8	25.5	20.4	19.0	21.5	19.4	24.3	62.3	22.6	24.6	26.4	26.3	21.4	20.9	33.5	26.0	17.2	23.6	22.1	25.4	29.2	29.5	10.5	17.8	45.9	19.6	17.4	26.5	19.2	20.7	11.6	13.5	14.7	25.0	15.5	11.4	16.6	23.4	18.7	25.5	12.7	8.7	14.5	7.5	24.9	10.7	18.7	26.1	18.0	20.9	8.4	13.0	26.2	13.1	22.8	14.4	17.3	19.1	43.4	22.1	29.1	20.6	9.9	14.6	17.4	8.7	13.2	20.1	14.6	17.5	12.0	9.6	8.4	40.0	13.8	7.7	10.8	18.5	19.3	8.5	9.4	14.3	14.7	9.6	14.9	14.3	15.4	7.2	9.0	15.3	19.3	11.7	28.2	9.0	19.6	24.1	15.4	17.1	26.5	10.5	15.5	16.1	17.8	8.8	15.1	12.3	45.9	17.4	14.5	9.9	19.1	19.2	25.7	25.0	29.1	29.5	24.0	23.6	27.0	20.0	25.5	26.0
UBASH3B	"KIAA1959, STS-1, TULA-2, TULA2"	ENSG00000154127	"Ubiquitin associated and SH3 domain containing B"	Q8TF42	11	122655675-122814473	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 32.5;lymphoid tissue: 27.7"	"Cell line enhanced"	"Detected in many"		"HEL: 41.7;HMC-1: 31.7;hTEC/SVTERT24-B: 25.9;REH: 24.9"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"cerebellum: 32.5;pons and medulla: 21.2"	"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038605, HPA038607"	Approved		Approved	"Plasma membrane"			2200000	"Plasma membrane"		"HPA038605: AB_10669648, HPA038607: "	"unprognostic (4.94e-2)"	"unprognostic (6.03e-3)"	"unprognostic (1.34e-1)"	"unprognostic (2.98e-1)"	"unprognostic (2.02e-1)"	"unprognostic (1.49e-1)"	"unprognostic (9.09e-2)"	"unprognostic (4.67e-3)"	"unprognostic (1.21e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.46e-3)"	"unprognostic (6.20e-2)"	"unprognostic (9.02e-3)"	"unprognostic (1.54e-1)"	"unprognostic (3.22e-2)"	"unprognostic (2.72e-3)"	"unprognostic (1.53e-1)"	4.3	1.3	2.8	5.5	4.0	7.2	1.5	32.5	4.9	4.0	1.5	0.7	0.0	1.7	1.3	0.3	1.8	1.1	2.4	1.3	3.4	3.5	1.5	1.7	5.5	10.9	5.1	1.9	0.8	1.2	0.6	0.9	16.8	21.2	1.3	1.8	0.9	1.3	0.9	1.8	4.1	2.4	2.3	2.1	27.7	1.7	2.1	0.2	23.9	2.9	1.7	3.8	3.4	1.3	1.0	1.7	9.8	11.0	6.5	4.9	1.8	4.4	10.9	2.0	2.6	0.8	1.6	10.3	15.8	8.8	6.4	5.0	4.3	2.4	1.8	1.2	8.4	2.2	0.0	5.6	10.3	0.0	0.3	41.7	0.3	3.6	2.4	5.0	31.7	1.4	0.3	25.9	9.6	4.3	0.0	0.0	6.2	0.1	6.1	3.2	0.8	2.6	24.9	1.2	0.2	10.2	3.8	4.5	0.1	4.2	0.3	3.5	0.0	1.3	11.2	8.4	4.5	4.9	6.5	0.3	0.0	5.3	4.4	7.1	15.2	0.0	1.3	9.8	2.0	6.5	2.2	0.3	2.6	1.8	1.7	1.0	3.0	1.6	2.8	6.5	11.0	0.2	4.9	1.8	2.8	4.0	32.5	4.9	3.4	3.5	5.1	1.9	21.2	0.2
UBE2D2	"UBC4, UbcH5B"	ENSG00000131508	"Ubiquitin conjugating enzyme E2 D2"	P62837	5	139526431-139628433	"Enzymes, Plasma proteins, Predicted intracellular proteins, Transporters"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003920	Approved		Approved	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		"HPA003920: AB_1858519"	"unprognostic (1.14e-1)"	"unprognostic (2.75e-3)"	"prognostic favourable (5.09e-5)"	"prognostic favourable (5.90e-4)"	"unprognostic (2.33e-1)"	"unprognostic (8.19e-3)"	"prognostic unfavourable (9.63e-7)"	"unprognostic (7.41e-3)"	"unprognostic (2.17e-1)"	"unprognostic (1.21e-1)"	"unprognostic (9.33e-2)"	"unprognostic (1.41e-3)"	"prognostic unfavourable (2.09e-5)"	"unprognostic (8.00e-2)"	"unprognostic (1.01e-1)"	"unprognostic (4.20e-1)"	"unprognostic (1.07e-1)"	35.6	25.0	41.2	31.5	39.9	44.2	35.9	31.9	49.6	43.9	50.4	35.5	31.5	22.2	35.5	52.2	44.8	47.6	27.1	34.8	39.5	40.5	37.2	39.5	34.8	55.6	40.5	36.1	35.3	41.7	23.8	35.3	33.6	35.9	30.8	46.4	30.7	30.5	37.9	80.6	33.2	37.4	39.3	41.9	41.3	29.1	68.0	29.3	71.0	34.4	31.2	64.5	42.2	36.1	34.3	39.3	40.8	23.0	22.5	41.7	19.5	36.5	24.4	42.8	29.9	28.9	37.1	27.4	38.7	36.2	45.6	53.4	62.8	34.8	52.3	51.0	39.9	23.2	42.0	65.2	61.1	33.7	24.5	29.6	27.0	36.0	56.6	28.9	26.4	29.1	33.7	45.2	67.7	48.6	25.6	44.8	42.2	36.7	44.6	41.2	23.5	26.6	34.0	44.5	37.8	47.9	43.3	39.0	25.8	33.8	43.5	61.4	27.2	25.7	31.8	34.8	19.4	28.9	47.2	32.2	52.3	73.3	24.9	47.7	27.7	14.8	20.9	40.8	22.6	18.8	24.7	34.1	32.7	31.7	23.4	34.3	41.7	35.2	34.5	22.5	23.0	39.3	40.0	19.5	41.2	39.9	31.9	49.6	39.5	40.5	40.5	36.1	35.9	29.3
UBE2D4	HBUCE1	ENSG00000078967	"Ubiquitin conjugating enzyme E2 D4 (putative)"	Q9Y2X8	7	43926438-43956136	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 48.6"	"Cell line enhanced"	"Detected in all"		"SH-SY5Y: 24.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA003920	Approved		Approved	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		"HPA003920: AB_1858519"	"unprognostic (9.95e-3)"	"unprognostic (6.76e-2)"	"unprognostic (6.87e-2)"	"unprognostic (8.94e-2)"	"unprognostic (8.24e-2)"	"unprognostic (5.24e-2)"	"unprognostic (2.42e-1)"	"unprognostic (3.58e-3)"	"unprognostic (4.74e-2)"	"unprognostic (5.04e-2)"	"prognostic favourable (4.86e-4)"	"prognostic favourable (5.77e-4)"	"prognostic favourable (6.51e-4)"	"unprognostic (1.11e-1)"	"unprognostic (8.74e-3)"	"unprognostic (1.89e-1)"	"unprognostic (1.34e-1)"	10.1	13.1	14.7	5.0	13.3	4.5	9.1	13.8	17.4	8.8	7.6	11.4	7.9	5.3	7.5	11.2	8.0	9.0	7.2	23.8	14.2	10.0	12.7	15.3	8.4	5.3	12.1	9.4	7.9	17.4	8.7	6.9	5.9	11.9	8.7	6.2	8.1	10.6	9.1	48.6	9.4	5.3	10.3	12.8	7.3	6.5	5.1	6.1	2.7	9.6	16.1	5.7	7.7	6.5	10.7	11.8	12.9	20.5	7.7	14.0	6.7	3.7	3.2	1.9	8.9	9.2	3.7	1.5	1.9	4.6	2.4	3.1	1.7	4.5	3.7	5.2	4.9	4.3	2.5	2.0	3.6	8.1	4.1	3.9	4.9	4.3	3.4	8.5	8.0	2.9	4.3	2.7	4.1	2.9	4.3	7.6	3.2	2.4	5.0	4.9	4.3	4.1	3.1	2.7	5.6	5.0	4.6	7.3	24.7	3.9	7.9	2.9	3.9	2.6	2.5	1.6	4.9	3.3	5.4	11.0	8.2	1.8	4.7	11.2	8.7	6.3	11.7	12.9	9.3	18.4	9.5	10.3	11.6	10.5	11.8	10.7	14.0	11.5	1.1	7.7	20.5	10.2	9.4	6.7	14.7	13.3	13.8	17.4	14.2	10.0	12.1	9.4	11.9	6.1
UBE2S	E2-EPF	ENSG00000108106	"Ubiquitin conjugating enzyme E2 S"	Q16763	19	55399745-55407777	"Enzymes, Predicted intracellular proteins"	"Cell cycle, Cell division, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 68.0;lymphoid tissue: 60.2;testis: 69.4"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB015228, HPA057150"	Approved		Approved	"Nucleoplasm,Plasma membrane"				"Plasma membrane"	Nucleoplasm	"CAB015228: , HPA057150: "	"unprognostic (2.79e-1)"	"unprognostic (2.42e-1)"	"unprognostic (2.57e-1)"	"prognostic unfavourable (2.05e-4)"	"unprognostic (9.54e-2)"	"unprognostic (1.41e-1)"	"prognostic unfavourable (8.00e-6)"	"unprognostic (1.42e-3)"	"unprognostic (2.32e-1)"	"unprognostic (2.31e-1)"	"unprognostic (8.08e-2)"	"unprognostic (4.52e-2)"	"prognostic unfavourable (8.16e-8)"	"unprognostic (1.05e-1)"	"unprognostic (9.51e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.75e-1)"	10.2	9.2	18.0	19.5	15.9	68.0	4.7	11.4	21.6	6.1	12.0	9.1	4.5	8.4	7.1	7.2	17.1	6.0	9.7	18.0	18.7	18.1	5.9	5.6	6.3	22.9	13.7	14.4	6.4	6.0	3.7	12.9	9.8	12.9	7.0	7.1	6.2	4.9	5.3	7.3	6.2	7.3	10.7	15.3	11.0	10.6	69.4	8.2	60.2	5.9	14.3	21.1	10.0	7.1	4.5	3.1	6.0	1.9	0.6	2.6	0.3	59.4	32.2	28.3	22.6	1.8	2.6	5.0	48.4	14.7	29.9	27.3	21.8	21.3	57.9	20.1	12.1	17.5	28.4	12.6	13.3	45.3	94.2	34.6	18.5	7.0	5.4	41.3	33.7	2.8	3.5	22.0	21.3	11.7	34.3	40.6	18.7	15.7	56.0	21.5	71.1	54.7	49.3	21.8	20.8	8.0	12.7	72.0	39.0	61.7	15.3	27.4	10.9	22.5	17.9	18.1	51.3	15.3	115.2	32.7	78.5	67.9	18.9	29.3	65.3	1.1	1.9	2.9	1.8	1.5	1.2	4.5	2.6	2.6	1.5	1.6	2.5	1.5	6.0	0.6	0.9	3.1	1.0	0.3	18.0	15.9	11.4	21.6	18.7	18.1	13.7	14.4	12.9	8.2
UBE3C	"KIAA0010, KIAA10"	ENSG00000009335	"Ubiquitin protein ligase E3C"	Q15386	7	157138913-157269372	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039915	Approved		Approved	"Nucleoplasm,Plasma membrane,Mitochondria"				Mitochondria	"Nucleoplasm, Plasma membrane"	"HPA039915: AB_10795264"	"unprognostic (2.83e-2)"	"unprognostic (9.27e-3)"	"unprognostic (2.41e-1)"	"unprognostic (2.29e-1)"	"unprognostic (1.19e-2)"	"unprognostic (3.14e-2)"	"unprognostic (1.36e-1)"	"unprognostic (7.02e-2)"	"unprognostic (2.34e-2)"	"unprognostic (1.58e-1)"	"unprognostic (3.01e-3)"	"unprognostic (8.64e-2)"	"prognostic favourable (9.18e-6)"	"unprognostic (9.74e-2)"	"unprognostic (1.86e-1)"	"unprognostic (1.87e-1)"	"unprognostic (3.60e-2)"	24.7	21.0	14.0	17.9	23.1	12.4	19.8	25.5	29.9	21.3	23.4	17.2	15.3	17.4	28.8	16.8	26.8	18.8	24.8	31.8	14.4	13.8	21.2	30.5	16.7	16.7	14.5	15.1	20.7	22.1	29.6	20.3	21.3	22.3	19.0	21.0	20.2	31.7	21.5	51.2	21.2	23.9	25.7	16.1	20.5	21.8	35.9	11.1	20.3	15.6	24.5	24.4	23.1	19.1	2.5	4.0	2.1	4.6	3.7	6.6	2.9	22.5	17.9	11.5	23.0	20.7	21.8	12.8	25.0	21.6	21.1	21.4	16.1	18.9	12.2	22.3	27.5	14.4	17.9	23.1	25.2	22.2	16.4	12.4	12.6	11.6	20.7	18.6	18.3	19.3	21.3	23.4	19.5	24.6	18.1	13.7	29.8	19.7	18.2	11.8	18.3	21.7	10.5	13.0	25.1	21.9	24.9	18.5	19.1	24.6	21.2	18.3	10.9	13.1	22.0	26.7	5.7	65.4	31.0	13.7	13.8	12.3	30.6	27.8	30.5	0.5	3.5	2.1	4.8	4.6	6.6	2.5	5.2	5.2	4.0	2.5	4.9	5.9	1.3	3.7	4.5	3.6	5.2	2.9	14.0	23.1	25.5	29.9	14.4	13.8	14.5	15.1	22.3	11.1
UBQLN2	"Chap1, CHAP1/DSK2, Dsk2, LIC-2, N4BP4, PLIC-2, PLIC2, RIHFB2157"	ENSG00000188021	"Ubiquilin 2"	Q9UHD9	X	56563639-56567868	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	Autophagy		"Amyotrophic lateral sclerosis, Disease mutation, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006431, CAB013481"	Enhanced		Supported	"Plasma membrane,Cytosol"			200000	Cytosol	"Plasma membrane"	"CAB013481: AB_2533341, HPA006431: AB_1078707"	"unprognostic (1.23e-2)"	"unprognostic (2.88e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.51e-3)"	"unprognostic (1.76e-2)"	"unprognostic (5.08e-2)"	"prognostic unfavourable (2.29e-4)"	"unprognostic (2.66e-1)"	"unprognostic (1.25e-1)"	"unprognostic (4.42e-1)"	"unprognostic (1.55e-1)"	"unprognostic (1.13e-1)"	"unprognostic (8.81e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.45e-1)"	"unprognostic (8.88e-2)"	"unprognostic (8.42e-3)"	13.4	20.8	27.0	13.9	40.7	9.4	16.2	34.9	35.3	17.3	13.6	17.8	15.0	11.1	17.0	16.7	18.1	18.2	14.5	20.8	26.2	28.6	13.9	18.9	14.0	16.4	21.2	26.6	27.0	10.6	25.5	18.3	15.6	20.8	21.1	12.5	13.3	13.7	21.5	24.6	13.5	11.6	18.7	18.8	13.9	12.9	5.4	16.7	18.0	20.9	10.9	17.7	16.4	14.1	5.5	10.9	25.0	19.4	12.1	20.4	10.9	18.8	14.1	14.1	16.5	32.5	20.8	8.9	15.3	18.2	11.5	12.8	7.8	8.9	14.5	16.7	18.0	11.1	26.9	17.0	13.9	22.3	16.2	5.8	19.4	8.3	17.1	11.4	12.9	19.3	21.7	15.4	13.6	10.0	6.8	16.0	18.1	8.8	14.6	10.0	11.7	16.8	13.2	18.3	13.6	23.2	14.8	17.5	16.4	22.0	9.8	8.9	16.4	8.5	11.2	12.2	12.5	17.6	9.2	6.1	7.4	10.0	13.7	12.1	10.3	25.0	14.1	14.1	9.9	19.3	11.1	5.1	15.1	11.5	10.9	5.5	20.4	12.2	12.4	12.1	19.4	3.9	14.1	10.9	27.0	40.7	34.9	35.3	26.2	28.6	21.2	26.6	20.8	16.7
UBR2	"bA49A4.1, C6orf133, dJ392M17.3, KIAA0349"	ENSG00000024048	"Ubiquitin protein ligase E3 component n-recognin 2"	Q8IWV8	6	42564062-42693504	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 25.2"	"Lineage enriched"	"Detected in all"	4	"granulocytes: 25.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027869, HPA027880"	Approved		Approved	"Nucleoplasm,Plasma membrane"				Nucleoplasm	"Plasma membrane"	"HPA027869: AB_10600416, HPA027880: AB_10601217"	"unprognostic (3.26e-1)"	"unprognostic (1.29e-1)"	"unprognostic (8.33e-2)"	"unprognostic (2.95e-2)"	"unprognostic (1.08e-2)"	"unprognostic (4.23e-2)"	"unprognostic (1.32e-1)"	"unprognostic (7.24e-2)"	"unprognostic (5.05e-2)"	"prognostic favourable (1.65e-4)"	"unprognostic (1.12e-1)"	"unprognostic (7.53e-2)"	"unprognostic (1.30e-2)"	"unprognostic (3.88e-1)"	"unprognostic (1.81e-1)"	"unprognostic (5.78e-2)"	"unprognostic (7.77e-3)"	19.8	18.8	14.4	21.8	16.7	22.1	18.6	26.6	20.4	17.2	19.3	17.8	17.8	20.1	29.5	16.8	16.2	15.6	16.2	16.8	13.8	13.2	17.8	24.0	19.3	18.0	16.7	12.9	20.8	24.6	28.0	26.3	16.3	17.2	16.5	20.1	15.8	18.3	15.6	33.5	18.0	24.6	19.9	15.9	21.3	18.2	9.2	17.2	26.1	20.1	14.9	17.7	18.9	29.8	3.6	3.5	25.2	5.7	3.9	4.4	1.9	15.7	8.0	9.3	14.6	19.2	18.5	12.6	12.2	13.2	10.8	11.3	11.5	6.5	10.9	9.7	13.1	16.0	13.4	10.4	13.8	14.6	9.4	17.2	11.9	14.9	15.6	16.6	11.9	13.0	11.4	10.7	11.8	12.2	20.1	13.8	10.4	12.8	13.0	14.7	8.5	7.8	11.6	13.9	16.2	12.4	13.8	11.1	8.8	12.3	11.9	11.9	11.6	16.1	17.6	9.9	7.7	12.0	8.8	12.8	11.3	16.8	5.2	12.5	6.0	10.4	4.6	9.2	4.4	4.8	3.7	3.4	2.9	3.4	3.5	3.6	3.0	3.3	25.2	3.9	5.7	2.6	3.3	1.9	14.4	16.7	26.6	20.4	13.8	13.2	16.7	12.9	17.2	17.2
UBTD1	FLJ11807	ENSG00000165886	"Ubiquitin domain containing 1"	Q9HAC8	10	97498868-97571209	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"eosinophil: 7.5;neutrophil: 8.5"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA034825	Uncertain		Approved	"Vesicles,Plasma membrane,Cytosol"				Vesicles	"Plasma membrane, Cytosol"	"HPA034825: AB_10602254"	"unprognostic (1.52e-1)"	"unprognostic (1.48e-1)"	"prognostic unfavourable (5.54e-4)"	"unprognostic (2.43e-1)"	"unprognostic (1.78e-1)"	"unprognostic (3.90e-2)"	"unprognostic (3.63e-3)"	"unprognostic (1.43e-2)"	"unprognostic (1.66e-3)"	"unprognostic (9.25e-3)"	"unprognostic (2.45e-1)"	"unprognostic (4.78e-1)"	"unprognostic (6.62e-3)"	"unprognostic (8.80e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.47e-3)"	"unprognostic (3.50e-3)"	16.0	5.6	7.7	7.3	7.1	10.2	20.5	5.1	9.0	11.5	4.6	5.8	9.7	2.9	6.6	13.9	8.1	8.3	9.0	23.8	6.8	6.5	15.6	11.2	26.0	8.3	9.1	4.8	8.9	12.9	3.1	7.8	5.3	6.4	6.5	1.5	8.9	10.7	10.8	24.2	22.7	2.5	7.0	6.7	5.3	4.1	30.3	5.7	1.0	12.9	10.9	4.4	10.3	8.6	0.3	1.7	8.5	3.4	0.0	0.4	0.5	9.0	9.0	2.4	11.9	10.1	9.6	2.8	10.4	15.3	11.2	8.6	6.0	7.9	1.1	12.7	7.0	10.9	2.4	13.9	1.5	2.8	4.7	1.1	2.8	7.5	14.6	1.0	3.1	13.1	4.7	12.2	3.0	17.8	0.6	1.7	7.1	4.3	0.4	9.2	3.9	16.6	0.9	4.2	1.0	8.6	3.4	0.8	2.5	4.7	2.9	13.4	10.8	6.8	19.1	14.2	8.7	14.8	13.5	2.2	2.5	0.4	12.0	6.2	7.4	1.3	3.4	7.5	0.2	0.8	0.2	0.3	0.1	0.0	1.7	0.0	0.1	0.0	8.5	0.0	0.9	1.2	0.4	0.5	7.7	7.1	5.1	8.1	6.8	6.5	9.1	4.8	6.4	5.7
UCP3	SLC25A9	ENSG00000175564	"Uncoupling protein 3"	P55916	11	74000281-74009435	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters"	Transport		"Diabetes mellitus, Disease mutation, Obesity"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	15	"skeletal muscle: 99.6"	"Cell line enriched"	"Detected in many"	4	"HDLM-2: 17.8"	"Low cancer specificity"	"Detected in some"			"Region enriched"	"Detected in single"	4	"cerebellum: 1.1"	"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010771, HPA072225"	Enhanced		Approved	"Nucleoplasm,Plasma membrane,Cytosol"				Nucleoplasm	"Plasma membrane, Cytosol"	"CAB010771: AB_261839, HPA072225: "	"unprognostic (3.76e-3)"	"unprognostic (1.24e-1)"	"unprognostic (2.82e-1)"	"unprognostic (5.98e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.49e-2)"	"unprognostic (3.95e-3)"	"unprognostic (6.61e-2)"	"unprognostic (1.25e-1)"	"unprognostic (8.58e-2)"	"unprognostic (2.13e-4)"	"unprognostic (1.61e-2)"	"unprognostic (3.25e-6)"	"unprognostic (2.68e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.76e-1)"	"unprognostic (2.50e-4)"	0.9	0.2	0.2	0.3	0.2	0.6	0.2	1.1	0.2	0.2	0.2	0.2	0.2	0.1	0.2	0.5	0.9	0.2	0.2	0.2	0.2	0.1	0.2	0.2	0.2	0.3	0.2	0.2	0.2	0.2	0.2	0.4	0.2	0.2	0.2	0.2	0.2	1.0	0.2	99.6	0.3	0.2	0.2	0.2	0.5	0.1	0.6	0.2	0.2	0.6	6.4	0.8	0.2	0.2	0.8	0.1	0.7	0.3	0.2	2.1	0.4	0.2	2.0	2.0	1.7	0.8	0.4	0.4	0.5	0.5	0.5	0.3	0.5	0.4	1.0	0.3	0.4	2.2	0.8	0.4	0.8	17.8	0.7	0.4	2.4	0.2	0.6	1.2	1.7	0.5	1.4	1.3	0.1	0.6	0.5	1.4	0.7	1.2	0.8	1.6	1.0	1.4	1.6	4.2	0.6	1.1	0.6	1.2	1.2	0.5	0.9	0.7	0.2	1.1	0.4	0.3	1.4	0.6	1.2	1.6	1.7	0.8	0.3	1.1	0.6	0.0	0.3	0.7	2.1	0.1	0.9	0.0	1.5	1.8	0.0	0.8	0.6	1.2	0.1	0.2	0.0	0.1	0.4	0.4	0.2	0.2	1.1	0.2	0.2	0.1	0.2	0.2	0.2	0.2
UNC5A	"KIAA1976, UNC5H1"	ENSG00000113763	"Unc-5 netrin receptor A"	Q6ZN44	5	176810477-176880898	"Predicted membrane proteins"	Apoptosis	"Developmental protein, Receptor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"adrenal gland: 11.9;brain: 35.3"	"Cell line enriched"	"Detected in some"	9	"SCLC-21H: 43.3"	"Cancer enhanced"	"Detected in many"		"ovarian cancer: 7.5"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"basophil: 2.8;eosinophil: 1.4"	"Lineage enhanced"	"Detected in single"		"granulocytes: 2.8"	"Group enriched"	"Detected in all"	4	"amygdala: 42.5;basal ganglia: 24.9;cerebral cortex: 36.4;hippocampal formation: 44.5;hypothalamus: 19.1"	"Low region specificity"	"Detected in all"			HPA071450			Approved	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		"HPA071450: "	"unprognostic (5.95e-2)"	"unprognostic (1.15e-1)"	"unprognostic (4.18e-3)"	"prognostic unfavourable (2.23e-4)"	"unprognostic (5.26e-2)"	"unprognostic (2.23e-1)"	"unprognostic (6.66e-3)"	"unprognostic (5.06e-3)"	"unprognostic (3.52e-1)"	"unprognostic (1.36e-1)"	"unprognostic (5.07e-1)"	"unprognostic (9.95e-2)"	"unprognostic (3.77e-5)"	"unprognostic (6.39e-2)"	"unprognostic (2.89e-1)"	"unprognostic (2.27e-1)"	"unprognostic (5.17e-2)"	0.9	11.9	10.5	1.1	11.1	1.2	1.4	35.3	30.9	1.1	0.7	0.4	0.0	1.3	0.8	0.9	0.7	1.5	1.0	0.7	7.6	4.6	0.7	0.7	0.9	1.7	1.6	12.6	0.9	3.2	0.6	5.1	0.6	2.1	0.8	0.7	0.3	0.9	0.7	0.6	0.7	0.9	0.8	0.8	0.6	1.2	1.3	0.5	0.0	0.8	0.0	0.7	0.9	0.2	0.0	0.0	2.8	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.1	0.0	0.0	0.7	0.0	0.0	0.0	1.2	5.0	0.0	43.3	1.9	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	2.8	0.3	1.4	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.6	0.0	0.0	0.0	10.5	11.1	35.3	22.2	7.6	4.6	1.6	12.6	2.1	0.5
UNC79	KIAA1409	ENSG00000133958	"Unc-79 homolog, NALCN channel complex subunit"	Q9P2D8	14	93333219-93707876	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 17.6;pituitary gland: 18.9"	"Group enriched"	"Detected in some"	5	"REH: 8.3;SCLC-21H: 6.1;SH-SY5Y: 3.9;U-937: 3.0"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"							HPA071881			Approved	"Nucleoplasm,Plasma membrane"				"Plasma membrane"	Nucleoplasm	"HPA071881: "	"unprognostic (8.42e-2)"	"unprognostic (2.07e-1)"	"unprognostic (6.70e-2)"	"unprognostic (6.91e-2)"	"unprognostic (1.06e-1)"	"unprognostic (7.73e-2)"	"unprognostic (2.99e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.31e-1)"	"unprognostic (5.73e-3)"	"unprognostic (8.03e-3)"	"unprognostic (2.87e-1)"	"unprognostic (3.39e-2)"	"unprognostic (2.66e-2)"	"unprognostic (5.57e-2)"	"unprognostic (3.03e-2)"	"unprognostic (7.47e-2)"	1.1	3.9	7.1	1.0	12.1	0.9	1.0	17.6	14.6	1.0	1.1	4.5	0.0	1.1	1.1	1.1	1.2	2.0	1.1	1.2	6.7	5.8	1.4	1.1	1.0	1.0	3.2	9.1	1.1	5.0	1.4	18.9	1.0	6.8	1.0	1.1	1.3	1.0	1.0	1.6	1.0	1.1	1.2	3.0	0.9	1.9	7.0	3.5	0.0	1.3	0.0	1.0	1.0	0.3	0.1	0.2	0.6	0.3	0.1	0.1	0.0	0.0	0.0	0.1	0.1	1.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	1.1	0.0	8.3	0.0	0.0	0.2	0.2	6.1	3.9	0.1	0.0	0.0	0.1	0.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	3.0	0.0	0.0	0.0	0.6	0.0	0.3	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	7.1	12.1	17.6	14.6	6.7	5.8	3.2	9.1	6.8	3.5
UQCC1	"BFZB, C20orf44, CBP3, FLJ10850, UQCC"	ENSG00000101019	"Ubiquinol-cytochrome c reductase complex assembly factor 1"	Q9NVA1	20	35302566-35412141	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 70.2"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA034875	Approved		Approved	"Nucleoplasm,Plasma membrane,Actin filaments"				"Plasma membrane"	"Nucleoplasm, Actin filaments"	"HPA034875: AB_10603226"	"unprognostic (9.66e-2)"	"unprognostic (3.93e-1)"	"unprognostic (3.45e-1)"	"unprognostic (8.72e-3)"	"unprognostic (4.01e-1)"	"unprognostic (1.31e-1)"	"unprognostic (5.73e-2)"	"unprognostic (2.75e-1)"	"unprognostic (2.82e-2)"	"unprognostic (7.66e-2)"	"unprognostic (3.42e-2)"	"unprognostic (7.01e-2)"	"unprognostic (6.72e-3)"	"unprognostic (3.23e-1)"	"unprognostic (3.60e-1)"	"unprognostic (5.27e-2)"	"unprognostic (1.34e-2)"	12.6	19.2	13.7	10.6	24.5	2.5	10.1	19.6	23.9	10.9	13.3	15.7	12.1	13.0	14.2	14.2	10.5	11.7	8.4	34.3	13.5	15.9	20.0	17.2	8.7	10.9	16.6	18.2	11.9	10.8	19.8	17.0	10.1	20.1	11.9	17.5	15.8	12.1	12.9	70.2	9.2	11.3	15.5	15.5	11.2	12.2	13.2	13.4	8.9	14.2	17.1	13.8	11.0	9.9	13.5	13.5	16.3	11.9	19.7	15.2	9.6	6.8	9.9	11.2	10.3	11.4	12.5	1.6	13.0	14.1	23.3	16.2	32.1	13.5	21.8	24.6	8.1	18.1	19.7	22.5	17.7	6.5	7.8	29.3	13.2	25.7	7.2	17.5	8.7	12.2	23.0	12.4	15.6	7.9	12.6	7.2	16.2	8.9	20.0	6.3	9.4	20.4	11.0	17.5	12.0	21.4	7.7	15.8	10.6	11.0	53.0	11.4	7.9	11.2	7.4	15.9	10.1	8.3	11.8	11.2	12.1	9.1	28.4	10.2	12.8	16.3	7.7	11.0	12.7	11.9	15.2	10.3	12.1	12.5	13.5	13.5	14.6	13.2	0.3	19.7	7.7	11.5	11.2	9.6	13.7	24.5	19.6	23.9	13.5	15.9	16.6	18.2	20.1	13.4
USP2	UBP41	ENSG00000036672	"Ubiquitin specific peptidase 2"	O75604	11	119355215-119381726	"Enzymes, Predicted intracellular proteins"	"Biological rhythms, Cell cycle, Myogenesis, Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 79.9"	"Cell line enriched"	"Detected in many"	4	"U-266/70: 34.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"naive CD4 T-cell: 1.3"	"Lineage enriched"	"Detected in single"	13	"T-cells: 1.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006777, HPA007222"	Approved		Supported	"Plasma membrane,Cytosol"				Cytosol	"Plasma membrane"	"HPA006777: AB_1080507, HPA007222: AB_1080505"	"unprognostic (6.83e-2)"	"unprognostic (2.02e-2)"	"unprognostic (5.54e-2)"	"unprognostic (1.37e-2)"	"unprognostic (1.25e-1)"	"unprognostic (7.46e-3)"	"unprognostic (1.00e-1)"	"unprognostic (5.27e-2)"	"unprognostic (1.24e-1)"	"unprognostic (5.24e-3)"	"unprognostic (8.02e-3)"	"unprognostic (7.33e-2)"	"prognostic favourable (3.09e-11)"	"unprognostic (1.58e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.96e-2)"	"unprognostic (2.66e-2)"	3.1	4.8	6.9	1.4	12.2	1.5	1.6	12.6	16.1	2.5	5.9	10.0	0.0	7.9	2.6	6.4	5.9	7.0	2.2	26.8	5.7	3.1	29.7	10.6	2.2	0.7	5.7	6.2	2.9	10.1	18.4	7.6	1.3	6.7	2.3	3.9	19.1	3.2	2.4	79.9	4.6	11.7	4.2	3.8	0.8	2.7	36.1	8.8	0.0	2.2	25.2	1.0	1.9	2.0	0.0	0.0	0.0	0.0	0.0	1.3	0.3	3.4	0.3	0.5	1.9	0.1	0.1	0.7	0.4	0.2	0.0	0.3	3.6	0.5	5.9	1.1	0.6	0.6	4.7	1.7	0.1	4.2	0.6	1.7	2.5	7.3	1.6	0.0	1.6	0.6	0.3	0.4	1.2	0.3	8.2	0.5	1.0	2.4	0.0	0.4	0.9	0.7	0.0	1.3	0.8	2.7	0.2	7.2	2.2	2.0	1.6	0.4	5.3	3.6	0.0	0.0	0.9	0.5	0.5	34.4	7.6	0.1	0.0	1.1	0.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.7	0.0	0.0	1.3	0.7	0.0	0.0	0.0	0.0	0.3	0.3	6.9	12.2	12.6	16.1	5.7	3.1	5.7	6.2	6.7	8.8
USP20	KIAA1003	ENSG00000136878	"Ubiquitin specific peptidase 20"	Q9Y2K6	9	129834698-129881838	"Enzymes, Predicted intracellular proteins"	"Endocytosis, Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"K-562: 30.4;MOLT-4: 27.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006287, HPA007008"	Uncertain	Supported	Approved	"Nucleoplasm,Plasma membrane,Cytosol"				"Nucleoplasm, Plasma membrane, Cytosol"		"HPA006287: AB_1080510, HPA007008: "	"unprognostic (2.64e-2)"	"prognostic favourable (8.01e-4)"	"prognostic unfavourable (2.48e-4)"	"prognostic favourable (4.01e-4)"	"unprognostic (4.69e-1)"	"unprognostic (1.89e-2)"	"unprognostic (2.25e-1)"	"unprognostic (2.55e-3)"	"unprognostic (1.24e-1)"	"unprognostic (7.89e-2)"	"prognostic favourable (1.54e-7)"	"unprognostic (2.09e-1)"	"prognostic favourable (5.65e-5)"	"unprognostic (1.76e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.19e-2)"	"unprognostic (1.24e-2)"	7.8	13.2	10.5	15.2	14.6	24.4	8.5	23.0	19.6	13.2	12.1	12.7	10.2	9.7	13.3	6.2	9.3	11.6	12.5	8.8	10.5	13.7	8.0	7.3	9.1	19.6	9.6	16.1	16.8	12.9	11.5	19.0	8.0	11.9	14.9	6.1	10.8	13.7	17.2	10.2	14.0	11.8	20.0	8.8	14.6	10.2	14.0	8.8	51.5	19.3	4.2	15.3	15.6	10.0	3.8	2.4	4.8	1.7	9.0	10.7	5.4	3.0	2.9	5.2	7.0	6.8	5.8	7.4	4.9	4.1	3.7	2.6	2.4	3.3	4.1	4.2	4.7	7.6	3.1	3.5	1.5	22.2	4.1	7.6	8.0	1.6	4.8	7.1	5.7	5.1	5.1	4.9	3.7	4.0	30.4	5.1	2.2	8.0	27.8	16.9	4.1	7.0	4.7	5.8	7.0	2.9	3.3	1.1	5.8	5.7	7.2	4.6	7.5	10.0	5.9	4.1	1.9	5.5	3.2	5.1	7.4	2.9	8.2	9.4	3.8	1.0	1.7	4.8	8.6	1.4	9.3	3.7	8.8	8.3	2.4	3.8	10.4	8.9	2.8	9.0	1.3	2.1	10.7	5.4	10.5	14.6	23.0	19.6	10.5	13.7	9.6	16.1	11.9	8.8
USP4	"UNP, Unph"	ENSG00000114316	"Ubiquitin specific peptidase 4"	Q13107	3	49277831-49340712	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"	Proto-oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA018499	Approved		Supported	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		"HPA018499: AB_1858689"	"unprognostic (2.34e-3)"	"unprognostic (1.52e-1)"	"unprognostic (2.22e-3)"	"unprognostic (6.12e-2)"	"unprognostic (3.51e-1)"	"unprognostic (4.33e-2)"	"unprognostic (9.42e-2)"	"prognostic favourable (4.46e-5)"	"unprognostic (3.54e-1)"	"unprognostic (9.07e-3)"	"unprognostic (2.78e-2)"	"unprognostic (1.70e-3)"	"prognostic favourable (4.29e-5)"	"unprognostic (7.30e-2)"	"unprognostic (1.00e-1)"	"unprognostic (1.18e-2)"	"unprognostic (1.65e-2)"	22.1	18.4	21.4	22.4	29.3	41.4	23.1	30.3	32.5	20.7	20.1	26.8	16.9	16.1	23.6	20.9	23.5	19.3	17.5	22.8	22.2	18.0	20.2	18.5	25.7	25.5	20.2	17.5	23.6	17.1	23.6	19.7	22.1	24.3	20.9	21.9	23.6	19.1	21.3	25.7	27.6	19.4	25.9	20.4	30.6	17.7	25.0	19.7	36.8	21.2	14.1	42.4	22.1	22.0	17.0	24.1	59.4	27.3	21.5	18.6	22.2	6.2	7.2	10.1	13.4	18.7	20.1	6.8	17.2	15.3	22.3	20.1	7.7	15.9	12.2	6.8	25.0	8.5	13.4	24.4	20.8	18.8	4.0	27.0	14.4	8.5	27.4	14.2	15.6	20.6	10.7	24.4	20.1	25.7	9.4	19.4	20.6	10.7	16.8	24.2	8.5	12.7	6.9	6.3	10.6	17.5	13.1	8.4	11.2	12.5	8.8	6.3	6.1	22.9	22.8	15.0	8.2	18.7	10.0	15.5	7.5	17.8	13.5	22.6	17.2	18.0	27.3	30.0	16.9	22.1	18.6	17.0	17.6	16.9	24.1	14.1	17.1	15.0	59.4	21.5	24.4	9.6	18.6	22.2	21.4	29.3	30.3	32.5	22.2	18.0	20.2	17.5	24.3	19.7
UTP20	"1A6/DRIM, DRIM"	ENSG00000120800	"UTP20, small subunit processome component"	O75691	12	101280109-101386616	"Predicted intracellular proteins"	"rRNA processing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049341			Supported	"Nucleoli,Plasma membrane"				Nucleoli	"Plasma membrane"	"HPA049341: "	"unprognostic (3.04e-2)"	"unprognostic (1.22e-1)"	"unprognostic (3.92e-2)"	"unprognostic (1.51e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.15e-1)"	"prognostic unfavourable (1.15e-5)"	"unprognostic (8.34e-2)"	"unprognostic (4.30e-2)"	"unprognostic (8.15e-3)"	"unprognostic (2.81e-1)"	"unprognostic (2.22e-2)"	"prognostic favourable (8.87e-4)"	"unprognostic (2.88e-1)"	"unprognostic (3.44e-1)"	"unprognostic (8.30e-2)"	"unprognostic (6.92e-3)"	14.7	11.9	8.4	10.7	9.7	8.3	15.3	8.4	9.6	14.1	8.0	11.8	7.0	5.0	12.5	8.4	10.9	10.3	5.8	8.3	6.7	5.8	8.0	12.0	12.0	17.8	9.0	6.3	16.3	14.2	17.9	9.5	9.7	8.2	8.8	10.1	9.9	13.8	8.5	13.1	10.8	8.0	9.4	7.1	11.3	8.6	12.6	9.7	11.9	9.8	11.0	12.9	9.4	13.8	3.1	2.8	0.1	1.1	2.0	2.8	0.6	4.4	11.2	8.5	3.9	7.6	8.9	10.4	7.7	6.1	12.4	6.9	12.8	3.2	11.9	4.1	8.6	9.3	18.7	8.0	16.1	5.3	7.6	12.6	6.0	9.5	4.3	20.9	5.8	5.8	4.2	17.2	5.9	8.5	19.8	2.4	9.0	5.8	9.0	5.9	22.2	11.7	10.3	13.9	9.3	5.2	13.6	9.8	6.6	14.5	9.2	8.7	9.7	4.7	9.6	14.7	7.2	10.2	15.0	4.5	6.7	20.0	8.0	9.6	22.4	0.1	0.8	0.1	1.9	1.1	1.9	3.1	2.1	2.4	1.4	2.4	2.3	2.8	0.1	2.0	0.7	2.8	1.8	0.6	8.4	9.7	8.4	9.6	6.7	5.8	9.0	6.3	8.2	9.7
VAMP5		ENSG00000168899	"Vesicle associated membrane protein 5"	O95183	2	85584408-85593412	"Predicted membrane proteins"	"Differentiation, Myogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HHSteC: 33.7;HUVEC TERT2: 63.0;LHCN-M2: 74.0;TIME: 43.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035082	Supported		Approved	"Nucleoplasm,Plasma membrane"				"Nucleoplasm, Plasma membrane"		"HPA035082: AB_10610564"	"unprognostic (1.92e-1)"	"unprognostic (3.09e-2)"	"unprognostic (6.09e-2)"	"unprognostic (1.13e-2)"	"unprognostic (4.16e-2)"	"unprognostic (1.25e-3)"	"unprognostic (1.28e-2)"	"unprognostic (5.29e-2)"	"unprognostic (1.17e-2)"	"unprognostic (3.49e-2)"	"unprognostic (2.22e-1)"	"unprognostic (7.59e-2)"	"prognostic unfavourable (1.28e-5)"	"unprognostic (9.61e-3)"	"unprognostic (3.46e-2)"	"unprognostic (1.71e-2)"	"unprognostic (2.60e-1)"	26.2	25.8	12.6	18.9	14.1	11.7	27.5	4.3	9.2	17.9	22.1	8.5	9.2	7.6	18.9	27.2	24.3	18.3	18.8	37.0	11.0	10.9	18.5	31.2	28.8	32.1	16.8	9.6	19.6	6.3	3.2	7.2	24.4	17.7	29.0	6.9	16.0	7.7	13.0	70.9	9.5	17.0	25.5	14.1	33.3	12.3	13.7	8.1	18.0	17.5	19.8	13.0	21.8	25.8	10.2	13.8	27.5	80.4	14.3	39.4	39.3	0.1	0.0	0.4	0.0	16.0	28.1	0.4	17.0	27.0	16.7	18.5	6.7	2.6	0.0	0.4	29.4	0.1	0.0	0.4	7.4	24.0	0.5	0.3	0.4	9.3	33.7	0.7	0.1	19.4	1.6	7.0	0.2	63.0	0.0	0.0	74.0	2.4	10.4	2.3	0.0	0.1	15.6	0.0	0.4	0.4	0.6	0.0	0.6	0.1	4.8	0.1	0.5	0.8	43.0	0.4	1.2	1.3	0.0	0.0	0.5	0.4	19.7	0.9	11.4	8.2	38.1	27.5	31.7	80.4	29.8	9.7	24.1	23.5	12.8	10.2	18.5	22.3	11.8	14.3	64.4	13.8	39.4	39.3	12.6	14.1	4.3	9.2	11.0	10.9	16.8	9.6	17.7	8.1
VANGL1	STB2	ENSG00000173218	"VANGL planar cell polarity protein 1"	Q8TAA9	1	115641953-115698224	"Disease related genes, Predicted membrane proteins"			"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"NK-cell: 8.9"	"Group enriched"	"Detected in many"	7	"dendritic cells: 3.5;NK-cells: 8.9;T-cells: 4.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA025235, CAB076375"	Approved		Approved	"Plasma membrane"				"Plasma membrane"		"CAB076375: , HPA025235: AB_1858718"	"unprognostic (1.04e-2)"	"unprognostic (2.04e-2)"	"prognostic favourable (7.53e-4)"	"unprognostic (9.94e-2)"	"unprognostic (1.71e-2)"	"unprognostic (5.18e-2)"	"unprognostic (2.18e-3)"	"unprognostic (5.11e-3)"	"unprognostic (2.11e-1)"	"unprognostic (6.43e-3)"	"prognostic unfavourable (7.89e-4)"	"unprognostic (1.88e-2)"	"unprognostic (1.74e-2)"	"unprognostic (7.71e-3)"	"unprognostic (1.21e-1)"	"unprognostic (4.50e-3)"	"unprognostic (9.06e-3)"	7.0	8.6	2.2	5.8	3.1	2.0	16.4	1.2	2.5	14.0	9.3	5.3	8.3	4.0	13.2	8.8	14.4	13.7	5.3	12.7	3.2	2.3	11.8	7.1	12.1	7.4	2.1	1.9	8.9	11.5	5.5	2.2	5.3	2.4	9.4	7.1	6.6	9.5	11.0	2.1	9.8	6.6	15.9	2.0	4.7	6.6	7.9	2.6	18.0	11.8	10.0	10.0	10.2	9.4	0.3	3.5	0.0	0.8	8.9	4.3	1.4	21.3	9.1	3.0	4.0	11.2	10.1	5.9	8.3	6.0	10.9	8.7	5.2	10.7	0.0	14.4	9.6	27.1	5.0	14.7	7.2	25.0	6.1	11.9	8.5	4.2	4.1	3.5	5.2	5.3	10.5	7.8	8.3	10.8	7.2	6.6	11.0	28.6	17.5	1.4	7.5	8.7	0.0	8.6	6.2	5.0	14.4	2.7	3.6	15.0	10.0	7.1	5.1	3.8	11.6	7.5	11.9	16.4	15.1	0.9	1.0	0.0	10.2	6.3	18.4	0.0	0.8	0.0	3.0	0.5	0.8	0.3	1.9	2.9	3.5	0.0	0.7	3.3	0.0	8.9	0.8	3.0	4.3	1.4	2.2	3.1	1.2	2.5	3.2	2.3	2.1	1.9	2.4	2.6
VCPIP1	"DUBA3, FLJ23132, KIAA1850, VCIP135"	ENSG00000175073	"Valosin containing protein interacting protein 1"	Q96JH7	8	66628487-66667217	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA023932	Uncertain		Approved	"Plasma membrane,Centrosome"				"Plasma membrane"	Centrosome	"HPA023932: "	"unprognostic (1.12e-1)"	"unprognostic (1.31e-2)"	"unprognostic (9.13e-2)"	"unprognostic (1.10e-2)"	"unprognostic (4.01e-2)"	"unprognostic (5.56e-2)"	"unprognostic (5.23e-2)"	"unprognostic (7.21e-2)"	"unprognostic (2.80e-1)"	"unprognostic (3.96e-1)"	"unprognostic (5.23e-3)"	"unprognostic (7.28e-2)"	"unprognostic (6.12e-3)"	"unprognostic (2.03e-2)"	"unprognostic (1.83e-1)"	"unprognostic (2.13e-2)"	"unprognostic (8.58e-3)"	9.5	8.7	15.7	12.6	14.5	30.9	8.9	14.4	15.1	7.5	8.4	7.0	3.8	7.0	7.8	8.7	8.1	6.9	7.0	6.7	10.2	9.2	8.3	12.3	10.5	13.6	10.3	13.7	7.8	9.0	14.0	5.9	8.0	12.3	7.0	7.8	6.0	9.0	7.1	14.8	7.3	10.0	6.3	9.6	14.7	8.0	10.8	11.7	11.6	8.0	2.8	13.3	7.9	7.0	2.6	3.4	11.3	8.8	2.8	4.3	1.7	8.8	8.0	4.2	5.5	12.7	9.0	4.0	7.1	7.2	5.5	6.3	4.7	8.4	11.9	2.1	9.5	7.9	6.7	5.9	7.9	8.9	4.8	13.3	7.9	5.9	7.7	4.4	14.3	9.7	8.8	5.9	10.8	5.9	8.9	11.6	8.0	4.3	9.5	7.6	7.9	5.6	6.1	6.5	6.0	7.9	7.0	2.4	4.7	5.5	8.4	6.1	8.6	7.3	11.8	7.2	5.4	6.3	4.7	10.3	5.0	12.8	7.2	6.4	5.4	9.2	3.2	6.7	4.3	5.2	3.6	2.0	2.7	3.1	3.4	2.6	2.2	2.9	11.3	2.8	8.8	1.3	3.3	1.7	15.7	14.5	14.4	15.1	10.2	9.2	10.3	13.7	12.3	11.7
VPS8	"FLJ32099, KIAA0804"	ENSG00000156931	"VPS8, CORVET complex subunit"	Q8N3P4	3	184812143-185052614	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036871	Uncertain		Approved	"Plasma membrane,Cytosol"				Cytosol	"Plasma membrane"	"HPA036871: AB_10672103"	"unprognostic (4.36e-2)"	"unprognostic (3.97e-3)"	"unprognostic (1.53e-1)"	"unprognostic (7.95e-2)"	"unprognostic (5.11e-2)"	"unprognostic (4.43e-2)"	"unprognostic (1.27e-3)"	"unprognostic (1.74e-1)"	"unprognostic (3.21e-2)"	"unprognostic (5.98e-3)"	"unprognostic (1.98e-1)"	"unprognostic (8.82e-2)"	"unprognostic (4.74e-2)"	"unprognostic (3.15e-1)"	"unprognostic (2.56e-1)"	"unprognostic (8.10e-3)"	"unprognostic (4.97e-2)"	12.6	11.1	14.9	11.1	20.9	22.6	12.0	21.6	24.8	15.5	12.5	18.2	8.0	9.1	16.4	19.0	11.5	10.1	12.5	20.3	17.1	19.3	12.5	9.2	13.8	14.8	21.5	13.6	16.7	10.1	21.8	23.6	13.3	28.4	12.8	16.7	12.1	9.5	12.0	28.4	14.2	9.9	14.5	21.9	14.9	14.1	17.8	15.9	13.2	17.5	9.0	11.5	12.5	11.6	3.9	6.0	17.7	4.9	3.9	6.4	3.1	10.8	6.6	10.1	10.1	21.2	18.9	6.7	10.7	11.8	7.9	11.0	8.4	5.7	11.7	18.8	16.7	12.9	10.9	13.1	15.2	21.1	9.7	12.8	8.3	4.9	13.1	8.6	17.3	13.4	12.6	11.1	11.3	19.7	6.5	8.5	14.3	7.8	6.9	5.1	6.6	6.3	8.6	19.5	9.1	7.8	19.0	10.4	6.8	12.4	13.2	9.7	20.9	4.6	17.3	12.2	6.9	12.3	9.4	10.5	12.7	16.0	13.9	10.9	9.5	11.7	4.9	16.2	4.0	3.7	3.8	3.5	4.3	4.0	6.0	3.9	6.4	4.3	17.7	3.9	4.6	1.7	3.5	3.1	14.9	20.9	21.6	24.8	17.1	19.3	21.5	13.6	28.4	15.9
VWA5B1	FLJ32784	ENSG00000158816	"Von Willebrand factor A domain containing 5B1"	Q5TIE3	1	20290919-20354894	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"brain: 17.6;epididymis: 6.4;testis: 6.9"	"Cell line enriched"	"Detected in single"	9	"SCLC-21H: 5.2"	"Low cancer specificity"	"Detected in single"			"Region enriched"	"Detected in many"	5	"pons and medulla: 17.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"HPA027496, HPA028405, HPA064829"	Enhanced		Approved	"Plasma membrane,Mitochondria,Cytosol"	"Secreted in male reproductive system"			Mitochondria	"Plasma membrane, Cytosol"	"HPA027496: AB_10599853, HPA028405: AB_10600992, HPA064829: "	"unprognostic (2.34e-1)"	"unprognostic (2.91e-1)"	"unprognostic (7.78e-2)"	"unprognostic (1.16e-2)"	"unprognostic (4.73e-2)"	"unprognostic (1.21e-2)"		"unprognostic (1.09e-1)"		"unprognostic (1.86e-2)"	"unprognostic (4.39e-2)"	"unprognostic (1.73e-1)"	"unprognostic (5.41e-4)"	"unprognostic (7.43e-4)"	"unprognostic (1.82e-2)"	"unprognostic (3.33e-2)"	"unprognostic (1.03e-1)"	0.0	1.2	0.7	0.2	3.3	0.0	0.0	0.0	0.5	0.0	0.0	6.1	0.0	0.0	0.0	6.4	0.1	0.7	0.5	0.1	2.8	3.3	2.0	0.0	0.1	0.2	0.2	0.4	0.0	0.1	2.2	5.6	0.2	17.6	0.2	0.0	0.0	4.3	1.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	6.9	0.5	0.0	0.5	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.1	0.0	0.0	0.0	5.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	3.3	0.0	0.5	2.8	3.3	0.2	0.4	17.6	0.5
VWA7	"C6orf27, G7c, NG37"	ENSG00000204396	"Von Willebrand factor A domain containing 7"	Q9Y334	6	31765590-31777294	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"fallopian tube: 19.6;pituitary gland: 20.5"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 2.1;HeLa: 3.3;Karpas-707: 3.0;RPTEC TERT1: 2.2;U-266/70: 4.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"basophil: 1.2"	"Low lineage specificity"	"Detected in single"			"Group enriched"	"Detected in some"	5	"cerebellum: 7.8;pons and medulla: 4.1"	"Low region specificity"	"Detected in many"			"HPA046954, HPA054262"	Approved		Approved	"Plasma membrane,Cytosol"	"Secreted - unknown location"			"Plasma membrane, Cytosol"		"HPA046954: , HPA054262: "	"unprognostic (9.13e-2)"	"unprognostic (8.60e-4)"	"unprognostic (9.99e-2)"	"unprognostic (2.43e-1)"	"unprognostic (2.85e-3)"	"unprognostic (4.96e-3)"	"unprognostic (6.38e-2)"	"unprognostic (4.40e-2)"	"unprognostic (2.68e-1)"	"unprognostic (5.84e-2)"	"unprognostic (1.65e-2)"	"unprognostic (9.25e-2)"	"prognostic favourable (4.35e-8)"	"unprognostic (3.75e-2)"	"unprognostic (2.37e-1)"	"unprognostic (9.48e-2)"	"unprognostic (7.66e-2)"	1.1	1.6	3.1	1.4	9.5	1.1	1.2	5.6	10.5	1.1	1.9	0.0	3.9	2.6	4.6	3.0	1.1	19.6	2.0	3.9	1.6	5.5	5.6	1.5	2.5	1.2	1.7	5.4	1.4	2.5	5.1	20.5	1.0	9.7	1.3	1.7	0.8	1.7	2.0	5.3	1.7	3.3	2.3	2.3	1.3	5.8	1.3	2.3	0.0	1.8	0.6	1.3	1.3	0.8	0.2	0.0	1.2	0.0	0.0	0.4	0.0	0.4	1.1	0.4	0.4	0.0	0.0	0.2	0.0	0.0	0.1	0.0	1.1	2.1	0.5	0.7	0.3	0.9	0.7	0.2	0.0	0.0	0.0	0.1	3.3	0.5	0.1	0.0	0.9	0.1	0.9	0.1	0.0	0.0	0.2	3.0	0.0	0.2	0.0	0.5	0.0	0.1	0.3	0.0	2.0	2.2	0.0	0.3	0.1	0.4	0.1	0.0	0.1	0.1	0.0	0.3	0.8	0.0	0.1	4.4	1.2	0.1	0.0	0.6	0.1	1.2	0.0	0.0	0.3	0.0	0.0	0.2	0.2	0.2	0.0	0.1	0.0	0.1	0.4	0.0	0.0	0.0	0.4	0.0	3.1	9.5	5.6	10.5	1.6	5.5	1.7	5.4	9.7	2.3
WARS2	TrpRS	ENSG00000116874	"Tryptophanyl tRNA synthetase 2, mitochondrial"	Q9UGM6	1	119031216-119140671	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Protein biosynthesis"	"Aminoacyl-tRNA synthetase, Ligase"	"Disease mutation, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA069692	Enhanced		Supported	"Plasma membrane,Mitochondria"				Mitochondria	"Plasma membrane"	"HPA069692: "	"unprognostic (1.00e-1)"	"unprognostic (2.25e-1)"	"unprognostic (2.03e-1)"	"unprognostic (5.64e-2)"	"unprognostic (3.42e-1)"	"unprognostic (7.05e-2)"	"unprognostic (7.73e-3)"	"unprognostic (3.72e-1)"	"unprognostic (2.14e-2)"	"unprognostic (1.17e-2)"	"unprognostic (3.96e-2)"	"unprognostic (6.76e-3)"	"prognostic favourable (1.45e-4)"	"unprognostic (4.83e-2)"	"unprognostic (1.83e-1)"	"unprognostic (9.88e-3)"	"unprognostic (4.71e-2)"	17.3	16.7	6.8	11.7	8.3	2.8	14.6	7.5	8.7	12.9	11.2	7.7	7.6	12.3	13.5	10.4	13.4	14.9	8.8	12.1	6.2	6.1	15.3	14.9	9.2	12.4	6.4	6.1	14.7	17.8	15.1	12.3	14.9	8.3	14.1	12.7	11.3	10.5	10.4	12.2	10.0	13.1	9.0	5.4	9.9	11.2	6.9	6.1	11.6	12.8	13.2	14.2	14.3	10.4	7.2	9.0	0.5	6.9	5.3	7.4	4.9	10.2	4.5	6.0	6.3	7.7	17.4	6.5	5.8	8.2	6.1	7.3	11.2	4.7	15.1	9.4	9.2	6.9	10.8	9.8	9.3	8.1	14.1	7.1	12.0	10.7	15.7	11.5	4.1	13.3	7.6	8.8	16.1	9.0	11.1	11.0	11.2	11.9	6.8	6.7	8.1	9.2	5.0	20.0	7.6	16.5	14.3	8.9	5.4	9.0	12.6	13.0	5.6	9.0	6.9	6.6	8.0	12.4	10.9	5.3	3.6	6.7	8.1	9.7	12.2	0.0	6.9	0.5	5.1	4.9	7.4	6.6	5.4	6.7	9.0	7.2	6.5	6.2	0.3	5.3	3.0	4.5	6.0	4.9	6.8	8.3	7.5	8.7	6.2	6.1	6.4	6.1	8.3	6.1
WAS	"IMD2, THC, WASP, WASPA"	ENSG00000015285	"Wiskott-Aldrich syndrome"	P42768	X	48676596-48691427	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"			"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 30.7;lymphoid tissue: 55.9"	"Cell line enhanced"	"Detected in some"		"Daudi: 21.3;HMC-1: 45.7;MOLT-4: 19.4;NB-4: 21.1;RPMI-8226: 26.0;U-266/70: 24.2;U-937: 24.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"eosinophil: 20.3"	"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA002022, CAB004290"	Enhanced		Approved	"Plasma membrane,Cytosol"			320000	"Plasma membrane"	Cytosol	"CAB004290: AB_628445, HPA002022: AB_1080581"	"unprognostic (1.43e-3)"	"unprognostic (2.09e-3)"	"unprognostic (2.36e-2)"	"prognostic favourable (4.95e-4)"	"unprognostic (9.89e-2)"	"prognostic favourable (3.78e-4)"	"unprognostic (5.12e-3)"	"unprognostic (7.60e-2)"	"unprognostic (1.54e-2)"	"unprognostic (2.86e-1)"	"unprognostic (7.40e-2)"	"unprognostic (3.60e-1)"	"prognostic unfavourable (5.58e-6)"	"unprognostic (2.24e-1)"	"unprognostic (2.37e-2)"	"unprognostic (3.55e-2)"	"unprognostic (1.71e-1)"	7.6	4.0	4.9	28.9	7.8	30.7	3.3	2.0	5.1	2.7	4.4	5.9	0.5	4.8	2.4	5.6	3.7	4.5	4.4	3.0	4.6	4.1	4.1	5.0	12.6	29.9	7.6	1.3	2.6	2.2	0.7	2.6	5.4	6.0	3.2	3.2	3.5	5.4	1.9	1.4	2.2	14.3	3.7	12.8	55.9	4.1	1.7	7.3	53.2	2.8	1.4	33.2	5.8	2.5	2.1	3.5	20.3	5.3	2.1	3.2	2.0	0.2	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	21.3	0.0	0.0	0.7	0.0	0.0	0.0	12.2	0.1	18.8	0.2	0.0	0.2	9.6	45.7	0.0	0.0	0.0	0.0	0.0	0.2	13.1	0.0	2.1	19.4	21.1	0.1	0.1	16.9	0.0	26.0	0.0	0.0	0.1	0.2	0.3	0.2	0.2	0.1	19.2	0.1	0.0	0.1	0.3	0.0	24.2	11.8	14.9	0.1	24.4	0.0	1.8	4.6	20.3	3.0	5.0	2.2	1.8	2.3	2.5	3.5	2.1	2.1	2.3	18.1	2.1	5.3	1.8	3.2	2.0	4.9	7.8	2.0	5.1	4.6	4.1	7.6	1.3	6.0	7.3
WASF2	"SCAR2, WAVE2"	ENSG00000158195	"WAS protein family member 2"	Q9Y6W5	1	27404226-27490158	"Predicted intracellular proteins"	"Host-virus interaction"	Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB022632, HPA045288"	Enhanced		Approved	"Plasma membrane,Cytosol"			470000	"Plasma membrane"	Cytosol	"CAB022632: , HPA045288: "	"unprognostic (9.58e-2)"	"unprognostic (8.93e-2)"	"unprognostic (6.28e-2)"	"unprognostic (1.02e-1)"	"unprognostic (4.40e-1)"	"unprognostic (2.27e-2)"	"prognostic unfavourable (5.29e-8)"	"unprognostic (3.94e-2)"	"unprognostic (4.14e-2)"	"prognostic unfavourable (8.48e-4)"	"unprognostic (7.60e-3)"	"unprognostic (1.10e-1)"	"unprognostic (9.15e-3)"	"unprognostic (2.24e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.47e-1)"	"unprognostic (8.26e-2)"	36.9	23.3	22.0	23.8	30.0	30.0	28.6	13.6	24.0	31.9	28.8	33.2	13.2	15.7	36.9	16.0	55.3	28.8	22.3	20.5	22.8	13.1	20.2	11.6	29.4	31.1	32.5	12.6	38.8	24.0	21.3	14.8	29.7	23.2	26.4	23.3	22.2	25.6	26.1	11.4	35.1	26.7	42.9	31.5	34.0	26.4	20.7	32.7	32.3	21.6	22.2	35.2	39.1	30.3	18.9	21.8	36.9	38.4	8.5	12.9	16.8	24.1	11.6	26.9	24.4	19.6	25.7	15.6	19.7	18.4	21.8	19.7	10.0	26.1	16.8	19.1	30.8	19.4	21.7	32.4	26.2	23.5	13.6	36.6	20.5	11.8	26.5	29.2	21.2	23.5	35.4	23.7	44.4	27.3	29.1	8.7	29.5	8.7	21.7	13.5	21.7	17.8	45.5	33.1	17.1	15.6	13.7	13.4	14.8	34.4	15.4	25.8	12.8	17.8	35.7	18.1	18.8	37.5	15.5	18.0	23.7	22.5	21.4	36.3	20.3	14.8	23.3	18.5	12.9	29.1	10.5	14.1	10.2	8.9	14.8	18.9	10.7	8.1	36.9	8.5	38.4	21.8	10.2	16.8	22.0	30.0	13.6	24.0	22.8	13.1	32.5	12.6	23.2	32.7
WDR12	"FLJ10881, YTM1"	ENSG00000138442	"WD repeat domain 12"	Q9GZL7	2	202874782-203014798	"Plasma proteins, Predicted intracellular proteins"	"Ribosome biogenesis, rRNA processing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036389	Uncertain		Approved	"Nucleoli,Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"	Nucleoli	"HPA036389: AB_10670716"	"unprognostic (1.08e-2)"	"unprognostic (3.59e-1)"	"unprognostic (8.17e-2)"	"unprognostic (3.59e-3)"	"unprognostic (1.24e-2)"	"unprognostic (9.40e-3)"	"prognostic unfavourable (2.57e-6)"	"unprognostic (1.52e-1)"	"unprognostic (6.14e-2)"	"unprognostic (4.78e-2)"	"unprognostic (4.58e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.69e-1)"	"unprognostic (5.21e-2)"	"unprognostic (2.66e-1)"	"unprognostic (9.69e-3)"	"unprognostic (4.48e-2)"	5.8	9.7	7.2	5.5	16.1	6.7	7.6	11.5	15.2	5.9	6.2	6.5	3.7	8.9	7.1	7.0	8.0	6.7	5.0	8.4	6.8	8.6	11.1	8.7	4.2	6.4	7.4	8.9	7.3	5.7	6.7	8.0	6.6	12.6	4.9	8.7	6.7	5.4	5.2	11.0	7.7	6.0	7.4	6.2	5.3	5.6	17.1	8.2	9.6	7.1	5.1	7.5	5.8	5.6	5.4	6.9	3.6	5.0	3.6	5.9	3.0	4.3	4.6	5.3	10.0	10.0	8.6	9.7	6.6	5.3	8.2	8.0	11.6	6.1	7.9	6.1	5.3	5.5	14.3	10.6	13.2	4.0	8.9	13.4	7.4	13.7	6.5	17.4	8.2	7.8	7.7	9.7	19.4	8.5	20.9	5.2	9.0	5.0	11.9	10.2	12.1	11.7	8.7	8.3	12.4	9.0	5.2	9.3	8.2	5.2	6.8	8.1	4.0	11.5	6.8	7.4	6.0	6.1	7.3	6.8	10.3	13.3	7.3	11.9	7.3	3.6	4.7	2.0	4.2	5.0	5.9	5.3	4.0	4.3	6.0	5.4	5.2	5.0	2.1	3.6	4.5	6.9	4.3	3.0	7.2	16.1	11.5	15.2	6.8	8.6	7.4	8.9	12.6	8.2
WDR13		ENSG00000101940	"WD repeat domain 13"	Q9H1Z4	X	48590042-48608867	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000913	Supported		Supported	"Nucleoplasm,Plasma membrane,Centriolar satellite"				Nucleoplasm	"Plasma membrane, Centriolar satellite"	"HPA000913: AB_1858795"	"unprognostic (5.03e-2)"	"unprognostic (6.53e-3)"	"unprognostic (3.65e-3)"	"unprognostic (2.10e-3)"	"unprognostic (3.50e-1)"	"unprognostic (1.54e-3)"	"unprognostic (3.54e-2)"	"unprognostic (6.76e-2)"	"unprognostic (2.40e-2)"	"unprognostic (3.48e-1)"	"unprognostic (1.58e-2)"	"unprognostic (1.33e-1)"	"unprognostic (2.82e-1)"	"unprognostic (2.99e-1)"	"unprognostic (1.66e-1)"	"unprognostic (2.65e-1)"	"unprognostic (4.32e-2)"	24.5	30.4	39.9	13.9	36.9	15.7	19.1	14.4	33.9	18.6	25.5	17.6	41.5	23.0	26.0	41.2	23.1	30.8	21.1	49.8	30.2	18.9	24.2	50.2	19.3	11.1	20.0	35.8	35.0	74.7	21.8	24.4	23.9	17.0	19.6	14.4	16.5	30.4	35.8	48.5	21.7	22.0	20.2	17.5	17.4	22.7	11.0	20.5	8.6	21.9	21.1	10.5	17.9	19.7	16.8	21.1	29.2	28.2	17.3	13.8	15.9	14.9	22.0	11.0	34.0	15.2	22.4	8.4	10.4	19.0	12.1	11.1	13.0	24.1	10.4	10.0	21.2	12.9	5.5	22.7	4.3	12.3	9.7	7.1	25.9	23.6	34.6	6.1	19.4	21.1	32.5	17.1	31.5	16.5	7.0	13.3	16.7	21.5	8.4	10.7	7.9	17.3	8.1	11.7	18.8	21.3	11.9	12.8	15.9	11.7	24.5	24.0	15.6	11.9	27.3	12.6	18.7	19.8	9.9	15.5	5.7	3.8	18.6	9.2	17.3	29.2	23.1	12.7	11.9	24.7	9.5	16.8	12.6	11.3	21.1	13.4	10.0	11.4	16.0	17.3	28.2	13.3	13.8	15.9	39.9	36.9	14.4	33.9	30.2	18.9	20.0	35.8	17.0	20.5
WDR53	"MGC12928, MGC64882"	ENSG00000185798	"WD repeat domain 53"	Q7Z5U6	3	196554177-196568674	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 48.0"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA016420	Approved		Approved	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		"HPA016420: AB_1858812"	"unprognostic (3.29e-2)"	"unprognostic (4.24e-3)"	"unprognostic (9.89e-2)"	"unprognostic (2.29e-3)"	"unprognostic (2.26e-1)"	"unprognostic (4.71e-2)"	"prognostic unfavourable (1.57e-6)"	"unprognostic (4.49e-2)"	"prognostic unfavourable (3.09e-4)"	"unprognostic (2.57e-1)"	"unprognostic (2.10e-3)"	"unprognostic (4.48e-3)"	"unprognostic (8.01e-3)"	"unprognostic (1.68e-1)"	"unprognostic (1.12e-1)"	"unprognostic (5.38e-2)"	"unprognostic (1.97e-1)"	4.3	4.3	5.9	6.8	6.9	7.2	5.2	6.4	5.9	4.0	4.2	4.5	7.1	2.1	4.9	6.6	5.1	3.9	3.5	4.0	4.8	3.8	4.0	5.4	3.8	5.5	5.9	4.3	4.3	3.3	7.5	11.9	4.4	6.1	4.1	4.1	4.8	4.0	4.5	6.8	6.7	4.5	4.1	5.0	6.2	4.0	48.0	4.6	7.4	4.2	3.2	6.5	3.9	4.2	7.5	5.9	13.9	6.7	6.5	14.9	4.9	18.7	4.0	7.3	6.5	7.4	6.5	11.6	9.9	7.7	11.3	10.7	11.0	10.0	8.9	33.4	6.0	11.0	9.1	8.5	14.2	14.0	7.9	9.0	9.9	7.2	9.3	12.6	7.4	5.3	12.6	10.0	11.0	8.8	8.8	17.3	8.6	17.5	10.7	13.0	9.9	11.8	12.9	12.5	19.0	6.2	6.6	7.2	7.8	6.9	10.3	14.5	26.4	11.8	8.1	9.6	9.1	10.7	19.3	14.7	29.4	26.7	6.3	16.3	9.6	9.6	5.1	13.9	8.6	4.4	14.0	7.5	12.3	8.7	4.1	7.1	10.3	6.2	4.4	6.5	6.7	5.9	14.9	4.9	5.9	6.9	6.4	5.9	4.8	3.8	5.9	4.3	6.1	4.6
WDR6		ENSG00000178252	"WD repeat domain 6"	Q9NNW5	3	49007062-49015953	"Predicted intracellular proteins"	"Cell cycle"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042622	Approved		Supported	"Plasma membrane,Cytosol"				Cytosol	"Plasma membrane"	"HPA042622: AB_10966784"	"unprognostic (2.41e-2)"	"unprognostic (2.03e-1)"	"unprognostic (2.14e-1)"	"unprognostic (1.26e-2)"	"unprognostic (4.80e-2)"	"unprognostic (1.05e-1)"	"prognostic unfavourable (2.97e-6)"	"unprognostic (1.79e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.01e-3)"	"unprognostic (1.94e-2)"	"prognostic favourable (4.52e-5)"	"unprognostic (1.13e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.87e-1)"	"unprognostic (1.61e-2)"	15.8	36.7	21.5	26.1	23.5	14.9	19.7	29.9	29.9	32.7	31.0	30.8	56.4	27.5	39.0	37.0	18.7	33.1	32.6	20.4	20.1	20.4	26.0	22.0	21.1	28.2	22.8	26.9	60.9	46.0	56.7	55.8	24.3	22.1	39.0	22.1	34.3	33.4	54.4	23.9	26.6	28.3	40.8	17.5	29.1	24.7	23.7	22.1	26.9	50.7	20.3	25.1	31.2	24.6	12.3	14.4	10.3	12.9	11.7	18.9	12.0	17.4	24.1	39.9	33.8	26.8	21.9	27.0	26.1	21.6	29.5	24.0	21.4	25.3	28.1	16.7	41.6	20.0	31.8	36.5	21.1	22.3	21.1	26.6	59.1	28.1	27.2	27.4	12.0	39.3	26.3	27.2	20.6	21.5	15.1	30.1	26.7	34.7	31.8	31.3	35.4	22.4	18.7	17.1	17.7	35.0	51.9	19.4	36.4	19.6	16.1	11.3	28.0	22.0	28.7	22.0	35.4	21.3	34.6	53.2	22.7	24.4	29.8	35.2	15.7	3.7	9.1	10.3	16.9	12.9	18.9	12.0	12.5	12.9	11.3	12.3	14.7	10.9	3.4	11.7	6.5	14.4	10.5	12.0	21.5	23.5	29.9	29.9	20.1	20.4	22.8	26.9	22.1	22.1
WIPF1	"WASPIP, WIP"	ENSG00000115935	"WAS/WASL interacting protein family member 1"	O43516	2	174559572-174682916	"Disease related genes, Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Daudi: 44.5;Karpas-707: 64.1;U-266/70: 51.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003739, CAB009737, HPA070706"	Enhanced		Approved	"Plasma membrane,Cytosol"			290000	Cytosol	"Plasma membrane"	"CAB009737: AB_2288577, HPA003739: AB_1858783, HPA070706: "	"unprognostic (4.76e-2)"	"unprognostic (4.80e-2)"	"unprognostic (1.49e-1)"	"unprognostic (9.88e-2)"	"unprognostic (1.87e-1)"	"unprognostic (2.27e-3)"	"unprognostic (2.05e-1)"	"unprognostic (1.21e-1)"	"unprognostic (7.22e-2)"	"unprognostic (1.26e-1)"	"unprognostic (3.25e-2)"	"unprognostic (1.46e-1)"	"prognostic unfavourable (1.14e-4)"	"unprognostic (3.65e-2)"	"unprognostic (5.43e-2)"	"unprognostic (1.58e-1)"	"unprognostic (2.50e-2)"	20.6	7.3	10.5	47.0	14.4	23.2	21.6	2.1	9.2	17.1	16.5	20.2	6.6	8.7	14.3	11.4	10.3	9.8	17.2	12.0	14.6	10.5	9.0	7.8	22.6	55.7	21.1	5.6	8.7	4.7	5.7	4.2	15.6	10.9	10.6	10.7	10.5	10.5	11.7	4.0	7.3	21.3	13.8	44.2	55.5	9.9	4.5	14.9	42.9	11.4	8.9	51.7	22.8	15.3	12.3	8.2	52.7	12.9	17.8	25.0	15.3	0.1	1.4	3.4	0.0	8.7	15.4	3.5	6.4	5.5	2.5	4.0	0.3	0.2	44.5	1.9	9.6	0.1	0.5	0.0	3.4	30.1	0.8	23.4	5.8	0.0	3.3	19.5	37.0	6.4	1.0	5.9	0.5	5.6	0.6	64.1	7.5	0.0	21.6	17.9	4.0	0.2	18.6	1.4	8.3	2.3	0.1	0.5	7.1	0.0	1.8	3.8	0.0	9.5	4.3	8.8	2.4	6.3	6.1	51.2	31.3	23.3	13.3	13.4	24.2	12.1	10.8	26.2	25.0	11.9	21.0	12.3	16.8	24.5	8.2	10.3	13.8	18.1	52.7	17.8	12.9	3.6	18.7	15.3	10.5	14.4	2.1	9.2	14.6	10.5	21.1	5.6	10.9	14.9
WWP1	"AIP5, DKFZP434D2111"	ENSG00000123124	"WW domain containing E3 ubiquitin protein ligase 1"	Q9H0M0	8	86342738-86478420	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Host-virus interaction, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA023180	Approved		Approved	"Golgi apparatus,Plasma membrane,Cytosol"				Cytosol	"Golgi apparatus, Plasma membrane"	"HPA023180: AB_10602587"	"unprognostic (3.89e-1)"	"unprognostic (6.63e-2)"	"unprognostic (3.81e-2)"	"unprognostic (7.91e-2)"	"unprognostic (3.70e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.93e-1)"	"unprognostic (4.24e-2)"	"unprognostic (1.83e-1)"	"unprognostic (9.43e-3)"	"unprognostic (3.09e-3)"	"unprognostic (1.48e-1)"	"prognostic favourable (5.45e-5)"	"unprognostic (2.35e-1)"	"unprognostic (4.63e-1)"	"unprognostic (3.19e-3)"	"unprognostic (1.01e-1)"	15.4	9.1	9.7	15.6	14.1	5.2	20.9	8.5	9.5	11.5	16.9	7.5	21.1	8.7	11.9	19.3	11.7	7.2	22.0	40.7	8.7	8.5	16.9	37.2	10.2	15.9	10.0	7.8	10.1	11.3	40.7	7.3	15.6	12.7	17.8	11.3	8.9	11.8	9.4	58.0	13.8	13.0	18.4	9.9	19.1	11.4	10.4	9.5	11.1	11.2	18.0	12.5	14.5	12.3	3.7	2.6	6.5	2.8	2.9	10.4	2.3	22.9	10.8	7.5	5.3	9.4	9.3	6.9	8.4	8.9	6.7	8.0	7.6	14.1	9.9	5.7	14.3	19.7	10.5	13.4	11.6	12.2	8.4	11.3	9.6	17.8	6.9	4.5	5.9	8.4	17.2	7.3	13.6	29.4	5.9	11.6	11.3	11.4	10.8	3.4	4.5	12.2	7.1	9.0	8.7	15.0	17.6	2.2	5.2	8.3	42.1	8.9	12.5	4.2	33.8	10.0	11.9	10.6	4.3	13.8	8.4	10.1	12.4	0.8	7.6	6.5	2.8	4.8	7.2	2.4	6.0	3.7	8.7	7.1	1.9	3.6	10.4	6.3	1.7	2.9	2.8	2.6	8.0	2.3	9.7	14.1	8.5	9.5	8.7	8.5	10.0	7.8	12.7	9.5
XIAP	"API3, BIRC4, hILP"	ENSG00000101966	"X-linked inhibitor of apoptosis"	P98170	X	123859724-123913979	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Apoptosis, Ubl conjugation pathway, Wnt signaling pathway"	"Protease inhibitor, Thiol protease inhibitor, Transferase"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"CAB009203, HPA042428"	Approved		Supported	"Nucleoplasm,Plasma membrane,Cytosol"				"Nucleoplasm, Cytosol"	"Plasma membrane"	"CAB009203: AB_2257167, HPA042428: "	"prognostic unfavourable (9.21e-4)"	"unprognostic (8.43e-2)"	"unprognostic (1.50e-2)"	"unprognostic (2.14e-1)"	"unprognostic (1.40e-1)"	"unprognostic (9.41e-2)"	"unprognostic (1.95e-2)"	"unprognostic (8.51e-2)"	"unprognostic (9.17e-2)"	"unprognostic (3.90e-2)"	"unprognostic (7.50e-2)"	"unprognostic (4.41e-2)"	"unprognostic (3.15e-3)"	"unprognostic (8.21e-3)"	"unprognostic (2.26e-1)"	"unprognostic (4.99e-2)"	"unprognostic (4.65e-2)"	17.4	14.4	20.0	18.1	20.2	12.0	15.9	21.3	18.9	17.2	19.4	14.5	22.9	16.1	17.4	17.0	18.9	12.6	14.7	15.7	18.9	22.1	19.8	19.4	16.5	15.5	18.8	14.6	13.9	19.7	36.6	26.1	18.2	15.9	15.6	16.8	16.9	14.6	22.9	21.5	14.2	23.4	17.0	19.0	15.8	16.2	7.0	12.3	13.9	24.3	11.4	14.0	15.4	20.5	5.7	4.3	11.1	3.9	3.3	5.5	1.9	11.5	9.9	7.8	6.7	9.2	11.9	10.2	12.6	9.4	6.9	5.9	4.4	13.6	10.8	18.7	10.7	4.3	11.5	7.9	12.7	11.2	6.3	7.3	8.3	6.7	11.7	13.2	15.2	8.2	12.3	11.4	14.7	9.5	11.5	12.5	13.3	12.0	7.3	6.4	6.4	7.8	7.9	9.1	11.4	10.4	16.8	5.3	7.7	17.2	10.0	10.1	6.1	6.5	11.7	0.3	4.7	20.6	14.0	10.5	10.5	12.0	14.2	9.4	8.7	11.1	2.6	3.5	5.0	2.3	4.7	4.6	3.8	5.5	1.4	5.7	4.4	3.0	8.2	3.3	3.9	4.3	2.5	1.9	20.0	20.2	21.3	18.9	18.9	22.1	18.8	14.6	15.9	12.3
XIRP1	"CMYA1, DKFZp451D042, Xin"	ENSG00000168334	"Xin actin binding repeat containing 1"	Q702N8	3	39183210-39192596	"Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	9	"heart muscle: 95.0;skeletal muscle: 219.0"	"Group enriched"	"Detected in some"	5	"HSkMC: 9.1;LHCN-M2: 2.3;RH-30: 6.1"	"Cancer enhanced"	"Detected in some"		"head and neck cancer: 2.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA016750, HPA018458, CAB026391"	Enhanced		Approved	"Nucleoplasm,Plasma membrane,Actin filaments"				"Plasma membrane, Actin filaments"	Nucleoplasm	"CAB026391: , HPA016750: AB_1858884, HPA018458: AB_1858885"	"unprognostic (2.19e-1)"	"unprognostic (6.40e-2)"	"unprognostic (1.13e-1)"	"unprognostic (9.75e-2)"	"unprognostic (2.76e-1)"	"unprognostic (2.43e-2)"	"unprognostic (4.94e-2)"	"unprognostic (2.66e-3)"	"unprognostic (1.66e-3)"	"unprognostic (1.46e-1)"	"unprognostic (5.30e-2)"	"unprognostic (6.26e-2)"	"unprognostic (1.02e-5)"	"unprognostic (2.08e-2)"	"unprognostic (2.78e-2)"	"unprognostic (6.86e-4)"	"unprognostic (4.12e-2)"	1.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.2	0.0	0.0	0.0	1.7	1.9	0.0	0.4	95.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.4	0.0	0.1	0.2	0.3	1.1	0.0	0.0	1.3	0.0	219.0	0.0	0.1	0.1	0.0	0.2	0.0	0.0	0.0	0.1	4.9	18.2	2.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.6	0.1	0.0	0.0	0.0	0.0	0.0	1.1	9.1	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	6.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.3	0.0
XIRP2	CMYA3	ENSG00000163092	"Xin actin binding repeat containing 2"	A4UGR9	2	166888487-167259753	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"		Actin-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	6	"skeletal muscle: 292.8"	"Cell line enhanced"	"Detected in some"		"AN3-CA: 3.2;HEL: 1.5;HUVEC TERT2: 8.5;U-2197: 6.0"	"Cancer enriched"	"Detected in some"	5	"head and neck cancer: 3.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA034813, HPA074599"	Enhanced		Approved	"Nucleoplasm,Plasma membrane"				"Plasma membrane"	Nucleoplasm	"HPA034813: AB_10602588, HPA074599: "					"unprognostic (5.27e-4)"	"unprognostic (5.96e-3)"		"unprognostic (7.42e-2)"	"unprognostic (2.42e-1)"					"unprognostic (1.74e-1)"	"unprognostic (2.56e-1)"			7.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	3.3	0.0	0.0	24.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	4.3	0.0	292.8	0.0	0.0	0.0	0.0	0.1	0.0	0.6	0.0	0.0	2.3	51.0	2.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	1.5	0.0	0.2	0.2	0.0	0.0	0.9	0.0	0.2	0.7	8.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	6.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
XPNPEP2		ENSG00000122121	"X-prolyl aminopeptidase 2"	O43895	X	129738974-129769538	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Aminopeptidase, Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	9	"intestine: 145.6;kidney: 49.7"	"Cell line enhanced"	"Detected in some"		"ASC diff: 6.2;ASC TERT1: 32.6;HSkMC: 16.5"	"Group enriched"	"Detected in many"	6	"colorectal cancer: 5.3;liver cancer: 18.3;stomach cancer: 3.9"	"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	4	"gdT-cell: 7.3;intermediate monocyte: 2.1;MAIT T-cell: 2.2;memory CD4 T-cell: 2.4;memory CD8 T-cell: 4.8;naive CD8 T-cell: 3.6;non-classical monocyte: 4.4;T-reg: 2.2"	"Group enriched"	"Detected in many"	7	"monocytes: 4.4;T-cells: 7.3"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"HPA000339, CAB025136, CAB025269, HPA064568"	Enhanced		Approved	"Plasma membrane,Cytosol"	"Intracellular and membrane"		8900000	"Plasma membrane, Cytosol"		"CAB025136: , CAB025269: , HPA000339: AB_1858894, HPA064568: "	"unprognostic (7.95e-2)"	"unprognostic (5.73e-2)"	"unprognostic (2.56e-1)"	"unprognostic (6.21e-3)"	"unprognostic (3.54e-2)"	"unprognostic (1.54e-1)"	"unprognostic (4.04e-1)"	"unprognostic (3.26e-1)"	"unprognostic (3.01e-1)"	"unprognostic (2.41e-2)"	"unprognostic (3.07e-1)"	"unprognostic (9.28e-3)"	"unprognostic (2.77e-2)"	"unprognostic (6.53e-2)"	"unprognostic (3.18e-2)"	"unprognostic (1.39e-2)"	"unprognostic (3.26e-3)"	4.7	0.5	0.0	1.1	0.1	0.0	3.2	0.0	0.1	1.7	57.4	0.1	0.8	37.0	1.2	1.7	4.2	3.4	1.3	2.6	0.0	0.0	49.7	8.0	1.0	1.2	0.0	0.0	3.5	0.9	0.0	0.0	0.6	0.1	3.6	2.0	0.7	0.7	0.3	1.6	2.1	145.6	2.5	0.1	0.2	1.7	1.2	0.0	0.1	0.9	1.4	0.3	4.0	10.7	0.4	0.8	0.2	4.4	0.0	7.3	1.3	0.0	0.0	0.4	0.0	6.2	32.6	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.8	0.0	0.0	16.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.4	0.0	0.6	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	7.3	2.1	2.2	0.0	2.4	4.8	0.3	0.4	0.7	3.6	0.2	0.0	4.4	0.8	2.2	1.3	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0
XPO6	"FLJ22519, KIAA0370, RANBP20"	ENSG00000169180	"Exportin 6"	Q96QU8	16	28097979-28211920	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in all"	7	"neutrophil: 56.4"	"Lineage enriched"	"Detected in all"	9	"granulocytes: 56.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038246	Uncertain		Approved	"Nucleoplasm,Nucleoli,Plasma membrane,Cytosol"				"Nucleoplasm, Nucleoli"	"Plasma membrane, Cytosol"	"HPA038246: AB_10674550"	"unprognostic (1.17e-1)"	"unprognostic (5.43e-2)"	"unprognostic (1.07e-1)"	"unprognostic (3.76e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.03e-1)"	"prognostic unfavourable (3.68e-4)"	"unprognostic (2.22e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.31e-2)"	"unprognostic (4.48e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.01e-3)"	"unprognostic (2.10e-1)"	"unprognostic (5.36e-2)"	"unprognostic (8.50e-2)"	"prognostic unfavourable (8.80e-4)"	18.4	14.1	24.3	32.0	25.0	47.9	17.7	16.0	30.6	12.4	17.7	30.4	9.9	13.4	13.5	12.0	16.8	14.1	14.9	9.6	27.5	23.9	13.3	19.1	20.6	54.6	25.6	16.9	15.3	13.2	22.0	18.0	25.9	21.7	14.1	17.0	16.3	19.4	13.1	8.3	18.8	18.3	16.3	23.8	50.4	14.8	28.9	19.8	37.1	18.0	7.8	31.8	17.2	13.2	5.2	2.6	56.4	4.4	2.7	6.5	2.0	28.4	20.4	18.0	19.3	12.5	19.9	20.7	35.2	31.9	41.3	41.8	28.6	20.4	20.2	30.4	32.0	18.6	42.7	27.0	50.2	45.5	26.5	22.1	28.8	31.8	29.6	30.8	24.9	15.6	20.1	36.6	36.3	23.7	40.2	10.2	27.9	31.9	37.0	36.8	30.5	19.5	34.8	21.4	33.5	15.3	14.5	35.2	19.1	17.4	29.1	15.4	20.9	20.4	25.1	34.9	23.4	29.7	29.3	23.9	30.2	30.0	26.6	32.2	29.4	4.7	2.7	8.4	4.1	3.0	4.4	5.2	4.7	4.4	2.0	3.9	5.2	6.5	56.4	2.7	4.4	2.6	3.8	2.0	24.3	25.0	16.0	30.6	27.5	23.9	25.6	16.9	21.7	19.8
XYLT1	"PXYLT1, XT-I"	ENSG00000103489	"Xylosyltransferase 1"	Q86Y38	16	17101769-17470881	"Disease related genes, Enzymes, Potential drug targets, Predicted secreted proteins"		"Glycosyltransferase, Transferase"	"Disease mutation, Dwarfism"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 21.6"	"Cell line enhanced"	"Detected in many"		"ASC diff: 18.8;U-2197: 19.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007478, HPA007966"	Approved		Approved	"Endoplasmic reticulum,Plasma membrane"	"Secreted to blood"		30000	"Plasma membrane"	"Endoplasmic reticulum"	"HPA007478: AB_1080616, HPA007966: AB_1080618"	"unprognostic (1.82e-1)"	"unprognostic (7.17e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.38e-2)"	"unprognostic (2.83e-1)"	"unprognostic (9.12e-2)"	"unprognostic (8.13e-2)"	"unprognostic (9.40e-2)"	"unprognostic (2.41e-3)"	"unprognostic (2.82e-2)"	"unprognostic (2.11e-1)"	"unprognostic (1.01e-1)"	"unprognostic (8.66e-3)"	"unprognostic (2.49e-1)"	"unprognostic (1.76e-1)"	"unprognostic (2.95e-1)"	"unprognostic (6.05e-2)"	5.7	5.9	6.3	21.6	3.1	5.9	7.0	3.8	6.7	8.0	7.4	1.4	0.9	3.9	7.4	3.0	4.9	3.2	4.4	3.8	6.3	4.2	1.9	0.9	2.9	7.5	4.3	2.2	5.5	2.6	0.2	1.8	5.4	2.6	4.4	4.9	3.4	2.6	4.3	1.3	4.1	4.7	5.1	3.9	6.3	3.2	3.0	2.1	4.6	2.7	6.7	6.6	4.7	4.2	1.2	0.8	1.2	3.6	0.9	0.7	0.5	0.0	0.1	2.6	0.0	18.8	11.7	3.2	8.4	4.3	0.9	0.4	0.1	0.2	2.0	0.0	10.1	0.2	0.0	1.7	1.5	4.0	0.2	2.5	0.0	0.0	0.2	3.6	3.4	4.3	0.2	5.4	0.8	0.0	0.3	7.9	0.9	0.3	0.0	3.9	2.8	0.0	1.2	0.0	0.4	0.0	3.8	0.7	5.1	0.6	2.6	0.5	0.6	2.3	0.0	8.8	1.0	19.3	0.0	8.8	0.5	3.8	9.8	4.1	7.4	0.6	0.6	1.2	0.6	2.5	0.7	1.2	0.5	0.3	0.8	1.2	0.5	0.4	0.3	0.9	3.6	0.2	0.7	0.5	6.3	3.1	3.8	5.3	6.3	4.2	4.3	2.2	2.6	2.1
YIPF4	"FinGER4, MGC11061"	ENSG00000119820	"Yip1 domain family member 4"	Q9BSR8	2	32277910-32316594	"Predicted intracellular proteins, Predicted membrane proteins"	"Host-virus interaction"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017884	Supported		Supported	"Golgi apparatus,Vesicles,Plasma membrane"				"Golgi apparatus"	"Vesicles, Plasma membrane"	"HPA017884: AB_1853855"	"unprognostic (5.61e-3)"	"unprognostic (8.50e-2)"	"unprognostic (3.88e-2)"	"unprognostic (3.17e-3)"	"unprognostic (3.05e-1)"	"unprognostic (7.64e-2)"	"unprognostic (3.45e-2)"	"unprognostic (3.61e-2)"	"unprognostic (3.69e-1)"	"unprognostic (8.70e-2)"	"unprognostic (4.15e-1)"	"unprognostic (1.54e-1)"	"unprognostic (2.29e-3)"	"unprognostic (1.90e-1)"	"unprognostic (1.59e-1)"	"unprognostic (3.88e-2)"	"unprognostic (6.11e-2)"	15.2	15.3	15.7	12.3	19.2	6.0	19.5	24.9	27.2	15.6	16.0	21.7	16.9	13.6	19.6	17.7	15.3	13.3	12.3	19.1	17.7	16.5	18.7	24.0	13.4	12.9	18.5	13.3	17.9	32.9	14.2	22.3	19.2	17.6	16.1	15.0	15.4	24.1	14.2	16.8	16.5	14.6	15.8	17.7	15.4	14.7	15.2	16.3	18.7	23.6	12.2	13.6	14.6	14.2	5.0	5.8	16.5	6.0	7.0	5.4	4.4	8.3	4.2	8.4	7.5	9.8	12.6	4.4	7.2	7.3	7.6	5.0	5.6	6.4	4.5	5.1	7.8	6.6	8.9	6.3	9.9	7.2	13.8	7.2	9.9	10.1	11.6	9.5	6.2	8.7	12.2	6.8	10.9	6.4	9.8	9.4	8.2	5.5	7.4	10.0	6.8	7.3	5.2	12.4	8.4	8.1	3.6	9.5	9.1	6.2	6.3	10.7	3.5	8.1	7.1	10.1	4.8	7.0	6.8	14.0	17.2	5.4	15.9	9.3	5.5	12.5	6.0	5.9	5.0	5.4	4.3	5.0	5.1	4.7	4.9	4.8	5.4	4.7	16.5	7.0	5.2	5.8	4.7	4.4	15.7	19.2	24.9	18.9	17.7	16.5	18.5	13.3	17.6	16.3
YTHDC1	"KIAA1966, YT521, YT521-B"	ENSG00000083896	"YTH domain containing 1"	Q96MU7	4	68310387-68350089	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036462	Supported		Approved	"Nucleoplasm,Plasma membrane"				Nucleoplasm	"Plasma membrane"	"HPA036462: AB_10669793"	"unprognostic (1.02e-1)"	"unprognostic (8.44e-3)"	"unprognostic (5.74e-3)"	"unprognostic (1.35e-1)"	"unprognostic (7.59e-2)"	"unprognostic (1.33e-3)"	"unprognostic (1.52e-3)"	"unprognostic (8.28e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.09e-1)"	"unprognostic (2.35e-2)"	"unprognostic (1.41e-2)"	"unprognostic (6.64e-3)"	"unprognostic (1.63e-2)"	"unprognostic (1.70e-1)"	"unprognostic (4.05e-1)"	"prognostic favourable (7.29e-5)"	22.1	16.6	25.1	28.8	33.2	101.8	24.3	38.4	25.8	30.3	20.8	24.4	24.0	16.7	29.2	25.1	25.4	20.2	17.6	18.5	23.5	19.6	19.8	19.5	21.1	26.8	26.1	23.4	39.7	24.2	27.6	32.4	33.2	22.8	25.2	21.3	13.8	22.7	30.2	32.9	26.1	21.2	27.6	25.4	23.6	20.6	17.7	35.1	30.2	23.8	20.2	26.7	34.8	30.3	18.0	15.1	41.6	9.3	7.5	11.1	3.2	17.4	10.5	21.5	12.9	12.9	11.3	17.8	19.2	12.2	12.1	12.7	12.9	16.1	28.6	15.8	9.8	13.2	20.1	16.9	19.7	21.2	12.2	21.8	15.0	14.3	13.3	23.0	16.9	10.6	18.4	10.8	25.9	13.0	20.6	16.8	17.6	13.3	26.8	20.8	16.1	10.4	23.5	24.3	12.7	18.9	20.3	18.6	14.6	16.8	18.2	13.9	14.2	16.1	13.8	13.9	14.7	9.5	12.7	17.6	11.8	29.9	9.4	15.0	12.7	20.2	8.3	14.7	9.9	5.0	7.7	12.7	8.0	7.9	4.6	18.0	11.1	9.2	41.6	7.5	9.3	15.1	7.3	3.2	25.1	33.2	38.4	25.8	23.5	19.6	26.1	23.4	22.8	35.1
ZBED3	MGC15435	ENSG00000132846	"Zinc finger BED-type containing 3"	Q96IU2	5	77072072-77087323	"Predicted intracellular proteins, Transcription factors"	"Wnt signaling pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 19.6;MOLT-4: 18.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			HPA055995	Approved		Approved	"Nucleoplasm,Plasma membrane"				"Plasma membrane"	Nucleoplasm	"HPA055995: "	"unprognostic (3.23e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.24e-2)"	"unprognostic (1.22e-1)"	"unprognostic (3.78e-2)"	"unprognostic (4.02e-2)"	"unprognostic (2.97e-1)"	"unprognostic (1.45e-2)"	"unprognostic (6.96e-3)"	"unprognostic (1.82e-2)"	"unprognostic (8.64e-3)"	"unprognostic (3.63e-1)"	"prognostic favourable (1.68e-4)"	"unprognostic (2.08e-1)"	"unprognostic (1.92e-1)"	"unprognostic (5.41e-2)"	"unprognostic (1.08e-1)"	14.4	5.2	8.0	3.0	16.6	3.4	13.0	6.7	10.8	10.5	6.9	20.5	6.4	5.7	15.8	12.7	3.8	10.6	5.3	6.5	9.5	6.2	18.0	16.2	7.3	3.3	22.7	7.2	12.2	10.9	13.9	9.0	3.6	9.5	7.8	6.5	8.3	8.3	10.3	3.7	3.9	5.0	13.0	10.5	5.0	8.7	4.0	13.7	5.2	16.4	1.6	2.8	5.4	5.8	0.2	1.8	0.3	1.1	0.1	0.8	0.2	3.3	2.7	3.6	19.6	15.0	1.0	0.2	1.1	3.3	1.7	4.6	5.8	1.6	0.0	7.3	2.2	0.4	1.9	1.2	1.5	1.1	3.6	2.6	5.9	6.6	9.0	3.5	1.0	16.8	4.5	0.8	3.4	5.5	0.0	7.3	1.0	3.3	18.5	0.5	2.3	1.6	7.7	6.8	1.0	8.1	1.2	3.9	8.3	3.9	3.3	5.6	4.9	2.4	2.2	1.5	3.0	3.4	4.5	5.3	5.0	7.5	2.4	6.7	3.5	0.0	1.1	0.3	0.4	0.4	0.4	0.1	0.3	0.5	0.9	0.2	0.8	0.8	0.3	0.1	0.1	1.8	0.0	0.2	8.0	16.6	6.7	10.8	9.5	6.2	22.7	7.2	9.5	13.7
ZBTB8OS	ARCH	ENSG00000176261	"Zinc finger and BTB domain containing 8 opposite strand"	Q8IWT0	1	32600172-32650903	"Predicted intracellular proteins"	"tRNA processing"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046315	Approved		Approved	"Plasma membrane"				"Plasma membrane"		"HPA046315: "	"unprognostic (3.41e-2)"	"unprognostic (1.39e-2)"	"unprognostic (1.08e-1)"	"unprognostic (9.08e-2)"	"unprognostic (1.82e-1)"	"unprognostic (8.14e-2)"	"prognostic unfavourable (4.25e-4)"	"unprognostic (9.63e-2)"	"prognostic unfavourable (8.56e-4)"	"unprognostic (5.18e-2)"	"unprognostic (3.84e-1)"	"unprognostic (1.40e-1)"	"prognostic unfavourable (7.11e-8)"	"unprognostic (1.94e-2)"	"unprognostic (2.79e-1)"	"unprognostic (1.68e-1)"	"unprognostic (1.42e-1)"	16.1	18.8	20.9	21.2	22.3	14.5	16.7	21.7	21.1	13.1	25.6	11.9	21.4	24.9	13.9	29.5	20.6	15.5	12.2	20.7	16.9	15.8	23.2	26.6	15.5	25.9	23.5	18.6	10.4	20.3	9.2	36.6	13.6	20.9	15.9	26.8	15.3	19.0	18.5	29.5	13.4	28.6	16.2	18.0	22.3	20.6	11.1	23.0	8.4	18.7	20.3	32.5	14.8	13.5	36.0	26.1	33.8	35.4	22.4	40.1	18.0	18.2	10.6	9.4	16.0	16.7	15.2	13.0	20.8	21.0	16.6	16.9	25.0	20.5	20.3	19.2	15.1	13.7	16.4	16.2	22.2	27.1	15.1	16.5	22.0	41.5	13.7	23.7	15.3	15.1	17.8	14.6	17.6	18.0	16.3	27.7	21.2	14.4	18.1	13.8	29.3	16.4	14.6	20.4	19.8	19.7	21.8	19.1	14.8	16.8	16.9	26.0	11.6	19.7	12.8	23.2	14.0	18.6	25.8	42.1	41.2	57.4	16.6	29.6	22.9	15.8	29.2	33.8	24.4	33.9	23.5	36.0	27.0	28.9	20.4	23.1	22.5	24.2	32.5	22.4	35.4	26.1	40.1	18.0	20.9	22.3	21.7	21.1	16.9	15.8	23.5	18.6	20.9	23.0
ZDHHC5	"DHHC5, KIAA1748, ZNF375"	ENSG00000156599	"Zinc finger DHHC-type containing 5"	Q9C0B5	11	57667747-57701187	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA014670	Approved		Approved	"Nucleoplasm,Plasma membrane,Cell Junctions"				"Plasma membrane"	"Nucleoplasm, Cell Junctions"	"HPA014670: AB_2257442"	"unprognostic (1.34e-1)"	"unprognostic (3.47e-2)"	"unprognostic (2.51e-1)"	"unprognostic (2.29e-1)"	"unprognostic (5.32e-2)"	"unprognostic (1.70e-2)"	"unprognostic (9.82e-3)"	"unprognostic (1.74e-3)"	"unprognostic (4.36e-2)"	"unprognostic (9.78e-2)"	"prognostic unfavourable (6.74e-5)"	"unprognostic (1.76e-1)"	"unprognostic (4.72e-3)"	"unprognostic (2.16e-1)"	"unprognostic (6.80e-2)"	"unprognostic (2.06e-2)"	"unprognostic (1.74e-3)"	19.6	18.2	6.9	14.2	16.1	13.0	17.3	12.4	19.2	20.0	18.7	14.1	20.9	14.6	19.8	15.9	45.8	16.0	19.1	18.2	8.2	8.1	27.8	24.8	18.7	18.0	8.5	8.2	16.2	21.3	31.4	13.9	31.4	12.8	15.5	18.2	19.1	29.3	18.4	31.3	33.2	25.9	15.2	8.7	21.5	16.3	35.7	7.8	26.4	25.5	23.9	39.1	23.3	26.0	9.4	13.4	15.5	11.3	6.9	13.1	9.0	27.9	31.1	12.2	12.4	27.0	20.8	23.0	26.3	31.6	22.1	16.5	18.8	34.5	18.9	34.2	31.1	39.6	19.0	31.2	19.7	23.2	8.6	16.0	14.3	16.7	30.3	30.0	27.2	29.3	28.2	32.6	33.1	24.8	21.1	23.9	27.8	16.8	16.9	8.4	14.8	18.7	16.8	24.7	23.3	25.2	41.6	8.9	11.4	24.5	27.7	25.7	29.7	17.2	29.1	28.6	14.9	30.0	18.3	17.4	21.5	16.3	21.3	15.5	24.8	15.5	8.1	9.8	11.1	10.1	13.1	9.0	10.9	9.4	8.0	9.4	11.0	11.1	10.2	6.9	11.3	13.4	9.8	9.0	6.9	16.1	12.4	19.2	8.2	8.1	8.5	8.2	12.8	7.8
ZFP41	"FLJ00028, FLJ38705, ZNF753"	ENSG00000181638	"ZFP41 zinc finger protein"		8	143246821-143262705	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"											"HPA047232, HPA056268"	Uncertain		Approved	"Nucleoplasm,Nucleoli,Plasma membrane"				Nucleoli	"Nucleoplasm, Plasma membrane"	"HPA047232: , HPA056268: "	"unprognostic (9.16e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.47e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.45e-2)"	"prognostic unfavourable (3.46e-5)"	"unprognostic (4.92e-2)"	"unprognostic (7.18e-2)"	"unprognostic (3.53e-2)"	"unprognostic (4.16e-3)"	"unprognostic (2.98e-1)"	"unprognostic (1.55e-2)"	"unprognostic (6.89e-2)"	"unprognostic (1.59e-1)"	"unprognostic (3.44e-2)"	"unprognostic (3.20e-1)"	7.8	6.6	10.3	6.5	9.0	4.1	5.6	12.6	13.7	8.0	8.8	10.7	6.5	9.4	12.5	6.8	5.7	9.2	5.6	6.3	10.8	14.3	6.5	5.8	6.3	6.7	10.7	7.4	13.1	9.1	11.4	10.2	3.5	9.6	7.7	4.5	8.9	12.6	9.1	8.1	12.1	9.1	7.3	7.4	8.5	7.2	10.6	8.6	4.6	8.0	4.6	6.7	6.7	10.0	0.9	3.7	0.1	0.9	0.7	2.2	0.8	7.1	11.3	4.9	6.6	5.7	4.5	5.8	4.3	2.3	8.5	5.8	5.6	5.9	3.9	6.4	5.6	5.8	5.4	5.6	4.2	6.2	6.5	5.0	5.5	4.3	8.0	1.9	3.1	4.7	8.0	5.4	8.1	3.9	10.5	3.9	4.0	12.7	5.2	2.1	7.3	11.3	2.8	4.0	1.4	3.7	6.4	6.3	8.7	12.1	3.3	6.4	8.5	3.9	4.1	6.4	11.5	5.0	6.8	6.3	4.7	1.9	5.7	4.8	8.4	0.0	0.6	0.1	1.3	0.9	2.2	0.4	1.1	0.9	0.5	0.9	1.9	1.2	0.0	0.7	0.1	3.7	0.9	0.8	10.3	9.0	12.6	13.7	10.8	14.3	10.7	7.4	9.6	8.6
ZFP90	"KIAA1954, NK10, ZNF756"	ENSG00000184939	"ZFP90 zinc finger protein"	Q8TF47	16	68530090-68576072	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029017	Uncertain		Supported	"Vesicles,Plasma membrane,Centrosome"				"Vesicles, Plasma membrane, Centrosome"		"HPA029017: AB_10669653"	"unprognostic (3.27e-1)"	"unprognostic (1.71e-2)"	"unprognostic (1.56e-1)"	"unprognostic (1.45e-2)"	"unprognostic (3.11e-1)"	"unprognostic (2.47e-1)"	"unprognostic (3.68e-3)"	"unprognostic (1.78e-1)"	"unprognostic (5.19e-2)"	"unprognostic (7.33e-2)"	"unprognostic (1.35e-3)"	"unprognostic (3.43e-1)"	"prognostic favourable (1.78e-4)"	"unprognostic (1.47e-2)"	"unprognostic (2.37e-1)"	"unprognostic (1.33e-1)"	"unprognostic (9.60e-2)"	9.6	9.0	16.9	11.5	19.3	7.8	16.2	24.0	19.5	14.2	8.9	18.9	10.4	4.4	15.8	18.2	7.6	14.3	9.5	10.3	15.5	19.8	11.6	7.9	9.6	12.4	16.7	20.5	18.1	8.7	29.1	16.5	8.3	20.0	13.1	9.3	11.4	8.7	13.6	10.0	13.2	8.3	13.6	16.1	13.2	11.2	11.6	19.6	15.8	11.0	3.6	15.5	11.3	9.6	5.8	2.6	7.8	1.9	5.2	8.8	3.0	7.1	7.8	14.7	13.9	13.1	14.0	6.6	6.8	7.8	9.3	10.8	5.5	4.8	7.7	8.8	8.6	6.8	9.0	8.6	10.7	6.7	3.7	1.9	1.5	9.2	10.2	0.0	7.3	12.1	14.2	8.6	12.0	7.4	3.8	2.9	11.4	12.8	7.6	7.4	5.5	5.9	14.1	5.1	5.1	6.4	5.1	16.7	12.7	19.4	1.5	7.3	11.7	10.2	5.3	8.8	5.3	7.4	3.9	5.6	10.4	9.4	2.9	2.7	7.0	7.8	1.7	2.8	6.4	1.9	8.8	5.8	6.0	7.4	2.4	4.1	8.7	7.5	0.5	5.2	1.3	2.6	6.8	3.0	16.9	19.3	24.0	19.5	15.5	19.8	16.7	20.5	20.0	19.6
ZFYVE28	KIAA1643	ENSG00000159733	"Zinc finger FYVE-type containing 28"	Q9HCC9	4	2269582-2418663	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"brain: 63.6"	"Cell line enhanced"	"Detected in many"		"HMC-1: 11.0;NB-4: 11.9;U-266/70: 12.6"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in all"	4	"cerebellum: 63.6"	"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038175, HPA057587"	Approved		Approved	"Nucleoplasm,Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"	Nucleoplasm	"HPA038175: AB_10697244, HPA057587: "	"unprognostic (1.59e-1)"	"unprognostic (4.60e-2)"	"unprognostic (7.68e-2)"	"unprognostic (3.08e-3)"	"unprognostic (9.89e-3)"	"unprognostic (3.79e-2)"	"unprognostic (3.17e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.66e-1)"	"unprognostic (4.78e-3)"	"unprognostic (2.56e-2)"	"unprognostic (3.64e-2)"	"prognostic favourable (1.35e-6)"	"unprognostic (6.05e-2)"	"unprognostic (5.27e-2)"	"unprognostic (2.97e-1)"	"unprognostic (2.41e-2)"	4.5	8.6	7.7	5.1	15.8	3.1	3.7	63.6	15.1	3.7	7.4	4.6	1.8	10.4	4.1	3.1	3.4	4.3	5.9	2.4	7.1	5.5	5.7	4.2	4.4	6.1	7.9	8.0	3.4	7.3	7.9	7.5	1.8	9.9	2.9	5.1	5.8	9.5	5.4	4.3	5.7	11.9	2.8	9.4	7.0	7.5	7.9	6.7	1.2	5.3	3.1	4.0	4.5	3.2	3.1	0.7	0.9	0.4	0.3	4.4	1.3	0.8	1.0	0.2	3.7	2.1	0.7	0.1	1.8	3.1	1.0	0.3	0.1	6.6	0.0	1.9	3.2	3.8	1.2	0.3	0.6	9.5	1.3	0.2	4.2	0.3	4.3	0.7	11.0	3.0	0.6	1.1	0.1	3.0	1.8	8.1	0.9	2.2	0.1	11.9	0.1	8.1	0.0	0.0	3.9	1.5	0.5	5.8	0.4	1.8	0.1	1.0	2.4	0.3	0.5	1.7	0.0	5.4	0.1	12.6	9.1	0.1	5.3	2.3	1.8	0.9	0.4	0.1	4.4	0.0	1.9	0.9	2.3	3.2	0.7	3.1	3.2	3.2	0.1	0.3	0.3	0.2	4.0	1.3	7.7	15.8	63.6	15.1	7.1	5.5	7.9	8.0	9.9	6.7
ZGPAT	"dJ583P15.3, FLJ14972, GPATC6, GPATCH6, KIAA1847, MGC44880, ZC3H9, ZC3HDC9, ZIP"	ENSG00000197114	"Zinc finger CCCH-type and G-patch domain containing"	Q8N5A5	20	63707465-63736142	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 56.1"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA056705			Supported	"Nucleoplasm,Plasma membrane"				"Nucleoplasm, Plasma membrane"		"HPA056705: "	"unprognostic (4.50e-2)"	"unprognostic (2.74e-1)"	"unprognostic (5.30e-2)"	"unprognostic (4.42e-2)"	"unprognostic (8.58e-2)"	"prognostic favourable (6.17e-5)"	"unprognostic (1.06e-1)"	"unprognostic (6.97e-2)"	"unprognostic (2.52e-1)"	"unprognostic (1.54e-1)"	"unprognostic (9.31e-3)"	"unprognostic (1.60e-2)"	"unprognostic (3.43e-3)"	"unprognostic (1.37e-1)"	"unprognostic (4.11e-2)"	"unprognostic (1.24e-1)"	"unprognostic (9.86e-3)"	9.3	9.8	9.6	13.6	14.5	14.5	8.0	20.2	13.2	7.6	8.9	12.0	10.8	11.1	12.9	6.1	9.1	8.1	11.2	8.8	10.3	7.1	11.7	56.1	7.2	11.0	16.9	10.7	7.3	12.6	8.3	10.8	9.0	14.2	8.3	3.9	8.0	14.0	8.8	9.2	10.5	10.8	9.4	8.5	11.7	10.3	14.9	15.0	11.3	8.0	5.8	13.5	8.3	9.2	15.6	21.7	19.2	16.4	20.2	23.8	13.0	8.5	11.1	4.3	7.0	3.6	2.5	10.1	8.9	5.9	14.2	5.9	23.7	11.8	8.9	17.1	5.0	15.8	2.9	10.6	1.8	6.0	7.7	8.4	9.6	24.2	7.1	5.2	14.9	6.4	9.0	5.8	2.3	7.7	9.1	8.4	4.6	8.6	12.8	12.4	7.1	13.9	13.6	3.3	9.1	7.9	8.0	8.3	10.3	12.7	14.4	7.9	9.9	14.8	8.7	22.2	7.9	8.4	11.4	8.3	13.1	12.3	14.0	5.2	9.9	6.6	16.0	19.2	23.8	16.4	23.1	15.6	20.4	21.5	15.1	14.5	20.3	20.5	17.0	20.2	13.2	21.7	19.8	13.0	9.6	14.5	20.2	13.2	10.3	7.1	16.9	10.7	14.2	15.0
ZMYND10	"BLU, CILD22"	ENSG00000004838	"Zinc finger MYND-type containing 10"	O75800	3	50341110-50346852	"Disease related genes, Plasma proteins, Predicted intracellular proteins"			"Ciliopathy, Disease mutation, Kartagener syndrome, Primary ciliary dyskinesia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	8	"fallopian tube: 55.7;testis: 99.4"	"Cell line enhanced"	"Detected in many"		"T-47d: 10.4;U-87 MG: 7.3"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 12.6"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"NK-cell: 3.8"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA035255			Approved	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		"HPA035255: AB_10601928"	"unprognostic (2.93e-3)"	"unprognostic (2.98e-3)"	"unprognostic (1.15e-2)"	"unprognostic (3.85e-3)"	"unprognostic (4.44e-1)"	"unprognostic (7.78e-3)"	"unprognostic (4.71e-2)"	"unprognostic (6.13e-2)"	"unprognostic (1.15e-2)"	"unprognostic (1.33e-1)"	"unprognostic (3.12e-2)"	"unprognostic (6.73e-2)"	"prognostic favourable (6.75e-5)"	"unprognostic (8.25e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.18e-1)"	0.1	0.1	1.9	0.2	4.8	0.3	0.6	0.3	0.8	1.6	0.1	5.5	0.2	0.2	0.9	4.6	0.2	55.7	0.3	0.1	2.6	3.1	0.5	0.2	4.7	0.2	0.2	0.3	4.2	0.2	1.4	1.6	0.1	10.2	0.1	0.1	0.3	0.2	0.2	0.2	0.2	0.1	0.3	0.5	0.2	0.1	99.4	1.2	0.1	0.8	0.1	0.1	0.1	0.0	0.4	1.1	0.8	0.7	3.8	2.5	0.5	2.7	1.0	0.4	0.8	1.0	1.6	0.8	0.4	1.7	2.9	0.9	0.2	1.4	1.0	1.1	1.7	0.6	2.4	0.1	0.3	1.1	1.1	2.5	3.5	0.1	0.1	0.7	1.2	0.1	0.3	3.7	0.2	0.2	0.6	0.6	0.4	1.4	0.5	3.4	0.0	1.1	1.0	0.1	0.8	3.6	0.1	2.9	1.1	0.3	0.8	0.2	10.4	0.9	0.0	0.8	0.7	1.8	0.2	1.3	0.6	0.3	7.3	3.3	0.2	0.3	0.4	0.3	2.5	0.4	1.0	0.1	0.2	0.4	1.1	0.4	0.1	0.5	0.8	3.8	0.7	0.4	0.1	0.5	1.9	4.8	0.3	0.8	2.6	3.1	0.2	0.3	10.2	1.2
ZNF10	KOX1	ENSG00000256223	"Zinc finger protein 10"	P21506	12	133130575-133159465	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pituitary gland: 57.6"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			HPA003204	Uncertain		Approved	"Nucleoplasm,Vesicles,Plasma membrane"				"Vesicles, Plasma membrane"	Nucleoplasm	"HPA003204: AB_1080663"	"unprognostic (1.55e-2)"	"unprognostic (2.77e-3)"	"unprognostic (4.32e-2)"	"unprognostic (1.35e-1)"	"unprognostic (6.48e-2)"	"unprognostic (2.67e-3)"	"unprognostic (1.87e-1)"	"unprognostic (6.39e-3)"	"unprognostic (4.02e-3)"	"unprognostic (2.13e-1)"	"unprognostic (3.35e-3)"	"unprognostic (2.50e-2)"	"unprognostic (3.94e-2)"	"unprognostic (3.41e-1)"	"unprognostic (1.52e-1)"	"unprognostic (4.36e-2)"	"unprognostic (5.13e-3)"	4.8	12.7	5.7	4.9	11.5	6.3	10.5	13.0	9.9	9.3	7.9	7.8	14.4	3.0	12.7	20.7	5.1	10.2	9.9	6.7	5.0	5.6	7.3	7.6	6.4	4.4	8.5	6.4	18.2	10.3	22.6	57.6	4.2	8.3	12.2	5.4	8.8	6.2	16.4	5.1	7.2	5.6	12.3	8.8	5.0	8.2	12.1	7.9	6.8	17.3	5.1	5.6	8.1	7.2	4.4	4.4	1.8	0.7	8.6	8.8	2.4	3.1	2.0	9.9	0.0	11.1	4.7	6.0	4.0	3.6	5.0	3.4	3.6	2.2	0.0	5.6	4.0	1.6	6.3	3.3	3.7	0.0	5.8	7.3	9.3	3.7	3.3	4.4	2.5	4.9	3.1	5.4	6.0	4.0	5.2	0.0	5.9	1.1	10.6	9.4	10.2	4.1	8.8	6.3	4.9	3.9	7.2	10.0	6.3	8.0	1.1	3.3	6.2	4.3	3.9	3.7	3.4	3.4	3.3	0.2	0.0	11.6	1.1	1.6	3.3	1.1	0.6	1.8	4.0	0.7	4.5	4.2	4.6	5.5	1.7	4.4	8.8	4.4	0.7	8.6	0.5	4.4	1.2	2.4	5.7	11.5	13.0	9.9	5.0	5.6	8.5	6.4	8.3	7.9
ZNF18	"HDSG1, KOX11, Zfp535, ZKSCAN6, ZNF535, ZSCAN38"	ENSG00000154957	"Zinc finger protein 18"	P17022	17	11977439-11997510	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006144	Uncertain		Approved	"Nucleoplasm,Golgi apparatus,Plasma membrane,Cytosol"				"Nucleoplasm, Golgi apparatus"	"Plasma membrane, Cytosol"	"HPA006144: AB_1080683"	"unprognostic (2.99e-3)"	"prognostic favourable (6.32e-4)"	"unprognostic (2.32e-1)"	"unprognostic (2.50e-2)"	"unprognostic (4.91e-2)"	"unprognostic (2.72e-3)"	"unprognostic (2.28e-2)"	"unprognostic (5.93e-3)"	"unprognostic (1.25e-1)"	"unprognostic (2.93e-2)"	"prognostic favourable (5.12e-6)"	"unprognostic (2.28e-1)"	"prognostic unfavourable (3.06e-6)"	"unprognostic (1.52e-2)"	"unprognostic (9.31e-2)"	"unprognostic (3.34e-2)"	"unprognostic (3.53e-3)"	8.3	6.8	8.2	7.0	13.9	15.7	9.6	9.4	15.5	8.5	7.2	13.2	3.5	6.4	14.1	9.5	8.8	7.5	7.2	7.3	9.0	8.7	6.5	13.2	6.2	10.5	9.9	9.8	10.4	7.8	8.4	11.8	5.1	14.5	9.8	9.2	12.5	9.0	7.1	8.2	12.8	8.2	7.8	10.8	12.3	6.2	15.5	9.2	15.6	8.4	14.3	10.2	7.7	7.6	9.1	8.8	19.6	7.6	7.0	11.2	5.6	3.1	6.6	7.0	10.5	13.3	11.8	3.7	4.6	8.1	6.0	6.5	3.0	5.4	10.8	6.9	5.0	6.6	5.8	7.2	6.6	8.1	4.9	6.4	6.7	4.2	9.4	3.7	8.6	9.7	11.8	4.6	8.4	9.1	3.7	5.1	8.2	3.3	11.8	7.2	5.2	3.0	9.9	7.1	4.8	8.7	3.9	2.7	5.9	7.8	3.9	6.1	5.5	3.4	7.1	7.2	3.6	3.2	3.5	5.7	4.1	5.3	8.3	8.3	8.4	10.6	5.9	6.6	11.0	5.8	10.2	9.1	10.2	10.3	5.8	8.2	11.0	11.2	19.6	7.0	7.6	8.8	10.6	5.6	8.2	13.9	9.4	15.5	9.0	8.7	9.9	9.8	14.5	9.2
ZNF2	"A1-5, Zfp661, ZNF661"	ENSG00000275111	"Zinc finger protein 2"	Q9BSG1	2	95165432-95184317	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041358	Uncertain		Approved	"Nucleoplasm,Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"	Nucleoplasm	"HPA041358: AB_10795539"	"unprognostic (1.18e-1)"	"unprognostic (6.41e-3)"	"unprognostic (5.81e-2)"	"unprognostic (9.29e-2)"	"unprognostic (4.47e-2)"	"unprognostic (6.03e-2)"	"unprognostic (1.13e-3)"	"prognostic favourable (4.69e-5)"	"unprognostic (1.47e-2)"	"unprognostic (1.78e-1)"	"unprognostic (2.37e-2)"	"unprognostic (2.63e-2)"	"unprognostic (2.66e-3)"	"unprognostic (2.57e-2)"	"unprognostic (6.78e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.40e-2)"	5.1	4.1	5.2	3.2	6.3	0.7	4.0	6.4	6.1	5.3	2.6	6.4	2.5	3.3	5.4	5.7	3.5	4.8	2.3	4.6	5.1		4.2	2.7	3.5	4.3	5.3	5.0	6.5	2.8	6.5	7.1	3.1	5.2	4.8	2.5	4.9	3.7	5.5	4.2	4.7	2.2	4.1	6.1	4.3	3.5	4.3	5.9	4.3	5.0	4.5	5.0	4.3	4.0	7.2	5.0	15.1	6.2	4.2	8.6	4.5	5.3	5.2	6.4	10.7	9.5	7.5	4.2	6.0	7.9	8.2	10.9	5.6	3.7	3.4	4.3	5.7	4.5	6.8	4.5	8.7	7.5	5.9	7.9	4.2	6.9	7.8	4.1	5.2	6.4	6.4	7.5	11.7	7.1	5.3	2.8	8.5	4.9	5.8	5.7	2.8	7.2	5.6	11.1	4.4	4.7	3.2	5.4	7.4	5.6	8.1	6.8	5.0	6.2	5.8	10.0	5.8	7.9	5.0	4.9	4.3	4.2	6.7	5.4	7.6	5.9	4.4	15.1	8.6	6.2	6.2	7.2	7.0	7.5	5.0	6.9	8.5	8.6	3.6	4.2	4.7	4.1	7.6	4.5										
ZNF20	KOX13	ENSG00000132010	"Zinc finger protein 20"	P17024	19	12092843-12140407	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 18.5"	"Low lineage specificity"	"Detected in all"											HPA020887	Uncertain		Approved	"Nucleoplasm,Plasma membrane"				"Plasma membrane"	Nucleoplasm	"HPA020887: AB_2218842"	"unprognostic (1.77e-2)"	"unprognostic (1.06e-2)"	"unprognostic (1.69e-2)"	"unprognostic (1.20e-3)"	"unprognostic (4.00e-2)"	"unprognostic (1.08e-4)"	"unprognostic (1.69e-1)"	"unprognostic (2.14e-2)"	"unprognostic (1.57e-3)"	"unprognostic (1.04e-1)"	"unprognostic (4.40e-2)"	"unprognostic (7.01e-2)"	"unprognostic (9.23e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.50e-2)"	"unprognostic (1.15e-2)"	"unprognostic (1.21e-3)"	3.3	4.0	2.7	3.5	4.0	4.9	6.3	3.5	3.7	7.3	4.4	2.3	9.5	1.8	6.3	7.8	4.5	10.3	2.7	2.5	3.0	2.8	5.6	2.6	3.6	4.3	2.8	1.3	6.6	6.1	4.0	9.5	3.8	4.0	9.1	4.4	2.7	4.6	4.0	1.9	6.2	7.5	3.9	2.9	6.0	4.4	14.8	3.8	8.9	9.3	3.9	3.9	5.3	4.5	2.3	2.2	18.5	2.2	6.0	3.3	1.0	3.3	0.1	4.6	9.6	2.1	3.5	3.5	2.9	5.3	2.7	3.8	1.0	1.8	3.1	3.3	3.4	2.1	2.5	2.1	2.8	2.5	0.7	1.3	3.5	1.6	1.2	0.1	3.0	2.9	4.6	1.1	1.6	1.6	2.0	0.5	5.7	1.3	4.0	3.6	7.8	2.6	3.0	2.6	1.7	3.4	7.3	2.0	4.6	2.7	1.9	3.9	3.6	5.2	0.0	6.4	2.2	6.3	2.0	5.2	2.9	3.1	0.4	0.0	2.5	9.7	2.2	5.1	1.5	1.1	1.5	1.5	1.3	1.5	1.2	2.3	1.4	1.2	18.5	6.0	2.0	2.2	3.3	1.0	2.7	4.0	3.5	3.7	3.0	2.8	2.8	1.3	4.0	3.8
ZNF227		ENSG00000131115	"Zinc finger protein 227"	Q86WZ6	19	44207547-44237268	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA030573	Uncertain		Approved	"Plasma membrane"				"Plasma membrane"		"HPA030573: AB_10610702"	"unprognostic (3.01e-2)"	"unprognostic (1.79e-2)"	"unprognostic (7.14e-2)"	"unprognostic (2.77e-2)"	"unprognostic (4.74e-2)"	"unprognostic (1.66e-2)"	"unprognostic (8.05e-2)"	"unprognostic (7.89e-2)"	"unprognostic (1.52e-2)"	"unprognostic (1.08e-1)"	"unprognostic (5.68e-3)"	"unprognostic (1.94e-1)"	"unprognostic (4.88e-2)"	"unprognostic (1.27e-1)"	"unprognostic (2.21e-2)"	"unprognostic (9.91e-2)"	"prognostic favourable (2.64e-4)"	10.4	11.5	13.6	8.3	13.3	6.3	12.7	24.7	14.4	12.9	10.3	13.0	8.7	8.0	15.4	12.1	10.1	12.6	9.0	8.9	12.3	11.7	10.0	11.0	9.4	14.0	13.5	12.5	17.6	9.9	18.5	28.0	11.4	15.7	13.3	9.0	9.6	9.3	11.2	10.0	9.6	8.9	12.8	15.3	13.4	12.6	10.7	17.6	20.8	12.7	4.3	16.2	12.3	13.2	12.1	5.8	13.0	4.5	10.6	13.1	4.9	5.1	7.4	8.9	11.1	7.3	6.4	4.2	5.1	7.4	5.0	9.7	3.6	4.1	9.1	7.9	4.7	3.0	10.1	5.4	6.7	11.8	12.8	15.9	8.0	4.4	5.2	13.8	7.0	5.7	6.0	4.8	9.2	7.3	1.5	0.2	5.3	2.8	13.0	3.7	14.3	3.9	7.8	9.0	7.7	5.1	9.5	15.2	15.6	11.4	5.2	4.0	4.3	7.5	6.2	5.5	9.1	4.1	6.5	21.3	28.2	20.0	3.6	5.8	7.3	13.0	4.5	8.6	10.7	3.2	11.7	11.4	10.0	10.3	5.4	12.1	13.1	11.1	4.1	10.6	2.9	5.8	11.8	4.9	13.6	13.3	24.7	14.4	12.3	11.7	13.5	12.5	15.7	17.6
ZNF229		ENSG00000278318	"Zinc finger protein 229"	Q9UJW7	19	44417519-44448578	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"hTERT-HME1: 9.1"	"Low cancer specificity"	"Detected in many"							"Cell type enhanced"	"Detected in some"		"NK-cell: 4.8"	"Low lineage specificity"	"Detected in many"											HPA001494	Uncertain		Approved	"Vesicles,Plasma membrane"				Vesicles	"Plasma membrane"	"HPA001494: AB_1080692"	"unprognostic (2.59e-1)"	"unprognostic (7.41e-4)"	"unprognostic (2.13e-1)"	"unprognostic (1.08e-1)"	"unprognostic (3.90e-1)"	"unprognostic (2.17e-1)"	"unprognostic (3.34e-2)"	"unprognostic (7.18e-3)"	"unprognostic (1.17e-2)"	"unprognostic (4.66e-2)"	"unprognostic (4.18e-2)"	"unprognostic (5.04e-3)"	"prognostic favourable (8.43e-5)"	"unprognostic (3.66e-3)"	"unprognostic (2.01e-2)"	"unprognostic (2.18e-1)"	"unprognostic (4.34e-1)"	1.7	4.1	6.6	0.5	8.2	0.4	2.3	7.7	4.0	2.9	1.2	1.5	1.1	1.7	3.6	2.6	1.9	4.8	1.4	3.1	4.8		2.1	1.7	1.4	0.8	1.8	2.2	6.0	0.9	10.5	8.7	2.5	3.9	2.9	0.4	3.4	2.5	2.2	1.9	0.8	0.6	2.7	4.5	1.2	1.2	2.1	3.8	1.5	6.6	0.0	0.8	2.7	0.9	1.4	0.4	0.5	0.1	4.8	1.1	0.4	0.0	4.8	3.8	0.1	4.1	2.7	0.0	5.8	2.5	3.3	4.2	0.0	0.7	0.0	2.7	3.6	2.0	0.0	4.4	2.1	0.0	1.7	0.7	1.0	0.3	6.7	0.1	0.0	4.2	0.1	2.8	9.1	2.9	0.2	0.0	3.7	0.1	0.0	0.0	3.4	1.3	0.0	0.0	1.6	3.0	7.5	1.2	1.2	2.7	0.4	0.0	0.1	0.0	3.0	2.5	0.1	0.8	0.2	5.0	2.8	0.0	0.0	0.0	3.6	0.0	0.1	0.5	0.0	0.0	0.0	0.4	0.0	0.0	0.4	1.4	1.1	0.4	0.0	4.8	0.0	0.4	0.0	0.4										
ZNF276	"CENP-Z, CENPZ, MGC45417, ZADT, ZFP276, ZNF477"	ENSG00000158805	"Zinc finger protein 276"	Q8N554	16	89720400-89740903	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021309, HPA022255"	Uncertain		Approved	"Nucleoplasm,Nucleoli,Plasma membrane,Cytosol"				"Nucleoplasm, Cytosol"	"Nucleoli, Plasma membrane"	"HPA021309: AB_1859024, HPA022255: AB_1859025"	"unprognostic (1.45e-2)"	"unprognostic (7.05e-2)"	"unprognostic (1.17e-2)"	"unprognostic (8.25e-3)"	"unprognostic (1.17e-1)"	"unprognostic (2.95e-3)"	"unprognostic (1.27e-1)"	"unprognostic (3.70e-2)"	"unprognostic (1.92e-1)"	"unprognostic (7.85e-2)"	"unprognostic (1.59e-2)"	"unprognostic (1.36e-3)"	"prognostic unfavourable (3.37e-4)"	"unprognostic (2.65e-2)"	"unprognostic (4.14e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.62e-3)"	9.7	9.8	9.0	18.6	13.1	25.5	7.9	20.2	12.3	10.8	11.1	30.6	9.4	16.0	9.0	8.4	14.5	11.4	9.5	6.7	9.8	7.3	8.4	10.1	9.6	21.7	21.3	11.2	13.5	10.9	11.0	11.6	7.4	12.6	10.2	8.8	8.1	11.3	11.4	11.4	18.5	15.3	6.8	9.9	22.2	12.2	6.4	18.4	11.1	10.1	8.1	15.1	9.5	10.3	2.9	2.0	4.5	1.9	5.0	10.1	2.4	5.0	4.2	3.4	8.9	2.8	3.9	6.1	3.4	2.1	3.2	1.2	5.4	5.3	6.6	4.4	3.6	9.2	4.3	3.8	2.3	4.1	23.2	5.9	7.9	2.1	5.4	5.7	7.8	5.3	5.1	4.3	3.5	4.8	10.8	5.7	1.4	7.0	7.3	13.1	2.5	9.5	11.7	3.8	4.4	4.0	2.9	9.3	7.8	7.5	6.8	4.2	9.2	8.3	5.4	5.3	7.2	4.1	2.9	20.5	6.6	3.5	4.2	9.5	5.2	4.3	1.7	2.8	10.1	1.9	4.8	2.0	5.5	7.6	1.8	2.9	5.6	7.2	4.5	5.0	1.2	2.0	4.0	2.4	9.0	13.1	20.2	11.3	9.8	7.3	21.3	11.2	12.6	18.4
ZNF277	"NRIF4, ZNF277P"	ENSG00000198839	"Zinc finger protein 277"	Q9NRM2	7	112206588-112343096	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA027307	Uncertain		Approved	"Nucleoplasm,Plasma membrane"				Nucleoplasm	"Plasma membrane"	"HPA027307: AB_1859164"	"unprognostic (2.04e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.07e-1)"	"unprognostic (3.95e-2)"	"unprognostic (7.76e-2)"	"unprognostic (3.17e-2)"	"unprognostic (1.43e-1)"	"unprognostic (4.18e-2)"	"unprognostic (4.60e-2)"	"unprognostic (7.61e-2)"	"unprognostic (1.88e-2)"	"unprognostic (2.85e-1)"	"prognostic favourable (9.47e-4)"	"unprognostic (1.05e-1)"	"unprognostic (2.64e-2)"	"unprognostic (2.46e-1)"	"unprognostic (1.06e-1)"	15.2	14.8	11.2	12.9	16.2	10.9	20.1	9.3	13.8	13.6	13.9	8.4	8.8	13.7	14.7	8.8	18.4	12.6	14.3	14.4	11.8	9.1	22.7	30.0	19.2	14.3	11.3	11.9	15.4	23.5	13.5	16.4	8.1	11.6	17.1	14.2	5.5	14.9	12.9	12.7	17.7	13.4	15.9	16.1	13.7	14.6	10.2	14.1	23.9	22.4	11.1	15.6	26.6	13.6	13.3	10.4	9.5	14.3	12.4	17.2	9.1	5.8	6.1	8.2	10.2	13.6	37.8	6.4	5.8	12.7	4.8	10.4	5.6	9.3	13.2	11.5	6.2	4.9	5.1	10.0	11.5	7.0	7.9	5.3	6.0	12.5	13.3	10.3	7.8	21.8	18.0	9.3	12.3	16.8	9.4	14.1	9.1	9.5	14.3	19.9	4.9	6.3	8.0	9.7	13.7	14.3	6.8	6.3	12.6	7.1	13.6	14.0	5.5	11.0	10.4	6.7	4.1	17.6	5.5	10.3	8.4	13.1	5.7	10.1	7.6	7.1	11.6	9.5	11.2	14.3	15.9	13.3	15.2	17.2	10.4	11.2	16.3	13.5	9.3	12.4	11.6	10.1	17.0	9.1	11.2	16.2	9.3	13.8	11.8	9.1	11.3	11.9	11.6	14.1
ZNF337	dJ694B14.1	ENSG00000130684	"Zinc finger protein 337"	Q9Y3M9	20	25674215-25696841	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"											"HPA044303, HPA064219"	Approved		Approved	"Nuclear speckles,Plasma membrane"				"Plasma membrane"	"Nuclear speckles"	"HPA044303: , HPA064219: "	"unprognostic (2.14e-1)"	"unprognostic (2.19e-2)"	"unprognostic (1.65e-2)"	"unprognostic (1.80e-1)"	"unprognostic (1.30e-1)"	"unprognostic (5.81e-3)"	"unprognostic (4.54e-3)"	"unprognostic (6.99e-2)"	"unprognostic (2.34e-1)"	"unprognostic (1.34e-2)"	"unprognostic (3.15e-2)"	"unprognostic (9.36e-4)"	"prognostic unfavourable (2.87e-6)"	"unprognostic (1.29e-1)"	"unprognostic (1.54e-1)"	"unprognostic (3.93e-2)"	"unprognostic (8.82e-3)"	10.4	9.8	11.7	9.0	14.3	10.8	13.6	49.5	14.8	17.9	14.6	16.1	13.3	7.0	19.8	19.4	9.6	18.0	9.0	8.4	10.9	9.8	9.4	6.9	13.5	12.3	15.1	14.2	23.1	8.4	20.3	19.0	9.3	11.2	16.6	10.9	11.0	8.6	17.2	11.9	12.9	11.1	15.4	9.4	13.4	8.7	7.0	14.9	19.0	12.2	6.0	11.0	14.3	26.1	3.8	3.9	4.8	3.9	5.3	9.6	3.8	7.8	14.5	11.6	8.1	9.4	12.0	9.7	6.9	6.1	5.4	6.7	2.9	7.4	10.0	6.6	6.2	12.9	7.8	22.3	7.4	3.6	6.1	6.2	9.4	12.6	8.3	5.5	6.7	11.1	20.0	6.2	18.5	8.3	5.4	8.9	10.3	8.9	15.0	10.2	3.1	10.3	9.4	10.9	4.9	5.5	8.7	9.5	10.1	7.0	11.1	9.3	6.5	7.7	11.0	11.5	6.1	7.6	8.9	12.5	6.7	3.6	5.5	4.7	9.2	0.0	2.4	4.8	7.2	3.9	7.9	3.8	6.0	6.8	3.9	3.2	8.4	9.6	0.1	5.3	2.2	3.9	3.9	3.8	11.7	14.3	49.5	14.8	10.9	9.8	15.1	14.2	11.2	14.9
ZNF397	"MGC13250, ZNF47, ZSCAN15"	ENSG00000186812	"Zinc finger protein 397"	Q8NF99	18	35241030-35267133	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026087	Uncertain		Approved	"Nucleoli,Plasma membrane,Microtubules,Cytosol"				"Nucleoli, Plasma membrane, Cytosol"	Microtubules	"HPA026087: AB_1859243"	"unprognostic (1.97e-1)"	"unprognostic (2.82e-2)"	"unprognostic (2.12e-1)"	"unprognostic (3.09e-1)"	"unprognostic (6.35e-2)"	"unprognostic (1.15e-2)"	"unprognostic (1.74e-3)"	"unprognostic (1.45e-2)"	"unprognostic (1.48e-2)"	"unprognostic (3.28e-2)"	"prognostic favourable (9.44e-4)"	"unprognostic (2.46e-2)"	"unprognostic (2.17e-3)"	"unprognostic (3.83e-2)"	"unprognostic (4.44e-2)"	"unprognostic (1.06e-1)"	"unprognostic (2.09e-3)"	15.1	17.7	20.3	16.8	31.1	5.7	20.6	23.9	26.4	16.2	15.0	27.9	16.7	13.3	22.7	16.5	13.4	15.2	12.9	14.6	20.2	13.8	14.9	12.7	13.6	18.8	34.8	19.3	23.6	17.1	25.3	24.8	14.7	25.6	18.4	18.0	13.8	17.5	16.3	15.0	17.2	15.9	18.9	30.5	19.0	16.7	11.9	35.1	22.0	20.2	8.3	19.2	17.3	16.8	13.3	8.1	12.4	9.4	4.8	9.4	2.2	2.9	5.8	13.8	12.5	15.3	13.0	6.6	6.1	6.1	3.0	4.0	2.1	4.2	15.1	5.5	4.8	8.1	8.9	6.6	4.3	9.5	5.5	0.6	7.6	6.1	5.1	7.2	5.5	5.8	9.0	3.6	10.6	1.9	8.8	10.6	7.8	6.4	12.1	5.6	11.9	2.3	12.8	4.0	10.7	6.3	7.9	15.0	12.9	9.9	5.3	5.9	9.2	5.4	3.0	10.2	5.7	3.4	2.7	17.2	6.4	8.8	9.0	5.1	9.6	9.4	5.1	8.4	6.6	8.0	4.8	10.3	6.3	5.3	3.6	13.3	9.4	6.5	12.4	4.8	9.4	8.1	3.2	2.2	20.3	31.1	23.9	26.4	20.2	13.8	34.8	19.3	25.6	35.1
ZNF407	"FLJ13839, FLJ20307, KIAA1703"	ENSG00000215421	"Zinc finger protein 407"	Q9C0G0	18	74597870-75065671	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028255, HPA041673"	Uncertain		Approved	"Nucleoplasm,Plasma membrane"				"Nucleoplasm, Plasma membrane"		"HPA028255: AB_10603466, HPA041673: "	"unprognostic (3.96e-1)"	"unprognostic (1.95e-1)"	"unprognostic (2.48e-1)"	"unprognostic (8.62e-2)"	"unprognostic (4.61e-2)"	"unprognostic (2.09e-2)"	"unprognostic (1.76e-2)"	"unprognostic (4.31e-1)"	"unprognostic (1.19e-3)"	"unprognostic (4.04e-4)"	"unprognostic (3.47e-2)"	"unprognostic (2.22e-1)"	"prognostic favourable (9.79e-5)"	"unprognostic (8.87e-2)"	"unprognostic (3.07e-1)"	"unprognostic (1.24e-1)"	"unprognostic (3.11e-2)"	7.7	6.3	8.5	11.7	11.4	12.0	7.6	15.5	10.5	11.8	9.4	5.3	5.8	5.8	11.7	5.2	7.3	9.4	5.5	8.1	7.3	5.2	6.6	6.0	7.4	7.9	7.8	5.7	12.8	6.0	14.9	13.2	10.8	9.0	7.6	6.0	5.9	8.4	7.7	13.3	7.7	10.3	8.7	7.5	11.2	7.5	10.0	7.7	18.1	9.4	8.2	7.6	9.9	9.2	2.4	3.6	6.0	2.6	3.0	3.1	0.9	4.6	4.9	5.5	5.1	4.1	6.0	3.9	6.2	5.4	4.6	5.0	2.0	2.7	6.7	1.8	8.7	5.5	5.2	6.7	6.9	11.1	3.2	8.6	6.6	3.8	3.7	12.9	7.5	5.5	3.1	7.4	6.4	6.9	4.8	9.9	7.0	3.6	6.3	1.8	3.2	4.4	6.5	7.2	5.3	3.3	8.7	5.3	5.0	5.8	3.7	4.4	4.2	5.5	9.6	10.4	4.4	2.8	4.9	3.5	7.2	7.1	3.8	5.6	6.1	4.0	1.9	2.3	3.1	2.6	2.9	2.1	2.3	1.7	0.7	2.4	2.6	3.1	6.0	3.0	1.6	3.6	0.6	0.9	8.5	11.4	15.5	10.5	7.3	5.2	7.8	5.7	9.0	7.7
ZNF503	"FLJ45745, MGC2555, Nlz2"	ENSG00000165655	"Zinc finger protein 503"	Q96F45	10	75397830-75401906	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEK 293: 38.2;PC-3: 49.5;U-87 MG: 15.4"	"Cancer enhanced"	"Detected in all"		"ovarian cancer: 62.9"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"classical monocyte: 1.6;myeloid DC: 1.4"	"Group enriched"	"Detected in many"	16	"dendritic cells: 1.4;monocytes: 1.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA026848	Approved		Approved	"Nucleoplasm,Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"	Nucleoplasm	"HPA026848: AB_10610704"	"unprognostic (1.18e-1)"	"unprognostic (8.56e-2)"	"unprognostic (8.63e-3)"	"unprognostic (7.41e-2)"	"unprognostic (2.82e-1)"	"unprognostic (3.57e-2)"	"unprognostic (9.63e-2)"	"unprognostic (7.42e-2)"	"unprognostic (3.42e-2)"	"unprognostic (3.22e-1)"	"unprognostic (6.53e-2)"	"prognostic unfavourable (3.50e-4)"	"prognostic favourable (1.97e-4)"	"unprognostic (1.53e-1)"	"unprognostic (8.28e-2)"	"unprognostic (2.05e-1)"	"unprognostic (1.59e-1)"	9.4	23.1	2.3	6.2	7.2	2.2	14.1	0.8	4.7	47.8	10.2	3.0	20.8	9.0	28.1	15.1	27.8	14.1	15.3	5.8	3.4	3.0	22.1	5.7	16.5	2.6	4.8	1.5	38.1	19.4	4.0	3.0	4.8	7.5	21.3	2.5	18.5	6.4	50.7	2.9	3.2	6.6	10.1	8.0	7.6	9.4	7.3	2.9	0.5	7.7	8.5	3.7	14.4	25.0	0.0	1.4	0.0	1.6	0.0	0.0	0.1	1.7	1.6	0.3	2.1	3.6	2.4	0.5	1.5	0.9	0.6	0.5	2.4	6.8	0.0	4.5	1.5	3.1	0.2	1.6	0.4	0.0	38.2	0.0	4.1	7.9	2.9	1.9	4.3	6.5	1.6	1.2	0.7	0.1	0.0	0.0	0.8	0.8	0.0	6.0	0.0	49.5	0.0	1.9	0.0	0.9	1.3	1.4	1.7	2.8	0.2	8.2	0.3	1.3	1.2	5.0	5.6	10.3	4.2	0.0	0.0	0.0	15.4	8.8	3.9	0.0	1.6	0.0	0.0	0.4	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	2.3	7.2	0.8	3.6	3.4	3.0	4.8	1.5	7.5	2.9
ZNF510	KIAA0972	ENSG00000081386	"Zinc finger protein 510"	Q9Y2H8	9	96755865-96778129	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA049139	Uncertain		Approved	"Nucleoplasm,Plasma membrane"				"Nucleoplasm, Plasma membrane"		"HPA049139: "	"unprognostic (2.70e-2)"	"unprognostic (3.44e-1)"	"unprognostic (1.07e-1)"	"unprognostic (6.92e-2)"	"unprognostic (2.01e-2)"	"unprognostic (1.43e-2)"	"unprognostic (3.78e-1)"	"unprognostic (1.21e-2)"	"unprognostic (8.50e-3)"	"unprognostic (3.90e-2)"	"unprognostic (1.06e-1)"	"unprognostic (4.34e-2)"	"prognostic favourable (5.94e-4)"	"unprognostic (1.02e-2)"	"unprognostic (1.17e-1)"	"unprognostic (5.17e-2)"	"unprognostic (2.18e-2)"	9.1	9.2	10.9	6.5	15.7	5.7	12.7	23.0	13.9	14.4	8.8	6.3	11.6	4.6	11.5	8.1	7.9	10.7	6.5	7.4	11.5	10.3	8.9	8.5	8.4	11.4	8.6	12.3	14.9	10.7	13.5	19.8	6.9	10.1	12.6	9.3	5.2	7.5	11.2	9.2	6.2	6.8	11.3	9.2	10.1	6.8	8.2	9.1	14.9	11.2	4.3	13.3	13.9	10.7	5.9	1.3	3.8	2.9	6.4	7.7	2.1	5.0	5.2	11.4	8.5	9.7	9.1	5.9	5.7	11.4	9.6	8.5	4.8	3.8	6.6	3.0	6.0	11.1	3.3	5.3	8.6	10.7	5.4	9.4	9.6	2.4	5.8	3.6	6.2	7.9	7.2	8.2	10.3	9.2	9.5	6.5	9.4	4.6	10.4	4.7	8.1	5.2	6.8	18.6	3.2	5.0	4.9	11.8	9.5	11.1	5.2	5.6	3.8	6.8	8.1	6.2	5.9	6.9	6.6	11.3	11.9	4.9	3.5	2.5	6.2	2.3	1.2	3.8	3.8	1.9	7.7	3.6	5.0	3.0	1.0	5.9	5.7	5.2	0.4	6.4	2.9	1.3	7.1	2.1	10.9	15.7	23.0	13.9	11.5	10.3	8.6	12.3	10.1	9.1
ZNF571	HSPC059	ENSG00000180479	"Zinc finger protein 571"	Q7Z3V5	19	37554782-37594790	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"thyroid gland: 61.8"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"											HPA054762			Approved	"Nucleoplasm,Nucleoli,Plasma membrane"				"Nucleoplasm, Nucleoli"	"Plasma membrane"	"HPA054762: "	"unprognostic (1.16e-1)"	"unprognostic (3.01e-2)"	"unprognostic (3.92e-2)"	"unprognostic (1.19e-1)"	"unprognostic (5.21e-2)"	"unprognostic (1.88e-2)"	"unprognostic (1.19e-1)"	"unprognostic (9.03e-4)"	"unprognostic (5.77e-2)"	"unprognostic (9.82e-2)"	"unprognostic (1.22e-3)"	"unprognostic (3.90e-2)"	"unprognostic (2.14e-2)"	"unprognostic (8.93e-2)"	"unprognostic (2.62e-1)"	"unprognostic (4.89e-2)"	"unprognostic (2.71e-4)"	6.5	6.7	8.6	3.2	12.9	6.1	12.5	12.5	12.8	5.9	4.2	9.8	4.4	2.3	6.7	8.7	3.9	6.0	4.5	4.2	10.4	7.2	6.4	4.2	4.1	4.4	15.3	9.4	8.5	3.8	11.5	12.2	4.8	13.4	7.1	3.4	5.1	3.6	4.5	3.5	7.1	3.7	7.7	14.3	4.8	3.5	8.5	15.8	3.7	61.8	3.3	5.0	6.6	5.3	9.4	4.1	4.9	1.3	3.7	8.4	3.2	1.8	1.0	6.3	9.1	4.7	4.7	2.0	2.7	4.4	6.6	8.2	1.9	1.7	9.6	8.6	2.8	2.4	2.0	2.9	11.0	2.1	7.9	5.1	2.7	1.1	5.4	1.9	5.8	2.6	5.2	6.3	5.7	1.3	2.4	0.8	5.3	1.7	9.5	2.1	15.8	3.5	4.8	3.0	5.0	9.0	11.6	13.6	9.5	6.4	2.1	3.2	9.7	1.3	0.8	3.0	3.9	3.2	6.9	7.7	15.8	13.2	0.5	0.8	6.5	1.8	0.8	4.9	6.7	1.3	6.1	8.7	6.3	6.5	2.7	9.4	7.8	8.4	1.5	3.7	1.2	4.1	4.2	3.2	8.6	12.9	12.5	12.8	10.4	7.2	15.3	9.4	13.4	15.8
ZNF598	"FLJ00086, HEL2"	ENSG00000167962	"Zinc finger protein 598"		16	1997654-2009823	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041760, HPA041896"	Approved		Approved	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		"HPA041760: AB_10794787, HPA041896: AB_10796464"	"unprognostic (9.43e-2)"	"unprognostic (1.34e-2)"	"unprognostic (8.17e-2)"	"unprognostic (6.76e-3)"	"unprognostic (3.44e-1)"	"unprognostic (1.20e-1)"	"unprognostic (2.22e-2)"	"unprognostic (7.07e-3)"	"unprognostic (1.22e-1)"	"unprognostic (4.45e-2)"	"unprognostic (1.43e-1)"	"unprognostic (5.06e-2)"	"unprognostic (4.69e-2)"	"unprognostic (1.78e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.81e-2)"	"unprognostic (7.81e-2)"	8.4	6.1	4.1	9.1	9.4	14.3	13.9	10.6	9.5	8.3	7.7	8.8	4.7	9.9	8.7	4.0	10.0	7.1	4.8	5.6	5.2	4.1	5.9	12.2	7.8	9.1	4.2	7.1	9.8	24.8	6.5	12.9	8.1	6.4	8.9	3.2	6.8	15.6	7.3	12.9	15.3	9.9	9.5	2.9	11.8	12.4	10.1	6.1	10.0	7.7	10.6	12.5	6.8	7.6	1.8	3.2	0.6	0.9	1.2	1.7	0.5	9.9	12.8	3.3	7.9	3.0	4.1	9.5	7.4	3.8	4.9	3.9	13.9	6.0	9.9	9.3	4.8	11.7	5.4	9.2	1.3	14.1	30.8	7.7	13.6	7.6	13.5	12.3	8.8	4.5	12.6	7.8	15.1	5.3	17.3	15.5	2.5	17.1	11.7	19.1	9.6	15.6	26.7	6.5	23.1	2.4	3.6	15.8	12.9	7.5	9.3	12.0	6.5	20.6	8.6	10.5	12.5	9.0	13.9	17.4	15.4	13.0	4.5	11.8	9.6	0.6	0.6	0.2	1.2	0.7	1.7	1.1	1.2	0.9	0.7	1.8	1.1	1.6	0.4	1.2	0.9	3.2	0.3	0.5	4.1	9.4	10.6	9.5	5.2	4.1	4.2	7.1	6.4	6.1
ZNF599	FLJ30663	ENSG00000153896	"Zinc finger protein 599"	Q96NL3	19	34758076-34773229	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA014701	Uncertain		Approved	"Nucleoplasm,Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"	Nucleoplasm	"HPA014701: AB_1859371"	"unprognostic (3.52e-3)"	"unprognostic (1.42e-3)"	"unprognostic (1.99e-2)"	"unprognostic (9.35e-3)"	"unprognostic (9.20e-2)"	"unprognostic (5.16e-3)"	"unprognostic (3.95e-3)"	"unprognostic (1.72e-2)"	"unprognostic (1.70e-2)"	"unprognostic (7.35e-3)"	"unprognostic (1.77e-3)"	"unprognostic (5.03e-2)"	"unprognostic (4.42e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.00e-1)"	"unprognostic (2.71e-2)"	"unprognostic (8.12e-3)"	5.9	8.1	10.0	5.2	12.5	2.4	8.5	16.8	8.0	10.1	6.5	11.7	5.8	4.5	12.2	21.4	4.4	14.1	6.5	5.8	10.3	6.8	9.7	4.9	6.0	5.7	10.5	5.7	11.4	5.7	14.3	13.2	6.0	8.1	10.4	5.5	11.6	7.4	9.5	5.5	8.0	5.4	7.1	8.1	6.5	5.9	19.9	11.2	10.4	13.2	6.0	6.2	6.4	7.2	4.3	3.8	6.4	4.8	5.7	6.7	2.9	5.3	2.7	5.9	5.5	6.6	8.9	3.2	2.0	5.5	4.9	5.8	2.3	3.6	0.6	5.7	3.7	2.8	3.9	2.5	6.1	0.6	4.9	4.1	5.4	6.6	5.0	0.9	4.7	8.0	3.7	2.2	2.3	5.6	6.9	0.5	7.6	2.1	10.3	4.3	2.6	0.2	5.6	5.6	3.3	6.1	1.3	7.1	10.1	6.6	1.2	3.9	3.5	0.5	3.0	4.9	5.5	3.6	2.1	6.2	6.7	0.5	3.0	0.1	4.6	3.1	1.1	6.4	6.1	2.5	4.0	2.0	6.5	3.5	1.7	4.3	6.7	5.9	0.6	5.7	4.8	3.8	4.9	2.9	10.0	12.5	16.8	8.0	10.3	6.8	10.5	5.7	8.1	11.2
ZNF646	KIAA0296	ENSG00000167395	"Zinc finger protein 646"	O15015	16	31074422-31084196	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 19.8"	"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042364, HPA066468"	Uncertain		Approved	"Nucleoplasm,Plasma membrane,Cytosol"				"Nucleoplasm, Plasma membrane, Cytosol"		"HPA042364: AB_10794796, HPA066468: "	"unprognostic (1.61e-2)"	"unprognostic (2.18e-1)"	"unprognostic (8.08e-2)"	"unprognostic (1.18e-2)"	"unprognostic (4.66e-1)"	"unprognostic (6.20e-3)"	"prognostic unfavourable (1.28e-6)"	"unprognostic (3.23e-2)"	"unprognostic (4.21e-2)"	"unprognostic (6.96e-2)"	"unprognostic (1.16e-2)"	"unprognostic (9.83e-2)"	"unprognostic (2.07e-2)"	"unprognostic (2.65e-1)"	"unprognostic (1.93e-1)"	"unprognostic (1.07e-1)"	"unprognostic (2.16e-1)"	9.8	6.4	5.9	10.4	7.6	13.4	7.3	12.2	7.8	10.2	6.8	10.4	8.2	10.6	9.8	6.8	7.5	8.6	7.6	5.9	6.8	5.5	6.9	6.1	13.5	11.3	10.6	5.6	10.3	8.2	10.1	9.4	8.0	7.2	7.9	4.9	5.8	9.8	14.2	12.4	10.6	9.6	6.5	7.4	12.9	9.1	36.1	9.2	24.7	7.7	5.2	11.5	7.8	10.8	4.0	5.2	19.8	3.7	3.4	4.3	1.5	6.1	12.9	8.5	6.6	6.1	4.8	11.2	6.8	7.2	8.2	7.6	9.4	5.9	12.1	10.9	5.8	8.3	7.0	7.4	3.2	13.8	6.6	8.9	11.5	7.8	6.3	11.5	14.0	6.1	6.8	8.8	5.1	4.9	14.1	7.1	6.2	9.8	12.7	7.9	11.5	6.7	20.4	16.6	12.1	2.6	5.9	12.4	12.5	7.8	8.3	4.1	6.9	10.1	9.9	10.4	5.9	6.9	6.3	11.9	10.9	12.3	9.4	12.5	8.1	5.9	3.7	9.4	4.3	3.3	2.2	3.3	2.0	1.7	3.5	4.0	2.2	2.5	19.8	3.4	2.1	5.2	2.0	1.5	5.9	7.6	12.2	7.8	6.8	5.5	10.6	5.6	7.2	9.2
ZNF688		ENSG00000229809	"Zinc finger protein 688"	P0C7X2	16	30569346-30572734	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048922	Uncertain		Approved	"Nucleoplasm,Plasma membrane,Cell Junctions"				Nucleoplasm	"Plasma membrane, Cell Junctions"	"HPA048922: AB_2680557"	"prognostic favourable (5.90e-4)"	"prognostic favourable (7.74e-4)"	"unprognostic (1.68e-1)"	"prognostic favourable (4.58e-5)"	"unprognostic (1.37e-1)"	"unprognostic (1.76e-2)"	"unprognostic (4.01e-1)"	"prognostic favourable (3.24e-4)"	"unprognostic (1.11e-1)"	"unprognostic (3.26e-2)"	"prognostic favourable (6.61e-4)"	"unprognostic (7.75e-2)"	"unprognostic (5.14e-2)"	"unprognostic (7.08e-2)"	"unprognostic (2.48e-1)"	"unprognostic (4.12e-2)"	"unprognostic (4.03e-2)"	10.7	11.9	14.2	11.8	11.8	13.7	8.0	13.8	16.7	8.8	15.3	15.5	12.1	20.5	11.5	9.6	12.0	13.5	14.5	17.2	13.1	10.6	11.2	12.4	10.3	19.9	12.1	11.5	12.9	14.7	8.4	14.0	7.8	11.2	11.8	9.0	11.0	13.8	10.1	32.5	9.5	14.4	14.2	11.0	13.9	13.0	24.6	8.3	21.6	13.7	8.3	10.0	10.4	13.3	6.1	5.4	12.6	5.4	15.1	6.8	2.8	7.6	5.8	5.9	6.2	11.3	2.9	2.5	4.4	6.1	3.7	2.9	1.8	11.7	4.1	8.9	5.5	5.7	1.6	2.8	4.1	12.0	3.6	2.8	2.3	1.4	3.0	3.8	12.5	5.8	6.2	4.0	4.8	3.7	2.9	9.5	4.2	4.6	10.9	4.3	2.1	1.9	9.3	2.4	6.0	6.5	2.5	8.5	9.4	1.5	11.6	9.8	12.7	6.4	2.9	3.2	3.5	3.8	3.4	13.5	9.4	4.3	9.9	3.3	5.5	12.6	3.9	8.3	4.8	3.9	5.8	5.5	5.6	5.4	3.9	6.1	4.8	4.4	6.0	15.1	5.4	5.4	6.8	2.8	14.2	11.8	13.8	16.7	13.1	10.6	12.1	11.5	11.2	8.3
ZNF706	HSPC038	ENSG00000120963	"Zinc finger protein 706"	Q9Y5V0	8	101177878-101206193	"Predicted intracellular proteins"	"Translation regulation"	Repressor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042793			Approved	"Plasma membrane"				"Plasma membrane"		"HPA042793: AB_10795710"	"unprognostic (2.05e-2)"	"unprognostic (3.29e-2)"	"unprognostic (2.04e-1)"	"prognostic unfavourable (3.12e-5)"	"unprognostic (1.60e-1)"	"unprognostic (1.26e-1)"	"unprognostic (2.48e-3)"	"unprognostic (5.22e-2)"	"unprognostic (3.19e-2)"	"unprognostic (1.21e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.19e-1)"	"prognostic unfavourable (5.90e-11)"	"unprognostic (9.65e-2)"	"unprognostic (1.59e-1)"	"unprognostic (3.57e-1)"	"unprognostic (2.17e-2)"	28.0	24.6	38.4	34.5	40.8	26.3	39.4	35.5	39.0	21.8	35.9	34.5	21.5	37.1	23.0	38.5	42.4	20.5	29.9	27.8	37.0	25.4	23.4	34.6	34.1	45.5	32.8	40.0	23.9	82.3	26.9	28.9	30.1	29.3	21.6	36.1	20.9	29.4	21.2	31.6	53.6	50.4	25.7	32.6	30.1	34.5	31.1	32.1	21.2	25.1	33.6	39.4	23.9	28.7	63.6	85.4	32.4	73.1	19.3	46.4	38.1	41.8	24.1	42.3	13.4	15.2	17.6	27.1	17.5	22.6	18.1	19.5	17.2	25.9	25.4	30.6	20.8	23.0	24.2	23.6	21.0	18.8	21.0	25.4	14.9	33.0	20.1	18.9	24.8	15.3	37.1	17.1	37.4	30.8	27.5	49.7	16.0	29.5	39.6	52.3	12.8	59.8	16.7	14.1	52.0	24.0	21.7	28.1	12.6	12.2	20.4	75.0	21.3	20.1	20.4	10.0	20.5	26.3	18.1	42.2	40.5	40.8	26.9	41.8	46.0	32.4	45.9	24.9	23.7	71.9	24.3	63.6	33.1	30.1	42.3	49.0	37.5	35.8	6.2	19.3	73.1	85.4	46.4	38.1	38.4	40.8	35.5	39.0	37.0	25.4	32.8	40.0	29.3	32.1
ZNF717	"X17, ZNF838"	ENSG00000227124	"Zinc finger protein 717"		3	75709643-75785583	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"K-562: 37.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											HPA044549	Uncertain		Approved	"Nucleoplasm,Nuclear bodies,Plasma membrane"				"Nucleoplasm, Nuclear bodies"	"Plasma membrane"	"HPA044549: AB_10964630"	"unprognostic (2.49e-1)"	"unprognostic (4.44e-2)"	"unprognostic (1.52e-1)"	"unprognostic (2.49e-2)"	"unprognostic (2.61e-1)"	"unprognostic (1.00e-1)"	"unprognostic (2.18e-1)"	"unprognostic (3.80e-2)"	"unprognostic (3.20e-1)"	"unprognostic (2.16e-2)"	"unprognostic (2.36e-1)"	"unprognostic (1.45e-2)"	"unprognostic (3.60e-6)"	"unprognostic (3.88e-2)"	"unprognostic (2.08e-2)"	"unprognostic (1.00e-1)"	"unprognostic (1.36e-1)"	8.1	8.6	11.9	7.2	14.4	4.6	11.2	12.1	12.4	7.7	6.7	11.7	7.3	6.9	11.0	24.6	7.7	11.3	8.1	8.2	10.9	8.3	13.4	10.5	6.8	6.2	16.2	7.1	12.6	12.7	14.7	22.8	7.3	12.6	9.4	8.9	10.8	9.9	9.6	6.1	13.7	7.3	10.9	15.6	10.1	10.1	11.2	13.6	8.4	16.2	5.3	8.4	8.6	7.8	9.5	6.2	6.8	5.3	4.0	10.2	3.2	7.2	4.6	4.4	2.7	4.8	6.8	2.6	2.5	4.8	3.0	3.9	6.2	6.2	3.9	4.2	4.5	3.7	7.0	5.2	2.8	0.4	6.7	7.6	7.0	0.7	9.4	0.3	6.8	6.6	4.3	7.4	11.2	0.6	37.8	9.3	4.0	2.4	0.8	10.1	5.0	8.2	5.7	4.3	21.4	4.9	3.5	3.6	17.1	2.1	4.3	9.1	15.0	3.5	0.9	7.8	10.6	6.4	1.0	11.2	13.7	4.6	4.2	0.8	4.7	1.5	4.0	6.8	3.6	5.3	1.8	7.6	5.1	3.4	4.1	9.5	10.2	6.2	1.0	4.0	4.9	6.2	1.9	3.2	11.9	14.4	12.1	12.4	10.9	8.3	16.2	7.1	12.6	13.6
ZNF783	DKFZp667J212	ENSG00000204946	"Zinc finger family member 783"	Q6ZMS7	7	149262171-149297302	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"											HPA020375	Uncertain		Approved	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		"HPA020375: AB_1859453"	"unprognostic (3.17e-3)"	"unprognostic (2.54e-1)"	"unprognostic (8.40e-3)"	"unprognostic (1.16e-1)"	"unprognostic (6.13e-2)"	"unprognostic (1.08e-3)"	"unprognostic (4.28e-3)"	"unprognostic (1.05e-1)"	"unprognostic (4.24e-3)"	"unprognostic (1.12e-1)"	"unprognostic (1.02e-1)"	"unprognostic (3.29e-2)"	"prognostic unfavourable (2.24e-7)"	"unprognostic (2.49e-2)"	"unprognostic (6.05e-2)"	"unprognostic (1.61e-2)"	"prognostic favourable (4.11e-4)"	10.1	8.1	11.4	14.4	14.9	6.5	15.1	14.3	15.8	11.5	9.4	15.4	9.9	10.0	13.1	11.2	8.2	13.0	11.0	7.2	11.6	7.7	8.5	4.6	8.6	16.1	13.1	18.4	17.2	11.2	9.4	10.2	7.2	12.5	13.0	9.7	12.2	9.3	13.5	11.6	12.6	12.2	20.1	15.4	17.7	9.1	9.2	12.5	2.9	11.8	6.2	15.0	9.9	16.1	3.8	2.7	0.5	4.5	1.5	3.2	1.1	3.3	3.4	5.7	4.1	3.8	7.2	5.4	2.2	1.1	5.0	2.2	5.4	6.4	11.6	5.6	3.5	2.2	4.0	4.2	2.2	3.1	3.6	7.4	7.5	1.1	8.7	4.8	9.3	7.5	8.8	4.5	5.6	3.3	5.9	5.9	4.1	7.2	7.2	7.5	12.8	4.7	1.6	0.5	10.1	5.6	5.7	4.6	9.6	8.5	4.0	5.7	4.4	9.8	5.0	4.0	0.9	2.2	4.7	9.2	5.8	0.1	5.7	1.7	8.7	0.3	1.1	0.5	3.2	2.2	2.5	2.3	2.0	2.0	1.3	3.8	2.7	2.2	0.4	1.5	4.5	2.7	1.2	1.1	11.4	14.9	14.3	15.8	11.6	7.7	13.1	18.4	12.5	12.5
ZNF785	FLJ32130	ENSG00000197162	"Zinc finger protein 785"	A8K8V0	16	30573740-30585771	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											HPA030510			Approved	"Nucleoplasm,Plasma membrane"				"Nucleoplasm, Plasma membrane"		"HPA030510: "	"unprognostic (2.85e-2)"	"unprognostic (1.29e-1)"	"unprognostic (8.25e-2)"	"unprognostic (2.47e-1)"	"unprognostic (2.35e-1)"	"unprognostic (4.15e-2)"	"unprognostic (2.54e-4)"	"prognostic favourable (8.99e-4)"	"unprognostic (1.55e-1)"	"unprognostic (2.08e-1)"	"prognostic favourable (2.03e-5)"	"unprognostic (3.37e-2)"	"unprognostic (5.65e-2)"	"unprognostic (1.46e-1)"	"unprognostic (3.13e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.54e-2)"	5.9	8.7	15.8	7.9	13.6	4.8	8.3	26.8	16.6	10.9	7.7	14.7	8.7	14.2	12.4	9.8	6.9	10.2	8.3	6.2	12.6	7.6	7.8	6.1	6.5	8.7	15.7	12.2	14.7	9.1	11.9	12.7	6.1	11.8	10.8	8.2	10.8	10.5	9.5	9.2	12.6	10.7	7.5	9.5	9.5	12.4	3.9	19.2	8.8	9.9	4.3	8.8	10.4	9.6	5.1	5.4	4.9	5.1	3.3	3.5	1.0	4.9	0.4	4.8	6.4	6.0	6.8	1.5	4.3	3.9	4.5	3.4	6.6	7.9	5.1	5.1	4.1	7.0	0.1	2.8	2.6	3.4	1.3	6.2	13.7	1.5	4.4	0.5	10.7	4.4	6.1	3.0	2.8	4.7	5.8	6.4	4.1	8.5	6.1	5.8	2.8	2.8	16.2	5.5	2.5	4.2	5.1	13.3	9.4	3.5	4.4	2.6	5.6	5.3	7.0	1.8	4.8	4.0	0.3	0.9	2.6	2.1	5.7	3.8	7.2	4.7	2.6	1.0	2.3	1.6	2.5	5.1	2.8	1.9	1.9	3.1	3.5	2.7	4.9	3.3	5.1	5.4	3.3	1.0	15.8	13.6	26.8	16.6	12.6	7.6	15.7	12.2	11.8	19.2
ZNF79	pT7	ENSG00000196152	"Zinc finger protein 79"	Q15937	9	127424374-127445372	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA028977	Uncertain		Approved	"Nucleoplasm,Plasma membrane,Cytosol"				Cytosol	"Nucleoplasm, Plasma membrane"	"HPA028977: AB_10602359"	"unprognostic (4.56e-2)"	"unprognostic (3.59e-2)"	"unprognostic (1.15e-1)"	"prognostic favourable (6.83e-5)"	"unprognostic (2.84e-2)"	"unprognostic (2.45e-2)"	"unprognostic (2.11e-1)"	"prognostic favourable (5.96e-4)"	"unprognostic (3.41e-1)"	"unprognostic (1.13e-2)"	"prognostic favourable (5.42e-5)"	"unprognostic (4.53e-3)"	"prognostic favourable (6.04e-7)"	"unprognostic (6.09e-3)"	"unprognostic (5.01e-1)"	"unprognostic (5.23e-2)"	"unprognostic (1.32e-1)"	9.9	11.0	7.6	6.7	7.8	6.7	8.1	18.3	8.5	9.2	9.6	10.3	6.9	5.6	12.9	10.4	7.0	9.4	5.6	6.8	6.8	5.3	6.8	9.5	6.8	8.3	7.5	5.2	9.1	9.5	13.2	11.8	8.1	8.4	11.2	8.2	10.7	12.2	8.3	13.2	8.7	7.7	8.3	6.1	10.2	8.8	21.1	8.6	12.8	8.5	4.8	10.5	13.3	9.9	8.5	7.5	7.4	6.0	9.4	11.8	4.9	2.2	4.5	6.0	3.6	6.8	4.0	16.9	5.6	6.8	6.7	7.7	4.8	2.1	4.8	2.3	4.1	7.0	4.5	6.8	5.3	4.8	2.9	3.3	7.3	5.3	8.0	7.8	5.3	4.0	7.7	8.3	6.7	6.9	5.6	7.2	6.3	4.9	6.1	2.9	4.8	5.8	5.1	8.4	6.8	2.8	3.3	6.9	4.6	10.6	5.5	3.2	7.2	4.5	4.8	4.3	3.9	4.2	4.3	9.8	20.8	6.2	5.5	2.4	7.1	3.3	4.9	7.4	9.3	6.0	10.6	7.4	6.4	11.8	7.0	8.5	8.4	9.1	6.5	9.4	4.0	7.5	7.9	4.9	7.6	7.8	18.3	8.5	6.8	5.3	7.5	5.2	8.4	8.6
ZNF839	C14orf131	ENSG00000022976	"Zinc finger protein 839"	A8K0R7	14	102317377-102342702	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							HPA020434	Uncertain		Approved	"Nucleoplasm,Plasma membrane"				"Plasma membrane"	Nucleoplasm	"HPA020434: AB_10669862"	"unprognostic (7.83e-2)"	"unprognostic (1.96e-1)"	"unprognostic (2.28e-1)"	"unprognostic (8.81e-2)"	"unprognostic (1.49e-1)"	"unprognostic (2.33e-1)"	"unprognostic (6.73e-2)"	"unprognostic (5.69e-2)"	"unprognostic (1.85e-1)"	"unprognostic (7.10e-3)"	"prognostic favourable (4.57e-4)"	"unprognostic (2.40e-2)"	"prognostic favourable (5.00e-4)"	"unprognostic (1.32e-1)"	"unprognostic (2.17e-2)"	"unprognostic (1.08e-1)"	"unprognostic (8.21e-2)"	8.9	9.9	10.9	10.6	14.1	11.3	15.7	11.6	16.9	11.1	10.2	14.4	9.0	8.1	15.3	11.2	8.4	19.7	7.8	8.4	11.1	10.1	9.7	13.0	6.8	11.0	8.8	13.4	12.9	15.6	14.3	13.2	9.0	8.9	10.1	9.5	13.0	11.9	13.4	18.6	21.6	10.3	10.6	8.3	15.2	8.7	39.7	7.8	11.3	12.9	8.8	11.8	7.8	9.5	1.9	2.1	3.5	1.9	0.3	2.6	0.4	8.6	7.9	10.3	18.6	4.8	8.2	17.7	6.8	5.6	8.5	7.0	3.0	7.4	9.0	5.6	4.6	8.5	6.7	17.1	6.6	12.0	12.7	6.2	7.2	5.0	4.3	5.8	5.5	6.5	12.9	16.5	15.4	11.3	13.2	11.8	11.9	16.1	8.8	9.4	13.8	8.0	19.2	6.3	5.6	7.6	7.1	5.6	17.5	5.6	7.2	6.0	16.2	9.6	4.4	5.5	5.0	7.6	6.0	11.7	8.4	10.3	4.3	7.0	9.0	0.0	0.7	2.3	2.4	1.9	2.6	1.9	1.6	1.5	1.3	1.4	2.6	2.2	3.5	0.3	0.4	2.1	2.1	0.4	10.9	14.1	11.6	16.9	11.1	10.1	8.8	13.4	8.9	7.8
ZSCAN22	"HKR2, ZNF50"	ENSG00000182318	"Zinc finger and SCAN domain containing 22"	P10073	19	58327019-58342332	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HEK 293: 17.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA006471	Uncertain		Approved	"Plasma membrane,Actin filaments,Cytosol"				"Plasma membrane, Cytosol"	"Actin filaments"	"HPA006471: AB_2221026"	"unprognostic (5.55e-3)"	"unprognostic (2.24e-1)"	"unprognostic (6.56e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.93e-1)"	"unprognostic (3.82e-2)"	"unprognostic (2.47e-3)"	"unprognostic (1.52e-1)"	"unprognostic (2.91e-1)"	"unprognostic (1.15e-1)"	"unprognostic (2.15e-3)"	"unprognostic (5.00e-2)"	"unprognostic (7.59e-2)"	"unprognostic (2.59e-2)"	"unprognostic (1.74e-1)"	"unprognostic (5.22e-3)"	"unprognostic (1.07e-1)"	4.8	5.6	4.1	8.5	6.1	3.0	10.8	9.3	6.2	6.7	4.8	4.7	9.3	5.1	5.7	4.2	6.1	4.6	3.5	4.9	4.3	4.1	4.2	7.7	4.8	4.8	9.7	3.7	7.8	7.3	9.4	9.1	5.3	6.8	5.1	4.3	2.7	7.0	9.2	6.1	8.1	5.2	5.6	3.9	5.2	5.5	5.7	6.2	8.0	6.5	4.3	6.4	4.6	5.3	3.2	3.0	2.7	2.3	3.2	5.6	2.3	2.8	5.2	2.8	4.3	3.4	2.0	3.1	2.4	1.2	1.5	1.4	2.7	2.0	2.3	1.6	2.0	2.2	4.0	2.7	1.6	3.5	17.8	4.8	4.8	2.5	2.7	3.8	5.0	2.4	2.7	3.3	3.5	2.2	4.8	4.4	2.6	2.3	1.9	1.8	2.4	5.8	2.6	4.4	3.9	1.6	3.8	4.5	3.2	3.5	4.9	2.2	2.3	2.6	2.0	8.1	2.4	2.0	4.1	4.4	6.0	1.7	3.2	2.7	2.8	0.3	2.1	2.7	5.6	1.8	3.9	2.6	3.3	4.6	3.0	3.2	2.9	2.9	0.7	3.2	2.3	1.4	2.6	2.3	4.1	6.1	9.3	6.2	4.3	4.1	9.7	3.7	6.8	6.2
ZSCAN29	"FLJ35867, Zfp690, ZNF690"	ENSG00000140265	"Zinc finger and SCAN domain containing 29"	Q8IWY8	15	43358172-43371025	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"eosinophil: 6.9"	"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA007241, HPA011109"	Enhanced		Approved	"Nucleoplasm,Plasma membrane,Actin filaments"				Nucleoplasm	"Plasma membrane, Actin filaments"	"HPA007241: AB_10600420, HPA011109: AB_10611525"	"unprognostic (3.90e-2)"	"unprognostic (2.70e-1)"	"unprognostic (1.15e-1)"	"unprognostic (4.06e-2)"	"unprognostic (2.21e-2)"	"unprognostic (2.02e-2)"	"unprognostic (1.57e-1)"	"unprognostic (5.25e-1)"	"unprognostic (2.12e-2)"	"unprognostic (4.77e-3)"	"unprognostic (1.64e-1)"	"unprognostic (1.44e-3)"	"unprognostic (9.61e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.31e-1)"	"unprognostic (8.33e-2)"	"unprognostic (3.43e-2)"	8.3	8.9	13.5	14.2	14.2	6.6	9.4	15.9	15.2	11.0	9.8	12.1	9.3	11.8	12.6	12.5	11.0	9.6	11.9	7.2	14.7	8.0	8.1	10.3	9.2	13.2	19.1	12.0	10.7	15.4	12.5	13.9	13.0	15.4	9.7	10.5	7.9	11.2	9.5	13.6	7.7	13.0	9.0	13.3	11.9	11.8	20.9	15.0	16.8	11.1	9.4	13.7	11.0	12.5	2.1	1.0	6.9	1.0	2.3	1.9	0.6	7.4	8.2	19.4	11.9	6.8	7.2	10.5	5.9	9.2	10.5	11.0	12.7	5.4	7.3	9.9	7.2	22.2	14.2	7.2	9.5	19.0	7.8	16.2	12.3	9.9	7.6	11.0	14.2	6.3	12.8	7.1	10.1	5.3	15.0	9.0	8.4	4.7	10.5	9.1	9.7	6.3	16.5	10.8	9.0	6.1	9.1	13.9	15.0	9.1	15.0	6.9	10.5	17.2	5.9	12.4	9.8	9.3	10.6	17.4	23.9	14.2	7.2	10.9	9.3	1.1	0.7	6.9	1.2	1.0	1.0	2.1	1.2	0.8	1.0	1.6	0.6	1.7	1.8	2.3	0.8	0.9	1.9	0.6	13.5	14.2	15.9	15.2	14.7	8.0	19.1	12.0	15.4	15.0
ZSWIM1	"C20orf162, dJ337O18.5"	ENSG00000168612	"Zinc finger SWIM-type containing 1"	Q9BR11	20	45881227-45885266	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041147, HPA046751"	Uncertain		Approved	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		"HPA041147: , HPA046751: "	"unprognostic (6.27e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.87e-1)"	"unprognostic (1.51e-2)"	"unprognostic (1.69e-2)"	"unprognostic (1.95e-1)"	"prognostic unfavourable (5.47e-4)"	"unprognostic (9.06e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.02e-1)"	"prognostic favourable (1.77e-4)"	"unprognostic (1.78e-1)"	"unprognostic (2.77e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.78e-1)"	"unprognostic (4.64e-1)"	"unprognostic (4.29e-2)"	11.3	13.8	7.3	7.6	11.4	10.2	7.8	17.2	15.7	7.3	8.5	10.4	5.6	8.8	10.1	7.8	9.3	9.3	10.1	9.8	7.5	7.7	12.8	11.3	6.9	9.5	6.9	8.5	12.6	14.1	10.0	11.4	12.2	6.3	10.3	7.7	14.1	10.4	8.1	27.3	12.3	10.6	9.1	8.1	12.2	8.7	9.0	9.5	16.1	11.5	9.8	13.3	9.6	7.0	5.4	4.4	6.9	3.7	1.2	5.3	1.4	6.3	8.0	6.0	7.2	10.9	6.4	6.1	4.3	5.7	10.0	9.2	18.2	7.5	7.6	13.2	6.3	15.3	9.7	12.3	7.5	2.9	5.7	9.9	10.0	12.4	6.7	8.0	10.2	9.1	10.4	8.3	8.0	7.7	8.7	6.1	5.7	19.2	9.0	6.6	3.3	9.0	6.9	8.7	5.3	6.4	9.4	8.0	5.1	15.1	22.3	5.1	13.2	6.0	6.3	10.9	6.8	5.8	6.3	6.1	4.3	7.7	8.6	6.3	5.5	3.8	2.9	6.9	1.0	3.7	0.7	5.4	3.7	1.6	1.6	5.1	5.3	4.7	3.1	1.2	3.5	4.4	3.0	1.4	7.3	11.4	17.2	15.7	7.5	7.7	6.9	8.5	6.3	9.5
ZSWIM8	"4832404P21Rik, KIAA0913"	ENSG00000214655	"Zinc finger SWIM-type containing 8"	A7E2V4	10	73785582-73801797	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041244	Approved		Approved	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		"HPA041244: AB_10794269"	"unprognostic (8.83e-2)"	"unprognostic (2.86e-1)"	"unprognostic (2.89e-3)"	"unprognostic (1.44e-1)"	"unprognostic (4.00e-2)"	"prognostic favourable (5.61e-4)"	"unprognostic (3.11e-1)"	"unprognostic (1.64e-1)"	"unprognostic (2.97e-1)"	"unprognostic (1.69e-1)"	"unprognostic (2.24e-3)"	"unprognostic (1.31e-1)"	"unprognostic (1.52e-1)"	"unprognostic (2.41e-1)"	"unprognostic (1.98e-1)"	"unprognostic (2.49e-1)"	"unprognostic (2.52e-1)"	22.5	30.2	27.1	17.7	27.9	35.3	20.6	29.8	32.4	21.7	27.2	38.1	29.7	25.6	25.5	43.3	33.1	19.9	24.9	19.8	25.9	20.4	28.8	43.1	22.3	20.9	34.0	24.9	26.4	23.3	39.0	50.0	28.1	28.6	29.9	17.8	29.8	30.3	28.9	19.5	48.2	34.8	27.9	20.0	36.8	21.8	29.1	37.0	22.7	30.1	15.9	22.2	21.7	24.0	3.5	6.6	9.0	4.2	1.9	5.7	1.7	5.8	10.0	12.5	20.6	29.9	14.4	7.3	7.5	21.0	10.8	13.0	8.8	4.9	3.3	5.4	12.4	9.1	4.4	8.9	5.4	5.3	9.2	4.7	10.6	11.6	22.6	3.2	18.4	23.3	16.0	13.4	15.7	12.6	6.5	6.5	12.3	8.9	4.8	9.7	3.7	31.6	5.9	5.9	1.9	15.3	12.6	3.0	13.7	6.2	18.7	10.6	12.4	6.8	12.6	12.2	7.2	5.4	7.6	16.6	8.9	2.1	13.1	4.8	6.1	4.3	4.1	3.2	5.7	2.7	3.3	3.5	2.6	2.4	3.2	2.7	1.1	3.7	9.0	1.9	4.2	6.6	3.2	1.7	27.1	27.9	29.8	32.4	25.9	20.4	34.0	24.9	28.6	37.0